Citrus Sinensis ID: 037946

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-
Protein Sequence
LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTSQPLIKQSANKS
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHHHccccHHHHccccccccccccccccccEEEEEccccccHHHHHHccccccEEEEccccEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHHccccccccccEEEEEEcccEEEEEEEccccccHHHHHcccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccEEEHHHHHccccHHccccccccccEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEccccEEEEEEEcccccHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHccHHEEcccccccEEEEEEEEccccccHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccHHHHccccccccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHHcccccccccccccccccccccccc
Coil and Loop (DISEMBL)
LIAVILASVTIALLASWILVTRNHRYKvekasgmstlppgaedfsypwtfipfqklnFTIDNILECLkdenvigkgcsgvvykaempngelIAVKKLWktkrdeepvdSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQgnrnldweTRYKIAVGSAQGLAylhhdcvpailhrdvkcnnilldsKYEAYLADFGLAKLMNSTNYHHAMSRvagsygyiapgkckLQIIYGYTmniteksdvySYGVVLLEILSgrsavqpqigdgLHIVEWVKKkmgsfepavsildtklqglpDQMVQEMLQTLGIAMFcvnsspaerptMKEVVALLMEVKsapeelgktsqplikqsanks
Flexible Loop (DISEMBL)
LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGvvykaempngeLIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKsapeelgktsqplikqsanks
Low Complexity Region (SEG)
LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISngnlqqllqgnrnlDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTSQPLIKQSANKS
Disordered region (IsUnstruct)
*IAVILASVTIALLASWILVTRNHRYKVEKASG**TLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN************VAL**************************
Disordered Region (DISOPRED)
LIAVILASVTIALLASWILVTRNH*************************FIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKK*W*************AEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL**************************
Disordered Region (DISEMBL)
LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTSQPLIKQSANKS
Disordered Region (DISPRO)
LIAVILASVTIALLASWILVTRNHR**********************WTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI*DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV**********************
Transmembrane Helix (TMHMM)
iHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTSQPLIKQSANKS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	371	2.2.26 [Sep-21-2011]
C0LGF5	1072	Probable LRR receptor-lik	yes	no	0.970	0.335	0.802	1e-173
C0LGV1	1135	LRR receptor-like serine/	no	no	0.803	0.262	0.542	1e-100
Q9LHP4	1141	Receptor-like protein kin	no	no	0.838	0.272	0.524	1e-100
O49545	1003	Leucine-rich repeat recep	no	no	0.832	0.308	0.490	2e-87
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.795	0.294	0.491	3e-84
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.811	0.289	0.467	1e-83
O65440	992	Leucine-rich repeat recep	no	no	0.789	0.295	0.504	3e-80
Q9SYQ8	980	Receptor protein kinase C	no	no	0.776	0.293	0.496	4e-80
C0LGR3	1091	Probable LRR receptor-lik	no	no	0.787	0.267	0.469	4e-79
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.778	0.262	0.490	7e-79

>sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2

 Score =  608 bits (1569), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 301/375 (80%), Positives = 329/375 (87%), Gaps = 15/375 (4%)

Query: 1    LIAVILASVTIALLASWILVTRN-HRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFT 59
            L AVILAS+TIA+LA+W+L+ RN H YK  + S  S     AEDFSYPWTFIPFQKL  T
Sbjct: 707  LTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPST--AEDFSYPWTFIPFQKLGIT 764

Query: 60   IDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD----EEPVDSFAAEIQ 115
            ++NI+  L DENVIGKGCSG+VYKAE+PNG+++AVKKLWKTK +    E  +DSFAAEIQ
Sbjct: 765  VNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTKDNNEEGESTIDSFAAEIQ 824

Query: 116  ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQG 175
            ILG+IRHRNIVKLLGYCSNKSVKLLLYNY  NGNLQQLLQGNRNLDWETRYKIA+G+AQG
Sbjct: 825  ILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGNRNLDWETRYKIAIGAAQG 884

Query: 176  LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM-NSTNYHHAMSRVAGSYGY 234
            LAYLHHDCVPAILHRDVKCNNILLDSKYEA LADFGLAKLM NS NYH+AMSRVAGSYGY
Sbjct: 885  LAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMNSPNYHNAMSRVAGSYGY 944

Query: 235  IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
            IAP        YGYTMNITEKSDVYSYGVVLLEILSGRSAV+PQIGDGLHIVEWVKKKMG
Sbjct: 945  IAPE-------YGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGDGLHIVEWVKKKMG 997

Query: 295  SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
            +FEPA+S+LD KLQGLPDQ+VQEMLQTLGIAMFCVN SP ERPTMKEVV LLMEVK +PE
Sbjct: 998  TFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKEVVTLLMEVKCSPE 1057

Query: 355  ELGKTSQPLIKQSAN 369
            E GKTSQPLIK S++
Sbjct: 1058 EWGKTSQPLIKPSSS 1072

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  365 bits (938), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 174/321 (54%), Positives = 231/321 (71%), Gaps = 23/321 (7%)

Query: 46   YPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLW------- 98
            + W F PFQKLNFT++++L+CL + NVIGKGCSG+VYKAEMPN E+IAVKKLW       
Sbjct: 764  WTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNL 823

Query: 99   -KTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQ-- 155
             +  +     DSF+AE++ LG IRH+NIV+ LG C NK+ +LL+Y+Y+SNG+L  LL   
Sbjct: 824  NEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHER 883

Query: 156  -GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
             G  +L WE RYKI +G+AQGLAYLHHDCVP I+HRD+K NNIL+   +E Y+ DFGLAK
Sbjct: 884  SGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAK 943

Query: 215  LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA 274
            L++  ++  + + +AGSYGYIAP        YGY+M ITEKSDVYSYGVV+LE+L+G+  
Sbjct: 944  LVDDGDFARSSNTIAGSYGYIAPE-------YGYSMKITEKSDVYSYGVVVLEVLTGKQP 996

Query: 275  VQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPA 334
            + P I DGLHIV+WVKK        + ++D  LQ  P+  V+EM+QTLG+A+ C+N  P 
Sbjct: 997  IDPTIPDGLHIVDWVKKIRD-----IQVIDQGLQARPESEVEEMMQTLGVALLCINPIPE 1051

Query: 335  ERPTMKEVVALLMEVKSAPEE 355
            +RPTMK+V A+L E+    EE
Sbjct: 1052 DRPTMKDVAAMLSEICQEREE 1072

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  364 bits (934), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 174/332 (52%), Positives = 237/332 (71%), Gaps = 21/332 (6%)

Query: 45   SYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKT---- 100
            +Y W F PFQKLNF++D I+ CL + NVIGKGCSGVVY+A++ NGE+IAVKKLW      
Sbjct: 764  TYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNG 823

Query: 101  ---KRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGN 157
               ++ +   DSF+AE++ LG IRH+NIV+ LG C N++ +LL+Y+Y+ NG+L  LL   
Sbjct: 824  GHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER 883

Query: 158  R--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL 215
            R  +LDW+ RY+I +G+AQGLAYLHHDC+P I+HRD+K NNIL+   +E Y+ADFGLAKL
Sbjct: 884  RGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKL 943

Query: 216  MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV 275
            ++  +     + VAGSYGYIAP        YGY+M ITEKSDVYSYGVV+LE+L+G+  +
Sbjct: 944  VDEGDIGRCSNTVAGSYGYIAPE-------YGYSMKITEKSDVYSYGVVVLEVLTGKQPI 996

Query: 276  QPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
             P + +G+H+V+WV++  GS E    +LD+ L+   +    EM+Q LG A+ CVNSSP E
Sbjct: 997  DPTVPEGIHLVDWVRQNRGSLE----VLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDE 1052

Query: 336  RPTMKEVVALLMEVKSAPEELGKTSQPLIKQS 367
            RPTMK+V A+L E+K   EE  K    L+K+S
Sbjct: 1053 RPTMKDVAAMLKEIKQEREEYAKVDL-LLKKS 1083

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  322 bits (826), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 160/326 (49%), Positives = 218/326 (66%), Gaps = 17/326 (5%)

Query: 45  SYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE 104
           S  W    FQ+L+FT D++L+ LK++N+IGKG +G+VYK  MPNG+L+AVK+L    R  
Sbjct: 672 SRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGS 731

Query: 105 EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDW 162
                F AEIQ LG IRHR+IV+LLG+CSN    LL+Y Y+ NG+L ++L G +  +L W
Sbjct: 732 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 791

Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
           +TRYKIA+ +A+GL YLHHDC P I+HRDVK NNILLDS +EA++ADFGLAK +  +   
Sbjct: 792 DTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTS 851

Query: 223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG 282
             MS +AGSYGYIAP        Y YT+ + EKSDVYS+GVVLLE+++GR  V  + GDG
Sbjct: 852 ECMSAIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELVTGRKPVG-EFGDG 903

Query: 283 LHIVEWVKKKMGSFEPAV-SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE 341
           + IV+WV+K   S + +V  +LD +L  +P   + E+     +AM CV     ERPTM+E
Sbjct: 904 VDIVQWVRKMTDSNKDSVLKVLDPRLSSIP---IHEVTHVFYVAMLCVEEQAVERPTMRE 960

Query: 342 VVALLMEVKSAPEELGKTSQPLIKQS 367
           VV +L E+   P       QP+ + +
Sbjct: 961 VVQILTEIPKLPP---SKDQPMTESA 983

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  312 bits (799), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 152/309 (49%), Positives = 207/309 (66%), Gaps = 14/309 (4%)

Query: 48  WTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV 107
           W    FQ+L+FT D++L+ LK++N+IGKG +G+VYK  MP G+L+AVK+L          
Sbjct: 671 WRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHD 730

Query: 108 DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETR 165
             F AEIQ LG IRHR+IV+LLG+CSN    LL+Y Y+ NG+L ++L G +  +L W TR
Sbjct: 731 HGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTR 790

Query: 166 YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
           YKIA+ +A+GL YLHHDC P I+HRDVK NNILLDS +EA++ADFGLAK +  +     M
Sbjct: 791 YKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECM 850

Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           S +AGSYGYIAP        Y YT+ + EKSDVYS+GVVLLE+++G+  V  + GDG+ I
Sbjct: 851 SAIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELITGKKPVG-EFGDGVDI 902

Query: 286 VEWVKKKMGSFEPAV-SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
           V+WV+    S +  V  ++D +L  +P   V E+     +A+ CV     ERPTM+EVV 
Sbjct: 903 VQWVRSMTDSNKDCVLKVIDLRLSSVP---VHEVTHVFYVALLCVEEQAVERPTMREVVQ 959

Query: 345 LLMEVKSAP 353
           +L E+   P
Sbjct: 960 ILTEIPKIP 968

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  310 bits (793), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 150/321 (46%), Positives = 215/321 (66%), Gaps = 20/321 (6%)

Query: 47   PWTFIPFQKLNFTIDNILECL-KDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE 105
            PW    FQ+LNFT D+++ECL K +N++G G +G VYKAEMPNGE+IAVKKLW   ++  
Sbjct: 698  PWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENG 757

Query: 106  PV----DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNL- 160
             +        AE+ +LG++RHRNIV+LLG C+N+   +LLY Y+ NG+L  LL G     
Sbjct: 758  KIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTM 817

Query: 161  ----DWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM 216
                +W   Y+IA+G AQG+ YLHHDC P I+HRD+K +NILLD+ +EA +ADFG+AKL+
Sbjct: 818  TAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI 877

Query: 217  NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
             +     +MS VAGSYGYIAP        Y YT+ + +KSD+YSYGV+LLEI++G+ +V+
Sbjct: 878  QT---DESMSVVAGSYGYIAPE-------YAYTLQVDKKSDIYSYGVILLEIITGKRSVE 927

Query: 277  PQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER 336
            P+ G+G  IV+WV+ K+ + E    +LD  +      + +EM Q L IA+ C + SP +R
Sbjct: 928  PEFGEGNSIVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDR 987

Query: 337  PTMKEVVALLMEVKSAPEELG 357
            P M++V+ +L E K   + +G
Sbjct: 988  PPMRDVLLILQEAKPKRKTVG 1008

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3

 Score =  299 bits (765), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 155/307 (50%), Positives = 203/307 (66%), Gaps = 14/307 (4%)

Query: 48  WTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV 107
           W  I FQKL F  ++ILEC+K+ +VIGKG  G+VYK  MPNGE +AVKKL    +     
Sbjct: 691 WKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHD 750

Query: 108 DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN--LDWETR 165
           +  AAEIQ LG IRHRNIV+LL +CSNK V LL+Y Y+ NG+L ++L G     L WETR
Sbjct: 751 NGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETR 810

Query: 166 YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN-YHHA 224
            +IA+ +A+GL YLHHDC P I+HRDVK NNILL  ++EA++ADFGLAK M   N     
Sbjct: 811 LQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASEC 870

Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH 284
           MS +AGSYGYIAP        Y YT+ I EKSDVYS+GVVLLE+++GR  V     +G+ 
Sbjct: 871 MSSIAGSYGYIAPE-------YAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGID 923

Query: 285 IVEWVKKKMG-SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           IV+W K +   + +  V I+D +L  +P   + E ++   +AM CV     ERPTM+EVV
Sbjct: 924 IVQWSKIQTNCNRQGVVKIIDQRLSNIP---LAEAMELFFVAMLCVQEHSVERPTMREVV 980

Query: 344 ALLMEVK 350
            ++ + K
Sbjct: 981 QMISQAK 987

Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3

 Score =  298 bits (763), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 155/312 (49%), Positives = 208/312 (66%), Gaps = 24/312 (7%)

Query: 45  SYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKL--WKTKR 102
           S  W    FQKL+F  +++LECLK+EN+IGKG +G+VY+  MPN   +A+K+L    T R
Sbjct: 670 SLAWKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGR 729

Query: 103 DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NL 160
            +     F AEIQ LG IRHR+IV+LLGY +NK   LLLY Y+ NG+L +LL G++  +L
Sbjct: 730 SDH---GFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHL 786

Query: 161 DWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN 220
            WETR+++AV +A+GL YLHHDC P ILHRDVK NNILLDS +EA++ADFGLAK +    
Sbjct: 787 QWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGA 846

Query: 221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG 280
               MS +AGSYGYIAP        Y YT+ + EKSDVYS+GVVLLE+++G+  V  + G
Sbjct: 847 ASECMSSIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVG-EFG 898

Query: 281 DGLHIVEWVKKKMGSF-EPA-----VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPA 334
           +G+ IV WV+       +P+     V+I+D +L G P   +  ++    IAM CV    A
Sbjct: 899 EGVDIVRWVRNTEEEITQPSDAAIVVAIVDPRLTGYP---LTSVIHVFKIAMMCVEEEAA 955

Query: 335 ERPTMKEVVALL 346
            RPTM+EVV +L
Sbjct: 956 ARPTMREVVHML 967

Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1

 Score =  295 bits (755), Expect = 4e-79,   Method: Compositional matrix adjust.
 Identities = 147/313 (46%), Positives = 206/313 (65%), Gaps = 21/313 (6%)

Query: 48   WTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV 107
            W    +QKL+F+ID+I++ L   NVIG G SGVVY+  +P+GE +AVKK+W     +E  
Sbjct: 741  WEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAVKKMWS----KEES 796

Query: 108  DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN---LDWET 164
             +F +EI+ LG IRHRNIV+LLG+CSN+++KLL Y+Y+ NG+L   L G      +DWE 
Sbjct: 797  GAFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGCVDWEA 856

Query: 165  RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS-----T 219
            RY + +G A  LAYLHHDC+P I+H DVK  N+LL   +E YLADFGLA+ ++       
Sbjct: 857  RYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGI 916

Query: 220  NYHHAMSR--VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +     +R  +AGSYGY+AP    +Q        ITEKSDVYSYGVVLLE+L+G+  + P
Sbjct: 917  DLAKPTNRPPMAGSYGYMAPEHASMQ-------RITEKSDVYSYGVVLLEVLTGKHPLDP 969

Query: 278  QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP 337
             +  G H+V+WV+  +   +    +LD +L G  D ++ EMLQTL +A  CV++   ERP
Sbjct: 970  DLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGRTDSIMHEMLQTLAVAFLCVSNKANERP 1029

Query: 338  TMKEVVALLMEVK 350
             MK+VVA+L E++
Sbjct: 1030 LMKDVVAMLTEIR 1042

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  294 bits (753), Expect = 7e-79,   Method: Compositional matrix adjust.
 Identities = 149/304 (49%), Positives = 207/304 (68%), Gaps = 15/304 (4%)

Query: 53   FQKLNFTIDNILECLK---DENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDS 109
            F K  FT   +++  +   ++ V+G+G  G VYKAEM  GE+IAVKKL          +S
Sbjct: 782  FPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNS 841

Query: 110  FAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL-QQLLQGNRN--LDWETRY 166
            F AEI  LG IRHRNIVKL G+C +++  LLLY Y+S G+L +QL +G +N  LDW  RY
Sbjct: 842  FRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARY 901

Query: 167  KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
            +IA+G+A+GL YLHHDC P I+HRD+K NNILLD +++A++ DFGLAKL++  +Y  +MS
Sbjct: 902  RIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLID-LSYSKSMS 960

Query: 227  RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
             VAGSYGYIAP        Y YTM +TEK D+YS+GVVLLE+++G+  VQP +  G  +V
Sbjct: 961  AVAGSYGYIAPE-------YAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLV 1012

Query: 287  EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             WV++ + +  P + + D +L     + V EM   L IA+FC ++SPA RPTM+EVVA++
Sbjct: 1013 NWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072

Query: 347  MEVK 350
             E +
Sbjct: 1073 TEAR 1076

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	371
223452532	979	leucine-rich repeat transmembrane protei	0.981	0.371	0.854	0.0
356534025	1081	PREDICTED: probable LRR receptor-like se	0.981	0.336	0.854	0.0
356574561	1079	PREDICTED: probable LRR receptor-like se	0.978	0.336	0.854	0.0
359495205	1060	PREDICTED: probable LRR receptor-like se	0.981	0.343	0.870	0.0
255572297	1075	Leucine-rich repeat receptor protein kin	0.967	0.333	0.873	0.0
449494185	1136	PREDICTED: probable LRR receptor-like se	0.981	0.320	0.843	0.0
449446494	1066	PREDICTED: probable LRR receptor-like se	0.981	0.341	0.843	0.0
444737617	1078	Putative Receptor-like protein kinase 2	0.959	0.330	0.795	1e-174
224589412	1053	leucine-rich repeat receptor-like protei	0.970	0.341	0.802	1e-172
334183022	1072	leucine-rich receptor-like protein kinas	0.970	0.335	0.802	1e-171

>gi|223452532|gb|ACM89593.1| leucine-rich repeat transmembrane protein kinase [Glycine max]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/371 (85%), Positives = 342/371 (92%), Gaps = 7/371 (1%)

Query: 1   LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
           L+ VILASVTI L++SWILVTRNH Y+VEK  G ST   GAEDFSYPWTFIPFQK+NF+I
Sbjct: 616 LVTVILASVTIILISSWILVTRNHGYRVEKTLGASTSTSGAEDFSYPWTFIPFQKINFSI 675

Query: 61  DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           DNIL+CL+DENVIGKGCSGVVYKAEMPNGELIAVKKLWK  + +E VDSFAAEIQILG+I
Sbjct: 676 DNILDCLRDENVIGKGCSGVVYKAEMPNGELIAVKKLWKASKADEAVDSFAAEIQILGYI 735

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
           RHRNIV+ +GYCSN+S+ LLLYNYI NGNL+QLLQGNRNLDWETRYKIAVGSAQGLAYLH
Sbjct: 736 RHRNIVRFIGYCSNRSINLLLYNYIPNGNLRQLLQGNRNLDWETRYKIAVGSAQGLAYLH 795

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
           HDCVPAILHRDVKCNNILLDSK+EAYLADFGLAKLM+S NYHHAMSRVAGSYGYIAP   
Sbjct: 796 HDCVPAILHRDVKCNNILLDSKFEAYLADFGLAKLMHSPNYHHAMSRVAGSYGYIAPE-- 853

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                YGY+MNITEKSDVYSYGVVLLEILSGRSAV+  +GDG HIVEWVK+KMGSFEPAV
Sbjct: 854 -----YGYSMNITEKSDVYSYGVVLLEILSGRSAVESHVGDGQHIVEWVKRKMGSFEPAV 908

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
           SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS PEE+GKTS
Sbjct: 909 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSQPEEMGKTS 968

Query: 361 QPLIKQSANKS 371
           QPLIKQS+N+S
Sbjct: 969 QPLIKQSSNQS 979

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356534025|ref|XP_003535558.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g34110-like [Glycine max]

 Score =  669 bits (1725), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/371 (85%), Positives = 342/371 (92%), Gaps = 7/371 (1%)

Query: 1    LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
            L+ VILASVTI L++SWILVTRNH Y+VEK  G ST   GAEDFSYPWTFIPFQK+NF+I
Sbjct: 718  LVTVILASVTIILISSWILVTRNHGYRVEKTLGASTSTSGAEDFSYPWTFIPFQKINFSI 777

Query: 61   DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
            DNIL+CL+DENVIGKGCSGVVYKAEMPNGELIAVKKLWK  + +E VDSFAAEIQILG+I
Sbjct: 778  DNILDCLRDENVIGKGCSGVVYKAEMPNGELIAVKKLWKASKADEAVDSFAAEIQILGYI 837

Query: 121  RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
            RHRNIV+ +GYCSN+S+ LLLYNYI NGNL+QLLQGNRNLDWETRYKIAVGSAQGLAYLH
Sbjct: 838  RHRNIVRFIGYCSNRSINLLLYNYIPNGNLRQLLQGNRNLDWETRYKIAVGSAQGLAYLH 897

Query: 181  HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            HDCVPAILHRDVKCNNILLDSK+EAYLADFGLAKLM+S NYHHAMSRVAGSYGYIAP   
Sbjct: 898  HDCVPAILHRDVKCNNILLDSKFEAYLADFGLAKLMHSPNYHHAMSRVAGSYGYIAPE-- 955

Query: 241  KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                 YGY+MNITEKSDVYSYGVVLLEILSGRSAV+  +GDG HIVEWVK+KMGSFEPAV
Sbjct: 956  -----YGYSMNITEKSDVYSYGVVLLEILSGRSAVESHVGDGQHIVEWVKRKMGSFEPAV 1010

Query: 301  SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
            SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS PEE+GKTS
Sbjct: 1011 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSQPEEMGKTS 1070

Query: 361  QPLIKQSANKS 371
            QPLIKQS+N+S
Sbjct: 1071 QPLIKQSSNQS 1081

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574561|ref|XP_003555414.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g34110-like [Glycine max]

 Score =  660 bits (1704), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/370 (85%), Positives = 339/370 (91%), Gaps = 7/370 (1%)

Query: 2    IAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTID 61
            + VILASVTI L++SWILVTRNH YKVEK  G ST   GAEDFSYPWTFIPFQK+NF+ID
Sbjct: 717  VTVILASVTIILISSWILVTRNHGYKVEKTLGASTSTSGAEDFSYPWTFIPFQKVNFSID 776

Query: 62   NILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
            +IL+CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWK  + +E VDSFAAEIQILG+IR
Sbjct: 777  DILDCLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKASKADEAVDSFAAEIQILGYIR 836

Query: 122  HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH 181
            HRNIV+L+GYCSN SV LLLYNYI NGNL+QLLQGNR+LDWETRYKIAVGSAQGLAYLHH
Sbjct: 837  HRNIVRLIGYCSNGSVNLLLYNYIPNGNLRQLLQGNRSLDWETRYKIAVGSAQGLAYLHH 896

Query: 182  DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
            DCVPAILHRDVKCNNILLDSK+EAYLADFGLAKLM+S  YHHAMSRVAGSYGYIAP    
Sbjct: 897  DCVPAILHRDVKCNNILLDSKFEAYLADFGLAKLMHSPTYHHAMSRVAGSYGYIAPE--- 953

Query: 242  LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
                YGY+MNITEKSDVYSYGVVLLEILSGRSAV+  +GDG HIVEWVK+KMGSFEPAVS
Sbjct: 954  ----YGYSMNITEKSDVYSYGVVLLEILSGRSAVESHVGDGQHIVEWVKRKMGSFEPAVS 1009

Query: 302  ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTSQ 361
            ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSP ERPTMKEVVALLMEVKS PEE+GKTSQ
Sbjct: 1010 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPTERPTMKEVVALLMEVKSQPEEMGKTSQ 1069

Query: 362  PLIKQSANKS 371
            PLIKQS+N+S
Sbjct: 1070 PLIKQSSNQS 1079

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359495205|ref|XP_002263569.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g34110-like [Vitis vinifera]

 Score =  659 bits (1699), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/371 (87%), Positives = 342/371 (92%), Gaps = 7/371 (1%)

Query: 1    LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
            LI VILASV ++++ASWILVTRNH+Y VEK+SG S    GAEDFSYPWTFIPFQKLNFTI
Sbjct: 697  LICVILASVIMSVIASWILVTRNHKYMVEKSSGTSASSSGAEDFSYPWTFIPFQKLNFTI 756

Query: 61   DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
            DNIL+CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKT +DE+PVDSFA+EIQILGHI
Sbjct: 757  DNILDCLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTMKDEDPVDSFASEIQILGHI 816

Query: 121  RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
            RHRNIVKLLGYCSNK VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH
Sbjct: 817  RHRNIVKLLGYCSNKCVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 876

Query: 181  HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            HDC+P ILHRDVKCNNILLDSKYEAYLADFGLAK+M S NYH A+SRVAGSYGYIAP   
Sbjct: 877  HDCLPTILHRDVKCNNILLDSKYEAYLADFGLAKMMISPNYHQAISRVAGSYGYIAPE-- 934

Query: 241  KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                 YGYTMNITEKSDVYSYGVVLLEILSGRSAV+PQ G GLHIVEWVKKKMGSFEPA 
Sbjct: 935  -----YGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQAGGGLHIVEWVKKKMGSFEPAA 989

Query: 301  SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
            S+LD+KLQGLPDQM+QEMLQTLGIAMFCVNSSP ERPTMKEVVALLMEVKS PEE GKTS
Sbjct: 990  SVLDSKLQGLPDQMIQEMLQTLGIAMFCVNSSPVERPTMKEVVALLMEVKSPPEEWGKTS 1049

Query: 361  QPLIKQSANKS 371
            QPLIK S+N+S
Sbjct: 1050 QPLIKGSSNQS 1060

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572297|ref|XP_002527087.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223533510|gb|EEF35250.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis]

 Score =  657 bits (1694), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/371 (87%), Positives = 344/371 (92%), Gaps = 12/371 (3%)

Query: 1    LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
            LI+VILASVTIA++A WIL+TRNHRY VEK+SG S   PGAEDFSYPWTFIPFQKL+FT+
Sbjct: 717  LISVILASVTIAVIALWILLTRNHRYMVEKSSGASASSPGAEDFSYPWTFIPFQKLHFTV 776

Query: 61   DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
            DNIL+CL+DENVIGKGCSGVVYKAEMPNG+LIAVKKLWK KRDEEPVDSFAAEIQILGHI
Sbjct: 777  DNILDCLRDENVIGKGCSGVVYKAEMPNGDLIAVKKLWKMKRDEEPVDSFAAEIQILGHI 836

Query: 121  RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
            RHRNIVKLLGYCSNKSVKLLLYNYI NGNLQQLLQ NRNLDWETRYKIAVGSAQGLAYLH
Sbjct: 837  RHRNIVKLLGYCSNKSVKLLLYNYIPNGNLQQLLQENRNLDWETRYKIAVGSAQGLAYLH 896

Query: 181  HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            HDCVPAILHRDVKCNNILLDSK+EAYLADFGLAK+MNS NYH+A+SRVAGSY        
Sbjct: 897  HDCVPAILHRDVKCNNILLDSKFEAYLADFGLAKMMNSPNYHNAISRVAGSYE------- 949

Query: 241  KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                 YGYTMNITEKSDVYSYGVVLLEILSGRSAV+ Q+GDGLHIVEWVKKKMGSFEPAV
Sbjct: 950  -----YGYTMNITEKSDVYSYGVVLLEILSGRSAVESQLGDGLHIVEWVKKKMGSFEPAV 1004

Query: 301  SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
            SILD+KLQGLPD MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS PEE GKTS
Sbjct: 1005 SILDSKLQGLPDPMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSPPEEWGKTS 1064

Query: 361  QPLIKQSANKS 371
            QPLIKQS+N++
Sbjct: 1065 QPLIKQSSNQN 1075

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449494185|ref|XP_004159472.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g34110-like [Cucumis sativus]

 Score =  655 bits (1689), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/371 (84%), Positives = 338/371 (91%), Gaps = 7/371 (1%)

Query: 1    LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
            LI++ILA+V + L A WILV+RN +Y  EK SG  +    AEDFSYPWTFIPFQKLNFTI
Sbjct: 773  LISIILAAVVVILFALWILVSRNRKYMEEKHSGTLSSASAAEDFSYPWTFIPFQKLNFTI 832

Query: 61   DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
            DNILE +KDEN+IGKGCSGVVYKA+MPNGEL+AVKKLWKTK+DEE VDS AAEIQILGHI
Sbjct: 833  DNILESMKDENIIGKGCSGVVYKADMPNGELVAVKKLWKTKQDEEAVDSCAAEIQILGHI 892

Query: 121  RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
            RHRNIVKL+GYCSN+SVK+LLYNYISNGNLQQLLQGNRNLDWETRYKIAVG+AQGLAYLH
Sbjct: 893  RHRNIVKLVGYCSNRSVKILLYNYISNGNLQQLLQGNRNLDWETRYKIAVGTAQGLAYLH 952

Query: 181  HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            HDCVPAILHRDVKCNNILLDSK+EAYLADFGLAKLMN+ NYHHA+SRVAGSYGYIAP   
Sbjct: 953  HDCVPAILHRDVKCNNILLDSKFEAYLADFGLAKLMNTPNYHHAISRVAGSYGYIAPE-- 1010

Query: 241  KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                 YGYTMNITEKSDVYSYGVVLLEILSGRSA++ Q+GDGLHIVEWVKKKM SFEPA+
Sbjct: 1011 -----YGYTMNITEKSDVYSYGVVLLEILSGRSAIETQVGDGLHIVEWVKKKMASFEPAI 1065

Query: 301  SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
            +ILDTKLQ LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS PEE GKTS
Sbjct: 1066 TILDTKLQSLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSPPEEWGKTS 1125

Query: 361  QPLIKQSANKS 371
            QPLIKQS+  S
Sbjct: 1126 QPLIKQSSTIS 1136

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446494|ref|XP_004141006.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g34110-like [Cucumis sativus]

 Score =  654 bits (1688), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/371 (84%), Positives = 338/371 (91%), Gaps = 7/371 (1%)

Query: 1    LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
            LI++ILA+V + L A WILV+RN +Y  EK SG  +    AEDFSYPWTFIPFQKLNFTI
Sbjct: 703  LISIILAAVVVILFALWILVSRNRKYMEEKHSGTLSSASAAEDFSYPWTFIPFQKLNFTI 762

Query: 61   DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
            DNILE +KDEN+IGKGCSGVVYKA+MPNGEL+AVKKLWKTK+DEE VDS AAEIQILGHI
Sbjct: 763  DNILESMKDENIIGKGCSGVVYKADMPNGELVAVKKLWKTKQDEEAVDSCAAEIQILGHI 822

Query: 121  RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
            RHRNIVKL+GYCSN+SVK+LLYNYISNGNLQQLLQGNRNLDWETRYKIAVG+AQGLAYLH
Sbjct: 823  RHRNIVKLVGYCSNRSVKILLYNYISNGNLQQLLQGNRNLDWETRYKIAVGTAQGLAYLH 882

Query: 181  HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            HDCVPAILHRDVKCNNILLDSK+EAYLADFGLAKLMN+ NYHHA+SRVAGSYGYIAP   
Sbjct: 883  HDCVPAILHRDVKCNNILLDSKFEAYLADFGLAKLMNTPNYHHAISRVAGSYGYIAPE-- 940

Query: 241  KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                 YGYTMNITEKSDVYSYGVVLLEILSGRSA++ Q+GDGLHIVEWVKKKM SFEPA+
Sbjct: 941  -----YGYTMNITEKSDVYSYGVVLLEILSGRSAIETQVGDGLHIVEWVKKKMASFEPAI 995

Query: 301  SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
            +ILDTKLQ LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS PEE GKTS
Sbjct: 996  TILDTKLQSLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSPPEEWGKTS 1055

Query: 361  QPLIKQSANKS 371
            QPLIKQS+  S
Sbjct: 1056 QPLIKQSSTIS 1066

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|444737617|emb|CCM07274.1| Putative Receptor-like protein kinase 2 [Musa balbisiana]

 Score =  617 bits (1590), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 291/366 (79%), Positives = 328/366 (89%), Gaps = 10/366 (2%)

Query: 1    LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
            L+ VIL S+T+  +A WILV RN +   EKA  +S+    +++FSYPWTF+PFQKL+FT+
Sbjct: 717  LVCVILGSITLLFVALWILVNRNRKLAAEKALTISS--SISDEFSYPWTFVPFQKLSFTV 774

Query: 61   DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
            DNIL+CLKDENVIGKGCSG+VYKAEMPNGELIAVKKLWKTK++EE +D+F +EIQILGHI
Sbjct: 775  DNILQCLKDENVIGKGCSGIVYKAEMPNGELIAVKKLWKTKKEEELIDTFESEIQILGHI 834

Query: 121  RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
            RHRNIVKLLGYCSNK VKLLLYNYISNGNLQQLLQ NRNLDWETRY+IA+GSAQGLAYLH
Sbjct: 835  RHRNIVKLLGYCSNKCVKLLLYNYISNGNLQQLLQENRNLDWETRYRIALGSAQGLAYLH 894

Query: 181  HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            HDC+PAILHRDVKCNNILLDSK+EAYLADFGLAKLM+S N+HHAMSR+AGSYGYIAP   
Sbjct: 895  HDCIPAILHRDVKCNNILLDSKFEAYLADFGLAKLMSSPNFHHAMSRIAGSYGYIAPE-- 952

Query: 241  KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                 YGYT NITEKSDVYS+GVVLLEILSGRSA++P +GDGLHIVEWVKKKM SFEPA+
Sbjct: 953  -----YGYTTNITEKSDVYSFGVVLLEILSGRSAIEPMVGDGLHIVEWVKKKMASFEPAI 1007

Query: 301  SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
            +ILD KLQG+P+QMVQEMLQTLGIAMFCVNSSP ERPTMKEVVA LMEVKS PE+ GKT+
Sbjct: 1008 NILDPKLQGMPNQMVQEMLQTLGIAMFCVNSSPLERPTMKEVVAFLMEVKSPPEDWGKTA 1067

Query: 361  -QPLIK 365
             QPLIK
Sbjct: 1068 QQPLIK 1073

Source: Musa balbisiana

Species: Musa balbisiana

Genus: Musa

Family: Musaceae

Order: Zingiberales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224589412|gb|ACN59240.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana]

 Score =  609 bits (1570), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 301/375 (80%), Positives = 329/375 (87%), Gaps = 15/375 (4%)

Query: 1    LIAVILASVTIALLASWILVTRN-HRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFT 59
            L AVILAS+TIA+LA+W+L+ RN H YK  + S  S     AEDFSYPWTFIPFQKL  T
Sbjct: 688  LTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPST--AEDFSYPWTFIPFQKLGIT 745

Query: 60   IDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD----EEPVDSFAAEIQ 115
            ++NI+  L DENVIGKGCSG+VYKAE+PNG+++AVKKLWKTK +    E  +DSFAAEIQ
Sbjct: 746  VNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTKDNNEEGESTIDSFAAEIQ 805

Query: 116  ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQG 175
            ILG+IRHRNIVKLLGYCSNKSVKLLLYNY  NGNLQQLLQGNRNLDWETRYKIA+G+AQG
Sbjct: 806  ILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGNRNLDWETRYKIAIGAAQG 865

Query: 176  LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM-NSTNYHHAMSRVAGSYGY 234
            LAYLHHDCVPAILHRDVKCNNILLDSKYEA LADFGLAKLM NS NYH+AMSRVAGSYGY
Sbjct: 866  LAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMNSPNYHNAMSRVAGSYGY 925

Query: 235  IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
            IAP        YGYTMNITEKSDVYSYGVVLLEILSGRSAV+PQIGDGLHIVEWVKKKMG
Sbjct: 926  IAPE-------YGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGDGLHIVEWVKKKMG 978

Query: 295  SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
            +FEPA+S+LD KLQGLPDQ+VQEMLQTLGIAMFCVN SP ERPTMKEVV LLMEVK +PE
Sbjct: 979  TFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKEVVTLLMEVKCSPE 1038

Query: 355  ELGKTSQPLIKQSAN 369
            E GKTSQPLIK S++
Sbjct: 1039 EWGKTSQPLIKPSSS 1053

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334183022|ref|NP_174673.3| leucine-rich receptor-like protein kinase [Arabidopsis thaliana] gi|263549150|sp|C0LGF5.2|Y1341_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g34110; Flags: Precursor gi|332193550|gb|AEE31671.1| leucine-rich receptor-like protein kinase [Arabidopsis thaliana]

 Score =  608 bits (1569), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 301/375 (80%), Positives = 329/375 (87%), Gaps = 15/375 (4%)

Query: 1    LIAVILASVTIALLASWILVTRN-HRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFT 59
            L AVILAS+TIA+LA+W+L+ RN H YK  + S  S     AEDFSYPWTFIPFQKL  T
Sbjct: 707  LTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPST--AEDFSYPWTFIPFQKLGIT 764

Query: 60   IDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD----EEPVDSFAAEIQ 115
            ++NI+  L DENVIGKGCSG+VYKAE+PNG+++AVKKLWKTK +    E  +DSFAAEIQ
Sbjct: 765  VNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTKDNNEEGESTIDSFAAEIQ 824

Query: 116  ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQG 175
            ILG+IRHRNIVKLLGYCSNKSVKLLLYNY  NGNLQQLLQGNRNLDWETRYKIA+G+AQG
Sbjct: 825  ILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGNRNLDWETRYKIAIGAAQG 884

Query: 176  LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM-NSTNYHHAMSRVAGSYGY 234
            LAYLHHDCVPAILHRDVKCNNILLDSKYEA LADFGLAKLM NS NYH+AMSRVAGSYGY
Sbjct: 885  LAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMNSPNYHNAMSRVAGSYGY 944

Query: 235  IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
            IAP        YGYTMNITEKSDVYSYGVVLLEILSGRSAV+PQIGDGLHIVEWVKKKMG
Sbjct: 945  IAPE-------YGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGDGLHIVEWVKKKMG 997

Query: 295  SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
            +FEPA+S+LD KLQGLPDQ+VQEMLQTLGIAMFCVN SP ERPTMKEVV LLMEVK +PE
Sbjct: 998  TFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKEVVTLLMEVKCSPE 1057

Query: 355  ELGKTSQPLIKQSAN 369
            E GKTSQPLIK S++
Sbjct: 1058 EWGKTSQPLIKPSSS 1072

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	371
TAIR|locus:2154344	1135	AT5G48940 [Arabidopsis thalian	0.908	0.296	0.489	1.8e-87
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.838	0.272	0.509	7.7e-87
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.840	0.311	0.475	1.7e-75
TAIR|locus:2161158	1041	PXY "PHLOEM INTERCALATED WITH	0.808	0.288	0.453	1.8e-73
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.795	0.294	0.472	1.6e-72
TAIR|locus:2161825	1090	AT5G56040 [Arabidopsis thalian	0.905	0.308	0.410	7.6e-71
TAIR|locus:2120412	992	BAM3 "BARELY ANY MERISTEM 3" [	0.789	0.295	0.485	5.5e-70
TAIR|locus:2131518	1091	AT4G26540 [Arabidopsis thalian	0.916	0.311	0.432	9.8e-70
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.832	0.280	0.455	2.2e-68
TAIR|locus:2204350	980	CLV1 "AT1G75820" [Arabidopsis	0.776	0.293	0.474	7.4e-68

TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)]

 Score = 874 (312.7 bits), Expect = 1.8e-87, P = 1.8e-87
 Identities = 179/366 (48%), Positives = 239/366 (65%)

Query:     2 IAV-ILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
             IA+ +L SVT  L    +L     +  +   +   T     E+  + W F PFQKLNFT+
Sbjct:   724 IAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSET----GENL-WTWQFTPFQKLNFTV 778

Query:    61 DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKT-------KRDEEPV-DSFAA 112
             +++L+CL + NVIGKGCSG+VYKAEMPN E+IAVKKLW         K     V DSF+A
Sbjct:   779 EHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSA 838

Query:   113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXX---XXDWETRYKIA 169
             E++ LG IRH+NIV+ LG C NK+ +LL+Y+Y+S                  WE RYKI 
Sbjct:   839 EVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKII 898

Query:   170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
             +G+AQGLAYLHHDCVP I+HRD+K NNIL+   +E Y+ DFGLAKL++  ++  + + +A
Sbjct:   899 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIA 958

Query:   230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV 289
             GSYGYIAP        YGY+M ITEKSDVYSYGVV+LE+L+G+  + P I DGLHIV+WV
Sbjct:   959 GSYGYIAPE-------YGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWV 1011

Query:   290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             KK        + ++D  LQ  P+  V+EM+QTLG+A+ C+N  P +RPTMK+V A+L E+
Sbjct:  1012 KKIRD-----IQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEI 1066

Query:   350 KSAPEE 355
                 EE
Sbjct:  1067 CQEREE 1072

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 868 (310.6 bits), Expect = 7.7e-87, P = 7.7e-87
 Identities = 169/332 (50%), Positives = 228/332 (68%)

Query:    45 SYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTK--- 101
             +Y W F PFQKLNF++D I+ CL + NVIGKGCSGVVY+A++ NGE+IAVKKLW      
Sbjct:   764 TYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNG 823

Query:   102 -RDEEPV---DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI--SXXXXXXXXX 155
               DE+     DSF+AE++ LG IRH+NIV+ LG C N++ +LL+Y+Y+            
Sbjct:   824 GHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER 883

Query:   156 XXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL 215
                  DW+ RY+I +G+AQGLAYLHHDC+P I+HRD+K NNIL+   +E Y+ADFGLAKL
Sbjct:   884 RGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKL 943

Query:   216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV 275
             ++  +     + VAGSYGYIAP        YGY+M ITEKSDVYSYGVV+LE+L+G+  +
Sbjct:   944 VDEGDIGRCSNTVAGSYGYIAPE-------YGYSMKITEKSDVYSYGVVVLEVLTGKQPI 996

Query:   276 QPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
              P + +G+H+V+WV++  GS E    +LD+ L+   +    EM+Q LG A+ CVNSSP E
Sbjct:   997 DPTVPEGIHLVDWVRQNRGSLE----VLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDE 1052

Query:   336 RPTMKEVVALLMEVKSAPEELGKTSQPLIKQS 367
             RPTMK+V A+L E+K   EE  K    L+K+S
Sbjct:  1053 RPTMKDVAAMLKEIKQEREEYAKVDL-LLKKS 1083

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 761 (272.9 bits), Expect = 1.7e-75, P = 1.7e-75
 Identities = 157/330 (47%), Positives = 210/330 (63%)

Query:    45 SYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE 104
             S  W    FQ+L+FT D++L+ LK++N+IGKG +G+VYK  MPNG+L+AVK+L    R  
Sbjct:   672 SRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGS 731

Query:   105 EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI--SXXXXXXXXXXXXXXDW 162
                  F AEIQ LG IRHR+IV+LLG+CSN    LL+Y Y+                  W
Sbjct:   732 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 791

Query:   163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
             +TRYKIA+ +A+GL YLHHDC P I+HRDVK NNILLDS +EA++ADFGLAK +  +   
Sbjct:   792 DTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTS 851

Query:   223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG 282
               MS +AGSYGYIAP        Y YT+ + EKSDVYS+GVVLLE+++GR  V  + GDG
Sbjct:   852 ECMSAIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELVTGRKPVG-EFGDG 903

Query:   283 LHIVEWVKKKMGSFEPAV-SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE 341
             + IV+WV+K   S + +V  +LD +L  +P   + E+     +AM CV     ERPTM+E
Sbjct:   904 VDIVQWVRKMTDSNKDSVLKVLDPRLSSIP---IHEVTHVFYVAMLCVEEQAVERPTMRE 960

Query:   342 VVALLMEVKSAPEELGKTSQPLIKQSANKS 371
             VV +L E+   P       QP+  +SA +S
Sbjct:   961 VVQILTEIPKLPPS---KDQPMT-ESAPES 986

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)]

 Score = 742 (266.3 bits), Expect = 1.8e-73, P = 1.8e-73
 Identities = 146/322 (45%), Positives = 210/322 (65%)

Query:    47 PWTFIPFQKLNFTIDNILECL-KDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE 105
             PW    FQ+LNFT D+++ECL K +N++G G +G VYKAEMPNGE+IAVKKLW   ++  
Sbjct:   698 PWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENG 757

Query:   106 PV----DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY-----ISXXXXXXXXXX 156
              +        AE+ +LG++RHRNIV+LLG C+N+   +LLY Y     +           
Sbjct:   758 KIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTM 817

Query:   157 XXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM 216
                 +W   Y+IA+G AQG+ YLHHDC P I+HRD+K +NILLD+ +EA +ADFG+AKL+
Sbjct:   818 TAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI 877

Query:   217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
              +     +MS VAGSYGYIAP        Y YT+ + +KSD+YSYGV+LLEI++G+ +V+
Sbjct:   878 QTDE---SMSVVAGSYGYIAPE-------YAYTLQVDKKSDIYSYGVILLEIITGKRSVE 927

Query:   277 PQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMV-QEMLQTLGIAMFCVNSSPAE 335
             P+ G+G  IV+WV+ K+ + E    +LD K  G    ++ +EM Q L IA+ C + SP +
Sbjct:   928 PEFGEGNSIVDWVRSKLKTKEDVEEVLD-KSMGRSCSLIREEMKQMLRIALLCTSRSPTD 986

Query:   336 RPTMKEVVALLMEVKSAPEELG 357
             RP M++V+ +L E K   + +G
Sbjct:   987 RPPMRDVLLILQEAKPKRKTVG 1008

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010089 "xylem development" evidence=IMP

GO:0010223 "secondary shoot formation" evidence=IMP

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 733 (263.1 bits), Expect = 1.6e-72, P = 1.6e-72
 Identities = 146/309 (47%), Positives = 196/309 (63%)

Query:    48 WTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV 107
             W    FQ+L+FT D++L+ LK++N+IGKG +G+VYK  MP G+L+AVK+L          
Sbjct:   671 WRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHD 730

Query:   108 DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI--SXXXXXXXXXXXXXXDWETR 165
               F AEIQ LG IRHR+IV+LLG+CSN    LL+Y Y+                  W TR
Sbjct:   731 HGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTR 790

Query:   166 YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
             YKIA+ +A+GL YLHHDC P I+HRDVK NNILLDS +EA++ADFGLAK +  +     M
Sbjct:   791 YKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECM 850

Query:   226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
             S +AGSYGYIAP        Y YT+ + EKSDVYS+GVVLLE+++G+  V  + GDG+ I
Sbjct:   851 SAIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELITGKKPVG-EFGDGVDI 902

Query:   286 VEWVKKKMGSFEPAV-SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
             V+WV+    S +  V  ++D +L  +P   V E+     +A+ CV     ERPTM+EVV 
Sbjct:   903 VQWVRSMTDSNKDCVLKVIDLRLSSVP---VHEVTHVFYVALLCVEEQAVERPTMREVVQ 959

Query:   345 LLMEVKSAP 353
             +L E+   P
Sbjct:   960 ILTEIPKIP 968

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)]

 Score = 722 (259.2 bits), Expect = 7.6e-71, P = 7.6e-71
 Identities = 153/373 (41%), Positives = 229/373 (61%)

Query:     4 VILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNI 63
             ++ ASV + L+A + LV      K ++ +G        E+    W    +QKL+F+ID+I
Sbjct:   708 LVAASVVLVLMAVYTLV------KAQRITGKQ------EELD-SWEVTLYQKLDFSIDDI 754

Query:    64 LECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
             ++ L   NVIG G SGVVY+  +P+GE +AVKK+W  + +     +F +EI  LG IRHR
Sbjct:   755 VKNLTSANVIGTGSSGVVYRVTIPSGETLAVKKMWSKEENR----AFNSEINTLGSIRHR 810

Query:   124 NIVKLLGYCSNKSVKLLLYNYISXXXXXX----XXXXXXXXDWETRYKIAVGSAQGLAYL 179
             NI++LLG+CSN+++KLL Y+Y+                   DWE RY + +G A  LAYL
Sbjct:   811 NIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLHGAGKGSGGADWEARYDVVLGVAHALAYL 870

Query:   180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR-------VAGSY 232
             HHDC+P ILH DVK  N+LL S++E+YLADFGLAK+++        S        +AGSY
Sbjct:   871 HHDCLPPILHGDVKAMNVLLGSRFESYLADFGLAKIVSGEGVTDGDSSKLSNRPPLAGSY 930

Query:   233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
             GY+AP    +Q       +ITEKSDVYSYGVVLLE+L+G+  + P +  G H+V+WV+  
Sbjct:   931 GYMAPEHASMQ-------HITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVQWVRDH 983

Query:   293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
             +   +    ILD +L+G  D ++ EMLQTL ++  CV++  ++RP MK++VA+L E++  
Sbjct:   984 LAGKKDPREILDPRLRGRADPIMHEMLQTLAVSFLCVSNKASDRPMMKDIVAMLKEIRQF 1043

Query:   353 PEELGKTSQPLIK 365
               ++ ++   +IK
Sbjct:  1044 --DMDRSESDMIK 1054

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
 Identities = 149/307 (48%), Positives = 194/307 (63%)

Query:    48 WTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV 107
             W  I FQKL F  ++ILEC+K+ +VIGKG  G+VYK  MPNGE +AVKKL    +     
Sbjct:   691 WKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHD 750

Query:   108 DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI--SXXXXXXXXXXXXXXDWETR 165
             +  AAEIQ LG IRHRNIV+LL +CSNK V LL+Y Y+                  WETR
Sbjct:   751 NGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETR 810

Query:   166 YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN-YHHA 224
              +IA+ +A+GL YLHHDC P I+HRDVK NNILL  ++EA++ADFGLAK M   N     
Sbjct:   811 LQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASEC 870

Query:   225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH 284
             MS +AGSYGYIAP        Y YT+ I EKSDVYS+GVVLLE+++GR  V     +G+ 
Sbjct:   871 MSSIAGSYGYIAPE-------YAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGID 923

Query:   285 IVEWVKKKMG-SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             IV+W K +   + +  V I+D +L  +P   + E ++   +AM CV     ERPTM+EVV
Sbjct:   924 IVQWSKIQTNCNRQGVVKIIDQRLSNIP---LAEAMELFFVAMLCVQEHSVERPTMREVV 980

Query:   344 ALLMEVK 350
              ++ + K
Sbjct:   981 QMISQAK 987

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048437 "floral organ development" evidence=IGI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)]

 Score = 712 (255.7 bits), Expect = 9.8e-70, P = 9.8e-70
 Identities = 162/375 (43%), Positives = 231/375 (61%)

Query:     1 LIAVILASVTIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTI 60
             LI V++ +V + L+A + LV         +A+G   L  G E  S  W    +QKL+F+I
Sbjct:   706 LILVVVTAVLV-LMAVYTLVRA-------RAAGKQLL--GEEIDS--WEVTLYQKLDFSI 753

Query:    61 DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
             D+I++ L   NVIG G SGVVY+  +P+GE +AVKK+W     +E   +F +EI+ LG I
Sbjct:   754 DDIVKNLTSANVIGTGSSGVVYRITIPSGESLAVKKMWS----KEESGAFNSEIKTLGSI 809

Query:   121 RHRNIVKLLGYCSNKSVKLLLYNYI---SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
             RHRNIV+LLG+CSN+++KLL Y+Y+   S              DWE RY + +G A  LA
Sbjct:   810 RHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGCVDWEARYDVVLGVAHALA 869

Query:   178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN---STNYHHAM--SR--VAG 230
             YLHHDC+P I+H DVK  N+LL   +E YLADFGLA+ ++   +T    A   +R  +AG
Sbjct:   870 YLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLAKPTNRPPMAG 929

Query:   231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK 290
             SYGY+AP    +Q        ITEKSDVYSYGVVLLE+L+G+  + P +  G H+V+WV+
Sbjct:   930 SYGYMAPEHASMQ-------RITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVKWVR 982

Query:   291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
               +   +    +LD +L G  D ++ EMLQTL +A  CV++   ERP MK+VVA+L E++
Sbjct:   983 DHLAEKKDPSRLLDPRLDGRTDSIMHEMLQTLAVAFLCVSNKANERPLMKDVVAMLTEIR 1042

Query:   351 SAPEELGKTSQPLIK 365
                 ++G++    IK
Sbjct:  1043 HI--DVGRSETEKIK 1055

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 700 (251.5 bits), Expect = 2.2e-68, P = 2.2e-68
 Identities = 149/327 (45%), Positives = 209/327 (63%)

Query:    53 FQKLNFTIDNILECLKD--ENVI-GKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDS 109
             F K  FT   +++  ++  E+V+ G+G  G VYKAEM  GE+IAVKKL          +S
Sbjct:   782 FPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNS 841

Query:   110 FAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX---DWETRY 166
             F AEI  LG IRHRNIVKL G+C +++  LLLY Y+S                 DW  RY
Sbjct:   842 FRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARY 901

Query:   167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
             +IA+G+A+GL YLHHDC P I+HRD+K NNILLD +++A++ DFGLAKL++  +Y  +MS
Sbjct:   902 RIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLID-LSYSKSMS 960

Query:   227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
              VAGSYGYIAP        Y YTM +TEK D+YS+GVVLLE+++G+  VQP +  G  +V
Sbjct:   961 AVAGSYGYIAPE-------YAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLV 1012

Query:   287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              WV++ + +  P + + D +L     + V EM   L IA+FC ++SPA RPTM+EVVA++
Sbjct:  1013 NWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072

Query:   347 MEVK--SAPEELGKTSQ-PLIKQSANK 370
              E +  S+      TS+ PL + +++K
Sbjct:  1073 TEARGSSSLSSSSITSETPLEEANSSK 1099

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)]

 Score = 690 (248.0 bits), Expect = 7.4e-68, P = 7.4e-68
 Identities = 148/312 (47%), Positives = 196/312 (62%)

Query:    45 SYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWK--TKR 102
             S  W    FQKL+F  +++LECLK+EN+IGKG +G+VY+  MPN   +A+K+L    T R
Sbjct:   670 SLAWKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGR 729

Query:   103 DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI--SXXXXXXXXXXXXXX 160
              +     F AEIQ LG IRHR+IV+LLGY +NK   LLLY Y+                 
Sbjct:   730 SDH---GFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHL 786

Query:   161 DWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN 220
              WETR+++AV +A+GL YLHHDC P ILHRDVK NNILLDS +EA++ADFGLAK +    
Sbjct:   787 QWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGA 846

Query:   221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG 280
                 MS +AGSYGYIAP        Y YT+ + EKSDVYS+GVVLLE+++G+  V  + G
Sbjct:   847 ASECMSSIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVG-EFG 898

Query:   281 DGLHIVEWVKKKMGSF-EPA-----VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPA 334
             +G+ IV WV+       +P+     V+I+D +L G P   +  ++    IAM CV    A
Sbjct:   899 EGVDIVRWVRNTEEEITQPSDAAIVVAIVDPRLTGYP---LTSVIHVFKIAMMCVEEEAA 955

Query:   335 ERPTMKEVVALL 346
              RPTM+EVV +L
Sbjct:   956 ARPTMREVVHML 967

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0007172 "signal complex assembly" evidence=IDA

GO:0016021 "integral to membrane" evidence=TAS

GO:0030154 "cell differentiation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0016020 "membrane" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGF5	Y1341_ARATH	2, ., 7, ., 1, 1, ., 1	0.8026	0.9703	0.3358	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00005395001 SubName- Full=Chromosome undetermined scaffold_151, whole genome shotgun sequence; (1039 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	371
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-14
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (407), Expect = 5e-47
 Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 26/274 (9%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G G  G VYKA     G+++AVK L K     +   +   EI+IL  + H NIV+L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
              +K    L+  Y   G+L   L     L  +   KIA+   +GL YLH +    I+HR
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHR 122

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  NILLD      +ADFGLAK +   +     + V G+  Y+AP     +++ G   
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFV-GTPWYMAP-----EVLLGGNG 175

Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
               K DV+S GV+L E+L+G+     +   D L ++   +      E       +    
Sbjct: 176 -YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI--RRILGPPLEFDEPKWSSGS-- 230

Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
                  E  + L       +  P++RPT +E++
Sbjct: 231 -------EEAKDLIKKCLNKD--PSKRPTAEEIL 255

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  156 bits (398), Expect = 1e-45
 Identities = 79/299 (26%), Positives = 126/299 (42%), Gaps = 61/299 (20%)

Query: 67  LKDENVIGKGCSGVVYKAE-----MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           L     +G+G  G VYK +           +AVK L K    E+ ++ F  E +I+  + 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLD 59

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLH 180
           H N+VKLLG C+ +    ++  Y+  G+L   L+ NR  L        A+  A+G+ YL 
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 181 -HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
             + +    HRD+   N L+       ++DFGL++ +   +Y+                 
Sbjct: 120 SKNFI----HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG------------- 162

Query: 240 CKLQI-----------IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVE 287
            KL I            +      T KSDV+S+GV+L EI +     QP  G     ++E
Sbjct: 163 GKLPIRWMAPESLKEGKF------TSKSDVWSFGVLLWEIFTL--GEQPYPGMSNEEVLE 214

Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           ++K   G   P       +    P ++   MLQ       C    P +RPT  E+V +L
Sbjct: 215 YLKN--GYRLP-------QPPNCPPELYDLMLQ-------CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  155 bits (395), Expect = 3e-45
 Identities = 81/300 (27%), Positives = 128/300 (42%), Gaps = 62/300 (20%)

Query: 67  LKDENVIGKGCSGVVYKAE-----MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           L     +G+G  G VYK             +AVK L K    E+ ++ F  E +I+  + 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLD 59

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYL 179
           H NIVKLLG C+ +   +++  Y+  G+L   L+ NR   L        A+  A+G+ YL
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 180 H-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
              + +    HRD+   N L+       ++DFGL++ +   +Y+                
Sbjct: 120 ESKNFI----HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG------------ 163

Query: 239 KCKLQI-----------IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIV 286
             KL I            +      T KSDV+S+GV+L EI +     +P  G     ++
Sbjct: 164 -GKLPIRWMAPESLKEGKF------TSKSDVWSFGVLLWEIFTL--GEEPYPGMSNAEVL 214

Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E++KK  G   P       K    P ++ + MLQ       C    P +RPT  E+V +L
Sbjct: 215 EYLKK--GYRLP-------KPPNCPPELYKLMLQ-------CWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  152 bits (386), Expect = 1e-44
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 17/200 (8%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G+G  G VY A     G+ +A+K + K +     ++    EI+IL  + H NIVKL G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLH-HDCVPAILH 189
             +++   L+  Y   G+L+ LL+ N   L  +   +I +   +GL YLH +     I+H
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG----IIH 115

Query: 190 RDVKCNNILLDSK-YEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+K  NILLDS   +  LADFGL+KL+ S      +  + G+  Y+AP     +++ G 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAP-----EVLLGK 168

Query: 249 TMNITEKSDVYSYGVVLLEI 268
               +EKSD++S GV+L E+
Sbjct: 169 -GYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  145 bits (369), Expect = 2e-41
 Identities = 78/304 (25%), Positives = 128/304 (42%), Gaps = 71/304 (23%)

Query: 71  NVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
             +G+G  G VYK ++         +AVK L K    EE    F  E +++  + H N+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN---------LDWETRYKIAVGSAQGLA 177
           +LLG C+ +    L+  Y+  G+L   L+ +R          L  +     A+  A+G+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           YL        +HRD+   N L+       ++DFGL++ +   +Y            Y   
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY------------YRKK 164

Query: 238 GKCKLQI-----------IYGYTMNITEKSDVYSYGVVLLEILS-GRS---AVQPQIGDG 282
              KL I           I+      T KSDV+S+GV+L EI + G +    +  +    
Sbjct: 165 TGGKLPIRWMAPESLKDGIF------TSKSDVWSFGVLLWEIFTLGATPYPGLSNE---- 214

Query: 283 LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             ++E+++K  G   P       K +  PD++ + ML        C    P +RPT  E+
Sbjct: 215 -EVLEYLRK--GYRLP-------KPEYCPDELYELMLS-------CWQLDPEDRPTFSEL 257

Query: 343 VALL 346
           V  L
Sbjct: 258 VERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  144 bits (367), Expect = 3e-41
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)

Query: 68  KDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +    +G+G  G VY A     G+L+A+K + K K  ++  +    EI+IL  ++H NIV
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR-ERILREIKILKKLKHPNIV 60

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-WETRYKIAVGSAQGLAYLHHDCVP 185
           +L     ++    L+  Y   G+L  LL+    L   E R+         L YLH     
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLHSKG-- 117

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I+HRD+K  NILLD      LADFGLA+ ++       ++   G+  Y+AP     +++
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAP-----EVL 168

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT 305
            G      +  D++S GV+L E+L+G+    P     L + + + K    F P    +  
Sbjct: 169 LG--KGYGKAVDIWSLGVILYELLTGKPPF-PGDDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
           + +     +++++L          +  P +R T +E + 
Sbjct: 226 EAK----DLIRKLLV--------KD--PEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (366), Expect = 5e-41
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 64/296 (21%)

Query: 72  VIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            +G+G  G VYK  +          +AVK L K    EE  + F  E  I+  + H NIV
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLH-HDCV 184
           +LLG C+      ++  Y+  G+L   L+ +   L  +   ++A+  A+G+ YL   + V
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFV 124

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
               HRD+   N L+       ++DFGL++ +   +Y            Y   G  KL I
Sbjct: 125 ----HRDLAARNCLVTENLVVKISDFGLSRDIYEDDY------------YRKRGGGKLPI 168

Query: 245 -----------IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKK- 291
                       +      T KSDV+S+GV+L EI +     QP  G     ++E ++  
Sbjct: 169 KWMAPESLKDGKF------TSKSDVWSFGVLLWEIFTL--GEQPYPGMSNEEVLELLEDG 220

Query: 292 -KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            ++            + +  PD++ + MLQ       C    P +RPT  E+V  L
Sbjct: 221 YRL-----------PRPENCPDELYELMLQ-------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  137 bits (348), Expect = 2e-38
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 37/275 (13%)

Query: 71  NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
            ++G+G  G VY A     GEL+AVK +  +   EE +++   EI+IL  ++H NIV+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 130 GYCSNKSVK-LLLY-NYISNGNLQQLLQGNRNLDWET---RYKIAVGSAQGLAYLH-HDC 183
           G   ++    L ++  Y+S G+L  LL+    L  E    +Y   +   +GLAYLH +  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVIRKYTRQI--LEGLAYLHSNG- 121

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I+HRD+K  NIL+DS     LADFG AK +           V G+  ++AP   + +
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
             YG        +D++S G  ++E+ +G+     ++G+ +  +     K+GS        
Sbjct: 179 -EYGR------AADIWSLGCTVIEMATGK-PPWSELGNPMAAL----YKIGS-------- 218

Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
             +   +P+ + +E    L     C+   P +RPT
Sbjct: 219 SGEPPEIPEHLSEEAKDFL---RKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  143 bits (362), Expect = 2e-37
 Identities = 101/353 (28%), Positives = 162/353 (45%), Gaps = 44/353 (12%)

Query: 2   IAVILASVTIALLASWILV-TRNHR----YKVEKASGMSTLPPGAEDFSYPWTFIPFQKL 56
           I   L +  +  L ++  V  R        +VE   G              W    F   
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT-------------WELQFFDSK 678

Query: 57  ---NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAE 113
              + TI++IL  LK+ENVI +G  G  YK +     +  V K  +         S  A+
Sbjct: 679 VSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK--EINDVNSIPSSEIAD 736

Query: 114 IQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA 173
              +G ++H NIVKL+G C ++    L++ YI   NL ++L   RNL WE R KIA+G A
Sbjct: 737 ---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---RNLSWERRRKIAIGIA 790

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
           + L +LH  C PA++  ++    I++D K E +L    L  L+ +       S       
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------A 843

Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM 293
           Y+AP   +       T +ITEKSD+Y +G++L+E+L+G+S    + G    IVEW +   
Sbjct: 844 YVAPETRE-------TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY 896

Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
                 + I D  ++G       E+++ + +A+ C  + P  RP   +V+  L
Sbjct: 897 SDCHLDMWI-DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  116 bits (294), Expect = 1e-30
 Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 25/213 (11%)

Query: 66  CLKDENVIGKGCSGVVYKAE-MPNGELIAVKKL-WKTKRDEEPVDSFAAEIQILGHIRHR 123
             +    IGKG  G VYKA     G+ +A+K +  ++K  +E +     EIQIL   +H 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI---INEIQILKKCKHP 57

Query: 124 NIVKLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA---QGLAYL 179
           NIVK  G Y     + +++  + S G+L+ LL+       E+  +IA       +GL YL
Sbjct: 58  NIVKYYGSYLKKDELWIVM-EFCSGGSLKDLLKSTNQTLTES--QIAYVCKELLKGLEYL 114

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H +    I+HRD+K  NILL S  E  L DFGL+  ++ T   + M    G+  ++AP  
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAP-- 166

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              ++I G       K+D++S G+  +E+  G+
Sbjct: 167 ---EVING--KPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 2e-30
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 17/205 (8%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           ++IG+G  GVVYK   +  G+ +A+K++   K  EE + S   EI +L +++H NIVK +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           G         ++  Y  NG+L+Q+++  G         Y   V   QGLAYLH      +
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV--LQGLAYLHEQ---GV 120

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  NIL        LADFG+A  +N        + V G+  ++AP     ++I  
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAP-----EVIEM 173

Query: 248 YTMNITEKSDVYSYGVVLLEILSGR 272
                +  SD++S G  ++E+L+G 
Sbjct: 174 --SGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (276), Expect = 2e-27
 Identities = 77/306 (25%), Positives = 120/306 (39%), Gaps = 27/306 (8%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWK-TKRDEEPVDSFAAEIQILGHIRH-RNIVKLL 129
            +G+G  G VY A   + +L+A+K L K  +   + V+ F  EIQIL  + H  NIVKL 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLL---QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
            +  ++    L+  Y+  G+L+ LL        L       I       L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 187 ILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTNYH----HAMSRVAGSYGYIAPGKCK 241
           I+HRD+K  NILLD       L DFGLAKL+             S   G+ GY+AP    
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP---- 177

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
             ++       +  SD++S G+ L E+L+G    + +                      S
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTSQ 361
            L      L  +   ++L+        +   P  R +      L  ++ +  +       
Sbjct: 238 PLSPSNPELISKAASDLLKK------LLAKDPKNRLSSSS--DLSHDLLAHLKLKESDLS 289

Query: 362 PLIKQS 367
            L+K  
Sbjct: 290 DLLKPD 295

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  104 bits (263), Expect = 4e-26
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 40/284 (14%)

Query: 64  LECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH 122
           LE +K   V+G+G SGVVYK    P G++ A+KK+     DEE       E++ L     
Sbjct: 3   LERVK---VLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCES 58

Query: 123 RNIVKLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH 181
             +VK  G +     + ++L  Y+  G+L  LL+    +       IA    +GL YLH 
Sbjct: 59  PYVVKCYGAFYKEGEISIVL-EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP---- 237
                I+HRD+K +N+L++SK E  +ADFG++K++ +T      + V G+  Y++P    
Sbjct: 118 K--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYMSPERIQ 173

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
           G+      Y Y       +D++S G+ LLE   G+    P              +   FE
Sbjct: 174 GES-----YSY------AADIWSLGLTLLECALGKFPFLPP------------GQPSFFE 210

Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE 341
              +I D     LP +      +   I+  C+   P +RP+  E
Sbjct: 211 LMQAICDGPPPSLPAEEFSPEFRDF-ISA-CLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 4e-26
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 42/274 (15%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IGKG  G V   +   G+ +AVK L   K D     +F AE  ++  +RH N+V+LLG  
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCL---KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 133 SNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
              +   ++  Y++ G+L   L  +G   +    +   A+   +G+ YL        +HR
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+   N+L+     A ++DFGLAK     +      ++     + AP   + +       
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKK------ 175

Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK--KMGSFEPAVSILDTKLQ 308
             + KSDV+S+G++L EI S      P+I     +V  V+K  +M + E           
Sbjct: 176 -FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVEKGYRMEAPE----------- 222

Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P ++ + M         C    PA+RPT K++
Sbjct: 223 GCPPEVYKVMKD-------CWELDPAKRPTFKQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (251), Expect = 3e-24
 Identities = 76/313 (24%), Positives = 134/313 (42%), Gaps = 64/313 (20%)

Query: 64  LECLKDENVIGKGCSGVVYKAEMPNG------ELIAVKKLWKTKRDEEPVDSFAAEIQIL 117
            + +  +  +G+G  G V+  E  +       EL+AVK L K     +    F  E ++L
Sbjct: 4   RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELL 62

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGN--------------RNLDWE 163
            + +H NIVK  G C+     ++++ Y+ +G+L + L+ +                L   
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 164 TRYKIAVGSAQGLAYL--HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY 221
              +IAV  A G+ YL   H      +HRD+   N L+       + DFG+++ + +T+Y
Sbjct: 123 QLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177

Query: 222 HHAMSRVAGS----YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQ 276
           +    RV G       ++ P      I+Y      T +SDV+S+GVVL EI + G+   Q
Sbjct: 178 Y----RVGGHTMLPIRWMPPE----SIMYR---KFTTESDVWSFGVVLWEIFTYGK---Q 223

Query: 277 PQIGDGLH-IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
           P  G     ++E + +           L  + +  P ++   ML        C    P +
Sbjct: 224 PWYGLSNEEVIECITQ---------GRLLQRPRTCPSEVYDIMLG-------CWKRDPQQ 267

Query: 336 RPTMKEVVALLME 348
           R  +K++   L +
Sbjct: 268 RINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 99.3 bits (248), Expect = 5e-24
 Identities = 86/288 (29%), Positives = 129/288 (44%), Gaps = 40/288 (13%)

Query: 67  LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           L+    +G G SGVV K    P G+++AVK +     +E        E+ IL       I
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYI 61

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLL-QGNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
           V   G   N     +   Y+  G+L ++L +    +      KIAV   +GL YLH    
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH- 120

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
             I+HRDVK +NIL++S+ +  L DFG++ +L+NS     A + V G+  Y+AP +    
Sbjct: 121 -KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFV-GTSSYMAPER---- 170

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
            I G   ++  KSD++S G+ L+E+ +GR    P                G FE    I+
Sbjct: 171 -IQGNDYSV--KSDIWSLGLSLIELATGRFPYPP----------ENDPPDGIFELLQYIV 217

Query: 304 DTKLQGLPDQMVQEMLQTLGIAMF---CVNSSPAERPTMKEVVALLME 348
           +     LP        Q      F   C+   P ERP+ KE    L+E
Sbjct: 218 NEPPPRLPSGKFSPDFQD-----FVNLCLIKDPRERPSYKE----LLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 23/222 (10%)

Query: 67  LKDENVIGKGCSGVVYKAEMPN-----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LK    +G+G  G V            GE +AVK L     +E+    F  EI+IL  + 
Sbjct: 6   LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLD 64

Query: 122 HRNIVKLLGYC---SNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLA 177
           H NIVK  G C     +S++L++  Y+ +G+L+  LQ +R  ++ +     +    +G+ 
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIM-EYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD 123

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIA 236
           YL        +HRD+   NIL++S+    ++DFGLAK++    +Y++          + A
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQP 277
           P   +              SDV+S+GV L E+ + G  +  P
Sbjct: 181 PECLRTSKFSSA-------SDVWSFGVTLYELFTYGDPSQSP 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 18/209 (8%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           N IG G  G VY A  +  GEL+AVK++     D + +   A E+++L  ++H N+VK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPA 186
           G   ++    +   Y S G L++LL+  R LD      I V + Q   GLAYLH      
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---IRVYTLQLLEGLAYLHSH---G 119

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLM--NSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
           I+HRD+K  NI LD      L DFG A  +  N+T     +  +AG+  Y+AP     ++
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP-----EV 174

Query: 245 IYGYTMNITEKS-DVYSYGVVLLEILSGR 272
           I G       ++ D++S G V+LE+ +G+
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.8 bits (241), Expect = 5e-23
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 17/210 (8%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKL----WKTKRDEEP----VDSFAAEIQILGHIRH 122
           +IGKG  G VY A  +  GE++AVK++        R +      V +  +EI+ L  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD 182
            NIV+ LG+ + +    +   Y+  G++   L+     + +          +GLAYLH  
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               ILHRD+K +N+L+D+     ++DFG++K  +    +     + GS  ++AP     
Sbjct: 128 ---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP----- 179

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           ++I+ Y+   + K D++S G V+LE+ +GR
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 95.6 bits (239), Expect = 1e-22
 Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 43/281 (15%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             IGKG  G VY      +G+L  +K++  +   E+  +    E++IL  + H NI+K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63

Query: 130 GYCSNKSVKLLLY---NYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHD 182
            Y  +   K  L     Y   G+L Q ++      +    E      V     L YLH  
Sbjct: 64  -YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               ILHRD+K  NI L S     L DFG++K+++ST    A + V   Y Y++P  C+ 
Sbjct: 123 ---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKTVVGTPY-YLSPELCQN 177

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM-GSFEPAVS 301
           +    Y      KSD++S G VL E+ + +   +   G+ L  +    K + G + P  S
Sbjct: 178 K---PY----NYKSDIWSLGCVLYELCTLKHPFE---GENLLEL--ALKILKGQYPPIPS 225

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
              ++L+     +V  +LQ            P ERP++ ++
Sbjct: 226 QYSSELR----NLVSSLLQK----------DPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 80/304 (26%), Positives = 135/304 (44%), Gaps = 54/304 (17%)

Query: 63  ILECLKDENVIGKGCSGVVYKAEM--PNGELIAVKKLWKTKRDEEPV---DSFAAEIQIL 117
            L  ++    +G+G  G VYK E+  PN  L A     KT ++         F  E +++
Sbjct: 3   PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELM 62

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLL----------------QGNRNLD 161
             ++H NIV LLG C+ +    +L+ Y+++G+L + L                    +LD
Sbjct: 63  SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122

Query: 162 WETRYKIAVGSAQGLAYL--HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST 219
                 IA+  A G+ YL  HH      +HRD+   N L+       ++DFGL++ + S 
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
           +Y+   S+      ++ P      I+YG     T +SD++S+GVVL EI S    +QP  
Sbjct: 178 DYYRVQSKSLLPVRWMPPEA----ILYG---KFTTESDIWSFGVVLWEIFS--YGLQPYY 228

Query: 280 G-DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
           G     ++E ++ +          L    +  P ++   M++       C N  PA RP 
Sbjct: 229 GFSNQEVIEMIRSR---------QLLPCPEDCPARVYALMIE-------CWNEIPARRPR 272

Query: 339 MKEV 342
            K++
Sbjct: 273 FKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.0 bits (234), Expect = 4e-22
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)

Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQILGHIRHRNIVKL 128
           E  +G G  G V++    N   +A+K L   K D+      F  E+Q L  +RH++++ L
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
              CS      ++   +  G+L   L+    + L   +   +A   A+G+AYL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
            +HRD+   NIL+       +ADFGLA+L+    Y  +  ++   Y + AP        +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEA----ASH 178

Query: 247 GYTMNITEKSDVYSYGVVLLEILS 270
           G     + KSDV+S+G++L E+ +
Sbjct: 179 G---TFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 31/212 (14%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKL-WKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           IG+G  G VYKA     GEL+A+KK+  + +++  P+ +   EI++L  +RH NIV+L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA-IREIKLLQKLRHPNIVRLKE 65

Query: 131 YCSNKSVK--LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA--------QGLAYLH 180
             ++K      +++ Y+ + +L  LL            K              +GL YLH
Sbjct: 66  IVTSKGKGSIYMVFEYMDH-DLTGLLD-------SPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            +    ILHRD+K +NIL+++     LADFGLA+     N     +RV   + Y  P   
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW-YRPP--- 170

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             +++ G T     + D++S G +L E+  G+
Sbjct: 171 --ELLLGAT-RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             IGKG  G V K     +G+++  K++      E+      +E+ IL  ++H NIV+  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 130 GYCSNKSVKLL-LY-NYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDC 183
               ++S + L +   Y   G+L QL+Q      + ++ E  ++I       L   H+  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 184 VP--AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
            P   +LHRD+K  NI LD+     L DFGLAK++   +   A + V   Y Y++P    
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTPY-YMSP---- 179

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            + +    M+  EKSD++S G ++ E+ +  
Sbjct: 180 -EQLNH--MSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 1e-21
 Identities = 68/212 (32%), Positives = 94/212 (44%), Gaps = 32/212 (15%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G V      + G+L A+K L K K    + V+    E  IL  I H  IVKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 131 YCS---NKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK-IAVGSAQGLAYLH-HDCVP 185
           + +    + + L+L  Y   G L   L        E R +  A      L YLH      
Sbjct: 59  HYAFQTEEKLYLVL-EYAPGGELFSHLSKEGRFS-EERARFYAAEIVLALEYLHSLG--- 113

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKCK 241
            I++RD+K  NILLD+     L DFGLAK   S+      +   G+  Y+AP    GK  
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNT-FCGTPEYLAPEVLLGK-- 168

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
                GY   +    D +S GV+L E+L+G+ 
Sbjct: 169 -----GYGKAV----DWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 70/299 (23%), Positives = 135/299 (45%), Gaps = 47/299 (15%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDS-FAAEIQILGH 119
           L++   +G+G  G V+ A+    E      L+ VK L   K  +E + S F  E+ +   
Sbjct: 7   LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRK 64

Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR---------NLDWETRYKIAV 170
           + H+N+V+LLG C       ++  Y   G+L+Q L+  +          L  + +  +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG 230
             A G+ +L +      +HRD+   N L+ S+ E  ++   L+K + ++ Y+   + +  
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180

Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK 290
              ++AP +   +  +      + KSDV+S+GV++ E+ +      P    GL   E + 
Sbjct: 181 PLRWLAP-EAVQEDDF------STKSDVWSFGVLMWEVFT--QGELPF--YGLSDEEVLN 229

Query: 291 K-KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           + + G  E  V       +G P ++ + M +       C   +P +RP+  E+V+ L E
Sbjct: 230 RLQAGKLELPVP------EGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.2 bits (227), Expect = 4e-21
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G+G  G VYKA     G+++A+K +      EE +     EI IL       IVK  G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV----PVEEDLQEIIKEISILKQCDSPYIVKYYG 65

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
                +   ++  Y   G++  +++  N+ L  E    I   + +GL YLH +     +H
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIH 122

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+K  NILL+ + +A LADFG++  +  T      + V G+  ++AP     ++I    
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAP-----EVIQEIG 175

Query: 250 MNITEKSDVYSYGVVLLEILSGR 272
            N   K+D++S G+  +E+  G+
Sbjct: 176 YN--NKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 90.8 bits (226), Expect = 5e-21
 Identities = 75/272 (27%), Positives = 119/272 (43%), Gaps = 41/272 (15%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G V+         +AVK L   K      ++F  E QI+  +RH  +V+L   C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 133 SNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           S +    ++  Y+S G+L   L+    + L       +A   A+G+AYL        +HR
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY---IHR 127

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKCKLQIIYGY 248
           D+   NIL+       +ADFGLA+L+    Y    +R    +   + AP        YG 
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPEA----ANYG- 179

Query: 249 TMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFE-PAVSILDTK 306
               T KSDV+S+G++L EI++ GR         G+   E +++    +  P       +
Sbjct: 180 --RFTIKSDVWSFGILLTEIVTYGRVPYP-----GMTNREVLEQVERGYRMP-------R 225

Query: 307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
               P+++   MLQ       C +  P ERPT
Sbjct: 226 PPNCPEELYDLMLQ-------CWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 43/281 (15%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKK---LWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +G G  G VY+   + +G+  AVK+       +  +E V     EI +L  ++H NIV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVP 185
           LG    +    +    +  G+L +LL+   +        I + + Q   GL YLH     
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQILLGLEYLHDR--- 121

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRD+K  NIL+D+     LADFG+AK +   ++        GS  ++AP     Q  
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGG 178

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRS--AVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           YG        +D++S G  +LE+ +G+   +    +     I      +     P     
Sbjct: 179 YGL------AADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG-----RSKELPP----- 222

Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
                 +PD +  E    +   + C+   P+ RPT  E++ 
Sbjct: 223 ------IPDHLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 20/205 (9%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIRHRNIVKLLG 130
           IG+G  GVVYKA +   GE++A+KK+ K + + E +   A  EI++L  + H NI+KLL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK-IAVGSAQGLAYLHHDCVPAILH 189
              +K    L++ ++   +L +L++  +    E+  K       QGLA+ H      ILH
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILH 121

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTN--YHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           RD+K  N+L++++    LADFGLA+   S    Y H    V   + Y AP     +++ G
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH---YVVTRW-YRAP-----ELLLG 172

Query: 248 YTMNITEKSDVYSYGVVLLEILSGR 272
                +   D++S G +  E+LS R
Sbjct: 173 DKG-YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.8 bits (220), Expect = 3e-20
 Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 44/281 (15%)

Query: 70  ENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           ++ +G G  G VY+         +AVK L   K D   V+ F  E  ++  I+H N+V+L
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
           LG C+ +    ++  +++ GNL   L+    + ++      +A   +  + YL       
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 124

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
            +HRD+   N L+   +   +ADFGL++LM                 Y A    K  I +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------------YTAHAGAKFPIKW 171

Query: 247 ----GYTMN-ITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
                   N  + KSDV+++GV+L EI +   +  P I D   + E ++K      P   
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKGYRMERP--- 227

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                 +G P ++ + M         C   +P++RP+  E+
Sbjct: 228 ------EGCPPKVYELMRA-------CWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 72/291 (24%), Positives = 122/291 (41%), Gaps = 57/291 (19%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
            VIG G + VVY A  +PN E +A+K++   K     VD    E+Q +    H N+VK  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKY- 64

Query: 130 GYCS--NKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAV---GSAQGLAYLHHDCV 184
            Y S        L+  Y+S G+L  +++ +          IA       +GL YLH +  
Sbjct: 65  -YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLM--NSTNYHHAMSRVAGSYGYIAPGKCKL 242
              +HRD+K  NILL       +ADFG++  +               G+  ++AP    +
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE--VM 178

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
           + ++GY      K+D++S+G+  +E+ +G +                     S  P + +
Sbjct: 179 EQVHGY----DFKADIWSFGITAIELATGAAP-------------------YSKYPPMKV 215

Query: 303 LDTKLQGLPDQM------------VQEMLQTLGIAMFCVNSSPAERPTMKE 341
           L   LQ  P  +             ++M+        C+   P++RPT +E
Sbjct: 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISL------CLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 36/290 (12%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLL 129
           V+G+G  GVV K      GE++A+KK +K   D+E V   A  E+++L  +RH NIV L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLH-HDCVPAI 187
                K    L++ Y+    L +LL+ +   L  +          Q +AY H H+ +   
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII--- 122

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
            HRD+K  NIL+       L DFG A+ + +         VA  + Y AP     +++ G
Sbjct: 123 -HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAP-----ELLVG 175

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW-VKKKMGSFEPAVSIL--- 303
            T N  +  DV++ G ++ E+L G   + P  GD      + ++K +G   P+   L   
Sbjct: 176 DT-NYGKPVDVWAIGCIMAELLDGE-PLFP--GDSDIDQLYLIQKCLGPLPPSHQELFSS 231

Query: 304 DTKLQGL--PDQMVQEMLQ----------TLGIAMFCVNSSPAERPTMKE 341
           + +  G+  P+    E L+           L     C+   P ER T  E
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 73/298 (24%), Positives = 132/298 (44%), Gaps = 59/298 (19%)

Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNI 125
           +G+G  G V KAE            +AVK L K    E+ +    +E++++  I +H+NI
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--------NLDWETRYKI--------A 169
           + LLG C+ +    ++  Y ++GNL+  L+  R        +        +        A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
              A+G+ +L        +HRD+   N+L+   +   +ADFGLA+ ++  +Y+   +   
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLH-IVE 287
               ++AP +     +Y      T +SDV+S+GV+L EI + G S   P  G  +  + +
Sbjct: 196 LPVKWMAP-EALFDRVY------THQSDVWSFGVLLWEIFTLGGS---PYPGIPVEELFK 245

Query: 288 WVK--KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            +K   +M            K Q    ++   M         C +  P++RPT K++V
Sbjct: 246 LLKEGYRM-----------EKPQNCTQELYHLMRD-------CWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 46/287 (16%)

Query: 71  NVIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            VIGKG  G VY   +   +G+ I  AVK L +   D E V+ F  E  I+    H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 127 KLLGYC-SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVG----SAQGLAYLHH 181
            LLG C  ++   L++  Y+ +G+L+  +   R+       K  +G     A+G+ YL  
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYLAS 116

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC- 240
                 +HRD+   N +LD  +   +ADFGLA+ +    Y+   +          P K  
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL----PVKWM 169

Query: 241 ---KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
               LQ     T   T KSDV+S+GV+L E+++  +   P + D   I  ++ +     +
Sbjct: 170 ALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQGRRLLQ 223

Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
           P         +  PD + + ML        C +  P  RPT  E+V+
Sbjct: 224 P---------EYCPDPLYEVMLS-------CWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.0 bits (213), Expect = 2e-19
 Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 32/216 (14%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVD---SFAAEIQILGHIRHRNIVKLL 129
           IGKG  G VYK  +     +AVK    T R   P D    F  E +IL    H NIVKL+
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
           G C  K    ++   +  G+L   L+  +N L  +   ++++ +A G+ YL        +
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---I 115

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+   N L+       ++DFG             MSR      Y      K QI   +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFG-------------MSREEEGGIYTVSDGLK-QIPIKW 161

Query: 249 T----MNI---TEKSDVYSYGVVLLEILSGRSAVQP 277
           T    +N    T +SDV+SYG++L E  S      P
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E + + + +G+G  G V K  + N  +I   K   T  + +       E++I    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 125 IVKLLGYCSNKSVKLL--LYNYISNGNLQQLL-----QGNRNLDWETRYKIAVGSAQGLA 177
           IVK  G   ++S   +     Y   G+L  +      +G R +  +   KIA    +GL+
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLS 119

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIA 236
           YLH      I+HRD+K +NILL  K +  L DFG++ +L+NS     A +    S+ Y+A
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSF-YMA 171

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           P +     I G   +IT  SDV+S G+ LLE+   R
Sbjct: 172 PER-----IQGKPYSIT--SDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 85.3 bits (211), Expect = 5e-19
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 25/210 (11%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKL----WKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           N IGKG  GVV+K     +  + A+K++       +  EE +D    E ++L  +    I
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYI 61

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
           ++      +K    ++  Y  NG+L +LL  Q  R L  +  ++  +    GLA+LH   
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCKL 242
              ILHRD+K  N+ LD+     + D G+AKL++ +TN+ + +    G+  Y++P  C+ 
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI---VGTPYYLSPELCED 175

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           +          EKSDV++ GVVL E  +G+
Sbjct: 176 K-------PYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.6 bits (212), Expect = 5e-19
 Identities = 81/291 (27%), Positives = 118/291 (40%), Gaps = 49/291 (16%)

Query: 72  VIGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
            IG+G  G VY+     P  E IAV  K  K        + F  E  I+    H +IVKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 129 LGYCSNKSVKLL--LYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHH-DCV 184
           +G  +   V ++  L      G L+  LQ N+  LD  +    +   +  LAYL     V
Sbjct: 73  IGVITENPVWIVMELAPL---GELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV 129

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
               HRD+   N+L+ S     L DFGL++ +   +Y+ A S+      ++AP     + 
Sbjct: 130 ----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA-SKGKLPIKWMAPESINFR- 183

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK--MGSFEPAVSI 302
                   T  SDV+ +GV + EIL     V+P         + VK    +G  E     
Sbjct: 184 ------RFTSASDVWMFGVCMWEILM--LGVKP--------FQGVKNNDVIGRIE----- 222

Query: 303 LDTKLQG--LPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVK 350
                 G  LP  M      TL   M  C    P++RP   E+ A L ++ 
Sbjct: 223 -----NGERLP--MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 24/214 (11%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLW-------KTKRDEEPVDSFAAEIQILGHIRHR 123
           +IG G  G VY      +GEL+AVK++           R    +D+ A EI +L  ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA-QGLAYLHHD 182
           NIV+ LG   +     +   Y+  G++  LL      + ET  +  V    +GL YLH+ 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE-ETLVRNFVRQILKGLNYLHNR 125

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM--NSTNYHHAMSR--VAGSYGYIAPG 238
               I+HRD+K  NIL+D+K    ++DFG++K +  NS +     +R  + GS  ++AP 
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             K Q  Y      T K+D++S G +++E+L+G+
Sbjct: 183 VVK-QTSY------TRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 60/279 (21%)

Query: 89  GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC---SNKSVKLLLYNYI 145
           GE++AVKKL  +    E +  F  EI+IL  ++H NIVK  G C     ++++L++  Y+
Sbjct: 33  GEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM-EYL 89

Query: 146 SNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLH-HDCVPAILHRDVKCNNILLDSKY 203
             G+L+  LQ +R  LD       A    +G+ YL     V    HRD+   NIL++S+ 
Sbjct: 90  PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYV----HRDLATRNILVESEN 145

Query: 204 EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT-MNITE-----KSD 257
              + DFGL K++     ++ +           PG+     I+ Y   ++TE      SD
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVRE---------PGESP---IFWYAPESLTESKFSVASD 193

Query: 258 VYSYGVVLLEIL--SGRSAVQP-----QIGDG-------LHIVEWVKKKMGSFEPAVSIL 303
           V+S+GVVL E+   S +S   P      +G+         H++E +K       P     
Sbjct: 194 VWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAP----- 248

Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                G P ++   M +       C N+ P++RP+  E+
Sbjct: 249 ----PGCPAEIYAIMKE-------CWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)

Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+GC G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS------------ 172
           I+ LLG C+      ++  Y S GNL++ L+  R    E  Y IA               
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 173 ----AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 143 TYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P I
Sbjct: 199 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYPGI 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 42/266 (15%)

Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNL 150
           +AVK L  T    E  ++  +E++I+ H+  H NIV LLG C+     L++  Y   G+L
Sbjct: 68  VAVKMLKPTAHSSER-EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126

Query: 151 QQLLQGNRN--LDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYL 207
              L+  R   L  E     +   A+G+A+L   +C+    HRD+   N+LL       +
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNVLLTHGKIVKI 182

Query: 208 ADFGLAK-LMNSTNYHHAMSRVAGS----YGYIAPGKCKLQIIYGYTMNITEKSDVYSYG 262
            DFGLA+ +MN +NY      V G+      ++AP +     +Y      T +SDV+SYG
Sbjct: 183 CDFGLARDIMNDSNY-----VVKGNARLPVKWMAP-ESIFNCVY------TFESDVWSYG 230

Query: 263 VVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTL 322
           ++L EI S  S   P +       + +K+     +P  +         P ++  ++++T 
Sbjct: 231 ILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA---------PAEIY-DIMKT- 279

Query: 323 GIAMFCVNSSPAERPTMKEVVALLME 348
                C ++ P +RPT K++V L+ +
Sbjct: 280 -----CWDADPLKRPTFKQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 37/278 (13%)

Query: 72  VIGKGCSG--VVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           V+GKG  G   +Y+    +  L+  K++  T+  E+       EI IL  ++H NI+   
Sbjct: 7   VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAV--GSAQGLAYLHHDCVPAI 187
            +  + +  L+   Y + G L   +   +   +E    +         ++Y+H      I
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GI 122

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           LHRD+K  NI L       L DFG++K++  + Y  A + V   Y Y++P  C+     G
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVVGTPY-YMSPELCQ-----G 175

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM-GSFEPAVSILDTK 306
              N   KSD+++ G VL E+L+ +        D  + +  V K + G++ P VS+  ++
Sbjct: 176 VKYN--FKSDIWALGCVLYELLTLKRTF-----DATNPLNLVVKIVQGNYTPVVSVYSSE 228

Query: 307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
           L      +V  +LQ            P +RPT  EV+ 
Sbjct: 229 LI----SLVHSLLQQ----------DPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 18/207 (8%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKL-WKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           N IG+G  G+VY+A +  +GE++A+KK+    +RD  P+ S   EI +L ++RH NIV+L
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVEL 71

Query: 129 LGYCSNKSVK--LLLYNYISNGNLQQLLQGNRNLDWETRYK-IAVGSAQGLAYLHHDCVP 185
                 K +    L+  Y    +L  LL        E++ K + +   +GL YLH +   
Sbjct: 72  KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF-- 128

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I+HRD+K +N+LL  K    +ADFGLA+            +V  +  Y AP     +++
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVV-TLWYRAP-----ELL 180

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGR 272
            G T   T   D+++ G +L E+L+ +
Sbjct: 181 LGCT-TYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 41/286 (14%)

Query: 73  IGKGCSGVVYKAE--MPNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +G G  GVV + E     G++I  AVK L K+ +  + +D F  E  I+  + H N+++L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
            G      + ++       G+L   L      +    T    AV  A G+ YL       
Sbjct: 62  YGVVLTHPLMMV-TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---R 117

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGL--AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
            +HRD+   NILL S  +  + DFGL  A   N  +Y          + + AP   +   
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLR--- 173

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSI 302
               T   +  SDV+ +GV L E+ + G    +P  G  G  I++ + K+    E     
Sbjct: 174 ----TRTFSHASDVWMFGVTLWEMFTYGE---EPWAGLSGSQILKKIDKEGERLE----- 221

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
              + +  P  +   MLQ       C   +PA+RPT   +   L E
Sbjct: 222 ---RPEACPQDIYNVMLQ-------CWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 2e-18
 Identities = 56/168 (33%), Positives = 80/168 (47%), Gaps = 45/168 (26%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNI 125
           K E  +G+G  GVVYKA +   GE++A+KK+ +   +EE + S A  EI +L  ++H NI
Sbjct: 3   KLEK-LGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 126 VKLLG-YCSNKSVKLL-------LYNYISNGN-----------LQQLLQGNRNLDWETRY 166
           VKLL    + + + L+       L  Y+               + QLL+G          
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRG---------- 110

Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
                    LAY H      ILHRD+K  NIL++      LADFGLA+
Sbjct: 111 ---------LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 80/298 (26%), Positives = 122/298 (40%), Gaps = 56/298 (18%)

Query: 73  IGKGCSGVVYKAEMPN---GE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           IG+G  G V++A  P     E   ++AVK L +    +   D F  E  ++    H NIV
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDHPNIV 71

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR----------------------NLDWET 164
           KLLG C+      LL+ Y++ G+L + L+                          L    
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
           +  IA   A G+AYL        +HRD+   N L+       +ADFGL++ + S +Y+ A
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH 284
               A    ++ P      I Y      T +SDV++YGVVL EI S    +QP  G    
Sbjct: 189 SENDAIPIRWMPPE----SIFYN---RYTTESDVWAYGVVLWEIFS--YGMQPYYG---- 235

Query: 285 IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                   M   E    + D  +   PD    E+   +     C +  P++RP+   +
Sbjct: 236 --------MAHEEVIYYVRDGNVLSCPDNCPLELYNLM---RLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.7 bits (204), Expect = 5e-18
 Identities = 72/291 (24%), Positives = 124/291 (42%), Gaps = 47/291 (16%)

Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           E   GK   G +Y   M + +L+A+K L K   + +    F  E  ++  + H NIV LL
Sbjct: 15  ECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVCLL 73

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLL-----------------QGNRNLDWETRYKIAVGS 172
           G  + +    +L+ Y++ G+L + L                     +LD      IA+  
Sbjct: 74  GVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI 133

Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+ YL        +H+D+   NIL+  +    ++D GL++ + S +Y+    +     
Sbjct: 134 AAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKK 291
            ++ P      I+YG     +  SD++S+GVVL EI S    +QP  G     ++E V+K
Sbjct: 191 RWMPPEA----IMYG---KFSSDSDIWSFGVVLWEIFS--FGLQPYYGFSNQEVIEMVRK 241

Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           +          L    +  P +M   M +       C    P+ RP  K++
Sbjct: 242 RQ---------LLPCSEDCPPRMYSLMTE-------CWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 6e-18
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 29/207 (14%)

Query: 71  NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             IG G  G VYKA     GEL+A+K +     D+   +    EI +L   RH NIV   
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD--FEIIQQEISMLKECRHPNIVAYF 66

Query: 130 G-YCSNKSVKL-LLYNYISNGNLQQLLQ-GNRNLDWETRYKIA---VGSAQGLAYLHHDC 183
           G Y      KL ++  Y   G+LQ + Q     L   +  +IA     + +GLAYLH   
Sbjct: 67  GSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPL---SELQIAYVCRETLKGLAYLHETG 121

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAPGKC 240
               +HRD+K  NILL    +  LADFG++  + +T     +++     G+  ++AP   
Sbjct: 122 K---IHRDIKGANILLTEDGDVKLADFGVSAQLTAT-----IAKRKSFIGTPYWMAPEVA 173

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLE 267
            ++   GY      K D+++ G+  +E
Sbjct: 174 AVERKGGY----DGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 82.3 bits (203), Expect = 8e-18
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 23/291 (7%)

Query: 67  LKDENVIGKGCSGVV--YKAEMPN---GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LK   V+G+G  G V  Y  +  N   GE++AVK L K +  ++    +  EI IL  + 
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLY 64

Query: 122 HRNIVKLLGYCSNKSVK--LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYL 179
           H NIVK  G CS +  K   L+  Y+  G+L+  L  +  L+       A    +G+AYL
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYL 123

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H       +HRD+   N+LLD+     + DFGLAK +   + ++ +     S  +    +
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
           C  +  + Y       SDV+S+GV L E+L+   + Q        ++   K+   +    
Sbjct: 181 CLKENKFSYA------SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG-PKQGQMTVVRL 233

Query: 300 VSILDTKLQ-GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
           + +L+  ++   P    QE+     +   C  +    RPT + ++ +L E+
Sbjct: 234 IELLERGMRLPCPKNCPQEVYI---LMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIV 126
            V+GKG  G VY      G+LIAVK++     +    E+  +    E+ +L  ++H NIV
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
           + LG C + +   +   ++  G++  +L     L      K       G+AYLH++CV  
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV-- 123

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAK--LMNSTNYHHA--MSRVAGSYGYIAPGKCKL 242
            +HRD+K NN++L       L DFG A+       +  H+  +  + G+  ++AP     
Sbjct: 124 -VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP----- 177

Query: 243 QII----YGYTMNITEKSDVYSYGVVLLEILSGR 272
           ++I    YG       KSD++S G  + E+ +G+
Sbjct: 178 EVINESGYG------RKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 16/209 (7%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA---EIQILGHIRH 122
           L+   ++G G  G V+K   +P G+ I +    KT +D     +F      +  +G + H
Sbjct: 9   LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHH 181
             IV+LLG C   S++L+       G+L   ++ +R +LD +      V  A+G+ YL  
Sbjct: 69  AYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
                ++HR++   NILL S     +ADFG+A L+   +  +  S       ++A     
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE--- 181

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILS 270
             I++G     T +SDV+SYGV + E++S
Sbjct: 182 -SILFG---RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 81.3 bits (201), Expect = 1e-17
 Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 41/272 (15%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G V++    N   +AVK L   K        F AE QI+  +RH  +++L   C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 133 SNKSVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           + +    ++   +  G+L + LQG   R L       +A   A G+AYL        +HR
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHR 127

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKCKLQIIYGY 248
           D+   N+L+       +ADFGLA+++    Y    +R    +   + AP       +Y  
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYE---AREGAKFPIKWTAPEA----ALYN- 179

Query: 249 TMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSILDTK 306
               + KSDV+S+G++L EI++ GR    P  G     +++ V +      P        
Sbjct: 180 --RFSIKSDVWSFGILLTEIVTYGR---MPYPGMTNAEVLQQVDQGYRMPCPP------- 227

Query: 307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
             G P ++   ML        C    P +RPT
Sbjct: 228 --GCPKELYDIMLD-------CWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 34/219 (15%)

Query: 66  CLKDENVIGKGCSGVVYKAEMP-NGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
            +  E VIG G  G V +  +   G+    +A+K L     D++ +D F  E  I+G   
Sbjct: 5   YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFD 63

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLH 180
           H NI++L G  +     +++  Y+ NG+L + L+ N           +  G A G+ YL 
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY----GYI- 235
                  +HRD+   NIL++S     ++DFGL++ +  +           +Y    G I 
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---------ATYTTKGGKIP 171

Query: 236 ----APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               AP      I Y      T  SDV+S+G+V+ E++S
Sbjct: 172 IRWTAPEA----IAYR---KFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 77/246 (31%), Positives = 119/246 (48%), Gaps = 33/246 (13%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEE--PVDSFAAEIQILGHIRHRNIVK 127
             IG+G  G VYKA +   GEL+A+KK+ +   ++E  P+ +   EI+IL  + HRNIV 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIR-EIKILRQLNHRNIVN 70

Query: 128 LLGYCSNKSVKL----------LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLA 177
           L    ++K   L          L++ Y+ +  +  L  G  +   +          +GL 
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           Y H       LHRD+KC+NILL++K +  LADFGLA+L NS       ++V   + Y  P
Sbjct: 131 YCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW-YRPP 186

Query: 238 GKCKLQIIYG---YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
                +++ G   Y   I    DV+S G +L E+ + +   Q      L  +E + +  G
Sbjct: 187 -----ELLLGEERYGPAI----DVWSCGCILGELFTKKPIFQAN--QELAQLELISRLCG 235

Query: 295 SFEPAV 300
           S  PAV
Sbjct: 236 SPCPAV 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 24/213 (11%)

Query: 67  LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAA---EIQILGHIRH 122
           L+   V+G G  G VYK   +P GE + +    K  R+E    +      E  ++  + H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYL-- 179
            ++V+LLG C +  V  L+   +  G L   ++ ++ N+  +      V  A+G++YL  
Sbjct: 69  PHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM--NSTNYHHAMSRVAGSYGYIAP 237
                  ++HRD+   N+L+ +     + DFGLAKL+  +   YH    +V     ++A 
Sbjct: 128 KR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMAL 180

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            +  L  IY      T KSDV+SYGV + E+++
Sbjct: 181 -ESILHRIY------THKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G+V+         +A+K + +    EE    F  E Q++  + H  +V+L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 133 SNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
           + +S   L++ ++ +G L   L+  R     ET   + +   +G+AYL    V   +HRD
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV---IHRD 125

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+       ++DFG+ + +    Y         S G   P K     ++ ++  
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQY-------TSSTGTKFPVKWSSPEVFSFS-K 177

Query: 252 ITEKSDVYSYGVVLLEILS 270
            + KSDV+S+GV++ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 69/291 (23%), Positives = 122/291 (41%), Gaps = 46/291 (15%)

Query: 73  IGKGCSGVVYKA-----EMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+           E  +A+K + +     E ++ F  E  ++      ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETR----------YKIAVGSAQGL 176
           +LLG  S     L++   ++ G+L+  L+  R                  ++A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL        +HRD+   N ++       + DFG+ + +  T+Y+    +      ++A
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K     G     T KSDV+S+GVVL E+ +   A QP  G              S 
Sbjct: 190 PESLK----DGV---FTTKSDVWSFGVVLWEMAT--LAEQPYQGL-------------SN 227

Query: 297 EPAVS-ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E  +  ++D     LP+    ++L+   +   C   +P  RPT  E+V+ L
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLLE---LMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 74/296 (25%), Positives = 127/296 (42%), Gaps = 46/296 (15%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM-----PNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILG 118
           + +     +G G  G VY+           EL +AVK L ++  +++  D F  E  I+ 
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FLMEALIMS 64

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-------LDWETRYKIAVG 171
              H+NIV+L+G    +  + +L   ++ G+L+  L+ NR        L  +     A  
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRV 228
            A+G  YL  +     +HRD+   N LL  K     A +ADFG+A+ +   +Y+    R 
Sbjct: 125 VAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVE 287
                ++ P +  L  I+      T K+DV+S+GV+L EI S G      +      ++E
Sbjct: 182 MLPIKWMPP-EAFLDGIF------TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVME 232

Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           +V    G  +P         +G P  + + M         C   +P +RP    ++
Sbjct: 233 FVTGG-GRLDPP--------KGCPGPVYRIMTD-------CWQHTPEDRPNFATIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 89/333 (26%), Positives = 135/333 (40%), Gaps = 85/333 (25%)

Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGE-----------------LIA 93
            P Q LNF           E  +G+G  G V+  E    +                 L+A
Sbjct: 2   FPRQPLNFV----------EK-LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVA 50

Query: 94  VKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQL 153
           VK L     D    D F  E++IL  +   NI +LLG C+      ++  Y+ NG+L Q 
Sbjct: 51  VKVLRPDASDNARED-FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109

Query: 154 LQ-----------GNRNLDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDS 201
           LQ            +++L + T   +A   A G+ YL   + V    HRD+   N L+  
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV----HRDLATRNCLVGK 165

Query: 202 KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI-------IYGYTMNITE 254
            Y   +ADFG+++ + S++Y     RV G     AP    L I       +       T 
Sbjct: 166 NYTIKIADFGMSRNLYSSDY----YRVQGR----AP----LPIRWMAWESVLL--GKFTT 211

Query: 255 KSDVYSYGVVLLEILS-GRSAVQP--QIGDGLHIVEWVKKKMGSF--EPAVSILDTKLQG 309
           KSDV+++GV L EIL+  R   QP   + D     + V +  G F  +    I   +   
Sbjct: 212 KSDVWAFGVTLWEILTLCRE--QPYEHLTD-----QQVIENAGHFFRDDGRQIYLPRPPN 264

Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
            P  + + ML+       C      +RPT +E+
Sbjct: 265 CPKDIYELMLE-------CWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 74/296 (25%), Positives = 131/296 (44%), Gaps = 53/296 (17%)

Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+GC G V  AE        PN  +    K+ K    ++ +    +E++++  I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR----------------NLDWETRYKI 168
           I+ LLG C+      +L  Y S GNL++ L+  R                 L ++     
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           A   A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +++ +Y+   + 
Sbjct: 140 AYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV+L EI +   +  P    G+ + E
Sbjct: 196 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLLWEIFTLGGSPYP----GIPVEE 244

Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             K           + +      P     E+     I   C ++ P++RPT K++V
Sbjct: 245 LFK----------LLKEGHRMDKPANCTHELYM---IMRECWHAVPSQRPTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.1 bits (195), Expect = 6e-17
 Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 41/280 (14%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK---RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           V+G+G  G+V+       + + + K    +   +DE    +   E Q+L  + H NI++ 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER--LAAQNECQVLKLLSHPNIIEY 64

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPA 186
                     +++  Y   G L + +Q   N  LD +T     V   Q L  LHH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV---QILLALHHVHTKL 121

Query: 187 ILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
           ILHRD+K  NILLD       + DFG++K+++S +       V G+  YI+P  C+    
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCE---- 174

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM-GSFEPAVSILD 304
            G   N  +KSD+++ G VL E+ S + A      +  ++   V K M G+F P      
Sbjct: 175 -GKPYN--QKSDIWALGCVLYELASLKRAF-----EAANLPALVLKIMSGTFAPISDRYS 226

Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
             L+    Q++  ML          N  P++RP + +++A
Sbjct: 227 PDLR----QLILSML----------NLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.5 bits (196), Expect = 7e-17
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            +  V+GKG  G+VY A ++     IA+K++   +RD   V     EI +  +++HRNIV
Sbjct: 11  GERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIV 68

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDC 183
           + LG  S      +    +  G+L  LL+       +    I   + Q   GL YLH + 
Sbjct: 69  QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127

Query: 184 VPAILHRDVKCNNILLDSKYEAYL--ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
              I+HRD+K +N+L+++ Y   +  +DFG +K +   N         G+  Y+AP    
Sbjct: 128 --QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAP---- 178

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            ++I          +D++S G  ++E+ +G+
Sbjct: 179 -EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 21/207 (10%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G VYKA+     L A  K+ + +  EE ++ F  EI IL   +H NIV L    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 133 SNKSVKLLLYNYISNGNLQQL-LQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
             ++   +L  +   G L  + L+  R L   T  +I     Q    L +LH      ++
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGL---TEPQIRYVCRQMLEALNFLHSH---KVI 125

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  NILL    +  LADFG++    ST          G+  ++AP     +++   
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAP-----EVVACE 178

Query: 249 TMNITE---KSDVYSYGVVLLEILSGR 272
           T        K+D++S G+ L+E+    
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 56/298 (18%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHIRHRNIVKLL 129
           IG+G  GVV+K      G+++A+KK    + +++PV    A  EI++L  ++H N+V L+
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAIL 188
                K    L++ Y  +  L +L +  R +      KI   + Q + + H H+C+    
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI---- 122

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNS-----TNYHHAMSRVAGSYGYIAPGKCKLQ 243
           HRDVK  NIL+  + +  L DFG A+++       T+Y      VA  + Y AP      
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY------VATRW-YRAPELLVGD 175

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILS------GRSAVQPQIGDGLHIVEWVKKKMGSFE 297
             YG  +      DV++ G V  E+L+      G+S V     D L++   ++K +G   
Sbjct: 176 TQYGPPV------DVWAIGCVFAELLTGQPLWPGKSDV-----DQLYL---IRKTLGDLI 221

Query: 298 PA-VSILDT----KLQGLPDQMVQEML---------QTLGIAMFCVNSSPAERPTMKE 341
           P    I  T    K   +P+   +E L           L     C+   P ER + +E
Sbjct: 222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 86/295 (29%), Positives = 137/295 (46%), Gaps = 50/295 (16%)

Query: 64  LECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH 122
           LE + D   +G G  G V K + +P G ++A KK+               E+QI+   R 
Sbjct: 7   LETISD---LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRS 62

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD 182
             IV   G   N++   +   ++  G+L ++ +    +  E   KIAV   +GL YL++ 
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN- 121

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
            V  I+HRD+K +NIL++S+ +  L DFG++ +L+NS     A + V G+  Y++P +  
Sbjct: 122 -VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFV-GTSTYMSPER-- 173

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRS--AVQPQIGDGLHIVEWVKKKMGSFEPA 299
              I G     T KSDV+S G+ ++E+  G+   A      D            G  +P 
Sbjct: 174 ---IQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------------GQDDPM 216

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMF----------CVNSSPAERPTMKEVVA 344
             ILD     L  Q+VQE    L  + F          C+   P ERPT +++ A
Sbjct: 217 -GILD-----LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 22/214 (10%)

Query: 67  LKDENVIGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LK    +G+G  G V    Y  E  N GE +AVK L K +     +     EI+IL ++ 
Sbjct: 6   LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLY 64

Query: 122 HRNIVKLLGYCSN---KSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLA 177
           H NIVK  G C+      +KL++  ++ +G+L++ L  N+N ++ + + K AV   +G+ 
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIA 236
           YL        +HRD+   N+L++S+++  + DFGL K +     Y+     +     + A
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           P +C +Q  +         SDV+S+GV L E+L+
Sbjct: 181 P-ECLIQSKF------YIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 47/234 (20%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHI-RHRN 124
           K   +IG+G    V  A E    +  A+K L K +   E+ V     E ++L  +  H  
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWE-TRYKIAVGSAQ---GLAYLH 180
           I+KL     ++     +  Y  NG L Q ++   +LD + TR+  A    +    L YLH
Sbjct: 64  IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA----EILLALEYLH 119

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH--------------HAMS 226
                 I+HRD+K  NILLD      + DFG AK+++  +                    
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 227 RVAGSY-G---YIAP----GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           R   S+ G   Y++P     K              + SD+++ G ++ ++L+G+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKP-----------AGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 31/212 (14%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVD-SFAA--EIQILGHIRHRNIVKL 128
           +G+G   VVYKA     G ++A+KK+   +R E     +F A  EI++L  ++H NI+ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 129 LG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK-IAVGSAQGLAYLHHDCVPA 186
           L  +    ++ L+   ++   +L+++++    +      K   + + +GL YLH +    
Sbjct: 68  LDVFGHKSNINLVF-EFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---W 122

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY---HHAMSRVAGSYGYIAPGKCKLQ 243
           ILHRD+K NN+L+ S     LADFGLA+   S N    H  ++R      Y AP     +
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAP-----E 172

Query: 244 IIYG---YTMNITEKSDVYSYGVVLLEILSGR 272
           +++G   Y + +    D++S G +  E+L   
Sbjct: 173 LLFGARHYGVGV----DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 71/286 (24%), Positives = 120/286 (41%), Gaps = 55/286 (19%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKL-WKTKRDEEPVDSFAAEIQILGHIRHRNIVK--- 127
           +GKG  G VYK + + + +  A+K++   +   +E  D+   EI+IL  + H NI+    
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPNIISYKE 66

Query: 128 --LLGYCSNKSVKLL-------LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAY 178
             L G   NK   ++       L   IS    ++     + +  +  ++I +   +GL  
Sbjct: 67  AFLDG---NKLCIVMEYAPFGDLSKAISKRKKKR-----KLIPEQEIWRIFIQLLRGLQA 118

Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH      ILHRD+K  NILL +     + D G++K++             G+  Y+AP 
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPE 171

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             K +  Y Y      KSD++S G +L E+ +     + +    L      K + G + P
Sbjct: 172 VWKGR-PYSY------KSDIWSLGCLLYEMATFAPPFEARSMQDLR----YKVQRGKYPP 220

Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
              I    LQ      ++ MLQ            P  RP   +++A
Sbjct: 221 IPPIYSQDLQ----NFIRSMLQV----------KPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 38/226 (16%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQIL---GHI 120
           +K ++VIG+G  G V KA +    L    A+K++ +    ++  D FA E+++L   GH 
Sbjct: 9   IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGH- 66

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS-------- 172
            H NI+ LLG C ++    L   Y  +GNL   L+ +R L+ +  + IA  +        
Sbjct: 67  -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 173 --------AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
                   A+G+ YL        +HRD+   NIL+   Y A +ADFGL++          
Sbjct: 126 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKT 181

Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           M R+   +  I      +     YT N    SDV+SYGV+L EI+S
Sbjct: 182 MGRLPVRWMAIESLNYSV-----YTTN----SDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 38/286 (13%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+    +G G  G V+         +AVK L   K      +SF  E QI+  +RH  
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDK 62

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S G+L   L+    R L       +A   A G+AY+   
Sbjct: 63  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER- 120

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKC 240
                +HRD++  NIL+       +ADFGLA+L+    Y    +R    +   + AP   
Sbjct: 121 --MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAA 175

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
               +YG     T KSDV+S+G++L E+++      P + +   ++E V++      P  
Sbjct: 176 ----LYG---RFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRMPCP-- 225

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
                  Q  P  + + MLQ       C    P ERPT + + + L
Sbjct: 226 -------QDCPISLHELMLQ-------CWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 74/296 (25%), Positives = 130/296 (43%), Gaps = 53/296 (17%)

Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+GC G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR----------------NLDWETRYKI 168
           I+ LLG C+      ++  Y S GNL++ L+  R                 L ++     
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           A   A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ ++  +Y+   + 
Sbjct: 146 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E
Sbjct: 202 GRLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEE 250

Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             K           + +      P     E+   +     C ++ P++RPT K++V
Sbjct: 251 LFK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 60/218 (27%), Positives = 110/218 (50%), Gaps = 22/218 (10%)

Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV K +     LI  +KL   +      +    E+Q+L    
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61

Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++  G+L Q+L+  + +  E   K+++   +GLAYL 
Sbjct: 62  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 121 EK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 173

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 174 LQ-------GTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.6 bits (191), Expect = 8e-16
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 31/212 (14%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           N IG G  G VYK    P G L A+K ++    ++        EI+IL  + H N+VK  
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCH 138

Query: 130 G-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             +  N  +++LL  ++  G+L+    G    D +    +A     G+AYLH      I+
Sbjct: 139 DMFDHNGEIQVLL-EFMDGGSLE----GTHIADEQFLADVARQILSGIAYLHRR---HIV 190

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM----SRVAGSYGYIAPGKCKLQI 244
           HRD+K +N+L++S     +ADFG+++++  T     M    S V G+  Y++P +    +
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQT-----MDPCNSSV-GTIAYMSPERINTDL 244

Query: 245 ---IY-GYTMNITEKSDVYSYGVVLLEILSGR 272
               Y GY        D++S GV +LE   GR
Sbjct: 245 NHGAYDGYA------GDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 65/228 (28%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL-- 129
           IG+G  G+V+KA +   GE +A+KK+   + +    +    EI+ L   +H  +VKLL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 130 -----------GYCSNKSVKLLLYNYISN-----------GNLQQLLQGNRNLDWETRYK 167
                       Y  +      L   + +             ++ LL+G           
Sbjct: 68  FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKG----------- 111

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
                   +AY+H +    I+HRD+K  N+L+ +     +ADFGLA+L +        S 
Sbjct: 112 --------VAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSH 159

Query: 228 VAGSYGYIAPGKCKLQIIYG---YTMNITEKSDVYSYGVVLLEILSGR 272
              +  Y AP     +++YG   Y   +    D+++ G +  E+L+G 
Sbjct: 160 QVATRWYRAP-----ELLYGARKYDPGV----DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDE-EPVDSFAAEIQILGHIRHRNIVKL 128
            VIGKG  G V   +     ++ A+K + K K  E   V +   E +IL  + H  +V L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 129 -LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
              +   +++ L++ + +  G+L+  L        E            L YLH      I
Sbjct: 66  WYSFQDEENMYLVV-DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GI 121

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           +HRD+K +NILLD +   ++ DF +A K+   T      +  +G+ GY+AP     +++ 
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----TTSTSGTPGYMAP-----EVLC 172

Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
               ++    D +S GV   E L G+
Sbjct: 173 RQGYSV--AVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)

Query: 73  IGKGCSGVVYKA--EMPNGELI--AVKKLWKTKRDEEPVDS--FAAEIQILGHIRHRNIV 126
           +G G  G V K    M +G+ +  AVK L   K++        F  E  ++  + H  IV
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL---KQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
           +L+G C  + + L++      G L + L+  R +      ++A   A G+AYL       
Sbjct: 60  RLIGVCKGEPLMLVM-ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---H 115

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNS-TNYHHAMSRVAGSY--GYIAPGKCKLQ 243
            +HRD+   N+LL ++++A ++DFG+++ + + ++Y+ A    AG +   + AP     +
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA--TTAGRWPLKWYAP-----E 168

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILS 270
            I       + KSDV+SYGV L E  S
Sbjct: 169 CINYGKF--SSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 76/310 (24%), Positives = 136/310 (43%), Gaps = 57/310 (18%)

Query: 73  IGKGCSGVVYKAEMPNGE--------LIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHR 123
           +G+GC G V +AE    +         +AVK L     D++  D   +E++++  I +H+
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD-LISEMELMKLIGKHK 78

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR----------------NLDWETRYK 167
           NI+ LLG C+ +    ++  Y + GNL++ L+  R                 L ++    
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 168 IAVGSAQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
            A   A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ ++  +Y+   S
Sbjct: 139 CAYQVARGMEYLESRRCI----HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
                  ++AP +     +Y      T +SDV+S+G+++ EI +   +  P I       
Sbjct: 195 NGRLPVKWMAP-EALFDRVY------THQSDVWSFGILMWEIFTLGGSPYPGI------- 240

Query: 287 EWVKKKMGSFEPAVSIL-DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
                     E    +L +      P     E+     +   C ++ P +RPT K++V  
Sbjct: 241 --------PVEELFKLLREGHRMDKPSNCTHEL---YMLMRECWHAVPTQRPTFKQLVEA 289

Query: 346 LMEVKSAPEE 355
           L +V +A  E
Sbjct: 290 LDKVLAAVSE 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 70/283 (24%), Positives = 131/283 (46%), Gaps = 38/283 (13%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKL---WKTKRDEEPV-DSFAAEIQILGHIRHRNIV 126
            +G G     Y+A ++  G L+AVK++     T  ++E V ++   EI+++  + H +I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
           ++LG     S   L   +++ G++  LL   G         Y   +   +GL+YLH +  
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL--LRGLSYLHEN-- 122

Query: 185 PAILHRDVKCNNILLDSK-YEAYLADFGLAKLMNS--TNYHHAMSRVAGSYGYIAPGKCK 241
             I+HRDVK  N+L+DS      +ADFG A  + +  T       ++ G+  ++AP    
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP---- 177

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP-QIGDGLHIVEWVKKKMGSFEPAV 300
            +++ G         DV+S G V++E+ + +      +  + L ++     K+ S   A 
Sbjct: 178 -EVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIASATTAP 230

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           SI +    GL D           + + C+   P +RP  +E++
Sbjct: 231 SIPEHLSPGLRD-----------VTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 38/286 (13%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 62

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S G+L   L+G   + L       +A   A G+AY+   
Sbjct: 63  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 120

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKC 240
                +HRD++  NIL+       +ADFGLA+L+    Y    +R    +   + AP   
Sbjct: 121 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAA 175

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
               +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P  
Sbjct: 176 ----LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCP 225

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
                     P+ +   M Q       C    P ERPT + + A L
Sbjct: 226 P-------ECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 66/223 (29%), Positives = 93/223 (41%), Gaps = 44/223 (19%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLL 129
           VIG+G  G VYKA     G+L+A+K +     DEE  +    E  IL     H NI    
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEE--EEIKEEYNILRKYSNHPNIATFY 69

Query: 130 G-------------------YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAV 170
           G                    C   SV  L+         + L +  + L  E    I  
Sbjct: 70  GAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---------KGLRKKGKRLKEEWIAYILR 120

Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG 230
            + +GLAYLH + V   +HRD+K  NILL    E  L DFG++  ++ST          G
Sbjct: 121 ETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IG 175

Query: 231 SYGYIAPG--KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           +  ++AP    C  Q    Y      +SDV+S G+  +E+  G
Sbjct: 176 TPYWMAPEVIACDEQPDASYDA----RSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 23/209 (11%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
                IGKG  G VYKA +    +++A+K +   +  E+ ++    EIQ L   R   I 
Sbjct: 4   TLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
           K  G    K  KL ++  Y   G+   LL+  + LD      I      GL YLH +   
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGK- 119

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAPGKCKL 242
             +HRD+K  NILL  + +  LADFG++  + ST     MS+     G+  ++AP     
Sbjct: 120 --IHRDIKAANILLSEEGDVKLADFGVSGQLTST-----MSKRNTFVGTPFWMAP----- 167

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           ++I     +  EK+D++S G+  +E+  G
Sbjct: 168 EVIKQSGYD--EKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 38/228 (16%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNG--ELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-R 121
           E +K E+VIG+G  G V +A +     ++ A  K+ K    E     FA E+++L  +  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY--------------- 166
           H NI+ LLG C N+    +   Y   GNL   L+ +R L+ +  +               
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 167 -KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
            + A   A G+ YL        +HRD+   N+L+     + +ADFGL             
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGL------------- 165

Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMN---ITEKSDVYSYGVVLLEILS 270
           SR    Y     G+  ++ +   ++N    T KSDV+S+GV+L EI+S
Sbjct: 166 SRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 80/300 (26%), Positives = 126/300 (42%), Gaps = 60/300 (20%)

Query: 66  CLKDENVIGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRH 122
            +  + VIG G  G V++   +MP  + +AV  K  K    E+    F +E  I+G   H
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWE-TRYKIA---VGSAQGLAY 178
            NI++L G  +     +++  Y+ NG L + L   R+ D E + Y++     G A G+ Y
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKY 122

Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS---YGYI 235
           L        +HRD+   NIL++S  E  ++DFGL++++   +        +G      + 
Sbjct: 123 LSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSGGKIPIRWT 177

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS---------GRSAVQPQIGDGLHIV 286
           AP      I Y      T  SDV+S+G+V+ E++S             V   I DG  + 
Sbjct: 178 APEA----IAY---RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL- 229

Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
                      PA           P  + Q MLQ       C     A RP   ++V LL
Sbjct: 230 -----------PAP-------MDCPSAVYQLMLQ-------CWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 5e-15
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 17/204 (8%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEE---PVDSFAAEIQILGHIRHRNIVKL 128
           +G+G  G VY   ++  G  +AVK++       E    V++   EIQ+L +++H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 129 LGYCSNKSVKLLLY-NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
            G C      L ++  Y+  G+++  L+    L      K      +G+ YLH +    I
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MI 125

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH-AMSRVAGSYGYIAPGKCKLQIIY 246
           +HRD+K  NIL DS     L DFG +K + +       M  V G+  +++P     ++I 
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP-----EVIS 180

Query: 247 GYTMNITEKSDVYSYGVVLLEILS 270
           G       K+DV+S G  ++E+L+
Sbjct: 181 GEGYG--RKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.9 bits (181), Expect = 5e-15
 Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 38/286 (13%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ +  +G+GC G V+         +A+K L   K      ++F  E QI+  +RH  
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDK 62

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHD 182
           +V L    S + +  ++  ++  G+L   L+    + L       +A   A G+AY+   
Sbjct: 63  LVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER- 120

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKC 240
                +HRD++  NIL+       +ADFGLA+L+    Y    +R    +   + AP   
Sbjct: 121 --MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAA 175

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
               +YG     T KSDV+S+G++L E+++      P + +   ++E V++      P  
Sbjct: 176 ----LYG---RFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCP-- 225

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
                  QG P+ + + M         C    P ERPT + + + L
Sbjct: 226 -------QGCPESLHELMKL-------CWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 24/210 (11%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKT-KRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           I KG  G V+ A+  + G++ A+K + K     +  VD    E  IL   +   +VKL  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 131 YCSNKSVK--LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAI 187
           Y S +  K   L+  Y+  G+L  LL+   +LD +            L YLH +  +   
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII--- 115

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAK--LMNSTNYHHAMS----RVAGSYGYIAPGKCK 241
            HRD+K +NIL+DS     L DFGL+K  L+      +       R+ G+  YIAP    
Sbjct: 116 -HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP---- 170

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
            ++I G     ++  D +S G +L E L G
Sbjct: 171 -EVILG--QGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 51/289 (17%)

Query: 71  NVIGKGCSGVVY----KAEMPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
           N +G G  G VY       +  G     +AVK L K   D+E  + F  E  ++ +  H 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-------LDWETRYKIAVGSAQGL 176
           NIVKLLG C     + ++   +  G+L   L+  R        L  +    I +  A+G 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSK-YEA----YLADFGLAKLMNSTNYHHAMSRVAGS 231
            YL        +HRD+   N L+  K Y+A     + DFGLA+ +  ++Y+         
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWV 289
             ++AP +  L   +      T +SDV+S+GV++ EIL+ G+   QP    +   +++ V
Sbjct: 177 VRWMAP-ESLLDGKF------TTQSDVWSFGVLMWEILTLGQ---QPYPALNNQEVLQHV 226

Query: 290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
               G  +          +  PD++ Q M         C    P+ERPT
Sbjct: 227 TAG-GRLQKP--------ENCPDKIYQLMTN-------CWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 72/212 (33%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 73  IGKGCSGVVYK-AEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLG 130
           IGKG  G VYK     +G L AVK L      +E ++   AE  IL  +  H N+VK  G
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE---AEYNILQSLPNHPNVVKFYG 86

Query: 131 --YCSNKSV--KLLLYNYISNGN-----LQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH 181
             Y ++K V  +L L   + NG      ++ LL   + LD      I  G+  GL +LH+
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--K 239
           +    I+HRDVK NNILL ++    L DFG++  + ST      S   G+  ++AP    
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIA 201

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           C+ Q  Y Y      + DV+S G+  +E+  G
Sbjct: 202 CEQQYDYSY----DARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 37/221 (16%)

Query: 73  IGKGCSGVVYKAE----MPNGE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G V+ AE    +P  +  L+AVK L   +  E     F  E ++L  ++H++IV
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIV 70

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGN---------------RNLDWETRYKIAVG 171
           +  G C+     L+++ Y+ +G+L + L+ +                 L       IA  
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 172 SAQGLAYLH--HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
            A G+ YL   H      +HRD+   N L+       + DFG+++ + ST+Y+    R  
Sbjct: 131 IASGMVYLASLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P      I+Y      T +SD++S+GVVL EI +
Sbjct: 186 LPIRWMPPE----SILY---RKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 49/278 (17%)

Query: 91  LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL 150
           L+AVK L +   ++   + F  EI+I+  ++  NI++LL  C       ++  Y+ NG+L
Sbjct: 48  LVAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 151 QQLLQGNR-----------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL 199
            Q L  +             + + T   +A   A G+ YL        +HRD+   N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163

Query: 200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVA-----GSYGYIAPGKCKLQIIYGYTMNITE 254
              Y   +ADFG+++ + S +Y+    R        S+  I  GK             T 
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK------------FTT 211

Query: 255 KSDVYSYGVVLLEILSGRSAVQP--QIGDGLHIVEWVKKKMGSF--EPAVSILDTKLQGL 310
            SDV+++GV L EIL+     QP  Q+ D     E V +  G F  +    +   K    
Sbjct: 212 ASDVWAFGVTLWEILT-LCKEQPYSQLSD-----EQVIENTGEFFRDQGRQVYLPKPALC 265

Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           PD + + ML        C   +  ERP+ +E+ A L+E
Sbjct: 266 PDSLYKLMLS-------CWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 29/218 (13%)

Query: 66  CLKDENVIGKGCSGVVYKAEM-PNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           C+K E VIG G  G V +  +   G+    +A+K L K+   E+    F +E  I+G   
Sbjct: 5   CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFD 63

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAV------GSAQG 175
           H NI+ L G  +     +++  ++ NG L   L+ N     + ++ +        G A G
Sbjct: 64  HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN-----DGQFTVIQLVGMLRGIAAG 118

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYG- 233
           + YL        +HRD+   NIL++S     ++DFGL++ L + T+     S + G    
Sbjct: 119 MKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 234 -YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            + AP     +         T  SDV+SYG+V+ E++S
Sbjct: 176 RWTAPEAIAYR-------KFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 31/214 (14%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
            K+   IG+G SG VYKA +   G+ +A+KK+   K+++E       EI I+   +H NI
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE---LIINEILIMKDCKHPNI 77

Query: 126 VKLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA---QGLAYLH- 180
           V     Y     + +++  Y+  G+L  ++  N     E +  IA       QGL YLH 
Sbjct: 78  VDYYDSYLVGDELWVVM-EYMDGGSLTDIITQNFVRMNEPQ--IAYVCREVLQGLEYLHS 134

Query: 181 -HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
            +     ++HRD+K +NILL       LADFG A  +         + V G+  ++AP  
Sbjct: 135 QN-----VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAP-- 185

Query: 240 CKLQIIYG--YTMNITEKSDVYSYGVVLLEILSG 271
              ++I    Y   +    D++S G++ +E+  G
Sbjct: 186 ---EVIKRKDYGPKV----DIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLW-KTKRDEEPVDSF--AAEIQILGHIRHRNIVKL 128
           IG G  G VYKA  P+ G  +A+K +  +T  D  P+ +    A ++ L    H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 129 LGYC----SNKSVKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHD 182
           +  C    +++  K+ L     + +L+  L       L  ET   +     +GL +LH +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
           C   I+HRD+K  NIL+ S  +  LADFGLA++    +   A++ V  +  Y AP +  L
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAP-EVLL 180

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEIL 269
           Q  Y   +      D++S G +  E+ 
Sbjct: 181 QSTYATPV------DMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 70/221 (31%), Positives = 107/221 (48%), Gaps = 36/221 (16%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLLG 130
           IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + H NIVKLL 
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA--------QGLAYLHHD 182
               ++   L++ ++     Q L    + +D      I +           QGLA+ H  
Sbjct: 67  VIHTENKLYLVFEFLH----QDL---KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPGKC 240
            V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP   
Sbjct: 120 RV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP--- 169

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
             +I+ G     T   D++S G +  E+++ R A+ P  GD
Sbjct: 170 --EILLGCKYYST-AVDIWSLGCIFAEMVT-RRALFP--GD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 47/296 (15%)

Query: 72  VIGKGCSGVVYKAEMPNGEL----IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++G+G  G V + ++   +     +AVK +         ++ F +E   +    H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 128 LLGYCSNKSVK------LLLYNYISNGNLQQLLQGNR------NLDWETRYKIAVGSAQG 175
           L+G C   S        +++  ++ +G+L   L  +R       L  +T  K  V  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           + YL +      +HRD+   N +L       +ADFGL+K + S +Y+          G I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ--------GRI 174

Query: 236 APGKCKLQIIYGYTMNI-TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
           A    K   I      + T KSDV+++GV + EI +      P + +             
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------------ 222

Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAM-FCVNSSPAERPTMKEVVALLMEV 349
                  I D    G   +  ++ L  L   M  C  + P +RPT  ++  +L  +
Sbjct: 223 ------EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV+  +      +A+K + +    E   D F  E +++  + H N+V+L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 133 SNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
           + +    ++  Y++NG L   L+  +  L  E    +     + + YL  +     +HRD
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF---IHRD 125

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+       ++DFGLA+ +    Y         S G   P K     ++ Y+  
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQY-------TSSQGTKFPVKWAPPEVFDYS-R 177

Query: 252 ITEKSDVYSYGVVLLEILSG 271
            + KSDV+S+GV++ E+ S 
Sbjct: 178 FSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.6 bits (173), Expect = 7e-14
 Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 44/289 (15%)

Query: 73  IGKGCSGVVYKAEMPNG--ELIAVKKLW-------KTKRD-EEPVDSFAAEIQILG-HIR 121
           +G G  G VYK    N    L+A+K++        K KR+ ++ +    +E+ I+   +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLL----QGNRNLDWETRYKIAVGSAQGLA 177
           H NIV+            ++ + I    L +      +  +    E  + I V     L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           YLH +    I+HRD+  NNI+L    +  + DFGLAK     +    ++ V G+  Y  P
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSCP 182

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
              K    YG      EK+DV+++G +L ++      +QP          +    M S  
Sbjct: 183 EIVK-NEPYG------EKADVWAFGCILYQM----CTLQP---------PFYSTNMLSL- 221

Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            A  I++   + LP+ M  E +    +   C+      RP + +V A++
Sbjct: 222 -ATKIVEAVYEPLPEGMYSEDVT--DVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 23/207 (11%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH---RNIVK 127
           +IG+G  G VY+   +P G ++A+K +      ++ V     E+ +L  +R     NI K
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAV---GSAQGLAYLHHDCV 184
             G         ++  Y   G+++ L++         +Y I+V        L Y+H    
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKY-ISVIIREVLVALKYIHKV-- 120

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             ++HRD+K  NIL+ +     L DFG+A L+N  +     S   G+  ++AP     ++
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STFVGTPYWMAP-----EV 172

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSG 271
           I       T K+D++S G+ + E+ +G
Sbjct: 173 ITEGKYYDT-KADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 53/150 (35%), Positives = 82/150 (54%), Gaps = 16/150 (10%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLLG 130
           IG+G  GVVYK      G+++A+KK+ + + +EE V S A  EI +L  ++H NIV L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 131 YCSNKSVKLLLYNYISNGNLQQL--LQGNRNLDWET----RYKIAVGSAQGLAYLHHDCV 184
               +S   L++ ++S    + L  L   + +D E      Y+I     QG+ + H    
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCHSR-- 120

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAK 214
             +LHRD+K  N+L+D+K    LADFGLA+
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 35/280 (12%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVK 127
           E  IGKG   VVYKA  + +G ++A+KK+   +  D +       EI +L  + H N++K
Sbjct: 7   EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIK 66

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDC 183
            L      +   ++      G+L ++++      R +   T +K  V     L ++H   
Sbjct: 67  YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK- 125

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I+HRD+K  N+ + +     L D GL +  +S     A S V   Y Y++P +    
Sbjct: 126 --RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPY-YMSPERIHEN 181

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK-KMGSFEPAVSI 302
              GY      KSD++S G +L E+ + +S   P  GD +++    KK +   + P    
Sbjct: 182 ---GYNF----KSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEKCDYPP---- 227

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                  LP     E L+ L ++  C+N  P +RP +  V
Sbjct: 228 -------LPADHYSEELRDL-VSR-CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 47/300 (15%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDS----FAAEIQILGHIRHRNIVKL 128
           +G+G  G V+ AE  N      K L   K  ++P  +    F  E ++L +++H +IVK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLL----------------QGNRNLDWETRYKIAVGS 172
            G C +    ++++ Y+ +G+L + L                Q    L       IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+ YL        +HRD+   N L+ +     + DFG+++ + ST+Y+          
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
            ++ P      I+Y      T +SDV+S+GV+L EI +       Q+ +   ++E + + 
Sbjct: 190 RWMPPE----SIMY---RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIECITQG 241

Query: 293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                P V          P ++   ML        C    P +R  +KE+  +L  +  A
Sbjct: 242 RVLERPRVC---------PKEVYDIMLG-------CWQREPQQRLNIKEIYKILHALGKA 285

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           LK    IGKG  G V   +   G  +AVK +    +++    +F AE  ++  +RH N+V
Sbjct: 8   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62

Query: 127 KLLGY-CSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
           +LLG     K    ++  Y++ G+L   L  +G   L  +   K ++   + + YL  + 
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN- 121

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD+   N+L+     A ++DFGL K  +ST     +        + AP   + +
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREK 174

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
                    + KSDV+S+G++L EI S      P+I
Sbjct: 175 -------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 203

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 48/145 (33%), Positives = 79/145 (54%), Gaps = 8/145 (5%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLLG 130
           IG+G  G V+KA+     E++A+K++ +   D+E V S A  EI +L  ++H+NIV+L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
              +     L++ Y    +L++     N ++D E          +GLA+ H      +LH
Sbjct: 67  VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLH 122

Query: 190 RDVKCNNILLDSKYEAYLADFGLAK 214
           RD+K  N+L++   E  LADFGLA+
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G VYKA+      +A  K+ +TK +EE ++ +  EI+IL    H  IVKLLG  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 133 SNKSVKLLLYNYISNGNLQQ-LLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                  ++  +   G +   +L+ +R L       I     + L YLH      I+HRD
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRD 135

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LL    +  LADFG++   N        S +   Y ++AP     +++   TM 
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPY-WMAP-----EVVMCETMK 188

Query: 252 ITE---KSDVYSYGVVLLEI 268
            T    K+D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 35/287 (12%)

Query: 73  IGKGCSGVVYKAEMPNGELIA---VKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G V   E   G   A   VK+L  +   +E    F  E+Q    + H N+++ L
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ-LLFLQEVQPYRELNHPNVLQCL 61

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNL-----DWETRYKIAVGSAQGLAYLHHDCV 184
           G C      LL+  +   G+L+  L+ NR +       +   ++A   A GL +LH    
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +H D+   N  L +     + D+GLA      +Y+      A    ++AP   +L  
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP---ELVE 175

Query: 245 IYG---YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
           I G      + T+KS+++S GV + E+ +      P + D   +++ V ++         
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVREQ-------- 226

Query: 302 ILDTKLQGLPDQMVQEMLQT--LGIAMFCVNSSPAERPTMKEVVALL 346
             D K   LP   +          +  FC    P  RPT +EV  LL
Sbjct: 227 --DIK---LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 40/224 (17%)

Query: 67  LKDENVIGKGCSGVVYKAEM---PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
           LKD   IG+G  G V K  M   P+G ++AVK++  T  DE+       ++ ++  +R  
Sbjct: 6   LKDLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTV-DEKEQKRLLMDLDVV--MRSS 60

Query: 124 N---IVKLLGYCSNKSVKLL-----------LYNYISNGNLQQLLQGNRNLDWETRYKIA 169
           +   IVK  G    +    +            Y Y+              +  E   KIA
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-------VLKSVIPEEILGKIA 113

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRV 228
           V + + L YL  +    I+HRDVK +NILLD      L DFG++ +L++S     A +R 
Sbjct: 114 VATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI----AKTRD 167

Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           AG   Y+AP +       GY +    +SDV+S G+ L E+ +G+
Sbjct: 168 AGCRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 49/154 (31%), Positives = 84/154 (54%), Gaps = 25/154 (16%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLLG 130
           IG+G  GVVYKA +   GE++A+KK+ + + ++E V S A  EI +L  + H NIV+LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA----------QGLAYLH 180
              +++   L++ ++ + +L++ +        ++     +             QG+AY H
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKKYM--------DSSPLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
                 +LHRD+K  N+L+D +    LADFGLA+
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 68/235 (28%), Positives = 109/235 (46%), Gaps = 65/235 (27%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVD--SFAA----EIQILGHI 120
           ++ + IG+G  G+V  A   P G  +A+KK+        P +  +F      EI+IL   
Sbjct: 8   QNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILRRF 60

Query: 121 RHRNIVKLL------GYCSNKSV------------KLLLYNYISNGNLQQLLQGNRNLDW 162
           +H NI+ +L       + S   V            KL+   ++SN ++Q  L        
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-------- 112

Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
              Y+I     +GL Y+H   V   LHRD+K +N+LL++  +  + DFGLA++ +  + H
Sbjct: 113 ---YQIL----RGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162

Query: 223 HAM--SRVAGSYGYIAPGKCKLQIIY---GYTMNITEKSDVYSYGVVLLEILSGR 272
                  VA  + Y AP     +I+    GYT  I    D++S G +L E+LS R
Sbjct: 163 TGFLTEYVATRW-YRAP-----EIMLNSKGYTKAI----DIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 31/196 (15%)

Query: 91  LIAVKKLW----KTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           L+AVK L     KT R++     F  EI+I+  +++ NI++LLG C +     ++  Y+ 
Sbjct: 46  LVAVKMLRADVTKTARND-----FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100

Query: 147 NGNLQQLLQGNR------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKC 194
           NG+L Q L                ++       +AV  A G+ YL        +HRD+  
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157

Query: 195 NNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITE 254
            N L+ + Y   +ADFG+++ + S +Y+    R      ++A       I+ G     T 
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE----SILLG---KFTT 210

Query: 255 KSDVYSYGVVLLEILS 270
            SDV+++GV L E+ +
Sbjct: 211 ASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 42/224 (18%)

Query: 71  NVIGKGCSGVVYKAEMPNG--ELIAVKKLWKTKRDEEPVDSFAAEIQIL---GHIRHRNI 125
           +VIG+G  G V KA +      + A  K  K    ++    FA E+++L   GH  H NI
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 58

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY----------------KIA 169
           + LLG C ++    L   Y  +GNL   L+ +R L+ +  +                  A
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
              A+G+ YL        +HRD+   NIL+   Y A +ADFGL             SR  
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL-------------SRGQ 162

Query: 230 GSYGYIAPGKCKLQIIYGYTMN---ITEKSDVYSYGVVLLEILS 270
             Y     G+  ++ +   ++N    T  SDV+SYGV+L EI+S
Sbjct: 163 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 43/282 (15%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +GKG  G VYK    P G  +A+K++ + + DE   +    E+ IL       IV   G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
              +    +   Y+  G+L +L  G      +  +   +I     +GL +L  +    I+
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125

Query: 189 HRDVKCNNILLDSKYEAYLADFG----LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
           HRDVK  N+L++   +  L DFG    L   +  TN         G   Y+AP +     
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--------IGCQSYMAPER----- 172

Query: 245 IYGYTMN----ITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
           I     N     T +SDV+S G+ +LE+  GR    P+    +            F    
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI------------FAQLS 220

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           +I+D     LP     +    +     C+N  P  RPT  ++
Sbjct: 221 AIVDGDPPTLPSGYSDDAQDFVAK---CLNKIPNRRPTYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHR-NIVKLL 129
           I KG  G VY A+    G+  A+K L K+    +  V +  AE  I+        + KL 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +K    L+  Y++ G+   L++  G    DW  +Y   V    G+  LH      I
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV--VLGVEDLHQR---GI 118

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAK--LMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
           +HRD+K  N+L+D      L DFGL++  L N         +  G+  Y+AP     + I
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--------KKFVGTPDYLAP-----ETI 165

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSG 271
            G  +   + SD +S G V+ E L G
Sbjct: 166 LG--VGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 19/215 (8%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKL-WKTKRDEEPVDSFAAEIQ 115
           F  D+  +   D   IG G  G VY A ++ N E++A+KK+ +  K+  E       E++
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK-IAVGSAQ 174
            L  +RH N ++  G    +    L+  Y   G+   LL+ ++    E     +  G+ Q
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQ 126

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GLAYLH      ++HRDVK  NILL       L DFG A +M   N       V   Y +
Sbjct: 127 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPY-W 177

Query: 235 IAPGKCKLQIIYGYTMNITE-KSDVYSYGVVLLEI 268
           +AP     ++I        + K DV+S G+  +E+
Sbjct: 178 MAP-----EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 37/211 (17%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +G+G  G V+ A+  + GE++A+K++ K+   K +E  V     E  IL   +   +VKL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDILTTTKSEWLVKL 66

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNL-DWETRYKI-----AVGSAQGLAYLHHD 182
           L    +     L   Y+  G+ + LL     L +   R+ +     AV +   L Y+H  
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH-- 124

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                  RD+K  N L+D+     L DFGL+K      Y ++   V GS  Y+AP     
Sbjct: 125 -------RDLKPENFLIDASGHIKLTDFGLSK--GIVTYANS---VVGSPDYMAP----- 167

Query: 243 QIIYG--YTMNITEKSDVYSYGVVLLEILSG 271
           +++ G  Y   +    D +S G +L E L G
Sbjct: 168 EVLRGKGYDFTV----DYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVD---SFAAEIQILGHIRHRNIVKL 128
           ++GKG  G V+K  + +   +AVK    T +++ P +    F +E +IL    H NIVKL
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVK----TCKEDLPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLH-HDCVPA 186
           +G C+ +    ++   +  G+    L+  ++ L  +   K A+ +A G+AYL   +C+  
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI-- 115

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
             HRD+   N L+       ++DFG+++  +   Y  +  +      + AP        Y
Sbjct: 116 --HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALN----Y 168

Query: 247 GYTMNITEKSDVYSYGVVLLEILS 270
           G     + +SDV+SYG++L E  S
Sbjct: 169 G---RYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 31/210 (14%)

Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWK----TKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +G G  G V   ++       A+K + K        +E + S   E +IL    H  IVK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 128 LLGYCS---NKSVKLLLYNYISNGNLQQLLQGNRNLD-WETRYKIA-VGSAQGLAYLHHD 182
           L  Y +    K + +L+  Y   G L  +L+     D +  R+ IA V  A    YLH+ 
Sbjct: 58  L--YRTFKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLHNR 112

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               I++RD+K  N+LLDS     L DFG AK + S           G+  Y+AP     
Sbjct: 113 ---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF---CGTPEYVAP----- 161

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           +II     + +   D +S G++L E+L+GR
Sbjct: 162 EIILNKGYDFS--VDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.4 bits (167), Expect = 3e-13
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +IG+G  G V + E   G+ +AVK +    + +    +F  E  ++  + H+N+V+LLG 
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
             +  + +++   +S GNL   L+  G   +      + ++  A+G+ YL       ++H
Sbjct: 68  ILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   NIL+     A ++DFGLA+ + S    ++   V     + AP   K +      
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVK----WTAPEALKHK------ 172

Query: 250 MNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
              + KSDV+SYGV+L E+ S   A  P++
Sbjct: 173 -KFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 52/151 (34%), Positives = 86/151 (56%), Gaps = 18/151 (11%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLLG 130
           IG+G  GVVYKA +    E IA+KK+ + ++++E V S A  EI +L  ++H NIV+L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETR------YKIAVGSAQGLAYLHHDCV 184
              ++    L++ Y+ + +L++ +  + +     R      Y+I     +G+AY H    
Sbjct: 69  VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQI----LRGIAYCHSH-- 121

Query: 185 PAILHRDVKCNNILLDSKYEAY-LADFGLAK 214
             +LHRD+K  N+L+D +  A  LADFGLA+
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 47/198 (23%), Positives = 94/198 (47%), Gaps = 20/198 (10%)

Query: 81  VYKAEMPNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL 139
           +YK    N + + ++   K  +  +  +D    EI+ L  I   NI+K+ G+  +    L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 140 ----LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAILHRDVKC 194
               L+  Y + G L+++L   ++L ++T+  +A+   +GL  L+ +   P   ++++  
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTS 151

Query: 195 NNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITE 254
            + L+   Y+  +   GL K+++S  + +    V  SY          +++       T 
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSY----------KMLNDIFSEYTI 201

Query: 255 KSDVYSYGVVLLEILSGR 272
           K D+YS GVVL EI +G+
Sbjct: 202 KDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 68.0 bits (166), Expect = 5e-13
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +A+K L   K+     ++F AE  ++  ++H  
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPR 62

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKI--AVGSAQGLAYLHHD 182
           +V+L    + + +  ++  Y+ NG+L   L+    +       I  A   A+G+A++   
Sbjct: 63  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-- 119

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA--- 174

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILS-GR 272
            I YG     T KSDV+S+G++L EI++ GR
Sbjct: 175 -INYG---TFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 68.6 bits (167), Expect = 5e-13
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 18/210 (8%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LK   V+G G  G VYK   +P GE +    A+K L +T   +  V+ F  E  I+  + 
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD 67

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLH 180
           H ++V+LLG C + +++L+    + +G L   +  ++ N+  +      V  A+G+ YL 
Sbjct: 68  HPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                 ++HRD+   N+L+ S     + DFGLA+L+      +          ++A    
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA---- 179

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            L+ I  +    T +SDV+SYGV + E+++
Sbjct: 180 -LECI--HYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 36/299 (12%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            +    +G G  GVV K       LI  +KL   +      +    E+++L       IV
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 127 KLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
              G + S+  + + +  ++  G+L Q+L+    +      KI++   +GL YL      
Sbjct: 63  GFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KH 119

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
            I+HRDVK +NIL++S+ E  L DFG++ +L++S     A S V G+  Y++P   +LQ 
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFV-GTRSYMSPE--RLQG 172

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI-----VEWVKKKMGSFEPA 299
            + YT+    +SD++S G+ L+E+  GR  + P     L       V   + K      +
Sbjct: 173 TH-YTV----QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227

Query: 300 VSILDTK----LQGLPDQMVQEMLQTLGIAMF----------CVNSSPAERPTMKEVVA 344
               D+     +  L D +V E    L    F          C+  +P ER  +KE+  
Sbjct: 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G VYKA+     ++A  K+  TK +EE ++ +  EI IL    H NIVKLL   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 133 SNKSVKLLLYNYISNGNLQQ-LLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             ++   +L  + + G +   +L+  R L       +   + + L YLH +    I+HRD
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRD 128

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--KCKLQIIYGYT 249
           +K  NIL     +  LADFG++   N+       S +   Y ++AP    C+      Y 
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRPYD 186

Query: 250 MNITEKSDVYSYGVVLLEI 268
                K+DV+S G+ L+E+
Sbjct: 187 Y----KADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 52/283 (18%)

Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVD---SFAAEIQILGHIRHRNIVKL 128
           IG+G  G V+   +  +   +AVK      R+  P D    F  E +IL    H NIV+L
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
           +G C+ K    ++   +  G+    L+  G R L  +   ++   +A G+ YL       
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHC-- 115

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
            +HRD+   N L+  K    ++DFG             MSR      Y + G  K QI  
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFG-------------MSREEEDGVYASTGGMK-QIPV 160

Query: 247 GYTM-------NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +T          + +SDV+S+G++L E  S  +     + +        ++   + E  
Sbjct: 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQG 212

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           V +   +L   PD + + M +       C    P +RP+   V
Sbjct: 213 VRLPCPEL--CPDAVYRLMER-------CWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 26/213 (12%)

Query: 68  KDENV--IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHR 123
           K EN+  +G+G  G+V K +    G+++A+KK  +++ D+  V   A  EI++L  +RH 
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKM-VKKIAMREIRMLKQLRHE 60

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
           N+V L+     K    L++ ++ +  L  L +    LD     K      +G+ + H   
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH- 119

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS-----TNYHHAMSRVAGSYGYIAPG 238
              I+HRD+K  NIL+       L DFG A+ + +     T+Y      VA  + Y AP 
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY------VATRW-YRAPE 170

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
                  YG  +      D+++ G ++ E+L+G
Sbjct: 171 LLVGDTKYGRAV------DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 22/218 (10%)

Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       LI  +KL   +      +    E+Q+L    
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61

Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + + + +  G+L Q+L+    +  +   K+++   +GL YL 
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEH-MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 173

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 174 LQ-------GTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 23/202 (11%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKL-WKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           IG G  G VY A ++   E++A+KK+ +  K+  E       E++ L  +RH N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK-IAVGSAQGLAYLHHDCVPAILH 189
               +    L+  Y   G+   +L+ ++    E     I  G+ QGLAYLH       +H
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---IH 138

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+K  NILL       LADFG A L++  N     S V   Y ++AP     ++I    
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPY-WMAP-----EVILA-- 185

Query: 250 MN---ITEKSDVYSYGVVLLEI 268
           M+      K DV+S G+  +E+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.0 bits (166), Expect = 8e-13
 Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 31/223 (13%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIV 126
           V+GKG  G V  A +  +G L AVK L   K+D    ++ V+    E +IL   R+   +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVL---KKDVILQDDDVECTMTEKRILSLARNHPFL 58

Query: 127 KLLGYCSNKSVKLL-LYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQGLAYLHHD 182
             L  C     +L  +  +++ G+L   +Q +R  D E R   Y   + SA  L +LH  
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EARARFYAAEITSA--LMFLHDK 115

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAK--LMNSTNYHHAMSRVAGSYGYIAPGKC 240
               I++RD+K +N+LLD +    LADFG+ K  + N        S   G+  YIAP   
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEIL 168

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
           + +++YG ++      D ++ GV+L E+L G +  + +  D L
Sbjct: 169 Q-EMLYGPSV------DWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 70/219 (31%), Positives = 100/219 (45%), Gaps = 23/219 (10%)

Query: 64  LECLKDENVIGKGCSGVVYKAEM----PNGELIAVKKLWKTK--RDEEPVDSFAAEIQIL 117
            E LK   V+G G  G V+         +G+L A+K L K    +  +  +    E Q+L
Sbjct: 2   FELLK---VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58

Query: 118 GHIRHRNIVKLLGYCSNKSVKL-LLYNYISNGNL-QQLLQGNRNLDWETRYKIAVGS-AQ 174
            HIR    +  L Y      KL L+ +YI+ G L   L Q  R  + E   +I  G    
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEV--QIYSGEIVL 116

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L +LH      I++RD+K  NILLDS     L DFGL+K  +      A S   G+  Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEY 172

Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +AP      I+ G      +  D +S GV++ E+L+G S
Sbjct: 173 MAP-----DIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 23/209 (11%)

Query: 72  VIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRD----EEPVDSFAAEIQILGHI-RHRNI 125
           V+GKG  G V  AE+    EL AVK L   K+D    ++ V+    E ++L    +H  +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKI-AVGSAQGLAYLHHDCV 184
            +L      K     +  Y++ G+L   +Q +   D E R +  A     GL +LH    
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD-EPRARFYAAEIVLGLQFLHER-- 115

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I++RD+K +N+LLDS+    +ADFG+ K           S   G+  YIAP     +I
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAP-----EI 167

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +           D ++ GV+L E+L+G+S
Sbjct: 168 LSY--QPYGPAVDWWALGVLLYEMLAGQS 194

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 73  IGKGCSGVVYKA--EMPNGE-LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           +G G  G V K   +M   E  +AVK L     D    D    E  ++  + +  IV+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G C  +S  +L+      G L + LQ N+++  +   ++    + G+ YL        +H
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVH 118

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNS-TNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + AP +C        
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP-EC-------- 169

Query: 249 TMN---ITEKSDVYSYGVVLLEILS 270
            MN    + KSDV+S+GV++ E  S
Sbjct: 170 -MNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 73  IGKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G V+ AE  N        L+AVK L K   D    D F  E ++L +++H +IV
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKD-FHREAELLTNLQHEHIV 70

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLL-----------QGN--RNLDWETRYKIAVGSA 173
           K  G C      ++++ Y+ +G+L + L           +GN    L       IA   A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
            G+ YL        +HRD+   N L+       + DFG+++ + ST+Y+           
Sbjct: 131 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           ++ P      I+Y      T +SDV+S GVVL EI +
Sbjct: 188 WMPPE----SIMY---RKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 37/221 (16%)

Query: 66  CLKDENVIGKG-----CSG---VVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQIL 117
           C+K E VIG G     CSG   +  K E+P    +A+K L K    E+    F +E  I+
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIP----VAIKTL-KAGYTEKQRRDFLSEASIM 59

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAV------G 171
           G   H NI+ L G  +     +++  Y+ NG+L   L+ +     + ++ +        G
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-----DGQFTVIQLVGMLRG 114

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
            A G+ YL        +HRD+   NIL++S     ++DFGL++++   +   A +   G 
Sbjct: 115 IASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEAAYTTRGGK 170

Query: 232 YG--YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               + AP      I Y      T  SDV+SYG+V+ E++S
Sbjct: 171 IPIRWTAPEA----IAY---RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 17/208 (8%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLW---KTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++G+G  G VY   ++  G  +A K++    ++    + V +   EIQ+L +++H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 128 LLGYCSNKSVKLL--LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
             G   +++ K L     Y+  G+++  L+    L      K      +G++YLH +   
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN--- 125

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQI 244
            I+HRD+K  NIL DS     L DFG +K + +       +  V G+  +++P     ++
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP-----EV 180

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGR 272
           I G       K+DV+S G  ++E+L+ +
Sbjct: 181 ISGEGYG--RKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 22/218 (10%)

Query: 64  LECLKDENVIGKGCSGVVY---KAEMPN-GELIAVKKLWKTK--RDEEPVDSFAAEIQIL 117
            E LK   V+G G  G V+   K    + G+L A+K L K    +  + V+    E  +L
Sbjct: 2   FELLK---VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 118 GHIRHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA-QG 175
            H+R    +  L Y      KL L+ +Y+S G +   L    N   E   +   G     
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-EDEVRFYSGEIILA 117

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           L +LH      I++RD+K  NILLDS+    L DFGL+K   S       S   G+  Y+
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYM 173

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           AP     +II G   +  +  D +S G+++ E+L+G S
Sbjct: 174 AP-----EIIRGKGGH-GKAVDWWSLGILIFELLTGAS 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 52/176 (29%), Positives = 79/176 (44%), Gaps = 62/176 (35%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKK-LWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL- 129
           +G+G  G VYKA ++  G ++A+KK L   ++D  P+ +   EI+IL  ++H N+V L+ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74

Query: 130 ----------------------------GYCSNKSVKLL---LYNYISNGNLQQLLQGNR 158
                                       G   N SVKL    +  Y     + QLL+G  
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY-----MLQLLEG-- 127

Query: 159 NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
                            + YLH +    ILHRD+K  NIL+D++    +ADFGLA+
Sbjct: 128 -----------------INYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 77/289 (26%), Positives = 126/289 (43%), Gaps = 52/289 (17%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVD-------SFAAEIQILG 118
           ++ + ++G G  G VYKA  +    ++AVK +        P+D          +E++IL 
Sbjct: 3   IQYQEILGHGNGGTVYKAYHLLTRRILAVKVI--------PLDITVELQKQIMSELEILY 54

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAY 178
                 I+   G    ++   +   ++  G+L       R +      +IAV   +GL Y
Sbjct: 55  KCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTY 110

Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAP 237
           L       ILHRDVK +N+L++++ +  L DFG++ +L+NS     A + V G+  Y+AP
Sbjct: 111 LWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYV-GTNAYMAP 162

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
            +     I G    I   SDV+S G+  +E+  GR    PQI          +K  GS  
Sbjct: 163 ER-----ISGEQYGI--HSDVWSLGISFMELALGRFPY-PQI----------QKNQGSLM 204

Query: 298 PA---VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           P      I+D     LP     E    +     C+   P ERP  + ++
Sbjct: 205 PLQLLQCIVDEDPPVLPVGQFSEKF--VHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 72  VIGKGCSGVVYKAEM----PNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNI 125
           V+G G  G V+          G+L A+K L K    +  +  +    E Q+L  +R    
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 126 VKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS-AQGLAYLHHDC 183
           +  L Y      KL L+ +Y++ G L   L    +   E+  ++ +      L +LH   
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT-ESEVRVYIAEIVLALDHLHQ-- 123

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I++RD+K  NILLDS+    L DFGL+K   +     A S   G+  Y+AP     +
Sbjct: 124 -LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP-----E 176

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +I G +    +  D +S GV+  E+L+G S
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 19/215 (8%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKL-WKTKRDEEPVDSFAAEIQ 115
           F  D+  E     + IG G  G VY A      E++AVKK+ +  K+  E       E++
Sbjct: 14  FYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73

Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK-IAVGSAQ 174
            L  ++H N ++  G    +    L+  Y   G+   LL+ ++    E     I  G+ Q
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQ 132

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GLAYLH      ++HRD+K  NILL    +  LADFG A   +  N     S V   Y +
Sbjct: 133 GLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-----SFVGTPY-W 183

Query: 235 IAPGKCKLQIIYGYTMNITE-KSDVYSYGVVLLEI 268
           +AP     ++I        + K DV+S G+  +E+
Sbjct: 184 MAP-----EVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 69/287 (24%), Positives = 134/287 (46%), Gaps = 40/287 (13%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK E  +G G  G V+ A       +AVK +   K     V++F AE  ++  ++H  
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDK 62

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLL---QGNRNLDWETRYKIAVGSAQGLAYLHH 181
           +VKL    + + +  ++  +++ G+L   L   +G++          +   A+G+A++  
Sbjct: 63  LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQ 120

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGK 239
                 +HRD++  NIL+ +     +ADFGLA+++    Y    +R    +   + AP  
Sbjct: 121 R---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEA 174

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
               I +G   + T KSDV+S+G++L+EI++      P    G+   E ++    + E  
Sbjct: 175 ----INFG---SFTIKSDVWSFGILLMEIVTYGRIPYP----GMSNPEVIR----ALERG 219

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             +     +  P+++   M++       C  + P ERPT + + ++L
Sbjct: 220 YRMPRP--ENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKL-WKTKRDEEPVDSFAAEIQ 115
           F  ++  +   D   IG G  G VY A ++   E++A+KK+ +  K+  E       E++
Sbjct: 18  FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77

Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK-IAVGSAQ 174
            L  I+H N ++  G    +    L+  Y   G+   LL+ ++    E     I  G+ Q
Sbjct: 78  FLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQ 136

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GLAYLH      ++HRD+K  NILL    +  LADFG A + +  N     S V   Y +
Sbjct: 137 GLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----SFVGTPY-W 187

Query: 235 IAPGKCKLQIIYGYTMNITE-KSDVYSYGVVLLEI 268
           +AP     ++I        + K DV+S G+  +E+
Sbjct: 188 MAP-----EVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 46/224 (20%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 64

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+           QL+     LD+   +K  +GS      
Sbjct: 65  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 114

Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 115 CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171

Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 172 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 55/225 (24%), Positives = 111/225 (49%), Gaps = 21/225 (9%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVV-YKAEMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q++N TI  + +  +D   +G G  G V    +   G  +A+KKL++  + E        
Sbjct: 4   QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63

Query: 113 EIQILGHIRHRNIVKLLGYCS-----NKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK 167
           E+++L H++H N++ LL   +     ++     L       +L +L++  +  +   ++ 
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF- 122

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           +     +GL Y+H      I+HRD+K  N+ ++   E  + DFGLA+  +S    + ++R
Sbjct: 123 LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR 179

Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                 Y AP     ++I  + M+ T+  D++S G ++ E+L+G+
Sbjct: 180 -----WYRAP-----EVILNW-MHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 25/210 (11%)

Query: 72  VIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRD----EEPVDSFAAEIQILG-HIRHRNI 125
           V+GKG  G V  AE+    E  A+K L   K+D    ++ V+    E ++L     H  +
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKAL---KKDVVLEDDDVECTMVERRVLALAWEHPFL 58

Query: 126 VKLLGYCSNKSVKLLLY--NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
             L  +C+ ++ + L +   Y++ G+L   +Q +   D       A     GL +LH   
Sbjct: 59  THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK- 115

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I++RD+K +N+LLD      +ADFG+ K   + N     S   G+  YIAP     +
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAP-----E 166

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           I+ G   N  E  D +S+GV+L E+L G+S
Sbjct: 167 ILKGQKYN--ESVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 60/302 (19%)

Query: 72  VIGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
            +G+G  G V KA             +AVK L +     E  D   +E  +L  + H ++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNHPHV 65

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQ-------------GNRN---LDWETRYKIA 169
           +KL G CS     LL+  Y   G+L+  L+             GNRN   LD      + 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 170 VGS--------AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY 221
           +G         ++G+ YL       ++HRD+   N+L+    +  ++DFGL++ +   + 
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
           +   S+      ++A  +     IY      T +SDV+S+GV+L EI++      P I  
Sbjct: 183 YVKRSKGRIPVKWMAI-ESLFDHIY------TTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235

Query: 282 GLHIVEWVKKKMGSFEPAVSILDTKLQ-GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK 340
                          E   ++L T  +   P+   +EM     + + C    P +RPT  
Sbjct: 236 ---------------ERLFNLLKTGYRMERPENCSEEMYN---LMLTCWKQEPDKRPTFA 277

Query: 341 EV 342
           ++
Sbjct: 278 DI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 34/276 (12%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IG+G  G +Y A+   + E   +K++  TK   +  ++   E+ +L  ++H NIV    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIA--VGSAQGLAYLHHDCVPAIL 188
                    ++  Y   G+L + +   R + +     ++  V  + GL ++H      IL
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KIL 123

Query: 189 HRDVKCNNILLDSK-YEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           HRD+K  NI L      A L DFG+A+ +N +          G+  Y++P  C+      
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQ------ 175

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
                  K+D++S G VL E+ + +    P  G+ LH +  +K   G F P        L
Sbjct: 176 -NRPYNNKTDIWSLGCVLYELCTLK---HPFEGNNLHQLV-LKICQGYFAPISPNFSRDL 230

Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           + L  Q+ +               SP +RP++  ++
Sbjct: 231 RSLISQLFK--------------VSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 65.6 bits (161), Expect = 6e-12
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 53/230 (23%)

Query: 68  KDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHIRHRN 124
           +    IG G  GVV  A     G  +A+KK+     D   +D+     EI++L H+RH N
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD--LIDAKRILREIKLLRHLRHEN 60

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGN------------LQQLLQGNRNLDWETR----YKI 168
           I+ LL         +L      + N            L ++++  + L  +      Y+I
Sbjct: 61  IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI 112

Query: 169 AVGSAQGLAYLHHDCVPA-ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMS 226
             G    L YLH     A ++HRD+K +NIL++S  +  + DFGLA+ ++        ++
Sbjct: 113 LRG----LKYLHS----ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 227 R-VAGSYGYIAPGKCKLQIIYG---YTMNITEKSDVYSYGVVLLEILSGR 272
             V   + Y AP     +++     YT  I    D++S G +  E+L+ +
Sbjct: 165 EYVVTRW-YRAP-----ELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.1 bits (158), Expect = 6e-12
 Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 27/218 (12%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVK--KLWKTKRDEEPVDSFA---AEIQILGHIRHRNIV 126
           +G G  G VYKA  +  GEL AVK  KL       EP D F+    EI ++   +H NIV
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKL-------EPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
              G   ++    +   Y   G+LQ +      L       +   + QGLAYLH      
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---G 126

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
            +HRD+K  NILL    +  LADFG+A  + +T          G+  ++AP    ++   
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNG 184

Query: 247 GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH 284
           GY     +  D+++ G+  +E+    + +QP + D LH
Sbjct: 185 GY----NQLCDIWAVGITAIEL----AELQPPMFD-LH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 64.5 bits (157), Expect = 7e-12
 Identities = 62/275 (22%), Positives = 118/275 (42%), Gaps = 36/275 (13%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +A+K + +    E   D F  E +++  + H  +V+L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 133 SNKSVKLLLYNYISNGNLQQLL-QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
           + +    ++  Y+SNG L   L +  +        ++     +G+AYL        +HRD
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRD 125

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+D +    ++DFGL++ +    Y         S G   P +     +  Y+  
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWSPPEVLLYS-K 177

Query: 252 ITEKSDVYSYGVVLLEILS-GRSAVQP-QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
            + KSDV+++GV++ E+ S G+    P +  +    VE V + +  + P           
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK---MPYERFNNSETVEKVSQGLRLYRP----------- 223

Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
               +  E +    I   C +    ERPT +++++
Sbjct: 224 ---HLASEKVYA--IMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 64.9 bits (159), Expect = 7e-12
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 39/213 (18%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTK----RDEEPVDSFAAEIQILGHIRHRNIV 126
            +G G  G V       +G+  A+K L K K    +  E V +   E +IL  IRH  +V
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN---EKRILQSIRHPFLV 64

Query: 127 KLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQ---GLAYLH 180
            L G +  + ++ L++  Y+  G L   L+ +          Y     +AQ    L YLH
Sbjct: 65  NLYGSFQDDSNLYLVM-EYVPGGELFSHLRKSGRFPEPVARFY-----AAQVVLALEYLH 118

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                 I++RD+K  N+LLDS     + DFG AK +    Y      + G+  Y+AP   
Sbjct: 119 SL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY-----TLCGTPEYLAP--- 167

Query: 241 KLQIIY--GYTMNITEKSDVYSYGVVLLEILSG 271
             +II   GY   +    D ++ G+++ E+L+G
Sbjct: 168 --EIILSKGYGKAV----DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 41/218 (18%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-------------EEPVDSFAAEIQIL 117
           ++GKG  G V+ AE+    +  A+K L   K+D             E+ V S A E   L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEHPFL 58

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLY--NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQG 175
            H+          YC+ ++ + L +   Y++ G+L   +Q     D       A     G
Sbjct: 59  THL----------YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG 108

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           L +LH      I++RD+K +NILLD+     +ADFG+ K   +           G+  YI
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYI 163

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           AP     +I+ G   N +   D +S+GV+L E+L G+S
Sbjct: 164 AP-----EILLGQKYNTS--VDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 68/281 (24%), Positives = 119/281 (42%), Gaps = 47/281 (16%)

Query: 91  LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL 150
           L+AVK L +   ++   + F  E++IL  ++  NI++LLG C ++    ++  Y+ NG+L
Sbjct: 48  LVAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106

Query: 151 QQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI----------------LHRDVKC 194
            Q L  +   D E     AV  A  L  + +  +  +                +HRD+  
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLAT 166

Query: 195 NNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITE 254
            N L+       +ADFG+++ + + +Y+    R      ++A  +C   I+ G     T 
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA-WEC---ILMG---KFTT 219

Query: 255 KSDVYSYGVVLLEILS-------GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
            SDV+++GV L EIL        G    +  I +         +++  F P         
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCP----- 274

Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           QGL + M+Q           C +    ERP+  ++ A L E
Sbjct: 275 QGLYELMLQ-----------CWSRDCRERPSFSDIHAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 46/231 (19%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA---------EIQIL 117
           K    IG G  GVV  A +  +G+ +A+KK+           +F           E++IL
Sbjct: 8   KPIENIGSGAYGVVCSAIDTRSGKKVAIKKI---------PHAFDVPTLAKRTLRELKIL 58

Query: 118 GHIRHRNIVKLLGYCSN-----KSVKLLLYNYISNGNLQQLLQGNRNLDWET----RYKI 168
            H +H NI+ +           K V +++   +   +L  ++  ++ L  E      Y++
Sbjct: 59  RHFKHDNIIAIRDILRPPGADFKDVYVVMD--LMESDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM--NSTNYHHAMS 226
                +GL Y+H   V   +HRD+K +N+L++   E  + DFG+A+ +  + T + + M+
Sbjct: 117 L----RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
               +  Y AP    L  +  YT  I    D++S G +  E+L GR  + P
Sbjct: 170 EYVATRWYRAPE--LLLSLPEYTTAI----DMWSVGCIFAEML-GRRQLFP 213

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 73/185 (39%)

Query: 65  ECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEE----PVDSFAAEIQILGH 119
           E L   N I +G  GVVY+A +   GE++A+KKL   K ++E    P+ S   EI IL  
Sbjct: 8   EKL---NRIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLR-EINILLK 60

Query: 120 IRHRNIVKL----LGYCSNK--------------------------SVKLLLYNYISNGN 149
           ++H NIV +    +G   +K                           VK L         
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL--------- 111

Query: 150 LQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLAD 209
           + QLL                    G+A+LH +    ILHRD+K +N+LL+++    + D
Sbjct: 112 MLQLL-------------------SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICD 149

Query: 210 FGLAK 214
           FGLA+
Sbjct: 150 FGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 33/272 (12%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IGKG  G VYK  +    E++A+K +   +  E+ ++    EI +L       I +  G 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +   ++  Y+  G+   LL+    L+      I     +GL YLH +     +HRD
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSE---RKIHRD 126

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LL  + +  LADFG+A  +  T      +   G+  ++AP   K Q  Y +   
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIK-QSAYDF--- 180

Query: 252 ITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLP 311
              K+D++S G+  +E+  G    +P   D LH +  +     +  P        L+G  
Sbjct: 181 ---KADIWSLGITAIELAKG----EPPNSD-LHPMRVLFLIPKNSPPT-------LEGQY 225

Query: 312 DQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            +  +E ++       C+N  P  RPT KE++
Sbjct: 226 SKPFKEFVEA------CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 58/226 (25%), Positives = 114/226 (50%), Gaps = 21/226 (9%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 6   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65

Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++   +L  +++  +  D   ++ 
Sbjct: 66  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+     +    M+ 
Sbjct: 126 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176

Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 177 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 216

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 21/185 (11%)

Query: 102 RDEEPVDSFAAEIQILGHIRHRNIVKLL--GYCSNKSVKLLLYNYISNGNLQQLLQGNRN 159
            +E     F  E  +   + H NIV LL  G      +   ++ Y+    L+++L  +  
Sbjct: 17  EEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLL-FAVFEYVPGRTLREVLAADGA 75

Query: 160 LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLM 216
           L      ++ +     LA  H+     I+HRD+K  NI++     +  A + DFG+  L+
Sbjct: 76  LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132

Query: 217 NSTNYHHAMS-----RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
                    +      V G+  Y AP + + +        +T  SD+Y++G++ LE L+G
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRGE-------PVTPNSDLYAWGLIFLECLTG 185

Query: 272 RSAVQ 276
           +  VQ
Sbjct: 186 QRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLW---KTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++G+G  G VY   +   G  +AVK++    ++    + V++   EIQ+L ++ H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 128 LLGYCSNKSVKLL--LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
             G   +   + L     ++  G+++  L+    L      K      +G++YLH +   
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN--- 125

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQI 244
            I+HRD+K  NIL DS     L DFG +K + +       M  V G+  +++P     ++
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP-----EV 180

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGR 272
           I G       K+D++S G  ++E+L+ +
Sbjct: 181 ISGEGYG--RKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 56/289 (19%)

Query: 79  GVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           G VYK  +         + +A+K L K K +    + F  E  +   ++H NIV LLG  
Sbjct: 19  GKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 133 SNKSVKLLLYNYISNGNLQQLL--------QGNRNLDWETR--------YKIAVGSAQGL 176
           + +    ++++Y S+ +L + L         G+ + D   +          I    A G+
Sbjct: 78  TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137

Query: 177 AYL--HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            +L  HH       H+D+   N+L+  K    ++D GL + + + +Y+  M        +
Sbjct: 138 EFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRW 192

Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKM 293
           ++P      I+YG     +  SD++SYGVVL E+ S    +QP  G     ++E ++ + 
Sbjct: 193 MSPEA----IMYG---KFSIDSDIWSYGVVLWEVFS--YGLQPYCGYSNQDVIEMIRNRQ 243

Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
               P            P  +   ML+       C N  P+ RP  K++
Sbjct: 244 VLPCP---------DDCPAWVYTLMLE-------CWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 29/165 (17%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA--------EIQILGHI-RH 122
           +G G  G VY A     GEL+A+KK+ K K        F +        E++ L  +  H
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM-KKK--------FYSWEECMNLREVKSLRKLNEH 57

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLH 180
            NIVKL            ++ Y+  GNL QL+  +  +         I     QGLA++H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS----TNY 221
                   HRD+K  N+L+       +ADFGLA+ + S    T+Y
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 70/289 (24%), Positives = 128/289 (44%), Gaps = 37/289 (12%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVK 127
           E  IG+G    VY+A  + + + +A+KK+   +  D +       EI +L  + H N++K
Sbjct: 7   EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66

Query: 128 LL-GYCSNKSVKLLLYNYISNGNLQQLL----QGNRNLDWETRYKIAVGSAQGLAYLHHD 182
            L  +  +  + ++L      G+L Q++    +  R +   T +K  V     + ++H  
Sbjct: 67  YLDSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS-TNYHHAMSRVAGSYGYIAPGKCK 241
               ++HRD+K  N+ + +     L D GL +  +S T   H++    G+  Y++P +  
Sbjct: 126 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIH 179

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
                GY      KSD++S G +L E+ + +S   P  GD          KM  F     
Sbjct: 180 EN---GYNF----KSDIWSLGCLLYEMAALQS---PFYGD----------KMNLFSLCQK 219

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
           I       LP +   E L+ L ++M C+   P +RP +  V  +  ++ 
Sbjct: 220 IEQCDYPPLPTEHYSEKLREL-VSM-CIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 70/253 (27%), Positives = 100/253 (39%), Gaps = 62/253 (24%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G V+       G++ A+K L K+   KR++  +    AE  IL       IVK
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADADSPWIVK 65

Query: 128 LLGYCSNKSVKLLLY--NYISNGNLQQLLQGNRNLDWET-RYKI-----AVGSAQGLAYL 179
           L  Y S +  + L     Y+  G+L  LL        ET R+ I     A+ S   L ++
Sbjct: 66  L--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFI 123

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-------------------- 219
           H         RD+K +NIL+D+     LADFGL K MN                      
Sbjct: 124 H---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 220 -------NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                        +   G+  YIAP     +++ G       + D +S GV+L E+L G 
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAP-----EVLRG--TPYGLECDWWSLGVILYEMLYGF 227

Query: 273 SAVQPQIGDGLHI 285
               P   D L  
Sbjct: 228 P---PFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E +K    +G G  G V+     N   +AVK L   K     V +F  E  ++  ++H  
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDK 62

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHD 182
           +V+L    + +    ++  Y++ G+L   L+ +    +        +   A+G+AY+   
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKC 240
                +HRD++  N+L+       +ADFGLA+++    Y    +R    +   + AP   
Sbjct: 123 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEA- 175

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              I +G   + T KSDV+S+G++L EI++
Sbjct: 176 ---INFG---SFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLW---KTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++G+G  G VY   +   G  +AVK++     ++   + V++   EIQ+L ++RH  IV+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 128 LLGYCSNKSVKLL--LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
             G   +   K L     Y+  G+++  L+    L      +      QG++YLH +   
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN--- 125

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQI 244
            I+HRD+K  NIL DS     L DFG +K + +       +  V G+  +++P     ++
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP-----EV 180

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
           I G       K+DV+S    ++E+L+
Sbjct: 181 ISGEGYG--RKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 51/223 (22%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-------------EEPVDSFAAEIQIL 117
           V+GKG  G V  AE+   GE  AVK L   K+D             E+ V + A E   L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKAL---KKDVVLIDDDVECTMVEKRVLALAWENPFL 58

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLY--NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ- 174
            H+          YC+ ++ + L +   +++ G+L   +Q     D    Y+    +A+ 
Sbjct: 59  THL----------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL---YRATFYAAEI 105

Query: 175 --GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
             GL +LH      I++RD+K +N++LD      +ADFG+ K  N    + A S   G+ 
Sbjct: 106 VCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRA-STFCGTP 160

Query: 233 GYIAPGKCKLQIIYG--YTMNITEKSDVYSYGVVLLEILSGRS 273
            YIAP     +I+ G  YT ++    D +S+GV+L E+L G+S
Sbjct: 161 DYIAP-----EILQGLKYTFSV----DWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 17/157 (10%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVD-SFAAEIQILGHIR---HRNI 125
             IG+G  G VYKA ++  G  +A+KK+ +    EE +  S   EI +L  +    H NI
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 126 VKLLGYCSNKSVK-----LLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAY 178
           V+LL  C            L++ ++   +L   L       L  ET   +     +G+ +
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL 215
           LH      I+HRD+K  NIL+ S  +  +ADFGLA++
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 51/231 (22%)

Query: 64  LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR- 121
           L  L++   IG G  G VYK      G ++AVK++ +T   EE         +IL  +  
Sbjct: 14  LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-------NKRILMDLDV 66

Query: 122 ----HR--NIVKLLGY-CSNKSVKLL----------LYNYISNGNLQQLLQGNRNLDWET 164
               H    IVK  GY  ++  V +           L   I     + +L          
Sbjct: 67  VLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG--------- 117

Query: 165 RYKIAVGSAQGLAYL--HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNY 221
             K+ V   + L YL   H     ++HRDVK +NILLD+     L DFG++ +L++S   
Sbjct: 118 --KMTVAIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS--- 168

Query: 222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             A +R AG   Y+AP +               ++DV+S G+ L+E+ +G+
Sbjct: 169 -KAKTRSAGCAAYMAPERIDPPDPNP---KYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 51/290 (17%)

Query: 72  VIGKGCSG-VVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           V+G G +G V+    + +GE  AVK +      E   +   AE+  L +    +IVK   
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95

Query: 131 YCSNKSVK------------LLLYNYISNGNLQQLLQGNRNLDWETR-YKIAVGSAQGLA 177
            C     K             L+ +Y + G+L+Q ++     +   R ++  +   Q L 
Sbjct: 96  -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
            +HH     ++HRD+K  NILL S     L DFG +K+  +T          G+  Y+AP
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214

Query: 238 G---KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM- 293
               +             ++K+D++S GV+L E+L+ +        DG ++ E + K + 
Sbjct: 215 EIWRRKPY----------SKKADMFSLGVLLYELLTLKRPF-----DGENMEEVMHKTLA 259

Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           G ++P           LP  +  EM Q +  A+    S P  RP+  +++
Sbjct: 260 GRYDP-----------LPPSISPEM-QEIVTALLS--SDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLG 130
           IGKG  G V+K     NG   AVK L      +E ++   AE  IL  +  H N+VK  G
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE---AEYNILKALSDHPNVVKFYG 82

Query: 131 YCSNKSVK-----LLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCV 184
               K VK      L+    + G++  L++G  +  +      IA    + L  L H  V
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--KCKL 242
              +HRDVK NNILL ++    L DFG++  + ST      S   G+  ++AP    C+ 
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQ 200

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           Q+   Y      + DV+S G+  +E+  G
Sbjct: 201 QLDSTY----DARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 37/274 (13%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IGKG  G V+K      + +   K+   +  E+ ++    EI +L       + K  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 133 SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDV 192
              +   ++  Y+  G+   LL+    LD      I     +GL YLH +     +HRD+
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE---KKIHRDI 127

Query: 193 KCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI 252
           K  N+LL    E  LADFG+A  +  T      +   G+  ++AP   K Q  Y      
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIK-QSAY------ 178

Query: 253 TEKSDVYSYGVVLLEILSGR---SAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
             K+D++S G+  +E+  G    S + P     + ++  + K      P        L+G
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLIPKN----NPPT------LEG 223

Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              + ++E ++       C+N  P+ RPT KE++
Sbjct: 224 NYSKPLKEFVEA------CLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           VIG+G    V    +   E I   K+ K +   D+E +D    E  +     +   +  L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 130 GYCSNKSVKLL-LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             C     +L  +  Y++ G+L   +Q  R L  E     +   +  L YLH      I+
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GII 118

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +RD+K +N+LLDS+    L D+G+ K           S   G+  YIAP   + +  YG+
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGF 175

Query: 249 TMNITEKSDVYSYGVVLLEILSGRS 273
           ++      D ++ GV++ E+++GRS
Sbjct: 176 SV------DWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 18/173 (10%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEE-PVDSFA 111
            +  F   + +   +    IG+G  G V+KA      +++A+KK+      E  P+ +  
Sbjct: 1   DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60

Query: 112 AEIQILGHIRHRNIVKLLGYCSNKSVK--------LLLYNYISNGNLQQLLQGNRNLDW- 162
            EI+IL  ++H N+V L+  C  K+           L++ +  + +L  LL  N+N+ + 
Sbjct: 61  -EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS-NKNVKFT 117

Query: 163 -ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
                K+      GL Y+H +    ILHRD+K  NIL+       LADFGLA+
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 33/213 (15%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIV 126
           V+GKG  G V  AE+    E+ A+K L   K+D    ++ VD    E +IL        +
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVL---KKDVILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 127 KLLGYCSNKSVKLLLY--NYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQGLAYLHH 181
             L +C  ++   L +   Y++ G+L   +Q +R  D E R   Y   V  A  L +LH 
Sbjct: 59  TAL-HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-EPRSRFYAAEVTLA--LMFLHR 114

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAK--LMNSTNYHHAMSRVAGSYGYIAPGK 239
                +++RD+K +NILLD++    LADFG+ K  ++N        +   G+  YIAP  
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEI 167

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            + ++ YG ++      D ++ GV++ E+++G+
Sbjct: 168 LQ-ELEYGPSV------DWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 39/227 (17%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPV-DSFAAEIQILGHIRHRNIVKLLG 130
           IGKG  G VY A  P     +A+KK+ +   +   +   F  E +I   + H  IV +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNR---NLDWETRYKIAVGS--------AQGLAYL 179
            CS+         YI    L+ LL+      +L  E   K +VG+           + Y+
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN-------------STNYHHAMS 226
           H      +LHRD+K +NILL    E  + D+G A                     + +M+
Sbjct: 130 HSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186

Query: 227 ---RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              ++ G+  Y+AP +          +  +E +D+Y+ GV+L ++L+
Sbjct: 187 IPGKIVGTPDYMAPERLL-------GVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 55/215 (25%), Positives = 104/215 (48%), Gaps = 31/215 (14%)

Query: 69  DENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           + + +G G  G V  A     G  +A+KKL +  +          E+++L H+ H N++ 
Sbjct: 19  NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIG 78

Query: 128 LLG-YCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQGLAYL 179
           LL  +    S++    + L  ++   +L  +++  +  D   +   Y+I     +GL Y+
Sbjct: 79  LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLKYI 134

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMSRVAGSYGYIAP 237
           H      I+HRD+K +NI ++   E  + DFGLA+  +   T Y      VA  + Y AP
Sbjct: 135 HS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY------VATRW-YRAP 184

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                +I+  + M+  +  D++S G ++ E+L+G+
Sbjct: 185 -----EIMLNW-MHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 61.4 bits (149), Expect = 9e-11
 Identities = 63/261 (24%), Positives = 115/261 (44%), Gaps = 51/261 (19%)

Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQ 151
           I + K+   +R+E        E+ +L +++H NIV+            ++ +Y   G+L 
Sbjct: 33  INISKMSPKEREES-----RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLY 87

Query: 152 QLLQGNRN--------LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY 203
           + +   R         LDW  +  +A      L ++H      ILHRD+K  NI L    
Sbjct: 88  KKINAQRGVLFPEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDG 138

Query: 204 EAYLADFGLAKLMNSTNYHHAMSRVA-GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYG 262
              L DFG+A+++NST     ++R   G+  Y++P  C+             KSD+++ G
Sbjct: 139 TIKLGDFGIARVLNST---VELARTCIGTPYYLSPEICE-------NRPYNNKSDIWALG 188

Query: 263 VVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTL 322
            VL E+ + + A +   G+  ++V  +K   GS+ P  S     L+ L  Q+ +      
Sbjct: 189 CVLYEMCTLKHAFEA--GNMKNLV--LKIIRGSYPPVSSHYSYDLRNLVSQLFKR----- 239

Query: 323 GIAMFCVNSSPAERPTMKEVV 343
                    +P +RP++  ++
Sbjct: 240 ---------NPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 27/219 (12%)

Query: 65  ECLKDENVIGKGCSGVVYKA-EMPNG-ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR- 121
           EC+ +   IG+G  G V+KA ++ NG   +A+K++     +E    S   E+ +L H+  
Sbjct: 4   ECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 122 --HRNIVKLLGYCS----NKSVKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSA 173
             H N+V+L   C+    ++  KL L     + +L   L       +  ET   +     
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
           +GL +LH      ++HRD+K  NIL+ S  +  LADFGLA++    ++  A++ V  +  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174

Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           Y AP +  LQ  Y   +      D++S G +  E+   +
Sbjct: 175 YRAP-EVLLQSSYATPV------DLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG- 130
           IG G  G+V  A +   G  +AVKKL +  +++        E+ +L  + H+NI+ LL  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 131 YCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
           +   KS++    + L   + + NL Q++  +  LD E    +      G+ +LH      
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHS---AG 143

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+    TN+   M+    +  Y AP     ++I 
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-CTNF--MMTPYVVTRYYRAP-----EVIL 195

Query: 247 GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK 290
           G  M   E  D++S G ++ E++ G    Q       HI +W K
Sbjct: 196 G--MGYKENVDIWSVGCIMGELVKGSVIFQGTD----HIDQWNK 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 7/144 (4%)

Query: 73  IGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G+G    V+K        L+A+K++ + + +E    +   E+ +L +++H NIV L   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA-QGLAYLHHDCVPAILHR 190
              +    L++ Y+ + +L+Q L    NL      KI +    +GL+Y H      ILHR
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHR 127

Query: 191 DVKCNNILLDSKYEAYLADFGLAK 214
           D+K  N+L++ K E  LADFGLA+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 28/207 (13%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLG 130
           IG+G    V KA     G+  A+K + K  +  E V++   EIQ L  +  H NI++L+ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65

Query: 131 YC-SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETR-----YKIAVGSAQGLAYLHHDCV 184
                K+ +L L   + + NL +L++G +    E R     Y++     + L ++H +  
Sbjct: 66  VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLL----KSLDHMHRN-- 119

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I HRD+K  NIL+       LADFG  +           +    +  Y AP +C L  
Sbjct: 120 -GIFHRDIKPENILIK-DDILKLADFGSCR---GIYSKPPYTEYISTRWYRAP-ECLLTD 173

Query: 245 -IYGYTMNITEKSDVYSYGVVLLEILS 270
             YG  M      D+++ G V  EILS
Sbjct: 174 GYYGPKM------DIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 45/234 (19%), Positives = 86/234 (36%), Gaps = 66/234 (28%)

Query: 72  VIGKGCSGV----VYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +IGK    +    + K + P   L+AVKK+      +E +     EI     ++H NI+ 
Sbjct: 5   LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK----------IAVGSAQGLA 177
            +      S   ++   ++ G+ + LL        +T +           I       L 
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLL--------KTHFPEGLPELAIAFILKDVLNALD 115

Query: 178 YLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           Y+H    +    HR VK ++ILL    +  L           +   +++S +        
Sbjct: 116 YIHSKGFI----HRSVKASHILLSGDGKVVL-----------SGLRYSVSMIKH------ 154

Query: 237 PGKCKLQIIYGYTMNI-------------------TEKSDVYSYGVVLLEILSG 271
            GK + ++++ +  +                     EKSD+YS G+   E+ +G
Sbjct: 155 -GK-RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHIRHRNIVKLL 129
           +G+G    VYK     NG+L+A+K +  + + EE V  F A  E  +L  ++H NIV L 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVI--SMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
                K     ++ Y+     Q ++Q    L             +GLAY+H      ILH
Sbjct: 70  DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILH 126

Query: 190 RDVKCNNILLDSKYEAYLADFGLA--KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           RD+K  N+L+    E  LADFGLA  K + S  Y    S    +  Y  P      ++ G
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTY----SSEVVTLWYRPP-----DVLLG 177

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSA 274
            T + +   D++  G + +E+L G+ A
Sbjct: 178 AT-DYSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQIL---GHIRHRN 124
           V+G+G  G V  AE    GEL A+K L K     RDE  V+S   E +I       RH  
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANSERHPF 63

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
           +V L      +     +  Y + G+L   +  +   +    +  A     GL YLH +  
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC-VVLGLQYLHEN-- 120

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I++RD+K +N+LLD++    +ADFGL K      +    S   G+  ++AP     ++
Sbjct: 121 -KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAP-----EV 172

Query: 245 IYGYTMNITEKS-----DVYSYGVVLLEILSGRS 273
                  +TE S     D +  GV++ E+L G S
Sbjct: 173 -------LTETSYTRAVDWWGLGVLIYEMLVGES 199

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAA---EIQILGHIRHRNIVKL 128
           IG G  G VYKA   N GEL A+K +       EP + FA    EI ++   +H NIV  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVI-----KLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
            G    +    +   +   G+LQ +      L       ++  + QGL YLH       +
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKM 128

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  NILL       LADFG++  + +T          G+  ++AP    ++   GY
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERKGGY 186

Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH 284
                +  D+++ G+  +E+    + +QP + D LH
Sbjct: 187 ----NQLCDIWAVGITAIEL----AELQPPMFD-LH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           VIG+G    V    +   + I   K+ K +   D+E +D    E  +         +  L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 130 GYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             C   + +L L+  Y++ G+L   +Q  R L  E     A      L +LH      I+
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GII 118

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +RD+K +N+LLD+     L D+G+ K           S   G+  YIAP   + +  YG+
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE-EYGF 175

Query: 249 TMNITEKSDVYSYGVVLLEILSGRS 273
           ++      D ++ GV++ E+++GRS
Sbjct: 176 SV------DWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 71/293 (24%), Positives = 130/293 (44%), Gaps = 46/293 (15%)

Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 72

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETR-----------YKIAVGSAQG 175
           +LLG  S     L++   +++G+L+  L+  R  + E              ++A   A G
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +AYL+       +HRD+   N ++   +   + DFG+ + +  T+Y+    +      ++
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
           AP   K  +        T  SD++S+GVVL EI S   A QP    GL   + +K     
Sbjct: 189 APESLKDGV-------FTTSSDMWSFGVVLWEITS--LAEQPY--QGLSNEQVLK----- 232

Query: 296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                 ++D      PD   + +   + +   C   +P  RPT  E+V LL +
Sbjct: 233 -----FVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 55/186 (29%), Positives = 81/186 (43%), Gaps = 46/186 (24%)

Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAG 230
           AQG+ +L   +C+    HRDV   N+LL     A + DFGLA+ +MN +N          
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMNDSN---------- 267

Query: 231 SYGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLH 284
              Y+  G  +L + +    +I     T +SDV+SYG++L EI S G+S   P I     
Sbjct: 268 ---YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-PGILVNSK 323

Query: 285 IVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             + VK+  +M                 PD    E+     I   C N  P ERPT  ++
Sbjct: 324 FYKMVKRGYQMSR---------------PDFAPPEIYS---IMKMCWNLEPTERPTFSQI 365

Query: 343 VALLME 348
             L+  
Sbjct: 366 SQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 33/212 (15%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRD-EEPVDSFAA-EIQILGHIRHRNIVKLL 129
           +G+G    VYK      GE++A+K++     D EE   S A  EI ++  ++H NIV+L 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRLH 64

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLL--QGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPA 186
                ++  +L++ Y+   +L++ +   G R  LD  T         +G+A+ H +    
Sbjct: 65  DVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---R 120

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMN---STNYHHAMSRVAGSYGYIAPGKCKLQ 243
           +LHRD+K  N+L++ + E  LADFGLA+      +T      S    +  Y AP      
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-----FSNEVVTLWYRAP-----D 170

Query: 244 IIYG---YTMNITEKSDVYSYGVVLLEILSGR 272
           ++ G   Y+ +I    D++S G ++ E+++GR
Sbjct: 171 VLLGSRTYSTSI----DIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 40/221 (18%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
           LK   V+G G  G VYK   +P+GE +    A+K L +    K ++E +D    E  ++ 
Sbjct: 9   LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD----EAYVMA 64

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-------LDWETRYKIAVG 171
            +    + +LLG C   +V+L+    +  G L   ++ N++       L+W       V 
Sbjct: 65  GVGSPYVCRLLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNW------CVQ 117

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM--NSTNYHHAMSRVA 229
            A+G++YL       ++HRD+   N+L+ S     + DFGLA+L+  + T YH    +V 
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174

Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
             +         L+ I       T +SDV+SYGV + E+++
Sbjct: 175 IKW-------MALESI--LHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIV 126
           V+GKG  G V  AE     EL A+K L   K+D    ++ V+    E ++L        +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKIL---KKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
             L  C     +L  +  Y++ G+L   +Q             A   + GL +LH     
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR--- 120

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV-AGSYGYIAPGKCKLQI 244
            I++RD+K +N++LDS+    +ADFG+ K           +R   G+  YIAP     Q 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQ- 176

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGR 272
            YG ++      D ++YGV+L E+L+G+
Sbjct: 177 PYGKSV------DWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 24/205 (11%)

Query: 73  IGKGCSGVVYKAEMPNGEL--IAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLL 129
           +G G  G V  A   N +   +A+K+  K+K   ++ VD   +E +IL +I H   V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVG---SAQGLAYLHHDCVPA 186
           G   ++S   L+  ++  G     L+ N+      R+   VG   +AQ +    +     
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSLN 151

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I++RD+K  N+LLD      + DFG AK++++  Y      + G+  YIAP +  L + +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY-----TLCGTPEYIAP-EILLNVGH 205

Query: 247 GYTMNITEKSDVYSYGVVLLEILSG 271
           G      + +D ++ G+ + EIL G
Sbjct: 206 G------KAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 16/205 (7%)

Query: 69  DENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D   +G G  G+V  A +   G+ +A+KK+ K             E+++L H+RH NI+ 
Sbjct: 14  DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIIS 73

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L     +    +     +   +L +LL          +Y       +GL Y+H      +
Sbjct: 74  LSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-FLYQILRGLKYVHS---AGV 129

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K +NIL++   +  + DFGLA++ +          V+  Y Y AP     +I+  
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRY-YRAP-----EIMLT 179

Query: 248 YTMNITEKSDVYSYGVVLLEILSGR 272
           +      + D++S G +  E+L G+
Sbjct: 180 W-QKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 50/166 (30%), Positives = 68/166 (40%), Gaps = 29/166 (17%)

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLL--------LYNYISNGNLQQLLQGNRNLDWET 164
           EI IL  I HR I+ L+     KS   +        L+ Y+           +  L  E 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV---------DRSGPLPLEQ 186

Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHH 223
              I     + LAYLH      I+HRDVK  NI LD    A L DFG A KL    +   
Sbjct: 187 AITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD--- 240

Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
              +  G  G +     +L  +  Y      K+D++S G+VL E+ 
Sbjct: 241 -TPQCYGWSGTLETNSPELLALDPYCA----KTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 67/293 (22%), Positives = 126/293 (43%), Gaps = 46/293 (15%)

Query: 73  IGKGCSGVVYKA-------EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           +G+G  G+VY+        + P    +A+K + +     E ++ F  E  ++      ++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 71

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLL-------QGNRNLDWETRYKI---AVGSAQG 175
           V+LLG  S     L++   ++ G+L+  L       + N      +  K+   A   A G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +      ++
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
           +P   K  +        T  SDV+S+GVVL EI +   A QP  G          +++  
Sbjct: 189 SPESLKDGV-------FTTYSDVWSFGVVLWEIAT--LAEQPYQG-------MSNEQVLR 232

Query: 296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           F     +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 233 FVMEGGLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 73  IGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHIRHRNIVKLL 129
           +G+G    VYK +   NG+L+A+K +   +  EE    F A  E  +L  ++H NIV L 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLLH 69

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
                K    L++ Y+     Q + +    L  E          +GL+Y+H      ILH
Sbjct: 70  DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILH 126

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+K  N+L+    E  LADFGLA+  +  +  H  S    +  Y  P      ++ G T
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPP-----DVLLGST 179

Query: 250 MNITEKSDVYSYGVVLLEILSGRSA 274
              +   D++  G + +E++ G +A
Sbjct: 180 -EYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 37/284 (13%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVK 127
           E  IG+G    VY+A  + +G  +A+KK+      D +       EI +L  + H N++K
Sbjct: 7   EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLL----QGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
                   +   ++      G+L +++    +  R +  +T +K  V     L ++H   
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR- 125

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS-TNYHHAMSRVAGSYGYIAPGKCKL 242
              ++HRD+K  N+ + +     L D GL +  +S T   H++    G+  Y++P +   
Sbjct: 126 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHE 180

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK-KMGSFEPAVS 301
               GY      KSD++S G +L E+ + +S   P  GD +++    KK +   + P  S
Sbjct: 181 N---GYNF----KSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCDYPPLPS 230

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
                     D   +E+ Q + +   C+N  P +RP +  V  +
Sbjct: 231 ----------DHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 28/216 (12%)

Query: 70  ENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK- 127
           + VIGKG  GVV  A +   GE +A+KK+               EI++L  +RH +IV+ 
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 128 ---LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
              +L     +   + +   +   +L Q+++ N +L  E          + L Y+H   V
Sbjct: 65  KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANV 124

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--------TNYHHAMSRVAGSYGYIA 236
               HRD+K  NIL ++  +  + DFGLA++  +        T+Y      VA  + Y A
Sbjct: 125 ---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY------VATRW-YRA 174

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           P  C       YT  I    D++S G +  E+L+G+
Sbjct: 175 PELCG-SFFSKYTPAI----DIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIRHRN-IVKLL 129
           IG+G  G VYKA +   G+L+A+KK  + + DEE +   A  EI +L  +     IV+LL
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 130 G--YCSNKSVKLLLY---NYISNGNLQQLLQGNRN-----LDWETRYKIAVGSAQGLAYL 179
              +   K+ K  LY    Y+ + +L++ +  N       L  +T         +G+A+ 
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 180 HHDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAK 214
           H      ++HRD+K  N+L+D  K    +AD GL +
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 37/274 (13%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IGKG  G V+K      + +   K+   +  E+ ++    EI +L       + K  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 133 SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPAILH 189
              +   ++  Y+  G+   LL+     D    ++IA    +   GL YLH +     +H
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAG-PFD---EFQIATMLKEILKGLDYLHSE---KKIH 124

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+K  N+LL  + +  LADFG+A  +  T      +   G+  ++AP     ++I    
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP-----EVIQQSA 177

Query: 250 MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
            +   K+D++S G+  +E+  G    +P   D +H +  V   +    P        L G
Sbjct: 178 YD--SKADIWSLGITAIELAKG----EPPNSD-MHPMR-VLFLIPKNNPPT------LTG 223

Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              +  +E +        C+N  P+ RPT KE++
Sbjct: 224 EFSKPFKEFIDA------CLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 23/213 (10%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHIRHRNIVKLL 129
           IG+G  G+V  A      E +A+KK+      +  +D+     EI++L H+ H N++ + 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 130 GYCSNKSVKLLLYNYIS----NGNLQQLLQGNRNL-DWETRYKIAVGSAQGLAYLHHDCV 184
                   +     YI     + +L Q+++ ++ L D   +Y +     +GL Y+H    
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLKYIHS--- 126

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             +LHRD+K +N+LL++  +  + DFGLA+  +       M+    +  Y AP    L  
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK--GDFMTEYVVTRWYRAPE--LLLN 182

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
              YT  I    DV+S G +  E+L GR  + P
Sbjct: 183 CSEYTTAI----DVWSVGCIFAELL-GRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 53/204 (25%), Positives = 103/204 (50%), Gaps = 19/204 (9%)

Query: 73  IGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +G G  G V K   +M   ++    K+ K + ++   D    E +I+  + +  IV+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
            C  +++ +L+    S G L + L G ++ +      ++    + G+ YL        +H
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVH 118

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNS-TNYHHAMSRVAGSY--GYIAPGKCKLQIIY 246
           RD+   N+LL +++ A ++DFGL+K + +  +Y+ A  R AG +   + AP +C   I +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA--RSAGKWPLKWYAP-EC---INF 172

Query: 247 GYTMNITEKSDVYSYGVVLLEILS 270
                 + +SDV+SYG+ + E  S
Sbjct: 173 ---RKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 39/223 (17%)

Query: 73  IGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG G  GVV+    P +G+ +A+KK+    ++         E+++L   +H N++  L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ----------------G 175
                +      Y+    + +L+Q +        +KI V S Q                G
Sbjct: 68  LQPPHIDPFEEIYV----VTELMQSDL-------HKIIV-SPQPLSSDHVKVFLYQILRG 115

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           L YLH      ILHRD+K  N+L++S     + DFGLA++       H    V   Y Y 
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
           AP     +I+ G   + T   D++S G +  E+L  R   Q Q
Sbjct: 172 AP-----EILMGSR-HYTSAVDIWSVGCIFAELLGRRILFQAQ 208

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 19/161 (11%)

Query: 73  IGKGCSGVVYKAEMPN---GELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKL 128
           IG+G  G VYKA+  N   G+  A+KK    K     +   A  EI +L  ++H N+V L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 129 LGYCSNKSVKL--LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA-----QGLAYLHH 181
           +      + K   LL++Y +  +L Q+++ +R     +     V S       G+ YLH 
Sbjct: 68  VEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126

Query: 182 DCVPAILHRDVKCNNILLDSKYEAY----LADFGLAKLMNS 218
           +    +LHRD+K  NIL+  +        + D GLA+L N+
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 59/276 (21%), Positives = 118/276 (42%), Gaps = 34/276 (12%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV+  +      +A+K + +    EE    F  E +++  + H  +V+L G C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 133 SNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
           + +    ++  ++ NG L   L+  +  L  +    +     +G+ YL  +   + +HRD
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRD 125

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+ S     ++DFG+ + +    Y         S G   P K     ++ ++  
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWSPPEVFNFS-K 177

Query: 252 ITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
            + KSDV+S+GV++ E+ + G+   + +      +VE + +    + P           L
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRGFRLYRPK----------L 225

Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
               V E++        C +  P  RPT  E++  +
Sbjct: 226 ASMTVYEVM------YSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 67/206 (32%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKT---KRDEEPVDSFAAEIQIL-GHIRHRNIV 126
           VIGKG  G V  A+   +G+  AVK L K    K+ E+      AE  +L  +++H  +V
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ--KHIMAERNVLLKNVKHPFLV 59

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKI-AVGSAQGLAYLHHDCVP 185
            L            + +Y++ G L   LQ  R+   E R +  A   A  L YLH     
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP-EPRARFYAAEIASALGYLHS---L 115

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I++RD+K  NILLDS+    L DFGL K      +    S   G+  Y+AP   + Q  
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQ-P 172

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSG 271
           Y  T+      D +  G VL E+L G
Sbjct: 173 YDRTV------DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 24/227 (10%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           +++N T+  + E       +G G  G V  A +   GE +A+KKL +  + E        
Sbjct: 4   EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYN-YISNGNLQQLLQGNRNLDW-ETRYKIAV 170
           E+ +L H++H N++ LL   ++        + Y+    +Q  LQ        E + +  V
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123

Query: 171 -GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
                GL Y+H      I+HRD+K  N+ ++   E  + DFGLA+        HA + + 
Sbjct: 124 YQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMT 172

Query: 230 G---SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           G   +  Y AP     ++I  + M+  +  D++S G ++ E+L+G++
Sbjct: 173 GYVVTRWYRAP-----EVILNW-MHYNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 40/194 (20%)

Query: 160 LDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMN 217
           LD E     +   A+G+++L   +C+    HRD+   NILL       + DFGLA+ + N
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGR 272
            +N             Y+  G  +L + +    +I     T +SDV+SYG++L EI S  
Sbjct: 267 DSN-------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 313

Query: 273 SAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSS 332
           S+  P +       + +K+      P  +         P +M   M         C ++ 
Sbjct: 314 SSPYPGMPVDSKFYKMIKEGYRMLSPECA---------PSEMYDIMKS-------CWDAD 357

Query: 333 PAERPTMKEVVALL 346
           P +RPT K++V L+
Sbjct: 358 PLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 27/212 (12%)

Query: 73  IGKGCSGVVYKAEMPNGELI---AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           +G+G  G V + ++   + I   AVK +         ++ F +E   +    H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 130 GYCSNKSVK------LLLYNYISNGNLQQLLQGNR------NLDWETRYKIAVGSAQGLA 177
           G C            +++  ++ +G+L   L  +R       L  +   K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           YL      + +HRD+   N +L+      +ADFGL+K + + +Y+          G IA 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ--------GRIAK 175

Query: 238 GKCKLQIIYGYTMNI-TEKSDVYSYGVVLLEI 268
              K   I      + T KSDV+S+GV + EI
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 32/216 (14%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILG-HIRHRNIVKLL 129
           V+G G  G VYK   +  G+L A+K +  T+ +EE +     EI +L  +  HRNI    
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK---LEINMLKKYSHHRNIATYY 79

Query: 130 GYCSNKSVK------LLLYNYISNGNLQQLLQGNR----NLDWETRYKIAVGSAQGLAYL 179
           G    KS         L+  +   G++  L++  +      DW     I     +GLA+L
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHL 137

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H      ++HRD+K  N+LL    E  L DFG++  ++ T      +   G+  ++AP  
Sbjct: 138 H---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEV 192

Query: 240 CKLQ----IIYGYTMNITEKSDVYSYGVVLLEILSG 271
                     Y Y      +SD++S G+  +E+  G
Sbjct: 193 IACDENPDATYDY------RSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 69/233 (29%), Positives = 105/233 (45%), Gaps = 70/233 (30%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEI---QILGHIRHRNIVKL 128
           +GKG  G+V+KA +    E++A+KK++   R+         EI   Q LG   H NIVKL
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--HPNIVKL 72

Query: 129 LGYC---SNKSVKLL-------LYNYISNGNLQ---------QLLQGNRNLDWETRYKIA 169
           L      ++K + L+       L+  I    L+         QLL+              
Sbjct: 73  LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKA------------- 119

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS----------T 219
                 L Y+H      ++HRD+K +NILL+S     LADFGLA+ ++           T
Sbjct: 120 ------LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           +Y      VA  + Y AP     +I+ G T   T+  D++S G +L E+L G+
Sbjct: 171 DY------VATRW-YRAP-----EILLGST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.4 bits (137), Expect = 4e-09
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW-ETRYKIAVGSAQGLAYLH 180
           + N +KL    +     +L+ +YI +G+L  LL+    L   E + KI     + L  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK-KIIRQLVEALNDLH 126

Query: 181 -HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
            H     I+H D+K  N+L D +K   YL D+GL K++ + + +       G+  Y +P 
Sbjct: 127 KH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPE 176

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           K K    Y  +       D ++ GV+  E+L+G
Sbjct: 177 KIKGH-NYDVSF------DWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           VIGKG  G V  A+   +G   AVK L K    + +E     A    +L +++H  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 129 LGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKI-AVGSAQGLAYLHHDCVPA 186
             Y    + KL  + +Y++ G L   LQ  R    E R +  A   A  + YLH      
Sbjct: 62  -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL-EPRARFYAAEVASAIGYLHS---LN 116

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I++RD+K  NILLDS+    L DFGL K           S   G+  Y+AP   + +  Y
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE-PY 173

Query: 247 GYTMNITEKSDVYSYGVVLLEILSG 271
             T+      D +  G VL E+L G
Sbjct: 174 DRTV------DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 15/202 (7%)

Query: 73  IGKGCSGVVYKAEMPNGE-LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G+G    VYK      + L+A+K++     +  P  +   E+ +L  ++H NIV L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA-QGLAYLHHDCVPAILHR 190
              +    L++ Y+ + +L+Q L    N       K+ +    +GL Y H      +LHR
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHR 128

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+L++ + E  LADFGLA+  +     ++   V  +  Y  P      I+ G T 
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPP-----DILLGST- 180

Query: 251 NITEKSDVYSYGVVLLEILSGR 272
           + + + D++  G +  E+ +GR
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 28/216 (12%)

Query: 72  VIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++GKG  G V +A++     + + +AVK L         ++ F  E   +    H N++K
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 128 LLGYCSNKSVK------LLLYNYISNGNLQQLLQGNR------NLDWETRYKIAVGSAQG 175
           L+G       K      +++  ++ +G+L   L  +R       L  +T  +  +  A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           + YL        +HRD+   N +L+      +ADFGL+K + S +Y+          G  
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ--------GCA 174

Query: 236 APGKCKLQIIYGYTMNI-TEKSDVYSYGVVLLEILS 270
           +    K   +     N+ T  SDV+++GV + EI++
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 38/108 (35%), Positives = 63/108 (58%), Gaps = 12/108 (11%)

Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAM 225
           KIAV   + L YLH     +++HRDVK +N+L++   +  L DFG++  L++S     A 
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV----AK 160

Query: 226 SRVAGSYGYIAPGKCKLQI-IYGYTMNITEKSDVYSYGVVLLEILSGR 272
           +  AG   Y+AP +   ++   GY +    KSDV+S G+ ++E+ +GR
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 38/180 (21%)

Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
           A+G+ +L    C+    HRD+   NILL       + DFGLA+             +   
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLAR------------DIYKD 232

Query: 232 YGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
             Y+  G  +L + +     I     T +SDV+S+GV+L EI S  ++  P    G+ I 
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVKID 288

Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E   +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 289 EEFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 55/226 (24%), Positives = 110/226 (48%), Gaps = 21/226 (9%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN T+  + E  ++   +G G  G V  A +    + +AVKKL +  +          
Sbjct: 4   QELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR 63

Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYK 167
           E+++L H++H N++ LL  +    S++    + L   +   +L  +++  +  D   ++ 
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 124 I-YQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTG 174

Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L G++
Sbjct: 175 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           VIG+G    V   E+     I   K+ K +   D+E +D    E  +     +   +  L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 130 GYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             C     +L  +  ++S G+L   +Q  R L  E     +   +  L +LH      I+
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GII 118

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII--- 245
           +RD+K +N+LLD++    L D+G+ K           S   G+  YIAP     +I+   
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAP-----EILRGE 171

Query: 246 -YGYTMNITEKSDVYSYGVVLLEILSGRS 273
            YG+++      D ++ GV++ E+++GRS
Sbjct: 172 DYGFSV------DWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 20/204 (9%)

Query: 73  IGKGCSGVVYKAEMPNGELI----AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           IGKG  G V +    + + I     ++K     R E  V    AE  +L  +    IV L
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSE--VTHTLAERTVLAQVNCPFIVPL 58

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                +     L+  +I+ G L   LQ     D  +R +    +A+ L  L +     ++
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFD-LSRARFY--TAELLCALENLHKFNVI 115

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKL-MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +RD+K  NILLD +    L DFGL KL M   +     +   G+  Y+AP   +L + +G
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAP---ELLLGHG 169

Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
           YT  +    D ++ GV+L E+L+G
Sbjct: 170 YTKAV----DWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 69/244 (28%), Positives = 114/244 (46%), Gaps = 36/244 (14%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQ 115
            FT+    + LK    IG G  G+V  A +   G+ +A+KKL +  ++         E+ 
Sbjct: 11  TFTVLKRYQNLK---PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV 67

Query: 116 ILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYKIAV 170
           ++  + H+NI+ LL  +   KS++    + L   + + NL Q++Q   +LD E    +  
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLY 125

Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS----TNYHHAMS 226
               G+ +LH      I+HRD+K +NI++ S     + DFGLA+   +    T Y     
Sbjct: 126 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----- 177

Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
            V   Y Y AP     ++I G  M   E  D++S G ++ E++ G   V     D  HI 
Sbjct: 178 -VVTRY-YRAP-----EVILG--MGYKENVDIWSVGCIMGEMIRGT--VLFPGTD--HID 224

Query: 287 EWVK 290
           +W K
Sbjct: 225 QWNK 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 23/208 (11%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLLG 130
           +GKG  G V   ++ N G++ A KKL K +  ++  +  A  E +IL  +    IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQ---GLAYLHHDCVP 185
              +K+   L+ + ++ G+L+  +   G R L+ E   ++   SAQ   G+ +LH     
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME---RVIHYSAQITCGILHLHS---M 114

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I++RD+K  N+LLD +    L+D GLA  +        +++ AG+ GY+AP   K +  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILK-EEP 170

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRS 273
           Y Y +      D ++ G  + E+++GR+
Sbjct: 171 YSYPV------DWFAMGCSIYEMVAGRT 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 16/217 (7%)

Query: 73  IGKGCSGVVYKAEMPNGE-LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G+G    V+K      E L+A+K++     +  P  +   E+ +L  ++H NIV L   
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA-QGLAYLHHDCVPAILHR 190
                   L++ Y+ + +L+Q +    N+      KI +    +GLAY H      +LHR
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHR 128

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+L++ + E  LADFGLA+  +     ++   V  +  Y  P      ++ G + 
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP-----DVLLG-SS 180

Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQ-PQIGDGLHIV 286
             + + D++  G +  E+ SGR       + D LH++
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 25/208 (12%)

Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 130 G-YCSNKSVKLLLYNYI----SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
             +   KS++     YI     + NL Q++Q    LD E    +      G+ +LH    
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS--- 144

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EV 196

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGR 272
           I G  M   E  D++S G ++ E++ G 
Sbjct: 197 ILG--MGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 72  VIGKGCSGVVYKAEMPNGE-LIAVKKLWKT----KRDEEPVDSFAAEIQILGHIRHRNIV 126
           VIGKG  G V  A     E   AVK L K     K++E+ + S      +L +++H  +V
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS--ERNVLLKNVKHPFLV 59

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVP 185
            L            + +YI+ G L   LQ  R  L+   R+  A   A  L YLH     
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---L 115

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I++RD+K  NILLDS+    L DFGL K   +  ++   S   G+  Y+AP     +++
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAP-----EVL 168

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSG 271
           +    + T   D +  G VL E+L G
Sbjct: 169 HKQPYDRT--VDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWK----TKRDEEPVDSFAAEIQILGHIRHRNIV 126
           VIGKG  G V  A+   +G+  AVK L K     +++++ +   A    +L +++H  +V
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLV 59

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS-AQGLAYLHHDCV 184
            L  Y    + KL  + ++++ G L   LQ  R+   E R +      A  L YLH    
Sbjct: 60  GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-EPRARFYAAEIASALGYLHS--- 114

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I++RD+K  NILLDS+    L DFGL K           +   G+  Y+AP   + Q 
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ- 171

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSG 271
            Y  T+      D +  G VL E+L G
Sbjct: 172 PYDNTV------DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 29/214 (13%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIRHRNIVKLLG 130
           +GKG  G V   ++   G++ A KKL K +  +   +  A  E +IL  +  R IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 131 YCSNKSVKLLLYNYISNG-----NLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHD 182
           Y       L L   + NG     ++  +  G      E R      +AQ   GL +LH  
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFP-EARAIFY--AAQIICGLEHLHQR 114

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               I++RD+K  N+LLD      ++D GLA  +            AG+ GY+AP +   
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAP-EVLQ 167

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
             +Y +++      D ++ G  L E+++GRS  +
Sbjct: 168 GEVYDFSV------DWFALGCTLYEMIAGRSPFR 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 73/267 (27%), Positives = 107/267 (40%), Gaps = 71/267 (26%)

Query: 25  RYKVEKA--SGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVY 82
           R  +EKA  S + T  PGAE F++             IDN            K C  VV 
Sbjct: 86  RAGIEKAGFSILETFTPGAEGFAFA-----------CIDN------------KTCEHVVI 122

Query: 83  KAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG-YCSNKSVKLLL 141
           KA    G                     A E  IL  I H +I++L G +  NK   L+L
Sbjct: 123 KAGQRGGT--------------------ATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162

Query: 142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS 201
             Y ++  L   L   RN+       I     + + YLH +    I+HRD+K  NI ++ 
Sbjct: 163 PRYKTD--LYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINH 217

Query: 202 KYEAYLADFGLAKL---MNSTNYHHAMSRVAGSYGYIAPGKCKL--QIIYGYTMNITEKS 256
             +  L DFG A     +N+  Y+       G  G IA    +L  +  YG  +      
Sbjct: 218 PGDVCLGDFGAACFPVDINANKYY-------GWAGTIATNAPELLARDPYGPAV------ 264

Query: 257 DVYSYGVVLLEILSGRSAVQPQIGDGL 283
           D++S G+VL E+ +   ++  +  DGL
Sbjct: 265 DIWSAGIVLFEMATCHDSLFEK--DGL 289

Length = 391

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 12/202 (5%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           V+G+G  GVV K       E++A+KK   ++ +EE  ++   E+++L  ++  NIV+L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
               +    L++ Y+   N+ +LL+   N     + +  +   Q +  +H      I+HR
Sbjct: 68  AFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYI--YQLIKAIHWCHKNDIVHR 124

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+L+       L DFG A+ ++  +  +    VA  + Y +P +  L   YG  +
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSP-ELLLGAPYGKAV 182

Query: 251 NITEKSDVYSYGVVLLEILSGR 272
                 D++S G +L E+  G+
Sbjct: 183 ------DMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 49/200 (24%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G SG V+ A ++  G+ +A+K++   K+ ++ +     EI ++  +++ NIV  L  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLDS 84

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  Y++ G+L  ++     +D      +     Q L +LH +    ++HRD
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K +N+LL       L DFG    +  T      S + G+  ++AP +   +  YG    
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAP-EVVTRKAYG---- 193

Query: 252 ITEKSDVYSYGVVLLEILSG 271
              K D++S G++ +E++ G
Sbjct: 194 --PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G V       + ++ A+K L K    KR +     F  E  I+ H     IV+
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQ 107

Query: 128 LLGYCSNKSVKLL--LYNYISNGNLQQLLQGNRNL--DWETRYKIAVGSAQGLAYLHHDC 183
           L  + + +  K L  +  Y+  G+L  L+  N ++   W   Y   V  A  L  +H   
Sbjct: 108 L--HYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLA--LDAIHS-- 160

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRDVK +N+LLD      LADFG    M++       + V G+  YI+P   K Q
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQ 218

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSG 271
              GY      + D +S GV L E+L G
Sbjct: 219 GGDGY---YGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILG-HIRHRNIVKLL 129
           ++G G  G VYK   +  G+L A+K +  T  +EE +     EI +L  +  HRNI    
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYY 69

Query: 130 GYCSNKSVK------LLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHH 181
           G    K+         L+  +   G++  L++  +   L  E    I     +GL++LH 
Sbjct: 70  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--K 239
                ++HRD+K  N+LL    E  L DFG++  ++ T      +   G+  ++AP    
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEVIA 184

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           C       Y      KSD++S G+  +E+  G
Sbjct: 185 CDENPDATYDF----KSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 83/272 (30%), Positives = 127/272 (46%), Gaps = 41/272 (15%)

Query: 72  VIGKGCSGVVY---KAEMPN-GELIAVKKLWK-TKRDEEPVDSFAAEIQILGHIRHRNIV 126
           V+G+G  G V+   K   P+ G+L A+K L K T +  + V +   E  IL  + H  IV
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWE-TRYKIAVGSAQGLAYLHHDCV 184
           KL  Y      KL L+ +++  G+L   L        E  ++ +A   A  L +LH    
Sbjct: 62  KL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS--- 116

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I++RD+K  NILLD +    L DFGL+K   S ++        G+  Y+AP     + 
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR- 173

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
             G+T +    +D +S+GV++ E+L+G    Q +            +K    E    IL 
Sbjct: 174 --GHTQS----ADWWSFGVLMFEMLTGSLPFQGK-----------DRK----ETMTMILK 212

Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER 336
            KL G+P  +  E  Q+L  A+F  N  PA R
Sbjct: 213 AKL-GMPQFLSPEA-QSLLRALFKRN--PANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 32/208 (15%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKK--LWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G +G+V  A +   G  +AVKK  L K +R E   +    E+ I+   +H NIV++ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN----EVVIMRDYQHPNIVEMY 82

Query: 130 G-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             Y     + +++  ++  G L  ++   R ++ E    + +   + L++LH      ++
Sbjct: 83  SSYLVGDELWVVM-EFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQ---GVI 137

Query: 189 HRDVKCNNILLDSKYEAYLADFGL-AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII-- 245
           HRD+K ++ILL S     L+DFG  A++  S       S V   Y ++AP     ++I  
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPY-WMAP-----EVISR 189

Query: 246 --YGYTMNITEKSDVYSYGVVLLEILSG 271
             YG     TE  D++S G++++E++ G
Sbjct: 190 LPYG-----TE-VDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 27/206 (13%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTK----RDEEPVDSFAAEIQILGHIRHRNIVK 127
           +G G  G V+   +  +    A+K +   +    + E+ V +   E ++L  + H  I++
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEVSHPFIIR 65

Query: 128 LLGYCSNKSVKLL--LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
           L  + +    + L  L  Y+  G L   L+ +      T    A      L YLH     
Sbjct: 66  L--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK--- 120

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I++RD+K  NILLD +    L DFG AK +    +      + G+  Y+AP     ++I
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-----TLCGTPEYLAP-----EVI 170

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSG 271
                N  +  D ++ G+++ E+L G
Sbjct: 171 QSKGHN--KAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 29/169 (17%)

Query: 113 EIQILGHIRHRNIVKL--------LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWET 164
           EI  LG + H NI+K+          Y   +     LY+++ +         +R L  +T
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW---KDRPLLKQT 269

Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
           R  I       + Y+H      ++HRD+K  NI L+   +  L DFG A           
Sbjct: 270 R-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK------ 319

Query: 225 MSRVAGSYGY---IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
             R A  YG+   +A    ++    GY     E +D++S G++LL++LS
Sbjct: 320 -EREAFDYGWVGTVATNSPEILAGDGY----CEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 25/205 (12%)

Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 130 G-YCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
             +   KS++    + L   + + NL Q++Q    LD E    +      G+ +LH    
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS--- 137

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EV 189

Query: 245 IYGYTMNITEKSDVYSYGVVLLEIL 269
           I G  M   E  D++S G ++ E++
Sbjct: 190 ILG--MGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 46/200 (23%), Positives = 99/200 (49%), Gaps = 16/200 (8%)

Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G +G+V  A +  +G+L+AVKK+    R ++  +    E+ I+   +H N+V++   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  ++  G L  ++   R ++ E    + +   + L+ LH      ++HRD
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQ---GVIHRD 141

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K ++ILL       L+DFG    ++          + G+  ++AP +   ++ YG    
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAP-ELISRLPYG---- 194

Query: 252 ITEKSDVYSYGVVLLEILSG 271
              + D++S G++++E++ G
Sbjct: 195 --PEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 17/206 (8%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLL 129
           V+GKG  G V   ++   G++ A K+L K +  +   +S A  E QIL  +  + +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
                K    L+   ++ G+L+  +   GN   + E     A     GL  LH +     
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NT 123

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           ++RD+K  NILLD      ++D GLA  +       ++    G+ GY+AP     Q  Y 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQ-RYT 179

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRS 273
            +       D +  G ++ E++ G+S
Sbjct: 180 LS------PDYWGLGCLIYEMIEGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 17/209 (8%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLL 129
           V+GKG  G V   ++   G++ A KKL K +  +   +S A  E QIL  +  R +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
                K    L+   ++ G+L+  +   G    +       A     GL  LH +    I
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           ++RD+K  NILLD      ++D GLA  ++         RV G+ GY+AP   K +    
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVKNE---R 177

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           YT +     D ++ G +L E+++G+S  Q
Sbjct: 178 YTFS----PDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 45/299 (15%)

Query: 63  ILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH 122
            L  L  E   G+   G++   +    E + VK + K    E  V     E  +L  + H
Sbjct: 9   TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQESCLLYGLSH 67

Query: 123 RNIVKLLGYCSNKSVK-LLLYNYISNGNLQQLLQGNRNLDWE------TRYKIAVGS--A 173
           +NI+ +L  C        +LY Y++ GNL+  LQ  R  +        T+  + +    A
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
            G++YLH      ++H+D+   N ++D + +  + D  L++ +   +YH           
Sbjct: 128 CGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM 293
           ++A     L          +  SDV+S+GV+L E+++      P +            ++
Sbjct: 185 WMALE--SLV-----NKEYSSASDVWSFGVLLWELMT--LGQTPYV------------EI 223

Query: 294 GSFEPAVSILDTK-LQ---GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
             FE A  + D   L      PD++   M         C    P ERP+  ++V  L +
Sbjct: 224 DPFEMAAYLKDGYRLAQPINCPDELFAVMA-------CCWALDPEERPSFSQLVQCLTD 275

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 29/284 (10%)

Query: 73  IGKGCSGVVYKAEMPNG---ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G V   E+ +G     + VK+L  +   +E +  F  E Q    ++H N+++ L
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLLQCL 61

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNR-----NLDWETRYKIAVGSAQGLAYLHHDCV 184
           G C+  +  LL+  +   G+L+  L+  R       D  T  ++A   A GL +LH +  
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +H D+   N LL +     + D+GL+      +Y+    ++     +IAP    +  
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE--LVDE 176

Query: 245 IYG--YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
           ++G    ++ T++S+V+S GV + E+    S     + D   +   V+      E  + +
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR------EQQLKL 230

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +L+        E++Q   +        P +RP+ +EV  LL
Sbjct: 231 PKPRLKLPLSDRWYEVMQFCWL-------QPEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G +G+V  A E   G+ +AVKK+    R ++  +    E+ I+    H N+V +   
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  ++  G L  ++   R ++ E    + +   + L+YLH+     ++HRD
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQ---GVIHRD 143

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K ++ILL S     L+DFG    + S       S V   Y ++AP +   ++ YG    
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPY-WMAP-EVISRLPYG---- 196

Query: 252 ITEKSDVYSYGVVLLEILSG 271
              + D++S G++++E++ G
Sbjct: 197 --TEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 64/246 (26%)

Query: 72  VIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDE-EPVDSFAAEIQILGHIRHRNIVKLL 129
           VIG+G  G V   +  + G + A+KKL K++  E E V    AE  IL    +  +VKL 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL- 66

Query: 130 GYCS--NKSVKLLLYNYISNGNLQQLLQGNRNL-DWETRYKI-----AVGSAQGLAYLHH 181
            Y S  +++   L+  Y+  G++  LL       + ETR+ I     A+ S   L Y+H 
Sbjct: 67  -YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH- 124

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGL----------------------------A 213
                   RD+K +N+LLD+K    L+DFGL                            +
Sbjct: 125 --------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 214 KLMNSTNYHHAMSR--------VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVL 265
           K M+S        R          G+  YIAP +  LQ  Y       ++ D +S GV++
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAP-EVFLQTGYN------KECDWWSLGVIM 229

Query: 266 LEILSG 271
            E+L G
Sbjct: 230 YEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 25/220 (11%)

Query: 72  VIGKGCSGVVYKAEMPNG-ELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIV 126
           V+GKG  G V  AE     EL A+K L   K+D    ++ V+    E ++L        +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKIL---KKDVVIQDDDVECTMVEKRVLALSGKPPFL 63

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
             L  C     +L  +  Y++ G+L   +Q             A   A GL +LH     
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK--- 120

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS--RVAGSYGYIAPGKCKLQ 243
            I++RD+K +N++LDS+    +ADFG+ K     N    ++     G+  YIAP     Q
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
             YG ++      D +++GV+L E+L+G++  + +  D L
Sbjct: 177 -PYGKSV------DWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 20/202 (9%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVK--KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G +G+V  A E  +G  +AVK   L K +R E   +    E+ I+   +H+N+V++ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN----EVVIMRDYQHQNVVEMY 84

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
                     +L  ++  G L  ++   R L+ E    +     Q L YLH      ++H
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQ---GVIH 140

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+K ++ILL       L+DFG    + S +     S V   Y ++AP +   +  YG  
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPY-WMAP-EVISRTPYG-- 195

Query: 250 MNITEKSDVYSYGVVLLEILSG 271
              TE  D++S G++++E++ G
Sbjct: 196 ---TE-VDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 9/154 (5%)

Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHI 120
           LE  K  + +G+G    VYK      G+L+A+K++   + + E    F A  E  +L  +
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDL 60

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
           +H NIV L      K    L++ Y+     Q +      L             +GLAY H
Sbjct: 61  KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
                 +LHRD+K  N+L+  + E  LADFGLA+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 37/224 (16%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           N+IG G  GVVY+A  +   E +A+KK+ +  + +        E+ I+ ++ H NI+ L 
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINIIFLK 125

Query: 130 GY----CSNKSVKLLLYN----YISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAY 178
            Y    C  K+ K +  N    +I     + +    RN      + + + S Q    LAY
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 179 LHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           +H      I HRD+K  N+L+D   +   L DFG AK  N      ++S +   + Y AP
Sbjct: 186 IHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRF-YRAP 239

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLE------ILSGRSAV 275
                +++ G T N T   D++S G ++ E      I SG+S+V
Sbjct: 240 -----ELMLGAT-NYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277

Length = 440

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 41/217 (18%)

Query: 72  VIGKGCSGVVYKAEMPNG-ELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIV 126
           V+GKG  G V  AE     EL A+K L   K+D    ++ V+    E ++L        +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKIL---KKDVIIQDDDVECTMVEKRVLALPGKPPFL 63

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS------AQGLAYL 179
             L  C     +L  +  Y++ G+L   +Q         ++K           A GL +L
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPHAVFYAAEIAIGLFFL 117

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H      I++RD+K +N++LD++    +ADFG+ K   +           G+  YIAP  
Sbjct: 118 HSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAP-- 170

Query: 240 CKLQII----YGYTMNITEKSDVYSYGVVLLEILSGR 272
              +II    YG ++      D +++GV+L E+L+G+
Sbjct: 171 ---EIIAYQPYGKSV------DWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 72  VIGKGCSGVV----YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G V    +K+      +  + K    KR +     F  E  I+       +V+
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 107

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLD----WETRYKIAVGSAQGLAYLHHDC 183
           L     +     ++  Y+  G+L  L+    N D    W   Y   V  A  L  +H   
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLA--LDAIHS-- 160

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              ++HRDVK +N+LLD      LADFG    M+ T      + V G+  YI+P   K Q
Sbjct: 161 -MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSG 271
              GY      + D +S GV L E+L G
Sbjct: 219 GGDGY---YGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 62/290 (21%)

Query: 72  VIGKGCSG-VVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK--- 127
           V+GKG  G V       +G+   +KKL           +   E Q+L  ++H NIV    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 128 -----------LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGL 176
                      ++G+C        LY+ +      +LL  N+ ++W       V  A  L
Sbjct: 67  SWEGEDGLLYIVMGFCEGGD----LYHKLKEQK-GKLLPENQVVEW------FVQIAMAL 115

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            YLH      ILHRD+K  N+ L       + D G+A+++   N     S + G+  Y++
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMS 170

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P +      Y Y      KSDV++ G  + E+ + + A                K M S 
Sbjct: 171 P-ELFSNKPYNY------KSDVWALGCCVYEMATLKHAFN-------------AKDMNSL 210

Query: 297 EPAVSILDTKLQGLP---DQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
                I++ KL  +P      + E++ T+      ++  P +RP++K ++
Sbjct: 211 --VYRIIEGKLPPMPKDYSPELGELIATM------LSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)

Query: 71  NVIGKGCSGVVYKAEMPN-GELIAVKKL----WKT--KRDEEPVDS----FAA--EIQIL 117
             +G+G  G V KA     G+++A+KK+          +D + V      F    E++I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 118 GHIRHRNIVKLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGL 176
             I+H NI+ L+  Y     + L++   I   +L++++     L       I +    GL
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMD--IMASDLKKVVDRKIRLTESQVKCILLQILNGL 132

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
             LH       +HRD+   NI ++SK    +ADFGLA+
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 15/152 (9%)

Query: 72  VIGKGCSGVVYKAEM----PNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNI 125
           V+GKG  G V++         G++ A+K L K    R+++      AE  IL  ++H  I
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 126 VKLLGYCSNKSVKL-LLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHD 182
           V L+ Y      KL L+  Y+S G L   L+  G    D    Y   +  A  L +LH  
Sbjct: 63  VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA--LEHLHQQ 119

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
               I++RD+K  NILLD++    L DFGL K
Sbjct: 120 ---GIIYRDLKPENILLDAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 31/167 (18%)

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLL--------LYNYISNGNLQQLLQGNRNLDWET 164
           E  +L ++ H +++++     + ++  +        LY Y++  +        R L  + 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS--------RPLPIDQ 158

Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL-MNSTNYHH 223
              I     +GL YLH      I+HRDVK  NI ++   +  + D G A+  + +  +  
Sbjct: 159 ALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215

Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               +AG+    AP     +++     N   K+D++S G+VL E+L+
Sbjct: 216 ----LAGTVETNAP-----EVLARDKYN--SKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 16/200 (8%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G SG VY A ++  G+ +A+K++   ++ ++ +     EI ++   ++ NIV  L  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 84

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  Y++ G+L  ++     +D      +     Q L +LH +    ++HRD
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K +NILL       L DFG    +  T      S + G+  ++AP +   +  YG    
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAP-EVVTRKAYG---- 193

Query: 252 ITEKSDVYSYGVVLLEILSG 271
              K D++S G++ +E++ G
Sbjct: 194 --PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 28/166 (16%)

Query: 131 YCSNKSVKLL--LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
           +CS ++ + L  +  Y+  G+   LL+    L  +        +   L YLH+     I+
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIV 123

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAK--LMNSTN--YHHAMSR---------VAGSYGYI 235
           HRD+K +N+L+ S     L DFGL+K  LM+ T   Y   + +         V G+  YI
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI 183

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
           AP   ++ +  GY   +    D ++ G++L E L G     P  GD
Sbjct: 184 AP---EVILRQGYGKPV----DWWAMGIILYEFLVG---CVPFFGD 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 61/242 (25%)

Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++GKG  G V+   +   G+L A+K L K    KR++  V     E +IL  + H  +  
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK--VKRVLTEQEILATLDHPFLPT 65

Query: 128 LLGYCSNKSVKLLLY--NYISNGNLQQLLQ---GNRNLDWETRYKIA-VGSAQGLAYLHH 181
           L  Y S ++   L    +Y   G L +LLQ   G    +   R+  A V  A  L YLH 
Sbjct: 66  L--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA--LEYLH- 120

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA------------ 229
             +  I++RD+K  NILL       L+DF L+K  +       +S+              
Sbjct: 121 --LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP--PPVSKALRKGSRRSSVNSI 176

Query: 230 -----------------GSYGYIAPGKCKLQII--YGYTMNITEKSDVYSYGVVLLEILS 270
                            G+  YIAP     ++I   G+   +    D ++ G++L E+L 
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAP-----EVISGDGHGSAV----DWWTLGILLYEMLY 227

Query: 271 GR 272
           G 
Sbjct: 228 GT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 38/180 (21%)

Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
           A+G+ +L    C+    HRD+   NILL       + DFGLA+             +   
Sbjct: 183 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLAR------------DIYKD 226

Query: 232 YGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
             Y+  G  +L + +    +I     T +SDV+S+GV+L EI S  ++  P    G+ I 
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP----GVQID 282

Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E   +++          +      P+    E+   +   + C +++P +RPT  E+V +L
Sbjct: 283 EEFCRRLK---------EGTRMRAPEYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 16/200 (8%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G SG VY A ++  G+ +A++++   ++ ++ +     EI ++   ++ NIV  L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 85

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  Y++ G+L  ++     +D      +     Q L +LH +    ++HRD
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K +NILL       L DFG    +  T      S + G+  ++AP +   +  YG    
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAP-EVVTRKAYG---- 194

Query: 252 ITEKSDVYSYGVVLLEILSG 271
              K D++S G++ +E++ G
Sbjct: 195 --PKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 26/210 (12%)

Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G V   +M   G+L A KKL K + +  +  +    E +IL  +  R IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 131 YCSNKSVKLLLYNYISNG-----NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
           Y       L L   I NG     ++  + + N                 GL +LH     
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
            I++RD+K  N+LLD+     ++D GLA +L +  +        AG+ G++AP     ++
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY---AGTPGFMAP-----EL 168

Query: 245 IYG--YTMNITEKSDVYSYGVVLLEILSGR 272
           + G  Y  ++    D ++ GV L E+++ R
Sbjct: 169 LQGEEYDFSV----DYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 29/209 (13%)

Query: 71  NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE----EPVDSFAAEIQILGHIRHRNI 125
             +G G  G V  A+    GE  A+K L   K+ E    + V   A E  IL  + H  I
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCL---KKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 126 VKLL-GYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHD 182
           V ++  +     V  LL  ++  G L   L+  G    D    Y   +  A    YLH  
Sbjct: 81  VNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FEYLHSK 137

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               I++RD+K  N+LLD+K    + DFG AK +    +      + G+  Y+AP     
Sbjct: 138 ---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-----TLCGTPEYLAP----- 184

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           ++I        +  D ++ GV+L E ++G
Sbjct: 185 EVIQSKGHG--KAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 44/281 (15%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           V+G+G  G     +  N +     K  +  +    V+    E  +L  ++H NIV     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRN--------LDWETRYKIAVGSAQGLAYLHHDC 183
                   ++  Y   G+L Q ++  R         L W  +  + V       ++H   
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV------QHIHEKR 120

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
           V   LHRD+K  NI L    +  L DFG A+L+ S    +A + V   Y Y+ P   +  
Sbjct: 121 V---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYACTYVGTPY-YVPPEIWE-- 173

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
                 M    KSD++S G +L E+ + +   Q       +++  +K   GS++P     
Sbjct: 174 -----NMPYNNKSDIWSLGCILYELCTLKHPFQA--NSWKNLI--LKVCQGSYKP----- 219

Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
                 LP     E L++L   MF  N  P  RP+   +++
Sbjct: 220 ------LPSHYSYE-LRSLIKQMFKRN--PRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 26/215 (12%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +++G+G  G V    E   G++ A+K + K+    +E V  F  E  IL       I +L
Sbjct: 7   SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLD---------WETRYKIAVGSAQGLAYL 179
                +K    L+  Y   G+L  LL  NR  D         +     +A+ S   + Y+
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H         RD+K  N+L+D      LADFG A  + +    ++   V G+  YIAP  
Sbjct: 125 H---------RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPE- 173

Query: 240 CKLQIIYGYTMNITEKS-DVYSYGVVLLEILSGRS 273
             L  + G          D +S GV+  E++ GRS
Sbjct: 174 -VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 17/206 (8%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLL 129
           V+GKG  G V   ++   G++ A KKL K +  +   ++ A  E +IL  +  R +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
                K    L+   ++ G+L+  +   GN   D +     A     GL  L  +    I
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RI 123

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           ++RD+K  NILLD +    ++D GLA  +          RV G+ GY+AP     +    
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMAPEVINNE---K 177

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRS 273
           YT +     D +  G ++ E++ G+S
Sbjct: 178 YTFS----PDWWGLGCLIYEMIQGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 17/209 (8%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLL 129
           V+GKG  G V   ++   G++ A KKL K +  +   ++ A  E QIL  +  R +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
                K    L+   ++ G+L+  +   GN   D E     A     GL  LH +    I
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RI 123

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           ++RD+K  NILLD      ++D GLA  +          RV G+ GY+AP   K +  Y 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMAPEVVKNE-RYT 179

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           ++       D +  G ++ E++ G+S  +
Sbjct: 180 FS------PDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 30/221 (13%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWK---TKRDEEPVDSFAAEIQILGHI 120
           E LK   VIG+G  G V   +M N G++ A+K L K    KR E     F  E  +L + 
Sbjct: 4   EILK---VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE--TACFREERDVLVNG 58

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKI-----AVGSA 173
             R I  L     +++   L+ +Y   G+L  LL    +R  +   R+ +     A+ S 
Sbjct: 59  DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA-GSY 232
             L Y+H         RD+K +N+LLD      LADFG    + +       S VA G+ 
Sbjct: 119 HQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTP 167

Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
            YI+P    LQ +         + D +S GV + E+L G +
Sbjct: 168 DYISPE--ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 30/207 (14%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL-G 130
           IG+G SG VY A ++  G+ +A+K++    + +   +    EI ++   +H NIV  L  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA------QGLAYLHHDCV 184
           Y     + +++  Y++ G+L  ++        ET       +A      Q L +LH + V
Sbjct: 85  YLVGDELWVVM-EYLAGGSLTDVVT-------ETCMDEGQIAAVCRECLQALEFLHSNQV 136

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+K +NILL       L DFG    +  T      S + G+  ++AP +   + 
Sbjct: 137 ---IHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAP-EVVTRK 190

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSG 271
            YG       K D++S G++ +E++ G
Sbjct: 191 AYG------PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 5/145 (3%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           I +G  G VY   +  N +L AVK + K    ++  V    AE   L   +   IV L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
              + +   L+  Y+  G+++ LL      D E   K     A  L YLH      I+HR
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHR 128

Query: 191 DVKCNNILLDSKYEAYLADFGLAKL 215
           D+K +N+L+ ++    L DFGL+K+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 38/180 (21%)

Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
           A+G+ +L    C+    HRD+   NILL       + DFGLA+             +   
Sbjct: 184 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLAR------------DIYKD 227

Query: 232 YGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
             Y+  G  +L + +    +I     T +SDV+S+GV+L EI S  ++  P    G+ I 
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP----GVQIN 283

Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E   +++           T+++  P+    E+     I + C    P ERPT   +V +L
Sbjct: 284 EEFCQRLKD--------GTRMRA-PENATPEI---YRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)

Query: 73  IGKGCSGVVYKA---EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKL 128
           +G+G  G+V  A   E    E +A+KK+      +        E+++L H R H+NI  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 129 LGY---CSNKSVKLLLYNYISNGNLQQLLQGNRNL-DWETR---YKIAVGSAQGLAYLHH 181
                       +L LY  +   +L Q+++  + L D   +   Y+I  G    L Y+H 
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCG----LKYIHS 123

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA--MSRVAGSYGYIAPGK 239
             V   LHRD+K  N+L+++  E  + DFGLA+  +     +A  M+    +  Y AP  
Sbjct: 124 ANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP-- 178

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              +I+  +  + T+  DV+S G +L E+L  +
Sbjct: 179 ---EIMLSFQ-SYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 17/199 (8%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           + +GC  +  K E+P    +A+  L     D++    F AE   LG   H NIV+L G  
Sbjct: 21  LCRGCLKLPSKRELP----VAIHTLRAGCSDKQRR-GFLAEALTLGQFDHSNIVRLEGVI 75

Query: 133 SNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
           +  +  +++  Y+SNG L   L+ +   L       +  G A G+ YL        +H+ 
Sbjct: 76  TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKG 132

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +  + +L++S     ++ F   +   S   +  MS  +    + AP      I Y +   
Sbjct: 133 LAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPEA----IQYHH--- 184

Query: 252 ITEKSDVYSYGVVLLEILS 270
            +  SDV+S+G+V+ E++S
Sbjct: 185 FSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 10/152 (6%)

Query: 64  LECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIR 121
            E LK   VIG+G  G V   +  + G + A+K L K    ++E V    AE  IL    
Sbjct: 3   FESLK---VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD 59

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNL-DWETRYKIAVGSAQGLAYLH 180
              +VK+     +K    L+  ++  G++  LL     L + ET++ IA  +   +  +H
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH 118

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGL 212
                  +HRD+K +N+LLDSK    L+DFGL
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 10/152 (6%)

Query: 64  LECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIR 121
            E LK   VIG+G  G V   +  + G + A+K L K    ++E V    AE  IL    
Sbjct: 3   FESLK---VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNL-DWETRYKIAVGSAQGLAYLH 180
              +VK+     +K    L+  ++  G++  LL     L +  T++ IA  +   +  +H
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH 118

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGL 212
                  +HRD+K +N+LLD+K    L+DFGL
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 30/211 (14%)

Query: 72  VIGKGCSG-VVYKAEMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++GKG  G V+   E   G+  A+K L K     +DE  V     E ++L + RH  +  
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE--VAHTLTESRVLQNTRHPFLTA 59

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWE-TR-YKIAVGSAQGLAYLHHDCVP 185
           L            +  Y + G L   L   R    +  R Y   + SA  L YLH     
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHSC--- 114

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            +++RD+K  N++LD      + DFGL K     +    M    G+  Y+AP     +++
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP-----EVL 167

Query: 246 ----YGYTMNITEKSDVYSYGVVLLEILSGR 272
               YG  +      D +  GVV+ E++ GR
Sbjct: 168 EDNDYGRAV------DWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 36/220 (16%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL-- 129
           +G G +G+V+ A +    + +AVKK+  T  D + V     EI+I+  + H NIVK+   
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 130 ----GYCSNKSVKLLLY---NYIS----NGNLQQLLQGNRNLDWETR---YKIAVGSAQG 175
               G    + V  L      YI       +L  +L+     +   R   Y++     +G
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL----RG 126

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHA--MSRVAGSY 232
           L Y+H   V   LHRD+K  N+ ++++     + DFGLA++++  +Y H   +S    + 
Sbjct: 127 LKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDP-HYSHKGYLSEGLVTK 182

Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            Y +P     +++     N T+  D+++ G +  E+L+G+
Sbjct: 183 WYRSP-----RLLLSPN-NYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHIRHRNIVKLLG 130
           +G+G  G VYKA+  +G+    +K +  K+ E    S +A  EI +L  ++H N++ L  
Sbjct: 9   VGRGTYGHVYKAKRKDGK---DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65

Query: 131 -YCSNKSVKL-LLYNYI-------------SNGNLQQLLQGNRNLDWETRYKIAVGSAQG 175
            + S+   K+ LL++Y              S  N ++ +Q  R++     Y+I      G
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQIL----DG 120

Query: 176 LAYLHHDCVPAILHRDVKCNNILL----DSKYEAYLADFGLAKLMNSTNYHHA-MSRVAG 230
           + YLH + V   LHRD+K  NIL+      +    +AD G A+L NS     A +  V  
Sbjct: 121 IHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           ++ Y AP     +++ G   + T+  D+++ G +  E+L+
Sbjct: 178 TFWYRAP-----ELLLG-ARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 71/255 (27%), Positives = 96/255 (37%), Gaps = 36/255 (14%)

Query: 40  GAEDFSYPWTFIPFQKLNFTIDNILECLKDE-----------------NVIGKGCSGVVY 82
           G +   Y   F P  + N  IDN L   KD                   VIG+G  G V 
Sbjct: 2   GLDALVYDLDF-PALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ 60

Query: 83  KAEMPNGELIAVKKLWKTKRDEEPVDS--FAAEIQILGHIRHRNIVKLLGYCSNKSVKLL 140
                +   +   KL       +  DS  F  E  I+       +V+L     +     +
Sbjct: 61  LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120

Query: 141 LYNYISNGNLQQLLQGNRNLD----WETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNN 196
           +  Y+  G+L  L+    N D    W   Y   V  A  L  +H       +HRDVK +N
Sbjct: 121 VMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLA--LDAIHS---MGFIHRDVKPDN 172

Query: 197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKS 256
           +LLD      LADFG    MN        + V G+  YI+P   K Q   GY      + 
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY---YGREC 228

Query: 257 DVYSYGVVLLEILSG 271
           D +S GV L E+L G
Sbjct: 229 DWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 42/169 (24%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIGKG  G V   +    G++ A+K L K+   K+D+  +    AE  +L       +V 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQ--LAHVKAERDVLAESDSPWVVS 65

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWE------TRYKIAVGSAQGLAYLHH 181
           L     +     L+  ++  G+L  +L     + ++      TR+ +A            
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTML-----IKYDTFSEDVTRFYMA------------ 108

Query: 182 DCVPAI--------LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
           +CV AI        +HRD+K +NIL+D      L+DFGL     ST +H
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGL-----STGFH 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 65/263 (24%), Positives = 117/263 (44%), Gaps = 28/263 (10%)

Query: 72  VIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN---IVK 127
           +IG+G  G VY     + G++ A+K L K +   +  ++ A   +I+  +        + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 128 LLGYCSNKSVKL-LLYNYISNGNLQ-QLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
            + Y  +   KL  + + ++ G+L   L Q     + E R+  A     GL ++H+  V 
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRFV- 118

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             ++RD+K  NILLD      ++D GLA   +    H ++    G++GY+AP   +    
Sbjct: 119 --VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGTA 172

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG-----SFEPAV 300
           Y         +D +S G +L ++L G S  +       H ++ +   +      SF P  
Sbjct: 173 Y------DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPE- 225

Query: 301 SILDTKLQGLPDQMVQEMLQTLG 323
             L + L+GL  + V + L  LG
Sbjct: 226 --LKSLLEGLLQRDVSKRLGCLG 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.0 bits (111), Expect = 7e-06
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 25/213 (11%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHIRHRNIVKLLG 130
           +G+G  G VYKA+  +G+     + +  K+ E    S +A  EI +L  ++H N++ L  
Sbjct: 9   VGRGTYGHVYKAKRKDGK---DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65

Query: 131 -YCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR-YKIAVGSAQGLAY-----LHHD 182
            + S+   K+ LL++Y  + +L  +++ +R      +  ++  G  + L Y     +H+ 
Sbjct: 66  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 183 CVPAILHRDVKCNNILL----DSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAP 237
               +LHRD+K  NIL+      +    +AD G A+L NS     A +  V  ++ Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
                +++ G   + T+  D+++ G +  E+L+
Sbjct: 185 -----ELLLG-ARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.0 bits (111), Expect = 7e-06
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 26/209 (12%)

Query: 72  VIGKGCSG-VVYKAEMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++GKG  G V+   E  +G+  A+K L K     +DE  V     E ++L + RH  +  
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE--VAHTLTESRVLKNTRHPFLTS 59

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L      K     +  Y++ G L   L   R    +            L YLH      I
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII-- 245
           ++RD+K  N++LD      + DFGL K          M    G+  Y+AP     +++  
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAP-----EVLED 169

Query: 246 --YGYTMNITEKSDVYSYGVVLLEILSGR 272
             YG  +      D +  GVV+ E++ GR
Sbjct: 170 NDYGRAV------DWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRN---IV 126
           IGKG  G VY+    +   + A+K L K +    +E V     E  IL          IV
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE-VAHTIGERNILVRTLLDESPFIV 59

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS-AQGLAYLH-HDCV 184
            L       S   L+ +Y+S G L   LQ       E R K  +      L +LH +D  
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-EDRAKFYIAELVLALEHLHKYD-- 116

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I++RD+K  NILLD+     L DFGL+K   + N     +   G+  Y+AP     ++
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAP-----EV 167

Query: 245 IY---GYTMNITEKSDVYSYGVVLLEILSGRS 273
           +    GYT ++    D +S GV++ E+  G S
Sbjct: 168 LLDEKGYTKHV----DFWSLGVLVFEMCCGWS 195

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 51/193 (26%), Positives = 76/193 (39%), Gaps = 26/193 (13%)

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
           N+V L  Y  ++    L+  +   G L   +    N+  E   + A      L  LH + 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE- 104

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I+ RD+  NNILLD +    L  F     +  +    A+  +     Y AP      
Sbjct: 105 --GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPE----- 152

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP-----QIGDGLHIVEWVKKKMGSFEP 298
              G     TE  D +S G +L E+L+G++ V+           L+I EWV       E 
Sbjct: 153 --VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVS------EE 204

Query: 299 AVSILDTKLQGLP 311
           A S+L   LQ  P
Sbjct: 205 ARSLLQQLLQFNP 217

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 24/217 (11%)

Query: 73  IGKGCSGV--VYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G   +  VY A   P G L+ V+        EE + +   E+ +    RH NI+   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
              +  S   ++  +++ G+   LL+      +       I  G+ +GL YLH +     
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GY 122

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG--------YIAPGK 239
           +HR++K ++IL+    +  ++  GL+ L +    +   ++V   +         +++P  
Sbjct: 123 IHRNIKASHILISG--DGLVSLSGLSHLYSLVR-NGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
            + Q +YGY +    KSD+YS G+   E+ +GR   Q
Sbjct: 180 LR-QDLYGYNV----KSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 38/288 (13%)

Query: 73  IGKGCSGVVYKAEM---PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G V  +E+        + VK+L K     +  + F  +      ++H NI++ L
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKEL-KANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETR-------YKIAVGSAQGLAYLH-H 181
           G C      LL++ Y   G+L+  L       W  R        ++A   A G+ ++H H
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP---G 238
           +     LH D+   N  L S     + D+G+       +Y            ++AP   G
Sbjct: 119 N----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
           +    +I   T   T+ S+V++ GV L E+    +     + D   ++  V K     + 
Sbjct: 175 EFHGGLI---TAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIK-----DQ 225

Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            V +   +L+    +   E+LQ      FC   SP +R T +EV  LL
Sbjct: 226 QVKLFKPQLELPYSERWYEVLQ------FCW-LSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKL---WKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           VIG+G  G V   ++ N + +   K+   W+  +  E    F  E  +L +  ++ I  L
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA-CFREERDVLVNGDNQWITTL 66

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIA--VGSAQGLAYLHHDCV 184
                +++   L+ +Y   G+L  LL    +R  +   R+ +A  V +   +  LH+   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFG-LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              +HRD+K +NIL+D      LADFG   KLM       +++   G+  YI+P    LQ
Sbjct: 124 ---VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPE--ILQ 176

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
            +         + D +S GV + E+L G +
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 17/209 (8%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKL---WKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           VIG+G  G V   +M + E I   K+   W+  +  E    F  E  +L +   + I  L
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETA-CFREERNVLVNGDCQWITTL 66

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIA--VGSAQGLAYLHHDCV 184
                +++   L+ +Y   G+L  LL    +R  +   R+ IA  V +   +  LH+   
Sbjct: 67  HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--- 123

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+K +N+LLD      LADFG    MN      + S   G+  YI+P    LQ 
Sbjct: 124 ---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS-SVAVGTPDYISPE--ILQA 177

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +         + D +S GV + E+L G +
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 85/302 (28%)

Query: 73  IGKGCSGVVY-----KA----------EMPNGELIAVKKLWKTKRDEEPVDSFAA--EIQ 115
           +GKG  G VY     KA          E+P GEL              P ++  A  E Q
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL-------------NPNETVQANQEAQ 54

Query: 116 ILGHIRHRNIVKLLG-------------YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW 162
           +L  + H  IVK                YC  + +   L      G   + L  N+  +W
Sbjct: 55  LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG---KTLSENQVCEW 111

Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNY 221
             +  +      G+ Y+H      ILHRD+K  NI L +     + DFG+++ LM S + 
Sbjct: 112 FIQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL 161

Query: 222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
               +   G+  Y++P   K Q   GY      KSD++S G +L E+     A + Q  +
Sbjct: 162 ---ATTFTGTPYYMSPEALKHQ---GY----DSKSDIWSLGCILYEMCCLAHAFEGQ--N 209

Query: 282 GLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE 341
            L +V             + I++     LP+   ++ L ++  +M  +N  P+ RP+  E
Sbjct: 210 FLSVV-------------LRIVEGPTPSLPETYSRQ-LNSIMQSM--LNKDPSLRPSAAE 253

Query: 342 VV 343
           ++
Sbjct: 254 IL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 43/185 (23%)

Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAG 230
           A+G+ +L   +CV    HRD+   N+LL       + DFGLA+ +M+ +N          
Sbjct: 247 ARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSN---------- 292

Query: 231 SYGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
              Y++ G   L + +    +I     T  SDV+SYG++L EI S      P    G+ +
Sbjct: 293 ---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP----GMIV 345

Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT---MKEV 342
                 K+ S               PD   QE+     I + C NS P +RP+   + ++
Sbjct: 346 DSTFYNKIKS---------GYRMAKPDHATQEVYD---IMVKCWNSEPEKRPSFLHLSDI 393

Query: 343 VALLM 347
           V  L+
Sbjct: 394 VESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 9/101 (8%)

Query: 67  LKDENVIGKGCSGVVYKA------EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           LK    +G+G  G V +A      +  +   +AVK L +     E   +   E++IL HI
Sbjct: 9   LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-YKALMTELKILIHI 67

Query: 121 -RHRNIVKLLGYCSNKSVKLL-LYNYISNGNLQQLLQGNRN 159
             H N+V LLG C+     L+ +  Y   GNL   L+  R 
Sbjct: 68  GHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRE 108

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 38/121 (31%), Positives = 59/121 (48%), Gaps = 18/121 (14%)

Query: 48  WTFI-PFQ-----KLNFTIDNILECLKDENVIGKGCSGVVYKA------EMPNGELIAVK 95
           +TFI P Q     K  F  DN    L+    +G G  G V +A      +  N   +AVK
Sbjct: 19  YTFIDPTQLPYNEKWEFPRDN----LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK 74

Query: 96  KLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLL 154
            L K     +  ++  +E++IL H+ +H+NIV LLG C++    L++  Y   G+L   L
Sbjct: 75  ML-KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Query: 155 Q 155
           +
Sbjct: 134 R 134

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 13/102 (12%)

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL ++H+  V   ++RD+K  NILLD      ++D GLA   +    H ++    G++GY
Sbjct: 109 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 161

Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           +AP   +  + Y         +D +S G +L ++L G S  +
Sbjct: 162 MAPEVLQKGVAY------DSSADWFSLGCMLFKLLRGHSPFR 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 57/246 (23%), Positives = 104/246 (42%), Gaps = 34/246 (13%)

Query: 103 DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL-QQLLQGNRNLD 161
           DE       +E+  L    H  IVK      +    LL+  Y S G+L +Q+ Q  +   
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL 164

Query: 162 WETRYKIAVGSAQ---GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS 218
               Y++ +   Q    L  +H      ++HRD+K  NI L       L DFG +K  + 
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221

Query: 219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQP 277
           +      S   G+  Y+AP   + +         ++K+D++S GV+L E+L+  R    P
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERK-------RYSKKADMWSLGVILYELLTLHRPFKGP 274

Query: 278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP 337
              + +  V +     G ++P    + + ++ L D ++ +              +PA RP
Sbjct: 275 SQREIMQQVLY-----GKYDPFPCPVSSGMKALLDPLLSK--------------NPALRP 315

Query: 338 TMKEVV 343
           T ++++
Sbjct: 316 TTQQLL 321

Length = 478

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 32/212 (15%)

Query: 72  VIGKGCSG-VVYKAEMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++GKG  G V+   E   G   A+K L K     +DE  V     E ++L + RH   + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRH-PFLT 58

Query: 128 LLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNL--DWETRYKIAVGSAQGLAYLHHDCV 184
            L Y      +L  +  Y + G L   L   R    +    Y   + SA  L YLH   V
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHSRDV 116

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              ++RD+K  N++LD      + DFGL K     +    M    G+  Y+AP     ++
Sbjct: 117 ---VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP-----EV 166

Query: 245 I----YGYTMNITEKSDVYSYGVVLLEILSGR 272
           +    YG  +      D +  GVV+ E++ GR
Sbjct: 167 LEDNDYGRAV------DWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 43/188 (22%), Positives = 83/188 (44%), Gaps = 35/188 (18%)

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLL--LYNYISNG----NLQQLLQGNRNLDWETRY 166
           E+ ++  ++H+NIV+ +    NK+ + L  L  +   G    N+Q+  +    ++     
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 167 KIAVGSAQGLAYLHH----DCVPAILHRDVKCNNILLDSKYE-----------------A 205
            I       LAY H+         +LHRD+K  NI L +                    A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 206 YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVL 265
            + DFGL+K +   +  H+     G+  Y +P     +++   T +  +KSD+++ G ++
Sbjct: 182 KIGDFGLSKNIGIESMAHS---CVGTPYYWSP-----ELLLHETKSYDDKSDMWALGCII 233

Query: 266 LEILSGRS 273
            E+ SG++
Sbjct: 234 YELCSGKT 241

Length = 1021

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 25/209 (11%)

Query: 72  VIGKGCSG-VVYKAEMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++GKG  G V+   E   G   A+K L K     +DE  V     E ++L + RH  +  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNSRHPFLTA 59

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L            +  Y + G L   L   R    +            L YLH +    +
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 117

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII-- 245
           ++RD+K  N++LD      + DFGL K          M    G+  Y+AP     +++  
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP-----EVLED 170

Query: 246 --YGYTMNITEKSDVYSYGVVLLEILSGR 272
             YG  +      D +  GVV+ E++ GR
Sbjct: 171 NDYGRAV------DWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.9 bits (91), Expect = 0.001
 Identities = 30/145 (20%), Positives = 51/145 (35%), Gaps = 14/145 (9%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV--KLLG 130
           +  G +  VY     + + +      K     E       E+ IL  +  + +   K+L 
Sbjct: 6   LKGGLTNRVYLLGTKDEDYV-----LKINPSREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
              +     LL  +I    L         +  E +  IA   A+ LA LH   +  + H 
Sbjct: 61  SGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113

Query: 191 DVKCNNILLDSKYEAYLADFGLAKL 215
           D+   NIL+D      + D+  A  
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 51/209 (24%)

Query: 76  GCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN 134
           G  G V+++  P+  + + VK  W          S   E ++L  + H  ++ LL     
Sbjct: 180 GSEGCVFESSHPDYPQRVVVKAGWYA--------SSVHEARLLRRLSHPAVLALLDVRVV 231

Query: 135 KSVKLL--------LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLA---YLHHDC 183
             +  L        LY Y+            R L      ++   + Q L+   Y+H + 
Sbjct: 232 GGLTCLVLPKYRSDLYTYLG--------ARLRPLG---LAQVTAVARQLLSAIDYIHGE- 279

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN---STNYHHAMSRVAGSYGYIAPGKC 240
              I+HRD+K  N+L++   +  L DFG A       ST +H+    +AG+    AP   
Sbjct: 280 --GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG---IAGTVDTNAP--- 331

Query: 241 KLQIIYG--YTMNITEKSDVYSYGVVLLE 267
             +++ G  YT ++    D++S G+V+ E
Sbjct: 332 --EVLAGDPYTPSV----DIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	371
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.63
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.57
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.43
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.22
COG4248	637	Uncharacterized protein with protein kinase and he	99.19
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.14
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
COG0661	517	AarF Predicted unusual protein kinase [General fun	99.01
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.93
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
PRK09902	216	hypothetical protein; Provisional	98.91
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.85
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.82
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.62
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.57
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.5
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.39
PLN02876	822	acyl-CoA dehydrogenase	98.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.23
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.23
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.23
PRK10593	297	hypothetical protein; Provisional	98.17
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.12
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.1
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.1
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.96
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.93
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.82
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.78
PRK05231	319	homoserine kinase; Provisional	97.67
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.62
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.43
PLN02756	418	S-methyl-5-thioribose kinase	97.36
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.32
KOG2270	520	consensus Serine/threonine protein kinase involved	97.3
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.29
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.24
PLN02236	344	choline kinase	97.21
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.12
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.99
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.9
PRK12396	409	5-methylribose kinase; Reviewed	96.9
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.87
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.77
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.73
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.61
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.45
PRK11768	325	serine/threonine protein kinase; Provisional	96.3
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.24
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.17
PTZ00384	383	choline kinase; Provisional	96.15
PRK06148	1013	hypothetical protein; Provisional	96.14
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	96.12

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-53  Score=389.05  Aligned_cols=281  Identities=43%  Similarity=0.758  Sum_probs=235.8

Q ss_pred             ccHH---HHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec
Q 037946           58 FTID---NILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN  134 (371)
Q Consensus        58 ~~~~---~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  134 (371)
                      |+++   ..++.|...+.||+|+||.||+|...+|..||||++.......  ..+|.+|+.++.+++|||+|+++|||.+
T Consensus        65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e  142 (361)
T KOG1187|consen   65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE  142 (361)
T ss_pred             eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence            4544   4467899999999999999999999888999999884433221  4569999999999999999999999999


Q ss_pred             CC-eEEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcccc
Q 037946          135 KS-VKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG  211 (371)
Q Consensus       135 ~~-~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  211 (371)
                      .+ ..++|+|||++|+|.+++....  .++|..+.+||.++|+||+|||+.+.+.|+||||||+|||+|+++++||+|||
T Consensus       143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG  222 (361)
T KOG1187|consen  143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG  222 (361)
T ss_pred             CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence            99 5999999999999999998765  79999999999999999999999887789999999999999999999999999


Q ss_pred             CccccCC-CCcccccccc-cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-CCchhHHHH
Q 037946          212 LAKLMNS-TNYHHAMSRV-AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI-GDGLHIVEW  288 (371)
Q Consensus       212 ~~~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~-~~~~~~~~~  288 (371)
                      +++.... ..   ..... .||.+|+|||.+       ..+..+.++|||||||+|.||+||+.+..... .+...+.+|
T Consensus       223 La~~~~~~~~---~~~~~~~gt~gY~~PEy~-------~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  223 LAKLGPEGDT---SVSTTVMGTFGYLAPEYA-------STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             CcccCCcccc---ceeeecCCCCccCChhhh-------ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            9965443 21   11222 799999999954       35678999999999999999999998887544 334458899


Q ss_pred             HHHHhcCCCccccccCcccCC-CChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          289 VKKKMGSFEPAVSILDTKLQG-LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      .+..+.. .....++|+++.. ..+. ...+.++..++.+|++.+|.+||+|.||++.|..+...
T Consensus       293 ~~~~~~~-~~~~eiiD~~l~~~~~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  293 AKPLLEE-GKLREIVDPRLKEGEYPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHC-cchhheeCCCccCCCCCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            8777777 4788899999863 3221 15677788899999999999999999999999665543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-53  Score=370.05  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=213.5

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-eEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-VKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  143 (371)
                      .++..+.||+|..|+||++.. .+++.+|+|++. ...++...+++.+|+++++..+||+||.+||.|.+.+ .+.++||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            355578899999999999965 468999999993 3445666788999999999999999999999999998 4999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||++|+|.+++...+.+++..+.+++.+|++||.|||+ +   +||||||||+|||+++.|+|||||||.+..+..+   
T Consensus       159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            99999999999998999999999999999999999996 6   9999999999999999999999999999887655   


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ...+..||..|||||.+.++       .|+.++||||||++++||.+|+.|+.+.........+.+......       
T Consensus       233 -~a~tfvGT~~YMsPERi~g~-------~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-------  297 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGE-------SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-------  297 (364)
T ss_pred             -hcccccccccccChhhhcCC-------cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-------
Confidence             34678899999999988754       788899999999999999999999987633333444444433332       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                         .....|..  .....+..++..||++||.+|||++|+++|-+-..
T Consensus       298 ---ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  298 ---PPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             ---CCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence               22223332  12223444677799999999999999999865543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-54  Score=378.07  Aligned_cols=264  Identities=25%  Similarity=0.351  Sum_probs=219.4

Q ss_pred             HHHHhccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCc-----chHHHHHHHHHHHhccCCCCceeeeceEec
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDE-----EPVDSFAAEIQILGHIRHRNIVKLLGYCSN  134 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  134 (371)
                      +.+.+.|...+.||+|+||.|-+|. .++|+.||||++.+.....     .......+|+++|++|+|||||++.+++..
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            3456778889999999999999994 5679999999997654332     122346799999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC---CceEEcccc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK---YEAYLADFG  211 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg  211 (371)
                      .+..||||||++||.|.+.+-.++.+.+.....+++|++.|+.|||++   ||+||||||+|||++.+   ..+||+|||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999999999999999999999999999999999999   99999999999999766   679999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN-ITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      +|+..+...   .+.+.||||.|.|||++...     +.. +..+.|+||+||+||-+++|.+||.....+. .+.+.+.
T Consensus       325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~k-----g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI~  395 (475)
T KOG0615|consen  325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASK-----GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQIL  395 (475)
T ss_pred             hhhccccce---ehhhhcCCccccChhheecC-----CeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHHh
Confidence            999887554   67889999999999999754     222 2358999999999999999999998665442 2333333


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      +             +++.-.|.....-....+.+|.+||..||++|||++|++++-|--
T Consensus       396 ~-------------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  396 K-------------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             c-------------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            3             333333344445555677799999999999999999999987644

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-52  Score=376.84  Aligned_cols=260  Identities=33%  Similarity=0.542  Sum_probs=209.0

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-eEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-VKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  145 (371)
                      +...+.||+|+||+||+|.+.....||+|++.....+....+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3445569999999999999954444999999765555444789999999999999999999999999888 799999999


Q ss_pred             CCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCeeEcCCC-ceEEccccCccccCCCCc
Q 037946          146 SNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPA-ILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       146 ~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~  221 (371)
                      ++|+|.+++..  ...+++..+..++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999987  67899999999999999999999999   7 99999999999999998 99999999998765432 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ..+....||+.|||||++.+.     ...++.++||||||+++|||+||..||.....  ..+...+..   .      
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~---~------  261 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVV---G------  261 (362)
T ss_pred             -ccccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh---c------
Confidence             233457899999999998743     34789999999999999999999999975543  222111111   1      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                         ......+....+   .+..++.+||+.||++||++.+++..|..+....
T Consensus       262 ---~~Rp~~p~~~~~---~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  262 ---GLRPPIPKECPP---HLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ---CCCCCCCccCCH---HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence               111111222222   2334566699999999999999999999886533

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-52  Score=382.46  Aligned_cols=251  Identities=24%  Similarity=0.392  Sum_probs=211.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ..|...++||+|||+.||.+++ .+|+.||+|++.+... ...+.+.+.+|+++.++|+|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688899999999999999987 7899999999965433 4556788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+|++++|..++++.+.+++..+..+..||+.||.|||++   +|+|||||..|+|++++.+|||+|||+|..+....  
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--  172 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc--
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999999887553  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....+.||||.|.|||++..+       .++..+||||+||++|.|++|++||+...-  .+....++....        
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~-------gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--kety~~Ik~~~Y--------  235 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKS-------GHSFEVDIWSLGCVMYTLLVGRPPFETKTV--KETYNKIKLNEY--------  235 (592)
T ss_pred             cccceecCCCcccChhHhccC-------CCCCchhhhhhhhHHHhhhhCCCCcccchH--HHHHHHHHhcCc--------
Confidence            244678999999999998733       568899999999999999999999974321  112222222111        


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                            ..|..+..   ...+||.++|+.||.+|||+++|+.+=
T Consensus       236 ------~~P~~ls~---~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  236 ------SMPSHLSA---EAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             ------ccccccCH---HHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence                  12221112   234577889999999999999999874

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-51  Score=374.15  Aligned_cols=254  Identities=28%  Similarity=0.471  Sum_probs=211.8

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      ++..+.||+|-||.||.|.+.....||+|.+...   ....+.|.+|+++|++|+|+|||+++++|..++.+|||||||+
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            4556789999999999999977779999999543   2334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          147 NGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       147 ~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      .|+|.++|+.  ...+...+.+.++.|||+||+||+++   ++|||||.++||||++++.+||+|||+++...+..+ ..
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TA  360 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce-ee
Confidence            9999999986  55689999999999999999999999   999999999999999999999999999995555443 23


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....-+..|.|||.+.       .+.++.+||||||||+||||+| |+.|+....  ..++.+.+.++.+..       
T Consensus       361 ~~~~kfPIkWtAPEa~~-------~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~le~GyRlp-------  424 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALN-------YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELLERGYRLP-------  424 (468)
T ss_pred             cCCCCCCceecCHHHHh-------hCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHHHHHHhccCcCC-------
Confidence            34445677899999876       3478999999999999999998 666665432  345556666655543       


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                        +...+|+++.+.|..       ||+.+|++||||+.+...|.++...
T Consensus       425 --~P~~CP~~vY~lM~~-------CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  425 --RPEGCPDEVYELMKS-------CWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             --CCCCCCHHHHHHHHH-------HhhCCcccCCCHHHHHHHHHHhhhc
Confidence              335677766554444       9999999999999999999888643

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-52  Score=350.51  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=206.1

Q ss_pred             hccccCCccccCCceEEEEE-EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeec-eEecCCe-EEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG-YCSNKSV-KLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv  141 (371)
                      ..|.+.+.||+|+||.||++ +..+|..+|.|.+.-...+....+....|+.+|++|+|||||++++ -+.+.+. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            34777889999999999999 4578999999999765666777788999999999999999999998 3444444 8999


Q ss_pred             EeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          142 YNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCV-PAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ||+|.+|+|..+++.    .+.+++..+|+++.|++.||..+|++.. .-++||||||.||+++.+|.|||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999853    4569999999999999999999999422 13999999999999999999999999999987


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....  ....+.+|||.||+||.+.       +..|+.+|||||+||++|||+.-++||.+.     ++.+...+     
T Consensus       179 ~s~~--tfA~S~VGTPyYMSPE~i~-------~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K-----  239 (375)
T KOG0591|consen  179 SSKT--TFAHSLVGTPYYMSPERIH-------ESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK-----  239 (375)
T ss_pred             cchh--HHHHhhcCCCcccCHHHHh-------cCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH-----
Confidence            6653  3446788999999999887       447899999999999999999999999764     22222222     


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                           +.....+.+|++....  ++..|+..|+..||+.||+.-.++..+
T Consensus       240 -----I~qgd~~~~p~~~YS~--~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  240 -----IEQGDYPPLPDEHYST--DLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             -----HHcCCCCCCcHHHhhh--HHHHHHHHHccCCcccCCCcchHHHHH
Confidence                 2223445566554433  344577779999999999854444433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-51  Score=357.59  Aligned_cols=202  Identities=30%  Similarity=0.473  Sum_probs=182.2

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ..|...+.||+|+||+||+|+. .++..||||.+.+........+.+..|+++|+.++|||||.+++++.+++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            3577788899999999999965 468999999997765566677888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC------CceEEccccCccccC
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK------YEAYLADFGLAKLMN  217 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~------~~~kl~Dfg~~~~~~  217 (371)
                      ||.||+|.+++++.+.+++..+..+..|+|.||++||++   +||||||||.||||+..      -.+||+|||+++.+.
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            999999999999999999999999999999999999999   99999999999999765      568999999999987


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI  279 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  279 (371)
                      ...   ...+.+|+|.|||||++..+       .|+.|+|+||+|+++|+|++|..||....
T Consensus       167 ~~~---~a~tlcGSplYMAPEV~~~~-------~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  167 PGS---MAETLCGSPLYMAPEVIMSQ-------QYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             chh---HHHHhhCCccccCHHHHHhc-------cccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            654   34678999999999988633       78899999999999999999999997543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-50  Score=384.22  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=215.2

Q ss_pred             cccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ....+.||+|+||.||+|+..      ....||||.++. ..+.+...+|.+|++.++.++|||||+++|+|.+++..|+
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            444678999999999999653      346799999943 4455577899999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceE
Q 037946          141 LYNYISNGNLQQLLQGN--------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY  206 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~k  206 (371)
                      |+|||..|+|.++|...              .+++..+.+.+|.|||.||.||.++   .+|||||.++|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEE
Confidence            99999999999999432              2378899999999999999999999   999999999999999999999


Q ss_pred             EccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhH
Q 037946          207 LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHI  285 (371)
Q Consensus       207 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  285 (371)
                      |+|||+++.....+|.+......-..+|||||.+.       .+.||++||||||||+|||+++ |..|+....+  +++
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-------y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--~EV  714 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-------YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--QEV  714 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhh-------cCcccchhhhhhhhhhhhhhhccccCcccccch--HHH
Confidence            99999999999998877665666788999999776       4489999999999999999997 8888766543  344


Q ss_pred             HHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .+.++...        + -+...++|.+++.       |+..||+.+|++||+|+||-..|+....+.+
T Consensus       715 Ie~i~~g~--------l-L~~Pe~CP~~vY~-------LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  715 IECIRAGQ--------L-LSCPENCPTEVYS-------LMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HHHHHcCC--------c-ccCCCCCCHHHHH-------HHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            44433311        1 2333556655444       5555999999999999999999998876554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.8e-49  Score=335.73  Aligned_cols=268  Identities=22%  Similarity=0.348  Sum_probs=212.2

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+...++|+|+||.||+++.+ +|+.||||++..+..++...+-.++|+++|++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777889999999999999764 69999999997766666666778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ||+..-|.++-.....++.+.+.+++.|++.|+.|+|++   +++||||||+||||+.+|.+||||||+|+.+....  .
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d  156 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--D  156 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc--c
Confidence            999966666666677799999999999999999999999   99999999999999999999999999999887433  2


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc-cc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV-SI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  302 (371)
                      ..+..+.|.+|.|||++.+.      ..|+.++||||+||++.||++|.+.|.+..+  ....-.+....+...+.. ++
T Consensus       157 ~YTDYVATRWYRaPELLvGD------tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGD------TQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             hhhhhhhhhhccChhhhccc------CcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHHHHHH
Confidence            44667789999999998764      3567899999999999999999988764432  222333444444432221 11


Q ss_pred             cCc----------c---cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDT----------K---LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~----------~---~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      +..          .   +............-+++++..|++.||.+|++-++++.+
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111          0   111111122223345789999999999999999998865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-49  Score=345.09  Aligned_cols=251  Identities=27%  Similarity=0.358  Sum_probs=205.3

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc-chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE-EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..++||+|+||.||.++. .+++.+|+|++.+....+ ...+....|..+|..++||.||+++-.|++.+.+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            3588899999999999999964 468999999997655433 35678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+.||.|..+|++++.+++..+..++..|+.||.|||++   +||||||||+|||+|.+|+++|+|||+|+..-...  
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--  179 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--  179 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC--
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999998654432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..+.+.+||+.|||||++...       .++.++|.||||+++|||++|.+||....     ...++......       
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~-------gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~-------  240 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGK-------GYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKG-------  240 (357)
T ss_pred             CccccccCCccccChHHHhcC-------CCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcC-------
Confidence            345678999999999988743       78899999999999999999999996432     22222222221       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC----CHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP----TMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP----s~~evl~~  345 (371)
                         ++...+.-+..   ...+++.+.++.||++|.    .+.+|.++
T Consensus       241 ---k~~~~p~~ls~---~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  241 ---KLPLPPGYLSE---EARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             ---cCCCCCccCCH---HHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence               11122211112   233466779999999995    56666554

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=355.76  Aligned_cols=274  Identities=27%  Similarity=0.421  Sum_probs=217.5

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.+.....||+|.||+||+|.+.  -.||||++..+....++.+.|.+|+..+++-+|.||+-|.|+|...+. .||+.+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            44566788999999999999883  359999998877778899999999999999999999999999998887 999999


Q ss_pred             cCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+|.+|..+++..+ +++......|+.|+|+||.|||.+   +|||||||..||++.+++.|||+|||++..-..-....
T Consensus       469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            99999999997644 588899999999999999999999   99999999999999999999999999986532221112


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......|...|||||+++.+    ...+|+..+||||||+++|||+||..||.....+               ..+..+-
T Consensus       546 q~~qp~gsilwmAPEvIRmq----d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d---------------qIifmVG  606 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQ----DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD---------------QIIFMVG  606 (678)
T ss_pred             ccCCCccchhhhcHHHHhhc----ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh---------------heEEEec
Confidence            23445688899999999844    3678999999999999999999999999843332               1122222


Q ss_pred             Cc----ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCCC-CCchhhhh
Q 037946          304 DT----KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGK-TSQPLIKQ  366 (371)
Q Consensus       304 ~~----~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~-~~~~~~~~  366 (371)
                      ++    ++........++   +.+|+..||.+++++||.+.+|+..|..+....+-+.. .|.|-+.+
T Consensus       607 rG~l~pd~s~~~s~~pk~---mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~~~  671 (678)
T KOG0193|consen  607 RGYLMPDLSKIRSNCPKA---MKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPVLLR  671 (678)
T ss_pred             ccccCccchhhhccCHHH---HHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccchhh
Confidence            22    111111112233   33466779999999999999999999888875554443 45554443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-47  Score=335.86  Aligned_cols=261  Identities=29%  Similarity=0.426  Sum_probs=201.1

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC--eEEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS--VKLLLY  142 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  142 (371)
                      .+...+.||+|+||.||++... +|+..|||.....  +....+.+.+|+.+|++++|||||+++|......  .++++|
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3556788999999999999664 4899999988543  2222677899999999999999999999854444  688999


Q ss_pred             eecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccCccccCC-C
Q 037946          143 NYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGLAKLMNS-T  219 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~-~  219 (371)
                      ||+++|+|.+++.+.+ .+++..+..+..|++.||.|||++   +++||||||+|||++. ++.+||+|||++..... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999998876 799999999999999999999999   9999999999999999 79999999999987764 2


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ..........||+.|||||++..      +.....++|||||||++.||+||..||.....    ..+++-.....    
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~----~~~~~~~ig~~----  238 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRN------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFE----EAEALLLIGRE----  238 (313)
T ss_pred             ccccccccccCCccccCchhhcC------CCcCCccchhhhcCCEEEeccCCCCcchhhcc----hHHHHHHHhcc----
Confidence            22223446789999999998762      11223599999999999999999999865311    11111111111    


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                           ......|+.+..   ...+++.+|+..||++|||+++++++........
T Consensus       239 -----~~~P~ip~~ls~---~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  239 -----DSLPEIPDSLSD---EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -----CCCCCCCcccCH---HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                 001122222222   2334677799999999999999999976655433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-47  Score=339.29  Aligned_cols=268  Identities=25%  Similarity=0.326  Sum_probs=212.3

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKLL  140 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  140 (371)
                      .+.|+..+.||+|+||.||+|++ .+|+.||+|++..+...+....-..+|+.+|++|+||||+++.+...+.  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            35677788999999999999954 6799999999977766677777889999999999999999999988766  78999


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |+|||+. +|.-++.+. -.+++.++..+++|++.||.|||++   +++|||||.+|||||.+|.+||+|||+|+.+...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999998 898888774 4699999999999999999999999   9999999999999999999999999999977665


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .. ..+.+.+-|.+|.|||++.+..      .|+.+.|+||.||+|.||++|++.+++..  +.+-...+-+..+.....
T Consensus       272 ~~-~~~T~rVvTLWYRpPELLLG~t------~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--EveQl~kIfklcGSP~e~  342 (560)
T KOG0600|consen  272 GS-APYTSRVVTLWYRPPELLLGAT------SYGTAVDLWSVGCILAELFLGKPILQGRT--EVEQLHKIFKLCGSPTED  342 (560)
T ss_pred             CC-cccccceEEeeccChHHhcCCc------ccccceeehhhhHHHHHHHcCCCCcCCcc--HHHHHHHHHHHhCCCChh
Confidence            43 2356667899999999998763      56889999999999999999999987643  222233333334332111


Q ss_pred             ccccCcccC--------CCChhhHHHH-----HHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSILDTKLQ--------GLPDQMVQEM-----LQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~~~~~~~--------~~~~~~~~~~-----~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      . +-..++.        ......+.+.     ...++|+..+|..||.+|.|+.++++.
T Consensus       343 ~-W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  343 Y-WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             c-cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1 1101111        1111112221     134678888999999999999998875

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-47  Score=335.32  Aligned_cols=262  Identities=24%  Similarity=0.364  Sum_probs=205.9

Q ss_pred             hccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+...+||.|..++||+|+ .+.++.||||++..+.-. ...+.+.+|+..|+.++||||++++..|..++.+|+||.
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            357888899999999999995 567899999999554333 337889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||.+|++.++++..  ..+++..+..+.+++++||.|||.+   |.||||||+.||||+++|.|||+|||.+..+..+..
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999999753  3499999999999999999999999   999999999999999999999999999877655442


Q ss_pred             ccc-c-ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          222 HHA-M-SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       222 ~~~-~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ... . .+..||++|||||++..+     -..|+.|+||||||++..||.+|..||..+.+-.     .....+....+.
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~-----~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-----vLl~tLqn~pp~  251 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQ-----LHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-----VLLLTLQNDPPT  251 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhc-----ccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-----HHHHHhcCCCCC
Confidence            211 1 566899999999997643     3357899999999999999999999998665421     111112111111


Q ss_pred             ccccCcccCCCCh-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSILDTKLQGLPD-QMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ..     ....+. +.........+++..||.+||++|||+.+++++
T Consensus       252 ~~-----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 LL-----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cc-----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            00     011111 111111234456667999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-48  Score=361.10  Aligned_cols=274  Identities=26%  Similarity=0.421  Sum_probs=222.3

Q ss_pred             hccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      +..++.++||.|.||.||+|+.+    ....||||.++. ...+.+..+|+.|+.||.+++||||+++.|+......++|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            35567899999999999999764    245799999954 4456778899999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |+|||++|+|+.+|+. .+.+++.++..+...||.||+||.++   ++|||||.++|||++++...|++|||+++.+.+.
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999999975 45699999999999999999999999   9999999999999999999999999999987554


Q ss_pred             C-cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          220 N-YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       220 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      . .........-..+|.|||.+..       ..++.+|||||||+++||.++ |..|+....+.  ++..-+.+.++-. 
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~-------RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--dVIkaIe~gyRLP-  854 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVIKAIEQGYRLP-  854 (996)
T ss_pred             CCccccccCCccceeecChhHhhh-------cccCchhhccccceEEEEecccCCCcccccchH--HHHHHHHhccCCC-
Confidence            3 1111222234679999998763       378999999999999999875 99998765442  3334444444332 


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCCC-------CCchhhhhh
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGK-------TSQPLIKQS  367 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~-------~~~~~~~~~  367 (371)
                              ...++|..+.+.       +.+||++|-.+||+|.+|+..|.++..+|..+..       .++++++++
T Consensus       855 --------pPmDCP~aL~qL-------MldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld~~  916 (996)
T KOG0196|consen  855 --------PPMDCPAALYQL-------MLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLDRS  916 (996)
T ss_pred             --------CCCCCcHHHHHH-------HHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccCCC
Confidence                    224666655554       4559999999999999999999999999887663       356666543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=341.39  Aligned_cols=270  Identities=23%  Similarity=0.306  Sum_probs=211.4

Q ss_pred             HHHHhccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCC-e
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKS-V  137 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~  137 (371)
                      -.+.++|+..+.||.|+||.||+|. ..+|+.||||++++.....+ .-.-++|+..|++++ ||||+++.+++.+.+ .
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            3466789999999999999999995 56799999999976554422 223478999999998 999999999999888 9


Q ss_pred             EEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          138 KLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      +|+|||||+. +|.++++. ++.+++..+..|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|+..
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            9999999977 99999975 45699999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      .+..   ..+..+.|.+|.|||++..      .+.|+.+.|+|++||+++|+.+-++.|.+..+  ..-.-.+-..++..
T Consensus       161 ~Skp---PYTeYVSTRWYRAPEvLLr------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  161 RSKP---PYTEYVSTRWYRAPEVLLR------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTP  229 (538)
T ss_pred             ccCC---CcchhhhcccccchHHhhh------ccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCC
Confidence            7664   4567789999999999873      45789999999999999999999988864322  11112223333321


Q ss_pred             Ccccc--------ccCcccC-----CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          297 EPAVS--------ILDTKLQ-----GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       297 ~~~~~--------~~~~~~~-----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .....        .+.-.+.     .+..-+.....+.++++.+|+++||.+|||+.+++++-
T Consensus       230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            11000        0000111     11111123445667899999999999999999999974

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.8e-46  Score=311.08  Aligned_cols=264  Identities=24%  Similarity=0.332  Sum_probs=208.9

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|...+.||+|.||.||+|++ .+|+.||||++......+......++|++.|+.++|+||+.++++|.+.+.+.+|+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            567778999999999999964 5799999999976544444456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ++. +|...++... .++..++..++.++++|++|||++   .|+||||||.|+|++++|.+||+|||+++.+.+.+.  
T Consensus        83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--  156 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--  156 (318)
T ss_pred             ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc--
Confidence            977 9999997654 589999999999999999999999   999999999999999999999999999999887653  


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....+.|..|.|||.+-+..      .|+...|+||.||++.||+.|.+.|.+.. | .+-...+-..++..   ....
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr------~Yg~~VDmWavGCI~AELllr~P~fpG~s-D-idQL~~If~~LGTP---~~~~  225 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSR------QYGTGVDMWAVGCIFAELLLRVPFFPGDS-D-IDQLSKIFRALGTP---TPDQ  225 (318)
T ss_pred             ccccceeeeeccChHHhccch------hcCCcchhhhHHHHHHHHHccCCCCCCCc-h-HHHHHHHHHHcCCC---Cccc
Confidence            223447899999999887654      45678999999999999999987775432 2 22223333333321   1111


Q ss_pred             CcccCCCChh--------------hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          304 DTKLQGLPDQ--------------MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       304 ~~~~~~~~~~--------------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .+.+...|+.              ......+.++++..++.+||.+|+|++|++++=
T Consensus       226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence            2222222211              012233557899999999999999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=343.42  Aligned_cols=259  Identities=25%  Similarity=0.332  Sum_probs=207.7

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC---cchHHHHHHHHHHHhccC-CCCceeeeceEecCCeE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD---EEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  138 (371)
                      ...|...+.||+|+||.|+.|.. .+++.||+|.+.+....   ....+.+.+|+.++++++ ||||++++.++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            45688899999999999999954 57899999977543221   123456678999999998 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-CceEEccccCccccC
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKLMN  217 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~  217 (371)
                      |+||||+.||+|.+++.+.+++++..+..++.|++.|++|||++   +|+||||||+|+|+|.+ +++||+|||++....
T Consensus        96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999988999999999999999999999999   99999999999999999 999999999999874


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ..  .....+.+||+.|+|||++.+...     ..+.++||||+||+||.|++|..||...     ............  
T Consensus       173 ~~--~~~l~t~cGsp~Y~aPEvl~~~~~-----Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~~l~~ki~~~--  238 (370)
T KOG0583|consen  173 GE--DGLLKTFCGSPAYAAPEVLSGKGT-----YSGKAADVWSLGVILYVLLCGRLPFDDS-----NVPNLYRKIRKG--  238 (370)
T ss_pred             CC--CCcccCCCCCcccCCHHHhCCCCC-----cCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcC--
Confidence            11  235578899999999999986531     1247899999999999999999999752     222222221111  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                               ...+|... . ...+..++.+|+..||.+|+|+.+++++=|-..
T Consensus       239 ---------~~~~p~~~-~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 ---------EFKIPSYL-L-SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ---------CccCCCCc-C-CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                     11122211 1 334556788899999999999999997665544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-47  Score=345.52  Aligned_cols=254  Identities=23%  Similarity=0.348  Sum_probs=205.1

Q ss_pred             HHHhccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      +....|..-..||+|+.|.||.|. ..+++.||||++....  ....+-+++|+.+|+..+|+|||.+++.|...+.+|+
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            334678888899999999999995 4578999999995433  3445678999999999999999999999988899999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||||++||+|.+.+.... +++.++..++..+++||+|||.+   +|+|||||.+|||++.+|.+||+|||+|..+....
T Consensus       348 VMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             EEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            999999999999998766 99999999999999999999999   99999999999999999999999999999877654


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .  ...+..|||+|||||++...       .|+++.||||||++++||+-|.+||....    .+... ........   
T Consensus       424 ~--KR~TmVGTPYWMAPEVvtrk-------~YG~KVDIWSLGIMaIEMveGEPPYlnE~----PlrAl-yLIa~ng~---  486 (550)
T KOG0578|consen  424 S--KRSTMVGTPYWMAPEVVTRK-------PYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRAL-YLIATNGT---  486 (550)
T ss_pred             C--ccccccCCCCccchhhhhhc-------ccCccccchhhhhHHHHHhcCCCCccCCC----hHHHH-HHHhhcCC---
Confidence            2  44677899999999988743       78899999999999999999999986421    11111 11111111   


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                          +.+. .++.+..   .+-+++.+||..||++|+++.|+|+|-
T Consensus       487 ----P~lk-~~~klS~---~~kdFL~~cL~~dv~~RasA~eLL~Hp  524 (550)
T KOG0578|consen  487 ----PKLK-NPEKLSP---ELKDFLDRCLVVDVEQRASAKELLEHP  524 (550)
T ss_pred             ----CCcC-CccccCH---HHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence                1111 1111112   233467779999999999999999984

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=338.38  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=206.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc-chHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE-EPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      ..|.+++.||+|+|++|++|+. .+++.||||++.+..... .....+..|-..|.+| +||.|++++-.|.|...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            4588899999999999999964 568999999986654332 3345677899999999 899999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      +||+++|+|.++|..-+.+++.....++.+|+.||.|||++   |||||||||+|||+|++|++||+|||.++.+.+...
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999999999999999999999999999999999999   999999999999999999999999999998754322


Q ss_pred             c---------cc--cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          222 H---------HA--MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       222 ~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      .         ..  ..+++||..|.+||++.       ....+..+|||+|||+||+|+.|.+||....  +..+.+.+.
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-------~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyliFqkI~  300 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLN-------DSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLIFQKIQ  300 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhc-------CCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHHHHHHH
Confidence            1         01  14578999999999886       4467899999999999999999999997542  222223233


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ..-..+.          .++++       .+.+|+.+.|-.||.+|+|.++|.+|.
T Consensus       301 ~l~y~fp----------~~fp~-------~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  301 ALDYEFP----------EGFPE-------DARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HhcccCC----------CCCCH-------HHHHHHHHHHccCccccccHHHHhhCc
Confidence            2222211          12222       233477778999999999999999883

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.6e-47  Score=345.32  Aligned_cols=249  Identities=27%  Similarity=0.397  Sum_probs=213.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|.+.+.||+|+||.||||+. .+.+.||+|.+.+....+.....+.+|+++++.++||||+.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            3566677899999999999954 568999999998877777778889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+.| +|..++...+.++++.+..++.++..||.|||+.   +|+|||+||.|||++..|.+|+||||+++.+....  .
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--S  155 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc--e
Confidence            9987 9999999999999999999999999999999999   99999999999999999999999999999887654  3


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...+..|||.|||||++.       +.+|+..+|.||+||++|||++|++||.     ...+...++........     
T Consensus       156 vltsikGtPlYmAPElv~-------e~pyd~~sDlWslGcilYE~~~G~PPF~-----a~si~~Lv~~I~~d~v~-----  218 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVE-------EQPYDHTSDLWSLGCILYELYVGQPPFY-----ARSITQLVKSILKDPVK-----  218 (808)
T ss_pred             eeeeccCcccccCHHHHc-------CCCccchhhHHHHHHHHHHHhcCCCCch-----HHHHHHHHHHHhcCCCC-----
Confidence            556778999999999876       4488999999999999999999999995     33455555554433211     


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                            .|.   .....+..++...+.+||.+|.|-.+++.|
T Consensus       219 ------~p~---~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 ------PPS---TASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ------Ccc---cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                  111   222234456667899999999999999877

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-45  Score=340.74  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=198.0

Q ss_pred             hccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC-C
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK-S  136 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  136 (371)
                      ++|+..+.||+|+||.||+|..      .+++.||+|++... ........+.+|+.+++.+ +||||++++++|... +
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            4688889999999999999963      23568999998532 2334456789999999999 899999999988764 4


Q ss_pred             eEEEEEeecCCCCHHHHhccC-----------------------------------------------------------
Q 037946          137 VKLLLYNYISNGNLQQLLQGN-----------------------------------------------------------  157 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------------------  157 (371)
                      ..+++|||+++|+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            688999999999999998642                                                           


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccc
Q 037946          158 ---RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY  234 (371)
Q Consensus       158 ---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y  234 (371)
                         ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               2377888999999999999999999   9999999999999999999999999999865433211122334567889


Q ss_pred             cCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChh
Q 037946          235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQ  313 (371)
Q Consensus       235 ~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      +|||++.       +..++.++|||||||++|||++ |..||.....+. .....+.    .....     ......+  
T Consensus       243 ~aPE~~~-------~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~----~~~~~-----~~~~~~~--  303 (338)
T cd05102         243 MAPESIF-------DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLK----DGTRM-----RAPENAT--  303 (338)
T ss_pred             cCcHHhh-------cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHh----cCCCC-----CCCCCCC--
Confidence            9999775       3367889999999999999997 988886533221 1111111    10000     0001111  


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          314 MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       314 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                           ..+.+++.+||+.||++|||+.|+++.|.++..
T Consensus       304 -----~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 -----PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             -----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                 234568888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-46  Score=343.21  Aligned_cols=259  Identities=24%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             cccCCccccCCceEEEEEEeCC--C--CE-EEEEEeccc-CCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMPN--G--EL-IAVKKLWKT-KRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~--~--~~-vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ....+.||+|+||.||+|+...  +  .. ||+|..... .....+..++++|+++|++++|||||+++|++.....+|+
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            4445899999999999996543  2  23 899988642 3556778899999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |||+|.||+|.++|+..+. ++..+...++.+.|.||+|||++   +++||||.++|+|++.++.+||+|||+++...  
T Consensus       239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--  313 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--  313 (474)
T ss_pred             EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc--
Confidence            9999999999999998774 99999999999999999999999   99999999999999999999999999987643  


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHH-HHHhcCCC
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWV-KKKMGSFE  297 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~  297 (371)
                      .+........-+..|+|||.+.       .+.++.++|||||||++||+++ |..|+.+...  ..+..++ ......  
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~-------~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~kI~~~~~r~--  382 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLN-------TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAKIVKNGYRM--  382 (474)
T ss_pred             ceeeccccccCcceecChhhhc-------cCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHHHHhcCccC--
Confidence            1111111224677999999876       4478999999999999999998 7887764432  2333333 211111  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                                 ..+.....++.   .++..||..||++||||.++.+.|..+....+.
T Consensus       383 -----------~~~~~~p~~~~---~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  383 -----------PIPSKTPKELA---KVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             -----------CCCCCCHHHHH---HHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                       11111122222   245569999999999999999999998766654

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=365.27  Aligned_cols=260  Identities=29%  Similarity=0.469  Sum_probs=210.4

Q ss_pred             ccccCCccccCCceEEEEEEeC--CCC----EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP--NGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ..+..+.||+|+||.||.|...  +|.    .||+|.+.+ ..+.+...+|++|..+|+.++|||||+++|+|.+....+
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            4556788999999999999654  343    499999854 445677889999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          140 LLYNYISNGNLQQLLQGN-------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      +++|||.+|+|..+|++.       ..++..+++.++.|||+|+.||+++   ++|||||.++|+|++....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999865       3489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      |+.+...++........-...|||||.+.       .+.++.++|||||||+|||++| |..||. ... +.++...+..
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~-------d~iFtskSDvWsFGVllWEifslG~~PY~-~~~-n~~v~~~~~~  919 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLK-------DGIFTSKSDVWSFGVLLWEIFSLGATPYP-SRS-NFEVLLDVLE  919 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHh-------hcccccccchhhhHHHHHHHHhCCCCCCC-Ccc-hHHHHHHHHh
Confidence            99777776654444445667999999776       4689999999999999999999 555553 332 2233332222


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .-+-         +....+|+..++.|       ..||+.+|++||+|..|++.+..+.++..
T Consensus       920 ggRL---------~~P~~CP~~ly~lM-------~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  920 GGRL---------DPPSYCPEKLYQLM-------LQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             CCcc---------CCCCCCChHHHHHH-------HHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            1111         22356776655444       44999999999999999999988876554

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-46  Score=322.16  Aligned_cols=283  Identities=23%  Similarity=0.358  Sum_probs=217.9

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-----C
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-----K  135 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~  135 (371)
                      ++...|...+.||+|+||.|+.+.+ .+|+.||+|++..........++-.+|+.+|+.++|+||+.+.+++..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3445566678999999999999954 578999999997667777778899999999999999999999998754     4


Q ss_pred             CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      +.+|+|+|+|+ .+|...++.+..++...+..+..|+++||.|+|+.   +++||||||+|++++.+..+||+|||+|+.
T Consensus        99 ~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   99 NDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             ceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceee
Confidence            67899999995 49999999999999999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .........++...-|.+|.|||++..      ...|+.+.||||.||++.||++|++.|.+.  +..+-...+....+.
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~--d~v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLN------SSEYTKAIDIWSVGCILAEMLTGKPLFPGK--DYVHQLQLILELLGT  246 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhc------cccccchhhhhhhhHHHHHHHcCCCCCCCC--chHHHHHHHHHhcCC
Confidence            865422234566778999999998753      457899999999999999999999988654  222333334443333


Q ss_pred             CCccc-cccC--------cccCCCChh-----hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH--hcccCCCccC
Q 037946          296 FEPAV-SILD--------TKLQGLPDQ-----MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL--MEVKSAPEEL  356 (371)
Q Consensus       296 ~~~~~-~~~~--------~~~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L--~~~~~~~~~~  356 (371)
                      ..... ..+.        ..+...+..     ........++|+.+||..||.+|+|++|.+++-  ..+.....|+
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            21110 0000        000111111     111122456789999999999999999999984  4444333333

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=338.74  Aligned_cols=242  Identities=26%  Similarity=0.462  Sum_probs=199.9

Q ss_pred             cCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           69 DENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      ..+.||.|+.|.||+|+. .++.||||++..-         -..+++-|++|+||||+.|.|+|.....+|||||||..|
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            367899999999999998 5689999987321         135788999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccc
Q 037946          149 NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV  228 (371)
Q Consensus       149 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  228 (371)
                      -|...|+..+.++......|..+||.||+|||.+   .|||||||.-||||+.+..|||+|||-++...+..   .+-++
T Consensus       198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSF  271 (904)
T KOG4721|consen  198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSF  271 (904)
T ss_pred             cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhh
Confidence            9999999999999999999999999999999999   99999999999999999999999999998765542   44578


Q ss_pred             cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      +||..|||||++..       .+.++|+|||||||+||||+||..||..-.....     +   ++-...  .+--+...
T Consensus       272 aGTVaWMAPEvIrn-------ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----I---wGVGsN--sL~LpvPs  334 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRN-------EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----I---WGVGSN--SLHLPVPS  334 (904)
T ss_pred             hhhHhhhCHHHhhc-------CCcccccceehhHHHHHHHHhcCCCccccchhee-----E---EeccCC--cccccCcc
Confidence            99999999999874       4899999999999999999999999864322110     0   110000  11122334


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .+|+...-       |+..||+..|..||+|.+++.||....
T Consensus       335 tcP~Gfkl-------L~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  335 TCPDGFKL-------LLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             cCchHHHH-------HHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            45544322       444599999999999999999998765

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-45  Score=331.44  Aligned_cols=264  Identities=25%  Similarity=0.398  Sum_probs=215.5

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.+.+.++||+|-||.|..+....+..||||.++.. .......+|.+|+++|.+++||||+.++|+|..++.+++|+||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            455668899999999999998877899999999653 3345568999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++..+  +...-....+++.||+.||+||.+-   ++|||||.++|+|+|.++++||+|||+++-+...++.
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999876  3345566788999999999999999   9999999999999999999999999999988888887


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS--GRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.-....-+.+|||+|.+.       .+.++.+||+|+||+++||+++  ...||.....  +.+.+-.........  .
T Consensus       694 ~vqgr~vlpiRwmawEsil-------lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~--~  762 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESIL-------LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQG--R  762 (807)
T ss_pred             eeecceeeeeeehhHHHHH-------hccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCC--c
Confidence            7777777889999999765       5589999999999999999874  7777754332  233333333333322  2


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      +++-.+..-+|..+       ++++..||+.|.++|||++++..+|++..
T Consensus       763 ~~~l~~P~~cp~~l-------yelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  763 QVVLSRPPACPQGL-------YELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ceeccCCCcCcHHH-------HHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            23333334455543       34566699999999999999999987653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=332.03  Aligned_cols=246  Identities=26%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|+..+.||+|+||.||+|.+ .+++.||+|++..+ ..+...+.+..|+.++.+++++||.++||.+..+..++++|||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            355567899999999999954 57899999999543 3455678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      |.||++.+.++....+++..+.-+..++..|+.|||++   +.+|||||+.|||+..+|.||++|||.+.++.....  .
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--r  167 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--R  167 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh--c
Confidence            99999999999998889999999999999999999999   999999999999999999999999999988776653  3


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc--
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI--  302 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  302 (371)
                      ..+.+|||.|||||+++++       .|+.++||||||++.+||.+|.+|+....+.               ..+..+  
T Consensus       168 r~tfvGTPfwMAPEVI~~~-------~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------rvlflIpk  225 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQS-------GYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------RVLFLIPK  225 (467)
T ss_pred             cccccccccccchhhhccc-------cccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------eEEEeccC
Confidence            3778999999999999843       6788999999999999999999998754331               111111  


Q ss_pred             -cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 -LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                       .-+.+.+..      ...+-+++..||++||+.|||+.+++++
T Consensus       226 ~~PP~L~~~~------S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  226 SAPPRLDGDF------SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCcccccc------CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence             112222222      2223346666999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1e-44  Score=326.29  Aligned_cols=251  Identities=22%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCc-chHHHHHHHHHHHhccCCCCceeeeceEec----CCeEEEEEee
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE-EPVDSFAAEIQILGHIRHRNIVKLLGYCSN----KSVKLLLYNY  144 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  144 (371)
                      ...||+|++|.||+|.. +|+.||+|++....... ...+.+.+|+.++++++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            35799999999999988 78999999986543322 224678899999999999999999999876    4578999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++|+|.+++.....+++.....++.+++.||.|||+..  +++||||||+||++++++.+||+|||+++......    
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            999999999998888999999999999999999999732  78899999999999999999999999998654332    


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                       ....|+..|+|||.+.+.     ...++.++|||||||++|||++|..||....  ...+...+.   .....      
T Consensus       178 -~~~~~~~~y~aPE~~~~~-----~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--~~~~~~~i~---~~~~~------  240 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDI-----FSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--TKEIYDLII---NKNNS------  240 (283)
T ss_pred             -ccccCcccccCHHHhhhc-----cccccchhhhhHHHHHHHHHHHCCCCCCCCC--HHHHHHHHH---hcCCC------
Confidence             234588999999987531     2367899999999999999999999996432  122222211   11000      


Q ss_pred             cccC-CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          305 TKLQ-GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       305 ~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      .... ..++       .+.+++.+||+.||++|||++|+++.|+++..
T Consensus       241 ~~~~~~~~~-------~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        241 LKLPLDCPL-------EIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCCCcCcH-------HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            0111 1222       24457788999999999999999999988753

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-45  Score=323.72  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=216.2

Q ss_pred             HHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      .++.-+|++.+.||+|.||.|-+|.. ..|+.||||.+.++.. +++..-.+.+|++||+.|+||||+.++.+|.+.+.+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            35566788889999999999999964 6799999999987664 455667889999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      .+||||..+|.|.+++...+.+++..+..++.||..|+.|+|.+   +++|||||.+|||+|.++++||+|||++..+..
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999988776


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..   ...++||+|-|.+||.+.+..|      -++..|-|||||+||.|+.|..||++.  |...++..+..+..... 
T Consensus       206 ~k---fLqTFCGSPLYASPEIvNG~PY------~GPEVDsWsLGvLLYtLVyGtMPFDG~--Dhk~lvrQIs~GaYrEP-  273 (668)
T KOG0611|consen  206 KK---FLQTFCGSPLYASPEIVNGTPY------KGPEVDSWSLGVLLYTLVYGTMPFDGR--DHKRLVRQISRGAYREP-  273 (668)
T ss_pred             cc---HHHHhcCCcccCCccccCCCCC------CCCccchhhHHHHHHHHhhcccccCCc--hHHHHHHHhhcccccCC-
Confidence            64   4578899999999999876532      247899999999999999999999754  23344444333222210 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                                .-|.       +.-.||+|||..||++|-|+.+|..+-|
T Consensus       274 ----------~~PS-------dA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  274 ----------ETPS-------DASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ----------CCCc-------hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                      1111       2234888999999999999999999975

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.2e-45  Score=331.81  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=203.9

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+....||+|+||.||.|+. .+|+.+|+|++.+... ...+.+.++.|-.+|...++|.||+++-.|++...+|+||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            4578889999999999999965 4699999999976553 3567788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC----
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS----  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----  218 (371)
                      ||++||++..+|.+.+.+++..+..++.+++.|+..+|..   |+|||||||+|+|||..|++||+|||+|.-+..    
T Consensus       221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            9999999999999999999999999999999999999999   999999999999999999999999999853211    


Q ss_pred             ------------------CCccc-----cc------------------ccccccccccCCCCccchhhhcccCCCCCcch
Q 037946          219 ------------------TNYHH-----AM------------------SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSD  257 (371)
Q Consensus       219 ------------------~~~~~-----~~------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D  257 (371)
                                        .+...     ..                  .+.+|||.|+|||++.+.       .|+..+|
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-------gY~~~cD  370 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-------GYGKECD  370 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-------CCCcccc
Confidence                              00000     00                  124799999999998744       5788999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCCch--hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCC
Q 037946          258 VYSYGVVLLEILSGRSAVQPQIGDGL--HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE  335 (371)
Q Consensus       258 iwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~  335 (371)
                      +|||||++|||+.|.+||..+.+++.  .+..|......          +.-....       ....+||.+|+. ||++
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f----------P~~~~~s-------~eA~DLI~rll~-d~~~  432 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF----------PEEVDLS-------DEAKDLITRLLC-DPEN  432 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC----------CCcCccc-------HHHHHHHHHHhc-CHHH
Confidence            99999999999999999987654421  12222111110          1001111       344567777888 9999


Q ss_pred             CC---CHHHHHHHHh
Q 037946          336 RP---TMKEVVALLM  347 (371)
Q Consensus       336 RP---s~~evl~~L~  347 (371)
                      |.   .++||.+|-+
T Consensus       433 RLG~~G~~EIK~HPf  447 (550)
T KOG0605|consen  433 RLGSKGAEEIKKHPF  447 (550)
T ss_pred             hcCcccHHHHhcCCc
Confidence            96   5888887743

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=309.15  Aligned_cols=200  Identities=26%  Similarity=0.361  Sum_probs=180.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||.|+||.|.+++. .+|..+|+|++.+... ...+.+...+|..+|+.+.||+++++++.|.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            3477788999999999999965 4688999999965432 2345678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||.+||.|.+++++.+++++..+..++.+|+.||+|||+.   ++++|||||+|||+|.+|.+||+|||+++.....   
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            9999999999999999999999999999999999999999   9999999999999999999999999999987654   


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI  279 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  279 (371)
                        +-+.||||.|+|||.+...       .+..++|.|||||++|||+.|.+||....
T Consensus       198 --T~TlCGTPeYLAPEii~sk-------~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSK-------GYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             --EEEecCCccccChHHhhcC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence              3678999999999988743       77889999999999999999999997543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-44  Score=334.83  Aligned_cols=252  Identities=27%  Similarity=0.361  Sum_probs=209.7

Q ss_pred             cccCCccccCCceEEEEEE-eCCCCEEEEEEeccc-CCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKT-KRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      |+.++-||.|+.|.|-.|+ ..+|+.+|||.+.+. .........+.+|+-+|+.+.|||++++|++|.++.++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            5667889999999999995 568999999999665 33455567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++|.|.+++-..+++++..+.+++.||+.|+.|+|..   ++|||||||+|+|+|.++++||+|||+|..-....   .
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---l  167 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---L  167 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc---c
Confidence            99999999999999999999999999999999999999   99999999999999999999999999997654443   4


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..+.||+|.|.+||++.+..|.      +.++||||.||+||.|+||+.||.++  +-..+...++.+...         
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYd------G~~sDVWSCGVILfALLtG~LPFdDd--Nir~LLlKV~~G~f~---------  230 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYD------GRPSDVWSCGVILFALLTGKLPFDDD--NIRVLLLKVQRGVFE---------  230 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCC------CCccccchhHHHHHHHHhCCCCCCCc--cHHHHHHHHHcCccc---------
Confidence            5678999999999999877543      46899999999999999999999732  112233333333222         


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                           +|..+..+   +.+|+.+|+..||++|.|++||++|-+-.
T Consensus       231 -----MPs~Is~e---aQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  231 -----MPSNISSE---AQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             -----CCCcCCHH---HHHHHHHHhccCccccccHHHHhhCchhh
Confidence                 22222222   33477789999999999999999996544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-43  Score=366.19  Aligned_cols=274  Identities=33%  Similarity=0.586  Sum_probs=217.8

Q ss_pred             ccHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC
Q 037946           58 FTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS  136 (371)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  136 (371)
                      +..+++...+...+.||+|+||.||+|.. .++..||+|++......      ...|++.+++++||||++++++|.+.+
T Consensus       683 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~  756 (968)
T PLN00113        683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEK  756 (968)
T ss_pred             hhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence            46677778888899999999999999976 57899999988432211      134688999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ..|+||||+++|+|.++++.   +++..+..++.|++.||+|||..+.++++||||||+||+++.++..++. ||.....
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999999999999964   8999999999999999999996545599999999999999999888875 5554332


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ...      ....+|+.|+|||.+.       +..++.++|||||||++|||+||+.|+.........+.+|.+..... 
T Consensus       833 ~~~------~~~~~t~~y~aPE~~~-------~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-  898 (968)
T PLN00113        833 CTD------TKCFISSAYVAPETRE-------TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-  898 (968)
T ss_pred             ccC------CCccccccccCccccc-------CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc-
Confidence            211      2236889999999765       34678999999999999999999999976655556677776654433 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      ......+++.+.............+.+++.+||+.||++|||++|+++.|.++....+.
T Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  957 (968)
T PLN00113        899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS  957 (968)
T ss_pred             cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence            22333445544333333345666778899999999999999999999999998765443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-43  Score=321.94  Aligned_cols=262  Identities=24%  Similarity=0.391  Sum_probs=197.6

Q ss_pred             hccccCCccccCCceEEEEEEeCC-----------------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCcee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-----------------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK  127 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  127 (371)
                      ++|+..+.||+|+||.||+|.+.+                 +..||+|.+... ........+.+|+.++++++||||++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            457778899999999999996532                 336999988543 23344567999999999999999999


Q ss_pred             eeceEecCCeEEEEEeecCCCCHHHHhccC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 037946          128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGN-------------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAIL  188 (371)
Q Consensus       128 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~  188 (371)
                      +++++.+.+..++||||+++|+|.+++...                   ..+++..++.++.|++.||.|||+.   +++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            999999999999999999999999998543                   2367788999999999999999999   999


Q ss_pred             ecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHH
Q 037946          189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEI  268 (371)
Q Consensus       189 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el  268 (371)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||.+.       ...++.++||||||+++|||
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el  233 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-------MGKFTTASDVWAFGVTLWEI  233 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-------cCCCCchhhhHHHHHHHHHH
Confidence            99999999999999999999999998765443222233445688999999764       33578899999999999999


Q ss_pred             HhC--CCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          269 LSG--RSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       269 ~~g--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      +++  ..|+...  +.......+..........  ........++.       .+.+++.+||+.||++|||+.+|.+.|
T Consensus       234 ~~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-------~~~~li~~cl~~~p~~RPs~~~i~~~l  302 (304)
T cd05096         234 LMLCKEQPYGEL--TDEQVIENAGEFFRDQGRQ--VYLFRPPPCPQ-------GLYELMLQCWSRDCRERPSFSDIHAFL  302 (304)
T ss_pred             HHccCCCCCCcC--CHHHHHHHHHHHhhhcccc--ccccCCCCCCH-------HHHHHHHHHccCCchhCcCHHHHHHHH
Confidence            974  4555432  2222223222222111100  00011112222       345577889999999999999999988


Q ss_pred             hc
Q 037946          347 ME  348 (371)
Q Consensus       347 ~~  348 (371)
                      .+
T Consensus       303 ~~  304 (304)
T cd05096         303 TE  304 (304)
T ss_pred             hC
Confidence            63

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.5e-44  Score=335.20  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=198.0

Q ss_pred             hccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      ++|+..+.||+|+||.||+|..      .++..||+|++.... .....+.+.+|+.+++.+ +||||++++++|.+.+.
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            4688889999999999999963      235689999985432 233456788999999999 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC-----------------------------------------------------------
Q 037946          138 KLLLYNYISNGNLQQLLQGNR-----------------------------------------------------------  158 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~-----------------------------------------------------------  158 (371)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999885421                                                           


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          159 ----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       159 ----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                                      .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                            367888999999999999999999   9999999999999999999999999999876543321


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .......++..|+|||.+.       +..++.++|||||||++|||++ |..||.....+ ......+......   .  
T Consensus       271 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~---~--  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRM---L--  337 (375)
T ss_pred             cccCCCCCCcceeChhHhc-------CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccC---C--
Confidence            1222334567899999765       3367889999999999999998 77777543222 1222222211100   0  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                        .+  ...+       ..+.+++.+||+.||++|||++|+++.|++.
T Consensus       338 --~~--~~~~-------~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 --SP--ECAP-------SEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             --CC--CCCC-------HHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              00  1111       2345678889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-44  Score=331.49  Aligned_cols=244  Identities=23%  Similarity=0.300  Sum_probs=195.4

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      +.||+|+||.||++.. .+|+.||+|++..... .......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 4689999999865332 2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccc
Q 037946          149 NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV  228 (371)
Q Consensus       149 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  228 (371)
                      +|.+++...+.+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++......  ......
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~  155 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF  155 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccce
Confidence            9999999888899999999999999999999999   99999999999999999999999999987533221  123456


Q ss_pred             cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .||+.|+|||.+.+       ..++.++|||||||++|||++|..||....  .......+   ....           .
T Consensus       156 ~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~---~~~~-----------~  212 (323)
T cd05571         156 CGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELI---LMEE-----------I  212 (323)
T ss_pred             ecCccccChhhhcC-------CCCCccccCcccchhhhhhhcCCCCCCCCC--HHHHHHHH---HcCC-----------C
Confidence            79999999998753       357889999999999999999999996432  11221111   1110           0


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVAL  345 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~  345 (371)
                      ..+....   ..+.+++.+||+.||++||     ++.+++++
T Consensus       213 ~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         213 RFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCC---HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1111111   2344577889999999999     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=327.81  Aligned_cols=249  Identities=21%  Similarity=0.261  Sum_probs=200.6

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +|+..+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            4777889999999999999764 689999999854322 22345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---  155 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---  155 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence            999999999999888899999999999999999999999   99999999999999999999999999998654322   


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                        ....||+.|+|||.+.+       ..++.++|||||||++|+|++|..||.....  ......+.   ....      
T Consensus       156 --~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~~i~---~~~~------  215 (291)
T cd05612         156 --WTLCGTPEYLAPEVIQS-------KGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYEKIL---AGKL------  215 (291)
T ss_pred             --ccccCChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH---hCCc------
Confidence              34569999999997653       3567899999999999999999999864322  12221111   1100      


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHHhc
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALLME  348 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L~~  348 (371)
                           ..+...   ...+.+++.+||+.||.+||+     +++++++-+-
T Consensus       216 -----~~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         216 -----EFPRHL---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             -----CCCccC---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence                 111111   123445788899999999995     9999998643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-44  Score=308.25  Aligned_cols=267  Identities=24%  Similarity=0.294  Sum_probs=208.9

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe--cCCeEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS--NKSVKLL  140 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  140 (371)
                      .+.|+..+.|++|+||.||+|++ ++++.||+|+++.+....-.-...++|+.+|.+.+|||||.+-.+..  +-+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            45688889999999999999965 46899999999765544444456789999999999999999988764  3467999


Q ss_pred             EEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |||||+. +|.+++.+-+ ++...++..+..|+++|++|||+.   .|+||||||+|+|+++.|.+||+|||+|+.+++.
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999988 9999998765 799999999999999999999999   9999999999999999999999999999998876


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      -  ..+...+-|.+|.|||++.+.      ..|+++.|+||+||++.||+++.+.|.+...  ..-.+.+-...+.   .
T Consensus       231 ~--k~~T~lVVTLWYRaPELLLG~------~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGt---P  297 (419)
T KOG0663|consen  231 L--KPYTPLVVTLWYRAPELLLGA------KTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGT---P  297 (419)
T ss_pred             c--ccCcceEEEeeecCHHHhcCC------cccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCC---C
Confidence            3  456777899999999998764      3678999999999999999999988865432  2222333333322   1


Q ss_pred             ccccCcccCC-----------CChhhHH-------HHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 VSILDTKLQG-----------LPDQMVQ-------EMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~~~~-----------~~~~~~~-------~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...+.+.+..           .+...+.       ....-++++...+.+||.+|.|++|.+++=+
T Consensus       298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~  363 (419)
T KOG0663|consen  298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY  363 (419)
T ss_pred             ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence            1112222111           1111111       1123456888899999999999999998743

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=321.25  Aligned_cols=265  Identities=25%  Similarity=0.335  Sum_probs=202.9

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc------------chHHHHHHHHHHHhccCCCCceeeec
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE------------EPVDSFAAEIQILGHIRHRNIVKLLG  130 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~~  130 (371)
                      .++|+..+.||+|.||.|-+|+. .+++.||+|++.+.....            ...+...+|+.+|++++|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            47899999999999999999965 468999999986543211            12468899999999999999999999


Q ss_pred             eEecC--CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEc
Q 037946          131 YCSNK--SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLA  208 (371)
Q Consensus       131 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  208 (371)
                      +..+.  +.+|+|+|||..|.+...-.....+++.++++++.++..||.|||.+   +|+||||||+|+|++++|+|||+
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence            97654  67899999999888765444444489999999999999999999999   99999999999999999999999


Q ss_pred             cccCccccCCCC---cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhH
Q 037946          209 DFGLAKLMNSTN---YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI  285 (371)
Q Consensus       209 Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  285 (371)
                      |||.+.......   .........|||.|+|||.+.....   ....+.+.||||+||+||.|+.|+.||..+.     .
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~---~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-----~  324 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS---FSYSGFALDIWALGVTLYCLLFGQLPFFDDF-----E  324 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC---ccccchhhhhhhhhhhHHHhhhccCCcccch-----H
Confidence            999998663321   1122334679999999998875311   1234578999999999999999999996432     2


Q ss_pred             HHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      .+...+....          .+. +|.. ...-..+-+||.++|.+||++|.+..+|..|.|....
T Consensus       325 ~~l~~KIvn~----------pL~-fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  325 LELFDKIVND----------PLE-FPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHHHhcC----------ccc-CCCc-ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            2222222221          111 1111 0112233347888999999999999999999987764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-45  Score=330.19  Aligned_cols=251  Identities=26%  Similarity=0.385  Sum_probs=209.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe-EEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV-KLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  142 (371)
                      ++|...+.+|+|+||.++..+. .++..+++|++.-....+...+....|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            4677889999999999999854 357899999997777777777788999999999999999999999988888 99999


Q ss_pred             eecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          143 NYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      +||+||+|.+.+...+  .++++.+..++.|++.|+.|||++   .|+|||||+.|||++.++.|||+|||+++.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999997654  589999999999999999999998   99999999999999999999999999999987764


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                        ....+..||+.||.||.+.       +.+|..|+|||||||++|||++-+++|......     ..+.+...      
T Consensus       161 --~~a~tvvGTp~YmcPEil~-------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~ki~~------  220 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILS-------DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELILKINR------  220 (426)
T ss_pred             --hhhheecCCCcccCHHHhC-------CCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHHHHhh------
Confidence              2345678999999999876       558999999999999999999999999754332     22222222      


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          ......+.....+   +..++..|+..+|..||++.+++.+
T Consensus       221 ----~~~~Plp~~ys~e---l~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 ----GLYSPLPSMYSSE---LRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----ccCCCCCccccHH---HHHHHHHHhhcCCccCCCHHHHhhC
Confidence                1122333322233   3346777999999999999999987

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.7e-44  Score=321.04  Aligned_cols=266  Identities=19%  Similarity=0.280  Sum_probs=201.1

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            5777889999999999999764 578999999865544455567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++++++..+......+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ ..
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  157 (287)
T cd07848          82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-AN  157 (287)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-cc
Confidence            99988777766666799999999999999999999999   999999999999999999999999999987643321 12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC-------
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE-------  297 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  297 (371)
                      .....||+.|+|||.+.       +..++.++|||||||++|||++|+.||...... .... .+........       
T Consensus       158 ~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~-~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         158 YTEYVATRWYRSPELLL-------GAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLF-TIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             ccccccccccCCcHHHc-------CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHHhhCCCCHHHHHhh
Confidence            23456899999999765       335788999999999999999999998654321 1111 1111111100       


Q ss_pred             ----ccccccCcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          298 ----PAVSILDTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       298 ----~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          .......+.... +....     .....+.+++.+||+.||++|||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         229 YSNPRFHGLRFPAVNH-PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hccchhcccccCcccC-cccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                000000000000 00000     012246678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6e-44  Score=321.82  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=196.0

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      |+..+.||+|+||.||+|.. .+++.||+|.+...... ......+.+|+.++++++|+|++++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            55667899999999999965 57899999998543322 23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++..  ...+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            999999988754  34589999999999999999999999   99999999999999999999999999998754332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......||+.|+|||.+.       +..++.++|||||||++|||++|+.||........  .+.+......       
T Consensus       157 -~~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~-------  219 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVIN-------NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKE-------  219 (285)
T ss_pred             -eecCCCCCCCccCHhhhc-------CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhc-------
Confidence             223456899999999875       33678899999999999999999999975433211  1111111110       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L  346 (371)
                         .....+....   ..+.+++.+||+.||.+||+     +++++++-
T Consensus       220 ---~~~~~~~~~s---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         220 ---DQEEYSEKFS---EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             ---ccccCCccCC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence               0001111111   13445778899999999997     89998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-44  Score=331.29  Aligned_cols=248  Identities=22%  Similarity=0.280  Sum_probs=200.0

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|.+..... .......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            35778889999999999999764 588999999864322 2334567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.......  
T Consensus        98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            9999999999999888899999999999999999999999   99999999999999999999999999998664432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                         ....||+.|+|||.+.+       ..++.++|||||||++|||++|..||....  .....+.+.   .....    
T Consensus       173 ---~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~---~~~~~----  233 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQS-------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--PFRIYEKIL---AGRLK----  233 (329)
T ss_pred             ---ceecCChhhcCHHHHcC-------CCCCCcceeechHHHHHHHHcCCCCCCCCC--HHHHHHHHh---cCCcC----
Confidence               24579999999998753       356789999999999999999999986432  111111111   11000    


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L  346 (371)
                          .....+      ..+.+++.+||+.||.+||+     +++++++-
T Consensus       234 ----~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp  272 (329)
T PTZ00263        234 ----FPNWFD------GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP  272 (329)
T ss_pred             ----CCCCCC------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence                011111      12345788899999999996     78998774

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.7e-43  Score=318.44  Aligned_cols=255  Identities=27%  Similarity=0.481  Sum_probs=200.0

Q ss_pred             ccccCCccccCCceEEEEEEeCC------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .|+..+.||+|+||.||+|....      ...||+|.+... ........+.+|+.++++++||||+++++++.+.+..+
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47778899999999999996532      257999988532 23344567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC
Q 037946          140 LLYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY  203 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~  203 (371)
                      ++|||+++++|.+++...                ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999998654                4578899999999999999999999   999999999999999999


Q ss_pred             ceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCc
Q 037946          204 EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDG  282 (371)
Q Consensus       204 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  282 (371)
                      .++|+|||++......+.........+++.|+|||.+.       +..++.++|||||||++|||++ |..||.....  
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--  232 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-------YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--  232 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhc-------cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            99999999998664443222333445788999999764       3467889999999999999998 9988865432  


Q ss_pred             hhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          283 LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ..+...+....     .    .......+       ..+.+|+.+||+.||.+||+++||+++|..+
T Consensus       233 ~~~~~~i~~~~-----~----~~~~~~~~-------~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 QEVIEMIRSRQ-----L----LPCPEDCP-------ARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHHHHcCC-----c----CCCcccCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            22222222110     0    00011222       2345577889999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8e-44  Score=328.78  Aligned_cols=270  Identities=24%  Similarity=0.346  Sum_probs=197.5

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----CeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----SVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  139 (371)
                      +|+..+.||+|+||.||+|.. .+++.||+|++............+.+|+.++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            367778999999999999965 4689999999864333334456788999999999999999999987543     3579


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +||||+. ++|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9999995 59999998888899999999999999999999999   9999999999999999999999999999764332


Q ss_pred             Cc-ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NY-HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. ........||+.|+|||++.+.     ...++.++|||||||++|||++|+.||.....  ......+....+....
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~  229 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSP  229 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhcc-----ccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCH
Confidence            21 1112345699999999976421     23578899999999999999999999864321  1111111111111000


Q ss_pred             c-------------ccccCccc-CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          299 A-------------VSILDTKL-QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       299 ~-------------~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .             ........ .............+.+++.+||+.||++|||++|++++-
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp  291 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP  291 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence            0             00000000 000000000112345688889999999999999999884

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7e-45  Score=303.79  Aligned_cols=268  Identities=22%  Similarity=0.358  Sum_probs=218.5

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCC---Ccc---hHHHHHHHHHHHhcc-CCCCceeeec
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKR---DEE---PVDSFAAEIQILGHI-RHRNIVKLLG  130 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~---~~~~~~~e~~~l~~l-~h~niv~~~~  130 (371)
                      ..+.+.+.|...+.||.|..+.|-++. ..+|..+|+|++.....   ++.   ..+.-..|+.||+++ .||+|+.+.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            356677788888999999999999884 45788999999854322   222   234456899999998 7999999999


Q ss_pred             eEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       131 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                      +++.+..+++|+|.|+.|.|.|++.+.-.+++....++..|+..|+.|||.+   +|+||||||+|||+|++.++||+||
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            9999999999999999999999999999999999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |+++.+....   .....||||+|+|||.+.++.+.+ ...|+...|+|++||++|.|+.|.+||..-  ...-+...+.
T Consensus       168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~-~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~Im  241 (411)
T KOG0599|consen  168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYEN-HPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRMIM  241 (411)
T ss_pred             ceeeccCCch---hHHHhcCCCcccChhheeeecccC-CCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHHHH
Confidence            9999988775   557789999999999999886544 456899999999999999999999999632  1222333344


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      .+...+..             ++........-+|+.+||+.||++|.|++|++++-+-
T Consensus       242 eGkyqF~s-------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  242 EGKYQFRS-------------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             hcccccCC-------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            33332211             2222222334457888999999999999999998543

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-43  Score=331.83  Aligned_cols=257  Identities=29%  Similarity=0.443  Sum_probs=197.7

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      ++|+..+.||+|+||.||+|...      ++..||+|++.... .......+.+|+.+++.+ +||||++++++|...+.
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            46888899999999999998642      34579999985433 233456788999999999 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccC------------------------------------------------------------
Q 037946          138 KLLLYNYISNGNLQQLLQGN------------------------------------------------------------  157 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~------------------------------------------------------------  157 (371)
                      .++||||+++|+|.+++...                                                            
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999999999988532                                                            


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          158 ----------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       158 ----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                                ..+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      2367888999999999999999999   999999999999999999999999999976543321112223


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ..+++.|+|||++.       ...++.++|||||||++|||++ |..||.....+. .....+....          ...
T Consensus       274 ~~~~~~y~aPE~~~-------~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~----------~~~  335 (374)
T cd05106         274 ARLPVKWMAPESIF-------DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGY----------QMS  335 (374)
T ss_pred             CCCccceeCHHHhc-------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHccc----------Ccc
Confidence            34567899999764       3367899999999999999997 999986443221 1111111100          000


Q ss_pred             cC-CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          307 LQ-GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       307 ~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .. ..+       ..+.+++.+||+.||++|||+.++++.|.++.
T Consensus       336 ~~~~~~-------~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         336 RPDFAP-------PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            01 111       23445777899999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-44  Score=326.19  Aligned_cols=255  Identities=28%  Similarity=0.430  Sum_probs=210.0

Q ss_pred             ccccCCccccCCceEEEEEEeC---CCC--EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP---NGE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ..+..+.||+|-||.||+|...   .|+  .||||..+.+.. .+..+.|+.|..+|++++||||++++|+|.+. ..|+
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            3455678999999999999553   233  588898765444 34478999999999999999999999999864 5699


Q ss_pred             EEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |||+++.|.|..+++.++ .++......++.|++.||+|||++   ++|||||..+|||+.+.-.|||+|||+++.+...
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999998654 589999999999999999999999   9999999999999999999999999999999888


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .+.... ...-+.-|||||.+...       .++.+||||.|||.+||++. |..||++-.+.               ..
T Consensus       545 ~yYkaS-~~kLPIKWmaPESINfR-------rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------DV  601 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESINFR-------RFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------DV  601 (974)
T ss_pred             chhhcc-ccccceeecCccccchh-------cccchhhHHHHHHHHHHHHHhcCCcccccccc---------------ce
Confidence            765443 44567789999987633       78999999999999999885 99999866554               33


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      +..+-.+....+|+.+..   .++.|+.+||++||.+||+++|+...|.++.+
T Consensus       602 I~~iEnGeRlP~P~nCPp---~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPP---ALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEEecCCCCCCCCCCCCh---HHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            344444444455554433   34567888999999999999999999988764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-43  Score=324.90  Aligned_cols=245  Identities=24%  Similarity=0.303  Sum_probs=194.6

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      +.||+|+||.||++.. .+|+.||+|++..... .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999965 4689999999865322 2344567788999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccc
Q 037946          149 NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV  228 (371)
Q Consensus       149 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  228 (371)
                      +|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.......  ......
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~  155 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF  155 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccccc
Confidence            9999998888899999999999999999999999   99999999999999999999999999987533221  122345


Q ss_pred             cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .||+.|+|||.+.       +..++.++|||||||++|||++|..||.....  .....   .......           
T Consensus       156 ~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~---~~~~~~~-----------  212 (323)
T cd05595         156 CGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFE---LILMEEI-----------  212 (323)
T ss_pred             cCCcCcCCccccc-------CCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--HHHHH---HHhcCCC-----------
Confidence            6999999999875       33678899999999999999999999864322  11111   1111100           


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                      ..+.....   .+.+++.+||+.||++||     ++.+++++-
T Consensus       213 ~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         213 RFPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             CCCCCCCH---HHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence            11111111   234577779999999998     899998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-43  Score=308.14  Aligned_cols=274  Identities=23%  Similarity=0.323  Sum_probs=207.9

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC-ceeeeceEecCC------
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN-IVKLLGYCSNKS------  136 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------  136 (371)
                      ..|...+.||+|+||+||+|+. .+|+.||+|++..+...+-.-....+|+.+++.++|+| |+.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3455567799999999999964 57899999999665443333455689999999999999 999999998777      


Q ss_pred             eEEEEEeecCCCCHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          137 VKLLLYNYISNGNLQQLLQGNR----NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      ..++||||++. +|..++....    .++...+..+..|++.||+|||++   +|+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            88999999976 9999997655    578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      ++...-..  .......+|..|.|||++.+.      ..|+...||||+||++.||+++++.|.+...  ......+-..
T Consensus       167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs------~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~  236 (323)
T KOG0594|consen  167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGS------TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRL  236 (323)
T ss_pred             HHHhcCCc--ccccccEEEeeccCHHHhcCC------CcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHH
Confidence            99765332  235667799999999998754      2578899999999999999999988865543  2222223333


Q ss_pred             hcCCCc--c---ccccCcc--cCCC--ChhhH----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HhcccCC
Q 037946          293 MGSFEP--A---VSILDTK--LQGL--PDQMV----QEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVKSA  352 (371)
Q Consensus       293 ~~~~~~--~---~~~~~~~--~~~~--~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  352 (371)
                      .+....  .   ....+.+  ....  +....    ....+..+++.+|++++|.+|.|++.+++|  +..+...
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            332111  1   1111111  1111  11111    112356789999999999999999999998  5555433

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-43  Score=325.13  Aligned_cols=246  Identities=23%  Similarity=0.297  Sum_probs=196.1

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      +.||+|+||.||++.. .+++.||+|++..... .......+.+|+.+++.++||||+++.+++.+.+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999965 4689999999865432 2344567889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccc
Q 037946          149 NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV  228 (371)
Q Consensus       149 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  228 (371)
                      +|.+++.....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++......  ......
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~  155 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTF  155 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccc
Confidence            9999998888899999999999999999999999   99999999999999999999999999987543221  123445


Q ss_pred             cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .||+.|+|||.+.       +..++.++|||||||++|+|++|..||.....  ...   ........           .
T Consensus       156 ~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~~---~~~~~~~~-----------~  212 (328)
T cd05593         156 CGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKL---FELILMED-----------I  212 (328)
T ss_pred             cCCcCccChhhhc-------CCCCCccCCccccchHHHHHhhCCCCCCCCCH--HHH---HHHhccCC-----------c
Confidence            7999999999875       33568899999999999999999999964321  111   11111110           0


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHh
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLM  347 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~  347 (371)
                      ..+.....   .+.+++.+||+.||++||     ++.+++++-+
T Consensus       213 ~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         213 KFPRTLSA---DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             cCCCCCCH---HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence            11111111   344577889999999997     8999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-44  Score=294.37  Aligned_cols=251  Identities=26%  Similarity=0.342  Sum_probs=205.8

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc-chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE-EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+.++.||+|-||.||.|+. +++..||+|++.++.... .....+.+|+++-+.|+||||+++|++|.+....|+++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            478899999999999999964 568899999997654322 334578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |..+|+|...|+  ...++++...+.++.|+|.|+.|+|.+   +++||||||+|+|++.++.+||+|||.+.....+  
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~--  177 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN--  177 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCC--
Confidence            999999999998  666799999999999999999999999   9999999999999999999999999999765422  


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                        ...+.+||..|.|||...       +..++...|+|++|++.||++.|.+||.....+  +....+.+.--       
T Consensus       178 --kR~tlcgt~dyl~pEmv~-------~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--etYkrI~k~~~-------  239 (281)
T KOG0580|consen  178 --KRKTLCGTLDYLPPEMVE-------GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--ETYKRIRKVDL-------  239 (281)
T ss_pred             --CceeeecccccCCHhhcC-------CCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--HHHHHHHHccc-------
Confidence              446789999999999765       447789999999999999999999999765422  12222221111       


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                       ..+  ...+    .   ...++|.+|+.++|.+|.+..|++++-+-.
T Consensus       240 -~~p--~~is----~---~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  240 -KFP--STIS----G---GAADLISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             -cCC--cccC----h---hHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence             111  1111    1   234577889999999999999999987654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.1e-44  Score=329.07  Aligned_cols=248  Identities=24%  Similarity=0.296  Sum_probs=198.7

Q ss_pred             hccccCCccccCCceEEEEEEeCC--CCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN--GELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|...+  +..||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            357778899999999999996533  36899999854322 233456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....... 
T Consensus       110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-  185 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-  185 (340)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence            99999999999999888899999999999999999999999   99999999999999999999999999998654322 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                          ....||+.|+|||++.+       ..++.++|||||||++|||++|..||.....  .....   .......    
T Consensus       186 ----~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~---~i~~~~~----  245 (340)
T PTZ00426        186 ----YTLCGTPEYIAPEILLN-------VGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLIYQ---KILEGII----  245 (340)
T ss_pred             ----ceecCChhhcCHHHHhC-------CCCCccccccchhhHHHHHhcCCCCCCCCCH--HHHHH---HHhcCCC----
Confidence                34579999999998753       3567899999999999999999999964321  11111   1111100    


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                             ..+.....   .+.+++.+||+.||++|+     ++++++++-
T Consensus       246 -------~~p~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp  285 (340)
T PTZ00426        246 -------YFPKFLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP  285 (340)
T ss_pred             -------CCCCCCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence                   01111111   234577889999999995     899999874

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=326.82  Aligned_cols=256  Identities=22%  Similarity=0.269  Sum_probs=202.1

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            4777889999999999999765 589999999865432 22345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....     
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----  153 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----  153 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence            999999999999888899999999999999999999999   999999999999999999999999999976543     


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......||+.|+|||.+.+       ..++.++|||||||++|||++|..||......  .....+........      
T Consensus       154 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~------  218 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRG-------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLKYWKETLQ------  218 (333)
T ss_pred             ccCCcccCccccChhHhcC-------CCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHHhcccccc------
Confidence            2234579999999998753       36788999999999999999999999643221  21111111111000      


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .+...   +........+.+++.+||+.+|.+||++++++++-+
T Consensus       219 ~~~~~---~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         219 RPVYD---DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             CCCCC---ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence            00000   000011223456778899999999999999998843

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=332.87  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..++||+|+||+|+++..+ +++.+|||.+++... ..+..+..+.|.+|+... +||.++.++..|+..+++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            56888999999999999999654 688999999977653 456678889999999888 599999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+.||+ ..+++..+.+++..+..++..|+.||.|||++   +||+||||.+|||+|.+|.+||+|||+++..-... 
T Consensus       448 mey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-  522 (694)
T KOG0694|consen  448 MEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-  522 (694)
T ss_pred             EEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC-
Confidence            99999999 44445556799999999999999999999999   99999999999999999999999999998654332 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ..+.+.+|||.|||||++.++       .|+.++|.|||||+||||+.|..||.++..+  ++.+-+...         
T Consensus       523 -~~TsTfCGTpey~aPEil~e~-------~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--e~FdsI~~d---------  583 (694)
T KOG0694|consen  523 -DRTSTFCGTPEFLAPEVLTEQ-------SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--EVFDSIVND---------  583 (694)
T ss_pred             -CccccccCChhhcChhhhccC-------cccchhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHhcC---------
Confidence             366789999999999998744       7899999999999999999999999865433  332221110         


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~  345 (371)
                        +.   ..|-   -...+.+.|+.++|..||++|.-     +++|.++
T Consensus       584 --~~---~yP~---~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  584 --EV---RYPR---FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             --CC---CCCC---cccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence              01   1111   11223455777899999999984     4566554

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.4e-43  Score=318.95  Aligned_cols=268  Identities=23%  Similarity=0.311  Sum_probs=196.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            45788899999999999999764 688999999854322 2233467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+.+ +|.+++.. ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            9965 77777654 45689999999999999999999999   99999999999999999999999999987543322  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc----
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP----  298 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  298 (371)
                      .......+|+.|+|||++.+      ...++.++|||||||++|+|++|..||.........+ ..+.........    
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~  230 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLG------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL-ERIFLVLGTPNEDTWP  230 (303)
T ss_pred             ccCCCCcccCCCCChHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHHhCCCChhhcc
Confidence            12234568999999997642      2246788999999999999999999997543211111 111111111000    


Q ss_pred             ----cccccCcccCC-CChhhHH------HHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          299 ----AVSILDTKLQG-LPDQMVQ------EMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       299 ----~~~~~~~~~~~-~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                          ........... .+.....      ....+.+++.+||+.||++|||++|++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~  289 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE  289 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence                00000000000 0111100      012345688889999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.8e-43  Score=313.45  Aligned_cols=255  Identities=21%  Similarity=0.351  Sum_probs=197.1

Q ss_pred             hccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      +.|+..+.||+|+||.||+|.+.    .+..||+|.+.... +......+.+|+.++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            35777889999999999999642    35689999985432 23344678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++|+|.+++... ..+++..++.++.|++.||+|||++   +++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999764 4689999999999999999999999   9999999999999999999999999987654322


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. .......++..|+|||.+.       ...++.++|||||||++||+++ |..||.....  ......+..   . ..
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~---~-~~  226 (266)
T cd05064         161 AI-YTTMSGKSPVLWAAPEAIQ-------YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKAVED---G-FR  226 (266)
T ss_pred             ch-hcccCCCCceeecCHHHHh-------hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHC---C-CC
Confidence            11 1112334567899999764       3367889999999999999875 9988864322  222222211   1 00


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .     +....++.       .+.+++.+||+.+|++||++++|++.|.++
T Consensus       227 ~-----~~~~~~~~-------~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 L-----PAPRNCPN-------LLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             C-----CCCCCCCH-------HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0     11112222       344577779999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.7e-43  Score=320.51  Aligned_cols=268  Identities=24%  Similarity=0.353  Sum_probs=204.3

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||++... ++..+|+|.+... ........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            46778889999999999999764 6788999988543 233445679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++.....+++..+..++.|++.||.|||+++  +++||||||+||+++.++.+||+|||++......    
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----  157 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  157 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence            9999999999998888999999999999999999999862  6999999999999999999999999998765432    


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC-Ccccc-
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF-EPAVS-  301 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~-  301 (371)
                      ......||+.|+|||.+.       +..++.++|||||||++|||++|+.||......  .+...+....... ..... 
T Consensus       158 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         158 MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             ccccCCCCcCcCCHhHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccc
Confidence            223456999999999775       336788999999999999999999999643221  1111111000000 00000 


Q ss_pred             -------------------------------ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          302 -------------------------------ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       302 -------------------------------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                                                     +........+..  .....+.+++.+||+.||++|||++|++++.+--.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNG--VFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCc--cccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                                           000000000000  11234567899999999999999999999976544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-44  Score=324.56  Aligned_cols=242  Identities=25%  Similarity=0.297  Sum_probs=192.7

Q ss_pred             cccCCceEEEEEEeC-CCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           73 IGKGCSGVVYKAEMP-NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      ||+|+||.||+|... +++.||+|++.... ........+..|+.++++++||||+++++++.+.+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999764 58899999985432 2334456788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccc
Q 037946          151 QQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG  230 (371)
Q Consensus       151 ~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  230 (371)
                      .+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......  .......|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g  155 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG  155 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence            99998888899999999999999999999999   99999999999999999999999999987543322  12344579


Q ss_pred             cccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCC
Q 037946          231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL  310 (371)
Q Consensus       231 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      |+.|+|||.+.       +..++.++|||||||++|||++|..||.....     .+..........           ..
T Consensus       156 t~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~~-----------~~  212 (312)
T cd05585         156 TPEYLAPELLL-------GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEPL-----------RF  212 (312)
T ss_pred             CcccCCHHHHc-------CCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCC-----------CC
Confidence            99999999875       33678899999999999999999999964321     122222221100           11


Q ss_pred             ChhhHHHHHHHHHHHhcccCCCCCCCCC---HHHHHHH
Q 037946          311 PDQMVQEMLQTLGIAMFCVNSSPAERPT---MKEVVAL  345 (371)
Q Consensus       311 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~~  345 (371)
                      +....   ..+.+++.+||+.||.+||+   +.|++++
T Consensus       213 ~~~~~---~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         213 PDGFD---RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCcCC---HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            11111   12345778899999999974   6777766

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.6e-43  Score=315.51  Aligned_cols=266  Identities=21%  Similarity=0.297  Sum_probs=197.4

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            35777889999999999999654 68899999985432 22334567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++ +|.+++.... .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9985 8998886544 478999999999999999999999   99999999999999999999999999997654332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc---
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA---  299 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  299 (371)
                      .......+++.|+|||.+.+      ...++.++||||+||++|+|++|..||.....  ......+..........   
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLG------STEYSTPIDMWGVGCILYEMATGRPMFPGSTV--KEELHLIFRLLGTPTEETWP  229 (288)
T ss_pred             ccccCceecccccChHHhcC------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhh
Confidence            12234568999999997652      23567899999999999999999999865432  12222222221110000   


Q ss_pred             --------ccccCcccCCCCh--hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 --------VSILDTKLQGLPD--QMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 --------~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                              .....+.....+.  ..........+++.+|++.||.+|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                    0000000000000  000112245678999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.8e-43  Score=327.76  Aligned_cols=259  Identities=25%  Similarity=0.357  Sum_probs=199.1

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  137 (371)
                      ++|.+.+.||+|+||.||+|...      .+..||+|++... ......+.+.+|+++++++. ||||++++++|.+.+.
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            46888899999999999999752      2346999998543 23344567999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccC------------------------------------------------------------
Q 037946          138 KLLLYNYISNGNLQQLLQGN------------------------------------------------------------  157 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~------------------------------------------------------------  157 (371)
                      .|+|||||++|+|.+++...                                                            
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            99999999999999987532                                                            


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC
Q 037946          158 ------------------------------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS  201 (371)
Q Consensus       158 ------------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~  201 (371)
                                                          ..+++..+..++.|++.||+|||+.   +++||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                                2367788899999999999999999   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 037946          202 KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG  280 (371)
Q Consensus       202 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~  280 (371)
                      ++.+||+|||+++...............+++.|+|||.+.       +..++.++|||||||++|||++ |..||.....
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-------DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            9999999999998654432222223345778899999765       3357889999999999999997 8888864332


Q ss_pred             CchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          281 DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      +. .....+...    ...     ......+       ..+.+++.+||+.||++|||+.+|.+.|.++.+
T Consensus       346 ~~-~~~~~~~~~----~~~-----~~~~~~~-------~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         346 DS-TFYNKIKSG----YRM-----AKPDHAT-------QEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             hH-HHHHHHhcC----CCC-----CCCccCC-------HHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            21 111111110    000     0001122       234557888999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.5e-43  Score=324.53  Aligned_cols=260  Identities=23%  Similarity=0.363  Sum_probs=196.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            45667789999999999999754 68999999985432 33445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+.    ...++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++......  .
T Consensus       153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            9999998653    3356788889999999999999999   99999999999999999999999999998654332  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......||..|+|||.+....  ..+...+.++|||||||++|||++|+.||......+  .............      
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~------  293 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMSQP------  293 (353)
T ss_pred             cccccccCccccCcccccccc--ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhccCC------
Confidence            223457999999999875321  112234568999999999999999999996322211  1111111110000      


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                          ...+..   ....+.+++.+||+.||++|||+.|++++-+-...
T Consensus       294 ----~~~~~~---~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        294 ----PEAPAT---ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ----CCCCCc---cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                001111   11234567788999999999999999998655443

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.3e-43  Score=313.43  Aligned_cols=255  Identities=25%  Similarity=0.462  Sum_probs=198.9

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      +.|...+.||+|+||.||+|...      +++.||+|.+.... .......+.+|+++++.++|||++++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            34677789999999999999653      34789999985432 233457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          139 LLLYNYISNGNLQQLLQGN--------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      +++|||+++++|.+++...              ..+++..+..++.|++.|+.|||++   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            9999999999999999654              2378889999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGL  283 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  283 (371)
                      +||+|||++................+++.|+|||.+.       +..++.++||||||+++|||++ |..||.....  .
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~  231 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--E  231 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhc-------cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--H
Confidence            9999999997654433222223445678999999765       3467889999999999999998 9998854322  2


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ...+.+....     .    .......+       ..+.+++.+||+.||++||+++|+++.|.+
T Consensus       232 ~~~~~~~~~~-----~----~~~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         232 EVIECITQGR-----L----LQRPRTCP-------SEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHHHcCC-----c----CCCCCCCC-------HHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            2222222110     0    00001122       234567888999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.1e-43  Score=314.94  Aligned_cols=259  Identities=25%  Similarity=0.437  Sum_probs=200.9

Q ss_pred             hccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ..|...+.||+|+||.||++..      .++..+|+|.+..  ........+.+|++++++++|||++++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC--cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3577788999999999999964      2345689998743  2334456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCce
Q 037946          139 LLLYNYISNGNLQQLLQGNR-------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEA  205 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~  205 (371)
                      +++|||+++++|.+++....             .+++..++.++.|++.||+|||++   +++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            99999999999999986443             489999999999999999999999   99999999999999999999


Q ss_pred             EEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 037946          206 YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLH  284 (371)
Q Consensus       206 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  284 (371)
                      ||+|||++................+++.|+|||.+.       +..++.++||||||+++|+|++ |..||.....  ..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~  230 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE  230 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence            999999998664433222223334678899999765       2357889999999999999998 8888753321  11


Q ss_pred             HHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          285 IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                      ....+..   . ..     .......+       ..+.+++.+||+.||.+|||++++++.|+++....
T Consensus       231 ~~~~i~~---~-~~-----~~~~~~~~-------~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         231 VIECITQ---G-RV-----LQRPRTCP-------KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHHHHHc---C-Cc-----CCCCCCCC-------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            2111111   1 00     00011122       23566888899999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-43  Score=312.99  Aligned_cols=248  Identities=34%  Similarity=0.537  Sum_probs=188.8

Q ss_pred             CCccccCCceEEEEEEeC-----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           70 ENVIGKGCSGVVYKAEMP-----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .+.||.|+||.||+|.+.     .+..|+||.+.. .......+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            467999999999999775     357899999843 33444578899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++...  ..+++..++.++.|++.||.|||++   +++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999876  6799999999999999999999999   9999999999999999999999999999876433322


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ...........|+|||.+...       .++.++||||||+++|||++ |..|+...  +...+...+......      
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~-------~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~~~~~~~------  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDG-------EYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKLKQGQRL------  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHS-------EESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHHHTTEET------
T ss_pred             ccccccccccccccccccccc-------ccccccccccccccccccccccccccccc--ccccccccccccccc------
Confidence            223344578899999976532       47889999999999999999 66776433  222322222211110      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                         .....++.       .+.+++..||+.||++|||+.++++.|
T Consensus       225 ---~~~~~~~~-------~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ---PIPDNCPK-------DIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TSBTTSBH-------HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eeccchhH-------HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               01112232       234567779999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.3e-43  Score=338.49  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=200.1

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-----
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-----  136 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  136 (371)
                      ..++|...+.||+|+||.||+|.. .+++.||+|.+.....+......+.+|+..+..++|+|++++.+.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            345788899999999999999964 56899999998665555566678899999999999999999987764332     


Q ss_pred             ---eEEEEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcc
Q 037946          137 ---VKLLLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       137 ---~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                         ..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               36899999999999998864    34689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  289 (371)
                      ||+++...............||+.|+|||.+.       +..++.++|||||||++|||++|..||....     ..+.+
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~  254 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-------RKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVM  254 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHH
Confidence            99998765432222334567999999999775       3367899999999999999999999986432     11222


Q ss_pred             HHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ......          .....+.....   .+.+++.+||+.||.+||++.+++++
T Consensus       255 ~~~~~~----------~~~~~~~~~~~---~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTLAG----------RYDPLPPSISP---EMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHhcC----------CCCCCCCCCCH---HHHHHHHHHcccChhhCcCHHHHHhC
Confidence            221111          01111111112   34457778999999999999999875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-42  Score=308.13  Aligned_cols=250  Identities=21%  Similarity=0.397  Sum_probs=196.7

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .|+..+.||+|+||.||++...++..+|+|.+...   ......+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            46677889999999999998877788999987432   223467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++|+|.+++.. ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||+|||.++........ .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S  157 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence            99999999875 34689999999999999999999999   9999999999999999999999999999865433211 1


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....++..|+|||.+.+       ..++.++||||||+++|||++ |..||....  .......+......       .
T Consensus       158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~~~-------~  221 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNF-------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGFRL-------Y  221 (256)
T ss_pred             cCCCCCchhhCChhhccc-------CccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCCC-------C
Confidence            122335678999998752       356789999999999999999 888885432  22222222221110       0


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .+  ...       ...+.+++.+||+.||++|||++++++.|.
T Consensus       222 ~~--~~~-------~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         222 RP--KLA-------SMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CC--CCC-------CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            00  011       124566888899999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.2e-43  Score=321.21  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=193.9

Q ss_pred             CccccCCceEEEEEEe----CCCCEEEEEEecccCC--CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           71 NVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKR--DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.||+|+||.||++..    .+++.||+|.+.....  .......+..|+.+++.++||||+++++++...+..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999965    3578999999864322  223345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|.+++...+.+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......  ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  156 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TV  156 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Cc
Confidence            99999999998888899999999999999999999999   99999999999999999999999999987543322  12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....||+.|+|||++.+       ..++.++|||||||++|||++|..||.....  .   ..........        
T Consensus       157 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~pf~~~~~--~---~~~~~~~~~~--------  216 (323)
T cd05584         157 THTFCGTIEYMAPEILMR-------SGHGKAVDWWSLGALMYDMLTGAPPFTAENR--K---KTIDKILKGK--------  216 (323)
T ss_pred             ccccCCCccccChhhccC-------CCCCCcceecccHHHHHHHhcCCCCCCCCCH--H---HHHHHHHcCC--------
Confidence            234569999999998753       3567899999999999999999999964321  1   1111111110        


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                         ...++...   ..+.+++.+||+.||++||     ++++++++-
T Consensus       217 ---~~~~~~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         217 ---LNLPPYLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             ---CCCCCCCC---HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence               01111111   1344678889999999999     899988864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-44  Score=310.90  Aligned_cols=265  Identities=27%  Similarity=0.372  Sum_probs=198.0

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-----eEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-----VKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  139 (371)
                      .|...+++|.|+||.||+|.. .+++.||||+...+..-.      .+|+++|+.++|||||++.-+|....     ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            366678999999999999965 457999999997665433      47999999999999999988775432     234


Q ss_pred             EEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-CceEEccccCcc
Q 037946          140 LLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAK  214 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~  214 (371)
                      +||||++. +|.+.++.    +..++.-.+.-+..|+++||+|||+.   +||||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            79999988 99998873    56788889999999999999999998   99999999999999976 999999999999


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      .+..+..   ..+...|..|.|||++.+.      .+|+.+.||||.||++.||+-|++.|.++.+. .++.+ +-+.++
T Consensus       175 ~L~~~ep---niSYicSRyYRaPELifga------~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~e-Iik~lG  243 (364)
T KOG0658|consen  175 VLVKGEP---NISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVE-IIKVLG  243 (364)
T ss_pred             eeccCCC---ceeEEEeccccCHHHHcCc------cccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHH-HHHHhC
Confidence            9877652   2455678899999988654      36789999999999999999999999875432 22222 223333


Q ss_pred             CCCcc-ccccC--------cccCCCCh---hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HhcccC
Q 037946          295 SFEPA-VSILD--------TKLQGLPD---QMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVKS  351 (371)
Q Consensus       295 ~~~~~-~~~~~--------~~~~~~~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~  351 (371)
                      ..... .....        +.+...+.   .......+.++++.+++.++|.+|.++.|++.+  .+++..
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            21000 00000        11111110   001122345678888999999999999999976  344443

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-42  Score=323.79  Aligned_cols=263  Identities=20%  Similarity=0.257  Sum_probs=197.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .+|...+.||+|+||.||++.+ .+++.||+|...        ...+.+|++++++++||||+++++++......++|||
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            4688899999999999999965 468899999652        1346789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ++. ++|..++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....... ..
T Consensus       164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            995 58999988888899999999999999999999999   99999999999999999999999999997543221 11


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-----CchhHHHHHHHHhcCCCc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-----DGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~  298 (371)
                      ......||+.|+|||++.+       ..++.++|||||||++|||++|..|+.....     +.......+....+....
T Consensus       239 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        239 KYYGWAGTIATNAPELLAR-------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             ccccccCccCCCChhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            2234579999999998753       3678899999999999999999988753321     011111111111111000


Q ss_pred             c---------cccc---------CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          299 A---------VSIL---------DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       299 ~---------~~~~---------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .         ....         .+...............+.+++.+||+.||.+|||++|++++-+
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence            0         0000         00000011111122335667899999999999999999998754

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.9e-42  Score=310.74  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=192.2

Q ss_pred             ccccCCccccCCceEEEEEEeC--CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc---CCCCceeeeceEe-----cC
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP--NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI---RHRNIVKLLGYCS-----NK  135 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~~  135 (371)
                      +|+..+.||+|+||.||+|...  +++.||+|.+............+.+|+.+++.+   +||||++++++|.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            5788889999999999999752  467899999865444444445566777777765   6999999999885     34


Q ss_pred             CeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      ...++||||++ ++|.+++...  ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56899999997 5899988653  4589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      +......   ......||+.|+|||.+.       +..++.++|||||||++|||++|.+||.....  ......+....
T Consensus       158 ~~~~~~~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~  225 (290)
T cd07862         158 RIYSFQM---ALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVI  225 (290)
T ss_pred             EeccCCc---ccccccccccccChHHHh-------CCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHh
Confidence            7654332   234456899999999764       33578899999999999999999999865422  12222222221


Q ss_pred             cCCCcc-----ccccCcccCCCChhhHH-----HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          294 GSFEPA-----VSILDTKLQGLPDQMVQ-----EMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       294 ~~~~~~-----~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ....+.     ...........+.....     ....+.+++.+||+.||++|||+.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            110000     00000000000000000     11233468899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-43  Score=335.86  Aligned_cols=250  Identities=21%  Similarity=0.266  Sum_probs=195.6

Q ss_pred             ccccCCccccCCceEEEEEEeC-C-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-N-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|...+.||+|++|.||+|... + ++.||+|.+..  ........+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            4778889999999999999543 3 67788887632  233444677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          144 YISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       144 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999987743    44689999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .........+||+.|+|||++.       +..++.++|||||||++|||++|..||....  ...+...+..  ....  
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--~~~~~~~~~~--~~~~--  289 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWE-------RKRYSKKADMWSLGVILYELLTLHRPFKGPS--QREIMQQVLY--GKYD--  289 (478)
T ss_pred             cccccccccCCCccccCHhHhC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh--CCCC--
Confidence            3222334567999999999765       3367889999999999999999999986432  1121111111  0100  


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                           +.....+       ..+.+++.+||+.||++||++.+++.+
T Consensus       290 -----~~~~~~s-------~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 -----PFPCPVS-------SGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             -----CCCccCC-------HHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                 0011111       234557788999999999999998754

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-42  Score=320.41  Aligned_cols=259  Identities=28%  Similarity=0.411  Sum_probs=198.0

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEec-CC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSN-KS  136 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~  136 (371)
                      ++|+..+.||+|+||.||+|...      +++.||+|++.... .......+..|+.+++++ +|+||++++++|.. ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            36888899999999999999532      35789999885322 233446788999999999 89999999998764 46


Q ss_pred             eEEEEEeecCCCCHHHHhccC-----------------------------------------------------------
Q 037946          137 VKLLLYNYISNGNLQQLLQGN-----------------------------------------------------------  157 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------------------  157 (371)
                      ..+++|||+++++|.+++...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            688999999999999998532                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccccccccccc
Q 037946          158 --RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI  235 (371)
Q Consensus       158 --~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  235 (371)
                        ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              2578999999999999999999999   99999999999999999999999999998764432222223345677899


Q ss_pred             CCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhh
Q 037946          236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQM  314 (371)
Q Consensus       236 aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      |||.+.       +..++.++|||||||++|||++ |..||.....++ .....+....    .         ...+.. 
T Consensus       243 aPE~~~-------~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----~---------~~~~~~-  300 (337)
T cd05054         243 APESIF-------DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT----R---------MRAPEY-  300 (337)
T ss_pred             CcHHhc-------CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC----C---------CCCCcc-
Confidence            999764       3467899999999999999998 988886433221 1111111100    0         001111 


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          315 VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       315 ~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                        ....+.+++.+||+.+|++||++.|++++|.++.+
T Consensus       301 --~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         301 --ATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             --CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              11235567888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-42  Score=308.49  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=196.7

Q ss_pred             cccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe-----
Q 037946           67 LKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV-----  137 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  137 (371)
                      |...+.||+|+||.||+|....    +..||+|++............+.+|+..++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567889999999999996532    3679999986544445556789999999999999999999998865544     


Q ss_pred             -EEEEEeecCCCCHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          138 -KLLLYNYISNGNLQQLLQGN------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       138 -~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                       .+++|||+++++|.+++...      ..+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             79999999999999988432      3589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  289 (371)
                      |+++...............++..|+|||.+.       ...++.++||||||+++|||++ |..||....  .....+.+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~~~  228 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYDYL  228 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH
Confidence            9998765443222222334577899999764       3367889999999999999999 777775332  22222222


Q ss_pred             HHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ....    .         ...+..   ....+.+++.+||+.||++|||+.|+++.|.++
T Consensus       229 ~~~~----~---------~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHGN----R---------LKQPED---CLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcCC----C---------CCCCcC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2110    0         111111   122456678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-43  Score=311.39  Aligned_cols=279  Identities=27%  Similarity=0.406  Sum_probs=207.6

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhc--cCCCCceeeeceEecCC----eEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH--IRHRNIVKLLGYCSNKS----VKLL  140 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~l  140 (371)
                      .+..+.||+|.||.||+|.. +++.||||++     ..+..+.|.+|-+|.+.  ++|+||++|+++-....    .+++
T Consensus       212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKif-----p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIF-----PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             hhhHHHhhcCccceeehhhc-cCceeEEEec-----CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            44567899999999999988 5699999998     34566788899888876  48999999999876555    7899


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD------CVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      |++|.+.|+|.++|..+- ++|....+++..+++||+|||+.      ..+.|+|||||.+|||+.+|++..|+|||++.
T Consensus       286 Vt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             EeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            999999999999998765 89999999999999999999974      34689999999999999999999999999999


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      .+............+||.+|||||++.+...... ...-.+.||||+|.+||||+++..-+++....+..+ . +...++
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d-~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql-p-fe~evG  441 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD-RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL-P-FEAEVG  441 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhccccc-HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC-c-hhHHhc
Confidence            8876655555566889999999999987643332 233367899999999999999876553211110000 0 000000


Q ss_pred             C---CCccc-cccCccc-CCCChhhH--HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          295 S---FEPAV-SILDTKL-QGLPDQMV--QEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       295 ~---~~~~~-~~~~~~~-~~~~~~~~--~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      .   .+.+. .++..+. ..+++...  ..+..+-+.+..||..||+.|.|+.=+.+.++++....+.
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            0   00000 0111111 12222221  3344555688889999999999999999999888766654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.4e-43  Score=323.80  Aligned_cols=246  Identities=22%  Similarity=0.298  Sum_probs=194.9

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      +.||+|+||.||++.. .+++.||+|.+..... .......+..|+++++.++||||+++.+++.+.+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999965 4689999999865332 2334567788999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          149 NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       149 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      +|.+++.....+++..+..++.|++.||.|||+ +   +++||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  155 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKT  155 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccccc
Confidence            999999888889999999999999999999997 6   99999999999999999999999999987543222  12234


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||++.       +..++.++|||||||++|+|++|..||.....  ......+   .....          
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i---~~~~~----------  213 (325)
T cd05594         156 FCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELI---LMEEI----------  213 (325)
T ss_pred             ccCCcccCCHHHHc-------cCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHH---hcCCC----------
Confidence            56999999999765       33678899999999999999999999964322  1111111   11100          


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHh
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLM  347 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~  347 (371)
                       ..+....   ..+.+++.+||+.||++|+     ++.+++++-+
T Consensus       214 -~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         214 -RFPRTLS---PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             -CCCCCCC---HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence             0111111   1344577889999999996     8999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.4e-42  Score=325.49  Aligned_cols=256  Identities=23%  Similarity=0.262  Sum_probs=194.7

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            467778999999999999965 4688999999865332 33456778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc--
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY--  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  221 (371)
                      |+++|+|.+++.+...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++........  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            999999999998888899999999999999999999999   999999999999999999999999999754311000  


Q ss_pred             -------------------------------------------ccccccccccccccCCCCccchhhhcccCCCCCcchh
Q 037946          222 -------------------------------------------HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDV  258 (371)
Q Consensus       222 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di  258 (371)
                                                                 ........||+.|+|||.+.+       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di  231 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-------KGYTQLCDW  231 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-------CCCCCccce
Confidence                                                       000123469999999998753       357889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhc--ccCCCCCCC
Q 037946          259 YSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMF--CVNSSPAER  336 (371)
Q Consensus       259 wslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--cl~~dP~~R  336 (371)
                      |||||++|||++|..||........  ...+   ... ...  ..-+.....++    +   +.+++.+  |+..+|..|
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~--~~~i---~~~-~~~--~~~~~~~~~s~----~---~~dli~~ll~~~~~~~~R  296 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTET--QLKV---INW-ENT--LHIPPQVKLSP----E---AVDLITKLCCSAEERLGR  296 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHH--HHHH---Hcc-ccc--cCCCCCCCCCH----H---HHHHHHHHccCcccccCC
Confidence            9999999999999999975432211  1111   100 000  00001111222    2   2233433  667777789


Q ss_pred             CCHHHHHHHH
Q 037946          337 PTMKEVVALL  346 (371)
Q Consensus       337 Ps~~evl~~L  346 (371)
                      |++++++++-
T Consensus       297 ~~~~~~l~hp  306 (381)
T cd05626         297 NGADDIKAHP  306 (381)
T ss_pred             CCHHHHhcCc
Confidence            9999999984

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-44  Score=329.81  Aligned_cols=256  Identities=25%  Similarity=0.300  Sum_probs=200.9

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +|...+.||+|+||.||+|... +++.||+|++..... .......+..|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            5777889999999999999764 689999999865432 22455678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC---
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN---  220 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  220 (371)
                      |+++++|.+++.....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            999999999998888899999999999999999999998   99999999999999999999999999997654432   


Q ss_pred             ------------------------cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 037946          221 ------------------------YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ  276 (371)
Q Consensus       221 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  276 (371)
                                              .........||+.|+|||.+.+       ..++.++|||||||++|||++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-------TPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCceeeEecchhhhhhccCCCCCC
Confidence                                    0011234569999999998753       367899999999999999999999996


Q ss_pred             CCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-HHHHHHHHh
Q 037946          277 PQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-MKEVVALLM  347 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~L~  347 (371)
                      .....  .   ........ ...  ...+.....+       ..+.+++.+|+. ||.+||+ +++++++.+
T Consensus       232 ~~~~~--~---~~~~i~~~-~~~--~~~p~~~~~~-------~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         232 SDTLQ--E---TYNKIINW-KES--LRFPPDPPVS-------PEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             CCCHH--H---HHHHHhcc-CCc--ccCCCCCCCC-------HHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            54321  1   11111110 000  0001001112       233456677997 9999999 999999853

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-42  Score=310.83  Aligned_cols=256  Identities=23%  Similarity=0.398  Sum_probs=196.1

Q ss_pred             HhccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      .++|+..+.||+|+||.||+|...      .+..||+|++... .......++.+|+.+++.++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            356888899999999999998642      3467999987432 222345678999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEE
Q 037946          138 KLLLYNYISNGNLQQLLQGNR----------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL  207 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl  207 (371)
                      .++||||+++++|.+++.+..          .+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532          357788999999999999999998   9999999999999999999999


Q ss_pred             ccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHH
Q 037946          208 ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIV  286 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  286 (371)
                      +|||+++...............+++.|+|||.+.       ...++.++|||||||++|||++ |..||.....  ....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~  231 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVL  231 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhh-------cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence            9999987655443222222334578899999764       3357889999999999999999 6777753321  2222


Q ss_pred             HHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ..+...  ...       ......++       .+.+++.+||+.||++|||+.|+++.|.+
T Consensus       232 ~~~~~~--~~~-------~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         232 RFVMEG--GLL-------DKPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHcC--CcC-------CCCCCCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            221110  000       00111221       34557888999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=301.92  Aligned_cols=259  Identities=24%  Similarity=0.328  Sum_probs=208.6

Q ss_pred             hccccCCccccCCceEEEEE-EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|..-+.||+|.|+.|+++ ..++|+.+|+|.+..........+++.+|++|-+.|+||||+++.....+.+..|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            45666778999999999998 56789999999886555555577889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEccccCccccCCCC
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ++.|++|-.-+-...-+++..+...+.||+.+|.|+|++   +|||||+||+|+++-+   ..-+||+|||++..++...
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            999999976554445578889999999999999999999   9999999999999943   4569999999999887443


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                         .-....|||.|||||++..       .+++..+|||+.||+||-|+.|.+||.+.  +...+.+.+......+..  
T Consensus       168 ---~~~G~~GtP~fmaPEvvrk-------dpy~kpvDiW~cGViLfiLL~G~~PF~~~--~~~rlye~I~~g~yd~~~--  233 (355)
T KOG0033|consen  168 ---AWHGFAGTPGYLSPEVLKK-------DPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYEQIKAGAYDYPS--  233 (355)
T ss_pred             ---ccccccCCCcccCHHHhhc-------CCCCCcchhhhhhHHHHHHHhCCCCCCCc--cHHHHHHHHhccccCCCC--
Confidence               2345679999999998873       48899999999999999999999999753  233444544443322211  


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                          +.....    .+   ..-+|+++||..||.+|.|+.|.+++-|-...
T Consensus       234 ----~~w~~i----s~---~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  234 ----PEWDTV----TP---EAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             ----cccCcC----CH---HHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence                111111    12   23347788999999999999999999877653

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-42  Score=307.40  Aligned_cols=253  Identities=24%  Similarity=0.422  Sum_probs=199.9

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.|+..+.||+|+||.||+|...++..||+|.+...   ....+.+.+|+.++++++|+||+++++.+.+.+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            457788999999999999998878888999987432   23356889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++..  ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999999865  34588899999999999999999999   9999999999999999999999999999876543211


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......++..|+|||.+.       ...++.++||||||+++|+|++ |..||.....  ......+....    .   
T Consensus       160 -~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~----~---  222 (261)
T cd05072         160 -AREGAKFPIKWTAPEAIN-------FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQRGY----R---  222 (261)
T ss_pred             -ccCCCccceecCCHHHhc-------cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCC----C---
Confidence             122334677899999764       3356789999999999999998 8888854321  12222221110    0   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                        .+.....+.       .+.+++.+||+.+|++|||++++.+.|+++
T Consensus       223 --~~~~~~~~~-------~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 --MPRMENCPD-------ELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --CCCCCCCCH-------HHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              011112222       345578889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.7e-42  Score=305.86  Aligned_cols=259  Identities=21%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+.... ........+.+|+++++.++|||++++++++.+.+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            3577888999999999999965 468999999875422 23344567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988852    34588999999999999999999999   999999999999999999999999999886544


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..  .......+++.|+|||.+..       ..++.++|+||||+++|||++|+.||.....+.......+..   . . 
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~-~-  224 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ---C-D-  224 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---C-C-
Confidence            32  11234568899999997652       356789999999999999999999986443222222211111   0 0 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                              ....+..  .....+.+++.+||+.+|++||++.++++.|++++
T Consensus       225 --------~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 --------YPPLPTE--HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --------CCCCChh--hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                    0111111  11233556788899999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-42  Score=306.06  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=194.7

Q ss_pred             ccccCCceEEEEEEe---CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKGCSGVVYKAEM---PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .||+|+||.||+|.+   .++..+|+|++..........+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999954   357889999986544444556789999999999999999999998864 5678999999999


Q ss_pred             CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc-cccc
Q 037946          149 NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH-AMSR  227 (371)
Q Consensus       149 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~  227 (371)
                      +|.+++.....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......... ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999998888899999999999999999999999   99999999999999999999999999998765443111 1122


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ..++..|+|||.+.       ...++.++|+||||+++|||++ |..||.....  ......+...    ..        
T Consensus       158 ~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~----~~--------  216 (257)
T cd05116         158 GKWPVKWYAPECMN-------YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESG----ER--------  216 (257)
T ss_pred             CCCCccccCHhHhc-------cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC----CC--------
Confidence            33467899999764       2356789999999999999998 8888864322  2222222211    00        


Q ss_pred             cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                       ...+.....   .+.+++.+||+.||++||++++|...|.++
T Consensus       217 -~~~~~~~~~---~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 -MECPQRCPP---EMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -CCCCCCCCH---HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence             011111112   344578889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=290.10  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=205.4

Q ss_pred             hccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----CeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----SVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  138 (371)
                      ++|++.+.||+|||+-||.+. ..+++.+|+|++.-  ...+..+..++|++..++++|||+++++.++..+     ...
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c--~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC--HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeec--cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            578889999999999999995 56789999999853  3356678899999999999999999999876433     458


Q ss_pred             EEEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          139 LLLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      |+++.|...|+|.+.+..    ...+++.+++.++.++++||.+||+.. +.+.||||||.|||+++.+.++|.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999998854    335999999999999999999999983 259999999999999999999999999997


Q ss_pred             ccCCCCcc-------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 037946          215 LMNSTNYH-------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       215 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  287 (371)
                      ...-.-..       +.-.....|..|.|||++..+    .....++++|||||||+||+|+.|..||......+..   
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk----~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS---  250 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK----SHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS---  250 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecc----cCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe---
Confidence            64322100       011234578899999998855    2446789999999999999999999999644332111   


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                                ....+..+.++ .|... .....+.+++.+|++.||.+||++.+++..++.+.
T Consensus       251 ----------laLAv~n~q~s-~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  251 ----------LALAVQNAQIS-IPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------EEEeeeccccc-cCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      11112222211 12111 13345667888899999999999999999998765

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-42  Score=316.84  Aligned_cols=259  Identities=23%  Similarity=0.370  Sum_probs=199.1

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCC----EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .|+..+.||+|+||.||+|.+. +++    .||+|.+.. .......+++.+|+.+++.++||||++++|+|... ..++
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc-cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            4777889999999999999753 333    389998843 22334456789999999999999999999999764 5679


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++||+++|+|.+++... ..+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999764 4588999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..........++..|+|||.+.       ...++.++||||||+++|||++ |..||.....  ..+.......    ..
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~~~----~~  229 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESIL-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKG----ER  229 (316)
T ss_pred             CcceeccCCccceeecChHHhc-------cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhCC----CC
Confidence            3222222334567899999765       3467889999999999999998 8888854321  1222211110    00


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .     +....++       ..+..++.+||+.||.+|||+.+++..|.++...+.
T Consensus       230 ~-----~~~~~~~-------~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         230 L-----PQPPICT-------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             C-----CCCCCCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            0     0001111       234567888999999999999999999998876554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.6e-43  Score=322.92  Aligned_cols=256  Identities=23%  Similarity=0.303  Sum_probs=197.6

Q ss_pred             cccCCccccCCceEEEEEEe----CCCCEEEEEEecccCC--CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKR--DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  139 (371)
                      |+..+.||+|+||.||++..    .+++.||+|++.+...  .....+.+..|+.+++.+ +||||+++++++.+.+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            66778999999999999865    3578999999854322  223345678999999999 5999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +||||+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus        82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999765433


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .. .......||+.|+|||.+.+.      ..++.++|||||||++|||++|..||........ ........... .  
T Consensus       159 ~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~-~--  227 (332)
T cd05614         159 EK-ERTYSFCGTIEYMAPEIIRGK------GGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC-D--  227 (332)
T ss_pred             CC-CccccccCCccccCHHHhcCC------CCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC-C--
Confidence            21 122345799999999987532      2357889999999999999999999964332211 11111111111 0  


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHh
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~  347 (371)
                           +.   .+.....   .+.+++.+||+.||++||     ++++++++-+
T Consensus       228 -----~~---~~~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         228 -----PP---FPSFIGP---EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             -----CC---CCCCCCH---HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence                 11   1111111   234577789999999999     7889988743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.9e-43  Score=319.92  Aligned_cols=244  Identities=25%  Similarity=0.342  Sum_probs=193.0

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +++.||+|++.+... .....+.+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999764 588999999864322 234456778888888876 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~  155 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTST  155 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999987543222  12344


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|+|++|..||.....  ..+..   .........       .
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~---~i~~~~~~~-------~  216 (320)
T cd05590         156 FCGTPDYIAPEILQ-------EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--DDLFE---AILNDEVVY-------P  216 (320)
T ss_pred             cccCccccCHHHHc-------CCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHH---HHhcCCCCC-------C
Confidence            57999999999765       33578899999999999999999999964321  12222   111110000       0


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCH------HHHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM------KEVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~~  345 (371)
                      ...+       ..+.+++.+||+.||++||++      ++++++
T Consensus       217 ~~~~-------~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         217 TWLS-------QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCC-------HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            1111       134557788999999999998      777776

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.3e-42  Score=307.51  Aligned_cols=254  Identities=21%  Similarity=0.367  Sum_probs=193.0

Q ss_pred             ccCCccccCCceEEEEEEeCC-CC--EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC------CeE
Q 037946           68 KDENVIGKGCSGVVYKAEMPN-GE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK------SVK  138 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  138 (371)
                      ...+.||+|+||.||+|.+.. +.  .+|+|.+..........+.+..|+.+++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            346789999999999997644 33  589998865444455567889999999999999999999987432      346


Q ss_pred             EEEEeecCCCCHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          139 LLLYNYISNGNLQQLLQG------NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      +++|||+++|+|.+++..      ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999998732      23478999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++...............+++.|+|||.+.       +..++.++||||||+++|||++ |..||...  +...+.+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~  229 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLA-------DRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENSEIYDYLRQ  229 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHcc-------CCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHc
Confidence            98765443221222334677899999764       3357889999999999999999 77777542  22222222221


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .    ...     ......+       ..+.+++.+||+.||++|||++++++.|+++
T Consensus       230 ~----~~~-----~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 G----NRL-----KQPPDCL-------DGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C----CCC-----CCCCCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1    000     0001121       2345688889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-42  Score=306.04  Aligned_cols=256  Identities=24%  Similarity=0.387  Sum_probs=200.2

Q ss_pred             hccccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|.+..    ...||+|.+... ........+.+|+.++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            357788899999999999997642    457999988543 234445678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +|||+++++|.+++... ..+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999998664 4689999999999999999999999   9999999999999999999999999999877532


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..........+++.|+|||.+.       ...++.++||||||+++|+|++ |..||....  .......+......   
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~---  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIA-------YRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAVEDGYRL---  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhc-------cCCCccccchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCCCC---
Confidence            2111222334567899999765       3357889999999999999998 888885432  12222222111000   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                            +.....+       ..+.+++.+||+.+|++||++++++++|.++
T Consensus       228 ------~~~~~~~-------~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ------PPPMDCP-------SALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  0011222       2345678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-43  Score=330.67  Aligned_cols=256  Identities=20%  Similarity=0.273  Sum_probs=194.8

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++.. .+++.||+|++.+... .......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            477788999999999999965 4789999999854322 23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc-
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  222 (371)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.+...... 
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            999999999998888899999999999999999999999   9999999999999999999999999998643211000 


Q ss_pred             -----------c---------------------------------ccccccccccccCCCCccchhhhcccCCCCCcchh
Q 037946          223 -----------H---------------------------------AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDV  258 (371)
Q Consensus       223 -----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di  258 (371)
                                 .                                 ......||+.|+|||++.+       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di  231 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-------QGYGQECDW  231 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-------CCCCCceee
Confidence                       0                                 0012469999999998753       357889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCC--
Q 037946          259 YSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER--  336 (371)
Q Consensus       259 wslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R--  336 (371)
                      |||||++|||++|..||.....  ....   ...... ......  +......       ..+.+++.+|+. +|.+|  
T Consensus       232 wSlGvil~elltG~~Pf~~~~~--~~~~---~~i~~~-~~~~~~--p~~~~~s-------~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENS--HETY---RKIINW-RETLYF--PDDIHLS-------VEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCH--HHHH---HHHHcc-CCccCC--CCCCCCC-------HHHHHHHHHHhc-CHhhcCC
Confidence            9999999999999999964322  1111   111110 000000  0000111       233456777887 67665  


Q ss_pred             -CCHHHHHHHHh
Q 037946          337 -PTMKEVVALLM  347 (371)
Q Consensus       337 -Ps~~evl~~L~  347 (371)
                       +|+.|++++-+
T Consensus       296 r~~~~~~l~hp~  307 (377)
T cd05629         296 RGGAHEIKSHPF  307 (377)
T ss_pred             CCCHHHHhcCCC
Confidence             59999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-43  Score=323.11  Aligned_cols=244  Identities=25%  Similarity=0.324  Sum_probs=192.7

Q ss_pred             CccccCCceEEEEEEe----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           71 NVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      +.||+|+||.||++..    .+|+.+|+|++............+..|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    357899999986543333344567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccc
Q 037946          147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS  226 (371)
Q Consensus       147 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  226 (371)
                      +|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  ....
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~  156 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAY  156 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Ccee
Confidence            999999998888899999999999999999999999   99999999999999999999999999987654332  1223


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ...||+.|+|||.+..       ..++.++|||||||++|||++|+.||.....  ......+   ....          
T Consensus       157 ~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~i---~~~~----------  214 (318)
T cd05582         157 SFCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMTMI---LKAK----------  214 (318)
T ss_pred             cccCChhhcCHHHHcC-------CCCCCccceeccceEeeeeccCCCCCCCCCH--HHHHHHH---HcCC----------
Confidence            4579999999997653       3567899999999999999999999964321  1221111   1110          


Q ss_pred             cCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 037946          307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVAL  345 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~  345 (371)
                       ...+....   ..+.+++.+||+.||++||+     +.+++++
T Consensus       215 -~~~p~~~~---~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         215 -LGMPQFLS---PEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             -CCCCCCCC---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence             01111111   12345778899999999999     5556654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.9e-42  Score=314.24  Aligned_cols=200  Identities=26%  Similarity=0.419  Sum_probs=173.0

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||++... ++..+|+|.+... ........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            46888899999999999999764 5788999987543 233445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+..  +++|+||||+||++++++.+||+|||++.......   
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---  158 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence            9999999999988888999999999999999999999752  79999999999999999999999999987653321   


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                       .....||+.|+|||.+.+       ..++.++|||||||++|+|++|..||...
T Consensus       159 -~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         159 -ANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             -cccCCCCccccCHHHhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence             234468999999997753       35788999999999999999999998644

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-42  Score=321.62  Aligned_cols=203  Identities=27%  Similarity=0.369  Sum_probs=173.5

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++.. .+++.||+|++.+... .......+..|+.++..++||||+++++.+.+....|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            477788999999999999965 4689999999854322 23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc-
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  222 (371)
                      |+++|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            999999999999888899999999999999999999999   9999999999999999999999999998754321100 


Q ss_pred             --------------------------------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh
Q 037946          223 --------------------------------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS  270 (371)
Q Consensus       223 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  270 (371)
                                                      ......+||+.|+|||++.+       ..++.++|||||||++|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-------CCCCCchhhhhhHHHHHHHHh
Confidence                                            00123479999999998753       357889999999999999999


Q ss_pred             CCCCCCCC
Q 037946          271 GRSAVQPQ  278 (371)
Q Consensus       271 g~~p~~~~  278 (371)
                      |..||...
T Consensus       232 G~~Pf~~~  239 (363)
T cd05628         232 GYPPFCSE  239 (363)
T ss_pred             CCCCCCCC
Confidence            99999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.8e-42  Score=311.46  Aligned_cols=247  Identities=23%  Similarity=0.300  Sum_probs=191.3

Q ss_pred             cccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           73 IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        73 ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      ||+|+||+||++.. .+++.||+|.+...... ....+.+..|+++++.++||||+++.+++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999965 46889999998543322 23346678899999999999999999999999999999999999999


Q ss_pred             HHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccc
Q 037946          151 QQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS  226 (371)
Q Consensus       151 ~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  226 (371)
                      .+++.    ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            98874    345689999999999999999999999   999999999999999999999999999976544321  223


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ...||+.|+|||.+.       +..++.++||||||+++|||++|+.||........ ...........          .
T Consensus       156 ~~~g~~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~----------~  217 (280)
T cd05608         156 GYAGTPGFMAPELLQ-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILND----------S  217 (280)
T ss_pred             ccCCCcCccCHHHhc-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhccc----------C
Confidence            457899999999775       33677899999999999999999999965432211 11111111100          0


Q ss_pred             cCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                       ...+...   ...+.+++.+||+.||++||     ++++++++-
T Consensus       218 -~~~~~~~---~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~  258 (280)
T cd05608         218 -VTYPDKF---SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP  258 (280)
T ss_pred             -CCCcccC---CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence             0111111   12344577889999999999     778888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-42  Score=311.46  Aligned_cols=257  Identities=25%  Similarity=0.451  Sum_probs=199.3

Q ss_pred             ccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .|...+.||+|+||.||+|...      ++..+++|.+..  ........+.+|++++++++||||+++++++...+..+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            3666788999999999999642      345688888732  22333467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC
Q 037946          140 LLYNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY  203 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~  203 (371)
                      +||||+++++|.+++....                .+++..++.++.|++.|++|||++   +++||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            9999999999999996532                378999999999999999999999   999999999999999999


Q ss_pred             ceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCc
Q 037946          204 EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDG  282 (371)
Q Consensus       204 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  282 (371)
                      .++|+|||++................++..|+|||.+.+       ..++.++||||||+++|||++ |..||.....  
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--  231 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--  231 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999976554432222234457889999997653       357889999999999999999 8888754322  


Q ss_pred             hhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          283 LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      ....+.+..   .  ...    ......+       ..+.+++.+||+.||++|||++++++.|.++...
T Consensus       232 ~~~~~~~~~---~--~~~----~~~~~~~-------~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         232 TEVIECITQ---G--RVL----ERPRVCP-------KEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHHHHhC---C--CCC----CCCccCC-------HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            122221111   0  000    0011122       2345678889999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-43  Score=328.24  Aligned_cols=255  Identities=23%  Similarity=0.314  Sum_probs=196.2

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            4777889999999999999764 689999999864322 23445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++..+.......
T Consensus        82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            999999999998888899999999999999999999999   99999999999999999999999999987543211000


Q ss_pred             ------------------------------------ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHH
Q 037946          224 ------------------------------------AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLE  267 (371)
Q Consensus       224 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e  267 (371)
                                                          ......||+.|+|||++.       ...++.++|||||||++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-------QTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-------CCCCCCeeeeecchhHHHH
Confidence                                                011246999999999765       3357889999999999999


Q ss_pred             HHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC---HHHHHH
Q 037946          268 ILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT---MKEVVA  344 (371)
Q Consensus       268 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~  344 (371)
                      |++|..||.....  ...   ....... ......  +.....++       .+.+++.+|+. +|.+|++   ++++++
T Consensus       232 l~~G~~Pf~~~~~--~~~---~~~i~~~-~~~~~~--~~~~~~s~-------~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         232 MLVGYPPFCSDNP--QET---YRKIINW-KETLQF--PDEVPLSP-------EAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hhcCCCCCCCCCH--HHH---HHHHHcC-CCccCC--CCCCCCCH-------HHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999964322  111   1111110 000000  00001111       23346666886 9999998   999988


Q ss_pred             HH
Q 037946          345 LL  346 (371)
Q Consensus       345 ~L  346 (371)
                      +-
T Consensus       296 h~  297 (364)
T cd05599         296 HP  297 (364)
T ss_pred             CC
Confidence            74

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.9e-43  Score=326.34  Aligned_cols=260  Identities=23%  Similarity=0.265  Sum_probs=200.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||++.. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            4688889999999999999965 4688999999854322 2233456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++.+. .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........ 
T Consensus       123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-  197 (370)
T cd05596         123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-  197 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence            999999999998764 488999999999999999999999   999999999999999999999999999987644321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||.+....   ....++.++|||||||++|||++|..||......     ............   .
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~~~---~  266 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHKNS---L  266 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCC---CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCCc---C
Confidence            1223457999999999876331   1234788999999999999999999999653221     111111111000   0


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE--RPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L~  347 (371)
                            ..+.. ......+.+++.+|++.+|.+  |||++|++++-+
T Consensus       267 ------~~~~~-~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         267 ------TFPDD-IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             ------CCCCc-CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence                  01110 001123445778899999988  999999998853

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.9e-42  Score=308.45  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=197.6

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCC----EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .|+..+.||+|+||.||+|.+. +++    .+++|.+.. ........++..|+..+++++||||+++++++.. ...++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc-ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            4677789999999999999753 344    477777632 2223344677888889999999999999998864 55788


Q ss_pred             EEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++||+++|+|.+++.. ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||.++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999975 45689999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..........++..|+|||.+.       ++.++.++||||||+++|||++ |..||.....  ....+.+...    ..
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~----~~  229 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESIL-------FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKG----ER  229 (279)
T ss_pred             CcccccCCCCCcccccCHHHhc-------cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCC----Cc
Confidence            3222233445778999999764       3467899999999999999998 9888864322  2222222111    10


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .   ..+  ..++       ..+..++.+||..||++|||+.|+++.|..+...++
T Consensus       230 ~---~~~--~~~~-------~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~  273 (279)
T cd05111         230 L---AQP--QICT-------IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP  273 (279)
T ss_pred             C---CCC--CCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence            0   000  1111       234557778999999999999999999998876553

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=331.54  Aligned_cols=263  Identities=24%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             ccccCCccccCCceEEEEEEeCCC-CEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeece-Ee---c---CC
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNG-ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGY-CS---N---KS  136 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~---~---~~  136 (371)
                      ++++.+.|.+|||+.||.|.+..+ ..||+|++...  ++...+.+.+|+++|+.|. |+|||.+++. ..   .   .-
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            466788999999999999987665 99999998643  7788899999999999995 9999999993 21   1   23


Q ss_pred             eEEEEEeecCCCCHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          137 VKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      .++++||||.||.|-|++.  -+..+++..+++|+.|+++|+++||.. .+.+||||||-+||||+.+|..||||||.+.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            5689999999999999996  344599999999999999999999996 3479999999999999999999999999986


Q ss_pred             ccCCCCc-cccc------ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 037946          215 LMNSTNY-HHAM------SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       215 ~~~~~~~-~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  287 (371)
                      -...... ....      -...-|+.|.|||++.-    -.+..+++|+|||+|||+||-|+....||+...        
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl----ysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------  262 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL----YSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------  262 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhh----hcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence            4322210 0000      12346999999999862    235578999999999999999999999996421        


Q ss_pred             HHHHHhcCCCccccccCcccCCCC-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCC
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLP-DQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELG  357 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  357 (371)
                                 ...+++....-.+ +....   .+-.||..||+.||.+||++-+++..+.++...+..+.
T Consensus       263 -----------~laIlng~Y~~P~~p~ys~---~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~  319 (738)
T KOG1989|consen  263 -----------KLAILNGNYSFPPFPNYSD---RLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP  319 (738)
T ss_pred             -----------ceeEEeccccCCCCccHHH---HHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence                       2234444333222 22233   34447788999999999999999999999877665443

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.1e-42  Score=303.61  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=191.1

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGN  149 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  149 (371)
                      +.||+|+||.||+|... +++.+|+|..... ........+.+|++++++++||||+++++++...+..++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            36899999999999764 6889999987432 234455779999999999999999999999999999999999999999


Q ss_pred             HHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccc
Q 037946          150 LQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV  228 (371)
Q Consensus       150 L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  228 (371)
                      |.+++... ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...............
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99999754 4589999999999999999999999   9999999999999999999999999998765432211111112


Q ss_pred             cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..+..|+|||.+.       +..++.++||||||+++|||++ |..|+.....  ......+..   . ..         
T Consensus       157 ~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~~~~~~---~-~~---------  214 (252)
T cd05084         157 QIPVKWTAPEALN-------YGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTREAIEQ---G-VR---------  214 (252)
T ss_pred             CCceeecCchhhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHHHHHHc---C-CC---------
Confidence            2356799999765       3357889999999999999998 7777753221  111111111   0 00         


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...+...   ...+.+++.+||+.||++|||++++++.|.
T Consensus       215 ~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELC---PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            0111111   124556888899999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.7e-42  Score=320.22  Aligned_cols=201  Identities=27%  Similarity=0.365  Sum_probs=169.4

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC----
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS----  136 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  136 (371)
                      .+.++|+..+.||+|+||.||++.. .+|+.||+|++............+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4567899999999999999999965 45899999998655444555677889999999999999999999886443    


Q ss_pred             --eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          137 --VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       137 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                        ..|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence              57999999976 66666643  478899999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      ......   ......||+.|+|||.+.+       ..++.++|||||||++|+|++|..||...
T Consensus       172 ~~~~~~---~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         172 TACTNF---MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccCc---cCCCCcccCCCCCchhccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            643322   2234568999999998753       36788999999999999999999999744

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-43  Score=325.51  Aligned_cols=260  Identities=21%  Similarity=0.226  Sum_probs=199.9

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            477788999999999999965 4689999999865432 23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++|+|.+++... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999876 6799999999999999999999999   9999999999999999999999999999876543311


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......||+.|+|||++...... ....++.++|||||||++|||++|..||.....  .   ......... ......
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~---~~~~~i~~~-~~~~~~  230 (330)
T cd05601         159 -NSKLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--A---KTYNNIMNF-QRFLKF  230 (330)
T ss_pred             -eeecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeeccCCCCCCCCCH--H---HHHHHHHcC-CCccCC
Confidence             22334689999999987632111 134577899999999999999999999964322  1   111111111 000000


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                        +.....+       ..+.+++.+|++ ||.+|||+++++++-
T Consensus       231 --~~~~~~~-------~~~~~li~~ll~-~p~~R~t~~~l~~h~  264 (330)
T cd05601         231 --PEDPKVS-------SDFLDLIQSLLC-GQKERLGYEGLCCHP  264 (330)
T ss_pred             --CCCCCCC-------HHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence              0001111       223456677997 999999999999873

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-42  Score=304.72  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=198.8

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.|+..+.||+|++|.||+|...+++.||+|.+....   ...+.+.+|+.++++++|||++++++++...+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            4577788999999999999987777889999985432   2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++....  .+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999997644  689999999999999999999999   9999999999999999999999999999876533211


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       .......+..|+|||.+.       ...++.++||||||+++|||++ |..||....  .......+..   . ...  
T Consensus       160 -~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~---~-~~~--  223 (261)
T cd05068         160 -AREGAKFPIKWTAPEAAL-------YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQQVDQ---G-YRM--  223 (261)
T ss_pred             -ccCCCcCceeccCccccc-------cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHc---C-CCC--
Confidence             111222346899999765       3367889999999999999999 888885432  1122221111   1 000  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                         +.....+       ..+.+++.+||+.+|++||+++++++.|+++
T Consensus       224 ---~~~~~~~-------~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 ---PCPPGCP-------KELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---CCCCcCC-------HHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence               0011122       2345577889999999999999999999764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5e-42  Score=306.27  Aligned_cols=257  Identities=23%  Similarity=0.308  Sum_probs=199.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.. .+++.||+|++...  .......+.+|+.++++++||||+++++++...+..++|||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            4588889999999999999975 56889999998532  22334567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......  .
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            999999999998878899999999999999999999999   99999999999999999999999999998664332  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......|++.|+|||.+...    ....++.++|+|||||++|||++|..|+........ ...+     .. .   ...
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~-----~~-~---~~~  227 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVE----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLM-----SK-S---NFQ  227 (267)
T ss_pred             ccCccccCccccCHhHcccc----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heee-----ec-C---CCC
Confidence            12345688999999976422    133467899999999999999999999853321100 0000     00 0   000


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .+.....    ......+.+++.+||+.||++|||+++++++|
T Consensus       228 ~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 PPKLKDK----TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCccc----cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0000000    01122455678889999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-42  Score=310.69  Aligned_cols=253  Identities=23%  Similarity=0.376  Sum_probs=195.4

Q ss_pred             cccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      |...+.||+|+||.||+|...      .+..||+|++.... .....+.+..|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            556678999999999999653      24789999985332 22345678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          141 LYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      ++||+++++|.+++...                ..+++..+..++.|++.||.|||++   +++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            99999999999998421                2478888999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGL  283 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  283 (371)
                      +||+|||+++...............+++.|+|||.+.       ...++.++||||||+++|||++ |..|+.....  .
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~  233 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-------YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--Q  233 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHh-------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--H
Confidence            9999999988765443322333445678999999764       3457889999999999999998 7777754321  2


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ...+.+.....         .+....++.       .+.+++.+||+.+|.+||++++|++.|+.
T Consensus       234 ~~~~~i~~~~~---------~~~~~~~~~-------~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 DVIEMIRNRQV---------LPCPDDCPA-------WVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHcCCc---------CCCCCCCCH-------HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22222221100         001112222       23457778999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=317.17  Aligned_cols=260  Identities=24%  Similarity=0.290  Sum_probs=210.4

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHHHHhccC-CCCceeeeceEecCCe
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSV  137 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  137 (371)
                      +++...|+..+.||.|.||.||++..+ +|+.+|+|.+.+.... ......+.+|+.+|+++. ||||+.+.+++.+...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            455677888999999999999999765 4999999999665432 234578899999999998 9999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC----CceEEccccCc
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK----YEAYLADFGLA  213 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~  213 (371)
                      +++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.   +++||||||+|+|+...    +.+|++|||++
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999999998766 499999999999999999999999   99999999999999543    47999999999


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      ......   ......+||+.|+|||++..       ..++..+|+||+||++|.|++|.+||..........  .+....
T Consensus       187 ~~~~~~---~~~~~~~Gtp~y~APEvl~~-------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--~i~~~~  254 (382)
T KOG0032|consen  187 KFIKPG---ERLHTIVGTPEYVAPEVLGG-------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--AILRGD  254 (382)
T ss_pred             eEccCC---ceEeeecCCccccCchhhcC-------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--HHHcCC
Confidence            987763   35577899999999998763       478999999999999999999999998765432221  111111


Q ss_pred             cCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .      ...+    ...+..   ....-+++..|+..||.+|+|+.++++|-|--
T Consensus       255 ~------~f~~----~~w~~i---s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  255 F------DFTS----EPWDDI---SESAKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             C------CCCC----CCcccc---CHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence            0      1111    111111   22333477889999999999999999997733

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.3e-42  Score=315.73  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=194.0

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +++.||+|++..... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999764 578999999865332 234456678899998866 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  .....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~  155 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTT  155 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999987543322  12234


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|||++|..||.....  ....   ..........     +  
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~~---~~i~~~~~~~-----p--  216 (321)
T cd05591         156 FCGTPDYIAPEILQ-------ELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDLF---ESILHDDVLY-----P--  216 (321)
T ss_pred             cccCccccCHHHHc-------CCCCCCccceechhHHHHHHhcCCCCCCCCCH--HHHH---HHHHcCCCCC-----C--
Confidence            56999999999765       33678899999999999999999999964322  1221   1111110000     0  


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCC-------CHHHHHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERP-------TMKEVVALL  346 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-------s~~evl~~L  346 (371)
                      ...+       ..+.+++.+||+.||++||       ++++++++-
T Consensus       217 ~~~~-------~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp  255 (321)
T cd05591         217 VWLS-------KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP  255 (321)
T ss_pred             CCCC-------HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence            0111       2345577889999999999       889998774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.5e-42  Score=308.73  Aligned_cols=254  Identities=24%  Similarity=0.449  Sum_probs=196.6

Q ss_pred             ccccCCccccCCceEEEEEEe-----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .|+..+.||+|+||.||+|..     ..+..+|+|.+... ........+.+|+.+++.++||||+++++++...+..|+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            466678999999999999964     24678999998542 223445678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC
Q 037946          141 LYNYISNGNLQQLLQGN-----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY  203 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~  203 (371)
                      +|||+++++|.+++...                 ..+++..+..++.|++.||.|||++   +++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            99999999999998422                 2378889999999999999999999   999999999999999999


Q ss_pred             ceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCc
Q 037946          204 EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDG  282 (371)
Q Consensus       204 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  282 (371)
                      .+||+|||+++...............++..|+|||.+.       ...++.++||||||+++|||++ |..||....  .
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~  232 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-------YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--N  232 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhc-------cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--H
Confidence            99999999998764443222233445677899999764       3357889999999999999998 888875432  1


Q ss_pred             hhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          283 LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ..+.+.+....    ..     +.....+.       .+.+++.+||+.||++||++.+++++|..
T Consensus       233 ~~~~~~~~~~~----~~-----~~~~~~~~-------~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMVRKRQ----LL-----PCSEDCPP-------RMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHcCC----cC-----CCCCCCCH-------HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            22222222110    00     01112222       33457777999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-42  Score=316.83  Aligned_cols=244  Identities=25%  Similarity=0.369  Sum_probs=189.2

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|.. .+++.||+|.+..... .....+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999975 4578999999865432 223345566677777654 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~  155 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST  155 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999997643322  12344


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|||++|..||.....  ..+.   ...... .       +  
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~---~~i~~~-~-------~--  213 (316)
T cd05592         156 FCGTPDYIAPEILK-------GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELF---DSILND-R-------P--  213 (316)
T ss_pred             ccCCccccCHHHHc-------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHcC-C-------C--
Confidence            57999999999775       33578899999999999999999999964322  1211   111111 0       0  


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHH-HHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK-EVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~~  345 (371)
                       ..+...   ...+.+++.+||+.||++||++. +++++
T Consensus       214 -~~~~~~---~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         214 -HFPRWI---SKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             -CCCCCC---CHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence             011111   11234577789999999999865 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.9e-42  Score=318.16  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=194.0

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||++.. .+++.||+|++.+... .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999965 4688999999965432 233456688999999988 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~  155 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTST  155 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999987532221  12344


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC---chhHHHHHHHHhcCCCccccccC
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD---GLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..||+.|+|||++.+       ..++.++|||||||++|+|++|..||......   .....++.......         
T Consensus       156 ~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         156 FCGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             ccCCccccCHHHHcC-------CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            679999999998753       35788999999999999999999999532111   11111111111111         


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC------HHHHHHH
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT------MKEVVAL  345 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~evl~~  345 (371)
                       .....+...   ...+.+++.+||+.||.+||+      +++++++
T Consensus       220 -~~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 -KQIRIPRSL---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -CCCCCCCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             001111111   123455778899999999997      7888876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-42  Score=318.10  Aligned_cols=248  Identities=23%  Similarity=0.311  Sum_probs=194.4

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCC-CceeeeceEecCCeEEEEEe
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHR-NIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e  143 (371)
                      |+..+.||+|+||.||+|... +++.||+|++..... .....+.+..|.+++..++|+ +|+++++++.+.+..|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            666789999999999999654 578999999865432 234456788999999999765 57888999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.......  .
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  156 (324)
T cd05587          82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--K  156 (324)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--C
Confidence            999999999998888899999999999999999999999   99999999999999999999999999987532221  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......||+.|+|||++.+       ..++.++|||||||++|||++|..||.....  ......+.   ....      
T Consensus       157 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~---~~~~------  218 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQSIM---EHNV------  218 (324)
T ss_pred             ceeeecCCccccChhhhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHH---cCCC------
Confidence            2234579999999998753       3578899999999999999999999964322  22221111   1100      


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM-----KEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~  345 (371)
                           ..+....   ..+.+++.+||+.||.+|++.     ++++++
T Consensus       219 -----~~~~~~~---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         219 -----SYPKSLS---KEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -----CCCCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 1111111   134557788999999999976     677765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.1e-42  Score=317.42  Aligned_cols=248  Identities=25%  Similarity=0.349  Sum_probs=191.3

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHH---hccCCCCceeeeceEecCCeEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQIL---GHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      |+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+..|.+++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            45567899999999999965 4689999999865332 233445667776655   567899999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++++|..++.. ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-  155 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence            999999999998865 4599999999999999999999999   99999999999999999999999999987533222 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       .......||+.|+|||.+.+       ..++.++|||||||++|||++|..||.....  .....   ..... ..   
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~G~~pf~~~~~--~~~~~---~i~~~-~~---  218 (324)
T cd05589         156 -DRTSTFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--EEVFD---SIVND-EV---  218 (324)
T ss_pred             -CcccccccCccccCHhHhcC-------CCCCcccchhhHHHHHHHHHhCCCCCCCCCH--HHHHH---HHHhC-CC---
Confidence             22345679999999998753       3578899999999999999999999864321  11111   11111 00   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                             ..+....   ..+.+++.+||+.||.+||     ++.+++++-
T Consensus       219 -------~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         219 -------RYPRFLS---REAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             -------CCCCCCC---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence                   0111111   2234577889999999999     688887764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.7e-42  Score=304.13  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=195.5

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .|+..+.||+|+||.||.|...++..+|+|.+....   .....+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            467778899999999999987666779999885322   23467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      .+++|.+++... ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++........ .
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence            999999999764 4689999999999999999999999   9999999999999999999999999998765443321 1


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....++..|+|||.+.       +..++.++||||||+++|+|++ |..||.....  ......+......        
T Consensus       158 ~~~~~~~~~y~~pe~~~-------~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~--------  220 (256)
T cd05113         158 SVGSKFPVRWSPPEVLL-------YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKVSQGLRL--------  220 (256)
T ss_pred             cCCCccChhhCCHHHHh-------cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHhcCCCC--------
Confidence            12233567899999764       3357889999999999999998 8888753321  1222222111100        


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                       ......       ...+.+++.+||+.||.+||++.++++.|+
T Consensus       221 -~~~~~~-------~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 -YRPHLA-------SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCC-------CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             000111       124456778899999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-42  Score=316.53  Aligned_cols=244  Identities=25%  Similarity=0.353  Sum_probs=190.5

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +|+.||+|.+..... ..........|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999764 688999999865432 123445667788888754 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST  155 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence            99999998888899999999999999999999999   99999999999999999999999999987432221  12345


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|||++|..||....  ...+.+.+..   . .       +  
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--~~~~~~~~~~---~-~-------~--  213 (316)
T cd05620         156 FCGTPDYIAPEILQ-------GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--EDELFESIRV---D-T-------P--  213 (316)
T ss_pred             cCCCcCccCHHHHc-------CCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHh---C-C-------C--
Confidence            67999999999775       3367889999999999999999999996432  2222222211   1 0       0  


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCH-HHHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM-KEVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-~evl~~  345 (371)
                       ..+...   ...+.+++.+||+.||++||++ ++++++
T Consensus       214 -~~~~~~---~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         214 -HYPRWI---TKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             -CCCCCC---CHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence             111111   1134457788999999999997 467644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=311.97  Aligned_cols=254  Identities=25%  Similarity=0.315  Sum_probs=197.2

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      |+..+.||+|+||.||++.. .+++.||+|++...... ......+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            66678899999999999975 46899999998543322 22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            9999999888543  4589999999999999999999999   99999999999999999999999999998654332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......|++.|+|||.+.       +..++.++||||+|+++|||++|..||......  ...+.+......       
T Consensus       157 -~~~~~~~~~~y~aPE~~~-------~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~~~~~~~~-------  219 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVK-------NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREEVERRVKE-------  219 (285)
T ss_pred             -ccccccCCCCccCcHHhc-------CCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHHHHHHhhh-------
Confidence             223446899999999765       335788999999999999999999999753321  111111111111       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHhc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLME  348 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~~  348 (371)
                         .....+...   ...+.+++.+||+.||++||     ++++++++-+-
T Consensus       220 ---~~~~~~~~~---~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05605         220 ---DQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF  264 (285)
T ss_pred             ---cccccCccc---CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence               001111111   12334578889999999999     89999887443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=307.20  Aligned_cols=262  Identities=25%  Similarity=0.388  Sum_probs=196.0

Q ss_pred             hccccCCccccCCceEEEEEEeCC---------------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN---------------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL  129 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  129 (371)
                      ++|+..+.||+|+||.||++....               ...||+|.+... ........+.+|++++++++|||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            467888999999999999986532               235899988543 2334456789999999999999999999


Q ss_pred             ceEecCCeEEEEEeecCCCCHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 037946          130 GYCSNKSVKLLLYNYISNGNLQQLLQGN------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNI  197 (371)
Q Consensus       130 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Ni  197 (371)
                      +++...+..++||||+++++|.+++...            ..+++..++.++.|++.||+|||++   +++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            9999999999999999999999998543            2368889999999999999999999   999999999999


Q ss_pred             eEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh--CCCCC
Q 037946          198 LLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS--GRSAV  275 (371)
Q Consensus       198 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~--g~~p~  275 (371)
                      ++++++.+||+|||++................++..|+|||.+.       +..++.++||||||+++|+|++  |..||
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlG~~l~el~~~~~~~p~  233 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-------LGKFTTASDVWAFGVTLWEMFTLCKEQPY  233 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc-------cCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999997654433222223344577899999764       3457899999999999999998  45565


Q ss_pred             CCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          276 QPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      .....  ......+..........  .........+       ..+.+++.+||+.||++|||+++|++.|.+
T Consensus       234 ~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~-------~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         234 SLLSD--EQVIENTGEFFRNQGRQ--IYLSQTPLCP-------SPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             cccCh--HHHHHHHHHhhhhcccc--ccCCCCCCCC-------HHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            43221  22222111111110000  0000011111       245668888999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-42  Score=318.91  Aligned_cols=250  Identities=23%  Similarity=0.349  Sum_probs=193.0

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +++.||+|.+.+... .......+..|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999754 578999999865432 233455678899888876 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~  155 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTST  155 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999987533221  12234


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC---chhHHHHHHHHhcCCCccccccC
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD---GLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|||++|..||......   ......++........       
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------  221 (329)
T cd05618         156 FCGTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------  221 (329)
T ss_pred             ccCCccccCHHHHc-------CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------
Confidence            57999999999775       336788999999999999999999998532111   1111122211111100       


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC------HHHHHHH
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT------MKEVVAL  345 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~evl~~  345 (371)
                         ...|...   ...+.+++.+||+.||++||+      +.+++++
T Consensus       222 ---~~~p~~~---~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 ---IRIPRSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---CCCCCCC---CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               1111111   123445788899999999998      5787776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.2e-43  Score=326.93  Aligned_cols=203  Identities=26%  Similarity=0.318  Sum_probs=171.8

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            467788999999999999965 4688999999854322 23445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc--
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY--  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  221 (371)
                      |+++|+|.+++.+.+.+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++..+.....  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            999999999998888899999999999999999999999   999999999999999999999999999753211000  


Q ss_pred             -------------------------------------------ccccccccccccccCCCCccchhhhcccCCCCCcchh
Q 037946          222 -------------------------------------------HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDV  258 (371)
Q Consensus       222 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di  258 (371)
                                                                 ........||+.|+|||++.+       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di  231 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDW  231 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-------CCCCCeeeE
Confidence                                                       000123469999999998753       357889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCC
Q 037946          259 YSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       259 wslG~~l~el~~g~~p~~~~  278 (371)
                      |||||++|||++|..||...
T Consensus       232 wSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             EechHHHHHHHhCCCCCCCC
Confidence            99999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.3e-42  Score=316.26  Aligned_cols=244  Identities=26%  Similarity=0.338  Sum_probs=193.5

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +++.||+|++.+... .......+..|..+++.+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 578999999865432 234456778899999888 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||++.......  .....
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTST  155 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999986532221  12234


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|+|++|..||....  ......   ........    .   .
T Consensus       156 ~~g~~~y~aPE~~~-------~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--~~~~~~---~i~~~~~~----~---~  216 (318)
T cd05570         156 FCGTPDYIAPEILS-------YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--EDELFQ---SILEDEVR----Y---P  216 (318)
T ss_pred             eecCccccCHHHhc-------CCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--HHHHHH---HHHcCCCC----C---C
Confidence            56899999999775       3367889999999999999999999996432  112211   11111000    0   0


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM-----KEVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~  345 (371)
                      ...+       ..+.+++.+||+.||.+|||+     .+++++
T Consensus       217 ~~~~-------~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLS-------KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCC-------HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            1111       234567888999999999999     888876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3e-41  Score=305.79  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=200.0

Q ss_pred             hccccCCccccCCceEEEEEEeCC-----------------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCcee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-----------------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK  127 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  127 (371)
                      ++|+..+.||+|+||.||+|....                 +..||+|.+.... .......+.+|++++++++|||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            467888999999999999986532                 2458999885432 2345678899999999999999999


Q ss_pred             eeceEecCCeEEEEEeecCCCCHHHHhccCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 037946          128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-----------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNN  196 (371)
Q Consensus       128 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  196 (371)
                      +++++...+..+++||++++++|.+++....           .+++..++.++.|++.||+|||++   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999999999999999999999997655           689999999999999999999999   99999999999


Q ss_pred             eeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh--CCCC
Q 037946          197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS--GRSA  274 (371)
Q Consensus       197 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~--g~~p  274 (371)
                      |+++.++.++|+|||+++...............+++.|+|||.+.       ...++.++||||||+++|||++  |..|
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~~~~~~~p  233 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-------LGKFTTKSDVWAFGVTLWEILTLCREQP  233 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-------cCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence            999999999999999998665443323334455778999999764       2357889999999999999998  5566


Q ss_pred             CCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          275 VQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      +....  .................  ....+.....+       ..+.+++.+||+.||++|||+.||++.|++
T Consensus       234 ~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-------~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         234 YEHLT--DQQVIENAGHFFRDDGR--QIYLPRPPNCP-------KDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             CCCcC--hHHHHHHHHhccccccc--cccCCCccCCC-------HHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            64221  22222222221111000  00001111111       245668888999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-41  Score=303.42  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=196.6

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|...+.||+|++|.||+|.+. .++.||+|.+..   +......+.+|+++++.++|||++++++++...+..+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecC---CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            4666788999999999999654 588999998743   233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999998653  3589999999999999999999999   9999999999999999999999999999876543211


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......++..|+|||.+.       +..++.++||||||+++|||++ |..|+....  .........   .....   
T Consensus       161 -~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~---~~~~~---  224 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLA-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLE---KGYRM---  224 (263)
T ss_pred             -ccCCCCCccccCCHHHhc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHH---CCCCC---
Confidence             112223466899999664       3367889999999999999998 888875432  122211111   11000   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                         ......+       ..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       225 ---~~~~~~~-------~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ---ERPEGCP-------PKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---CCCCCCC-------HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               0011222       2345577889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-41  Score=307.03  Aligned_cols=267  Identities=26%  Similarity=0.375  Sum_probs=195.1

Q ss_pred             ccCCccccCCceEEEEEEe-----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEEE
Q 037946           68 KDENVIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKLL  140 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  140 (371)
                      ...+.||+|+||.||.+..     .++..||+|.+.... .......+.+|+++++.++||||+++++++...  ...++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            7778999999999988642     357789999985432 223456788999999999999999999987653  46789


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      +|||+++++|.+++... .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.......
T Consensus        86 v~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            99999999999999765 499999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccc-cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          221 YHHA-MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       221 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .... .....++..|+|||.+.       +..++.++||||||+++|||++|..|+.................. .....
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~-------~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~  233 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLK-------ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-TVVRL  233 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhc-------ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc-chhhh
Confidence            1111 12234567799999764       335788999999999999999999997543221111110000000 00000


Q ss_pred             ccccCccc-CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          300 VSILDTKL-QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       300 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ....+... ...+...   ...+.+++..||+.||++|||++++++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNC---PQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCC---CHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00011100 0111111   124556788899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.2e-42  Score=321.36  Aligned_cols=268  Identities=21%  Similarity=0.304  Sum_probs=199.7

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-----eEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-----VKLL  140 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  140 (371)
                      |+..+.||+|+||.||++.. .+++.||+|++............+.+|+++++.++||||+++++++...+     ..|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            56678999999999999975 47899999998544334445567899999999999999999999998776     7899


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||||+. ++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......
T Consensus        82 v~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          82 VTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             Eeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            999996 48999888888899999999999999999999999   99999999999999999999999999998654332


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc-
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA-  299 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  299 (371)
                       ........+|+.|+|||.+.+.      ..++.++|||||||++|||++|+.||.....  ......+....+..... 
T Consensus       158 -~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         158 -SKHMTQEVVTQYYRAPEILMGS------RHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             -cccCCCCCcCCCcCCHHHHcCC------CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCHHH
Confidence             1122344688999999976532      2467899999999999999999999965432  12222222211110000 


Q ss_pred             --------ccccCcccCCCCh--hh----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 --------VSILDTKLQGLPD--QM----VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 --------~~~~~~~~~~~~~--~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                              ...+.......+.  ..    ......+.+++.+||+.||++|||+.|++++-+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  290 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY  290 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence                    0000000000000  00    001224566888999999999999999998743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=323.38  Aligned_cols=266  Identities=27%  Similarity=0.377  Sum_probs=209.8

Q ss_pred             ccHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecC
Q 037946           58 FTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK  135 (371)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  135 (371)
                      |.-++....|...+.||.|+||.||-|++ .+.+.||||++.-+.. +.+..++++.|+..|++++|||++.+-|+|...
T Consensus        19 F~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   19 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             HccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            34455566788888999999999999964 5788999999854332 344568899999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          136 SVKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      .+.|+|||||-| +-.|++.- .+++.+-.+..|+.+.+.||+|||+.   +.||||||+.|||+++.|.|||+|||.+.
T Consensus        99 ~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAs  174 (948)
T KOG0577|consen   99 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSAS  174 (948)
T ss_pred             chHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchh
Confidence            999999999965 88888864 34588899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ...+.      ++++|||+|||||++.    .-..+.|+-++||||||++..||.-+++|......  ..-.-.+...  
T Consensus       175 i~~PA------nsFvGTPywMAPEVIL----AMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQN--  240 (948)
T KOG0577|consen  175 IMAPA------NSFVGTPYWMAPEVIL----AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQN--  240 (948)
T ss_pred             hcCch------hcccCCccccchhHhe----eccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHhc--
Confidence            76544      5678999999999987    34567899999999999999999999999764321  1111111111  


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                        .      .+.+..  +   .....+..++..||++-|.+|||..+++.+-.-....|+
T Consensus       241 --e------sPtLqs--~---eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  241 --E------SPTLQS--N---EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             --C------CCCCCC--c---hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence              1      111111  1   112233446677999999999999999998665554443

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.6e-42  Score=323.15  Aligned_cols=260  Identities=22%  Similarity=0.263  Sum_probs=196.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||++... +++.+|+|.+.+... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888899999999999999764 578999999854322 2233456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++... .+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++........ 
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-  197 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-  197 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence            999999999999765 589999999999999999999999   999999999999999999999999999987644321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||++....   ....++.++|||||||++|||++|..||.....  .   .............   
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~---~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--~---~~~~~i~~~~~~~---  266 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--V---GTYSKIMDHKNSL---  266 (370)
T ss_pred             eecccCCCCcccCCHHHHhccC---CCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--H---HHHHHHHhCCccc---
Confidence            1223567999999999875321   122467899999999999999999999964321  1   1111111110000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE--RPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L~  347 (371)
                            ..+.. ......+.+++.+|+..++.+  ||++.|++++-+
T Consensus       267 ------~~p~~-~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         267 ------NFPED-VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             ------CCCCc-ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence                  01110 001112334566688755543  899999999854

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.8e-42  Score=317.77  Aligned_cols=244  Identities=26%  Similarity=0.310  Sum_probs=188.8

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHH-HHhccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQ-ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999764 689999999854322 2223344555554 56789999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTST  155 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccccc
Confidence            99999999888899999999999999999999999   99999999999999999999999999987543222  12344


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||++.       +..++.++|||||||++|||++|..||.....  .   +...........    ..   
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~---~~~~~i~~~~~~----~~---  216 (323)
T cd05575         156 FCGTPEYLAPEVLR-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--A---EMYDNILNKPLR----LK---  216 (323)
T ss_pred             ccCChhhcChhhhc-------CCCCCccccccccchhhhhhhcCCCCCCCCCH--H---HHHHHHHcCCCC----CC---
Confidence            57999999999775       33578899999999999999999999864321  1   222222111000    00   


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCH----HHHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM----KEVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~evl~~  345 (371)
                      ...+       ..+.+++.+||+.||.+||++    .+++++
T Consensus       217 ~~~~-------~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         217 PNIS-------VSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             CCCC-------HHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence            1111       234457788999999999987    466654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.9e-42  Score=314.31  Aligned_cols=244  Identities=24%  Similarity=0.341  Sum_probs=190.3

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhc-cCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGH-IRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +++.||+|.+..... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999764 578999999865422 22334566778888876 4999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCT  155 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceee
Confidence            99999998888899999999999999999999999   99999999999999999999999999987532221  12234


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|||++|..||....  ...+...+..   . .       +..
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i~~---~-~-------~~~  215 (316)
T cd05619         156 FCGTPDYIAPEILL-------GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSIRM---D-N-------PCY  215 (316)
T ss_pred             ecCCccccCHHHHc-------CCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh---C-C-------CCC
Confidence            56999999999775       3357889999999999999999999986432  1222222111   0 0       000


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHH-HHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK-EVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~~  345 (371)
                      ....+      ..+.+++.+||+.||++||++. ++.++
T Consensus       216 ~~~~~------~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         216 PRWLT------REAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             CccCC------HHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence            11111      1344577889999999999996 67654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.1e-43  Score=327.53  Aligned_cols=256  Identities=23%  Similarity=0.268  Sum_probs=193.7

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++.. .+++.||+|.+..... .......+.+|+++++.++||||+++++.+.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            477788999999999999965 4689999999854322 22345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC---
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN---  220 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  220 (371)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++..+....   
T Consensus        82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            999999999998888899999999999999999999999   99999999999999999999999999975321000   


Q ss_pred             --------------------------------------cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHH
Q 037946          221 --------------------------------------YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYG  262 (371)
Q Consensus       221 --------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  262 (371)
                                                            .........||+.|+|||++.+       ..++.++||||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG  231 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDWWSVG  231 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-------CCCCcceeeeecc
Confidence                                                  0000113469999999998753       3568899999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC---CH
Q 037946          263 VVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP---TM  339 (371)
Q Consensus       263 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP---s~  339 (371)
                      |++|||++|..||......  ...   ...... .....  .+.....+.    .   +.+++.+|+ .+|.+|+   |+
T Consensus       232 vilyell~G~~Pf~~~~~~--~~~---~~i~~~-~~~~~--~~~~~~~s~----~---~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         232 VILYEMLVGQPPFLADTPA--ETQ---LKVINW-ETTLH--IPSQAKLSR----E---ASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             ceeeehhhCCCCCCCCCHH--HHH---HHHhcc-Ccccc--CCCCCCCCH----H---HHHHHHHHh-cCHhhcCCCCCH
Confidence            9999999999999654321  111   111110 00000  000111221    2   223444455 4999999   99


Q ss_pred             HHHHHHHh
Q 037946          340 KEVVALLM  347 (371)
Q Consensus       340 ~evl~~L~  347 (371)
                      .+++++-+
T Consensus       296 ~ell~h~~  303 (376)
T cd05598         296 DEIKAHPF  303 (376)
T ss_pred             HHHhCCCC
Confidence            99998843

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.1e-42  Score=308.80  Aligned_cols=257  Identities=26%  Similarity=0.423  Sum_probs=198.9

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      ++|+..+.||+|+||.||++...      ....+|+|.+.... .......+.+|+.+++++ +||||+++++++...+.
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            35777889999999999999653      23679999885432 233456788999999999 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhcc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC
Q 037946          138 KLLLYNYISNGNLQQLLQG----------------NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS  201 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~----------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~  201 (371)
                      .+++|||+++|+|.+++..                ...+++..++.++.|++.||+|||+.   +++||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            9999999999999999853                34588999999999999999999999   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 037946          202 KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG  280 (371)
Q Consensus       202 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~  280 (371)
                      ++.+||+|||+++...............++..|+|||.+.       +..++.++|||||||++|||++ |..|+.....
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhc-------cCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            9999999999998765543222223334567899999764       3367889999999999999998 8888753221


Q ss_pred             CchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          281 DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                        .........   . ..         ...+..   ....+.+++.+||+.||++|||+.|+++.|..+.
T Consensus       241 --~~~~~~~~~---~-~~---------~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 --EELFKLLKE---G-YR---------MEKPQN---CTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHHHc---C-Cc---------CCCCCC---CCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              122221111   1 00         001111   1124556888899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.9e-42  Score=303.28  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=200.3

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ..|+..+.||.|+||.||+|...+++.+|+|.+...  .......+..|+.+++.++|||++++++++.+.+..++||||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            347778899999999999998877899999998543  222456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.+||+|||.+........ 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            9999999999753  4589999999999999999999999   999999999999999999999999999977644321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......++..|+|||.+.       ...++.++||||||+++|+|++ |..||....  .......+..   ....   
T Consensus       160 -~~~~~~~~~~~~~PE~~~-------~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~---~~~~---  223 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAAS-------HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQITA---GYRM---  223 (261)
T ss_pred             -cccCCCCceEecCHHHHc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHHh---CCcC---
Confidence             122344677899999764       3357789999999999999998 788885432  1222222221   1000   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                         +.....+       ..+.+++.+||+.||++|||++++++.|+.+
T Consensus       224 ---~~~~~~~-------~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ---PCPAKCP-------QEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---CCCCCCC-------HHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               0011122       2344677889999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=301.34  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=194.1

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .|+..+.||+|+||.||+|.+.++..+|+|.+....   .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            366778999999999999988777789999874322   23356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++++|.+++.. ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||+++........ .
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~  157 (256)
T cd05059          82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S  157 (256)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence            99999999865 34689999999999999999999999   9999999999999999999999999999765433211 1


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....++..|+|||.+.       +..++.++||||||+++|+|++ |..||.....  ......+....   ..     
T Consensus       158 ~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~---~~-----  220 (256)
T cd05059         158 SQGTKFPVKWAPPEVFD-------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVESVSAGY---RL-----  220 (256)
T ss_pred             cCCCCCCccccCHHHhc-------cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHHHcCC---cC-----
Confidence            11222456799999765       3357789999999999999999 7888754321  22222111110   00     


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                       ......+       ..+.+++.+||+.+|++|||+.|+++.|
T Consensus       221 -~~~~~~~-------~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 -YRPKLAP-------TEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCCCCCC-------HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             0001112       2455688889999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.6e-41  Score=300.90  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=199.4

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|++|.||+|.. .+++.|++|.+............+.+|+++++.++|||++++++++.+.+..|+||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            55667899999999999965 46899999998654445556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          146 SNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       146 ~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ++++|.+++...  ..+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--  156 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--  156 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc--
Confidence            999999999764  5689999999999999999999999   999999999999999999999999999887654431  


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......|++.|+|||.+.       +..++.++|+||||+++|+|++|..||....  ......   .....        
T Consensus       157 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~---~~~~~--------  216 (256)
T cd08529         157 FANTIVGTPYYLSPELCE-------DKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALIL---KIIRG--------  216 (256)
T ss_pred             hhhccccCccccCHHHhc-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHH---HHHcC--------
Confidence            223456889999999764       3357789999999999999999999986432  111111   11111        


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        .....+.   .....+.+++.+||+.+|++||++.+++++
T Consensus       217 --~~~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 --VFPPVSQ---MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --CCCCCcc---ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence              1111111   111234567888999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=300.83  Aligned_cols=248  Identities=27%  Similarity=0.466  Sum_probs=198.1

Q ss_pred             CccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           71 NVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      +.||+|+||.||+|....    +..+++|.+....... ..+.+.+|++.++.++|+|++++++++.+....+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            368999999999997643    7889999986543332 46789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          147 NGNLQQLLQGN---------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       147 ~~~L~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      +++|.+++...         ..+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999875         7799999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ............+++.|+|||.+..       ..++.++||||||+++|+|++ |..||....  ...+.+.+..   . 
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~---~-  223 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD-------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRK---G-  223 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc-------CCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHc---C-
Confidence            5432222344567889999997652       267889999999999999999 588876442  2222222221   1 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .         ....+...   ...+.+++.+||+.||++|||+.+++++|+
T Consensus       224 ~---------~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 Y---------RLPKPEYC---PDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C---------CCCCCccC---ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0         00111111   224556788899999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-41  Score=309.91  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=198.0

Q ss_pred             hccccCCccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  135 (371)
                      +.|...+.||+|+||.||++...        +...+|+|.+.... .......+..|+.+++.+ +||||+++++++...
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            46888999999999999999642        23469999885432 234456788999999999 799999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      +..|+||||+++|+|.+++...+                .+++..+..++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            99999999999999999997532                478899999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||.++...............+++.|+|||.+.       +..++.++|||||||++|||++ |..||...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~~~g~~p~~~~  246 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  246 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc-------cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            999999999999987654432211122233557899999764       3357889999999999999998 77777432


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      .  ...+...+..   . ..         ...+...   ...+.+++.+||+.+|++|||+.++++.|.++..
T Consensus       247 ~--~~~~~~~~~~---~-~~---------~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         247 P--VEELFKLLKE---G-HR---------MDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             C--HHHHHHHHHc---C-CC---------CCCCCcC---CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            1  1122111111   1 00         0111111   1234457888999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=305.30  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=197.6

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|+..+.||+|+||.||+|...      .+..||+|.+.... .......+.+|+.+++.++|||++++++++......
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            45777889999999999999653      23689999974322 233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEc
Q 037946          139 LLLYNYISNGNLQQLLQGN----------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLA  208 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  208 (371)
                      ++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            9999999999999998642          2367889999999999999999999   99999999999999999999999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  287 (371)
                      |||+++...............++..|+|||.+.       +..++.++||||||+++|||++ |..||....  ......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~  232 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-------DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEVLK  232 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHh-------cCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHHHHH
Confidence            999998665443222223445688999999764       3357889999999999999998 888875322  222222


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .+..   . .         ....+...   ...+.+++.+||+.+|++|||+.++++.|+
T Consensus       233 ~~~~---~-~---------~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVID---G-G---------HLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHhc---C-C---------CCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            2221   0 0         00111111   124456888899999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.2e-42  Score=317.85  Aligned_cols=201  Identities=25%  Similarity=0.355  Sum_probs=169.7

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----  135 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  135 (371)
                      .+.++|+..+.||+|+||.||++.. ..++.||+|++............+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4567899999999999999999965 4688999999865544455567788999999999999999999987543     


Q ss_pred             -CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          136 -SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                       ...|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence             357999999976 67776653  488999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      ......   ......||+.|+|||.+.+       ..++.++|||||||++|+|++|..||...
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             cCCCcc---ccCCccccCCccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            654432   2234568999999998753       35788999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-41  Score=314.40  Aligned_cols=270  Identities=22%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC---
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK---  135 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---  135 (371)
                      ..++.++|...+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            345667899999999999999999965 4688999999865433334456778999999999999999999887533   


Q ss_pred             ---CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          136 ---SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       136 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                         ...|++||++ +++|.+++.. ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence               4568999988 6799888764 4599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      ++.....     .....||+.|+|||.+.+      ...++.++|||||||++|+|++|..||.....  ......+...
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~  231 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDY--IDQLKRIMEV  231 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcC------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHH
Confidence            9865432     234568999999998753      13567899999999999999999999864321  1111111111


Q ss_pred             hcCCCcc-c-cc-------cCcccCCCChhhHHH-----HHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          293 MGSFEPA-V-SI-------LDTKLQGLPDQMVQE-----MLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       293 ~~~~~~~-~-~~-------~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ....... . .+       ....+...+......     ...+.+++.+||+.||.+|||+.|++++-+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~  300 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY  300 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            1110000 0 00       000001111111110     112457889999999999999999998843

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.6e-42  Score=314.98  Aligned_cols=248  Identities=23%  Similarity=0.319  Sum_probs=194.2

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEe
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      |+..+.||+|+||.||+|... +++.||+|.+.+... .....+.+..|..++..+ +|++|+++++++.+.+..|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            566788999999999999654 578999999865432 233345677788888877 58899999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~  156 (323)
T cd05616          82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--V  156 (323)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--C
Confidence            999999999998888899999999999999999999999   99999999999999999999999999987543222  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......||+.|+|||.+.+       ..++.++|||||||++|||++|..||.....  ..+...+..   ...      
T Consensus       157 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~---~~~------  218 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIME---HNV------  218 (323)
T ss_pred             ccccCCCChhhcCHHHhcC-------CCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHHHHh---CCC------
Confidence            2234579999999998753       3678999999999999999999999964322  222222111   100      


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM-----KEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~  345 (371)
                           ..+....   ..+.+++.+||+.||++|++.     .+++++
T Consensus       219 -----~~p~~~s---~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         219 -----AYPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             -----CCCCcCC---HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                 1111111   234557888999999999974     677654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2e-41  Score=304.14  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=195.3

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|...+.||+|++|.||+|...      .+..||+|..... ........+..|+.+++.++|+||+++++++.+.+..
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            45777889999999999999764      3567888877432 2233446789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC---ceEEc
Q 037946          139 LLLYNYISNGNLQQLLQGNR-------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY---EAYLA  208 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~  208 (371)
                      ++||||+++++|.+++...+       .+++..+..++.|++.||+|||++   +++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            99999999999999986543       488999999999999999999999   999999999999998755   59999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  287 (371)
                      |||+++................+..|+|||.+.       +..++.++|||||||++|||++ |..||.....  ..+..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~~~~  232 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL-------DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVME  232 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHh-------cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence            999998764333222222333456899999764       3467899999999999999997 8888864322  12222


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      .+..   . ...     ......+       ..+.+++.+||+.||++|||+.+++++|++
T Consensus       233 ~~~~---~-~~~-----~~~~~~~-------~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         233 FVTG---G-GRL-----DPPKGCP-------GPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHc---C-CcC-----CCCCCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            2111   1 000     0011122       234567888999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-41  Score=317.93  Aligned_cols=267  Identities=22%  Similarity=0.297  Sum_probs=197.9

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----  135 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  135 (371)
                      .+.++|...+.||+|+||.||++.. ..++.||+|++............+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            3467899999999999999999965 4688999999865544555567788999999999999999999987543     


Q ss_pred             -CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          136 -SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                       ...|+||||+++ +|.+.+..  .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence             357999999976 77777753  478899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ......   ......||+.|+|||++.       +..++.++|||||||++|+|++|+.||.....  ......+.....
T Consensus       175 ~~~~~~---~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~  242 (364)
T cd07875         175 TAGTSF---MMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQLG  242 (364)
T ss_pred             ccCCCC---cccCCcccCCcCCHHHHh-------CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcC
Confidence            654432   223456899999999875       33678899999999999999999999964321  111111111111


Q ss_pred             CCCc-ccccc----------CcccCCC--------------ChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          295 SFEP-AVSIL----------DTKLQGL--------------PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       295 ~~~~-~~~~~----------~~~~~~~--------------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ...+ ....+          .+.....              ..........+.+++.+||+.||.+|||++|++++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  319 (364)
T ss_pred             CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            0000 00000          0000000              000001122456789999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-40  Score=297.49  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=203.3

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|... +|+.||+|.+..... +......+.+|++++++++|+|++++++++.+.+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            35777889999999999999765 789999998854332 3334678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ||+++++|.+++..    ...+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998853    34589999999999999999999999   999999999999999999999999999876544


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ...  ......+++.|+|||.+.       +..++.++|+||||+++|+|++|..||.....+.....+....       
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------  222 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-------  222 (267)
T ss_pred             CCc--ccceecCCccccCHHHhc-------cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-------
Confidence            321  123346889999999764       3357789999999999999999999986433221111111111       


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                            ......+..  .....+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus       223 ------~~~~~~~~~--~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 ------CDYPPLPAD--HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------CCCCCCChh--hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  001111110  11123456788899999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=299.47  Aligned_cols=254  Identities=23%  Similarity=0.354  Sum_probs=198.5

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc---chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE---EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .|...+.||+|++|.||++.. .+++.+|+|.+.......   .....+.+|++++++++||||+++++++.+.+..+++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            477788999999999999965 468999999986433221   2345788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            99999999999998888899999999999999999999999   999999999999999999999999999876543221


Q ss_pred             cc-ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          222 HH-AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .. ......++..|+|||.+.+       ..++.++||||||+++|||++|..||.....    . ..+...... ... 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~-~~~~~~~~~-~~~-  225 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISG-------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----M-AAIFKIATQ-PTN-  225 (263)
T ss_pred             ccccccCCCcCccccCcceecc-------CCCCchhhhHHHHHHHHHHHhCCCCccccch----H-HHHHHHhcc-CCC-
Confidence            11 1133457889999998763       3478899999999999999999999853211    1 111111111 000 


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                             ...+...   ...+.+++.+||+.+|.+|||+.+++++.
T Consensus       226 -------~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         226 -------PQLPSHV---SPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -------CCCCccC---CHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                   0111111   11334577789999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-41  Score=304.89  Aligned_cols=252  Identities=25%  Similarity=0.435  Sum_probs=194.2

Q ss_pred             ccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ++...+.||+|+||.||++...      ++..+|+|.+..  ........+.+|+++++.++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            4566788999999999999532      356788898742  33445568999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          140 LLYNYISNGNLQQLLQGNR---------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      ++|||+++++|.+++....               .+++..+..++.|++.|++|||+.   +++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            9999999999999986543               478999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGL  283 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  283 (371)
                      +||+|||++................+++.|+|||.+.       +..++.++|||||||++|||++ |..||.....  .
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~  231 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-------YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--T  231 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhc-------cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--H
Confidence            9999999997654433222222334578899999765       3357889999999999999998 8888743221  1


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .....+.   .. ...     ......++       .+.+++.+||+.||.+||+++|+++.|+
T Consensus       232 ~~~~~~~---~~-~~~-----~~~~~~~~-------~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 EAIECIT---QG-REL-----ERPRTCPP-------EVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHH---cC-ccC-----CCCCCCCH-------HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111111   11 000     00112222       2345777899999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.7e-41  Score=306.64  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=197.2

Q ss_pred             cccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      |+..+.||+|+||.||+|...      ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            566788999999999999652      23568888875322 23345678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 037946          141 LYNYISNGNLQQLLQGN------------------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNN  196 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  196 (371)
                      +|||+.+++|.+++...                        ..+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            99999999999998542                        2478899999999999999999999   99999999999


Q ss_pred             eeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 037946          197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAV  275 (371)
Q Consensus       197 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~  275 (371)
                      |++++++.+||+|||+++...............++..|+|||.+.       +..++.++||||||+++|||++ |..||
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~  230 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-------DHIYTTQSDVWSFGVLLWEIVTLGGNPY  230 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-------cCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence            999999999999999998654332211223344677899999654       3357889999999999999998 88888


Q ss_pred             CCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          276 QPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ....  ...+...+......         ......+       ..+.+++.+||+.||++||+++++++.|+++..
T Consensus       231 ~~~~--~~~~~~~~~~~~~~---------~~~~~~~-------~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         231 PGIA--PERLFNLLKTGYRM---------ERPENCS-------EEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCC--HHHHHHHHhCCCCC---------CCCCCCC-------HHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            5432  22222222211100         0011121       235567888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.6e-41  Score=303.69  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=198.9

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCC----EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .|+..+.||+|+||.||+|.+ .+++    .||+|.+... ........+.+|+.+++.++||||+++++++.. ...++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            467788999999999999964 3444    4899988532 233445678899999999999999999999875 45689


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +|||+++|+|.+++... ..+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.....
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            99999999999999764 4689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..........+++.|+|||.+.       +..++.++|||||||++|||++ |..||....  ...+..++......   
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~---  230 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESIL-------HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEKGERL---  230 (279)
T ss_pred             cceeecCCCccchhhCCHHHhc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCcC---
Confidence            3211122234567899999764       3357889999999999999998 888875332  12222222211100   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                            +.....+       ..+.+++.+||+.||++||++.++++.|.++...+.
T Consensus       231 ------~~~~~~~-------~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         231 ------PQPPICT-------IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             ------CCCccCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence                  0001111       234567888999999999999999999998876653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-42  Score=306.43  Aligned_cols=256  Identities=31%  Similarity=0.459  Sum_probs=199.3

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|+||.||++... +++.+|+|.+..............+|+.++++++||||+++++++.+....+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456778999999999999765 4668999999654443333444566999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccc
Q 037946          146 SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM  225 (371)
Q Consensus       146 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  225 (371)
                      ++++|.+++.....+++..+..++.|++.||.+||++   +++|+||||+||++++++.++|+|||.+......  ....
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENF  155 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccc
Confidence            9999999999777899999999999999999999999   9999999999999999999999999999764221  1233


Q ss_pred             ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ....+++.|+|||.+.      .....+.++||||+|+++|+|++|..|+.....  .................     .
T Consensus       156 ~~~~~~~~y~aPE~~~------~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~-----~  222 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQ------QGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKRPLPS-----S  222 (260)
T ss_dssp             SSSSSSGGGSCHHHHT------TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHTHHHH-----H
T ss_pred             cccccccccccccccc------ccccccccccccccccccccccccccccccccc--hhhhhhhhhcccccccc-----c
Confidence            4567899999999754      134678999999999999999999999875411  11112222111110000     0


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      . ..    .......+.+++.+||+.||++|||+++++++
T Consensus       223 ~-~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  223 S-QQ----SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             T-TS----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             c-cc----cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0 00    00001456678888999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=307.34  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=198.6

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      +.|...+.||+|+||.||++...      .+..+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            46888899999999999999641      34579999885432 233456789999999999 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          138 KLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      .+++|||+++|+|.+++....  .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++++|||++..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997543  389999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhc
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ..............+++.|+|||.+.       +..++.++|||||||++|||++ |..||.....+ ........... 
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~~~~~~-  261 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKEGY-  261 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhc-------cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHHHHcCC-
Confidence            54432111122334678899999764       3357889999999999999998 88887643322 11111111100 


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                        .       .   ..+...   ...+.+++.+||+.+|++|||++|+++.|.+.
T Consensus       262 --~-------~---~~~~~~---~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 --R-------M---AQPEHA---PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --c-------C---CCCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              0       0   001110   12355688889999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-41  Score=313.81  Aligned_cols=260  Identities=27%  Similarity=0.386  Sum_probs=196.0

Q ss_pred             hccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC-C
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK-S  136 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  136 (371)
                      ++|+..+.||+|+||.||+|.+      .+++.||+|++.... .......+.+|+.++.++ +||||+++++++... .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            4688899999999999999963      356889999985432 233456788999999999 789999999987654 5


Q ss_pred             eEEEEEeecCCCCHHHHhccC-----------------------------------------------------------
Q 037946          137 VKLLLYNYISNGNLQQLLQGN-----------------------------------------------------------  157 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------------------  157 (371)
                      ..+++|||+++|+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            678999999999999998542                                                           


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccccc
Q 037946          158 --------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA  229 (371)
Q Consensus       158 --------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  229 (371)
                              ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    1367788899999999999999999   99999999999999999999999999997654332111222334


Q ss_pred             ccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      +++.|+|||.+.       +..++.++||||||+++|+|++ |..||...... ......+...    ..      ....
T Consensus       243 ~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~----~~------~~~~  304 (343)
T cd05103         243 LPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEG----TR------MRAP  304 (343)
T ss_pred             CCcceECcHHhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhcc----CC------CCCC
Confidence            677899999764       3357889999999999999997 88887543222 1111111110    00      0000


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      ...+      ..+.+++.+||+.||++|||+.|++++|..+.++
T Consensus       305 ~~~~------~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         305 DYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1111      1345677889999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-41  Score=307.78  Aligned_cols=259  Identities=27%  Similarity=0.424  Sum_probs=199.2

Q ss_pred             HhccccCCccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEec
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSN  134 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  134 (371)
                      .++|...+.||+|+||.||+|...        ++..+|+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            346778899999999999999631        2457999987532 2334457889999999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNIL  198 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil  198 (371)
                      .+..|++|||+++|+|.+++.+.                ..+++..+..++.|++.||.|||++   +++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            99999999999999999998653                2477888999999999999999999   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 037946          199 LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQP  277 (371)
Q Consensus       199 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~  277 (371)
                      ++.++.+||+|||.++...............+++.|+|||.+.       +..++.++||||||+++|+|++ |..|+..
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999998765443222223345677899999764       3357889999999999999998 6777643


Q ss_pred             CCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ..     ..+........ ...     ......+       ..+.+++.+||+.+|++|||+.|+++.|.++..
T Consensus       243 ~~-----~~~~~~~~~~~-~~~-----~~~~~~~-------~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         243 IP-----VEELFKLLKEG-HRM-----DKPANCT-------NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             CC-----HHHHHHHHHcC-CcC-----CCCCCCC-------HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            21     11222221111 100     0001111       234457788999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.4e-41  Score=299.07  Aligned_cols=251  Identities=28%  Similarity=0.449  Sum_probs=195.6

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...++..+|+|.+.....   ....+.+|+.++++++|||++++++++. .+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            45778889999999999999887888899999854332   2357899999999999999999999875 4568999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.+++.||.|||+.   +++||||||+||++++++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999998753  3589999999999999999999999   9999999999999999999999999999876443211


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......++..|+|||.+.       ...++.++||||||+++|+|++ |..||....  .....+.+..   ....   
T Consensus       159 -~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~---~~~~---  222 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQVER---GYRM---  222 (260)
T ss_pred             -cccCCCCCccccChHHHh-------cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHc---CCCC---
Confidence             112233567899999654       3357889999999999999999 788875432  1222222111   1000   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                             ..+..   ....+.+++.+||+.||++|||++++.+.|.+
T Consensus       223 -------~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 -------PCPQD---CPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------CCCCc---CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                   01111   11235568888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-41  Score=309.09  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=200.0

Q ss_pred             hccccCCccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  135 (371)
                      ++|...+.||+|+||.||++...        ....+|+|.+... ........+..|+.+++++ +||||+++++++.+.
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            46778899999999999999642        2456899987532 2334466788999999999 699999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      +..+++|||+++|+|.+++...                ..+++..+..++.|++.||.|||++   +++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            9999999999999999999653                3478899999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||.++...............++..|+|||.+.       +..++.++||||||+++|+|++ |..||...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHc-------cCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999998765433222222233556899999764       3357889999999999999999 78877532


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      ..  ......+..   . ...     ......+.       .+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       241 ~~--~~~~~~~~~---~-~~~-----~~~~~~~~-------~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         241 PV--EELFKLLRE---G-HRM-----DKPSNCTH-------ELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             CH--HHHHHHHHc---C-CCC-----CCCCCCCH-------HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence            21  122222111   0 000     00111221       34457788999999999999999999998875443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.4e-41  Score=304.33  Aligned_cols=257  Identities=24%  Similarity=0.386  Sum_probs=196.2

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|+..+.||+|+||.||+|...      .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            56888899999999999999543      24579999875332 223345688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEc
Q 037946          139 LLLYNYISNGNLQQLLQGN----------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLA  208 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  208 (371)
                      ++||||+++|+|.+++...          ...+...+..++.|++.||.|||++   +++||||||+||++++++.++|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999642          2356778899999999999999999   99999999999999999999999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  287 (371)
                      |||+++...............++..|+|||.+.       +..++.++|||||||++|||++ |..||.....  .....
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-------~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~~~  232 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-------DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK  232 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhc-------cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence            999998654443222222334577899999764       3467889999999999999998 6777753221  12221


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .+   ... ...     ......+       ..+.+++.+||+.||++|||+.++++.|.+..
T Consensus       233 ~~---~~~-~~~-----~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         233 FV---MDG-GYL-----DQPDNCP-------ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HH---HcC-CCC-----CCCCCCC-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11   111 000     0001111       24556788899999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-41  Score=297.91  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=194.3

Q ss_pred             CccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           71 NVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      +.||+|+||.||+|.+..    +..+|+|.+...... .....+.+|+.++++++|||++++++++. .+..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            369999999999996422    268999998544332 34567899999999999999999999876 456799999999


Q ss_pred             CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc-cc
Q 037946          147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH-AM  225 (371)
Q Consensus       147 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~  225 (371)
                      +++|.+++.....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++......... ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            999999998888899999999999999999999999   99999999999999999999999999998764433111 11


Q ss_pred             ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ....++..|+|||.+.       +..++.++||||||+++|+|++ |..||....  .......+....    ..     
T Consensus       156 ~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~----~~-----  217 (257)
T cd05060         156 TAGRWPLKWYAPECIN-------YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGE----RL-----  217 (257)
T ss_pred             cCccccccccCHHHhc-------CCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCC----cC-----
Confidence            1222456899999764       3457889999999999999998 888885432  223333322211    00     


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ......+       ..+.+++.+||+.||++||++.++++.|..+.
T Consensus       218 ~~~~~~~-------~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECP-------QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCC-------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            0111111       24456888899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.9e-41  Score=303.06  Aligned_cols=244  Identities=24%  Similarity=0.337  Sum_probs=187.0

Q ss_pred             cccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           73 IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        73 ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      ||+|+||.||++.. .+|+.||+|.+...... ......+..|++++++++||||+++.+++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999965 46899999998543322 22234556799999999999999999999999999999999999999


Q ss_pred             HHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccc
Q 037946          151 QQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV  228 (371)
Q Consensus       151 ~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  228 (371)
                      .+++...  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            9988543  3588999999999999999999999   99999999999999999999999999987664432   22334


Q ss_pred             cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .|++.|+|||.+.       +..++.++|||||||++|||++|..||.....+. .............      ......
T Consensus       155 ~~~~~y~aPE~~~-------~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~------~~~~~~  220 (277)
T cd05607         155 AGTNGYMAPEILK-------EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDE------VKFEHQ  220 (277)
T ss_pred             CCCCCccCHHHHc-------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccc------cccccc
Confidence            6899999999765       3357889999999999999999999986432211 1111111111110      000001


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV  343 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl  343 (371)
                      ..+.       .+.+++.+||+.||++||++.|++
T Consensus       221 ~~~~-------~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         221 NFTE-------ESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             cCCH-------HHHHHHHHHhccCHhhCCCCccch
Confidence            1221       345678889999999999996554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-41  Score=297.88  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=197.6

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .|+..+.||.|+||.||+|.. .|+.||+|.+.....   ...++.+|+.+++.++|+|++++++++.+.+..++||||+
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            467788999999999999987 478999999854322   4678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          146 SNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       146 ~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ++++|.+++....  .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999999997655  689999999999999999999999   99999999999999999999999999998663321   


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        ....++..|+|||.+.       ...++.++||||||+++|+|++ |..||.....  ..+...+....    ..   
T Consensus       157 --~~~~~~~~~~ape~~~-------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~----~~---  218 (256)
T cd05039         157 --DSGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGY----RM---  218 (256)
T ss_pred             --ccCCCcccccCchhhc-------CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCC----CC---
Confidence              1234567899999764       3356789999999999999997 8888754321  12222221110    00   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                        ......+       ..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       219 --~~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 --EAPEGCP-------PEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --CCccCCC-------HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              0001112       2345678889999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.6e-41  Score=316.90  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=196.5

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  137 (371)
                      ++|...+.||+|+||.||+|++.      .+..||+|++.... .......+.+|+.++.++. ||||++++++|...+.
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            45777889999999999999753      34689999996432 2333457899999999997 9999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC-----------------------------------------------------------
Q 037946          138 KLLLYNYISNGNLQQLLQGNR-----------------------------------------------------------  158 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~-----------------------------------------------------------  158 (371)
                      .++||||+++|+|.+++...+                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999985431                                                           


Q ss_pred             ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          159 ---------------------------------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       159 ---------------------------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                                                             .+++..+..++.|++.||.|||+.   +++||||||+||++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence                                                   256778889999999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      ++++.+||+|||+++...............+++.|+|||.+.       +..++.++||||||+++|||++ |..||...
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-------NNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc-------CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999997653322111222345788999999764       3356889999999999999998 78887533


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ... ......+....    ..         ..+...   ...+.+++.+||+.+|.+||++++|++.|.++.
T Consensus       346 ~~~-~~~~~~~~~~~----~~---------~~p~~~---~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         346 PMN-EQFYNAIKRGY----RM---------AKPAHA---SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             Cch-HHHHHHHHcCC----CC---------CCCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            221 11111111110    00         011111   123455778899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-41  Score=313.01  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=193.5

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|.. .+++.||+|++..... .....+.+..|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999965 4578999999965432 234456788999999888 699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++...+.+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTST  155 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cceec
Confidence            99999998888899999999999999999999999   99999999999999999999999999987532221  12244


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc-hhHHHHHHHHhcCCCccccccCcc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG-LHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|||++|..||.....+. ....+........ .+        
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~--------  219 (327)
T cd05617         156 FCGTPNYIAPEILR-------GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KP--------  219 (327)
T ss_pred             ccCCcccCCHHHHC-------CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CC--------
Confidence            67999999999765       3367889999999999999999999996432221 1111111111111 00        


Q ss_pred             cCCCChhhHHHHHHHHHHHhcccCCCCCCCCC------HHHHHHH
Q 037946          307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT------MKEVVAL  345 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~evl~~  345 (371)
                       ...+....   ..+.+++.+||+.||++||+      +++++++
T Consensus       220 -~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         220 -IRIPRFLS---VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -CCCCCCCC---HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence             11111111   22345778899999999998      5677776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.9e-42  Score=319.58  Aligned_cols=260  Identities=22%  Similarity=0.251  Sum_probs=196.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||++... +++.+|+|.+..... .......+.+|..+++.++||||+++++.+.+.+..|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999764 688999999854222 2233456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++... .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++........ 
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-  197 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-  197 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-
Confidence            999999999998765 488999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||++..+.   ....++.++|||||||++|||++|..||.....  .   ............ ...
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~---~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~---~~~~~i~~~~~~-~~~  268 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--V---GTYSKIMNHKNS-LTF  268 (371)
T ss_pred             ccccCcccCccccCHHHHhccC---CCccCCCccceeehhHHHHHHHhCCCCCCCCCH--H---HHHHHHHcCCCc-ccC
Confidence            1223567999999999876431   123478899999999999999999999964321  1   112221111010 000


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE--RPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L~  347 (371)
                        +.....+       ..+.+++.+|+..++.+  ||+++|++++.+
T Consensus       269 --~~~~~~s-------~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         269 --PDDNDIS-------KEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             --CCcCCCC-------HHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence              0001111       12334667788844433  789999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-40  Score=296.49  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=187.3

Q ss_pred             ccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .||+|+||.||+|...   ++..+|+|.+..... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            5899999999999653   345799998754332 233457889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          149 NLQQLLQGNR-----NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       149 ~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +|.+++....     ..++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432     356778889999999999999999   99999999999999999999999999987544333222


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......++..|+|||.+...........++.++||||||+++|||++ |..||......  ........     ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~~~~-----~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYTVR-----EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHhh-----cccCCC
Confidence            22334578889999987532100011245789999999999999996 99888543221  11111110     001111


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..+.......   .   .+.+++..|| .+|++|||++||+..|+
T Consensus       231 ~~~~~~~~~~---~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPLS---D---RWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCCC---h---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111111111   1   2334666698 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8e-41  Score=298.45  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=201.5

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+..... ......++.+|+.+++.++|||++++++++.+.+..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            567778999999999999974 5789999998754322 23345688999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          144 YISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       144 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |+++++|.+++..    ...+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999998863    34589999999999999999999999   9999999999999999999999999998765443


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .  .......++..|+|||.+.       +..++.++|+||||+++|+|++|..||.....+..   .........    
T Consensus       160 ~--~~~~~~~~~~~~~ape~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~----  223 (267)
T cd08229         160 T--TAAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEQC----  223 (267)
T ss_pred             C--cccccccCCcCccCHHHhc-------CCCccchhhHHHHHHHHHHHHhCCCCcccccchHH---HHhhhhhcC----
Confidence            2  1223456899999999764       33567899999999999999999999864322211   111111100    


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                            .....+..  .....+.+++.+||+.||++|||+++|++.+.++.
T Consensus       224 ------~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 ------DYPPLPSD--HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ------CCCCCCcc--cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                  00111111  11123445778899999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.2e-42  Score=313.92  Aligned_cols=244  Identities=26%  Similarity=0.305  Sum_probs=187.6

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHH-HHhccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQ-ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +++.||+|++.+... .......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 688999999854322 1222344555554 67889999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      ++|...+.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTST  155 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999987532222  12234


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|||++|..||....  ....   ........           
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~---~~~i~~~~-----------  212 (321)
T cd05603         156 FCGTPEYLAPEVLR-------KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--VSQM---YDNILHKP-----------  212 (321)
T ss_pred             ccCCcccCCHHHhc-------CCCCCCcCcccccchhhhhhhcCCCCCCCCC--HHHH---HHHHhcCC-----------
Confidence            56999999999765       3357889999999999999999999996432  1111   11111110           


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCH----HHHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM----KEVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~evl~~  345 (371)
                      ...+...   ...+.+++.+||+.||.+||++    .+++++
T Consensus       213 ~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         213 LQLPGGK---TVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             CCCCCCC---CHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence            1111111   1234557888999999999975    355544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.8e-41  Score=306.26  Aligned_cols=259  Identities=28%  Similarity=0.406  Sum_probs=196.3

Q ss_pred             hccccCCccccCCceEEEEEEeCC-CC--EEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-GE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|...+ +.  .+++|.+.. .......+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            457778899999999999997643 33  478887742 22334456789999999999 79999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          141 LYNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      +|||+++++|.+++....                .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence            999999999999996532                478899999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGL  283 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  283 (371)
                      +||+|||++.......   .......+..|+|||.+.       ...++.++|||||||++|||++ |..||......  
T Consensus       158 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--  225 (297)
T cd05089         158 SKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLN-------YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--  225 (297)
T ss_pred             EEECCcCCCcccccee---ccCCCCcCccccCchhhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            9999999986432211   111123356799999764       3357889999999999999997 98988643221  


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      ....   ........      ......+       ..+.+++.+||+.+|.+|||++++++.|..+......
T Consensus       226 ~~~~---~~~~~~~~------~~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         226 ELYE---KLPQGYRM------EKPRNCD-------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             HHHH---HHhcCCCC------CCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1111   11111000      0001111       2345678889999999999999999999888755433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.3e-41  Score=303.59  Aligned_cols=264  Identities=23%  Similarity=0.329  Sum_probs=189.4

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc---CCCCceeeeceEec-----CC
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI---RHRNIVKLLGYCSN-----KS  136 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  136 (371)
                      +|+..+.||+|+||.||+|... +++.||+|.+............+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            3677789999999999999654 688999999865433333334556777777665   79999999998754     34


Q ss_pred             eEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          137 VKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      ..+++|||+++ +|.+++...  ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999985 898888653  3489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ......   ......||+.|+|||.+.       +..++.++|||||||++|+|++|.+||...... ..+.. +.....
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~-~~~~~~  224 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGK-IFDLIG  224 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhh-------CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHH-HHHHhC
Confidence            664332   223456899999999765       335788999999999999999999998643221 11111 111111


Q ss_pred             CCCc-----cccccCcccCCCC----hhhH-HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          295 SFEP-----AVSILDTKLQGLP----DQMV-QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       295 ~~~~-----~~~~~~~~~~~~~----~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ....     .............    .... .....+.+++.+||+.||++|||+.|++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000     0000000000000    0000 111234568888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.8e-42  Score=315.83  Aligned_cols=244  Identities=27%  Similarity=0.313  Sum_probs=188.3

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHH-HHhccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQ-ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|.. .+|+.+|+|++..... .......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999999965 4689999999854322 2233345555655 56779999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|..++.....+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  155 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTT  155 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999987533221  12345


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.       +..++.++|||||||++|||++|..||.....  ..+   .........    ...   
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~---~~~~~~~~~----~~~---  216 (325)
T cd05604         156 FCGTPEYLAPEVIR-------KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--AEM---YDNILHKPL----VLR---  216 (325)
T ss_pred             ccCChhhCCHHHHc-------CCCCCCcCccccccceehhhhcCCCCCCCCCH--HHH---HHHHHcCCc----cCC---
Confidence            57999999999875       33578899999999999999999999964321  111   122111100    000   


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHH----HHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK----EVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~----evl~~  345 (371)
                      ...+       ..+.+++.+|++.||.+||++.    +++++
T Consensus       217 ~~~~-------~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         217 PGAS-------LTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             CCCC-------HHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence            1111       2344577889999999999875    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.5e-41  Score=301.81  Aligned_cols=256  Identities=23%  Similarity=0.322  Sum_probs=197.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|...+.||+|+||.||+|.. .+++.||+|.+...  .......+.+|+.+++.++||||+++++.+.+.+..|++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            3567778899999999999965 46889999988533  22334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++...+.+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.......  .
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A  161 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence            999999999998888899999999999999999999999   99999999999999999999999999987654332  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......|++.|+|||.+...    ....++.++|+|||||++|+|++|..|+....... .....   ......+  ...
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~---~~~~~~~--~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLM---TKSNFQP--PKL  231 (267)
T ss_pred             ccccccCcccccChhhhccc----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhh---hccCCCC--Ccc
Confidence            22345689999999976421    13356789999999999999999999985432211 11000   0000000  000


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .. ....+       ..+.+++.+||+.||++|||+++++++
T Consensus       232 ~~-~~~~~-------~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 KD-KMKWS-------NSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc-cCCCC-------HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00 00111       134457888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1e-40  Score=299.99  Aligned_cols=258  Identities=22%  Similarity=0.424  Sum_probs=201.7

Q ss_pred             hccccCCccccCCceEEEEEEeCC-----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-CCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-KSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  138 (371)
                      ++|+..+.||+|+||.||+|....     +..|++|++.. .........+.+|+.+++.++|||++++++++.. +...
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            467788899999999999997654     68899998743 3334456778999999999999999999998766 5778


Q ss_pred             EEEEeecCCCCHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          139 LLLYNYISNGNLQQLLQGN--------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                      ++++||+++++|.+++...        ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998653        4588999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  289 (371)
                      |+++.+...+.........++..|+|||.+.       +..++.++||||||+++||+++ |..||...  +...+..++
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~  232 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLV-------NKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYL  232 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHh-------cCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHH
Confidence            9998765443322223345677899999764       3357889999999999999999 98888543  222222222


Q ss_pred             HHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ..   ... .     ......++       .+.+++.+||+.||++|||+.++++.|.++..
T Consensus       233 ~~---~~~-~-----~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 KD---GYR-L-----AQPINCPD-------ELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             Hc---CCC-C-----CCCCcCCH-------HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            21   110 0     00111222       34567888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.7e-41  Score=298.28  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=195.6

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|.+.+...||+|++....   .....+.+|+++++.++||||+++++.+. .+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            4588889999999999999987666789999985322   23357899999999999999999999875 4567999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999999753  3578999999999999999999999   9999999999999999999999999999866544311


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......++..|+|||...       ...++.++||||||+++|+|++ |..||.....  .....   ........   
T Consensus       159 -~~~~~~~~~~y~~PE~~~-------~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~~~~~---~~~~~~~~---  222 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLD---QVERGYRM---  222 (262)
T ss_pred             -cccCCcccceecCHhHhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--HHHHH---HHhcCCCC---
Confidence             112334677899999654       3467889999999999999999 7777753321  11111   11111000   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                             ..+.   .....+.+++.+||+.||++||++.++++.|++.
T Consensus       223 -------~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 -------PCPP---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -------CCcc---ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                   0011   1122455688889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.5e-42  Score=314.29  Aligned_cols=240  Identities=26%  Similarity=0.296  Sum_probs=184.6

Q ss_pred             CccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHH-HHhccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQ-ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|... +++.||+|++...... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999764 5788999998543221 222334444444 56788999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      ++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~  155 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTST  155 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCccc
Confidence            99999998888899999999999999999999999   99999999999999999999999999987543222  12345


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||++.       +..++.++|||||||++|+|++|..||.....  .....   ........    ..   
T Consensus       156 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~---~i~~~~~~----~~---  216 (325)
T cd05602         156 FCGTPEYLAPEVLH-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYD---NILNKPLQ----LK---  216 (325)
T ss_pred             ccCCccccCHHHHc-------CCCCCCccccccccHHHHHHhcCCCCCCCCCH--HHHHH---HHHhCCcC----CC---
Confidence            57999999999775       33678899999999999999999999964321  12111   11111000    00   


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE  341 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  341 (371)
                      ...++       .+.+++.+||+.||.+||++.+
T Consensus       217 ~~~~~-------~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         217 PNITN-------SARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             CCCCH-------HHHHHHHHHcccCHHHCCCCCC
Confidence            11221       2345777899999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-40  Score=297.82  Aligned_cols=258  Identities=24%  Similarity=0.352  Sum_probs=185.4

Q ss_pred             ccccCCceEEEEEEeCC---CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKGCSGVVYKAEMPN---GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .||+|+||.||+|...+   ...+|+|.+... ........+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            58999999999996433   356888876432 23344567889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          149 NLQQLLQGNR-----NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       149 ~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +|.+++....     ..++.....++.|++.|++|||++   +++||||||+||++++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999996543     246778899999999999999999   99999999999999999999999999987543332211


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+++.|+|||.+...........++.++|||||||++|||++ |..||.....  ....   .......  ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~---~~~~~~~--~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVL---KQVVREQ--DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHH---HHHhhcc--CccC
Confidence            22333467789999987533211223456889999999999999999 6667643211  1111   1111110  0111


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..+......+   .   .+.+++..|| .||++|||+++|++.|.
T Consensus       231 ~~~~~~~~~~---~---~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLKYS---D---RWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccccCC---H---HHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111111111   1   1223455588 49999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.8e-41  Score=299.59  Aligned_cols=253  Identities=24%  Similarity=0.411  Sum_probs=197.5

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCC----cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      |+..+.||.|+||.||+|...+++.+|+|.+......    ......+.+|+++++.++|+||+++.+++.+.+..+++|
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            6677899999999999998878999999988543322    223456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC--
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN--  220 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  220 (371)
                      ||+++++|.+++.+...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......  
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999999999998878899999999999999999999999   99999999999999999999999999987653211  


Q ss_pred             --cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          221 --YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       221 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                        .........|+..|+|||.+.       +..++.++|+||||+++|+|++|..||......  .  ......... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~--~~~~~~~~~-~~  226 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVIN-------ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--A--AMFYIGAHR-GL  226 (265)
T ss_pred             ccccccccccCCCccccChhhhc-------CCCCcchhhHHHHHHHHHHHHhCCCccccCChH--H--HHHHhhhcc-CC
Confidence              111123456899999999765       335678999999999999999999998643211  1  111100000 00


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                              ....+...   ...+.+++.+||+.+|++||++.+++++
T Consensus       227 --------~~~~~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 --------MPRLPDSF---SAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             --------CCCCCCCC---CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    01111111   1234557788999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.6e-41  Score=297.91  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=197.1

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.|+..+.||+|+||.||+|...+++.||+|.+....   .....+.+|+.++++++|||++++++++. .+..+++|||
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            4577788999999999999988888999999985332   23467899999999999999999998874 4568999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +.+++|.+++...  ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999998653  3588999999999999999999998   9999999999999999999999999999766533211


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......++..|+|||.+.       ...++.++||||||+++|||++ |..||....  .......+......      
T Consensus       159 -~~~~~~~~~~y~~pe~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~------  222 (260)
T cd05067         159 -AREGAKFPIKWTAPEAIN-------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERGYRM------  222 (260)
T ss_pred             -cccCCcccccccCHHHhc-------cCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCCCC------
Confidence             112334677899999764       3356889999999999999999 998886432  22222222111100      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                         +.....+       ..+.+++.+||+.+|++|||++++.+.|+.+
T Consensus       223 ---~~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         223 ---PRPDNCP-------EELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             ---CCCCCCC-------HHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence               0011122       2355678889999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.8e-41  Score=297.00  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=189.1

Q ss_pred             ccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .||+|+||.||+|.+.   .+..||+|.+... ......+.+.+|+.++++++||||+++++++. ....++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            3899999999999653   3457999988543 23344567899999999999999999999886 45789999999999


Q ss_pred             CHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc-ccc
Q 037946          149 NLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH-AMS  226 (371)
Q Consensus       149 ~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  226 (371)
                      +|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......... ...
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999875 45689999999999999999999999   99999999999999999999999999997654432111 112


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ...+++.|+|||.+.       ...++.++||||||+++|||++ |..||.....  ......+....    .       
T Consensus       157 ~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~----~-------  216 (257)
T cd05115         157 AGKWPLKWYAPECIN-------FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFIEQGK----R-------  216 (257)
T ss_pred             CCCCCcccCCHHHHc-------cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCC----C-------
Confidence            223467899999764       2356889999999999999996 9988864322  12222221110    0       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                        ...+...   ...+.+++.+||+.||++||++.+|.+.|..+
T Consensus       217 --~~~~~~~---~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 --LDCPAEC---PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              0111111   12344577889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.7e-40  Score=302.58  Aligned_cols=267  Identities=24%  Similarity=0.350  Sum_probs=201.1

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|+..+.||+|+||.||++.. .++..+|+|.+... ........+.+|++++++++||||+++++.+.+.+..++||||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            477788999999999999965 46788899887532 2233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|.+++...+.+++..+..++.|++.||.|||++.  +++|+||||+||+++.++.+||+|||++.......    
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----  154 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----  154 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence            999999999988888999999999999999999999731  89999999999999999999999999987553321    


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc----
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV----  300 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  300 (371)
                      .....+++.|+|||.+.       +..++.++|+||||+++|+|++|..||.....  ..................    
T Consensus       155 ~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         155 ANSFVGTRSYMSPERLQ-------GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRP  225 (308)
T ss_pred             cccCCCCcCccChhHhc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCccc
Confidence            23456899999999764       23567899999999999999999999854321  111111111000000000    


Q ss_pred             ---------------c----ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          301 ---------------S----ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       301 ---------------~----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                                     .    .........+..  .....+.+++.+||+.||++|||+.+++++.+-..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG--AFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCCccCcCc--ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                           0    000000000000  01123567889999999999999999999976544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.9e-41  Score=305.39  Aligned_cols=269  Identities=20%  Similarity=0.299  Sum_probs=197.3

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            35777889999999999999764 578899999854332 2333467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++ +|.+++... ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  158 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--  158 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence            9976 888877654 4588999999999999999999999   99999999999999999999999999997643332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc---
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA---  299 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  299 (371)
                      .......+|+.|+|||.+.+      ...++.++|||||||++|+|++|+.||......  .....+..........   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  230 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLG------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRLLGTPTEETWP  230 (309)
T ss_pred             cccccccccccccCCHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHh
Confidence            12234468999999997642      235678999999999999999999998644321  1112222111110000   


Q ss_pred             -----ccccCcccCCC-Chh----hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          300 -----VSILDTKLQGL-PDQ----MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       300 -----~~~~~~~~~~~-~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                           ....+...... +..    .......+.+++.+||+.||.+|||+.|++++-+-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  289 (309)
T cd07872         231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF  289 (309)
T ss_pred             hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence                 00000000000 000    00112234578889999999999999999986543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.8e-41  Score=306.18  Aligned_cols=257  Identities=28%  Similarity=0.424  Sum_probs=194.7

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCC--EEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .|+..+.||+|+||.||+|.+. ++.  .+|+|.+.. .........+.+|+.++.++ +||||+++++++.+.+..|+|
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            4677789999999999999754 444  457777632 22334456788999999999 899999999999999999999


Q ss_pred             EeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCce
Q 037946          142 YNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEA  205 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~  205 (371)
                      |||+++++|.+++....                .+++..++.++.|++.|++|||++   +++||||||+||+++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            99999999999986432                478999999999999999999999   99999999999999999999


Q ss_pred             EEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 037946          206 YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLH  284 (371)
Q Consensus       206 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  284 (371)
                      ||+|||++.......   ......++..|+|||.+.       ...++.++|||||||++|||+| |..||......  .
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~  231 (303)
T cd05088         164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--E  231 (303)
T ss_pred             EeCccccCcccchhh---hcccCCCcccccCHHHHh-------ccCCcccccchhhhhHHHHHHhcCCCCcccCChH--H
Confidence            999999986432111   111223467899999664       2356789999999999999998 99988543221  1


Q ss_pred             HHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          285 IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      ....+   .... ..     ......+       ..+.+++.+||+.+|++||+++++++.|.++.....
T Consensus       232 ~~~~~---~~~~-~~-----~~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         232 LYEKL---PQGY-RL-----EKPLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HHHHH---hcCC-cC-----CCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            11111   1100 00     0001111       134568888999999999999999999988754433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.6e-42  Score=320.35  Aligned_cols=203  Identities=26%  Similarity=0.374  Sum_probs=173.1

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++.. .+++.||+|++.... ........+..|+.++..++||||+++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            466778999999999999965 468999999985432 223445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc-
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  222 (371)
                      |+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++......... 
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            999999999998888899999999999999999999999   9999999999999999999999999998754321100 


Q ss_pred             --------------------------------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh
Q 037946          223 --------------------------------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS  270 (371)
Q Consensus       223 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  270 (371)
                                                      .......||+.|+|||++.+       ..++.++|||||||++|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-------CCCCCcceeccccceeeeccc
Confidence                                            00113469999999998753       367889999999999999999


Q ss_pred             CCCCCCCC
Q 037946          271 GRSAVQPQ  278 (371)
Q Consensus       271 g~~p~~~~  278 (371)
                      |..||...
T Consensus       232 G~~Pf~~~  239 (360)
T cd05627         232 GYPPFCSE  239 (360)
T ss_pred             CCCCCCCC
Confidence            99999654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-41  Score=311.50  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=193.1

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEe
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      |+..+.||+|+||.||+|.. .+++.||+|++.+... .....+.+..|..+++.+. |++|+++.+++.+.+..|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            55678899999999999965 4689999999865322 2334566788999998885 5778889999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||+++......  .
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~  156 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--V  156 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC--c
Confidence            999999999998888899999999999999999999999   99999999999999999999999999987543222  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......||+.|+|||.+.+       ..++.++|||||||++|||++|..||.....  ......+..   ...      
T Consensus       157 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~~---~~~------  218 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQSIME---HNV------  218 (323)
T ss_pred             cccCccCCccccCHHHHcC-------CCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHh---CCC------
Confidence            2234569999999997653       3578899999999999999999999965322  222222111   100      


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM-----KEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~  345 (371)
                           ..+...   ...+.+++.+||+.||.+|++.     +++.++
T Consensus       219 -----~~p~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         219 -----SYPKSL---SKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             -----CCCccC---CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                 011111   1234567888999999999974     556555

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-40  Score=296.45  Aligned_cols=252  Identities=26%  Similarity=0.450  Sum_probs=194.5

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|...+.||+|++|.||+|....+..+|+|.+...   ....+.+.+|++++++++|||++++++++. .+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC---CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            357777899999999999998777778999987432   223467889999999999999999998875 4567899999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999753  3478999999999999999999999   9999999999999999999999999999766443211


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......++..|+|||...       ...++.++||||||+++|+|++ |..||.....  ......+..   ....   
T Consensus       159 -~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~---~~~~---  222 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQVER---GYRM---  222 (260)
T ss_pred             -ccCCCccchhhCCHHHhc-------cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CCCC---
Confidence             112234677899999654       3467889999999999999999 8888754321  122222211   1000   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                             ..+..   ....+.+++.+||+.||++||+++++++.|+++
T Consensus       223 -------~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         223 -------PCPQG---CPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             -------CCCcc---cCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                   01111   112345577889999999999999999998763

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9e-41  Score=296.24  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=199.7

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||.|+||.||.++. .+++.+++|.+.....+......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            367788999999999999864 4688999999865544555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999764  4589999999999999999999999   999999999999999999999999999976644331 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......+++.|+|||.+.       +..++.++|+||||+++|+|++|..||.....  .   +........  ..   
T Consensus       157 -~~~~~~~~~~y~ape~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~---~~~~~~~~~--~~---  218 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQ-------GVKYNFKSDIWALGCVLYELLTLKRTFDATNP--L---NLVVKIVQG--NY---  218 (256)
T ss_pred             -cccccCCCccccCHhhcC-------CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--H---HHHHHHHcC--CC---
Confidence             223456899999999765       23567889999999999999999999864321  1   122221111  00   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                       .+.....+       ..+.+++.+||+.+|.+||++.++++++
T Consensus       219 -~~~~~~~~-------~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 -TPVVSVYS-------SELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -CCCccccC-------HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence             00001111       2344577789999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-40  Score=295.51  Aligned_cols=258  Identities=23%  Similarity=0.326  Sum_probs=185.0

Q ss_pred             ccccCCceEEEEEEeCCC---CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKGCSGVVYKAEMPNG---ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .||+|+||.||+|...++   ..+++|.+... ......+.+.+|+.+++.++||||+++++.|.+....|+||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            599999999999965433   34566665332 22334578999999999999999999999999999999999999999


Q ss_pred             CHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          149 NLQQLLQGN----RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       149 ~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +|.+++...    ...+...+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999753    3356777889999999999999999   999999999999999999999999999864332221122


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG-RSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....++..|+|||.+...........++.++||||||+++|||+++ ..||... . .......+   ...  ......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~-~~~~~~~~---~~~--~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-S-DREVLNHV---IKD--QQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-C-HHHHHHHH---Hhh--cccccC
Confidence            23456889999999875321111233467899999999999999975 4555322 1 11222211   111  111122


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ++.......      ..+.+++..|| .+|++||++++|++.|.
T Consensus       231 ~~~~~~~~~------~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELPYS------ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCCCc------HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222221111      12334666699 58999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.8e-41  Score=303.33  Aligned_cols=255  Identities=29%  Similarity=0.467  Sum_probs=196.5

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      +.|+..+.||+|+||.||+|...      ++..+|+|.+... ........+.+|+.++++++|||++++++++.+....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            35777889999999999999753      4678999988532 2334456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 037946          139 LLLYNYISNGNLQQLLQGN----------------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNN  196 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~----------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  196 (371)
                      +++|||+++++|.+++...                      ..+++..++.++.|++.||.|||++   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            9999999999999998632                      2477888999999999999999999   99999999999


Q ss_pred             eeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 037946          197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAV  275 (371)
Q Consensus       197 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~  275 (371)
                      |+++.++.++|+|||++.................+..|+|||.+.       +..++.++|||||||++|||++ |..||
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~~~~~p~  233 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-------YNRYTTESDVWAYGVVLWEIFSYGMQPY  233 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh-------cCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999987654433222222334567899999654       3367889999999999999998 77777


Q ss_pred             CCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          276 QPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      .....  .+....+.   ..          .....++.   ....+.+++.+||+.||++|||+.|+++.|++
T Consensus       234 ~~~~~--~~~~~~~~---~~----------~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         234 YGMAH--EEVIYYVR---DG----------NVLSCPDN---CPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCH--HHHHHHHh---cC----------CCCCCCCC---CCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            53221  12211111   11          00111111   11245568888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-40  Score=294.36  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=192.4

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      +.||+|+||.||+|...++..+|+|.+.... .......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            3689999999999988788999999885432 233345788999999999999999999999999999999999999999


Q ss_pred             HHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccccc
Q 037946          151 QQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA  229 (371)
Q Consensus       151 ~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  229 (371)
                      .+++.. ...+++..+..++.+++.||.|+|+.   +++|+||+|+||+++.++.+||+|||++......... ......
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~  155 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQ  155 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCC
Confidence            999865 34578999999999999999999999   9999999999999999999999999998764433211 112223


Q ss_pred             ccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      +++.|+|||.+.       +..++.++||||||+++|++++ |..||.....  ......+..   . ...         
T Consensus       156 ~~~~y~aPE~~~-------~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--~~~~~~~~~---~-~~~---------  213 (250)
T cd05085         156 IPIKWTAPEALN-------YGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--QQAREQVEK---G-YRM---------  213 (250)
T ss_pred             CcccccCHHHhc-------cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHHc---C-CCC---------
Confidence            467899999764       3357889999999999999998 8888864321  111111111   1 000         


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..+...   ...+.+++.+||+.+|++||++.|+++.|.
T Consensus       214 ~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 SCPQKC---PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            011111   124556888899999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.7e-41  Score=298.22  Aligned_cols=251  Identities=27%  Similarity=0.431  Sum_probs=195.8

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc-------chHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE-------EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      |...+.||.|++|.||+|.. .+++.+|+|.+.......       ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            56678999999999999965 457899999885443221       1235688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +++|||+++++|.+++.....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            99999999999999998888899999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCccc----ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          219 TNYHH----AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       219 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      .....    ......|+..|+|||.+.       +..++.++|+||||+++|+|++|..||.....  ..  . +.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~--~-~~~~~~  226 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVK-------QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQ--A-IFKIGE  226 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhc-------cCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HH--H-HHHHhc
Confidence            21111    112345888999999764       33567899999999999999999999864321  11  1 111100


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .       ..   ...+...   ...+.+++.+||+.||.+||++++++++
T Consensus       227 ~-------~~---~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 N-------AS---PEIPSNI---SSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             c-------CC---CcCCccc---CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            0       00   1111111   1234457778999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-41  Score=297.51  Aligned_cols=253  Identities=29%  Similarity=0.473  Sum_probs=199.2

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...++..+|+|.+....   .....+.+|+.++++++|||++++++++......+++|||
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4678889999999999999988778889999985322   3346789999999999999999999999998999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.+++.|+.|||++   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            9999999999764  3689999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .......++..|+|||.+.       +..++.++|+||||+++|+|++ |..||.....  ......+......      
T Consensus       159 ~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~------  223 (261)
T cd05034         159 TAREGAKFPIKWTAPEAAN-------YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERGYRM------  223 (261)
T ss_pred             hhhhccCCCccccCHHHhc-------cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC------
Confidence            1112223567899999664       3357889999999999999998 8888854321  1222221111100      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                         +.....+       ..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus       224 ---~~~~~~~-------~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         224 ---PRPPNCP-------EELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             ---CCCCCCC-------HHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence               0011122       2345678889999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-41  Score=315.59  Aligned_cols=267  Identities=20%  Similarity=0.209  Sum_probs=198.6

Q ss_pred             HhccccCCccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ..+|+..+.||+|+||.||++...   .+..||+|.+...       ....+|++++++++||||+++++++...+..|+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            346888999999999999999642   3578999987431       234679999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      +||++. ++|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.++|+|||++.......
T Consensus       164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            999996 58989887778899999999999999999999999   99999999999999999999999999998765543


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc-hhHHHHHHHHhcCCCcc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG-LHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  299 (371)
                      .........||+.|+|||++.       ...++.++|||||||++|||++|+.||....... ......+..........
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLA-------LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             ccccccccccccCccCHhHhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence            222233457999999999875       3357889999999999999999999997544321 11111111111110000


Q ss_pred             c-c-----------ccCc--ccCCCChhhH---HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          300 V-S-----------ILDT--KLQGLPDQMV---QEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       300 ~-~-----------~~~~--~~~~~~~~~~---~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      . .           ....  +.....+...   .....+..++.+||..||++|||+.|++.+-+=
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f  378 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF  378 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence            0 0           0000  0000000000   011234567888999999999999999998543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-41  Score=296.51  Aligned_cols=254  Identities=20%  Similarity=0.271  Sum_probs=204.0

Q ss_pred             hccccCCccccCCceEEEEEEeCC-CCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||.|.-|+||+++..+ +..+|+|++.+.... .....+...|-+||+.++||.+..+|..++.....|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456778899999999999998754 589999999665433 445677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC--
Q 037946          143 NYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--  218 (371)
                      |||+||+|..+.+.++  .+++..+..++..|+.||+|||-.   |||.|||||+||||.++|++-|+||.++.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999997654  599999999999999999999999   999999999999999999999999999754311  


Q ss_pred             -------------------------------CCcc---------------------cccccccccccccCCCCccchhhh
Q 037946          219 -------------------------------TNYH---------------------HAMSRVAGSYGYIAPGKCKLQIIY  246 (371)
Q Consensus       219 -------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~  246 (371)
                                                     ....                     ....+.+||-.|.|||++.++   
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~---  310 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE---  310 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC---
Confidence                                           0000                     011246799999999999854   


Q ss_pred             cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHh
Q 037946          247 GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAM  326 (371)
Q Consensus       247 ~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  326 (371)
                          ..+.++|+|+|||++|||+.|..||.+...++ .+..              ++... ...|.. ......+-+||+
T Consensus       311 ----GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~N--------------Iv~~~-l~Fp~~-~~vs~~akDLIr  369 (459)
T KOG0610|consen  311 ----GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRN--------------IVGQP-LKFPEE-PEVSSAAKDLIR  369 (459)
T ss_pred             ----CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHH--------------HhcCC-CcCCCC-CcchhHHHHHHH
Confidence                56789999999999999999999998776542 1111              11111 112211 133445667899


Q ss_pred             cccCCCCCCCCC----HHHHHHH
Q 037946          327 FCVNSSPAERPT----MKEVVAL  345 (371)
Q Consensus       327 ~cl~~dP~~RPs----~~evl~~  345 (371)
                      +.|.+||++|..    +.||.+|
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHhccChhhhhccccchHHhhcC
Confidence            999999999998    8888887

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.7e-40  Score=299.29  Aligned_cols=267  Identities=23%  Similarity=0.341  Sum_probs=201.5

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||+|++|.||+|... +++.||+|++..........+.+.+|+.++++++|||++++++++...+..++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            5777889999999999999765 589999999865443334446688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|..++.....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........  .
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~  156 (286)
T cd07847          82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D  156 (286)
T ss_pred             cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence            99999999888777899999999999999999999998   999999999999999999999999999987654431  1


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc-cccc-
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP-AVSI-  302 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-  302 (371)
                      .....++..|+|||.+.+      +..++.++||||||+++|+|++|..||...... ..... +......... .... 
T Consensus       157 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~  228 (286)
T cd07847         157 YTDYVATRWYRAPELLVG------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYL-IRKTLGDLIPRHQQIF  228 (286)
T ss_pred             ccCcccccccCCHHHHhC------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHH-HHHHhCCCChHHhhhc
Confidence            233457889999997642      234678999999999999999999998644321 11111 1111111000 0000 


Q ss_pred             ---------cCcccCCCCh--h-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 ---------LDTKLQGLPD--Q-MVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ---------~~~~~~~~~~--~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                               ..+......+  . .......+.+++.+||+.||++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                     0000000000  0 00112345678899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-41  Score=307.84  Aligned_cols=261  Identities=21%  Similarity=0.314  Sum_probs=207.4

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ..|+..+.||+||.+.||++...+.+.+|+|++.....+.....-|.+|+..|.+| .|.+|+.+++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            46888899999999999999887888999999877778888899999999999999 69999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +-+. +|..+|+.... .+...+..+..|++.++.++|..   ||||.||||.|+|+- .|.+||+|||+|..+......
T Consensus       441 ~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            8644 99999987654 33357888999999999999999   999999999999985 568999999999988777655


Q ss_pred             cccccccccccccCCCCccchhhhcccC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTM-----NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      -...+++||+.||+||.+..-... ..+     ..+++||||||||+||+|+.|+.||....       ..+.+...-..
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~-~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~aKl~aI~~  587 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSS-RENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIAKLHAITD  587 (677)
T ss_pred             eeeccccCcccccCHHHHhhcccc-ccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHHHHHhhcC
Confidence            556688999999999988743222 222     27889999999999999999999995321       11222111111


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      +...+   .+...++..     .+++++..||+.||.+|||..|++++-
T Consensus       588 P~~~I---efp~~~~~~-----~li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  588 PNHEI---EFPDIPEND-----ELIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             CCccc---cccCCCCch-----HHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence            11111   112222221     166677889999999999999999874

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.6e-41  Score=301.11  Aligned_cols=266  Identities=23%  Similarity=0.285  Sum_probs=194.7

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|++|.||+|... +++.||+|++............+.+|+.++++++|||++++++++.+++..|+||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            566788999999999999764 6899999998654434444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          146 SNGNLQQLLQGN---RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       146 ~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      + ++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  155 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--  155 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence            7 5888887543   4589999999999999999999999   99999999999999999999999999997654332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc----
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP----  298 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  298 (371)
                      .......+++.|+|||.+.+.      ..++.++||||||+++|+|+||+.||...... ................    
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGS------PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             ccccCCcccccccChHHhcCC------CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhc
Confidence            122334578999999976422      24578999999999999999999998643221 1111111110000000    


Q ss_pred             cc--cccCcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 AV--SILDTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ~~--~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ..  ...............     .....+.+++.+||+.||++|||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00  000000000000000     011234568888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.2e-41  Score=320.98  Aligned_cols=262  Identities=23%  Similarity=0.299  Sum_probs=189.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--------
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--------  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  135 (371)
                      ..|+..+.||+|+||.||+|.. .+++.||+|++....      ....+|+.+++.++||||+++++++...        
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4688899999999999999965 468999999884321      2235799999999999999998876322        


Q ss_pred             CeEEEEEeecCCCCHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADF  210 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Df  210 (371)
                      ..+++||||+++ +|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999986 7766653    456689999999999999999999999   999999999999998664 7999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |+++......   ......||+.|+|||++.+      ...++.++|||||||++|||++|.+||...... ..+... .
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i-~  284 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLG------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRI-I  284 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH-H
Confidence            9998765432   2234568999999997653      235788999999999999999999998654321 122221 1


Q ss_pred             HHhcCCCc-cccccCc-----ccCCCChhhHH------HHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          291 KKMGSFEP-AVSILDT-----KLQGLPDQMVQ------EMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       291 ~~~~~~~~-~~~~~~~-----~~~~~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...+.... ......+     ...........      ....+.+++.+||++||.+|||+.|++++-+
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            11111000 0000000     00000000000      1124567889999999999999999998743

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.1e-41  Score=302.69  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=194.8

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc-chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE-EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      |+..+.||+|+||.||++.. .+++.||+|.+....... .....+..|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            45567899999999999965 468899999985443222 2335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            9999999988543  3589999999999999999999999   99999999999999999999999999987654332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......|++.|+|||.+.       ...++.++||||||+++|+|++|..||........  .+..........     
T Consensus       157 -~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~~~-----  221 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVK-------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEVQ-----  221 (285)
T ss_pred             -cccCCCCCccccChHHHc-------CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhhhh-----
Confidence             122346899999999765       33578899999999999999999999975432210  001111100000     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L~  347 (371)
                       .......++       .+.+++.+||+.||++|||     ++|++++-+
T Consensus       222 -~~~~~~~~~-------~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         222 -EEYSEKFSP-------DARSLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             -hhcCccCCH-------HHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence             000111111       2345777899999999999     899998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-41  Score=337.41  Aligned_cols=257  Identities=21%  Similarity=0.310  Sum_probs=196.7

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--CCeEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--KSVKL  139 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  139 (371)
                      ..+.|++.+.||+|+||.||+|... +++.+|+|.+............+..|+.+++.++||||++++++|.+  ...+|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3457888999999999999999654 57789999886554455556788999999999999999999998754  45689


Q ss_pred             EEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeeEcC----------
Q 037946          140 LLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCV----PAILHRDVKCNNILLDS----------  201 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~----~~i~H~dlkp~Nill~~----------  201 (371)
                      +||||+++|+|.++|..    ...+++..++.++.||+.||.|||+.+.    .+|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            99999999999999864    3569999999999999999999998521    25999999999999964          


Q ss_pred             -------CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCC
Q 037946          202 -------KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA  274 (371)
Q Consensus       202 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p  274 (371)
                             .+.+||+|||++.......   ......||+.|+|||++...     ...++.++|||||||+||||++|..|
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge-----~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHE-----TKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhcc-----CCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                   3458999999998664432   22345699999999987532     23578899999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          275 VQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      |.....    ....+...... ..      ......+       ..+.+|+..||+.+|.+||++.+++.+
T Consensus       243 F~~~~~----~~qli~~lk~~-p~------lpi~~~S-------~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        243 FHKANN----FSQLISELKRG-PD------LPIKGKS-------KELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCcCCc----HHHHHHHHhcC-CC------CCcCCCC-------HHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            964321    11111111111 00      0011112       234557788999999999999999964

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.2e-41  Score=303.78  Aligned_cols=258  Identities=20%  Similarity=0.321  Sum_probs=200.8

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      ++.+...+|+..+.||+|++|.||+|.. .+++.+|+|.+....  ......+.+|+.+++.++|||++++++.+.....
T Consensus        14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            3444556788889999999999999965 468899999885432  2334678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .|+||||+++++|.+++.+. .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEEeecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            99999999999999998654 589999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...  .......+++.|+|||.+.       ...++.++|||||||++|+|++|..||.......    .+... .....
T Consensus       168 ~~~--~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~-~~~~~  233 (296)
T cd06654         168 PEQ--SKRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLI-ATNGT  233 (296)
T ss_pred             ccc--cccCcccCCccccCHHHHc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHH-hcCCC
Confidence            332  1123346889999999764       3356789999999999999999999996443211    11111 00000


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      +       . ...+...   ...+.+++.+||..||++|||+.+++++-+
T Consensus       234 ~-------~-~~~~~~~---~~~l~~li~~~l~~~p~~Rpt~~eil~~~~  272 (296)
T cd06654         234 P-------E-LQNPEKL---SAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (296)
T ss_pred             C-------C-CCCcccc---CHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence            0       0 0011111   123445788899999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-43  Score=295.56  Aligned_cols=246  Identities=24%  Similarity=0.358  Sum_probs=200.3

Q ss_pred             ccccCCccccCCceEEEEE-EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|.+..+||+|+||.||+| ...+|+.+|+|+..    .+...+++..|+.+|++...|++|++||.+.....+|+||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP----V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP----VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC----ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            3556678999999999999 44579999999872    245578899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |..|++.++++ +++++++..+..++.+.++||+|||..   .-+|||||+.|||++.+|.+||+|||.+.++.+.-  .
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A  184 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A  184 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence            99999999986 566799999999999999999999999   88999999999999999999999999998876543  2


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..++..|||.|||||++..       ..|..++||||||++..||..|++|+..-.+-               ..+..+.
T Consensus       185 KRNTVIGTPFWMAPEVI~E-------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------------RAIFMIP  242 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEE-------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------------RAIFMIP  242 (502)
T ss_pred             hhCccccCcccccHHHHHH-------hccchhhhHhhhcchhhhhhcCCCCccccccc---------------ceeEecc
Confidence            3456789999999998863       35678999999999999999999998632221               1111111


Q ss_pred             CcccC--CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 DTKLQ--GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~~~~~--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      -....  .-|....   -..-+++..||-++|++|-|+.+++++
T Consensus       243 T~PPPTF~KPE~WS---~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  243 TKPPPTFKKPEEWS---SEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCCCCChHhhh---hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11111  1122222   233457888999999999999999987

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.1e-40  Score=298.44  Aligned_cols=262  Identities=25%  Similarity=0.397  Sum_probs=196.0

Q ss_pred             hccccCCccccCCceEEEEEEeC-----------------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCcee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-----------------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK  127 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  127 (371)
                      ++|+..+.||+|+||.||++...                 ++..+|+|.+... ........+.+|+.+++.++|+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            45788899999999999998532                 2346899988533 23344568899999999999999999


Q ss_pred             eeceEecCCeEEEEEeecCCCCHHHHhccCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 037946          128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-----------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNN  196 (371)
Q Consensus       128 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  196 (371)
                      +++++.+.+..+++|||+++++|.+++....           .+++..+..++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            9999999999999999999999999986532           367788999999999999999999   99999999999


Q ss_pred             eeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh--CCCC
Q 037946          197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS--GRSA  274 (371)
Q Consensus       197 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~--g~~p  274 (371)
                      |+++.++.++|+|||++................+++.|+|||...       .+.++.++|||||||++|||++  |..|
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-------LGKFTTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-------cCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence            999999999999999998664433222223334567899999643       3467889999999999999998  6677


Q ss_pred             CCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          275 VQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      |.....  ................  ....+....++       ..+.+++.+||+.||.+||++.+|++.|.+
T Consensus       234 ~~~~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~~~-------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         234 YSQLSD--EQVIENTGEFFRDQGR--QVYLPKPALCP-------DSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ccccCh--HHHHHHHHHHHhhccc--cccCCCCCCCC-------HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            643221  1211111111111000  00111111222       234567888999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.8e-41  Score=300.73  Aligned_cols=257  Identities=24%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|+||.||+|... ++..+++|.+..  ........+.+|+++++.++|||++++++++...+..++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC--CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            556678999999999999764 477888888732  23345677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++++|..++.+ ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......  ..
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            99999998754 55689999999999999999999999   99999999999999999999999999987654322  12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....+++.|+|||.+...  ......++.++|||||||++|+|++|..||......     +.+..........  ...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~--~~~  230 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCE--TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEPPT--LAQ  230 (282)
T ss_pred             cccccccccccCHhhcccc--CCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHHHhhcCCCC--CCC
Confidence            2345689999999987532  112345678999999999999999999998543211     1111111110000  000


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                        ....+       ..+.+++.+||+.||.+||++.+++++-+-
T Consensus       231 --~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  265 (282)
T cd06643         231 --PSRWS-------SEFKDFLKKCLEKNVDARWTTTQLLQHPFV  265 (282)
T ss_pred             --ccccC-------HHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence              01111       234567788999999999999999987653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.4e-41  Score=301.49  Aligned_cols=262  Identities=28%  Similarity=0.430  Sum_probs=192.9

Q ss_pred             ccccCCccccCCceEEEEEEe-----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--CCeE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--KSVK  138 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  138 (371)
                      .|+..+.||+|+||.||++..     .+++.||+|++..  ......+.+.+|++++++++|||++++.+++..  ....
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH--STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            567778999999999999963     3578999999843  234455788999999999999999999998743  3568


Q ss_pred             EEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          139 LLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999999754 4589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcccc-cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          218 STNYHHA-MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       218 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....... .....++..|+|||.+.       +..++.++||||||+++|||++|..++......      +. ......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~-~~~~~~  225 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLT-------ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FM-RMMGND  225 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhc-------cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hh-hhcccc
Confidence            4321111 11222445699999764       335788999999999999999987765322110      00 000000


Q ss_pred             Cc-------cccccCcc-cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          297 EP-------AVSILDTK-LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       297 ~~-------~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ..       ........ ....+...   ...+.+++.+||+.+|++|||++|+++.|..+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         226 KQGQMIVYHLIELLKNNGRLPAPPGC---PAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccchHHHHHHHhcCCcCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00       00000000 00011111   12355688889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=310.18  Aligned_cols=254  Identities=26%  Similarity=0.416  Sum_probs=207.0

Q ss_pred             cccCCccccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .+...+||.|.||.||.|.|+. .-.||||.++.   +.-..++|+.|+.+|+.++|||+|+++|+|......|||+|||
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            4556789999999999998865 45799999843   4445789999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          146 SNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       146 ~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      .+|+|.++|+.+..  ++.-.++.++.||+.||.||..+   ++|||||.++|+|+.++..||++|||+++.+....|..
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            99999999987653  67778899999999999999999   99999999999999999999999999999887665321


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       -....-..-|.|||.+.       -+.++.++|||+|||+|||+.| |..|+.+-  +-.++..+..+.++..      
T Consensus       423 -HAGAKFPIKWTAPEsLA-------yNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--dlSqVY~LLEkgyRM~------  486 (1157)
T KOG4278|consen  423 -HAGAKFPIKWTAPESLA-------YNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYGLLEKGYRMD------  486 (1157)
T ss_pred             -ccCccCcccccCccccc-------ccccccchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHhcccccc------
Confidence             12233567899999775       2368999999999999999998 66666432  2234444444444432      


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                         ...+||+..++       |++.||+++|.+||+|.|+-+.++.+.+.
T Consensus       487 ---~PeGCPpkVYe-------LMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  487 ---GPEGCPPKVYE-------LMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             ---CCCCCCHHHHH-------HHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence               23578776544       45559999999999999999999887644

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.9e-41  Score=297.16  Aligned_cols=240  Identities=20%  Similarity=0.311  Sum_probs=183.1

Q ss_pred             CccccCCceEEEEEEeCC-------------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           71 NVIGKGCSGVVYKAEMPN-------------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      +.||+|+||.||+|....             ...+++|.+...  .......+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999996422             235888887432  23344678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc-------eEEcc
Q 037946          138 KLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE-------AYLAD  209 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~-------~kl~D  209 (371)
                      .+++|||+++++|..++.. ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.       ++++|
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999999998875 45689999999999999999999999   9999999999999987664       89999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEW  288 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  288 (371)
                      ||++......      ....++..|+|||.+..      ...++.++|||||||++|||++ |..|+......  ...  
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~--  219 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVED------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EKE--  219 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HHH--
Confidence            9998654322      23457889999997642      2356789999999999999984 77766432111  110  


Q ss_pred             HHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        .......          ... ..   ....+.+++.+||+.||.+||++.+|++.++
T Consensus       220 --~~~~~~~----------~~~-~~---~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 --RFYEGQC----------MLV-TP---SCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             --HHHhcCc----------cCC-CC---ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence              0011000          000 00   0123456888899999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.8e-41  Score=332.14  Aligned_cols=263  Identities=25%  Similarity=0.348  Sum_probs=199.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++...... ....+++.+|++++++++||||+++++++.+.+..|++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46788899999999999999764 5899999998654332 234567999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcccc
Q 037946          143 NYISNGNLQQLLQGN-----------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG  211 (371)
Q Consensus       143 e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  211 (371)
                      ||++|++|.+++.+.           ...++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998641           2356677899999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCc----------------ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 037946          212 LAKLMNSTNY----------------HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV  275 (371)
Q Consensus       212 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  275 (371)
                      ++........                ........||+.|+|||.+.       +..++.++|||||||++|||+||..||
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-------g~~~S~kSDIWSLGVILyELLTG~~PF  231 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-------GVPASESTDIYALGVILYQMLTLSFPY  231 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-------CCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence            9986521110                00112346999999999765       346788999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhcccCCC
Q 037946          276 QPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-TMKEVVALLMEVKSAP  353 (371)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~  353 (371)
                      ..........    ......  + ...  ......++       .+.+++.+||+.||++|| +++++++.|....+..
T Consensus       232 ~~~~~~ki~~----~~~i~~--P-~~~--~p~~~iP~-------~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~  294 (932)
T PRK13184        232 RRKKGRKISY----RDVILS--P-IEV--APYREIPP-------FLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS  294 (932)
T ss_pred             CCcchhhhhh----hhhccC--h-hhc--cccccCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence            6532211100    000000  0 000  00112222       234577789999999996 6788888887775543

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-40  Score=299.57  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=195.0

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++|||++++++.+...+..+++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            456678899999999999965 568899999985432 233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|..+    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----  149 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----  149 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence            999999765    3478889999999999999999999   99999999999999999999999999997654332    


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchh--HHHHHHHHhcCCCccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH--IVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  302 (371)
                      .....||..|+|||.+.+       ..++.++|+||||+++|+|++|..||.........  ........... .     
T Consensus       150 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-----  216 (279)
T cd06619         150 AKTYVGTNAYMAPERISG-------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-D-----  216 (279)
T ss_pred             ccCCCCChhhcCceeecC-------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-C-----
Confidence            234578999999997753       35688999999999999999999998653322111  11111111100 0     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                          ....+..  .....+.+++.+||+.||++||+++|++++.+-
T Consensus       217 ----~~~~~~~--~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~  256 (279)
T cd06619         217 ----PPVLPVG--QFSEKFVHFITQCMRKQPKERPAPENLMDHPFI  256 (279)
T ss_pred             ----CCCCCCC--cCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence                0111000  011234567888999999999999999988654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-40  Score=295.23  Aligned_cols=246  Identities=28%  Similarity=0.420  Sum_probs=191.9

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceE-ecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~  144 (371)
                      .|...+.||+|+||.||++.. .|..+|+|.+...    ...+.+.+|+.++++++|+|++++++++ ...+..+++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            577788999999999999976 4788999987432    2346789999999999999999999975 455678999999


Q ss_pred             cCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++....  .+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999999987543  478999999999999999999999   99999999999999999999999999987543322  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                         ....++..|+|||.+.       ...++.++||||||+++|+|++ |..||....  .......+....   ..   
T Consensus       157 ---~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~---~~---  218 (256)
T cd05082         157 ---DTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGY---KM---  218 (256)
T ss_pred             ---CCCccceeecCHHHHc-------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCC---CC---
Confidence               2334567899999764       3357889999999999999998 888875321  112222221110   00   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                         ......+.       .+.+++.+||+.+|++|||+.++++.|.++
T Consensus       219 ---~~~~~~~~-------~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 ---DAPDGCPP-------VVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---CCCCCCCH-------HHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               00012222       344577789999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.7e-41  Score=302.73  Aligned_cols=267  Identities=22%  Similarity=0.310  Sum_probs=196.0

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|+||.||+|... +|+.+|+|++............+.+|+.++++++|||++++++++.+.+..++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            666788999999999999764 6899999998654433344456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++ +|.+++.+ ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  ..
T Consensus        82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~  155 (284)
T cd07839          82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RC  155 (284)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CC
Confidence            75 78777754 56689999999999999999999999   99999999999999999999999999997654332  12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc-----c
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP-----A  299 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~  299 (371)
                      .....+++.|+|||.+.+.      ..++.++|||||||++|+|++|+.|+......... ...+.........     .
T Consensus       156 ~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGA------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             cCCCccccCCcChHHHhCC------cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-HHHHHHHhCCCChHHhHHh
Confidence            2334578899999976432      24578999999999999999999987543322211 1111111111000     0


Q ss_pred             ccccCc-ccCCCCh------hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          300 VSILDT-KLQGLPD------QMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       300 ~~~~~~-~~~~~~~------~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ....+. .....+.      ........+.+++.+||+.||.+|||+++++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            000000 0000000      0001122345688889999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-40  Score=303.00  Aligned_cols=195  Identities=26%  Similarity=0.372  Sum_probs=158.1

Q ss_pred             CCccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--CCeEEEEEee
Q 037946           70 ENVIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--KSVKLLLYNY  144 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  144 (371)
                      ++.||+|+||.||+|...   +++.+|+|.+....    ....+.+|+.++++++||||+++++++..  ....|++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999754   46789999984322    22456789999999999999999998854  4568899999


Q ss_pred             cCCCCHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE----cCCCceEEcccc
Q 037946          145 ISNGNLQQLLQGN---------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL----DSKYEAYLADFG  211 (371)
Q Consensus       145 ~~~~~L~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg  211 (371)
                      +.+ +|.+++...         ..+++..+..++.|++.||.|||++   +++||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            865 888877422         2488999999999999999999999   99999999999999    456789999999


Q ss_pred             CccccCCCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          212 LAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       212 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      +++........ .......||+.|+|||.+.+.      ..++.++||||+||++|+|++|.+||...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA------RHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCC------CCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99876443211 122345689999999987532      24678999999999999999999999644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.9e-41  Score=302.87  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=193.6

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      |+..+.||+|+||.||+|.. .+++.+|+|.+...... ......+.+|++++++++|+|++++.+.+.+++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            45567899999999999965 46889999998543322 22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.|++.||.|||++   +++||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999999888543  4699999999999999999999999   99999999999999999999999999987654332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......|++.|+|||.+.       +..++.++|+||||+++|+|++|..||...... ... ..+.........   .
T Consensus       157 -~~~~~~g~~~~~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~-~~~~~~~~~~~~---~  223 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLN-------NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKR-EEVDRRVLETEE---V  223 (285)
T ss_pred             -cccCCCCCcCccChHHhc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHHHhhhcccc---c
Confidence             123446899999999765       335788999999999999999999999643221 111 111111111000   0


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~  345 (371)
                      .   ....+.       .+.+++.+||+.||++||+     +++++.+
T Consensus       224 ~---~~~~~~-------~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         224 Y---SAKFSE-------EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             c---CccCCH-------HHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            0   011111       2345777899999999999     7788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=297.25  Aligned_cols=248  Identities=29%  Similarity=0.441  Sum_probs=188.7

Q ss_pred             CccccCCceEEEEEEeCC-CC--EEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecC
Q 037946           71 NVIGKGCSGVVYKAEMPN-GE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      +.||+|+||.||+|...+ +.  .+++|.+.. .......+.+.+|+++++++ +||||+++++++...+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc-cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            368999999999997643 43  468887742 22334456788999999999 89999999999999999999999999


Q ss_pred             CCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          147 NGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       147 ~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                      +|+|.+++....                .+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence            999999986532                478899999999999999999998   9999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  289 (371)
                      |++.......   .......+..|+|||.+.       ...++.++||||||+++|||++ |..||.....  .....  
T Consensus       157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~--  222 (270)
T cd05047         157 GLSRGQEVYV---KKTMGRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYE--  222 (270)
T ss_pred             CCccccchhh---hccCCCCccccCChHHHc-------cCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHH--
Confidence            9986322111   111223466799999764       3357889999999999999997 8888854321  11111  


Q ss_pred             HHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                       ....... .     ......+       ..+.+++.+||+.||.+|||++++++.|.++.
T Consensus       223 -~~~~~~~-~-----~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 -KLPQGYR-L-----EKPLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -HHhCCCC-C-----CCCCcCC-------HHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence             1111100 0     0001111       23456888899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-40  Score=296.50  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=196.8

Q ss_pred             ccccCCccccCCceEEEEEEeC-CC---CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NG---ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .|+..+.||+|+||.||+|... ++   ..+|+|.+.... .....+.+..|+++++.++|||++++.+++.+.+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            4667789999999999999764 23   369999884422 234456789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++++|.+++.. ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999975 35689999999999999999999999   99999999999999999999999999997664432


Q ss_pred             ccccc-ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          221 YHHAM-SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       221 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..... .....++.|+|||.+.       ...++.++||||||+++|||++ |..||.....  ......+..   . ..
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~---~-~~  228 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIA-------YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAIND---G-FR  228 (268)
T ss_pred             ccceeccCCCcCceecCHHHhh-------cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhc---C-CC
Confidence            11111 1122356799999764       2356889999999999999997 9999854321  122222111   1 00


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                           .+.....+       ..+.+++.+||+.+|++||++.++++.|.++
T Consensus       229 -----~~~~~~~~-------~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 -----LPAPMDCP-------SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -----CCCCCCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 01111222       2345678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=304.43  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=212.3

Q ss_pred             hccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .-|...+.||+|.|..|-.|+ .-+|+.||||++.++..+......+..|++.|+.++|||||++|++...+..+|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            446777889999999999994 4589999999999888888888899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE-cCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL-DSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      +-++|+|.++|.. ...+.+..+.+++.||..|+.|+|..   .+|||||||+||.+ ..-|-|||.|||++..+.+.. 
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-  173 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence            9999999999865 45699999999999999999999999   99999999999987 567899999999998887765 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                        ...+.||+..|.|||++.+..      ...++.|||||||+||.|++|++||+.....  +-..++            
T Consensus       174 --kL~TsCGSLAYSAPEILLGDs------YDAPAVDiWSLGVILyMLVCGq~PFqeANDS--ETLTmI------------  231 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAPEILLGDS------YDAPAVDIWSLGVILYMLVCGQPPFQEANDS--ETLTMI------------  231 (864)
T ss_pred             --hhhcccchhhccCchhhhcCc------cCCcchhhhHHHHHHHHHHhCCCccccccch--hhhhhh------------
Confidence              557789999999999987652      2357999999999999999999999765432  112222            


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                       .|.+. ..|..   ....+.+||..||..||.+|-+.+||+..-|--
T Consensus       232 -mDCKY-tvPsh---vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  232 -MDCKY-TVPSH---VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             -hcccc-cCchh---hhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence             22221 12222   233455688889999999999999999986654

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=292.98  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=192.8

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      +.||+|+||.||++...+++.||+|.+...... .....+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            368999999999998766999999988543322 3556889999999999999999999999999999999999999999


Q ss_pred             HHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccccc
Q 037946          151 QQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA  229 (371)
Q Consensus       151 ~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  229 (371)
                      .+++.. ...+++..+..++.+++.|+.|||++   +++||||+|+||+++.++.++|+|||.+................
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999965 44688999999999999999999999   99999999999999999999999999997654322211112233


Q ss_pred             ccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ++..|+|||.+.       +..++.++|+||||+++|+|++ |..||.....  ......+....   .          .
T Consensus       157 ~~~~y~~PE~~~-------~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~---~----------~  214 (251)
T cd05041         157 IPIKWTAPEALN-------YGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGY---R----------M  214 (251)
T ss_pred             ceeccCChHhhc-------cCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCC---C----------C
Confidence            466799999764       3357889999999999999999 7777743321  11111111100   0          0


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..++..   ...+.+++.+||+.+|++|||+.|+++.|+
T Consensus       215 ~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         215 PAPQLC---PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCccC---CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            011111   123556888899999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-40  Score=300.40  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=198.4

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||.|+||.||+|... +++.+++|.+..  .+......+.+|+.+++.++|||++++++.+...+..++|||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            45778889999999999999764 588999999843  334456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++++|..++.+ ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.......  
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            9999999988754 45689999999999999999999999   99999999999999999999999999987543321  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......+++.|+|||.+....  .....++.++|||||||++|+|++|..||......     ..+........+.   
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~---  234 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCET--MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEPPT---  234 (292)
T ss_pred             cccceecCCccccCceeecccc--ccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHHhcCCCcc---
Confidence            1223456889999999875321  11335678999999999999999999998643211     1111111110000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                          . ..+..   ....+.+++.+||+.||++||++.+++++-
T Consensus       235 ----~-~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  270 (292)
T cd06644         235 ----L-SQPSK---WSMEFRDFLKTALDKHPETRPSAAQLLEHP  270 (292)
T ss_pred             ----C-CCCcc---cCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                0 00111   112345678889999999999999998863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-40  Score=315.91  Aligned_cols=262  Identities=19%  Similarity=0.250  Sum_probs=192.7

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|...+.||+|+||.||+|... .++.||+|...        ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5788889999999999999764 47889999642        12356899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +. ++|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 588888765 35699999999999999999999999   99999999999999999999999999998654332211


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC------chhHHHHHHHHhcCCC
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD------GLHIVEWVKKKMGSFE  297 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~  297 (371)
                      ......||+.|+|||++.       +..++.++|||||||++|||++|..++......      ...+...+........
T Consensus       318 ~~~~~~GT~~Y~APE~~~-------~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~  390 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLA-------GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD  390 (461)
T ss_pred             cccccCCCcCCcCHHHHc-------CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence            223456999999999775       335788999999999999999988765432211      1223333322111100


Q ss_pred             cccccc----------------CcccCC-CChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          298 PAVSIL----------------DTKLQG-LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       298 ~~~~~~----------------~~~~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ......                .+.... ...........+.+|+.+||+.||.+|||+.|++++-
T Consensus       391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp  456 (461)
T PHA03211        391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP  456 (461)
T ss_pred             cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence            000000                000000 0000011112455688999999999999999999873

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-40  Score=306.97  Aligned_cols=260  Identities=27%  Similarity=0.422  Sum_probs=198.5

Q ss_pred             hccccCCccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  135 (371)
                      .+|++.+.||+|+||.||+|...        .+..+|+|.+... ........+.+|+++++++ +||||++++++|...
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            35888899999999999999642        1236899987432 2334467889999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      +..+++|||+++|+|.+++...                ..+++..+..++.|++.||.|||++   +++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            9999999999999999998643                2377888999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||+++...............++..|+|||.+.       +..++.++||||||+++|||++ |..||...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc-------cCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999998665433222222234567899999765       3357789999999999999998 77777532


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                      .  .......+   ......      ......+       ..+.+++.+||+.+|.+|||+.|+++.|.++....
T Consensus       241 ~--~~~~~~~~---~~~~~~------~~~~~~~-------~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         241 P--VEELFKLL---KEGHRM------DKPANCT-------HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             C--HHHHHHHH---HcCCCC------CCCCCCC-------HHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            2  11111111   111000      0011111       23456788899999999999999999999887433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=297.93  Aligned_cols=260  Identities=25%  Similarity=0.396  Sum_probs=200.3

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCC----EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .+|+..+.||+|+||.||+|... +|+    .+|+|.+.... .......+.+|+.++++++|||++++++++.. ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            35777889999999999999753 233    58999874432 23455778999999999999999999999987 7889


Q ss_pred             EEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ++|||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999999764 4689999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...........++..|+|||.+.       ...++.++|+||||+++||+++ |..||.....  ..+...+...    .
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~----~  228 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESIL-------HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKG----E  228 (279)
T ss_pred             cccceecCCCcccccccCHHHhh-------cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCC----C
Confidence            33221222233467899999654       3367889999999999999998 9998864321  2222222110    0


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      ..     +.....+       ..+.+++.+||..||.+||++.++++.|.++...+.
T Consensus       229 ~~-----~~~~~~~-------~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         229 RL-----PQPPICT-------IDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             CC-----CCCCCCC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence            00     0001111       234567788999999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.3e-41  Score=299.17  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=193.9

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC------
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK------  135 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------  135 (371)
                      ...|+..+.||+|+||.||+|.. .+++.+|+|.+...   ......+..|+.+++++ +|||++++++++...      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            34577778899999999999965 45889999998543   23345788999999998 799999999998653      


Q ss_pred             CeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      ...|++|||+++++|.+++...  ..+++..+..++.|++.|++|||++   +++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            4689999999999999998763  3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      .......  .......|++.|+|||.+.+..  .....++.++|+|||||++|||++|..||......    ..... ..
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~-~~  229 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDE--NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFL-IP  229 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhcccc--CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHH-Hh
Confidence            7654322  1223456899999999875321  11335778999999999999999999998533211    11111 01


Q ss_pred             cCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ..  ......   ....+       ..+.+++.+||+.||.+|||+++++++
T Consensus       230 ~~--~~~~~~---~~~~~-------~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         230 RN--PAPRLK---SKKWS-------KKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             cC--CCCCCC---CCCcC-------HHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            00  000000   01111       234567888999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.7e-40  Score=293.40  Aligned_cols=248  Identities=27%  Similarity=0.434  Sum_probs=192.7

Q ss_pred             CccccCCceEEEEEEeCC--C--CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           71 NVIGKGCSGVVYKAEMPN--G--ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      +.||+|++|.||+|.+.+  +  ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.+ ...+++|||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            368999999999997633  3  36899998554333 556789999999999999999999999988 88999999999


Q ss_pred             CCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc-
Q 037946          147 NGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH-  223 (371)
Q Consensus       147 ~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  223 (371)
                      +++|.+++.+..  .+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.+||+|||++.......... 
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999997654  689999999999999999999999   99999999999999999999999999998765432111 


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......++..|+|||.+.       ...++.++||||||+++|||++ |..||.....  ..+...+..   .....   
T Consensus       156 ~~~~~~~~~~y~~pE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~---~~~~~---  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLR-------TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQILKKIDK---EGERL---  220 (257)
T ss_pred             cccCCCCCceecCHHHhc-------ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh---cCCcC---
Confidence            112345788999999765       3357889999999999999998 9998853321  222221111   10000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        ......+       ..+.+++.+||+.+|++|||+.++++.|.
T Consensus       221 --~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 --ERPEACP-------QDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CCCccCC-------HHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              0001112       23455778899999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=305.77  Aligned_cols=206  Identities=24%  Similarity=0.286  Sum_probs=172.4

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++... +++.||+|++.+.. ........+.+|..+++.++|+||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            5777889999999999999754 58999999985422 223345668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++|+|.+++.. ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-  157 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-
Confidence            9999999999976 45689999999999999999999999   999999999999999999999999999876544321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                      .......||+.|+|||++....  .....++.++|||||||++|+|++|..||..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ccccceeccccccCHHHHhhcc--ccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            1112346999999999875320  0123467899999999999999999999864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-40  Score=294.77  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=195.4

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-CCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-KSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  144 (371)
                      |+..+.||+|++|.||++... +++.+|+|++..........+.+.+|++++++++|||++++.+.+.. .+..|++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            677889999999999999654 57899999986544444556678999999999999999999988764 4568999999


Q ss_pred             cCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++..  ...+++..+..++.+++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--  156 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--  156 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC--
Confidence            999999999875  34589999999999999999999999   99999999999999999999999999998664432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......+++.|+|||.+.       +..++.++||||||+++++|++|..||.....     ...........      
T Consensus       157 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~------  218 (257)
T cd08223         157 DMASTLIGTPYYMSPELFS-------NKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGK------  218 (257)
T ss_pred             CccccccCCcCccChhHhc-------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcC------
Confidence            1223456899999999764       34667899999999999999999999853221     11111111110      


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          +...+..   ....+.+++.+||+.||++|||+.+++++
T Consensus       219 ----~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 ----LPPMPKD---YSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----CCCCccc---cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0111111   11234568888999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-40  Score=299.45  Aligned_cols=259  Identities=25%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||+|+||.||++... +++.||+|.+... ........+.+|+.++++++||||+++++.+...+..|+||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            4677889999999999999764 6899999988532 2334456889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          145 ISNGNLQQLLQGN---RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       145 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      +++++|.+++...   ..+++..+..++.|++.||.|||++.  +++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999998763   36899999999999999999999632  89999999999999999999999999987654332 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                         .....+++.|+|||.+.+.. ......++.++|+|||||++|+|++|..||......  ...........       
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~-------  224 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGG-PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIVD-------  224 (286)
T ss_pred             ---cccCCCccCccCcchhcCCC-CCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHHhh-------
Confidence               23346888999999875321 112234678999999999999999999998643221  11111111111       


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                         ......+..   ....+.+++.+||+.+|++||++++++++-+
T Consensus       225 ---~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         225 ---GDPPTLPSG---YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             ---cCCCCCCcc---cCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence               111112221   1223445778899999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-40  Score=301.41  Aligned_cols=258  Identities=20%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      +..+...+|+..+.||+|+||.||+|.. .+++.||+|.+....  ....+.+.+|+.+++.++|||++++++++...+.
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            4456667899999999999999999975 578999999985322  2334678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .|+||||+++++|.+++.+. .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EEEeecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            99999999999999998654 489999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ....  ......+++.|+|||.+.       +..++.++|+|||||++|+|++|..||........ ..    ..... .
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~~----~~~~~-~  231 (297)
T cd06656         167 PEQS--KRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----LIATN-G  231 (297)
T ss_pred             CCcc--CcCcccCCccccCHHHHc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-ee----eeccC-C
Confidence            4321  123446889999999764       33567899999999999999999999964322110 00    00000 0


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                            .+. ...+...   ...+.+++.+||+.||++||++.+++++=+
T Consensus       232 ------~~~-~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (297)
T cd06656         232 ------TPE-LQNPERL---SAVFRDFLNRCLEMDVDRRGSAKELLQHPF  271 (297)
T ss_pred             ------CCC-CCCcccc---CHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence                  000 0011111   122345778899999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-40  Score=295.73  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=197.4

Q ss_pred             hccccCCccccCCceEEEEEEeC-C---CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-N---GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .+|+..+.||+|+||.||+|... +   +..+|+|.+.... .......+.+|+.++++++||||+++++++.+.+..|+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            35777889999999999999653 2   3379999885432 23345688999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++++|.+++... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999764 4589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             Cccc-ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          220 NYHH-AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       220 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .... ......++..|+|||.+.       +..++.++|+||||+++||+++ |..||.....  ......+....   .
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~---~  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIEEGY---R  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhc-------cCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHhCCC---c
Confidence            2111 111223456899999765       3357889999999999999886 9999864322  12222221110   0


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .      +.....+.       .+.+++.+||+.+|.+||++.++++.|.++
T Consensus       228 ~------~~~~~~~~-------~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 L------PAPMDCPA-------ALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C------CCCCCCCH-------HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0      11112222       334577889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=312.87  Aligned_cols=245  Identities=26%  Similarity=0.263  Sum_probs=187.8

Q ss_pred             cccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc---CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           73 IGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI---RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        73 ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      ||+|+||.||+|.. .+++.||+|++..... ..........|..++...   +||||+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999965 4689999999854322 222334556677777665   699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      |+|.+++.....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~  155 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT  155 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccC
Confidence            99999998888899999999999999999999999   99999999999999999999999999987543322  12345


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..||+.|+|||.+.+.      ..++.++|||||||++|+|++|..||.....  ...   ..........   ...   
T Consensus       156 ~~gt~~y~aPE~~~~~------~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~~~---~~~i~~~~~~---~~~---  218 (330)
T cd05586         156 FCGTTEYLAPEVLLDE------KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--QQM---YRNIAFGKVR---FPK---  218 (330)
T ss_pred             ccCCccccCHHHHcCC------CCCCCccceeccccEEEEeccCCCCCCCCCH--HHH---HHHHHcCCCC---CCC---
Confidence            5799999999987532      2367899999999999999999999864321  111   1111111000   000   


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCC----CHHHHHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERP----TMKEVVALL  346 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP----s~~evl~~L  346 (371)
                      ...++       .+.+++.+||+.||.+||    ++.+++++-
T Consensus       219 ~~~~~-------~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~  254 (330)
T cd05586         219 NVLSD-------EGRQFVKGLLNRNPQHRLGAHRDAVELKEHP  254 (330)
T ss_pred             ccCCH-------HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence            01111       234577789999999998    678887763

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=319.16  Aligned_cols=266  Identities=17%  Similarity=0.226  Sum_probs=191.2

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC------CCceeeeceEecC-
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH------RNIVKLLGYCSNK-  135 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~-  135 (371)
                      .++|+..+.||+|+||.||+|.. .+++.||||++...   ......+..|+.+++.++|      ++++.+++++... 
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            35788889999999999999965 45788999998432   1223445667777766654      4588888888654 


Q ss_pred             CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCC-----------
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKY-----------  203 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~-----------  203 (371)
                      ...|+|||++ +++|.+++...+.+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++           
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccccccc
Confidence            5788999988 66999999888889999999999999999999997 5   999999999999998765           


Q ss_pred             -----ceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          204 -----EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       204 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                           .+||+|||.+.....     ......||+.|+|||++.+       ..++.++|||||||++|||++|+.||...
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLG-------LGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             CCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhc-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                 499999998864322     2245679999999998753       36788999999999999999999999654


Q ss_pred             CCCchhHHHHHHHHhcCCCcc----------ccccCc--ccCCC--C-----------hhhHHHHHHHHHHHhcccCCCC
Q 037946          279 IGDGLHIVEWVKKKMGSFEPA----------VSILDT--KLQGL--P-----------DQMVQEMLQTLGIAMFCVNSSP  333 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~--~~~~~--~-----------~~~~~~~~~~~~l~~~cl~~dP  333 (371)
                      ..  ......+....+.....          ....+.  .+...  +           .........+.+|+.+||++||
T Consensus       349 ~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        349 DN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             Ch--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            32  22222222222111000          000000  00000  0           0000112345679999999999


Q ss_pred             CCCCCHHHHHHHHhccc
Q 037946          334 AERPTMKEVVALLMEVK  350 (371)
Q Consensus       334 ~~RPs~~evl~~L~~~~  350 (371)
                      ++|||++|+++|-+-..
T Consensus       427 ~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        427 QKRLNARQMTTHPYVLK  443 (467)
T ss_pred             hhCCCHHHHhcCccccc
Confidence            99999999999765433

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=293.77  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=199.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||.|+||.||+|.. .+++.+++|.+....  ......+.+|++++++++|||++++++++.+.+..|++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            3577788999999999999975 357889999985432  2356788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||.+.......  
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            99999999999776 6799999999999999999999999   99999999999999999999999999987654432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......++..|+|||.+...    ....++.++|+||||+++|+|++|..|+....... .... ..  ......    
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~~~~-~~--~~~~~~----  223 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVE----RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-ALFL-IS--KSNFPP----  223 (262)
T ss_pred             hccccccCCccccCchhhccc----ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HH--hccCCC----
Confidence            122345688899999976532    11356789999999999999999999986432211 1111 00  000000    


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        .... ..   ......+.+++.+||+.||.+|||+.+++.+
T Consensus       224 --~~~~-~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         224 --PKLK-DK---EKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             --cccc-ch---hhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0000 01   1222345678899999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.2e-40  Score=296.10  Aligned_cols=255  Identities=24%  Similarity=0.426  Sum_probs=196.5

Q ss_pred             ccccCCccccCCceEEEEEEeCC-C---CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPN-G---ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .|+..+.||+|+||.||+|.... +   ..||+|.+... ........+..|+.+++.++||||+++.+++.+.+..++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            46778899999999999997642 3   36999998542 2344567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++++|.+++.. .+.+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999875 45689999999999999999999999   99999999999999999999999999987654432


Q ss_pred             cccccccc---cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          221 YHHAMSRV---AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       221 ~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ........   ..+..|+|||.+.       ...++.++||||||+++|||++ |..||....  ......++....   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i~~~~---  228 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIEQDY---  228 (269)
T ss_pred             cccccccccCCCcceeecCHhHhc-------cCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHHHcCC---
Confidence            11111111   1245799999764       3357889999999999999886 998885432  222222222110   


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                       ..     +.....+.       .+.+++.+||+.+|++||+++++++.|+++
T Consensus       229 -~~-----~~~~~~~~-------~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 -RL-----PPPMDCPT-------ALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -cC-----CCcccCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00     11112222       234577789999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-40  Score=299.55  Aligned_cols=259  Identities=24%  Similarity=0.387  Sum_probs=195.8

Q ss_pred             cccCCccccCCceEEEEEEe-----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKL  139 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  139 (371)
                      |+..+.||+|+||.||.+..     .++..||+|.+... ........+.+|+.+++.++|||++++.+++.+.  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            56778899999999999963     35788999998543 2334456789999999999999999999998775  5689


Q ss_pred             EEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+++++|.+++... ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||+++....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999654 3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC----------chhHHH
Q 037946          219 TNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD----------GLHIVE  287 (371)
Q Consensus       219 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----------~~~~~~  287 (371)
                      .... .......++..|+|||.+.       +..++.++||||||+++|||++++.|.......          ......
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLI-------QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhc-------cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            3211 1122345777899999754       335788999999999999999987664321110          000001


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .+.. ...         ......+..   ....+.+++.+||+.||++|||++++++.|.++
T Consensus       235 ~~~~-~~~---------~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRV-LEE---------GKRLPRPPN---CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHH-HHc---------CccCCCCCC---CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1110 000         000011111   123456688889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=299.87  Aligned_cols=258  Identities=24%  Similarity=0.333  Sum_probs=200.0

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||.|+||.||++... ++..+|+|.+..  ........+..|++++++++|||++++++.+...+..|+|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            45777889999999999999764 688999999843  234455678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++++|.+++... ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--  157 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--  157 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence            99999999998763 5689999999999999999999999   99999999999999999999999999987654332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......+++.|+|||.+..+.  .....++.++|+||||+++|+|++|..||.....  ...   .........+.  .
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--~~~---~~~~~~~~~~~--~  228 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACET--FKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--MRV---LLKILKSEPPT--L  228 (280)
T ss_pred             cccceeecchhhcCHHHHhhcc--cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--HHH---HHHHhcCCCCC--c
Confidence            1223456899999999875331  1233567899999999999999999999864321  111   11111110000  0


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..  ....+       ..+.+++.+||+.+|.+||++.+++++-+
T Consensus       229 ~~--~~~~~-------~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         229 DQ--PSKWS-------SSFNDFLKSCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             CC--cccCC-------HHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence            00  01111       13445777899999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-40  Score=302.25  Aligned_cols=254  Identities=20%  Similarity=0.339  Sum_probs=199.1

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      ...+|+..+.||.|++|.||+|.. .+++.||+|.+...  .......+.+|+.+++.++|||++++++++...+..|+|
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            345688889999999999999964 57899999988532  233456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      +||+++++|.+++... .+++..+..++.|++.|++|||++   +++|+||+|+||+++.++.+||+|||++........
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999999999998754 589999999999999999999999   999999999999999999999999999876544321


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                        ......+++.|+|||.+.       +..++.++|||||||++|+|++|..||......  .....+..  .. ...  
T Consensus       171 --~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~~~~~--~~-~~~--  234 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIAT--NG-TPE--  234 (296)
T ss_pred             --cCCCcCCCccccCcchhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh--cC-Ccc--
Confidence              123446889999999765       235678999999999999999999998643221  11111110  00 000  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                            ...+.....   .+.+++.+||..||++|||+.+++.+=+
T Consensus       235 ------~~~~~~~~~---~~~~li~~~l~~dp~~Rpt~~~il~~~~  271 (296)
T cd06655         235 ------LQNPEKLSP---IFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (296)
T ss_pred             ------cCCcccCCH---HHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                  001111111   3445778899999999999999998744

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.5e-40  Score=293.24  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=196.1

Q ss_pred             hccccCCccccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|...+ ++.+++|.+....    ....+.+|+++++.++|||++++++.+.+....|+++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            357778899999999999997654 7899999984321    16789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++++|.+++.. ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999999999965 45689999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......++..|+|||.+.       +..++.++||||||+++|+|++|..|+.......  ...   .....       
T Consensus       155 -~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--~~~---~~~~~-------  214 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQ-------EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--AIF---MIPNK-------  214 (256)
T ss_pred             -ccccccCCccccCHHHHh-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--hhh---hhccC-------
Confidence             223345888999999764       2357889999999999999999999986432211  000   00000       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ..... ..+..   ....+.+++.+||+.||++|||+.|++++
T Consensus       215 ~~~~~-~~~~~---~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         215 PPPTL-SDPEK---WSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCCC-Cchhh---cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            00000 01111   11235567888999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=319.15  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=209.2

Q ss_pred             cccCCccccCCceEEEEEEe-CCCC----EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .+..++||+|+||+||+|.+ +.|+    +||+|++.. ..+.....+++.|+-+|.+++|||+++++|+|.... +.+|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            45568899999999999954 4443    688998843 445556789999999999999999999999998766 7899


Q ss_pred             EeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ++|++.|+|.++++.++ .+-.+..+.|+.|||+||.|||.+   .++||||.++|||+.+-..+||.|||+++......
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999999997654 588999999999999999999999   99999999999999999999999999999887766


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .........-.+.|||-|.+.       ...++.++|||||||++||++| |..|++....+  ++.+..+...+     
T Consensus       853 ~ey~~~~gK~pikwmale~i~-------~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~dlle~geR-----  918 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIR-------IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPDLLEKGER-----  918 (1177)
T ss_pred             ccccccccccCcHHHHHHHhh-------ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhHHHhcccc-----
Confidence            555555555677899998665       4578999999999999999998 88888654332  22222222111     


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                              -..|+   ...++++.++.+||..|+..||+|+++.+.+.++...+..
T Consensus       919 --------LsqPp---iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr  963 (1177)
T KOG1025|consen  919 --------LSQPP---ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR  963 (1177)
T ss_pred             --------CCCCC---CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence                    11111   3345566677779999999999999999999999877664

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.6e-40  Score=293.23  Aligned_cols=252  Identities=25%  Similarity=0.447  Sum_probs=196.4

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.|+..+.||+|+||.||++...++..+|+|.+..   .......+.+|+++++.++|+|++++.+.+.+ ...+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCC---ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            45777889999999999999877778899998743   22345678899999999999999999999887 778999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999999753  4578889999999999999999998   9999999999999999999999999999765443211


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......++..|+|||.+.       ...++.++|+||||+++|++++ |..||....  .......+....    ..  
T Consensus       159 -~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~----~~--  222 (260)
T cd05073         159 -AREGAKFPIKWTAPEAIN-------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGY----RM--  222 (260)
T ss_pred             -cccCCcccccccCHhHhc-------cCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCC----CC--
Confidence             112234567899999765       2356889999999999999999 888875432  122222221110    00  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                         +.....+       ..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus       223 ---~~~~~~~-------~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         223 ---PRPENCP-------EELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ---CCcccCC-------HHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence               0111122       2345677889999999999999999999763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-40  Score=296.40  Aligned_cols=261  Identities=25%  Similarity=0.358  Sum_probs=203.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||++... +++.||+|++... ........+.+|+++++.++||||+++++.+.+.+..++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            34667789999999999999654 5889999987543 234445788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++...+.+++..+..++.+++.||.|||+..  +++|+||+|+||++++++.++|+|||++.......   
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            9999999999988888999999999999999999999731  89999999999999999999999999986543221   


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC------chhHHHHHHHHhcCCC
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD------GLHIVEWVKKKMGSFE  297 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~  297 (371)
                       .....|+..|+|||.+.       +..++.++|||||||++|+|++|..||......      ...+.++.......  
T Consensus       159 -~~~~~~~~~~~aPE~~~-------~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  228 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQ-------GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE--  228 (284)
T ss_pred             -cCccccCcccCCHHHHc-------cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc--
Confidence             23456899999999764       236788999999999999999999999754331      11112222222211  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                              .....+..  .....+.+++.+||+.||++|||++|++++..-+..
T Consensus       229 --------~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 --------PPPRLPSS--DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             --------cCCCCCch--hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                    01111111  011234567888999999999999999998655543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-40  Score=307.25  Aligned_cols=206  Identities=23%  Similarity=0.267  Sum_probs=171.7

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++... +++.+|+|.+.+... .......+..|..++..++|+||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            4777889999999999999764 578899999854221 22334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++|+|.+++.+ ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ 
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-  157 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-  157 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc-
Confidence            9999999999976 45689999999999999999999999   999999999999999999999999999876543321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                      .......||+.|+|||++....  .....++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAME--DGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             ceecccccCccccCHHHHhccc--cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            1223356999999999875321  1123578899999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.8e-41  Score=308.17  Aligned_cols=206  Identities=25%  Similarity=0.277  Sum_probs=172.5

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +|+..+.||+|+||.||++... +++.||+|.+.+.. ........+.+|..++..++|+||+.+++++.+.+..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5777889999999999999764 57889999985422 122334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++|+|.+++.. ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ 
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  157 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-  157 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence            9999999999976 46789999999999999999999999   999999999999999999999999999976654321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                      .......||+.|+|||.+....  .....++.++|||||||++|+|++|+.||..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAME--DGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             eeeccccCCcccCCHHHHhccc--cCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            1123356999999999875310  0113567899999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.1e-40  Score=294.40  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|+..+.||.|+||.||+|.. .++..+|+|++....... ....+.+|+.+++.++|+|++++++.+...+..+++||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            577788999999999999975 467899999985433322 567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          145 ISNGNLQQLLQGN---RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       145 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999999764   4589999999999999999999999   999999999999999999999999999877655432


Q ss_pred             cc--ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          222 HH--AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ..  ......|+..|+|||.+...      ..++.++|+||||+++|+|++|..||...... ......    ...... 
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~-  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQV------HGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLT----LQNDPP-  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccc------cCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHH----hcCCCC-
Confidence            21  22334689999999976522      25688999999999999999999998643221 111111    111000 


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        ..    .... ........+.+++.+||+.||++|||+.+++++
T Consensus       226 --~~----~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 --SL----ETGA-DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --Cc----CCcc-ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              00    0000 000111234567888999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-40  Score=294.33  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=195.1

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|+||.||++... +++.+|+|.+.... .....+.+.+|+.+++.++|||++++.+.+.+.+..|++|||+
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            566788999999999999654 68899999885432 2334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          146 SNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       146 ~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ++++|.+++..  ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            99999998864  34578999999999999999999999   999999999999999999999999999976644321  


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......|++.|+|||.+.       +..++.++|+||||+++|+|++|..||.....  ...   .......        
T Consensus       156 ~~~~~~~~~~~~aPE~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~---~~~~~~~--------  215 (255)
T cd08219         156 YACTYVGTPYYVPPEIWE-------NMPYNNKSDIWSLGCILYELCTLKHPFQANSW--KNL---ILKVCQG--------  215 (255)
T ss_pred             ccccccCCccccCHHHHc-------cCCcCchhhhhhhchhheehhhccCCCCCCCH--HHH---HHHHhcC--------
Confidence            223456899999999764       23578899999999999999999999864321  111   1111111        


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        .....+...   ...+.+++.+||+.||++|||+.++++.
T Consensus       216 --~~~~~~~~~---~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 --SYKPLPSHY---SYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCCCCCccc---CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              001111111   1134467888999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-40  Score=298.90  Aligned_cols=260  Identities=24%  Similarity=0.320  Sum_probs=196.0

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEe-----c
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCS-----N  134 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~  134 (371)
                      +..++|+..+.||+|+||.||++.. .+++.+|+|.+...   ......+.+|+.+++.+ +|||++++++++.     .
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            4556788889999999999999965 45789999987432   12235678899999999 7999999999873     4


Q ss_pred             CCeEEEEEeecCCCCHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                      ++..++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~df  168 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDF  168 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccC
Confidence            567899999999999999874    335688999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |++........  ......|++.|+|||.+....  .....++.++|||||||++|||++|..|+......  .  .. .
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~--~~-~  239 (286)
T cd06638         169 GVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQ--QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--R--AL-F  239 (286)
T ss_pred             CceeecccCCC--ccccccCCCcccChhhhchhh--hccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--H--HH-h
Confidence            99876644321  223456899999999875331  11345788999999999999999999998643211  1  11 1


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..... .. ....      .+...   ...+..++.+||+.||++|||+.|++++++
T Consensus       240 ~~~~~-~~-~~~~------~~~~~---~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         240 KIPRN-PP-PTLH------QPELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             hcccc-CC-Cccc------CCCCc---CHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            10000 00 0000      01100   113456788899999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=312.12  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=200.1

Q ss_pred             cccCCccccCCceEEEEEEeC--CCC--EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP--NGE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ....++||+|.||.|++|.|.  +|+  .||||.+..+.... ....|++|+.+|.+|+|||++++||+..+ ....+||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            444678999999999999774  343  68999996544332 67899999999999999999999999987 6678999


Q ss_pred             eecCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          143 NYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       143 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |+++.|+|.+.|..  ...+....+..++.|||.||.||.++   ++|||||..+|+|+-..-.|||+|||+++.++..+
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999976  34578889999999999999999999   99999999999999999999999999999998877


Q ss_pred             ccccccccc-ccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          221 YHHAMSRVA-GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       221 ~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..+.+.... -.+.|+|||.+.       ...++.+||||+|||++|||+| |..||.+-.  ...++..+...    + 
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLr-------h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~qIL~~iD~~----e-  332 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLR-------HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQILKNIDAG----E-  332 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhc-------cccccccchhhhhhhhHHhhhccCCCCCCCCC--HHHHHHhcccc----c-
Confidence            665554433 567899999776       4478999999999999999998 667775432  22232221110    0 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                          --++...++.       ++++++..||+.+|++||||..|.+.+-..
T Consensus       333 ----rLpRPk~cse-------dIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  333 ----RLPRPKYCSE-------DIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ----cCCCCCCChH-------HHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence                0122233333       455566679999999999999998655433

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=315.57  Aligned_cols=256  Identities=25%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             cccCCccccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      +++...||.|+||.||+|..+. +-..|.|++  ...+....+.|+-|++||....||+||++++.|...+.+||+.|||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvI--etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVI--ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhh--cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            3445679999999999996544 444566766  3445677889999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      .||-+..++- -.+.+++.++..+++|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+.+....  ...
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK  186 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence            9999988764 466799999999999999999999999   9999999999999999999999999998764432  234


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .+++.|||+|||||+..++.  ....+|+.++||||||++|.||..+.+|...     .+.+.-+.+......+.  +..
T Consensus       187 RDsFIGTPYWMAPEVvmCET--~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-----lnpMRVllKiaKSePPT--Llq  257 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCET--FKDQPYDYKADIWSLGITLIEMAQIEPPHHE-----LNPMRVLLKIAKSEPPT--LLQ  257 (1187)
T ss_pred             hccccCCcccccchheeecc--ccCCCchhhhhHHhhhhHHHHHhccCCCccc-----cchHHHHHHHhhcCCCc--ccC
Confidence            56788999999999999884  3456889999999999999999999988742     22222222222221111  111


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                            |..+   ...+-+++.+||.+||..||++.++++|-+
T Consensus       258 ------PS~W---s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf  291 (1187)
T KOG0579|consen  258 ------PSHW---SRSFSDFLKRCLVKNPRNRPPAAQLLKHPF  291 (1187)
T ss_pred             ------cchh---hhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence                  1111   122334666699999999999999998743

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.2e-40  Score=302.54  Aligned_cols=200  Identities=22%  Similarity=0.300  Sum_probs=165.1

Q ss_pred             CCccccC--CceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           70 ENVIGKG--CSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        70 ~~~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      .++||+|  +||+||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  7899999965 578999999986544444455677889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc--
Q 037946          147 NGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH--  222 (371)
Q Consensus       147 ~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  222 (371)
                      +|+|.+++..  ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.++++|||...........  
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            9999999965  34589999999999999999999999   9999999999999999999999999876443221110  


Q ss_pred             ---cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          223 ---HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       223 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                         .......++..|+|||.+...     ...++.++|||||||++|||++|..||..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccceecccChHHhhcc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence               011223567889999987521     13578899999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-40  Score=292.24  Aligned_cols=239  Identities=21%  Similarity=0.344  Sum_probs=184.9

Q ss_pred             CccccCCceEEEEEEeCCCC-----------EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           71 NVIGKGCSGVVYKAEMPNGE-----------LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      +.||+|+||.||+|...+..           .+++|.+....   .....+.+|+.+++.++|||++++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            36899999999999765432           47777764322   125788999999999999999999999988 7789


Q ss_pred             EEEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-------ceEEcccc
Q 037946          140 LLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-------EAYLADFG  211 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-------~~kl~Dfg  211 (371)
                      +||||+++|+|.+++.... .+++..+..++.|++.||.|||++   +++||||||+||+++.++       .+||+|||
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999999998765 789999999999999999999999   999999999999999888       79999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCchhHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG-RSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~  290 (371)
                      ++......      ....++..|+|||.+...     ...++.++||||||+++|+|++| ..|+.....  .....+..
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~  220 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNG-----QASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ  220 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCC-----CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh
Confidence            99765432      233467789999987532     13678899999999999999995 555543221  11111111


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                         ..          .....+..     ..+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 ---~~----------~~~~~~~~-----~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ---DQ----------HRLPMPDC-----AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---cC----------CCCCCCCc-----hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               00          00011110     45566888899999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-40  Score=301.37  Aligned_cols=255  Identities=20%  Similarity=0.362  Sum_probs=195.5

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .+.|.....||+|+||.||++.. .++..||+|.+..  ......+.+.+|+.+++.++|||++++++.+...+..++||
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL--RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec--chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            33444456799999999999965 4688999998743  22344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++... .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.......  
T Consensus        99 e~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--  172 (292)
T cd06658          99 EFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--  172 (292)
T ss_pred             eCCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence            999999999988654 589999999999999999999999   99999999999999999999999999987543322  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......|++.|+|||.+.       +..++.++||||||+++|||++|..||.....  ......+....         
T Consensus       173 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~---------  234 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVIS-------RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRDNL---------  234 (292)
T ss_pred             ccCceeecCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcC---------
Confidence            1223456899999999764       33578899999999999999999999864321  11111111110         


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                       ........    .....+..++.+||..||++|||+++++++-+--
T Consensus       235 -~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         235 -PPRVKDSH----KVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             -CCcccccc----ccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence             00001100    0111334567779999999999999999874443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.3e-40  Score=292.62  Aligned_cols=252  Identities=23%  Similarity=0.379  Sum_probs=191.5

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC---cchHHHHHHHHHHHhccCCCCceeeeceEec--CCeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD---EEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--KSVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  139 (371)
                      .|+..+.||+|+||.||+|.. .++..||+|++......   ......+.+|+.++++++||||+++++++.+  .+..+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            467788999999999999965 46899999988543322   2334578899999999999999999998865  36788


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++|||+++++|.+++.....+++...+.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            9999999999999998877899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             Cc-ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NY-HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. ........++..|+|||.+.       +..++.++|||||||++|||++|..||......     ..+...... . 
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~~~~-~-  225 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVIS-------GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKIATQ-P-  225 (266)
T ss_pred             cccCCccccCCccccccCHHHhC-------CCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHHhcC-C-
Confidence            11 11122345889999999764       335688999999999999999999998643211     111111111 0 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          ..+   ..+......   +..++ .||..+|++||+++|++++
T Consensus       226 ----~~~---~~~~~~~~~---~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 ----TNP---QLPSHISEH---ARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ----CCC---CCchhcCHH---HHHHH-HHhcCChhhCcCHHHHhcC
Confidence                011   111111111   22233 4888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.7e-40  Score=295.39  Aligned_cols=249  Identities=26%  Similarity=0.437  Sum_probs=191.2

Q ss_pred             CccccCCceEEEEEEeCC-------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           71 NVIGKGCSGVVYKAEMPN-------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.||+|+||.||+|...+       ++.+|+|.+... ........+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999997532       257899987432 223445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-----ceEEcccc
Q 037946          144 YISNGNLQQLLQGN-------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-----EAYLADFG  211 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-----~~kl~Dfg  211 (371)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++     .++++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999998642       3478899999999999999999998   999999999999999887     89999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  290 (371)
                      ++................++..|+|||.+.       ++.++.++||||||+++|||++ |..||....  .......+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~~  227 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLL-------DGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVT  227 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHc-------cCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHHh
Confidence            997654433222223334678899999764       3467899999999999999998 888875322  222222111


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      .   . ..         ...+...   ...+.+++.+||+.+|++||+++++++.|++
T Consensus       228 ~---~-~~---------~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 A---G-GR---------LQKPENC---PDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             c---C-Cc---------cCCcccc---hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   0 00         0111111   1234568888999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=293.05  Aligned_cols=279  Identities=27%  Similarity=0.333  Sum_probs=208.2

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhc--cCCCCceeeeceEecC---
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH--IRHRNIVKLLGYCSNK---  135 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~---  135 (371)
                      ..+..+....+.||+|.||.||+|.+ .|+.||||++..  .+   .+.+.+|.++.+.  |+|+||+.|++.-..+   
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s--rd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS--RD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc--cc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            34446677788999999999999999 689999999842  22   2567788888776  5999999999876443   


Q ss_pred             -CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCeeEcCCCceEEcc
Q 037946          136 -SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH-----DCVPAILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-----~~~~~i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                       ..+|+|++|.+.|||.|+|.+ ..++....++++..+|.||++||.     ++.|.|.|||||..|||+.+++...|+|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence             357999999999999999998 569999999999999999999995     4678999999999999999999999999


Q ss_pred             ccCccccCCCC-cc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCC----------CCCCC
Q 037946          210 FGLAKLMNSTN-YH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR----------SAVQP  277 (371)
Q Consensus       210 fg~~~~~~~~~-~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~----------~p~~~  277 (371)
                      +|+|-...... .- -..+..+||.+|||||++........-.. -..+||||||.++||+..+.          .||.+
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fes-yk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFES-YKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhh-hhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99997654432 11 12345679999999999886533221111 24689999999999998632          56554


Q ss_pred             CCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      ..+.+....++..-.      -.+-+++...+.. ...+.+..+.+|+..||..||.-|-|+--+...|.++.+.++
T Consensus       439 ~Vp~DPs~eeMrkVV------Cv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e  508 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVV------CVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE  508 (513)
T ss_pred             CCCCCCCHHHHhcce------eecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence            444433332221110      0111222222221 123566677789999999999999999999999999986444

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.8e-40  Score=293.92  Aligned_cols=261  Identities=26%  Similarity=0.419  Sum_probs=198.4

Q ss_pred             ccccCCccccCCceEEEEEEeC-----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--CCeE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--KSVK  138 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  138 (371)
                      .|+..+.||+|+||.||+|...     ++..+|+|.+...... .....+.+|+++++.++||||+++++++..  ....
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            4566788999999999999743     3688999998543332 356789999999999999999999999877  5678


Q ss_pred             EEEEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          139 LLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      +++|||+++++|.+++.... .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            99999999999999997654 589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchh---------HHH
Q 037946          218 STNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH---------IVE  287 (371)
Q Consensus       218 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---------~~~  287 (371)
                      ..... .......++..|+|||.+.       +..++.++||||||+++|||++|..|+.........         ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~-------~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLR-------TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHc-------cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            33211 1112234566799999654       336788999999999999999999987543322111         001


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ............     +....++       ..+.+++.+||+.+|++|||+.|++++|..+
T Consensus       234 ~~~~~~~~~~~~-----~~~~~~~-------~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGERL-----PRPPSCP-------DEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCCcC-----CCCccCC-------HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111110000     0001111       3455688889999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.7e-40  Score=292.67  Aligned_cols=253  Identities=28%  Similarity=0.470  Sum_probs=188.1

Q ss_pred             CccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe-cCCeEEEEEeec
Q 037946           71 NVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS-NKSVKLLLYNYI  145 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  145 (371)
                      +.||+|+||.||+|.+.    .+..+|+|.+.. .........+..|+.+++.++|||++++++++. .++..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCc-cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            36899999999999653    235799998743 222334568889999999999999999999775 455688999999


Q ss_pred             CCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc-
Q 037946          146 SNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH-  223 (371)
Q Consensus       146 ~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  223 (371)
                      .+++|.+++.+. ...++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......... 
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999764 3467888899999999999999999   99999999999999999999999999997654322111 


Q ss_pred             -ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 -AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......++..|+|||.+.       ...++.++||||||+++|||++|+.|+.... +...+...+   .......   
T Consensus       157 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~~---~~~~~~~---  222 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYL---LQGRRLL---  222 (262)
T ss_pred             cccccCcCCccccChhHhc-------cCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH---hcCCCCC---
Confidence             112334677899999764       3357889999999999999999655443221 122222211   1110000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                         .....+       ..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       223 ---~~~~~~-------~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         223 ---QPEYCP-------DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ---CCCcCC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence               001112       234567888999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-39  Score=291.73  Aligned_cols=258  Identities=27%  Similarity=0.406  Sum_probs=195.8

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc--------chHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE--------EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      |...+.||.|+||.||+|.. .+|+.+|+|.+.......        ...+.+..|+.+++.++|||++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            56678999999999999964 468999999874322111        123467889999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            999999999999999998888899999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ............|+..|+|||.+...     ...++.++|+||||+++|+|++|..|+....    ....... .... .
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~-~~~~-~  228 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSY-----SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIAAMFK-LGNK-R  228 (272)
T ss_pred             ccccccccccccCCccccCHHHhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHHHHHH-hhcc-c
Confidence            32211122344688999999976532     1236789999999999999999999985321    1111111 1100 0


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .............       ...+.+++.+||+.+|++|||+++++++
T Consensus       229 ~~~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPIPPDVSMNL-------SPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcCCccccccC-------CHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0000000000111       1234557778999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-40  Score=297.55  Aligned_cols=239  Identities=20%  Similarity=0.331  Sum_probs=182.5

Q ss_pred             ccccCCceEEEEEEeCC-------------------------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCce
Q 037946           72 VIGKGCSGVVYKAEMPN-------------------------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV  126 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  126 (371)
                      .||+|+||.||+|....                         ...||+|.+...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            59999999999996311                         135888887432  223346788999999999999999


Q ss_pred             eeeceEecCCeEEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC--
Q 037946          127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY--  203 (371)
Q Consensus       127 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~--  203 (371)
                      +++++|.+.+..++||||+++|+|..++.. .+.+++..+..++.|++.||+|||++   +++||||||+||+++..+  
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999865 45689999999999999999999999   999999999999997654  


Q ss_pred             -----ceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHH-hCCCCCCC
Q 037946          204 -----EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL-SGRSAVQP  277 (371)
Q Consensus       204 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~-~g~~p~~~  277 (371)
                           .+|++|||.+......      ....++..|+|||.+.+      ...++.++||||||+++|||+ +|..|+..
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPG------GNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence                 3799999997643222      22357788999997652      235688999999999999995 68888754


Q ss_pred             CCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ....  .........    .           ..+...   ...+.+++.+||+.+|++|||++++++.|.
T Consensus       225 ~~~~--~~~~~~~~~----~-----------~~~~~~---~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         225 RTPS--EKERFYEKK----H-----------RLPEPS---CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             cChH--HHHHHHHhc----c-----------CCCCCC---ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            3221  111111110    0           011110   113556788899999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.2e-40  Score=293.79  Aligned_cols=250  Identities=22%  Similarity=0.335  Sum_probs=197.7

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||+|+||.+|++.. .+++.||+|.+............+.+|+.++++++||||+++.+++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            366778999999999999965 4688999999865444444556889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++....  .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999986543  578999999999999999999999   999999999999999999999999999976544321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......|++.|+|||.+.       +...+.++|+||||+++++|++|..|+....  ..   +.+.......      
T Consensus       157 -~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--~~---~~~~~~~~~~------  217 (256)
T cd08218         157 -LARTCIGTPYYLSPEICE-------NRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--MK---NLVLKIIRGS------  217 (256)
T ss_pred             -hhhhccCCccccCHHHhC-------CCCCCCccchhHHHHHHHHHHcCCCCccCCC--HH---HHHHHHhcCC------
Confidence             122345888999999764       3356789999999999999999999985321  11   2222211110      


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          ....+...   ...+.+++.+||+.+|++||++++++++
T Consensus       218 ----~~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 ----YPPVSSHY---SYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ----CCCCcccC---CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                01111111   1234557888999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-40  Score=306.47  Aligned_cols=190  Identities=24%  Similarity=0.346  Sum_probs=160.4

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ..|+..+.||+|+||.||+|... +++.||+|.....        ....|+.++++++||||+++++++...+..++|||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            36889999999999999999764 5678999975221        23568999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ++.+ +|.+++.. ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......  
T Consensus       138 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             ccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            9964 78877754 56689999999999999999999999   99999999999999999999999999997533221  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ  276 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  276 (371)
                       ......||+.|+|||++.+       ..++.++|||||||++|||+++..++.
T Consensus       212 -~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLAR-------DKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             -ccccccccccccCCeecCC-------CCCCchhhHHHHHHHHHHHHHcCCccc
Confidence             2234569999999998753       357889999999999999999766653

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.6e-40  Score=294.16  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=195.7

Q ss_pred             ccccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +|...+.||+|+||.||+|...+    ...||+|..... ......+.+.+|+.++++++|||++++++++.+ +..++|
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            46677899999999999996533    246899987432 224455788999999999999999999998875 457899


Q ss_pred             EeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            99999999999997643 589999999999999999999998   99999999999999999999999999997664443


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .. ......++..|+|||.+.       ...++.++||||||+++|||++ |..||.....  ......+...    ...
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~~~~----~~~  227 (270)
T cd05056         162 YY-KASKGKLPIKWMAPESIN-------FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGRIENG----ERL  227 (270)
T ss_pred             ce-ecCCCCccccccChhhhc-------cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHcC----CcC
Confidence            21 112233556899999764       2356889999999999999996 9999864432  1222221110    000


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                           +.....+       ..+.+++.+||..+|++|||+.++++.|.++..
T Consensus       228 -----~~~~~~~-------~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 -----PMPPNCP-------PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -----CCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 0011222       234457788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4e-40  Score=294.87  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=193.9

Q ss_pred             cccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC------
Q 037946           67 LKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS------  136 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  136 (371)
                      |...+.||+|+||.||+|.+.    +++.+|+|.+..........+++.+|+++++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            445678999999999999643    4688999998665555556778899999999999999999999875432      


Q ss_pred             eEEEEEeecCCCCHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          137 VKLLLYNYISNGNLQQLLQGN------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                      ..++++||+.+|+|.+++...      ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999999887422      2478899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  289 (371)
                      |+++...............+++.|++||.+.       +..++.++||||||+++|+|++ |..|+....  ...+..++
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--~~~~~~~~  228 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLA-------DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYNYL  228 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHh-------cCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--HHHHHHHH
Confidence            9998764433222223334667899999654       3356789999999999999999 777775322  12222222


Q ss_pred             HHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ...    ....     .....+       ..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       229 ~~~----~~~~-----~~~~~~-------~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKG----NRLK-----QPPDCL-------EDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcC----CcCC-----CCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            211    0000     001111       2455678889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.7e-40  Score=291.65  Aligned_cols=250  Identities=22%  Similarity=0.424  Sum_probs=195.0

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .|+..+.||+|+||.||++.+.++..+|+|.+....   .....+.+|++++++++|||++++++++......+++|||+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            466678899999999999987778899999885332   22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++++|.+++... ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+......... .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~  157 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S  157 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence            999999999764 4589999999999999999999999   9999999999999999999999999998765433211 1


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....++..|+|||.+.       +..++.++||||||+++|||++ |..||.....  ...........   .    ..
T Consensus       158 ~~~~~~~~~~~aPe~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~---~----~~  221 (256)
T cd05112         158 STGTKFPVKWSSPEVFS-------FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAGF---R----LY  221 (256)
T ss_pred             cCCCccchhhcCHhHhc-------cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHhCCC---C----CC
Confidence            12223567899999764       3357789999999999999998 8888754321  11211111100   0    00


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .+  ...+       ..+.+++.+||+.+|++|||++++++.|.
T Consensus       222 ~~--~~~~-------~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 KP--RLAS-------QSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CC--CCCC-------HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            11  1111       24566888899999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.5e-40  Score=291.08  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=196.0

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+............+.+|++++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            366778899999999999965 4688999999865544555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-CceEEccccCccccCCCCc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~  221 (371)
                      +++++|.+++...  ..+++..+..++.+++.|++|||++   +++|+||+|+||+++.+ +.+||+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            9999999999763  3589999999999999999999999   99999999999999855 468999999998765432 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                        ......++..|+|||.+.       ...++.++||||||+++|+|++|..||.....  ...   +.......     
T Consensus       157 --~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~---~~~~~~~~-----  217 (256)
T cd08220         157 --KAYTVVGTPCYISPELCE-------GKPYNQKSDIWALGCVLYELASLKRAFEAANL--PAL---VLKIMSGT-----  217 (256)
T ss_pred             --cccccccCCcccCchhcc-------CCCCCcccchHHHHHHHHHHHhCCCCcccCch--HHH---HHHHHhcC-----
Confidence              122346889999999765       23567899999999999999999999854322  111   11111110     


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                           ....++.   ....+.+++.+||+.||++|||+.|++++
T Consensus       218 -----~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 -----FAPISDR---YSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -----CCCCCCC---cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                 0011111   11234457788999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.3e-40  Score=301.16  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=197.1

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCC----EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .|+..+.||+|+||.||+|.+. +++    .+|+|.+.... .......+.+|+.+++.++||||++++++|... ..++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            4667789999999999999653 444    47888874322 233345788999999999999999999998754 4679


Q ss_pred             EEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++||+++|+|.+++.... .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence            999999999999987644 589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..........++..|+|||.+.       +..++.++||||||+++|||++ |+.||.....  ....+++...    ..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~----~~  229 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIH-------YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKG----ER  229 (303)
T ss_pred             ccccccCCCccccccCCHHHhc-------cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC----CC
Confidence            3221222334577899999764       3357889999999999999997 8888854321  2222222211    00


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .     +.....       ..++.+++.+||..+|++||+++++++.|.++...+.
T Consensus       230 ~-----~~~~~~-------~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         230 L-----PQPPIC-------TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             C-----CCCCCC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            0     000111       1245567888999999999999999999999865554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-40  Score=296.40  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=195.5

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+.... .......+.+|+.++++++||||+++++++...+..|+||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            455567899999999999965 457889999875332 233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|.+++.. ..+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            999999999865 4589999999999999999999999   99999999999999999999999999997654432  11


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....++..|+|||.+.       +..++.++|+||||+++|||++|..|+......  .....    ...         
T Consensus       158 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~----~~~---------  215 (277)
T cd06642         158 RNTFVGTPFWMAPEVIK-------QSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVLFL----IPK---------  215 (277)
T ss_pred             hhcccCcccccCHHHhC-------cCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHHhh----hhc---------
Confidence            22345888999999765       335788999999999999999999998533221  11100    000         


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ........   .....+.+++.+||+.+|++||++.+++++-+
T Consensus       216 ~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         216 NSPPTLEG---QYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             CCCCCCCc---ccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence            00001111   11223456788899999999999999999743

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-40  Score=294.48  Aligned_cols=252  Identities=28%  Similarity=0.395  Sum_probs=198.7

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||.|++|.||+|... +++.+|+|.+.... .......+.+|+++++.++|||++++.+++.+....|+|+||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            4677788999999999999754 68899999985432 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|.+++... .+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++|+|||.++......  ..
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~  154 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SK  154 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--cc
Confidence            9999999999876 789999999999999999999999   99999999999999999999999999998765442  12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....+++.|+|||.+.       +..++.++||||||+++|+|++|..||......  .....+..   ...       
T Consensus       155 ~~~~~~~~~y~~PE~~~-------~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~---~~~-------  215 (274)
T cd06609         155 RNTFVGTPFWMAPEVIK-------QSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPK---NNP-------  215 (274)
T ss_pred             cccccCCccccChhhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhh---cCC-------
Confidence            23456888999999765       335789999999999999999999998643211  11111111   000       


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      +.+...  .   ....+.+++.+||..||++|||+++++++-+-
T Consensus       216 ~~~~~~--~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~  254 (274)
T cd06609         216 PSLEGN--K---FSKPFKDFVSLCLNKDPKERPSAKELLKHKFI  254 (274)
T ss_pred             CCCccc--c---cCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence            000000  0   11134457778999999999999999986443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5e-40  Score=292.50  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=197.0

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe--cCCeEEEEEe
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS--NKSVKLLLYN  143 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e  143 (371)
                      |+..+.||.|+||.||++.. .+++.+|+|.+..........+.+..|+++++.++|||++++++++.  .....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            56678899999999999964 46889999998655555556678899999999999999999999775  3456899999


Q ss_pred             ecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          144 YISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLH-----HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       144 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh-----~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      |+++++|.+++..    ...+++..++.++.|++.||.|||     +.   +++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence            9999999999865    356899999999999999999999     76   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      .......  ......+++.|+|||.+.       +..++.++|+||||+++|+|++|..|+....  .....+.+...  
T Consensus       159 ~~~~~~~--~~~~~~~~~~~~~pE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~--  225 (265)
T cd08217         159 ILGHDSS--FAKTYVGTPYYMSPEQLN-------HMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEG--  225 (265)
T ss_pred             cccCCcc--cccccccCCCccChhhhc-------CCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcC--
Confidence            7654431  123456899999999765       2356789999999999999999999986542  22222221110  


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                                 .....+..   ....+.+++.+||+.+|++|||+.+|+++
T Consensus       226 -----------~~~~~~~~---~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 -----------KFRRIPYR---YSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----------CCCCCccc---cCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                       01111111   12244567888999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-39  Score=292.93  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=199.0

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ..|+..+.||.|+||.||+|.+. +++.||+|.+... ........+.+|+.++++++|||++++++.+.+.+..++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            34666788999999999999764 5889999988532 223445788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++.. .++++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            9999999999875 4589999999999999999999999   999999999999999999999999999976644321  


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......++..|+|||.+.       ...++.++|+||||+++|||++|..|+......  ...   .. ...        
T Consensus       157 ~~~~~~~~~~y~apE~~~-------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~---~~-~~~--------  215 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQ-------QSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVL---FL-IPK--------  215 (277)
T ss_pred             ccccccCcccccCHhHhc-------cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHh---hh-hhc--------
Confidence            223346888999999764       335788999999999999999999998643221  110   00 000        


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                       ......+.   .....+.+++.+||+.+|++||++.+++++-+-
T Consensus       216 -~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06640         216 -NNPPTLTG---EFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI  256 (277)
T ss_pred             -CCCCCCch---hhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence             00011111   122345668888999999999999999988553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-39  Score=295.03  Aligned_cols=265  Identities=25%  Similarity=0.330  Sum_probs=197.4

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC---cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD---EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      |+..+.||+|++|.||+|... +++.||+|++......   ......+..|+++++.++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            566778999999999999754 6899999998654432   223456778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+ +++|.+++.... .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999 889999998766 799999999999999999999999   999999999999999999999999999987654421


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc---
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP---  298 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  298 (371)
                        ......+++.|+|||.+.+      ...++.++|||||||++|||++|.++|.....  ................   
T Consensus       158 --~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         158 --KMTHQVVTRWYRAPELLFG------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENW  227 (298)
T ss_pred             --cccccccceeeeCHHHHhC------CCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhhh
Confidence              2233457888999997632      23467899999999999999999777654321  1111111111111000   


Q ss_pred             -----cccccCc-ccCCCCh-h-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 -----AVSILDT-KLQGLPD-Q-MVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 -----~~~~~~~-~~~~~~~-~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                           ....... .....+. . .......+.+++.+||+.||++|||+.|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                 0000000 0000000 0 00112345678999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.3e-40  Score=295.20  Aligned_cols=267  Identities=22%  Similarity=0.380  Sum_probs=199.6

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            4677889999999999999765 589999999865443333456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|.++......+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~  156 (286)
T cd07846          82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EV  156 (286)
T ss_pred             CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cc
Confidence            99999999887777799999999999999999999999   99999999999999999999999999987654432  12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc-cccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA-VSIL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  303 (371)
                      .....++..|+|||.+.+      +..++.++||||||+++|||++|.+||.....  ......+.......... ....
T Consensus       157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         157 YTDYVATRWYRAPELLVG------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCcccceeeccCcHHhcc------ccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHh
Confidence            233457899999997642      22457789999999999999999988854321  11111111111110000 0000


Q ss_pred             C------cc-cCCC--Chhh----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 D------TK-LQGL--PDQM----VQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~------~~-~~~~--~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .      .. ....  ....    ......+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0      00 0000  0000    0112345668888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.8e-40  Score=290.78  Aligned_cols=258  Identities=30%  Similarity=0.452  Sum_probs=201.4

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|...+.||+|+||.||+|.. .+++.+++|.+..........+.+..|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            466778999999999999965 4688999999865544445678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|.+++.....+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99999999998887789999999999999999999999   999999999999999999999999999987654432111


Q ss_pred             --cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          225 --MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       225 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        .....+++.|+|||.+...    ....++.++||||||+++|+|++|..||...... ......+..  .. .     
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~----~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~--~~-~-----  224 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGG----KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGA--GH-K-----  224 (264)
T ss_pred             ccccCCcCCcCccChhhccCC----CCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhc--CC-C-----
Confidence              1234678899999987632    1124788999999999999999999998643211 111111110  00 0     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        +   ..+.. ......+.+++.+||+.+|++|||+.+++.+
T Consensus       225 --~---~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         225 --P---PIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             --C---CCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              0   01110 0112234467888999999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-39  Score=297.50  Aligned_cols=195  Identities=26%  Similarity=0.373  Sum_probs=157.5

Q ss_pred             CCccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe--cCCeEEEEEee
Q 037946           70 ENVIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS--NKSVKLLLYNY  144 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~  144 (371)
                      +..||+|+||.||+|...   ++..||+|.+....    ....+.+|+.+++.++||||+++++++.  .....++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            357999999999999754   35789999884322    2245788999999999999999999884  45678999999


Q ss_pred             cCCCCHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE----cCCCceEEcccc
Q 037946          145 ISNGNLQQLLQG---------NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL----DSKYEAYLADFG  211 (371)
Q Consensus       145 ~~~~~L~~~l~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg  211 (371)
                      +.+ +|.+++..         ...+++..+..++.|++.||.|||++   +++||||||+||++    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            875 77777642         22478899999999999999999999   99999999999999    566789999999


Q ss_pred             CccccCCCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          212 LAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       212 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      +++........ .......||+.|+|||.+.+      ...++.++|||||||++|||+||.+||...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcC------CCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            99876543211 12234568999999998652      234678999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3e-40  Score=299.43  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=195.9

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |.....||+|+||.||++.. .+++.||+|.+...  .......+.+|+.+++.++|||++++++++..++..|++|||+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            33445799999999999965 46899999998432  2233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccc
Q 037946          146 SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM  225 (371)
Q Consensus       146 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  225 (371)
                      ++++|.+++.. ..+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.+||+|||++.......  ...
T Consensus       101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~  174 (297)
T cd06659         101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR  174 (297)
T ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence            99999998765 4589999999999999999999999   99999999999999999999999999987554332  122


Q ss_pred             ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ....|+..|+|||.+.       +..++.++||||||+++|||++|..||.....  ......+..   .....    ..
T Consensus       175 ~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~---~~~~~----~~  238 (297)
T cd06659         175 KSLVGTPYWMAPEVIS-------RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRD---SPPPK----LK  238 (297)
T ss_pred             cceecCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhc---cCCCC----cc
Confidence            3456899999999764       33568899999999999999999999864321  111111111   00000    00


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .....+       ..+.+++.+||+.+|++||++++++++-.-..
T Consensus       239 ~~~~~~-------~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~  276 (297)
T cd06659         239 NAHKIS-------PVLRDFLERMLTREPQERATAQELLDHPFLLQ  276 (297)
T ss_pred             ccCCCC-------HHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence            011111       12445777899999999999999999755444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-39  Score=293.11  Aligned_cols=268  Identities=24%  Similarity=0.321  Sum_probs=200.7

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||+|++|.||+|.+ .+|+.||+|++............+.+|+.++++++|||++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            366778899999999999976 4689999999865444344557889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      + +++|.+++.. ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 9999999864 45689999999999999999999999   999999999999999999999999999987654331 1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc-----
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP-----  298 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  298 (371)
                      ......++..|+|||.+.+      ...++.++||||+|+++|||++|.+||....  +......+.........     
T Consensus       156 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         156 LYSHQVATRWYRAPELLYG------ARKYDPGVDLWAVGCIFAELLNGSPLFPGEN--DIEQLAIVFRTLGTPNEETWPG  227 (286)
T ss_pred             ccccccCcccccCceeeec------cccCCchhHHHHHHHHHHHHHcCCcCcCCCC--HHHHHHHHHHHcCCCChHHHhh
Confidence            2234568999999997642      2245789999999999999999977764332  11222222222111100     


Q ss_pred             ------cccccCcccCCCC-hhh-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          299 ------AVSILDTKLQGLP-DQM-VQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       299 ------~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                            ...+........+ ... ......+.+++.+||+.||++|||+++++++-
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                  0000000000000 000 01124556788999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.9e-40  Score=298.14  Aligned_cols=260  Identities=24%  Similarity=0.352  Sum_probs=199.1

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      +..+.|...+.||+|+||.||+|... +++.||+|.+..... .......+.+|+.+++.++|||++++.++|.+.+..|
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            33456888889999999999999754 689999998854322 2334567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+.+ ++.+++. ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99999975 7777664 345689999999999999999999999   999999999999999999999999999875433


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .      ....+++.|+|||.+.+.    ....++.++||||||+++|||++|..|+.....  ...   ....... ..
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--~~~---~~~~~~~-~~  231 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA---LYHIAQN-DS  231 (307)
T ss_pred             C------CCccCCccccCceeeecc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--HHH---HHHHhcC-CC
Confidence            2      234578899999986421    134578899999999999999999999853311  111   1111000 00


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                               ......  .....+.+++.+||+.||++||++.+++.+.+-....
T Consensus       232 ---------~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         232 ---------PTLSSN--DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             ---------CCCCch--hhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                     001000  1122456688889999999999999999987655433

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-39  Score=290.73  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=193.5

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC---cchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD---EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  139 (371)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+......   ......+.+|+.++++++||||+++++++.+.  ...+
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            467788999999999999965 45899999988543222   23356788999999999999999999988763  5678


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++|||+++++|.+++.+...+++.....++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            9999999999999998877889999999999999999999999   9999999999999999999999999998765432


Q ss_pred             Ccc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ... .......++..|+|||.+.+       ..++.++||||||+++|+|++|+.||.....    ... +......  .
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~-~~~~~~~--~  225 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAA-IFKIATQ--P  225 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-------CCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHH-HHHHhcC--C
Confidence            111 11233468899999997652       3567899999999999999999999864311    111 1111111  0


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                             .....+..   ....+..++.+||. +|++||+++|++++-
T Consensus       226 -------~~~~~~~~---~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         226 -------TNPVLPPH---VSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             -------CCCCCchh---hCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence                   00111211   12234456777885 999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-39  Score=289.58  Aligned_cols=250  Identities=27%  Similarity=0.404  Sum_probs=197.4

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC---CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR---DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      |+..+.||+|++|.||+|... +++.|++|.+.....   .....+.+.+|+.+++.++|||++++++++.+.+..+++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566788999999999999765 789999998854332   1234567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++.+...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.......  
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999987654432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......+++.|+|||.+...      ..++.++|+||||+++|+|++|..||.....  .   ......... ...   
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~------~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~---~~~~~~~~~-~~~---  220 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQ------GGYGLAADIWSLGCTVLEMATGKPPWSQLEG--V---AAVFKIGRS-KEL---  220 (258)
T ss_pred             -cccccCCCcceeCHHHhcCC------CCCCchhhhHHHHHHHHHHHhCCCCcccCcH--H---HHHHHHHhc-ccC---
Confidence             22345688999999975421      1368899999999999999999999864321  1   111111110 000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                           ...+...   ...+.+++.+||+.+|++||++.+++.+
T Consensus       221 -----~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         221 -----PPIPDHL---SDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -----CCcCCCc---CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                 1111111   1233457788999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-39  Score=289.03  Aligned_cols=249  Identities=30%  Similarity=0.530  Sum_probs=194.3

Q ss_pred             ccCCccccCCceEEEEEEeCC-----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           68 KDENVIGKGCSGVVYKAEMPN-----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +..+.||.|+||.||++....     +..+|+|.+... ........+..|+.+++.++|+|++++++++.+.+..+++|
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            456789999999999997643     388999998433 22225678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          143 NYISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||+++++|.+++.....  +++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999976554  89999999999999999999999   99999999999999999999999999998765543


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .... ....+++.|+|||.+.       +..++.++||||||+++++|++ |..|+...  +.......+....    ..
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~----~~  223 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLK-------DGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLKKGY----RL  223 (258)
T ss_pred             cccc-ccCCCcccccChHHhc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCC----CC
Confidence            2211 1233788999999763       3467889999999999999998 67776542  1222222221111    00


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                           ......+       ..+.+++.+||+.||++|||+.++++.|
T Consensus       224 -----~~~~~~~-------~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 -----PKPENCP-------PEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCCcCC-------HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 0011112       2345577889999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2e-39  Score=289.63  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=189.9

Q ss_pred             cCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           69 DENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      ....||+|+||.||+|.+. ++..||+|.+...  .....+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence            3457999999999999754 5788999987432  234456889999999999999999999999999999999999999


Q ss_pred             CCHHHHhccC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccCccccCCCCccc
Q 037946          148 GNLQQLLQGN-RNL--DWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       148 ~~L~~~l~~~-~~~--~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ++|.+++... ..+  ++..+..++.|++.||+|||++   +++||||||+||+++. ++.++|+|||.+.......  .
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~  164 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--P  164 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--C
Confidence            9999999754 445  7888999999999999999999   9999999999999976 6799999999987654332  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......+++.|+|||.+...     ...++.++|+||||+++|+|++|..|+.........  .+......         
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~~---------  228 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKG-----PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMFK---------  228 (268)
T ss_pred             ccccCCCCccccChhhhccc-----cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhhc---------
Confidence            22334588999999976421     123678999999999999999999998543211111  11000000         


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        .....+....   ..+.+++.+||+.+|++|||+.|++++
T Consensus       229 --~~~~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 --IHPEIPESLS---AEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --cCCCCCcccC---HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              0011111111   234457888999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-40  Score=299.20  Aligned_cols=253  Identities=24%  Similarity=0.294  Sum_probs=196.5

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc-chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE-EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +|+..+.||+|++|.||+|... +++.+|+|.+....... .....+..|+++++.++||||+++++.+.+....|++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            4777889999999999999764 48999999986543332 355678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |+.+++|.+++...  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999998754  4689999999999999999999999   999999999999999999999999999875432210


Q ss_pred             c---------------------------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCC
Q 037946          222 H---------------------------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA  274 (371)
Q Consensus       222 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p  274 (371)
                      .                           .......||..|+|||.+.       +..++.++||||||+++|+|++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-------GDGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-------CCCCCchHHHHHHHHHHHHHhhCCCC
Confidence            0                           0111235788999999765       33568899999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC----HHHHHHH
Q 037946          275 VQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT----MKEVVAL  345 (371)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs----~~evl~~  345 (371)
                      |...... ...    .........        .... .   .....+.+++.+||+.||++|||    ++|++++
T Consensus       232 f~~~~~~-~~~----~~~~~~~~~--------~~~~-~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         232 FKGSNRD-ETF----SNILKKEVT--------FPGS-P---PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCCchH-HHH----HHHhcCCcc--------CCCc-c---ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            8644321 111    111111000        0000 0   01234556778899999999999    8888886

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-39  Score=296.33  Aligned_cols=268  Identities=20%  Similarity=0.298  Sum_probs=196.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            45788889999999999999764 578999999854322 2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++ +|.+++.. ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++.......  
T Consensus        85 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          85 YLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            9975 88888765 45689999999999999999999999   99999999999999999999999999997644322  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc--cc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP--AV  300 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~  300 (371)
                      .......+++.|+|||.+.+      ...++.++||||||+++|+|++|..||.....  ......+.........  ..
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWP  230 (301)
T ss_pred             CcccccceeecccCcHHHhC------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhch
Confidence            12233457899999997642      22467899999999999999999999864422  1222222221111000  00


Q ss_pred             ccc------CcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SIL------DTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~------~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...      ............     .....+.+++.+||+.||.+|||++|++++-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            000      000000000000     01113456888999999999999999998644

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.9e-40  Score=290.60  Aligned_cols=250  Identities=23%  Similarity=0.285  Sum_probs=199.0

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc-chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE-EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +|+..+.||.|+||.||+|... +++.||+|.+....... ...+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            3667789999999999999764 58999999986543322 456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+.+++|.+++.....+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||.+.......   
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---  154 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---  154 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence            999999999998887899999999999999999999999   99999999999999999999999999998765442   


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......|+..|+|||.+..       ..++.++|+||||+++|+|++|..||.......  . ..+......        
T Consensus       155 ~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~-~~~~~~~~~--------  216 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCR-------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--R-DQIRAKQET--------  216 (258)
T ss_pred             cccccCCChhhcCHHHHcc-------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--H-HHHHHHhcc--------
Confidence            2234568889999997653       246889999999999999999999987544321  1 111111110        


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH--HHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM--KEVVA  344 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~--~evl~  344 (371)
                        .....+....   ..+.+++.+||+.||.+||++  +|+++
T Consensus       217 --~~~~~~~~~~---~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 --ADVLYPATWS---TEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             --ccccCcccCc---HHHHHHHHHHccCChhHcCCccHHHHhc
Confidence              0011111111   344567788999999999999  77664

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-39  Score=290.07  Aligned_cols=254  Identities=28%  Similarity=0.400  Sum_probs=200.7

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|+..+.||+|++|.||++... +++.+|+|.+..... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            3556678999999999999764 689999999855332 34556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++... ..+++..+..++.|++.|++|||+ .   +++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  155 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--  155 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence            9999999999876 778999999999999999999999 7   99999999999999999999999999987654322  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        .....++..|+|||.+.+       ..++.++||||||+++|+|++|..|+...........+.+........     
T Consensus       156 --~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----  221 (265)
T cd06605         156 --AKTFVGTSSYMAPERIQG-------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-----  221 (265)
T ss_pred             --hhcccCChhccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-----
Confidence              112568899999997642       367889999999999999999999986543222233333333222111     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                           ...+...  ....+.+++.+||..||++|||+.+++.+-
T Consensus       222 -----~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  258 (265)
T cd06605         222 -----PRLPSGK--FSPDFQDFVNLCLIKDPRERPSYKELLEHP  258 (265)
T ss_pred             -----CCCChhh--cCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence                 1111110  122345678889999999999999998763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=293.88  Aligned_cols=268  Identities=25%  Similarity=0.388  Sum_probs=201.8

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +|+..+.||+|+||.||+|... +++.||+|++............+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            4777889999999999999764 588999999865544555567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++++.+..+......+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||.+........ ..
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~  157 (288)
T cd07833          82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SP  157 (288)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cc
Confidence            99988877777777799999999999999999999999   999999999999999999999999999987655432 12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc-cc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS-IL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  303 (371)
                      .....++..|+|||.+...      ..++.++||||||+++|+|++|..||.....  ...............+... ..
T Consensus       158 ~~~~~~~~~~~~PE~~~~~------~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         158 LTDYVATRWYRAPELLVGD------TNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             ccCcccccCCcCCchhcCC------CCcCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHhhhc
Confidence            2345688999999987522      1567899999999999999999998864321  1111111111111111000 00


Q ss_pred             --Cc-----ccCCC--ChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 --DT-----KLQGL--PDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 --~~-----~~~~~--~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        +.     .....  +....     .....+.+++.+||+.+|++|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              00     00000  00000     002345678888999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.2e-39  Score=299.06  Aligned_cols=281  Identities=26%  Similarity=0.373  Sum_probs=204.1

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC--CeE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK--SVK  138 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  138 (371)
                      +.++|+..+.||+|+||.||+|.+. +++.+|+|++............+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888899999999999999764 588999999865444444556778899999999 999999999988643  468


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      |+||||+++ +|.+++... .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            999999975 999998776 789999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCcc---cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          219 TNYH---HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       219 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ....   .......||+.|+|||.+.+      ...++.++||||||+++|+|++|+.||.....  ......+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~--~~~~~~~~~~~~~  231 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLG------STRYTKGVDMWSVGCILGEMLLGKPLFPGTST--LNQLEKIIEVIGP  231 (337)
T ss_pred             ccccccCcchhcccccccccCceeeec------cccccccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCC
Confidence            3311   12234568999999997642      23467899999999999999999999854321  1111111111110


Q ss_pred             CCc----------cccccC----cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HhcccCCCccC
Q 037946          296 FEP----------AVSILD----TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVKSAPEEL  356 (371)
Q Consensus       296 ~~~----------~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~  356 (371)
                      ...          .....+    ................+.+++.+||+.||++|||+.+++++  +.++....++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~  308 (337)
T cd07852         232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP  308 (337)
T ss_pred             CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence            000          000000    00000000000012345678888999999999999999987  55665554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-40  Score=292.34  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=195.9

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCC-----
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKS-----  136 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-----  136 (371)
                      .++|+..+.||+|++|.||+|... +++.+++|.+...   ......+.+|+.+++++ +|+||+++++++.+..     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356888899999999999999764 5788999988432   22346789999999999 7999999999986544     


Q ss_pred             -eEEEEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcccc
Q 037946          137 -VKLLLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG  211 (371)
Q Consensus       137 -~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  211 (371)
                       ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             48999999999999999865    34689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++.......  .......|++.|+|||.+....  .....++.++||||||+++|+|++|..||...... ..+.    .
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~----~  229 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDE--QPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALF----K  229 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccc--cccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHH----H
Confidence            987654332  1223456899999999875431  11345678999999999999999999998643211 1111    1


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ....  ..     .... .+..   ....+.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~--~~-----~~~~-~~~~---~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 IPRN--PP-----PTLK-SPEN---WSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhcc--CC-----CCCC-chhh---cCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1111  00     0000 0111   11234568888999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.7e-40  Score=295.45  Aligned_cols=248  Identities=23%  Similarity=0.301  Sum_probs=198.5

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +|+..+.||+|++|.||++... +++.+|+|.+..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            4677889999999999999654 689999999854332 22345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......    
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            999999999998888899999999999999999999999   9999999999999999999999999999876443    


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                       .....+++.|+|||.+.       +...+.++||||||+++|+|++|..||....  .......+   .....      
T Consensus       155 -~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~---~~~~~------  215 (290)
T cd05580         155 -TYTLCGTPEYLAPEIIL-------SKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKI---LEGKV------  215 (290)
T ss_pred             -CCCCCCCccccChhhhc-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH---hcCCc------
Confidence             23446899999999764       2356789999999999999999999986432  11111111   11100      


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHh
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLM  347 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~  347 (371)
                           ..+...   ...+.+++.+||+.||.+||     +++|++++-+
T Consensus       216 -----~~~~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         216 -----RFPSFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             -----cCCccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence                 111111   12344577889999999999     8888887643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-39  Score=288.57  Aligned_cols=255  Identities=24%  Similarity=0.412  Sum_probs=197.2

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC----cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      |+..+.||+|++|.||++.. .+++.+|+|.+......    ......+..|+.++++++|||++++++++.+.+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            66778999999999999965 56899999998543321    12356789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.|||++   +++|+||+|+||+++.++ .++|+|||.+.......
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            99999999999998888899999999999999999999999   999999999999998776 59999999987765432


Q ss_pred             cc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          221 YH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       221 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..  .......++..|+|||.+.+       ..++.++|+||+|+++|+|++|..||.......  ....+......   
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~---  226 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRG-------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIASA---  226 (268)
T ss_pred             ccCCccccccccccceeCHhHhcc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHhcc---
Confidence            11  11223468899999997653       356789999999999999999999985432211  11111111000   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                            ......++.   ....+.+++.+||..+|++|||+.+++++
T Consensus       227 ------~~~~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         227 ------TTAPSIPEH---LSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ------CCCCCCchh---hCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                  000111111   12344557888999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-39  Score=293.72  Aligned_cols=267  Identities=22%  Similarity=0.255  Sum_probs=192.6

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.+++.++|+||+++.+++.+.+..|+|||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            4577888999999999999965 4688999999854332 2333467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+. ++|.+++. ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  157 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--  157 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence            996 57766654 345678888999999999999999999   99999999999999999999999999987643322  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc---
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA---  299 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  299 (371)
                      .......+++.|+|||.+.+.      ..++.++||||||+++|+|++|..||.........+.. +..........   
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGA------TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGVPTEDTWP  230 (291)
T ss_pred             CCCCCccccccccCCceeecC------CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCCCChhhhh
Confidence            122334578999999976521      24577899999999999999999998644321111111 11111100000   


Q ss_pred             -----ccccCcccCCCChh-------hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 -----VSILDTKLQGLPDQ-------MVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 -----~~~~~~~~~~~~~~-------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                           ..............       .......+.+++.+|++.||++|||++|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                 00000000000000       00112344568888999999999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4e-39  Score=288.80  Aligned_cols=255  Identities=25%  Similarity=0.448  Sum_probs=195.9

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      +.|...+.||+|+||.||+|...      +.+.+++|.+... ........+.+|++++++++|||++++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            35677788999999999999753      2467899987432 2233457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcc
Q 037946          139 LLLYNYISNGNLQQLLQGNR---------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                      ++||||+++++|.+++....         .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999997655         689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEW  288 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  288 (371)
                      ||++........ .......++..|+|||.+.       +...+.++||||||+++|+|++ |..||....  .......
T Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~~~~~~~  230 (275)
T cd05046         161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQ-------EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--DEEVLNR  230 (275)
T ss_pred             cccccccCcccc-cccCCceeEEeecChhhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCccccc--hHHHHHH
Confidence            999875433321 1223345678899999764       2356789999999999999999 667774321  1122221


Q ss_pred             HHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ...   .....     ......+.       .+.+++.+||+.||++|||+.++++.|++
T Consensus       231 ~~~---~~~~~-----~~~~~~~~-------~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         231 LQA---GKLEL-----PVPEGCPS-------RLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHc---CCcCC-----CCCCCCCH-------HHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            111   10000     00112222       34557888999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.4e-39  Score=293.00  Aligned_cols=265  Identities=23%  Similarity=0.309  Sum_probs=196.6

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  141 (371)
                      +.|+..+.||.|+||.||+|... +++.+|+|.+............+.+|+.++++++||||+++++++...  +..|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            45777889999999999999765 588999999865444444445678899999999999999999998777  899999


Q ss_pred             EeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++ +|.+++.... .+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 9999887644 589999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC----
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF----  296 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  296 (371)
                        .......+++.|+|||.+.+.      ..++.++|+||||+++|+|++|..||.....  ......+.......    
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         161 --KPYTQLVVTLWYRAPELLLGA------KEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             --cccccccccccccCchhhcCC------ccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchHH
Confidence              122334578899999976522      2357899999999999999999999864322  11111111111100    


Q ss_pred             -------Cccc--cccCcc---c-CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          297 -------EPAV--SILDTK---L-QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       297 -------~~~~--~~~~~~---~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                             ....  ......   + ...+..  .....+.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPAL--SLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHhhccchhcccccccccchhhhcccccc--CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   0000  000000   0 001110  012234568888999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-40  Score=292.63  Aligned_cols=241  Identities=19%  Similarity=0.333  Sum_probs=182.9

Q ss_pred             CccccCCceEEEEEEeCC--------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPN--------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.||+|+||.||+|....        ...+|+|.+..  ......+.+.+|..+++.++|||++++++++......++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc--hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            369999999999996532        23478887632  22334567889999999999999999999999989999999


Q ss_pred             eecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc--------eEEccccCc
Q 037946          143 NYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE--------AYLADFGLA  213 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~--------~kl~Dfg~~  213 (371)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||++   +++||||||+||+++.++.        ++++|||.+
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999997644 589999999999999999999999   9999999999999987765        699999998


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      ......      ....+++.|+|||.+..      ...++.++||||||+++|||++|..++...... ...... .  .
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~-~--~  219 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIEN------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQF-Y--E  219 (258)
T ss_pred             cccCCc------hhccccCCccCchhccC------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHH-H--H
Confidence            654332      23457889999998652      224678999999999999999996443221111 111110 0  0


Q ss_pred             cCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..            ...+...   ...+.+++.+||+.||++|||++++++.|+
T Consensus       220 ~~------------~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR------------HQLPAPK---WTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc------------ccCCCCC---cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00            0111111   123456888899999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-39  Score=287.93  Aligned_cols=245  Identities=27%  Similarity=0.457  Sum_probs=190.8

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.|+..+.||+|+||.||++.. +++.+|+|.+...    .....+.+|+.+++.++|||++++++++...+ .+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEEC
Confidence            4578889999999999999975 6788999988432    23467899999999999999999999987654 6999999


Q ss_pred             cCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++....  .+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++......   
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999999997543  478999999999999999999998   9999999999999999999999999998754322   


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                        ......+..|+|||.+.       +..++.++|+||||+++|+|++ |..||.....  ......+..   ....   
T Consensus       154 --~~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~---~~~~---  216 (254)
T cd05083         154 --VDNSKLPVKWTAPEALK-------HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--KEVKECVEK---GYRM---  216 (254)
T ss_pred             --CCCCCCCceecCHHHhc-------cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhC---CCCC---
Confidence              12233467899999664       3467889999999999999998 8888754321  112111111   1000   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                        . .....+       ..+.+++.+||+.+|++||+++++++.|.+
T Consensus       217 --~-~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 --E-PPEGCP-------ADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --C-CCCcCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              0 001122       234567888999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-39  Score=293.15  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=192.9

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEe------cC
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCS------NK  135 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~------~~  135 (371)
                      ...|+..+.||.|+||.||+|.. .+++.+|+|.+...   ......+..|+.+++++ +|||++++++++.      ..
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            35677788999999999999975 46889999987432   23345678899999998 7999999999884      34


Q ss_pred             CeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      +..|++|||+++|+|.+++...  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcch
Confidence            6789999999999999998653  3478888999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      .......  .......|++.|+|||.+..+  ......++.++|+|||||++|||++|..||...... ....    ...
T Consensus       169 ~~~~~~~--~~~~~~~~~~~y~aPE~l~~~--~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~~~----~~~  239 (282)
T cd06636         169 AQLDRTV--GRRNTFIGTPYWMAPEVIACD--ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RALF----LIP  239 (282)
T ss_pred             hhhhccc--cCCCcccccccccCHhhcCcc--cCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hhhh----hHh
Confidence            7654322  122345689999999987532  112345678999999999999999999998543211 1110    000


Q ss_pred             cCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .. .. ...   .....+       ..+.+++.+||+.||.+|||+.|++++
T Consensus       240 ~~-~~-~~~---~~~~~~-------~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         240 RN-PP-PKL---KSKKWS-------KKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hC-CC-CCC---cccccC-------HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            00 00 000   001111       235567888999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-39  Score=293.08  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=195.2

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||.|++|.||+|... +++.||+|++............+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            666788999999999999764 6899999998654444444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          146 SNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       146 ~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      . ++|.+++..  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......  .
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~  155 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--R  155 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--c
Confidence            6 589888854  35689999999999999999999999   99999999999999999999999999987654332  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC------
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE------  297 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  297 (371)
                      ......+++.|+|||.+.+      ...++.++||||||+++|+|+||+.||..... .......+........      
T Consensus       156 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ccccccccccccCCeEEec------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhh
Confidence            2233457889999997642      12357889999999999999999999864321 1111111111100000      


Q ss_pred             --------ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          298 --------PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       298 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                              ...............   .....+.+++.+||+.||++|||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVP---PLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcc---cCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                    000000000000000   011234568888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=291.94  Aligned_cols=265  Identities=25%  Similarity=0.337  Sum_probs=196.0

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||.|++|.||+|.. .+|..||+|++............+.+|+++++.++|||++++++++.+.+..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            45567899999999999965 47899999998654433444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          146 SNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       146 ~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      + ++|.+++....  .+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||.+.......  .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence            5 59999987765  689999999999999999999999   99999999999999999999999999997654332  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc----
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA----  299 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  299 (371)
                      ......+++.|+|||.+.+      ...++.++|+||||+++|+|++|..||..... .......... .......    
T Consensus       155 ~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~-~~~~~~~~~~~  226 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLG------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRT-LGTPDEDVWPG  226 (283)
T ss_pred             ccCccccccCCCCCceeec------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH-hCCCChHHhhh
Confidence            1233456889999997642      22467899999999999999999999864322 1111121111 0000000    


Q ss_pred             -------c-cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 -------V-SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 -------~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                             . ....................+.+++.+||+.||++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                   0 000000000000000011245568889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=290.04  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=197.0

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC---CCCceeeeceEecCCeEEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR---HRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  142 (371)
                      |+..+.||+|+||.||+|.. .+++.+|+|.+.... .......+.+|+.+++.++   |||++++++++.+....+++|
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            56677899999999999975 568999999885432 3344567889999999996   999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++... .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--  155 (277)
T ss_pred             ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--
Confidence            999999999998764 689999999999999999999999   99999999999999999999999999998765543  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......|+..|+|||.+.+      +..++.++|+||||+++|+|++|..||......     ..+......       
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~-------  217 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITE------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKS-------  217 (277)
T ss_pred             cccccccCCcceeCHHHhcc------CCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccC-------
Confidence            12234568999999997642      234678999999999999999999998643211     111100000       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                         .....+..  .....+.+++.+||+.||++||++.+++.+-+-
T Consensus       218 ---~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         218 ---KPPRLEDN--GYSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             ---CCCCCCcc--cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence               00111110  011234567788999999999999999986443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=292.80  Aligned_cols=267  Identities=22%  Similarity=0.330  Sum_probs=194.6

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|++|.||+|... +++.||+|.+...... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            45777889999999999999764 6899999998543322 223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+.+ +|.+++... ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            9985 999988654 4689999999999999999999999   99999999999999999999999999987543221  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc--
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV--  300 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  300 (371)
                      .......++..|+|||.+.+      ...++.++||||+|+++|+|++|..||......... ...+...........  
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLG------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-LHKIFRVLGTPTEETWP  230 (291)
T ss_pred             ccccccccccccCCcHHhhc------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHhcCCCChhhhh
Confidence            11122346889999997642      224678999999999999999999998644321111 111111111100000  


Q ss_pred             ------cccCcccCCCC-hh------hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          301 ------SILDTKLQGLP-DQ------MVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       301 ------~~~~~~~~~~~-~~------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                            ........... ..      .......+.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                  00000000000 00      00111345678899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-39  Score=297.10  Aligned_cols=254  Identities=22%  Similarity=0.268  Sum_probs=193.5

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++... +++.||+|.+..... .......+.+|+++++.++||||+++++.+...+..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            4677789999999999999654 578999998854332 22345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc--
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY--  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  221 (371)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++.......  
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            999999999998888899999999999999999999999   999999999999999999999999999864211100  


Q ss_pred             -----------ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          222 -----------HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       222 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                                 ........++..|+|||.+.       +..++.++|+||||+++|||++|..||.....  ..+.   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~~~~---~  226 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-------RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EELF---G  226 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhcc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---H
Confidence                       00111235788999999764       33578899999999999999999999864322  1111   1


Q ss_pred             HHhcCCCccccccCcccC-CCChhhHHHHHHHHHHHhcccCCCCCCCCCH---HHHHHHH
Q 037946          291 KKMGSFEPAVSILDTKLQ-GLPDQMVQEMLQTLGIAMFCVNSSPAERPTM---KEVVALL  346 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~---~evl~~L  346 (371)
                      ........     .+... ..+.       .+.+++.+||+.||++||+.   .+++++-
T Consensus       227 ~~~~~~~~-----~~~~~~~~~~-------~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         227 QVISDDIE-----WPEGDEALPA-------DAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHHhcccC-----CCCccccCCH-------HHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            11111000     00000 1122       23457888999999999984   5555553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-39  Score=293.77  Aligned_cols=258  Identities=26%  Similarity=0.365  Sum_probs=195.2

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC----
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK----  135 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----  135 (371)
                      +..++|...+.||+|+||.||++.. .+++.+|+|.+...   ......+.+|+.+++++ +|||++++++++...    
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            3456788889999999999999976 46889999988432   22345677899999998 899999999988643    


Q ss_pred             -CeEEEEEeecCCCCHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          136 -SVKLLLYNYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                       +..++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~df  172 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDF  172 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeec
Confidence             46899999999999999875    345689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |.+........  ......|+..|+|||.+.....  ....++.++|||||||++|||++|+.|+..... ...+..+  
T Consensus       173 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-~~~~~~~--  245 (291)
T cd06639         173 GVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQ--YDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-VKTLFKI--  245 (291)
T ss_pred             ccchhcccccc--cccCccCCccccChhhhcCCCC--cccccCCccchHHHHHHHHHHhhCCCCCCCCcH-HHHHHHH--
Confidence            99886554321  1233468899999998753311  122467899999999999999999999864321 1111111  


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        ...  ......      .+..   ....+.+++.+||+.||++||++.|++++
T Consensus       246 --~~~--~~~~~~------~~~~---~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         246 --PRN--PPPTLL------HPEK---WCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             --hcC--CCCCCC------cccc---cCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence              111  000000      0111   11235568888999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.2e-39  Score=288.43  Aligned_cols=251  Identities=24%  Similarity=0.406  Sum_probs=193.5

Q ss_pred             cccCCccccCCceEEEEEEeCC--CCEEEEEEecccC--------CCcchHHHHHHHHHHHhc-cCCCCceeeeceEecC
Q 037946           67 LKDENVIGKGCSGVVYKAEMPN--GELIAVKKLWKTK--------RDEEPVDSFAAEIQILGH-IRHRNIVKLLGYCSNK  135 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~  135 (371)
                      |+..+.||+|+||.||+|....  ++.+|+|.+....        .......++..|+.++.+ ++|||++++++++.+.
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5667889999999999997654  6889999875322        122334567788888875 7999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                      +..+++|||+++++|.+++.    ....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999998874    34468999999999999999999996 5   8999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |.+.......   ......|+..|+|||.+.       +..++.++|+||||+++|+|++|..||...  +.......+.
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~-------~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~  226 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVK-------NEPYGEKADVWAFGCILYQMCTLQPPFYST--NMLSLATKIV  226 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhc-------CCCCchHHHHHHHHHHHHHHHhCCCccccc--CHHHHHHHHh
Confidence            9998755442   223456899999999765       335788999999999999999999998532  1111111111


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..  ...       +......      ...+.+++.+||+.||++||++.|+.+++.
T Consensus       227 ~~--~~~-------~~~~~~~------~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EA--VYE-------PLPEGMY------SEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hc--cCC-------cCCcccC------CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            10  000       0001011      123456778899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=308.95  Aligned_cols=246  Identities=26%  Similarity=0.447  Sum_probs=197.0

Q ss_pred             ccccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           72 VIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      +||+|.||+||.|++.+ ....|||.+.  ..+....+.+..|+...++|+|.|||+++|.|..++..-|.||-.+||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIp--ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIP--EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecc--cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            69999999999997654 5678999883  34445567889999999999999999999999999999999999999999


Q ss_pred             HHHhcc-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc-CCCceEEccccCccccCCCCcccccc
Q 037946          151 QQLLQG-NRNL--DWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMS  226 (371)
Q Consensus       151 ~~~l~~-~~~~--~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~  226 (371)
                      .+++.+ .+++  ++..+-.+.+||++||.|||++   .|||||||-+||||+ -.|.+||+|||-++.+..-+  ..+.
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE  734 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE  734 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence            999964 5666  7889999999999999999999   999999999999996 57999999999998876544  3456


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ++.||..|||||++...     ...|+.++|||||||++.||.||++||.....-.   ..+.+-+...  .        
T Consensus       735 TFTGTLQYMAPEvIDqG-----~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGmyK--v--------  796 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQG-----PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGMYK--V--------  796 (1226)
T ss_pred             ccccchhhhChHhhccC-----CcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhhhccee--c--------
Confidence            78899999999998622     2357889999999999999999999996432211   1111111111  0        


Q ss_pred             cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      -..+|.++..+   .-.++.+|+..||.+||+++++++-
T Consensus       797 HP~iPeelsae---ak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  797 HPPIPEELSAE---AKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CCCCcHHHHHH---HHHHHHHHcCCCcccCccHHHhccC
Confidence            12334433333   3347888999999999999999863

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-39  Score=292.11  Aligned_cols=250  Identities=22%  Similarity=0.372  Sum_probs=194.8

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|...+.||+|++|.||++.. .+++.+++|++..  ......+.+.+|+.+++.++|||++++++++...+..++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL--RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec--cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            345557899999999999975 4688999998743  2233446688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +++++|.+++.. ..+++..+..++.|++.||+|||++   +++||||+|+||+++.++.++|+|||.+.......  ..
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~  171 (285)
T cd06648          98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PR  171 (285)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cc
Confidence            999999999987 5689999999999999999999999   99999999999999999999999999887554322  11


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....|++.|+|||.+.       +..++.++||||||+++|+|++|..||....  .......+..   ...+      
T Consensus       172 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~~~~~~---~~~~------  233 (285)
T cd06648         172 RKSLVGTPYWMAPEVIS-------RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAMKRIRD---NLPP------  233 (285)
T ss_pred             cccccCCccccCHHHhc-------CCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHh---cCCC------
Confidence            23356899999999764       3356789999999999999999999985422  1111111111   1000      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                       .... +.   .....+.+++.+||+.+|++|||+.+++++-
T Consensus       234 -~~~~-~~---~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  270 (285)
T cd06648         234 -KLKN-LH---KVSPRLRSFLDRMLVRDPAQRATAAELLNHP  270 (285)
T ss_pred             -CCcc-cc---cCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence             0000 00   0112455688889999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.2e-39  Score=292.16  Aligned_cols=255  Identities=21%  Similarity=0.305  Sum_probs=198.5

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      +...+|...+.||+|+||.||++.. .+++.||+|.+..  ......+.+.+|+.+++.++|||++++++.+...+..|+
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL--QQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecc--ccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence            3346788889999999999999965 4678999998743  223345678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |+||+++++|.+++.+. .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            99999999999998764 478999999999999999999999   99999999999999999999999999987654433


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .  ......+++.|+|||.+.       ...++.++|+||||+++|+|++|..||........ +    ........   
T Consensus       170 ~--~~~~~~~~~~y~~PE~~~-------~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~----~~~~~~~~---  232 (293)
T cd06647         170 S--KRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L----YLIATNGT---  232 (293)
T ss_pred             c--ccccccCChhhcCchhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-e----eehhcCCC---
Confidence            1  223346889999999764       23568899999999999999999999964322110 0    00000000   


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                          +. ...++.   ....+.+++.+||+.+|++||++++++.+-+
T Consensus       233 ----~~-~~~~~~---~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~  271 (293)
T cd06647         233 ----PE-LQNPEK---LSAIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (293)
T ss_pred             ----CC-CCCccc---cCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence                00 001111   1123445788899999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.7e-39  Score=301.72  Aligned_cols=200  Identities=27%  Similarity=0.383  Sum_probs=169.2

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC------
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK------  135 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  135 (371)
                      +.++|+..+.||+|+||.||+|.. .+++.||+|.+............+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            557899999999999999999965 4689999999865444444556788999999999999999999987543      


Q ss_pred             CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ...|+||||+.+ +|.+.+...  ++...+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            357999999965 888887654  89999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      .....   ......+++.|+|||.+.       +..++.++|||||||++|+|++|+.||...
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         168 AGTSF---MMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             CCCCC---CCCCCcccccccCHHHHh-------CCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            64432   123346889999999764       336788999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=303.83  Aligned_cols=260  Identities=23%  Similarity=0.294  Sum_probs=215.7

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ...|.....||+|.|+.|..|+. .++..||+|.+.++..+....+.+.+|+++|+.++|||||+++++......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            34577888999999999999954 46899999999888777777778999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+.+|.+.+++...+.+.+..+..++.|+.+|++|||++   +++|||||++|+|++.+.++||+|||++..+....  
T Consensus       135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~--  209 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL--  209 (596)
T ss_pred             EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc--
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999998877554  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ...+.+|++.|.|||++.+..      ...+++|+||+|++||.|++|..||++..-.+.               ...+
T Consensus       210 -~lqt~cgsppyAaPEl~~g~~------y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---------------r~rv  267 (596)
T KOG0586|consen  210 -MLQTFCGSPPYAAPELFNGKK------YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---------------RPRV  267 (596)
T ss_pred             -cccccCCCCCccChHhhcCcc------cCCcceehhhhhhhheeeeecccccCCcccccc---------------cchh
Confidence             557889999999999987653      346899999999999999999999975432110               0111


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      +..++ ..+..+..+   +-+++++++-.+|.+|++.+++.++-|.-.....
T Consensus       268 l~gk~-rIp~~ms~d---ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  268 LRGKY-RIPFYMSCD---CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             eeeee-cccceeech---hHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            11211 122222222   2346777889999999999999998776654443

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=307.05  Aligned_cols=248  Identities=25%  Similarity=0.448  Sum_probs=194.3

Q ss_pred             ccCCccccCCceEEEEEEeC-CCCEEEEEE--ecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe--EEEEE
Q 037946           68 KDENVIGKGCSGVVYKAEMP-NGELIAVKK--LWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV--KLLLY  142 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~--~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~  142 (371)
                      +...+||+|+|-+||+|.+. +|-.||=-.  +..-..++...++|..|+.+|+.|+||||+++|..|.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            33567999999999999653 465555322  22223455667899999999999999999999999977665  67899


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |.+..|+|..++++.+.++...+..|+.||++||.|||++. |+|+|||||.+||+|+. .|.|||+|+|+|....... 
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            99999999999999999999999999999999999999974 59999999999999975 5999999999998876553 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                         ..+..|||.|||||+..        ..|.+..||||||+.++||+|+..||.. .....++   +++..+...+.  
T Consensus       201 ---aksvIGTPEFMAPEmYE--------E~YnE~VDVYaFGMCmLEMvT~eYPYsE-C~n~AQI---YKKV~SGiKP~--  263 (632)
T KOG0584|consen  201 ---AKSVIGTPEFMAPEMYE--------ENYNELVDVYAFGMCMLEMVTSEYPYSE-CTNPAQI---YKKVTSGIKPA--  263 (632)
T ss_pred             ---cceeccCccccChHHHh--------hhcchhhhhhhhhHHHHHHHhccCChhh-hCCHHHH---HHHHHcCCCHH--
Confidence               24468999999999753        3688999999999999999999999852 2222333   33322221110  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          .+....+      ..+.++|.+|+.. .++|||+.|+|..
T Consensus       264 ----sl~kV~d------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  264 ----ALSKVKD------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----HhhccCC------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                0111111      2344588889998 9999999999875

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.4e-39  Score=294.53  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ..|...+.||+|+||.||++.. .++..+|+|.+..... .......+.+|+++++.++|||++++++++.+.+..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4467778899999999999975 4688999999854322 2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+.+ +|.+.+. ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......  
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            99975 7777764 355689999999999999999999999   9999999999999999999999999998654322  


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                          ....|++.|+|||.+...    ....++.++|||||||++|||++|..||.....  ......+.   ....    
T Consensus       179 ----~~~~~~~~y~aPE~~~~~----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~---~~~~----  241 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIA---QNES----  241 (317)
T ss_pred             ----ccccCCccccChhhhhcC----CCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHH---hccC----
Confidence                334688999999976421    134578899999999999999999999864321  11111111   1000    


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                            ......  .....+.+++.+||+.+|.+||++.++++++..+...++
T Consensus       242 ------~~~~~~--~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         242 ------PTLQSN--EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             ------CCCCCc--cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence                  000000  111234557888999999999999999999887764443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3e-39  Score=287.57  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=200.8

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|+..+.||+|++|.||+|... +++.|++|++...... .....+.+|+..++.++|||++++++++...+..+++|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            4667789999999999999765 5899999998543322 4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +++++|.+++.....+++..++.++.|++.|+.|||+ .   +++|+||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--  155 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--  155 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC--
Confidence            9999999999888889999999999999999999999 8   999999999999999999999999999987654431  


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......++..|+|||.+.       +..++.++|+||||+++|+|++|..|+......  ...+..........      
T Consensus       156 ~~~~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~------  220 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQ-------GESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDGPP------  220 (264)
T ss_pred             cccceeecccccCHhhhC-------CCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcCCC------
Confidence            112456889999999765       336788999999999999999999998654321  11111111111100      


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          ...+..  .....+.+++.+||+.+|++|||+.+++++
T Consensus       221 ----~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 ----PSLPAE--EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----CCCCcc--cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                111111  011244557777999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.6e-39  Score=288.80  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=195.7

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.. .+++.+|+|.+... ........+.+|+.++++++|||++++++++.+++..++|||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            4566778899999999999965 46889999987432 223445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++... .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        83 ~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          83 YLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             eCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            99999999998754 589999999999999999999999   999999999999999999999999999876544321  


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......++..|+|||.+.       +..++.++|+|||||++|+|++|..|+.....  ...   ....... ..     
T Consensus       157 ~~~~~~~~~~y~~PE~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~---~~~~~~~-~~-----  218 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIK-------QSAYDSKADIWSLGITAIELAKGEPPHSELHP--MKV---LFLIPKN-NP-----  218 (277)
T ss_pred             hhccccCCccccChhhhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCccch--HHH---HHHHhcC-CC-----
Confidence            123346888999999764       23567899999999999999999999853221  111   1111111 00     


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                       +.+....      ...+.+++.+||+.+|.+||++.+++++-
T Consensus       219 -~~~~~~~------~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  254 (277)
T cd06641         219 -PTLEGNY------SKPLKEFVEACLNKEPSFRPTAKELLKHK  254 (277)
T ss_pred             -CCCCccc------CHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence             0011111      12344577889999999999999999973

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-39  Score=296.26  Aligned_cols=276  Identities=23%  Similarity=0.339  Sum_probs=199.5

Q ss_pred             ccHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC
Q 037946           58 FTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS  136 (371)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  136 (371)
                      +...+..+.|+..+.||+|+||.||+|.. .+++.||+|.+............+.+|++++++++||||+++++++...+
T Consensus         5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865           5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            34455667799999999999999999965 46899999998654433444456678999999999999999999886554


Q ss_pred             --------eEEEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEE
Q 037946          137 --------VKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL  207 (371)
Q Consensus       137 --------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl  207 (371)
                              ..++||||+.+ +|.+++... ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence                    45999999975 888877654 3689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCccccCCCCcc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhH
Q 037946          208 ADFGLAKLMNSTNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI  285 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  285 (371)
                      +|||++.........  .......++..|+|||.+.+.      ..++.++||||||+++|||++|..||.....  ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~  232 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE------RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQ  232 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC------cccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHH
Confidence            999999765443211  112234578899999976422      2357899999999999999999998865432  222


Q ss_pred             HHHHHHHhcCCCccc-------cccCc-ccCCCCh-hhHH------HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          286 VEWVKKKMGSFEPAV-------SILDT-KLQGLPD-QMVQ------EMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~-------~~~~~-~~~~~~~-~~~~------~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ...+....+...+..       ...+. ....... ....      ....+.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            222333222111000       00000 0000000 0000      11234578999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7e-39  Score=285.14  Aligned_cols=246  Identities=25%  Similarity=0.311  Sum_probs=195.7

Q ss_pred             cccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           73 IGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      ||.|++|.||++... +++.+|+|.+..... .......+.+|+.+++.++||||+++++.+.+++..+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999764 489999999865433 234456799999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccc
Q 037946          151 QQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG  230 (371)
Q Consensus       151 ~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  230 (371)
                      .+++.+...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.......   ......+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~  154 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG  154 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence            99998888899999999999999999999998   99999999999999999999999999998765432   1223468


Q ss_pred             cccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCC
Q 037946          231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL  310 (371)
Q Consensus       231 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ++.|+|||.+.       ...++.++|+||||+++|+|++|..||.....+.....   ........         ....
T Consensus       155 ~~~~~~PE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~---------~~~~  215 (262)
T cd05572         155 TPEYVAPEIIL-------NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY---NDILKGNG---------KLEF  215 (262)
T ss_pred             CcCccChhHhc-------CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH---HHHhccCC---------CCCC
Confidence            89999999764       23567899999999999999999999975543222222   11111000         0111


Q ss_pred             ChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHH
Q 037946          311 PDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALL  346 (371)
Q Consensus       311 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L  346 (371)
                      +...   ...+.+++.+||+.||++||+     ++|++++-
T Consensus       216 ~~~~---~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~  253 (262)
T cd05572         216 PNYI---DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHK  253 (262)
T ss_pred             Cccc---CHHHHHHHHHHccCChhhCcCCcccCHHHHhcCh
Confidence            1111   224556788899999999999     88888753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-39  Score=288.23  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=195.6

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |...+.||+|+||.||+|... +|..+|+|.+..........+.+.+|+.+++.++|+|++++++.+.+.+..++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            566788999999999999654 5789999998654433445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccccCccccCCCCcc
Q 037946          146 SNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       146 ~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++ .+||+|||.+.......  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--  156 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--  156 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc--
Confidence            9999999986543  478999999999999999999999   999999999999998886 46999999998765432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......|++.|+|||.+.       +..++.++|+||||+++|+|++|..|+....     ..+++.......      
T Consensus       157 ~~~~~~~~~~~~~ape~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~------  218 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQ-------NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGY------  218 (257)
T ss_pred             ccccccCCCccccCHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhccc------
Confidence            1223345899999999654       3357889999999999999999999985332     122222222110      


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          .....+.   ....+.+++.+||+.+|++|||++|++++
T Consensus       219 ----~~~~~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 ----FAPISPN---FSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----CCCCCCC---CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                0111111   11235567788999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.6e-39  Score=287.91  Aligned_cols=262  Identities=24%  Similarity=0.285  Sum_probs=191.2

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecC--CeEEEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNK--SVKLLLY  142 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  142 (371)
                      |+..+.||+|+||.||+|.. .+++.+|+|++.....+... ....+|+.+++++. |||++++++++.+.  +..++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            45567899999999999965 46889999998654333322 34457888898885 99999999999887  8899999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+++ +|.+.+.. ...+++..+..++.|++.||.|||+.   +++||||+|+||+++. +.+||+|||++....... 
T Consensus        80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-  153 (282)
T cd07831          80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-  153 (282)
T ss_pred             ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence            99975 77777765 45689999999999999999999999   9999999999999999 999999999998764432 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc--
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA--  299 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  299 (371)
                        ......++..|+|||.+..      +..++.++|||||||++|||++|..||.....  .................  
T Consensus       154 --~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  223 (282)
T cd07831         154 --PYTEYISTRWYRAPECLLT------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVL  223 (282)
T ss_pred             --CcCCCCCCcccCChhHhhc------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHH
Confidence              1123457899999996532      23467899999999999999999999864322  12222222211110000  


Q ss_pred             -----ccccCcccCC-----CChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 -----VSILDTKLQG-----LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 -----~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                           ..........     ...........+.+++.+||+.||++|||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                 0000000000     000001123456778999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.7e-39  Score=289.46  Aligned_cols=255  Identities=23%  Similarity=0.339  Sum_probs=189.3

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHH-HhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQI-LGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+..+.||+|+||.||++... +|+.||+|++........ ...+..|..+ ++.++|||++++++++...+..|++||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4667788999999999999764 689999999855433222 3445556664 666799999999999999999999999


Q ss_pred             ecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          144 YISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       144 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |++ |+|.+++..    ...+++..++.++.|++.||+|||++.  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 588777643    346899999999999999999999852  8999999999999999999999999999865432


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .   ......++..|+|||.+.+..   ....++.++|+||||+++|+|++|..||.........+...    .....  
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~~--  225 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPEL---NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV----VEEPS--  225 (283)
T ss_pred             c---ccccccCCccccChhhcCCcc---cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH----HhcCC--
Confidence            2   112345888999999875321   11346789999999999999999999985432211111111    11100  


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                              ...+..  .....+.+++.+||+.+|++||++++++++-
T Consensus       226 --------~~~~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  262 (283)
T cd06617         226 --------PQLPAE--KFSPEFQDFVNKCLKKNYKERPNYPELLQHP  262 (283)
T ss_pred             --------CCCCcc--ccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                    011110  0112345678889999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-39  Score=299.16  Aligned_cols=283  Identities=21%  Similarity=0.298  Sum_probs=206.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe----cCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS----NKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~  139 (371)
                      +.|+..+.||+|++|.||+|.. .+++.||+|++............+.+|+.+++.++||||+++++++.    .....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5688888999999999999965 46899999998654433445567888999999999999999998875    345789


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +||||+. ++|.+++.....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            9999996 59999998888899999999999999999999999   9999999999999999999999999998765433


Q ss_pred             Ccc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          220 NYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       220 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...  .......++..|+|||.+..      ...++.++||||||+++|||++|+.||.....  ......+....+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~~~~~~~~~g~~~  232 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLS------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQLKLILSVLGSPS  232 (334)
T ss_pred             CcCCCcccccccccccccChHHhcC------CcccccccchHHHHHHHHHHHcCCCccCCCCh--HHHHHHHHHHhCCCh
Confidence            211  11224468899999997642      23468899999999999999999999964321  111111111111100


Q ss_pred             c----------cccccC--cccCCCC-hhh-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCCCC
Q 037946          298 P----------AVSILD--TKLQGLP-DQM-VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKT  359 (371)
Q Consensus       298 ~----------~~~~~~--~~~~~~~-~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~  359 (371)
                      .          .....+  +.....+ ... ......+.+++.+||+.+|++|||+.+++.+-+--....++..+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~  308 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT  308 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence            0          000000  0000000 000 011234566888899999999999999999877655555554433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=278.41  Aligned_cols=253  Identities=24%  Similarity=0.397  Sum_probs=194.9

Q ss_pred             ccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeec
Q 037946           68 KDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      +....||.|+.|.|++++.+ +|...|||.+.++.. .+...+++..+.++..- ++|.||+.+|+|..+..+++-||.|
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            34567999999999999764 589999999976544 34456777788877665 4999999999999999999999998


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      .. .+..++.+ ..++++..+-++...+..||.||.+++  +++|||+||+|||+|+.|++|+||||++..+.++.   .
T Consensus       174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A  247 (391)
T KOG0983|consen  174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A  247 (391)
T ss_pred             HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence            54 55555543 456899999999999999999999885  99999999999999999999999999998876654   3


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      -...+|-+.|||||.+...    ....|+.++||||||++|+||.||..||..-..+ .+.+..+..   ...+   .++
T Consensus       248 htrsAGC~~YMaPERidp~----~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltkvln---~ePP---~L~  316 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPP----DKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTKVLN---EEPP---LLP  316 (391)
T ss_pred             cccccCCccccCccccCCC----CCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHHHHh---cCCC---CCC
Confidence            3456799999999988743    2556889999999999999999999999754332 222222222   1111   111


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      +.. ++.       .+..+++..||.+|+.+||...+++++-
T Consensus       317 ~~~-gFS-------p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  317 GHM-GFS-------PDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             ccc-CcC-------HHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            111 122       2334466669999999999999999874

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=282.98  Aligned_cols=260  Identities=21%  Similarity=0.349  Sum_probs=215.3

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe-cCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS-NKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~  137 (371)
                      .+++...++-+|.||.||.|.+.      +.+.|.+|.++ ...++-+...++.|.-.+..+.|||+..+.+++. +...
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            45666778899999999999553      23456777764 3456677889999999999999999999999975 4567


Q ss_pred             EEEEEeecCCCCHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcc
Q 037946          138 KLLLYNYISNGNLQQLLQG--------NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                      .++++.++..|+|..++..        .+.++-.+...++.|++.|++|||+.   +++|.||.++|++||+...|||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEecc
Confidence            7889999999999999972        23477788999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEW  288 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  288 (371)
                      =.+++.+.+.+++...++...+..||+||.+.       +..|+.++|+|||||+||||+| |+.|+..-  |+.++..+
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~-------n~~yssasDvWsfGVllWELmtlg~~PyaeI--DPfEm~~y  510 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-------NSHYSSASDVWSFGVLLWELMTLGKLPYAEI--DPFEMEHY  510 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHh-------hhhhcchhhhHHHHHHHHHHHhcCCCCcccc--CHHHHHHH
Confidence            99999999999888888888889999999776       4478999999999999999998 77776432  45566666


Q ss_pred             HHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                      ++++.+-.++         .++|++++..|       ..||+..|++||++++++..|.++..+.
T Consensus       511 lkdGyRlaQP---------~NCPDeLf~vM-------acCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  511 LKDGYRLAQP---------FNCPDELFTVM-------ACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             HhccceecCC---------CCCcHHHHHHH-------HHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            6666555333         47887655544       4499999999999999999999886543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.6e-39  Score=296.31  Aligned_cols=270  Identities=21%  Similarity=0.317  Sum_probs=201.1

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----Ce
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----SV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  137 (371)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+............+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            34688888999999999999965 4689999999865433344456778899999999999999999987644     35


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .|++|||+. ++|.+++...+.+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            799999996 58999998888899999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...  .......++..|+|||.+..      ...++.++||||||+++|+|++|..||.....  ......+....+...
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~  229 (337)
T cd07858         160 EKG--DFMTEYVVTRWYRAPELLLN------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPS  229 (337)
T ss_pred             CCc--ccccccccccCccChHHHhc------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCC
Confidence            432  12234568889999997642      12467899999999999999999999864321  111111111111100


Q ss_pred             cc----------cccc-------CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--Hhccc
Q 037946          298 PA----------VSIL-------DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVK  350 (371)
Q Consensus       298 ~~----------~~~~-------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~  350 (371)
                      ..          ....       +.......+   .....+.+++.+||+.||++|||+++++++  +..+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFP---HANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hHHhhhcCchhhhHHHHhcCcccccCHHHHcc---cCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            00          0000       000000000   112345678899999999999999999999  55543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-39  Score=302.61  Aligned_cols=264  Identities=25%  Similarity=0.338  Sum_probs=202.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-C-----CCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-H-----RNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~  137 (371)
                      -+|.+.+.||+|+||.|.+|.+ .+++.||||++++   .....+.-..|+.+|..++ |     -|+|+++++|...++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            3788899999999999999965 5699999999954   3445567788999999996 3     489999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC--CCceEEccccCc
Q 037946          138 KLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS--KYEAYLADFGLA  213 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~  213 (371)
                      .|||+|.+.. +|.++++.+.  .++...+..++.||+.||.+||..   +|||+||||+|||+.+  ...+||+|||.+
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999999966 9999998654  588999999999999999999999   9999999999999965  346999999999


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      +.....-+     +..-+..|.|||++.       +.+|+.+.|+|||||++.||++|.+.|.+...  ......+.+..
T Consensus       339 c~~~q~vy-----tYiQSRfYRAPEVIL-------GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne--~DQl~~I~e~l  404 (586)
T KOG0667|consen  339 CFESQRVY-----TYIQSRFYRAPEVIL-------GLPYDTAIDMWSLGCILAELFTGEPLFPGDNE--YDQLARIIEVL  404 (586)
T ss_pred             cccCCcce-----eeeeccccccchhhc-------cCCCCCccceeehhhhHHhHhcCccccCCCCH--HHHHHHHHHHh
Confidence            87655432     455678899999987       55899999999999999999999877765432  22223333333


Q ss_pred             cCCCcc--------ccccCc-----------------------------ccC-CCC-------hhhH-HHHHHHHHHHhc
Q 037946          294 GSFEPA--------VSILDT-----------------------------KLQ-GLP-------DQMV-QEMLQTLGIAMF  327 (371)
Q Consensus       294 ~~~~~~--------~~~~~~-----------------------------~~~-~~~-------~~~~-~~~~~~~~l~~~  327 (371)
                      +.....        ...++.                             ... ..|       .... ..-..+++++.+
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence            321000        000000                             000 001       0000 223345789999


Q ss_pred             ccCCCCCCCCCHHHHHHHHhcc
Q 037946          328 CVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       328 cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      |+..||.+|+|+.+.++|-+--
T Consensus       485 ~L~~dP~~R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  485 CLEWDPAERITPAQALNHPFLT  506 (586)
T ss_pred             HhccCchhcCCHHHHhcCcccc
Confidence            9999999999999999985543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-38  Score=286.45  Aligned_cols=247  Identities=21%  Similarity=0.265  Sum_probs=187.3

Q ss_pred             ccccCCceEEEEEEe-CCCCEEEEEEecccCCCcc-hHHHHHHHHHHHh---ccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           72 VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEE-PVDSFAAEIQILG---HIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      .||+|+||.||++.. .+++.+|+|.+.+...... ....+.+|..+++   ..+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999976 4588999998865433222 2233444544433   3479999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccc
Q 037946          147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS  226 (371)
Q Consensus       147 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  226 (371)
                      +++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||++++++.++|+|||++.......    ..
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~  153 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH  153 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence            999999998888899999999999999999999999   99999999999999999999999999987554332    12


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ...||+.|+|||.+..      +..++.++|||||||++|+|++|..||..........   .......       ... 
T Consensus       154 ~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~-------~~~-  216 (279)
T cd05633         154 ASVGTHGYMAPEVLQK------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLT-------VNV-  216 (279)
T ss_pred             CcCCCcCccCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhhc-------CCc-
Confidence            3468999999997541      2346789999999999999999999996543322111   1111100       000 


Q ss_pred             cCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHh
Q 037946          307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLM  347 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~  347 (371)
                        ..++...   ..+.+++.+||+.||++||     |++|++++.+
T Consensus       217 --~~~~~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~  257 (279)
T cd05633         217 --ELPDSFS---PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF  257 (279)
T ss_pred             --CCccccC---HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence              1111111   2344577889999999999     6999999843

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-38  Score=286.14  Aligned_cols=261  Identities=25%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--CCeEEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--KSVKLLLY  142 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  142 (371)
                      +|+..+.||.|++|.||++.. .+++.+|+|.+.... .......+.+|++++++++||||+++++++.+  .+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            466678899999999999976 457899999885432 23455778999999999999999999998864  34789999


Q ss_pred             eecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999987643    44588999999999999999999999   999999999999999999999999999865433


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..    .....++..|+|||.+.       +..++.++||||||+++|+|++|..||...........+..........+
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQ-------GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP  226 (287)
T ss_pred             cc----cccccCCccccCHHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence            22    12345788999999764       34678899999999999999999999875422111111222111111000


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                             .+...+.........+.+++.+||+.||++|||+.|++++-+-
T Consensus       227 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         227 -------ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             -------hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence                   0011111000112345678899999999999999999997654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=333.48  Aligned_cols=257  Identities=26%  Similarity=0.384  Sum_probs=206.0

Q ss_pred             ccccCCccccCCceEEEEE-EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++.-+..||.|.||.||.| ...+|+..|+|-+.-..........+.+|..++..++|||+|+++|+-.+.+.++|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            4455788999999999999 556799999998855444445566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC--cc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN--YH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  222 (371)
                      |++|+|.+.+...+-.++....-+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.|.+...+.  ..
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            99999999999988888888888999999999999999   99999999999999999999999999998876542  11


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+-|||||++.+....    ....+.||||+||+..||+||+.||....++ -.++-    +.+.       
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~k----G~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy----~V~~------- 1456 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGK----GHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMY----HVAA------- 1456 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccC----CCCcchhhhcccceEEEeecCCCchhhccch-hHHHh----HHhc-------
Confidence            223456899999999999865322    2356899999999999999999999654332 22221    1111       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                        +.-...|..+.++   -.+++..|+..||++|.++.|++++=
T Consensus      1457 --gh~Pq~P~~ls~~---g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1457 --GHKPQIPERLSSE---GRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             --cCCCCCchhhhHh---HHHHHHHHHhcCchhhhHHHHHHHhh
Confidence              1222333332222   23477889999999999999998863

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.4e-39  Score=289.65  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      +..+.|+..+.||+|++|.||+|... ++..+++|++.....   ....+.+|+++++.++|+|++++++.+...+..|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            34456777889999999999999765 688999999854322   45678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++||+++++|.+++.... .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999999998876 799999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .  .......++..|+|||.+.       +..++.++|+||||+++|+|++|..|+......  .....+   ...  ..
T Consensus       170 ~--~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~---~~~--~~  233 (286)
T cd06614         170 K--SKRNSVVGTPYWMAPEVIK-------RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLI---TTK--GI  233 (286)
T ss_pred             h--hhhccccCCcccCCHhHhc-------CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---Hhc--CC
Confidence            2  1223345788999999764       235688999999999999999999998643221  111111   110  00


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ....  .....+       ..+.+++.+||+.+|.+|||+.+++++..
T Consensus       234 ~~~~--~~~~~~-------~~l~~li~~~l~~~p~~Rpt~~~il~~~~  272 (286)
T cd06614         234 PPLK--NPEKWS-------PEFKDFLNKCLVKDPEKRPSAEELLQHPF  272 (286)
T ss_pred             CCCc--chhhCC-------HHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence            0000  001111       23455788899999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-38  Score=281.93  Aligned_cols=253  Identities=28%  Similarity=0.427  Sum_probs=202.1

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEEEEEe
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKLLLYN  143 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  143 (371)
                      |...+.||+|++|.||+|... +++.+++|++..........+.+.+|+..+++++|||++++++.+.+.  +..+++||
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            556788999999999999765 689999999865544445678899999999999999999999999988  89999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++.+...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999999999998887899999999999999999999998   99999999999999999999999999998776554211


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......++..|+|||.+..       ...+.++||||||+++++|++|..||...... .   ........         
T Consensus       159 ~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~---~~~~~~~~---------  218 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRG-------EEYGRAADIWSLGCTVIEMATGKPPWSELGNP-M---AALYKIGS---------  218 (260)
T ss_pred             cccCCCCCccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-H---HHHHhccc---------
Confidence            1234568899999997653       24788999999999999999999998654311 1   11111110         


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .......+...   ...+.+++.+|++.||++||++.+++++
T Consensus       219 ~~~~~~~~~~~---~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHL---SEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCccc---CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            00111112211   2234557788999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-39  Score=292.46  Aligned_cols=268  Identities=24%  Similarity=0.321  Sum_probs=194.1

Q ss_pred             cccCCccccCCceEEEEEEeC---CCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP---NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKLL  140 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  140 (371)
                      |...+.||+|+||.||+|...   +++.||+|.+.... ........+.+|+.+++.++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            566788999999999999764   47899999986533 1223346678899999999999999999999888  88999


Q ss_pred             EEeecCCCCHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC----CCceEEcccc
Q 037946          141 LYNYISNGNLQQLLQG-----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS----KYEAYLADFG  211 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg  211 (371)
                      ||||+++ +|.+++..     ...+++..++.++.|++.||+|||++   +++||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999976 67776642     23688999999999999999999999   9999999999999999    9999999999


Q ss_pred             CccccCCCCc-ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc--------
Q 037946          212 LAKLMNSTNY-HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG--------  282 (371)
Q Consensus       212 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--------  282 (371)
                      ++........ ........+++.|+|||.+.+      ...++.++||||||+++|+|++|..||.....+.        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  231 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR  231 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence            9987644321 112234467899999997642      2246789999999999999999999997554332        


Q ss_pred             hhHHHHHHHHhcCC-----------Ccccccc-CcccCCCC-hhhH-------HHHHHHHHHHhcccCCCCCCCCCHHHH
Q 037946          283 LHIVEWVKKKMGSF-----------EPAVSIL-DTKLQGLP-DQMV-------QEMLQTLGIAMFCVNSSPAERPTMKEV  342 (371)
Q Consensus       283 ~~~~~~~~~~~~~~-----------~~~~~~~-~~~~~~~~-~~~~-------~~~~~~~~l~~~cl~~dP~~RPs~~ev  342 (371)
                      ..+...+. .....           ....... .......+ ....       .....+.+++.+||+.||++|||+.|+
T Consensus       232 ~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei  310 (316)
T cd07842         232 DQLERIFE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA  310 (316)
T ss_pred             HHHHHHHH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            01111111 11000           0000000 00000011 0111       112346779999999999999999999


Q ss_pred             HHH
Q 037946          343 VAL  345 (371)
Q Consensus       343 l~~  345 (371)
                      +++
T Consensus       311 l~~  313 (316)
T cd07842         311 LEH  313 (316)
T ss_pred             hcC
Confidence            875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.6e-39  Score=287.39  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=189.5

Q ss_pred             cccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           73 IGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        73 ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      ||+|+||+||++.. .+|+.||+|.+..... .......+..|+++++.++|||++++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999964 4689999999854322 223345667899999999999999999999999999999999999999


Q ss_pred             HHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccc
Q 037946          151 QQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV  228 (371)
Q Consensus       151 ~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  228 (371)
                      .+++.+..  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99997655  689999999999999999999999   99999999999999999999999999987654321   22334


Q ss_pred             cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .++..|+|||.+.       +..++.++||||||+++|+|++|..||........ ... +.....          ....
T Consensus       155 ~~~~~y~~PE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-~~~~~~----------~~~~  215 (277)
T cd05577         155 AGTPGYMAPEVLQ-------GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEE-LKRRTL----------EMAV  215 (277)
T ss_pred             cCCCCcCCHHHhc-------CCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHH-HHhccc----------cccc
Confidence            5788999999764       23467899999999999999999999865432110 001 111000          0001


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                      ..++..   ...+.+++.+||+.||++||     ++.+++++-
T Consensus       216 ~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~  255 (277)
T cd05577         216 EYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP  255 (277)
T ss_pred             cCCccC---CHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence            111111   12344577889999999999     777788763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-38  Score=289.64  Aligned_cols=272  Identities=25%  Similarity=0.340  Sum_probs=198.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++|+|++++++++.+.  +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            4588888999999999999976 4689999999864433333334567899999999999999999998655  568999


Q ss_pred             EeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+.+ +|.+++.. ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999975 88888765 45689999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc-
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA-  299 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  299 (371)
                        .......+++.|+|||.+.+      ...++.++||||||+++|||++|..||....  .......+.......... 
T Consensus       163 --~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07845         163 --KPMTPKVVTLWYRAPELLLG------CTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTPNESI  232 (309)
T ss_pred             --CCCCcccccccccChhhhcC------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChhh
Confidence              12223346788999997642      2246789999999999999999999986432  222222222211110000 


Q ss_pred             ------------ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          300 ------------VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       300 ------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                                  ...-.................+.+++.+||+.||++|||+++++++-+=-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                        000000000000000001234456889999999999999999998765543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-39  Score=310.00  Aligned_cols=275  Identities=18%  Similarity=0.218  Sum_probs=187.8

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeCC--CCEEEEEE--------------ecc-cCCCcchHHHHHHHHHHHhccCCC
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMPN--GELIAVKK--------------LWK-TKRDEEPVDSFAAEIQILGHIRHR  123 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~--------------~~~-~~~~~~~~~~~~~e~~~l~~l~h~  123 (371)
                      +.+.++|+..+.||+|+||.||++..+.  +...+.|.              +.+ ..........+.+|+.++++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            4566889999999999999999985432  22222221              100 011223345688999999999999


Q ss_pred             CceeeeceEecCCeEEEEEeecCCCCHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 037946          124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGN-----RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNIL  198 (371)
Q Consensus       124 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil  198 (371)
                      ||+++++++.+.+..|+++|++.+ +|.+++...     .......+..++.|++.||.|||++   +++||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            999999999999999999999865 777766432     2234567788999999999999999   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          199 LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       199 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      ++.++.+||+|||+++.+..... .......||+.|+|||++.+       ..++.++|||||||++|||++|..++...
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~~~~~p~~~  371 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAG-------DGYCEITDIWSCGLILLDMLSHDFCPIGD  371 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence            99999999999999987654321 12234579999999998753       35788999999999999999988655433


Q ss_pred             CC-Cc-hhHHHHHHHHhcCCCcc-------ccccCc-ccCCCC---hhhHHH---HHHHHHHHhcccCCCCCCCCCHHHH
Q 037946          279 IG-DG-LHIVEWVKKKMGSFEPA-------VSILDT-KLQGLP---DQMVQE---MLQTLGIAMFCVNSSPAERPTMKEV  342 (371)
Q Consensus       279 ~~-~~-~~~~~~~~~~~~~~~~~-------~~~~~~-~~~~~~---~~~~~~---~~~~~~l~~~cl~~dP~~RPs~~ev  342 (371)
                      .. .. ..+...+..........       ...++. .....+   ......   ..++.+++.+||+.||.+|||+.|+
T Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el  451 (501)
T PHA03210        372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL  451 (501)
T ss_pred             CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence            22 11 12222111100000000       000000 000000   000000   1123456888999999999999999


Q ss_pred             HHHHh
Q 037946          343 VALLM  347 (371)
Q Consensus       343 l~~L~  347 (371)
                      +++-+
T Consensus       452 L~hp~  456 (501)
T PHA03210        452 LALPL  456 (501)
T ss_pred             hhChh
Confidence            98744

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-38  Score=288.30  Aligned_cols=266  Identities=21%  Similarity=0.296  Sum_probs=191.6

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe-----E
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV-----K  138 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-----~  138 (371)
                      +|+..+.||+|+||.||+|.+. +++.||+|.+............+.+|+.+++.+ +|||++++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5777889999999999999764 689999998865443334456788899999999 46999999999876665     8


Q ss_pred             EEEEeecCCCCHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccC
Q 037946          139 LLLYNYISNGNLQQLLQG-----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGL  212 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~  212 (371)
                      |++|||+++ +|.+++..     ...+++..++.++.||+.||.|||++   +++||||+|+||+++. ++.+||+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999986 88888753     23579999999999999999999999   9999999999999998 89999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......  .......+++.|+|||.+.+      ...++.++||||||+++|+|++|..||..... ......... .
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~-~  227 (295)
T cd07837         158 GRAFSIPV--KSYTHEIVTLWYRAPEVLLG------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-LQQLLHIFK-L  227 (295)
T ss_pred             ceecCCCc--cccCCcccccCCCChHHhhC------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHH-H
Confidence            87653321  11223357889999997642      22467899999999999999999998864321 111111111 1


Q ss_pred             hcCCCcc--ccccCc----ccCC-CChhh----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          293 MGSFEPA--VSILDT----KLQG-LPDQM----VQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       293 ~~~~~~~--~~~~~~----~~~~-~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .......  ......    .... .+...    ......+.+++.+||+.||.+||+++|++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            1100000  000000    0000 00000    0112335668888999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-38  Score=294.29  Aligned_cols=287  Identities=24%  Similarity=0.326  Sum_probs=205.0

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC---
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK---  135 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---  135 (371)
                      +.++.++|...+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence            344556788889999999999999975 4689999999865443444456788999999999999999999988654   


Q ss_pred             ---CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          136 ---SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       136 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                         ...++|+||+.. +|..+..  ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          90 DEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             CCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence               346899999965 7877653  3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      ++.....     .....+++.|+|||.+.+      ...++.++|||||||++|||++|+.||.....  ......+...
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~  230 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPEVILN------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKV  230 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChhhhcC------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHh
Confidence            8764322     134467889999997642      12467899999999999999999999964321  1111111111


Q ss_pred             hcCCCc-cccccC--------cccCCCChhh-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HhcccCCCccC
Q 037946          293 MGSFEP-AVSILD--------TKLQGLPDQM-----VQEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVKSAPEEL  356 (371)
Q Consensus       293 ~~~~~~-~~~~~~--------~~~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~  356 (371)
                      .+...+ ......        ......+...     ......+.+++.+||+.||++||++++++.+  ++.+....++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~  310 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET  310 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence            110000 000000        0000000000     0112235578888999999999999999977  77776554444


Q ss_pred             CCCCchhhhhh
Q 037946          357 GKTSQPLIKQS  367 (371)
Q Consensus       357 ~~~~~~~~~~~  367 (371)
                      .  .+|..+.+
T Consensus       311 ~--~~~~~~~~  319 (342)
T cd07879         311 E--QQPYDDSL  319 (342)
T ss_pred             C--CCcccchh
Confidence            3  34444443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.6e-38  Score=281.65  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=199.0

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |...+.||.|+||.||++... +++.+|+|++............+.+|+++++.++|||++++.+.+...+..++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            566788999999999999764 5899999998655544466678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          146 SNGNLQQLLQGN----RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       146 ~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ++++|.+++...    ..+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  157 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-  157 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence            999999999763    6799999999999999999999999   99999999999999999999999999997765443 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       .......|++.|+|||.+.       ...++.++|+||+|+++++|++|..|+....  ..   +........      
T Consensus       158 -~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~---~~~~~~~~~------  218 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQ-------NKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--LL---ELALKILKG------  218 (258)
T ss_pred             -ceecceeeeecccChhHhc-------cCCCCccccHHHHHHHHHHHHcCCCCCCCCc--HH---HHHHHHhcC------
Confidence             1223456889999999754       3357889999999999999999999985432  11   112211111      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          .....+...   ...+.+++.+||+.+|++|||+.+++++
T Consensus       219 ----~~~~~~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         219 ----QYPPIPSQY---SSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ----CCCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                011111111   1234457778999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-38  Score=289.22  Aligned_cols=267  Identities=18%  Similarity=0.214  Sum_probs=193.0

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      +.+|.|+++.|+++.. +++.||+|++............+.+|+++++.++||||+++++++.+.+..+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3455556666666654 689999999866544555677899999999999999999999999999999999999999999


Q ss_pred             HHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc-----cc
Q 037946          151 QQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY-----HH  223 (371)
Q Consensus       151 ~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~  223 (371)
                      .+++...  ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||.+........     ..
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999753  4588999999999999999999999   999999999999999999999999999875543221     11


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC-------
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF-------  296 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------  296 (371)
                      ......++..|+|||.+...     ...++.++|+|||||++|||++|..||...... ....+.........       
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQN-----LQGYNEKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccCHHHhcCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCccccccCchh
Confidence            12334578889999987532     124678999999999999999999998643221 11111111100000       


Q ss_pred             ---Ccccc----ccCcccCCCC--hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          297 ---EPAVS----ILDTKLQGLP--DQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       297 ---~~~~~----~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                         .....    ...+......  .........+.+++.+||+.||++|||+++++++-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence               00000    0000000000  000111234567899999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=280.70  Aligned_cols=249  Identities=28%  Similarity=0.455  Sum_probs=199.3

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|++|.||++... +++.+++|.+............+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            566789999999999999654 6789999999665444456678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccc
Q 037946          146 SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM  225 (371)
Q Consensus       146 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  225 (371)
                      ++++|.+++.....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  156 (254)
T cd06627          82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DD  156 (254)
T ss_pred             CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--cc
Confidence            9999999998888899999999999999999999999   999999999999999999999999999987655432  12


Q ss_pred             ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ....++..|+|||.+..       ..++.++||||+|+++|+|++|..|+.....    ............         
T Consensus       157 ~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~---------  216 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-------SGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQDDH---------  216 (254)
T ss_pred             cccccchhhcCHhhhcC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhccCC---------
Confidence            34568899999997642       2467899999999999999999999864321    111111110110         


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        ...+...   ...+.+++.+||+.+|++|||+.+++.+
T Consensus       217 --~~~~~~~---~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         217 --PPLPEGI---SPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --CCCCCCC---CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence              0111111   1233457778999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.6e-38  Score=285.40  Aligned_cols=261  Identities=18%  Similarity=0.198  Sum_probs=180.9

Q ss_pred             hccccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcch---------HHHHHHHHHHHhccCCCCceeeece
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEP---------VDSFAAEIQILGHIRHRNIVKLLGY  131 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~  131 (371)
                      ++|...+.||+|+||.||+|...+    +..+|+|...........         ......+...+..++|+|++++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578889999999999999997644    345666653221111000         0112233445567789999999987


Q ss_pred             EecCC----eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEE
Q 037946          132 CSNKS----VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL  207 (371)
Q Consensus       132 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl  207 (371)
                      +....    ..++++|++.. ++.+.+......++..+..++.|++.||+|||++   +++||||||+|||++.++.++|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEE
Confidence            65443    34678888754 7777777666678888999999999999999999   9999999999999999999999


Q ss_pred             ccccCccccCCCCcc-----cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc
Q 037946          208 ADFGLAKLMNSTNYH-----HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG  282 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  282 (371)
                      +|||+++........     .......||+.|+|||...       +..++.++|||||||++|||++|..||.......
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-------~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-------GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            999999876432211     1112346999999999765       3467899999999999999999999997653322


Q ss_pred             hhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          283 LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .................    .......++       .+.+++..||+.+|++||+++++++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 NLIHAAKCDFIKRLHEG----KIKIKNANK-------FIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHhHHHHHHHhhhh----hhccCCCCH-------HHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11111111111110000    001122222       2445667799999999999999998763

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.8e-38  Score=285.25  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=192.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|++|.||+|... +|+.||+|.+............+.+|++++++++|||++++++++.+.+..|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            35777889999999999999764 68899999985544333445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccCccccCCCC
Q 037946          144 YISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |+++ +|.+++.....  +++..+..++.|++.||+|||++   +++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9965 88887755433  57888899999999999999999   9999999999999985 5679999999997654321


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                        .......+++.|+|||.+.+      ...++.++||||||+++|+|+||..||...... ..+.... .....  +..
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~-~~~~~--~~~  225 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIF-RILGT--PNE  225 (294)
T ss_pred             --cccccCceeecccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHhCC--CCh
Confidence              12233457889999997642      234678999999999999999999998643221 1111111 11110  000


Q ss_pred             cccC---------cccCCCChhh-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          301 SILD---------TKLQGLPDQM-----VQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       301 ~~~~---------~~~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ...+         ..........     ......+.+++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000         0000000000     0011234568888999999999999999975

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6e-38  Score=280.03  Aligned_cols=246  Identities=22%  Similarity=0.310  Sum_probs=186.7

Q ss_pred             HHHhccccCCcc--ccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           62 NILECLKDENVI--GKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        62 ~~~~~~~~~~~i--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      +..+.|+..+.+  |+|+||.||++.. .+++.+|+|.+.......       .|......+ +|||++++++.+...+.
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            344566666665  9999999999965 468889999875432211       122222222 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccccCcccc
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLM  216 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~  216 (371)
                      .|+||||+++++|.+++.+...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++ .++|+|||.+...
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999999998887899999999999999999999999   999999999999999988 9999999998765


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ...      ....++..|+|||.+.       ...++.++||||||+++|+|++|..||.....+......+.... .. 
T Consensus       161 ~~~------~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-  225 (267)
T PHA03390        161 GTP------SCYDGTLDYFSPEKIK-------GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK-  225 (267)
T ss_pred             CCC------ccCCCCCcccChhhhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc-
Confidence            433      2345889999999775       33567899999999999999999999975443322222222211 10 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-HHHHHHH
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-MKEVVAL  345 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~  345 (371)
                       .         ...++   .....+.+++.+||+.||.+||+ +++++++
T Consensus       226 -~---------~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 -K---------LPFIK---NVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -c---------CCccc---ccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence             0         00111   11123455777899999999995 6999865

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=273.96  Aligned_cols=259  Identities=22%  Similarity=0.271  Sum_probs=200.7

Q ss_pred             HHHhcccc-CCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEec----
Q 037946           62 NILECLKD-ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSN----  134 (371)
Q Consensus        62 ~~~~~~~~-~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----  134 (371)
                      .+++.|.+ -++||-|-.|.|-.+. ..+++.+|+|++...       ....+|++..-+. .|||||.++++|.+    
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            34555654 3679999999999984 457999999998421       3356788775555 69999999998753    


Q ss_pred             CCeEEEEEeecCCCCHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEcc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLAD  209 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~D  209 (371)
                      ...+.+|||.|+||.|.+.++..+.  +++..+..|..||+.|+.|||+.   +|.||||||+|+|...   +..+||+|
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            4567799999999999999987765  99999999999999999999999   9999999999999954   56799999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  289 (371)
                      ||+++....+.   ...+.+-||+|.|||++..+       .|+...|+||+||++|-|++|.+||....+....  .-+
T Consensus       208 fGFAK~t~~~~---~L~TPc~TPyYvaPevlg~e-------KydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--pgM  275 (400)
T KOG0604|consen  208 FGFAKETQEPG---DLMTPCFTPYYVAPEVLGPE-------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGM  275 (400)
T ss_pred             cccccccCCCc---cccCCcccccccCHHHhCch-------hcCCCCCccchhHHHHHhhcCCCcccccCCccCC--hhH
Confidence            99998765433   55778899999999998755       5778899999999999999999999876654221  111


Q ss_pred             HHHhcCCCccccccCcccCCCChhhH-HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMV-QEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      +.          -+....-.+|.+.. +.....-++|+.+|..+|++|.|+.+++++-|--...
T Consensus       276 k~----------rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  276 KR----------RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             Hh----------HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            11          11122223333333 3333444588889999999999999999987765433

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-38  Score=287.66  Aligned_cols=256  Identities=25%  Similarity=0.297  Sum_probs=196.2

Q ss_pred             cccCCccccCCceEEEEEEe----CCCCEEEEEEecccCC--CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKR--DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  139 (371)
                      |+..+.||+|+||.||++..    .+|+.||+|++.....  .....+.+.+|+.+++++ +|+||+++++.+..++..|
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            56678899999999999975    3688999999854322  122346778999999999 6999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999765443


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .. .......|+..|+|||.+...     ...++.++||||||+++|+|++|..|+..... .....+..........  
T Consensus       159 ~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~--  229 (290)
T cd05613         159 EV-ERAYSFCGTIEYMAPDIVRGG-----DGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEP--  229 (290)
T ss_pred             cc-cccccccCCcccCChhhccCC-----CCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccCC--
Confidence            21 112235688999999976521     22457789999999999999999999853221 1111222221111101  


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                               ..++..   ...+.+++.+||+.||++||     +.++++++-
T Consensus       230 ---------~~~~~~---~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~  269 (290)
T cd05613         230 ---------PYPQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP  269 (290)
T ss_pred             ---------CCCccC---CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCc
Confidence                     111111   12334577889999999997     788888763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.7e-38  Score=284.31  Aligned_cols=267  Identities=29%  Similarity=0.388  Sum_probs=196.3

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-----
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-----  136 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  136 (371)
                      ..+.|+..+.||+|+||.||+|... +++.||+|.+............+.+|++++++++|||++++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3467888899999999999999764 5889999998654433344457788999999999999999999987654     


Q ss_pred             -----eEEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          137 -----VKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       137 -----~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                           ..++||||+++ ++.+.+.+ ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcc
Confidence                 78999999987 67666654 34689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |.+........ .......++..|+|||.+..      ...++.++|||||||++|+|++|+.||....  .......+.
T Consensus       161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~  231 (302)
T cd07864         161 GLARLYNSEES-RPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELIS  231 (302)
T ss_pred             cccccccCCcc-cccccceeccCccChHHhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHH
Confidence            99976644331 11223346788999997642      2245789999999999999999999886432  222222222


Q ss_pred             HHhcCCCcc--ccc--------cCcc------cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          291 KKMGSFEPA--VSI--------LDTK------LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       291 ~~~~~~~~~--~~~--------~~~~------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .......+.  ..+        .+..      .......   ....+.+++..||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF---IPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHhCCCChhhcccccccccccccccccccccchhhhcCC---CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            222111100  000        0000      0000000   11245678888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-39  Score=318.58  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=190.8

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-------
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-------  134 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  134 (371)
                      ....|+..+.||+||||.||+++.+ +|+.||||++.... +......+.+|+..+++|+|||||+++..|.+       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4456777889999999999999654 89999999996555 56667889999999999999999998854310       


Q ss_pred             --------------------------------------------------------------------------------
Q 037946          135 --------------------------------------------------------------------------------  134 (371)
Q Consensus       135 --------------------------------------------------------------------------------  134 (371)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEeecCCCCHHHHhccCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 037946          135 ------------------------K--------SVKLLLYNYISNGNLQQLLQGNRNL-DWETRYKIAVGSAQGLAYLHH  181 (371)
Q Consensus       135 ------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~~i~~~l~~lh~  181 (371)
                                              .        ..+||=||||+..+|.+++.++... .....|+++.+|+.||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        1247889999998888888776654 577899999999999999999


Q ss_pred             CCCCCeEecCCCCCCeeEcCCCceEEccccCccccC----C------------CCcccccccccccccccCCCCccchhh
Q 037946          182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN----S------------TNYHHAMSRVAGSYGYIAPGKCKLQII  245 (371)
Q Consensus       182 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~~~  245 (371)
                      +   ++|||||||.||++|+++.|||+|||++....    .            .......+...||.-|+|||++...  
T Consensus       716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~--  790 (1351)
T KOG1035|consen  716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT--  790 (1351)
T ss_pred             C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc--
Confidence            9   99999999999999999999999999998621    0            0000122356799999999988643  


Q ss_pred             hcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHH
Q 037946          246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIA  325 (371)
Q Consensus       246 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  325 (371)
                        ....|+.|+|+|||||+|+||+.-   |....... ...    ..++.         +.+...++-.......-.++|
T Consensus       791 --~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa-~iL----~~LR~---------g~iP~~~~f~~~~~~~e~slI  851 (1351)
T KOG1035|consen  791 --SSNKYNSKIDMYSLGIVLFEMLYP---FGTSMERA-SIL----TNLRK---------GSIPEPADFFDPEHPEEASLI  851 (1351)
T ss_pred             --ccccccchhhhHHHHHHHHHHhcc---CCchHHHH-HHH----Hhccc---------CCCCCCcccccccchHHHHHH
Confidence              124789999999999999999874   43221111 111    11111         111111000112223334688


Q ss_pred             hcccCCCCCCCCCHHHHHHH
Q 037946          326 MFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       326 ~~cl~~dP~~RPs~~evl~~  345 (371)
                      +++++.||.+|||+.|+++.
T Consensus       852 ~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  852 RWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHhcCCCccCCCHHHHhhc
Confidence            89999999999999999873

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-38  Score=281.99  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|++|.||++.. .+++.+|+|.+............+.+|++++++++|+||+++.+++.+....++||||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            56678899999999999954 46889999998654444455677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          146 SNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       146 ~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ++++|.+++..    ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++....... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence            99999999865    35689999999999999999999999   99999999999999999999999999997765441 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                         .....+++.|+|||.+.       +..++.++|+||||+++|+|++|+.||.....  ......+.   .       
T Consensus       158 ---~~~~~~~~~~~~Pe~~~-------~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~---~-------  215 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWK-------GRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQ---R-------  215 (256)
T ss_pred             ---cccccCCccccCHHHHC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh---c-------
Confidence               22345889999999764       34567899999999999999999999864321  11111111   1       


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                         ......+.   .....+.+++.+||+.+|++|||+.+++++
T Consensus       216 ---~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         216 ---GKYPPIPP---IYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ---CCCCCCch---hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               01111111   122345668888999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-38  Score=289.63  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=198.2

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|...+.||+|+||.||+|... +++.+|+|.+..... ......++.+|+++++.++|+|++++.+++...+..++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44666788999999999999754 578899998854322 2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+. |++.+++. ....+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9997 57877764 345689999999999999999999999   9999999999999999999999999998765432  


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                          ....+++.|+|||.+...    ....++.++|||||||++|+|++|..|+...... .....+ .   ....    
T Consensus       169 ----~~~~~~~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~-~---~~~~----  231 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHI-A---QNES----  231 (308)
T ss_pred             ----ccccCCccccCHHHHhhc----ccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHH-h---hcCC----
Confidence                234688899999976421    1234678999999999999999999998543211 111111 1   0000    


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                            ......  .....+.+++.+||+.+|.+||++++++++.+.....++.
T Consensus       232 ------~~~~~~--~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~  277 (308)
T cd06634         232 ------PALQSG--HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (308)
T ss_pred             ------CCcCcc--cccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChh
Confidence                  000000  1112345678889999999999999999998877754443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.4e-38  Score=283.31  Aligned_cols=248  Identities=21%  Similarity=0.250  Sum_probs=187.6

Q ss_pred             ccccCCceEEEEEEe-CCCCEEEEEEecccCCCc-chHHHHHHHH---HHHhccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           72 VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE-EPVDSFAAEI---QILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      .||+|+||.||+|.. .+++.||+|.+....... .....+..|.   ..++..+|||++++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999965 458899999986543322 2122233443   34445689999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccc
Q 037946          147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS  226 (371)
Q Consensus       147 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  226 (371)
                      +++|.+++.....+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.......    ..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~  153 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH  153 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence            999999998888899999999999999999999999   99999999999999999999999999987654322    13


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ...|+..|+|||.+.+      +..++.++||||+|+++|+|++|..||............  ......        .  
T Consensus       154 ~~~~~~~y~aPE~~~~------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~~~--------~--  215 (278)
T cd05606         154 ASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTM--------A--  215 (278)
T ss_pred             CcCCCcCCcCcHHhcC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH--HHhhcc--------C--
Confidence            3468999999997642      224678999999999999999999999654322111111  010000        0  


Q ss_pred             cCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHhc
Q 037946          307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLME  348 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~~  348 (371)
                       ...+...   ...+.+++.+|+..+|.+||     ++++++++-+-
T Consensus       216 -~~~~~~~---s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~  258 (278)
T cd05606         216 -VELPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF  258 (278)
T ss_pred             -CCCCCcC---CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence             0111111   12445577789999999999     99999986433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-38  Score=282.72  Aligned_cols=266  Identities=26%  Similarity=0.337  Sum_probs=197.9

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEEEEEe
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKLLLYN  143 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  143 (371)
                      |+..+.||+|++|.||+|... +++.+|+|++............+.+|+++++.++|||++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            445678999999999999765 588999999966543344456788999999999999999999999888  89999999


Q ss_pred             ecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++ +|.+++... ..+++..++.++.|++.||+|||++   +++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 898888765 5799999999999999999999999   999999999999999999999999999987654431 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc----
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP----  298 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  298 (371)
                      .......++..|+|||.+.+.      ..++.++||||||+++|||++|..||.....  ......+.........    
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~------~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGA------TRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTDENWP  227 (287)
T ss_pred             ccccccccccccCCceeeEcc------ccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhcc
Confidence            112334568899999976532      2467899999999999999999999865432  1111222221111000    


Q ss_pred             -cccc-cCc--ccCC-CCh---hhHHH--HHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 -AVSI-LDT--KLQG-LPD---QMVQE--MLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 -~~~~-~~~--~~~~-~~~---~~~~~--~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                       ...+ ...  .... .+.   .....  ...+.+++.+||+.||++||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             0000 000  0000 000   00111  3356778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.7e-38  Score=278.18  Aligned_cols=248  Identities=28%  Similarity=0.408  Sum_probs=197.0

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|++|.||++... +++.+++|++.....  .....+.+|+++++.++|||++++++.+...+..++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            556678999999999999764 688999999854322  35678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++++|.+++... ..+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            999999999776 6799999999999999999999998   999999999999999999999999999987655431   


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....++..|+|||.+..       ..++.++|+||||+++|+|++|..|+......  ........  ..   .     
T Consensus       154 ~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~--~~---~-----  214 (253)
T cd05122         154 RNTMVGTPYWMAPEVING-------KPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIAT--NG---P-----  214 (253)
T ss_pred             ccceecCCcccCHHHHcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh--cC---C-----
Confidence            244568899999997642       34688999999999999999999998643211  11111111  00   0     


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                         ...+.. ......+.+++..||+.||++|||+.+++++
T Consensus       215 ---~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         215 ---PGLRNP-EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ---CCcCcc-cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               000000 0001235567788999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-38  Score=288.04  Aligned_cols=247  Identities=21%  Similarity=0.373  Sum_probs=192.1

Q ss_pred             CCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           70 ENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      ...||+|+||.||++.. .+++.||+|++..  ........+.+|+.+++.++|+|++++++.+...+..+++|||++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecc--cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            35799999999999965 4689999998742  22334567899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccc
Q 037946          149 NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV  228 (371)
Q Consensus       149 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  228 (371)
                      +|.+++... .+++.....++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus       103 ~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~  176 (292)
T cd06657         103 ALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL  176 (292)
T ss_pred             cHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence            999987654 589999999999999999999999   99999999999999999999999999987654322  122345


Q ss_pred             cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .|++.|+|||.+.       +..++.++|+||+|+++|+|++|..||.....  ......+......   ..    ....
T Consensus       177 ~~~~~y~~pE~~~-------~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~---~~----~~~~  240 (292)
T cd06657         177 VGTPYWMAPELIS-------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP---KL----KNLH  240 (292)
T ss_pred             ccCccccCHHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCc---cc----CCcc
Confidence            6889999999764       33567899999999999999999999864321  1211222111110   00    0011


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..+       ..+.+++.+||+.||.+||++.+++++=+
T Consensus       241 ~~~-------~~l~~li~~~l~~~P~~R~~~~~ll~~~~  272 (292)
T cd06657         241 KVS-------PSLKGFLDRLLVRDPAQRATAAELLKHPF  272 (292)
T ss_pred             cCC-------HHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence            112       12345777899999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=291.57  Aligned_cols=273  Identities=24%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----Ce
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----SV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  137 (371)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++... ........+..|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            35688889999999999999965 46899999998432 2233456788999999999999999999886544     35


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .|+++||+.+ +|.+++.. ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        83 ~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            7999999975 88887754 4589999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          218 STNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       218 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ..... .......||+.|+|||.+..      ...++.++|||||||++|+|++|+.||....  .......+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGvil~el~~G~~~f~~~~--~~~~~~~~~~~~~~~  229 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKD--YLHQLNLILGVLGTP  229 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCC
Confidence            33211 11223468999999997532      2346789999999999999999999985422  111111111111110


Q ss_pred             Cc--cccccCcc-------c---CCCCh--hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--Hhccc
Q 037946          297 EP--AVSILDTK-------L---QGLPD--QMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVK  350 (371)
Q Consensus       297 ~~--~~~~~~~~-------~---~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~  350 (371)
                      ..  ...+.+..       .   ...+.  ........+.+++.+||+.||++|||+.|++++  +....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            00  00000000       0   00000  000112345678889999999999999999998  55444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.7e-38  Score=289.81  Aligned_cols=263  Identities=20%  Similarity=0.322  Sum_probs=191.7

Q ss_pred             ccccC--CceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKG--CSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .||+|  +||+||++.. .+|+.||+|.+..........+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  9999999975 47899999998654444445678899999999999999999999999999999999999999


Q ss_pred             CHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc---
Q 037946          149 NLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH---  223 (371)
Q Consensus       149 ~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---  223 (371)
                      +|.+++.+.  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999998764  3489999999999999999999999   99999999999999999999999998654332211000   


Q ss_pred             --ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc-
Q 037946          224 --AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV-  300 (371)
Q Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  300 (371)
                        ......++..|+|||.+.+.     ...++.++|||||||++|||++|..||....... ........  ....+.. 
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~~  233 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQD-----LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKG--PPYSPLDI  233 (328)
T ss_pred             ccccccccCccCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcC--CCCCCccc
Confidence              01112356679999987532     2346789999999999999999999986443211 11110000  0000000 


Q ss_pred             --------------------------------cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 --------------------------------SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 --------------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                                                      ........  .+........+.+++.+||+.||++|||++|++++-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence                                            00000000  0011123345677999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-38  Score=281.81  Aligned_cols=264  Identities=24%  Similarity=0.299  Sum_probs=192.0

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc---CCCCceeeeceEecCCe-----
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI---RHRNIVKLLGYCSNKSV-----  137 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  137 (371)
                      |+..+.||+|+||.||+|... +++.+|+|.+............+.+|+.+++++   +|||++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            455678999999999999775 489999999865443333345566788777666   69999999999988776     


Q ss_pred             EEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          138 KLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      .+++|||+.+ +|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8988886643  489999999999999999999999   999999999999999999999999999977


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .....   ......++..|+|||.+.       +..++.++|+||||+++|+|++|.+||..... ..............
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~-------~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~  225 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLL-------QSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLP  225 (287)
T ss_pred             ccCCc---ccccccccccccChHHhc-------cCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCC
Confidence            64432   123345788999999765       33567899999999999999999888864322 11111111111000


Q ss_pred             C----Ccc----ccccCcccCCCChhhH-HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          296 F----EPA----VSILDTKLQGLPDQMV-QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       296 ~----~~~----~~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .    ...    ...........+.... .....+.+++.+||+.||++||++++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0    000    0000111111111111 112345678899999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=299.81  Aligned_cols=199  Identities=30%  Similarity=0.472  Sum_probs=171.4

Q ss_pred             CCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC------eEEEEE
Q 037946           70 ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS------VKLLLY  142 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~  142 (371)
                      .+.||+|+||.||+|+ ..+|+.||||.+.... .....+...+|+++|++++|||||+++++-.+..      ...++|
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            4579999999999997 5689999999986543 4556688999999999999999999998765433      567999


Q ss_pred             eecCCCCHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc--CCC--ceEEccccCccc
Q 037946          143 NYISNGNLQQLLQG---NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD--SKY--EAYLADFGLAKL  215 (371)
Q Consensus       143 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~--~~~--~~kl~Dfg~~~~  215 (371)
                      |||.+|+|...+.+   ...+++...+.+..+++.||.|||.+   +|+||||||.||++-  .+|  .-||+|||.|+.
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            99999999999975   44699999999999999999999999   999999999999982  333  469999999998


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD  281 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  281 (371)
                      ++++.   ...+..||+.|.+||++..      ...|+..+|.|||||++|+++||..||.+..+.
T Consensus       174 l~d~s---~~~S~vGT~~YLhPel~E~------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  174 LDDNS---LFTSLVGTEEYLHPELYER------QKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             CCCCC---eeeeecCchhhcChHHHhh------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            87775   5678899999999998653      346788899999999999999999999876554

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-38  Score=288.95  Aligned_cols=280  Identities=23%  Similarity=0.313  Sum_probs=207.0

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-----eEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-----VKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  139 (371)
                      +|+..+.||.|++|.||+|... +++.||+|++............+.+|+.+++.++||||+++.+++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            3677789999999999999764 4899999998654433445578899999999999999999999987775     789


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++|||+++ +|.+++.+...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+......
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            99999975 8999998888899999999999999999999999   9999999999999999999999999999876544


Q ss_pred             Ccc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ... .......+++.|+|||.+.+.      ..++.++|+||||+++|+|++|..||.....  ......+.........
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~  228 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSS------SRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLNLIVEVLGTPSE  228 (330)
T ss_pred             ccccccccccccccCcCCceeeecc------cCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHhcCCCCh
Confidence            210 112344678999999987632      1568899999999999999999999864432  1212222221111100


Q ss_pred             c----------ccccCcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HhcccCCCccCCC
Q 037946          299 A----------VSILDTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVKSAPEELGK  358 (371)
Q Consensus       299 ~----------~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~  358 (371)
                      .          ...+.. .........     .....+.+++.+||+.+|.+|||+.+++++  +..+...+.+..+
T Consensus       229 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~  304 (330)
T cd07834         229 EDLKFITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA  304 (330)
T ss_pred             hHhhhccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCC
Confidence            0          000000 000000000     012345668888999999999999999997  5555554444443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=282.44  Aligned_cols=244  Identities=23%  Similarity=0.288  Sum_probs=183.6

Q ss_pred             CccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHH-hccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQIL-GHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|.. .+++.||+|.+...... ......+..|..++ ...+|||++++++++...+..|++|||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999965 45889999998543221 22233445555444 455899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      ++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....      ...
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~  152 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK  152 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence            99999998888899999999999999999999999   999999999999999999999999999875432      133


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCccc
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL  307 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ..+++.|+|||.+.+       ..++.++||||||+++|+|++|..||.....  ......+...  . ..   ......
T Consensus       153 ~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~--~-~~---~~~~~~  217 (260)
T cd05611         153 FVGTPDYLAPETILG-------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAVFDNILSR--R-IN---WPEEVK  217 (260)
T ss_pred             CCCCcCccChhhhcC-------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhc--c-cC---CCCccc
Confidence            458889999997653       2467899999999999999999999864322  1111111110  0 00   000000


Q ss_pred             CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHH---HHHHH
Q 037946          308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK---EVVAL  345 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~---evl~~  345 (371)
                      ...+       ..+.+++.+||+.||++||++.   |++.+
T Consensus       218 ~~~~-------~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         218 EFCS-------PEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             ccCC-------HHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            1112       2345678889999999999664   55444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.1e-38  Score=283.52  Aligned_cols=264  Identities=22%  Similarity=0.365  Sum_probs=194.8

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||.|++|.||+|... +|+.||+|++..... ......+.+|+.+++.++|||++++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            667789999999999999764 688999999854332 233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          146 SNGNLQQLLQGN---RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       146 ~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ++ +|.+++...   ..+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            86 888887643   3589999999999999999999999   99999999999999999999999999997654322  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc----
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP----  298 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  298 (371)
                      .......+++.|++||.+.+      +..++.++||||||+++|+|++|..||......  .....+.........    
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  226 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLG------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWP  226 (284)
T ss_pred             cccccccccccccChHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHH
Confidence            12233457889999997642      224578999999999999999999998654321  111111111110000    


Q ss_pred             ---cccccCcccCCCChhhHH-----HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 ---AVSILDTKLQGLPDQMVQ-----EMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                         ..................     ....+.+++.+||+.||.+||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               000000111111111111     12234578888999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=282.16  Aligned_cols=265  Identities=27%  Similarity=0.369  Sum_probs=197.4

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||.|++|.||+|... +++.+++|++............+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            445678999999999999654 6899999998654444445678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++ +|.+++.. ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            76 88887765 45789999999999999999999999   99999999999999999999999999997765543  12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc-c-ccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP-A-VSI  302 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~  302 (371)
                      .....++..|+|||.+.+      ...++.++|+||||+++|+|++|+.||.....  ......+......... . ...
T Consensus       155 ~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd05118         155 YTHYVVTRWYRAPELLLG------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKF  226 (283)
T ss_pred             ccCccCcccccCcHHHhc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccc
Confidence            233458889999997642      12568899999999999999999988854322  1111111111111000 0 000


Q ss_pred             cC-----------cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LD-----------TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~-----------~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .+           ................+.+++.+||+.||.+||++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00           00000000001123456678999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=307.87  Aligned_cols=255  Identities=28%  Similarity=0.443  Sum_probs=201.2

Q ss_pred             cccCCccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           67 LKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      ....+.||+|.||.|++|...        ....||||.+...... ...+.+..|+++|+.+ .|||++.++|+|...+.
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            345568999999999999542        1457999998654444 6778999999999999 69999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC
Q 037946          138 KLLLYNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS  201 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~  201 (371)
                      .++|+||+..|+|.++++..+                .++..+++.++.|||.||+||+++   +++||||.++|||+..
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecC
Confidence            999999999999999997766                488899999999999999999999   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCcccccccc-cccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 037946          202 KYEAYLADFGLAKLMNSTNYHHAMSRV-AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQI  279 (371)
Q Consensus       202 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~  279 (371)
                      +..+||+|||+++.....++.....+. .-...|||||.+.       ...|+.+||||||||+|||++| |..|+.. .
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-------~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~  525 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-------DRVFTSKSDVWSFGILLWEIFTLGGTPYPG-I  525 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-------cCcccccchhhHHHHHHHHHhhCCCCCCCC-C
Confidence            999999999999976655533221111 1345699999765       3578999999999999999998 5556543 2


Q ss_pred             CCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .....+.++++.+.....+         ..++++       ++.++..||+.+|++||++.++.+.+...
T Consensus       526 ~~~~~l~~~l~~G~r~~~P---------~~c~~e-------iY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  526 PPTEELLEFLKEGNRMEQP---------EHCSDE-------IYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             CcHHHHHHHHhcCCCCCCC---------CCCCHH-------HHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            2233344444443332111         233333       34566669999999999999999999884

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.8e-38  Score=282.36  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=191.0

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      |...+.||+|+||.||++.. .+++.+|+|.+...... .....+.+|+.++.++. ||||+++++++...+..+++|||
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            44557899999999999965 45899999998543322 44567889999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          145 ISNGNLQQLLQ-----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       145 ~~~~~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +.. ++.++..     ....+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            865 6655432     3456899999999999999999999732  8999999999999999999999999999765433


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .   ......|++.|+|||.+....    ...++.++||||||+++|+|++|..||....    ...+.+........+.
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~  230 (288)
T cd06616         162 I---AKTRDAGCRPYMAPERIDPSA----RDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDPPI  230 (288)
T ss_pred             C---ccccccCccCccCHHHhcccc----ccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCCCc
Confidence            2   112345889999999875321    1357889999999999999999999986432    1112222211110100


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        ..    ...+   ......+.+++.+||+.||++|||+++++++-+
T Consensus       231 --~~----~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~  269 (288)
T cd06616         231 --LS----NSEE---REFSPSFVNFINLCLIKDESKRPKYKELLEHPF  269 (288)
T ss_pred             --CC----CcCC---CccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence              00    0000   011224556888899999999999999998743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.9e-39  Score=273.33  Aligned_cols=271  Identities=23%  Similarity=0.290  Sum_probs=203.6

Q ss_pred             HhccccCCccccCCceEEEEEEeC-C----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-CCe
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-N----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-KSV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  137 (371)
                      ...|+....||+|+||.||+|... +    ...+|+|++..+....-......+|+..++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            456888999999999999999332 2    2368999986654433334567899999999999999999999877 788


Q ss_pred             EEEEEeecCCCCHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC----CceEEc
Q 037946          138 KLLLYNYISNGNLQQLLQG-----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK----YEAYLA  208 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~  208 (371)
                      +++++||.+. +|..+|+-     .+.++...+..+..||+.|+.|||++   =++||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence            9999999988 89998853     24588999999999999999999999   89999999999999877    999999


Q ss_pred             cccCccccCCCCc-ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-----c
Q 037946          209 DFGLAKLMNSTNY-HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD-----G  282 (371)
Q Consensus       209 Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-----~  282 (371)
                      |||+++.+...-. ....+..+.|..|.|||++.+.      ..|+++.|||+.||++.||+|-.+.|.....+     +
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa------~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P  252 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA------RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP  252 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhccc------ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence            9999998765431 1233556789999999998754      36799999999999999999999888654332     1


Q ss_pred             --hhHHHHHHHHhcCCCccccccCcccCCCChh----------------hH---H----HHHHHHHHHhcccCCCCCCCC
Q 037946          283 --LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQ----------------MV---Q----EMLQTLGIAMFCVNSSPAERP  337 (371)
Q Consensus       283 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~---~----~~~~~~~l~~~cl~~dP~~RP  337 (371)
                        ..-++.+-..++.   ..+-..+.+...|+-                +.   .    .....++|+.++|++||.+|.
T Consensus       253 fq~dQl~rIf~vLG~---Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI  329 (438)
T KOG0666|consen  253 FQHDQLDRIFEVLGT---PTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI  329 (438)
T ss_pred             chHHHHHHHHHHcCC---CccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence              1112222222222   111112222222221                00   0    011247899999999999999


Q ss_pred             CHHHHHHHHh
Q 037946          338 TMKEVVALLM  347 (371)
Q Consensus       338 s~~evl~~L~  347 (371)
                      |+++.+++..
T Consensus       330 ta~qAleh~y  339 (438)
T KOG0666|consen  330 TAEQALEHPY  339 (438)
T ss_pred             cHHHHhcccc
Confidence            9999999853

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.4e-38  Score=288.69  Aligned_cols=273  Identities=21%  Similarity=0.258  Sum_probs=198.3

Q ss_pred             hccc-cCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcc------------hHHHHHHHHHHHhccCCCCceeeec
Q 037946           65 ECLK-DENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEE------------PVDSFAAEIQILGHIRHRNIVKLLG  130 (371)
Q Consensus        65 ~~~~-~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~~~~  130 (371)
                      ++|. ..+.||.|+||.||+|.+. +++.||+|++........            ....+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 3567999999999999754 689999999854332210            0125778999999999999999999


Q ss_pred             eEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       131 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                      ++...+..+++|||+. |+|.+++.....+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence            9999999999999997 59999998888899999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCc------------ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          211 GLAKLMNSTNY------------HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       211 g~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      |.+........            ........+++.|+|||.+.+.      ..++.++||||||+++|+|++|..||...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA------EKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccC------CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99976552110            0111233468899999977522      24578999999999999999999998644


Q ss_pred             CCCchhHHHHHHHHhcCCCcc--ccc-----cCcccCCCChhh----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          279 IGDGLHIVEWVKKKMGSFEPA--VSI-----LDTKLQGLPDQM----VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..  ......+..........  ...     ..+.....+...    ......+.+++.+||+.+|++|||++|++.+-+
T Consensus       238 ~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        238 NE--IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             CH--HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            32  22222222222111100  000     000000000000    011234567888899999999999999999765


Q ss_pred             cc
Q 037946          348 EV  349 (371)
Q Consensus       348 ~~  349 (371)
                      --
T Consensus       316 ~~  317 (335)
T PTZ00024        316 FK  317 (335)
T ss_pred             cC
Confidence            54

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=278.82  Aligned_cols=263  Identities=24%  Similarity=0.315  Sum_probs=193.0

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      |...+.||+|++|.||+|... +++.|++|++...... .......+|+..+++++ |||++++++++.+++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            455678999999999999765 5788999998543322 22234567999999998 99999999999999999999999


Q ss_pred             cCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      + +|+|.+++....  .+++..+..++.|++.+|.|||++   +++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence            9 779999887654  689999999999999999999999   99999999999999999999999999997664432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc----
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP----  298 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  298 (371)
                       ......++..|+|||.+..      +..++.++|+||||+++|||++|..||...... ... ..+.........    
T Consensus       154 -~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~  224 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEI-DQL-YKICSVLGTPTKQDWP  224 (283)
T ss_pred             -CcCCCCCcccccCceeeec------CcCcCCccchhhHHHHHHHHHhCCCccCCCChH-HHH-HHHHHhcCCCChhhhh
Confidence             1123457889999997642      234678999999999999999999888543221 111 111111100000    


Q ss_pred             ----cccccCcccCCCCh----hh-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 ----AVSILDTKLQGLPD----QM-VQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ----~~~~~~~~~~~~~~----~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          .....+........    .. ......+.+++.+||+.||++|||++|++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence                00000000000000    00 0112346678999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-38  Score=286.55  Aligned_cols=258  Identities=22%  Similarity=0.265  Sum_probs=195.7

Q ss_pred             cccCCccccCCceEEEEEEe----CCCCEEEEEEecccCC--CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEE
Q 037946           67 LKDENVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKR--DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  139 (371)
                      |+..+.||+|++|.||++..    .+++.||+|.+.....  .......+.+|+.++.++ +|||++++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            55677899999999999864    3568899999854322  122345688999999999 6999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            9999999999999998777899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ... ......|+..|+|||.+.+.     ....+.++||||||+++|+|++|..||...... ....+..........+ 
T Consensus       159 ~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~-  230 (288)
T cd05583         159 EEE-RAYSFCGTIEYMAPEVIRGG-----SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPP-  230 (288)
T ss_pred             ccc-ccccccCCccccCHHHhcCC-----CCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHccCCC-
Confidence            211 12234588999999976432     123578999999999999999999998533221 1111222221111010 


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                            .....+       ..+.+++.+||+.||++|||+.++.+.|..
T Consensus       231 ------~~~~~~-------~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         231 ------FPKTMS-------AEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ------CCcccC-------HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                  001111       234457788999999999998777666544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-38  Score=278.79  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=193.0

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC---CcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR---DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  139 (371)
                      .|+..+.||+|+||.||+|.. .+++.+|+|.+.....   .......+.+|++++++++||||+++++++.+.  +..+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            477788999999999999965 4689999998743221   233456788999999999999999999998664  5688


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++|||+++++|.+++.+...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||+++.....
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            9999999999999998877799999999999999999999999   9999999999999999999999999999865332


Q ss_pred             Ccc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ... .......++..|+|||.+.+       ...+.++|+|||||++|+|++|+.||....    .... +...... . 
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~-~~~~~~~-~-  225 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-------EGYGRKADVWSVACTVVEMLTEKPPWAEYE----AMAA-IFKIATQ-P-  225 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccC----HHHH-HHHHHcC-C-
Confidence            110 11223468899999997653       356789999999999999999999986331    1111 1111111 0 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                             .....++....   .+.+++..||+ +|..||++.+++++
T Consensus       226 -------~~~~~p~~~~~---~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         226 -------TKPMLPDGVSD---ACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -------CCCCCCcccCH---HHHHHHHHHhc-CcccCccHHHHhcC
Confidence                   00112222112   23446777999 67999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-37  Score=284.66  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=192.5

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|...+.||+|+||.||+|.. .+++.|++|++..... .......+.+|+++++.++|||++++++++.+.+..|+||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            3466677899999999999975 4688999999854332 2334467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+.+ ++.+++.. ...+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.+||+|||++.....   
T Consensus       101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            99965 77777654 45689999999999999999999999   999999999999999999999999999864322   


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                         .....|+..|+|||.+...    ....++.++||||||+++|+|++|..|+.....  ...   .........+  .
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~---~~~~~~~~~~--~  239 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA---LYHIAQNDSP--T  239 (313)
T ss_pred             ---CCCccccccccChhhcccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHH---HHHHHhcCCC--C
Confidence               2345688999999986421    134577899999999999999999999864321  111   1111111000  0


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...   ...+       ..+.+++.+||+.+|.+||++.+++.+-+
T Consensus       240 ~~~---~~~~-------~~l~~li~~~l~~~P~~Rp~~~~~l~~~~  275 (313)
T cd06633         240 LQS---NEWT-------DSFRGFVDYCLQKIPQERPASAELLRHDF  275 (313)
T ss_pred             CCc---cccC-------HHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            000   0111       12445778899999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.3e-38  Score=286.41  Aligned_cols=270  Identities=23%  Similarity=0.313  Sum_probs=193.1

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-------
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-------  135 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  135 (371)
                      .++|+..+.||+|+||.||+|... +++.+|+|++............+.+|+++++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            356888899999999999999754 689999999855433333335677899999999999999999887443       


Q ss_pred             -CeEEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          136 -SVKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                       ...++||||+.+ +|...+.. ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346999999976 67666654 45799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCccc---------ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 037946          214 KLMNSTNYHH---------AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH  284 (371)
Q Consensus       214 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  284 (371)
                      ..........         ......+++.|+|||.+.+      ...++.++||||||+++|||++|.+||......  .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--~  234 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--D  234 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhC------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence            7654332111         1123356888999997642      224678999999999999999999998643321  1


Q ss_pred             HHHHHHHHhcCCCcc--------ccccC-cccCCCChhhH----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          285 IVEWVKKKMGSFEPA--------VSILD-TKLQGLPDQMV----QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ....+........+.        ..... ......+....    .....+.+++.+||+.||++|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            111111111110000        00000 00001111100    111345678999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=278.09  Aligned_cols=250  Identities=24%  Similarity=0.304  Sum_probs=202.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|...++||+|.||.|-.++. .+++.+|+|++++... ..+....-+.|-++|+..+||.+..+--.|+.++.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            4577789999999999999964 4789999999976543 2344566789999999999999999988899999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||..||.|.-++++.+.+++.....+...|..||.|||++   +||.||+|.+|.|+|.+|++||+|||+|+.-..  +-
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g  322 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YG  322 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc--cc
Confidence            9999999999999999999999999999999999999999   999999999999999999999999999985433  23


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..+.+.||||.|+|||++.       ...|+.+.|.|.+||++|||++|+.||.....  ..+.+.+...--        
T Consensus       323 ~t~kTFCGTPEYLAPEVle-------DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFeLIl~ed~--------  385 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFELILMEDL--------  385 (516)
T ss_pred             ceeccccCChhhcCchhhc-------cccccceeehhhhhHHHHHHHhccCcccccch--hHHHHHHHhhhc--------
Confidence            4678899999999999876       55788999999999999999999999975433  233333222111        


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~  345 (371)
                            .+|..+.++...   |+.-.|.+||.+|.     .+.||.++
T Consensus       386 ------kFPr~ls~eAkt---LLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  386 ------KFPRTLSPEAKT---LLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ------cCCccCCHHHHH---HHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                  122222222222   44557889999995     45666654

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-38  Score=290.05  Aligned_cols=270  Identities=24%  Similarity=0.328  Sum_probs=197.3

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-  136 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  136 (371)
                      +++++.++|+..+.||+|+||.||++.. .++..||+|++............+.+|+.+++.++||||+++++++.... 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            4556677899999999999999999964 46899999998554333444567889999999999999999999886543 


Q ss_pred             -----eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcccc
Q 037946          137 -----VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG  211 (371)
Q Consensus       137 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  211 (371)
                           ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence                 458999998 6799988875 4589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++......     .....+++.|+|||.+.+      ...++.++|+||||+++|+|++|..||...... ........ 
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~-  230 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILN------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMK-  230 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-
Confidence            99765432     133467899999997642      124678999999999999999999998643221 11111111 


Q ss_pred             HhcCCC-ccccccC--------cccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          292 KMGSFE-PAVSILD--------TKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       292 ~~~~~~-~~~~~~~--------~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ...... .....+.        ..+........     .....+.+++.+|++.||++|||+.+++.+-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~  299 (343)
T cd07880         231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP  299 (343)
T ss_pred             hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            000000 0000000        00000000000     0112355788889999999999999999653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=270.68  Aligned_cols=268  Identities=19%  Similarity=0.292  Sum_probs=205.9

Q ss_pred             CCccccCCceEEEEE-EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecCC
Q 037946           70 ENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      .+.||+|+++.|-.+ ...+|..+|||++.+  .......++.+|++++.+. .|+||+.++++|++....|+|||.|.|
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidK--q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDK--QPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhc--CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            467999999999998 567899999999944  3445667899999999998 699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC---ceEEccccCccccCCCCc---
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY---EAYLADFGLAKLMNSTNY---  221 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~---  221 (371)
                      |.|.+.|+....+++..+..+.++|+.||.|||.+   ||.||||||+|||-.+..   -||||||.+.........   
T Consensus       161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99999999999999999999999999999999999   999999999999986554   479999999754322211   


Q ss_pred             --ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc-----hhHHHHHHHHhc
Q 037946          222 --HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG-----LHIVEWVKKKMG  294 (371)
Q Consensus       222 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~  294 (371)
                        .....+.+|+..|||||+..-  +.+....|+.+.|.|||||+||-|++|.+||.+.-+.+     -+..+-.+    
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~--fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ----  311 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDV--FVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ----  311 (463)
T ss_pred             CCCccccCcccchhhcchhHHhh--hccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH----
Confidence              112235679999999998753  24445678999999999999999999999998775531     00000000    


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHH-HHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQT-LGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                        ..+..-+...--.+|++....+-.. -+++...+-.|+.+|.++..++++-+--.
T Consensus       312 --~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~  366 (463)
T KOG0607|consen  312 --NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR  366 (463)
T ss_pred             --HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence              1111122222334455444333322 34777788899999999999998755443

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7e-38  Score=281.19  Aligned_cols=251  Identities=23%  Similarity=0.333  Sum_probs=197.8

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +|...+.||.|++|.||+|... +++.||+|++..... .......+.+|..++++++ ||||+++++++.+.+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            4777889999999999999764 689999999855322 2334467889999999998 999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |++++++|.+++...+.+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            9999999999999888899999999999999999999999   9999999999999999999999999998765443211


Q ss_pred             ------------------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 037946          223 ------------------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH  284 (371)
Q Consensus       223 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  284 (371)
                                        .......++..|+|||.+.       ....+.++|+||||++++++++|..|+.....  ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~  229 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YL  229 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhC-------CCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HH
Confidence                              1122345788999999764       23578899999999999999999999864321  11


Q ss_pred             HHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH----HHHHHH
Q 037946          285 IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM----KEVVAL  345 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~evl~~  345 (371)
                      ....+.   ..           ....+...   ...+.+++.+||+.||++|||+    .+++++
T Consensus       230 ~~~~~~---~~-----------~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 TFQKIL---KL-----------EYSFPPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHHH---hc-----------CCCCCCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            111111   00           00111111   1234457778999999999999    888765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-37  Score=284.58  Aligned_cols=266  Identities=21%  Similarity=0.309  Sum_probs=196.0

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-CCeEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-KSVKLL  140 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l  140 (371)
                      +.++|+..+.||.|+||.||+|.. .+++.||+|++............+..|+++++.++|||++++.+++.. .+..|+
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            456788899999999999999965 478999999986544444455678899999999999999999998865 567899


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      +|||+ +++|.+++... .+++..+..++.|++.||.|||++   +++||||+|+||++++++.++|+|||.+...... 
T Consensus        88 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          88 VTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             Eeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            99998 45898888754 478888999999999999999999   9999999999999999999999999998754332 


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC---
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE---  297 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  297 (371)
                          .....+++.|+|||.+..      ...++.++||||||+++|+|++|..||.....  ......+....+...   
T Consensus       162 ----~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~  229 (328)
T cd07856         162 ----MTGYVSTRYYRAPEIMLT------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDV  229 (328)
T ss_pred             ----cCCCcccccccCceeeec------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence                133457889999997642      12568899999999999999999999854321  111111111111100   


Q ss_pred             -------ccccccCccc--CCCCh-hh-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          298 -------PAVSILDTKL--QGLPD-QM-VQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       298 -------~~~~~~~~~~--~~~~~-~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                             .....+....  ...+. .. ......+.+++.+||+.+|++|||+++++.+-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence                   0000000000  00000 00 01123456688889999999999999998874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.6e-38  Score=282.96  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=192.0

Q ss_pred             hccccCCccccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|++|.||+|...+ ++.||+|.+..... ......+..|+.++... .||||+++++++.+....|++|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            347778899999999999997754 89999999854322 23345667777767666 5999999999999999999999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||+.+ ++.+++.. ...+++..+..++.|++.||+|||+ .   +++||||+|+||++++++.+||+|||++.......
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            99855 77777654 4568999999999999999999997 5   89999999999999999999999999987654332


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                         ......++..|+|||.+.....   ...++.++||||||+++|+|++|..||.....+ ...   ..........  
T Consensus       170 ---~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~---~~~~~~~~~~--  237 (296)
T cd06618         170 ---AKTRSAGCAAYMAPERIDPPDP---NPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEV---LTKILQEEPP--  237 (296)
T ss_pred             ---cccCCCCCccccCHhhcCCCCC---ccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHH---HHHHhcCCCC--
Confidence               1123357889999998753311   234678999999999999999999998642211 111   1111111100  


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                              ..+.. ......+.+++.+||+.||++||++++++++.+
T Consensus       238 --------~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         238 --------SLPPN-EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             --------CCCCC-CCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence                    00000 001123456788899999999999999998865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-37  Score=287.31  Aligned_cols=271  Identities=22%  Similarity=0.308  Sum_probs=197.6

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--  135 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--  135 (371)
                      ++..+.++|...+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++.+++...  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            4556668899999999999999999964 5689999999865433334456788999999999999999999987543  


Q ss_pred             ----CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcccc
Q 037946          136 ----SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG  211 (371)
Q Consensus       136 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  211 (371)
                          +..|++++++ +++|.+++... .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg  165 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  165 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccc
Confidence                3467888887 67998888654 589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++......     .....+++.|+|||.+.+      ...++.++|||||||++|+|++|..||.....  ......+..
T Consensus       166 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--~~~~~~~~~  232 (345)
T cd07877         166 LARHTDDE-----MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILR  232 (345)
T ss_pred             cccccccc-----ccccccCCCccCHHHHhC------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence            98764332     234468899999997642      12467899999999999999999999854321  111111111


Q ss_pred             HhcCCCc-ccc-ccC-------cccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          292 KMGSFEP-AVS-ILD-------TKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       292 ~~~~~~~-~~~-~~~-------~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ......+ ... +.+       ..+...+....     .....+.+++..|++.||.+||++.+++++-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence            1111000 000 000       00000000000     01123456888899999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-37  Score=286.37  Aligned_cols=268  Identities=21%  Similarity=0.283  Sum_probs=193.0

Q ss_pred             cccCCccccCCceEEEEEEeC-C--CCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEec----CCeE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-N--GELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSN----KSVK  138 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~  138 (371)
                      |+..+.||+|+||.||++... .  +..||+|++............+.+|+.+++++ +||||+++++.+..    ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            566778999999999999764 3  67899999854433334456788999999999 59999999986532    2457


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      |+++|++. ++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            88999986 59999998888899999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCcc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          219 TNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       219 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....  .......||+.|+|||.+.+      ...++.++||||||+++|+|++|..||....  .......+....+..
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~  229 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKPVFKGKD--YVDQLNQILQVLGTP  229 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC--HHHHHHHHHHHhCCC
Confidence            3211  11233468999999997542      2246789999999999999999999885422  111111111111110


Q ss_pred             Ccc--ccccCc-------ccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          297 EPA--VSILDT-------KLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       297 ~~~--~~~~~~-------~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ...  ..+..+       .....+....     .....+.+++.+||+.||++|||+++++.+=
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~  293 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP  293 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            000  000000       0000000000     0123456788899999999999999998874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-38  Score=290.79  Aligned_cols=268  Identities=21%  Similarity=0.313  Sum_probs=198.6

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe--
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV--  137 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--  137 (371)
                      .++.++|+..+.||+|++|.||+|... +++.||+|++............+.+|+.+++.++|||++++.+++...+.  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            345567888899999999999999764 57899999985543334445677889999999999999999988765554  


Q ss_pred             ----EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          138 ----KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       138 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                          .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence                89999998 5699999876 4599999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      ......     .....++..|+|||.+..      ...++.++||||||+++|+|++|..||.....  ......+....
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~  232 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLV  232 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhc
Confidence            865432     234467889999997642      12467899999999999999999999864322  11111111111


Q ss_pred             cCCCccccccC---------------ccc-CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          294 GSFEPAVSILD---------------TKL-QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       294 ~~~~~~~~~~~---------------~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ....  .....               ... .............+.+++.+||+.||++|||+.|++++-+-
T Consensus       233 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~  301 (343)
T cd07851         233 GTPD--EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL  301 (343)
T ss_pred             CCCC--HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence            1100  00000               000 00000000113356678899999999999999999987433

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=279.91  Aligned_cols=265  Identities=25%  Similarity=0.358  Sum_probs=197.3

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |+..+.||+|++|.||+|... +++.+|+|.+............+..|+.+++.++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            344568999999999999664 5899999998655434444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++ +|.+++... ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+........  .
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            85 999999876 5799999999999999999999999   999999999999999999999999999976544321  2


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc-----
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA-----  299 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  299 (371)
                      .....++..|+|||.+..      ...++.++|+||||+++|||++|..||.....  ......+..........     
T Consensus       155 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07829         155 YTHEVVTLWYRAPEILLG------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGV  226 (282)
T ss_pred             cCccccCcCcCChHHhcC------CcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhh
Confidence            233456788999997642      22567899999999999999999988854321  11111111111100000     


Q ss_pred             ccc--cCcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSI--LDTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~--~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ...  .+...........     .....+.+++.+||..||++||++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000  0111111100000     112356778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-37  Score=275.25  Aligned_cols=247  Identities=26%  Similarity=0.357  Sum_probs=190.4

Q ss_pred             cccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           73 IGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      ||.|+||.||++... +|+.+++|.+..... .......+.+|++++++++|||++++++.+...+..|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999775 489999999854332 224556789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc------ccc
Q 037946          151 QQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY------HHA  224 (371)
Q Consensus       151 ~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~  224 (371)
                      .+++.+...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........      ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            99998877899999999999999999999999   999999999999999999999999999876433311      012


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....++..|+|||.+..       ...+.++|+||||+++|+|++|..||.....  .....   .........     
T Consensus       158 ~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~---~~~~~~~~~-----  220 (265)
T cd05579         158 DKRIVGTPDYIAPEVILG-------QGHSKTVDWWSLGCILYEFLVGIPPFHGETP--EEIFQ---NILNGKIEW-----  220 (265)
T ss_pred             ccCcccCccccCHHHhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHH---HHhcCCcCC-----
Confidence            233457889999997652       3467899999999999999999999864322  11111   111100000     


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      +  ...     .....+..++.+||+.+|++|||+.++.+.|
T Consensus       221 ~--~~~-----~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         221 P--EDV-----EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             C--ccc-----cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            0  000     0112345577889999999999994444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=271.72  Aligned_cols=255  Identities=25%  Similarity=0.351  Sum_probs=193.8

Q ss_pred             cccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHH-HhccCCCCceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQI-LGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++....||.|+||+|++-. .++|+..|||++..... +....+++.|.+. ++.-++||||++||.+...+..|+-||+
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            3446789999999999984 56799999999965443 3444567777775 4455899999999999999999999999


Q ss_pred             cCCCCHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          145 ISNGNLQQLLQ-----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       145 ~~~~~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |+- +|..+.+     ....+++..+-.+......||.||....  .++|||+||+|||+|..|.+||||||++.++..+
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            965 7766543     3456899999999999999999998874  8999999999999999999999999999877554


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      -   .....+|-..|||||.+...     ...|..+|||||||++|||+.||..|+....+    +.+.+......-.+.
T Consensus       222 i---AkT~daGCrpYmAPERi~p~-----~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~  289 (361)
T KOG1006|consen  222 I---AKTVDAGCRPYMAPERIDPS-----DKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPI  289 (361)
T ss_pred             H---HhhhccCCccccChhccCCc-----cCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCe
Confidence            2   33455788999999988743     22478899999999999999999999865432    333333333221111


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                              -..+.+.......+..++.-|+.+|-.+||++++++++
T Consensus       290 --------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  290 --------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             --------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                    11111212223344445556999999999999999875

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=284.47  Aligned_cols=202  Identities=27%  Similarity=0.351  Sum_probs=175.9

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|..-++||+||||.||-+.. .+|+.+|.|++.+.... .......++|-.+|.+++.+.||.+-..|...+.+|+|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            3466678999999999999965 46999999988554322 233456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          143 NYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ..|.||+|..+|.+.+  .++++.+..++.+|+.||.+||..   +||.||+||+|||+|+.|+++|+|.|+|..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999997655  799999999999999999999999   99999999999999999999999999998877664


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI  279 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  279 (371)
                         .....+||.+|||||++..+       .|+...|.|||||++|||+.|+.||....
T Consensus       342 ---~~~~rvGT~GYMAPEvl~ne-------~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  342 ---PIRGRVGTVGYMAPEVLQNE-------VYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             ---ccccccCcccccCHHHHcCC-------cccCCccHHHHHhHHHHHHcccCchhhhh
Confidence               23344899999999998744       57889999999999999999999997443

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=309.82  Aligned_cols=261  Identities=24%  Similarity=0.240  Sum_probs=206.2

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|.+.++||+|+||.|..++. .+++.||.|++.+.... ......|..|-.+|..-+.+=|+.+.-.|.|.+++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            4578889999999999999976 45889999999663332 344567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |||+||+|..++.....+++..+..++..|.-||.-||+.   |+|||||||+|||+|..|++||+|||.|-.+..... 
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-  230 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-  230 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCc-
Confidence            9999999999999988999999999999999999999999   999999999999999999999999999988875542 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      -.....+|||.|.+||++......  .+.|++.+|.||+||++|||+.|..||..+     .+++=+.+......     
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~--~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk~-----  298 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDG--KGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHKE-----  298 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCC--ccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchhh-----
Confidence            234567899999999999865222  368999999999999999999999999643     33332222222200     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC---HHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT---MKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~~L~  347 (371)
                          .-.+|++ .......-+||++.+. +|+.|..   ++++..|..
T Consensus       299 ----~l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF  340 (1317)
T KOG0612|consen  299 ----SLSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF  340 (1317)
T ss_pred             ----hcCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence                1122211 1111222234444444 7899988   999988854

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=268.97  Aligned_cols=242  Identities=29%  Similarity=0.338  Sum_probs=191.9

Q ss_pred             cccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           73 IGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      ||.|+||.||++... +++.+|+|.+...... ......+..|+.+++.++|||++++++.+.+++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999764 5899999998554322 23566889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccc
Q 037946          151 QQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG  230 (371)
Q Consensus       151 ~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  230 (371)
                      .+++.....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.......  .......+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~  155 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG  155 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence            99999888899999999999999999999998   99999999999999999999999999997764432  12344568


Q ss_pred             cccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCC
Q 037946          231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL  310 (371)
Q Consensus       231 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      +..|+|||.+.+       ...+.++|+||||+++|+|++|..||.....  ......+..   ..           ...
T Consensus       156 ~~~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~---~~-----------~~~  212 (250)
T cd05123         156 TPEYLAPEVLLG-------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK---DP-----------LRF  212 (250)
T ss_pred             CccccChHHhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc---CC-----------CCC
Confidence            889999997652       3467899999999999999999999854321  121111111   10           011


Q ss_pred             ChhhHHHHHHHHHHHhcccCCCCCCCCCH---HHHHHH
Q 037946          311 PDQMVQEMLQTLGIAMFCVNSSPAERPTM---KEVVAL  345 (371)
Q Consensus       311 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~---~evl~~  345 (371)
                      +...   ...+.+++.+||..||++||++   ++++++
T Consensus       213 ~~~~---~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         213 PEFL---SPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CCCC---CHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            1111   1233457788999999999999   666554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.2e-37  Score=284.32  Aligned_cols=268  Identities=22%  Similarity=0.281  Sum_probs=189.5

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--------
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--------  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  135 (371)
                      .+|...+.||.|+||.||+|.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            5688889999999999999965 468999999984432  24456788999999999999999999776543        


Q ss_pred             ------CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc-CCCceEEc
Q 037946          136 ------SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD-SKYEAYLA  208 (371)
Q Consensus       136 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~  208 (371)
                            ...|+||||+++ +|.+++... .+++..+..++.|++.||.|||+.   +++||||||+||+++ .++.+||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence                  357899999974 898888654 589999999999999999999999   999999999999997 45678999


Q ss_pred             cccCccccCCCCccc-ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 037946          209 DFGLAKLMNSTNYHH-AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  287 (371)
                      |||.+.......... ......++..|+|||.+..      ...++.++|||||||++|+|++|+.||...... .....
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~  230 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQL  230 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhC------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence            999997654321111 1122357889999997542      224678999999999999999999999643221 11111


Q ss_pred             HHHHHhcCC--------CccccccC--cccCCCC-hhh-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          288 WVKKKMGSF--------EPAVSILD--TKLQGLP-DQM-VQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       288 ~~~~~~~~~--------~~~~~~~~--~~~~~~~-~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .........        ........  ......+ ... ......+.+++.+||+.||.+|||+.+++.+=
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~  301 (342)
T cd07854         231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP  301 (342)
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence            000000000        00000000  0000000 000 01112355688889999999999999999763

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.9e-37  Score=272.94  Aligned_cols=249  Identities=23%  Similarity=0.324  Sum_probs=188.1

Q ss_pred             ccccCCccccCCceEEEEEEeCC-CCEEEEEEecccC---CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTK---RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +|...+.||+|+||.||++.... +..+++|.+....   ........+..|+.+++.++|||++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36677899999999999996643 4455666553322   1223345677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          142 YNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      |||+++++|.+++..    ...+++..++.++.|++.|+.|||+.   +++|+||+|+||++++ +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998853    45689999999999999999999999   9999999999999975 569999999987654


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...  .......|++.|+|||.+.       ...++.++|+||||+++|+|++|..|+....     ...........  
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~--  220 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALK-------HQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEG--  220 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcC--
Confidence            432  1223456888999999654       2356788999999999999999999985321     11222221111  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                              .....++..   ...+.+++.+||+.||++||++.|++++
T Consensus       221 --------~~~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 --------PTPSLPETY---SRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --------CCCCCcchh---cHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                    011111111   1234557888999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-39  Score=264.57  Aligned_cols=275  Identities=23%  Similarity=0.355  Sum_probs=205.0

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe--------c
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS--------N  134 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--------~  134 (371)
                      .++|+...+||+|.||.||+|+.+ .|+.||+|+..-+...+-.-...++|+.+|..+.|+|++.+++.|.        +
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            445666788999999999999654 5788899876443333333456789999999999999999998874        3


Q ss_pred             CCeEEEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      ....|+||.+|+. +|.-++.+. ..++...+.++..++..||.|+|+.   .++|||+||.|+||+.+|.+||+|||++
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence            3558999999987 999999876 5799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          214 KLMNSTNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       214 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      +.+...+..  ....+.+.|..|.+||.+.+..      .++++.|||.-||++.||+||.+.++...+  ..-...++.
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r------~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~  243 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR------EYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQ  243 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhccc------ccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHH
Confidence            876554321  1223445699999999987653      567899999999999999999998876543  333344555


Q ss_pred             HhcCCCccc--c-----ccCc-ccCCCChhhH----HHHH------HHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          292 KMGSFEPAV--S-----ILDT-KLQGLPDQMV----QEML------QTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       292 ~~~~~~~~~--~-----~~~~-~~~~~~~~~~----~~~~------~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ..+...+..  .     +... .+...+....    ..+.      ..++|+..++..||.+|+++++++++-.=..
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            444322110  0     0000 0011111111    1111      3467888899999999999999998865433

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=239.72  Aligned_cols=266  Identities=23%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |...++||+|.||+||+|+. .+++.||+|+...+..++..-...++|+-+++.++|.|||+++++.......-+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            44456899999999999954 56899999999777666666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      .. +|..+..+ ++.++.+.+..+..|+.+||.++|++   ++.|||+||.|.+|+.+|++|++|||+++.++-..  ..
T Consensus        84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv--rc  157 (292)
T KOG0662|consen   84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC  157 (292)
T ss_pred             hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence            76 88887754 56799999999999999999999999   99999999999999999999999999999877653  12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC-----CCcc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS-----FEPA  299 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~  299 (371)
                      ......|..|.+|.++-+..      -|+...|+||-||++.|+.....|..+-..-..++....+. .+.     ...+
T Consensus       158 ysaevvtlwyrppdvlfgak------ly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~-lg~p~ed~wps~  230 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAK------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEDQWPSM  230 (292)
T ss_pred             eeceeeeeeccCcceeeeee------hhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH-hCCCccccCCcc
Confidence            33456799999999876543      46788999999999999997555544332222333333222 221     1112


Q ss_pred             ccccCcccCCCChh---hHHHHHH----HHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSILDTKLQGLPDQ---MVQEMLQ----TLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~~~~~~~~~~~~---~~~~~~~----~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .++.+-..-...+.   ..+.+..    -.+++++.+.-+|.+|.++++.+++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            22222221111111   1111111    1356677777899999999998875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=271.55  Aligned_cols=241  Identities=25%  Similarity=0.325  Sum_probs=194.2

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .|+...+||+|+||.|.+|.. .+.+.+|||+++++... .+..+.-+.|-++|... +-|.++.+..+++.-+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            477788999999999999954 45688999999776532 33345557788888877 4678889999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+.||+|...++.-+.+.+..+..++..||-||-+||++   +|+.||||.+||++|.+|++||+|||+++.--...  
T Consensus       430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~--  504 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG--  504 (683)
T ss_pred             EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccCC--
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999997643332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..+.+.+|||.|+|||.+..+       +|+.++|.||+||+||||+.|++||+++..  .++..-+..+.-.       
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Yq-------PYgksvDWWa~GVLLyEmlaGQpPFdGeDE--~elF~aI~ehnvs-------  568 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQ-------PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQAIMEHNVS-------  568 (683)
T ss_pred             cceeeecCCCcccccceEEec-------ccccchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHccCc-------
Confidence            355788999999999998744       788999999999999999999999986543  3444333332222       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP  337 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP  337 (371)
                             .|..+..   ..+.|+...+.+.|.+|.
T Consensus       569 -------yPKslSk---EAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  569 -------YPKSLSK---EAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -------CcccccH---HHHHHHHHHhhcCCcccc
Confidence                   2222222   233455557788898885

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.5e-36  Score=264.74  Aligned_cols=219  Identities=22%  Similarity=0.223  Sum_probs=171.2

Q ss_pred             CCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCHHHHh
Q 037946           76 GCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLL  154 (371)
Q Consensus        76 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  154 (371)
                      |.+|.||++.+ .+++.+|+|++....       .+.+|...+....|||++++++++.+.+..+++|||+++|+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            89999999965 468999999985432       1233445555667999999999999999999999999999999999


Q ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccc
Q 037946          155 QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY  234 (371)
Q Consensus       155 ~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y  234 (371)
                      .....+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++|||.+.......     ....++..|
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y  148 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY  148 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence            8877899999999999999999999999   99999999999999999999999999886654322     234567789


Q ss_pred             cCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhh
Q 037946          235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQM  314 (371)
Q Consensus       235 ~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      +|||.+.       ...++.++|+||+|+++|||++|..|+.......              ...   ..   ...++..
T Consensus       149 ~aPE~~~-------~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~~---~~---~~~~~~~  201 (237)
T cd05576         149 CAPEVGG-------ISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NTH---TT---LNIPEWV  201 (237)
T ss_pred             cCCcccC-------CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------ccc---cc---cCCcccC
Confidence            9999764       2356789999999999999999998764321100              000   00   0111111


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCCH
Q 037946          315 VQEMLQTLGIAMFCVNSSPAERPTM  339 (371)
Q Consensus       315 ~~~~~~~~~l~~~cl~~dP~~RPs~  339 (371)
                         ...+.+++.+||+.||++||++
T Consensus       202 ---~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         202 ---SEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ---CHHHHHHHHHHccCCHHHhcCC
Confidence               1234557888999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-36  Score=301.25  Aligned_cols=147  Identities=31%  Similarity=0.384  Sum_probs=132.8

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+..|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            46778899999999999999764 689999999854332 2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      ||+.+++|.+++.....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=283.59  Aligned_cols=244  Identities=25%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             HHhccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  140 (371)
                      ..+.|+....+|.|+|+.|-.+. ..+++..++|++.+...+      -.+|+.++... +|||++++.+.+.++...|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence            35677888889999999998884 456889999999554222      23566666555 79999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE-cCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL-DSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |||.+.|+-+.+.+...+... ..+..|+.+|+.++.|||++   +++||||||+|||+ ++.++++|+|||.++.....
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999999999988888777666 77888999999999999999   99999999999999 69999999999999876654


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                           ....+-|..|.|||++..       ..+++++||||||++||+|++|+.||.....+ .++...+..        
T Consensus       470 -----~~tp~~t~~y~APEvl~~-------~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~--------  528 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAI-------QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQM--------  528 (612)
T ss_pred             -----hcccchhhcccChhhhcc-------CCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcC--------
Confidence                 345678999999998763       37899999999999999999999999866654 222222111        


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                           +..+....      ...-+|+.+||+.||.+||+++++..+-+.
T Consensus       529 -----~~~s~~vS------~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  529 -----PKFSECVS------DEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -----CccccccC------HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                 11111111      122347777999999999999999998777

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=280.94  Aligned_cols=249  Identities=21%  Similarity=0.313  Sum_probs=200.4

Q ss_pred             CCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           70 ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .++||+|.||+||-|. .++|+.||||++.+......+...+.+|+.||++++||.||.+--.|+..+.+++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            5789999999999995 467999999999887777777789999999999999999999999999999999999999764


Q ss_pred             CHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC---CceEEccccCccccCCCCcccc
Q 037946          149 NLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK---YEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       149 ~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      -|.-++. ..+++++.....++.||+.||.|||.+   +|+|+||||+|||+.+.   -.+||||||+++.++...   .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            4444443 345699999999999999999999999   99999999999999654   359999999999998775   3


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..+..|||.|+|||++...       .|...-|+||.||++|--++|..||-    +++.+.+.++.....+.+      
T Consensus       723 RrsVVGTPAYLaPEVLrnk-------GyNrSLDMWSVGVIiYVsLSGTFPFN----EdEdIndQIQNAaFMyPp------  785 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNK-------GYNRSLDMWSVGVIIYVSLSGTFPFN----EDEDINDQIQNAAFMYPP------  785 (888)
T ss_pred             hhhhcCCccccCHHHHhhc-------cccccccceeeeEEEEEEecccccCC----CccchhHHhhccccccCC------
Confidence            4678899999999998743       56778999999999999999999985    334444444433322211      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                             ..+.+.....+++|...|+..=.+|-|.+..+.+-|.
T Consensus       786 -------~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  786 -------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL  822 (888)
T ss_pred             -------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence                   1111222334556777788888899999988877553

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=286.97  Aligned_cols=253  Identities=24%  Similarity=0.328  Sum_probs=202.5

Q ss_pred             ccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEe-----cCCeE
Q 037946           66 CLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCS-----NKSVK  138 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~  138 (371)
                      .+++.+.||.|.+|.||+++ .++++.+|+|++..+   .+..+++..|.++++.+ +|||++.++|++.     .++.+
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            46667889999999999995 457899999998443   33446778899999988 7999999999874     45789


Q ss_pred             EEEEeecCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          139 LLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      |+|||||.+||.-|++++  ...+.|..+..|+..++.|+.+||..   .++|||+|-.|||++.++.|||+|||.+.++
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            999999999999999876  44689999999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +...  ....+..|||.|||||++.+....  ...|+..+|+||||++..||.-|.+|+-...+-               
T Consensus       174 dsT~--grRnT~iGtP~WMAPEViac~e~~--d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------------  234 (953)
T KOG0587|consen  174 DSTV--GRRNTFIGTPYWMAPEVIACDESP--DATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------------  234 (953)
T ss_pred             eccc--ccccCcCCCcccccceeeecccCC--CCCcccccchhhccceeehhcCCCCCccCcchh---------------
Confidence            7654  344667899999999999977444  456788999999999999999999998644321               


Q ss_pred             CccccccCcc-cCC-CChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          297 EPAVSILDTK-LQG-LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       297 ~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ..+..+.+.. +.- -|.   ....++.++|..|+.+|-++||+..+++++-
T Consensus       235 raLF~IpRNPPPkLkrp~---kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  235 RALFLIPRNPPPKLKRPK---KWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             hhhccCCCCCCccccchh---hHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence            1111111110 000 122   2334455688889999999999999998863

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=277.36  Aligned_cols=259  Identities=22%  Similarity=0.262  Sum_probs=209.5

Q ss_pred             ccccCCccccCCceEEEEEEeCCCC-EEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGE-LIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .++....||-||||.|=.+...+.+ .+|+|.+++... +..+.+.+..|-++|...+.|.||++|..|.+...+|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3455667999999999999764433 389998865443 45566788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      -|-||.|+..+...+.++......++..+..|+.|||++   +||.|||||+|+++|.+|-+||.|||+++++....   
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---  574 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---  574 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC---
Confidence            999999999999999999999999999999999999999   99999999999999999999999999999988775   


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .+.+++|||.|.|||++..       ...+.++|.||||+++|||++|.+||....  +......+.+++...       
T Consensus       575 KTwTFcGTpEYVAPEIILn-------KGHD~avDyWaLGIli~ELL~G~pPFs~~d--pmktYn~ILkGid~i-------  638 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILN-------KGHDRAVDYWALGILIYELLTGSPPFSGVD--PMKTYNLILKGIDKI-------  638 (732)
T ss_pred             ceeeecCCcccccchhhhc-------cCcchhhHHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHhhhhhh-------
Confidence            6678999999999998873       356789999999999999999999997643  333334444443321       


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHHhcccCCCc
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALLMEVKSAPE  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L~~~~~~~~  354 (371)
                           .+|..+.   ....+++.+.+..+|.+|.-     +.+|..|-|=.-=.++
T Consensus       639 -----~~Pr~I~---k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  639 -----EFPRRIT---KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             -----hcccccc---hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence                 1121111   12234666677889999975     7888888665443343

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=242.48  Aligned_cols=200  Identities=24%  Similarity=0.385  Sum_probs=166.9

Q ss_pred             cCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHh-ccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           69 DENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILG-HIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        69 ~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      ....||+|++|.|-+-+ .++|...|+|++..+..+. ...+.+.|+.+.. ...+|.+|.+||...+...+++-||.|+
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~  128 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD  128 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence            35679999999998885 4689999999997655543 3455667777644 4589999999999999999999999996


Q ss_pred             CCCHHHH----hccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          147 NGNLQQL----LQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       147 ~~~L~~~----l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      . +|..+    +.....+++..+-+++..+..||.|||++  ..++|||+||+|||||.+|.||+||||++..+.++-  
T Consensus       129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--  203 (282)
T KOG0984|consen  129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--  203 (282)
T ss_pred             h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh--
Confidence            6 88665    45677899999999999999999999998  499999999999999999999999999998876553  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                       ..+...|...|||||.+..+.   .+..|+-+|||||||++++||.+++.|+...
T Consensus       204 -Akt~daGCkpYmaPEri~~e~---n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  204 -AKTMDAGCKPYMAPERINPEL---NQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             -HHHHhcCCCccCChhhcCccc---Ccccceeehhhhhhhhhhhhhhhcccccccc
Confidence             223356888999999988652   2236899999999999999999999998643

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=264.70  Aligned_cols=262  Identities=20%  Similarity=0.286  Sum_probs=200.0

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC--C----CceeeeceEec
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH--R----NIVKLLGYCSN  134 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~~~~~~~  134 (371)
                      .+..+|.+...+|+|.||.|..+.+ ..+..||+|+++.   -..-.+..+-|++++.++.+  |    -++.+.+||.-
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            3478999999999999999999954 3478999999843   22334566889999999942  2    24667788999


Q ss_pred             CCeEEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-----------
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-----------  201 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-----------  201 (371)
                      .++.|+|+|.+ |-|+.+++..+.  +++...+..++.|++.++++||+.   +++|-||||+|||+.+           
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence            99999999998 559999998754  578899999999999999999999   9999999999999832           


Q ss_pred             ---------CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCC
Q 037946          202 ---------KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR  272 (371)
Q Consensus       202 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~  272 (371)
                               +..++++|||.++......     ...+.|..|.|||++.+-       ..+.++||||+||+|+||.||.
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL-------GwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL-------GWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc-------CcCCccCceeeeeEEEEeeccc
Confidence                     2348999999998754432     456789999999999843       6789999999999999999999


Q ss_pred             CCCCCCCCCchhHHHHHHHHhcCCCccccccCc---------cc-------C-------CCChhh-------HHHHHHHH
Q 037946          273 SAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT---------KL-------Q-------GLPDQM-------VQEMLQTL  322 (371)
Q Consensus       273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~-------~-------~~~~~~-------~~~~~~~~  322 (371)
                      ..|+...+  .+-+.++...++.....+ +...         ++       .       ..+...       -.+..+++
T Consensus       307 ~LFqtHen--~EHLaMMerIlGp~P~~m-i~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf  383 (415)
T KOG0671|consen  307 TLFQTHEN--LEHLAMMERILGPIPSRM-IKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF  383 (415)
T ss_pred             eecccCCc--HHHHHHHHHhhCCCcHHH-hhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence            99987652  232345555554321111 0000         00       0       001100       13455688


Q ss_pred             HHHhcccCCCCCCCCCHHHHHHH
Q 037946          323 GIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       323 ~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      +|+.+||.+||.+|+|+.|++.+
T Consensus       384 DLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  384 DLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHHHccCccccccHHHHhcC
Confidence            99999999999999999999976

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=269.70  Aligned_cols=264  Identities=25%  Similarity=0.344  Sum_probs=198.3

Q ss_pred             hccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCC-----cchHHHHHHHHHHHhccCCCCceeeeceEe-cCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRD-----EEPVDSFAAEIQILGHIRHRNIVKLLGYCS-NKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~  137 (371)
                      ++|-...+||+|||+.||+|. ....+.||||+-......     +.-.....+|.+|.+.|+||.||++|+++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            455567889999999999995 456788999975433221     222345679999999999999999999985 5677


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc---CCCceEEccccCcc
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD---SKYEAYLADFGLAK  214 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~  214 (371)
                      .|.|.|||+|.+|.-+|+.++.+++..+..|+.||+.||.||.... ++|||-||||.|||+-   ..|.+||+|||+++
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            8899999999999999999999999999999999999999999864 5899999999999994   45889999999999


Q ss_pred             ccCCCCcccc-----cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 037946          215 LMNSTNYHHA-----MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       215 ~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  289 (371)
                      .++...+...     +....||.+|++||.+.-.   ......+.++||||+||++|.++.|+.||....... .+++  
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg---kePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILq--  695 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG---KEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQ--  695 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecC---CCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHh--
Confidence            9877655422     3456799999999987621   113457889999999999999999999997543321 1111  


Q ss_pred             HHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                       .     ..   ++...--.+|.. ....-..-.+|++||++.-++|....++...
T Consensus       696 -e-----NT---IlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  696 -E-----NT---ILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             -h-----hc---hhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence             1     11   111110111111 0111122347788999999999988887654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.3e-35  Score=284.81  Aligned_cols=267  Identities=16%  Similarity=0.169  Sum_probs=168.8

Q ss_pred             hccccCCccccCCceEEEEEEeC-C----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeece------Ee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-N----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY------CS  133 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  133 (371)
                      +.|...+.||+|+||.||+|... +    +..||+|++.....    .+....+  .++...+.++..+...      +.
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            46888899999999999999764 4    68999998743211    1111111  1122222222222211      24


Q ss_pred             cCCeEEEEEeecCCCCHHHHhccCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 037946          134 NKSVKLLLYNYISNGNLQQLLQGNRN--------------------LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVK  193 (371)
Q Consensus       134 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  193 (371)
                      .....++||||+.+++|.+++.....                    .....+..++.|++.||.|||++   +++|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            56778999999999999999865421                    12334667999999999999999   99999999


Q ss_pred             CCCeeEcC-CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcc---------------cCCCCCcch
Q 037946          194 CNNILLDS-KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY---------------TMNITEKSD  257 (371)
Q Consensus       194 p~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---------------~~~~~~~~D  257 (371)
                      |+|||++. ++.+||+|||+++...... ........+|+.|+|||.+........               ..+++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 6899999999998654332 122345678999999996542211110               123456789


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc---ccccCcccCCCChhhH----HHHHHHHHHHhcccC
Q 037946          258 VYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA---VSILDTKLQGLPDQMV----QEMLQTLGIAMFCVN  330 (371)
Q Consensus       258 iwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~----~~~~~~~~l~~~cl~  330 (371)
                      ||||||+||||+++..+...      ....+...........   ................    .......+|+.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999997665421      1111111111000000   0011111000000000    011123468899999


Q ss_pred             CCCCCCCCHHHHHHHHh
Q 037946          331 SSPAERPTMKEVVALLM  347 (371)
Q Consensus       331 ~dP~~RPs~~evl~~L~  347 (371)
                      .||++|||++++++|-+
T Consensus       436 ~dP~kR~ta~e~L~Hpf  452 (566)
T PLN03225        436 FKGRQRISAKAALAHPY  452 (566)
T ss_pred             CCcccCCCHHHHhCCcC
Confidence            99999999999999844

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.5e-34  Score=253.32  Aligned_cols=240  Identities=28%  Similarity=0.406  Sum_probs=189.5

Q ss_pred             CceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCHHHHhc
Q 037946           77 CSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQ  155 (371)
Q Consensus        77 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  155 (371)
                      +||.||+|... +++.+|+|++....... ....+.+|++.+++++|+|++++++.+......+++|||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc-HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999775 48999999985433222 16789999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccccccccccc
Q 037946          156 GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI  235 (371)
Q Consensus       156 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  235 (371)
                      ....+++..++.++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.......   ......++..|+
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            777789999999999999999999999   99999999999999999999999999998765542   234456888999


Q ss_pred             CCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhH
Q 037946          236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMV  315 (371)
Q Consensus       236 aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (371)
                      +||.+.       ...++.++||||||+++++|++|..|+.... +.....+..........       ......+    
T Consensus       154 ~pE~~~-------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~~~-------~~~~~~~----  214 (244)
T smart00220      154 APEVLL-------GKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPPFP-------PPEWKIS----  214 (244)
T ss_pred             CHHHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCCCc-------cccccCC----
Confidence            999764       3356789999999999999999999986421 22222222211111000       0000011    


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          316 QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       316 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                         ..+.+++.+||..+|++||++.+++++
T Consensus       215 ---~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      215 ---PEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             ---HHHHHHHHHHccCCchhccCHHHHhhC
Confidence               245557888999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-35  Score=269.48  Aligned_cols=207  Identities=25%  Similarity=0.328  Sum_probs=174.9

Q ss_pred             ccccCCccccCCceEEEEEE-eCCCCEEEEEEeccc-CCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKT-KRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|...+.||-|+||.|++++ ..+...+|.|.+.+. ....++......|-.||..-+++=||++|-.|.+.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            45557889999999999995 445778999988543 2345667788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC------
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN------  217 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~------  217 (371)
                      |++||++..+|-+-+-+.+..+..++..+.+|+.+.|.+   |+|||||||+|||||.+|++||+|||+|.-+.      
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            999999999999988899999999999999999999999   99999999999999999999999999986321      


Q ss_pred             ---CCC--cccc-----------------------------cccccccccccCCCCccchhhhcccCCCCCcchhHHHHH
Q 037946          218 ---STN--YHHA-----------------------------MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGV  263 (371)
Q Consensus       218 ---~~~--~~~~-----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~  263 (371)
                         ..+  ..+.                             ....+||+.|+|||++...       .++..+|.||.||
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-------g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-------GYTQLCDWWSVGV  859 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-------CccccchhhHhhH
Confidence               100  0000                             0124699999999998733       5688999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCc
Q 037946          264 VLLEILSGRSAVQPQIGDG  282 (371)
Q Consensus       264 ~l~el~~g~~p~~~~~~~~  282 (371)
                      +||||+.|+.||..+.+.+
T Consensus       860 il~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCc
Confidence            9999999999998766543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=250.06  Aligned_cols=267  Identities=21%  Similarity=0.317  Sum_probs=202.8

Q ss_pred             ccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-----eEEEE
Q 037946           68 KDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-----VKLLL  141 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  141 (371)
                      +..+.||.|+||.||.+++ ++|+.||+|++......-....++.+|+.++..++|.|++..++...-.+     .+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999999976 47999999998655555556678999999999999999999888765432     45788


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      +|.|.. +|..++-+...++...+.-+..||++||+|||+.   +|.||||||.|.|++++..+||||||+++..+..+ 
T Consensus       136 TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-  210 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-  210 (449)
T ss_pred             HHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh-
Confidence            999865 9999999989999999999999999999999999   99999999999999999999999999999766544 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC-----
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF-----  296 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  296 (371)
                      ...+.....|-+|.|||.+++..      .|+.+.||||.||++.||+.++..|+...+  .+-.+++-..++..     
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaR------hYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGAR------RYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAM  282 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcch------hhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHH
Confidence            33445566799999999998653      578899999999999999999988876533  33334444433321     


Q ss_pred             -----CccccccCcccCC--------CChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          297 -----EPAVSILDTKLQG--------LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       297 -----~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                           +....+++.....        .... -..--..+.+...++..||.+|.+..+.+.++..
T Consensus       283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~-~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  283 KYACEGAKNHVLRAGLRAPDTQRLYKIASP-DDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHHhhhhHHHhhccCCCCCCccceeeecCC-cccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence                 1111122211111        0000 0111123446666899999999999998887643

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-33  Score=266.45  Aligned_cols=272  Identities=17%  Similarity=0.199  Sum_probs=176.1

Q ss_pred             HhccccCCccccCCceEEEEEEe-----------------CCCCEEEEEEecccCCCc------------chHHHHHHHH
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-----------------PNGELIAVKKLWKTKRDE------------EPVDSFAAEI  114 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~e~  114 (371)
                      .+.|...++||+|+||.||+|..                 .+++.||||++.......            ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            34688889999999999999953                 235689999985422110            0112234577


Q ss_pred             HHHhccCCCCc-----eeeeceEec--------CCeEEEEEeecCCCCHHHHhccCC-----------------------
Q 037946          115 QILGHIRHRNI-----VKLLGYCSN--------KSVKLLLYNYISNGNLQQLLQGNR-----------------------  158 (371)
Q Consensus       115 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~-----------------------  158 (371)
                      .++.+++|.++     ++++++|..        .+..++||||+++++|.+++....                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     667777643        356899999999999999886421                       


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCC
Q 037946          159 -NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP  237 (371)
Q Consensus       159 -~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  237 (371)
                       .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ .......+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence             245677889999999999999999   999999999999999999999999999976543321 111223458899999


Q ss_pred             CCccchhhhcc---------------cCCCCCcchhHHHHHHHHHHHhCCC-CCCCCCCCchhHHH--HHHHHhcCCCcc
Q 037946          238 GKCKLQIIYGY---------------TMNITEKSDVYSYGVVLLEILSGRS-AVQPQIGDGLHIVE--WVKKKMGSFEPA  299 (371)
Q Consensus       238 E~~~~~~~~~~---------------~~~~~~~~DiwslG~~l~el~~g~~-p~~~~~~~~~~~~~--~~~~~~~~~~~~  299 (371)
                      |.+........               ......+.||||+||++++|++|.. |+........+...  .....+......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98763321100               0112245799999999999999886 44321111101000  000000000000


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCC---CCCCCHHHHHHHHh
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSP---AERPTMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP---~~RPs~~evl~~L~  347 (371)
                          ...+. ..+   .......+++.+++..+|   .+|+|++|+++|-+
T Consensus       460 ----~~~~~-~~d---~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        460 ----KYDFS-LLD---RNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             ----CCCcc-ccc---ccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence                00000 011   112234456777888765   68999999998754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=248.38  Aligned_cols=201  Identities=24%  Similarity=0.366  Sum_probs=175.7

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|...++||+|+|..|..++. ++.+.+|+|++++.... .+...-...|-.++.+- +||.+|.+..+|.....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            4577789999999999999965 45788999998765443 33344456777777765 799999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      .||.+||+|.-.++++++++++.+..+...|+-||.|||++   ||+.||||.+|+|+|..|.+||+|+|+++.--... 
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g-  405 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-  405 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC-
Confidence            99999999999999999999999999999999999999999   99999999999999999999999999998643332 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                       +.+.+.+|||.|.|||.+.++       .|....|.|+|||+++||+.|+.||.-
T Consensus       406 -d~tstfcgtpnyiapeilrge-------eygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  406 -DTTSTFCGTPNYIAPEILRGE-------EYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             -cccccccCCCcccchhhhccc-------ccCceehHHHHHHHHHHHHcCCCCcce
Confidence             356789999999999998755       677889999999999999999999963

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=275.10  Aligned_cols=242  Identities=26%  Similarity=0.424  Sum_probs=183.2

Q ss_pred             cCCccccCCce-EEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEeecC
Q 037946           69 DENVIGKGCSG-VVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        69 ~~~~ig~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      ..+.+|.|+.| .||+|.. .|+.||||++..     .......+|+..|+.- +||||+++++.-.+....||..|.|.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             cHHHcccCCCCcEEEEEee-CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            34668999987 4799987 679999999843     2334567999999887 79999999999999999999999997


Q ss_pred             CCCHHHHhccCC-C---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---C--CceEEccccCccccC
Q 037946          147 NGNLQQLLQGNR-N---LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---K--YEAYLADFGLAKLMN  217 (371)
Q Consensus       147 ~~~L~~~l~~~~-~---~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~--~~~kl~Dfg~~~~~~  217 (371)
                      . +|.+++.... .   ......+.+..|++.||++||+.   ++|||||||.||||+.   +  ..++|+|||+++++.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6 9999998741 1   11144577889999999999998   9999999999999976   3  468999999999986


Q ss_pred             CCCccc-ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCchhHHHHHHHHhcC
Q 037946          218 STNYHH-AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG-RSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       218 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ...... ......||-+|+|||++...       .-+.++||||+||++|+.++| ..||......+.++..      +.
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~-------~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------~~  729 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLRED-------RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------GN  729 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhcc-------ccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------Cc
Confidence            654221 23456799999999998744       345689999999999999986 7787644332222211      00


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                       ...     -.+...++.      ...+||.+|++.+|..||++.+|+.|
T Consensus       730 -~~L-----~~L~~~~d~------eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  730 -YTL-----VHLEPLPDC------EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -cce-----eeeccCchH------HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence             000     011111111      34568889999999999999999876

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.5e-33  Score=227.63  Aligned_cols=260  Identities=22%  Similarity=0.266  Sum_probs=192.6

Q ss_pred             hccccCCccccCCceEEEEEE-eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecC--CeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNK--SVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l  140 (371)
                      +.|+..+.+|+|.++.||.|. ..+++.++||.++.     .....+.+|+.+|..|. ||||++++++..+.  ....+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            467888999999999999994 56789999999843     34567899999999996 99999999998665  45679


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-CceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~  219 (371)
                      ++||..+.+...+..   .++...+..++.+++.||.|+||+   ||+|||+||.|++||.. -.++|+|||++....+.
T Consensus       113 iFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             HhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999999877766653   478888999999999999999999   99999999999999865 56899999999887665


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc-
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP-  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  298 (371)
                      .   ..+....+..|--||++..-+      .++-+-|+|||||+|..|+..+.||..-..+..+++... +.++..+- 
T Consensus       187 ~---eYnVRVASRyfKGPELLVdy~------~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa-kVLGt~el~  256 (338)
T KOG0668|consen  187 K---EYNVRVASRYFKGPELLVDYQ------MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA-KVLGTDELY  256 (338)
T ss_pred             c---eeeeeeehhhcCCchheeech------hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH-HHhChHHHH
Confidence            4   223334667888999887432      356678999999999999999999876555544443322 11211000 


Q ss_pred             -----cccccCcccCC------------CChhhHHH--HHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 -----AVSILDTKLQG------------LPDQMVQE--MLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 -----~~~~~~~~~~~------------~~~~~~~~--~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                           ..-.+++...+            +.....+.  ....++++.+.|.+|.++|||++|.+.+
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                 00001111110            00000000  1345678888999999999999999886

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=256.57  Aligned_cols=198  Identities=24%  Similarity=0.333  Sum_probs=170.8

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcc------hHHHHHHHHHHHhccC---CCCceeeeceEecC
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEE------PVDSFAAEIQILGHIR---HRNIVKLLGYCSNK  135 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  135 (371)
                      .|+..+.+|+|+||.|+.|..+ +...|++|.+.++..-.+      ..-.+-.|++||.+++   |+||++++.+|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            3777899999999999999654 567899998876542211      1123457999999997   99999999999999


Q ss_pred             CeEEEEEeecC-CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          136 SVKLLLYNYIS-NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       136 ~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      +.+|++||-.. +-+|.++|...+.+++..+..|++||+.|+++||++   +|+|||||-+|+.++.+|.+||+|||.+.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchh
Confidence            99999999874 558999999999999999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ  276 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  276 (371)
                      .....    ..+..+||..|.|||++.++.|.      +..-|||++|++||.++....||.
T Consensus       719 ~~ksg----pfd~f~gtv~~aapevl~g~~y~------gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 YTKSG----PFDVFVGTVDYAAPEVLGGEKYL------GKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhcCC----CcceeeeeccccchhhhCCCccC------CCcchhhhhhheeeEEEeccCCCc
Confidence            76554    34678899999999999877544      456899999999999999988874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.5e-31  Score=226.62  Aligned_cols=212  Identities=35%  Similarity=0.558  Sum_probs=179.6

Q ss_pred             cccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCHH
Q 037946           73 IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQ  151 (371)
Q Consensus        73 ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  151 (371)
                      ||+|++|.||++...+ ++.+++|++....... ....+.+|++.++.+.|++++++++++......+++||++++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            6899999999997753 8999999985432211 3577899999999999999999999999999999999999999999


Q ss_pred             HHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccCccccCCCCccccccccc
Q 037946          152 QLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGLAKLMNSTNYHHAMSRVA  229 (371)
Q Consensus       152 ~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  229 (371)
                      +++... ..++...+..++.+++.++++||+.   +++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            999876 5689999999999999999999999   9999999999999999 89999999999987654421  123455


Q ss_pred             ccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCC
Q 037946          230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG  309 (371)
Q Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      +...|++||.+...      ...+.++|+|++|+++++|                                         
T Consensus       155 ~~~~~~~pe~~~~~------~~~~~~~D~~~lg~~~~~l-----------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGK------GYYSEKSDIWSLGVILYEL-----------------------------------------  187 (215)
T ss_pred             CCCCccChhHhccc------CCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence            78899999976421      2567889999999999999                                         


Q ss_pred             CChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       310 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                               ..+.+++.+|++.||++||++.++++++
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                     2344567779999999999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-33  Score=235.99  Aligned_cols=261  Identities=24%  Similarity=0.321  Sum_probs=195.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC------e
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS------V  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  137 (371)
                      .+|...+.+|.|.- .|..+.+ -.++.||+|++..........++..+|...+..++|+|+++++.++.-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35677788999988 6666643 36899999998766655666778899999999999999999999986543      4


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .|+|||+|.. +|...+.  -.++-..+.++..|+++|++|||+.   +|+||||||+||++..++.+||.|||+++.-+
T Consensus        96 ~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence            6999999976 9988887  4478899999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ..   ..++....|..|.|||++.+       ..+.+.+||||+||++.||++|+-.|.+.    ..+..|.+..-....
T Consensus       170 ~~---~~mtpyVvtRyyrapevil~-------~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgt  235 (369)
T KOG0665|consen  170 TD---FMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGT  235 (369)
T ss_pred             cc---cccCchhheeeccCchheec-------cCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcC
Confidence            43   24556778999999998863       34788999999999999999999887532    222233222111111


Q ss_pred             ccccccCc-------------c------cCCCChhhH--------HHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          298 PAVSILDT-------------K------LQGLPDQMV--------QEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       298 ~~~~~~~~-------------~------~~~~~~~~~--------~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      +.....+.             .      ....|+...        -..-.+-+++.+||-.||++|.|++++++|-
T Consensus       236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence            11000000             0      000111110        1122334688899999999999999999984

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.98  E-value=1.5e-32  Score=248.00  Aligned_cols=268  Identities=21%  Similarity=0.265  Sum_probs=206.3

Q ss_pred             cHHHHH-hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccC------CCCceeeec
Q 037946           59 TIDNIL-ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR------HRNIVKLLG  130 (371)
Q Consensus        59 ~~~~~~-~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~  130 (371)
                      .+.++. .+|.+....|+|-||+|.+|.+. .|+.||||++.+.   +.....=+.|+++|++|+      --+.++++.
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            344443 67888888999999999999764 4789999999543   333345578999999995      247899999


Q ss_pred             eEecCCeEEEEEeecCCCCHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-CceE
Q 037946          131 YCSNKSVKLLLYNYISNGNLQQLLQGNR---NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAY  206 (371)
Q Consensus       131 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~k  206 (371)
                      .|...+++|+|+|-+.. +|.++|+.-+   .+....+..++.|+.-||..|...   +++|.||||.|||+++. ..+|
T Consensus       502 ~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence            99999999999999865 9999997543   488899999999999999999998   99999999999999875 5689


Q ss_pred             EccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHH
Q 037946          207 LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV  286 (371)
Q Consensus       207 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  286 (371)
                      |||||.|.....+.    ...+..+..|.|||++.+       .+|+...|+||.||+||||.||+..|.+..++  +++
T Consensus       578 LCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG-------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN--~ML  644 (752)
T KOG0670|consen  578 LCDFGSASFASENE----ITPYLVSRFYRAPEIILG-------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNN--QML  644 (752)
T ss_pred             eccCcccccccccc----ccHHHHHHhccCcceeec-------CcccCCccceeeceeeEEeeccceecCCCCcH--HHH
Confidence            99999998766554    122334567999998874       47888999999999999999999998766543  444


Q ss_pred             HHHHHHhcCCCcc----------------------------------ccccCc---------ccCCCChhhHHHHHHHHH
Q 037946          287 EWVKKKMGSFEPA----------------------------------VSILDT---------KLQGLPDQMVQEMLQTLG  323 (371)
Q Consensus       287 ~~~~~~~~~~~~~----------------------------------~~~~~~---------~~~~~~~~~~~~~~~~~~  323 (371)
                      .+.....+.+...                                  +..+.+         ..+..+++....+.++.+
T Consensus       645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd  724 (752)
T KOG0670|consen  645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD  724 (752)
T ss_pred             HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence            4444444333111                                  001111         012245555666777888


Q ss_pred             HHhcccCCCCCCCCCHHHHHHHH
Q 037946          324 IAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       324 l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      |+..|+..||++|.|..+.|.|-
T Consensus       725 LLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  725 LLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             HHHHHhccChhhcCCHHHHhcCC
Confidence            99999999999999999998763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2e-32  Score=228.98  Aligned_cols=257  Identities=18%  Similarity=0.289  Sum_probs=195.2

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeece-EecCCeE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGY-CSNKSVK  138 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~  138 (371)
                      ++.+.|++.+.+|+|-||.+-+++.+ +++.+++|.+.+   .....++|.+|..---.| .|.||+.-|.+ |+..+.+
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~---p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR---PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc---chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            45678999999999999999999654 577889998733   344567888888765555 58899988765 6677778


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE-c-CCCceEEccccCcccc
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL-D-SKYEAYLADFGLAKLM  216 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill-~-~~~~~kl~Dfg~~~~~  216 (371)
                      ++++||++.|+|.+-+...+ +-+.....++.|+++|+.|+|++   ++||||||.+|||| + +.-.+||||||.++..
T Consensus        98 vF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             EEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence            89999999999999887654 78888999999999999999999   99999999999999 2 3347999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +...     .....+..|.+||.+..-  .+......+.+|||.||+++|.++||+.||+....++....+|.+..-+..
T Consensus       174 g~tV-----~~~~~~~~y~~pe~~~~~--~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  174 GTTV-----KYLEYVNNYHAPELCDTV--VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             Ccee-----hhhhhhcccCCcHHHhhc--cccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence            6543     223356789999976522  222334578899999999999999999999977777777777766544432


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV  343 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl  343 (371)
                      .           ..|+........++++..+-+..+|++|-...++.
T Consensus       247 ~-----------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  247 P-----------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             c-----------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            2           22222223333455677779999999995444443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-33  Score=257.04  Aligned_cols=255  Identities=23%  Similarity=0.316  Sum_probs=199.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+....+|.|++|.||++++ .+++..|+|.++....  ....-+..|+-+++..+||||+.++|-+......++.||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            4577788999999999999965 4689999999854433  234556789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ||.+|+|.+.-+..+++++-++..+++...+|++|||++   +-+|||||-.||++++.|.+|+.|||.+.++...-  .
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A  167 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh--h
Confidence            999999999999999999999999999999999999999   88999999999999999999999999998776543  2


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      +..++.||++|||||+..    .+..+.|...+|||++|++..|+---++|.....+    .......-.+.+.+.    
T Consensus       168 KrksfiGtpywmapEvaa----verkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~l~LmTkS~~qpp----  235 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAA----VERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRALFLMTKSGFQPP----  235 (829)
T ss_pred             hhhcccCCccccchhHHH----HHhcccccccccccccccchhhhhhcCCcccccch----HHHHHHhhccCCCCC----
Confidence            345778999999999866    34466788999999999999999887776532211    111111111111111    


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA  344 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  344 (371)
                        . ........+..   -+++.-|+.++|++|||++.+++
T Consensus       236 --~-lkDk~kws~~f---h~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 --T-LKDKTKWSEFF---HNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             --c-ccCCccchHHH---HHHHHHHhcCCCccCCChhhhee
Confidence              1 11111111222   22444599999999999998877

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.9e-30  Score=222.37  Aligned_cols=200  Identities=34%  Similarity=0.458  Sum_probs=170.6

Q ss_pred             cccCCccccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |...+.||.|++|.||++.... ++.+|+|.+...... .....+.+|++.++.++|+|++++++++......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            3456789999999999997754 889999998543322 25678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++++|.+++..... +++.....++.+++.++.+||+.   +++|+|++|.||+++.++.++|+|||.+....... ...
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~  155 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AAL  155 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccc
Confidence            99999999988776 89999999999999999999999   99999999999999999999999999998765432 012


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                      .....++..|++||.+.      ....++.++|+|+||+++++|++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLL------GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhc------CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            23456788999999763      134567799999999999999999999953

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-29  Score=227.39  Aligned_cols=130  Identities=26%  Similarity=0.389  Sum_probs=109.2

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-----C---CCceeeeceEe--
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-----H---RNIVKLLGYCS--  133 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~--  133 (371)
                      .+|.+.++||-|.|++||++.+ .+.+.||+|+.+   ....-.+..+.|+++|++++     |   ..||++++.|.  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK---SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK---SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe---hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            4788889999999999999955 467889999873   23344567789999999983     2   36899999885  


Q ss_pred             --cCCeEEEEEeecCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc
Q 037946          134 --NKSVKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD  200 (371)
Q Consensus       134 --~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~  200 (371)
                        ++.++|||+|++ |.+|..+|..  .+.++...+..|+.||+.||.|||+++  +|||-||||+|||+.
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence              456899999998 5588888864  456999999999999999999999997  999999999999984

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=3.5e-30  Score=228.00  Aligned_cols=270  Identities=25%  Similarity=0.340  Sum_probs=199.4

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEe
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCS  133 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  133 (371)
                      .+..+.+.|...++||+|+|++||++.+.    ..+.||+|.+.....    ..++.+|+++|..+ .+.||+++.+++.
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhc
Confidence            34456678889999999999999999543    468899999855332    35689999999999 6999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccC
Q 037946          134 NKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGL  212 (371)
Q Consensus       134 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~  212 (371)
                      .++.+.+|+||++..+..++...   ++...+..++..+..||+++|.+   |||||||||+|+|.+. .+.-.|.|||+
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence            99999999999999898888876   66889999999999999999999   9999999999999974 56678999999


Q ss_pred             ccccCCC----------------------------------Cccc--------ccccccccccccCCCCccchhhhcccC
Q 037946          213 AKLMNST----------------------------------NYHH--------AMSRVAGSYGYIAPGKCKLQIIYGYTM  250 (371)
Q Consensus       213 ~~~~~~~----------------------------------~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~  250 (371)
                      +...+..                                  .+..        ......||++|.|||++..      ..
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k------~~  253 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR------CP  253 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh------cc
Confidence            8711000                                  0000        0012469999999998752      23


Q ss_pred             CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH--------HHhcCCCccccccCc-c----------cCCC-
Q 037946          251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK--------KKMGSFEPAVSILDT-K----------LQGL-  310 (371)
Q Consensus       251 ~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~----------~~~~-  310 (371)
                      .-++++||||.||+++.++++..||.....|-..+.+.+-        +.....+. ..+.++ .          .... 
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~-~~l~~ksn~~~~~e~~~~f~s~~  332 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGR-ILLWQKSNIPTIPELRVNFETLH  332 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCc-eeeeccccccccHHHHhchhccC
Confidence            4578999999999999999999999877766444443321        11111111 000000 0          0000 


Q ss_pred             ------------ChhhHHHH--HHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          311 ------------PDQMVQEM--LQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       311 ------------~~~~~~~~--~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                                  ......+.  ..+++++.+|+..||.+|.|+++.+.+
T Consensus       333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                        00000111  146789999999999999999999986

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=8.7e-30  Score=259.31  Aligned_cols=198  Identities=17%  Similarity=0.228  Sum_probs=135.5

Q ss_pred             ccCC-CCceeeeceE-------ecCCeEEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 037946          119 HIRH-RNIVKLLGYC-------SNKSVKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH  189 (371)
Q Consensus       119 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  189 (371)
                      .++| +||.+++++|       .+....+.+||++ +++|.+++.. ...+++..++.++.||+.||.|||++   +|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            4455 5777777776       2334567788887 5599999975 44599999999999999999999999   9999


Q ss_pred             cCCCCCCeeEcCC-------------------CceEEccccCccccCCCCc--------------ccccccccccccccC
Q 037946          190 RDVKCNNILLDSK-------------------YEAYLADFGLAKLMNSTNY--------------HHAMSRVAGSYGYIA  236 (371)
Q Consensus       190 ~dlkp~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y~a  236 (371)
                      |||||+|||++..                   +.+|++|||+++.......              ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   4455666666543211000              000012358899999


Q ss_pred             CCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHH
Q 037946          237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQ  316 (371)
Q Consensus       237 PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (371)
                      ||++.+       ..++.++|||||||+||||++|..|+....   ...... ....         .       ++....
T Consensus       184 PE~~~~-------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~-~~~~---------~-------~~~~~~  236 (793)
T PLN00181        184 PEEDNG-------SSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSL-RHRV---------L-------PPQILL  236 (793)
T ss_pred             hhhhcc-------CCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHH-HHhh---------c-------Chhhhh
Confidence            998753       367899999999999999999887753211   111111 1000         0       011111


Q ss_pred             HHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          317 EMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       317 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .......++.+||+.||.+||++.|++++-+
T Consensus       237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             cCHHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence            1223345677899999999999999998754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.7e-28  Score=203.82  Aligned_cols=169  Identities=20%  Similarity=0.188  Sum_probs=124.8

Q ss_pred             CCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccc
Q 037946          148 GNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS  226 (371)
Q Consensus       148 ~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  226 (371)
                      |+|.+++.. ...+++..++.++.|++.||.|||++   +      ||+||+++.++.+|+  ||.+.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            689999986 45699999999999999999999998   5      999999999999999  99987654322      


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK  306 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                       ..||+.|+|||++.+       ..++.++|||||||++|||++|..||.........+...... .....       +.
T Consensus        64 -~~g~~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~-------~~  127 (176)
T smart00750       64 -SRVDPYFMAPEVIQG-------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-MPADD-------PR  127 (176)
T ss_pred             -CCCcccccChHHhcC-------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-hccCC-------cc
Confidence             258999999998763       367889999999999999999999986433222222221111 11100       00


Q ss_pred             cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .. ...........+.+++.+||+.||.+||++.|+++++....
T Consensus       128 ~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 DR-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cc-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            00 01111111124677899999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=206.48  Aligned_cols=251  Identities=20%  Similarity=0.329  Sum_probs=188.9

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecC
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      +....+|.+...|..|+|+++ |..+++|++....-.....+.|..|.-.++-+.||||++++|.|.......++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            344557889999999999995 4556778875444444455789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEc--cccCccccCCCCcc
Q 037946          147 NGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLA--DFGLAKLMNSTNYH  222 (371)
Q Consensus       147 ~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~  222 (371)
                      .|+|...++....  .+..++.+++.++++|++|||+.. +-+.---|....++||++.+++|+  |--++.+       
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq-------  342 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------  342 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence            9999999987665  677889999999999999999973 133344688999999999988864  3222211       


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        .....-.|.||+||.+....    ....-.++|+|||++++|||.|+..||....+-+-               -+++
T Consensus       343 --e~gr~y~pawmspealqrkp----ed~n~raadmwsfaillwel~trevpfadlspmec---------------gmki  401 (448)
T KOG0195|consen  343 --EVGRAYSPAWMSPEALQRKP----EDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKI  401 (448)
T ss_pred             --ccccccCcccCCHHHHhcCc----hhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhh
Confidence              12234578999999887432    22335689999999999999999999964433211               1111


Q ss_pred             -cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          303 -LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                       +.+-....|+.....+.+++.|   |++.||.+||.++.|+-.|+++.
T Consensus       402 aleglrv~ippgis~hm~klm~i---cmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNI---CMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHH---HhcCCCCcCCCcceehhhHHHhc
Confidence             1122224455555667776666   99999999999999999988764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.8e-27  Score=215.09  Aligned_cols=183  Identities=17%  Similarity=0.136  Sum_probs=137.0

Q ss_pred             HHhccccCCccccCCceEEEEEEeC--CCCEEEEEEecccCC---CcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP--NGELIAVKKLWKTKR---DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      +..+|...+.||+|+||+||+|...  +++.+|||++.....   .......+.+|+++|++++|+|+++.+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            4467889999999999999999654  577789998743211   22345678999999999999999853322   245


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeeEcCCCceEEccccCcccc
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDV-KCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      .|+||||++|++|... ...   .   ...++.+++.+|.|||++   +++|||| ||+|||++.++.+||+|||+++.+
T Consensus        93 ~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             cEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            7999999999999732 211   1   146788999999999999   9999999 999999999999999999999876


Q ss_pred             CCCCcccc------cccccccccccCCCCccchhhhcccCCCCCcchhH
Q 037946          217 NSTNYHHA------MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVY  259 (371)
Q Consensus       217 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw  259 (371)
                      ........      ..+..+++.|+|||.+..+.-. .....+..+|-|
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~-~~~~~~~~~dgW  210 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERK-ILARKSLPSRIW  210 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhc-cccccccccCcE
Confidence            54431111      1345688899999988755322 223344556766

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=5.6e-24  Score=194.54  Aligned_cols=260  Identities=22%  Similarity=0.283  Sum_probs=184.8

Q ss_pred             ccccCCccccCCceEEEEEEeCCC--CEEEEEEecccCCCcchHHHHHHHHHHHhccCC----CCceeeeceE-ecCCeE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNG--ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH----RNIVKLLGYC-SNKSVK  138 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~  138 (371)
                      +|...+.||+|+||.||.+...+.  ..+|+|.-........  ..+..|..++..+..    +++..++... ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            688899999999999999976543  4788887644322211  257788888888863    5888888888 477788


Q ss_pred             EEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-----CceEEcccc
Q 037946          139 LLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-----YEAYLADFG  211 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfg  211 (371)
                      |+||+.+ |.+|.++....  +.++......++.|++.+|.++|+.   |++||||||.|+++...     ..+.|.|||
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            9999988 67999988543  5799999999999999999999999   99999999999999765     458999999


Q ss_pred             Ccc--ccCCCCc----cc-c-cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCch
Q 037946          212 LAK--LMNSTNY----HH-A-MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL  283 (371)
Q Consensus       212 ~~~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  283 (371)
                      +++  .......    .. . .....||..|+++....       +...+.+.|+||++.++.|+..|..||........
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-------~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-------GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhC-------CCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            998  3221111    01 1 22456999999998544       45778999999999999999999999864432211


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                       ... +.........     .. ....++   .....+...   +-..+..++|....+...|.+....
T Consensus       246 -~~~-~~~~~~~~~~-----~~-~~~~~~---~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  246 -KSK-FEKDPRKLLT-----DR-FGDLKP---EEFAKILEY---IDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             -HHH-HHHHhhhhcc-----cc-ccCCCh---HHHHHHHHH---hhccCCcCCCCHHHHHHHHHHHHHh
Confidence             111 1111111000     00 122222   222222222   4447899999999999998776543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.5e-26  Score=222.05  Aligned_cols=259  Identities=21%  Similarity=0.233  Sum_probs=186.7

Q ss_pred             ccCCccccCCceEEEEEEe-CCCCEEEEEEecc---cCCCc-chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           68 KDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDE-EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .....+|.|++|.|+.... ...+.++.|....   ....+ .....+..|+.+-..+.|||++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3567899999998887743 2344455554321   11111 11223677888889999999988877777766666669


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |||++ +|..++.+...++...+-.+++|+..|++|+|++   |+.|||+|++|++++.+|.+||+|||.+..+.-....
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            99999 9999999988899999999999999999999999   9999999999999999999999999998765433222


Q ss_pred             --cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          223 --HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                        ......+|+..|+|||.+.+..      ......||||.|++++.|.+|+.||.....+.....    ....  ... 
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~------ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~~~--~~~-  543 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKE------YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TNNY--SDQ-  543 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccc------cCcchhhhhhccceEEEEecCCCccccccccccchh----hhcc--ccc-
Confidence              3445678999999999887442      224678999999999999999999976655432210    0000  000 


Q ss_pred             cccCcccCCCChhhHHHHH-HHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SILDTKLQGLPDQMVQEML-QTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~-~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                          .....-+..+...+. ....++.++++.||.+|.|+++|++-=|
T Consensus       544 ----~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  544 ----RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             ----cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence                000111111122211 1234788899999999999999987544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.1e-23  Score=192.53  Aligned_cols=262  Identities=27%  Similarity=0.362  Sum_probs=196.8

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcc-hHHHHHHHHHHHhccCCC-CceeeeceEecCCeEEEEEee
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE-PVDSFAAEIQILGHIRHR-NIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  144 (371)
                      |...+.||.|+||.||++...  ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            455678999999999999875  7899999866554443 577899999999999988 799999999888888999999


Q ss_pred             cCCCCHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccccCccccCCCC
Q 037946          145 ISNGNLQQLLQGNR---NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTN  220 (371)
Q Consensus       145 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  220 (371)
                      +.++++.+++....   .++......+..|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999998887765   799999999999999999999999   999999999999999988 79999999998655443


Q ss_pred             ccc----ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC--chhHHHHHHHHhc
Q 037946          221 YHH----AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD--GLHIVEWVKKKMG  294 (371)
Q Consensus       221 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~  294 (371)
                      ...    ......||..|++||.+.+..    ....+...|+||+|++++++++|..|+......  .......+.....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence            221    235667999999999765310    135678999999999999999999996544321  1222222222111


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .      ...........  ......+.+++..|+..+|..|.+..+....
T Consensus       233 ~------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P------SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c------ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1      00000000000  1112334457777999999999998887765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=9.1e-24  Score=182.04  Aligned_cols=201  Identities=19%  Similarity=0.295  Sum_probs=165.5

Q ss_pred             ccccCCccccCCceEEEEE-EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEe
Q 037946           66 CLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      .|+++++||+|+||.++.| +.-+++.||||.-..    ....-.+..|.+..+.| ..++|..++-+...+-+-.+|||
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            6889999999999999999 567899999997422    22234567888888888 57899999888888888889999


Q ss_pred             ecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-----CCceEEccccCccccC
Q 037946          144 YISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-----KYEAYLADFGLAKLMN  217 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~  217 (371)
                      ++ |.+|.|+..-+ +.++...+..+|.|++.-++|+|++   .+|.|||||+|+||..     ...+.++|||+++.+.
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            98 67999988654 4699999999999999999999999   9999999999999954     3458899999999876


Q ss_pred             CCCccc-----ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 037946          218 STNYHH-----AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD  281 (371)
Q Consensus       218 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  281 (371)
                      +.....     ...+..||.+||+=....       +..-+.+.|+-|||-++++.+-|..||++-..+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHl-------GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccc-------cchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            654222     124567999999976544       335578899999999999999999999876554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.9e-24  Score=181.80  Aligned_cols=141  Identities=17%  Similarity=0.133  Sum_probs=110.2

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcch-------H-----------------HHHHHHHHHHhccCCCCc
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEP-------V-----------------DSFAAEIQILGHIRHRNI  125 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------~-----------------~~~~~e~~~l~~l~h~ni  125 (371)
                      ...||+|+||.||+|...+|+.||+|++.........       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999998778999999999654321111       1                 122359999999988776


Q ss_pred             eeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       126 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      .....+..  ...++||||++++++.........++...+..++.|++.+|.++ |+.   +++||||||+||+++ ++.
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence            43322222  22389999999987766544456789999999999999999999 688   999999999999998 578


Q ss_pred             eEEccccCcccc
Q 037946          205 AYLADFGLAKLM  216 (371)
Q Consensus       205 ~kl~Dfg~~~~~  216 (371)
                      ++|+|||++...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-23  Score=194.99  Aligned_cols=225  Identities=24%  Similarity=0.379  Sum_probs=166.9

Q ss_pred             HhccCCCCceeeeceEecCCeEEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 037946          117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCN  195 (371)
Q Consensus       117 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~  195 (371)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. .-.+++.....+.++++.||.|||...  ...|+.++.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence            4678999999999999999999999999999999999987 556899999999999999999999972  3399999999


Q ss_pred             CeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 037946          196 NILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV  275 (371)
Q Consensus       196 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  275 (371)
                      |+++|..+.+||+|||+.................-..-|.|||.+............+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            99999999999999999877643110111122234557999999886543333334678999999999999999999999


Q ss_pred             CCCCCCc--hhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          276 QPQIGDG--LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       276 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                      .......  .++..+++..  .    ...+.+......    .....++.++..||..+|.+||+++.+-..+..+....
T Consensus       159 ~~~~~~~~~~eii~~~~~~--~----~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKG--G----SNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccCChHHHHHHHHhc--C----CCCcCcchhhhh----hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            7644332  2333333330  1    111112111110    11114566778899999999999999999888776543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=3.1e-23  Score=171.35  Aligned_cols=202  Identities=22%  Similarity=0.312  Sum_probs=163.7

Q ss_pred             hccccCCccccCCceEEEEE-EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC-CCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH-RNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  142 (371)
                      ..|...+.||+|+||.+|.| ...+|+.||+|.-......    ..+..|..+.+.|++ ..|..+..+..+.+.-.+||
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            46888999999999999999 5678999999986433322    346788899988864 67777888888889999999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~  218 (371)
                      +.+ |.+|.++..- .+.++..+++.++.|++.-++|+|.+   +++||||||+|.|..-   ...+.++|||+++.+-+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 7799999864 45689999999999999999999999   9999999999999953   45688999999988754


Q ss_pred             CCcc-----cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 037946          219 TNYH-----HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD  281 (371)
Q Consensus       219 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  281 (371)
                      ....     .......||.+|.+--...       +..-+.+.|+-|+|.+|...--|..||++-...
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~-------g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHL-------GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhh-------hhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            4321     1224567999998865332       234477899999999999999999999876543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=4e-23  Score=174.36  Aligned_cols=143  Identities=17%  Similarity=0.180  Sum_probs=112.1

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcch------------------------HHHHHHHHHHHhccCCCCc
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEP------------------------VDSFAAEIQILGHIRHRNI  125 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni  125 (371)
                      ...||+|++|.||+|...+|+.||||++.........                        ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4579999999999998778999999998654321110                        1223578999999999987


Q ss_pred             eeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCc
Q 037946          126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       126 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      .....+...  ..++||||++++++.........++......++.|++.++.++|+ .   +++||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCC
Confidence            544333322  248999999988654443334567888999999999999999999 8   999999999999999 889


Q ss_pred             eEEccccCccccCC
Q 037946          205 AYLADFGLAKLMNS  218 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~  218 (371)
                      ++|+|||++.....
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-24  Score=212.34  Aligned_cols=255  Identities=20%  Similarity=0.262  Sum_probs=184.2

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHH---HHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSF---AAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .+...+.||++.|=+|.+|+++.|. |+||++.+... ....+.|   +.|++ ...+++||.+++.-+-......|+|=
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p-~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDP-TISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCC-CCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            4556788999999999999988877 89999865332 2223333   44454 55669999999988877777778888


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc-----C
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM-----N  217 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~-----~  217 (371)
                      +|... +|.|.+...+-+..-+..-++.|++.|+..+|..   ||+|||||.+||||++=+-+.|+||..-+..     +
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            88876 9999999888888888888999999999999999   9999999999999999999999999886532     2


Q ss_pred             CCCcccccccccccccccCCCCccchh---hhcccC-CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHH
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQI---IYGYTM-NITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~-~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.++....++...-.+|.|||.+....   ...... ..+++.||||+||++.||++ |+++|.     -.++..+   .
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----LSQL~aY---r  248 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----LSQLLAY---R  248 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----HHHHHhH---h
Confidence            223333444555666899999887522   112222 26889999999999999998 566662     1122221   1


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      -+. .   ......+..+.+.      .+..++..|++.||++|.++++.++.
T Consensus       249 ~~~-~---~~~e~~Le~Ied~------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  249 SGN-A---DDPEQLLEKIEDV------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccC-c---cCHHHHHHhCcCc------cHHHHHHHHHccCchhccCHHHHHHh
Confidence            111 0   0011111222222      23346666999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=8.4e-24  Score=179.97  Aligned_cols=173  Identities=14%  Similarity=0.148  Sum_probs=132.2

Q ss_pred             HhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcc-hHHH------HHHHHHHHhccCCCCceeeeceEecC-
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE-PVDS------FAAEIQILGHIRHRNIVKLLGYCSNK-  135 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~-  135 (371)
                      ..+|+..+++|.|+||.||.+.. ++..+|+|.+.......+ ....      +.+|+..+.+++||+|..+..++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            46889999999999999999866 577899999965443332 2223      57999999999999999988875433 


Q ss_pred             -------CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEc
Q 037946          136 -------SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLA  208 (371)
Q Consensus       136 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  208 (371)
                             +..+++|||++|.+|.++..    ++.    ....+++.++..+|+.   +++|||++|+|++++.+| ++|+
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEE
Confidence                   35789999999999988742    233    2456999999999999   999999999999999988 9999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS  270 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  270 (371)
                      |||.........   ..            +.+..+      ..+..++|+||||+++.....
T Consensus       177 Dfg~~~~~~e~~---a~------------d~~vle------r~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        177 DLSGKRCTAQRK---AK------------DRIDLE------RHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             ECCCcccccchh---hH------------HHHHHH------hHhcccccccceeEeehHHHH
Confidence            999987553221   10            111111      123468999999999877644

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-21  Score=173.18  Aligned_cols=206  Identities=20%  Similarity=0.260  Sum_probs=138.2

Q ss_pred             CCCCceeeeceEec---------------------------CCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHH
Q 037946          121 RHRNIVKLLGYCSN---------------------------KSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA  173 (371)
Q Consensus       121 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~  173 (371)
                      +|||||++.++|.+                           +...|+||..++. +|..++..+. .+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence            59999999987632                           3457999998876 9999997765 56666777899999


Q ss_pred             HHHHHHHhCCCCCeEecCCCCCCeeE--cCCC--ceEEccccCccccCCCC----cccccccccccccccCCCCccchhh
Q 037946          174 QGLAYLHHDCVPAILHRDVKCNNILL--DSKY--EAYLADFGLAKLMNSTN----YHHAMSRVAGSYGYIAPGKCKLQII  245 (371)
Q Consensus       174 ~~l~~lh~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~  245 (371)
                      +|+.|||.+   ++.|||+|.+|||+  |+|+  .+.++|||.+-.-....    +....-...|...-||||+...-..
T Consensus       352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            999999999   99999999999999  4444  36799999986543321    1111223457778999997652210


Q ss_pred             hcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHH
Q 037946          246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIA  325 (371)
Q Consensus       246 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  325 (371)
                      -..-. .-.++|.|+.|.+.||+++...||.....-..+...+-              ...+...++......   .+++
T Consensus       429 p~avv-ny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq--------------e~qLPalp~~vpp~~---rqlV  490 (598)
T KOG4158|consen  429 PNAVV-NYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ--------------ESQLPALPSRVPPVA---RQLV  490 (598)
T ss_pred             Cceee-ccchhhhhhhhhhHHHHhccCCcccccchheechhhhh--------------hhhCCCCcccCChHH---HHHH
Confidence            10011 23589999999999999999999975322111111100              011112222222222   2355


Q ss_pred             hcccCCCCCCCCCHHHHHHHHhcc
Q 037946          326 MFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       326 ~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ...++.||++|++.+-..+.|+-.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~Ls  514 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLNLS  514 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHHHH
Confidence            568999999999988776665443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.3e-21  Score=163.12  Aligned_cols=188  Identities=13%  Similarity=0.064  Sum_probs=138.1

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCc--chHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEeecC
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE--EPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      ...|++|+||+||.+.. .+.+++.+.+.....-.  .....+.+|+++|++++ |+++.+++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            46799999999998866 67888877763322211  11235789999999995 5788888876    34699999999


Q ss_pred             CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeeEcCCCceEEccccCccccCCCCcc---
Q 037946          147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDV-KCNNILLDSKYEAYLADFGLAKLMNSTNYH---  222 (371)
Q Consensus       147 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---  222 (371)
                      |.+|.+.+...       ...++.|++.+|.++|++   |++|||| ||+|||++.++.++|+|||++.........   
T Consensus        82 G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         82 GAAMYQRPPRG-------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             CccHHhhhhhh-------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            99987654221       135778999999999999   9999999 799999999999999999999865443310   


Q ss_pred             -c---c----cccccccccccCCCCccchhhhcccCCCC-CcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          223 -H---A----MSRVAGSYGYIAPGKCKLQIIYGYTMNIT-EKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       223 -~---~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                       .   .    ......++.|++|+.-...      ...+ ...+.++-|.-+|.++||+.+...+
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l------~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVL------KRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhh------ccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence             0   0    0112367788888743211      1223 4568889999999999999887544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4e-23  Score=192.31  Aligned_cols=188  Identities=27%  Similarity=0.317  Sum_probs=160.8

Q ss_pred             ccccCCceEEEEEEe----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEeecC
Q 037946           72 VIGKGCSGVVYKAEM----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      .+|+|+||.|+.++.    ..|..+|.|.+++.............|-.++...+ ||.++++...++.....++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998732    34678898888654332222225567788888886 9999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccc
Q 037946          147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS  226 (371)
Q Consensus       147 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  226 (371)
                      +|.|...+.....+++.....+...++-++..+|+.   +++|||+|++||+++.+|.+++.|||.++..-....     
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----  152 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence            999999999999999999999999999999999999   999999999999999999999999999987655431     


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                       .+||..|||||++.         ....++|.||||++.+||+||..||..
T Consensus       153 -~cgt~eymApEI~~---------gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 -ACGTYEYRAPEIIN---------GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             -cccchhhhhhHhhh---------ccCCcccchhhhhhHHHHhhCCCCCch
Confidence             28999999999875         347789999999999999999999975

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=1.4e-21  Score=171.25  Aligned_cols=239  Identities=19%  Similarity=0.254  Sum_probs=146.5

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCC----------CCceeeece--
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRH----------RNIVKLLGY--  131 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h----------~niv~~~~~--  131 (371)
                      .+..++.||.|+++.||.+++. +|+.+|+|+...... .....+.+.+|.-....+.+          -.++..++.  
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455778999999999999774 589999998854432 23345667776655544322          112111111  


Q ss_pred             -------Ee---cCC-----eEEEEEeecCCCCHHHHhc---cC-C---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 037946          132 -------CS---NKS-----VKLLLYNYISNGNLQQLLQ---GN-R---NLDWETRYKIAVGSAQGLAYLHHDCVPAILH  189 (371)
Q Consensus       132 -------~~---~~~-----~~~lv~e~~~~~~L~~~l~---~~-~---~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  189 (371)
                             +.   +.+     ..+++|+-+.+ +|.+++.   .. .   .+....+..+..|+.+.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                   11   111     23667887744 8888753   21 1   233455667779999999999999   9999


Q ss_pred             cCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhc-ccCCCCCcchhHHHHHHHHHH
Q 037946          190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG-YTMNITEKSDVYSYGVVLLEI  268 (371)
Q Consensus       190 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~DiwslG~~l~el  268 (371)
                      +||+|+|++++.+|.++|+||+.....+...     .....+..|.|||.......++ ....++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999887654432     1134567899999665331111 234578899999999999999


Q ss_pred             HhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCC
Q 037946          269 LSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER  336 (371)
Q Consensus       269 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R  336 (371)
                      +||..||........                   .+..+..|. .+.+.+..   ||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~-------------------~~~~f~~C~-~~Pe~v~~---LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEAD-------------------PEWDFSRCR-DMPEPVQF---LIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGST-------------------SGGGGTTSS----HHHHH---HHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCcccc-------------------ccccchhcC-CcCHHHHH---HHHHHccCCcccC
Confidence            999999964432210                   000233443 33333333   6777999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=1e-20  Score=160.58  Aligned_cols=137  Identities=13%  Similarity=0.200  Sum_probs=106.1

Q ss_pred             ccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-----CCCCceeeeceEecCC---eEE
Q 037946           68 KDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-----RHRNIVKLLGYCSNKS---VKL  139 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~  139 (371)
                      ...+.||+|+||.||. ...++. .+||++....  ....+.+.+|+.+++.+     .||||++++|++.++.   .++
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcC-eEEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            4467899999999996 333444 4799885422  22446789999999999     5799999999998763   434


Q ss_pred             -EEEee--cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeeEcC----CCceEEcccc
Q 037946          140 -LLYNY--ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGL-AYLHHDCVPAILHRDVKCNNILLDS----KYEAYLADFG  211 (371)
Q Consensus       140 -lv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg  211 (371)
                       +||||  +.+++|.+++.+. .+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    ++.++|+||+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence             78999  5579999999764 36655  35677888777 999999   9999999999999974    3479999955


Q ss_pred             Ccc
Q 037946          212 LAK  214 (371)
Q Consensus       212 ~~~  214 (371)
                      .+.
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            543

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.6e-20  Score=163.35  Aligned_cols=143  Identities=16%  Similarity=0.162  Sum_probs=112.4

Q ss_pred             cccCCccccCCceEEEEEE--eCCCCEEEEEEecccCCCcc----------------------hHHHHHHHHHHHhccCC
Q 037946           67 LKDENVIGKGCSGVVYKAE--MPNGELIAVKKLWKTKRDEE----------------------PVDSFAAEIQILGHIRH  122 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h  122 (371)
                      |...+.||+|++|.||+|.  ..+|+.||+|++........                      ....+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            6677899999999999997  56899999999864321100                      11235689999999975


Q ss_pred             CC--ceeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCeeE
Q 037946          123 RN--IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA-ILHRDVKCNNILL  199 (371)
Q Consensus       123 ~n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-i~H~dlkp~Nill  199 (371)
                      .+  +.+++++    ...++||||+++++|.................++.|++.++.+||+.   + ++||||||+||++
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli  182 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILV  182 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEE
Confidence            33  3344432    23489999999988877664555567777889999999999999999   8 9999999999999


Q ss_pred             cCCCceEEccccCccccC
Q 037946          200 DSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~  217 (371)
                      + ++.++|+|||.+....
T Consensus       183 ~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             E-CCCEEEEEChhhhccC
Confidence            9 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.3e-19  Score=155.86  Aligned_cols=136  Identities=21%  Similarity=0.346  Sum_probs=114.3

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcc------hHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE------PVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.||+|++|.||+|.. .|..+++|+.........      ....+.+|+.++..+.|+++.....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4799999999999987 678899998643222111      124578899999999999988777777777888999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ++|++|.+++.....    ....++.+++.+|.++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999875432    7888999999999999999   999999999999999 78899999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=5e-21  Score=175.15  Aligned_cols=173  Identities=24%  Similarity=0.391  Sum_probs=128.4

Q ss_pred             CeEEEEEeecCCCCHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNR---NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      ...||.|++|...+|.+|+.+.+   ..++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            35789999999999999997544   36778889999999999999   6   899999999999999999999999999


Q ss_pred             ccccCCCC----cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCC-CCCCCCCCchhHHH
Q 037946          213 AKLMNSTN----YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS-AVQPQIGDGLHIVE  287 (371)
Q Consensus       213 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~-p~~~~~~~~~~~~~  287 (371)
                      ........    .........||..||+||++.++       .|+.++||||||++|+||++-.. ++.       ..  
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-------~y~~kvdIyaLGlil~EL~~~f~T~~e-------r~--  466 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-------QYSEKVDIYALGLILAELLIQFSTQFE-------RI--  466 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhh-------hhhhhcchhhHHHHHHHHHHHhccHHH-------HH--
Confidence            87665443    11233456799999999998855       67899999999999999998221 110       00  


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHH
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV  342 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  342 (371)
                                  ...-+-+-..+|+....+...-+.++.+++...|.+||++.+.
T Consensus       467 ------------~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  467 ------------ATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ------------HhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence                        0000111123333334444444567888999999999955544

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.6e-19  Score=153.58  Aligned_cols=140  Identities=19%  Similarity=0.182  Sum_probs=109.4

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcc--------------------hHHHHHHHHHHHhccCCCC--
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE--------------------PVDSFAAEIQILGHIRHRN--  124 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~h~n--  124 (371)
                      |...+.||+|+||.||++...+|+.||||++........                    .......|+.++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            556788999999999999887899999998754321100                    1123577888999988774  


Q ss_pred             ceeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       125 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      +...++    .+..+++|||+++++|..+...      .....++.+++.++.++|+.   +++||||+|+||+++.++.
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCc
Confidence            333433    2455899999999999776431      34567889999999999998   9999999999999999999


Q ss_pred             eEEccccCccccCCC
Q 037946          205 AYLADFGLAKLMNST  219 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~  219 (371)
                      ++|+|||++......
T Consensus       164 ~~liDfg~~~~~~~~  178 (198)
T cd05144         164 IYIIDWPQMVSTDHP  178 (198)
T ss_pred             EEEEECCccccCCCc
Confidence            999999999765443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2.1e-19  Score=178.62  Aligned_cols=194  Identities=22%  Similarity=0.237  Sum_probs=152.9

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC---CCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR---HRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|.+.+.||+|+||+||+|...+|+.||+|+-.....-     +|.--.+++.+|+   -+.|..+.....-.+..++|
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            456677889999999999998778999999986432221     2333344455554   23344455555566777899


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-------CCceEEccccCcc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-------KYEAYLADFGLAK  214 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-------~~~~kl~Dfg~~~  214 (371)
                      +||.+.|+|.+++...+.+++..+..++.|++..+..||..   +|||+||||+|.+|..       ...++|+|||.+.
T Consensus       773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            99999999999999999999999999999999999999999   9999999999999932       3448999999997


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCC
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS  273 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~  273 (371)
                      .+.-..........++|-.+-.+|+..       +.+.+...|.|.|+.+++-|+.|+.
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~-------grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMRE-------GRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhc-------CCCCchhhhhHHHHHHHHHHHHHHH
Confidence            664433223455667888888999765       4477889999999999999999974

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.7e-19  Score=152.42  Aligned_cols=132  Identities=21%  Similarity=0.373  Sum_probs=107.9

Q ss_pred             ccccCCceEEEEEEeCCCCEEEEEEecccCCCc------chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           72 VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE------EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .||+|+||.||+|.. ++..+++|.........      ....++.+|+++++.+.|+++.....++.+.+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 67889999864332111      12356788999999999887655555555667779999999


Q ss_pred             CCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          146 SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       146 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      +|++|.+++.....       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998765331       7899999999999999   999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=8.9e-19  Score=170.82  Aligned_cols=137  Identities=23%  Similarity=0.349  Sum_probs=111.8

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccC-CC-----cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTK-RD-----EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .|...+.||+|+||.||+|.+.. +.+++|+..... ..     ....+++.+|+++++.++|++++....++.+.+..+
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            34567899999999999998744 445555432211 11     112356889999999999999988877777777889


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      +||||+++++|.+++.        ....++.+++.+|.+||+.   +++|||+||+||++ +++.++|+|||+++.
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999999886        3567899999999999999   99999999999999 678899999999975

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=6.4e-18  Score=142.44  Aligned_cols=139  Identities=22%  Similarity=0.267  Sum_probs=99.0

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHH----------------------HHHHHHHhccCCCC--c
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSF----------------------AAEIQILGHIRHRN--I  125 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~n--i  125 (371)
                      .+.||+|+||.||+|...+++.||||++............+                      ..|.+.+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988789999999986533221111111                      35666666664432  3


Q ss_pred             eeeeceEecCCeEEEEEeecCCCCHHH-HhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCC
Q 037946          126 VKLLGYCSNKSVKLLLYNYISNGNLQQ-LLQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKY  203 (371)
Q Consensus       126 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~  203 (371)
                      .+.++.    ...++||||++++++.. .+.... .. .....++.+++.++.++|. .   +++|+||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CC
Confidence            334332    23589999999854321 111111 11 5678899999999999999 7   999999999999999 89


Q ss_pred             ceEEccccCccccCC
Q 037946          204 EAYLADFGLAKLMNS  218 (371)
Q Consensus       204 ~~kl~Dfg~~~~~~~  218 (371)
                      .++++|||.+.....
T Consensus       152 ~~~liDfg~a~~~~~  166 (187)
T cd05119         152 KVYIIDVPQAVEIDH  166 (187)
T ss_pred             cEEEEECcccccccC
Confidence            999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=3e-19  Score=174.80  Aligned_cols=167  Identities=27%  Similarity=0.342  Sum_probs=121.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.|..|++|.||..+.+ ..+.+|.|.-++ .       .+++.  ++.....|.+|                 
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-------lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-------LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhccccc-c-------hhhhc--cccccCCccee-----------------
Confidence            35777889999999999999764 467788854311 1       11111  33333444443                 


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC---
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN---  220 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  220 (371)
                          |+=...+++.++++..        ++.+++|||+.   +|+|||+||+|.+|+.-|.+|++|||+++......   
T Consensus       136 ----gDc~tllk~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ----chhhhhcccCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence                4555566666655543        37889999999   99999999999999999999999999987532110   


Q ss_pred             ---------ccc-ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 037946          221 ---------YHH-AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG  280 (371)
Q Consensus       221 ---------~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  280 (371)
                               .+. .....+|||.|.|||++..+       .|...+|+|++|+++||.+.|+.||.++..
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-------gygkpvdwwamGiIlyeFLVgcvpffGdtp  263 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-------GYGKPVDWWAMGIILYEFLVGCVPFFGDTP  263 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhh-------ccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence                     000 11345899999999988755       567899999999999999999999987644

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.7e-19  Score=175.47  Aligned_cols=258  Identities=23%  Similarity=0.281  Sum_probs=191.7

Q ss_pred             cccCCccccCCceEEEEEEeC--CCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEe
Q 037946           67 LKDENVIGKGCSGVVYKAEMP--NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      |...+.||+|+|+.|-.....  ....+|+|.+.....+.........|..+-..+. |+|++.+++...+.+..++.++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            555677999999999888542  3455677766444444555566667888888886 9999999999999999999999


Q ss_pred             ecCCCCHHHHh-ccCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeeEcCCC-ceEEccccCccccCC-
Q 037946          144 YISNGNLQQLL-QGNR-NLDWETRYKIAVGSAQGLAYLH-HDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNS-  218 (371)
Q Consensus       144 ~~~~~~L~~~l-~~~~-~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~-  218 (371)
                      +..++++.+.+ .... ..+......++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||++..+.. 
T Consensus       102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999988 5554 6777888899999999999999 77   999999999999999999 999999999987766 


Q ss_pred             CCcccccccccc-cccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          219 TNYHHAMSRVAG-SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       219 ~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ..........+| ++.|+|||...+.      ....+..|+||.|+++..+++|..|+............|....     
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~------~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-----  247 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGK------AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-----  247 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccch------hhcCCCcccccccccccccccCCCCccccccccccceeecccc-----
Confidence            333334445668 9999999987643      2345789999999999999999999875443322211221111     


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                             ......+.  -........++.+++..+|..|.+.+++...=+
T Consensus       248 -------~~~~~~~~--~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~  288 (601)
T KOG0590|consen  248 -------GRFTQLPW--NSISDQAHDLLHKILKENPSNRLSIEELKLDNW  288 (601)
T ss_pred             -------cccccCcc--ccCChhhhhcccccccCCchhcccccccccccc
Confidence                   00000001  011223445677789899999999998766533

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=1.9e-17  Score=134.12  Aligned_cols=134  Identities=22%  Similarity=0.216  Sum_probs=112.7

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC--CCceeeeceEecCCeEEEEEeecCC
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH--RNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      .+.||.|.++.||++...+ ..+++|.......    ...+..|+..++.++|  .++.+++++....+..+++|||+++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            4579999999999998744 7899998743322    4578899999999976  5888999888888889999999998


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      +.+..+       +......++.+++.+++++|.....+++|+|++|+||+++.++.++++|||.+..
T Consensus        78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777654       5567778899999999999986434799999999999999999999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.8e-16  Score=138.21  Aligned_cols=137  Identities=21%  Similarity=0.274  Sum_probs=105.8

Q ss_pred             CCccc-cCCceEEEEEEeCCCCEEEEEEecccC------C-----CcchHHHHHHHHHHHhccCCCCc--eeeeceEecC
Q 037946           70 ENVIG-KGCSGVVYKAEMPNGELIAVKKLWKTK------R-----DEEPVDSFAAEIQILGHIRHRNI--VKLLGYCSNK  135 (371)
Q Consensus        70 ~~~ig-~G~~g~V~~~~~~~~~~vavK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  135 (371)
                      ...|| .||.|+||.+.. .+..+++|.+....      .     +.....++.+|++++..++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45688 899999999977 47889999874321      1     11233567899999999998875  5666654322


Q ss_pred             -C---eEEEEEeecCC-CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          136 -S---VKLLLYNYISN-GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       136 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                       .   ..++|||+++| .+|.+++... .++...    +.+++.++.+||+.   |++||||||.|||++.++.++|+||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence             2   23599999997 6999988654 355443    56899999999999   9999999999999999999999999


Q ss_pred             cCccc
Q 037946          211 GLAKL  215 (371)
Q Consensus       211 g~~~~  215 (371)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            99865

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.63  E-value=2.8e-15  Score=141.78  Aligned_cols=153  Identities=19%  Similarity=0.227  Sum_probs=105.7

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCc----------------------------ch----
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE----------------------------EP----  106 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------~~----  106 (371)
                      .++++...|. .+.||+|++|.||+|+..+|+.||||+.+......                            ..    
T Consensus       112 ~~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~  190 (437)
T TIGR01982       112 PLEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEF  190 (437)
T ss_pred             CHHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHH
Confidence            3444445554 46899999999999999999999999985431000                            00    


Q ss_pred             ------HHHHHHHHHHHhcc----CCCCceeeeceEe-cCCeEEEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHH
Q 037946          107 ------VDSFAAEIQILGHI----RHRNIVKLLGYCS-NKSVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQ  174 (371)
Q Consensus       107 ------~~~~~~e~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~  174 (371)
                            .-.|.+|.+.+.++    .|.+-+.+-.++. ..+..++||||++|++|.++.... ...+   ...++..++.
T Consensus       191 ~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~  267 (437)
T TIGR01982       191 EKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLAR  267 (437)
T ss_pred             HHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHH
Confidence                  00244555555554    2333344433332 244578999999999998876432 1222   3446666665


Q ss_pred             -HHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          175 -GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       175 -~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                       .+..+|..   |++|+|++|.||+++.++.++++|||++..+..
T Consensus       268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             46788988   999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=8.4e-16  Score=133.10  Aligned_cols=208  Identities=22%  Similarity=0.357  Sum_probs=141.8

Q ss_pred             HHHHhccCCCCceeeeceEecC-----CeEEEEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 037946          114 IQILGHIRHRNIVKLLGYCSNK-----SVKLLLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCV  184 (371)
Q Consensus       114 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~  184 (371)
                      ..-+-++.|.|||++..|+.+.     ....+++|||..|++.++|++    +..+......+|+.||..||.|||+ +.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            3345566799999999988654     456889999999999999975    3457888889999999999999999 56


Q ss_pred             CCeEecCCCCCCeeEcCCCceEEccc--cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHH
Q 037946          185 PAILHRDVKCNNILLDSKYEAYLADF--GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYG  262 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~~~kl~Df--g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  262 (371)
                      +.++|+++..+-|++..+|-+|++--  ......-............+-++|.+||       ++...+.+.++|||+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~-------sg~~tn~~~a~dIy~fg  269 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPE-------SGTTTNTTGASDIYKFG  269 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCC-------cCcccccccchhhhhhh
Confidence            79999999999999999998887421  1111100000001112345778999999       66667778899999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHH
Q 037946          263 VVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV  342 (371)
Q Consensus       263 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  342 (371)
                      +...||..|..-....... ....+-+.      ..+...-++...              +++.+|++..|..||+++++
T Consensus       270 mcAlemailEiq~tnseS~-~~~ee~ia------~~i~~len~lqr--------------~~i~kcl~~eP~~rp~ar~l  328 (458)
T KOG1266|consen  270 MCALEMAILEIQSTNSESK-VEVEENIA------NVIIGLENGLQR--------------GSITKCLEGEPNGRPDARLL  328 (458)
T ss_pred             HHHHHHHHheeccCCCcce-eehhhhhh------hheeeccCcccc--------------CcCcccccCCCCCCcchhhh
Confidence            9999999886542211110 00000000      001111111111              24455999999999999999


Q ss_pred             HHHHhccc
Q 037946          343 VALLMEVK  350 (371)
Q Consensus       343 l~~L~~~~  350 (371)
                      +-|.-.+.
T Consensus       329 lfHpllfe  336 (458)
T KOG1266|consen  329 LFHPLLFE  336 (458)
T ss_pred             hcCceeee
Confidence            88765553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.57  E-value=3.6e-15  Score=142.72  Aligned_cols=151  Identities=13%  Similarity=0.118  Sum_probs=100.4

Q ss_pred             ccHHHHHhccccCCccccCCceEEEEEEeCC-CCEEEEEEecccCCC----------------------------c----
Q 037946           58 FTIDNILECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRD----------------------------E----  104 (371)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------~----  104 (371)
                      -..+++...|+. +.||+|++|.||+|+.++ |+.||||+++.....                            .    
T Consensus       113 ~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        113 GPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             CCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            345666667776 789999999999998877 999999998643100                            0    


Q ss_pred             chHH------HHHHHHHHHhcc----CCCCceeeeceEec-CCeEEEEEeecCCCCHHHHh--ccCC----CCCHHHHHH
Q 037946          105 EPVD------SFAAEIQILGHI----RHRNIVKLLGYCSN-KSVKLLLYNYISNGNLQQLL--QGNR----NLDWETRYK  167 (371)
Q Consensus       105 ~~~~------~~~~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~----~~~~~~~~~  167 (371)
                      +..+      ++.+|+..+.++    .+.+.+.+-.++.+ ....++||||++|+.+.++.  ...+    .+....+..
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence            0011      234444444444    24444444444332 45678999999999998753  2222    122223333


Q ss_pred             HHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC----ceEEccccCccccCCC
Q 037946          168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFGLAKLMNST  219 (371)
Q Consensus       168 i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~  219 (371)
                      ++.|+       ...   |++|+|+||.||+++.++    .++++|||++..++..
T Consensus       272 ~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        272 FFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            33333       345   999999999999999888    9999999999876543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=9.2e-15  Score=136.71  Aligned_cols=200  Identities=24%  Similarity=0.237  Sum_probs=162.3

Q ss_pred             hccccCCcccc--CCceEEEEEEe---CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGK--GCSGVVYKAEM---PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  138 (371)
                      ..+...+.+|.  |.+|.||.++.   .++..+|+|+-...........+=.+|+...+.+ .|+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45666788999  99999999955   4688999998654444333334445677777777 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeeEcCC-CceEEccccC
Q 037946          139 LLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQ----GLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGL  212 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~----~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~  212 (371)
                      ++-+|+|. .+|.++...... ++...++....+...    |+..+|+.   +++|-|+||.||+...+ ...+++|||+
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence            99999996 588888776555 788889999999999    99999999   99999999999999998 8889999999


Q ss_pred             ccccCCCCccccc---ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 037946          213 AKLMNSTNYHHAM---SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ  276 (371)
Q Consensus       213 ~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  276 (371)
                      ...+.........   ....|...|++||...        +.++..+|||++|.+..+-.++..++.
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--------~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--------GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc--------cccchHhhhcchhhhhHhhHhhccccc
Confidence            9988776633222   2335778899999764        356789999999999999999887664

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.6e-13  Score=113.58  Aligned_cols=130  Identities=18%  Similarity=0.152  Sum_probs=94.7

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCce-eeeceEecCCeEEEEEeecCCCC
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV-KLLGYCSNKSVKLLLYNYISNGN  149 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~  149 (371)
                      +.|+.|.++.||+++.. ++.+++|.......   ....+..|+.+++.+.+.+++ +++.+.  ....++||||++|.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence            46889999999999874 78899998743221   123457899999988655544 444433  234579999999988


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          150 LQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC--VPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       150 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      +.+.    . .   .......+++.+|+.||+..  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTE----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            7653    1 1   11345678999999999982  12359999999999999 67899999999853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.45  E-value=1.6e-12  Score=108.58  Aligned_cols=138  Identities=17%  Similarity=0.179  Sum_probs=98.2

Q ss_pred             CccccCCceEEEEEEeCC-------CCEEEEEEecccCC-----------C---------cchHHHHH----HHHHHHhc
Q 037946           71 NVIGKGCSGVVYKAEMPN-------GELIAVKKLWKTKR-----------D---------EEPVDSFA----AEIQILGH  119 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~~~----~e~~~l~~  119 (371)
                      ..||.|--+.||.|...+       +..+|||..+....           +         ......+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999996543       47899998643210           0         11122333    79999998


Q ss_pred             cCC--CCceeeeceEecCCeEEEEEeecCCCCHHH-HhccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCC
Q 037946          120 IRH--RNIVKLLGYCSNKSVKLLLYNYISNGNLQQ-LLQGNRNLDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVKCN  195 (371)
Q Consensus       120 l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dlkp~  195 (371)
                      +..  -++..++.+    ...++||||+.++.+.. .+.. ..++......+..+++.+|..+ |..   +++|+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            853  344555543    45689999997654322 2222 2355566777889999999998 888   9999999999


Q ss_pred             CeeEcCCCceEEccccCccccC
Q 037946          196 NILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       196 Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      ||+++ ++.+.|+|||.+....
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCC
Confidence            99997 4679999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=1.7e-12  Score=123.01  Aligned_cols=169  Identities=17%  Similarity=0.220  Sum_probs=127.0

Q ss_pred             EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHH
Q 037946           85 EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWET  164 (371)
Q Consensus        85 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  164 (371)
                      +..++.+|.|........  .......+-++.|+.++||||++++..+...+..|+|+|-+.  -|..+++...   ...
T Consensus        33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~  105 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEE  105 (690)
T ss_pred             eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHH
Confidence            344678888887744332  445667888999999999999999999999999999999874  5666665533   555


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchh
Q 037946          165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI  244 (371)
Q Consensus       165 ~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  244 (371)
                      ...-+.||+.||.|||+.+  +++|++|.-..|+++..|+.||++|.++........  .......-..|..|+.+..  
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~--  179 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP--  179 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc--
Confidence            6667899999999999764  999999999999999999999999999865543321  0111122234666764321  


Q ss_pred             hhcccCCCCCcchhHHHHHHHHHHHhCCC
Q 037946          245 IYGYTMNITEKSDVYSYGVVLLEILSGRS  273 (371)
Q Consensus       245 ~~~~~~~~~~~~DiwslG~~l~el~~g~~  273 (371)
                             -.-..|.|.||++++|++.|..
T Consensus       180 -------s~~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  180 -------SEWSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             -------cccchhhhhHHHHHHHHhCccc
Confidence                   1134699999999999999943

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.37  E-value=6.3e-12  Score=108.70  Aligned_cols=143  Identities=21%  Similarity=0.282  Sum_probs=109.8

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCC--CceeeeceEecC---CeEEEEEeec
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR--NIVKLLGYCSNK---SVKLLLYNYI  145 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~  145 (371)
                      +.|+.|..+.||++...+|+.+++|........ .....+..|.++++.+.+.  ++.+++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            468999999999998766688999987433221 2345688999999999753  456677766554   3668999999


Q ss_pred             CCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 037946          146 SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC------------------------------------------  183 (371)
Q Consensus       146 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------------------  183 (371)
                      +|.++.+.+.. ..++......++.+++++|..||+..                                          
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99888776543 45777788888888888888888521                                          


Q ss_pred             -----------CCCeEecCCCCCCeeEcC--CCceEEccccCccc
Q 037946          184 -----------VPAILHRDVKCNNILLDS--KYEAYLADFGLAKL  215 (371)
Q Consensus       184 -----------~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~  215 (371)
                                 ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       246799999999999998  66789999988853

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=7.1e-13  Score=124.16  Aligned_cols=247  Identities=17%  Similarity=0.156  Sum_probs=170.4

Q ss_pred             hccccCCccccCCceEEEEEEe--CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM--PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      ..|.....||.|.|+.|+....  .++..+++|.+.+..........-+.|+.+...+ .|.++++.+..|......|+=
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            3456677899999999999843  4678899998765544433333345666666666 588888888777777778899


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-CceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~  220 (371)
                      -|||.++++...+.-...+++...+....|++.++.++|++   .++|+|++|+||++..+ +.-+++|||....+....
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec
Confidence            99999999888875555688888999999999999999999   99999999999999876 788899999986422111


Q ss_pred             ccccccccccccccc-CCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          221 YHHAMSRVAGSYGYI-APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                           ....+.-++. ..|.+..      ...+..+.|++|||..+.+.+++......- .                 ..
T Consensus       422 -----~~~~~~~r~~p~~~~~~e------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~-----------------~~  472 (524)
T KOG0601|consen  422 -----GVFHHIDRLYPIAEILLE------DYPHLSKADIFSLGLSVDEAITGSPLSESG-V-----------------QS  472 (524)
T ss_pred             -----ccccccccccccchhhcc------ccccccccccccccccccccccCcccCccc-c-----------------cc
Confidence                 1112233344 2444332      346678999999999999999987543211 0                 00


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..+........+..    ..+...+...+...++..||.+.++..+..
T Consensus       473 ~~i~~~~~p~~~~~----~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  473 LTIRSGDTPNLPGL----KLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             eeeecccccCCCch----HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            11111111111111    122223444488999999999988776554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2.9e-11  Score=97.75  Aligned_cols=132  Identities=24%  Similarity=0.385  Sum_probs=100.9

Q ss_pred             ccccCCceEEEEEEeCCCCEEEEEEecc-cCCCcc-----hHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           72 VIGKGCSGVVYKAEMPNGELIAVKKLWK-TKRDEE-----PVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .+++|+-+.+|.+.+. |..+++|.-.+ ....++     ...+-.+|+++++.+.--.|....=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999763 44466664322 222222     1345678999999987656555555667777888999999


Q ss_pred             CCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          146 SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       146 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      +|..|.+.+...       ...++..+-.-+.-||..   +++|+||.++||.++.++ +.++|||++..
T Consensus        82 ~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999998776       255677778888899999   999999999999998776 99999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=5.1e-11  Score=95.90  Aligned_cols=142  Identities=20%  Similarity=0.284  Sum_probs=105.0

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccC-CCc-----chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTK-RDE-----EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ...|-+|+-+.|+++.+ .|+...||.-.... .-+     -...+-.+|++.+.++.--.|....-++.+...-.++||
T Consensus        12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            45788999999999988 67888887542221 111     123567789999998865455443345666677789999


Q ss_pred             ecCC-CCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc---eEEccccCccc
Q 037946          144 YISN-GNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKL  215 (371)
Q Consensus       144 ~~~~-~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~  215 (371)
                      |++| .++.+++....  ....+....++..+-+.+.-||..   +++|+||..+||++..++.   +.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9987 47888876533  233444478899999999999999   9999999999999966543   57999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.22  E-value=3.9e-12  Score=125.64  Aligned_cols=206  Identities=21%  Similarity=0.228  Sum_probs=149.2

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.+...+.+-+|+++.++.+.-. .|...+.|...... ......+....+-.++-..++|.++...--+.-....++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            34555667889999999988532 34444555432211 11222333444444444456677777665566677889999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC---
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST---  219 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---  219 (371)
                      +|..+++|...+++.+..+.......+..+..+.+|||+.   .+.|+|++|.|.++..++..++.|||.....+..   
T Consensus       884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            9999999999999988888777788888899999999998   7999999999999999999999999843221100   


Q ss_pred             ------------------C--------cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCC
Q 037946          220 ------------------N--------YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS  273 (371)
Q Consensus       220 ------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~  273 (371)
                                        .        .........||+.|.+||.+.+       ......+|+|+.|++++|.++|.+
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-------~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-------RRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-------ccCCCcchhhhhhhhhhhhhcCCC
Confidence                              0        0001123468999999997763       356788999999999999999999


Q ss_pred             CCCCCCC
Q 037946          274 AVQPQIG  280 (371)
Q Consensus       274 p~~~~~~  280 (371)
                      ||.....
T Consensus      1034 p~na~tp 1040 (1205)
T KOG0606|consen 1034 PFNAETP 1040 (1205)
T ss_pred             CCCCcch
Confidence            9975544

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.19  E-value=1.6e-09  Score=97.90  Aligned_cols=270  Identities=15%  Similarity=0.157  Sum_probs=157.0

Q ss_pred             cCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeece------EecC-CeEEE
Q 037946           69 DENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGY------CSNK-SVKLL  140 (371)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~-~~~~l  140 (371)
                      .++.||+|+-+.+|..-.  -...+.|+.+.......  .   .-...|... .||-+-.=+-|      ..+. ...-+
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            466799999999997632  12245577654322111  1   122233333 45543221111      1122 22567


Q ss_pred             EEeecCCCC-HHHHh------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          141 LYNYISNGN-LQQLL------QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       141 v~e~~~~~~-L~~~l------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      +|..+++.. ...+.      ++.+..+|..+++++..++.+.+-||..   |.+-+|+.++|+|+++++.|.|.|=..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            787776642 22222      2345588999999999999999999999   9999999999999999999999885543


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCC--ch-hHHHHH
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG-RSAVQPQIGD--GL-HIVEWV  289 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~--~~-~~~~~~  289 (371)
                      ......   .......|...|.+||.=.-....  +...+..+|.|.||+++++++.| +.||.+-...  .. .....+
T Consensus       165 qi~~ng---~~~~cpVg~~eftPPElQ~~~sf~--g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         165 QINANG---TLHLCPVGVSEFTPPELQTLPSFV--GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             eeccCC---ceEecccCccccCCHHHhcccccc--ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            332211   123456789999999964322222  23456789999999999999986 8888643221  11 111111


Q ss_pred             HHHhcCCCcc-ccccCcccCCCChhhHHHHHHHHHHHhcccCC--CCCCCCCHHHHHHHHhcccCCCcc
Q 037946          290 KKKMGSFEPA-VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNS--SPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       290 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~--dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      ......+.+. ..-..+.....|-+++.-..+  -+...|+..  ++.-|||++-.+..|..+.++...
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vq--AlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQ--ALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHH--HHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            1111111110 111112222233222211111  133346653  366899999999998888755443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.14  E-value=9.2e-10  Score=97.16  Aligned_cols=141  Identities=15%  Similarity=0.146  Sum_probs=99.0

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCc---------chHHHHHHHHHHHhccCCCCc--eeeeceEec-----
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE---------EPVDSFAAEIQILGHIRHRNI--VKLLGYCSN-----  134 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----  134 (371)
                      +.+-+.....|+++.. +|+.+.||+........         .....+.+|...+..+..-+|  ...+.+...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455777766 67889999763222100         111246788888887743333  233333322     


Q ss_pred             CCeEEEEEeecCCC-CHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-------CCc
Q 037946          135 KSVKLLLYNYISNG-NLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-------KYE  204 (371)
Q Consensus       135 ~~~~~lv~e~~~~~-~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-------~~~  204 (371)
                      ....++|||++++. +|.+++..  ....+......++.+++..+.-||..   |++|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999886 89999864  33456677788999999999999999   9999999999999975       467


Q ss_pred             eEEccccCccc
Q 037946          205 AYLADFGLAKL  215 (371)
Q Consensus       205 ~kl~Dfg~~~~  215 (371)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            89999998853

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=1.1e-08  Score=94.78  Aligned_cols=165  Identities=17%  Similarity=0.279  Sum_probs=125.5

Q ss_pred             ceEEEEE-EeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe----cCCeEEEEEeecCC-CCHH
Q 037946           78 SGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS----NKSVKLLLYNYISN-GNLQ  151 (371)
Q Consensus        78 ~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-~~L~  151 (371)
                      ..+.|++ ...+|..|++|+++....  ........-+++++++.|+|+|++.+++.    ....+++|++|+++ ++|.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            3578888 356899999999943222  11123355688999999999999988875    34567899999886 4676


Q ss_pred             HHhc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          152 QLLQ---------------GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       152 ~~l~---------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ++-.               .+...++..+|.++.|+..||.++|+.   |+.-+-|.|++|+++.+.+++|+..|+....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            6542               223477899999999999999999999   9999999999999999999999988887655


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS  273 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~  273 (371)
                      ....              .  |.+.+          -.+-|.=.||.++..|.||..
T Consensus       444 ~~d~--------------~--~~le~----------~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  444 QEDP--------------T--EPLES----------QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCCC--------------C--cchhH----------HhhhhHHHHHHHHHHHhhccc
Confidence            4332              1  11221          235688899999999999964

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=1.1e-09  Score=91.27  Aligned_cols=128  Identities=27%  Similarity=0.320  Sum_probs=81.6

Q ss_pred             EEEEEEeCCCCEEEEEEecccC--------------C--------Cc--chHHHHHHHHHHHhccCCC--CceeeeceEe
Q 037946           80 VVYKAEMPNGELIAVKKLWKTK--------------R--------DE--EPVDSFAAEIQILGHIRHR--NIVKLLGYCS  133 (371)
Q Consensus        80 ~V~~~~~~~~~~vavK~~~~~~--------------~--------~~--~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  133 (371)
                      .||.|...+|+.+|+|......              .        ..  .......+|.+.|.++..-  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899988889999999864321              0        00  0123457899999999765  345555332 


Q ss_pred             cCCeEEEEEeecC--CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          134 NKSVKLLLYNYIS--NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAY-LHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       134 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                         ...+||||++  |..+..+....  ++......++.++...+.. +|..   |++|+||.+.||+++++ .+.++||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence               3469999998  54444433222  1133445667777775555 5787   99999999999999988 8999999


Q ss_pred             cCccccC
Q 037946          211 GLAKLMN  217 (371)
Q Consensus       211 g~~~~~~  217 (371)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9986543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=99.01  E-value=1.6e-09  Score=103.46  Aligned_cols=158  Identities=21%  Similarity=0.280  Sum_probs=103.1

Q ss_pred             cccccHHHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCC--------------------c--------ch
Q 037946           55 KLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD--------------------E--------EP  106 (371)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------~--------~~  106 (371)
                      .++..+++....|+. +.|+.++-|.||+|+..+|+.||||+.+.....                    .        ..
T Consensus       116 eLG~~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~v  194 (517)
T COG0661         116 ELGRPIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEV  194 (517)
T ss_pred             HhCCCHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHH
Confidence            334456666777764 689999999999999999999999998653100                    0        00


Q ss_pred             HH----------HHHHHHHHHhcc----CCCCceeeeceE-ecCCeEEEEEeecCCCCHHHHh--ccCCCCCHHHHHHHH
Q 037946          107 VD----------SFAAEIQILGHI----RHRNIVKLLGYC-SNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIA  169 (371)
Q Consensus       107 ~~----------~~~~e~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~  169 (371)
                      .+          .+.+|..-+.++    ++..-+++-.++ .-.+...++|||++|..+.+..  +. ...+...+....
T Consensus       195 v~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~  273 (517)
T COG0661         195 VDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELL  273 (517)
T ss_pred             HHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHH
Confidence            11          223444444443    222223333333 3456678999999999988874  33 335543333322


Q ss_pred             HHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       170 ~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      .++.  +..+=..   |++|.|.+|.||+++.+|.+.+.|||+...+.+.
T Consensus       274 ~~~f--~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         274 VRAF--LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHH--HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            2222  2222224   8999999999999999999999999999876554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=1.4e-08  Score=86.61  Aligned_cols=126  Identities=25%  Similarity=0.333  Sum_probs=91.8

Q ss_pred             CCCEEEEEEecccCCC-----cchHHHHHHHHHHHhccCCCCc--eeeeceEecC----CeEEEEEeecCCC-CHHHHhc
Q 037946           88 NGELIAVKKLWKTKRD-----EEPVDSFAAEIQILGHIRHRNI--VKLLGYCSNK----SVKLLLYNYISNG-NLQQLLQ  155 (371)
Q Consensus        88 ~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~  155 (371)
                      .++.+-+|.+......     .-...+..+|...+..+..-+|  .+.+.+....    ...++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            3556666654322111     1223467788887777743332  3444444332    2458999999884 8999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC---ceEEccccCcccc
Q 037946          156 GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY---EAYLADFGLAKLM  216 (371)
Q Consensus       156 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~  216 (371)
                      .....+......++.+++..++-||..   |++|+|+++.|||++.++   .+.++||+-++..
T Consensus       111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWEQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhcccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            755577788889999999999999999   999999999999999887   8899999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=1.6e-08  Score=86.95  Aligned_cols=136  Identities=22%  Similarity=0.184  Sum_probs=96.1

Q ss_pred             ccCCccccCCceEEEEEEeCCCCEEEEEEecccC------------------CC--cchHHHHHHHHHHHhccCCC--Cc
Q 037946           68 KDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTK------------------RD--EEPVDSFAAEIQILGHIRHR--NI  125 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~--~~~~~~~~~e~~~l~~l~h~--ni  125 (371)
                      ..+..||.|--|.||.|..++|..+|+|.-....                  .+  ........+|.+.|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            3468899999999999999999999999532110                  00  11233557899999998644  55


Q ss_pred             eeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCce
Q 037946          126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEA  205 (371)
Q Consensus       126 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~  205 (371)
                      .+.++    .+...+|||+++|-.|...-     ++.+..-.++..|+.-+.-+-..   |++|+|+++-||+++++|.+
T Consensus       174 P~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         174 PKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCE
Confidence            55543    45568999999985554322     13334444555555555555566   99999999999999999999


Q ss_pred             EEccccCccc
Q 037946          206 YLADFGLAKL  215 (371)
Q Consensus       206 kl~Dfg~~~~  215 (371)
                      .++||--+..
T Consensus       242 ~vIDwPQ~v~  251 (304)
T COG0478         242 VVIDWPQAVP  251 (304)
T ss_pred             EEEeCccccc
Confidence            9999966543

>PRK09902 hypothetical protein; Provisional

Probab=98.91  E-value=3.9e-08  Score=82.50  Aligned_cols=138  Identities=13%  Similarity=0.121  Sum_probs=102.6

Q ss_pred             cccCCceEEEEEEeCCCCEEEEEEeccc-CCC---cchHHHHHHHHHHHhccCCCC--ceeeeceEe---c--CCeEEEE
Q 037946           73 IGKGCSGVVYKAEMPNGELIAVKKLWKT-KRD---EEPVDSFAAEIQILGHIRHRN--IVKLLGYCS---N--KSVKLLL  141 (371)
Q Consensus        73 ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~---~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~---~--~~~~~lv  141 (371)
                      -|+||-+.|++... +|+.+-+|+.... ..+   +.....|.+|...+.++..-+  +.++. ++.   .  .-..++|
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            36799999999876 4557888986421 111   335578999999999985433  33333 222   1  1235799


Q ss_pred             EeecCC-CCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc--eEEccccCccc
Q 037946          142 YNYISN-GNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE--AYLADFGLAKL  215 (371)
Q Consensus       142 ~e~~~~-~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~  215 (371)
                      +|-+++ .+|.+++.+.  .+.+......+..+++..++-||+.   ++.|+|+-+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 4899998663  3467777889999999999999999   9999999999999987677  99999987754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=1.8e-09  Score=103.14  Aligned_cols=153  Identities=21%  Similarity=0.311  Sum_probs=98.5

Q ss_pred             HHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc------cc-cccccccccCCCCccc
Q 037946          170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA------MS-RVAGSYGYIAPGKCKL  242 (371)
Q Consensus       170 ~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~------~~-~~~gt~~y~aPE~~~~  242 (371)
                      .+++.|+.|+|..  +++||++|.|++|.++..+..||+.|+++...........      .. .......|.|||.+.+
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455999999987  5999999999999999999999999999866544221100      00 1124567999997653


Q ss_pred             hhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHH
Q 037946          243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTL  322 (371)
Q Consensus       243 ~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (371)
                             ...+.++|+||+|+++|.+..|+.+.....+..... . ...     .....-....-...|.+....+..  
T Consensus       184 -------~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~-~~~-----~~~~~~~~~~s~~~p~el~~~l~k--  247 (700)
T KOG2137|consen  184 -------TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-S-FSR-----NLLNAGAFGYSNNLPSELRESLKK--  247 (700)
T ss_pred             -------ccccccccceeeeeEEEEEecCCcchhhccCCcchh-h-hhh-----cccccccccccccCcHHHHHHHHH--
Confidence                   356789999999999999996555443222221110 0 000     000000111114455555555444  


Q ss_pred             HHHhcccCCCCCCCCCHHHHHHH
Q 037946          323 GIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       323 ~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                           .+..++..||++.++...
T Consensus       248 -----~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  248 -----LLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             -----HhcCCcccCcchhhhhcc
Confidence                 889999999988776543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.82  E-value=4.1e-08  Score=93.62  Aligned_cols=157  Identities=20%  Similarity=0.221  Sum_probs=100.1

Q ss_pred             ccccHHHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCc-----------------------------ch
Q 037946           56 LNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE-----------------------------EP  106 (371)
Q Consensus        56 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------------------~~  106 (371)
                      ++-+++++.+.|. .+.||..+.|.||+|+.++|+.||||+.+......                             +.
T Consensus       153 lG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~  231 (538)
T KOG1235|consen  153 LGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEI  231 (538)
T ss_pred             hCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHH
Confidence            4556677777765 36899999999999999999999999976531100                             00


Q ss_pred             ------HHHHHHHHHHH----hccCCCCc---eeeece-EecCCeEEEEEeecCCCCHHHHh--ccCCCCCHHHHHHHHH
Q 037946          107 ------VDSFAAEIQIL----GHIRHRNI---VKLLGY-CSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAV  170 (371)
Q Consensus       107 ------~~~~~~e~~~l----~~l~h~ni---v~~~~~-~~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~  170 (371)
                            .-+|.+|++-.    +.+.|-+.   |.+-.+ +.-.....++||||+|..+.|.-  .+. .++...+...+.
T Consensus       232 ~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~  310 (538)
T KOG1235|consen  232 AKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLV  310 (538)
T ss_pred             HhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHH
Confidence                  01233343322    23345441   122222 23345678999999998776653  333 366655444444


Q ss_pred             HHHHHHHHHHhCCCCCeEecCCCCCCeeEcC----CCceEEccccCccccCCC
Q 037946          171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDS----KYEAYLADFGLAKLMNST  219 (371)
Q Consensus       171 ~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~~  219 (371)
                      +...-+-+.  .   |++|.|-+|.||+++.    ++.+.+.|||+.......
T Consensus       311 ~~~~~qIf~--~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  311 EAYLEQIFK--T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHHHHHh--c---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            333222222  2   8999999999999984    678999999998765543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=3.1e-07  Score=79.44  Aligned_cols=136  Identities=15%  Similarity=0.192  Sum_probs=84.5

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--ceeeeceEecCCeEEEEEeecCCC
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      ..||+|..+.||+.   .+..+++|.....    .......+|.++++.+..-+  +.+++.+..+.+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            46899999999984   2456778876321    13345688999999886433  466777777888888999999996


Q ss_pred             C-HHHHh---------------------ccC--CCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEecC
Q 037946          149 N-LQQLL---------------------QGN--RNLDWETRY-KIAV----------GSAQ-GLAYLHHD-CVPAILHRD  191 (371)
Q Consensus       149 ~-L~~~l---------------------~~~--~~~~~~~~~-~i~~----------~i~~-~l~~lh~~-~~~~i~H~d  191 (371)
                      + +...+                     +.-  ...+..... .+..          .+.. ...+|... ....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 22111                     110  011111100 0000          0111 12222211 123679999


Q ss_pred             CCCCCeeEcCCCceEEccccCcc
Q 037946          192 VKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       192 lkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      +.|.||++++++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999998875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.62  E-value=1.6e-07  Score=79.95  Aligned_cols=138  Identities=20%  Similarity=0.289  Sum_probs=87.6

Q ss_pred             ccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHH----------------------HHHHHHHHHhccCCCC--cee
Q 037946           72 VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVD----------------------SFAAEIQILGHIRHRN--IVK  127 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~----------------------~~~~e~~~l~~l~h~n--iv~  127 (371)
                      .|++|--+.||+|...++..+|+|+............                      =...|+.-|+++...+  +.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            4566777899999877899999999854321111100                      0134555555553222  222


Q ss_pred             eeceEecCCeEEEEEeecCCCCH-HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceE
Q 037946          128 LLGYCSNKSVKLLLYNYISNGNL-QQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY  206 (371)
Q Consensus       128 ~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~k  206 (371)
                      -+.+.    .-.+||||+..... .-.|+.- ++.......+..++.+.+.-|-...  ++||+||+.-|||+. ++.+.
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEE
Confidence            22222    23689999865311 1111211 2333357777888888888877632  999999999999999 88999


Q ss_pred             EccccCccccC
Q 037946          207 LADFGLAKLMN  217 (371)
Q Consensus       207 l~Dfg~~~~~~  217 (371)
                      ++|||-+....
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999986554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.57  E-value=5.1e-07  Score=76.11  Aligned_cols=138  Identities=19%  Similarity=0.199  Sum_probs=86.2

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcch-HH------HHHHHHHHHhccC---CCCceeeeceE--
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEP-VD------SFAAEIQILGHIR---HRNIVKLLGYC--  132 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~~------~~~~e~~~l~~l~---h~niv~~~~~~--  132 (371)
                      .+|...+++-......|.+-.. +|+.+++|.........+. ..      ...+++..+..+.   -.....++-+.  
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            3455556666666666777665 6788999976442221111 11      1223444343332   22222222222  


Q ss_pred             ---ecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcc
Q 037946          133 ---SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       133 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                         .-....+++|||++|..|.+...    +++    .++..+.+++.-+|..   |+.|+|..|+|+++++++ +++.|
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEE
Confidence               22345568999999988776543    222    2456677889999999   999999999999998655 99999


Q ss_pred             ccCccc
Q 037946          210 FGLAKL  215 (371)
Q Consensus       210 fg~~~~  215 (371)
                      |+..+.
T Consensus       178 ~~~k~~  183 (229)
T PF06176_consen  178 TQGKRM  183 (229)
T ss_pred             Cccccc
Confidence            987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=1.8e-06  Score=75.08  Aligned_cols=139  Identities=19%  Similarity=0.232  Sum_probs=82.2

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--ceeeeceE---ecCCeEEEEEeec
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKLLGYC---SNKSVKLLLYNYI  145 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~---~~~~~~~lv~e~~  145 (371)
                      +.|+.|..+.||+....+ ..+++|.....    .....+..|..+++.+....  +.+++.++   ......+++|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            468999999999998866 68999986322    45567788999988885332  45566543   2334578999999


Q ss_pred             CCCCHHH----------------Hh---ccC----CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 037946          146 SNGNLQQ----------------LL---QGN----RNLDWET---------RYKI------------AVGSAQ-GLAYLH  180 (371)
Q Consensus       146 ~~~~L~~----------------~l---~~~----~~~~~~~---------~~~i------------~~~i~~-~l~~lh  180 (371)
                      +|..+..                .+   +..    .......         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                11   111    1111000         0000            111222 233333


Q ss_pred             h----CCCCCeEecCCCCCCeeEc-CCCceEEccccCcc
Q 037946          181 H----DCVPAILHRDVKCNNILLD-SKYEAYLADFGLAK  214 (371)
Q Consensus       181 ~----~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~  214 (371)
                      .    .....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2    1234799999999999999 66777899998874

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.50  E-value=2.1e-06  Score=75.38  Aligned_cols=136  Identities=18%  Similarity=0.159  Sum_probs=83.2

Q ss_pred             cccCCc-eEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEeecCCCCH
Q 037946           73 IGKGCS-GVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYNYISNGNL  150 (371)
Q Consensus        73 ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L  150 (371)
                      |..|.. ..||+.... +..+.+|......     ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            445555 789999764 4678888763221     235677888888883 34455677777766778999999999877


Q ss_pred             HHHh-------------------ccCC----CCCH--HHHHHHHH--------------------HHHHHHHHHHh----
Q 037946          151 QQLL-------------------QGNR----NLDW--ETRYKIAV--------------------GSAQGLAYLHH----  181 (371)
Q Consensus       151 ~~~l-------------------~~~~----~~~~--~~~~~i~~--------------------~i~~~l~~lh~----  181 (371)
                      ....                   ++-.    +...  ........                    .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6432                   1100    0110  00000000                    01111222211    


Q ss_pred             CCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       182 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      ...+.++|+|+.|.||++++++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            112469999999999999998878899998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.39  E-value=7.5e-08  Score=91.49  Aligned_cols=182  Identities=20%  Similarity=0.150  Sum_probs=128.1

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC-ceeeeceEecCCeEEEEEeecCCC
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN-IVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      -+-.++|+++.++|.+....+....+.+...       ....-++++|.+++||| .+..++-+......++.++++.++
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            3457899999999987543333334443211       34567889999999999 666677777778889999999876


Q ss_pred             -CHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccc
Q 037946          149 -NLQQLL-QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS  226 (371)
Q Consensus       149 -~L~~~l-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  226 (371)
                       +..... ...-.+...+.......-+++++++|+.   .-+|+|    ||+..+ +..+.+||+....+....   ...
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~  388 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR  388 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence             221111 1111233344455566667889999987   568988    777665 678999999988766543   446


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ  276 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  276 (371)
                      ...+|+.|+|||+..       .+.+....|+|++|+--.++.-|.+|-.
T Consensus       389 t~~~~~~~~~pev~~-------~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQ-------ENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCCCCCCCCCchhhc-------ccccccCCCccCCCcchhhcCCCCCCCC
Confidence            677999999999765       3456778999999998888877776653

>PLN02876 acyl-CoA dehydrogenase

Probab=98.36  E-value=7.9e-06  Score=84.13  Aligned_cols=146  Identities=17%  Similarity=0.275  Sum_probs=90.4

Q ss_pred             CCccccCCceEEEEEEeCCC---CEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCc--eeeeceEecC---CeEEE
Q 037946           70 ENVIGKGCSGVVYKAEMPNG---ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNI--VKLLGYCSNK---SVKLL  140 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l  140 (371)
                      .+.++.|.++.+|+.....+   ..+++|+..... .......+.+|+++++.+. |+++  .+++.+|.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            45688999999999876543   367777753211 1122356889999999995 6665  7778887764   46789


Q ss_pred             EEeecCCCCHHH--------------------Hh---ccCC-----------CCC--HHHHHHHHH--------------
Q 037946          141 LYNYISNGNLQQ--------------------LL---QGNR-----------NLD--WETRYKIAV--------------  170 (371)
Q Consensus       141 v~e~~~~~~L~~--------------------~l---~~~~-----------~~~--~~~~~~i~~--------------  170 (371)
                      ||||++|..+.+                    .+   +.-.           +..  ..++..+..              
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998864321                    11   1100           000  111211111              


Q ss_pred             -HHHHHHHHHHhCC--------CCCeEecCCCCCCeeEcC-CCc-eEEccccCcccc
Q 037946          171 -GSAQGLAYLHHDC--------VPAILHRDVKCNNILLDS-KYE-AYLADFGLAKLM  216 (371)
Q Consensus       171 -~i~~~l~~lh~~~--------~~~i~H~dlkp~Nill~~-~~~-~kl~Dfg~~~~~  216 (371)
                       .+...+.+|..+.        .+.+||+|+++.|++++. ++. +-|.||+++..-
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence             1233456664421        135999999999999985 333 569999998753

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=5.3e-06  Score=67.07  Aligned_cols=129  Identities=22%  Similarity=0.318  Sum_probs=88.8

Q ss_pred             ccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCcee-eeceEecCCeEEEEEeecC
Q 037946           68 KDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK-LLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~  146 (371)
                      +..+.|++|.+|.||+|.+. |..+|+|+-..    +.....+..|++++..+.-.++.+ ++.+..+    ++.|||+.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            44578999999999999984 56899998643    334567889999999987666543 3333322    34599999


Q ss_pred             CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCCeeEcCCCceEEccccCccc
Q 037946          147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVK-CNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       147 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk-p~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      |..|.++....   +..++.    .++..-.-|-..   ||-|+.|. |...++-.++.+.|+||..++.
T Consensus        96 G~~L~~~~~~~---~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGG---DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhcc---cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            98888776543   333333    344443345555   89999887 5555555555899999998873

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.23  E-value=5.9e-06  Score=69.13  Aligned_cols=103  Identities=24%  Similarity=0.287  Sum_probs=83.3

Q ss_pred             HHHHHHHhccCC-CCceeeeceEecCCeEEEEEeecCCCCHHH---HhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 037946          111 AAEIQILGHIRH-RNIVKLLGYCSNKSVKLLLYNYISNGNLQQ---LLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA  186 (371)
Q Consensus       111 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~  186 (371)
                      ..|.-+++.+++ +++.+++|+|..    +++.||...+++..   .+......+|..+.+++.+++..+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888888866 699999999953    67899998766542   1223334789999999999999999999865546


Q ss_pred             eEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       187 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      +.-.|++++|+-+++++++|+.|.+.+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999998876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.23  E-value=1.1e-05  Score=70.38  Aligned_cols=73  Identities=10%  Similarity=0.143  Sum_probs=44.4

Q ss_pred             CccccCCce-EEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCC---CceeeeceEecC---CeEEEEEe
Q 037946           71 NVIGKGCSG-VVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR---NIVKLLGYCSNK---SVKLLLYN  143 (371)
Q Consensus        71 ~~ig~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e  143 (371)
                      +.|+.|+.. .||+..    ..+++|....    ......+.+|.++++.+...   .+.++++.....   ...+++|+
T Consensus         3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRLG----DDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEcC----CceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            357777766 588762    3467776422    12345788999999887532   233344333322   23588999


Q ss_pred             ecCCCCHH
Q 037946          144 YISNGNLQ  151 (371)
Q Consensus       144 ~~~~~~L~  151 (371)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.23  E-value=7.9e-06  Score=83.05  Aligned_cols=207  Identities=21%  Similarity=0.217  Sum_probs=140.8

Q ss_pred             HHHHHHHhccCCCCceeeeceEecCCeE----EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 037946          111 AAEIQILGHIRHRNIVKLLGYCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA  186 (371)
Q Consensus       111 ~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~  186 (371)
                      ..|...+....|+|++.++.|-......    .+..++|...++.+.++.-...+......+..+...|+.|+|+.   .
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~---~  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL---S  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---c
Confidence            4566677788999999998886443322    34567888889999999988899999999999999999999998   6


Q ss_pred             eEecCCCCC---CeeEcCCCceEEc--cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHH
Q 037946          187 ILHRDVKCN---NILLDSKYEAYLA--DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSY  261 (371)
Q Consensus       187 i~H~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl  261 (371)
                      ..|.=+..+   +-..+.++.+.++  ||+.+........   .....-+..|.+||.....     ....+...|+|.+
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~-----~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKEN-----TAKKSRLTDLWCL  378 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccc-----cchhhhhhHHHHH
Confidence            666655555   5555667777777  9999877655542   2223345567788765422     2334455799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHH
Q 037946          262 GVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE  341 (371)
Q Consensus       262 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  341 (371)
                      |..+..+..|..+.....                  ....+.+.   ....       .......+|+..++++|+++.+
T Consensus       379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~---~~~~-------~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA------------------VPVSLLDV---LSTS-------ELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHhhhhhcCccccccc------------------chhhhhcc---ccch-------hhhhhhhhhcchhhhhccchhh
Confidence            999999999876532110                  00000000   0000       1223445599999999999999


Q ss_pred             HHHHHhcccCCCccC
Q 037946          342 VVALLMEVKSAPEEL  356 (371)
Q Consensus       342 vl~~L~~~~~~~~~~  356 (371)
                      ++.+...-.+...+.
T Consensus       431 ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  431 LLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhchhccccccccc
Confidence            999876554444433

>PRK10593 hypothetical protein; Provisional

Probab=98.17  E-value=4.9e-05  Score=68.64  Aligned_cols=77  Identities=9%  Similarity=0.046  Sum_probs=55.4

Q ss_pred             cCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC---CCceeeeceEec---CCeEEEEE
Q 037946           69 DENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH---RNIVKLLGYCSN---KSVKLLLY  142 (371)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~  142 (371)
                      ..+.||.|..+.||.....++ .+++|.. +..   .....+..|.+.++.+.-   -.+.+++++|.+   .+..++||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~-~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMA-RSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEe-ccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            345799999999999976555 4666764 221   122568899999998843   356778877754   36689999


Q ss_pred             eecCCCCH
Q 037946          143 NYISNGNL  150 (371)
Q Consensus       143 e~~~~~~L  150 (371)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.12  E-value=0.00012  Score=61.60  Aligned_cols=131  Identities=18%  Similarity=0.284  Sum_probs=90.9

Q ss_pred             cCCccccCCceEEEEEEeCCCCEEEEEEecccC--------------CCcchHHHHHHHHHHHhccC------CCCceee
Q 037946           69 DENVIGKGCSGVVYKAEMPNGELIAVKKLWKTK--------------RDEEPVDSFAAEIQILGHIR------HRNIVKL  128 (371)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~niv~~  128 (371)
                      ....||+|+.=.||.-  ++.....||+.....              ..........+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3467999999998875  344557888885544              11122455666666555554      7899999


Q ss_pred             eceEecCCeEEEEEeecCC------CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC
Q 037946          129 LGYCSNKSVKLLLYNYISN------GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK  202 (371)
Q Consensus       129 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~  202 (371)
                      +|+...+.-.-+|+|.+.+      .||.+++.... ++. .   +...+-.-..||-+.   .|+.+|++|+||++...
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence            9999999888999997632      36888886544 555 3   333344455677777   99999999999999432


Q ss_pred             --C--ceEEcc
Q 037946          203 --Y--EAYLAD  209 (371)
Q Consensus       203 --~--~~kl~D  209 (371)
                        +  .+.|+|
T Consensus       155 ~~~~~~lvlID  165 (199)
T PF10707_consen  155 DSGEFRLVLID  165 (199)
T ss_pred             CCCceEEEEEe
Confidence              2  466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.10  E-value=5.5e-05  Score=63.23  Aligned_cols=127  Identities=25%  Similarity=0.417  Sum_probs=89.6

Q ss_pred             hccccCCccccCCc-eEEEEEEeCCCCEEEEEEecc---cC--------CC-c-------chHHHHHHHHHHHhccC---
Q 037946           65 ECLKDENVIGKGCS-GVVYKAEMPNGELIAVKKLWK---TK--------RD-E-------EPVDSFAAEIQILGHIR---  121 (371)
Q Consensus        65 ~~~~~~~~ig~G~~-g~V~~~~~~~~~~vavK~~~~---~~--------~~-~-------~~~~~~~~e~~~l~~l~---  121 (371)
                      ..++..+.||.|.- |.||+++. +|+.+|+|.+..   ..        .. +       .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            45777889999999 99999988 678999999321   00        00 0       12346788888888874   


Q ss_pred             CCCc--eeeeceEecC------------------CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 037946          122 HRNI--VKLLGYCSNK------------------SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH  181 (371)
Q Consensus       122 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~  181 (371)
                      +.++  ++++||..-.                  ....||.||.+...         .++.    .-+.+|.+-+..+|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILHK  182 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHHH
Confidence            4566  8999986211                  12357888776533         2333    334567777888999


Q ss_pred             CCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       182 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      .   +|+-+|+++.|..     .-||+|||.+
T Consensus       183 ~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 L---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             C---CeeeccCcccccc-----CCEEEecccC
Confidence            8   9999999999997     3489999875

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.10  E-value=5e-05  Score=66.21  Aligned_cols=73  Identities=16%  Similarity=0.227  Sum_probs=46.5

Q ss_pred             CccccCCceEEEEEEeCC--CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMPN--GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.|..|-...+|+....+  ++.|++|.....   ........+|+.+++.+...++ .++++.+.  +  .++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~---~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK---TELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCC---ccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence            357778888999997654  678888876321   1111223478888888854333 44444332  1  379999998


Q ss_pred             CCH
Q 037946          148 GNL  150 (371)
Q Consensus       148 ~~L  150 (371)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.96  E-value=0.00029  Score=65.80  Aligned_cols=77  Identities=18%  Similarity=0.264  Sum_probs=54.1

Q ss_pred             CccccCCceEEEEEEeCCC-CEEEEEEecccCC----C-cchHHHHHHHHHHHhccC---CCCceeeeceEecCCeEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPNG-ELIAVKKLWKTKR----D-EEPVDSFAAEIQILGHIR---HRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~-~~vavK~~~~~~~----~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.||.|.+..||++...+| +.++||.-.....    . +...++...|.+.|+.+.   -.++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999988776 4899998532111    1 224567788888888863   2356667665  44667899


Q ss_pred             EeecCCCC
Q 037946          142 YNYISNGN  149 (371)
Q Consensus       142 ~e~~~~~~  149 (371)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.93  E-value=7.7e-05  Score=65.97  Aligned_cols=135  Identities=16%  Similarity=0.088  Sum_probs=76.5

Q ss_pred             cccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEEEeecCCCCHH
Q 037946           73 IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLLYNYISNGNLQ  151 (371)
Q Consensus        73 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~~L~  151 (371)
                      +..|-.+.+|+... +++.+++|......  ........+|..+++.+...++ .+++..+.    -++||||++|..+.
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            55677889999874 56788888753221  1110134678888888854333 33333332    36899999986653


Q ss_pred             HH-----------------hccC----CCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCCeEecCCCCC
Q 037946          152 QL-----------------LQGN----RNLDWE-TRYKIAVGS---------AQGLAYLHHD-----CVPAILHRDVKCN  195 (371)
Q Consensus       152 ~~-----------------l~~~----~~~~~~-~~~~i~~~i---------~~~l~~lh~~-----~~~~i~H~dlkp~  195 (371)
                      ..                 +++.    .+++.. .+..+..++         ...+..+-..     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 1111    112211 111111111         1112222211     1236899999999


Q ss_pred             CeeEcCCCceEEccccCccc
Q 037946          196 NILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       196 Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ||+++.++ +.++||+.+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999988753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.82  E-value=0.00023  Score=64.42  Aligned_cols=139  Identities=17%  Similarity=0.203  Sum_probs=82.2

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--ceeeece------EecCCeEEEE
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKLLGY------CSNKSVKLLL  141 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv  141 (371)
                      .+.|..|....+|+.... +..+++|+...     .....+..|++++..+.+.+  +.+++..      ....+..++|
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            345777888899998764 45688887632     12345667888877774332  3344331      1234566899


Q ss_pred             EeecCCCCHHH----H-------h---c----cCC-------CCCHHHHH----------HHHHHHHHHHHHHHh----C
Q 037946          142 YNYISNGNLQQ----L-------L---Q----GNR-------NLDWETRY----------KIAVGSAQGLAYLHH----D  182 (371)
Q Consensus       142 ~e~~~~~~L~~----~-------l---~----~~~-------~~~~~~~~----------~i~~~i~~~l~~lh~----~  182 (371)
                      +++++|..+..    .       +   +    ...       ...+....          .....+..++.++..    .
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99999876422    0       0   0    000       01111100          011123334444443    1


Q ss_pred             CCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       183 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      ...++||+|+.|.|+++++++.+.|.||+.+.
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            22379999999999999998777899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.78  E-value=0.00024  Score=64.47  Aligned_cols=136  Identities=22%  Similarity=0.296  Sum_probs=79.4

Q ss_pred             ccccCCceEEEEEEeCC-------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEEEe
Q 037946           72 VIGKGCSGVVYKAEMPN-------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  143 (371)
                      .+..|-...+|+....+       ++.+++|......   .......+|.+++..+...++ .++++.+..    .+|+|
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e   77 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE   77 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence            45566677899987654       5788999864322   222345778888888753333 345554432    35899


Q ss_pred             ecCCCCHHHHh-----------------ccC--C-------CCC--HHHHHH--------------------------HH
Q 037946          144 YISNGNLQQLL-----------------QGN--R-------NLD--WETRYK--------------------------IA  169 (371)
Q Consensus       144 ~~~~~~L~~~l-----------------~~~--~-------~~~--~~~~~~--------------------------i~  169 (371)
                      |++|.++....                 ++.  .       ..+  +.....                          ..
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            99887664310                 110  0       000  001101                          11


Q ss_pred             HHHHHHHHHHHh------CCCCCeEecCCCCCCeeEcCC----CceEEccccCcc
Q 037946          170 VGSAQGLAYLHH------DCVPAILHRDVKCNNILLDSK----YEAYLADFGLAK  214 (371)
Q Consensus       170 ~~i~~~l~~lh~------~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~  214 (371)
                      ..+...+.++..      .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122223334432      133479999999999999985    889999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.67  E-value=0.0023  Score=58.57  Aligned_cols=138  Identities=14%  Similarity=0.225  Sum_probs=74.3

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--ceeeec------eEecCCeEEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKLLG------YCSNKSVKLLLY  142 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~------~~~~~~~~~lv~  142 (371)
                      +.|+.|....+|+....+| .+++|+..  ....   ..+..|...+..|...+  +.+++.      +....+..++++
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            4566777789999876554 68888763  1122   23334555555552211  222221      122345678999


Q ss_pred             eecCCCCHH-----------HHh---c----cC-------CCCCH-HHHHH------------HH-HHHHHHHHHHHhC-
Q 037946          143 NYISNGNLQ-----------QLL---Q----GN-------RNLDW-ETRYK------------IA-VGSAQGLAYLHHD-  182 (371)
Q Consensus       143 e~~~~~~L~-----------~~l---~----~~-------~~~~~-~~~~~------------i~-~~i~~~l~~lh~~-  182 (371)
                      +|++|..+.           ..+   +    ..       ..+.+ .....            .. ..+...+..+... 
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            999886431           111   1    00       00111 11111            11 1111122333211 


Q ss_pred             ---CCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          183 ---CVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       183 ---~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                         -..++||+|+.|.||+++.+...-++||+.+.
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence               23489999999999999976656899998875

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.64  E-value=0.00086  Score=60.48  Aligned_cols=136  Identities=17%  Similarity=0.246  Sum_probs=81.8

Q ss_pred             CCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC--CCceeeeceEecCC--eEEEEEeecCCCCHH
Q 037946           76 GCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH--RNIVKLLGYCSNKS--VKLLLYNYISNGNLQ  151 (371)
Q Consensus        76 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~~~L~  151 (371)
                      |-.-.+|..... ++.+++. ...............+|+.+++.+.-  --+...++.|.++.  ..|.||+|++|..+.
T Consensus        36 G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~  113 (321)
T COG3173          36 GWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW  113 (321)
T ss_pred             CcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence            333345555443 7778887 32112233445667788888888743  23345577776665  779999999884332


Q ss_pred             HHhccCCCCCHHHHHHHH-HHHHHHHHHHH--------------------------------------------------
Q 037946          152 QLLQGNRNLDWETRYKIA-VGSAQGLAYLH--------------------------------------------------  180 (371)
Q Consensus       152 ~~l~~~~~~~~~~~~~i~-~~i~~~l~~lh--------------------------------------------------  180 (371)
                      +.+..... .    -.++ ..++..|+-||                                                  
T Consensus       114 ~~~~~~~~-~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~  188 (321)
T COG3173         114 SALPPESL-G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE  188 (321)
T ss_pred             CcCCcccc-h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence            22211100 0    0111 23333333333                                                  


Q ss_pred             hC-----CCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          181 HD-----CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       181 ~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ..     ..+.++|+|+.+.|++++.+.-+-+.||+++..-++
T Consensus       189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            22     224799999999999999988899999999975443

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.62  E-value=0.0015  Score=59.43  Aligned_cols=140  Identities=17%  Similarity=0.226  Sum_probs=79.4

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--ceeeece------EecCCeEEEE
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKLLGY------CSNKSVKLLL  141 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv  141 (371)
                      .+.++.|....+|+....++ .+++|......    ....+..|.+++..|...+  +.+++..      ....+..+++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            34567777789999876444 57788763311    1234556677776663222  3333332      1224567899


Q ss_pred             EeecCCCCHH-----H------Hh---cc-CCC----------C-CHHHHH------------HHHHHHHHHHHHHHh--
Q 037946          142 YNYISNGNLQ-----Q------LL---QG-NRN----------L-DWETRY------------KIAVGSAQGLAYLHH--  181 (371)
Q Consensus       142 ~e~~~~~~L~-----~------~l---~~-~~~----------~-~~~~~~------------~i~~~i~~~l~~lh~--  181 (371)
                      ++|++|..+.     +      .+   +. ...          . .|....            .....+...++++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            9999885431     1      11   10 000          0 011000            011123334555532  


Q ss_pred             --CCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          182 --DCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       182 --~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                        ....++||+|+.+.|++++.++.+.++||+.+.
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              123489999999999999988877899998874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.43  E-value=0.0024  Score=57.05  Aligned_cols=31  Identities=29%  Similarity=0.446  Sum_probs=25.9

Q ss_pred             CCeEecCCCCCCeeEcCCCc-eEEccccCccc
Q 037946          185 PAILHRDVKCNNILLDSKYE-AYLADFGLAKL  215 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~  215 (371)
                      +.++|+|++|.||+++.++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            36899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.36  E-value=0.0039  Score=58.19  Aligned_cols=82  Identities=15%  Similarity=0.137  Sum_probs=53.1

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCC--C---cchHHHHHHHHHHHhccC---CCCceeeeceEecCCeEEEE
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKR--D---EEPVDSFAAEIQILGHIR---HRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  141 (371)
                      .+.||.|....||+.... +..++||+-.....  +   +....+-..|.+.|+.+.   -.++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            356899999999999864 56799997642111  1   123445556677776663   246777888776  445788


Q ss_pred             EeecCC--CCHHHHh
Q 037946          142 YNYISN--GNLQQLL  154 (371)
Q Consensus       142 ~e~~~~--~~L~~~l  154 (371)
                      ||++++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3444433

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.32  E-value=0.0034  Score=57.54  Aligned_cols=74  Identities=14%  Similarity=0.133  Sum_probs=49.2

Q ss_pred             ccccCCceEEEEEEeCCC-CEEEEEEecccC-----CCcchHHHHHHHHHHHhccC--CCC-ceeeeceEecCCeEEEEE
Q 037946           72 VIGKGCSGVVYKAEMPNG-ELIAVKKLWKTK-----RDEEPVDSFAAEIQILGHIR--HRN-IVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~-~~vavK~~~~~~-----~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~  142 (371)
                      .||.|...-||++..++| +.++||.-....     .-+-...+...|.+.|+...  -|. +.+++  +.+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            479999999999987654 589999753211     11334566678888887763  343 44444  34556667999


Q ss_pred             eecCC
Q 037946          143 NYISN  147 (371)
Q Consensus       143 e~~~~  147 (371)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.30  E-value=0.0018  Score=58.72  Aligned_cols=142  Identities=16%  Similarity=0.190  Sum_probs=91.0

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCC---C-------------------cc-hHHH-HHHHHHHHhccCCCCc
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKR---D-------------------EE-PVDS-FAAEIQILGHIRHRNI  125 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-------------------~~-~~~~-~~~e~~~l~~l~h~ni  125 (371)
                      ...|..|--+.||.+...+|..+|||+.+-+-.   +                   +. ...- ...|++-|++++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            345778888899999988999999998743210   0                   00 0111 1356777777765543


Q ss_pred             eeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCce
Q 037946          126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEA  205 (371)
Q Consensus       126 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~  205 (371)
                      . +-....- ....+||+|+....-..-.-..-.++...+..+-.+++.-|.-|-..|  ++||.||+--|+|+- +|.+
T Consensus       229 P-~PePIlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~l  303 (520)
T KOG2270|consen  229 P-CPEPILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKL  303 (520)
T ss_pred             C-CCCceee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEE
Confidence            2 1111111 123689999854221111112233666677778888888888887766  899999999999985 5679


Q ss_pred             EEccccCcccc
Q 037946          206 YLADFGLAKLM  216 (371)
Q Consensus       206 kl~Dfg~~~~~  216 (371)
                      .++|-+-+...
T Consensus       304 yiIDVSQSVE~  314 (520)
T KOG2270|consen  304 YIIDVSQSVEH  314 (520)
T ss_pred             EEEEccccccC
Confidence            99998877543

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.29  E-value=0.0033  Score=57.26  Aligned_cols=30  Identities=20%  Similarity=0.429  Sum_probs=27.6

Q ss_pred             CCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          185 PAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      .++||+|+.++|++++.++.+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            489999999999999999999999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.24  E-value=0.00039  Score=61.88  Aligned_cols=137  Identities=14%  Similarity=0.120  Sum_probs=92.5

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccC----------------CCcc----hHHHHHHHHHHHhccCC--CC
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTK----------------RDEE----PVDSFAAEIQILGHIRH--RN  124 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~----~~~~~~~e~~~l~~l~h--~n  124 (371)
                      +.+++.||-|.-+.+|.+-+..|+..++|.-....                ....    ..-...+|+..|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            45688999999999999998889999988421100                0000    11234578888888743  23


Q ss_pred             ceeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       125 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      +.+.+    +.+..++|||++.+-.|...-+-   .+.   -.+...+..-+.-|-.+   |+||+|+.-=||++++++.
T Consensus       174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d~---~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  174 VPKPI----DHNRHCVVMELVDGYPLRQVRHV---EDP---PTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCcc----cccceeeHHHhhcccceeeeeec---CCh---HHHHHHHHHHHHHHHHc---CceecccchheeEEecCCC
Confidence            33333    44567899999988666543221   122   23334444555566677   9999999999999999999


Q ss_pred             eEEccccCcccc
Q 037946          205 AYLADFGLAKLM  216 (371)
Q Consensus       205 ~kl~Dfg~~~~~  216 (371)
                      ++++||--+...
T Consensus       241 i~vIDFPQmvS~  252 (465)
T KOG2268|consen  241 IVVIDFPQMVST  252 (465)
T ss_pred             EEEeechHhhcc
Confidence            999999776443

>PLN02236 choline kinase

Probab=97.21  E-value=0.0039  Score=57.63  Aligned_cols=136  Identities=18%  Similarity=0.250  Sum_probs=77.8

Q ss_pred             ccccCCceEEEEEEeCC-----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEEEeec
Q 037946           72 VIGKGCSGVVYKAEMPN-----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  145 (371)
                      .+-.|-...+|+....+     ++.+++|......  . ..-.-.+|..+++.+..-++ .++++.+..+    .|.+|+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            45557777899986532     3678888764321  2 22223678888888854444 3455555332    478998


Q ss_pred             CCCCHHHH-----------------hccCC------CCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 037946          146 SNGNLQQL-----------------LQGNR------NLDWETRYKIAVGS-----------------AQGLAYL----HH  181 (371)
Q Consensus       146 ~~~~L~~~-----------------l~~~~------~~~~~~~~~i~~~i-----------------~~~l~~l----h~  181 (371)
                      ++.++...                 +++..      ...+..+.++..++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665321                 01111      01122222332111                 1112222    21


Q ss_pred             -CCCCCeEecCCCCCCeeEcC-CCceEEccccCcc
Q 037946          182 -DCVPAILHRDVKCNNILLDS-KYEAYLADFGLAK  214 (371)
Q Consensus       182 -~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~  214 (371)
                       .....++|+|+++.||++++ ++.+.++||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             12237899999999999986 4789999998875

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.12  E-value=0.0028  Score=59.95  Aligned_cols=50  Identities=16%  Similarity=0.319  Sum_probs=39.0

Q ss_pred             HHHHHHHHHHhccCCCCceeeeceEecC-CeEEEEEeecCCCCHHHHhccCC
Q 037946          108 DSFAAEIQILGHIRHRNIVKLLGYCSNK-SVKLLLYNYISNGNLQQLLQGNR  158 (371)
Q Consensus       108 ~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~  158 (371)
                      ..++-..++++.+.|+|....+.+-... ....+|||++. .+|.+.+....
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~   77 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN   77 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc
Confidence            4567788899999999999888776433 45678999984 49999887654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.99  E-value=0.011  Score=53.88  Aligned_cols=29  Identities=34%  Similarity=0.584  Sum_probs=25.3

Q ss_pred             CCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          185 PAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      .+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999987 668899998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.90  E-value=0.00013  Score=76.43  Aligned_cols=160  Identities=14%  Similarity=0.072  Sum_probs=109.8

Q ss_pred             HHHHHHHHHHHhccCCCCceeeeceEe--cCCeEEEEEeecCCCCHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH
Q 037946          107 VDSFAAEIQILGHIRHRNIVKLLGYCS--NKSVKLLLYNYISNGNLQQLLQGN----RNLDWETRYKIAVGSAQGLAYLH  180 (371)
Q Consensus       107 ~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh  180 (371)
                      .+....|..-.+...|+++...+.-..  .....|..++++.+|.+.+.+-++    ..++..-+...-.+......-+|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            344555666666678888766544332  234558899999999999988432    23343333333334355555555


Q ss_pred             hCCC--CCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchh
Q 037946          181 HDCV--PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDV  258 (371)
Q Consensus       181 ~~~~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di  258 (371)
                      +...  .-.+|+++|+-|.+|..+-++|++++|+.+.....  ....+...+++.|+.|++..       ...++.++|+
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N-------~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKN-------EIKFTKRSDI 1423 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHH-------HHhhhhHHHH
Confidence            5421  24689999999999999999999999999833222  12335566888999998654       3356777999


Q ss_pred             HHHHHHHHHHHhCCCCC
Q 037946          259 YSYGVVLLEILSGRSAV  275 (371)
Q Consensus       259 wslG~~l~el~~g~~p~  275 (371)
                      |..|+.+|++.-|..++
T Consensus      1424 lr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHHhcccHHH
Confidence            99999999998887665

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.90  E-value=0.0068  Score=56.33  Aligned_cols=75  Identities=15%  Similarity=0.130  Sum_probs=51.1

Q ss_pred             CccccCCceEEEEEEeCC-CCEEEEEEecccC----CCcchHHHHHHHHHHHhccC--CCC-ceeeeceEecCCeEEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPN-GELIAVKKLWKTK----RDEEPVDSFAAEIQILGHIR--HRN-IVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~  142 (371)
                      +.||.|.-.-||++...+ ++.++||.-....    .-+-..++..-|.+.|+...  .|. +.+++  +.+.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHHH
Confidence            468999999999998743 5689999653211    12345677788888888773  343 44454  34556667899


Q ss_pred             eecCC
Q 037946          143 NYISN  147 (371)
Q Consensus       143 e~~~~  147 (371)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            98854

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.87  E-value=0.011  Score=54.45  Aligned_cols=137  Identities=16%  Similarity=0.255  Sum_probs=75.6

Q ss_pred             ccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEEEeecC
Q 037946           72 VIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  146 (371)
                      .|..|=...+|+....+    +..|++|......   ...-.-.+|..+++.+..-++ .++++++. ++   +|.+|++
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~   93 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN   93 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence            34456667788886432    2378888764321   122233678888888865444 34555553 22   4888887


Q ss_pred             CCCHHHH-------h----------ccCC-----CC-CHHHHHHHHHHH----------------------HHHHHH---
Q 037946          147 NGNLQQL-------L----------QGNR-----NL-DWETRYKIAVGS----------------------AQGLAY---  178 (371)
Q Consensus       147 ~~~L~~~-------l----------~~~~-----~~-~~~~~~~i~~~i----------------------~~~l~~---  178 (371)
                      +.+|..-       +          ++..     .. -+..+..+..++                      ..-+..   
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            7655220       1          1111     01 122222222221                      111111   


Q ss_pred             -HHhC-CCCCeEecCCCCCCeeEcC-CCceEEccccCccc
Q 037946          179 -LHHD-CVPAILHRDVKCNNILLDS-KYEAYLADFGLAKL  215 (371)
Q Consensus       179 -lh~~-~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~  215 (371)
                       +.+. ...-++|.|+.+.||++++ ++.++++||..|..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence             1111 1124899999999999974 57899999998853

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.77  E-value=0.0076  Score=55.57  Aligned_cols=58  Identities=17%  Similarity=0.192  Sum_probs=41.9

Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeeEc
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAILHRDVKCNNILLD  200 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dlkp~Nill~  200 (371)
                      .++-+|..|-++..+++... .++....+++.-.+.|+--+- -.   +++|.|+.|.||++.
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEE
Confidence            45666778888888887544 455666777777777755432 23   899999999999994

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.73  E-value=0.0066  Score=51.89  Aligned_cols=30  Identities=33%  Similarity=0.455  Sum_probs=21.7

Q ss_pred             CeEecCCCCCCeeE-cCCCceEEccccCccc
Q 037946          186 AILHRDVKCNNILL-DSKYEAYLADFGLAKL  215 (371)
Q Consensus       186 ~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~  215 (371)
                      .++|+|+.|.||++ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            68999999999999 8899999999988853

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.61  E-value=0.016  Score=49.38  Aligned_cols=75  Identities=17%  Similarity=0.266  Sum_probs=52.3

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC---CCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH---RNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.+..|.--..|...+ ...++.||+-     .......|..|+.-|..+.-   -++.+++.+-.+.++.|+||||++.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            3455555555666654 4578888974     23445677888887777744   4566777788888999999999987


Q ss_pred             CCHH
Q 037946          148 GNLQ  151 (371)
Q Consensus       148 ~~L~  151 (371)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            6654

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.45  E-value=0.014  Score=52.37  Aligned_cols=73  Identities=19%  Similarity=0.259  Sum_probs=46.6

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC---CCCceeeeceEecCCeEEEEEeecC
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR---HRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      .+.++.|....+|+.. .+++.+.||.-.     ......|..|.+-|+.|.   --.+.+++++....+..++||||++
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            4568889999999988 477899999863     222345778888888873   3346678888777777899999998


Q ss_pred             CC
Q 037946          147 NG  148 (371)
Q Consensus       147 ~~  148 (371)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.30  E-value=0.16  Score=46.58  Aligned_cols=70  Identities=11%  Similarity=0.137  Sum_probs=42.5

Q ss_pred             CceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--cee---eec--eEecCCeEEEEEeecCCCC
Q 037946           77 CSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVK---LLG--YCSNKSVKLLLYNYISNGN  149 (371)
Q Consensus        77 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~---~~~--~~~~~~~~~lv~e~~~~~~  149 (371)
                      .-..||+....++..+++|......   .....+..|.+.+..|....  ++.   .-|  ....++..+.++++++|..
T Consensus        37 ~eN~vy~v~~~~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDEDGRRVVAKFYRPER---WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecCCCCEEEEEEcCccc---CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            4457999987778889999863222   23455667777777663211  222   112  1233456788999988764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.24  E-value=0.019  Score=52.23  Aligned_cols=76  Identities=21%  Similarity=0.197  Sum_probs=58.7

Q ss_pred             CCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      ....|++|++. |+.+.    ......+++...++.+.+..++-+..+.  ..=|||+.-.||+|+ +|++.|+||-+++
T Consensus       298 ~~y~yl~~kdh-gt~is----~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS----IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             ceEEEEEEecC-Cceee----eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence            34556778875 33432    2233567888999999888888888773  789999999999999 9999999999998


Q ss_pred             ccCC
Q 037946          215 LMNS  218 (371)
Q Consensus       215 ~~~~  218 (371)
                      .-.+
T Consensus       370 l~~~  373 (488)
T COG5072         370 LSYS  373 (488)
T ss_pred             cccC
Confidence            5433

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.17  E-value=0.033  Score=47.23  Aligned_cols=118  Identities=14%  Similarity=0.077  Sum_probs=71.5

Q ss_pred             CCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCCCHHHHhc
Q 037946           76 GCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQ  155 (371)
Q Consensus        76 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  155 (371)
                      |+.++.-++...-| +..+|++....- .-...-|..+.+++++++  .|+++..-  +...+-++.|+|.....     
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~-~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPC-CINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCc-ccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence            44455555533223 345565522111 112345678899988874  56776632  33445688999854111     


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          156 GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       156 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                          ..    ..++.-=..+|.-.|+.. ++.+|+|-.|+||+=|+.|.+||.|=+..
T Consensus       142 ----~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 ----NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ----ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence                00    112222245677788643 48999999999999999999999997653

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=96.15  E-value=0.068  Score=50.05  Aligned_cols=74  Identities=16%  Similarity=0.326  Sum_probs=43.7

Q ss_pred             CccccCCceEEEEEEeCCC--CE-----EEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPNG--EL-----IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  142 (371)
                      +.|..|-...+|++...++  ..     |.++..   .......-.-.+|+++++.+...++ .++++.+..    +++.
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~---g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS---STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEec---cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            3455677889999965432  22     333332   1111222233678999999865555 445555532    5899


Q ss_pred             eecCCCCHH
Q 037946          143 NYISNGNLQ  151 (371)
Q Consensus       143 e~~~~~~L~  151 (371)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999987664

>PRK06148 hypothetical protein; Provisional

Probab=96.14  E-value=0.28  Score=52.12  Aligned_cols=30  Identities=37%  Similarity=0.515  Sum_probs=25.7

Q ss_pred             CCeEecCCCCCCeeEcCCC--ceE-EccccCcc
Q 037946          185 PAILHRDVKCNNILLDSKY--EAY-LADFGLAK  214 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~--~~k-l~Dfg~~~  214 (371)
                      .++||+|+.+.||+++.++  .+. |+|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            3799999999999999875  555 99999885

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=96.12  E-value=0.0049  Score=47.40  Aligned_cols=58  Identities=22%  Similarity=0.335  Sum_probs=43.0

Q ss_pred             cccHHHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc
Q 037946           57 NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI  120 (371)
Q Consensus        57 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l  120 (371)
                      +-+++++.+.|. .+.||.|+.|.||+|+.++|+.||||+.+..     ..+.+...+.+++.+
T Consensus         4 G~~~~~~F~~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~-----i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen    4 GKPIDEIFDEFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPG-----IEEQIEADLRILRRL   61 (119)
T ss_pred             CCCHHHHHHHCC-cchhhheehhhheeeeecccchhhhhhcchH-----HHHHHHHHHHHHHHH
Confidence            446677777776 4789999999999999989999999997432     234455556555543

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	371
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-49
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-31
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-31
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-27
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-04
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-04
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-04
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-04
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-04
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-04
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-04
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-04
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-04
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-04
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 112/302 (37%), Positives = 176/302 (58%), Gaps = 25/302 (8%)
Query: 53  FQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAA 112
            ++L    DN      ++N++G+G  G VYK  + +G L+AVK+L K +R +     F  
Sbjct: 30  LRELQVASDN----FSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERXQGGELQFQT 84
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX----DWETRYKI 168
           E++++    HRN+++L G+C   + +LL+Y Y++                  DW  R +I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A+GSA+GLAYLH  C P I+HRDVK  NILLD ++EA + DFGLAKLM+  + H   + V
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 203
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA---VQPQIGDGLHI 285
            G+ G+IAP        Y  T   +EK+DV+ YGV+LLE+++G+ A    +    D + +
Sbjct: 204 RGTIGHIAPE-------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 286 VEWVKKKMGSFEPAVSILDTKLQG-LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
           ++WVK  +   +   +++D  LQG   D+ V++++Q   +A+ C  SSP ERP M EVV 
Sbjct: 257 LDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQ---VALLCTQSSPMERPKMSEVVR 312
Query: 345 LL 346
           +L
Sbjct: 313 ML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  190 bits (483), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 112/302 (37%), Positives = 175/302 (57%), Gaps = 25/302 (8%)
Query: 53  FQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAA 112
            ++L    DN      ++N++G+G  G VYK  + +G L+AVK+L K +R +     F  
Sbjct: 22  LRELQVASDN----FXNKNILGRGGFGKVYKGRLADGXLVAVKRL-KEERTQGGELQFQT 76
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX----DWETRYKI 168
           E++++    HRN+++L G+C   + +LL+Y Y++                  DW  R +I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A+GSA+GLAYLH  C P I+HRDVK  NILLD ++EA + DFGLAKLM+  + H   + V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 195
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA---VQPQIGDGLHI 285
            G  G+IAP        Y  T   +EK+DV+ YGV+LLE+++G+ A    +    D + +
Sbjct: 196 RGXIGHIAPE-------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 286 VEWVKKKMGSFEPAVSILDTKLQG-LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
           ++WVK  +   +   +++D  LQG   D+ V++++Q   +A+ C  SSP ERP M EVV 
Sbjct: 249 LDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQ---VALLCTQSSPMERPKMSEVVR 304
Query: 345 LL 346
           +L
Sbjct: 305 ML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 98/305 (32%), Positives = 152/305 (49%), Gaps = 29/305 (9%)
Query: 50  FIPFQKLNFTIDNILECLKDEN---VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEP 106
            +PF+     + ++ E   + +   +IG G  G VYK  + +G  +A+K+  +T    + 
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQG 78
Query: 107 VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXX----XXXXXXXXDW 162
           ++ F  EI+ L   RH ++V L+G+C  ++  +L+Y Y+                    W
Sbjct: 79  IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
           E R +I +G+A+GL YLH     AI+HRDVK  NILLD  +   + DFG++K     +  
Sbjct: 139 EQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA-VQPQIGD 281
           H    V G+ GYI P        Y     +TEKSDVYS+GVVL E+L  RSA VQ    +
Sbjct: 196 HLXXVVKGTLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 282 GLHIVEWV--KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLG-IAMFCVNSSPAERPT 338
            +++ EW       G  E  V         L D++  E L+  G  A+ C+  S  +RP+
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVD------PNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 339 MKEVV 343
           M +V+
Sbjct: 303 MGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 98/305 (32%), Positives = 151/305 (49%), Gaps = 29/305 (9%)
Query: 50  FIPFQKLNFTIDNILECLKDEN---VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEP 106
            +PF+     + ++ E   + +   +IG G  G VYK  + +G  +A+K+  +T    + 
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQG 78
Query: 107 VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXX----XXXXXXXXDW 162
           ++ F  EI+ L   RH ++V L+G+C  ++  +L+Y Y+                    W
Sbjct: 79  IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
           E R +I +G+A+GL YLH     AI+HRDVK  NILLD  +   + DFG++K        
Sbjct: 139 EQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQT 195
Query: 223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA-VQPQIGD 281
           H    V G+ GYI P        Y     +TEKSDVYS+GVVL E+L  RSA VQ    +
Sbjct: 196 HLXXVVKGTLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 282 GLHIVEWV--KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLG-IAMFCVNSSPAERPT 338
            +++ EW       G  E  V         L D++  E L+  G  A+ C+  S  +RP+
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVD------PNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 339 MKEVV 343
           M +V+
Sbjct: 303 MGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 93/291 (31%), Positives = 146/291 (50%), Gaps = 29/291 (9%)
Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           N +G+G  GVVYK  + N   +AVKKL        EE    F  EI+++   +H N+V+L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 129 LGYCSNKSVKLLLYNYI---SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           LG+ S+     L+Y Y+   S               W  R KIA G+A G+ +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 152
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRD+K  NILLD  + A ++DFGLA+           SR+ G+  Y+AP   + +  
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE-- 210
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAV----QPQIGDGLHIVEWVKKKMGSFEPAVS 301
                 IT KSD+YS+GVVLLEI++G  AV    +PQ+     +++  ++     +    
Sbjct: 211 ------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-----LLDIKEEIEDEEKTIED 259
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +D K+       V+ M     +A  C++    +RP +K+V  LL E+ ++
Sbjct: 260 YIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 145/291 (49%), Gaps = 29/291 (9%)
Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           N +G+G  GVVYK  + N   +AVKKL        EE    F  EI+++   +H N+V+L
Sbjct: 31  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 129 LGYCSNKSVKLLLYNYI---SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           LG+ S+     L+Y Y+   S               W  R KIA G+A G+ +LH +   
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 146
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRD+K  NILLD  + A ++DFGLA+            R+ G+  Y+AP   + +  
Sbjct: 147 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE-- 204
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAV----QPQIGDGLHIVEWVKKKMGSFEPAVS 301
                 IT KSD+YS+GVVLLEI++G  AV    +PQ+     +++  ++     +    
Sbjct: 205 ------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-----LLDIKEEIEDEEKTIED 253
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +D K+       V+ M     +A  C++    +RP +K+V  LL E+ ++
Sbjct: 254 YIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 145/291 (49%), Gaps = 29/291 (9%)
Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           N +G+G  GVVYK  + N   +AVKKL        EE    F  EI+++   +H N+V+L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 129 LGYCSNKSVKLLLYNYI---SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           LG+ S+     L+Y Y+   S               W  R KIA G+A G+ +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 152
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRD+K  NILLD  + A ++DFGLA+            R+ G+  Y+AP   + +  
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE-- 210
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAV----QPQIGDGLHIVEWVKKKMGSFEPAVS 301
                 IT KSD+YS+GVVLLEI++G  AV    +PQ+     +++  ++     +    
Sbjct: 211 ------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-----LLDIKEEIEDEEKTIED 259
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +D K+       V+ M     +A  C++    +RP +K+V  LL E+ ++
Sbjct: 260 YIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 139/291 (47%), Gaps = 29/291 (9%)
Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           N  G+G  GVVYK  + N   +AVKKL        EE    F  EI++    +H N+V+L
Sbjct: 28  NKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 129 LGYCSNKSVKLLLYNYI---SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           LG+ S+     L+Y Y    S               W  R KIA G+A G+ +LH +   
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHEN--- 143
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRD+K  NILLD  + A ++DFGLA+           SR+ G+  Y AP   + +  
Sbjct: 144 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE-- 201
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAV----QPQIGDGLHIVEWVKKKMGSFEPAVS 301
                 IT KSD+YS+GVVLLEI++G  AV    +PQ+     +++  ++     +    
Sbjct: 202 ------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-----LLDIKEEIEDEEKTIED 250
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +D K        V+       +A  C++    +RP +K+V  LL E  ++
Sbjct: 251 YIDKKXNDADSTSVE---AXYSVASQCLHEKKNKRPDIKKVQQLLQEXTAS 298

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 142/291 (48%), Gaps = 50/291 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 20  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +A+G+ Y
Sbjct: 78  TKPQLAIVTQWCEGSSLYHHLHAS--------------ETKFEMKKLIDIARQTARGMDY 123
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP 
Sbjct: 124 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 180
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+E V +  GS  P
Sbjct: 181 VIRMQDSNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGR--GSLSP 233
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
            +S + +     P +M + M +       C+     ERP+   ++A + E+
Sbjct: 234 DLSKVRSN---CPKRMKRLMAE-------CLKKKRDERPSFPRILAEIEEL 274

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 141/291 (48%), Gaps = 50/291 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +A+G+ Y
Sbjct: 90  TKPQLAIVTQWCEGSSLYHHLHAS--------------ETKFEMKKLIDIARQTARGMDY 135
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA   +  +  H   +++GS  ++AP 
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+E V +  GS  P
Sbjct: 193 VIRMQDSNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGR--GSLSP 245
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
            +S + +     P +M + M +       C+     ERP+   ++A + E+
Sbjct: 246 DLSKVRSN---CPKRMKRLMAE-------CLKKKRDERPSFPRILAEIEEL 286

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 141/291 (48%), Gaps = 50/291 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +A+G+ Y
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHLHAS--------------ETKFEMKKLIDIARQTARGMDY 135
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA   +  +  H   +++GS  ++AP 
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+E V +  GS  P
Sbjct: 193 VIRMQDSNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGR--GSLSP 245
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
            +S + +     P +M + M +       C+     ERP+   ++A + E+
Sbjct: 246 DLSKVRSN---CPKRMKRLMAE-------CLKKKRDERPSFPRILAEIEEL 286

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G V++AE  +G  +AVK L +     E V+ F  E+ I+  +RH NIV  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 133 SNKSVKLLLYNYISXXXXXX---XXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           +      ++  Y+S                 D   R  +A   A+G+ YLH+   P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVH 162
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           R++K  N+L+D KY   + DFGL++L  ST    +    AG+  ++AP     +++    
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAP-----EVLRDEP 215
Query: 250 MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
            N  EKSDVYS+GV+L E+ +                  +++  G+  PA  +     + 
Sbjct: 216 SN--EKSDVYSFGVILWELAT------------------LQQPWGNLNPAQVVAAVGFKC 255
Query: 310 LPDQMVQEM-LQTLGIAMFCVNSSPAERPTMKEVVALLME-VKSA 352
              ++ + +  Q   I   C  + P +RP+   ++ LL   +KSA
Sbjct: 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G V++AE  +G  +AVK L +     E V+ F  E+ I+  +RH NIV  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 133 SNKSVKLLLYNYISXXXXXX---XXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           +      ++  Y+S                 D   R  +A   A+G+ YLH+   P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVH 162
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+K  N+L+D KY   + DFGL++L  S       +  AG+  ++AP     +++    
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA--AGTPEWMAP-----EVLRDEP 215
Query: 250 MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
            N  EKSDVYS+GV+L E+ +                  +++  G+  PA  +     + 
Sbjct: 216 SN--EKSDVYSFGVILWELAT------------------LQQPWGNLNPAQVVAAVGFKC 255
Query: 310 LPDQMVQEM-LQTLGIAMFCVNSSPAERPTMKEVVALLME-VKSA 352
              ++ + +  Q   I   C  + P +RP+   ++ LL   +KSA
Sbjct: 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 18  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 76  TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 121
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP 
Sbjct: 122 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 179 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 231
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 232 DLSKVRS---NCPKAMKRLMAE-------CLKKKRDERPLFPQILA 267

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 16  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 119
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP 
Sbjct: 120 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 177 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 229
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 230 DLSKVRSN---CPKAMKRLMAE-------CLKKKRDERPLFPQILA 265

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 21  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 124
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP 
Sbjct: 125 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 182 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 234
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 235 DLSKVRSN---CPKAMKRLMAE-------CLKKKRDERPLFPQILA 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 21  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 124
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP 
Sbjct: 125 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 182 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 234
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 235 DLSKVRSN---CPKAMKRLMAE-------CLKKKRDERPLFPQILA 270

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 43  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 101 TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 146
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP 
Sbjct: 147 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 203
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 204 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 256
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 257 DLSKVRS---NCPKAMKRLMAE-------CLKKKRDERPLFPQILA 292

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 44  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 102 TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 147
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP 
Sbjct: 148 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 204
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 205 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 257
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 258 DLSKVRSN---CPKAMKRLMAE-------CLKKKRDERPLFPQILA 293

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 16  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 74  TAPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 119
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP 
Sbjct: 120 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 177 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 229
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 230 DLSKVRSN---CPKAMKRLMAE-------CLKKKRDERPLFPQILA 265

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 16  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 119
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA   +  +  H   +++GS  ++AP 
Sbjct: 120 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 176
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 177 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 229
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 230 DLSKVRS---NCPKAMKRLMAE-------CLKKKRDERPLFPQILA 265

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 36  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 94  TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 139
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA   +  +  H   +++GS  ++AP 
Sbjct: 140 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 196
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 197 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 249
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 250 DLSKVRS---NCPKAMKRLMAE-------CLKKKRDERPLFPQILA 285

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 50/286 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G VYK +  +G+ +AVK L  T    + + +F  E+ +L   RH NI+  +GY 
Sbjct: 44  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 133 SNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYK------IAVGSAQGLAY 178
           +   + ++        LY+++                 ET+++      IA  +AQG+ Y
Sbjct: 102 TKPQLAIVTQWCEGSSLYHHLHII--------------ETKFEMIKLIDIARQTAQGMDY 147
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH     +I+HRD+K NNI L       + DFGLA   +  +  H   +++GS  ++AP 
Sbjct: 148 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 204
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
             ++Q    Y+     +SDVY++G+VL E+++G+      I +   I+  V +  G   P
Sbjct: 205 VIRMQDKNPYSF----QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR--GYLSP 257
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
            +S + +     P  M + M +       C+     ERP   +++A
Sbjct: 258 DLSKVRS---NCPKAMKRLMAE-------CLKKKRDERPLFPQILA 293

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 47/285 (16%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           E V+G+G  GVV KA+    + +A+K++      E    +F  E++ L  + H NIVKL 
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLY 68
Query: 130 GYCSNKSVKLL-------LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
           G C N    ++       LYN +                W       +  +QG+AYLH  
Sbjct: 69  GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSM 122
Query: 183 CVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
              A++HRD+K  N+LL +      + DFG A      +    M+   GS  ++AP    
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAP---- 173
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
            ++  G   N +EK DV+S+G++L E+++ R     +IG     + W     G+  P + 
Sbjct: 174 -EVFEG--SNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHN-GTRPPLIK 228
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            L   ++ L  +              C +  P++RP+M+E+V ++
Sbjct: 229 NLPKPIESLMTR--------------CWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 47/285 (16%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           E V+G+G  GVV KA+    + +A+K++      E    +F  E++ L  + H NIVKL 
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 130 GYCSNKSVKLL-------LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
           G C N    ++       LYN +                W       +  +QG+AYLH  
Sbjct: 68  GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSM 121
Query: 183 CVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
              A++HRD+K  N+LL +      + DFG A      +    M+   GS  ++AP    
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAP---- 172
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
            ++  G   N +EK DV+S+G++L E+++ R     +IG     + W     G+  P + 
Sbjct: 173 -EVFEG--SNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHN-GTRPPLIK 227
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            L   ++ L  +              C +  P++RP+M+E+V ++
Sbjct: 228 NLPKPIESLMTR--------------CWSKDPSQRPSMEEIVKIM 258

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 113/248 (45%), Gaps = 49/248 (19%)
Query: 38  PPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKL 97
           P G  D SY W     + +  T             IG G  G VYK +  +G+ +AVK L
Sbjct: 21  PRGQRDSSYYWEIEASEVMLST------------RIGSGSFGTVYKGKW-HGD-VAVKIL 66
Query: 98  WKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL--------LYNYISXXX 149
                  E   +F  E+ +L   RH NI+  +GY +  ++ ++        LY ++    
Sbjct: 67  KVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQ- 125
Query: 150 XXXXXXXXXXXDWETRYK------IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY 203
                        ET+++      IA  +AQG+ YLH      I+HRD+K NNI L    
Sbjct: 126 -------------ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGL 169
Query: 204 EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGV 263
              + DFGLA + +  +    + +  GS  ++AP   ++Q    ++     +SDVYSYG+
Sbjct: 170 TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF----QSDVYSYGI 225
Query: 264 VLLEILSG 271
           VL E+++G
Sbjct: 226 VLYELMTG 233

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 72  VIGKGCSGVVYK-AEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           V+GKGC G   K      GE++ +K+L   + DEE   +F  E++++  + H N++K +G
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 131 YCSNKSVKLLLYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
                     +  YI                 W  R   A   A G+AYLH      I+H
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR------------VAGSYGYIAP 237
           RD+  +N L+       +ADFGLA+LM          R            V G+  ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
                ++I G + +  EK DV+S+G+VL EI+ GR    P 
Sbjct: 192 -----EMINGRSYD--EKVDVFSFGIVLCEII-GRVNADPD 224

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE---PVDSFAAEIQILGHIRHRNIV 126
           E +IG G  G VY+A    G+ +AVK   +   DE+    +++   E ++   ++H NI+
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAA-RHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
            L G C  K   L L    +                +     AV  A+G+ YLH + +  
Sbjct: 70  ALRGVCL-KEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 187 ILHRDVKCNNILLDSKYEA--------YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           I+HRD+K +NIL+  K E          + DFGLA+  + T    A    AG+Y ++AP 
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYAWMAPE 184
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
             +  +        ++ SDV+SYGV+L E+L+G
Sbjct: 185 VIRASM-------FSKGSDVWSYGVLLWELLTG 210

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG+G  GVVYKA+   GE  A+KK+   K DE    +   EI IL  ++H NIVKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDV 192
             K   +L++ ++               +  T     +    G+AY H   V   LHRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDL 126
Query: 193 KCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           K  N+L++ + E  +ADFGLA+        Y H +     +  Y AP        Y  T+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKYSTTI 182
Query: 251 NITEKSDVYSYGVVLLEILSG 271
                 D++S G +  E+++G
Sbjct: 183 ------DIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG+G  GVVYKA+   GE  A+KK+   K DE    +   EI IL  ++H NIVKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDV 192
             K   +L++ ++               +  T     +    G+AY H   V   LHRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDL 126
Query: 193 KCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           K  N+L++ + E  +ADFGLA+        Y H +     +  Y AP        Y  T+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYSTTI 182
Query: 251 NITEKSDVYSYGVVLLEILSG 271
                 D++S G +  E+++G
Sbjct: 183 ------DIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG+G  GVVYKA+   GE  A+KK+   K DE    +   EI IL  ++H NIVKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDV 192
             K   +L++ ++               +  T     +    G+AY H      +LHRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDL 126
Query: 193 KCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           K  N+L++ + E  +ADFGLA+        Y H +     +  Y AP        Y  T+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYSTTI 182
Query: 251 NITEKSDVYSYGVVLLEILSG 271
                 D++S G +  E+++G
Sbjct: 183 ------DIWSVGCIFAEMVNG 197

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 26/232 (11%)
Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEP--- 106
            P  +L    DN +E    E  IGKG  G+V+K  +  +  ++A+K L     + E    
Sbjct: 8   FPKSRLPTLADNEIEY---EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 107 --VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET 164
                F  E+ I+ ++ H NIVKL G   N   ++++                    W  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSV 123
Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE-----AYLADFGLAKLMNST 219
           + ++ +  A G+ Y+ +   P I+HRD++  NI L S  E     A +ADFGL     S 
Sbjct: 124 KLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-----SQ 177
Query: 220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              H++S + G++ ++AP     + I     + TEK+D YS+ ++L  IL+G
Sbjct: 178 QSVHSVSGLLGNFQWMAP-----ETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 41/285 (14%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIR 121
           LE  +    +GKG  G VY A   N + I A+K L+K + ++  V+     E++I  H+R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H NI++L GY  + +   L+  Y                D +         A  L+Y H 
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA---GSYGYIAPG 238
                ++HRD+K  N+LL S  E  +ADFG +        H   SR A   G+  Y+ P 
Sbjct: 127 K---KVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPP- 175
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
               ++I G   +  EK D++S GV+  E L G+   +       +      K++   E 
Sbjct: 176 ----EMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQDTY------KRISRVE- 222
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             +  D   +G  D ++  +L+           +P++RP ++EV+
Sbjct: 223 -FTFPDFVTEGARD-LISRLLK----------HNPSQRPMLREVL 255

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEP--- 106
            P  +L    DN +E    E  IGKG  G+V+K  +  +  ++A+K L     + E    
Sbjct: 8   FPKSRLPTLADNEIEY---EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 107 --VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET 164
                F  E+ I+ ++ H NIVKL G   N   ++++                    W  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSV 123
Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE-----AYLADFGLAKLMNST 219
           + ++ +  A G+ Y+ +   P I+HRD++  NI L S  E     A +ADFG      S 
Sbjct: 124 KLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQ 177
Query: 220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              H++S + G++ ++AP     + I     + TEK+D YS+ ++L  IL+G
Sbjct: 178 QSVHSVSGLLGNFQWMAP-----ETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 118/275 (42%), Gaps = 52/275 (18%)
Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISXXXX 150
           +AVK L  T   +E  ++  +E++I+ H+ +H NIV LLG C++    L++  Y      
Sbjct: 71  VAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 151 XXXXXXXXXXDW--------ETRYKIAVGS--AQGLAYL-HHDCVPAILHRDVKCNNILL 199
                     D         E R  +   S  AQG+A+L   +C+    HRDV   N+LL
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLL 185
Query: 200 DSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI-----T 253
            + + A + DFGLA+ +MN +N             YI  G  +L + +    +I     T
Sbjct: 186 TNGHVAKIGDFGLARDIMNDSN-------------YIVKGNARLPVKWMAPESIFDCVYT 232
Query: 254 EKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQ 313
            +SDV+SYG++L EI S      P I       + VK      +PA +         P  
Sbjct: 233 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA---------PKN 283
Query: 314 MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           +         I   C    P  RPT +++ + L E
Sbjct: 284 I-------YSIMQACWALEPTHRPTFQQICSFLQE 311

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEP--- 106
            P  +L    DN +E    E  IGKG  G+V+K  +  +  ++A+K L     + E    
Sbjct: 8   FPKSRLPTLADNEIEY---EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 107 --VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET 164
                F  E+ I+ ++ H NIVKL G   N   ++++                    W  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSV 123
Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE-----AYLADFGLAKLMNST 219
           + ++ +  A G+ Y+ +   P I+HRD++  NI L S  E     A +ADF L     S 
Sbjct: 124 KLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL-----SQ 177
Query: 220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              H++S + G++ ++AP     + I     + TEK+D YS+ ++L  IL+G
Sbjct: 178 QSVHSVSGLLGNFQWMAP-----ETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 118/275 (42%), Gaps = 52/275 (18%)
Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISXXXX 150
           +AVK L  T   +E  ++  +E++I+ H+ +H NIV LLG C++    L++  Y      
Sbjct: 79  VAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 151 XXXXXXXXXXDW--------ETRYKIAVGS--AQGLAYL-HHDCVPAILHRDVKCNNILL 199
                     D         E R  +   S  AQG+A+L   +C+    HRDV   N+LL
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLL 193
Query: 200 DSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI-----T 253
            + + A + DFGLA+ +MN +N             YI  G  +L + +    +I     T
Sbjct: 194 TNGHVAKIGDFGLARDIMNDSN-------------YIVKGNARLPVKWMAPESIFDCVYT 240
Query: 254 EKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQ 313
            +SDV+SYG++L EI S      P I       + VK      +PA +         P  
Sbjct: 241 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA---------PKN 291
Query: 314 MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           +         I   C    P  RPT +++ + L E
Sbjct: 292 I-------YSIMQACWALEPTHRPTFQQICSFLQE 319

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 132
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTELCGTLDYLPP-----EMIEGRMH 183
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 184 D--EKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVE--FTFPDFVTEGA 233
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 234 RD-LISRLLK----------HNPSQRPMLREVL 255

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 132
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 183
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 184 D--EKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVE--FTFPDFVTEGA 233
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 234 RD-LISRLLK----------HNPSQRPMLREVL 255

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIR 121
           LE  +    +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H NI++L GY  + +   L+  Y                D +         A  L+Y H 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
             V   +HRD+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P    
Sbjct: 127 KRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTXLCGTLDYLPP---- 175
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
            ++I G   +  EK D++S GV+  E L G+   +       +  +   K++   E   +
Sbjct: 176 -EMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FT 224
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             D   +G  D ++  +L+           +P++RP ++EV+
Sbjct: 225 FPDFVTEGARD-LISRLLK----------HNPSQRPMLREVL 255

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+KT+ ++  V+     E++I  H+RH NI++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H   V   +HR
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV---IHR 136
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 137 DIKPENLLLGSNGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 187
Query: 251 NITEKSDVYSYGVVLLEILSG 271
           +  EK D++S GV+  E L G
Sbjct: 188 D--EKVDLWSLGVLCYEFLVG 206

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H   V   +HR
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV---IHR 133
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + ++G+  Y+ P     ++I G   
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSCHAPSSR----RTTLSGTLDYLPP-----EMIEGRMH 184
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 185 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 234
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 235 RD-LISRLLK----------HNPSQRPMLREVL 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIR 121
           LE  +    +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+R
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H NI++L GY  + +   L+  Y                D +         A  L+Y H 
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
             V   +HRD+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P    
Sbjct: 126 KRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP---- 174
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
            ++I G   +  EK D++S GV+  E L G+   +       +  +   K++   E   +
Sbjct: 175 -EMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FT 223
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             D   +G  D ++  +L+           +P++RP ++EV+
Sbjct: 224 FPDFVTEGARD-LISRLLK----------HNPSQRPMLREVL 254

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H   V   +HR
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV---IHR 135
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 186
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 187 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 236
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 237 RD-LISRLLK----------HNPSQRPMLREVL 258

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIR 121
           LE  +    +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+R
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H NI++L GY  + +   L+  Y                D +         A  L+Y H 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
             V   +HRD+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P    
Sbjct: 131 KRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP---- 179
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
            ++I G   +  EK D++S GV+  E L G+   +       +  +   K++   E   +
Sbjct: 180 -EMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FT 228
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             D   +G  D ++  +L+           +P++RP ++EV+
Sbjct: 229 FPDFVTEGARD-LISRLLK----------HNPSQRPMLREVL 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 132
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP-----EMIEGRMH 183
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 184 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 233
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 234 RD-LISRLLK----------HNPSQRPMLREVL 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 41/285 (14%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIR 121
           LE  +    +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H NI++L GY  + +   L+  Y                D +         A  L+Y H 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA---GSYGYIAPG 238
             V   +HRD+K  N+LL S  E  +ADFG +        H   SR A   G+  Y+ P 
Sbjct: 127 KRV---IHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPP- 175
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
               ++I G   +  EK D++S GV+  E L G+   +       +  +   K++   E 
Sbjct: 176 ----EMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE- 222
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             +  D   +G  D ++  +L+           +P++RP ++EV+
Sbjct: 223 -FTFPDFVTEGARD-LISRLLK----------HNPSQRPMLREVL 255

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/318 (25%), Positives = 127/318 (39%), Gaps = 61/318 (19%)
Query: 62  NILECLKDENVIGKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEEPVDSFAAEIQ 115
           N +E ++D   IG+G  G V++A  P         ++AVK L +    +   D F  E  
Sbjct: 47  NNIEYVRD---IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAA 102
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS--------XXXXXXXXXXXXXXDWETRYK 167
           ++    + NIVKLLG C+      LL+ Y++                      D  TR +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 168 ----------------IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG 211
                           IA   A G+AYL        +HRD+   N L+       +ADFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG 219
Query: 212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           L++ + S +Y+ A    A    ++ P      I Y      T +SDV++YGVVL EI S 
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPES----IFYN---RYTTESDVWAYGVVLWEIFS- 271
Query: 272 RSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNS 331
              +QP  G            M   E    + D  +   P+    E+   + +   C + 
Sbjct: 272 -YGLQPYYG------------MAHEEVIYYVRDGNILACPENCPLELYNLMRL---CWSK 315
Query: 332 SPAERPTMKEVVALLMEV 349
            PA+RP+   +  +L  +
Sbjct: 316 LPADRPSFCSIHRILQRM 333

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 132
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP-----EMIEGRMH 183
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 184 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 233
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 234 RD-LISRLLK----------HNPSQRPMLREVL 255

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 137
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 188
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 189 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 238
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 239 RD-LISRLLK----------HNPSQRPMLREVL 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 135
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 186
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 187 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 236
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 237 RD-LISRLLK----------HNPSQRPMLREVL 258

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 158
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 159 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 209
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 210 D--EKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVE--FTFPDFVTEGA 259
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 260 RD-LISRLLK----------HNPSQRPMLREVL 281

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 133
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP-----EMIEGRMH 184
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 185 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 234
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 235 RD-LISRLLK----------HNPSQRPMLREVL 256

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 137
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 188
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 189 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 238
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 239 RD-LISRLLK----------HNPSQRPMLREVL 260

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 56/279 (20%)
Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYI----- 145
           +AVK L  T   +E  ++  +E++I+ H+ +H NIV LLG C++    L++  Y      
Sbjct: 79  VAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 146 -------SXXXXXXXXXXXXXXDWETRYKIAVGS--AQGLAYL-HHDCVPAILHRDVKCN 195
                  S                 TR  +   S  AQG+A+L   +C+    HRDV   
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCI----HRDVAAR 193
Query: 196 NILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI-- 252
           N+LL + + A + DFGLA+ +MN +N             YI  G  +L + +    +I  
Sbjct: 194 NVLLTNGHVAKIGDFGLARDIMNDSN-------------YIVKGNARLPVKWMAPESIFD 240
Query: 253 ---TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
              T +SDV+SYG++L EI S      P I       + VK      +PA +        
Sbjct: 241 CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA-------- 292
Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
            P  +         I   C    P  RPT +++ + L E
Sbjct: 293 -PKNI-------YSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 41/276 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 135
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA---GSYGYIAPGKCKLQIIYG 247
           D+K  N+LL S  E  +ADFG +        H   SR A   G+  Y+ P     ++I G
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPP-----EMIEG 183
Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
              +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   
Sbjct: 184 RMHD--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVT 233
Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           +G  D ++  +L+           +P++RP ++EV+
Sbjct: 234 EGARD-LISRLLK----------HNPSQRPMLREVL 258

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 56/279 (20%)
Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYI----- 145
           +AVK L  T   +E  ++  +E++I+ H+ +H NIV LLG C++    L++  Y      
Sbjct: 79  VAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 146 -------SXXXXXXXXXXXXXXDWETRYKIAVGS--AQGLAYL-HHDCVPAILHRDVKCN 195
                  S                 TR  +   S  AQG+A+L   +C+    HRDV   
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI----HRDVAAR 193
Query: 196 NILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI-- 252
           N+LL + + A + DFGLA+ +MN +N             YI  G  +L + +    +I  
Sbjct: 194 NVLLTNGHVAKIGDFGLARDIMNDSN-------------YIVKGNARLPVKWMAPESIFD 240
Query: 253 ---TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
              T +SDV+SYG++L EI S      P I       + VK      +PA +        
Sbjct: 241 CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA-------- 292
Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
            P  +         I   C    P  RPT +++ + L E
Sbjct: 293 -PKNI-------YSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+KT+ ++  V+     E++I  H+RH NI++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H   V   +HR
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV---IHR 136
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+        + G+  Y+ P     ++I G   
Sbjct: 137 DIKPENLLLGSNGELKIADFGWSVHAPSSR----RDTLCGTLDYLPP-----EMIEGRMH 187
Query: 251 NITEKSDVYSYGVVLLEILSG 271
           +  EK D++S GV+  E L G
Sbjct: 188 D--EKVDLWSLGVLCYEFLVG 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 137
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP-----EMIEGRMH 188
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 189 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 238
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 239 RD-LISRLLK----------HNPSQRPMLREVL 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIR 121
           LE  +    +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+R
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H NI++L GY  + +   L+  Y                D +         A  L+Y H 
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
             V   +HRD+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P    
Sbjct: 124 KRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP---- 172
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
            ++I G   +  EK D++S GV+  E L G+   +       +  +   K++   E   +
Sbjct: 173 -EMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FT 221
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             D   +G  D ++  +L+           +P++RP ++EV+
Sbjct: 222 FPDFVTEGARD-LISRLLK----------HNPSQRPMLREVL 252

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 149
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 150 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 200
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 201 D--EKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVE--FTFPDFVTEGA 250
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 251 RD-LISRLLK----------HNPSQRPMLREVL 272

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 41/276 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 158
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAPGKCKLQIIYG 247
           D+K  N+LL S  E  +ADFG +        H   SR   + G+  Y+ P     ++I G
Sbjct: 159 DIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYLPP-----EMIEG 206
Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
              +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   
Sbjct: 207 RMHD--EKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVE--FTFPDFVT 256
Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           +G  D ++  +L+           +P++RP ++EV+
Sbjct: 257 EGARD-LISRLLK----------HNPSQRPMLREVL 281

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 133
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+        + G+  Y+ P     ++I G   
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RDTLCGTLDYLPP-----EMIEGRMH 184
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 185 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 234
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 235 RD-LISRLLK----------HNPSQRPMLREVL 256

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIR 121
           LE  +    +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+R
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H NI++L GY  + +   L+  Y                D +         A  L+Y H 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
             V   +HRD+K  N+LL S  E  +ADFG +    S+        + G+  Y+ P    
Sbjct: 130 KRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RDDLCGTLDYLPP---- 178
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
            ++I G   +  EK D++S GV+  E L G+   +       +  +   K++   E   +
Sbjct: 179 -EMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FT 227
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             D   +G  D ++  +L+           +P++RP ++EV+
Sbjct: 228 FPDFVTEGARD-LISRLLK----------HNPSQRPMLREVL 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIR 121
           LE  +    +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H NI++L GY  + +   L+  Y                D +         A  L+Y H 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
             V   +HRD+K  N+LL S  E  +ADFG +    S+        + G+  Y+ P    
Sbjct: 127 KRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP---- 175
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
            ++I G   +  EK D++S GV+  E L G+   +       +  +   K++   E   +
Sbjct: 176 -EMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FT 224
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             D   +G  D ++  +L+           +P++RP ++EV+
Sbjct: 225 FPDFVTEGARD-LISRLLK----------HNPSQRPMLREVL 255

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 134
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+        + G+  Y+ P     ++I G   
Sbjct: 135 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP-----EMIEGRMH 185
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 186 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 235
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 236 RD-LISRLLK----------HNPSQRPMLREVL 257

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 137
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+      + + G+  Y+ P     + I G   
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP-----EXIEGRXH 188
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 189 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 238
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 239 RD-LISRLLK----------HNPSQRPXLREVL 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H   V   +HR
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV---IHR 135
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+        + G+  Y+ P     ++I G   
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP-----EMIEGRMH 186
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 187 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 236
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 237 RD-LISRLLK----------HNPSQRPMLREVL 258

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H   V   +HR
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV---IHR 137
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +ADFG +    S+        + G+  Y+ P     ++I G   
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLXGTLDYLPP-----EMIEGRMH 188
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 189 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 238
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 239 RD-LISRLLK----------HNPSQRPMLREVL 260

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 58/281 (20%)
Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYISXXXX 150
           +AVK L  T   +E  ++  +E++I+ H+ +H NIV LLG C++    L++  Y      
Sbjct: 79  VAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 151 XXXXXXXXXXDWETRYK----------------IAVGSAQGLAYL-HHDCVPAILHRDVK 193
                       E  Y                  +   AQG+A+L   +C+    HRDV 
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCI----HRDVA 193
Query: 194 CNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI 252
             N+LL + + A + DFGLA+ +MN +N             YI  G  +L + +    +I
Sbjct: 194 ARNVLLTNGHVAKIGDFGLARDIMNDSN-------------YIVKGNARLPVKWMAPESI 240
Query: 253 -----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
                T +SDV+SYG++L EI S      P I       + VK      +PA +      
Sbjct: 241 FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA------ 294
Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
              P  +         I   C    P  RPT +++ + L E
Sbjct: 295 ---PKNI-------YSIMQACWALEPTHRPTFQQICSFLQE 325

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 55  KLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVD-SFAA 112
           K  FTID+  + ++    +GKG  G VY A E  N  ++A+K L+K++ ++E V+     
Sbjct: 8   KRKFTIDD-FDIVRP---LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           EI+I  H+RH NI+++  Y  ++    L+  +                D +         
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A  L Y H      ++HRD+K  N+L+  K E  +ADFG +    S         + G+ 
Sbjct: 124 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRXMCGTL 176
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
            Y+ P     ++I G T +  EK D++  GV+  E L G
Sbjct: 177 DYLPP-----EMIEGKTHD--EKVDLWCAGVLCYEFLVG 208

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 71  NVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDE--EPVDSFA-AEIQILGHIRHRNIV 126
           + +G+G    VYKA   N  +++A+KK+    R E  + ++  A  EI++L  + H NI+
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
            LL    +KS   L+++++                        + + QGL YLH      
Sbjct: 76  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 132
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN---YHHAMSRVAGSYGYIAPGKCKLQ 243
           ILHRD+K NN+LLD      LADFGLAK   S N    H  ++R      Y AP     +
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR-----WYRAP-----E 182
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEIL 269
           +++G  M      D+++ G +L E+L
Sbjct: 183 LLFGARM-YGVGVDMWAVGCILAELL 207

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 142/310 (45%), Gaps = 34/310 (10%)
Query: 63  ILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-- 120
           ++EC      +GKG  G V++  + +GE +AVK    + RDE+   S+  E +I   +  
Sbjct: 12  LVEC------VGKGRYGEVWRG-LWHGESVAVKIF--SSRDEQ---SWFRETEIYNTVLL 59
Query: 121 RHRNIVKLLG---YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
           RH NI+  +       N S +L L  +                +     ++AV +A GLA
Sbjct: 60  RHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLA 119
Query: 178 YLHHDCV-----PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH---AMSRVA 229
           +LH +       PAI HRD K  N+L+ S  +  +AD GLA +M+S    +     +   
Sbjct: 120 HLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRV 178
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV 289
           G+  Y+AP     QI         + +D++++G+VL EI + R+ V   + D       V
Sbjct: 179 GTKRYMAPEVLDEQIRTD-CFESYKWTDIWAFGLVLWEI-ARRTIVNGIVEDYRPPFYDV 236
Query: 290 KKKMGSFEP--AVSILDTKLQGLPDQMVQEMLQTLGIAMF---CVNSSPAERPTMKEVVA 344
                SFE    V  +D +   +P+++  + + + G+A     C   +P+ R T   +  
Sbjct: 237 VPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLS-GLAQMMRECWYPNPSARLTALRIKK 295
Query: 345 LLMEVKSAPE 354
            L ++ ++PE
Sbjct: 296 TLQKISNSPE 305

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 55  KLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVD-SFAA 112
           K  FTID+          +GKG  G VY A E  N  ++A+K L+K++ ++E V+     
Sbjct: 9   KRKFTIDD----FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 64
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           EI+I  H+RH NI+++  Y  ++    L+  +                D +         
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 124
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A  L Y H      ++HRD+K  N+L+  K E  +ADFG +    S         + G+ 
Sbjct: 125 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRXMCGTL 177
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
            Y+ P     ++I G T +  EK D++  GV+  E L G
Sbjct: 178 DYLPP-----EMIEGKTHD--EKVDLWCAGVLCYEFLVG 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H      ++HR
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 134
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +A+FG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 135 DIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 185
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 186 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 235
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 236 RD-LISRLLK----------HNPSQRPMLREVL 257

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  IGKGCSGVVYKAEMPNGELI-AVKKLWKTKRDEEPVD-SFAAEIQILGHIRHRNIVKLLG 130
           +GKG  G VY A     + I A+K L+K + ++  V+     E++I  H+RH NI++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y  + +   L+  Y                D +         A  L+Y H   V   +HR
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV---IHR 135
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+LL S  E  +A+FG +    S+      + + G+  Y+ P     ++I G   
Sbjct: 136 DIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDYLPP-----EMIEGRMH 186
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL 310
           +  EK D++S GV+  E L G+   +       +  +   K++   E   +  D   +G 
Sbjct: 187 D--EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE--FTFPDFVTEGA 236
Query: 311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            D ++  +L+           +P++RP ++EV+
Sbjct: 237 RD-LISRLLK----------HNPSQRPMLREVL 258

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G +G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQI 116
           N     ++E  +    +G+G  GVVYKA+   G ++A+K++     DE    +   EI +
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISL 72
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQG 175
           L  + H NIV L+    ++    L++ ++                 +++ KI +    +G
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ-DSQIKIYLYQLLRG 131
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYG 233
           +A+ H      ILHRD+K  N+L++S     LADFGLA+       +Y H +     +  
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLW 184
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           Y AP      ++ G +   +   D++S G +  E+++G+
Sbjct: 185 YRAP-----DVLMG-SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQI 116
           N     ++E  +    +G+G  GVVYKA+   G ++A+K++     DE    +   EI +
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISL 72
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQG 175
           L  + H NIV L+    ++    L++ ++                 +++ KI +    +G
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ-DSQIKIYLYQLLRG 131
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYG 233
           +A+ H      ILHRD+K  N+L++S     LADFGLA+       +Y H +     +  
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLW 184
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           Y AP      ++ G +   +   D++S G +  E+++G+
Sbjct: 185 YRAP-----DVLMG-SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 106/229 (46%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 77
Query: 128 L--LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG-------- 175
           L    Y S +   ++  N +               D+  ET Y++A   ++         
Sbjct: 78  LRYFFYSSGEKKDVVYLNLV--------------LDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 176 -----------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHH 223
                      LAY+H      I HRD+K  N+LLD       L DFG AK +       
Sbjct: 124 VKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEP 178
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            +S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 179 NVSXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 130
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA---- 186
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 187 --EPVDVWSCGIVLTAMLAG 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 130
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 186
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 187 --EPVDVWSCGIVLTAMLAG 204

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 111
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 112 ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 160 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 217 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 52  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 105
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 106 ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 153
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 154 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 210
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 211 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 62  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 115
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 116 ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 163
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 164 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 220
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 221 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 60  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 113
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 114 ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 161
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 162 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 218
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 219 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 103 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 156
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 157 ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 204
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 205 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 261
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 262 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 111
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 112 ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 160 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 214
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 215 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/319 (23%), Positives = 127/319 (39%), Gaps = 57/319 (17%)
Query: 56  LNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGE-----LIAVKKLWKTKRDEEPVDSF 110
           L FT +    C+  + VIG G  G VYK  +          +A+K L     +++ VD F
Sbjct: 35  LKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-F 93
Query: 111 AAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAV 170
             E  I+G   H NI++L G  S     +++  Y+               D E      V
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLV 150
Query: 171 GSAQGLAY-LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS---TNYHHAMS 226
           G  +G+A  + +      +HRD+   NIL++S     ++DFGL++++       Y  +  
Sbjct: 151 GMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS---------GRSAVQP 277
           ++     + AP     +         T  SDV+S+G+V+ E+++             V  
Sbjct: 211 KIP--IRWTAPEAISYR-------KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261
Query: 278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP 337
            I DG                    L T +   P  + Q M+Q       C     A RP
Sbjct: 262 AINDGFR------------------LPTPMD-CPSAIYQLMMQ-------CWQQERARRP 295
Query: 338 TMKEVVALLMEVKSAPEEL 356
              ++V++L ++  AP+ L
Sbjct: 296 KFADIVSILDKLIRAPDSL 314

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 29  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 82
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 83  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 130
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 131 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 187
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 188 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 128
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 184
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 185 --EPVDVWSCGIVLTAMLAG 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 130
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 186
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 187 --EPVDVWSCGIVLTAMLAG 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRD 130
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 186
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 187 --EPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRD 130
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 186
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 187 --EPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRD 130
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 186
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 187 --EPVDVWSCGIVLTAMLAG 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 130
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 186
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 187 --EPVDVWSCGIVLTAMLAG 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 37  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 90
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 91  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 138
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAK--LMNSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK  +    N  +
Sbjct: 139 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 195
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 196 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRD 130
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 186
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 187 --EPVDVWSCGIVLTAMLAG 204

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 36  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 89
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 90  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 137
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 138 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 192
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 193 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 43  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 96
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 97  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 144
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 145 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 199
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 200 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 9/221 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
             E  DV+S G+VL  +L+G               +W +KK
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKK 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 77
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 78  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 183 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 36  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 89
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 90  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 137
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 138 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 192
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 193 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 32  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 85
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 86  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 133
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 134 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 188
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 189 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
            +G+G  G V  A     E     K+   KR  +  ++   EI I   + H N+VK  G+
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
               +++ L   Y S                    +       G+ YLH      I HRD
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP   K +  +     
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA---- 185
Query: 252 ITEKSDVYSYGVVLLEILSG 271
             E  DV+S G+VL  +L+G
Sbjct: 186 --EPVDVWSCGIVLTAMLAG 203

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 25  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 78
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 79  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 126
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 127 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 181
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 182 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 77
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 78  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 180
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 181 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 38/287 (13%)
Query: 73  IGKGCSGVVYKAE--MPNGELIAVK-KLWKTKRDEEP--VDSFAAEIQILGHIRHRNIVK 127
           +G G  GVV + E   P+G+ ++V  K  K     +P  +D F  E+  +  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 128 LLGYCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           L G      +K++  L    S                 +RY + V  A+G+ YL      
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK--- 134
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG-SYGYIAPGKCKLQI 244
             +HRD+   N+LL ++    + DFGL + +   + H+ M       + + AP   K   
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK--- 191
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSIL 303
               T   +  SD + +GV L E+ +     +P IG +G  I+  + K+ G   P     
Sbjct: 192 ----TRTFSHASDTWMFGVTLWEMFT--YGQEPWIGLNGSQILHKIDKE-GERLP----- 239
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
             + +  P  +   M+Q       C    P +RPT   +   L+E +
Sbjct: 240 --RPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLLEAQ 277

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 77
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 78  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 180
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 181 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 38/287 (13%)
Query: 73  IGKGCSGVVYKAE--MPNGELIAVK-KLWKTKRDEEP--VDSFAAEIQILGHIRHRNIVK 127
           +G G  GVV + E   P+G+ ++V  K  K     +P  +D F  E+  +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 128 LLGYCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           L G      +K++  L    S                 +RY + V  A+G+ YL      
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK--- 140
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG-SYGYIAPGKCKLQI 244
             +HRD+   N+LL ++    + DFGL + +   + H+ M       + + AP   K   
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK--- 197
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSIL 303
               T   +  SD + +GV L E+ +     +P IG +G  I+  + K+ G   P     
Sbjct: 198 ----TRTFSHASDTWMFGVTLWEMFT--YGQEPWIGLNGSQILHKIDKE-GERLP----- 245
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
             + +  P  +   M+Q       C    P +RPT   +   L+E +
Sbjct: 246 --RPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLLEAQ 283

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 38/287 (13%)
Query: 73  IGKGCSGVVYKAE--MPNGELIAVK-KLWKTKRDEEP--VDSFAAEIQILGHIRHRNIVK 127
           +G G  GVV + E   P+G+ ++V  K  K     +P  +D F  E+  +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 128 LLGYCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           L G      +K++  L    S                 +RY + V  A+G+ YL      
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK--- 130
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG-SYGYIAPGKCKLQI 244
             +HRD+   N+LL ++    + DFGL + +   + H+ M       + + AP   K   
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK--- 187
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSIL 303
               T   +  SD + +GV L E+ +     +P IG +G  I+  + K+ G   P     
Sbjct: 188 ----TRTFSHASDTWMFGVTLWEMFT--YGQEPWIGLNGSQILHKIDKE-GERLP----- 235
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
             + +  P  +   M+Q       C    P +RPT   +   L+E +
Sbjct: 236 --RPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLLEAQ 273

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + KR +        E+QI+  + H NIV+
Sbjct: 28  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVR 81
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
                       L Y + S              D+  ET Y++A   ++           
Sbjct: 82  ------------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 129
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAM 225
                    LAY+H      I HRD+K  N+LLD       L DFG AK +        +
Sbjct: 130 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 184
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           S +   Y Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 185 SXICSRY-YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG- 130
           V  +G  G V+KA++ N E +AVK ++  +  +   + +  E+  L  ++H NI++ +G 
Sbjct: 31  VKARGRFGCVWKAQLLN-EYVAVK-IFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGA 86
Query: 131 --YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC----- 183
               ++  V L L                    W     IA   A+GLAYLH D      
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 184 --VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
              PAI HRD+K  N+LL +   A +ADFGLA    +           G+  Y+AP    
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE--V 204
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           L+    +  +   + D+Y+ G+VL E+ S
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 38/287 (13%)
Query: 73  IGKGCSGVVYKAE--MPNGELIAVK-KLWKTKRDEEP--VDSFAAEIQILGHIRHRNIVK 127
           +G G  GVV + E   P+G+ ++V  K  K     +P  +D F  E+  +  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 128 LLGYCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           L G      +K++  L    S                 +RY + V  A+G+ YL      
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK--- 134
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG-SYGYIAPGKCKLQI 244
             +HRD+   N+LL ++    + DFGL + +   + H+ M       + + AP   K   
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK--- 191
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSIL 303
               T   +  SD + +GV L E+ +     +P IG +G  I+  + K+ G   P     
Sbjct: 192 ----TRTFSHASDTWMFGVTLWEMFT--YGQEPWIGLNGSQILHKIDKE-GERLP----- 239
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
             + +  P  +   M+Q       C    P +RPT   +   L+E +
Sbjct: 240 --RPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLLEAQ 277

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 38/287 (13%)
Query: 73  IGKGCSGVVYKAE--MPNGELIAVK-KLWKTKRDEEP--VDSFAAEIQILGHIRHRNIVK 127
           +G G  GVV + E   P+G+ ++V  K  K     +P  +D F  E+  +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 128 LLGYCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           L G      +K++  L    S                 +RY + V  A+G+ YL      
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK--- 130
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG-SYGYIAPGKCKLQI 244
             +HRD+   N+LL ++    + DFGL + +   + H+ M       + + AP   K   
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK--- 187
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSIL 303
               T   +  SD + +GV L E+ +     +P IG +G  I+  + K+ G   P     
Sbjct: 188 ----TRTFSHASDTWMFGVTLWEMFT--YGQEPWIGLNGSQILHKIDKE-GERLP----- 235
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
             + +  P  +   M+Q       C    P +RPT   +   L+E +
Sbjct: 236 --RPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLLEAQ 273

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 122/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+GC G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 209 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 265 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 313
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 314 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 359

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 122/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+GC G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 152 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 208 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 256
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 257 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 302

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 122/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+GC G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 150 TYQLARGMEYLASQKCI----HRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 206 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 254
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 255 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 300

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 30/287 (10%)
Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  GVV+K    + G+++A+KK  +++ D         EI++L  ++H N+V LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH-HDCVPAILHR 190
              K    L++ Y                       I   + Q + + H H+C+    HR
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI----HR 126
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           DVK  NIL+       L DFG A+L+   + ++    VA  + Y +P     +++ G T 
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYD-DEVATRW-YRSP-----ELLVGDT- 178
Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ-- 308
                 DV++ G V  E+LSG   + P   D +  +  ++K +G   P    + +  Q  
Sbjct: 179 QYGPPVDVWAIGCVFAELLSG-VPLWPGKSD-VDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 309 ---GLPDQMVQEMLQ---------TLGIAMFCVNSSPAERPTMKEVV 343
               +PD    E L+          LG+   C++  P ER T ++++
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 122/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+GC G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 155 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 211 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 259
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 260 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 305

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 16/225 (7%)
Query: 52  PFQKLNFTIDNILEC--LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVD 108
           P +K N  +  I +   L+   V+G G  G V+K   +P GE I +    K   D+    
Sbjct: 16  PSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ 75
Query: 109 SFAA---EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETR 165
           SF A    +  +G + H +IV+LLG C   S++L+                      +  
Sbjct: 76  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL 135
Query: 166 YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
               V  A+G+ YL       ++HR++   N+LL S  +  +ADFG+A L+   +     
Sbjct: 136 LNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 192
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           S       ++A     L+ I  +    T +SDV+SYGV + E+++
Sbjct: 193 SEAKTPIKWMA-----LESI--HFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 121/288 (42%), Gaps = 65/288 (22%)
Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNY------ 144
           +AVK L  T   +E  ++  +E++I+ H+ +H NIV LLG C++    L++  Y      
Sbjct: 64  VAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 145 ---------------ISXXXXXXXXXXXXXXDWETRYKIAVGS--AQGLAYL-HHDCVPA 186
                          ++                E R  +   S  AQG+A+L   +C+  
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI-- 180
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             HRDV   N+LL + + A + DFGLA+ +MN +N             YI  G  +L + 
Sbjct: 181 --HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-------------YIVKGNARLPVK 225
Query: 246 YGYTMNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
           +    +I     T +SDV+SYG++L EI S      P I       + VK      +PA 
Sbjct: 226 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 285
Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           +           + +  ++Q       C    P  RPT +++ + L E
Sbjct: 286 A----------PKNIYSIMQA------CWALEPTHRPTFQQICSFLQE 317

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 71  NVIGKGCSGVVY--KAEMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVK 127
           + +G G  G V   K E+  G  +AVK L + K R  + V     EIQ L   RH +I+K
Sbjct: 22  DTLGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L    S  S   ++  Y+S              D +   ++      G+ Y H   V   
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV--- 137
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+   A +ADFGL+ +M+   +   +    GS  Y AP     ++I G
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSPNYAAP-----EVISG 189
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
             +    + D++S GV+L  +L G
Sbjct: 190 -RLYAGPEVDIWSSGVILYALLCG 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKL-WKTKRDEEPVDSFAAEIQ 115
           F  D+  +   D   IG G  G VY A ++ N E++A+KK+ +  K+  E       E++
Sbjct: 47  FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
            L  +RH N ++  G    +    L+  Y                       +  G+ QG
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 176 LAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           LAYLH H+    ++HRDVK  NILL       L DFG A +M   N         G+  +
Sbjct: 167 LAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYW 216
Query: 235 IAPGKCKLQIIYGYTMNITE-KSDVYSYGVVLLEI 268
           +AP     ++I        + K DV+S G+  +E+
Sbjct: 217 MAP-----EVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 38/287 (13%)
Query: 73  IGKGCSGVVYKAE--MPNGELIAVK-KLWKTKRDEEP--VDSFAAEIQILGHIRHRNIVK 127
           +G G  GVV + E   P+G+ ++V  K  K     +P  +D F  E+  +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 128 LLGYCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           L G      +K++  L    S                 +RY + V  A+G+ YL      
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK--- 140
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG-SYGYIAPGKCKLQI 244
             +HRD+   N+LL ++    + DFGL + +   + H  M       + + AP   K   
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK--- 197
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSIL 303
               T   +  SD + +GV L E+ +     +P IG +G  I+  + K+ G   P     
Sbjct: 198 ----TRTFSHASDTWMFGVTLWEMFT--YGQEPWIGLNGSQILHKIDKE-GERLP----- 245
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
             + +  P  +   M+Q       C    P +RPT   +   L+E +
Sbjct: 246 --RPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLLEAQ 283

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 38/287 (13%)
Query: 73  IGKGCSGVVYKAE--MPNGELIAVK-KLWKTKRDEEP--VDSFAAEIQILGHIRHRNIVK 127
           +G G  GVV + E   P+G+ ++V  K  K     +P  +D F  E+  +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 128 LLGYCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           L G      +K++  L    S                 +RY + V  A+G+ YL      
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK--- 130
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG-SYGYIAPGKCKLQI 244
             +HRD+   N+LL ++    + DFGL + +   + H  M       + + AP   K   
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK--- 187
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSIL 303
               T   +  SD + +GV L E+ +     +P IG +G  I+  + K+ G   P     
Sbjct: 188 ----TRTFSHASDTWMFGVTLWEMFT--YGQEPWIGLNGSQILHKIDKE-GERLP----- 235
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
             + +  P  +   M+Q       C    P +RPT   +   L+E +
Sbjct: 236 --RPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLLEAQ 273

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 125/299 (41%), Gaps = 57/299 (19%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 126 VKLLGYCSNKSVKLL----------LYNYISXXXXXXXXXXXXXXDWETRYKIAVGS--- 172
           V LLG C+     L+          L  Y+               D+ T   +   S   
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A+G+ +L        +HRD+   NILL  K    + DFGLA+             +    
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR------------DIYKDP 198
Query: 233 GYIAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
            Y+  G  +L + +     I ++     SDV+S+GV+L EI S  ++  P    G+ I E
Sbjct: 199 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVKIDE 254
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 255 EFXRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKL-WKTKRDEEPVDSFAAEIQ 115
           F  D+  +   D   IG G  G VY A ++ N E++A+KK+ +  K+  E       E++
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
            L  +RH N ++  G    +    L+  Y                       +  G+ QG
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 176 LAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           LAYLH H+    ++HRDVK  NILL       L DFG A +M   N         G+  +
Sbjct: 128 LAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYW 177
Query: 235 IAPGKCKLQIIYGYTMNITE-KSDVYSYGVVLLEI 268
           +AP     ++I        + K DV+S G+  +E+
Sbjct: 178 MAP-----EVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 67  LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAA---EIQILGHIRH 122
           L+   V+G G  G V+K   +P GE I +    K   D+    SF A    +  +G + H
Sbjct: 15  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 123 RNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
            +IV+LLG C   S++L+                      +      V  A+G+ YL   
Sbjct: 75  AHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               ++HR++   N+LL S  +  +ADFG+A L+   +     S       ++A     L
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA-----L 186
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILS 270
           + I  +    T +SDV+SYGV + E+++
Sbjct: 187 ESI--HFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 69  DENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  V+GKG  G+VY   ++ N   IA+K++   +RD         EI +  H++H+NIV+
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCV 184
            LG  S      +    +                 +    I   + Q   GL YLH +  
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 185 PAILHRDVKCNNILLDSKYEAYL--ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
             I+HRD+K +N+L+++ Y   L  +DFG +K +   N         G+  Y+AP     
Sbjct: 142 -QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAP----- 192
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           +II        + +D++S G  ++E+ +G+
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 69  DENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  V+GKG  G+VY   ++ N   IA+K++   +RD         EI +  H++H+NIV+
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCV 184
            LG  S      +    +                 +    I   + Q   GL YLH +  
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 127
Query: 185 PAILHRDVKCNNILLDSKYEAYL--ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
             I+HRD+K +N+L+++ Y   L  +DFG +K +   N         G+  Y+AP     
Sbjct: 128 -QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAP----- 178
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           +II        + +D++S G  ++E+ +G+
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 42/294 (14%)
Query: 70  ENVIGKGCSGVVYKAE----MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           + VIGKG  GVVY  E      N    A+K L +    ++ V++F  E  ++  + H N+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-VEAFLREGLLMRGLNHPNV 84
Query: 126 VKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHD 182
           + L+G     + +  +L  Y+               +   +  I+ G   A+G+ YL   
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGMEYLAEQ 143
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH----HAMSRVAGSYGYIAPG 238
                +HRD+   N +LD  +   +ADFGLA+ +    Y+    H  +R+   +  +   
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE-- 198
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
              LQ     T   T KSDV+S+GV+L E+L+ R A   +  D   +  ++ +     +P
Sbjct: 199 --SLQ-----TYRFTTKSDVWSFGVLLWELLT-RGAPPYRHIDPFDLTHFLAQGRRLPQP 250
Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                       PD + Q M Q       C  + PA RPT + +V  + ++ SA
Sbjct: 251 EYC---------PDSLYQVMQQ-------CWEADPAVRPTFRVLVGEVEQIVSA 288

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 205
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 206 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 247
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 248 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 292

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 138/312 (44%), Gaps = 42/312 (13%)
Query: 34  MSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELI 92
           MS+ PP    F         Q++  T   +    +D   +G G  G V  A +   G  +
Sbjct: 1   MSSPPPARSGFYR-------QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKV 53
Query: 93  AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG-YCSNKSVKLLLYNYISXXXXX 151
           A+KKL++  + E        E+++L H+RH N++ LL  +  ++++      Y+      
Sbjct: 54  AIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG 113
Query: 152 XXXXXXXXXD--WETRYKIAVGSA-QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLA 208
                    +   E R +  V    +GL Y+H      I+HRD+K  N+ ++   E  + 
Sbjct: 114 TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKIL 170
Query: 209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEI 268
           DFGLA+  +S      ++R      Y AP     ++I  + M  T+  D++S G ++ E+
Sbjct: 171 DFGLARQADSEMXGXVVTR-----WYRAP-----EVILNW-MRYTQTVDIWSVGCIMAEM 219
Query: 269 LSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA--VSILDTK-----LQGLPDQMVQEMLQT 321
           ++G++  +    D L  ++ + K  G+  PA  V  L +      ++GLP+      L+ 
Sbjct: 220 ITGKTLFKG--SDHLDQLKEIMKVTGT-PPAEFVQRLQSDEAKNYMKGLPE------LEK 270
Query: 322 LGIAMFCVNSSP 333
              A    N+SP
Sbjct: 271 KDFASILTNASP 282

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 122/288 (42%), Gaps = 34/288 (11%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 202
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P + +   I  ++ +     +P      
Sbjct: 203 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP------ 251
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
              +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 252 ---EYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 289

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR---HRNIVKL 128
           IG G  G VYKA  P+ G  +A+K +     +E    S   E+ +L  +    H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 129 LGYC----SNKSVKL-LLYNYISXXXXXXXXXXXXX-XDWETRYKIAVGSAQGLAYLHHD 182
           +  C    +++ +K+ L++ ++                  ET   +     +GL +LH +
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
           C   I+HRD+K  NIL+ S     LADFGLA++    +Y  A++ V  +  Y AP +  L
Sbjct: 132 C---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVTLWYRAP-EVLL 184
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEIL 269
           Q  Y   +      D++S G +  E+ 
Sbjct: 185 QSTYATPV------DMWSVGCIFAEMF 205

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 122/288 (42%), Gaps = 34/288 (11%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 229
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P + +   I  ++ +     +P      
Sbjct: 230 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP------ 278
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
              +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 279 ---EYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 316

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 210
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 211 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 252
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 253 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 297

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 208
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 209 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 250
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 251 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 295

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 122/288 (42%), Gaps = 34/288 (11%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 210
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P + +   I  ++ +     +P      
Sbjct: 211 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP------ 259
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
              +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 260 ---EYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 297

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 207
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 208 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 249
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 250 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 294

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 125/299 (41%), Gaps = 57/299 (19%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 126 VKLLGYCSNKSVKLL----------LYNYISXXXXXXXXXXXXXXDWETRYKIAVGS--- 172
           V LLG C+     L+          L  Y+               D+ T   +   S   
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A+G+ +L        +HRD+   NILL  K    + DFGLA+             +    
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR------------DIYKDP 198
Query: 233 GYIAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
            Y+  G  +L + +     I ++     SDV+S+GV+L EI S  ++  P    G+ I E
Sbjct: 199 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVKIDE 254
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 255 EFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 122/288 (42%), Gaps = 34/288 (11%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 228
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P + +   I  ++ +     +P      
Sbjct: 229 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP------ 277
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
              +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 278 ---EYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 315

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y+   ++              LQ 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 209
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 210 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 251
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 252 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 296

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    EE +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 313

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +G G    VY AE     + +A+K ++   R+ EE +  F  E+     + H+NIV ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
                    L+  YI                 +T          G+ + H      I+HR
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHR 135
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  NIL+DS     + DFG+AK ++ T+     + V G+  Y +P + K +       
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGTVQYFSPEQAKGEA------ 188
Query: 251 NITEKSDVYSYGVVLLEILSGR 272
              E +D+YS G+VL E+L G 
Sbjct: 189 -TDECTDIYSIGIVLYEMLVGE 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 72  VIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           ++G+G  G+V K    + G ++A+KK  ++  D+        EI++L  +RH N+V LL 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
            C  K    L++ ++               D++   K       G+ + H      I+HR
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHR 148
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  NIL+       L DFG A+ + +            +  Y AP      + YG  +
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAV 206
Query: 251 NITEKSDVYSYGVVLLEILSG 271
                 DV++ G ++ E+  G
Sbjct: 207 ------DVWAIGCLVTEMFMG 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 63
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++S                    K  +    QGLA+ H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 124 SHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 175
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 176 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 62
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++S                    K  +    QGLA+ H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 123 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 174
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 175 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++S                    K  +    QGLA+ H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 122 SHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 173
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 174 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 63
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++S                    K  +    QGLA+ H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 124 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 175
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 176 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 205

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR---HRNIVKL 128
           IG G  G VYKA  P+ G  +A+K +     +E    S   E+ +L  +    H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 129 LGYC----SNKSVKL-LLYNYISXXXXXXXXXXXXX-XDWETRYKIAVGSAQGLAYLHHD 182
           +  C    +++ +K+ L++ ++                  ET   +     +GL +LH +
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
           C   I+HRD+K  NIL+ S     LADFGLA++    +Y  A+  V  +  Y AP +  L
Sbjct: 132 C---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVTLWYRAP-EVLL 184
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEIL 269
           Q  Y   +      D++S G +  E+ 
Sbjct: 185 QSTYATPV------DMWSVGCIFAEMF 205

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 71  NVIGKGCSGVVYKAEMPNGELIAVK-------KLWKTKRDEEPVDSFAAEIQILGHIRHR 123
            +  +G  G V+KA++ N + +AVK       + W+++R          EI     ++H 
Sbjct: 21  EIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSER----------EIFSTPGMKHE 69
Query: 124 NIVKLLG---YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
           N+++ +      SN  V+L L                    W     +A   ++GL+YLH
Sbjct: 70  NLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLH 129
Query: 181 HDCV--------PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
            D          P+I HRD K  N+LL S   A LADFGLA                G+ 
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            Y+AP    L+    +  +   + D+Y+ G+VL E++S
Sbjct: 190 RYMAPE--VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G VYKA+     ++A  K+  TK +EE ++ +  EI IL    H NIVKLL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA-QGLAYLHHDCVPAILHRD 191
             ++   +L  + +                E++ ++        L YLH +    I+HRD
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRD 160
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--KCKLQIIYGYT 249
           +K  NIL     +  LADFG++   N+       S +   Y ++AP    C+      Y 
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRPYD 218
Query: 250 MNITEKSDVYSYGVVLLEI 268
                K+DV+S G+ L+E+
Sbjct: 219 Y----KADVWSLGITLIEM 233

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 129/297 (43%), Gaps = 29/297 (9%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 174
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +         + + +SD++S G+ L+E+  GR  + P         E  +  M  FE  
Sbjct: 175 LQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK-----EDSRPPMAIFELL 222
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEEL 356
             I++     LP  +     Q       C+  +PAER  +K+++      +S  EE+
Sbjct: 223 DYIVNEPPPKLPSGVFSLEFQDF--VNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 277

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 101/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + K  +        E+QI+  + H NIV+
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVR 77
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
           L             Y + S              D+  ET Y++A   ++           
Sbjct: 78  LR------------YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 183 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G VYKA+     ++A  K+  TK +EE ++ +  EI IL    H NIVKLL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA-QGLAYLHHDCVPAILHRD 191
             ++   +L  + +                E++ ++        L YLH +    I+HRD
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRD 160
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--KCKLQIIYGYT 249
           +K  NIL     +  LADFG++    +T          G+  ++AP    C+      Y 
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 250 MNITEKSDVYSYGVVLLEI 268
                K+DV+S G+ L+E+
Sbjct: 219 Y----KADVWSLGITLIEM 233

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 101/229 (44%), Gaps = 57/229 (24%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + K  +        E+QI+  + H NIV+
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVR 77
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW--ETRYKIAVGSAQG---------- 175
           L             Y + S              D+  ET Y++A   ++           
Sbjct: 78  LR------------YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 176 ---------LAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLM--NSTNYHH 223
                    LAY+H      I HRD+K  N+LLD       L DFG AK +     N  +
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             SR      Y AP     ++I+G T + T   DV+S G VL E+L G+
Sbjct: 183 ICSRY-----YRAP-----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G VYKA+     ++A  K+  TK +EE ++ +  EI IL    H NIVKLL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA-QGLAYLHHDCVPAILHRD 191
             ++   +L  + +                E++ ++        L YLH +    I+HRD
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRD 160
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--KCKLQIIYGYT 249
           +K  NIL     +  LADFG++    +T          G+  ++AP    C+      Y 
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 250 MNITEKSDVYSYGVVLLEI 268
                K+DV+S G+ L+E+
Sbjct: 219 Y----KADVWSLGITLIEM 233

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LK   V+G G  G VYK   +P GE +    A+K L +T   +  V+ F  E  I+  + 
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD 98
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H ++V+LLG C + +++L+                      +      V  A+G+ YL  
Sbjct: 99  HPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 158
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
                ++HRD+   N+L+ S     + DFGLA+L+      +          ++A     
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA----- 210
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           L+ I  +    T +SDV+SYGV + E+++
Sbjct: 211 LECI--HYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 62  NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGH 119
             +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKE 65
Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAY 178
           + H NIVKLL     ++   L++ ++                     K  +    QGLA+
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIA 236
            H   V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y A
Sbjct: 126 CHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRA 178
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           P     +I+ G     T   D++S G +  E+++ R+
Sbjct: 179 P-----EILLGXKYYST-AVDIWSLGCIFAEMVTRRA 209

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR---HRNIVKL 128
           IG G  G VYKA  P+ G  +A+K +     +E    S   E+ +L  +    H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 129 LGYC----SNKSVKL-LLYNYISXXXXXXXXXXXXX-XDWETRYKIAVGSAQGLAYLHHD 182
           +  C    +++ +K+ L++ ++                  ET   +     +GL +LH +
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
           C   I+HRD+K  NIL+ S     LADFGLA++    +Y  A+  V  +  Y AP +  L
Sbjct: 132 C---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTLWYRAP-EVLL 184
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEIL 269
           Q  Y   +      D++S G +  E+ 
Sbjct: 185 QSTYATPV------DMWSVGCIFAEMF 205

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGXKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 106
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 107 YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 156
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 207
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 208 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 266 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 309
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 310 FRDLALRVDQIRD 322

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 75
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 76  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 125
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK---------EP 176
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 177 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 235 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 278
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 279 FRDLALRVDQIRD 291

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 313

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 79
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 80  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 129
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 130 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 180
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 181 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 238
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 239 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 282
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 283 FRDLALRVDQIRD 295

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 135/313 (43%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 76
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 77  YKGVCYSAGRRNLKLIM-EYLP---------YGSLRDYLQKHKERIDHIKLLQYTSQICK 126
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HR++   NIL++++    + DFGL K++     ++ +           P
Sbjct: 127 GMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK---------EP 177
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 178 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 235
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 236 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 279
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 280 FRDLALRVDQIRD 292

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G+V+     N + +A+K + +    E   D F  E +++  + H  +V+L G C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE---DDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXX-XXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             ++   L++ ++                  ET   + +   +G+AYL   CV   +HRD
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRD 148
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+       ++DFG+ + +    Y         S G   P K     ++ ++  
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVKWASPEVFSFS-R 200
Query: 252 ITEKSDVYSYGVVLLEILS 270
            + KSDV+S+GV++ E+ S
Sbjct: 201 YSSKSDVWSFGVLMWEVFS 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 81
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 82  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 131
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 132 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 182
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 183 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 240
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 241 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 284
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 285 FRDLALRVDQIRD 297

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 44/278 (15%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 135
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N L+   +   +ADFGL++LM                 Y AP   K  I +   
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-------------YTAPAGAKFPIKWTAP 182
Query: 250 MNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
            ++     + KSDV+++GV+L EI +   +  P I D   + E ++K      P      
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP------ 235
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
              +G P++ V E+++       C   +P++RP+  E+
Sbjct: 236 ---EGCPEK-VYELMRA------CWQWNPSDRPSFAEI 263

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 75
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 76  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 125
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 176
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 177 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 235 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 278
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 279 FRDLALRVDQIRD 291

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 74
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 75  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 133
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 134 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA---- 186
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 187 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 235
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A E
Sbjct: 236 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTATE 277

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LK   V+G G  G VYK   +P GE +    A+K L +T   +  V+ F  E  I+  + 
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD 75
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H ++V+LLG C + +++L+                      +      V  A+G+ YL  
Sbjct: 76  HPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 135
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
                ++HRD+   N+L+ S     + DFGLA+L+      +          ++A     
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA----- 187
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           L+ I  +    T +SDV+SYGV + E+++
Sbjct: 188 LECI--HYRKFTHQSDVWSYGVTIWELMT 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 117/278 (42%), Gaps = 44/278 (15%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N L+   +   +ADFGL++LM                 Y AP   K  I +   
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-------------YTAPAGAKFPIKWTAP 183
Query: 250 MNITE-----KSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
            ++       KSDV+++GV+L EI +   +  P I D   + E ++K      P      
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP------ 236
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
              +G P++ V E+++       C   +P++RP+  E+
Sbjct: 237 ---EGCPEK-VYELMRA------CWQWNPSDRPSFAEI 264

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 63
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 124 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 175
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 176 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 205

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 78
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 79  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 128
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 129 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 179
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 180 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 237
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 238 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 281
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 282 FRDLALRVDQIRD 294

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 313

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 192
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 193 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 240
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 241 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 62  NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGH 119
             +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKE 65
Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAY 178
           + H NIVKLL     ++   L++ ++                     K  +    QGLA+
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIA 236
            H   V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y A
Sbjct: 126 CHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRA 178
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           P     +I+ G     T   D++S G +  E+++ R+
Sbjct: 179 P-----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 73
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 74  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 123
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 124 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 174
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 175 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 232
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 233 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 276
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 277 FRDLALRVDQIRD 289

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 82
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 83  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 132
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 133 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 183
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 184 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 241
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 242 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 285
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 286 FRDLALRVDQIRD 298

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 192
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 193 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 240
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 241 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 34/288 (11%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ YL     
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y      V    G   P K  + +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEXXSVHNKTGAKLPVKW-MAL 205
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P + +   I  ++ +     +P      
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP------ 258
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
              +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 259 ---EYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 296

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 138
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYN----- 191
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 192 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 239
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 240 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 266

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 80
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 81  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 130
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 131 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 181
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 182 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 239
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 240 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 283
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 284 FRDLALRVDQIRD 296

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 74
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 75  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 124
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 125 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 175
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 176 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 233
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 234 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 277
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 278 FRDLALRVDQIRD 290

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYN----- 187
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 188 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 235
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 236 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 262

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 75
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 76  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 125
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 176
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 177 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 235 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 278
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 279 FRDLALRVDQIRD 291

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 62
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 123 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 174
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 175 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 204

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 79
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 80  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 138
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 139 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA---- 191
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 192 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 240
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A E
Sbjct: 241 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTATE 282

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 63
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
                 +LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 175
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 176 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 205

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 62
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
                 +LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 174
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 175 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 63
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 124 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 175
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 176 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 187
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 188 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 235
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 236 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 63
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 124 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 175
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 176 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 205

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 313

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 120 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 171
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 172 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 64
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
                 +LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 176
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 177 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 110/247 (44%), Gaps = 27/247 (10%)
Query: 37  LPPGAEDFSYPWTF-IPFQKLN-FTIDNILECLKDENVIGKG-----CSGVVYKAEMPNG 89
           + PG + F  P+TF  P + +  F  +  + C+K E VIG G     CSG +   ++P  
Sbjct: 3   MTPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHL---KLPGK 59
Query: 90  E--LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISX 147
               +A+K L K+   E+    F +E  I+G   H N++ L G  +  +  +++  ++  
Sbjct: 60  REIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 118
Query: 148 XXXXXXXXXXXXXDWETRYKIAVGSAQGLAY-LHHDCVPAILHRDVKCNNILLDSKYEAY 206
                        D +      VG  +G+A  + +      +HRD+   NIL++S     
Sbjct: 119 GSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCK 175
Query: 207 LADFGLAKLMNSTNYHHAMSRVAGS---YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGV 263
           ++DFGL++ +         +   G      + AP   + +         T  SDV+SYG+
Sbjct: 176 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-------KFTSASDVWSYGI 228
Query: 264 VLLEILS 270
           V+ E++S
Sbjct: 229 VMWEVMS 235

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    S + + +++ Y                         +A   A G+AY+    
Sbjct: 75  LVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM- 133
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 134 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA--- 187
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
            +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P     
Sbjct: 188 -LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPEC 240
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
              L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 241 PESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 313

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 62
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 123 SHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 174
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 175 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
                 +LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 34/292 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  IRH  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKIRHEK 74
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX--DWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA-- 187
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
             +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P    
Sbjct: 188 --LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPE 239
Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
               L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 240 CPESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 122 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 173
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 174 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 203

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 313

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 187
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 188 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 235
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 236 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 262

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 93
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 94  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 143
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 144 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 194
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 195 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 253 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 296
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 297 FRDLALRVDQIRD 309

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 34/292 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 125 IVKLLGYCSNKSVKLLLYNYISX--XXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + + +++  Y+S                       +A   A G+AY+   
Sbjct: 75  LVQLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA-- 187
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
             +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P    
Sbjct: 188 --LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPE 239
Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
               L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 240 CPESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 120 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 171
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 172 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 187
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 188 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 235
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 236 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 262

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 120 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 171
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 172 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
                 +LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 173
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 174 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 203

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 69  DENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           D  VIG G  GVVY+A++  +GEL+A+KK+ + K  +        E+QI+  + H NIV+
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVR 77
Query: 128 LLGYCSNKSVKL------LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAY 178
           L  +  +   K       L+ +Y+                      + +   Q    LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           +H      I HRD+K  N+LLD       L DFG AK +        +S +   Y Y AP
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRAP 191
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                ++I+G T + T   DV+S G VL E+L G+
Sbjct: 192 -----ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 122 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 173
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 174 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 192
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 193 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 240
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 241 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 192
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 193 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 240
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 241 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
                 +LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 173
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 174 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +G+G  G V    Y  E  N GE +AVK L K +     +     EI+IL ++ H NIVK
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 128 LLGYCSN---KSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV 184
             G C+      +KL++    S              + + + K AV   +G+ YL     
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N+L++S+++  + DFGL K + +      +     S  +    +C +Q 
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
            +         SDV+S+GV L E+L+
Sbjct: 205 KFYIA------SDVWSFGVTLHELLT 224

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 52  PFQKLNFTIDNILECLKDENVIGKGCSGVVYK-AEMPNGELIAVKKLWKTKRDEEPVDSF 110
           P Q  +FT ++    LKD   IG+G  G V K    P+G+++AVK++ ++  DE+     
Sbjct: 13  PEQHWDFTAED----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQL 67
Query: 111 AAEIQILGHIRHRN---IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXD----WE 163
             ++ ++  +R  +   IV+  G    +    +    +S              D     E
Sbjct: 68  LMDLDVV--MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 164 TRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYH 222
              KI + + + L +L  +    I+HRD+K +NILLD      L DFG++ +L++S    
Sbjct: 126 ILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI--- 180
Query: 223 HAMSRVAGSYGYIAPGKCKLQIIY-GYTMNITEKSDVYSYGVVLLEILSGR 272
            A +R AG   Y+AP +        GY +    +SDV+S G+ L E+ +GR
Sbjct: 181 -AKTRDAGCRPYMAPERIDPSASRQGYDV----RSDVWSLGITLYELATGR 226

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 120 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 171
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 172 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 201

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G+V+     N + +A+K + +    EE    F  E +++  + H  +V+L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXX-XXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             ++   L++ ++                  ET   + +   +G+AYL   CV   +HRD
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRD 128
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+       ++DFG+ + +    Y         S G   P K     ++ ++  
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVKWASPEVFSFS-R 180
Query: 252 ITEKSDVYSYGVVLLEILS 270
            + KSDV+S+GV++ E+ S
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ +L     
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y      V    G   P K  + +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKW-MAL 206
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 252
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 253 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 297

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 189
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 190 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 237
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 238 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 189
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 190 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 237
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 238 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 264

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ +L     
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y      V    G   P K  + +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKW-MAL 204
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 250
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 251 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 295

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 147
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 200
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 201 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 248
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 249 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 275

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 73/313 (23%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 93
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC- 183
             G C     +++KL++  Y+               D+  ++K  +   + L Y    C 
Sbjct: 94  YKGVCYSAGRRNLKLIM-EYLPYGSLR---------DYLQKHKERIDHIKLLQYTSQICK 143
Query: 184 ------VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                     +HRD+   NIL++++    + DFGL K++        +           P
Sbjct: 144 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EP 194
Query: 238 GKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG--- 282
           G+    I +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+    
Sbjct: 195 GESP--IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 283 ----LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
                H++E +K       P          G PD++   M +       C N++  +RP+
Sbjct: 253 QMIVFHLIELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPS 296
Query: 339 MKEVVALLMEVKS 351
            +++   + +++ 
Sbjct: 297 FRDLALRVDQIRD 309

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 187
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 188 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 235
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 236 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 187
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 188 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 235
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 236 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +Y+   + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 313

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ +L     
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y      V    G   P K  + +
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKW-MAL 211
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 257
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 258 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 302

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G+V+     N + +A+K + +    EE    F  E +++  + H  +V+L G C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXX-XXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             ++   L++ ++                  ET   + +   +G+AYL   CV   +HRD
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRD 126
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+       ++DFG+ + +    Y         S G   P K     ++ ++  
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVKWASPEVFSFS-R 178
Query: 252 ITEKSDVYSYGVVLLEILS 270
            + KSDV+S+GV++ E+ S
Sbjct: 179 YSSKSDVWSFGVLMWEVFS 197

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 137/311 (44%), Gaps = 48/311 (15%)
Query: 52  PFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFA 111
           P++K  + I    E LK E  +G G  G V+ A       +AVK +   K     V++F 
Sbjct: 177 PWEKDAWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFL 231
Query: 112 AEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI--- 168
           AE  ++  ++H  +VKL    + + + +     I+              D  ++  +   
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKEPIYI-----ITEFMAKGSLLDFLKSDEGSKQPLPKL 286
Query: 169 ---AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
              +   A+G+A++        +HRD++  NIL+ +     +ADFGLA+++    Y    
Sbjct: 287 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---T 340
Query: 226 SRVAGSY--GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
           +R    +   + AP      I +G   + T KSDV+S+G++L+EI++      P + +  
Sbjct: 341 AREGAKFPIKWTAPE----AINFG---SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP- 392
Query: 284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            ++  +++      P         +  P+++         I M C  + P ERPT + + 
Sbjct: 393 EVIRALERGYRMPRP---------ENCPEEL-------YNIMMRCWKNRPEERPTFEYIQ 436
Query: 344 ALLMEVKSAPE 354
           ++L +  +A E
Sbjct: 437 SVLDDFYTATE 447

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 64
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
                 +LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 176
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 177 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 125/298 (41%), Gaps = 52/298 (17%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNV 94
Query: 126 VKLLGYCSNKSVKLLL------YNYISXXXXXXXXXXXXXXDWETRYK----------IA 169
           V LLG C+     L++      +  +S                E  YK           +
Sbjct: 95  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 170 VGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
              A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +            
Sbjct: 155 FQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E 
Sbjct: 211 RLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDEE 259
Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 260 FCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ +L     
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y      V    G   P K  + +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKW-MAL 207
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 253
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 254 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 298

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ +L     
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y      V    G   P K  + +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKW-MAL 206
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 252
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 253 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 297

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 118/291 (40%), Gaps = 41/291 (14%)
Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           + VIG G + VV  A   P  E +A+K++   ++ +  +D    EIQ +    H NIV  
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 129 LGYCSNKSVKLLLYNYIS--------XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
                 K    L+   +S                      D  T   I     +GL YLH
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM---NSTNYHHAMSRVAGSYGYIAP 237
            +     +HRDVK  NILL       +ADFG++  +        +       G+  ++AP
Sbjct: 139 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
               ++ + GY      K+D++S+G+  +E+ +G +          H    +K  M + +
Sbjct: 196 E--VMEQVRGYDF----KADIWSFGITAIELATGAAP--------YHKYPPMKVLMLTLQ 241
Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAM-----FCVNSSPAERPTMKEVV 343
                L+T +Q       +EML+  G +       C+   P +RPT  E++
Sbjct: 242 NDPPSLETGVQD------KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 111/246 (45%), Gaps = 25/246 (10%)
Query: 31  ASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSG-VVYKAEMPNG 89
           A+G S   PG    + P  F+      F+     +  K + V+GKG  G V+   +   G
Sbjct: 21  AAGTSG-GPGDHLHATPGMFVQHSTAIFS-----DRYKGQRVLGKGSFGEVILCKDKITG 74
Query: 90  ELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXX 148
           +  AVK + K + + +   +S   E+Q+L  + H NI+KL  +  +K    L+    +  
Sbjct: 75  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 134
Query: 149 XXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEA--- 205
                             +I      G+ Y+H +    I+HRD+K  N+LL+SK +    
Sbjct: 135 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI 191
Query: 206 YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVL 265
            + DFGL+    ++     M    G+  YIAP     ++++G      EK DV+S GV+L
Sbjct: 192 RIIDFGLSTHFEASK---KMKDKIGTAYYIAP-----EVLHG---TYDEKCDVWSTGVIL 240
Query: 266 LEILSG 271
             +LSG
Sbjct: 241 YILLSG 246

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 34/292 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 67
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX--DWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 68  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 126
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 127 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA-- 180
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
             +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P    
Sbjct: 181 --LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPE 232
Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
               L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 233 CPESLH---DLMCQ-----------CWRKEPEERPTFEYLQAFLEDYFTSTE 270

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G+V+     N + +A+K + +    EE    F  E +++  + H  +V+L G C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXX-XXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             ++   L++ ++                  ET   + +   +G+AYL   CV   +HRD
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRD 131
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+       ++DFG+ + +    Y         S G   P K     ++ ++  
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVKWASPEVFSFS-R 183
Query: 252 ITEKSDVYSYGVVLLEILS 270
            + KSDV+S+GV++ E+ S
Sbjct: 184 YSSKSDVWSFGVLMWEVFS 202

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 111/246 (45%), Gaps = 25/246 (10%)
Query: 31  ASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSG-VVYKAEMPNG 89
           A+G S   PG    + P  F+      F+     +  K + V+GKG  G V+   +   G
Sbjct: 22  AAGTSG-GPGDHLHATPGMFVQHSTAIFS-----DRYKGQRVLGKGSFGEVILCKDKITG 75
Query: 90  ELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXX 148
           +  AVK + K + + +   +S   E+Q+L  + H NI+KL  +  +K    L+    +  
Sbjct: 76  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 135
Query: 149 XXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEA--- 205
                             +I      G+ Y+H +    I+HRD+K  N+LL+SK +    
Sbjct: 136 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI 192
Query: 206 YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVL 265
            + DFGL+    ++     M    G+  YIAP     ++++G      EK DV+S GV+L
Sbjct: 193 RIIDFGLSTHFEASK---KMKDKIGTAYYIAP-----EVLHG---TYDEKCDVWSTGVIL 241
Query: 266 LEILSG 271
             +LSG
Sbjct: 242 YILLSG 247

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +G+G  G V    Y  E  N GE +AVK L K +     +     EI+IL ++ H NIVK
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 128 LLGYCSN---KSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV 184
             G C+      +KL++    S              + + + K AV   +G+ YL     
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR-- 133
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N+L++S+++  + DFGL K + +      +     S  +    +C +Q 
Sbjct: 134 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
            +         SDV+S+GV L E+L+
Sbjct: 193 KFYIA------SDVWSFGVTLHELLT 212

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 73  IGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIRHRNIVKLLG 130
           IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + H NIVKLL 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLHHDCVPAILH 189
               ++   L++ ++                     K  +    QGLA+ H   V   LH
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 125
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           RD+K  N+L++++    LADFGLA+        Y H +     +  Y AP     +I+ G
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP-----EILLG 176
Query: 248 YTMNITEKSDVYSYGVVLLEILSGRS 273
                T   D++S G +  E+++ R+
Sbjct: 177 CKYYST-AVDIWSLGCIFAEMVTRRA 201

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM   T   HA ++      + AP           
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLAYN----- 185
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 186 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DPSQVYELLEKDYRMERP---------E 233
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 234 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 260

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 34/292 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 63
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX--DWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 64  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 122
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 123 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA-- 176
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
             +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P    
Sbjct: 177 --LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPE 228
Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
               L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 229 CPESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 266

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 119/291 (40%), Gaps = 41/291 (14%)
Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           + VIG G + VV  A   P  E +A+K++   ++ +  +D    EIQ +    H NIV  
Sbjct: 15  QEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSY 73
Query: 129 LGYCSNKSVKLLLYNYIS--------XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
                 K    L+   +S                      D  T   I     +GL YLH
Sbjct: 74  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 133
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS---TNYHHAMSRVAGSYGYIAP 237
            +     +HRDVK  NILL       +ADFG++  + +      +       G+  ++AP
Sbjct: 134 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 190
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
               ++ + GY      K+D++S+G+  +E+ +G +          H    +K  M + +
Sbjct: 191 E--VMEQVRGYDF----KADIWSFGITAIELATGAAP--------YHKYPPMKVLMLTLQ 236
Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAM-----FCVNSSPAERPTMKEVV 343
                L+T +Q       +EML+  G +       C+   P +RPT  E++
Sbjct: 237 NDPPSLETGVQD------KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           VIG G  GVV++A++   + +A+KK+ + KR +        E+QI+  ++H N+V L  +
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAF 100
Query: 132 CSNKSVKL------LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHD 182
             +   K       L+  Y+                      I +   Q    LAY+H  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 183 CVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
               I HRD+K  N+LLD       L DFG AK++ +   +  +S +   Y Y AP    
Sbjct: 161 ---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSXICSRY-YRAP---- 210
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            ++I+G T N T   D++S G V+ E++ G+
Sbjct: 211 -ELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 34/288 (11%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ +L     
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    Y      V    G   P K  + +
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKW-MAL 265
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P + +   I  ++ +     +P      
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP------ 318
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
              +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 319 ---EYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 356

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 78
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 79  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 137
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 138 --NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEA---- 190
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 191 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 239
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A E
Sbjct: 240 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTATE 281

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 70  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA---- 181
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 182 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 230
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A
Sbjct: 231 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 75
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 76  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 134
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 135 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA---- 187
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 188 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 236
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A
Sbjct: 237 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 118/293 (40%), Gaps = 36/293 (12%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 65
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX--DWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 66  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 124
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 125 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA-- 178
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
             +YG     T KSDV+S+G++L E+ +      P + +                    +
Sbjct: 179 --LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------------EV 215
Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVKSAPE 354
           LD   +G       E  ++L   M  C    P ERPT + + A L +  ++ E
Sbjct: 216 LDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 268

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    +  HA ++      + AP           
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFP--IKWTAPESLAYN----- 185
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 186 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DPSQVYELLEKDYRMERP---------E 233
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 234 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 260

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 50/300 (16%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY-------KIAVGSAQGLA 177
           +V+L    S + +      YI                   +Y        +A   A G+A
Sbjct: 241 LVQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYI 235
           Y+        +HRD++  NIL+       +ADFGLA+L+    Y    +R    +   + 
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWT 348
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
           AP       +YG     T KSDV+S+G++L E+ +      P +         V ++   
Sbjct: 349 APEAA----LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGM---------VNRE--- 389
Query: 296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVKSAPE 354
                 +LD   +G       E  ++L   M  C    P ERPT + + A L +  ++ E
Sbjct: 390 ------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 55/318 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +     + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM 347
             K           + +      P     E+   +     C ++ P++RPT K++V  L 
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLD 314
Query: 348 EV--KSAPEELGKTSQPL 363
            +   +  EE    SQPL
Sbjct: 315 RILTLTTNEEYLDLSQPL 332

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 38/294 (12%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX--DWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKC 240
                +HRD++  NIL+       +ADFGLA+L+    Y    +R    +   + AP   
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAA 187
Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
               +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P  
Sbjct: 188 ----LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCP 237
Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                 L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 238 PECPESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    S + + ++  Y                         +A   A G+AY+    
Sbjct: 75  LVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM- 133
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 134 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA--- 187
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
            +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P     
Sbjct: 188 -LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPEC 240
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
              L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 241 PESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 50/300 (16%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY-------KIAVGSAQGLA 177
           +V+L    S + +      YI                   +Y        +A   A G+A
Sbjct: 241 LVQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYI 235
           Y+        +HRD++  NIL+       +ADFGLA+L+    Y    +R    +   + 
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWT 348
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
           AP       +YG     T KSDV+S+G++L E+ +      P +         V ++   
Sbjct: 349 APEAA----LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGM---------VNRE--- 389
Query: 296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVKSAPE 354
                 +LD   +G       E  ++L   M  C    P ERPT + + A L +  ++ E
Sbjct: 390 ------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 59/306 (19%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 78
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV 184
             G C     +++KL++                   D     +      +G+ YL     
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   NIL++++    + DFGL K++        +           PG+    I
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EPGESP--I 184
Query: 245 IYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG-------LHI 285
            +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+         H+
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 244
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
           +E +K       P          G PD++   M +       C N++  +RP+ +++   
Sbjct: 245 IELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPSFRDLALR 288
Query: 346 LMEVKS 351
           + +++ 
Sbjct: 289 VDQIRD 294

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM   T   HA ++      + AP           
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLAYN----- 185
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 186 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DPSQVYELLEKDYRMERP---------E 233
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 234 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 260

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 68  KDENVIGKGCSG-VVYKAEMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNI 125
           K + V+GKG  G V+   +   G+  AVK + K + + +   +S   E+Q+L  + H NI
Sbjct: 35  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 94
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           +KL  +  +K    L+    +                    +I      G+ Y+H +   
Sbjct: 95  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--- 151
Query: 186 AILHRDVKCNNILLDSKYEA---YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
            I+HRD+K  N+LL+SK +     + DFGL+    ++     M    G+  YIAP     
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAP----- 203
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           ++++G      EK DV+S GV+L  +LSG
Sbjct: 204 EVLHG---TYDEKCDVWSTGVILYILLSG 229

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 52  PFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFA 111
           P++K  + I    E LK E  +G G  G V+ A       +AVK +   K     V++F 
Sbjct: 4   PWEKDAWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFL 58
Query: 112 AEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI--- 168
           AE  ++  ++H  +VKL    + + + +     I+              D  ++  +   
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVTKEPIYI-----ITEFMAKGSLLDFLKSDEGSKQPLPKL 113
Query: 169 ---AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
              +   A+G+A++        +HRD++  NIL+ +     +ADFGLA+++    Y  A 
Sbjct: 114 IDFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR 169
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
                   + AP      I +G   + T KSDV+S+G++L+EI++      P + +   +
Sbjct: 170 EGAKFPIKWTAPE----AINFG---SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EV 221
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
           +  +++      P         +  P+++         I M C  + P ERPT + + ++
Sbjct: 222 IRALERGYRMPRP---------ENCPEEL-------YNIMMRCWKNRPEERPTFEYIQSV 265
Query: 346 L 346
           L
Sbjct: 266 L 266

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 59/306 (19%)
Query: 73  IGKGCSGVV----YKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           +GKG  G V    Y     N GE++AVKKL  +   EE +  F  EI+IL  ++H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 78
Query: 128 LLGYC---SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV 184
             G C     +++KL++                   D     +      +G+ YL     
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   NIL++++    + DFGL K++        +           PG+    I
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK---------EPGESP--I 184
Query: 245 IYGYTMNITEK-----SDVYSYGVVLLEILS--GRSAVQP-----QIGDG-------LHI 285
            +    ++TE      SDV+S+GVVL E+ +   +S   P      IG+         H+
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 244
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
           +E +K       P          G PD++   M +       C N++  +RP+ +++   
Sbjct: 245 IELLKNNGRLPRP---------DGCPDEIYMIMTE-------CWNNNVNQRPSFRDLALR 288
Query: 346 LMEVKS 351
           + +++ 
Sbjct: 289 VDQIRD 294

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV K +     LI  +KL   +      +    E+Q+L    
Sbjct: 13  LKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 72
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 E   K+++   +GLAYL 
Sbjct: 73  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y+AP +
Sbjct: 132 EKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMAPER 184
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 185 LQ-------GTHYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 34/292 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 125 IVKLLGYCSNKSVKLLLYNYISX--XXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA-- 187
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
             +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P    
Sbjct: 188 --LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPE 239
Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
               L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 240 CPESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 75
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 76  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 134
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 135 --NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEA---- 187
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 188 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 236
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A E
Sbjct: 237 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTATE 278

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 55/300 (18%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 84
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA---------------- 169
           V LLG C+     L++                   ++   YK+A                
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLIC 143
Query: 170 --VGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
                A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +    
Sbjct: 144 YSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
                  ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I 
Sbjct: 200 DARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKID 248
Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E   +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 249 EEFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 55/300 (18%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 84
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA---------------- 169
           V LLG C+     L++                   ++   YK+A                
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLIC 143
Query: 170 --VGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
                A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +    
Sbjct: 144 YSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
                  ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I 
Sbjct: 200 DARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKID 248
Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E   +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 249 EEFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    S + + +++ Y                         +A   A G+AY+    
Sbjct: 75  LVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM- 133
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 134 --NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEXTARQGAKFPIKWTAPEAA--- 187
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
            +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P     
Sbjct: 188 -LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPEC 240
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
              L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 241 PESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 77
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 78  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 136
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 137 --NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEA---- 189
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 190 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 238
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A E
Sbjct: 239 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTATE 280

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 70  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEA---- 181
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 182 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 230
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A E
Sbjct: 231 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTATE 272

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGL++ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
                 +LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 124/300 (41%), Gaps = 55/300 (18%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 84
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA---------------- 169
           V LLG C+     L++                   ++   YK+A                
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF-VPYKVAPEDLYKDFLTLEHLIC 143
Query: 170 --VGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
                A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +          
Sbjct: 144 YSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
                  ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I 
Sbjct: 200 DARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKID 248
Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E   +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 249 EEFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 21/228 (9%)
Query: 52  PFQKLNFTIDNILECLKDENVIGKG-----CSGVVYKAEMPNGELIAVKKLWKTKRDEEP 106
           P+  + F  +  +  +K E VIG G     C G + KA       +A+K L K    E  
Sbjct: 1   PWGSMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRL-KAPGKKESCVAIKTL-KGGYTERQ 58
Query: 107 VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY 166
              F +E  I+G   H NI++L G  +N    ++L  ++               D +   
Sbjct: 59  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLN---DGQFTV 115
Query: 167 KIAVGSAQGLAY-LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
              VG  +G+A  + +    + +HRD+   NIL++S     ++DFGL++ +   +     
Sbjct: 116 IQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 226 SRVAGS---YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +   G      + AP     +         T  SD +SYG+V+ E++S
Sbjct: 176 TSSLGGKIPIRWTAPEAIAFR-------KFTSASDAWSYGIVMWEVMS 216

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 116/292 (39%), Gaps = 34/292 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 64
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    S + + ++  Y                         +A   A G+AY+    
Sbjct: 65  LVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 123
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 124 --NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEXTARQGAKFPIKWTAPEAA--- 177
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
            +YG     T KSDV+S+G++L E+ +      P + +                    +L
Sbjct: 178 -LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------------EVL 215
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVKSAPE 354
           D   +G       E  ++L   M  C    P ERPT + + A L +  ++ E
Sbjct: 216 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM   T   HA ++      + AP           
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLAYN----- 192
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 193 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 240
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 241 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 267

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 50/300 (16%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY-------KIAVGSAQGLA 177
           +V+L    S + +      YI                   +Y        +A   A G+A
Sbjct: 241 LVQLYAVVSEEPI------YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYI 235
           Y+        +HRD++  NIL+       +ADFGLA+L+    Y    +R    +   + 
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWT 348
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
           AP       +YG     T KSDV+S+G++L E+ +      P +         V ++   
Sbjct: 349 APEAA----LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGM---------VNRE--- 389
Query: 296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVKSAPE 354
                 +LD   +G       E  ++L   M  C    P ERPT + + A L +  ++ E
Sbjct: 390 ------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G +G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 70  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKCK 241
               +HRD++  NIL+       +ADFGLA+L+         +R    +   + AP    
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDA---EXTAREGAKFPIKWTAPEA-- 181
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
             I YG     T KSDV+S+G++L EI++      P + +         + + + E    
Sbjct: 182 --INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYR 228
Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
           ++       PD   +E+ Q + +   C    P +RPT   + ++L +  +A E
Sbjct: 229 MVR------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTATE 272

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 FVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 68  KDENVIGKGCSG-VVYKAEMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNI 125
           K + V+GKG  G V+   +   G+  AVK + K + + +   +S   E+Q+L  + H NI
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
           +KL  +  +K    L+    +                    +I      G+ Y+H +   
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--- 145
Query: 186 AILHRDVKCNNILLDSKYEA---YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
            I+HRD+K  N+LL+SK +     + DFGL+    ++     M    G+  YIAP     
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAP----- 197
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           ++++G      EK DV+S GV+L  +LSG
Sbjct: 198 EVLHG---TYDEKCDVWSTGVILYILLSG 223

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 55/318 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        P   +    K+ K    E+ +    +E++++  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI---------------- 168
           I+ LLG C+      ++  Y S                E  Y I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
               A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+ +     + 
Sbjct: 163 TYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     +Y      T +SDV+S+GV++ EI +   +  P    G+ + E
Sbjct: 219 GRLPVKWMAP-EALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP----GIPVEE 267
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM 347
             K           + +      P     E+   +     C ++ P++RPT K++V  L 
Sbjct: 268 LFK----------LLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLD 314
Query: 348 EV--KSAPEELGKTSQPL 363
            +   +  EE    SQPL
Sbjct: 315 RILTLTTNEEYLDLSQPL 332

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 FVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  Y                  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           A   A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ ++  +Y+   + 
Sbjct: 197 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E
Sbjct: 253 GRLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEE 301
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 302 LFK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 347

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 66
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 127 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAG 177
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 178 FVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 64
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 65  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 123
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 124 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA---- 176
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 177 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 225
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A
Sbjct: 226 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 135
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM   T   HA ++      + AP           
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLAYN----- 188
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 189 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 236
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 237 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 263

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVD-SFAAEI 114
           +FTID+     +    +GKG  G VY A E  +  ++A+K L+K++ ++E V+     EI
Sbjct: 19  HFTIDD----FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREI 74
Query: 115 QILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ 174
           +I  H+ H NI++L  Y  ++    L+  Y                D +    I    A 
Sbjct: 75  EIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELAD 134
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L Y H      ++HRD+K  N+LL  K E  +ADFG +    S         + G+  Y
Sbjct: 135 ALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR----RKTMCGTLDY 187
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           + P     ++I G   N  EK D++  GV+  E+L G
Sbjct: 188 LPP-----EMIEGRMHN--EKVDLWCIGVLCYELLVG 217

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 34/297 (11%)
Query: 70  ENVIGKGCSG-VVY-KAEMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           E +IG G SG V Y +  +P    + V  K  K    E     F +E  I+G   H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL-AYLHHDCVP 185
           +L G  +   + +++  Y+               D +      VG  +G+ A + +    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS--YGYIAPGKCKLQ 243
             +HRD+   N+L+DS     ++DFGL++++   +   A +   G     + AP     +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
                    +  SDV+S+GVV+ E+L+         G+  +     +  + S E    + 
Sbjct: 230 -------TFSSASDVWSFGVVMWEVLA--------YGERPYWNMTNRDVISSVEEGYRL- 273
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
                G P  + Q ML        C +   A+RP   ++V++L  +  +PE L  T+
Sbjct: 274 -PAPMGCPHALHQLMLD-------CWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 42/292 (14%)
Query: 72  VIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G VY   +   +G+ I  AVK L +   D   V  F  E  I+    H N++ 
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 128 LLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG--SAQGLAYLHHDCV 184
           LLG C  ++   L++  Y+               +   +  I  G   A+G+ +L     
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              +HRD+   N +LD K+   +ADFGLA+ M    +    ++              LQ 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ- 211
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
               T   T KSDV+S+GV+L E+++  +   P +               +F+  V +L 
Sbjct: 212 ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------NTFDITVYLLQ 253
Query: 305 TKL----QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
            +     +  PD + + ML+       C +     RP+  E+V+ +  + S 
Sbjct: 254 GRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFST 298

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 76
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 137 I-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 187
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 188 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 51/298 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  Y                  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A   A+G+ YL        +HRD+   N+L+       +ADFGLA+ ++  +Y+   +  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E 
Sbjct: 205 RLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEEL 253
Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 254 FK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 298

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 90
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 151 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 201
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 202 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + IG G  G V  A +   G  +AVKKL +  +          
Sbjct: 16  QELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 75
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 136 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTG 186
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 187 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 30  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 89
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 150 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 200
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 201 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 34/297 (11%)
Query: 70  ENVIGKGCSG-VVY-KAEMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           E +IG G SG V Y +  +P    + V  K  K    E     F +E  I+G   H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL-AYLHHDCVP 185
           +L G  +   + +++  Y+               D +      VG  +G+ A + +    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS--YGYIAPGKCKLQ 243
             +HRD+   N+L+DS     ++DFGL++++   +   A +   G     + AP     +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
                    +  SDV+S+GVV+ E+L+         G+  +     +  + S E    + 
Sbjct: 230 -------TFSSASDVWSFGVVMWEVLA--------YGERPYWNMTNRDVISSVEEGYRL- 273
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS 360
                G P  + Q ML        C +   A+RP   ++V++L  +  +PE L  T+
Sbjct: 274 -PAPMGCPHALHQLMLD-------CWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 66
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 127 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 177
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 178 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 118/291 (40%), Gaps = 32/291 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 71
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    S + + ++  Y                         ++   A G+AY+    
Sbjct: 72  LVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM- 130
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 131 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA--- 184
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
            +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P     
Sbjct: 185 -LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPEC 237
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
              L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 238 PESLH---DLMCQ-----------CWRKEPEERPTFEYLQAFLEDYFTSTE 274

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN---KSVKLLLYNY 144
            GE++AVK L K     +    +  EI IL  + H +I+K  G C +   KS++L++  Y
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVM-EY 99
Query: 145 ISXXXXXXXXXXXXXXDWETRYKIAVGS--------AQGLAYLHHDCVPAILHRDVKCNN 196
           +               D+  R+ I +           +G+AYLH       +HR++   N
Sbjct: 100 VPLGSLR---------DYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARN 147
Query: 197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKS 256
           +LLD+     + DFGLAK +   + ++ +     S  +    +C  +  + Y       S
Sbjct: 148 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA------S 201
Query: 257 DVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQ 316
           DV+S+GV L E+L+   + Q      L ++   + +M        +   +    PD+   
Sbjct: 202 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPC 261
Query: 317 EMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
           E+     +   C  +  + RPT + ++ +L  V
Sbjct: 262 EVYH---LMKNCWETEASFRPTFENLIPILKTV 291

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 44/229 (19%)
Query: 67  LKDENVIGKGCSGVVYKAEMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQIL---GHI 120
           +K ++VIG+G  G V KA +    L    A+K++ +    ++  D FA E+++L   GH 
Sbjct: 17  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGH- 74
Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA------- 173
            H NI+ LLG C ++    L   Y                + +  + IA  +A       
Sbjct: 75  -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 174 ---------QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
                    +G+ YL        +HRD+   NIL+   Y A +ADFGL            
Sbjct: 134 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL------------ 178
Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMN---ITEKSDVYSYGVVLLEILS 270
            SR    Y     G+  ++ +   ++N    T  SDV+SYGV+L EI+S
Sbjct: 179 -SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 51/298 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  Y                  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A   A+G+ YL        +HRD+   N+L+       +ADFGLA+ ++  +Y+   +  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E 
Sbjct: 206 RLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEEL 254
Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 255 FK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 299

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 40/295 (13%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX--DWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 324 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKC 240
                +HRD++  NIL+       +ADFGLA+L+    Y    +R    +   + AP   
Sbjct: 383 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAA 436
Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
               +YG     T KSDV+S+G++L E+ +      P +         V ++        
Sbjct: 437 ----LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGM---------VNRE-------- 472
Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVKSAPE 354
            +LD   +G       E  ++L   M  C    P ERPT + + A L +  ++ E
Sbjct: 473 -VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 95
Query: 126 VKLLGYCSNKSVKLL----------LYNYISXXXXXXXXXXXXXXDWETRYKI------- 168
           V LLG C+     L+          L  Y+               D    +         
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           +   A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +     
Sbjct: 156 SFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E
Sbjct: 212 ARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDE 260
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 261 EFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 307

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 44/229 (19%)
Query: 67  LKDENVIGKGCSGVVYKAEMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQIL---GHI 120
           +K ++VIG+G  G V KA +    L    A+K++ +    ++  D FA E+++L   GH 
Sbjct: 27  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGH- 84
Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA------- 173
            H NI+ LLG C ++    L   Y                + +  + IA  +A       
Sbjct: 85  -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 174 ---------QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
                    +G+ YL        +HRD+   NIL+   Y A +ADFGL            
Sbjct: 144 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL------------ 188
Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMN---ITEKSDVYSYGVVLLEILS 270
            SR    Y     G+  ++ +   ++N    T  SDV+SYGV+L EI+S
Sbjct: 189 -SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 126 VKLLGYCSNKSVKLL----------LYNYISXXXXXXXXXXXXXXDWETRYKI------- 168
           V LLG C+     L+          L  Y+               D    +         
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           +   A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +     
Sbjct: 154 SFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E
Sbjct: 210 ARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDE 258
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 259 EFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 51/298 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  Y                  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A   A+G+ YL        +HRD+   N+L+       +ADFGLA+ ++  +Y+   +  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E 
Sbjct: 213 RLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEEL 261
Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 262 FK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 306

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 32/272 (11%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK--LLLYNYI 145
            GE++AVK L K     +    +  EI IL  + H +I+K  G C +       L+  Y+
Sbjct: 59  TGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 146 SXXXXXXXXXXXXXXDWETRYKIAVGS--------AQGLAYLHHDCVPAILHRDVKCNNI 197
                          D+  R+ I +           +G+AYLH       +HRD+   N+
Sbjct: 118 PLGSLR---------DYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNV 165
Query: 198 LLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSD 257
           LLD+     + DFGLAK +   +  + +     S  +    +C  +  + Y       SD
Sbjct: 166 LLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYA------SD 219
Query: 258 VYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQE 317
           V+S+GV L E+L+   + Q      L ++   + +M        +   +    PD+   E
Sbjct: 220 VWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE 279
Query: 318 MLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
           +   +     C  +  + RPT + ++ +L  V
Sbjct: 280 VYHLM---KNCWETEASFRPTFENLIPILKTV 308

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 130
Query: 126 VKLLGYCSNKSVKLL----------LYNYISXXXXXXXXXXXXXXDWETRYKI------- 168
           V LLG C+     L+          L  Y+               D    +         
Sbjct: 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           +   A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +     
Sbjct: 191 SFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E
Sbjct: 247 ARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDE 295
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 296 EFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 342

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 51/298 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  Y                  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A   A+G+ YL        +HRD+   N+L+       +ADFGLA+ ++  +Y+   +  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E 
Sbjct: 213 RLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEEL 261
Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 262 FK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 306

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 51/298 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  Y                  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A   A+G+ YL        +HRD+   N+L+       +ADFGLA+ ++  +Y+   +  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E 
Sbjct: 202 RLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEEL 250
Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 251 FK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 295

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN---KSVKLLLYNY 144
            GE++AVK L K     +    +  EI IL  + H +I+K  G C +   KS++L++  Y
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVM-EY 99
Query: 145 ISXXXXXXXXXXXXXXDWETRYKIAVGS--------AQGLAYLHHDCVPAILHRDVKCNN 196
           +               D+  R+ I +           +G+AYLH       +HR++   N
Sbjct: 100 VPLGSLR---------DYLPRHSIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARN 147
Query: 197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKS 256
           +LLD+     + DFGLAK +   + ++ +     S  +    +C  +  + Y       S
Sbjct: 148 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA------S 201
Query: 257 DVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQ 316
           DV+S+GV L E+L+   + Q      L ++   + +M        +   +    PD+   
Sbjct: 202 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPC 261
Query: 317 EMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
           E+     +   C  +  + RPT + ++ +L  V
Sbjct: 262 EVYH---LMKNCWETEASFRPTFENLIPILKTV 291

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 71
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 72  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 130
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 131 --NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEA---- 183
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 184 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 232
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A
Sbjct: 233 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTA 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 70  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEA---- 181
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 182 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 230
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A
Sbjct: 231 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 109/226 (48%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 90
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M  
Sbjct: 151 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMXG 201
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 202 XVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL K  +          
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR 82
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 143 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 193
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 194 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+ K+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 121 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 172
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 173 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 202

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+ K+ +   + E V S A  EI +L  + 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS-AQGLAYLH 180
           H NIVKLL     ++   L++ ++                     K  +    QGLA+ H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPG 238
              V   LHRD+K  N+L++++    LADFGLA+        Y H +     +  Y AP 
Sbjct: 120 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP- 171
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +I+ G     T   D++S G +  E+++ R+
Sbjct: 172 ----EILLGCKYYST-AVDIWSLGCIFAEMVTRRA 201

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 119/292 (40%), Gaps = 34/292 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX--DWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD+   NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 134 ---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA-- 187
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
             +YG     T KSDV+S+G++L E+ +      P + +   +++ V++  G   P    
Sbjct: 188 --LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER--GYRMPCPPE 239
Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
               L    D M Q           C    P ERPT + + A L +  ++ E
Sbjct: 240 CPESLH---DLMCQ-----------CWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 73  IGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEE----PVDSF--AAEIQILGHIRHRNI 125
           IG G  G VYKA  P+ G  +A+K +            P+ +    A ++ L    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 126 VKLLGYC----SNKSVKL-LLYNYISXXXXXXXXXXXXX-XDWETRYKIAVGSAQGLAYL 179
           V+L+  C    +++ +K+ L++ ++                  ET   +     +GL +L
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H +C   I+HRD+K  NIL+ S     LADFGLA++    +Y  A++ V  +  Y AP +
Sbjct: 137 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYRAP-E 189
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
             LQ  Y   +      D++S G +  E+ 
Sbjct: 190 VLLQSTYATPV------DMWSVGCIFAEMF 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 70
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 71  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 129
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+   N   A         + AP      
Sbjct: 130 --NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEA---- 182
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 183 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 231
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A
Sbjct: 232 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTA 271

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 36/230 (15%)
Query: 62  NILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDS--FA----AEI 114
           NI    + ++++G+G  GVV  A   P GE++A+KK+       EP D   FA     EI
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREI 60
Query: 115 QILGHIRHRNIVKLLGYCSNKSVKLLLYNYI----SXXXXXXXXXXXXXXDWETRYKIAV 170
           +IL H +H NI+ +       S +     YI                   D   +Y I  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-Y 119
Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--------TNYH 222
            + + +  LH   V   +HRD+K +N+L++S  +  + DFGLA++++         T   
Sbjct: 120 QTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             M+    +  Y AP        Y   M      DV+S G +L E+   R
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAELFLRR 220

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G+V+     N + +A+K + +    EE    F  E +++  + H  +V+L G C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXX-XXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             ++   L+  ++                  ET   + +   +G+AYL   CV   +HRD
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+       ++DFG+ + +    Y         S G   P K     ++ ++  
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVKWASPEVFSFS-R 181
Query: 252 ITEKSDVYSYGVVLLEILS 270
            + KSDV+S+GV++ E+ S
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 123/296 (41%), Gaps = 49/296 (16%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNV 95
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDW-----ETRYK----------IAV 170
           V LLG C+     L++                   ++     E  YK           + 
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG 230
             A+G+ +L        +HRD+   NILL  K    + DFGLA+ +              
Sbjct: 156 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK 290
              ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E   
Sbjct: 213 PLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDEEFC 261
Query: 291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 262 RRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 75
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 136 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTG 186
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 187 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 128/297 (43%), Gaps = 35/297 (11%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 22  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 81
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 82  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 141 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 193
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +         + + +SD++S G+ L+E+  GR      IG G          M  FE  
Sbjct: 194 LQ-------GTHYSVQSDIWSMGLSLVEMAVGRYP----IGSG-------SGSMAIFELL 235
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEEL 356
             I++     LP  +     Q       C+  +PAER  +K+++      +S  EE+
Sbjct: 236 DYIVNEPPPKLPSGVFSLEFQDF--VNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 290

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 126 VKLLGYCSNKSVKLL----------LYNYISXXXXXXXXXXXXXXDWETRYKI------- 168
           V LLG C+     L+          L  Y+               D    +         
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           +   A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +           
Sbjct: 154 SFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E
Sbjct: 210 ARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDE 258
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 259 EFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 22  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 81
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 142 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTG 192
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 193 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 61  DNILECLKDENVIGKGCSGVVYKA-EMPNG-ELIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           D   EC+ +   IG+G  G V+KA ++ NG   +A+K++     +E    S   E+ +L 
Sbjct: 10  DQQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 119 HIR---HRNIVKLLGYCS----NKSVKL-LLYNYISXXXXXXXXXXXXX-XDWETRYKIA 169
           H+    H N+V+L   C+    ++  KL L++ ++                  ET   + 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
               +GL +LH      ++HRD+K  NIL+ S  +  LADFGLA++    ++  A++ V 
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
            +  Y AP +  LQ  Y   +      D++S G +  E+ 
Sbjct: 181 VTLWYRAP-EVLLQSSYATPV------DLWSVGCIFAEMF 213

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 36/230 (15%)
Query: 62  NILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDS--FA----AEI 114
           NI    + ++++G+G  GVV  A   P GE++A+KK+       EP D   FA     EI
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREI 60
Query: 115 QILGHIRHRNIVKLLGYCSNKSVKLLLYNYI----SXXXXXXXXXXXXXXDWETRYKIAV 170
           +IL H +H NI+ +       S +     YI                   D   +Y I  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-Y 119
Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--------TNYH 222
            + + +  LH   V   +HRD+K +N+L++S  +  + DFGLA++++         T   
Sbjct: 120 QTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             M+    +  Y AP        Y   M      DV+S G +L E+   R
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAELFLRR 220

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 40/295 (13%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGNMSPEAFLQEAQVMKKLRHEK 241
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXX--DWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S                       +A   A G+AY+   
Sbjct: 242 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 299
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY--GYIAPGKC 240
                +HRD++  NIL+       +ADFGL +L+    Y    +R    +   + AP   
Sbjct: 300 --MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY---TARQGAKFPIKWTAPEAA 354
Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
               +YG     T KSDV+S+G++L E+ +      P +         V ++        
Sbjct: 355 ----LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGM---------VNRE-------- 390
Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVKSAPE 354
            +LD   +G       E  ++L   M  C    P ERPT + + A L +  ++ E
Sbjct: 391 -VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 444

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 71  NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           + +G G  G V   E    G  +AVK L + K R  + V     EIQ L   RH +I+KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 129 LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
               S  +   ++  Y+S              +     ++       + Y H   V   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV---V 133
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+LLD+   A +ADFGL+ +M+   +   +    GS  Y AP     ++I G 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAP-----EVISG- 184
Query: 249 TMNITEKSDVYSYGVVLLEILSG 271
            +    + D++S GV+L  +L G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G VYKA+      +A  K+ +TK +EE ++ +  EI+IL    H  IVKLLG  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA-QGLAYLHHDCVPAILHRD 191
            +     ++  +                  E + ++      + L +LH      I+HRD
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 134
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+L+  + +  LADFG++   N        S +   Y ++AP     +++   TM 
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPY-WMAP-----EVVMCETMK 187
Query: 252 ITE---KSDVYSYGVVLLEI 268
            T    K+D++S G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 84
Query: 126 VKLLGYCSNKSVKLL----------LYNYISXXXXXXXXXXXXXXDWETRYKI------- 168
           V LLG C+     L+          L  Y+               D    +         
Sbjct: 85  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           +   A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +           
Sbjct: 145 SFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E
Sbjct: 201 ARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDE 249
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 250 EFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 109/226 (48%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 76
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 137 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTG 187
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 188 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY        L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  Y+               +        +A   +  + YL        +H
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK---NFIH 153
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           RD+   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYN----- 206
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
           T +I  KSDV+++GV+L EI +   +  P I D   + + ++K     +P         +
Sbjct: 207 TFSI--KSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYDLLEKGYRMEQP---------E 254
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P + V E+++       C   SPA+RP+  E 
Sbjct: 255 GCPPK-VYELMRA------CWKWSPADRPSFAET 281

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 XVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 34  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 93
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 154 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 204
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 205 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 72
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 133 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTG 183
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 184 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++   +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 21  QELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 80
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 81  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 140
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 141 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 191
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 192 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 231

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 71  NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           + +G G  G V   E    G  +AVK L + K R  + V     EIQ L   RH +I+KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 129 LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
               S  +   ++  Y+S              +     ++       + Y H   V   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV---V 133
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+LLD+   A +ADFGL+ +M+   +   +    GS  Y AP     ++I G 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRDSCGSPNYAAP-----EVISG- 184
Query: 249 TMNITEKSDVYSYGVVLLEILSG 271
            +    + D++S GV+L  +L G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 72
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 133 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 183
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 184 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 61  DNILECLKDENVIGKGCSGVVYKA-EMPNG-ELIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           D   EC+ +   IG+G  G V+KA ++ NG   +A+K++     +E    S   E+ +L 
Sbjct: 10  DQQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 119 HIR---HRNIVKLLGYCS----NKSVKL-LLYNYISXXXXXXXXXXXXX-XDWETRYKIA 169
           H+    H N+V+L   C+    ++  KL L++ ++                  ET   + 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
               +GL +LH      ++HRD+K  NIL+ S  +  LADFGLA++    ++  A++ V 
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
            +  Y AP +  LQ  Y   +      D++S G +  E+ 
Sbjct: 181 VTLWYRAP-EVLLQSSYATPV------DLWSVGCIFAEMF 213

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 51/298 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  Y                  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A   A+G+ YL        +HRD+   N+L+       +ADFGLA+ ++  +Y+   +  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E 
Sbjct: 198 RLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEEL 246
Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 247 FK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 291

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 138 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 188
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 189 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 73
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 74  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGXLLDYVREHKDNIGSQYLLNW 123
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 124 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 181 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 215

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 30  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 89
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 150 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 200
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 201 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 75
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 136 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 186
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 187 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 10  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 69
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 129
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 130 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 180
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 181 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 127 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 177
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 178 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 90
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 151 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 201
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 202 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 117/283 (41%), Gaps = 36/283 (12%)
Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVD---SFAAEIQILGHIRHRNIVKL 128
           IG+G  G V+   +  +  L+AVK    + R+  P D    F  E +IL    H NIV+L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 129 LGYCSNKSVKLLLYNYIS-XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           +G C+ K    ++   +                  +T  ++   +A G+ YL   C    
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC--- 234
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+   N L+  K    ++DFG+++      Y  +         + AP      + YG
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA----LNYG 290
Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
                + +SDV+S+G++L E  S  ++  P + +     E+V+K  G   P   +     
Sbjct: 291 ---RYSSESDVWSFGILLWETFSLGASPYPNLSNQ-QTREFVEK--GGRLPCPEL----- 339
Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
              PD + + M Q       C    P +RP+   +   L  ++
Sbjct: 340 --CPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 8   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 67
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 128 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 178
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 179 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 76
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 137 I-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 187
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 188 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 22  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 81
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 142 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 192
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 193 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 72
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 133 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 183
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 184 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 51/298 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  Y                  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A   A+G+ YL        +HRD+   N+L+       +ADFGLA+ ++  +Y+   +  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E 
Sbjct: 213 RLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEEL 261
Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            K           + +      P     E+   +     C ++ P++RPT K++V  L
Sbjct: 262 FK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 306

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 65
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    + + + ++  Y                         +A   A+G+A++    
Sbjct: 66  LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 124
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HR+++  NIL+       +ADFGLA+L+    Y  A         + AP      
Sbjct: 125 --NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA---- 177
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
           I YG     T KSDV+S+G++L EI++      P + +         + + + E    ++
Sbjct: 178 INYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMV 226
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                  PD   +E+ Q + +   C    P +RPT   + ++L +  +A
Sbjct: 227 R------PDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTA 266

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 82
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 143 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 193
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 194 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 76
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 137 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 187
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 188 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 75
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 136 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 186
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 187 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 82
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 143 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 193
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 194 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 8   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 67
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 128 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 178
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 179 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 9   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 68
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 128
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 129 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 179
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 180 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 219

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 4/143 (2%)
Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G V+KA+     E++A+K++     DE    S   EI +L  ++H+NIV+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             +     L++ +                D E          +GL + H      +LHRD
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRD 126
Query: 192 VKCNNILLDSKYEAYLADFGLAK 214
           +K  N+L++   E  LADFGLA+
Sbjct: 127 LKPQNLLINRNGELKLADFGLAR 149

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 53/299 (17%)
Query: 73  IGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NI 125
           +G+G  G V +A+            +AVK L +     E   +  +E++IL HI H  N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNV 93
Query: 126 VKLLGYCSNKSVKLL----------LYNYISXXXXXXXXXXXXXXDWETRYKI------- 168
           V LLG C+     L+          L  Y+               D    +         
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           +   A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +           
Sbjct: 154 SFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E
Sbjct: 210 ARLPLKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDE 258
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              +++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 259 EFCRRLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 72
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 133 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 183
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 184 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 76
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 77  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 126
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 127 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 184 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 218

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G VYKA+      +A  K+ +TK +EE ++ +  EI+IL    H  IVKLLG  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA-QGLAYLHHDCVPAILHRD 191
            +     ++  +                  E + ++      + L +LH      I+HRD
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 142
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+L+  + +  LADFG++   N        S +   Y ++AP     +++   TM 
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPY-WMAP-----EVVMCETMK 195
Query: 252 ITE---KSDVYSYGVVLLEI 268
            T    K+D++S G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 75
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 183 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G+ +AVK + KT+ +   +     E++I+  + H NIVKL  
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 131 YCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +   +++  V + Q   Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N   + + +    GS  Y AP     ++  G
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAAP-----ELFQG 186
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 187 KKYDGPE-VDVWSLGVILYTLVSG 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 34/292 (11%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 71
Query: 125 IVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +V+L    S + + ++  Y                         ++   A G+AY+    
Sbjct: 72  LVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM- 130
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD++  NIL+       +ADFGLA+L+    +  A         + AP      
Sbjct: 131 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW-TARQGAKFPIKWTAPEAA--- 184
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
            +YG     T KSDV+S+G++L E+ +      P + +                    +L
Sbjct: 185 -LYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------------REVL 222
Query: 304 DTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLMEVKSAPE 354
           D   +G       E  ++L   M  C    P ERPT + + A L +  ++ E
Sbjct: 223 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 274

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 73
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 74  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 123
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 124 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 181 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 74
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 182 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 216

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 20/221 (9%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKAE----MPNGELIAVKKLWKTK--RDEEPVDSFAAE 113
           I+N  E LK   V+G G  G V+          G+L A+K L K    +  +  +    E
Sbjct: 53  IEN-FELLK---VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 114 IQILGHIRHRNIVKLLGYCSNKSVKL-LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
            Q+L HIR    +  L Y      KL L+ +YI+                 T +++ +  
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF---TEHEVQIYV 165
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
            + +  L H     I++RD+K  NILLDS     L DFGL+K   +     A     G+ 
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTI 224
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
            Y+AP      I+ G      +  D +S GV++ E+L+G S
Sbjct: 225 EYMAP-----DIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G+ +AVK + KT+ +   +     E++I+  + H NIVKL  
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 131 YCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +   +++  V + Q   Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N   + + +    GS  Y AP     ++  G
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAAP-----ELFQG 186
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 187 KKYDGPE-VDVWSLGVILYTLVSG 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 61  DNILECLKDENVIGKGCSGVVYKA-EMPNG-ELIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           D   EC+ +   IG+G  G V+KA ++ NG   +A+K++     +E    S   E+ +L 
Sbjct: 10  DQQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 119 HIR---HRNIVKLLGYCS----NKSVKL-LLYNYISXXXXXXXXXXXXX-XDWETRYKIA 169
           H+    H N+V+L   C+    ++  KL L++ ++                  ET   + 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
               +GL +LH      ++HRD+K  NIL+ S  +  LADFGLA++    ++  A++ V 
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
            +  Y AP +  LQ  Y   +      D++S G +  E+ 
Sbjct: 181 VTLWYRAP-EVLLQSSYATPV------DLWSVGCIFAEMF 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 33/246 (13%)
Query: 40  GAEDFSYPWTF-IPFQKLN-FTIDNILECLKDENVIGKG-----CSGVVYKAEMPNGE-- 90
           G   F  P+TF  P Q +  F  +    C+K E VIG G     CSG   + ++P     
Sbjct: 2   GVRTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSG---RLKVPGKREI 58
Query: 91  LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXX 150
            +A+K L     D++  D F +E  I+G   H NI+ L G  +     +++  Y+     
Sbjct: 59  CVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 117
Query: 151 XXXXXXXXXXDWETRYKIA------VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE 204
                       + R+ +        G   G+ YL      + +HRD+   NIL++S   
Sbjct: 118 DAFLRKN-----DGRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLV 169
Query: 205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVV 264
             ++DFG+++++         +R     G   P +        Y    T  SDV+SYG+V
Sbjct: 170 CKVSDFGMSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAIAYR-KFTSASDVWSYGIV 223
Query: 265 LLEILS 270
           + E++S
Sbjct: 224 MWEVMS 229

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+        H    
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDE 178
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +    GY+A    +   I    M+  +  D++S G ++ E+L+GR+
Sbjct: 179 MT---GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 63  ILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-- 120
           +LEC      +GKG  G V++     GE +AVK    + RDE+   S+  E ++   +  
Sbjct: 41  LLEC------VGKGRYGEVWRGSW-QGENVAVKIF--SSRDEK---SWFRETELYNTVML 88
Query: 121 RHRNIVKLLG---YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
           RH NI+  +       + S +L L  +                D  +  +I +  A GLA
Sbjct: 89  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLA 148
Query: 178 YLHHDCV-----PAILHRDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSR-VAG 230
           +LH +       PAI HRD+K  NIL+    +  +AD GLA + + STN     +    G
Sbjct: 149 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 208
Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEI 268
           +  Y+AP +   + I     +  ++ D++++G+VL E+
Sbjct: 209 TKRYMAP-EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 72
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 180 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 214

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 63  ILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-- 120
           +LEC      +GKG  G V++     GE +AVK    + RDE+   S+  E ++   +  
Sbjct: 12  LLEC------VGKGRYGEVWRGSW-QGENVAVKIF--SSRDEK---SWFRETELYNTVML 59
Query: 121 RHRNIVKLLG---YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
           RH NI+  +       + S +L L  +                D  +  +I +  A GLA
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLA 119
Query: 178 YLHHDCV-----PAILHRDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSR-VAG 230
           +LH +       PAI HRD+K  NIL+    +  +AD GLA + + STN     +    G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEI 268
           +  Y+AP +   + I     +  ++ D++++G+VL E+
Sbjct: 180 TKRYMAP-EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+        H    
Sbjct: 138 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTADE 185
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +    GY+A    +   I    M+  +  D++S G ++ E+L+GR+
Sbjct: 186 MT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 62  NILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDS--FA----AEI 114
           NI    + ++++G+G  GVV  A   P GE++A+KK+       EP D   FA     EI
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREI 60
Query: 115 QILGHIRHRNIVKLLGYCSNKSVKLLLYNYI----SXXXXXXXXXXXXXXDWETRYKIAV 170
           +IL H +H NI+ +       S +     YI                   D   +Y I  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-Y 119
Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--------TNYH 222
            + + +  LH   V   +HRD+K +N+L++S  +  + DFGLA++++         T   
Sbjct: 120 QTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             M     +  Y AP        Y   M      DV+S G +L E+   R
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAELFLRR 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 63  ILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-- 120
           +LEC      +GKG  G V++     GE +AVK    + RDE+   S+  E ++   +  
Sbjct: 12  LLEC------VGKGRYGEVWRGSW-QGENVAVKIF--SSRDEK---SWFRETELYNTVML 59
Query: 121 RHRNIVKLLG---YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
           RH NI+  +       + S +L L  +                D  +  +I +  A GLA
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLA 119
Query: 178 YLHHDCV-----PAILHRDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSR-VAG 230
           +LH +       PAI HRD+K  NIL+    +  +AD GLA + + STN     +    G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEI 268
           +  Y+AP     + I     +  ++ D++++G+VL E+
Sbjct: 180 TKRYMAPEVLD-ETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IG G  G+V+     N + +A+K + +    EE    F  E +++  + H  +V+L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXX-XXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             ++   L++ ++                  ET   + +   +G+AYL      +++HRD
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRD 128
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+       ++DFG+ + +    Y         S G   P K     ++ ++  
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVKWASPEVFSFS-R 180
Query: 252 ITEKSDVYSYGVVLLEILS 270
            + KSDV+S+GV++ E+ S
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+        H    
Sbjct: 138 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTADE 185
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +    GY+A    +   I    M+  +  D++S G ++ E+L+GR+
Sbjct: 186 MT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 50/302 (16%)
Query: 73  IGKGCSGVVYKAE----MPNGE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G V+ AE    +P  +  L+AVK L   +  E     F  E ++L  ++H++IV
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 77
Query: 127 KLLGYCSNKSVKLLLYNYI---------------SXXXXXXXXXXXXXXDWETRYKIAVG 171
           +  G C+     L+++ Y+               +                     +A  
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
            A G+ YL        +HRD+   N L+       + DFG+++ + ST+Y+    R    
Sbjct: 138 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             ++ P      I+Y      T +SDV+S+GVVL EI +     QP          W   
Sbjct: 195 IRWMPPES----ILY---RKFTTESDVWSFGVVLWEIFT--YGKQP----------WY-- 233
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
           ++ + E    I   +    P     E+     I   C    P +R ++K+V A L  +  
Sbjct: 234 QLSNTEAIDCITQGRELERPRACPPEV---YAIMRGCWQREPQQRHSIKDVHARLQALAQ 290
Query: 352 AP 353
           AP
Sbjct: 291 AP 292

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 44/289 (15%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G V+         +A+K L   K      +SF  E QI+  ++H  +V+L    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL---KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETR-------YKIAVGSAQGLAYLHHDCVP 185
           S + +      YI               D E R         +A   A G+AY+      
Sbjct: 74  SEEPI------YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM--- 124
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRD++  NIL+ +     +ADFGLA+L+   N   A         + AP       +
Sbjct: 125 NYIHRDLRSANILVGNGLICKIADFGLARLIED-NEXTARQGAKFPIKWTAPEAA----L 179
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT 305
           YG     T KSDV+S+G++L E+++      P + +   ++E V++  G   P       
Sbjct: 180 YG---RFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVER--GYRMPCP----- 228
Query: 306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
             Q  P  + + M+        C    P ERPT + + + L +  +A E
Sbjct: 229 --QDCPISLHELMIH-------CWKKDPEERPTFEYLQSFLEDYFTATE 268

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           R++   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 394
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 395 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 442
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 443 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 469

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 123/296 (41%), Gaps = 37/296 (12%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 6   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 65
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 66  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                 I+HRDVK +NIL++S+ E  L DFG++  +         +   G+  Y++P + 
Sbjct: 125 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDEMANEFVGTRSYMSPERL 178
Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
           +         + + +SD++S G+ L+E+  GR               + +  M  FE   
Sbjct: 179 Q-------GTHYSVQSDIWSMGLSLVEMAVGR---------------YPRPPMAIFELLD 216
Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEEL 356
            I++     LP  +     Q       C+  +PAER  +K+++      +S  EE+
Sbjct: 217 YIVNEPPPKLPSAVFSLEFQDF--VNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 270

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G+ +AVK + KT+ +   +     E++I+  + H NIVKL  
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXX---XXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +   +++  V + Q   Y H      I
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ---YCHQKF---I 127
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N   + + +    GS  Y AP     ++  G
Sbjct: 128 VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAAP-----ELFQG 179
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 180 KKYDGPE-VDVWSLGVILYTLVSG 202

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+        H    
Sbjct: 138 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTADE 185
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +    GY+A    +   I    M+  +  D++S G ++ E+L+GR+
Sbjct: 186 MT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 70  ENVIGKGCSGVVYK-AEMPNGELIAVKKLWKT------KRDEEPVDSFAAEIQILGHIR- 121
           ++VIG+G S VV +      G   AVK +  T      ++ EE  ++   E  IL  +  
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
           H +I+ L+    + S   L+++ +                 +    I     + +++LH 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--K 239
           +    I+HRD+K  NILLD   +  L+DFG +  +        +  + G+ GY+AP   K
Sbjct: 219 N---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILK 272
Query: 240 CKLQIIY-GYTMNITEKSDVYSYGVVLLEILSG 271
           C +   + GY   +    D+++ GV+L  +L+G
Sbjct: 273 CSMDETHPGYGKEV----DLWACGVILFTLLAG 301

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G+ +AV+ + KT+ +   +     E++I+  + H NIVKL  
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 131 YCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +   +++  V + Q   Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N   + + +    GS  Y AP     ++  G
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDEFCGSPPYAAP-----ELFQG 186
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 187 KKYDGPE-VDVWSLGVILYTLVSG 209

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 50/302 (16%)
Query: 73  IGKGCSGVVYKAE----MPNGE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G V+ AE    +P  +  L+AVK L   +  E     F  E ++L  ++H++IV
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 83
Query: 127 KLLGYCSNKSVKLLLYNYI---------------SXXXXXXXXXXXXXXDWETRYKIAVG 171
           +  G C+     L+++ Y+               +                     +A  
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
            A G+ YL        +HRD+   N L+       + DFG+++ + ST+Y+    R    
Sbjct: 144 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             ++ P      I+Y      T +SDV+S+GVVL EI +     QP          W   
Sbjct: 201 IRWMPPES----ILY---RKFTTESDVWSFGVVLWEIFT--YGKQP----------WY-- 239
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
           ++ + E    I   +    P     E+     I   C    P +R ++K+V A L  +  
Sbjct: 240 QLSNTEAIDCITQGRELERPRACPPEV---YAIMRGCWQREPQQRHSIKDVHARLQALAQ 296
Query: 352 AP 353
           AP
Sbjct: 297 AP 298

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 44/229 (19%)
Query: 67  LKDENVIGKGCSGVVYKAEMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQIL---GHI 120
           +K ++VIG+G  G V KA +    L    A+K++ +    ++  D FA E+++L   GH 
Sbjct: 24  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGH- 81
Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA------- 173
            H NI+ LLG C ++    L   Y                + +  + IA  +A       
Sbjct: 82  -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 174 ---------QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
                    +G+ YL        +HR++   NIL+   Y A +ADFGL            
Sbjct: 141 LLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGL------------ 185
Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMN---ITEKSDVYSYGVVLLEILS 270
            SR    Y     G+  ++ +   ++N    T  SDV+SYGV+L EI+S
Sbjct: 186 -SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 50/302 (16%)
Query: 73  IGKGCSGVVYKAE----MPNGE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G V+ AE    +P  +  L+AVK L   +  E     F  E ++L  ++H++IV
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 106
Query: 127 KLLGYCSNKSVKLLLYNYI---------------SXXXXXXXXXXXXXXDWETRYKIAVG 171
           +  G C+     L+++ Y+               +                     +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
            A G+ YL        +HRD+   N L+       + DFG+++ + ST+Y+    R    
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             ++ P      I+Y      T +SDV+S+GVVL EI +     QP          W   
Sbjct: 224 IRWMPPES----ILY---RKFTTESDVWSFGVVLWEIFT--YGKQP----------WY-- 262
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
           ++ + E    I   +    P     E+     I   C    P +R ++K+V A L  +  
Sbjct: 263 QLSNTEAIDCITQGRELERPRACPPEV---YAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
Query: 352 AP 353
           AP
Sbjct: 320 AP 321

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 72
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGXLLDYVREHKDNIGSQYLLNW 122
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 180 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGL +  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 69
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 70  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 119
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 120 CVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 177 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 211

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/315 (23%), Positives = 129/315 (40%), Gaps = 46/315 (14%)
Query: 61  DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           D   E L+   +IGKG  G VY     +GE +A++ +   + +E+ + +F  E+      
Sbjct: 29  DIPFEQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 121 RHRNIVKLLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL 179
           RH N+V  +G C S   + ++                    D     +IA    +G+ YL
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGL---AKLMNSTNYHHAMSRVAGSYGYIA 236
           H      ILH+D+K  N+  D+  +  + DFGL   + ++ +      +    G   ++A
Sbjct: 147 H---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 237 PGKCKLQIIYGYTMNITEK-------SDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV 289
           P     +II   + +  E        SDV++ G +  E               LH  EW 
Sbjct: 203 P-----EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE---------------LHAREWP 242
Query: 290 KKKMGSFEPAVSILDTKLQGLPDQMVQEML--QTLGIAMFCVNSSPAERPTMKEVVALLM 347
            K     +PA +I+     G+   + Q  +  +   I +FC      ERPT  +++ +L 
Sbjct: 243 FKT----QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
Query: 348 EVKSAPEELGKTSQP 362
           ++   P+   + S P
Sbjct: 299 KL---PKRNRRLSHP 310

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G+ +AV+ + KT+ +   +     E++I+  + H NIVKL  
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 131 YCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +   +++  V + Q   Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N   + + +    GS  Y AP     ++  G
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAAP-----ELFQG 186
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 187 KKYDGPE-VDVWSLGVILYTLVSG 209

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 34  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 93
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M  
Sbjct: 154 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMXG 204
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 205 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 79
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 187 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 75
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 183 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 217

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H N+V+LLG 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWET--RYKIAVGSAQGLAYLHHDCVPAILH 189
           C+ +    ++  +++              +        +A   +  + YL        +H
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 380
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGY 248
           R++   N L+   +   +ADFGL++LM    Y  HA ++      + AP           
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN----- 433
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + KSDV+++GV+L EI +   +  P I D   + E ++K      P         +
Sbjct: 434 --KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP---------E 481
Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           G P++ V E+++       C   +P++RP+  E+
Sbjct: 482 GCPEK-VYELMRA------CWQWNPSDRPSFAEI 508

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 74
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 182 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 72
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 180 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 75
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 183 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 78
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 79  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 128
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 129 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 186 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 220

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 39  PGAEDFSYPWTF-IPFQKL----------NFTIDNILECLKDENVIGKGCSGVVYKAEMP 87
           PG   F  P TF  P Q +          N +ID ++   +     G+ CSG   + ++P
Sbjct: 17  PGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGE----FGEVCSG---RLKLP 69
Query: 88  NGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           + + I+V  K  K    E+    F  E  I+G   H NI++L G  +     +++  Y+ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129
Query: 147 XXXXXXXXXXXXXXDWETRYKIA------VGSAQGLAYLHHDCVPAILHRDVKCNNILLD 200
                           + ++ +        G A G+ YL        +HRD+   NIL++
Sbjct: 130 NGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILIN 181
Query: 201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYS 260
           S     ++DFGLA+++         +R     G   P +        Y    T  SDV+S
Sbjct: 182 SNLVCKVSDFGLARVLEDDPEAAYTTR-----GGKIPIRWTSPEAIAY-RKFTSASDVWS 235
Query: 261 YGVVLLEILS 270
           YG+VL E++S
Sbjct: 236 YGIVLWEVMS 245

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 75
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 183 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 217

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV----DSFAAEIQILGHIRHRNIVKL 128
           +G+G  G V+ AE  N      K L   K  ++P       F  E ++L +++H +IVK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 129 LGYCSNKSVKLLLYNY-----ISXXXXXXXXXXXXXXDWETR-----------YKIAVGS 172
            G C +    ++++ Y     ++              D + R             IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+ YL        +HRD+   N L+ +     + DFG+++ + ST+Y+          
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            ++ P      I+Y      T +SDV+S+GV+L EI +
Sbjct: 200 RWMPPE----SIMY---RKFTTESDVWSFGVILWEIFT 230

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 82
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 83  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 132
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 133 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 190 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 224

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 19/212 (8%)
Query: 67  LKDENVIGKGCSGVV----YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH 122
           +K E VIG G  G V     KA       +A+K L K    E     F +E  I+G   H
Sbjct: 18  VKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSEASIMGQFEH 76
Query: 123 RNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAY-LHH 181
            NI++L G  +N    ++L  ++               D +      VG  +G+A  + +
Sbjct: 77  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLN---DGQFTVIQLVGMLRGIASGMRY 133
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS---YGYIAPG 238
               + +HRD+   NIL++S     ++DFGL++ +   +     +   G      + AP 
Sbjct: 134 LAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               +         T  SD +SYG+V+ E++S
Sbjct: 194 AIAFR-------KFTSASDAWSYGIVMWEVMS 218

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 97
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 98  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 147
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 148 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 205 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 72
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 180 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + D+GLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G+ +AVK + KT+ +   +     E++I+  + H NIVKL  
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 131 YCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +   +++  V + Q   Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N   + + +    G+  Y AP     ++  G
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDAFCGAPPYAAP-----ELFQG 186
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 187 KKYDGPE-VDVWSLGVILYTLVSG 209

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 39  PGAEDFSYPWTF-IPFQKL----------NFTIDNILECLKDENVIGKGCSGVVYKAEMP 87
           PG   F  P TF  P Q +          N +ID ++   +     G+ CSG   + ++P
Sbjct: 17  PGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGE----FGEVCSG---RLKLP 69
Query: 88  NGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           + + I+V  K  K    E+    F  E  I+G   H NI++L G  +     +++  Y+ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129
Query: 147 XXXXXXXXXXXXXXDWETRYKIA------VGSAQGLAYLHHDCVPAILHRDVKCNNILLD 200
                           + ++ +        G A G+ YL        +HRD+   NIL++
Sbjct: 130 NGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLAARNILIN 181
Query: 201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYS 260
           S     ++DFGL++++         +R     G   P +        Y    T  SDV+S
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTSPEAIAY-RKFTSASDVWS 235
Query: 261 YGVVLLEILS 270
           YG+VL E++S
Sbjct: 236 YGIVLWEVMS 245

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 174
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 175 LQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 66
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 67  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 116
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 117 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 174 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 208

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+L  TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 7   QELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 66
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL 126
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 127 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 177
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 178 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 174
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 175 LQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 174
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 175 LQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 174
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 175 LQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 65  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 124
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 125 SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 184 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 236
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 237 LQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 4/143 (2%)
Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G V+KA+     E++A+K++     DE    S   EI +L  ++H+NIV+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
             +     L++ +                D E          +GL + H      +LHRD
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRD 126
Query: 192 VKCNNILLDSKYEAYLADFGLAK 214
           +K  N+L++   E  LA+FGLA+
Sbjct: 127 LKPQNLLINRNGELKLANFGLAR 149

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 119/290 (41%), Gaps = 50/290 (17%)
Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVD---SFAAEIQILGHIRHRNIVKL 128
           IG+G  G V+   +  +  L+AVK    + R+  P D    F  E +IL    H NIV+L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 129 LGYCSNKSVKLLLYNYIS-XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           +G C+ K    ++   +                  +T  ++   +A G+ YL   C    
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC--- 234
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG-------YIAPGKC 240
           +HRD+   N L+  K    ++DFG+++         A    A S G       + AP   
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR-------EEADGVXAASGGLRQVPVKWTAPEA- 286
Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
              + YG     + +SDV+S+G++L E  S  ++  P + +     E+V+K  G   P  
Sbjct: 287 ---LNYG---RYSSESDVWSFGILLWETFSLGASPYPNLSNQ-QTREFVEK--GGRLPCP 337
Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
            +        PD + + M Q       C    P +RP+   +   L  ++
Sbjct: 338 EL-------CPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 67  LKDENV-----IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
           LKD++      +G G  GVV+K       L+  +KL   +      +    E+Q+L    
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 122 HRNIVKLLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
              IV   G + S+  + + +  ++                 +   K+++   +GL YL 
Sbjct: 90  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGK 239
                 I+HRDVK +NIL++S+ E  L DFG++ +L++S       +   G+  Y++P +
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 201
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
            +         + + +SD++S G+ L+E+  GR  + P
Sbjct: 202 LQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGE-------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE       ++ +++    K ++E +D    E  ++ 
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILD----EAYVMA 106
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 107 SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 156
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 157 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 214 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 248

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 34/275 (12%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN---KSVKLLLYNY 144
            GE++AVK L K     +    +  EI+IL  + H +IVK  G C +   KSV+L++  Y
Sbjct: 37  TGEMVAVKAL-KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVM-EY 94
Query: 145 ISXXXXXXXXXXXXXXDWETRYKIAVGS--------AQGLAYLHHDCVPAILHRDVKCNN 196
           +               D+  R+ + +           +G+AYLH       +HR +   N
Sbjct: 95  VPLGSLR---------DYLPRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARN 142
Query: 197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKS 256
           +LLD+     + DFGLAK +   + ++ +     S  +    +C  +  + Y       S
Sbjct: 143 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYA------S 196
Query: 257 DVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQ 316
           DV+S+GV L E+L+   + Q        ++   + +M        +   +    PD+   
Sbjct: 197 DVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPC 256
Query: 317 EMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
           E+     +   C  +  + RPT + +V +L   + 
Sbjct: 257 EIYH---LMKNCWETEASFRPTFQNLVPILQTAQE 288

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 34/275 (12%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN---KSVKLLLYNY 144
            GE++AVK L K     +    +  EI+IL  + H +IVK  G C +   KSV+L++  Y
Sbjct: 36  TGEMVAVKAL-KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVM-EY 93
Query: 145 ISXXXXXXXXXXXXXXDWETRYKIAVGS--------AQGLAYLHHDCVPAILHRDVKCNN 196
           +               D+  R+ + +           +G+AYLH       +HR +   N
Sbjct: 94  VPLGSLR---------DYLPRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARN 141
Query: 197 ILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKS 256
           +LLD+     + DFGLAK +   + ++ +     S  +    +C  +  + Y       S
Sbjct: 142 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYA------S 195
Query: 257 DVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQ 316
           DV+S+GV L E+L+   + Q        ++   + +M        +   +    PD+   
Sbjct: 196 DVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPC 255
Query: 317 EMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
           E+     +   C  +  + RPT + +V +L   + 
Sbjct: 256 EIYH---LMKNCWETEASFRPTFQNLVPILQTAQE 287

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G V  A +  +GE +A+KKL +  + E        E+ +L H++H N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 132 CSNKSVKLLLYNY---ISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
            +  S     Y++   +                 E    +     +GL Y+H      ++
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AGVV 166
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+ ++   E  + DFGLA+  ++    + ++R      Y AP     ++I  +
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAP-----EVILSW 216
Query: 249 TMNITEKSDVYSYGVVLLEILSGRS 273
            M+  +  D++S G ++ E+L+G++
Sbjct: 217 -MHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DF LA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           +  IGKG  G V++ +   GE +AVK    + R+E       AEI     +RH NI+  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFR-EAEIYQTVMLRHENILGFI 102
Query: 130 GYCSNKS----VKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV- 184
               NK      +L L +                   E   K+A+ +A GLA+LH + V 
Sbjct: 103 A-ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 185 ----PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPG 238
               PAI HRD+K  NIL+       +AD GLA   +S       A +   G+  Y+AP 
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEI 268
                I   +  +  +++D+Y+ G+V  EI
Sbjct: 222 VLDDSINMKHFESF-KRADIYAMGLVFWEI 250

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 74
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFG AKL+ +    YH    
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 182 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 216

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 39  PGAEDFSYPWTF-IPFQKL----------NFTIDNILECLKDENVIGKGCSGVVYKAEMP 87
           PG   F  P TF  P Q +          N +ID ++   +     G+ CSG   + ++P
Sbjct: 17  PGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGE----FGEVCSG---RLKLP 69
Query: 88  NGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           + + I+V  K  K    E+    F  E  I+G   H NI++L G  +     +++  Y+ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129
Query: 147 XXXXXXXXXXXXXXDWETRYKIA------VGSAQGLAYLHHDCVPAILHRDVKCNNILLD 200
                           + ++ +        G A G+ YL        +HRD+   NIL++
Sbjct: 130 NGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILIN 181
Query: 201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYS 260
           S     ++DFGL++++         +R     G   P +        Y    T  SDV+S
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTSPEAIAY-RKFTSASDVWS 235
Query: 261 YGVVLLEILS 270
           YG+VL E++S
Sbjct: 236 YGIVLWEVMS 245

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 68  KDENVIGKGCSG-VVYKAEMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNI 125
           K + V+GKG  G V+   +   G+  AVK + K + + +   +S   E+Q+L  + H NI
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
            KL  +  +K    L+    +                    +I      G+ Y H +   
Sbjct: 89  XKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN--- 145
Query: 186 AILHRDVKCNNILLDSKYEA---YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
            I+HRD+K  N+LL+SK +     + DFGL+    ++       ++  +Y YIAP     
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KXKDKIGTAY-YIAP----- 197
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           ++++G      EK DV+S GV+L  +LSG
Sbjct: 198 EVLHG---TYDEKCDVWSTGVILYILLSG 223

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G  G V  A +  +GE +A+KKL +  + E        E+ +L H++H N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 132 CSNKSVKLLLYNY---ISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
            +  S     Y++   +                 E    +     +GL Y+H      ++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGVV 148
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+ ++   E  + DFGLA+  ++    + ++R      Y AP     ++I  +
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAP-----EVILSW 198
Query: 249 TMNITEKSDVYSYGVVLLEILSGRS 273
            M+  +  D++S G ++ E+L+G++
Sbjct: 199 -MHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 74
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFG AKL+ +    YH    
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 182 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+  G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 79
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 187 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 76
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L++                   D+   +K  +GS      
Sbjct: 77  SVDNPHVCRLLGICLTSTVQLIM----------QLMPFGCLLDYVREHKDNIGSQYLLNW 126
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFG AKL+ +    YH    
Sbjct: 127 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 184 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 218

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLG 130
           +GKG  G+V+K+ +   GE++AVKK++   ++         EI IL  +  H NIV LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 131 --YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--IAVGSAQGLAYLHHDCVPA 186
                N     L+++Y+                 E  +K  +     + + YLH      
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANIL----EPVHKQYVVYQLIKVIKYLHSG---G 129
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLM----------------NSTNYHHA---MSR 227
           +LHRD+K +NILL+++    +ADFGL++                  N+ N+      ++ 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              +  Y AP     +I+ G T   T+  D++S G +L EIL G+
Sbjct: 190 YVATRWYRAP-----EILLGST-KYTKGIDMWSLGCILGEILCGK 228

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 103/250 (41%), Gaps = 39/250 (15%)
Query: 39  PGAEDFSYPWTF-IPFQKL----------NFTIDNILECLKDENVIGKGCSGVVYKAEMP 87
           PG   F  P TF  P Q +          N +ID ++   +     G+ CSG   + ++P
Sbjct: 17  PGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGE----FGEVCSG---RLKLP 69
Query: 88  NGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           + + I+V  K  K    E+    F  E  I+G   H NI++L G  +     +++  Y+ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129
Query: 147 XXXXXXXXXXXXXXDWETRYKIA------VGSAQGLAYLHHDCVPAILHRDVKCNNILLD 200
                           + ++ +        G A G+ YL        +HRD+   NIL++
Sbjct: 130 NGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILIN 181
Query: 201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYS 260
           S     ++DFGL +++         +R     G   P +        Y    T  SDV+S
Sbjct: 182 SNLVCKVSDFGLGRVLEDDPEAAYTTR-----GGKIPIRWTSPEAIAY-RKFTSASDVWS 235
Query: 261 YGVVLLEILS 270
           YG+VL E++S
Sbjct: 236 YGIVLWEVMS 245

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IGKG  G V++ +   GE +AVK    + R+E       AEI     +RH NI+  +   
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFR-EAEIYQTVMLRHENILGFIA-A 91
Query: 133 SNKS----VKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV---- 184
            NK      +L L +                   E   K+A+ +A GLA+LH + V    
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 185 -PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPGKCK 241
            PAI HRD+K  NIL+       +AD GLA   +S       A +   G+  Y+AP    
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 211
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEI 268
             I   +  +  +++D+Y+ G+V  EI
Sbjct: 212 DSINMKHFESF-KRADIYAMGLVFWEI 237

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 66  CLKDENVIGKG-----CSGVVY---KAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQIL 117
           C+  E VIG G     CSG +    K E+P    +A+K L K    E+    F  E  I+
Sbjct: 23  CITIERVIGAGEFGEVCSGRLKLPGKRELP----VAIKTL-KVGYTEKQRRDFLGEASIM 77
Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL- 176
           G   H NI+ L G  +     +++  Y+               D +      VG  +G+ 
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKN---DGQFTVIQLVGMLRGIS 134
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG-SYGYI 235
           A + +      +HRD+   NIL++S     ++DFGL++++         +R       + 
Sbjct: 135 AGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP     +         T  SDV+SYG+V+ E++S
Sbjct: 195 APEAIAFR-------KFTSASDVWSYGIVMWEVVS 222

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 103/244 (42%), Gaps = 27/244 (11%)
Query: 39  PGAEDFSYPWTFIPFQKL--NFTIDNILECLKDENVIGKG-----CSGVVYKAEMPNGEL 91
           PG + +  P T+    +    F  +    C+K E VIG G     CSG   + ++P    
Sbjct: 15  PGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSG---RLKLPGKRD 71
Query: 92  IAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXX 150
           +AV  K  K    E+    F  E  I+G   H N+V L G  +     +++  ++     
Sbjct: 72  VAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGAL 131
Query: 151 XXXXXXXXXXDWETRYKIAVGSAQGLAY-LHHDCVPAILHRDVKCNNILLDSKYEAYLAD 209
                     D +      VG  +G+A  + +      +HRD+   NIL++S     ++D
Sbjct: 132 DAFLRKH---DGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSD 188
Query: 210 FGLAKLMNSTNYHHAMSRVAGS---YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLL 266
           FGL++++       A+    G      + AP   + +         T  SDV+SYG+V+ 
Sbjct: 189 FGLSRVIEDDP--EAVYTTTGGKIPVRWTAPEAIQYR-------KFTSASDVWSYGIVMW 239
Query: 267 EILS 270
           E++S
Sbjct: 240 EVMS 243

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 133/311 (42%), Gaps = 58/311 (18%)
Query: 52  PFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFA 111
           P++K  + I    E LK E  +G G  G V+ A       +AVK +   K     V++F 
Sbjct: 171 PWEKDAWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFL 225
Query: 112 AEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI--- 168
           AE  ++  ++H  +VKL    + + + +     I+              D  ++  +   
Sbjct: 226 AEANVMKTLQHDKLVKLHAVVTKEPIYI-----ITEFMAKGSLLDFLKSDEGSKQPLPKL 280
Query: 169 ---AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
              +   A+G+A++        +HRD++  NIL+ +     +ADFGLA            
Sbjct: 281 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA------------ 325
Query: 226 SRVAGSY--GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
            RV   +   + AP      I +G   + T KSDV+S+G++L+EI++      P + +  
Sbjct: 326 -RVGAKFPIKWTAPEA----INFG---SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP- 376
Query: 284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            ++  +++      P         +  P+++         I M C  + P ERPT + + 
Sbjct: 377 EVIRALERGYRMPRP---------ENCPEEL-------YNIMMRCWKNRPEERPTFEYIQ 420
Query: 344 ALLMEVKSAPE 354
           ++L +  +A E
Sbjct: 421 SVLDDFYTATE 431

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IGKG  G V++ +   GE +AVK    + R+E       AEI     +RH NI+  +   
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFR-EAEIYQTVMLRHENILGFIA-A 65
Query: 133 SNKS----VKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV---- 184
            NK      +L L +                   E   K+A+ +A GLA+LH + V    
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 185 -PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPGKCK 241
            PAI HRD+K  NIL+       +AD GLA   +S       A +   G+  Y+AP    
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEI 268
             I   +  +  +++D+Y+ G+V  EI
Sbjct: 186 DSINMKHFESF-KRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IGKG  G V++ +   GE +AVK    + R+E       AEI     +RH NI+  +   
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFR-EAEIYQTVMLRHENILGFIA-A 68
Query: 133 SNKS----VKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV---- 184
            NK      +L L +                   E   K+A+ +A GLA+LH + V    
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 185 -PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPGKCK 241
            PAI HRD+K  NIL+       +AD GLA   +S       A +   G+  Y+AP    
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 188
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEI 268
             I   +  +  +++D+Y+ G+V  EI
Sbjct: 189 DSINMKHFESF-KRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IGKG  G V++ +   GE +AVK    + R+E       AEI     +RH NI+  +   
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFR-EAEIYQTVMLRHENILGFIA-A 71
Query: 133 SNKS----VKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV---- 184
            NK      +L L +                   E   K+A+ +A GLA+LH + V    
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 185 -PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPGKCK 241
            PAI HRD+K  NIL+       +AD GLA   +S       A +   G+  Y+AP    
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 191
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEI 268
             I   +  +  +++D+Y+ G+V  EI
Sbjct: 192 DSINMKHFESF-KRADIYAMGLVFWEI 217

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  +  FGLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           IGKG  G V++ +   GE +AVK    + R+E       AEI     +RH NI+  +   
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFR-EAEIYQTVMLRHENILGFIA-A 66
Query: 133 SNKS----VKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCV---- 184
            NK      +L L +                   E   K+A+ +A GLA+LH + V    
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 185 -PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST--NYHHAMSRVAGSYGYIAPGKCK 241
            PAI HRD+K  NIL+       +AD GLA   +S       A +   G+  Y+AP    
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 186
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEI 268
             I   +  +  +++D+Y+ G+V  EI
Sbjct: 187 DSINMKHFESF-KRADIYAMGLVFWEI 212

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G  +A+K + KT+ +   +     E++I+  + H NIVKL  
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 131 YCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +  ++++  V + Q   Y H      I
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ---KRI 132
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N       +    GS  Y AP     ++  G
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDTFCGSPPYAAP-----ELFQG 184
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 185 KKYDGPE-VDVWSLGVILYTLVSG 207

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 79
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFG AKL+ +    YH    
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 187 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 221

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G+ +AVK + KT+ +   +     E++I   + H NIVKL  
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 131 YCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +   +++  V + Q   Y H      I
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N   + + +    G+  Y AP     ++  G
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFS---NEFTFGNKLDAFCGAPPYAAP-----ELFQG 186
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 187 KKYDGPE-VDVWSLGVILYTLVSG 209

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/352 (22%), Positives = 140/352 (39%), Gaps = 78/352 (22%)
Query: 28  VEKASGMST--LPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAE 85
           VE+ +G +   + P    + + W F P  +L+F              +G G  G V +A 
Sbjct: 12  VEEINGNNXVXIDPTQLPYDHKWEF-PRNRLSFG-----------KTLGAGAFGKVVEAT 59
Query: 86  M-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKL 139
                  +  +    K+ K        ++  +E+++L ++  H NIV LLG C+     L
Sbjct: 60  AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 119
Query: 140 LLYNYI------------------SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL-H 180
           ++  Y                   S              D E     +   A+G+A+L  
Sbjct: 120 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 179
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGK 239
            +C+    HRD+   NILL       + DFGLA+ + N +N             Y+  G 
Sbjct: 180 KNCI----HRDLAARNILLTHGRITKICDFGLARDIKNDSN-------------YVVKGN 222
Query: 240 CKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
            +L + +    +I     T +SDV+SYG+ L E+ S  S+  P +       + +K+   
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 282
Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              P         +  P +M  ++++T      C ++ P +RPT K++V L+
Sbjct: 283 MLSP---------EHAPAEMY-DIMKT------CWDADPLKRPTFKQIVQLI 318

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + D GLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +  IGKG    V  A  +  G  +AVK + KT+ +   +     E++I+  + H NIVKL
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 129 LGYCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
                 +    L+  Y S                 +   +++  V + Q   Y H     
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKY-- 134
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I+HRD+K  N+LLD      +ADFG +   N     + +    GS  Y AP     ++ 
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFS---NEFTVGNKLDTFCGSPPYAAP-----ELF 185
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSG 271
            G   +  E  DV+S GV+L  ++SG
Sbjct: 186 QGKKYDGPE-VDVWSLGVILYTLVSG 210

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 74
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFG AKL+ +    YH    
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 182 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+  G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 79
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 187 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 221

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + D GLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+  G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 72
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    YH    
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 180 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 214

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELI----AVKKLWKT---KRDEEPVDSFAAEIQILG 118
            K   V+G G  G VYK   +P GE +    A+K+L +    K ++E +D    E  ++ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 72
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS------ 172
            + + ++ +LLG C   +V+L+                    D+   +K  +GS      
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLI----------TQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 173 ----AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
               A+G+ YL       ++HRD+   N+L+ +     + DFG AKL+ +    YH    
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +V   +  +   +  L  IY      T +SDV+SYGV + E+++
Sbjct: 180 KVPIKWMAL---ESILHRIY------THQSDVWSYGVTVWELMT 214

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/339 (22%), Positives = 133/339 (39%), Gaps = 76/339 (22%)
Query: 39  PGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-----PNGELIA 93
           P    + + W F P  +L+F              +G G  G V +A        +  +  
Sbjct: 9   PTQLPYDHKWEF-PRNRLSFG-----------KTLGAGAFGKVVEATAYGLIKSDAAMTV 56
Query: 94  VKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYI------- 145
             K+ K        ++  +E+++L ++  H NIV LLG C+     L++  Y        
Sbjct: 57  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 146 -----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVK 193
                      S              D E     +   A+G+A+L   +C+    HRD+ 
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLA 172
Query: 194 CNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI 252
             NILL       + DFGLA+ + N +N             Y+  G  +L + +    +I
Sbjct: 173 ARNILLTHGRITKICDFGLARDIKNDSN-------------YVVKGNARLPVKWMAPESI 219
Query: 253 -----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
                T +SDV+SYG+ L E+ S  S+  P +       + +K+      P         
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--------- 270
Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +  P +M  ++++T      C ++ P +RPT K++V L+
Sbjct: 271 EHAPAEMY-DIMKT------CWDADPLKRPTFKQIVQLI 302

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 36/235 (15%)
Query: 60  IDNILECLKDENVI-----GKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEEPVD 108
           +D  ++ +K  N++     G+G  G V+ AE  N        L+AVK L K   D    D
Sbjct: 3   MDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKD 61
Query: 109 SFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXX----------- 157
            F  E ++L +++H +IVK  G C      ++++ Y+                       
Sbjct: 62  -FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 120
Query: 158 --XXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL 215
                       IA   A G+ YL        +HRD+   N L+       + DFG+++ 
Sbjct: 121 PPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 177
Query: 216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           + ST+Y+           ++ P      I+Y      T +SDV+S GVVL EI +
Sbjct: 178 VYSTDYYRVGGHTMLPIRWMPPES----IMY---RKFTTESDVWSLGVVLWEIFT 225

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 53/296 (17%)
Query: 73  IGKGCSGVVYKAEM-------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRN 124
           +G+G  G V  AE        PN       K+ K+   E+ +    +E++++  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK----------------I 168
           I+ LLG C+      ++  Y S                E  +                  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           A   A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ ++  +     + 
Sbjct: 156 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE 287
                 ++AP +     IY      T +SDV+S+GV+L EI +   +  P    G+ + E
Sbjct: 212 GRLPVKWMAP-EALFDRIY------THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEE 260
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
             K           + +      P     E+   +     C ++ P++RPT K++V
Sbjct: 261 LFK----------LLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLV 303

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/339 (22%), Positives = 133/339 (39%), Gaps = 76/339 (22%)
Query: 39  PGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-----PNGELIA 93
           P    + + W F P  +L+F              +G G  G V +A        +  +  
Sbjct: 32  PTQLPYDHKWEF-PRNRLSFG-----------KTLGAGAFGKVVEATAYGLIKSDAAMTV 79
Query: 94  VKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYI------- 145
             K+ K        ++  +E+++L ++  H NIV LLG C+     L++  Y        
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 139
Query: 146 -----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVK 193
                      S              D E     +   A+G+A+L   +C+    HRD+ 
Sbjct: 140 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLA 195
Query: 194 CNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI 252
             NILL       + DFGLA+ + N +N             Y+  G  +L + +    +I
Sbjct: 196 ARNILLTHGRITKICDFGLARHIKNDSN-------------YVVKGNARLPVKWMAPESI 242
Query: 253 -----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
                T +SDV+SYG+ L E+ S  S+  P +       + +K+      P         
Sbjct: 243 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--------- 293
Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +  P +M  ++++T      C ++ P +RPT K++V L+
Sbjct: 294 EHAPAEMY-DIMKT------CWDADPLKRPTFKQIVQLI 325

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/339 (22%), Positives = 133/339 (39%), Gaps = 76/339 (22%)
Query: 39  PGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-----PNGELIA 93
           P    + + W F P  +L+F              +G G  G V +A        +  +  
Sbjct: 32  PTQLPYDHKWEF-PRNRLSFG-----------KTLGAGAFGKVVEATAYGLIKSDAAMTV 79
Query: 94  VKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYI------- 145
             K+ K        ++  +E+++L ++  H NIV LLG C+     L++  Y        
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 139
Query: 146 -----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVK 193
                      S              D E     +   A+G+A+L   +C+    HRD+ 
Sbjct: 140 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLA 195
Query: 194 CNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI 252
             NILL       + DFGLA+ + N +N             Y+  G  +L + +    +I
Sbjct: 196 ARNILLTHGRITKICDFGLARDIKNDSN-------------YVVKGNARLPVKWMAPESI 242
Query: 253 -----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
                T +SDV+SYG+ L E+ S  S+  P +       + +K+      P         
Sbjct: 243 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--------- 293
Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +  P +M  ++++T      C ++ P +RPT K++V L+
Sbjct: 294 EHAPAEMY-DIMKT------CWDADPLKRPTFKQIVQLI 325

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A +   G  +AVKKL +  +          
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL  +   +S++    + L  ++               D   ++ 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + D GLA+  +       M+ 
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD-----EMTG 181
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+  +  D++S G ++ E+L+GR+
Sbjct: 182 YVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 76/339 (22%), Positives = 133/339 (39%), Gaps = 76/339 (22%)
Query: 39  PGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-----PNGELIA 93
           P    + + W F P  +L+F              +G G  G V +A        +  +  
Sbjct: 27  PTQLPYDHKWEF-PRNRLSFG-----------KTLGAGAFGKVVEATAYGLIKSDAAMTV 74
Query: 94  VKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNYI------- 145
             K+ K        ++  +E+++L ++  H NIV LLG C+     L++  Y        
Sbjct: 75  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 134
Query: 146 -----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL-HHDCVPAILHRDVK 193
                      S              D E     +   A+G+A+L   +C+    HRD+ 
Sbjct: 135 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLA 190
Query: 194 CNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI 252
             NILL       + DFGLA+ + N +N             Y+  G  +L + +    +I
Sbjct: 191 ARNILLTHGRITKICDFGLARDIKNDSN-------------YVVKGNARLPVKWMAPESI 237
Query: 253 -----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
                T +SDV+SYG+ L E+ S  S+  P +       + +K+      P         
Sbjct: 238 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--------- 288
Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +  P +M  ++++T      C ++ P +RPT K++V L+
Sbjct: 289 EHAPAEMY-DIMKT------CWDADPLKRPTFKQIVQLI 320

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
           A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +         
Sbjct: 203 AKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E   +
Sbjct: 259 LKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDEEFCR 307
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           ++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 308 RLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 350

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  +  + +G G  G V  + ++ +G  IAVKKL +  +          
Sbjct: 40  QELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR 99
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSV-----KLLLYNYISXXXXXXXXXXXXXXDWETRYK 167
           E+++L H++H N++ LL   +  +       + L  ++               D   ++ 
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 159
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M+ 
Sbjct: 160 I-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 210
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +  Y AP     +I+  + M+     D++S G ++ E+L+GR+
Sbjct: 211 YVATRWYRAP-----EIMLNW-MHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG--YCSNKSVKLLLYNYI 145
            G L+AVK+L  +  D++    F  EIQIL  +    IVK  G  Y   +    L+  Y+
Sbjct: 39  TGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 96
Query: 146 SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC-------VPAILHRDVKCNNIL 198
                          D+  R++  + +++ L Y    C           +HRD+   NIL
Sbjct: 97  PSGCLR---------DFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 147
Query: 199 LDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSD 257
           ++S+    +ADFGLAKL+    +Y+           + AP      I        + +SD
Sbjct: 148 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-------FSRQSD 200
Query: 258 VYSYGVVLLEILS 270
           V+S+GVVL E+ +
Sbjct: 201 VWSFGVVLYELFT 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 66  CLKDENVIGKG-----CSGVVYKAEMPNGE--LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           C+K E VIG G     CSG   + ++P      +A+K L     D++  D F +E  I+G
Sbjct: 15  CIKIEKVIGVGEFGEVCSG---RLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMG 70
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA------VGS 172
              H NI+ L G  +     +++  Y+                 + R+ +        G 
Sbjct: 71  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN-----DGRFTVIQLVGMLRGI 125
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
             G+ YL      + +HRD+   NIL++S     ++DFG+++++         +R     
Sbjct: 126 GSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----- 177
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           G   P +        Y    T  SDV+SYG+V+ E++S
Sbjct: 178 GGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMS 214

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
           A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +         
Sbjct: 210 AKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E   +
Sbjct: 266 LKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDEEFCR 314
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           ++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 315 RLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 357

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 66  CLKDENVIGKG-----CSGVVYKAEMPNGE--LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           C+K E VIG G     CSG   + ++P      +A+K L     D++  D F +E  I+G
Sbjct: 9   CIKIEKVIGVGEFGEVCSG---RLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMG 64
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA------VGS 172
              H NI+ L G  +     +++  Y+                 + R+ +        G 
Sbjct: 65  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN-----DGRFTVIQLVGMLRGI 119
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
             G+ YL      + +HRD+   NIL++S     ++DFG+++++         +R     
Sbjct: 120 GSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----- 171
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           G   P +        Y    T  SDV+SYG+V+ E++S
Sbjct: 172 GGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMS 208

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
           A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +         
Sbjct: 208 AKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E   +
Sbjct: 264 LKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDEEFCR 312
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           ++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 313 RLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 355

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 173 AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
           A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +     +         
Sbjct: 201 AKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             ++AP     + I+     I  +SDV+S+GV+L EI S  ++  P    G+ I E   +
Sbjct: 257 LKWMAP-----ETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYP----GVKIDEEFCR 305
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           ++           T+++  PD    EM QT+   + C +  P++RPT  E+V  L
Sbjct: 306 RLKE--------GTRMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 348

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 39  PGAEDFSYPWTF-IPFQKL----------NFTIDNILECLKDENVIGKGCSGVVYKAEMP 87
           PG   F  P T+  P Q +          N +ID ++   +     G+ CSG   + ++P
Sbjct: 17  PGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGE----FGEVCSG---RLKLP 69
Query: 88  NGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           + + I+V  K  K    E+    F  E  I+G   H NI++L G  +     +++  Y+ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129
Query: 147 XXXXXXXXXXXXXXDWETRYKIA------VGSAQGLAYLHHDCVPAILHRDVKCNNILLD 200
                           + ++ +        G A G+ YL        +HRD+   NIL++
Sbjct: 130 NGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILIN 181
Query: 201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYS 260
           S     ++DFGL++++         +R     G   P +        Y    T  SDV+S
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTSPEAIAY-RKFTSASDVWS 235
Query: 261 YGVVLLEILS 270
           YG+VL E++S
Sbjct: 236 YGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 39  PGAEDFSYPWTF-IPFQKL----------NFTIDNILECLKDENVIGKGCSGVVYKAEMP 87
           PG   +  P TF  P Q +          N +ID ++   +     G+ CSG   + ++P
Sbjct: 17  PGLRTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGE----FGEVCSG---RLKLP 69
Query: 88  NGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           + + I+V  K  K    E+    F  E  I+G   H NI++L G  +     +++  Y+ 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129
Query: 147 XXXXXXXXXXXXXXDWETRYKIA------VGSAQGLAYLHHDCVPAILHRDVKCNNILLD 200
                           + ++ +        G A G+ YL        +HRD+   NIL++
Sbjct: 130 NGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILIN 181
Query: 201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYS 260
           S     ++DFGL++++         +R     G   P +        Y    T  SDV+S
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTSPEAIAY-RKFTSASDVWS 235
Query: 261 YGVVLLEILS 270
           YG+VL E++S
Sbjct: 236 YGIVLWEVMS 245

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 103/246 (41%), Gaps = 31/246 (12%)
Query: 39  PGAEDFSYPWTF-IPFQKL----------NFTIDNILECLKDENVIGKGCSGVVYKAEMP 87
           PG   F  P TF  P Q +          N +ID ++   +     G+ CSG   + ++P
Sbjct: 17  PGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGE----FGEVCSG---RLKLP 69
Query: 88  NGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           + + I+V  K  K    E+    F  E  I+G   H NI++L G  + KS  +++     
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-KSKPVMIVTEXM 128
Query: 147 XXXXXXXXXXXXXXDWETRYKIAV--GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE 204
                          +     + +  G A G+ YL        +HRD+   NIL++S   
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLV 185
Query: 205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVV 264
             ++DFGL++++         +R     G   P +        Y    T  SDV+SYG+V
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTSPEAIAY-RKFTSASDVWSYGIV 239
Query: 265 LLEILS 270
           L E++S
Sbjct: 240 LWEVMS 245

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG--YCSNKSVKLLLYNYI 145
            G L+AVK+L  +  D++    F  EIQIL  +    IVK  G  Y   +    L+  Y+
Sbjct: 51  TGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108
Query: 146 SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC-------VPAILHRDVKCNNIL 198
                          D+  R++  + +++ L Y    C           +HRD+   NIL
Sbjct: 109 PSGCLR---------DFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159
Query: 199 LDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSD 257
           ++S+    +ADFGLAKL+    +Y+           + AP      I        + +SD
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-------FSRQSD 212
Query: 258 VYSYGVVLLEILS 270
           V+S+GVVL E+ +
Sbjct: 213 VWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG--YCSNKSVKLLLYNYI 145
            G L+AVK+L  +  D++    F  EIQIL  +    IVK  G  Y   +    L+  Y+
Sbjct: 38  TGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 95
Query: 146 SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC-------VPAILHRDVKCNNIL 198
                          D+  R++  + +++ L Y    C           +HRD+   NIL
Sbjct: 96  PSGCLR---------DFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 146
Query: 199 LDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSD 257
           ++S+    +ADFGLAKL+    +Y+           + AP      I        + +SD
Sbjct: 147 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-------FSRQSD 199
Query: 258 VYSYGVVLLEILS 270
           V+S+GVVL E+ +
Sbjct: 200 VWSFGVVLYELFT 212

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 64  LECLKDENVIGKG-----CSGVVYKAEMPNGE--LIAVKKLWKTKRDEEPVDSFAAEIQI 116
           + C+K E VIG G     CSG +   ++P      +A+K L K+   E+    F +E  I
Sbjct: 6   ISCVKIEQVIGAGEFGEVCSGHL---KLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASI 61
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +G   H N++ L G  +  +  +++  ++               D +      VG  +G+
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGI 118
Query: 177 AY-LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS---Y 232
           A  + +      +HR +   NIL++S     ++DFGL++ +         +   G     
Sbjct: 119 AAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            + AP   + +         T  SDV+SYG+V+ E++S
Sbjct: 179 RWTAPEAIQYR-------KFTSASDVWSYGIVMWEVMS 209

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 49/284 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  G V+  E  +  L  V K     R + P++   AEI++L  + H NI+K+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 133 SNKSVKLLLYN-YISXXXXXXXXXXXXXXDWETRYK---------IAVGSAQGLAYLHHD 182
            +       +N YI                 + R K         +       LAY H  
Sbjct: 90  ED------YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 183 CVPAILHRDVKCNNILL-DSKYEA--YLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
            V   +H+D+K  NIL  D+   +   + DFGLA+L  S  +    +  AG+  Y+AP  
Sbjct: 144 HV---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEV 197
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            K         ++T K D++S GVV+  +L+G     P  G  L   E V++K    EP 
Sbjct: 198 FK--------RDVTFKCDIWSAGVVMYFLLTG---CLPFTGTSL---EEVQQKATYKEPN 243
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            ++   + + L  Q V  + Q L          P  RP+  +V+
Sbjct: 244 YAV---ECRPLTPQAVDLLKQML-------TKDPERRPSAAQVL 277

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQ 115
           N +ID ++   +     G+ CSG   + ++P+ + I+V  K  K    E+    F  E  
Sbjct: 34  NISIDKVVGAGE----FGEVCSG---RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 86
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA------ 169
           I+G   H NI++L G  +     +++  Y+                 + ++ +       
Sbjct: 87  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-----DAQFTVIQLVGML 141
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
            G A G+ YL        +HRD+   NIL++S     ++DFGL++++         +R  
Sbjct: 142 RGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-- 196
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              G   P +        Y    T  SDV+SYG+VL E++S
Sbjct: 197 ---GGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMS 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQ 115
           N +ID ++   +     G+ CSG   + ++P+ + I+V  K  K    E+    F  E  
Sbjct: 17  NISIDKVVGAGE----FGEVCSG---RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 69
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA------ 169
           I+G   H NI++L G  +     +++  Y+                 + ++ +       
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-----DAQFTVIQLVGML 124
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
            G A G+ YL        +HRD+   NIL++S     ++DFGL++++         +R  
Sbjct: 125 RGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-- 179
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              G   P +        Y    T  SDV+SYG+VL E++S
Sbjct: 180 ---GGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMS 216

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IGKG    V  A  +  G  +A+K + KT+ +   +     E++I+  + H NIVKL  
Sbjct: 22  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 131 YCSNKSVKLLLYNYIS---XXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
               +    L+  Y S                 +  ++++  V + Q   Y H      I
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ---KRI 135
Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  N+LLD+     +ADFG +   N       +    G+  Y AP     ++  G
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAAP-----ELFQG 187
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
              +  E  DV+S GV+L  ++SG
Sbjct: 188 KKYDGPE-VDVWSLGVILYTLVSG 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDS----FAAEIQILGHIRHRNIVK 127
           +G+G  G VYKA     G+++A+K++        PV+S       EI I+      ++VK
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQV--------PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 128 LLG-YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             G Y  N  + +++    +                +    I   + +GL YLH      
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
            +HRD+K  NILL+++  A LADFG+A  +  T+     + V G+  ++AP     ++I 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAP-----EVIQ 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
               N    +D++S G+  +E+  G+
Sbjct: 199 EIGYNCV--ADIWSLGITAIEMAEGK 222

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 120/284 (42%), Gaps = 37/284 (13%)
Query: 72  VIGKGCSGVVYKAEMPN--GELIAVKKLWKTKRDEEPVDS---FAAEIQILGHIRHRNIV 126
           ++G+G  G VY+    N  GE I V    KT + +  +D+   F +E  I+ ++ H +IV
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAV--KTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH-DCVP 185
           KL+G    +   +++  Y                   T    ++   + +AYL   +CV 
Sbjct: 77  KLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV- 135
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
              HRD+   NIL+ S     L DFGL++ +   +Y+ A S       +++P     +  
Sbjct: 136 ---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA-SVTRLPIKWMSPESINFR-- 189
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT 305
                  T  SDV+ + V + EILS     QP          W++ K       + +L+ 
Sbjct: 190 -----RFTTASDVWMFAVCMWEILS--FGKQPFF--------WLENK-----DVIGVLEK 229
Query: 306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             +     +   +L TL     C +  P++RP   E+V  L +V
Sbjct: 230 GDRLPKPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDV 271

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 127 KLLGYCSNKSVKLL---------LYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +LLG  S     L+         L +Y+ S                +   ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL+       +HRD+   N ++   +   + DFG+ + +  T+Y+    +      ++A
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K  +        T  SD++S+GVVL EI S   A QP  G            + + 
Sbjct: 201 PESLKDGV-------FTTSSDMWSFGVVLWEITS--LAEQPYQG------------LSNE 239
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +    ++D      PD   + +   + +   C   +P  RPT  E+V LL
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLL 286

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 37/285 (12%)
Query: 71  NVIGKGCSGVVYKAEMPN--GELIAVKKLWKTKRDEEPVDS---FAAEIQILGHIRHRNI 125
            ++G+G  G VY+    N  GE I V    KT + +  +D+   F +E  I+ ++ H +I
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAV--KTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH-DCV 184
           VKL+G    +   +++  Y                   T    ++   + +AYL   +CV
Sbjct: 88  VKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 147
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
               HRD+   NIL+ S     L DFGL++ +   +Y+ A S       +++P     + 
Sbjct: 148 ----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA-SVTRLPIKWMSPESINFR- 201
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
                   T  SDV+ + V + EILS     QP          W++ K       + +L+
Sbjct: 202 ------RFTTASDVWMFAVCMWEILS--FGKQPFF--------WLENK-----DVIGVLE 240
Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
              +     +   +L TL     C +  P++RP   E+V  L +V
Sbjct: 241 KGDRLPKPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDV 283

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 120/284 (42%), Gaps = 37/284 (13%)
Query: 72  VIGKGCSGVVYKAEMPN--GELIAVKKLWKTKRDEEPVDS---FAAEIQILGHIRHRNIV 126
           ++G+G  G VY+    N  GE I V    KT + +  +D+   F +E  I+ ++ H +IV
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAV--KTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH-DCVP 185
           KL+G    +   +++  Y                   T    ++   + +AYL   +CV 
Sbjct: 73  KLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV- 131
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
              HRD+   NIL+ S     L DFGL++ +   +Y+ A S       +++P     +  
Sbjct: 132 ---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA-SVTRLPIKWMSPESINFR-- 185
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT 305
                  T  SDV+ + V + EILS     QP          W++ K       + +L+ 
Sbjct: 186 -----RFTTASDVWMFAVCMWEILS--FGKQPFF--------WLENK-----DVIGVLEK 225
Query: 306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             +     +   +L TL     C +  P++RP   E+V  L +V
Sbjct: 226 GDRLPKPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDV 267

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQ 115
           N +ID ++   +     G+ CSG   + ++P+ + I+V  K  K    E+    F  E  
Sbjct: 44  NISIDKVVGAGE----FGEVCSG---RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 96
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA------ 169
           I+G   H NI++L G  +     +++  Y+                 + ++ +       
Sbjct: 97  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-----DAQFTVIQLVGML 151
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
            G A G+ YL        +HRD+   NIL++S     ++DFGL++++         +R  
Sbjct: 152 RGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-- 206
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              G   P +        Y    T  SDV+SYG+VL E++S
Sbjct: 207 ---GGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQ 115
           N +ID ++   +     G+ CSG   + ++P+ + I+V  K  K    E+    F  E  
Sbjct: 46  NISIDKVVGAGE----FGEVCSG---RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA------ 169
           I+G   H NI++L G  +     +++  Y+                 + ++ +       
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-----DAQFTVIQLVGML 153
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
            G A G+ YL        +HRD+   NIL++S     ++DFGL++++         +R  
Sbjct: 154 RGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-- 208
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              G   P +        Y    T  SDV+SYG+VL E++S
Sbjct: 209 ---GGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMS 245

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSF 110
           Q+LN T+  + + L+    +G G  G V   Y A +   + +AVKKL +  +        
Sbjct: 17  QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRT 74
Query: 111 AAEIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETR 165
             E+++L H++H N++ LL  +    S++    + L   +               D   +
Sbjct: 75  YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQ 134
Query: 166 YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
           + +     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M
Sbjct: 135 F-LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----M 185
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +    +  Y AP     +I+  + M+  +  D++S G ++ E+L G++
Sbjct: 186 TGYVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 120/266 (45%), Gaps = 37/266 (13%)
Query: 71  NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL- 128
             IG G  GVV  A     G+ +A+KK+               E++IL H +H NI+ + 
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 120
Query: 129 ------LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
                 + Y   KSV ++L + +                   RY +     +GL Y+H  
Sbjct: 121 DILRPTVPYGEFKSVYVVL-DLMESDLHQIIHSSQPLTLEHVRYFL-YQLLRGLKYMHSA 178
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA--MSRVAGSYGYIAPGKC 240
            V   +HRD+K +N+L++   E  + DFG+A+ + ++   H   M+    +  Y AP   
Sbjct: 179 QV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP--- 232
Query: 241 KLQI-IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG---LHIVEWVKKKMGSF 296
           +L + ++ YT  I    D++S G +  E+L+ R     Q+  G   +H ++ +   +G+ 
Sbjct: 233 ELMLSLHEYTQAI----DLWSVGCIFGEMLARR-----QLFPGKNYVHQLQLIMMVLGTP 283
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTL 322
            PAV      +Q +  + V+  +Q+L
Sbjct: 284 SPAV------IQAVGAERVRAYIQSL 303

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 21/222 (9%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG- 130
           IG G  G+V  A +   G  +AVKKL +  +++        E+ +L  + H+NI+ LL  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 131 YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
           +   K+++    +Y  +               D E    +      G+ +LH      I+
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGII 146
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K +NI++ S     + DFGLA+   STN+   M+    +  Y AP     ++I G 
Sbjct: 147 HRDLKPSNIVVKSDCTLKILDFGLAR-TASTNF--MMTPYVVTRYYRAP-----EVILG- 197
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK 290
            M   E  D++S G ++ E++ G    Q       HI +W K
Sbjct: 198 -MGYKENVDIWSVGCIMGELVKGSVIFQ----GTDHIDQWNK 234

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 113/277 (40%), Gaps = 38/277 (13%)
Query: 64  LECLKDENVIGKGCSGVVY---KAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
            E LK   V+G+G  G V+   K   P+ G L A+K L K             E  IL  
Sbjct: 30  FELLK---VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILAD 86
Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL 179
           + H  +VKL      +    L+ +++                 E         A GL +L
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H      I++RD+K  NILLD +    L DFGL+K   + ++        G+  Y+AP  
Sbjct: 147 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEV 201
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
              Q   G++ +    +D +SYGV++ E+L+G    Q +                  E  
Sbjct: 202 VNRQ---GHSHS----ADWWSYGVLMFEMLTGSLPFQGK---------------DRKETM 239
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER 336
             IL  KL G+P Q +    Q+L  A+F  N  PA R
Sbjct: 240 TLILKAKL-GMP-QFLSTEAQSLLRALFKRN--PANR 272

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 82
Query: 127 KLLGYCSNKSVKLL---------LYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +LLG  S     L+         L +Y+ S                +   ++A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL+       +HRD+   N ++   +   + DFG+ + +  T+Y+    +      ++A
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K  +        T  SD++S+GVVL EI S   A QP  G            + + 
Sbjct: 200 PESLKDGV-------FTTSSDMWSFGVVLWEITS--LAEQPYQG------------LSNE 238
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +    ++D      PD   + +   + +   C   +P  RPT  E+V LL
Sbjct: 239 QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLL 285

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 120/266 (45%), Gaps = 37/266 (13%)
Query: 71  NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL- 128
             IG G  GVV  A     G+ +A+KK+               E++IL H +H NI+ + 
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 119
Query: 129 ------LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
                 + Y   KSV ++L + +                   RY +     +GL Y+H  
Sbjct: 120 DILRPTVPYGEFKSVYVVL-DLMESDLHQIIHSSQPLTLEHVRYFL-YQLLRGLKYMHSA 177
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA--MSRVAGSYGYIAPGKC 240
            V   +HRD+K +N+L++   E  + DFG+A+ + ++   H   M+    +  Y AP   
Sbjct: 178 QV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP--- 231
Query: 241 KLQI-IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG---LHIVEWVKKKMGSF 296
           +L + ++ YT  I    D++S G +  E+L+ R     Q+  G   +H ++ +   +G+ 
Sbjct: 232 ELMLSLHEYTQAI----DLWSVGCIFGEMLARR-----QLFPGKNYVHQLQLIMMVLGTP 282
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTL 322
            PAV      +Q +  + V+  +Q+L
Sbjct: 283 SPAV------IQAVGAERVRAYIQSL 302

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 14/109 (12%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSY 232
           Q L + H +    I+HRDVK  NIL+ +     + DFG+A+ + +S N     + V G+ 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            Y++P + +         ++  +SDVYS G VL E+L+G     P  GD
Sbjct: 184 QYLSPEQARGD-------SVDARSDVYSLGCVLYEVLTGEP---PFTGD 222

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSF 110
           Q+LN T+  + + L+    +G G  G V   Y A +   + +AVKKL +  +        
Sbjct: 17  QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRT 74
Query: 111 AAEIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETR 165
             E+++L H++H N++ LL  +    S++    + L   +               D   +
Sbjct: 75  YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQ 134
Query: 166 YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
           + +     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M
Sbjct: 135 F-LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----M 185
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +    +  Y AP     +I+  + M+  +  D++S G ++ E+L G++
Sbjct: 186 TGYVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDS---FAAEIQILGHIRH 122
           L+   V+G G  G VYK   +P+GE + +    K  R+     +      E  ++  +  
Sbjct: 19  LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 123 RNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
             + +LLG C   +V+L+                      +      +  A+G++YL   
Sbjct: 79  PYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED- 137
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM--NSTNYHHAMSRVAGSYGYIAPGKC 240
               ++HRD+   N+L+ S     + DFGLA+L+  + T YH    +V   +        
Sbjct: 138 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW-------M 188
Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            L+ I       T +SDV+SYGV + E+++
Sbjct: 189 ALESI--LRRRFTHQSDVWSYGVTVWELMT 216

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 26/241 (10%)
Query: 73  IGKGCSGVVYKAE-MPNGELIAVKK-LWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           IG+G  G V+KA     G+ +A+KK L + +++  P+ +   EI+IL  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 131 YCSNKSVKL--------LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
            C  K+           L++++                      ++      GL Y+H +
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 144
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAK---LMNSTNYHHAMSRVAGSYGYIAPGK 239
               ILHRD+K  N+L+       LADFGLA+   L  ++  +   +RV   + Y  P  
Sbjct: 145 ---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW-YRPPEL 200
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
              +  YG  +      D++  G ++ E+ + RS +  Q     H +  + +  GS  P 
Sbjct: 201 LLGERDYGPPI------DLWGAGCIMAEMWT-RSPIM-QGNTEQHQLALISQLCGSITPE 252
Query: 300 V 300
           V
Sbjct: 253 V 253

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 121/305 (39%), Gaps = 55/305 (18%)
Query: 72  VIGKGCSGVVYKAEMPNGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           ++G+G  G V +  +   +     +AVK +      +  ++ F +E   +    H N+++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 128 LLGYCSNKSVKLL--------------LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA 173
           LLG C   S + +              L+ Y+                 +T  K  V  A
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL---LYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
            G+ YL +      LHRD+   N +L       +ADFGL+K + S +Y+          G
Sbjct: 158 LGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ--------G 206
Query: 234 YIAPGKCKLQIIYGYTMNI-TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
            IA    K   I      + T KSDV+++GV + EI +    + P  G   H        
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNH-------- 256
Query: 293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMF-CVNSSPAERPTMKEVVALLME--V 349
                    + D  L G   +  ++ L  L   M+ C  + P +RPT   V+ L +E  +
Sbjct: 257 --------EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS-VLRLQLEKLL 307
Query: 350 KSAPE 354
           +S P+
Sbjct: 308 ESLPD 312

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSF 110
           Q+LN T+  + + L+    +G G  G V   Y A +   + +AVKKL +  +        
Sbjct: 9   QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRT 66
Query: 111 AAEIQILGHIRHRNIVKLLG-YCSNKSVK----LLLYNYISXXXXXXXXXXXXXXDWETR 165
             E+++L H++H N++ LL  +    S++    + L   +               D   +
Sbjct: 67  YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQ 126
Query: 166 YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
           + +     +GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+  +       M
Sbjct: 127 F-LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----M 177
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +    +  Y AP     +I+  + M+  +  D++S G ++ E+L G++
Sbjct: 178 TGYVATRWYRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLQGKA 219

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 56/299 (18%)
Query: 73  IGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+   G VYK  +         + +A+K L K K +    + F  E  +   ++H N+V
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 127 KLLGYCSNKSVKLLLYNYISX------XXXXXXXXXXXXXDWETRYKIAVGS-------- 172
            LLG  +      ++++Y S                    D +   K A+          
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 173 --AQGLAYL--HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
             A G+ YL  HH     ++H+D+   N+L+  K    ++D GL + + + +Y+  +   
Sbjct: 153 QIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 207
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVE 287
                ++AP      I+YG     +  SD++SYGVVL E+ S    +QP  G     +VE
Sbjct: 208 LLPIRWMAPEA----IMYG---KFSIDSDIWSYGVVLWEVFS--YGLQPYCGYSNQDVVE 258
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            ++ +             ++   PD           + + C N  P+ RP  K++ + L
Sbjct: 259 MIRNR-------------QVLPCPDDCPA---WVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 30/194 (15%)
Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG--YCSNKSVKLLLYNYI 145
            G L+AVK+L  +  D++    F  EIQIL  +    IVK  G  Y   +    L+  Y+
Sbjct: 35  TGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYL 92
Query: 146 SXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC-------VPAILHRDVKCNNIL 198
                          D+  R++  + +++ L Y    C           +HRD+   NIL
Sbjct: 93  PSGCLR---------DFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 143
Query: 199 LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG--YIAPGKCKLQIIYGYTMNITEKS 256
           ++S+    +ADFGLAKL+   +    + R  G     + AP      I        + +S
Sbjct: 144 VESEAHVKIADFGLAKLL-PLDKDXXVVREPGQSPIFWYAPESLSDNI-------FSRQS 195
Query: 257 DVYSYGVVLLEILS 270
           DV+S+GVVL E+ +
Sbjct: 196 DVWSFGVVLYELFT 209

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 56/299 (18%)
Query: 73  IGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+   G VYK  +         + +A+K L K K +    + F  E  +   ++H N+V
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 127 KLLGYCSNKSVKLLLYNYISX------XXXXXXXXXXXXXDWETRYKIAVGS-------- 172
            LLG  +      ++++Y S                    D +   K A+          
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 173 --AQGLAYL--HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
             A G+ YL  HH     ++H+D+   N+L+  K    ++D GL + + + +Y+  +   
Sbjct: 136 QIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVE 287
                ++AP      I+YG     +  SD++SYGVVL E+ S    +QP  G     +VE
Sbjct: 191 LLPIRWMAPEA----IMYG---KFSIDSDIWSYGVVLWEVFS--YGLQPYCGYSNQDVVE 241
Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            ++ +             ++   PD           + + C N  P+ RP  K++ + L
Sbjct: 242 MIRNR-------------QVLPCPDDCPA---WVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           ++GKG  G V K  +    +  AVK + K     +   +   E+++L  + H NI+KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
              + S   ++    +                    +I      G+ Y+H      I+HR
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHR 145
Query: 191 DVKCNNILLDSKY---EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           D+K  NILL+SK    +  + DFGL+           M    G+  YIAP     +++ G
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAP-----EVLRG 197
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
                 EK DV+S GV+L  +LSG
Sbjct: 198 ---TYDEKCDVWSAGVILYILLSG 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 44/290 (15%)
Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 127 KLLGYCSNKSVKLL---------LYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +LLG  S     L+         L +Y+ S                +   ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL+       +HRD+   N ++   +   + DFG+ + +  T Y+    +      ++A
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K  +        T  SD++S+GVVL EI S   A QP  G            + + 
Sbjct: 201 PESLKDGV-------FTTSSDMWSFGVVLWEITS--LAEQPYQG------------LSNE 239
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +    ++D      PD   + +   + +   C   +P  RPT  E+V LL
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLL 286

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 26/241 (10%)
Query: 73  IGKGCSGVVYKAE-MPNGELIAVKK-LWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           IG+G  G V+KA     G+ +A+KK L + +++  P+ +   EI+IL  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 131 YCSNKSVKL--------LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
            C  K+           L++++                      ++      GL Y+H +
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 144
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAK---LMNSTNYHHAMSRVAGSYGYIAPGK 239
               ILHRD+K  N+L+       LADFGLA+   L  ++  +   +RV   + Y  P  
Sbjct: 145 ---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW-YRPPEL 200
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
              +  YG  +      D++  G ++ E+ + RS +  Q     H +  + +  GS  P 
Sbjct: 201 LLGERDYGPPI------DLWGAGCIMAEMWT-RSPIM-QGNTEQHQLALISQLCGSITPE 252
Query: 300 V 300
           V
Sbjct: 253 V 253

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 14/152 (9%)
Query: 73  IGKGCSGVVYKAE-MPNGELIAVKK-LWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           IG+G  G V+KA     G+ +A+KK L + +++  P+ +   EI+IL  ++H N+V L+ 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 83
Query: 131 YCSNKSVKL--------LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
            C  K+           L++++                      ++      GL Y+H +
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 143
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
               ILHRD+K  N+L+       LADFGLA+
Sbjct: 144 ---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 14/127 (11%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSY 232
           Q L + H +    I+HRDVK  NI++ +     + DFG+A+ + +S N     + V G+ 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
            Y++P + +         ++  +SDVYS G VL E+L+G     P  GD    V +   +
Sbjct: 184 QYLSPEQARGD-------SVDARSDVYSLGCVLYEVLTGEP---PFTGDSPDSVAYQHVR 233
Query: 293 MGSFEPA 299
                P+
Sbjct: 234 EDPIPPS 240

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 26/241 (10%)
Query: 73  IGKGCSGVVYKAE-MPNGELIAVKK-LWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           IG+G  G V+KA     G+ +A+KK L + +++  P+ +   EI+IL  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 131 YCSNKSVKL--------LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
            C  K+           L++++                      ++      GL Y+H +
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 144
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAK---LMNSTNYHHAMSRVAGSYGYIAPGK 239
               ILHRD+K  N+L+       LADFGLA+   L  ++  +   +RV   + Y  P  
Sbjct: 145 ---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW-YRPPEL 200
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
              +  YG  +      D++  G ++ E+ + RS +  Q     H +  + +  GS  P 
Sbjct: 201 LLGERDYGPPI------DLWGAGCIMAEMWT-RSPIM-QGNTEQHQLALISQLCGSITPE 252
Query: 300 V 300
           V
Sbjct: 253 V 253

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           ++GKG  G V K  +    +  AVK + K     +   +   E+++L  + H NI+KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
              + S   ++    +                    +I      G+ Y+H      I+HR
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHR 145
Query: 191 DVKCNNILLDSKY---EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           D+K  NILL+SK    +  + DFGL+           M    G+  YIAP     +++ G
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAP-----EVLRG 197
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
                 EK DV+S GV+L  +LSG
Sbjct: 198 ---TYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           ++GKG  G V K  +    +  AVK + K     +   +   E+++L  + H NI+KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
              + S   ++    +                    +I      G+ Y+H      I+HR
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHR 145
Query: 191 DVKCNNILLDSKY---EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           D+K  NILL+SK    +  + DFGL+           M    G+  YIAP     +++ G
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAP-----EVLRG 197
Query: 248 YTMNITEKSDVYSYGVVLLEILSG 271
                 EK DV+S GV+L  +LSG
Sbjct: 198 ---TYDEKCDVWSAGVILYILLSG 218

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIV 126
           V+GKG  G V  A +   G+L AVK L   K+D    ++ V+    E +IL   R+   +
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVL---KKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 127 KLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKI-AVGSAQGLAYLHHDCV 184
             L  C     +L     +++              D E R +  A      L +LH    
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EARARFYAAEIISALMFLHDK-- 143
Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAK--LMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
             I++RD+K +N+LLD +    LADFG+ K  + N        +   G+  YIAP   + 
Sbjct: 144 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV----TTATFCGTPDYIAPEILQ- 197
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
           +++YG  +      D ++ GV+L E+L G +  + +  D L
Sbjct: 198 EMLYGPAV------DWWAMGVLLYEMLCGHAPFEAENEDDL 232

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 14/109 (12%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSY 232
           Q L + H +    I+HRDVK  NI++ +     + DFG+A+ + +S N     + V G+ 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            Y++P + +         ++  +SDVYS G VL E+L+G     P  GD
Sbjct: 184 QYLSPEQARGD-------SVDARSDVYSLGCVLYEVLTGEP---PFTGD 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 14/109 (12%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSY 232
           Q L + H +    I+HRDVK  NI++ +     + DFG+A+ + +S N     + V G+ 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            Y++P + +         ++  +SDVYS G VL E+L+G     P  GD
Sbjct: 184 QYLSPEQARGD-------SVDARSDVYSLGCVLYEVLTGEP---PFTGD 222

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQ 115
           N +ID ++   +     G+ CSG   + ++P+ + I+V  K  K    E+    F  E  
Sbjct: 17  NISIDKVVGAGE----FGEVCSG---RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 69
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAV--GSA 173
           I+G   H NI++L G  + KS  +++                    +     + +  G A
Sbjct: 70  IMGQFDHPNIIRLEGVVT-KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 128
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
            G+ YL        +HRD+   NIL++S     ++DFGL++++         +R     G
Sbjct: 129 SGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-----G 180
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              P +        Y    T  SDV+SYG+VL E++S
Sbjct: 181 GKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMS 216

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +      +A+KK+   +  +        EIQIL   RH N++ +   
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEH-QTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H   V   L
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANV---L 166
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+L+++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 167 HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP-----EIMLN 221
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 222 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 262

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 14/109 (12%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSY 232
           Q L + H +    I+HRDVK  NI++ +     + DFG+A+ + +S N     + V G+ 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            Y++P + +         ++  +SDVYS G VL E+L+G     P  GD
Sbjct: 184 QYLSPEQARGD-------SVDARSDVYSLGCVLYEVLTGEP---PFTGD 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 130/325 (40%), Gaps = 56/325 (17%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLAFRHENIIGINDI 91
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 148
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 149 HRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 203
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGR--------------------SAVQPQIGDGLH 284
             GYT +I    D++S G +L E+LS R                    S  Q  +  G++
Sbjct: 204 SKGYTKSI----DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGIN 259
Query: 285 I--------------VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN 330
           +              V W +    +   A+ +LD  L   P + + E+ Q L        
Sbjct: 260 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-EVEQALAHPYLAQY 318
Query: 331 SSPAERPTMKEVVALLMEVKSAPEE 355
             P++ P  +      ME+   P+E
Sbjct: 319 YDPSDEPIAEAPFKFDMELDDLPKE 343

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +G+G  G V  A     G+ +A+K + K    K D +       EI  L  +RH +I+KL
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ--GRIEREISYLRLLRHPHIIKL 69
Query: 129 LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                +K   +++  Y                + E R +        + Y H      I+
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRH---KIV 125
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+LLD      +ADFGL+ +M   N+   +    GS  Y AP     ++I G 
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAP-----EVISG- 176
Query: 249 TMNITEKSDVYSYGVVLLEILSGR 272
            +    + DV+S GV+L  +L  R
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 27/244 (11%)
Query: 63  ILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           +L+  ++   IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 120 IRHRNIVKLLG-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           + H+NI+ LL  +   KS++    +Y  +               D E    +      G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            +LH      I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRA 193
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK--KKMG 294
           P     ++I G  M   E  D++S GV++ E++ G   + P      HI +W K  +++G
Sbjct: 194 P-----EVILG--MGYKENVDIWSVGVIMGEMIKG-GVLFPGTD---HIDQWNKVIEQLG 242
Query: 295 SFEP 298
           +  P
Sbjct: 243 TPSP 246

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQ 115
           N +ID ++   +     G+ CSG   + ++P+ + I+V  K  K    E+    F  E  
Sbjct: 46  NISIDKVVGAGE----FGEVCSG---RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAV--GSA 173
           I+G   H NI++L G  + KS  +++                    +     + +  G A
Sbjct: 99  IMGQFDHPNIIRLEGVVT-KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
            G+ YL        +HRD+   NIL++S     ++DFGL++++         +R     G
Sbjct: 158 SGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-----G 209
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              P +        Y    T  SDV+SYG+VL E++S
Sbjct: 210 GKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMS 245

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 27/244 (11%)
Query: 63  ILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           +L+  ++   IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 120 IRHRNIVKLLG-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           + H+NI+ LL  +   KS++    +Y  +               D E    +      G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            +LH      I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRA 193
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK--KKMG 294
           P     ++I G  M   E  D++S GV++ E++ G   + P      HI +W K  +++G
Sbjct: 194 P-----EVILG--MGYKENVDIWSVGVIMGEMIKG-GVLFPGTD---HIDQWNKVIEQLG 242
Query: 295 SFEP 298
           +  P
Sbjct: 243 TPSP 246

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 84
Query: 127 KLLGYCSNKSVKLL---------LYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +LLG  S     L+         L +Y+ S                +   ++A   A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL+       +HR++   N ++   +   + DFG+ + +  T+Y+    +      ++A
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K  +        T  SD++S+GVVL EI S   A QP  G            + + 
Sbjct: 202 PESLKDGV-------FTTSSDMWSFGVVLWEITS--LAEQPYQG------------LSNE 240
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +    ++D      PD   + +   + +   C   +P  RPT  E+V LL
Sbjct: 241 QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLL 287

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 14/116 (12%)
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAM 225
           ++   + Q L + H +    I+HRDVK  NI++ +     + DFG+A+ + +S N     
Sbjct: 137 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
           + V G+  Y++P + +         ++  +SDVYS G VL E+L+G     P  GD
Sbjct: 194 AAVIGTAQYLSPEQARGD-------SVDARSDVYSLGCVLYEVLTGEP---PFTGD 239

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL--- 129
           IGKG  G V+  +   GE +AVK  + T   EE       EI     +RH NI+  +   
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 130 --GYCSNKSVKLL--------LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL 179
             G  S   + L+        LY+Y+               D ++  K+A  S  GL +L
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTTL----------DAKSMLKLAYSSVSGLCHL 150
Query: 180 HHDCV-----PAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHH--AMSRVAGS 231
           H +       PAI HRD+K  NIL+       +AD GLA K ++ TN       +RV G+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GT 209
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEI 268
             Y+ P      +   +  +    +D+YS+G++L E+
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYI-MADMYSFGLILWEV 245

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 127 KLLGYCSNKSVKLL---------LYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +LLG  S     L+         L +Y+ S                +   ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL+       +HR++   N ++   +   + DFG+ + +  T+Y+    +      ++A
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K  +        T  SD++S+GVVL EI S   A QP  G            + + 
Sbjct: 201 PESLKDGV-------FTTSSDMWSFGVVLWEITS--LAEQPYQG------------LSNE 239
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +    ++D      PD   + +   + +   C   +P  RPT  E+V LL
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLL 286

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 73  IGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G+G    VYK +      L+A+K++     +  P  +   E+ +L  ++H NIV L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 68
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
              +    L++ Y+               +            +GLAY H      +LHRD
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRD 125
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K  N+L++ + E  LADFGLA+  +     +    V  +  Y  P      I+ G T +
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPP-----DILLGST-D 177
Query: 252 ITEKSDVYSYGVVLLEILSGR-----SAVQPQI 279
            + + D++  G +  E+ +GR     S V+ Q+
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 201
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 202 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 242

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL ++H+  V   ++RD+K  NILLD      ++D GLA   +    H ++    G++GY
Sbjct: 303 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 355
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
           +AP   +  + Y  +      +D +S G +L ++L G S  +       H ++ +   M 
Sbjct: 356 MAPEVLQKGVAYDSS------ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 409
Query: 295 -----SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER 336
                SF P +  L   L+GL  + V   L  LG     V  SP  R
Sbjct: 410 VELPDSFSPELRSL---LEGLLQRDVNRRLGCLGRGAQEVKESPFFR 453

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL ++H+  V   ++RD+K  NILLD      ++D GLA   +    H ++    G++GY
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 356
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
           +AP   +  + Y  +      +D +S G +L ++L G S  +       H ++ +   M 
Sbjct: 357 MAPEVLQKGVAYDSS------ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 295 -----SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER 336
                SF P +  L   L+GL  + V   L  LG     V  SP  R
Sbjct: 411 VELPDSFSPELRSL---LEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL ++H+  V   ++RD+K  NILLD      ++D GLA   +    H ++    G++GY
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 356
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
           +AP   +  + Y  +      +D +S G +L ++L G S  +       H ++ +   M 
Sbjct: 357 MAPEVLQKGVAYDSS------ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 295 -----SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER 336
                SF P +  L   L+GL  + V   L  LG     V  SP  R
Sbjct: 411 VELPDSFSPELRSL---LEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +G+G  G V  A     G+ +A+K + K    K D +       EI  L  +RH +I+KL
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ--GRIEREISYLRLLRHPHIIKL 79
Query: 129 LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                +K   +++  Y                + E R +        + Y H      I+
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRH---KIV 135
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+LLD      +ADFGL+ +M   N+   +    GS  Y AP     ++I G 
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAP-----EVISG- 186
Query: 249 TMNITEKSDVYSYGVVLLEILSGR 272
            +    + DV+S GV+L  +L  R
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +G+G  G V  A     G+ +A+K + K    K D +       EI  L  +RH +I+KL
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ--GRIEREISYLRLLRHPHIIKL 73
Query: 129 LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                +K   +++  Y                + E R +        + Y H      I+
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRH---KIV 129
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+LLD      +ADFGL+ +M   N+   +    GS  Y AP     ++I G 
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAP-----EVISG- 180
Query: 249 TMNITEKSDVYSYGVVLLEILSGR 272
            +    + DV+S GV+L  +L  R
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL ++H+  V   ++RD+K  NILLD      ++D GLA   +    H ++    G++GY
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 356
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
           +AP   +  + Y  +      +D +S G +L ++L G S  +       H ++ +   M 
Sbjct: 357 MAPEVLQKGVAYDSS------ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 295 -----SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER 336
                SF P +  L   L+GL  + V   L  LG     V  SP  R
Sbjct: 411 VELPDSFSPELRSL---LEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           +G+G  G V  A     G+ +A+K + K    K D +       EI  L  +RH +I+KL
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ--GRIEREISYLRLLRHPHIIKL 78
Query: 129 LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                +K   +++  Y                + E R +        + Y H      I+
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRH---KIV 134
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+LLD      +ADFGL+ +M   N+   +    GS  Y AP     ++I G 
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAP-----EVISG- 185
Query: 249 TMNITEKSDVYSYGVVLLEILSGR 272
            +    + DV+S GV+L  +L  R
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 205
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 206 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 246

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           LK    IGKG  G V   +   G  +AVK +    +++    +F AE  ++  +RH N+V
Sbjct: 8   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 127 KLLGYCSNKSVKLLL---YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +LLG    +   L +   Y                    +   K ++   + + YL  + 
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 121
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD+   N+L+     A ++DFGL K  +ST     +        + AP   + +
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREK 174
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
                    + KSDV+S+G++L EI S      P+I
Sbjct: 175 -------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 203

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 201
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 202 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 242

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 201
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 202 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 242

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           LK    IGKG  G V   +   G  +AVK +    +++    +F AE  ++  +RH N+V
Sbjct: 23  LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 127 KLLGYCSNKSVKLLL---YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +LLG    +   L +   Y                    +   K ++   + + YL  + 
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 136
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD+   N+L+     A ++DFGL K  +ST     +        + AP   + +
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREK 189
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
                    + KSDV+S+G++L EI S      P+I
Sbjct: 190 -------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 97
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 154
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 209
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 210 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 250

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 201
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 202 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 242

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 21/213 (9%)
Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD----EEPVDSFAAEIQILG-HIRHRNI 125
           ++GKG  G V+ AE     +  A+K L   K+D    ++ V+    E ++L     H  +
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEHPFL 81
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
             +      K     +  Y++              D       A     GL +LH     
Sbjct: 82  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---K 138
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I++RD+K +NILLD      +ADFG+ K   +       +   G+  YIAP     +I+
Sbjct: 139 GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAP-----EIL 191
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
            G   N +   D +S+GV+L E+L G+S    Q
Sbjct: 192 LGQKYNHS--VDWWSFGVLLYEMLIGQSPFHGQ 222

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H   V   L
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---L 146
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 201
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 202 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 242

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           LK    IGKG  G V   +   G  +AVK +    +++    +F AE  ++  +RH N+V
Sbjct: 195 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 127 KLLGYCSNKSVKLLL---YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +LLG    +   L +   Y                    +   K ++   + + YL  + 
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 308
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD+   N+L+     A ++DFGL K  +ST     +        + AP   + +
Sbjct: 309 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREK 361
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
                    + KSDV+S+G++L EI S      P+I
Sbjct: 362 -------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 390

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 91
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 148
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 203
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 204 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 244

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +       +   EI+IL   RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDI 93
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 205
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 206 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 246

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 151
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 206
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 207 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 247

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 144
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 199
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 200 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 240

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 95
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 152
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 153 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 207
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 208 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 248

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 86
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 143
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 144 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 198
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 199 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 239

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 205
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 206 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 246

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 23/216 (10%)
Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           LK    IGKG  G V   +   G  +AVK +    +++    +F AE  ++  +RH N+V
Sbjct: 14  LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 68
Query: 127 KLLGYCSNKSVKLLL---YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDC 183
           +LLG    +   L +   Y                    +   K ++   + + YL  + 
Sbjct: 69  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 127
Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
               +HRD+   N+L+     A ++DFGL K  +ST     +        + AP   +  
Sbjct: 128 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALR-- 178
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
                    + KSDV+S+G++L EI S      P+I
Sbjct: 179 -----EAAFSTKSDVWSFGILLWEIYSFGRVPYPRI 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 20/207 (9%)
Query: 72  VIGKGCSGVVYK-AEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IG G  G   K     +G+++  K+L      E       +E+ +L  ++H NIV+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 131 YCSNKSVKLLLY--------NYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
              +++   L          +  S              ++  R    +  A    +   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN-STNYHHAMSRVAGSYGYIAPGKCK 241
               +LHRD+K  N+ LD K    L DFGLA+++N  T++  A     G+  Y++P +  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF---VGTPYYMSPEQMN 189
Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEI 268
                   M+  EKSD++S G +L E+
Sbjct: 190 -------RMSYNEKSDIWSLGCLLYEL 209

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 166
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 221
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 222 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 262

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 144
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 199
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 200 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 240

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 21/213 (9%)
Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD----EEPVDSFAAEIQILG-HIRHRNI 125
           ++GKG  G V+ AE     +  A+K L   K+D    ++ V+    E ++L     H  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 126 VKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVP 185
             +      K     +  Y++              D       A     GL +LH     
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---K 137
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I++RD+K +NILLD      +ADFG+ K   +       +   G+  YIAP     +I+
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAP-----EIL 190
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
            G   N     D +S+GV+L E+L G+S    Q
Sbjct: 191 LGQKYN--HSVDWWSFGVLLYEMLIGQSPFHGQ 221

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH-------- 122
           V+G+G  G V KA    +    A+KK+  T   EE + +  +E+ +L  + H        
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 123 -----RNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY-KIAVGSAQGL 176
                RN VK +     KS   +   Y                     Y ++     + L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK---------LMNSTNYHHAMSR 227
           +Y+H      I+HRD+K  NI +D      + DFGLAK          ++S N   +   
Sbjct: 130 SYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 228 VAGSYG---YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
           +  + G   Y+A      +++ G T +  EK D+YS G++  E++
Sbjct: 187 LTSAIGTAMYVAT-----EVLDG-TGHYNEKIDMYSLGIIFFEMI 225

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 30/170 (17%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
           +GL YLH +     +HRD+K  N+LL  + +  LADFG+A  +  T      +   G+  
Sbjct: 127 KGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NXFVGTPF 181
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM 293
           ++AP   K Q  Y +      K+D++S G+  +E+  G    +P   D LH +  +    
Sbjct: 182 WMAPEVIK-QSAYDF------KADIWSLGITAIELAKG----EPPNSD-LHPMRVLFLIP 229
Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            +  P        L+G   +  +E ++       C+N  P  RPT KE++
Sbjct: 230 KNSPPT-------LEGQHSKPFKEFVEA------CLNKDPRFRPTAKELL 266

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 205
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 206 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 246

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 106 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 162
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 163 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 215
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 216 -RFTSASDVWMFGVCMWEIL 234

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 13/160 (8%)
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           EI  L  +RH +I+KL    +  +  +++  Y                + E R +     
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGR-RFFQQI 117
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
              + Y H      I+HRD+K  N+LLD      +ADFGL+ +M   N+   +    GS 
Sbjct: 118 ICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSP 171
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            Y AP     ++I G  +    + DV+S G+VL  +L GR
Sbjct: 172 NYAAP-----EVING-KLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 37/289 (12%)
Query: 62  NILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGH 119
           N L   + E  IG+G    VY+A  + +G  +A+KK+      D +       EI +L  
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 120 IRHRNIVKLLG-YCSNKSVKLLL----YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ 174
           + H N++K    +  +  + ++L       +S              +  T +K  V    
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTVWKYFVQLCS 147
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L ++H      ++HRD+K  N+ + +     L D GL +  +S     A   + G+  Y
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYY 202
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK-KM 293
           ++P +       GY      KSD++S G +L E+ + +S   P  GD +++    KK + 
Sbjct: 203 MSPERIHEN---GYNF----KSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQ 252
Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             + P  S          D   +E+ Q + +   C+N  P +RP +  V
Sbjct: 253 CDYPPLPS----------DHYSEELRQLVNM---CINPDPEKRPDVTYV 288

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH-------- 122
           V+G+G  G V KA    +    A+KK+  T   EE + +  +E+ +L  + H        
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 123 -----RNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY-KIAVGSAQGL 176
                RN VK +     KS   +   Y                     Y ++     + L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK---------LMNSTNYHHAMSR 227
           +Y+H      I+HRD+K  NI +D      + DFGLAK          ++S N   +   
Sbjct: 130 SYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 228 VAGSYG---YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
           +  + G   Y+A      +++ G T +  EK D+YS G++  E++
Sbjct: 187 LTSAIGTAMYVAT-----EVLDG-TGHYNEKIDMYSLGIIFFEMI 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 187
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 188 -RFTSASDVWMFGVCMWEIL 206

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 44/290 (15%)
Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 127 KLLGYCSNKSVKLL---------LYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +LLG  S     L+         L +Y+ S                +   ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL+       +HRD+   N ++   +   + DFG+ + +  T+      +      ++A
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K  +        T  SD++S+GVVL EI S   A QP  G            + + 
Sbjct: 201 PESLKDGVF-------TTSSDMWSFGVVLWEITS--LAEQPYQG------------LSNE 239
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +    ++D      PD   + +   + +   C   +P  RPT  E+V LL
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLL 286

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 75  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 131
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 132 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 184
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 185 -RFTSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 83  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 139
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 192
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 193 -RFTSASDVWMFGVCMWEIL 211

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLAFRHENIIGINDI 91
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 148
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 203
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 204 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 244

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A++K+   +  +        EI+IL   RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 205
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 206 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 246

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   +     +  Y AP     +I+  
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP-----EIMLN 205
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 206 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 246

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 44/290 (15%)
Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 80
Query: 127 KLLGYCSNKSVKLL---------LYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +LLG  S     L+         L +Y+ S                +   ++A   A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL+       +HRD+   N ++   +   + DFG+ + +  T+      +      ++A
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K  +        T  SD++S+GVVL EI S   A QP  G            + + 
Sbjct: 198 PESLKDGVF-------TTSSDMWSFGVVLWEITS--LAEQPYQG------------LSNE 236
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +    ++D      PD   + +   + +   C   +P  RPT  E+V LL
Sbjct: 237 QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLL 283

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   YI                  +   I     Q   GL Y+H      +L
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 151
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   +     +  Y AP     +I+  
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP-----EIMLN 206
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 207 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 247

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 187
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 188 -RFTSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 80  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 136
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 137 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 189
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 190 -RFTSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 81  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 137
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 138 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 190
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 191 -RFTSASDVWMFGVCMWEIL 209

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 57/286 (19%)
Query: 73  IGKGCSG-VVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK---- 127
           IG+G  G  +      +G    +K++  ++   +  +    E+ +L +++H NIV+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 128 ---------LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAY 178
                    ++ YC        L+  I+              DW  +  +A      L +
Sbjct: 92  FEENGSLYIVMDYCEGGD----LFKRINAQKGVLFQEDQIL-DWFVQICLA------LKH 140
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA-GSYGYIAP 237
           +H      ILHRD+K  NI L       L DFG+A+++NST     ++R   G+  Y++P
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST---VELARACIGTPYYLSP 194
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
             C+             KSD+++ G VL E+ + + A +   G   ++V  +K   GSF 
Sbjct: 195 EICE-------NKPYNNKSDIWALGCVLYELCTLKHAFEA--GSMKNLV--LKIISGSFP 243
Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           P        L+ L  Q+ +               +P +RP++  ++
Sbjct: 244 PVSLHYSYDLRSLVSQLFKR--------------NPRDRPSVNSIL 275

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 44/290 (15%)
Query: 73  IGKGCSGVVYKA---EMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G+G  G+VY+    ++  GE    +AVK + ++    E ++ F  E  ++      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 127 KLLGYCSNKSVKLL---------LYNYI-SXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +LLG  S     L+         L +Y+ S                +   ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           AYL+       +HRD+   N ++   +   + DFG+ + +  T+      +      ++A
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF 296
           P   K  +        T  SD++S+GVVL EI S   A QP  G            + + 
Sbjct: 201 PESLKDGVF-------TTSSDMWSFGVVLWEITS--LAEQPYQG------------LSNE 239
Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +    ++D      PD   + +   + +   C   +P  RPT  E+V LL
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLL 286

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 18/206 (8%)
Query: 72  VIGKGCSGVVYK-AEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IG G  G   K     +G+++  K+L      E       +E+ +L  ++H NIV+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 131 YCSNKSVKLLLY--------NYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
              +++   L          +  S              ++  R    +  A    +   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               +LHRD+K  N+ LD K    L DFGLA+++N  +   A + V   Y Y++P +   
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTPY-YMSPEQMN- 189
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEI 268
                  M+  EKSD++S G +L E+
Sbjct: 190 ------RMSYNEKSDIWSLGCLLYEL 209

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 110/244 (45%), Gaps = 27/244 (11%)
Query: 63  ILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           +L+  ++   IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 120 IRHRNIVKLLG-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           + H+NI+ LL  +   KS++    +Y  +               D E    +      G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            +LH      I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRA 193
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK--KKMG 294
           P     ++I G  M   E  D++S G ++ E++ G   + P      HI +W K  +++G
Sbjct: 194 P-----EVILG--MGYKENVDIWSVGCIMGEMIKG-GVLFPGTD---HIDQWNKVIEQLG 242
Query: 295 SFEP 298
           +  P
Sbjct: 243 TPSP 246

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G  G+V  A +  N   +A+KK+   +  +        EI+IL   RH NI+ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ---GLAYLHHDCVPAIL 188
               +++ +   Y+                  +   I     Q   GL Y+H      +L
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 166
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA-MSRVAGSYGYIAPGKCKLQIIY- 246
           HRD+K +N+LL++  +  + DFGLA++ +  + H   ++    +  Y AP     +I+  
Sbjct: 167 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-----EIMLN 221
Query: 247 --GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
             GYT +I    D++S G +L E+LS R      I  G H ++ +   +G
Sbjct: 222 SKGYTKSI----DIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILG 262

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQI--LGHIR 121
           L+ LK   +IG+G  G VYK  + +   +AVK      R      +F  E  I  +  + 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ-----NFINEKNIYRVPLME 65
Query: 122 HRNIVKLL----GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
           H NI + +       ++  ++ LL                   DW +  ++A    +GLA
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 178 YLHHDC------VPAILHRDVKCNNILLDSKYEAYLADFGLA------KLMNSTNYHHAM 225
           YLH +        PAI HRD+   N+L+ +     ++DFGL+      +L+      +A 
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
               G+  Y+AP   +  +      +  ++ D+Y+ G++  EI 
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 18/221 (8%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPVDSFA 111
           +KL    DN+L  + D   +G G  G V +    M   ++    K+ K   ++   +   
Sbjct: 2   KKLFLKRDNLL--IADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 58
Query: 112 AEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG 171
            E QI+  + +  IV+L+G C  +++ L++                         ++   
Sbjct: 59  REAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
            + G+ YL        +HRD+   N+LL +++ A ++DFGL+K + + + ++  +R AG 
Sbjct: 119 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGK 174
Query: 232 Y--GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +   + AP     +         + +SDV+SYGV + E LS
Sbjct: 175 WPLKWYAPECINFR-------KFSSRSDVWSYGVTMWEALS 208

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 15/199 (7%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +AVK + +    E   D F  E Q +  + H  +VK  G C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 133 SNKSVKLLLYNYISX-XXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
           S +    ++  YIS               +     ++     +G+A+L        +HRD
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRD 129
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +   N L+D      ++DFG+ + +    Y         S G   P K     ++ Y   
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQY-------VSSVGTKFPVKWSAPEVFHY-FK 181
Query: 252 ITEKSDVYSYGVVLLEILS 270
            + KSDV+++G+++ E+ S
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 18/206 (8%)
Query: 72  VIGKGCSGVVYK-AEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IG G  G   K     +G+++  K+L      E       +E+ +L  ++H NIV+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 131 YCSNKSVKLLLY--------NYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHD 182
              +++   L          +  S              ++  R    +  A    +   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               +LHRD+K  N+ LD K    L DFGLA+++N            G+  Y++P +   
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--EDFAKEFVGTPYYMSPEQMN- 189
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEI 268
                  M+  EKSD++S G +L E+
Sbjct: 190 ------RMSYNEKSDIWSLGCLLYEL 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 48/294 (16%)
Query: 73  IGKGCSGVVYKA-------EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           +G+G  G+VY+        + P    +A+K + +     E ++ F  E  ++      ++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 90
Query: 126 VKLLGYCSNKSVKLLLYNYI----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
           V+LLG  S     L++   +          S                    ++A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +      ++
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMG 294
           +P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +   
Sbjct: 208 SPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVMEG-- 256
Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                  +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 257 ------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 296

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 67  LKDENVIGK-----GCSGVVYKAEMPNGELIAVKKLWKTK------RDEEPVDSFAAEIQ 115
           L+DE ++ K      C  V    E    + +A+K + K K      R+ +P  +   EI+
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETR---YKIAVGS 172
           IL  + H  I+K+  +   +   ++L                   +   +   Y++ +  
Sbjct: 67  ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA- 125
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSRVA 229
              + YLH +    I+HRD+K  N+LL S+ E  L    DFG +K++  T+    M  + 
Sbjct: 126 ---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 176
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           G+  Y+AP         GY   +    D +S GV+L   LSG
Sbjct: 177 GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSG 214

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 27/234 (11%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK--KKMGSFEP 298
           G  M   E  D++S G ++ E++ G   + P      HI +W K  +++G+  P
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMIKG-GVLFPGTD---HIDQWNKVIEQLGTPSP 246

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 29/177 (16%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +     
Sbjct: 139 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKK 291
            +++P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +
Sbjct: 196 RWMSPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVME 246
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                     +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 247 G--------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 287

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVH 514
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 567
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 568 -RFTSASDVWMFGVCMWEIL 586

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 110/244 (45%), Gaps = 27/244 (11%)
Query: 63  ILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           +L+  ++   IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 120 IRHRNIVKLLG-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           + H+NI+ LL  +   KS++    +Y  +               D E    +      G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            +LH      I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRA 193
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK--KKMG 294
           P     ++I G  M   E  D++S G ++ E++ G   + P      HI +W K  +++G
Sbjct: 194 P-----EVILG--MGYKENVDIWSVGCIMGEMIKG-GVLFPGTD---HIDQWNKVIEQLG 242
Query: 295 SFEP 298
           +  P
Sbjct: 243 TPSP 246

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 29/177 (16%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +     
Sbjct: 135 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKK 291
            +++P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +
Sbjct: 192 RWMSPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVME 242
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                     +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 243 G--------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 283

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 27/234 (11%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK--KKMGSFEP 298
           G  M   E  D++S G ++ E++ G   + P      HI +W K  +++G+  P
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMIKG-GVLFPGTD---HIDQWNKVIEQLGTPSP 246

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 67  LKDENVIGK-----GCSGVVYKAEMPNGELIAVKKLWKTK------RDEEPVDSFAAEIQ 115
           L+DE ++ K      C  V    E    + +A+K + K K      R+ +P  +   EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETR---YKIAVGS 172
           IL  + H  I+K+  +   +   ++L                   +   +   Y++ +  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA- 126
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSRVA 229
              + YLH +    I+HRD+K  N+LL S+ E  L    DFG +K++  T+    M  + 
Sbjct: 127 ---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           G+  Y+AP         GY   +    D +S GV+L   LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSG 215

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 48/294 (16%)
Query: 73  IGKGCSGVVYKA-------EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           +G+G  G+VY+        + P    +A+K + +     E ++ F  E  ++      ++
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 80
Query: 126 VKLLGYCSNKSVKLLLYNYI----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
           V+LLG  S     L++   +          S                    ++A   A G
Sbjct: 81  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +      ++
Sbjct: 141 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 197
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMG 294
           +P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +   
Sbjct: 198 SPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVMEG-- 246
Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                  +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 247 ------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 286

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 48/294 (16%)
Query: 73  IGKGCSGVVYKA-------EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           +G+G  G+VY+        + P    +A+K + +     E ++ F  E  ++      ++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 83
Query: 126 VKLLGYCSNKSVKLLLYNYI----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
           V+LLG  S     L++   +          S                    ++A   A G
Sbjct: 84  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +      ++
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMG 294
           +P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +   
Sbjct: 201 SPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVMEG-- 249
Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                  +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 250 ------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 289

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 67  LKDENVIGK-----GCSGVVYKAEMPNGELIAVKKLWKTK------RDEEPVDSFAAEIQ 115
           L+DE ++ K      C  V    E    + +A+K + K K      R+ +P  +   EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETR---YKIAVGS 172
           IL  + H  I+K+  +   +   ++L                   +   +   Y++ +  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA- 126
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSRVA 229
              + YLH +    I+HRD+K  N+LL S+ E  L    DFG +K++  T+    M  + 
Sbjct: 127 ---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           G+  Y+AP         GY   +    D +S GV+L   LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSG 215

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 48/294 (16%)
Query: 73  IGKGCSGVVYKA-------EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           +G+G  G+VY+        + P    +A+K + +     E ++ F  E  ++      ++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 90
Query: 126 VKLLGYCSNKSVKLLLYNYI----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
           V+LLG  S     L++   +          S                    ++A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +      ++
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMG 294
           +P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +   
Sbjct: 208 SPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVMEG-- 256
Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                  +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 257 ------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 296

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 26/234 (11%)
Query: 45  SYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSG---VVYKAEMPNGELIAVKKLWKTK 101
           S P  F   + +NF    IL        IGKG  G   +V K +    ++ A+K + K K
Sbjct: 1   SMPPVFDENEDVNFDHFEILRA------IGKGSFGKVCIVQKND--TKKMYAMKYMNKQK 52
Query: 102 ---RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXX 158
              R+E  V +   E+QI+  + H  +V L     ++    ++ + +             
Sbjct: 53  CVERNE--VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV 110
Query: 159 XXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS 218
               ET           L YL +     I+HRD+K +NILLD     ++ DF +A ++  
Sbjct: 111 HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                 ++ +AG+  Y+AP     +   GY+  +    D +S GV   E+L GR
Sbjct: 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGR 214

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG- 130
           IG G  G+V  A +   G  +AVKKL +  +++        E+ +L  + H+NI+ LL  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 131 YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
           +   K+++    +Y  +               D E    +      G+ +LH      I+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K +NI++ S     + DFGLA+    TN+   M+    +  Y AP   ++ +  GY
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLAR-TACTNF--MMTPYVVTRYYRAP---EVILGMGY 202
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK 290
             N+    D++S G ++ E++ G   V  Q  D  HI +W K
Sbjct: 203 AANV----DIWSVGCIMGELVKG--CVIFQGTD--HIDQWNK 236

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ +     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 135 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 187
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 188 -RFTSASDVWMFGVCMWEIL 206

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 67  LKDENVIGK-----GCSGVVYKAEMPNGELIAVKKLWKTK------RDEEPVDSFAAEIQ 115
           L+DE ++ K      C  V    E    + +A+K + K K      R+ +P  +   EI+
Sbjct: 14  LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETR---YKIAVGS 172
           IL  + H  I+K+  +   +   ++L                   +   +   Y++ +  
Sbjct: 74  ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA- 132
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSRVA 229
              + YLH +    I+HRD+K  N+LL S+ E  L    DFG +K++  T+    M  + 
Sbjct: 133 ---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 183
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           G+  Y+AP         GY   +    D +S GV+L   LSG
Sbjct: 184 GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSG 221

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 67  LKDENVIGK-----GCSGVVYKAEMPNGELIAVKKLWKTK------RDEEPVDSFAAEIQ 115
           L+DE ++ K      C  V    E    + +A+K + K K      R+ +P  +   EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETR---YKIAVGS 172
           IL  + H  I+K+  +   +   ++L                   +   +   Y++ +  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA- 126
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSRVA 229
              + YLH +    I+HRD+K  N+LL S+ E  L    DFG +K++  T+    M  + 
Sbjct: 127 ---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           G+  Y+AP         GY   +    D +S GV+L   LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSG 215

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 46/88 (52%), Gaps = 4/88 (4%)
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            ++HRDVK +N+LLD      LADFG    M+ T   H  + V G+  YI+P   K Q  
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQGG 252
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRS 273
            GY      + D +S GV L E+L G +
Sbjct: 253 DGY---YGRECDWWSVGVFLFEMLVGDT 277

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 29/177 (16%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +     
Sbjct: 142 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 198
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKK 291
            +++P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +
Sbjct: 199 RWMSPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVME 249
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                     +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 250 G--------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 290

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 29/177 (16%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +     
Sbjct: 141 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKK 291
            +++P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +
Sbjct: 198 RWMSPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVME 248
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                     +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 249 G--------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 289

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           VIG+G    V    +   + I   K+ K +   D+E +D    E  +     +   +  L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 130 GYCSNKSVKLLLY-NYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             C     +L     Y++                E     +   +  L YLH      I+
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGII 143
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +RD+K +N+LLDS+    L D+G+ K           S   G+  YIAP   + +  YG+
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGE-DYGF 200
Query: 249 TMNITEKSDVYSYGVVLLEILSGRS 273
           ++      D ++ GV++ E+++GRS
Sbjct: 201 SV------DWWALGVLMFEMMAGRS 219

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           VIG+G    V    +   + I   K+ K +   D+E +D    E  +     +   +  L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 130 GYCSNKSVKLLLY-NYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             C     +L     Y++                E     +   +  L YLH      I+
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GII 132
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +RD+K +N+LLDS+    L D+G+ K           S   G+  YIAP   + +  YG+
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGE-DYGF 189
Query: 249 TMNITEKSDVYSYGVVLLEILSGRS 273
           ++      D ++ GV++ E+++GRS
Sbjct: 190 SV------DWWALGVLMFEMMAGRS 208

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           VIG+G    V    +   + I   K+ K +   D+E +D    E  +     +   +  L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 130 GYCSNKSVKLLLY-NYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             C     +L     Y++                E     +   +  L YLH      I+
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGII 128
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +RD+K +N+LLDS+    L D+G+ K           S   G+  YIAP   + +  YG+
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGE-DYGF 185
Query: 249 TMNITEKSDVYSYGVVLLEILSGRS 273
           ++      D ++ GV++ E+++GRS
Sbjct: 186 SV------DWWALGVLMFEMMAGRS 204

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 36/173 (20%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
           +GL YLH +     +HRD+K  N+LL    E  LADFG+A  +  T      +   G+  
Sbjct: 135 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPF 189
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR---SAVQPQIGDGLHIVEWVK 290
           ++AP   K Q  Y        K+D++S G+  +E+  G    S + P     + ++  + 
Sbjct: 190 WMAPEVIK-QSAY------DSKADIWSLGITAIELARGEPPHSELHP-----MKVLFLIP 237
Query: 291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           K      P        L+G   + ++E ++       C+N  P+ RPT KE++
Sbjct: 238 KN----NPPT------LEGNYSKPLKEFVEA------CLNKEPSFRPTAKELL 274

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 27/234 (11%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK--KKMGSFEP 298
           G  M   E  D++S G ++ E++ G   + P      HI +W K  +++G+  P
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMIKG-GVLFPGTD---HIDQWNKVIEQLGTPSP 246

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 36/173 (20%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
           +GL YLH +     +HRD+K  N+LL    E  LADFG+A  +  T      +   G+  
Sbjct: 115 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPF 169
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR---SAVQPQIGDGLHIVEWVK 290
           ++AP   K Q  Y        K+D++S G+  +E+  G    S + P     + ++  + 
Sbjct: 170 WMAPEVIK-QSAY------DSKADIWSLGITAIELARGEPPHSELHP-----MKVLFLIP 217
Query: 291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           K      P        L+G   + ++E ++       C+N  P+ RPT KE++
Sbjct: 218 KN----NPPT------LEGNYSKPLKEFVEA------CLNKEPSFRPTAKELL 254

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 36/173 (20%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
           +GL YLH +     +HRD+K  N+LL    E  LADFG+A  +  T      +   G+  
Sbjct: 115 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPF 169
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR---SAVQPQIGDGLHIVEWVK 290
           ++AP   K Q  Y        K+D++S G+  +E+  G    S + P     + ++  + 
Sbjct: 170 WMAPEVIK-QSAY------DSKADIWSLGITAIELARGEPPHSELHP-----MKVLFLIP 217
Query: 291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           K      P        L+G   + ++E ++       C+N  P+ RPT KE++
Sbjct: 218 KN----NPPT------LEGNYSKPLKEFVEA------CLNKEPSFRPTAKELL 254

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 58/107 (54%), Gaps = 9/107 (8%)
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAM 225
           K+ V   + L YL       ++HRDVK +NILLD + +  L DFG++ +L++      A 
Sbjct: 128 KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD----KAK 181
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            R AG   Y+AP +           +I  ++DV+S G+ L+E+ +G+
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDI--RADVWSLGISLVELATGQ 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    +     
Sbjct: 170 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 226
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
            +++P   K  +   Y       SDV+S+GVVL EI +   A QP  G          ++
Sbjct: 227 RWMSPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQG-------LSNEQ 270
Query: 293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           +  F     +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 271 VLRFVMEGGLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 318

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 36/173 (20%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
           +GL YLH +     +HRD+K  N+LL    E  LADFG+A  +  T      +   G+  
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPF 184
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR---SAVQPQIGDGLHIVEWVK 290
           ++AP   K Q  Y        K+D++S G+  +E+  G    S + P     + ++  + 
Sbjct: 185 WMAPEVIK-QSAY------DSKADIWSLGITAIELARGEPPHSELHP-----MKVLFLIP 232
Query: 291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           K      P        L+G   + ++E ++       C+N  P+ RPT KE++
Sbjct: 233 KN----NPPT------LEGNYSKPLKEFVEA------CLNKEPSFRPTAKELL 269

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 101/241 (41%), Gaps = 51/241 (21%)
Query: 65  ECLKDENVIGKGCSGVVYKAEM----PNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGH 119
           E L+   V+G G  G V  A        G  I V  K+ K K D    ++  +E++++  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 120 I-RHRNIVKLLGYCSNKSVKLLLYNY------ISXXXXXXXXXXXXXXDWETRYKI---- 168
           +  H NIV LLG C+      L++ Y      ++              ++E + ++    
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 169 -------------AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK- 214
                        A   A+G+ +L      + +HRD+   N+L+       + DFGLA+ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITE-----KSDVYSYGVVLLEIL 269
           +M+ +NY             +  G  +L + +    ++ E     KSDV+SYG++L EI 
Sbjct: 222 IMSDSNY-------------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
Query: 270 S 270
           S
Sbjct: 269 S 269

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSG 271
           G  M   E  D++S G ++ E++ G
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G G    VYK      G  +A+K++ K   +E    +   EI ++  ++H NIV+L   
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA------------QGLAYL 179
              ++   L++ ++               D  T      G              QGLA+ 
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYM-------DSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H +    ILHRD+K  N+L++ + +  L DFGLA+        +  S    +  Y AP  
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDV 179
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                 Y  ++      D++S G +L E+++G+
Sbjct: 180 LMGSRTYSTSI------DIWSCGCILAEMITGK 206

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E +K    +G G  G V+     N   +AVK L   K     V +F  E  ++  ++H  
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDK 69
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXD--WETRYKIAVGSAQGLAYLHHD 182
           +V+L    + +    ++  Y++                        +   A+G+AY+   
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  N+L+       +ADFGLA+++    Y  A         + AP     
Sbjct: 130 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPE---- 181
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILS 270
            I +G     T KSDV+S+G++L EI++
Sbjct: 182 AINFG---CFTIKSDVWSFGILLYEIVT 206

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 17/250 (6%)
Query: 26  YKVEKASGMSTLPPGAEDFSYPWTFIP-FQKLNFTIDNILECLKDENVIGKGCSGVVYKA 84
           +  +K      LP   E F  P+      +     +D  L  L+D+  +G G  G V K 
Sbjct: 330 WAADKGPQREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKE-LGSGNFGTVKKG 388
Query: 85  --EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL 141
             +M         K+ K + ++  + D   AE  ++  + +  IV+++G C  +S  L++
Sbjct: 389 YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM 448
Query: 142 YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS 201
                              D +   ++    + G+ YL        +HRD+   N+LL +
Sbjct: 449 EMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVT 504
Query: 202 KYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYS 260
           ++ A ++DFGL+K + +  NY+ A +       + AP +C   I Y      + KSDV+S
Sbjct: 505 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP-EC---INY---YKFSSKSDVWS 557
Query: 261 YGVVLLEILS 270
           +GV++ E  S
Sbjct: 558 FGVLMWEAFS 567

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 147
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 199
Query: 247 GYTMNITEKSDVYSYGVVLLEILSG 271
           G  M   E  D++S G ++ E++ G
Sbjct: 200 G--MGYKENVDIWSVGCIMGEMIKG 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPEVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSG 271
           G  M   E  D++S G ++ E++ G
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 106/249 (42%), Gaps = 40/249 (16%)
Query: 64  LECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEP-VDSFAAEIQILGHIR 121
           +E  K  N++GKG    VY+AE +  G  +A+K + K    +   V     E++I   ++
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 122 HRNIVKLLGY-------------CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI 168
           H +I++L  Y             C N  +   L N +               + E R+ +
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-----------PFSENEARHFM 118
Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
                 G+ YLH      ILHRD+  +N+LL       +ADFGLA  +   +  H    +
Sbjct: 119 H-QIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--L 172
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ-IGDGLHIVE 287
            G+  YI+P +   +  +G       +SDV+S G +   +L GR       + + L+ V 
Sbjct: 173 CGTPNYISP-EIATRSAHGL------ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225
Query: 288 WVKKKMGSF 296
               +M SF
Sbjct: 226 LADYEMPSF 234

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +GKG   VV +  ++P G+  A K +   K           E +I   ++H NIV+L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
            S +    L+++ ++              ++ +    +    Q L  ++H  +  I+HRD
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIQQILESVNHCHLNGIVHRD 128
Query: 192 VKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +K  N+LL SK +     LADFGLA  +       A    AG+ GY++P   + +  YG 
Sbjct: 129 LKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLR-KDPYGK 185
Query: 249 TMNITEKSDVYSYGVVLLEILSG 271
            +      D+++ GV+L  +L G
Sbjct: 186 PV------DMWACGVILYILLVG 202

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 29/177 (16%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A G+AYL+ +     +HRD+   N  +   +   + DFG+ + +  T+Y+    +     
Sbjct: 135 ADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKK 291
            +++P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +
Sbjct: 192 RWMSPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVME 242
Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                     +LD K    PD +++ M         C   +P  RP+  E+++ + E
Sbjct: 243 G--------GLLD-KPDNCPDMLLELM-------RMCWQYNPKMRPSFLEIISSIKE 283

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 63  ILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           +L+  ++   IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 120 IRHRNIVKLLG-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           + H+NI+ LL  +   K+++    +Y  +               D E    +      G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            +LH      I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRA 193
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           P     ++I G  M   E  D++S G ++ E++  +
Sbjct: 194 P-----EVILG--MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +GKG   VV +  ++P G+  A K +   K           E +I   ++H NIV+L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
            S +    L+++ ++              ++ +    +    Q L  ++H  +  I+HRD
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIQQILESVNHCHLNGIVHRD 128
Query: 192 VKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +K  N+LL SK +     LADFGLA  +       A    AG+ GY++P   + +  YG 
Sbjct: 129 LKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLR-KDPYGK 185
Query: 249 TMNITEKSDVYSYGVVLLEILSG 271
            +      D+++ GV+L  +L G
Sbjct: 186 PV------DMWACGVILYILLVG 202

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNG----ELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
            E LK   V+G+G  G V+  +  +G    +L A+K L K             E  IL  
Sbjct: 26  FELLK---VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 120 IRHRNIVKL-LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAY 178
           + H  IVKL   + +   + L+L                   + + ++ +A   A  L +
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDH 141
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH      I++RD+K  NILLD +    L DFGL+K   S ++        G+  Y+AP 
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 196
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
               +   G+    T+ +D +S+GV++ E+L+G    Q
Sbjct: 197 VVNRR---GH----TQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+  + H+NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKLNHQNIV 97
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 150
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 208 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 241

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           VIG+G    V    +   + I   ++ K +   D+E +D    E  +     +   +  L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 130 GYCSNKSVKLLLY-NYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
             C     +L     Y++                E     +   +  L YLH      I+
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GII 175
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +RD+K +N+LLDS+    L D+G+ K           S   G+  YIAP   + +  YG+
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGF 232
Query: 249 TMNITEKSDVYSYGVVLLEILSGRS 273
           ++      D ++ GV++ E+++GRS
Sbjct: 233 SV------DWWALGVLMFEMMAGRS 251

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNG----ELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
            E LK   V+G+G  G V+  +  +G    +L A+K L K             E  IL  
Sbjct: 27  FELLK---VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 83
Query: 120 IRHRNIVKL-LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAY 178
           + H  IVKL   + +   + L+L                   + + ++ +A   A  L +
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDH 142
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH      I++RD+K  NILLD +    L DFGL+K   S ++        G+  Y+AP 
Sbjct: 143 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 197
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
               +   G+    T+ +D +S+GV++ E+L+G    Q
Sbjct: 198 VVNRR---GH----TQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 64  LECLKDENVIGKGCSGVVYKAEMPNG----ELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
            E LK   V+G+G  G V+  +  +G    +L A+K L K             E  IL  
Sbjct: 26  FELLK---VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 120 IRHRNIVKL-LGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAY 178
           + H  IVKL   + +   + L+L                   + + ++ +A   A  L +
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDH 141
Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           LH      I++RD+K  NILLD +    L DFGL+K   S ++        G+  Y+AP 
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 196
Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
               +   G+    T+ +D +S+GV++ E+L+G    Q
Sbjct: 197 VVNRR---GH----TQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 62/104 (59%), Gaps = 12/104 (11%)
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAM 225
           KIAV   + L +LH     +++HRDVK +N+L+++  +  + DFG++  L++S     A 
Sbjct: 157 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV----AK 210
Query: 226 SRVAGSYGYIAPGKCKLQIIY-GYTMNITEKSDVYSYGVVLLEI 268
           +  AG   Y+AP +   ++   GY++    KSD++S G+ ++E+
Sbjct: 211 TIDAGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIEL 250

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 81/200 (40%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVH 514
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ +     L DFGL++ M  + Y+ A S+      ++AP     +      
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR------ 567
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 568 -RFTSASDVWMFGVCMWEIL 586

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+  + H+NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKLNHQNIV 111
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 164
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 222 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 255

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 19/224 (8%)
Query: 61  DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           D + +  + E+ +G+G + +VY+ +    +     K+ K   D++ V +   EI +L  +
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRL 105
Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
            H NI+KL       +   L+   ++                           + +AYLH
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH 165
Query: 181 HDCVPAILHRDVKCNNILLDS---KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
            +    I+HRD+K  N+L  +        +ADFGL+K++    +   M  V G+ GY AP
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAP 219
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
                +I+ G       + D++S G++   +L G      + GD
Sbjct: 220 -----EILRGCAYG--PEVDMWSVGIITYILLCGFEPFYDERGD 256

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 366 LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 424
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 425 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 483
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + 
Sbjct: 484 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 540
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP +C   I Y      + KSDV+S+GV++ E  S
Sbjct: 541 AP-EC---INY---YKFSSKSDVWSFGVLMWEAFS 568

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 17/203 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +GKG   VV +       L    K+  TK+           E +I   ++H NIV+L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
              +S   L+++ ++                           + +AY H +    I+HR+
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRN 130
Query: 192 VKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +K  N+LL SK +     LADFGLA  +N +   H     AG+ GY++P   K       
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF---AGTPGYLSPEVLKKD----- 182
Query: 249 TMNITEKSDVYSYGVVLLEILSG 271
               ++  D+++ GV+L  +L G
Sbjct: 183 --PYSKPVDIWACGVILYILLVG 203

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 17/203 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +GKG   VV +       L    K+  TK+           E +I   ++H NIV+L   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
              +S   L+++ ++                           + +AY H +    I+HR+
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRN 153
Query: 192 VKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +K  N+LL SK +     LADFGLA  +N +   H     AG+ GY++P   K      Y
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF---AGTPGYLSPEVLKKD---PY 207
Query: 249 TMNITEKSDVYSYGVVLLEILSG 271
           +  +    D+++ GV+L  +L G
Sbjct: 208 SKPV----DIWACGVILYILLVG 226

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 17/203 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +GKG   VV +       L    K+  TK+           E +I   ++H NIV+L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
              +S   L+++ ++                           + +AY H +    I+HR+
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRN 130
Query: 192 VKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +K  N+LL SK +     LADFGLA  +N +   H     AG+ GY++P   K       
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF---AGTPGYLSPEVLKKD----- 182
Query: 249 TMNITEKSDVYSYGVVLLEILSG 271
               ++  D+++ GV+L  +L G
Sbjct: 183 --PYSKPVDIWACGVILYILLVG 203

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 88
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 141
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 199 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 232

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 22/114 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA----- 229
           GL +LH      I++RD+K +N++LDS+    +ADFG+ K        H M  V      
Sbjct: 132 GLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMMDGVTTREFC 181
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
           G+  YIAP     Q  YG ++      D ++YGV+L E+L+G+     +  D L
Sbjct: 182 GTPDYIAPEIIAYQ-PYGKSV------DWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 149
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 207 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 149
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 207 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 240

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 148
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M     +  Y AP     ++I 
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMVPFVVTRYYRAP-----EVIL 200
Query: 247 GYTMNITEKSDVYSYGVVLLEILSG 271
           G  M   E  D++S G ++ E++ G
Sbjct: 201 G--MGYKENVDIWSVGCIMGEMIKG 223

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 17/203 (8%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +GKG   VV +       L    K+  TK+           E +I   ++H NIV+L   
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
              +S   L+++ ++                           + +AY H +    I+HR+
Sbjct: 73  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRN 129
Query: 192 VKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           +K  N+LL SK +     LADFGLA  +N +   H     AG+ GY++P   K       
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF---AGTPGYLSPEVLKKD----- 181
Query: 249 TMNITEKSDVYSYGVVLLEILSG 271
               ++  D+++ GV+L  +L G
Sbjct: 182 --PYSKPVDIWACGVILYILLVG 202

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 99/221 (44%), Gaps = 18/221 (8%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPVDSFA 111
           +KL    DN+L  + D   +G G  G V +    M   ++    K+ K   ++   +   
Sbjct: 328 KKLFLKRDNLL--IADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 112 AEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVG 171
            E QI+  + +  IV+L+G C  +++ L++                         ++   
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
            + G+ YL        +HR++   N+LL +++ A ++DFGL+K + + + ++  +R AG 
Sbjct: 445 VSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGK 500
Query: 232 Y--GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           +   + AP     +         + +SDV+SYGV + E LS
Sbjct: 501 WPLKWYAPECINFR-------KFSSRSDVWSYGVTMWEALS 534

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 111
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 164
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 222 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD-FLMEALIISKFNHQNIV 111
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 164
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 222 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 113
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 166
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 224 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 257

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 63  ILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           +L+  ++   IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 120 IRHRNIVKLLG-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           + H+NI+ LL  +   K+++    +Y  +               D E    +      G+
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            +LH      I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y A
Sbjct: 133 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRA 186
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           P     ++I G  M   E  D++S G ++ E++  +
Sbjct: 187 P-----EVILG--MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 97
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 150
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 208 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 241

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 65  ECLKDENVIGKGCSGVVYKAE----MPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILG 118
           EC +   V+GKG  G V++         G++ A+K L K    R+ +      AE  IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 119 HIRHRNIVKLLGYCSNKSVKL-LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
            ++H  IV L+ Y      KL L+  Y+S                +T        +  L 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           +LH      I++RD+K  NI+L+ +    L DFGL K   S +         G+  Y+AP
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAP 190
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              ++ +  G+   +    D +S G ++ ++L+G
Sbjct: 191 ---EILMRSGHNRAV----DWWSLGALMYDMLTG 217

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 103
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 156
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 214 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 247

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 65  ECLKDENVIGKGCSGVVYKAE----MPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILG 118
           EC +   V+GKG  G V++         G++ A+K L K    R+ +      AE  IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 119 HIRHRNIVKLLGYCSNKSVKL-LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
            ++H  IV L+ Y      KL L+  Y+S                +T        +  L 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           +LH      I++RD+K  NI+L+ +    L DFGL K   S +         G+  Y+AP
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAP 190
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              ++ +  G+   +    D +S G ++ ++L+G
Sbjct: 191 ---EILMRSGHNRAV----DWWSLGALMYDMLTG 217

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 63  ILECLKDENVIGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           +L+  ++   IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 120 IRHRNIVKLLG-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           + H+NI+ LL  +   K+++    +Y  +               D E    +      G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            +LH      I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRA 193
Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           P     ++I G  M   E  D++S G ++ E++  +
Sbjct: 194 P-----EVILG--MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 190
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +    Y+       
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 248 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 281

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 123
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 176
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 234 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 267

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 32/180 (17%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
           +GL YLH +     +HRD+K  N+LL  + +  LADFG+A  +  T      +   G+  
Sbjct: 131 KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPF 185
Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM 293
           ++AP     ++I     +   K+D++S G+  +E+  G    +P   D +H         
Sbjct: 186 WMAP-----EVIQQSAYD--SKADIWSLGITAIELAKG----EPPNSD-MH--------- 224
Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLG-IAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                 + +L    +  P  +V +  ++       C+N  P+ RPT KE++     VK++
Sbjct: 225 -----PMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNS 279

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 114
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 167
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +    Y+       
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 225 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 258

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 23  LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 81
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 82  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 140
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + 
Sbjct: 141 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 197
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP +C   I Y      + KSDV+S+GV++ E  S
Sbjct: 198 AP-EC---INY---YKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 23  LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 81
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 82  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 140
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + 
Sbjct: 141 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 197
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP +C   I Y      + KSDV+S+GV++ E  S
Sbjct: 198 AP-EC---INY---YKFSSKSDVWSFGVLMWEAFS 225

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 34/239 (14%)
Query: 53  FQKLNFTIDN---ILECLKDENVIGK-----GCSGVVYKAEMPNGELIAVKKLWKTK--- 101
           F   + T+D+     + L+DE ++ K      C  V    E    + +A++ + K K   
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175
Query: 102 ---RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXX 158
              R+ +P  +   EI+IL  + H  I+K+  +   +   ++L                 
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR 235
Query: 159 XXDWETR---YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGL 212
             +   +   Y++ +     + YLH +    I+HRD+K  N+LL S+ E  L    DFG 
Sbjct: 236 LKEATCKLYFYQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
Query: 213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           +K++  T+    M  + G+  Y+AP         GY   +    D +S GV+L   LSG
Sbjct: 289 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSG 340

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 73  IGKGCSGVVYKAE---MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +G G  G VY+ +   MPN      +AVK L +   +++ +D F  E  I+    H+NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 97
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYK--------------IAVGS 172
           + +G       + +L   ++                ETR +              +A   
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 150
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVA 229
           A G  YL  +     +HRD+   N LL        A + DFG+A+ +   +Y+       
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
               ++ P +  ++ I+      T K+D +S+GV+L EI S
Sbjct: 208 LPVKWMPP-EAFMEGIF------TSKTDTWSFGVLLWEIFS 241

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 13  LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 71
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 72  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 130
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + 
Sbjct: 131 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP     + I  Y    + KSDV+S+GV++ E  S
Sbjct: 188 AP-----ECINYYK--FSSKSDVWSFGVLMWEAFS 215

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 21  LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 79
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 80  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 138
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + 
Sbjct: 139 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 195
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP +C   I Y      + KSDV+S+GV++ E  S
Sbjct: 196 AP-EC---INY---YKFSSKSDVWSFGVLMWEAFS 223

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 34/239 (14%)
Query: 53  FQKLNFTIDN---ILECLKDENVIGK-----GCSGVVYKAEMPNGELIAVKKLWKTK--- 101
           F   + T+D+     + L+DE ++ K      C  V    E    + +A++ + K K   
Sbjct: 130 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 189
Query: 102 ---RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXX 158
              R+ +P  +   EI+IL  + H  I+K+  +   +   ++L                 
Sbjct: 190 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR 249
Query: 159 XXDWETR---YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGL 212
             +   +   Y++ +     + YLH +    I+HRD+K  N+LL S+ E  L    DFG 
Sbjct: 250 LKEATCKLYFYQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 302
Query: 213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           +K++  T+    M  + G+  Y+AP         GY   +    D +S GV+L   LSG
Sbjct: 303 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSG 354

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 7   LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 65
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 66  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 124
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + 
Sbjct: 125 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 181
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP +C   I Y      + KSDV+S+GV++ E  S
Sbjct: 182 AP-EC---INY---YKFSSKSDVWSFGVLMWEAFS 209

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 39/225 (17%)
Query: 72  VIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH-------- 122
           V+G+G  G V KA    +    A+KK+  T   EE + +  +E+ +L  + H        
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVXLLASLNHQYVVRYYA 69
Query: 123 -----RNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY-KIAVGSAQGL 176
                RN VK       KS   +   Y                     Y ++     + L
Sbjct: 70  AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK---------LMNSTNY---HHA 224
           +Y+H      I+HR++K  NI +D      + DFGLAK          ++S N       
Sbjct: 130 SYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
           ++   G+  Y+A      +++ G T +  EK D YS G++  E +
Sbjct: 187 LTSAIGTAXYVAT-----EVLDG-TGHYNEKIDXYSLGIIFFEXI 225

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 1   LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 59
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 60  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 118
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + 
Sbjct: 119 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 175
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP     + I  Y    + KSDV+S+GV++ E  S
Sbjct: 176 AP-----ECINYYK--FSSKSDVWSFGVLMWEAFS 203

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 82/186 (44%), Gaps = 42/186 (22%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
            +G+ Y+H      ++HRD+K +NI L    +  + DFG   L+ S       +R  G+ 
Sbjct: 146 TKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFG---LVTSLKNDGKRTRSKGTL 199
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
            Y++P +   Q  YG  +      D+Y+ G++L E+              LH+ +     
Sbjct: 200 RYMSPEQISSQ-DYGKEV------DLYALGLILAEL--------------LHVCD----- 233
Query: 293 MGSFEPAVSILDTK---LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             +FE +    D +   +  + D+  + +LQ L      ++  P +RP   E++  L   
Sbjct: 234 -TAFETSKFFTDLRDGIISDIFDKKEKTLLQKL------LSKKPEDRPNTSEILRTLTVW 286
Query: 350 KSAPEE 355
           K +PE+
Sbjct: 287 KKSPEK 292

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 3   LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 62  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 120
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A +       + 
Sbjct: 121 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP     + I  Y    + KSDV+S+GV++ E  S
Sbjct: 178 AP-----ECINYYK--FSSKSDVWSFGVLMWEAFS 205

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 46/223 (20%)
Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILG-HIRHRNIVKLL 129
           ++G G  G VYK   +  G+L A+K +  T  +EE +     EI +L  +  HRNI    
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI---KQEINMLKKYSHHRNIATYY 87
Query: 130 G-------------------YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAV 170
           G                   +C   SV  L+ N                 +W     I  
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN---------TKGNTLKEEWIAY--ICR 136
Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG 230
              +GL++LH      ++HRD+K  N+LL    E  L DFG++  ++ T      +   G
Sbjct: 137 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIG 191
Query: 231 SYGYIAPG--KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           +  ++AP    C       Y      KSD++S G+  +E+  G
Sbjct: 192 TPYWMAPEVIACDENPDATYDF----KSDLWSLGITAIEMAEG 230

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 79/200 (39%), Gaps = 14/200 (7%)
Query: 73  IGKGCSGVVYKA--EMPNGELIAVK-KLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG+G  G V++     P    +AV  K  K    +   + F  E   +    H +IVKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
           G  +   V +++                   D  +    A   +  LAYL        +H
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVH 134
Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N+L+ S     L DFGL++ M  +    A S+      ++AP     +      
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKA-SKGKLPIKWMAPESINFR------ 187
Query: 250 MNITEKSDVYSYGVVLLEIL 269
              T  SDV+ +GV + EIL
Sbjct: 188 -RFTSASDVWMFGVCMWEIL 206

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 34/225 (15%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           E   GK      +  +   G      K+ K       +    +E  +L  + H +++KL 
Sbjct: 33  EGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXX----------------DWETRYKIAVGS- 172
           G CS     LL+  Y                                D      + +G  
Sbjct: 93  GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL 152
Query: 173 -------AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
                  +QG+ YL      +++HRD+   NIL+    +  ++DFGL++     + +   
Sbjct: 153 ISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYEED 204
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           S V  S G I      ++ ++ +    T +SDV+S+GV+L EI++
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/294 (21%), Positives = 118/294 (40%), Gaps = 48/294 (16%)
Query: 73  IGKGCSGVVYKA-------EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           +G+G  G+VY+        + P    +A+K + +     E ++ F  E  ++      ++
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 75
Query: 126 VKLLGYCSNKSVKLLLYNYI----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
           V+LLG  S     L++   +          S                    ++A   A G
Sbjct: 76  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+      +      ++
Sbjct: 136 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMG 294
           +P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +   
Sbjct: 193 SPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVMEG-- 241
Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                  +LD K    PD +++ M         C   +P  RP+  E+++ + E
Sbjct: 242 ------GLLD-KPDNCPDMLLELM-------RMCWQYNPKMRPSFLEIISSIKE 281

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 108 DSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY 166
           +  + EI I   + H+++V   G+   N  V ++L                   + E RY
Sbjct: 84  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 143
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
            +      G  YLH +    ++HRD+K  N+ L+   E  + DFGLA       Y     
Sbjct: 144 YLR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 196
Query: 227 RV-AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           +V  G+  YIAP     +   G++  +    DV+S G ++  +L G+   +       ++
Sbjct: 197 KVLCGTPNYIAPEVLSKK---GHSFEV----DVWSIGCIMYTLLVGKPPFETSCLKETYL 249
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              +KK   S    ++ +   L       +Q+MLQT           P  RPT+ E++
Sbjct: 250 --RIKKNEYSIPKHINPVAASL-------IQKMLQT----------DPTARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 108 DSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY 166
           +  + EI I   + H+++V   G+   N  V ++L                   + E RY
Sbjct: 86  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 145
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
            +      G  YLH +    ++HRD+K  N+ L+   E  + DFGLA       Y     
Sbjct: 146 YLR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 198
Query: 227 RV-AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           +V  G+  YIAP     +   G++  +    DV+S G ++  +L G+   +       ++
Sbjct: 199 KVLCGTPNYIAPEVLSKK---GHSFEV----DVWSIGCIMYTLLVGKPPFETSCLKETYL 251
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              +KK   S    ++ +   L       +Q+MLQT           P  RPT+ E++
Sbjct: 252 --RIKKNEYSIPKHINPVAASL-------IQKMLQT----------DPTARPTINELL 290

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 108 DSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY 166
           +  + EI I   + H+++V   G+   N  V ++L                   + E RY
Sbjct: 60  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 119
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
            +      G  YLH +    ++HRD+K  N+ L+   E  + DFGLA       Y     
Sbjct: 120 YLR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 172
Query: 227 RV-AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           +V  G+  YIAP     +   G++  +    DV+S G ++  +L G+   +       ++
Sbjct: 173 KVLCGTPNYIAPEVLSKK---GHSFEV----DVWSIGCIMYTLLVGKPPFETSCLKETYL 225
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              +KK   S    ++ +   L       +Q+MLQT           P  RPT+ E++
Sbjct: 226 --RIKKNEYSIPKHINPVAASL-------IQKMLQT----------DPTARPTINELL 264

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G SG VY A ++  G+ +A++++   ++ ++ +     EI ++   ++ NIV  L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 85
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  Y++              + +    +     Q L +LH +    ++HRD
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLHSN---QVIHRD 141
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K +NILL       L DFG    +  T      S + G+  ++AP +   +  YG    
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSEMVGTPYWMAP-EVVTRKAYG---- 194
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              K D++S G++ +E++ G
Sbjct: 195 --PKVDIWSLGIMAIEMIEG 212

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +A+K + +    E   D F  E +++ ++ H  +V+L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI----- 187
           + +    ++  Y++                E R++      Q L  +  D   A+     
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR-------EMRHRF---QTQQLLEMCKDVCEAMEYLES 138
Query: 188 ---LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              LHRD+   N L++ +    ++DFGL++ +    Y         S G   P +     
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWSPPE 191
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
           +  Y+   + KSD++++GV++ EI S
Sbjct: 192 VLMYS-KFSSKSDIWAFGVLMWEIYS 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +A+K + +    E   D F  E +++ ++ H  +V+L G C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI----- 187
           + +    ++  Y++                E R++      Q L  +  D   A+     
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLR-------EMRHRF---QTQQLLEMCKDVCEAMEYLES 122
Query: 188 ---LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              LHRD+   N L++ +    ++DFGL++ +    Y         S G   P +     
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWSPPE 175
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
           +  Y+   + KSD++++GV++ EI S
Sbjct: 176 VLMYS-KFSSKSDIWAFGVLMWEIYS 200

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 62/298 (20%)
Query: 66  CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFA-AEIQILGHI-RHR 123
           C KD  V+G G  G +    M +   +AVK++           SFA  E+Q+L     H 
Sbjct: 27  CPKD--VLGHGAEGTIVYRGMFDNRDVAVKRILPE------CFSFADREVQLLRESDEHP 78
Query: 124 NIVKLLGYCSNKSVKLLLYNYISXXX-XXXXXXXXXXXDWE----TRYKIAVGSAQGLAY 178
           N+++   +C+ K  +   + YI+               D+         +   +  GLA+
Sbjct: 79  NVIRY--FCTEKDRQ---FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 179 LHHDCVPAILHRDVKCNNILLD-----SKYEAYLADFGLAKLMNSTNYHHAMSR---VAG 230
           LH      I+HRD+K +NIL+       K +A ++DFGL K +      H+ SR   V G
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR--HSFSRRSGVPG 188
Query: 231 SYGYIAP----GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH-I 285
           + G+IAP      CK         N T   D++S G V   ++S          +G H  
Sbjct: 189 TEGWIAPEMLSEDCK--------ENPTYTVDIFSAGCVFYYVIS----------EGSHPF 230
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
            + ++++      A S+     +   D + +E+++ + IAM      P +RP+ K V+
Sbjct: 231 GKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKM-IAM-----DPQKRPSAKHVL 282

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +A+K + +    E   D F  E +++ ++ H  +V+L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI----- 187
           + +    ++  Y++                E R++      Q L  +  D   A+     
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLR-------EMRHRF---QTQQLLEMCKDVCEAMEYLES 123
Query: 188 ---LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              LHRD+   N L++ +    ++DFGL++ +    Y         S G   P +     
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSRGSKFPVRWSPPE 176
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
           +  Y+   + KSD++++GV++ EI S
Sbjct: 177 VLMYS-KFSSKSDIWAFGVLMWEIYS 201

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +A+K + +    E   D F  E +++ ++ H  +V+L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI----- 187
           + +    ++  Y++                E R++      Q L  +  D   A+     
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLR-------EMRHRF---QTQQLLEMCKDVCEAMEYLES 123
Query: 188 ---LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              LHRD+   N L++ +    ++DFGL++ +    Y         S G   P +     
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWSPPE 176
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
           +  Y+   + KSD++++GV++ EI S
Sbjct: 177 VLMYS-KFSSKSDIWAFGVLMWEIYS 201

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 147
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 199
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 200 G--MGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +A+K + +    E   D F  E +++ ++ H  +V+L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI----- 187
           + +    ++  Y++                E R++      Q L  +  D   A+     
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLR-------EMRHRF---QTQQLLEMCKDVCEAMEYLES 118
Query: 188 ---LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              LHRD+   N L++ +    ++DFGL++ +    Y         S G   P +     
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWSPPE 171
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
           +  Y+   + KSD++++GV++ EI S
Sbjct: 172 VLMYS-KFSSKSDIWAFGVLMWEIYS 196

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 68/162 (41%), Gaps = 17/162 (10%)
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           EI +L  + H NI+KL     +K    L+  +                D      I    
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSK---YEAYLADFGLAKLMNSTNYHHAMSRVA 229
             G+ YLH      I+HRD+K  NILL++K       + DFGL+   +    +    R+ 
Sbjct: 156 LSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLG 210
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
            +Y YIAP   K +          EK DV+S GV++  +L G
Sbjct: 211 TAY-YIAPEVLKKK--------YNEKCDVWSCGVIMYILLCG 243

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/294 (21%), Positives = 117/294 (39%), Gaps = 48/294 (16%)
Query: 73  IGKGCSGVVYKA-------EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           +G+G  G+VY+        + P    +A+K + +     E ++ F  E  ++      ++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 84
Query: 126 VKLLGYCSNKSVKLLLYNYI----------SXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
           V+LLG  S     L++   +          S                    ++A   A G
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+      +      ++
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMG 294
           +P   K  +   Y       SDV+S+GVVL EI +   A QP  G     ++ +V +   
Sbjct: 202 SPESLKDGVFTTY-------SDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVMEG-- 250
Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                  +LD K    PD + + M         C   +P  RP+  E+++ + E
Sbjct: 251 ------GLLD-KPDNCPDMLFELM-------RMCWQYNPKMRPSFLEIISSIKE 290

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +A+K + +    E   D F  E +++ ++ H  +V+L G C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI----- 187
           + +    ++  Y++                E R++      Q L  +  D   A+     
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLR-------EMRHRF---QTQQLLEMCKDVCEAMEYLES 129
Query: 188 ---LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              LHRD+   N L++ +    ++DFGL++ +    Y         S G   P +     
Sbjct: 130 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWSPPE 182
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
           +  Y+   + KSD++++GV++ EI S
Sbjct: 183 VLMYS-KFSSKSDIWAFGVLMWEIYS 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G SG VY A ++  G+ +A++++   ++ ++ +     EI ++   ++ NIV  L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 85
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  Y++              + +    +     Q L +LH +    ++HRD
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLHSN---QVIHRD 141
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K +NILL       L DFG    +  T      S + G+  ++AP +   +  YG    
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAP-EVVTRKAYG---- 194
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              K D++S G++ +E++ G
Sbjct: 195 --PKVDIWSLGIMAIEMIEG 212

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEP---VDSFAAEIQILGHIRHRNIV 126
            VIGKG   VV +      G+  AVK +   K    P    +    E  I   ++H +IV
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSA------QGLAYLH 180
           +LL   S+  +  +++ ++               D    Y  AV S       + L Y H
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRA--DAGFVYSEAVASHYMRQILEALRYCH 147
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
            +    I+HRDVK  N+LL SK  +    L DFG+A  +  +    A  RV G+  ++AP
Sbjct: 148 DN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL-VAGGRV-GTPHFMAP 202
Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              K +  YG  +      DV+  GV+L  +LSG
Sbjct: 203 EVVKRE-PYGKPV------DVWGCGVILFILLSG 229

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G SG VY A ++  G+ +A++++   ++ ++ +     EI ++   ++ NIV  L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 85
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  Y++              + +    +     Q L +LH +    ++HRD
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLHSN---QVIHRD 141
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K +NILL       L DFG    +  T      S + G+  ++AP +   +  YG    
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSXMVGTPYWMAP-EVVTRKAYG---- 194
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              K D++S G++ +E++ G
Sbjct: 195 --PKVDIWSLGIMAIEMIEG 212

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 140
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 192
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 193 G--MGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 145
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 197
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 198 G--MGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 139
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 191
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 192 G--MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 140
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 192
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 193 G--MGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 85/225 (37%), Gaps = 34/225 (15%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           E   GK      +  +   G      K+ K       +    +E  +L  + H +++KL 
Sbjct: 33  EGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXX----------------DWETRYKIAVGS- 172
           G CS     LL+  Y                                D      + +G  
Sbjct: 93  GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL 152
Query: 173 -------AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
                  +QG+ YL       ++HRD+   NIL+    +  ++DFGL++     + +   
Sbjct: 153 ISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYEED 204
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           S V  S G I      ++ ++ +    T +SDV+S+GV+L EI++
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G SG VY A ++  G+ +A++++   ++ ++ +     EI ++   ++ NIV  L  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 86
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  Y++              + +    +     Q L +LH +    ++HRD
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLHSN---QVIHRD 142
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K +NILL       L DFG    +  T      S + G+  ++AP +   +  YG    
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSXMVGTPYWMAP-EVVTRKAYG---- 195
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              K D++S G++ +E++ G
Sbjct: 196 --PKVDIWSLGIMAIEMIEG 213

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 147
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 199
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 200 G--MGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 13/133 (9%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSK--YEAYLADFGLAKLMNSTNY--HHAMSRVAG 230
            L YLH+     I HRD+K  N L  +   +E  L DFGL+K     N   ++ M+  AG
Sbjct: 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK 290
           +  ++AP     +++     +   K D +S GV+L  +L G +   P + D   I + + 
Sbjct: 237 TPYFVAP-----EVLNTTNESYGPKCDAWSAGVLLHLLLMG-AVPFPGVNDADTISQVLN 290
Query: 291 KKMGSFEPAVSIL 303
           KK+    P  ++L
Sbjct: 291 KKLCFENPNYNVL 303

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 58/103 (56%), Gaps = 10/103 (9%)
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
           KIAV   + L +LH     +++HRDVK +N+L+++  +  + DFG++  +       A  
Sbjct: 113 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKD 167
Query: 227 RVAGSYGYIAPGKCKLQIIY-GYTMNITEKSDVYSYGVVLLEI 268
             AG   Y+AP +   ++   GY++    KSD++S G+ ++E+
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIEL 206

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 184
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 236
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 237 G--MGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/301 (20%), Positives = 113/301 (37%), Gaps = 51/301 (16%)
Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E +K    +G G  G V+     N   +AVK L   K     V +F  E  ++  ++H  
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDK 68
Query: 125 IVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXD--WETRYKIAVGSAQGLAYLHHD 182
           +V+L    + +    ++  +++                        +   A+G+AY+   
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  N+L+       +ADFGLA+++    Y  A         + AP     
Sbjct: 129 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINF 184
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILS-------GRS--AVQPQIGDGLHIVEWVKKKM 293
                     T KS+V+S+G++L EI++       GR+   V   +  G  +        
Sbjct: 185 GC-------FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM-------- 229
Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP 353
                       +++  PD++         I   C      ERPT   + ++L +  +A 
Sbjct: 230 -----------PRMENCPDELYD-------IMKMCWKEKAEERPTFDYLQSVLDDFYTAT 271
Query: 354 E 354
           E
Sbjct: 272 E 272

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   K+++    +Y  +               D E    +      G+ +LH      
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 184
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 236
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 237 G--MGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 94/219 (42%), Gaps = 22/219 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKL-------WKTKRDEEPVDSFAAEIQI 116
           E  + + ++G+G S VV +    P  +  AVK +       +  +  +E  ++   E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 117 LGHIR-HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
           L  +  H NI++L       +   L+++ +                 +   KI     + 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +  LH      I+HRD+K  NILLD      L DFG +  ++       +  V G+  Y+
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 190
Query: 236 APG--KCKLQIIY-GYTMNITEKSDVYSYGVVLLEILSG 271
           AP   +C +   + GY   +    D++S GV++  +L+G
Sbjct: 191 APEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAG 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 70  ENVIGKGCSGVVYKA-EMPNGELIAVKKL-------WKTKRDEEPVDSFAAEIQILGHIR 121
           + ++G+G S VV +    P  +  AVK +       +  +  +E  ++   E+ IL  + 
Sbjct: 9   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 68
Query: 122 -HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLH 180
            H NI++L       +   L+++ +                 +   KI     + +  LH
Sbjct: 69  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 128
Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG-- 238
                 I+HRD+K  NILLD      L DFG +  ++       +  V G+  Y+AP   
Sbjct: 129 K---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEII 182
Query: 239 KCKLQIIY-GYTMNITEKSDVYSYGVVLLEILSG 271
           +C +   + GY   +    D++S GV++  +L+G
Sbjct: 183 ECSMNDNHPGYGKEV----DMWSTGVIMYTLLAG 212

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
           E RY     + QG+ YLH++    ++HRD+K  N+ L+   +  + DFGLA  +      
Sbjct: 143 EARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG-- 196
Query: 223 HAMSRVAGSYGYIAPGK-CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
                + G+  YIAP   CK     G++  +    D++S G +L  +L G+   +
Sbjct: 197 ERKKXLCGTPNYIAPEVLCK----KGHSFEV----DIWSLGCILYTLLVGKPPFE 243

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 140
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 192
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 193 G--MGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/298 (20%), Positives = 108/298 (36%), Gaps = 53/298 (17%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           E   GK      +  +   G      K+ K       +    +E  +L  + H +++KL 
Sbjct: 33  EGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXX----------------DWETRYKIAVGS- 172
           G CS     LL+  Y                                D      + +G  
Sbjct: 93  GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL 152
Query: 173 -------AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM 225
                  +QG+ YL       ++HRD+   NIL+    +  ++DFGL++     + +   
Sbjct: 153 ISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYEED 204
Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           S V  S G I      ++ ++ +    T +SDV+S+GV+L EI++      P I      
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPP---- 258
Query: 286 VEWVKKKMGSFEPAVSILDTKLQ-GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                      E   ++L T  +   PD   +EM +   + + C    P +RP   ++
Sbjct: 259 -----------ERLFNLLKTGHRMERPDNCSEEMYR---LMLQCWKQEPDKRPVFADI 302

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
           E RY     + QG+ YLH++    ++HRD+K  N+ L+   +  + DFGLA  +      
Sbjct: 143 EARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER 198
Query: 223 HAMSRVAGSYGYIAPGK-CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
                + G+  YIAP   CK     G++  +    D++S G +L  +L G+   +
Sbjct: 199 KKT--LCGTPNYIAPEVLCK----KGHSFEV----DIWSLGCILYTLLVGKPPFE 243

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
           E RY     + QG+ YLH++    ++HRD+K  N+ L+   +  + DFGLA  +      
Sbjct: 127 EARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG-- 180
Query: 223 HAMSRVAGSYGYIAPGK-CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
                + G+  YIAP   CK     G++  +    D++S G +L  +L G+   +
Sbjct: 181 ERKKDLCGTPNYIAPEVLCK----KGHSFEV----DIWSLGCILYTLLVGKPPFE 227

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 151
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M+    +  Y AP     ++I 
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP-----EVIL 203
Query: 247 GYTMNITEKSDVYSYGVVLLEIL 269
           G  M   E  D++S G ++ E++
Sbjct: 204 G--MGYKENVDLWSVGCIMGEMV 224

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
           E RY     + QG+ YLH++    ++HRD+K  N+ L+   +  + DFGLA  +      
Sbjct: 143 EARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG-- 196
Query: 223 HAMSRVAGSYGYIAPGK-CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
                + G+  YIAP   CK     G++  +    D++S G +L  +L G+   +
Sbjct: 197 ERKKDLCGTPNYIAPEVLCK----KGHSFEV----DIWSLGCILYTLLVGKPPFE 243

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 108 DSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY 166
           +  + EI I   + H+++V   G+   N  V ++L                   + E RY
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 121
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
            +      G  YLH +    ++HRD+K  N+ L+   E  + DFGLA       Y     
Sbjct: 122 YLR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 174
Query: 227 R-VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           + + G+  YIAP     +   G++  +    DV+S G ++  +L G+   +       ++
Sbjct: 175 KTLCGTPNYIAPEVLSKK---GHSFEV----DVWSIGCIMYTLLVGKPPFETSCLKETYL 227
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              +KK   S    ++ +   L       +Q+MLQT           P  RPT+ E++
Sbjct: 228 --RIKKNEYSIPKHINPVAASL-------IQKMLQT----------DPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 108 DSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY 166
           +  + EI I   + H+++V   G+   N  V ++L                   + E RY
Sbjct: 66  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 125
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
            +      G  YLH +    ++HRD+K  N+ L+   E  + DFGLA       Y     
Sbjct: 126 YLR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 178
Query: 227 R-VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           + + G+  YIAP     +   G++  +    DV+S G ++  +L G+   +       ++
Sbjct: 179 KTLCGTPNYIAPEVLSKK---GHSFEV----DVWSIGCIMYTLLVGKPPFETSCLKETYL 231
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              +KK   S    ++ +   L       +Q+MLQT           P  RPT+ E++
Sbjct: 232 --RIKKNEYSIPKHINPVAASL-------IQKMLQT----------DPTARPTINELL 270

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 94/219 (42%), Gaps = 22/219 (10%)
Query: 65  ECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKL-------WKTKRDEEPVDSFAAEIQI 116
           E  + + ++G+G S VV +    P  +  AVK +       +  +  +E  ++   E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 117 LGHIR-HRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQG 175
           L  +  H NI++L       +   L+++ +                 +   KI     + 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           +  LH      I+HRD+K  NILLD      L DFG +  ++       +  V G+  Y+
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRSVCGTPSYL 190
Query: 236 APG--KCKLQIIY-GYTMNITEKSDVYSYGVVLLEILSG 271
           AP   +C +   + GY   +    D++S GV++  +L+G
Sbjct: 191 APEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAG 225

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 73/180 (40%), Gaps = 38/180 (21%)
Query: 173 AQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
           A+G+ +L    C+    HRD+   NILL       + DFGLA+             +  +
Sbjct: 209 ARGMEFLSSRKCI----HRDLAARNILLSENNVVKICDFGLAR------------DIYKN 252
Query: 232 YGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
             Y+  G  +L + +    +I     + KSDV+SYGV+L EI S   +  P +       
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFC 312
Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
             +++ M    P  S               E+ Q   I + C +  P ERP   E+V  L
Sbjct: 313 SRLREGMRMRAPEYS-------------TPEIYQ---IMLDCWHRDPKERPRFAELVEKL 356

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 108 DSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRY 166
           +  + EI I   + H+++V   G+   N  V ++L                   + E RY
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 121
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
            +      G  YLH +    ++HRD+K  N+ L+   E  + DFGLA       Y     
Sbjct: 122 YLR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 174
Query: 227 R-VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           + + G+  YIAP     +   G++  +    DV+S G ++  +L G+   +       ++
Sbjct: 175 KTLCGTPNYIAPEVLSKK---GHSFEV----DVWSIGCIMYTLLVGKPPFETSCLKETYL 227
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              +KK   S    ++ +   L       +Q+MLQT           P  RPT+ E++
Sbjct: 228 --RIKKNEYSIPKHINPVAASL-------IQKMLQT----------DPTARPTINELL 266

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 17/100 (17%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSRVAGS 231
           G+ YLH      I+HRD+K  N+LL+SK +  L    DFGL+ +  +      M    G+
Sbjct: 148 GVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKERLGT 201
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
             YIAP   + +          EK DV+S GV+L  +L+G
Sbjct: 202 AYYIAPEVLRKK--------YDEKCDVWSIGVILFILLAG 233

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M     +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMEPEVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 199 G--MGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 61  DNILECLKDENVIGKGC-SGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           ++I +     +V+G G  S V+   +    +L+A+K + K K  E    S   EI +L  
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLHK 72
Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL 179
           I+H NIV L     +     L+   +S                    ++       + YL
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 180 HHDCVPAILHRDVKCNNIL---LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           H      I+HRD+K  N+L   LD   +  ++DFGL+K+ +  +    +S   G+ GY+A
Sbjct: 133 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVA 186
Query: 237 P 237
           P
Sbjct: 187 P 187

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 73  IGKGCSGVV---YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           IG G  G+V   Y A +     +A+KKL +  +++        E+ ++  + H+NI+ LL
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 130 G-YCSNKSVKLL--LYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
             +   KS++    +Y  +               D E    +      G+ +LH      
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 146
Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I+HRD+K +NI++ S     + DFGLA+   ++     M     +  Y AP     ++I 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMEPEVVTRYYRAP-----EVIL 198
Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
           G  M   E  D++S G ++ E++  +
Sbjct: 199 G--MGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 60  IDNILECLKDENVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPV-DSFAAEIQI 116
           +D  L  L+D+  +G G  G V K   +M         K+ K + ++  + D   AE  +
Sbjct: 7   LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 65
Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGL 176
           +  + +  IV+++G C  +S  L++                   D +   ++    + G+
Sbjct: 66  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGM 124
Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGSYGYI 235
            YL        +HRD+   N+LL +++ A ++DFGL+K + +  N + A +       + 
Sbjct: 125 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY 181
Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
           AP     + I  Y    + KSDV+S+GV++ E  S
Sbjct: 182 AP-----ECINYYK--FSSKSDVWSFGVLMWEAFS 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 84/215 (39%), Gaps = 24/215 (11%)
Query: 65  ECLKDENVIGKGC-SGVVYKAEMPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRH 122
           E  K   ++G+G  S VV   E+      A+K L K     E  V     E  ++  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 123 RNIVKLLGYCSNKSVKLLL-YNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHH 181
              VKL  +C     KL    +Y                D              L YLH 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
                I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y++P    
Sbjct: 156 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL-- 210
Query: 242 LQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
                     +TEK     SD+++ G ++ ++++G
Sbjct: 211 ----------LTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 73  IGKGCSGVVYKA--EMPNGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +GKG   VV +   + P  E    +I  KKL  + RD + ++    E +I   ++H NIV
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKL--SARDHQKLER---EARICRLLKHPNIV 93
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
           +L    S +    L+++ ++              ++ +    +    Q L  ++H     
Sbjct: 94  RLHDSISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIHQILESVNHIHQHD 150
Query: 187 ILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
           I+HRD+K  N+LL SK +     LADFGLA  +       A    AG+ GY++P   + +
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLSPEVLR-K 207
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSG 271
             YG  +      D+++ GV+L  +L G
Sbjct: 208 DPYGKPV------DIWACGVILYILLVG 229

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 15/183 (8%)
Query: 61  DNILECLKDENVIGKGC-SGVVYKAEMPNGELIAVKKLWKT--KRDEEPVDSFAAEIQIL 117
           ++I +  + +  +G G  S VV   E   G+L AVK + K   K  E  +++   EI +L
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIEN---EIAVL 74
Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLA 177
             I+H NIV L     + +   L+   +S                +    +       + 
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVY 134
Query: 178 YLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           YLH      I+HRD+K  N+L    D + +  ++DFGL+K+    +    MS   G+ GY
Sbjct: 135 YLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGY 188
Query: 235 IAP 237
           +AP
Sbjct: 189 VAP 191

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 72/313 (23%), Positives = 125/313 (39%), Gaps = 51/313 (16%)
Query: 59  TIDNILECLKD----ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEI 114
            I N  + LK+    E ++G G SG V       G  +AVK++       +  D    EI
Sbjct: 5   NIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEI 59
Query: 115 QILGHIR-HRNIVKLLGYCSNKSVKLL-----LYNYISXXXXXXXXXXXXXXDWETRYK- 167
           ++L     H N+++   YCS  + + L     L N                   +  Y  
Sbjct: 60  KLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 168 --IAVGSAQGLAYLHHDCVPAILHRDVKCNNILL--DSKYEA-----------YLADFGL 212
             +    A G+A+LH      I+HRD+K  NIL+   S++ A            ++DFGL
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 213 AKLMNS--TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            K ++S  +++   ++  +G+ G+ AP   +          +T   D++S G V   ILS
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 271 GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN 330
                 P  GD       + + + S +    + D  L      ++ +M          ++
Sbjct: 235 --KGKHP-FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM----------ID 281
Query: 331 SSPAERPTMKEVV 343
             P +RPT  +V+
Sbjct: 282 HDPLKRPTAMKVL 294

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 43/235 (18%)
Query: 67  LKDENVIGKGCSGVVYKAEMPNGELI-AVKKLWKTK------------------------ 101
           LKDE  IGKG  GVV  A   N     A+K L K K                        
Sbjct: 17  LKDE--IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 102 RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS--NKSVKLLLYNYISXXXXXXXXXXXXX 159
           +   P++    EI IL  + H N+VKL+      N+    +++  ++             
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 160 XDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST 219
            + + R+       +G+ YLH+     I+HRD+K +N+L+       +ADFG++     +
Sbjct: 135 SEDQARFYFQ-DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 220 NYHHAMSRVAGSYGYIAPGKCK--LQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           +    +S   G+  ++AP       +I  G  +      DV++ GV L   + G+
Sbjct: 191 D--ALLSNTVGTPAFMAPESLSETRKIFSGKAL------DVWAMGVTLYCFVFGQ 237

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G SG VY A ++  G+ +A++++   ++ ++ +     EI ++   ++ NIV  L  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 86
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  Y++              + +    +     Q L +LH +    ++HR+
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLHSN---QVIHRN 142
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K +NILL       L DFG    +  T      S + G+  ++AP +   +  YG    
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAP-EVVTRKAYG---- 195
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              K D++S G++ +E++ G
Sbjct: 196 --PKVDIWSLGIMAIEMIEG 213

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/252 (19%), Positives = 110/252 (43%), Gaps = 22/252 (8%)
Query: 27  KVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILEC------LKDENVIGKGCSGV 80
           +  + +GM   PPG          +  ++    +  +++       L +   IG+G +G+
Sbjct: 30  RARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGI 89
Query: 81  VYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL 139
           V  A +  +G+L+AVKK+    R ++  +    E+ I+   +H N+V++           
Sbjct: 90  VCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 147
Query: 140 LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL 199
           ++  ++               + E    + +   Q L+ LH      ++HRD+K ++ILL
Sbjct: 148 VVMEFLEGGALTDIVTHTRMNE-EQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILL 203
Query: 200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVY 259
                  L+DFG    ++          + G+  ++AP +   ++ YG       + D++
Sbjct: 204 THDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAP-ELISRLPYG------PEVDIW 254
Query: 260 SYGVVLLEILSG 271
           S G++++E++ G
Sbjct: 255 SLGIMVIEMVDG 266

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRDVK +N+LLD      LADFG    MN        + V G+  YI+P   K Q  
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 251
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRS 273
            GY      + D +S GV L E+L G +
Sbjct: 252 DGY---YGRECDWWSVGVFLYEMLVGDT 276

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRDVK +N+LLD      LADFG    MN        + V G+  YI+P   K Q  
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRS 273
            GY      + D +S GV L E+L G +
Sbjct: 247 DGY---YGRECDWWSVGVFLYEMLVGDT 271

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRDVK +N+LLD      LADFG    MN        + V G+  YI+P   K Q  
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 251
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRS 273
            GY      + D +S GV L E+L G +
Sbjct: 252 DGY---YGRECDWWSVGVFLYEMLVGDT 276

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 81/186 (43%), Gaps = 42/186 (22%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
            +G+ Y+H      +++RD+K +NI L    +  + DFG   L+ S        R  G+ 
Sbjct: 132 TKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFG---LVTSLKNDGKRXRSKGTL 185
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
            Y++P +   Q  YG  +      D+Y+ G++L E+              LH+ +     
Sbjct: 186 RYMSPEQISSQ-DYGKEV------DLYALGLILAEL--------------LHVCD----- 219
Query: 293 MGSFEPAVSILDTK---LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             +FE +    D +   +  + D+  + +LQ L      ++  P +RP   E++  L   
Sbjct: 220 -TAFETSKFFTDLRDGIISDIFDKKEKTLLQKL------LSKKPEDRPNTSEILRTLTVW 272
Query: 350 KSAPEE 355
           K +PE+
Sbjct: 273 KKSPEK 278

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G +G+V  A +  +G+L+AVKK+    R ++  +    E+ I+   +H N+V++   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  ++               + E    + +   Q L+ LH      ++HRD
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVTHTRMNE-EQIAAVCLAVLQALSVLHAQ---GVIHRD 150
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K ++ILL       L+DFG    ++          + G+  ++AP     ++ YG    
Sbjct: 151 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELIS-RLPYG---- 203
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              + D++S G++++E++ G
Sbjct: 204 --PEVDIWSLGIMVIEMVDG 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G +G+V  A +  +G+L+AVKK+    R ++  +    E+ I+   +H N+V++   
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  ++               + E    + +   Q L+ LH      ++HRD
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVTHTRMNE-EQIAAVCLAVLQALSVLHAQ---GVIHRD 152
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K ++ILL       L+DFG    ++          + G+  ++AP +   ++ YG    
Sbjct: 153 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAP-ELISRLPYG---- 205
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              + D++S G++++E++ G
Sbjct: 206 --PEVDIWSLGIMVIEMVDG 223

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 15/97 (15%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I++RD+K  NILLD      + DFG AK +    Y      + G+  Y
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYX-----LCGTPDY 169
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           IAP           T    +  D +S+G+++ E+L+G
Sbjct: 170 IAPEVVS-------TKPYNKSIDWWSFGILIYEMLAG 199

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 61  DNILECLKDENVIGKGC-SGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           ++I +     +V+G G  S V+   +    +L+A+K + K    E    S   EI +L  
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL-EGKEGSMENEIAVLHK 72
Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL 179
           I+H NIV L     +     L+   +S                    ++       + YL
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 180 HHDCVPAILHRDVKCNNIL---LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           H      I+HRD+K  N+L   LD   +  ++DFGL+K+ +  +    +S   G+ GY+A
Sbjct: 133 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVA 186
Query: 237 P 237
           P
Sbjct: 187 P 187

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G +G+V  A E   G+ +AVKK+    R ++  +    E+ I+    H N+V +   
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  ++               + E    + +   + L+YLH+     ++HRD
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTRMNE-EQIATVCLSVLRALSYLHNQ---GVIHRD 166
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K ++ILL S     L+DFG    ++          + G+  ++AP +   ++ YG  + 
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKX--LVGTPYWMAP-EVISRLPYGTEV- 222
Query: 252 ITEKSDVYSYGVVLLEILSG 271
                D++S G++++E++ G
Sbjct: 223 -----DIWSLGIMVIEMIDG 237

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G +G+V  A +  +G+L+AVKK+    R ++  +    E+ I+   +H N+V++   
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  ++               + E    + +   Q L+ LH      ++HRD
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRMNE-EQIAAVCLAVLQALSVLHAQ---GVIHRD 141
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K ++ILL       L+DFG    ++          + G+  ++AP     ++ YG    
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELIS-RLPYG---- 194
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              + D++S G++++E++ G
Sbjct: 195 --PEVDIWSLGIMVIEMVDG 212

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/252 (19%), Positives = 110/252 (43%), Gaps = 22/252 (8%)
Query: 27  KVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILEC------LKDENVIGKGCSGV 80
           +  + +GM   PPG          +  ++    +  +++       L +   IG+G +G+
Sbjct: 107 RARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGI 166
Query: 81  VYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL 139
           V  A +  +G+L+AVKK+    R ++  +    E+ I+   +H N+V++           
Sbjct: 167 VCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224
Query: 140 LLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL 199
           ++  ++               + E    + +   Q L+ LH      ++HRD+K ++ILL
Sbjct: 225 VVMEFLEGGALTDIVTHTRMNE-EQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILL 280
Query: 200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVY 259
                  L+DFG    ++          + G+  ++AP +   ++ YG  +      D++
Sbjct: 281 THDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAP-ELISRLPYGPEV------DIW 331
Query: 260 SYGVVLLEILSG 271
           S G++++E++ G
Sbjct: 332 SLGIMVIEMVDG 343

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 60/113 (53%), Gaps = 16/113 (14%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS--RVAG 230
           A GL +L       I++RD+K +N++LDS+    +ADFG+ K     N    ++     G
Sbjct: 452 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXFCG 504
Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
           +  YIAP     Q  YG ++      D +++GV+L E+L+G++  + +  D L
Sbjct: 505 TPDYIAPEIIAYQ-PYGKSV------DWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 87/206 (42%), Gaps = 29/206 (14%)
Query: 73  IGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC 132
           +G G  GVV   +      +A+K + +    E   D F  E +++ ++ H  +V+L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 133 SNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI----- 187
           + +    ++  Y++                E R++      Q L  +  D   A+     
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR-------EMRHRF---QTQQLLEMCKDVCEAMEYLES 138
Query: 188 ---LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
              LHRD+   N L++ +    ++DFGL++ +              S G   P +     
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEETSSVGSKFPVRWSPPE 191
Query: 245 IYGYTMNITEKSDVYSYGVVLLEILS 270
           +  Y+   + KSD++++GV++ EI S
Sbjct: 192 VLMYS-KFSSKSDIWAFGVLMWEIYS 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 20/178 (11%)
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           EIQ+L  +RH+N+++L+    N+  + +   Y+                 E R+ +    
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 173 A------QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
                   GL YLH      I+H+D+K  N+LL +     ++  G+A+ ++         
Sbjct: 113 GYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH 284
              GS  +  P     +I  G       K D++S GV L  I +G   + P  GD ++
Sbjct: 170 TSQGSPAFQPP-----EIANGLDTFSGFKVDIWSAGVTLYNITTG---LYPFEGDNIY 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 73  IGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG+G +G+V  A +  +G+L+AVKK+    R ++  +    E+ I+   +H N+V++   
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 132 CSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
                   ++  ++               + E    + +   Q L+ LH      ++HRD
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVTHTRMNE-EQIAAVCLAVLQALSVLHAQ---GVIHRD 145
Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
           +K ++ILL       L+DFG    ++          + G+  ++AP +   ++ YG    
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAP-ELISRLPYG---- 198
Query: 252 ITEKSDVYSYGVVLLEILSG 271
              + D++S G++++E++ G
Sbjct: 199 --PEVDIWSLGIMVIEMVDG 216

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 61  DNILECLKDENVIGKGC-SGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           ++I +     +V+G G  S V+   +    +L+A+K + K    E    S   EI +L  
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL-EGKEGSMENEIAVLHK 72
Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL 179
           I+H NIV L     +     L+   +S                    ++       + YL
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 180 HHDCVPAILHRDVKCNNIL---LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           H      I+HRD+K  N+L   LD   +  ++DFGL+K+ +  +    +S   G+ GY+A
Sbjct: 133 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVA 186
Query: 237 P 237
           P
Sbjct: 187 P 187

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 60/113 (53%), Gaps = 16/113 (14%)
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS--RVAG 230
           A GL +L       I++RD+K +N++LDS+    +ADFG+ K     N    ++     G
Sbjct: 131 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXFCG 183
Query: 231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
           +  YIAP     Q  YG ++      D +++GV+L E+L+G++  + +  D L
Sbjct: 184 TPDYIAPEIIAYQ-PYGKSV------DWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 61  DNILECLKDENVIGKGC-SGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           ++I +     +V+G G  S V+   +    +L+A+K + K    E    S   EI +L  
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL-EGKEGSMENEIAVLHK 72
Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYL 179
           I+H NIV L     +     L+   +S                    ++       + YL
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 180 HHDCVPAILHRDVKCNNIL---LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           H      I+HRD+K  N+L   LD   +  ++DFGL+K+ +  +    +S   G+ GY+A
Sbjct: 133 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVA 186
Query: 237 P 237
           P
Sbjct: 187 P 187

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 72  VIGKGCSGVVYKAEMPNGELI-AVKKLWKT----KRDEEPVDSFAAEIQILGHIRHRNIV 126
           VIGKG  G V  A     E+  AVK L K     K++E+ +   +    +L +++H  +V
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI--MSERNVLLKNVKHPFLV 102
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKI-AVGSAQGLAYLHHDCVP 185
            L            + +YI+                E R +  A   A  L YLH     
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCF-LEPRARFYAAEIASALGYLHSL--- 158
Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            I++RD+K  NILLDS+    L DFGL K   +  ++   S   G+  Y+AP     +++
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAP-----EVL 211
Query: 246 YGYTMNITEKSDVYSYGVVLLEILSG 271
           +    + T   D +  G VL E+L G
Sbjct: 212 HKQPYDRT--VDWWCLGAVLYEMLYG 235

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 73/189 (38%), Gaps = 19/189 (10%)
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ +L  + H NI+KL  +  +K    L+                          I    
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSRVA 229
             G  YLH      I+HRD+K  N+LL+SK    L    DFGL+           M    
Sbjct: 131 LSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERL 184
Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV 289
           G+  YIAP   +            EK DV+S GV+L  +L G      Q      I++ V
Sbjct: 185 GTAYYIAPEVLR--------KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ--EILKRV 234
Query: 290 KKKMGSFEP 298
           +K   SF+P
Sbjct: 235 EKGKFSFDP 243

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 72/313 (23%), Positives = 123/313 (39%), Gaps = 51/313 (16%)
Query: 59  TIDNILECLKD----ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEI 114
            I N  + LK+    E ++G G SG V       G  +AVK++       +  D    EI
Sbjct: 5   NIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEI 59
Query: 115 QILGHIR-HRNIVKLLGYCSNKSVKLL-----LYNYISXXXXXXXXXXXXXXDWETRYK- 167
           ++L     H N+++   YCS  + + L     L N                   +  Y  
Sbjct: 60  KLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 168 --IAVGSAQGLAYLHHDCVPAILHRDVKCNNILL--DSKYEA-----------YLADFGL 212
             +    A G+A+LH      I+HRD+K  NIL+   S++ A            ++DFGL
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 213 AKLMNS--TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
            K ++S    +   ++  +G+ G+ AP   +          +T   D++S G V   ILS
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 271 GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN 330
                 P  GD       + + + S +    + D  L      ++ +M          ++
Sbjct: 235 --KGKHP-FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM----------ID 281
Query: 331 SSPAERPTMKEVV 343
             P +RPT  +V+
Sbjct: 282 HDPLKRPTAMKVL 294

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 25/200 (12%)
Query: 75  KGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN 134
           K C+G  Y A++ N      KKL  + RD + ++    E +I   ++H NIV+L    S 
Sbjct: 25  KLCTGHEYAAKIIN-----TKKL--SARDHQKLER---EARICRLLKHSNIVRLHDSISE 74
Query: 135 KSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKC 194
           +    L+++ ++              ++ +    +    Q L  + H     ++HRD+K 
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMGVVHRDLKP 131
Query: 195 NNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMN 251
            N+LL SK +     LADFGLA  +       A    AG+ GY++P   + +  YG  + 
Sbjct: 132 ENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKE-AYGKPV- 187
Query: 252 ITEKSDVYSYGVVLLEILSG 271
                D+++ GV+L  +L G
Sbjct: 188 -----DIWACGVILYILLVG 202

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/97 (25%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           ++P     +       + ++ SD+++ G ++ ++++G
Sbjct: 201 VSPELLTEK-------SASKSSDLWALGCIIYQLVAG 230

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL-G 130
           IG+G +G+V  A E  +G  +AVK +    R ++  +    E+ I+   +H N+V++   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 131 YCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
           Y   + + +L+  ++               + E    +     Q LAYLH      ++HR
Sbjct: 111 YLVGEELWVLM-EFLQGGALTDIVSQVRLNE-EQIATVCEAVLQALAYLH---AQGVIHR 165
Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K ++ILL       L+DFG    ++          + G+  ++AP       +   ++
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX--LVGTPYWMAPE------VISRSL 217
Query: 251 NITEKSDVYSYGVVLLEILSG 271
             TE  D++S G++++E++ G
Sbjct: 218 YATE-VDIWSLGIMVIEMVDG 237

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 10/103 (9%)
Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
           KIAV   + L +LH     +++HRDVK +N+L+++  +    DFG++  +       A  
Sbjct: 140 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDV---AKD 194
Query: 227 RVAGSYGYIAPGKCKLQIIY-GYTMNITEKSDVYSYGVVLLEI 268
             AG   Y AP +   ++   GY++    KSD++S G+  +E+
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSV----KSDIWSLGITXIEL 233

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 122 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 179 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 48/108 (44%), Gaps = 16/108 (14%)
Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRDVK  NIL+ +   AYL DFG+A           +    G+  Y AP +         
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYXAPERFS------- 208
Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD-----GLHIVEWVKK 291
             + T ++D+Y+   VL E L+G    Q   GD     G HI + + +
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQ---GDQLSVXGAHINQAIPR 253

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 121 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 178 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPAFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 43/95 (45%), Gaps = 14/95 (14%)
Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           +GL +LH    P I+HRD+KC+NI +        + D GLA L  ++        V G+ 
Sbjct: 140 KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTP 194
Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLE 267
            + AP          Y     E  DVY++G   LE
Sbjct: 195 EFXAPEX--------YEEKYDESVDVYAFGXCXLE 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 56/127 (44%), Gaps = 19/127 (14%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSRVAGS 231
           G  YLH      I+HRD+K  N+LL+SK    L    DFGL+           M    G+
Sbjct: 116 GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGT 169
Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             YIAP   +            EK DV+S GV+L  +L G      Q      I++ V+K
Sbjct: 170 AYYIAPEVLR--------KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ--EILKRVEK 219
Query: 292 KMGSFEP 298
              SF+P
Sbjct: 220 GKFSFDP 226

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 119 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 176 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 177 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYK-AEMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q +    D++L+       +G G  GVV++  E   G   A K +      ++  ++   
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRK 203
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISX---XXXXXXXXXXXXXDWETRYKIA 169
           EIQ +  +RH  +V L     + +  +++Y ++S                 D    Y   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY--EAYLADFGLAKLMNSTNYHHAMSR 227
           V   +GL ++H +     +H D+K  NI+  +K   E  L DFGL   ++      ++  
Sbjct: 264 V--CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKV 315
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
             G+  + AP   + + +  YT       D++S GV+   +LSG S
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYT-------DMWSVGVLSYILLSGLS 354

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 43/232 (18%)
Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           ++IG G  G V +A +     ++A+KK+ +   D         EI IL  + H ++VK+L
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 130 GYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQ------------GLA 177
                K V+     Y+               D++  ++  V   +            G+ 
Sbjct: 119 DIVIPKDVEKFDELYV--------VLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL-------------------MNS 218
           Y+H      ILHRD+K  N L++      + DFGLA+                    MN 
Sbjct: 171 YVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
             + H  +      G++     +   +     N TE  DV+S G +  E+L+
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYK-AEMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q +    D++L+       +G G  GVV++  E   G   A K +      ++  ++   
Sbjct: 40  QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRK 97
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISX---XXXXXXXXXXXXXDWETRYKIA 169
           EIQ +  +RH  +V L     + +  +++Y ++S                 D    Y   
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 157
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY--EAYLADFGLAKLMNSTNYHHAMSR 227
           V   +GL ++H +     +H D+K  NI+  +K   E  L DFGL   ++      ++  
Sbjct: 158 V--CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKV 209
Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
             G+  + AP   + + +  YT       D++S GV+   +LSG S
Sbjct: 210 TTGTAEFAAPEVAEGKPVGYYT-------DMWSVGVLSYILLSGLS 248

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 201 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 199 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/97 (25%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           ++P     +       +  + SD+++ G ++ ++++G
Sbjct: 201 VSPELLTEK-------SAXKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 145 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 202 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 145 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 202 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 199 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 199 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 126/307 (41%), Gaps = 48/307 (15%)
Query: 67  LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRN 124
           L+   V+ +G    VY+A+ + +G   A+K+L     +EE   +   E+  +  +  H N
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPN 87
Query: 125 IVKLLGYCSNKSV----------KLLLYNYISXXXXXXXXXXXXXX---DWETRYKIAVG 171
           IV+   +CS  S+          + LL   +                    +T  KI   
Sbjct: 88  IVQ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS-TNYHHAMSRVAG 230
           + + + ++H    P I+HRD+K  N+LL ++    L DFG A  ++   +Y  +  R A 
Sbjct: 145 TCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 231 SYGYIAPGKCKL----QIIYGYT-MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
               I      +    +II  Y+   I EK D+++ G +L  +L  R   Q    DG  +
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCFR---QHPFEDGAKL 259
Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
                           I++ K    P      +  +L  AM  VN  P ER ++ EVV  
Sbjct: 260 ---------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVHQ 302
Query: 346 LMEVKSA 352
           L E+ +A
Sbjct: 303 LQEIAAA 309

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 201 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 201 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 201 VSP------------ELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 126 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 183 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 14/107 (13%)
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG-LAKLMNSTNYHHAMS 226
           IA+ S   L Y+H         RD+K +NIL+D      LADFG   KLM       +++
Sbjct: 186 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              G+  YI+P    LQ + G       + D +S GV + E+L G +
Sbjct: 237 --VGTPDYISPE--ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 147 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 204 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 176
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 177 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 219

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 176
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 177 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 219

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 199 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 52/253 (20%)
Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVY--KAEMPNG--ELIAVKKLWKTKRDEEPVDS 109
           +KL   +  +    K E+ IG+G    VY   A++  G  E IA+K L  T     P+  
Sbjct: 10  EKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPI-R 65
Query: 110 FAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIA 169
            AAE+Q L     ++ V  + YC  K+  +++   +                ++   +  
Sbjct: 66  IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA--MPYLEHESFLDILNSLSFQEVREYM 123
Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNST--------- 219
           +   + L  +H      I+HRDVK +N L + + + Y L DFGLA+  + T         
Sbjct: 124 LNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180
Query: 220 -----------------NYHHAMSRVAGSYGYIAP---GKCKLQIIYGYTMNITEKSDVY 259
                            +    ++  AG+ G+ AP    KC          N T   D++
Sbjct: 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP---------NQTTAIDMW 231
Query: 260 SYGVVLLEILSGR 272
           S GV+ L +LSGR
Sbjct: 232 SAGVIFLSLLSGR 244

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 126/314 (40%), Gaps = 57/314 (18%)
Query: 59  TIDNILECLKD----ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEI 114
            I N  + LK+    E ++G G SG V       G  +AVK++       +  D    EI
Sbjct: 23  NIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEI 77
Query: 115 QILGHIR-HRNIVKLLGYCSNKSVKLL-----LYNYISXXXXXXXXXXXXXXDWETRYK- 167
           ++L     H N+++   YCS  + + L     L N                   +  Y  
Sbjct: 78  KLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 135
Query: 168 --IAVGSAQGLAYLHHDCVPAILHRDVKCNNILL--DSKYEA-----------YLADFGL 212
             +    A G+A+LH      I+HRD+K  NIL+   S++ A            ++DFGL
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 213 AKLMNS--TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT-MNITEKSDVYSYGVVLLEIL 269
            K ++S    +   ++  +G+ G+ AP     +++   T   +T   D++S G V   IL
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAP-----ELLEESTKRRLTRSIDIFSMGCVFYYIL 247
Query: 270 SGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCV 329
           S      P  GD       + + + S +    + D  L      ++ +M          +
Sbjct: 248 S--KGKHP-FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM----------I 294
Query: 330 NSSPAERPTMKEVV 343
           +  P +RPT  +V+
Sbjct: 295 DHDPLKRPTAMKVL 308

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 126/314 (40%), Gaps = 57/314 (18%)
Query: 59  TIDNILECLKD----ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEI 114
            I N  + LK+    E ++G G SG V       G  +AVK++       +  D    EI
Sbjct: 23  NIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEI 77
Query: 115 QILGHIR-HRNIVKLLGYCSNKSVKLL-----LYNYISXXXXXXXXXXXXXXDWETRYK- 167
           ++L     H N+++   YCS  + + L     L N                   +  Y  
Sbjct: 78  KLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 135
Query: 168 --IAVGSAQGLAYLHHDCVPAILHRDVKCNNILL--DSKYEA-----------YLADFGL 212
             +    A G+A+LH      I+HRD+K  NIL+   S++ A            ++DFGL
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 213 AKLMNS--TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT-MNITEKSDVYSYGVVLLEIL 269
            K ++S    +   ++  +G+ G+ AP     +++   T   +T   D++S G V   IL
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAP-----ELLEESTKRRLTRSIDIFSMGCVFYYIL 247
Query: 270 SGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCV 329
           S      P  GD       + + + S +    + D  L      ++ +M          +
Sbjct: 248 S--KGKHP-FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM----------I 294
Query: 330 NSSPAERPTMKEVV 343
           +  P +RPT  +V+
Sbjct: 295 DHDPLKRPTAMKVL 308

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 198 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L YLH      I+HRD+K  NILL+      + DFG AK+++  +     +   G+  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 235 IAPGKCKLQIIYGYTMNITEK-----SDVYSYGVVLLEILSG 271
           ++P              +TEK     SD+++ G ++ ++++G
Sbjct: 198 VSPEL------------LTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 17/182 (9%)
Query: 62  NILECLKDENVIGKGC-SGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILG 118
           NI +      V+G G  S V    +   G+L A+K + K+   RD     S   EI +L 
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLK 61
Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAY 178
            I+H NIV L     + +   L+   +S                +    +       + Y
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 179 LHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           LH +    I+HRD+K  N+L    +   +  + DFGL+K+  +      MS   G+ GY+
Sbjct: 122 LHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYV 174
Query: 236 AP 237
           AP
Sbjct: 175 AP 176

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 25/233 (10%)
Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV-----DSFAA 112
           F  +N+ +       +G G   VV K    +  L    K  K +R +        +    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  I+H N++ L     NK+  +L+   ++                E   +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNI-LLDS---KYEAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI LLD    K    + DFGLA   +  ++ +    +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNI 177
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +GD
Sbjct: 178 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGD 220

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  IRH NI+ L     NK+  +L+   +S                +   +     
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI+L  K        L DFG+A  + + N       +
Sbjct: 125 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNI 178
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +G+
Sbjct: 179 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGE 221

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 15/114 (13%)
Query: 163 ETRYKIAVGSA-QGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKLMNSTN 220
           E R    +G A +GL YLH      ILH DVK +N+LL S    A L DFG A  +    
Sbjct: 184 EDRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 240
Query: 221 YHHAM---SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              ++     + G+  ++AP     +++ G + +   K DV+S   ++L +L+G
Sbjct: 241 LGKSLLTGDYIPGTETHMAP-----EVVLGRSCDA--KVDVWSSCCMMLHMLNG 287

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 84/209 (40%), Gaps = 26/209 (12%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           EN IG+G  G V K  +  G  I  A KK+   K   E VD F  EI+I+  + H NI++
Sbjct: 14  ENTIGRGSWGEV-KIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L     + +   L+    +                    +I       +AY H   V   
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV--- 127
Query: 188 LHRDVKCNNILL-----DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
            HRD+K  N L      DS  +  L DFGLA           M    G+  Y++P    L
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGK---MMRTKVGTPYYVSPQ--VL 180
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           + +YG       + D +S GV++  +L G
Sbjct: 181 EGLYG------PECDEWSAGVMMYVLLCG 203

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 76/186 (40%), Gaps = 40/186 (21%)
Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           I +  A+ + +LH      ++HRD+K +NI         + DFGL   M+       +  
Sbjct: 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 228 VAGSYG----------YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP 277
              +Y           Y++P +     I+G   N + K D++S G++L E+L   S    
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQ-----IHGN--NYSHKVDIFSLGLILFELLYSFSTQME 278
Query: 278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP 337
           ++     I+  V+           +L T+       MVQ+ML          + SP ERP
Sbjct: 279 RV----RIITDVRNL------KFPLLFTQKYPQEHMMVQDML----------SPSPTERP 318
Query: 338 TMKEVV 343
              +++
Sbjct: 319 EATDII 324

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  IRH NI+ L     NK+  +L+   +S                +   +     
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI+L  K        L DFG+A  + + N       +
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNI 171
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +G+
Sbjct: 172 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGE 214

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL  LH +    I++RD+K  NILLD      ++D GLA  ++         RV G+ GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGY 351
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           +AP   K +    YT +     D ++ G +L E+++G+S  Q
Sbjct: 352 MAPEVVKNE---RYTFS----PDWWALGCLLYEMIAGQSPFQ 386

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL  LH +    I++RD+K  NILLD      ++D GLA  ++         RV G+ GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGY 351
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           +AP   K +    YT +     D ++ G +L E+++G+S  Q
Sbjct: 352 MAPEVVKNE---RYTFS----PDWWALGCLLYEMIAGQSPFQ 386

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 84/209 (40%), Gaps = 26/209 (12%)
Query: 70  ENVIGKGCSGVVYKAEMPNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           EN IG+G  G V K  +  G  I  A KK+   K   E VD F  EI+I+  + H NI++
Sbjct: 31  ENTIGRGSWGEV-KIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 128 LLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L     + +   L+    +                    +I       +AY H   V   
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV--- 144
Query: 188 LHRDVKCNNILL-----DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
            HRD+K  N L      DS  +  L DFGLA           M    G+  Y++P    L
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGK---MMRTKVGTPYYVSPQ--VL 197
Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           + +YG       + D +S GV++  +L G
Sbjct: 198 EGLYG------PECDEWSAGVMMYVLLCG 220

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 130 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 183
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 184 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 216
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 217 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 255

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGS 172
           E+ IL  IRH NI+ L     NK+  +L+   +S                +   +     
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFGLAKLMNSTNYHHAMSRV 228
             G+ YLH      I H D+K  NI+L  K        L DFG+A  + + N       +
Sbjct: 139 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNI 192
Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            G+  ++AP     +I+    + +  ++D++S GV+   +LSG S   P +G+
Sbjct: 193 FGTPEFVAP-----EIVNYEPLGL--EADMWSIGVITYILLSGAS---PFLGE 235

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 45/227 (19%)
Query: 73  IGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG- 130
           +G+G  GVV++A+    +   A+K++    R E   +    E++ L  + H  IV+    
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 131 -YCSNKSVKLL-----LYNYISXXXXXXXXXXXXXXDW-------ETRYK-----IAVGS 172
               N + KL      +Y YI               DW       E R +     I +  
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLK----DWMNGRCTIEERERSVCLHIFLQI 127
Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH-------AM 225
           A+ + +LH      ++HRD+K +NI         + DFGL   M+             A 
Sbjct: 128 AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 226 SRVAGSYG---YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL 269
           +R  G  G   Y++P +     I+G +   + K D++S G++L E+L
Sbjct: 185 ARHTGQVGTKLYMSPEQ-----IHGNS--YSHKVDIFSLGLILFELL 224

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 131 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 184
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 185 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 217
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 218 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 256

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 180
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 181 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 213
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 214 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 252

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 131 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 184
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 185 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 217
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 218 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 256

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 185
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 186 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 218
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 219 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 257

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL +LH      I++RD+K  N+LLD      ++D GLA  + +          AG+ G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGF 355
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           +AP     +++ G   + +   D ++ GV L E+++ R   +
Sbjct: 356 MAP-----ELLLGEEYDFS--VDYFALGVTLYEMIAARGPFR 390

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 185
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 186 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 218
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 219 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 257

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 73  IGKGCSGVVYK------AEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +GKG   VV +       +    ++I  KKL  + RD + ++    E +I   ++H NIV
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKL--SARDHQKLER---EARICRLLKHPNIV 84
Query: 127 KLLGYCSNKSVKLLLYNYISXXXXXXXXXXXXXXDWETRYKIAVGSAQGLAYLHHDCVPA 186
           +L    S +    L+++ ++              ++ +    +    Q L  + H     
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG 141
Query: 187 ILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
           ++HRD+K  N+LL SK +     LADFGLA  +       A    AG+ GY++P   + +
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLR-K 198
Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSG 271
             YG  +      D+++ GV+L  +L G
Sbjct: 199 DPYGKPV------DLWACGVILYILLVG 220

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL +LH      I++RD+K  N+LLD      ++D GLA  + +          AG+ G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGF 355
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           +AP     +++ G   + +   D ++ GV L E+++ R   +
Sbjct: 356 MAP-----ELLLGEEYDFS--VDYFALGVTLYEMIAARGPFR 390

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL +LH      I++RD+K  N+LLD      ++D GLA  + +          AG+ G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGF 355
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           +AP     +++ G   + +   D ++ GV L E+++ R   +
Sbjct: 356 MAP-----ELLLGEEYDFS--VDYFALGVTLYEMIAARGPFR 390

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 185
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 186 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 218
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 219 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 257

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 227
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 228 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 260
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 261 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 299

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           GL +LH      I++RD+K  N+LLD      ++D GLA  + +          AG+ G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGF 355
Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ 276
           +AP     +++ G   + +   D ++ GV L E+++ R   +
Sbjct: 356 MAP-----ELLLGEEYDFS--VDYFALGVTLYEMIAARGPFR 390

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 146 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 199
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 200 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 232
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 233 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 271

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 200
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 201 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 233
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 234 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 272

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 212
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 213 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 245
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 246 EEII--RGQVFFRQRVSSECQHL--IRWCLALRPSDRPTFEEI 284

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 154 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 207
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 208 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 240
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 241 EEII--RGQVFFRQRVSXECQHL--IRWCLALRPSDRPTFEEI 279

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 227
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G    +       H  E ++ ++  F   
Sbjct: 228 IRYHRYHGRS------AAVWSLGILLYDMVCGDIPFE-------HDEEIIRGQV-FFRQR 273
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           VS              Q +++      +C+   P++RPT +E+
Sbjct: 274 VS-----------SECQHLIR------WCLALRPSDRPTFEEI 299

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 166 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 219
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G    +       H  E ++ ++  F   
Sbjct: 220 IRYHRYHGRS------AAVWSLGILLYDMVCGDIPFE-------HDEEIIRGQV-FFRQR 265
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           VS              Q +++      +C+   P++RPT +E+
Sbjct: 266 VS-----------SECQHLIR------WCLALRPSDRPTFEEI 291

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 38/163 (23%)
Query: 181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H+C   +LHRD+K  NIL+D ++ E  L DFG   L+  T Y    +   G+  Y  P  
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEW 200
Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
            +    +G +      + V+S G++L +++ G                        FE  
Sbjct: 201 IRYHRYHGRS------AAVWSLGILLYDMVCGDIP---------------------FEHD 233
Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             I+  + Q    Q V    Q L    +C+   P++RPT +E+
Sbjct: 234 EEII--RGQVFFRQRVSXECQHL--IRWCLALRPSDRPTFEEI 272

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	371
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-110
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-104
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-97
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-48
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-30
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-19
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  323 bits (831), Expect = e-110
 Identities = 114/287 (39%), Positives = 175/287 (60%), Gaps = 23/287 (8%)

Query: 69  DENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
           ++N++G+G  G VYK  + +G L+AVK+L K +R +     F  E++++    HRN+++L
Sbjct: 34  NKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRNLLRL 92

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRN----LDWETRYKIAVGSAQGLAYLHHDCV 184
            G+C   + +LL+Y Y++NG++   L+        LDW  R +IA+GSA+GLAYLH  C 
Sbjct: 93  RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
           P I+HRDVK  NILLD ++EA + DFGLAKLM+  +  H  + V G+ G+IAP       
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPE------ 205

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAV---QPQIGDGLHIVEWVKK--KMGSFEPA 299
            Y  T   +EK+DV+ YGV+LLE+++G+ A    +    D + +++WVK   K    E  
Sbjct: 206 -YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE-- 262

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            +++D  LQG      +E+ Q + +A+ C  SSP ERP M EVV +L
Sbjct: 263 -ALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  309 bits (793), Expect = e-104
 Identities = 100/308 (32%), Positives = 157/308 (50%), Gaps = 31/308 (10%)

Query: 51  IPFQKLNFTIDNILEC---LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKR--DEE 105
           +PF+     + ++ E       + +IG G  G VYK  + +G  +A+K+         EE
Sbjct: 22  VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81

Query: 106 PVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN----LD 161
               F  EI+ L   RH ++V L+G+C  ++  +L+Y Y+ NGNL++ L G+      + 
Sbjct: 82  ----FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137

Query: 162 WETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY 221
           WE R +I +G+A+GL YLH      I+HRDVK  NILLD  +   + DFG++K     + 
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194

Query: 222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
            H  + V G+ GYI P        Y     +TEKSDVYS+GVVL E+L  RSA+   +  
Sbjct: 195 THLSTVVKGTLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247

Query: 282 G-LHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
             +++ EW  +    G  E    I+D  L        + + +    A+ C+  S  +RP+
Sbjct: 248 EMVNLAEWAVESHNNGQLE---QIVDPNLADKIR--PESLRKFGDTAVKCLALSSEDRPS 302

Query: 339 MKEVVALL 346
           M +V+  L
Sbjct: 303 MGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  290 bits (745), Expect = 3e-97
 Identities = 92/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKR------DEEPVDSFAAEIQILGHIRHRN 124
           N +G+G  GVVYK  + N   +AVKKL            ++    F  EI+++   +H N
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQ----FDQEIKVMAKCQHEN 91

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLAYLHH 181
           +V+LLG+ S+     L+Y Y+ NG+L   L        L W  R KIA G+A G+ +LH 
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP---- 237
           +     +HRD+K  NILLD  + A ++DFGLA+           SR+ G+  Y+AP    
Sbjct: 152 NHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR 208

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
           G+            IT KSD+YS+GVVLLEI++G  AV         +++  ++     +
Sbjct: 209 GE------------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEK 255

Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                +D K+          +     +A  C++    +RP +K+V  LL E+ ++
Sbjct: 256 TIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  234 bits (599), Expect = 4e-75
 Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 22/300 (7%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           L+   V  +G  G V+KA     E +AVK      +          E+  L  ++H NI+
Sbjct: 26  LQLLEVKARGRFGCVWKA-QLLNEYVAVKIFPIQDKQSW---QNEYEVYSLPGMKHENIL 81

Query: 127 KLLGYC----SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD 182
           + +G      S      L+  +   G+L   L+ N  + W     IA   A+GLAYLH D
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHED 140

Query: 183 CV-------PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
                    PAI HRD+K  N+LL +   A +ADFGLA    +           G+  Y+
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
           AP    L+    +  +   + D+Y+ G+VL E+ S  +A    + + +   E    +  S
Sbjct: 201 APE--VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258

Query: 296 FEPAVSILDTKLQ--GLPDQMVQ-EMLQTLG-IAMFCVNSSPAERPTMKEVVALLMEVKS 351
            E    ++  K +   L D   +   +  L      C +     R +   V   + +++ 
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  198 bits (506), Expect = 2e-61
 Identities = 96/359 (26%), Positives = 158/359 (44%), Gaps = 60/359 (16%)

Query: 19  LVTRNHRYKVEKASGMST---LPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGK 75
           +   +H + +      +T      GA D       IP+  LN            +  IG 
Sbjct: 1   MKHHHHHHPMSDYDIPTTENLYFQGAMDGD-DMD-IPWCDLNI-----------KEKIGA 47

Query: 76  GCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK 135
           G  G V++AE  +G  +AVK L +     E V+ F  E+ I+  +RH NIV  +G  +  
Sbjct: 48  GSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106

Query: 136 SVKLLLYNYISNGNLQQLLQGN---RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDV 192
               ++  Y+S G+L +LL  +     LD   R  +A   A+G+ YLH+   P I+HR++
Sbjct: 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNL 165

Query: 193 KCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG--YTM 250
           K  N+L+D KY   + DFGL++L  ST    +    AG+  ++AP     +++       
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAP-----EVLRDEPS-- 216

Query: 251 NITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
              EKSDVYS+GV+L E+ + +   QP    +   +V  V  K       +       + 
Sbjct: 217 --NEKSDVYSFGVILWELATLQ---QPWGNLNPAQVVAAVGFK--CKRLEIP------RN 263

Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTSQPLIKQSA 368
           L  Q+   +         C  + P +RP+   ++ LL         L K++ P   +S 
Sbjct: 264 LNPQVAAIIEG-------CWTNEPWKRPSFATIMDLL-------RPLIKSAVPPPNRSD 308

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (490), Expect = 5e-59
 Identities = 83/316 (26%), Positives = 142/316 (44%), Gaps = 48/316 (15%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQIL 117
             ID   + ++ E V+G+G  GVV KA+    + +A+K++      E    +F  E++ L
Sbjct: 3   HMID--YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI----ESESERKAFIVELRQL 55

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN---LDWETRYKIAVGSAQ 174
             + H NIVKL G C N     L+  Y   G+L  +L G                +  +Q
Sbjct: 56  SRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAMSRVAGSYG 233
           G+AYLH     A++HRD+K  N+LL +      + DFG A  + +      M+   GS  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAA 168

Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP--QIGDGLHIVEWVKK 291
           ++AP     ++  G   N +EK DV+S+G++L E+++ R   +P  +IG     + W   
Sbjct: 169 WMAP-----EVFEG--SNYSEKCDVFSWGIILWEVITRR---KPFDEIGGPAFRIMWAVH 218

Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
                 P +       + LP  +   M +       C +  P++RP+M+E+V ++  +  
Sbjct: 219 N--GTRPPLI------KNLPKPIESLMTR-------CWSKDPSQRPSMEEIVKIMTHLM- 262

Query: 352 APEELGKTSQPLIKQS 367
                    +PL    
Sbjct: 263 --RYFPGADEPLQYPC 276

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  190 bits (485), Expect = 5e-58
 Identities = 69/329 (20%), Positives = 133/329 (40%), Gaps = 35/329 (10%)

Query: 53  FQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAA 112
                 ++D  L+ LK   +IG+G  G VYK  + +   +AVK    +  + +   +F  
Sbjct: 3   AAASEPSLD--LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANRQ---NFIN 54

Query: 113 EIQI--LGHIRHRNIVKLLGYCSNKSV-----KLLLYNYISNGNLQQLLQGNRNLDWETR 165
           E  I  +  + H NI + +      +       LL+  Y  NG+L + L  +   DW + 
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSS 113

Query: 166 YKIAVGSAQGLAYLHHD------CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST 219
            ++A    +GLAYLH +        PAI HRD+   N+L+ +     ++DFGL+  +   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 220 NY------HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
                    +A     G+  Y+AP   +  +      +  ++ D+Y+ G++  EI    +
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 274 AVQPQIGDGLHIV--EWVKKKMGSFEPAVSILDTKLQ--GLPD--QMVQEMLQTLG-IAM 326
            + P      + +  +       +FE    ++  + Q    P+  +     +++L     
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 327 FCVNSSPAERPTMKEVVALLMEVKSAPEE 355
            C +     R T +     + E+    E 
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWER 322

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  188 bits (480), Expect = 8e-58
 Identities = 70/293 (23%), Positives = 127/293 (43%), Gaps = 42/293 (14%)

Query: 67  LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEP-----VDSFAAEIQILGHI 120
           ++ E  IGKG  G+V+K   + +  ++A+K L     + E         F  E+ I+ ++
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYL 179
            H NIVKL G   N     ++  ++  G+L   L    + + W  + ++ +  A G+ Y+
Sbjct: 81  NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAY-----LADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            +   P I+HRD++  NI L S  E       +ADFGL++    +     +S + G++ +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQW 192

Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKM 293
           +AP     + I     + TEK+D YS+ ++L  IL+G     P        I      + 
Sbjct: 193 MAP-----ETIGAEEESYTEKADTYSFAMILYTILTGE---GPFDEYSYGKIKFINMIRE 244

Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
               P +       +  P ++   +         C +  P +RP    +V  L
Sbjct: 245 EGLRPTIP------EDCPPRLRNVIEL-------CWSGDPKKRPHFSYIVKEL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  188 bits (479), Expect = 9e-58
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 42/291 (14%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE--EPVDSFAAEIQILGHIRHRN 124
           L  E +IG G  G VY+A    G+ +AVK       ++  + +++   E ++   ++H N
Sbjct: 9   LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
           I+ L G C  +    L+  +   G L ++L   + +  +     AV  A+G+ YLH + +
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 185 PAILHRDVKCNNILLDSKYEAY--------LADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
             I+HRD+K +NIL+  K E          + DFGLA+  + T         AG+Y ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMA 182

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKKKMGS 295
           P     ++I       ++ SDV+SYGV+L E+L+G     P  G DGL +   V      
Sbjct: 183 P-----EVIRASM--FSKGSDVWSYGVLLWELLTGE---VPFRGIDGLAVAYGVAMN--K 230

Query: 296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
               +          P+   + M         C N  P  RP+   ++  L
Sbjct: 231 LALPIP------STCPEPFAKLMED-------CWNPDPHSRPSFTNILDQL 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  181 bits (461), Expect = 4e-55
 Identities = 57/301 (18%), Positives = 111/301 (36%), Gaps = 42/301 (13%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQI 116
           +  ID   + L     + +  SG ++K     G  I VK L            F  E   
Sbjct: 4   HSGID--FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLY---NYISNGNLQQLLQGNRN--LDWETRYKIAVG 171
           L    H N++ +LG C             +++  G+L  +L    N  +D     K A+ 
Sbjct: 61  LRIFSHPNVLPVLGAC-QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
            A+G+A+LH    P I    +   ++++D    A ++   +     S            +
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYA 171

Query: 232 YGYIAPGKCKLQIIYGYTMNI-TEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWV 289
             ++AP     + +     +     +D++S+ V+L E+++      P      + I   V
Sbjct: 172 PAWVAP-----EALQKKPEDTNRRSADMWSFAVLLWELVTRE---VPFADLSNMEIGMKV 223

Query: 290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             +     P +        G+   + + M         C+N  PA+RP    +V +L ++
Sbjct: 224 ALE--GLRPTIP------PGISPHVSKLMKI-------CMNEDPAKRPKFDMIVPILEKM 268

Query: 350 K 350
           +
Sbjct: 269 Q 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  179 bits (457), Expect = 6e-54
 Identities = 65/317 (20%), Positives = 128/317 (40%), Gaps = 39/317 (12%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQIL 117
           + I    E L+   +IGKG  G VY     +GE +A++ +   + +E+ + +F  E+   
Sbjct: 28  WDIP--FEQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAY 83

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGL 176
              RH N+V  +G C +     ++ +      L  +++  +  LD     +IA    +G+
Sbjct: 84  RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA---MSRVAGSYG 233
            YLH      ILH+D+K  N+  D+  +  + DFGL  +            +    G   
Sbjct: 144 GYLHA---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 234 YIAP--GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVK 290
           ++AP   +          +  ++ SDV++ G +  E+ +      P        I+  + 
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE---WPFKTQPAEAIIWQMG 256

Query: 291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
             M   +P +S +         ++   +L        C      ERPT  +++ +L ++ 
Sbjct: 257 TGM---KPNLSQIGM-----GKEISDILLF-------CWAFEQEERPTFTKLMDMLEKLP 301

Query: 351 ------SAPEELGKTSQ 361
                 S P    K+++
Sbjct: 302 KRNRRLSHPGHFWKSAE 318

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  176 bits (449), Expect = 3e-53
 Identities = 80/318 (25%), Positives = 142/318 (44%), Gaps = 40/318 (12%)

Query: 32  SGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGEL 91
            G      G+ D +  W  IP  ++                IG G  G VYK +  +G+ 
Sbjct: 3   KGHHHHHHGSRDAADDWE-IPDGQITV-----------GQRIGSGSFGTVYKGKW-HGD- 48

Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQ 151
           +AVK L  T    + + +F  E+ +L   RH NI+  +GY +      ++  +    +L 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLY 107

Query: 152 QLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF 210
             L  +    + +    IA  +A+G+ YLH     +I+HRD+K NNI L       + DF
Sbjct: 108 HHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDF 164

Query: 211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI-TEKSDVYSYGVVLLEIL 269
           GLA   +  +  H   +++GS  ++AP     ++I     N  + +SDVY++G+VL E++
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAP-----EVIRMQDSNPYSFQSDVYAFGIVLYELM 219

Query: 270 SGRSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFC 328
           +G+    P    +    +  +  + GS  P +S +       P +M + M +       C
Sbjct: 220 TGQ---LPYSNINNRDQIIEMVGR-GSLSPDLSKVR---SNCPKRMKRLMAE-------C 265

Query: 329 VNSSPAERPTMKEVVALL 346
           +     ERP+   ++A +
Sbjct: 266 LKKKRDERPSFPRILAEI 283

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  174 bits (444), Expect = 6e-52
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 36/314 (11%)

Query: 63  ILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH 122
           I + ++    IGKG  G V+  +   GE +AVK        EE       EI     +RH
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRH 90

Query: 123 RNIVKLLGYCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAY 178
            NI+  +      +       L+ +Y  NG+L   L+ +  LD ++  K+A  S  GL +
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSSVSGLCH 149

Query: 179 LH-----HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH--AMSRVAGS 231
           LH         PAI HRD+K  NIL+       +AD GLA    S         +   G+
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

Query: 232 YGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
             Y+ P     +++   ++N         +D+YS+G++L E+     +        L   
Sbjct: 210 KRYMPP-----EVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263

Query: 287 EWVKKKMGSFEPAVSILDTKL------QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK 340
           + V       +    +   KL      +   D+ +++M + +     C   +PA R T  
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLM---TECWAHNPASRLTAL 320

Query: 341 EVVALLMEVKSAPE 354
            V   L ++  + +
Sbjct: 321 RVKKTLAKMSESQD 334

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  172 bits (438), Expect = 3e-51
 Identities = 74/313 (23%), Positives = 123/313 (39%), Gaps = 58/313 (18%)

Query: 65  ECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
             L    V+GKGC G   K      GE++ +K+L   + DEE   +F  E++++  + H 
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHP 67

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHD 182
           N++K +G          +  YI  G L+ +++  +    W  R   A   A G+AYLH  
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH------------HAMSRVAG 230
               I+HRD+  +N L+       +ADFGLA+LM                       V G
Sbjct: 128 N---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 231 SYGYIAPGKCKLQIIYG--YTMNITEKSDVYSYGVVLLEILSGRSA------VQPQIGDG 282
           +  ++AP     ++I G  Y     EK DV+S+G+VL EI+   +A           G  
Sbjct: 185 NPYWMAP-----EMINGRSY----DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235

Query: 283 LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           +          G  +             P       ++       C +  P +RP+  ++
Sbjct: 236 VR---------GFLDRYCP------PNCPPSFFPITVR-------CCDLDPEKRPSFVKL 273

Query: 343 VALLMEVKSAPEE 355
              L  ++     
Sbjct: 274 EHWLETLRMHLAG 286

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  168 bits (428), Expect = 5e-50
 Identities = 74/315 (23%), Positives = 122/315 (38%), Gaps = 58/315 (18%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAE--IQILGHIRHRN 124
           +     +GKG  G V++     GE +AVK    + RDE+   S+  E  +     +RH N
Sbjct: 10  ITLLECVGKGRYGEVWRGSW-QGENVAVKIF--SSRDEK---SWFRETELYNTVMLRHEN 63

Query: 125 IVKLLGYC---SNKSVKLLLY-NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
           I+  +       + S +L L  +Y   G+L   LQ    LD  +  +I +  A GLA+LH
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLH 122

Query: 181 HDCV-----PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH--AMSRVAGSYG 233
            +       PAI HRD+K  NIL+    +  +AD GLA + + +        +   G+  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 234 YIAP----GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA--------------- 274
           Y+AP           I     +  ++ D++++G+VL E+     +               
Sbjct: 183 YMAPEVLDET-----IQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237

Query: 275 -VQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSP 333
              P   D   +V     +     P     D  L  L   M +           C   +P
Sbjct: 238 PNDPSFEDMRKVV--CVDQQRPNIPNRWFSDPTLTSLAKLMKE-----------CWYQNP 284

Query: 334 AERPTMKEVVALLME 348
           + R T   +   L +
Sbjct: 285 SARLTALRIKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (423), Expect = 1e-48
 Identities = 76/321 (23%), Positives = 130/321 (40%), Gaps = 56/321 (17%)

Query: 63  ILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH 122
           I   +  +  IGKG  G V++ +   GE +AVK        EE      AEI     +RH
Sbjct: 40  IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH 95

Query: 123 RNIVKLLGYCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAY 178
            NI+  +   +  +       L+ +Y  +G+L   L     +  E   K+A+ +A GLA+
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAH 154

Query: 179 LHHDCV-----PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH--AMSRVAGS 231
           LH + V     PAI HRD+K  NIL+       +AD GLA   +S       A +   G+
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

Query: 232 YGYIAPGKCKLQIIYGYTMNI-----TEKSDVYSYGVVLLEILSGRSA------------ 274
             Y+AP     +++   ++N+      +++D+Y+ G+V  EI    S             
Sbjct: 215 KRYMAP-----EVLDD-SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 275 ----VQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN 330
                 P + +   +V   ++K+    P        L+ +   M +           C  
Sbjct: 269 DLVPSDPSVEEMRKVV--CEQKLRPNIPNRWQSCEALRVMAKIMRE-----------CWY 315

Query: 331 SSPAERPTMKEVVALLMEVKS 351
           ++ A R T   +   L ++  
Sbjct: 316 ANGAARLTALRIKKTLSQLSQ 336

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (341), Expect = 2e-37
 Identities = 59/282 (20%), Positives = 116/282 (41%), Gaps = 37/282 (13%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           LK +  IG+G    VYK  +      +A  +L   K  +     F  E ++L  ++H NI
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 126 VKLLGYCSNKSVKLLLYN----YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH 181
           V+      +              +++G L+  L+  + +  +          +GL +L H
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL-H 146

Query: 182 DCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
              P I+HRD+KC+NI +        + D GLA L  ++        V G+  ++AP   
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP--- 199

Query: 241 KLQIIY-GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
             ++    Y     E  DVY++G+ +LE+ +     +    +  +  +  ++     +PA
Sbjct: 200 --EMYEEKY----DESVDVYAFGMCMLEMATS----EYPYSECQNAAQIYRRVTSGVKPA 249

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE 341
                     +    V+E+++       C+  +  ER ++K+
Sbjct: 250 ------SFDKVAIPEVKEIIEG------CIRQNKDERYSIKD 279

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  136 bits (344), Expect = 6e-37
 Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 56/304 (18%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
           E L     IG+G  G V+   +      +AVK   +T   +     F  E +IL    H 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHP 172

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLH-H 181
           NIV+L+G C+ K    ++   +  G+    L+     L  +T  ++   +A G+ YL   
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
            C+    HRD+   N L+  K    ++DFG+++      Y              + G  +
Sbjct: 233 CCI----HRDLAARNCLVTEKNVLKISDFGMSREEADGVY------------AASGGLRQ 276

Query: 242 L--------QIIYG-YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWVKK 291
           +         + YG Y+     +SDV+S+G++L E  S      P          E+V+K
Sbjct: 277 VPVKWTAPEALNYGRYSS----ESDVWSFGILLWETFSL--GASPYPNLSNQQTREFVEK 330

Query: 292 --KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             ++              +  PD + + M Q       C    P +RP+   +   L  +
Sbjct: 331 GGRL-----------PCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQSI 372

Query: 350 KSAP 353
           +   
Sbjct: 373 RKRH 376

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  133 bits (336), Expect = 1e-35
 Identities = 54/282 (19%), Positives = 103/282 (36%), Gaps = 35/282 (12%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH--RNIVKL 128
             IG G S  V++      ++ A+K +   + D + +DS+  EI  L  ++     I++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAI 187
             Y       + +     N +L   L+  +++D   R        + +  +H H     I
Sbjct: 122 YDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----I 176

Query: 188 LHRDVKCNNILLDS---KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKC 240
           +H D+K  N L+     K    L DFG+A  M             G+  Y+ P       
Sbjct: 177 VHSDLKPANFLIVDGMLK----LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
             +        I+ KSDV+S G +L  +  G+          ++ +  +   +       
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIINQISKLHAIIDPNHEIE 288

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                     PD   +++   L       +  P +R ++ E+
Sbjct: 289 ---------FPDIPEKDLQDVL-KCCLKRD--PKQRISIPEL 318

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  130 bits (329), Expect = 1e-35
 Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 38/281 (13%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IG G  G   K     +G+++  K+L      E       +E+ +L  ++H NIV+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 131 -YCSNKSVKLLLY-NYISNGNLQQLL----QGNRNLDWETRYKIAVGSAQGLAYLH--HD 182
                 +  L +   Y   G+L  ++    +  + LD E   ++       L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               +LHRD+K  N+ LD K    L DFGLA+++N      A + V G+  Y++P +   
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFV-GTPYYMSPEQMNR 190

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK-KMGSFEPAVS 301
                Y     EKSD++S G +L E+ +                E   K + G F     
Sbjct: 191 M---SY----NEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGKIREGKFRR--- 235

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                   +P +   E L  +   M  +      RP+++E+
Sbjct: 236 --------IPYRYSDE-LNEIITRMLNLK--DYHRPSVEEI 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  131 bits (331), Expect = 1e-35
 Identities = 54/282 (19%), Positives = 104/282 (36%), Gaps = 35/282 (12%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKL 128
             IG G S  V++      ++ A+K +   + D + +DS+  EI  L  ++  +  I++L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAI 187
             Y       + +     N +L   L+  +++D   R        + +  +H H     I
Sbjct: 94  YDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----I 148

Query: 188 LHRDVKCNNILLDS---KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKC 240
           +H D+K  N L+     K    L DFG+A  M             G+  Y+ P       
Sbjct: 149 VHSDLKPANFLIVDGMLK----LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
             +        I+ KSDV+S G +L  +  G+          ++ +  +   +       
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIINQISKLHAIIDPNHEIE 260

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                     PD   +++   L       +  P +R ++ E+
Sbjct: 261 ---------FPDIPEKDLQDVL-KCCLKRD--PKQRISIPEL 290

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  130 bits (330), Expect = 1e-35
 Identities = 70/305 (22%), Positives = 117/305 (38%), Gaps = 51/305 (16%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMP-----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
             LK    +G+G  G V            GE +AVK L          D    EI+IL +
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRN 79

Query: 120 IRHRNIVKLLGYCSNKSVK--LLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGL 176
           + H NIVK  G C+        L+  ++ +G+L++ L  N+  ++ + + K AV   +G+
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 177 AYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
            YL     V    HRD+   N+L++S+++  + DFGL K + +               Y 
Sbjct: 140 DYLGSRQYV----HRDLAARNVLVESEHQVKIGDFGLTKAIET-----------DKEYYT 184

Query: 236 APGKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIV 286
                           ++          SDV+S+GV L E+L+   S   P       I 
Sbjct: 185 VKDDRDSPVFWYAPECLMQS---KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

Query: 287 EWVKKKMGSFEPAVSILDT-----KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE 341
                +M      V+ L            PD++ Q M +       C    P+ R + + 
Sbjct: 242 PT-HGQMTVTR-LVNTLKEGKRLPCPPNCPDEVYQLMRK-------CWEFQPSNRTSFQN 292

Query: 342 VVALL 346
           ++   
Sbjct: 293 LIEGF 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  131 bits (332), Expect = 2e-35
 Identities = 57/282 (20%), Positives = 104/282 (36%), Gaps = 35/282 (12%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH--RNIVKL 128
             IG G S  V++      ++ A+K +   + D + +DS+  EI  L  ++     I++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAI 187
             Y       + +     N +L   L+  +++D   R        + +  +H H     I
Sbjct: 75  YDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----I 129

Query: 188 LHRDVKCNNILLDS---KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKC 240
           +H D+K  N L+     K    L DFG+A  M             G+  Y+ P       
Sbjct: 130 VHSDLKPANFLIVDGMLK----LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
             +        I+ KSDV+S G +L  +  G++   P       I +       + E   
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT---PFQQIINQISKLHAIIDPNHEIE- 241

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                     PD   +++   L       +  P +R ++ E+
Sbjct: 242 ---------FPDIPEKDLQDVL-KCCLKRD--PKQRISIPEL 271

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  131 bits (332), Expect = 2e-35
 Identities = 63/275 (22%), Positives = 117/275 (42%), Gaps = 35/275 (12%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IG+G  G     +   +G    +K++  ++   +  +    E+ +L +++H NIV+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 131 YCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                    ++ +Y   G+L + +  Q       +      V     L ++H      IL
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKIL 147

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  NI L       L DFG+A+++NST    A + + G+  Y++P  C+ +    Y
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACI-GTPYYLSPEICENK---PY 202

Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK-KMGSFEPAVSILDTKL 307
                 KSD+++ G VL E+ + + A      +   +   V K   GSF P         
Sbjct: 203 ----NNKSDIWALGCVLYELCTLKHAF-----EAGSMKNLVLKIISGSFPP--------- 244

Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             +      + L++L   +F  N  P +RP++  +
Sbjct: 245 --VSLHYSYD-LRSLVSQLFKRN--PRDRPSVNSI 274

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  132 bits (334), Expect = 5e-35
 Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 42/296 (14%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 240

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLH-H 181
           +V+L    S + +  ++  Y+S G+L   L+G     L       +A   A G+AY+   
Sbjct: 241 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY-HHAMSRVAGSYGYIAPGKC 240
           + V    HRD++  NIL+       +ADFGLA+L+    Y     ++      + AP   
Sbjct: 300 NYV----HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPE-- 351

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK--KMGSFEP 298
               +YG     T KSDV+S+G++L E+ +      P +     +++ V++  +M     
Sbjct: 352 --AALYG---RFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM----- 400

Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                       P+ +   M Q       C    P ERPT + + A L +  ++ E
Sbjct: 401 ------PCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTE 443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  133 bits (336), Expect = 7e-35
 Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 42/296 (14%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L   K      ++F  E Q++  +RH  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 323

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLH-H 181
           +V+L    S + +  ++  Y+S G+L   L+G     L       +A   A G+AY+   
Sbjct: 324 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY-HHAMSRVAGSYGYIAPGKC 240
           + V    HRD++  NIL+       +ADFGLA+L+    Y     ++      + AP   
Sbjct: 383 NYV----HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPE-- 434

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK--KMGSFEP 298
               +YG     T KSDV+S+G++L E+ +      P +     +++ V++  +M     
Sbjct: 435 --AALYG---RFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM----- 483

Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                       P+ +   M Q       C    P ERPT + + A L +  ++ E
Sbjct: 484 ------PCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTE 526

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  129 bits (326), Expect = 7e-35
 Identities = 74/360 (20%), Positives = 125/360 (34%), Gaps = 80/360 (22%)

Query: 24  HRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYK 83
           H +       +  L  G  D   P  F                LK    +G+G  G V  
Sbjct: 5   HHHHHHHHGALEVLFQGPGD---PTVFHK------------RYLKKIRDLGEGHFGKVSL 49

Query: 84  AEMPN-----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK 138
                     GE++AVK L K     +    +  EI IL  + H +I+K  G C +    
Sbjct: 50  YCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108

Query: 139 --LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAILHRDVKCN 195
              L+  Y+  G+L+  L  +  +        A    +G+AYLH    +    HRD+   
Sbjct: 109 SLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYI----HRDLAAR 163

Query: 196 NILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL--------QIIYG 247
           N+LLD+     + DFGLAK +   + +           Y                 +   
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEY-----------YRVREDGDSPVFWYAPECLKEY 212

Query: 248 -YTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT 305
            +       SDV+S+GV L E+L+   S+  P             + +G  +  +++L  
Sbjct: 213 KFYY----ASDVWSFGVTLYELLTHCDSSQSPPTK--------FLELIGIAQGQMTVLRL 260

Query: 306 -----------KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                      +    P ++   M         C  +  + RPT + ++ +L  V    +
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKN-------CWETEASFRPTFENLIPILKTVHEKYQ 313

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  128 bits (323), Expect = 2e-34
 Identities = 65/328 (19%), Positives = 123/328 (37%), Gaps = 69/328 (21%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           +      ++GKG  G V +A++   +     +AVK L         ++ F  E   +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 121 RHRNIVKLLGYCS------NKSVKLLLYNYISNGNLQQLLQGNR------NLDWETRYKI 168
            H ++ KL+G            + +++  ++ +G+L   L  +R      NL  +T  + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
            V  A G+ YL   + +    HRD+   N +L       +ADFGL++ + S +Y      
Sbjct: 143 MVDIACGMEYLSSRNFI----HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY------ 192

Query: 228 VAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
                 Y      KL         +    Y    T  SDV+++GV + EI++      P 
Sbjct: 193 ------YRQGCASKLPVKWLALESLADNLY----TVHSDVWAFGVTMWEIMTR--GQTPY 240

Query: 279 IG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
            G +   I  ++    ++            +     +++   M Q       C ++ P +
Sbjct: 241 AGIENAEIYNYLIGGNRL-----------KQPPECMEEVYDLMYQ-------CWSADPKQ 282

Query: 336 RPTMKEVVALLMEVKSAPEELGKTSQPL 363
           RP+   +   L  +      L  +  PL
Sbjct: 283 RPSFTCLRMELENILGHLSVLSTSQDPL 310

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  131 bits (330), Expect = 3e-34
 Identities = 70/297 (23%), Positives = 130/297 (43%), Gaps = 42/297 (14%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
             +  ++ +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 276

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLH- 180
           N+V+LLG C+ +    ++  +++ GNL   L+      +       +A   +  + YL  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY-HHAMSRVAGSYGYIAPGK 239
            + +    HR++   N L+   +   +ADFGL++LM    Y  HA ++      + AP  
Sbjct: 337 KNFI----HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE- 389

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK--KMGSFE 297
               + Y      + KSDV+++GV+L EI +   +  P I D   + E ++K  +M    
Sbjct: 390 ---SLAYN---KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRM---- 438

Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                   + +G P+++ + M         C   +P++RP+  E+      +     
Sbjct: 439 -------ERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFETMFQESS 481

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  127 bits (321), Expect = 3e-34
 Identities = 64/321 (19%), Positives = 124/321 (38%), Gaps = 70/321 (21%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
             L    ++G+G  G V +  +   +     +AVK +      +  ++ F +E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYI-----SNGNLQQLLQGNR------NLDWETRYKIA 169
            H N+++LLG C   S + +    +       G+L   L  +R      ++  +T  K  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 170 VGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           V  A G+ YL + + +    HRD+   N +L       +ADFGL+K + S +Y       
Sbjct: 154 VDIALGMEYLSNRNFL----HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY------- 202

Query: 229 AGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ 278
                Y      K+         +    Y    T KSDV+++GV + EI + G     P 
Sbjct: 203 -----YRQGRIAKMPVKWIAIESLADRVY----TSKSDVWAFGVTMWEIATRGM---TPY 250

Query: 279 IG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
            G     + +++    ++            + +   D++ + M         C  + P +
Sbjct: 251 PGVQNHEMYDYLLHGHRL-----------KQPEDCLDELYEIMYS-------CWRTDPLD 292

Query: 336 RPTMKEVVALLMEVKSAPEEL 356
           RPT   +   L ++  +  ++
Sbjct: 293 RPTFSVLRLQLEKLLESLPDV 313

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  126 bits (319), Expect = 5e-34
 Identities = 68/322 (21%), Positives = 126/322 (39%), Gaps = 69/322 (21%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMP-----NGELIAVKKLWKTKRD-EEPVDSFAAEIQILG 118
             LK    +GKG  G V            GE++AVKKL   +   EE +  F  EI+IL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILK 66

Query: 119 HIRHRNIVKLLGYCSNKSVK--LLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQG 175
            ++H NIVK  G C +   +   L+  Y+  G+L+  LQ ++  +D     +      +G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 176 LAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           + YL     +    HRD+   NIL++++    + DFGL K++                 +
Sbjct: 127 MEYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-----------F 171

Query: 235 IAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
                 +          +    +++     SDV+S+GVVL E+ +          +    
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSV----ASDVWSFGVVLYELFTY--------IEKSKS 219

Query: 286 VEWVKKKMGSFEPAVSILDTKL-------------QGLPDQMVQEMLQTLGIAMFCVNSS 332
                 +M   +    ++   L              G PD++   M +       C N++
Sbjct: 220 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE-------CWNNN 272

Query: 333 PAERPTMKEVVALLMEVKSAPE 354
             +RP+ +++   + +++    
Sbjct: 273 VNQRPSFRDLALRVDQIRDNMA 294

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  127 bits (322), Expect = 7e-34
 Identities = 70/306 (22%), Positives = 118/306 (38%), Gaps = 52/306 (16%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPNGE----LIAVKKLWKTKRDEEPVDSFAA 112
           +  I      +    VIG+G  G VY   + + +      AVK L     D   V  F  
Sbjct: 81  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT 139

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLL-YNYISNGNLQQLLQGNR-NLDWETRYKIAV 170
           E  I+    H N++ LLG C       L+   Y+ +G+L+  ++    N   +      +
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 171 GSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
             A+G+ +L     V    HRD+   N +LD K+   +ADFGLA+ M    +        
Sbjct: 200 QVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEF-------- 247

Query: 230 GSYGYIAPGKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG- 280
                      KL         +        T KSDV+S+GV+L E+++      P    
Sbjct: 248 --DSVHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTR--GAPPYPDV 300

Query: 281 DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK 340
           +   I  ++ +           L  + +  PD + + ML+       C +     RP+  
Sbjct: 301 NTFDITVYLLQGR--------RLL-QPEYCPDPLYEVMLK-------CWHPKAEMRPSFS 344

Query: 341 EVVALL 346
           E+V+ +
Sbjct: 345 ELVSRI 350

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  126 bits (318), Expect = 7e-34
 Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 52/306 (16%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEM--PNGELI--AVKKLWKTKRDEEPVDSFAA 112
           +  I      +    VIG+G  G VY   +   +G+ I  AVK L     D   V  F  
Sbjct: 17  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT 75

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLL-LYNYISNGNLQQLLQGNR-NLDWETRYKIAV 170
           E  I+    H N++ LLG C       L +  Y+ +G+L+  ++    N   +      +
Sbjct: 76  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 135

Query: 171 GSAQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
             A+G+ YL     V    HRD+   N +LD K+   +ADFGLA+ M    Y+   ++  
Sbjct: 136 QVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191

Query: 230 GSYGYIAPGKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG- 280
                      KL         +        T KSDV+S+GV+L E+++      P    
Sbjct: 192 A----------KLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTR--GAPPYPDV 236

Query: 281 DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK 340
           +   I  ++ +           L  + +  PD + + ML+       C +     RP+  
Sbjct: 237 NTFDITVYLLQGR--------RLL-QPEYCPDPLYEVMLK-------CWHPKAEMRPSFS 280

Query: 341 EVVALL 346
           E+V+ +
Sbjct: 281 ELVSRI 286

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  126 bits (319), Expect = 1e-33
 Identities = 78/319 (24%), Positives = 125/319 (39%), Gaps = 64/319 (20%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMP-----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
             LK  + +GKG  G V            G L+AVK+L +    ++  D F  EIQIL  
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRD-FQREIQILKA 80

Query: 120 IRHRNIVKLLGYCSNKSVK--LLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGL 176
           +    IVK  G       +   L+  Y+ +G L+  LQ +R  LD       +    +G+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 177 AYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM-NSTNYHHAMSRVAGSYGY 234
            YL    CV    HRD+   NIL++S+    +ADFGLAKL+    +Y            Y
Sbjct: 141 EYLGSRRCV----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDY------------Y 184

Query: 235 IAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLH 284
           +     +          +    ++     +SDV+S+GVVL E+ +      +        
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSR----QSDVWSFGVVLYELFTYCD---KSCSPSAEF 237

Query: 285 IVEWVKKKMGSFEPAVSILDTKLQ---------GLPDQMVQEMLQTLGIAMFCVNSSPAE 335
           +     ++     PA+S L   L+           P ++ + M         C   SP +
Sbjct: 238 LRMMGCERDV---PALSRLLELLEEGQRLPAPPACPAEVHELMKL-------CWAPSPQD 287

Query: 336 RPTMKEVVALLMEVKSAPE 354
           RP+   +   L  + S   
Sbjct: 288 RPSFSALGPQLDMLWSGSR 306

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  125 bits (316), Expect = 1e-33
 Identities = 74/308 (24%), Positives = 125/308 (40%), Gaps = 54/308 (17%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM---PNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
                + VIGKG  GVVY  E        +  A+K L +    ++    F  E  ++  +
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGL 79

Query: 121 RHRNIVKLLGYCS-NKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAY 178
            H N++ L+G     + +  +L  Y+ +G+L Q ++  + N   +      +  A+G+ Y
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 179 L-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           L     V    HRD+   N +LD  +   +ADFGLA+ +    Y          Y     
Sbjct: 140 LAEQKFV----HRDLAARNCMLDESFTVKVADFGLARDILDREY----------YSVQQH 185

Query: 238 GKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVE 287
              +L         +        T KSDV+S+GV+L E+L+ G     P    D   +  
Sbjct: 186 RHARLPVKWTALESLQTYR---FTTKSDVWSFGVLLWELLTRGA---PPYRHIDPFDLTH 239

Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM 347
           ++ +           L  + +  PD + Q M Q       C  + PA RPT + +V  + 
Sbjct: 240 FLAQGR--------RLP-QPEYCPDSLYQVMQQ-------CWEADPAVRPTFRVLVGEVE 283

Query: 348 EVKSAPEE 355
           ++ SA   
Sbjct: 284 QIVSALLG 291

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  125 bits (316), Expect = 2e-33
 Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 35/278 (12%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLL 129
            IG+G    VY+A  + +G  +A+KK+      D +       EI +L  + H N++K  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 130 G-YCSNKSVKLLLYNYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
             +  +  + ++L      G+L ++++      R +   T +K  V     L ++H    
Sbjct: 99  ASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-- 155

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             ++HRD+K  N+ + +     L D GL +  +S     A S V G+  Y++P +     
Sbjct: 156 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLV-GTPYYMSPERIHEN- 211

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD 304
             GY      KSD++S G +L E+ + +S       +   + + +++    + P      
Sbjct: 212 --GY----NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPP------ 257

Query: 305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                LP     E L+ L       +  P +RP +  V
Sbjct: 258 -----LPSDHYSEELRQLVNMCINPD--PEKRPDVTYV 288

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  125 bits (315), Expect = 3e-33
 Identities = 67/328 (20%), Positives = 121/328 (36%), Gaps = 71/328 (21%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           + +     +G G  G VY+ ++           +AVK L +   +++ +D F  E  I+ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIIS 88

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY-------KIAVG 171
              H+NIV+ +G       + +L   ++ G+L+  L+  R    +           +A  
Sbjct: 89  KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148

Query: 172 SAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSR 227
            A G  YL  +  +    HRD+   N LL       +    DFG+A+ +   +Y      
Sbjct: 149 IACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY------ 198

Query: 228 VAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
                 Y   G   L          + G +T     K+D +S+GV+L EI S      P 
Sbjct: 199 ------YRKGGCAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIFS--LGYMPY 246

Query: 279 IG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
                  ++E+V    +M              +  P  + + M Q       C    P +
Sbjct: 247 PSKSNQEVLEFVTSGGRMD-----------PPKNCPGPVYRIMTQ-------CWQHQPED 288

Query: 336 RPTMKEVVALLMEVKSAPEELGKTSQPL 363
           RP    ++  +      P+ +  T+ P+
Sbjct: 289 RPNFAIILERIEYCTQDPDVI-NTALPI 315

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  125 bits (315), Expect = 4e-33
 Identities = 71/314 (22%), Positives = 127/314 (40%), Gaps = 58/314 (18%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--MPNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHI 120
             +  E +IG G SG V      +P    +  A+K L     + +  D F +E  I+G  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQF 107

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYL 179
            H NI++L G  +   + +++  Y+ NG+L   L+ +           +  G   G+ YL
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 180 -HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
                V    HRD+   N+L+DS     ++DFGL++++                      
Sbjct: 168 SDLGYV----HRDLAARNVLVDSNLVCKVSDFGLSRVLED-----------DPDAAYTTT 212

Query: 239 KCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEW 288
             K+         I +      +  SDV+S+GVV+ E+L+ G    +P        ++  
Sbjct: 213 GGKIPIRWTAPEAIAFR---TFSSASDVWSFGVVMWEVLAYGE---RPYWNMTNRDVISS 266

Query: 289 VKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           V++  ++               G P  + Q ML        C +   A+RP   ++V++L
Sbjct: 267 VEEGYRL-----------PAPMGCPHALHQLMLD-------CWHKDRAQRPRFSQIVSVL 308

Query: 347 MEVKSAPEELGKTS 360
             +  +PE L  T+
Sbjct: 309 DALIRSPESLRATA 322

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  124 bits (314), Expect = 4e-33
 Identities = 66/311 (21%), Positives = 122/311 (39%), Gaps = 61/311 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKA----EMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGH 119
              K   V+G G  G VYK     E    ++ +A+K+L +     +       E  ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73

Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAY 178
           + + ++ +LLG C   +V+L+    +  G L   ++ ++ N+  +      V  A+G+ Y
Sbjct: 74  VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 179 L-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           L     V    HRD+   N+L+ +     + DFGLAKL+ +               Y A 
Sbjct: 133 LEDRRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----------YHAE 177

Query: 238 GKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVE 287
           G  K+         I++      T +SDV+SYGV + E+++ G    +P  G     I  
Sbjct: 178 GG-KVPIKWMALESILHR---IYTHQSDVWSYGVTVWELMTFGS---KPYDGIPASEISS 230

Query: 288 WVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
            ++K  ++    P               +   M +       C       RP  +E++  
Sbjct: 231 ILEKGERLPQ--P---------PICTIDVYMIMRK-------CWMIDADSRPKFRELIIE 272

Query: 346 LMEVKSAPEEL 356
             ++   P+  
Sbjct: 273 FSKMARDPQRY 283

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  124 bits (313), Expect = 5e-33
 Identities = 70/323 (21%), Positives = 127/323 (39%), Gaps = 71/323 (21%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMP-----NGELIAVKKLWKTKRD-EEPVDSFAAEIQILG 118
             LK    +GKG  G V            GE++AVKKL   +   EE +  F  EI+IL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILK 97

Query: 119 HIRHRNIVKLLGYCSNKSVK--LLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQG 175
            ++H NIVK  G C +   +   L+  Y+  G+L+  LQ ++  +D     +      +G
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157

Query: 176 LAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM-NSTNYHHAMSRVAGSYG 233
           + YL     +    HRD+   NIL++++    + DFGL K++     Y            
Sbjct: 158 MEYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------------ 201

Query: 234 YIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH 284
           Y      +          +    +++     SDV+S+GVVL E+ +          +   
Sbjct: 202 YKVKEPGESPIFWYAPESLTESKFSV----ASDVWSFGVVLYELFTY--------IEKSK 249

Query: 285 IVEWVKKKMGSFEPAVSILDTKL-------------QGLPDQMVQEMLQTLGIAMFCVNS 331
                  +M   +    ++   L              G PD++   M +       C N+
Sbjct: 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE-------CWNN 302

Query: 332 SPAERPTMKEVVALLMEVKSAPE 354
           +  +RP+ +++   + +++    
Sbjct: 303 NVNQRPSFRDLALRVDQIRDQMA 325

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  122 bits (309), Expect = 8e-33
 Identities = 59/303 (19%), Positives = 112/303 (36%), Gaps = 58/303 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
             L     IG G  G+V+     N + +A+K +   +      + F  E +++  + H  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPK 64

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYL-HHD 182
           +V+L G C  ++   L+  ++ +G L   L+  R     ET   + +   +G+AYL    
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
            +    HRD+   N L+       ++DFG+ + +    Y              +    K 
Sbjct: 125 VI----HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------------TSSTGTKF 167

Query: 243 --------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKK- 291
                      +      + KSDV+S+GV++ E+ S G+    P        +VE +   
Sbjct: 168 PVKWASPEVFSFS---RYSSKSDVWSFGVLMWEVFSEGK---IPYENRSNSEVVEDISTG 221

Query: 292 -KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
            ++            K +     + Q M         C    P +RP    ++  L E+ 
Sbjct: 222 FRL-----------YKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAEIA 263

Query: 351 SAP 353
            + 
Sbjct: 264 ESG 266

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (310), Expect = 9e-33
 Identities = 75/312 (24%), Positives = 123/312 (39%), Gaps = 59/312 (18%)

Query: 52  PFQKLNFTIDNILECLK-DENVIGKGCSGVVYKAE--MPNGEL-IAVKKLWKTKRDEEPV 107
             +     +D   + L  ++  +G G  G V K    M      +AVK L     D    
Sbjct: 5   EIRPKEVYLDR--KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 62

Query: 108 DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK 167
           D   AE  ++  + +  IV+++G C  +S  L++      G L + LQ NR++  +   +
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICEAESWMLVME-MAELGPLNKYLQQNRHVKDKNIIE 121

Query: 168 IAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
           +    + G+ YL   + V    HRD+   N+LL +++ A ++DFGL+K + +        
Sbjct: 122 LVHQVSMGMKYLEESNFV----HRDLAARNVLLVTQHYAKISDFGLSKALRA-------- 169

Query: 227 RVAGSYGYIAPGKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQP 277
                  Y A    K          I Y      + KSDV+S+GV++ E  S G+   +P
Sbjct: 170 ---DENYYKAQTHGKWPVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQ---KP 220

Query: 278 QIG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPA 334
             G  G  +   ++K  +MG   P          G P +M   M         C      
Sbjct: 221 YRGMKGSEVTAMLEKGERMGC--P---------AGCPREMYDLMNL-------CWTYDVE 262

Query: 335 ERPTMKEVVALL 346
            RP    V   L
Sbjct: 263 NRPGFAAVELRL 274

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  126 bits (318), Expect = 9e-33
 Identities = 70/306 (22%), Positives = 136/306 (44%), Gaps = 60/306 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK E  +G G  G V+ A       +AVK +   K     V++F AE  ++  ++H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDK 244

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYL-HH 181
           +VKL    + + +  ++  +++ G+L   L+ +             +   A+G+A++   
Sbjct: 245 LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
           + +    HRD++  NIL+ +     +ADFGLA+++    Y              A    K
Sbjct: 304 NYI----HRDLRAANILVSASLVCKIADFGLARVIEDNEY-------------TAREGAK 346

Query: 242 LQI--------IYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKK 291
             I         +G   + T KSDV+S+G++L+EI++ GR    P  G     ++  +++
Sbjct: 347 FPIKWTAPEAINFG---SFTIKSDVWSFGILLMEIVTYGR---IPYPGMSNPEVIRALER 400

Query: 292 --KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             +M            + +  P+++   M++       C  + P ERPT + + ++L + 
Sbjct: 401 GYRM-----------PRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDDF 442

Query: 350 KSAPEE 355
            +A E 
Sbjct: 443 YTATES 448

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  122 bits (308), Expect = 2e-32
 Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 60/305 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYL-HH 181
           +V+L    + + +  ++  Y+ NG+L   L+      L       +A   A+G+A++   
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
           + +    HRD++  NIL+       +ADFGLA+L+    Y              A    K
Sbjct: 129 NYI----HRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------------TAREGAK 171

Query: 242 LQI--------IYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKK 291
             I         YG     T KSDV+S+G++L EI++ GR    P  G     +++ +++
Sbjct: 172 FPIKWTAPEAINYG---TFTIKSDVWSFGILLTEIVTHGR---IPYPGMTNPEVIQNLER 225

Query: 292 --KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             +M            +    P+++ Q M         C    P +RPT   + ++L + 
Sbjct: 226 GYRM-----------VRPDNCPEELYQLMRL-------CWKERPEDRPTFDYLRSVLEDF 267

Query: 350 KSAPE 354
            +A E
Sbjct: 268 FTATE 272

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (312), Expect = 2e-32
 Identities = 67/328 (20%), Positives = 120/328 (36%), Gaps = 71/328 (21%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           + +     +G G  G VY+ ++           +AVK L +   +++ +D F  E  I+ 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIIS 129

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY-------KIAVG 171
              H+NIV+ +G       + +L   ++ G+L+  L+  R    +           +A  
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189

Query: 172 SAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYL---ADFGLAKLMNSTNYHHAMSR 227
            A G  YL  +  +    HRD+   N LL       +    DFG+A+ +    Y      
Sbjct: 190 IACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY------ 239

Query: 228 VAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
                 Y   G   L          + G +T     K+D +S+GV+L EI S      P 
Sbjct: 240 ------YRKGGCAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIFS--LGYMPY 287

Query: 279 IG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
                  ++E+V    +M              +  P  + + M Q       C    P +
Sbjct: 288 PSKSNQEVLEFVTSGGRMD-----------PPKNCPGPVYRIMTQ-------CWQHQPED 329

Query: 336 RPTMKEVVALLMEVKSAPEELGKTSQPL 363
           RP    ++  +      P+ +  T+ P+
Sbjct: 330 RPNFAIILERIEYCTQDPDVI-NTALPI 356

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (310), Expect = 2e-32
 Identities = 82/341 (24%), Positives = 139/341 (40%), Gaps = 85/341 (24%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQI 116
           + L     +G+G  G V  AE              +AVK L     +++  D   +E+++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEM 93

Query: 117 LGHI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS--- 172
           +  I +H+NI+ LLG C+      ++  Y S GNL++ L+  R    E  Y I       
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153

Query: 173 -------------AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS 218
                        A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 219 TNYHHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEIL 269
            +Y            Y      +L         +    YT     +SDV+S+GV++ EI 
Sbjct: 210 IDY------------YKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIF 253

Query: 270 S-GRSAVQPQIG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIA 325
           + G     P  G     + + +K+  +M            K     +++   M       
Sbjct: 254 TLGG---SPYPGIPVEELFKLLKEGHRM-----------DKPANCTNELYMMMRD----- 294

Query: 326 MFCVNSSPAERPTMKEVVALL---MEVKSAPEELGKTSQPL 363
             C ++ P++RPT K++V  L   + + +  E L   SQPL
Sbjct: 295 --CWHAVPSQRPTFKQLVEDLDRILTLTTNEEYL-DLSQPL 332

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  121 bits (307), Expect = 2e-32
 Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 57/308 (18%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--MPNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           E +    ++G+G  G VY+       GE I  AVK   K     +  + F +E  I+ ++
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNL 70

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYL 179
            H +IVKL+G    +   +++      G L   L+ N+N L   T    ++   + +AYL
Sbjct: 71  DHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129

Query: 180 -HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
              +CV    HRD+   NIL+ S     L DFGL++ +   +Y+ A              
Sbjct: 130 ESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA-------------S 172

Query: 239 KCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEW 288
             +L         I +      T  SDV+ + V + EILS G+   QP    +   ++  
Sbjct: 173 VTRLPIKWMSPESINFR---RFTTASDVWMFAVCMWEILSFGK---QPFFWLENKDVIGV 226

Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           ++K  G   P       K    P  +   M +       C +  P++RP   E+V  L +
Sbjct: 227 LEK--GDRLP-------KPDLCPPVLYTLMTR-------CWDYDPSDRPRFTELVCSLSD 270

Query: 349 VKSAPEEL 356
           V    +++
Sbjct: 271 VYQMEKDI 278

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (307), Expect = 2e-32
 Identities = 60/297 (20%), Positives = 109/297 (36%), Gaps = 57/297 (19%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G+G  GVV++A+   +    A+K++ +    E   +    E++ L  + H  IV+   
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 131 -------YCSNKSVKLLLYNYI-----SNGNLQQLLQGNRNL---DWETRYKIAVGSAQG 175
                      +     +Y YI        NL+  + G   +   +      I +  A+ 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG-- 233
           + +LH      ++HRD+K +NI         + DFGL   M+       +     +Y   
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 234 --------YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
                   Y++P     + I+G   + + K D++S G++L E+L       P       +
Sbjct: 188 TGQVGTKLYMSP-----EQIHG--NSYSHKVDIFSLGLILFELL------YPFSTQMERV 234

Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                 +   F P  +            MVQ+ML            SP ERP    +
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEY----VMVQDMLSP----------SPMERPEAINI 277

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  122 bits (308), Expect = 2e-32
 Identities = 75/319 (23%), Positives = 125/319 (39%), Gaps = 76/319 (23%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
             L     +G G  G V +A             +AVK L  +    E      +E+++L 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLS 81

Query: 119 HI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS----- 172
           ++  H NIV LLG C+     L++  Y   G+L   L+  R+    ++   A+       
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 173 -------------AQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS 218
                        A+G+A+L   +C+    HRD+   NILL       + DFGLA+ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 219 TNYHHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEIL 269
            +             Y+  G  +L         I    YT     +SDV+SYG+ L E+ 
Sbjct: 198 DSN------------YVVKGNARLPVKWMAPESIFNCVYTF----ESDVWSYGIFLWELF 241

Query: 270 SGRSAVQPQIGDGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMF 327
           S  S+  P +       + +K+  +M              +  P +M   M         
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRM-----------LSPEHAPAEMYDIMKT------- 283

Query: 328 CVNSSPAERPTMKEVVALL 346
           C ++ P +RPT K++V L+
Sbjct: 284 CWDADPLKRPTFKQIVQLI 302

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  121 bits (306), Expect = 3e-32
 Identities = 63/309 (20%), Positives = 120/309 (38%), Gaps = 61/309 (19%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
            +IG G  G V+KA+   +G+   +K++       E       E++ L  + H NIV   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDHVNIVHYN 70

Query: 130 GY-------------CSNKSVKLLLY---NYISNGNLQQLL--QGNRNLDWETRYKIAVG 171
           G               S++S    L+    +   G L+Q +  +    LD     ++   
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
             +G+ Y+H      +++RD+K +NI L    +  + DFGL   + +       +R  G+
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGT 184

Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             Y++P +   Q    Y     ++ D+Y+ G++L E+L                  +   
Sbjct: 185 LRYMSPEQISSQ---DY----GKEVDLYALGLILAELLHVCDT--AFETSKF----FTDL 231

Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
           + G           K + L    +Q++L             P +RP   E++  L   K 
Sbjct: 232 RDGIISDIFD---KKEKTL----LQKLLSK----------KPEDRPNTSEILRTLTVWKK 274

Query: 352 APEELGKTS 360
           +PE+  + +
Sbjct: 275 SPEKNERHT 283

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (307), Expect = 3e-32
 Identities = 75/323 (23%), Positives = 131/323 (40%), Gaps = 75/323 (23%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
             +  +  +G+G  G V+ AE  N        L+AVK L K        D F  E ++L 
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKD-FQREAELLT 72

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY------------ 166
           +++H +IVK  G C +    ++++ Y+ +G+L + L+ +                     
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 167 ----KIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY 221
                IA   A G+ YL     V    HRD+   N L+ +     + DFG+++ + ST+Y
Sbjct: 133 SQMLHIASQIASGMVYLASQHFV----HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 222 HHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS-G 271
                       Y   G   L         I+Y  +T     +SDV+S+GV+L EI + G
Sbjct: 189 ------------YRVGGHTMLPIRWMPPESIMYRKFTT----ESDVWSFGVILWEIFTYG 232

Query: 272 RSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN 330
           +   QP        ++E + +          +L+ + +  P ++   ML        C  
Sbjct: 233 K---QPWFQLSNTEVIECITQG--------RVLE-RPRVCPKEVYDVMLG-------CWQ 273

Query: 331 SSPAERPTMKEVVALLMEVKSAP 353
             P +R  +KE+  +L  +  A 
Sbjct: 274 REPQQRLNIKEIYKILHALGKAT 296

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  121 bits (305), Expect = 4e-32
 Identities = 55/296 (18%), Positives = 114/296 (38%), Gaps = 58/296 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           + L     +G G  GVV   +      +A+K +   K      D F  E +++ ++ H  
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEK 80

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYL-HHD 182
           +V+L G C+ +    ++  Y++NG L   L+  R     +   ++     + + YL    
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
            +    HRD+   N L++ +    ++DFGL++ +    Y              +    K 
Sbjct: 141 FL----HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------------TSSVGSKF 183

Query: 243 --------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKK- 291
                    ++Y      + KSD++++GV++ EI S G+    P          E + + 
Sbjct: 184 PVRWSPPEVLMYS---KFSSKSDIWAFGVLMWEIYSLGK---MPYERFTNSETAEHIAQG 237

Query: 292 -KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            ++            +     +++   M         C +    ERPT K +++ +
Sbjct: 238 LRL-----------YRPHLASEKVYTIMYS-------CWHEKADERPTFKILLSNI 275

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  122 bits (308), Expect = 4e-32
 Identities = 75/324 (23%), Positives = 131/324 (40%), Gaps = 74/324 (22%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
             +  +  +G+G  G V+ AE  N        L+AVK L K   +    D F  E ++L 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD-FQREAELLT 98

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY------------ 166
            ++H++IV+  G C+     L+++ Y+ +G+L + L+ +                     
Sbjct: 99  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 167 ---KIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
               +A   A G+ YL     V    HRD+   N L+       + DFG+++ + ST+Y 
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFV----HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY- 213

Query: 223 HAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS-GR 272
                      Y   G+  L         I+Y  +T     +SDV+S+GVVL EI + G+
Sbjct: 214 -----------YRVGGRTMLPIRWMPPESILYRKFTT----ESDVWSFGVVLWEIFTYGK 258

Query: 273 SAVQPQIG-DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNS 331
              QP         ++ + +           L+ + +  P ++   M         C   
Sbjct: 259 ---QPWYQLSNTEAIDCITQG--------RELE-RPRACPPEVYAIMRG-------CWQR 299

Query: 332 SPAERPTMKEVVALLMEVKSAPEE 355
            P +R ++K+V A L  +  AP  
Sbjct: 300 EPQQRHSIKDVHARLQALAQAPPV 323

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  120 bits (304), Expect = 4e-32
 Identities = 63/296 (21%), Positives = 115/296 (38%), Gaps = 58/296 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E +     +G G  GVV   +      +AVK +   K      D F  E Q +  + H  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPK 64

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYL-HHD 182
           +VK  G CS +    ++  YISNG L   L+ +   L+     ++     +G+A+L  H 
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
            +    HRD+   N L+D      ++DFG+ + +    Y             ++    K 
Sbjct: 125 FI----HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-------------VSSVGTKF 167

Query: 243 --------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKK- 291
                      Y      + KSDV+++G+++ E+ S G+    P        +V  V + 
Sbjct: 168 PVKWSAPEVFHYF---KYSSKSDVWAFGILMWEVFSLGK---MPYDLYTNSEVVLKVSQG 221

Query: 292 -KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
            ++            +     D + Q M         C +  P +RPT +++++ +
Sbjct: 222 HRL-----------YRPHLASDTIYQIMYS-------CWHELPEKRPTFQQLLSSI 259

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  122 bits (309), Expect = 5e-32
 Identities = 78/332 (23%), Positives = 135/332 (40%), Gaps = 83/332 (25%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE--------LIAVKKLWKTKRDEEPVDSFAAEIQI 116
           + L     +G+GC G V  AE    +         +AVK L     +++  D   +E+++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEM 139

Query: 117 LGHI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY--------- 166
           +  I +H+NI+ LLG C+      ++  Y S GNL++ L+  R    E  Y         
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199

Query: 167 -------KIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS 218
                        A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ +N+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 219 TNYHHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEIL 269
            +Y            Y      +L         +    YT     +SDV+S+GV++ EI 
Sbjct: 256 IDY------------YKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIF 299

Query: 270 S-GRSAVQPQIG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIA 325
           + G     P  G     + + +K+  +M            K     +++   M       
Sbjct: 300 TLGG---SPYPGIPVEELFKLLKEGHRM-----------DKPANCTNELYMMMRD----- 340

Query: 326 MFCVNSSPAERPTMKEVVALL--MEVKSAPEE 355
             C ++ P++RPT K++V  L  +   +  EE
Sbjct: 341 --CWHAVPSQRPTFKQLVEDLDRILTLTTNEE 370

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  121 bits (306), Expect = 6e-32
 Identities = 70/312 (22%), Positives = 128/312 (41%), Gaps = 63/312 (20%)

Query: 65  ECLKDENVIGKGCSGVVYKA----EMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGH 119
             L+   V+G G  G V+K     E  + ++ + +K + + K   +   +    +  +G 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS 71

Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAY 178
           + H +IV+LLG C   S++L+   Y+  G+L   ++ +R  L  +      V  A+G+ Y
Sbjct: 72  LDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130

Query: 179 LH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           L  H  V    HR++   N+LL S  +  +ADFG+A L+   +              +  
Sbjct: 131 LEEHGMV----HRNLAARNVLLKSPSQVQVADFGVADLLPPDDK------------QLLY 174

Query: 238 GKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIV 286
            + K          I +G YT     +SDV+SYGV + E+++ G    +P  G     + 
Sbjct: 175 SEAKTPIKWMALESIHFGKYTH----QSDVWSYGVTVWELMTFGA---EPYAGLRLAEVP 227

Query: 287 EWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
           + ++K  ++            + Q     +   M++       C       RPT KE+  
Sbjct: 228 DLLEKGERL-----------AQPQICTIDVYMVMVK-------CWMIDENIRPTFKELAN 269

Query: 345 LLMEVKSAPEEL 356
               +   P   
Sbjct: 270 EFTRMARDPPRY 281

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  120 bits (303), Expect = 6e-32
 Identities = 70/309 (22%), Positives = 113/309 (36%), Gaps = 61/309 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--MPNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           E ++    IG+G  G V++     P    +  A+K       D      F  E   +   
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 73

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYL 179
            H +IVKL+G  +   V  ++    + G L+  LQ  + +LD  +    A   +  LAYL
Sbjct: 74  DHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 180 -HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
                V    HRD+   N+L+ S     L DFGL++ M  + Y+ A              
Sbjct: 133 ESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-------------S 175

Query: 239 KCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEW 288
           K KL         I +      T  SDV+ +GV + EIL  G    +P  G     ++  
Sbjct: 176 KGKLPIKWMAPESINFR---RFTSASDVWMFGVCMWEILMHGV---KPFQGVKNNDVIGR 229

Query: 289 VKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           ++   ++                 P  +   M +       C    P+ RP   E+ A L
Sbjct: 230 IENGERL-----------PMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQL 271

Query: 347 MEVKSAPEE 355
             +    + 
Sbjct: 272 STILEEEKA 280

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  121 bits (306), Expect = 6e-32
 Identities = 69/309 (22%), Positives = 124/309 (40%), Gaps = 66/309 (21%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           E +     +G+G  G+VY+              +A+K + +     E ++ F  E  ++ 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMK 83

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR----------NLDWETRYKI 168
                ++V+LLG  S     L++   ++ G+L+  L+  R                  ++
Sbjct: 84  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 169 AVGSAQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           A   A G+AYL+ +  V    HRD+   N ++   +   + DFG+ + +  T+Y      
Sbjct: 144 AGEIADGMAYLNANKFV----HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY------ 193

Query: 228 VAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
                 Y   GK  L         +  G +    T  SDV+S+GVVL EI +   A QP 
Sbjct: 194 ------YRKGGKGLLPVRWMSPESLKDGVF----TTYSDVWSFGVVLWEIAT--LAEQPY 241

Query: 279 IGDGLH-IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP 337
            G     ++ +V +          +LD K    PD + + M         C   +P  RP
Sbjct: 242 QGLSNEQVLRFVME--------GGLLD-KPDNCPDMLFELMRM-------CWQYNPKMRP 285

Query: 338 TMKEVVALL 346
           +  E+++ +
Sbjct: 286 SFLEIISSI 294

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  121 bits (305), Expect = 1e-31
 Identities = 78/316 (24%), Positives = 123/316 (38%), Gaps = 74/316 (23%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILG 118
             L+    +G G  G V +A             +AVK L  T   +E      +E++I+ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMS 104

Query: 119 HI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN--------------LDWE 163
           H+ +H NIV LLG C++    L++  Y   G+L   L+                      
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 164 TRYKIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
                +   AQG+A+L   +C+    HRDV   N+LL + + A + DFGLA+ + + +  
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN- 219

Query: 223 HAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS-GR 272
                      YI  G  +L         I    YT+    +SDV+SYG++L EI S G 
Sbjct: 220 -----------YIVKGNARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIFSLGL 264

Query: 273 SAVQPQIGDGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN 330
           +   P I       + VK   +M            +    P  +   M         C  
Sbjct: 265 NPY-PGILVNSKFYKLVKDGYQM-----------AQPAFAPKNIYSIMQA-------CWA 305

Query: 331 SSPAERPTMKEVVALL 346
             P  RPT +++ + L
Sbjct: 306 LEPTHRPTFQQICSFL 321

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (302), Expect = 1e-31
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 19/207 (9%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           V+GKG  G+VY   ++ N   IA+K++   +RD         EI +  H++H+NIV+ LG
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86

Query: 131 YCSNKSVKLLLY-NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPA 186
              +++  + ++   +  G+L  LL+       +    I   + Q   GL YLH +    
Sbjct: 87  -SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142

Query: 187 ILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
           I+HRD+K +N+L+++      ++DFG +K +   N         G+  Y+AP     +II
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAP-----EII 195

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGR 272
                   + +D++S G  ++E+ +G+
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGK 222

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  120 bits (304), Expect = 1e-31
 Identities = 80/325 (24%), Positives = 131/325 (40%), Gaps = 79/325 (24%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHI- 120
             +K ++VIG+G  G V KA +    L    A+K++ +    ++  D FA E+++L  + 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLG 83

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY-------------- 166
            H NI+ LLG C ++    L   Y  +GNL   L+ +R L+ +  +              
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 167 --KIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH 223
               A   A+G+ YL     +    HRD+   NIL+   Y A +ADFGL++         
Sbjct: 144 LLHFAADVARGMDYLSQKQFI----HRDLAARNILVGENYVAKIADFGLSR---GQEV-- 194

Query: 224 AMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS-GRS 273
                     Y+     +L         + Y  YT      SDV+SYGV+L EI+S G  
Sbjct: 195 ----------YVKKTMGRLPVRWMAIESLNYSVYTT----NSDVWSYGVLLWEIVSLGG- 239

Query: 274 AVQPQIG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN 330
              P  G     + E + +  ++            K     D++   M Q       C  
Sbjct: 240 --TPYCGMTCAELYEKLPQGYRLE-----------KPLNCDDEVYDLMRQ-------CWR 279

Query: 331 SSPAERPTMKEVVALLMEVKSAPEE 355
             P ERP+  +++  L  +    + 
Sbjct: 280 EKPYERPSFAQILVSLNRMLEERKT 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  120 bits (303), Expect = 1e-31
 Identities = 57/303 (18%), Positives = 103/303 (33%), Gaps = 47/303 (15%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
              +G+G    V   E + +G   A+K++     +++  +    E  +     H NI++L
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRL 91

Query: 129 LGYCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRY------KIAVGSAQGLAY 178
           + YC  +        LL  +   G L   +   R  D            + +G  +GL  
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA-------GS 231
           +H        HRD+K  NILL  + +  L D G              +           +
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK 291
             Y AP    +     + + I E++DV+S G VL  ++ G     P              
Sbjct: 207 ISYRAPELFSV---QSHCV-IDERTDVWSLGCVLYAMMFGEG---PYDMVFQKGDSVALA 259

Query: 292 KMGSFE-PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
                  P      + L  L    +  M+         V+  P +RP +  +++ L  ++
Sbjct: 260 VQNQLSIPQSPRHSSALWQL----LNSMMT--------VD--PHQRPHIPLLLSQLEALQ 305

Query: 351 SAP 353
              
Sbjct: 306 PPA 308

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  119 bits (301), Expect = 2e-31
 Identities = 60/298 (20%), Positives = 118/298 (39%), Gaps = 56/298 (18%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           V+G+G  G V KA    +    A+KK+  T+       +  +E+ +L  + H+ +V+   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYA 69

Query: 131 ----------YCSNKSVKLLLY---NYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGL 176
                       +    K  L+    Y  NG L  L+   N N   +  +++     + L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA------------ 224
           +Y+H      I+HRD+K  NI +D      + DFGLAK ++ +                 
Sbjct: 130 SYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186

Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH 284
           ++   G+  Y+A         Y       EK D+YS G++  E++   S       + ++
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYN------EKIDMYSLGIIFFEMIYPFSTGM----ERVN 236

Query: 285 IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           I++ ++     F P       K++    ++++ ++             P +RP  + +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEK---KIIRLLIDH----------DPNKRPGARTL 281

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  118 bits (299), Expect = 3e-31
 Identities = 71/306 (23%), Positives = 126/306 (41%), Gaps = 60/306 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
             +  ++ +G G  G VY+       L +AVK L   K D   V+ F  E  ++  I+H 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 69

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYL-H 180
           N+V+LLG C+ +    ++  +++ GNL   L+      +       +A   +  + YL  
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            + +    HRD+   N L+   +   +ADFGL++LM   +             Y A    
Sbjct: 130 KNFI----HRDLAARNCLVGENHLVKVADFGLSRLMT-GDT------------YTAHAGA 172

Query: 241 KLQI--------IYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVK 290
           K  I         Y      + KSDV+++GV+L EI + G     P  G D   + E ++
Sbjct: 173 KFPIKWTAPESLAYN---KFSIKSDVWAFGVLLWEIATYGM---SPYPGIDLSQVYELLE 226

Query: 291 K--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           K  +M            + +G P+++ + M         C   +P++RP+  E+      
Sbjct: 227 KDYRM-----------ERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFET 268

Query: 349 VKSAPE 354
           +     
Sbjct: 269 MFQESS 274

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  119 bits (300), Expect = 3e-31
 Identities = 80/321 (24%), Positives = 122/321 (38%), Gaps = 81/321 (25%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           + LK    +G+G  G V +A+    +       +AVK L +     E      +E++IL 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILI 85

Query: 119 HI-RHRNIVKLLGYCSNKSVKLLL-YNYISNGNLQQLLQGNRNLDWETRYKIAVGS---- 172
           HI  H N+V LLG C+     L++   +   GNL   L+  RN     +           
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 173 ------------AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST 219
                       A+G+ +L    C+    HRD+   NILL  K    + DFGLA+ +   
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKD 201

Query: 220 NYHHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS 270
                         Y+  G  +L         I    YT+    +SDV+S+GV+L EI S
Sbjct: 202 PD------------YVRKGDARLPLKWMAPETIFDRVYTI----QSDVWSFGVLLWEIFS 245

Query: 271 -GRSAVQP--QIGDGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIA 325
            G     P   +         +K+  +M                   +M Q ML      
Sbjct: 246 LGA---SPYPGVKIDEEFCRRLKEGTRM-----------RAPDYTTPEMYQTMLD----- 286

Query: 326 MFCVNSSPAERPTMKEVVALL 346
             C +  P++RPT  E+V  L
Sbjct: 287 --CWHGEPSQRPTFSELVEHL 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  120 bits (303), Expect = 4e-31
 Identities = 76/330 (23%), Positives = 132/330 (40%), Gaps = 81/330 (24%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE--------LIAVKKLWKTKRDEEPVDSFAAEIQI 116
           + L     +G+G  G V  AE    +         +AVK L     +++  D   +E+++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEM 127

Query: 117 LGHI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS--- 172
           +  I +H+NI+ LLG C+      ++  Y S GNL++ LQ  R    E  Y  +      
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187

Query: 173 -------------AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS 218
                        A+G+ YL    C+    HRD+   N+L+       +ADFGLA+ ++ 
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHH 243

Query: 219 TNYHHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEIL 269
            +Y            Y      +L         +    YT     +SDV+S+GV+L EI 
Sbjct: 244 IDY------------YKKTTNGRLPVKWMAPEALFDRIYTH----QSDVWSFGVLLWEIF 287

Query: 270 S-GRSAVQPQIG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIA 325
           + G     P  G     + + +K+  +M            K     +++   M       
Sbjct: 288 TLGG---SPYPGVPVEELFKLLKEGHRM-----------DKPSNCTNELYMMMRD----- 328

Query: 326 MFCVNSSPAERPTMKEVVALLMEVKSAPEE 355
             C ++ P++RPT K++V  L  + +    
Sbjct: 329 --CWHAVPSQRPTFKQLVEDLDRIVALTSN 356

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (298), Expect = 4e-31
 Identities = 69/316 (21%), Positives = 121/316 (38%), Gaps = 74/316 (23%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
             ++    +G+   G VYK  +           +A+K L          + F  E  +  
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRA 67

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR----------------NLDW 162
            ++H N+V LLG  +      ++++Y S+G+L + L                     L+ 
Sbjct: 68  RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127

Query: 163 ETRYKIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY 221
                +    A G+ YL  H  V    H+D+   N+L+  K    ++D GL + + + +Y
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183

Query: 222 HHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVVLLEILS-G 271
                       Y   G   L         I+YG +++     SD++SYGVVL E+ S G
Sbjct: 184 ------------YKLLGNSLLPIRWMAPEAIMYGKFSI----DSDIWSYGVVLWEVFSYG 227

Query: 272 RSAVQPQIG-DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN 330
               QP  G     +VE ++ +         +L       P  +   M++       C N
Sbjct: 228 L---QPYCGYSNQDVVEMIRNR--------QVLP-CPDDCPAWVYALMIE-------CWN 268

Query: 331 SSPAERPTMKEVVALL 346
             P+ RP  K++ + L
Sbjct: 269 EFPSRRPRFKDIHSRL 284

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  119 bits (300), Expect = 5e-31
 Identities = 75/315 (23%), Positives = 129/315 (40%), Gaps = 55/315 (17%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--MPNGE---LIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
            C+  + VIG G  G VYK      +G+    +A+K L     +++ VD F  E  I+G 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQ 102

Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAY 178
             H NI++L G  S     +++  Y+ NG L + L+             +  G A G+ Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 179 L-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           L + + V    HRD+   NIL++S     ++DFGL++++                     
Sbjct: 163 LANMNYV----HRDLAARNILVNSNLVCKVSDFGLSRVLED-----------DPEATYTT 207

Query: 238 GKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVE 287
              K+         I Y      T  SDV+S+G+V+ E+++ G    +P        +++
Sbjct: 208 SGGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGE---RPYWELSNHEVMK 261

Query: 288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM 347
            +    G   P            P  + Q M+Q       C     A RP   ++V++L 
Sbjct: 262 AIND--GFRLP-------TPMDCPSAIYQLMMQ-------CWQQERARRPKFADIVSILD 305

Query: 348 EVKSAPEELGKTSQP 362
           ++  AP+ L   +  
Sbjct: 306 KLIRAPDSLKTLADF 320

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  120 bits (302), Expect = 5e-31
 Identities = 73/319 (22%), Positives = 124/319 (38%), Gaps = 54/319 (16%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--MPNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHI 120
             +  + V+G G  G V      +P+ + I  A+K L     +++  D F  E  I+G  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQF 103

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYL 179
            H NI++L G  +     +++  Y+ NG+L   L+ +           +  G A G+ YL
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 180 -HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
                V    HRD+   NIL++S     ++DFGL +++                      
Sbjct: 164 SDMGYV----HRDLAARNILINSNLVCKVSDFGLGRVLED-----------DPEAAYTTR 208

Query: 239 KCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEW 288
             K+         I Y      T  SDV+SYG+VL E++S G    +P        +++ 
Sbjct: 209 GGKIPIRWTSPEAIAYR---KFTSASDVWSYGIVLWEVMSYGE---RPYWEMSNQDVIKA 262

Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           V +  G   P            P  + Q ML        C       RP  +++V++L +
Sbjct: 263 VDE--GYRLP-------PPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSILDK 306

Query: 349 VKSAPEELGKTSQPLIKQS 367
           +   P  L   +    + S
Sbjct: 307 LIRNPGSLKIITSAAARPS 325

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  123 bits (309), Expect = 5e-31
 Identities = 64/308 (20%), Positives = 123/308 (39%), Gaps = 58/308 (18%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--MPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIR 121
             L  +  +G G  G V +    M   ++ +A+K L K   ++   +    E QI+  + 
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLD 394

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYL- 179
           +  IV+L+G C  +++ L++      G L + L G R  +      ++    + G+ YL 
Sbjct: 395 NPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 453

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
             + V    HR++   N+LL +++ A ++DFGL+K + + + +           Y A   
Sbjct: 454 EKNFV----HRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-----------YTARSA 498

Query: 240 CKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWV 289
            K          I +      + +SDV+SYGV + E LS G+   +P     G  ++ ++
Sbjct: 499 GKWPLKWYAPECINFR---KFSSRSDVWSYGVTMWEALSYGQ---KPYKKMKGPEVMAFI 552

Query: 290 KK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM 347
           ++  +M    P            P ++   M         C      +RP    V   + 
Sbjct: 553 EQGKRMEC--P---------PECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMR 594

Query: 348 EVKSAPEE 355
               +   
Sbjct: 595 ACYYSLAS 602

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  123 bits (309), Expect = 6e-31
 Identities = 71/305 (23%), Positives = 111/305 (36%), Gaps = 55/305 (18%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--MPNGELI--AVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           E ++    IG+G  G V++     P    +  A+K       D      F  E   +   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQF 448

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYL 179
            H +IVKL+G  +   V  ++    + G L+  LQ  +  LD  +    A   +  LAYL
Sbjct: 449 DHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507

Query: 180 H-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
                V    HRD+   N+L+ S     L DFGL++ M  + Y+ A              
Sbjct: 508 ESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-------------S 550

Query: 239 KCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG-DGLHIVEWV 289
           K KL         I +      T  SDV+ +GV + EIL     V+P  G     ++  +
Sbjct: 551 KGKLPIKWMAPESINFR---RFTSASDVWMFGVCMWEILMH--GVKPFQGVKNNDVIGRI 605

Query: 290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
           +            L       P  +   M +       C    P+ RP   E+ A L  +
Sbjct: 606 ENGE--------RLP-MPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLSTI 649

Query: 350 KSAPE 354
               +
Sbjct: 650 LEEEK 654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  117 bits (296), Expect = 7e-31
 Identities = 64/303 (21%), Positives = 122/303 (40%), Gaps = 58/303 (19%)

Query: 70  ENVIGKGCSGVVYKAE--MPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +  +G G  G V +    M   ++ +A+K L K   ++   +    E QI+  + +  IV
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYL-HHDCV 184
           +L+G C  +++ L++      G L + L G R  +      ++    + G+ YL   + V
Sbjct: 74  RLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL-- 242
               HRD+   N+LL +++ A ++DFGL+K + + + +           Y A    K   
Sbjct: 133 ----HRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----------YTARSAGKWPL 177

Query: 243 ------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKK--K 292
                  I +      + +SDV+SYGV + E LS G+   +P     G  ++ ++++  +
Sbjct: 178 KWYAPECINFR---KFSSRSDVWSYGVTMWEALSYGQ---KPYKKMKGPEVMAFIEQGKR 231

Query: 293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
           M    P            P ++   M         C      +RP    V   +     +
Sbjct: 232 MEC--P---------PECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMRACYYS 273

Query: 353 PEE 355
              
Sbjct: 274 LAS 276

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  118 bits (299), Expect = 7e-31
 Identities = 63/317 (19%), Positives = 120/317 (37%), Gaps = 61/317 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKA----EMPNGEL-IAVKKLWKTKRDEEPVDSFAAEIQILGH 119
              K   V+G G  G VYK     E    ++ +A+K+L +     +       E  ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73

Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAY 178
           + + ++ +LLG C   +V+L+    +  G L   ++ ++ N+  +      V  A+G+ Y
Sbjct: 74  VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 179 L-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
           L     V    HRD+   N+L+ +     + DFGLAKL+ +                   
Sbjct: 133 LEDRRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK------------EYHA 176

Query: 238 GKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVE 287
              K+         I++      T +SDV+SYGV + E+++ G    +P  G     I  
Sbjct: 177 EGGKVPIKWMALESILHR---IYTHQSDVWSYGVTVWELMTFGS---KPYDGIPASEISS 230

Query: 288 WVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
            ++K  ++    P               +   M++       C       RP  +E++  
Sbjct: 231 ILEKGERLPQ--P---------PICTIDVYMIMVK-------CWMIDADSRPKFRELIIE 272

Query: 346 LMEVKSAPEELGKTSQP 362
             ++   P+        
Sbjct: 273 FSKMARDPQRYLVIQGD 289

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  118 bits (298), Expect = 8e-31
 Identities = 67/331 (20%), Positives = 120/331 (36%), Gaps = 96/331 (29%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           + L     +G+G  G V KA   + +       +AVK L +     E  D   +E  +L 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLK 81

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS------ 172
            + H +++KL G CS     LL+  Y   G+L+  L+ +R +           +      
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141

Query: 173 ------------------AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA 213
                             +QG+ YL     V    HRD+   NIL+    +  ++DFGL+
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLV----HRDLAARNILVAEGRKMKISDFGLS 197

Query: 214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVV 264
           + +   +             Y+   + ++         +    YT     +SDV+S+GV+
Sbjct: 198 RDVYEEDS------------YVKRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVL 241

Query: 265 LLEILS-------GRSAVQPQIGDGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMV 315
           L EI++       G    +        +   +K   +M            +     ++M 
Sbjct: 242 LWEIVTLGGNPYPGIPPER--------LFNLLKTGHRM-----------ERPDNCSEEMY 282

Query: 316 QEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           + MLQ       C    P +RP   ++   L
Sbjct: 283 RLMLQ-------CWKQEPDKRPVFADISKDL 306

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (298), Expect = 1e-30
 Identities = 72/327 (22%), Positives = 117/327 (35%), Gaps = 87/327 (26%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           E L+   V+G G  G V  A             +AVK L +     E      +E++++ 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMT 103

Query: 119 HI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS----- 172
            +  H NIV LLG C+      L++ Y   G+L   L+  R    E   +          
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163

Query: 173 ------------------AQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA 213
                             A+G+ +L    CV    HRD+   N+L+       + DFGLA
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV----HRDLAARNVLVTHGKVVKICDFGLA 219

Query: 214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVV 264
           + + S +             Y+  G  +L         +  G YT+    KSDV+SYG++
Sbjct: 220 RDIMSDSN------------YVVRGNARLPVKWMAPESLFEGIYTI----KSDVWSYGIL 263

Query: 265 LLEILS-GRSAVQP--QIGDGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEML 319
           L EI S G     P   I    +  + ++   KM            +     +++   M 
Sbjct: 264 LWEIFSLGV---NPYPGIPVDANFYKLIQNGFKM-----------DQPFYATEEIYIIMQ 309

Query: 320 QTLGIAMFCVNSSPAERPTMKEVVALL 346
                   C      +RP+   + + L
Sbjct: 310 S-------CWAFDSRKRPSFPNLTSFL 329

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  117 bits (295), Expect = 1e-30
 Identities = 74/325 (22%), Positives = 131/325 (40%), Gaps = 64/325 (19%)

Query: 52  PFQKLNFTIDNILECLKDENVIGKGCSGVVYKAE--MPNGELI--AVKKL-WKTKRDEEP 106
           P Q L   I    + L+    +G G  GVV + E   P+G+ +  AVK L        E 
Sbjct: 7   PLQSLTCLIGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64

Query: 107 VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR-NLDWETR 165
           +D F  E+  +  + HRN+++L G      +K++       G+L   L+ ++ +    T 
Sbjct: 65  MDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTL 123

Query: 166 YKIAVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
            + AV  A+G+ YL     +    HRD+   N+LL ++    + DFGL + +   + H  
Sbjct: 124 SRYAVQVAEGMGYLESKRFI----HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-- 177

Query: 225 MSRVAGSYGYIAPGKCKL--------QIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAV 275
                    Y+     K+         +        +  SD + +GV L E+ + G+   
Sbjct: 178 ---------YVMQEHRKVPFAWCAPESLKTR---TFSHASDTWMFGVTLWEMFTYGQ--- 222

Query: 276 QPQIG----DGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNS 331
           +P IG      LH ++   +++    P         +  P  +   M+Q       C   
Sbjct: 223 EPWIGLNGSQILHKIDKEGERLPR--P---------EDCPQDIYNVMVQ-------CWAH 264

Query: 332 SPAERPTMKEVVALLMEVKSAPEEL 356
            P +RPT   +   L+E    P ++
Sbjct: 265 KPEDRPTFVALRDFLLEA--QPTDM 287

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (301), Expect = 2e-30
 Identities = 67/304 (22%), Positives = 116/304 (38%), Gaps = 61/304 (20%)

Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKL 128
           E ++G G SG V       G  +AVK++          D    EI++L     H N+++ 
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRY 74

Query: 129 LGYCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWETRYKIAVGSA-------QGLA 177
               +        + YI+    N NLQ L++     D   + +              G+A
Sbjct: 75  YCSETTDR-----FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAY-------------LADFGLAKLMNS--TNYH 222
           +LH      I+HRD+K  NIL+ +                  ++DFGL K ++S  +++ 
Sbjct: 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 223 HAMSRVAGSYGYIAP----GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ 278
             ++  +G+ G+ AP        LQ         T   D++S G V   ILS        
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRL----TRSIDIFSMGCVFYYILSKGK---HP 239

Query: 279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT 338
            GD       + + + S +    + D  L      ++ +M+          +  P +RPT
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID--------HD--PLKRPT 289

Query: 339 MKEV 342
             +V
Sbjct: 290 AMKV 293

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  118 bits (298), Expect = 5e-30
 Identities = 75/305 (24%), Positives = 117/305 (38%), Gaps = 60/305 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           + LK    IGKG  G V   +   G  +AVK +   K D      F AE  ++  +RH N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI---KNDATAQA-FLAEASVMTQLRHSN 247

Query: 125 IVKLLGYCSNKSVKLLLYN-YISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYL-H 180
           +V+LLG    +   L +   Y++ G+L   L+      L  +   K ++   + + YL  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
           ++ V    HRD+   N+L+     A ++DFGL K                          
Sbjct: 308 NNFV----HRDLAARNVLVSEDNVAKVSDFGLTK-----------------EASSTQDTG 346

Query: 241 KLQI----IYGYTMNI-TEKSDVYSYGVVLLEILS-GRSAVQPQIG-DGLHIVEWVKK-- 291
           KL +             + KSDV+S+G++L EI S GR    P        +V  V+K  
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR---VPYPRIPLKDVVPRVEKGY 403

Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
           KM               G P  +   M         C +   A RPT  ++   L  +++
Sbjct: 404 KM-----------DAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEHIRT 445

Query: 352 APEEL 356
               L
Sbjct: 446 HELHL 450

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (296), Expect = 7e-30
 Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 44/285 (15%)

Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKL 128
           ++V+G G  G +    M +   +AVK++          D    E+Q+L     H N+++ 
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADR---EVQLLRESDEHPNVIRY 83

Query: 129 LGYCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWETR-YKIAVGSAQGLAYLHHDC 183
                ++      + YI+       LQ+ ++             +   +  GLA+LH   
Sbjct: 84  FCTEKDRQ-----FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL- 137

Query: 184 VPAILHRDVKCNNILLDSKYE-----AYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAP 237
              I+HRD+K +NIL+          A ++DFGL K L    +     S V G+ G+IAP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
                          T   D++S G V   ++S         G  L     +     S +
Sbjct: 196 EMLSEDCKENP----TYTVDIFSAGCVFYYVISEG---SHPFGKSLQRQANILLGACSLD 248

Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                        P++    + + L   M  ++  P +RP+ K V
Sbjct: 249 CL----------HPEKHEDVIARELIEKMIAMD--PQKRPSAKHV 281

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  114 bits (289), Expect = 8e-30
 Identities = 76/321 (23%), Positives = 123/321 (38%), Gaps = 68/321 (21%)

Query: 52  PFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFA 111
            F +  + ++   + LK    IGKG  G V   +   G  +AVK +   K D      F 
Sbjct: 10  EFYRSGWALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI---KNDATAQA-FL 62

Query: 112 AEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN-YISNGNLQQLLQGNR--NLDWETRYKI 168
           AE  ++  +RH N+V+LLG    +   L +   Y++ G+L   L+      L  +   K 
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122

Query: 169 AVGSAQGLAYL-HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           ++   + + YL  ++ V    HRD+   N+L+     A ++DFGL K             
Sbjct: 123 SLDVCEAMEYLEGNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEA----------- 167

Query: 228 VAGSYGYIAPGKCKLQI--------IYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ 278
                        KL +                + KSDV+S+G++L EI S GR    P 
Sbjct: 168 ------SSTQDTGKLPVKWTAPEALREK---KFSTKSDVWSFGILLWEIYSFGR---VPY 215

Query: 279 IG-DGLHIVEWVKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
                  +V  V+K  KM               G P  + + M         C +   A 
Sbjct: 216 PRIPLKDVVPRVEKGYKMD-----------APDGCPPAVYEVMKN-------CWHLDAAM 257

Query: 336 RPTMKEVVALLMEVKSAPEEL 356
           RP+  ++   L  +K+    L
Sbjct: 258 RPSFLQLREQLEHIKTHELHL 278

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  115 bits (291), Expect = 1e-29
 Identities = 58/255 (22%), Positives = 100/255 (39%), Gaps = 34/255 (13%)

Query: 29  EKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMP 87
             ++ +  L P  ED          + +++     +  +  +  +G+G  G V++  +  
Sbjct: 22  SGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQ 81

Query: 88  NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG-YCSNKSVKLLLYNYIS 146
            G   AVKK+       E       E+     +    IV L G       V + +   + 
Sbjct: 82  TGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFM-ELLE 133

Query: 147 NGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPAILHRDVKCNNILLDSK- 202
            G+L QL++    L  E R        Q   GL YLH      ILH DVK +N+LL S  
Sbjct: 134 GGSLGQLIKQMGCLP-EDR--ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDG 187

Query: 203 YEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAPGKCKLQII--YGYTMNITEKSD 257
             A L DFG A  +       ++     + G+  ++AP     +++           K D
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP-----EVVMGKPC----DAKVD 238

Query: 258 VYSYGVVLLEILSGR 272
           ++S   ++L +L+G 
Sbjct: 239 IWSSCCMMLHMLNGC 253

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (290), Expect = 2e-29
 Identities = 32/315 (10%), Positives = 70/315 (22%), Gaps = 63/315 (20%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRN 124
           LK    +  G   VV+   ++   E  A+K            ++           +   +
Sbjct: 64  LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 125 IVKLLGYC-------------------------SNKSVKLLLYNYISNGNLQQLL----- 154
             +                                     LL    ++ +L+ L      
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 155 --QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL 212
                 +      + +     +  A L       ++H     +N+ +       L D   
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              + +          +    Y        + +   T   T   + +  G+ +  +    
Sbjct: 241 LWKVGTR-----GPASSVPVTYAPR-----EFLNASTATFTHALNAWQLGLSIYRVWCLF 290

Query: 273 SAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPD---QMVQEMLQTLGIAMFCV 329
               P       I    K+         S+       LPD    ++   L          
Sbjct: 291 L---PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN--------- 338

Query: 330 NSSPAERPTMKEVVA 344
                 R    E + 
Sbjct: 339 -FDRRRRLLPLEAME 352

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  114 bits (288), Expect = 3e-29
 Identities = 79/338 (23%), Positives = 127/338 (37%), Gaps = 92/338 (27%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE------LIAVKKLWKTKRDEEPVDSFAAEIQILG 118
             ++    IG+G  G V++A  P         ++AVK L +    +   D F  E  ++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMA 105

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY------------ 166
              + NIVKLLG C+      LL+ Y++ G+L + L+        +              
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165

Query: 167 ------------KIAVGSAQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA 213
                        IA   A G+AYL     V    HRD+   N L+       +ADFGL+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLS 221

Query: 214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKL--------QIIYG-YTMNITEKSDVYSYGVV 264
           + + S +Y            Y A G   +         I Y  YT     +SDV++YGVV
Sbjct: 222 RNIYSADY------------YKADGNDAIPIRWMPPESIFYNRYTT----ESDVWAYGVV 265

Query: 265 LLEILS-------GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQE 317
           L EI S       G +  +        ++ +V+          +IL    +  P ++   
Sbjct: 266 LWEIFSYGLQPYYGMAHEE--------VIYYVRDG--------NILA-CPENCPLELYNL 308

Query: 318 MLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE 355
           M         C +  PA+RP+   +  +L  +    E 
Sbjct: 309 MRL-------CWSKLPADRPSFCSIHRILQRMCERAEG 339

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  110 bits (278), Expect = 4e-28
 Identities = 61/277 (22%), Positives = 103/277 (37%), Gaps = 40/277 (14%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLL 129
            +G G  G V+K     +G L AVK+     R  +      AE+     + +H   V+L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                    L L   +   +LQQ  +    +L     +     +   LA+LH      ++
Sbjct: 124 QAWEEGG-ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLV 179

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY-G 247
           H DVK  NI L  +    L DFGL   + +           G   Y+AP     +++   
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ---EGDPRYMAP-----ELLQGS 231

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
           Y       +DV+S G+ +LE+        P  G+G       + + G   P         
Sbjct: 232 Y----GTAADVFSLGLTILEVACNMEL--PHGGEGWQ-----QLRQGYLPPE-------- 272

Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
                 +  E L+++ + M   +  P  R T + ++A
Sbjct: 273 --FTAGLSSE-LRSVLVMMLEPD--PKLRATAEALLA 304

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (277), Expect = 8e-28
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +GKG     ++  +    E+ A K + K+        +  + EI I   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-WETRYKIAVGSAQGLAYLHHDCVPAILH 189
           +  +     ++       +L +L +  + L   E RY +      G  YLH + V   +H
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL-RQIVLGCQYLHRNRV---IH 164

Query: 190 RDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAP----GKCKLQI 244
           RD+K  N+ L+   E  + DFGLA K+         +    G+  YIAP     K     
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIAPEVLSKK----- 216

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGR 272
             G+    + + DV+S G ++  +L G+
Sbjct: 217 --GH----SFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (274), Expect = 1e-27
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +GKG     ++  +    E+ A K + K+        +  + EI I   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-WETRYKIAVGSAQGLAYLHHDCVPAILH 189
           +  +     ++       +L +L +  + L   E RY +      G  YLH + V   +H
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL-RQIVLGCQYLHRNRV---IH 138

Query: 190 RDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAP----GKCKLQI 244
           RD+K  N+ L+   E  + DFGLA K+         +    G+  YIAP     K     
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIAPEVLSKK----- 190

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGR 272
             G+    + + DV+S G ++  +L G+
Sbjct: 191 --GH----SFEVDVWSIGCIMYTLLVGK 212

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  108 bits (272), Expect = 2e-27
 Identities = 43/229 (18%), Positives = 86/229 (37%), Gaps = 46/229 (20%)

Query: 65  ECLKDENVIGKGCSGVVYKAE--------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQI 116
           E L     +G+G    ++K            +   + +K L K  R+    +SF     +
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASM 65

Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQG 175
           +  + H+++V   G C      +L+  ++  G+L   L+ N+N ++   + ++A   A  
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 176 LAYL-HHDCVPAILHRDVKCNNILLDSKYEAY--------LADFGLAKLMNSTNYHHAMS 226
           + +L  +  +    H +V   NILL  + +          L+D G++  +   +      
Sbjct: 126 MHFLEENTLI----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI----- 176

Query: 227 RVAGSYGYIAPGK-----CKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
                             C   I      N+   +D +S+G  L EI S
Sbjct: 177 -------LQERIPWVPPEC---IENP--KNLNLATDKWSFGTTLWEICS 213

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (276), Expect = 8e-27
 Identities = 70/319 (21%), Positives = 117/319 (36%), Gaps = 45/319 (14%)

Query: 35  STLPPGAEDFSYPWTFIPFQK--LNFTIDNILECLKDENVIGKGCSGVVYKAEM-PNGEL 91
                G E+  +           +     ++ E  +    +G G  G V           
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64

Query: 92  IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQ 151
            A+K + KT            E+ +L  + H NI+KL  +  +K    L+      G L 
Sbjct: 65  RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124

Query: 152 QLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY---LA 208
             +      +      I      G+ YLH      I+HRD+K  N+LL+SK +     + 
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181

Query: 209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEI 268
           DFGL+ +  +      M    G+  YIAP     +++        EK DV+S GV+L  +
Sbjct: 182 DFGLSAVFENQKK---MKERLGTAYYIAP-----EVLRK---KYDEKCDVWSIGVILFIL 230

Query: 269 LSGRSAVQPQIGDGLH-IVEWVKKKMGSFE----PAVSILDTKLQGLPDQMVQEMLQTLG 323
           L+G     P  G     I+  V+K   +F+      VS    K       ++++MLQ   
Sbjct: 231 LAGY---PPFGGQTDQEILRKVEKGKYTFDSPEWKNVS-EGAK------DLIKQMLQF-- 278

Query: 324 IAMFCVNSSPAERPTMKEV 342
                       R + ++ 
Sbjct: 279 --------DSQRRISAQQA 289

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  108 bits (272), Expect = 1e-26
 Identities = 56/308 (18%), Positives = 109/308 (35%), Gaps = 42/308 (13%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           ++G+G +  V++      G+L A+K          PVD    E ++L  + H+NIVKL  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 131 Y--CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVP 185
               +    K+L+  +   G+L  +L+   N       +  +       G+ +L  +   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131

Query: 186 AILHRDVKCNNILLDSKYEAY----LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
            I+HR++K  NI+     +      L DFG A+ +           + G+  Y+ P    
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHP---- 184

Query: 242 LQIIYGYTMNI------TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
             +     +            D++S GV      +G    +P  G   +     K   G 
Sbjct: 185 -DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 296 FEPAVSILDTKLQGLPD------------QMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
              A+S +     G  D            + +Q +L  +   +   +    +     +  
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFDQFF 301

Query: 344 ALLMEVKS 351
           A   ++  
Sbjct: 302 AETSDILH 309

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  106 bits (266), Expect = 1e-26
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 27/209 (12%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +GKG    VY+A  +  G  +A+K + K        V     E++I   ++H +I++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 131 YCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
           Y  + +   L+     NG + + L  +     + E R+ +      G+ YLH   +   L
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSHGI---L 134

Query: 189 HRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAP----GKCKLQ 243
           HRD+  +N+LL       +ADFGLA +L      H+ +    G+  YI+P          
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL---CGTPNYISPEIATRSA--- 188

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGR 272
             +G       +SDV+S G +   +L GR
Sbjct: 189 --HGL------ESDVWSLGCMFYTLLIGR 209

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  106 bits (266), Expect = 2e-26
 Identities = 55/299 (18%), Positives = 106/299 (35%), Gaps = 42/299 (14%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           ++G+G +  V++      G+L A+K          PVD    E ++L  + H+NIVKL  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 131 Y--CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVP 185
               +    K+L+  +   G+L  +L+   N       +  +       G+ +L  +   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131

Query: 186 AILHRDVKCNNILLDSKYEAY----LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
            I+HR++K  NI+     +      L DFG A+ +           + G+  Y+ P    
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHP---- 184

Query: 242 LQIIYGYTMNI------TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
             +     +            D++S GV      +G    +P  G   +     K   G 
Sbjct: 185 -DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 296 FEPAVSILDTKLQGLPD------------QMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
              A+S +     G  D            + +Q +L  +   +   +    +     + 
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFDQF 300

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (268), Expect = 2e-26
 Identities = 45/224 (20%), Positives = 86/224 (38%), Gaps = 35/224 (15%)

Query: 72  VIGKGCSGVVYKAEMPNGELIAVKKLWKTK---------------RDEEPVDSFAAEIQI 116
            + +G    +   E  + +  A+KK  K+                  +   D F  E+QI
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA--- 173
           +  I++   +   G  +N     ++Y Y+ N ++ +  +    LD      I +      
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 174 -----QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
                   +Y+H++    I HRDVK +NIL+D      L+DFG ++ M       +    
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211

Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            G+Y ++ P     +     +     K D++S G+ L  +    
Sbjct: 212 -GTYEFMPP-----EFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  105 bits (264), Expect = 2e-26
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKL 128
             +GKG  G VY A E  +  ++A+K L+K +            E++I  H+RH NI++L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
            GY  + +   L+  Y   G + + LQ     D +         A  L+Y H      ++
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 131

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKCKLQI 244
           HRD+K  N+LL S  E  +ADFG +    S +    +    G+  Y+ P    G+     
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDL---CGTLDYLPPEMIEGR----- 182

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGR 272
              +     EK D++S GV+  E L G+
Sbjct: 183 --MH----DEKVDLWSLGVLCYEFLVGK 204

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  108 bits (272), Expect = 2e-26
 Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 44/283 (15%)

Query: 70  ENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVK 127
           + V+GKG  G V   +    G+  AVK + K + + +   +S   E+Q+L  + H NI+K
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L  +  +K    L+    + G L   +   +        +I      G+ Y+H +    I
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KI 147

Query: 188 LHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
           +HRD+K  N+LL+SK +     + DFGL+    ++     M    G+  YIAP     ++
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAP-----EV 199

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH-IVEWVKKKMGSFE----PA 299
           ++G      EK DV+S GV+L  +LSG     P  G   + I++ V+K   +FE      
Sbjct: 200 LHG---TYDEKCDVWSTGVILYILLSG---CPPFNGANEYDILKKVEKGKYTFELPQWKK 253

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           VS    K       ++++ML             P+ R + ++ 
Sbjct: 254 VS-ESAK------DLIRKMLTY----------VPSMRISARDA 279

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (266), Expect = 4e-26
 Identities = 70/306 (22%), Positives = 130/306 (42%), Gaps = 44/306 (14%)

Query: 64  LECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH 122
            +  +  + +G G  GVV+K    P+G ++A K +          +    E+Q+L     
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNS 90

Query: 123 RNIVKLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH 181
             IV   G + S+  + + +  ++  G+L Q+L+    +  +   K+++   +GL YL  
Sbjct: 91  PYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLA-KLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                I+HRDVK +NIL++S+ E  L DFG++ +L++S     A S V G+  Y++P + 
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFV-GTRSYMSPERL 202

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGR------------SAVQPQIGDGLHIVEW 288
           +    Y        +SD++S G+ L+E+  GR                 Q+         
Sbjct: 203 Q-GTHYSV------QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255

Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQM---VQEMLQTLGIAMF----------CVNSSPAE 335
             +  G       +       + + +   V E    L   +F          C+  +PAE
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315

Query: 336 RPTMKE 341
           R  +K+
Sbjct: 316 RADLKQ 321

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  105 bits (265), Expect = 5e-26
 Identities = 71/310 (22%), Positives = 124/310 (40%), Gaps = 56/310 (18%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVK 127
             V+ +G    VY+A+ + +G   A+K+L     +EE   +   E+  +  +  H NIV+
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90

Query: 128 LLGYCS-------NKSVKLLLYNYISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLA 177
                S           + LL   +  G L + L+   +   L  +T  KI   + + + 
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA-------- 229
           ++H    P I+HRD+K  N+LL ++    L DFG A  ++    +   ++          
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 230 --GSYGYIAPGKCKLQIIYGYT-MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
              +  Y  P     +II  Y+   I EK D+++ G +L  +   +              
Sbjct: 210 RNTTPMYRTP-----EIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP------------ 252

Query: 287 EWVKKKMGSFEPA--VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
                    FE    + I++ K    P      +  +L  AM  VN  P ER ++ EVV 
Sbjct: 253 ---------FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVH 301

Query: 345 LLMEVKSAPE 354
            L E+ +A  
Sbjct: 302 QLQEIAAARN 311

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  106 bits (266), Expect = 2e-25
 Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 43/282 (15%)

Query: 70  ENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
             ++GKG  G V K +     +  AVK + K     +   +   E+++L  + H NI+KL
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                + S   ++    + G L   +   +        +I      G+ Y+H      I+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIV 143

Query: 189 HRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
           HRD+K  NILL+SK +     + DFGL+           M    G+  YIAP     +++
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAP-----EVL 195

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH-IVEWVKKKMGSFE----PAV 300
            G      EK DV+S GV+L  +LSG     P  G   + I++ V+    +F+      +
Sbjct: 196 RG---TYDEKCDVWSAGVILYILLSG---TPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           S  D K       ++++ML             P+ R T  + 
Sbjct: 250 SD-DAK------DLIRKMLTF----------HPSLRITATQC 274

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (261), Expect = 3e-25
 Identities = 56/264 (21%), Positives = 96/264 (36%), Gaps = 47/264 (17%)

Query: 22  RNHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCS--G 79
            +H  +     GMS+  P    +                  +L        IGKG     
Sbjct: 5   HHHHMENLYFQGMSSFLPEGGCYE-----------------LLTV------IGKGFEDLM 41

Query: 80  VVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS-NKSV 137
            V  A   P GE + V+++       E V     E+ +     H NIV      +     
Sbjct: 42  TVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY--RATFIADN 99

Query: 138 KL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAV---GSAQGLAYLHHDCVPAILHRDVK 193
           +L ++ ++++ G+ + L+  +          IA    G  + L Y+HH      +HR VK
Sbjct: 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELA-IAYILQGVLKALDYIHHM---GYVHRSVK 155

Query: 194 CNNILLDSKYEAYLADFGLAKLMNSTN-----YHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
            ++IL+    + YL+       M S        H           +++P +   Q + GY
Sbjct: 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP-EVLQQNLQGY 214

Query: 249 TMNITEKSDVYSYGVVLLEILSGR 272
                 KSD+YS G+   E+ +G 
Sbjct: 215 ----DAKSDIYSVGITACELANGH 234

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  102 bits (256), Expect = 3e-25
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLL 129
            +GKG  G VY A E  N  ++A+K L+K++   E        EI+I  H+RH NI+++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-WETRYKIA-VGSAQGLAYLHHDCVPAI 187
            Y  ++    L+  +   G L + LQ +   D   +   +  +  A  L Y H   V   
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA--LHYCHERKV--- 135

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKCKLQ 243
           +HRD+K  N+L+  K E  +ADFG +    S      M    G+  Y+ P    GK    
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTM---CGTLDYLPPEMIEGK---- 187

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGR 272
               +     EK D++  GV+  E L G 
Sbjct: 188 ---TH----DEKVDLWCAGVLCYEFLVGM 209

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  105 bits (264), Expect = 5e-25
 Identities = 47/226 (20%), Positives = 82/226 (36%), Gaps = 39/226 (17%)

Query: 72  VIGKGCSGVVYKAE--MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
            I  G  G +Y A     NG  + +K L     D E      AE Q L  + H +IV++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 130 --GYCSNKSVKLLLY---NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
                +++    + Y    Y+   +L++       L         +     L+YLH    
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLHSI-- 201

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKC 240
             +++ D+K  NI+L  + +  L D G    +NS  Y      + G+ G+ AP       
Sbjct: 202 -GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPEIVRTG- 252

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
                       T  +D+Y+ G  L  +         + G  +  +
Sbjct: 253 -----------PTVATDIYTVGRTLAALTLDL---PTRNGRYVDGL 284

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  101 bits (254), Expect = 6e-25
 Identities = 49/307 (15%), Positives = 101/307 (32%), Gaps = 63/307 (20%)

Query: 62  NILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
                  +   IG G  G V+K  +  +G + A+K+  K         +   E+     +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 121 -RHRNIVKLLGYCSNKSVKLLLYN-YISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQ 174
            +H ++V+       +   +L+ N Y + G+L   +                 + +   +
Sbjct: 68  GQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLD-------------------SKYEAYLADFGLAKL 215
           GL Y+H     +++H D+K +NI +                    +K    + D G    
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV 275
           ++S           G   ++A    +    +        K+D+++  + ++         
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYTHLP------KADIFALALTVVCAAGAEPL- 230

Query: 276 QPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE 335
            P+ GD  H                 I   +L  +P  + QE    L   M   +  P  
Sbjct: 231 -PRNGDQWHE----------------IRQGRLPRIPQVLSQE-FTELLKVMIHPD--PER 270

Query: 336 RPTMKEV 342
           RP+   +
Sbjct: 271 RPSAMAL 277

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  104 bits (262), Expect = 7e-25
 Identities = 67/293 (22%), Positives = 112/293 (38%), Gaps = 54/293 (18%)

Query: 70  ENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-----------RDEEPVDSFAAEIQIL 117
              +G G  G V   +        A+K + K++             E+  +    EI +L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLA 177
             + H NI+KL     +K    L+  +   G L + +      D      I      G+ 
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           YLH      I+HRD+K  NILL++K       + DFGL+   +       +    G+  Y
Sbjct: 161 YLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYY 214

Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH-IVEWVKKKM 293
           IAP     +++        EK DV+S GV++  +L G     P  G     I++ V+K  
Sbjct: 215 IAP-----EVLKK---KYNEKCDVWSCGVIMYILLCGYP---PFGGQNDQDIIKKVEKGK 263

Query: 294 GSFE----PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
             F+      +S  + K      ++++ ML               +R T +E 
Sbjct: 264 YYFDFNDWKNIS-DEAK------ELIKLMLTY----------DYNKRCTAEEA 299

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  100 bits (252), Expect = 1e-24
 Identities = 52/234 (22%), Positives = 98/234 (41%), Gaps = 42/234 (17%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQ 115
           +  +    + L+    +G+G  GVV K   +P+G+++AVK++  T  + +       ++ 
Sbjct: 1   SMEVK--ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLD 57

Query: 116 ILGH-IRHRNIVKLLG-------------YCSNKSVKLLLYNYISNGNLQQLLQGNRNLD 161
           I    +     V   G                    K           + + + G     
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG----- 112

Query: 162 WETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL-AKLMNSTN 220
                KIAV   + L +LH     +++HRDVK +N+L+++  +  + DFG+   L++   
Sbjct: 113 -----KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV- 164

Query: 221 YHHAMSRVAGSYGYIAPG--KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              A    AG   Y+AP     +L    GY++    KSD++S G+ ++E+   R
Sbjct: 165 ---AKDIDAGCKPYMAPERINPELNQK-GYSV----KSDIWSLGITMIELAILR 210

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  101 bits (253), Expect = 2e-24
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 43/240 (17%)

Query: 55  KLNFTIDNILEC----LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDS 109
           KL  + +   +     LKD   IG+G  G V K    P+G+++AVK++ ++  DE+    
Sbjct: 8   KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQ 66

Query: 110 FAAEIQILGH-IRHRNIVKLLG-------------YCSNKSVKLLLYNYISNGNLQQLLQ 155
              ++ ++        IV+  G               S    K   Y Y           
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLD------- 119

Query: 156 GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL-AK 214
               +  E   KI + + + L +L  +    I+HRD+K +NILLD      L DFG+  +
Sbjct: 120 --DVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNI--TEKSDVYSYGVVLLEILSGR 272
           L++S     A +R AG   Y+AP     + I           +SDV+S G+ L E+ +GR
Sbjct: 176 LVDSI----AKTRDAGCRPYMAP-----ERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  103 bits (259), Expect = 2e-24
 Identities = 56/244 (22%), Positives = 100/244 (40%), Gaps = 38/244 (15%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL- 129
            +G G  G V +      GE +A+K+  + +   +  + +  EIQI+  + H N+V    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 130 -----GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW----ETRYKIA-VGSAQGLAYL 179
                   +   + LL   Y   G+L++ L    N         R  ++ + SA  L YL
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYL 137

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           H +    I+HRD+K  NI+L    +     + D G AK ++        +   G+  Y+A
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLA 191

Query: 237 PGKCKLQIIYG--YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
           P     +++    Y    T   D +S+G +  E ++G     P + +   +    K +  
Sbjct: 192 P-----ELLEQKKY----TVTVDYWSFGTLAFECITGFR---PFLPNWQPVQWHGKVREK 239

Query: 295 SFEP 298
           S E 
Sbjct: 240 SNEH 243

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  101 bits (253), Expect = 2e-24
 Identities = 45/332 (13%), Positives = 102/332 (30%), Gaps = 49/332 (14%)

Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDE 104
           +P  K         + +   +++G+G    VY+A         N +   +K        E
Sbjct: 51  LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE 110

Query: 105 EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW-- 162
                    ++ L        +K       ++  +L+    S G L   +   +N     
Sbjct: 111 --FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168

Query: 163 ---ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY-----------LA 208
                    A+     +  +H      I+H D+K +N +L + +              L 
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225

Query: 209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG--YTMNITEKSDVYSYGVVLL 266
           D G +  M         +    + G+        +++    +      + D +     + 
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCV-----EMLSNKPWNY----QIDYFGVAATVY 276

Query: 267 EILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD---TKLQGLPDQMVQEMLQTLG 323
            +L G      ++ +     E   + +    P + + +     +  +PD      L  L 
Sbjct: 277 CMLFGTY---MKVKN--EGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331

Query: 324 IAM---FCVNSSPAERPTMKEVVALLMEVKSA 352
             +   F  + +   R     ++ LL+E K +
Sbjct: 332 QKLKKVFQQHYTNKIRALRNRLIVLLLECKRS 363

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (251), Expect = 3e-24
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 14/210 (6%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH-IRHRN 124
           L++   +G G  G V+K      G +IAVK++ +   ++E       ++ ++        
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPY 85

Query: 125 IVKLLG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
           IV+  G + +N  V + +   +     +   +    +      K+ V   + L YL    
Sbjct: 86  IVQCFGTFITNTDVFIAM-ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK- 143

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGL-AKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
              ++HRDVK +NILLD + +  L DFG+  +L++      A  R AG   Y+AP +   
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK----AKDRSAGCAAYMAPERIDP 198

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                   +I  ++DV+S G+ L+E+ +G+
Sbjct: 199 PDPTKPDYDI--RADVWSLGISLVELATGQ 226

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  102 bits (255), Expect = 3e-24
 Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 57/228 (25%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTK------RDEEPVDSFAAEIQILGHIRHRN 124
            +G G  G V  A E    + +A++ + K K      R+ +P  +   EI+IL  + H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 125 IVKLLGYCSNKSVKLL--------LYNYI-SNGNL---------QQLLQGNRNLDWETRY 166
           I+K+  +   +   ++        L++ +  N  L          Q+L            
Sbjct: 202 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------------ 249

Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHH 223
                    + YLH +    I+HRD+K  N+LL S+ E     + DFG +K++  T+   
Sbjct: 250 -------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 297

Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
            M  + G+  Y+AP         GY        D +S GV+L   LSG
Sbjct: 298 -MRTLCGTPTYLAPEVLVSVGTAGY----NRAVDCWSLGVILFICLSG 340

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  101 bits (252), Expect = 3e-24
 Identities = 41/312 (13%), Positives = 92/312 (29%), Gaps = 73/312 (23%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPV----------------------- 107
           V+G+       +A +   GE   V   + T+R                            
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 108 ---DSFAAEIQILGHIRHRNIVKLLGYCSNKSV-KLLLYNYISNGNLQQLLQ-------G 156
                F     ++   + + ++++     +  V            NLQ   +        
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 157 NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM 216
           +++L    R ++ +   + LA LHH     ++H  ++  +I+LD +   +L  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 217 NSTNYHHAMSRVAGSYGYIAP----GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            +          + S G+  P     +  +         +T   D ++ G+V+  I    
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 273 SAVQPQIGDGL-HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNS 331
               P   D      EW+ +   +    V             +++  L+           
Sbjct: 311 L---PITKDAALGGSEWIFRSCKNIPQPVR-----------ALLEGFLRY---------- 346

Query: 332 SPAERPTMKEVV 343
              +R    + +
Sbjct: 347 PKEDRLLPLQAM 358

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 21/206 (10%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKT-KRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +G G    VY AE       +A+K ++   +  EE +  F  E+     + H+NIV ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
                    L+  YI    L + ++ +  L  +T          G+ + H      I+HR
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHR 135

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKCKLQIIY 246
           D+K  NIL+DS     + DFG+AK ++ T+     + V G+  Y +P    G+       
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGTVQYFSPEQAKGE------- 187

Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR 272
                  E +D+YS G+VL E+L G 
Sbjct: 188 ----ATDECTDIYSIGIVLYEMLVGE 209

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 99.7 bits (249), Expect = 5e-24
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 59/229 (25%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTK------RDEEPVDSFAAEIQILGHIRHRN 124
            +G G  G V  A E    + +A+K + K K      R+ +P  +   EI+IL  + H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 125 IVKLLGYCSNKSVKLL--------LYNYI-SNGNL---------QQLLQGNRNLDWETRY 166
           I+K+  +   +   ++        L++ +  N  L          Q+L            
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------------ 124

Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHH 223
                    + YLH +    I+HRD+K  N+LL S+ E     + DFG +K++  T+   
Sbjct: 125 -------LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172

Query: 224 AMSRVAGSYGYIAPGKCKLQIIYG-YTMNITEKSDVYSYGVVLLEILSG 271
            M  + G+  Y+AP     +++    T       D +S GV+L   LSG
Sbjct: 173 -MRTLCGTPTYLAP-----EVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  100 bits (250), Expect = 1e-23
 Identities = 47/316 (14%), Positives = 95/316 (30%), Gaps = 72/316 (22%)

Query: 67  LKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRH-- 122
           L    V+G+       +A     GE   V   + T+R     +     E+  L  +R   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 123 --------------RNIVKLLGYCSNKSVK----------LLLYNYISNGNLQQLLQ--- 155
                          ++VK         V+                    NLQ   +   
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 156 ----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG 211
                +++L    R ++ +   + LA LHH     ++H  ++  +I+LD +   +L  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 212 LAKLMNSTNYHHAMSRVAGSYG---YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEI 268
                 ++    A+S +   +      A     L     +   +T   D ++ G+ +  I
Sbjct: 257 HLVRDGAS----AVSPIGRGFAPPETTAE--RMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 269 LSGRSAVQPQIGDG-LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMF 327
                   P   D  L   EW+ +   +    V             +++  L+       
Sbjct: 311 WCADL---PNTDDAALGGSEWIFRSCKNIPQPVR-----------ALLEGFLR------- 349

Query: 328 CVNSSPAERPTMKEVV 343
                  +R    + +
Sbjct: 350 ---YPKEDRLLPLQAM 362

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 21/209 (10%)

Query: 70  ENVIGKGCSGVVYKAEMPN-GELIAVKKL-WKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
             ++G+G  G VY+AE      ++A+K +      D         E +  G ++  ++V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           +  +        +    I+  +L  +L+    L       I       L   H       
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GA 155

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKCKLQ 243
            HRDVK  NIL+ +   AYL DFG+A                G+  Y+AP          
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-GNTVGTLYYMAPERFSES---- 210

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                  + T ++D+Y+   VL E L+G 
Sbjct: 211 -------HATYRADIYALTCVLYECLTGS 232

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 41/217 (18%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G G  G V+  E   +G    +K + K +  + P++   AEI++L  + H NI+K+  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS-------------AQGLA 177
              +     ++      G L         L+     +    +                LA
Sbjct: 88  VFEDYHNMYIVMETCEGGEL---------LERIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           Y H      ++H+D+K  NIL           + DFGLA+L  S  +    +  AG+  Y
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALY 192

Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           +AP     ++      ++T K D++S GVV+  +L+G
Sbjct: 193 MAP-----EVFKR---DVTFKCDIWSAGVVMYFLLTG 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 33/214 (15%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
                IGKG  G V+K  +    +++A+K +   +  E+ ++    EI +L       + 
Sbjct: 25  TKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAV---GSAQGLAYLHHD 182
           K  G    K  KL ++  Y+  G+   LL+    LD ET  +IA       +GL YLH +
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLE-PGPLD-ET--QIATILREILKGLDYLHSE 138

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAPGK 239
                +HRD+K  N+LL    E  LADFG+A  +  T       +     G+  ++AP  
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-----QIKRNTFVGTPFWMAP-- 188

Query: 240 CKLQII--YGYTMNITEKSDVYSYGVVLLEILSG 271
              ++I    Y      K+D++S G+  +E+  G
Sbjct: 189 ---EVIKQSAY----DSKADIWSLGITAIELARG 215

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 38/214 (17%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           ++GKG  G V K  +    +  AVK + K     +   +   E+++L  + H NI+KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW---ETRY------KIAVGSAQGLAYLHH 181
              + S   ++    + G L          D      R+      +I      G+ Y+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139

Query: 182 DCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
                I+HRD+K  NILL+SK +     + DFGL+           M    G+  YIAP 
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAP- 192

Query: 239 KCKLQIIYG-YTMNITEKSDVYSYGVVLLEILSG 271
               +++ G Y     EK DV+S GV+L  +LSG
Sbjct: 193 ----EVLRGTY----DEKCDVWSAGVILYILLSG 218

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 26/215 (12%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           VIG G + VV  A   P  E +A+K+    ++ +  +D    EIQ +    H NIV    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQCHHPNIVSY-- 78

Query: 131 YCS-NKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYK-----IAV---GSAQGLAYLH 180
           Y S     +L L+   +S G++  +++                 IA       +GL YLH
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGL-AKLMNSTNYHHAMSR--VAGSYGYIAP 237
            +     +HRDVK  NILL       +ADFG+ A L    +      R    G+  ++AP
Sbjct: 139 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              +    Y +      K+D++S+G+  +E+ +G 
Sbjct: 196 EVMEQVRGYDF------KADIWSFGITAIELATGA 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 32/220 (14%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNI 125
           +   ++G G  G VYK   +  G+L A+K +       +  +    EI +L     HRNI
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNI 83

Query: 126 VKLLG-----YCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAV---GSAQGL 176
               G            +L L+  +   G++  L++  +    +  + IA       +GL
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAYICREILRGL 142

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYG 233
           ++LH   V   +HRD+K  N+LL    E  L DFG++  ++ T     + R     G+  
Sbjct: 143 SHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-----VGRRNTFIGTPY 194

Query: 234 YIAP--GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           ++AP    C       Y      KSD++S G+  +E+  G
Sbjct: 195 WMAPEVIACDENPDATY----DFKSDLWSLGITAIEMAEG 230

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 97.6 bits (243), Expect = 5e-23
 Identities = 53/249 (21%), Positives = 89/249 (35%), Gaps = 56/249 (22%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTK---RDEEPVDSFAAEIQILGHIRHRNIVK 127
            IG+G  GVV  A E     + A+K + K K    + + V+    E++++  + H NI +
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA-------------- 173
           L     ++    L+      G+L   L    +          V +               
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 174 --------------------------QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL 207
                                       L YLH+     I HRD+K  N L  +     +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209

Query: 208 --ADFGLAKLMNSTNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGV 263
              DFGL+K     N    + M+  AG+  ++AP     +++     +   K D +S GV
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP-----EVLNTTNESYGPKCDAWSAGV 264

Query: 264 VLLEILSGR 272
           +L  +L G 
Sbjct: 265 LLHLLLMGA 273

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 63/227 (27%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +GKG   VV +      G   A K +   K           E +I   ++H NIV+L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 131 YCSNKSVKLLLYNYISNGNL-------------------QQLLQGNRNLDWETRYKIAVG 171
               +S   L+++ ++ G L                   QQ+L+                
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES--------------- 117

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRV 228
               +AY H +    I+HR++K  N+LL SK +     LADFGLA  +N +    A    
Sbjct: 118 ----IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGF 167

Query: 229 AGSYGYIAPGKCKLQII----YGYTMNITEKSDVYSYGVVLLEILSG 271
           AG+ GY++P     +++    Y       +  D+++ GV+L  +L G
Sbjct: 168 AGTPGYLSP-----EVLKKDPYS------KPVDIWACGVILYILLVG 203

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 27/212 (12%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKT--KRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           +G G    V+ A  + +   +AVK L +    RD      F  E Q    + H  IV + 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 130 GYCSNKSVKLLLY----NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
                ++    L      Y+    L+ ++     +  +   ++   + Q L + H +   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--- 135

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM-SRVAGSYGYIAP----GKC 240
            I+HRDVK  NI++ +     + DFG+A+ +  +       + V G+  Y++P    G  
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD- 194

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                     ++  +SDVYS G VL E+L+G 
Sbjct: 195 ----------SVDARSDVYSLGCVLYEVLTGE 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 65/228 (28%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +GKG   VV +      G   A K +   K           E +I   ++H NIV+L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 131 YCSNKSVKLLLYNYISNGNL-------------------QQLLQGNRNLDWETRYKIAVG 171
               +S   L+++ ++ G L                   QQ+L+                
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES--------------- 140

Query: 172 SAQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSR 227
               +AY H +     I+HR++K  N+LL SK +     LADFGLA  +N +    A   
Sbjct: 141 ----IAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHG 189

Query: 228 VAGSYGYIAPGKCKLQII----YGYTMNITEKSDVYSYGVVLLEILSG 271
            AG+ GY++P     +++    Y       +  D+++ GV+L  +L G
Sbjct: 190 FAGTPGYLSP-----EVLKKDPYS------KPVDIWACGVILYILLVG 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           +    +G G  G VYKA     G L A K +    + EE ++ +  EI+IL    H  IV
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDHPYIV 79

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAV---GSAQGLAYLHHD 182
           KLLG       KL ++  +   G +  ++        E   +I V      + L +LH  
Sbjct: 80  KLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP--QIQVVCRQMLEALNFLHSK 136

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAP-- 237
               I+HRD+K  N+L+  + +  LADFG++     T     + +     G+  ++AP  
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-----LQKRDSFIGTPYWMAPEV 188

Query: 238 --GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              +      Y Y      K+D++S G+ L+E+   
Sbjct: 189 VMCETMKDTPYDY------KADIWSLGITLIEMAQI 218

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.8 bits (234), Expect = 4e-22
 Identities = 52/214 (24%), Positives = 84/214 (39%), Gaps = 40/214 (18%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            IG+G  G V  A +       A KK+ K   ++  VD F  EI+I+  + H NI++L  
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW---ETRY------KIAVGSAQGLAYLHH 181
              + +   L+    + G L          +    +  +      +I       +AY H 
Sbjct: 74  TFEDNTDIYLVMELCTGGEL---------FERVVHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 182 DCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
                + HRD+K  N L  +        L DFGLA           M    G+  Y++P 
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSP- 177

Query: 239 KCKLQIIYG-YTMNITEKSDVYSYGVVLLEILSG 271
               Q++ G Y      + D +S GV++  +L G
Sbjct: 178 ----QVLEGLY----GPECDEWSAGVMMYVLLCG 203

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 13/159 (8%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKL 128
             IG+G  GVV+K      G+++A+KK      D+  +   A  EI++L  ++H N+V L
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLL-QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L     K    L++ Y  +  +   L +  R +       I   + Q + + H       
Sbjct: 68  LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNS-----TNY 221
           +HRDVK  NIL+       L DFG A+L+        + 
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 93.7 bits (234), Expect = 5e-22
 Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 9/155 (5%)

Query: 64  LECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIR 121
           +E  +    IG+G  GVVYKA     GE++A+KK+ +   + E V S A  EI +L  + 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60

Query: 122 HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLAYL 179
           H NIVKLL     ++   L++ ++   +L++ +       +             QGLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
           H      +LHRD+K  N+L++++    LADFGLA+
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.2 bits (235), Expect = 6e-22
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 13/159 (8%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKL 128
            ++G+G  G+V K      G ++A+KK      D++ V   A  EI++L  +RH N+V L
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L  C  K    L++ ++ +  +   L+   N LD++   K       G+ + H      I
Sbjct: 90  LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---I 145

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNS-----TNY 221
           +HRD+K  NIL+       L DFG A+ + +      + 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 94.2 bits (235), Expect = 6e-22
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 12/151 (7%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKL 128
             +G+G  G VYKA +    E +A+K++ + + +EE V   A  E+ +L  ++HRNI++L
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                +     L++ Y  N +L++ +  N ++              G+ + H       L
Sbjct: 99  KSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCL 154

Query: 189 HRDVKCNNILLDSKYEAY-----LADFGLAK 214
           HRD+K  N+LL     +      + DFGLA+
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.4 bits (233), Expect = 8e-22
 Identities = 47/165 (28%), Positives = 85/165 (51%), Gaps = 7/165 (4%)

Query: 52  PFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFA 111
              + N     ++E  +    +G+G  GVVYKA+   G ++A+K++ +   ++E + S A
Sbjct: 8   SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTA 66

Query: 112 A-EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLL-QGNRNLDWETRYKIA 169
             EI +L  + H NIV L+    ++    L++ ++   +L+++L +    L         
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL 125

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
               +G+A+ H      ILHRD+K  N+L++S     LADFGLA+
Sbjct: 126 YQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 72/227 (31%), Positives = 107/227 (47%), Gaps = 51/227 (22%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            D  VIG G  GVVY+A    +GEL+A+KK+ + KR +        E+QI+  + H NIV
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKLDHCNIV 110

Query: 127 KLLGY-----CSNKSVKL-LLYNYISNGNLQQLL----QGNRNLDWET----RYKIAVGS 172
           +L  +          V L L+ +Y+    + ++     +  + L         Y++    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL---- 165

Query: 173 AQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNST--NYHHAMSRV 228
            + LAY+H       I HRD+K  N+LLD       L DFG AK +     N  +  SR 
Sbjct: 166 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 220

Query: 229 AGSYGYIAPGKCKLQIIYG---YTMNITEKSDVYSYGVVLLEILSGR 272
              Y Y AP     ++I+G   YT +I    DV+S G VL E+L G+
Sbjct: 221 ---Y-YRAP-----ELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 38/274 (13%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IGKG    V  A  +  G  +A+K + KT+ +   +     E++I+  + H NIVKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRD 191
              +    L+  Y S G +   L  +  +  +            + Y H      I+HRD
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRD 139

Query: 192 VKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG--YT 249
           +K  N+LLD+     +ADFG +           +    G+  Y AP     ++  G  Y 
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFCGAPPYAAP-----ELFQGKKYD 191

Query: 250 MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK-KMGSFEPAVSILDTKLQ 308
                + DV+S GV+L  ++SG     P   DG ++ E  ++   G +            
Sbjct: 192 ---GPEVDVWSLGVILYTLVSGSL---PF--DGQNLKELRERVLRGKYR----------- 232

Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
            +P  M  +  + L      +N  P +R T++++
Sbjct: 233 -IPFYMSTD-CENLLKRFLVLN--PIKRGTLEQI 262

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 92.2 bits (230), Expect = 2e-21
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 44/165 (26%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKL 128
             IG+G  G V+KA      E++A+K++ +   D+E V S A  EI +L  ++H+NIV+L
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 129 LG-YCSNKSVKLL-------LYNYISNGN-----------LQQLLQGNRNLDWETRYKIA 169
                S+K + L+       L  Y  + N           L QLL               
Sbjct: 67  HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL--------------- 111

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
               +GL + H      +LHRD+K  N+L++   E  LA+FGLA+
Sbjct: 112 ----KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 44/218 (20%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +GKG   VV +  ++  G+  A   +   K           E +I   ++H NIV+L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW---ETRYKIAVGSA------QGLAYLH- 180
             S +    L+++ ++ G L          +       Y  A  S       + + + H 
Sbjct: 78  SISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQQILEAVLHCHQ 128

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                 ++HR++K  N+LL SK +     LADFGLA  +       A    AG+ GY++P
Sbjct: 129 MG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSP 182

Query: 238 GKCKLQII----YGYTMNITEKSDVYSYGVVLLEILSG 271
                +++    YG      +  D+++ GV+L  +L G
Sbjct: 183 -----EVLRKDPYG------KPVDLWACGVILYILLVG 209

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 51/228 (22%), Positives = 84/228 (36%), Gaps = 56/228 (24%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKL 128
           ++G+G  G V +          AVK L K K  R      +   EIQ+L  +RH+N+++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 129 ---------------LGYCSNKSVKLLLYNYISNGNL---------QQLLQGNRNLDWET 164
                          + YC     ++L  + +               QL+ G        
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEML--DSVPEKRFPVCQAHGYFCQLIDG-------- 121

Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
                      L YLH      I+H+D+K  N+LL +     ++  G+A+ ++       
Sbjct: 122 -----------LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167

Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                GS  +  P     +I  G       K D++S GV L  I +G 
Sbjct: 168 CRTSQGSPAFQPP-----EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 27/212 (12%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKL-WKTKRDEEPVDSFAAEIQILGHIRHRNI 125
            D   IG G  G VY A ++ N E++A+KK+ +  K+  E       E++ L  +RH N 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 126 VKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAV---GSAQGLAYLHH 181
           ++  G C  +     L+  Y        L    + L  E   +IA    G+ QGLAYLH 
Sbjct: 117 IQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQ-EV--EIAAVTHGALQGLAYLHS 172

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG--K 239
                ++HRDVK  NILL       L DFG A +M   N         G+  ++AP    
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPEVIL 223

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              +  Y        K DV+S G+  +E+   
Sbjct: 224 AMDEGQYDG------KVDVWSLGITCIELAER 249

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.4 bits (228), Expect = 3e-21
 Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 7/146 (4%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKLL 129
             IG+G  GVVYKA+   GE  A+KK+ + ++++E + S    EI IL  ++H NIVKL 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLL-QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                K   +L++ ++   +L++LL      L+  T     +    G+AY H      +L
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAK 214
           HRD+K  N+L++ + E  +ADFGLA+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR 148

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 59/230 (25%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRD------EEPVDSFAAEIQILGHIR-HR 123
           VIG+G S VV +      G   AVK +  T         EE  ++   E  IL  +  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 124 NIVKLLGYC-SNKSVKLL--------LYNYI-SNGNL---------QQLLQGNRNLDWET 164
           +I+ L+    S+  + L+        L++Y+     L         + LL+         
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA-------- 212

Query: 165 RYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA 224
                      +++LH +    I+HRD+K  NILLD   +  L+DFG +  +        
Sbjct: 213 -----------VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--- 255

Query: 225 MSRVAGSYGYIAP---GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
           +  + G+ GY+AP        +   GY     ++ D+++ GV+L  +L+G
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGY----GKEVDLWACGVILFTLLAG 301

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 93.4 bits (232), Expect = 5e-21
 Identities = 56/260 (21%), Positives = 108/260 (41%), Gaps = 30/260 (11%)

Query: 23  NHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVY 82
           + + K+ +  G  +       F     + P Q +    D++L+       +G G  GVV+
Sbjct: 116 DEQGKIVRGKGTVSSNYDNYVFDIWKQYYP-QPVEIKHDHVLDHYDIHEELGTGAFGVVH 174

Query: 83  KA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL 141
           +  E   G   A K +      +   ++   EIQ +  +RH  +V L     + +  +++
Sbjct: 175 RVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232

Query: 142 YNYISNGNLQQLLQGNRNLDWETRY--KIAVGSAQ----GLAYLHHDCVPAILHRDVKCN 195
           Y ++S G L +     +  D   +     AV   +    GL ++H +     +H D+K  
Sbjct: 233 YEFMSGGELFE-----KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPE 284

Query: 196 NILLDSKYEAYL--ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNIT 253
           NI+  +K    L   DFGL   ++      ++    G+  + AP     ++  G    + 
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAP-----EVAEG--KPVG 334

Query: 254 EKSDVYSYGVVLLEILSGRS 273
             +D++S GV+   +LSG S
Sbjct: 335 YYTDMWSVGVLSYILLSGLS 354

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.3 bits (225), Expect = 6e-21
 Identities = 65/281 (23%), Positives = 115/281 (40%), Gaps = 47/281 (16%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G+G  G V  A      E +AVK +   +  + P ++   EI I   + H N+VK  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGH 73

Query: 132 CSNKSVKLLLYNYISNGNL-QQLLQGNRNLDWETRYK----IAVGSAQGLAYLHHDCVPA 186
               +++ L   Y S G L  ++       + + +      +A     G+ YLH      
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGI---G 125

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKCKL 242
           I HRD+K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP     +   
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR--- 182

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE-PAVS 301
                +     E  DV+S G+VL  +L+G     P         E+   K          
Sbjct: 183 ----EFH---AEPVDVWSCGIVLTAMLAGE---LPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
            +D+    L    + ++L            +P+ R T+ ++
Sbjct: 233 KIDSAPLAL----LHKILVE----------NPSARITIPDI 259

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 51/225 (22%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTK---RDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIGKG   VV +      G+  AVK +   K         +    E  I   ++H +IV+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-------WETRYKIAVGSA------Q 174
           LL   S+  +  +++ ++   +L                      Y  AV S       +
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 175 GLAYLH-HDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAG 230
            L Y H ++    I+HRDVK + +LL SK  +    L  FG+A  +  +          G
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVG 195

Query: 231 SYGYIAPGKCKLQII----YGYTMNITEKSDVYSYGVVLLEILSG 271
           +  ++AP     +++    YG      +  DV+  GV+L  +LSG
Sbjct: 196 TPHFMAP-----EVVKREPYG------KPVDVWGCGVILFILLSG 229

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 60/231 (25%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRD-------EEPVDSFAAEIQILGHI-RH 122
           ++G+G S VV +    P  +  AVK +  T          +E  ++   E+ IL  +  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 123 RNIVKLLGYC-SNKSVKLL--------LYNYI-SNGNL---------QQLLQGNRNLDWE 163
            NI++L     +N    L+        L++Y+     L         + LL+        
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV------- 136

Query: 164 TRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH 223
                       +  LH      I+HRD+K  NILLD      L DFG +  ++      
Sbjct: 137 ------------ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179

Query: 224 AMSRVAGSYGYIAP---GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
            +  V G+  Y+AP            GY     ++ D++S GV++  +L+G
Sbjct: 180 -LREVCGTPSYLAPEIIECSMNDNHPGY----GKEVDMWSTGVIMYTLLAG 225

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 50/221 (22%)

Query: 70  ENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
             V+G G    V+   +   G+L A+K + K+    +   S   EI +L  I+H NIV L
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIVTL 71

Query: 129 LG-YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW---ETRY------KIAVGSAQGLAY 178
              Y S     L++          QL+ G    D       Y       +       + Y
Sbjct: 72  EDIYESTTHYYLVM----------QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121

Query: 179 LH-HDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGY 234
           LH +     I+HRD+K  N+L  +  E     + DFGL+K+  +      MS   G+ GY
Sbjct: 122 LHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGY 173

Query: 235 IAPGKCKLQII----YGYTMNITEKSDVYSYGVVLLEILSG 271
           +AP     +++    Y       +  D +S GV+   +L G
Sbjct: 174 VAP-----EVLAQKPYS------KAVDCWSIGVITYILLCG 203

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 47/281 (16%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           +G+G  G V  A      E +AVK +   +  +   ++   EI I   + H N+VK  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIKKEICINKMLNHENVVKFYGH 73

Query: 132 CSNKSVKLLLYNYISNGNL-QQLLQGNRNLDWETRYK----IAVGSAQGLAYLHHDCVPA 186
               +++ L   Y S G L  ++       + + +      +A     G+ YLH      
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGI---G 125

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKCKL 242
           I HRD+K  N+LLD +    ++DFGLA +    N    ++++ G+  Y+AP     +   
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR--- 182

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK-KMGSFEPAVS 301
                +     E  DV+S G+VL  +L+G     P         E+    +  ++     
Sbjct: 183 ----EFH---AEPVDVWSCGIVLTAMLAGE---LPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
            +D+    L    + ++L            +P+ R T+ ++
Sbjct: 233 KIDSAPLAL----LHKILVE----------NPSARITIPDI 259

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 53/231 (22%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFA----AEIQILGHIRH 122
           + E + G+G  G V    E   G  +A+KK+ +  R       F       +Q L  + H
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-------FRNRELQIMQDLAVLHH 78

Query: 123 RNIVKLL------GYCSNKSVKL-LLYNYISNGNLQQLL----QGNRNLDWET----RYK 167
            NIV+L       G    + + L ++  Y+ +  L +      +              ++
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNST--NYHHA 224
           +     + +  LH   V  + HRD+K +N+L++ +     L DFG AK ++ +  N  + 
Sbjct: 138 LI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192

Query: 225 MSRVAGSYGYIAPGKCKLQIIYG---YTMNITEKSDVYSYGVVLLEILSGR 272
            SR    Y Y AP     ++I+G   YT  +    D++S G +  E++ G 
Sbjct: 193 CSR----Y-YRAP-----ELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 52/172 (30%), Positives = 71/172 (41%), Gaps = 47/172 (27%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA----EIQILGHIRHRNI 125
           + +G+G    VYKA +    +++A+KK+ K     E  D        EI++L  + H NI
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNI 74

Query: 126 VKLLGYCSNKSVKLL--------LYNYISNGN-----------LQQLLQGNRNLDWETRY 166
           + LL    +KS   L        L   I + +           +   L            
Sbjct: 75  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL------------ 122

Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS 218
                  QGL YLH      ILHRD+K NN+LLD      LADFGLAK   S
Sbjct: 123 -------QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 30/212 (14%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
                +G+G  G VYKA     G+++A+K++      E  +     EI I+      ++V
Sbjct: 32  DVLEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSPHVV 87

Query: 127 KLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAV---GSAQGLAYLHHD 182
           K  G    K+  L ++  Y   G++  +++       E   +IA     + +GL YLH  
Sbjct: 88  KYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED--EIATILQSTLKGLEYLHFM 144

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAPGK 239
                +HRD+K  NILL+++  A LADFG+A  +  T     M++   V G+  ++AP  
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-----MAKRNTVIGTPFWMAP-- 194

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              ++I     N    +D++S G+  +E+  G
Sbjct: 195 ---EVIQEIGYN--CVADIWSLGITAIEMAEG 221

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 49/212 (23%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 65  ECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
           +       IG+G SG VY A ++  G+ +A++++   ++ ++  +    EI ++   ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77

Query: 124 NIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD 182
           NIV  L        +L ++  Y++ G+L  ++     +D      +     Q L +LH +
Sbjct: 78  NIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAPGK 239
               ++HRD+K +NILL       L DFG    +         S+   + G+  ++AP  
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMAPEV 187

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              +  YG       K D++S G++ +E++ G
Sbjct: 188 VT-RKAYGP------KVDIWSLGIMAIEMIEG 212

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 48/176 (27%), Positives = 72/176 (40%), Gaps = 52/176 (29%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNIVKL 128
             IG+G  G V+KA     G+ +A+KK+   + ++E     A  EI+IL  ++H N+V L
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNL 81

Query: 129 LGYCSNKSVKLL----------------LYNYISNGN-----------LQQLLQGNRNLD 161
           +  C  K+                    L   +SN             +Q LL       
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL------- 134

Query: 162 WETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN 217
                        GL Y+H +    ILHRD+K  N+L+       LADFGLA+  +
Sbjct: 135 ------------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 56/212 (26%), Positives = 81/212 (38%), Gaps = 36/212 (16%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGY 131
           IG G  GV          EL+AVK + +    +E V     EI     +RH NIV+    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIINHRSLRHPNIVRFKEV 84

Query: 132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLD-WETRYK----IAVGSAQGLAYLHHDCVPA 186
               +   ++  Y S G L + +         E R+     ++     G++Y H   +  
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYCHSMQI-- 137

Query: 187 ILHRDVKCNNILLDSKYEAYL--ADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----GKC 240
             HRD+K  N LLD      L   DFG +K       H       G+  YIAP     + 
Sbjct: 138 -CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQ- 192

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                  Y     + +DV+S GV L  +L G 
Sbjct: 193 ------EYD---GKIADVWSCGVTLYVMLVGA 215

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 46/224 (20%)

Query: 68  KDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK 127
            +  VIG G  GVV++A++   + +A+KK+ + KR +        E+QI+  ++H N+V 
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVD 96

Query: 128 LLGY-CSNKSVKLLLYNYIS----NGNLQQLL----QGNRNLDWET----RYKIAVGSAQ 174
           L  +  SN   K  ++  +        + +      +  + +         Y++     +
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL----R 152

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGLAKLMNS--TNYHHAMSRVAGS 231
            LAY+H      I HRD+K  N+LLD       L DFG AK++ +   N  +  SR    
Sbjct: 153 SLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR---- 205

Query: 232 YGYIAPGKCKLQIIYG---YTMNITEKSDVYSYGVVLLEILSGR 272
           Y Y AP     ++I+G   YT NI    D++S G V+ E++ G+
Sbjct: 206 Y-YRAP-----ELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.0 bits (219), Expect = 7e-20
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 18/153 (11%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKR--DEEPVDSFAA-EIQILGHIRHRNIV 126
             +G G    VYK      G  +A+K++    +   EE   S A  EI ++  ++H NIV
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIV 66

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA------QGLAYLH 180
           +L      ++   L++ ++ N +L++ +      +     ++ +         QGLA+ H
Sbjct: 67  RLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLA 213
            +    ILHRD+K  N+L++ + +  L DFGLA
Sbjct: 126 ENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 39/213 (18%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G+G + +VY+  +    +  A+K L K   D++ V +   EI +L  + H NI+KL  
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKKIVRT---EIGVLLRLSHPNIIKLKE 115

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW---ETRY--KIAVGS----AQGLAYLHH 181
                +   L+   ++ G L          D    +  Y  + A  +     + +AYLH 
Sbjct: 116 IFETPTEISLVLELVTGGEL---------FDRIVEKGYYSERDAADAVKQILEAVAYLHE 166

Query: 182 DCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
           +    I+HRD+K  N+L  +        +ADFGL+K++        M  V G+ GY AP 
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAP- 219

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
               +I+ G       + D++S G++   +L G
Sbjct: 220 ----EILRG--CAYGPEVDMWSVGIITYILLCG 246

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.0 bits (219), Expect = 8e-20
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 13/156 (8%)

Query: 64  LECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKR--DEEPVDSFAA-EIQILGH 119
           +E     + +G+G    VYK        L+A+K++    R   EE     A  E+ +L  
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKD 56

Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLL-QGNRNLDWETRYKIAVGSAQGLAY 178
           ++H NIV L      +    L++ Y+   +L+Q L      ++            +GLAY
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
            H      +LHRD+K  N+L++ + E  LADFGLA+
Sbjct: 116 CHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 87.7 bits (218), Expect = 9e-20
 Identities = 42/211 (19%), Positives = 86/211 (40%), Gaps = 30/211 (14%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G+G  G+V++  E  + +    K +     D+  V     EI IL   RHRNI+ L  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLHE 68

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY--KIAVGSAQ----GLAYLHHDCV 184
              +    ++++ +IS  ++       R          +  V         L +LH    
Sbjct: 69  SFESMEELVMIFEFISGLDIF-----ERINTSAFELNEREIVSYVHQVCEALQFLHSH-- 121

Query: 185 PAILHRDVKCNNILLDSKYEAYL--ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
             I H D++  NI+  ++  + +   +FG A+ +   +       +  +  Y AP     
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAP----- 172

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           ++       ++  +D++S G ++  +LSG +
Sbjct: 173 EVHQHDV--VSTATDMWSLGTLVYVLLSGIN 201

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 54/301 (17%), Positives = 105/301 (34%), Gaps = 53/301 (17%)

Query: 62  NILECLKDENVIGKGCSGVV----YKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQIL 117
             L  L+   ++    + +        E  +   +  +          P+D+ + +I+ +
Sbjct: 56  KALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRM 115

Query: 118 GHIRHRNIVKLLGYCSNKSVKLLLY---NYISNGNLQQLLQ---GNRNLDWETRYKIAVG 171
                +N V         S K+ LY         NL+  +       + +      I + 
Sbjct: 116 DPFSTKNTVG---QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ 172

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST----------NY 221
            A+ + +LH      ++HRD+K +NI         + DFGL   M+              
Sbjct: 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229

Query: 222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
           +   +   G+  Y++P +        Y    + K D++S G++L E+L   S    ++  
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGN---NY----SHKVDIFSLGLILFELLYSFSTQMERV-- 280

Query: 282 GLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE 341
              I+  V+     F    +    +       MVQ+ML            SP ERP   +
Sbjct: 281 --RIITDVRN--LKFPLLFTQKYPQEH----MMVQDMLSP----------SPTERPEATD 322

Query: 342 V 342
           +
Sbjct: 323 I 323

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 24/210 (11%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTK------RDEEPVDSFAAEIQILGHIRHRNI 125
           +G G  G V+ A      + + VK + K K       ++  +     EI IL  + H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 126 VKLLGYCSNKS-VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCV 184
           +K+L    N+   +L++  + S  +L   +  +  LD      I       + YL     
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD- 150

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
             I+HRD+K  NI++   +   L DFG A  +             G+  Y AP     ++
Sbjct: 151 --IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAP-----EV 200

Query: 245 IYG--YTMNITEKSDVYSYGVVLLEILSGR 272
           + G  Y      + +++S GV L  ++   
Sbjct: 201 LMGNPYR---GPELEMWSLGVTLYTLVFEE 227

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 45/209 (21%), Positives = 90/209 (43%), Gaps = 25/209 (11%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G G  GVV++  E   G +   K +           +   EI I+  + H  ++ L  
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115

Query: 131 YCSNKSVKLLLYNYISNGNL-QQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPA 186
              +K   +L+  ++S G L  ++   +  +   +  ++     Q   GL ++H     +
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVINYMRQACEGLKHMHEH---S 169

Query: 187 ILHRDVKCNNILLDSKYEAYL--ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI 244
           I+H D+K  NI+ ++K  + +   DFGLA  +N       +     +  + AP     +I
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP-----EI 221

Query: 245 IYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +      +   +D+++ GV+   +LSG S
Sbjct: 222 VDR--EPVGFYTDMWAIGVLGYVLLSGLS 248

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 65  ECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
             L     IG+G +G+V  A E  +G  +AVK +   K+     +    E+ I+   +H 
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHF 102

Query: 124 NIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD 182
           N+V++         +L +L  ++  G L  ++   R L+ E    +     Q LAYLH  
Sbjct: 103 NVVEMYK-SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQ 160

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR---VAGSYGYIAPGK 239
               ++HRD+K ++ILL       L+DFG    ++       + +   + G+  ++AP  
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKSLVGTPYWMAPEV 212

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
              + +Y        + D++S G++++E++ G
Sbjct: 213 IS-RSLYAT------EVDIWSLGIMVIEMVDG 237

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 45/213 (21%), Positives = 82/213 (38%), Gaps = 28/213 (13%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAA----EIQILGHIRHR--N 124
           ++G G  G VY    + +   +A+K + K +  +            E+ +L  +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 125 IVKLLGYCSNKSVKLLLYNYISN-GNLQQLLQGNRNLD-WETRYKIAVGSAQGLAYLHHD 182
           +++LL +       +L+        +L   +     L     R        + + + H+ 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 168

Query: 183 CVPAILHRDVKCNNILLDS-KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
            V   LHRD+K  NIL+D  + E  L DFG   L+  T Y        G+  Y  P    
Sbjct: 169 GV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSPP---- 217

Query: 242 LQIIYG--YTMNITEKSDVYSYGVVLLEILSGR 272
            + I    Y       + V+S G++L +++ G 
Sbjct: 218 -EWIRYHRYH---GRSAAVWSLGILLYDMVCGD 246

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 24/210 (11%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVK 127
            IGKG  G V   +     ++ A+K + K    +R+E  V +   E+QI+  + H  +V 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE--VRNVFKELQIMQGLEHPFLVN 79

Query: 128 LLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWE-TRYKIA-VGSAQGLAYLH-HDC 183
           L  Y       + ++ + +  G+L+  LQ N +   E  +  I  +  A  L YL     
Sbjct: 80  LW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA--LDYLQNQR- 135

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I+HRD+K +NILLD     ++ DF +A ++        M+   G+  Y+AP     +
Sbjct: 136 ---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSR 189

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              GY+  +    D +S GV   E+L GR 
Sbjct: 190 KGAGYSFAV----DWWSLGVTAYELLRGRR 215

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 22/210 (10%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR-NIVKLL 129
            +G+G   VV +      G+  A K L K +R ++       EI +L   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPA 186
               N S  +L+  Y + G +  L       +  +   +     Q   G+ YLH +    
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLHQN---N 151

Query: 187 ILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
           I+H D+K  NILL S Y      + DFG+++ +        +  + G+  Y+AP     +
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAP-----E 203

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           I+      IT  +D+++ G++   +L+  S
Sbjct: 204 ILNY--DPITTATDMWNIGIIAYMLLTHTS 231

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 87.2 bits (216), Expect = 7e-19
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 29/212 (13%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHIRHRNIVK 127
           V+GKG  G V   ++   G++ A KKL K    KR          E QIL  +  R +V 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--EAMALNEKQILEKVNSRFVVS 248

Query: 128 LLGYCSNKSVKL-LLYNYISNGNLQQLLQ--GNRNLDWETRYKI-AVGSAQGLAYLHHDC 183
           L  Y       L L+   ++ G+L+  +   G      E R    A     GL  LH + 
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLHRE- 305

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I++RD+K  NILLD      ++D GLA  +             G+ GY+AP     +
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAP-----E 355

Query: 244 II--YGYTMNITEKSDVYSYGVVLLEILSGRS 273
           ++    YT +     D ++ G +L E+++G+S
Sbjct: 356 VVKNERYTFSP----DWWALGCLLYEMIAGQS 383

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.5 bits (212), Expect = 9e-19
 Identities = 53/230 (23%), Positives = 85/230 (36%), Gaps = 60/230 (26%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVK----KLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            +G G   +V K  E   G   A K    +  +  R     +    E+ IL  + H NI+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 127 KLLGYCSNKSVKLLLYNYISNGNL-------------------QQLLQGNRNLDWETRYK 167
            L     N++  +L+   +S G L                   +Q+L G           
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG----------- 127

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY----LADFGLAKLMNSTNYHH 223
                   + YLH      I H D+K  NI+L  K        L DFGLA  +       
Sbjct: 128 --------VNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--- 173

Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               + G+  ++AP     +I+      +  ++D++S GV+   +LSG S
Sbjct: 174 EFKNIFGTPEFVAP-----EIVNY--EPLGLEADMWSIGVITYILLSGAS 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 84.9 bits (211), Expect = 9e-19
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 20/159 (12%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA----EIQIL---GHIRH 122
             IG G  G VYKA +  +G  +A+K + +                 E+ +L       H
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEH 73

Query: 123 RNIVKLL----GYCSNKSVKLLL-YNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQG 175
            N+V+L+       +++ +K+ L + ++   +L+  L       L  ET   +     +G
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
           L +LH +C   I+HRD+K  NIL+ S     LADFGLA+
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 85.5 bits (212), Expect = 9e-19
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 67  LKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           +    ++G G  G V+K  E   G  +A K +      +   +    EI ++  + H N+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANL 148

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNL-QQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHH 181
           ++L     +K+  +L+  Y+  G L  +++  + NL   T     +   Q   G+ ++H 
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL---TELDTILFMKQICEGIRHMHQ 205

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYL--ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
                ILH D+K  NIL  ++    +   DFGLA+          +    G+  ++AP  
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAP-- 257

Query: 240 CKLQII-YGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +++ Y +   ++  +D++S GV+   +LSG S
Sbjct: 258 ---EVVNYDF---VSFPTDMWSVGVIAYMLLSGLS 286

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 38/175 (21%), Positives = 71/175 (40%), Gaps = 26/175 (14%)

Query: 73  IGKGCSGVVYKA---EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           +G+G  G VYKA   +  + +  A+K++   +     + +   EI +L  ++H N++ L 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACR-EIALLRELKHPNVISLQ 84

Query: 130 GYCSNKSVKLL----------LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYL 179
               + + + +          L++ I      +  +    L       +      G+ YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAY----LADFGLAKLMNS--TNYHHAMSRV 228
           H +    +LHRD+K  NIL+  +        +AD G A+L NS           V
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 46/235 (19%), Positives = 85/235 (36%), Gaps = 70/235 (29%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAA----EIQIL----GHIRH 122
           ++GKG  G V+    + +   +A+K + + +       S +     E+ +L        H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 123 RNIVKLLGYCSNKSVKLL----------LYNYI-SNGNL---------QQLLQGNRNLDW 162
             +++LL +   +   +L          L++YI   G L          Q++        
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA------ 151

Query: 163 ETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTNY 221
                        + + H   V   +HRD+K  NIL+D +   A L DFG   L++   Y
Sbjct: 152 -------------IQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195

Query: 222 HHAMSRVAGSYGYIAP----GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
                   G+  Y  P              Y       + V+S G++L +++ G 
Sbjct: 196 TDF----DGTRVYSPPEWISRH-------QYH---ALPATVWSLGILLYDMVCGD 236

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 28/214 (13%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVK----KLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            +G G   +V K  E   G   A K    +  +  R     +    E+ IL  + H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDC 183
            L     N++  +L+   +S G L   L    +L   +  +      Q   G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILDGVNYLHTK- 134

Query: 184 VPAILHRDVKCNNILLDSKYEAY----LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
              I H D+K  NI+L  K        L DFGLA  +           + G+  ++AP  
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAP-- 187

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
              +I+      +  ++D++S GV+   +LSG S
Sbjct: 188 ---EIVNY--EPLGLEADMWSIGVITYILLSGAS 216

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 49/230 (21%), Positives = 87/230 (37%), Gaps = 53/230 (23%)

Query: 70  ENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVK 127
           E+V+G+G    V     +   +  AVK +   K+          E+++L   + HRN+++
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKI-AVGS-------------A 173
           L+ +   +    L++  +  G++         L       I                  A
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSI---------LS-----HIHKRRHFNELEASVVVQDVA 121

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHH-----AM 225
             L +LH+     I HRD+K  NIL +   +     + DF L   +             +
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 226 SRVAGSYGYIAP----GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
               GS  Y+AP       +   IY       ++ D++S GV+L  +LSG
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYD------KRCDLWSLGVILYILLSG 222

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 46/249 (18%)

Query: 42  EDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK- 99
                 W ++  Q +    D      +   V+G+G  G V+  +M   G+L A KKL K 
Sbjct: 168 FLRFLQWKWLEAQPM--GEDW-FLDFR---VLGRGGFGEVFACQMKATGKLYACKKLNKK 221

Query: 100 --TKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL-LLYNYISNGNL----QQ 152
              KR          E +IL  +  R IV L  Y       L L+   ++ G++      
Sbjct: 222 RLKKRKG--YQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYN 278

Query: 153 LLQGNRNLDWETR---YKIAVGSAQ---GLAYLHHDCVPAILHRDVKCNNILLDSKYEAY 206
           + + N     E R   Y     +AQ   GL +LH      I++RD+K  N+LLD      
Sbjct: 279 VDEDNPGFQ-EPRAIFY-----TAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329

Query: 207 LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII--YGYTMNITEKSDVYSYGVV 264
           ++D GLA                G+ G++AP     +++    Y  ++    D ++ GV 
Sbjct: 330 ISDLGLAVE-LKAGQTKTKGYA-GTPGFMAP-----ELLLGEEYDFSV----DYFALGVT 378

Query: 265 LLEILSGRS 273
           L E+++ R 
Sbjct: 379 LYEMIAARG 387

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 55/230 (23%), Positives = 89/230 (38%), Gaps = 60/230 (26%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVK----KLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            +G G   +V K  +   G+  A K    +   + R     +    E+ IL  IRH NI+
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 127 KLLGYCSNKSVKLLLYNYISNGNL-------------------QQLLQGNRNLDWETRYK 167
            L     NK+  +L+   +S G L                   +Q+L G           
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG----------- 120

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY----LADFGLAKLMNSTNYHH 223
                   + YLH      I H D+K  NI+L  K        L DFG+A  + + N   
Sbjct: 121 --------VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--- 166

Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               + G+  ++AP     +I+      +  ++D++S GV+   +LSG S
Sbjct: 167 EFKNIFGTPEFVAP-----EIVNY--EPLGLEADMWSIGVITYILLSGAS 209

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 18/157 (11%)

Query: 71  NVIGKGCSGVVYKA--EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQIL---GHIRHRN 124
             IG+G  G V+KA      G  +A+K++ + +  EE +      E+ +L       H N
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75

Query: 125 IVKLL----GYCSNKSVKLLL-YNYISNGNLQQLL--QGNRNLDWETRYKIAVGSAQGLA 177
           +V+L        +++  KL L + ++   +L   L       +  ET   +     +GL 
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
           +LH      ++HRD+K  NIL+ S  +  LADFGLA+
Sbjct: 135 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 82.6 bits (205), Expect = 3e-18
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +G G  G V   E    G  +AVK L + K R  + V     EIQ L   RH +I+KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 131 YCSNKSVKLLLYNYISNGNL-QQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPA 186
             S  +   ++  Y+S G L   + +  R  + E R        Q    + Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ----QILSAVDYCHRHM--- 131

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           ++HRD+K  N+LLD+   A +ADFGL+ +M+   +        GS  Y AP     ++I 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNYAAP-----EVIS 183

Query: 247 G--YTMNITEKSDVYSYGVVLLEILSGR 272
           G  Y      + D++S GV+L  +L G 
Sbjct: 184 GRLYA---GPEVDIWSCGVILYALLCGT 208

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 29/216 (13%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G    V   +M   G++ A+K + K    KR E  V  F  E  +L +   R I +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE--VSCFREERDVLVNGDRRWITQ 125

Query: 128 LLGYCSNKSVKL-LLYNYISNGNLQQLLQ--GNRNLDWETRYKIA-VGSAQGLAYLHHDC 183
           L  +       L L+  Y   G+L  LL   G R      R+ +A +  A  +  +H   
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA--IDSVHRL- 181

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP------ 237
               +HRD+K +NILLD      LADFG    + +     ++  V G+  Y++P      
Sbjct: 182 --GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAV 238

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           G       YG         D ++ GV   E+  G++
Sbjct: 239 GGGPGTGSYGPEC------DWWALGVFAYEMFYGQT 268

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 50/252 (19%), Positives = 99/252 (39%), Gaps = 69/252 (27%)

Query: 68  KDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-EIQILGHIRHRNI 125
                +G G  G+V +  ++ +G+  A+KK+ +  R       +   E+ I+  + H NI
Sbjct: 10  SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNI 62

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDW----------------------E 163
           +KL+ Y      +        + + +   + N   +                       +
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 164 TRYKIA---VGSAQ----------------GLAYLHHDCVPAILHRDVKCNNILLDSK-Y 203
           T +K+    + S +                 + ++H      I HRD+K  N+L++SK  
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDN 179

Query: 204 EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG---YTMNITEKSDVYS 260
              L DFG AK +  +     ++ +   + Y AP     +++ G   YT +I    D++S
Sbjct: 180 TLKLCDFGSAKKLIPSEPS--VAYICSRF-YRAP-----ELMLGATEYTPSI----DLWS 227

Query: 261 YGVVLLEILSGR 272
            G V  E++ G+
Sbjct: 228 IGCVFGELILGK 239

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.1 bits (208), Expect = 6e-18
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +G G  G V   +    G  +AVK L + K R  + V     EIQ L   RH +I+KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-WETRYK----IAVGSAQGLAYLHHDCVP 185
             S  S   ++  Y+S G L   +  N  LD  E+R      ++     G+ Y H   V 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GVDYCHRHMV- 137

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRD+K  N+LLD+   A +ADFGL+ +M+   +        GS  Y AP     ++I
Sbjct: 138 --VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNYAAP-----EVI 187

Query: 246 YG--YTMNITEKSDVYSYGVVLLEILSGR 272
            G  Y      + D++S GV+L  +L G 
Sbjct: 188 SGRLYA---GPEVDIWSSGVILYALLCGT 213

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 75/360 (20%), Positives = 124/360 (34%), Gaps = 109/360 (30%)

Query: 65  ECLKDENVIGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           + LK    +G+G  G V +A+            +AVK L K         +  +E++IL 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILI 80

Query: 119 HI-RHRNIVKLLGYCSNKSVKLLL-YNYISNGNLQQLLQGNRN----------------- 159
           HI  H N+V LLG C+     L++   +   GNL   L+  RN                 
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140

Query: 160 ------LDWETRYKIAVGS----------AQGLAYLHHDCVPAILHRDVKCNNILLDSKY 203
                 +D + R      S           + L+ +  +  P  L++D      L+   +
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200

Query: 204 E-----AYLA-------------------------DFGLAKLMNSTNYHHAMSRVAGSYG 233
           +      +LA                         DFGLA+ +                 
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------------ 248

Query: 234 YIAPGKCKLQI----IYGYTMNI-TEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
           Y+  G  +L +           + T +SDV+S+GV+L EI S  ++  P +         
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308

Query: 289 VKK--KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +K+  +M                   +M Q ML        C +  P++RPT  E+V  L
Sbjct: 309 LKEGTRM-----------RAPDYTTPEMYQTMLD-------CWHGEPSQRPTFSELVEHL 350

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 64/254 (25%), Positives = 119/254 (46%), Gaps = 46/254 (18%)

Query: 34  MSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELI 92
           MS+ PP    F         Q++  T   +    +D   +G G  G V  A +   G  +
Sbjct: 1   MSSPPPARSGFYR-------QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKV 53

Query: 93  AVKKLWKTKRDEEPVDSFAA----EIQILGHIRHRNIVKLLG-YCSNKSVKLLLYNYIS- 146
           A+KKL++  + E     FA     E+++L H+RH N++ LL  +  ++++      Y+  
Sbjct: 54  AIKKLYRPFQSE----LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109

Query: 147 ---NGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHHDCVPAILHRDVKCNNILLD 200
                +L +L++  +  +   ++ +     Q   GL Y+H      I+HRD+K  N+ ++
Sbjct: 110 PFMGTDLGKLMKHEKLGEDRIQFLVY----QMLKGLRYIHA---AGIIHRDLKPGNLAVN 162

Query: 201 SKYEAYLADFGLAKLMNS--TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDV 258
              E  + DFGLA+  +S  T Y      V   + Y AP     ++I  + M  T+  D+
Sbjct: 163 EDCELKILDFGLARQADSEMTGY------VVTRW-YRAP-----EVILNW-MRYTQTVDI 209

Query: 259 YSYGVVLLEILSGR 272
           +S G ++ E+++G+
Sbjct: 210 WSVGCIMAEMITGK 223

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 50/222 (22%), Positives = 83/222 (37%), Gaps = 54/222 (24%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH-IRHRNIVKL 128
             IG G   V  +          AVK + K+KRD         EI+IL    +H NI+ L
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQHPNIITL 81

Query: 129 LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS-------------AQG 175
                +     ++   +  G L         LD      +                  + 
Sbjct: 82  KDVYDDGKYVYVVTELMKGGEL---------LD----KILRQKFFSEREASAVLFTITKT 128

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAY----LADFGLAKLMNSTNYHHAMSRVAGS 231
           + YLH      ++HRD+K +NIL   +        + DFG AK + + N    +     +
Sbjct: 129 VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYT 183

Query: 232 YGYIAPGKCKLQIIY--GYTMNITEKSDVYSYGVVLLEILSG 271
             ++AP     +++   GY        D++S GV+L  +L+G
Sbjct: 184 ANFVAP-----EVLERQGY----DAACDIWSLGVLLYTMLTG 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 48/225 (21%), Positives = 84/225 (37%), Gaps = 58/225 (25%)

Query: 70  ENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVK 127
           +  +G+G   +  K     + +  AVK +  +KR E        EI  L     H NIVK
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQK---EITALKLCEGHPNIVK 70

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKI-AVGS-------------A 173
           L     ++    L+   ++ G L          +     +I                   
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGEL---------FE-----RIKKKKHFSETEASYIMRKLV 116

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAG 230
             ++++H      ++HRD+K  N+L   + +     + DFG A+L    N    +     
Sbjct: 117 SAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCF 171

Query: 231 SYGYIAPGKCKLQII----YGYTMNITEKSDVYSYGVVLLEILSG 271
           +  Y AP     +++    Y       E  D++S GV+L  +LSG
Sbjct: 172 TLHYAAP-----ELLNQNGYD------ESCDLWSLGVILYTMLSG 205

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 52/233 (22%), Positives = 95/233 (40%), Gaps = 49/233 (21%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTK------------------------RDEEPV 107
           IGKG  GVV  A    +    A+K L K K                        +   P+
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 108 DSFAAEIQILGHIRHRNIVKL---LGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWET 164
           +    EI IL  + H N+VKL   L   +   + ++    ++ G + ++       + + 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVF-ELVNQGPVMEVPTLKPLSEDQA 139

Query: 165 RYK----IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN 220
           R+     I      G+ YLH+     I+HRD+K +N+L+       +ADFG++     ++
Sbjct: 140 RFYFQDLIK-----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNIT-EKSDVYSYGVVLLEILSGR 272
               +S   G+  ++AP     + +       + +  DV++ GV L   + G+
Sbjct: 192 AL--LSNTVGTPAFMAP-----ESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 55/222 (24%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
           +G+G  G V  A      + +A+K + +   +  +       EI  L  +RH +I+KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 131 YCSNKSVKLL--------LYNYI-SNGNL---------QQLLQGNRNLDWETRYKIAVGS 172
             +  +  ++        L++YI     +         QQ++                  
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA---------------- 120

Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
              + Y H      I+HRD+K  N+LLD      +ADFGL+ +M   N+        GS 
Sbjct: 121 ---IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSP 171

Query: 233 GYIAPGKCKLQIIYG--YTMNITEKSDVYSYGVVLLEILSGR 272
            Y AP     ++I G  Y      + DV+S G+VL  +L GR
Sbjct: 172 NYAAP-----EVINGKLYA---GPEVDVWSCGIVLYVMLVGR 205

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 28/216 (12%)

Query: 70  ENVIGKGCSGVVYKA-EMPNGELIAVK----KLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
              +G G   VV K  E   G   A K    +  K+ R     +    E+ IL  I+H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ---GLAYLHH 181
           ++ L     NK+  +L+   ++ G L   L    +L   T  +      Q   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYYLHS 132

Query: 182 DCVPAILHRDVKCNNILLDSKYEAY----LADFGLAKLMNSTNYHHAMSRVAGSYGYIAP 237
                I H D+K  NI+L  +        + DFGLA  ++  N       + G+  ++AP
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAP 186

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
                +I+      +  ++D++S GV+   +LSG S
Sbjct: 187 -----EIVNY--EPLGLEADMWSIGVITYILLSGAS 215

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 29/215 (13%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G V   ++    ++ A+K L K    KR E     F  E  +L +   + I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE--TACFREERDVLVNGDSKWITT 138

Query: 128 LLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQGLAYLH-HD 182
           L  Y       L L+ +Y   G+L  LL    +   E     Y   +  A  +  +H   
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA--IDSVHQLH 195

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP----G 238
                +HRD+K +NIL+D      LADFG    +       +   V G+  YI+P     
Sbjct: 196 ----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 250

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +  YG         D +S GV + E+L G +
Sbjct: 251 MEGGKGRYGPEC------DWWSLGVCMYEMLYGET 279

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 52/242 (21%), Positives = 95/242 (39%), Gaps = 44/242 (18%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAA- 112
           + L   +  +      +  I  G  G V       G  +A+K+++ T  D   V+  +  
Sbjct: 11  RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 113 --------EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS----NGNLQQLLQGNRNL 160
                   EI++L H  H NI+ L     +     +   Y+       +L Q++   R +
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV 130

Query: 161 --DWETRYKIAVGSAQ---GLAYLHHDCVPA-ILHRDVKCNNILLDSKYEAYLADFGLAK 214
                 +Y +         GL  LH     A ++HRD+   NILL    +  + DF LA+
Sbjct: 131 ISPQHIQYFMY----HILLGLHVLH----EAGVVHRDLHPGNILLADNNDITICDFNLAR 182

Query: 215 LMNS----TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS 270
              +    T+Y      V   + Y AP     +++  +    T+  D++S G V+ E+ +
Sbjct: 183 EDTADANKTHY------VTHRW-YRAP-----ELVMQF-KGFTKLVDMWSAGCVMAEMFN 229

Query: 271 GR 272
            +
Sbjct: 230 RK 231

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 58/245 (23%), Positives = 104/245 (42%), Gaps = 32/245 (13%)

Query: 38  PPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKK 96
            P     S      P Q      ++  +  K   ++G+G    V  A E+      A+K 
Sbjct: 7   EPRPGAGSLQHAQPPPQPRKKRPED-FKFGK---ILGEGSFSTVVLARELATSREYAIKI 62

Query: 97  LWKT---KRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQ 152
           L K    K ++  V     E  ++  + H   VKL     +   KL    +Y  NG L +
Sbjct: 63  LEKRHIIKENK--VPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLK 119

Query: 153 LLQGNRNLDWE-TRYKIA-VGSAQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLAD 209
            ++   + D   TR+  A + SA  L YLH       I+HRD+K  NILL+      + D
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSA--LEYLHGKG----IIHRDLKPENILLNEDMHIQITD 173

Query: 210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY--GYTMNITEKSDVYSYGVVLLE 267
           FG AK+++  +     +   G+  Y++P     +++       +    SD+++ G ++ +
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSP-----ELLTEKSACKS----SDLWALGCIIYQ 224

Query: 268 ILSGR 272
           +++G 
Sbjct: 225 LVAGL 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 32/219 (14%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHI 120
           E LK   ++GKG  G V   +    G   A+K L K     +DE  V     E ++L + 
Sbjct: 151 EYLK---LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNS 205

Query: 121 RHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQGL 176
           RH  +  L  Y      +L  +  Y + G L   L   R    E R   Y   + SA  L
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFS-EDRARFYGAEIVSA--L 261

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
            YLH +    +++RD+K  N++LD      + DFGL K          M    G+  Y+A
Sbjct: 262 DYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLA 317

Query: 237 PGKCKLQII--YGYTMNITEKSDVYSYGVVLLEILSGRS 273
           P     +++    Y   +    D +  GVV+ E++ GR 
Sbjct: 318 P-----EVLEDNDYGRAV----DWWGLGVVMYEMMCGRL 347

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVK 127
           VIG+G  G V         ++ A+K L K    KR +     F  E  I+       +V+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD--SAFFWEERDIMAFANSPWVVQ 133

Query: 128 LLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKIA-VGSAQGLAYLHHDCVP 185
           L  Y       L ++  Y+  G+L  L+      +   R+  A V  A  L  +H     
Sbjct: 134 LF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA--LDAIHSM--- 187

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
             +HRDVK +N+LLD      LADFG    MN        + V G+  YI+P     +++
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP-----EVL 241

Query: 246 --YGYTMNITEKSDVYSYGVVLLEILSGRS 273
              G       + D +S GV L E+L G +
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 79.2 bits (196), Expect = 9e-17
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 57/221 (25%)

Query: 73  IGKGCSGVVYKA-EMPNGELIAVKKL-----WKTKRDEEPVDSFAAEIQILGHIR-HRNI 125
           +G+G    V++A  + N E + VK L      K KR          EI+IL ++R   NI
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----------EIKILENLRGGPNI 93

Query: 126 VKLL----GYCSNKSVKLLLYNYISNGNLQQLLQGNRNL-DWETRYKIAVGSAQ---GLA 177
           + L        S      L++ +++N + +QL Q    L D++ R+ +     +    L 
Sbjct: 94  ITLADIVKDPVSRTPA--LVFEHVNNTDFKQLYQ---TLTDYDIRFYMY----EILKALD 144

Query: 178 YLH-HDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMN-STNYHHAMSRVAGSYGY 234
           Y H       I+HRDVK +N+++D ++ +  L D+GLA+  +    Y+    RVA  Y +
Sbjct: 145 YCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RVASRY-F 196

Query: 235 IAPGKCKLQIIYG---YTMNITEKSDVYSYGVVLLEILSGR 272
             P     +++     Y  ++    D++S G +L  ++  +
Sbjct: 197 KGP-----ELLVDYQMYDYSL----DMWSLGCMLASMIFRK 228

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 35/220 (15%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHI 120
           + LK   ++GKG  G V        G   A+K L K     +DE  V     E ++L + 
Sbjct: 8   DYLK---LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNT 62

Query: 121 RHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQGL 176
           RH  +  L  Y      +L  +  Y + G L   L   R    E R   Y   + SA  L
Sbjct: 63  RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARFYGAEIVSA--L 118

Query: 177 AYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
            YLH  D    +++RD+K  N++LD      + DFGL K     +    M    G+  Y+
Sbjct: 119 EYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 172

Query: 236 APGKCKLQII--YGYTMNITEKSDVYSYGVVLLEILSGRS 273
           AP     +++    Y   +    D +  GVV+ E++ GR 
Sbjct: 173 AP-----EVLEDNDYGRAV----DWWGLGVVMYEMMCGRL 203

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 32/214 (14%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKT---KRDEEPVDSFAAEIQILGHI---RHRN 124
           +IG+G  G VY       G++ A+K L K     +          E  +L  +       
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPF 253

Query: 125 IVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYKI-AVGSAQGLAYLHHD 182
           IV +  Y  +   KL  + + ++ G+L   L  +     E   +  A     GL ++H+ 
Sbjct: 254 IVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMHNR 311

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
               +++RD+K  NILLD      ++D GLA   +        + V G++GY+AP     
Sbjct: 312 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAP----- 359

Query: 243 QII---YGYTMNITEKSDVYSYGVVLLEILSGRS 273
           +++     Y  +     D +S G +L ++L G S
Sbjct: 360 EVLQKGVAYDSSA----DWFSLGCMLFKLLRGHS 389

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 77.0 bits (190), Expect = 5e-16
 Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 48/222 (21%)

Query: 69  DENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIV 126
            + V+G G +G V +      G+  A+K L+ + +  +       E+          +IV
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-------EVDHHWQASGGPHIV 85

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-----WETRY------KIAVGSAQG 175
            +L    N          I    + + ++G           +  +      +I       
Sbjct: 86  CILDVYENMHHGKRCL-LI----IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSY 232
           + +LH      I HRDVK  N+L  SK +     L DFG AK        +A+     + 
Sbjct: 141 IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTP 193

Query: 233 GYIAP---GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
            Y+AP   G  K    Y       +  D++S GV++  +L G
Sbjct: 194 YYVAPEVLGPEK----YD------KSCDMWSLGVIMYILLCG 225

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 38/228 (16%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA--EI 114
           + +    + L     +G G  G V  A +   G  +AVKKL +  +    + +     E+
Sbjct: 25  WEVPERYQNLS---PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYREL 79

Query: 115 QILGHIRHRNIVKLLG-YCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWETRYKIA 169
           ++L H++H N++ LL  +   +S++     Y+       +L  +++  +  D   ++ I 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139

Query: 170 VGSAQ---GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHA 224
               Q   GL Y+H      I+HRD+K +N+ ++   E  + DFGLA+      T Y   
Sbjct: 140 ----QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--- 189

Query: 225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              VA  + Y AP     +I+  + M+  +  D++S G ++ E+L+GR
Sbjct: 190 ---VATRW-YRAP-----EIMLNW-MHYNQTVDIWSVGCIMAELLTGR 227

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 57/229 (24%), Positives = 108/229 (47%), Gaps = 45/229 (19%)

Query: 62  NILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA----EIQI 116
            +L+  ++   IG G  G+V  A +      +A+KKL +  +++    + A     E+ +
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ----THAKRAYRELVL 114

Query: 117 LGHIRHRNIVKLLG-YCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWETR----YK 167
           +  + H+NI+ LL  +   K+++     Y+     + NL Q++Q    LD E      Y+
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQ 172

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS----TNYHH 223
           +  G    + +LH   +   +HRD+K +NI++ S     + DFGLA+   +    T Y  
Sbjct: 173 MLCG----IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-- 223

Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
               V   Y Y AP   ++ +  GY  N+    D++S G ++ E++  +
Sbjct: 224 ----VVTRY-YRAP---EVILGMGYKENV----DIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 40/226 (17%)

Query: 62  NILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA----EIQI 116
            + +       +G G  G V  A +  +GE +A+KKL +  + E     FA     E+ +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----IFAKRAYRELLL 76

Query: 117 LGHIRHRNIVKLLG-YCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWETRYKIAVG 171
           L H++H N++ LL  +    S++     Y+       +LQ+++      + + +Y +   
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF-SEEKIQYLVY-- 133

Query: 172 SAQ---GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMS 226
             Q   GL Y+H      ++HRD+K  N+ ++   E  + DFGLA+  ++  T Y     
Sbjct: 134 --QMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY----- 183

Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            V   + Y AP     ++I  + M+  +  D++S G ++ E+L+G+
Sbjct: 184 -VVTRW-YRAP-----EVILSW-MHYNQTVDIWSVGCIMAEMLTGK 221

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 53/301 (17%), Positives = 92/301 (30%), Gaps = 78/301 (25%)

Query: 30  KASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPN 88
             S            S P   +P    ++ I +  E      +IG G  G V +A +   
Sbjct: 21  SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH---LIGTGSYGHVCEAYDKLE 77

Query: 89  GELIAVKKLWKTKRDEEPVDSFAA----EIQILGHIRHRNIVKLL------GYCSNKSVK 138
             ++A+KK+ +   D             EI IL  + H ++VK+L             + 
Sbjct: 78  KRVVAIKKILRVFEDL----IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133

Query: 139 LL-------LYNYI-SNGNLQ---------QLLQGNRNLDWETRYKIAVGSAQGLAYLH- 180
           ++             +   L           LL                    G+ Y+H 
Sbjct: 134 VVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL-------------------VGVKYVHS 174

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                 ILHRD+K  N L++      + DFGLA+ ++     ++   ++     +     
Sbjct: 175 AG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 241 KLQIIYGYTM-------------------NITEKSDVYSYGVVLLEILSGRSAVQPQIGD 281
                    +                   N TE  DV+S G +  E+L+          D
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

Query: 282 G 282
            
Sbjct: 291 R 291

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 60/262 (22%), Positives = 108/262 (41%), Gaps = 35/262 (13%)

Query: 23  NHRYKVEKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVY 82
             +++  K    +  P      +         +    + +    L    V+GKG  G V 
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-FNFLM---VLGKGSFGKVM 358

Query: 83  KAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV 137
            +E     EL AVK L K    + D+  V+    E ++L    +   + +L   C     
Sbjct: 359 LSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKPPFLTQLH-SCFQTMD 415

Query: 138 KL-LLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQGLAYLHHDCVPAILHRDVK 193
           +L  +  Y++ G+L   +Q       E     Y   +     L +L       I++RD+K
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGRFK-EPHAVFYAAEIAIG--LFFLQSK---GIIYRDLK 469

Query: 194 CNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII--YGYTMN 251
            +N++LDS+    +ADFG+ K   +           G+  YIAP     +II    Y  +
Sbjct: 470 LDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAP-----EIIAYQPYGKS 522

Query: 252 ITEKSDVYSYGVVLLEILSGRS 273
           +    D +++GV+L E+L+G++
Sbjct: 523 V----DWWAFGVLLYEMLAGQA 540

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 49/253 (19%), Positives = 96/253 (37%), Gaps = 43/253 (16%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA--- 112
           N  + +         +IG+G  G VY A +    + +A+KK+ +   D            
Sbjct: 21  NVHVPDNYIIKH---LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL----IDCKRIL 73

Query: 113 -EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWE-TRY 166
            EI IL  ++   I++L        +      YI     + +L++L +    L  E  + 
Sbjct: 74  REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT 133

Query: 167 KIAVGSAQ---GLAYLHHDCVPA-ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
            +         G  ++H     + I+HRD+K  N LL+      + DFGLA+ +NS    
Sbjct: 134 ILY----NLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 223 HAMSRVAGSYGYIAPGKCKLQIIYGY--------------TMNITEKSDVYSYGVVLLEI 268
           + ++ +  +       K   + +  +                N T+  D++S G +  E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 269 LSGRSAVQPQIGD 281
           L+   +      +
Sbjct: 246 LNMLQSHINDPTN 258

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 50/222 (22%), Positives = 82/222 (36%), Gaps = 47/222 (21%)

Query: 69  DENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIV 126
              V+G G +G V +       E  A+K L    +          E+++     +  +IV
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------EVELHWRASQCPHIV 118

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-----WETRY------KIAVGSAQG 175
           +++    N          I    + + L G           +  +      +I     + 
Sbjct: 119 RIVDVYEN-LYAGRKCLLI----VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAY---LADFGLAKLMNSTNYHHAMSRVAGSY 232
           + YLH      I HRDVK  N+L  SK       L DFG AK   S N   +++    + 
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTP 227

Query: 233 GYIAP---GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG 271
            Y+AP   G  K    Y       +  D++S GV++  +L G
Sbjct: 228 YYVAPEVLGPEK----YD------KSCDMWSLGVIMYILLCG 259

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 61/237 (25%), Positives = 111/237 (46%), Gaps = 45/237 (18%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
            ++  +   +L+  ++   IG G  G+V  A +      +A+KKL +  +++    + A 
Sbjct: 14  VEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ----THAK 69

Query: 113 ----EIQILGHIRHRNIVKLLG-YCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWE 163
               E+ ++  + H+NI+ LL  +   KS++     YI     + NL Q++Q    LD E
Sbjct: 70  RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHE 127

Query: 164 TR----YKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS- 218
                 Y++      G+ +LH      I+HRD+K +NI++ S     + DFGLA+   + 
Sbjct: 128 RMSYLLYQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180

Query: 219 ---TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              T Y      V   Y Y AP   ++ +  GY  N+    D++S G ++ E++ G 
Sbjct: 181 FMMTPY------VVTRY-YRAP---EVILGMGYKENV----DIWSVGCIMGEMIKGG 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 31/232 (13%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           + +   + ++     + + IG+G  G+V  A +  N   +A+KK+      E        
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI---SPFEHQTYCQRT 72

Query: 113 --EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWETRY 166
             EI+IL   RH NI+ +       +++ +   YI       +L +LL+     +    Y
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132

Query: 167 KIAVGSAQ---GLAYLHHDCVPA-ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH 222
            +     Q   GL Y+H     A +LHRD+K +N+LL++  +  + DFGLA++ +  + H
Sbjct: 133 FLY----QILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

Query: 223 -HAMSR-VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
              ++  VA  + Y AP     +I+       T+  D++S G +L E+LS R
Sbjct: 185 TGFLTEYVATRW-YRAP-----EIMLNS-KGYTKSIDIWSVGCILAEMLSNR 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 55/245 (22%), Positives = 98/245 (40%), Gaps = 35/245 (14%)

Query: 37  LPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVK 95
           L    EDF   W           +D   + +K    +G G  G V   +   +G   A+K
Sbjct: 19  LAKAKEDFLKKWETPSQNTA--QLDQ-FDRIK---TLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 96  KLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQ 152
            L K    K  +  ++    E +IL  +    +VKL     + S   ++  Y++ G +  
Sbjct: 73  ILDKQKVVKLKQ--IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 153 LLQGNRNLDWET-RYKIA-VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF 210
            L+          R+  A +       YLH      +++RD+K  N+L+D +    + DF
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLT--FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY--GYTMNITEKSDVYSYGVVLLEI 268
           G AK +    +      + G+   +AP     +II   GY   +    D ++ GV++ E+
Sbjct: 186 GFAKRVKGRTW-----TLCGTPEALAP-----EIILSKGYNKAV----DWWALGVLIYEM 231

Query: 269 LSGRS 273
            +G  
Sbjct: 232 AAGYP 236

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 33/212 (15%)

Query: 72  VIGKGCSGVVYKAEM-PNGELIAVKKLWKT---KRDEEPVDSFAAEIQILGHIRHRNIVK 127
            +G G  G V+      NG   A+K L K    +  +  V+    E  +L  + H  I++
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ--VEHTNDERLMLSIVTHPFIIR 70

Query: 128 LLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWE-TRYKIA-VGSAQGLAYLH-HDC 183
           + G   +   ++ ++ +YI  G L  LL+ ++       ++  A V  A  L YLH  D 
Sbjct: 71  MWGTFQDAQ-QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA--LEYLHSKD- 126

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I++RD+K  NILLD      + DFG AK +    Y      + G+  YIAP     +
Sbjct: 127 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAP-----E 173

Query: 244 II--YGYTMNITEKSDVYSYGVVLLEILSGRS 273
           ++    Y  +I    D +S+G+++ E+L+G +
Sbjct: 174 VVSTKPYNKSI----DWWSFGILIYEMLAGYT 201

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 28/291 (9%), Positives = 76/291 (26%), Gaps = 64/291 (21%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLW-KTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             G       ++A        +A+  +  +    ++ +    +    L  I    + ++L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
                ++  L++  +I  G+LQ++   +         +     A      H      +  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVAL 152

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
                + + +    +  LA                          +              
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA----------- 179

Query: 250 MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
                + D+   G  L  +L  R    P    G+                ++  +    G
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRW---PLPEAGV-------------RSGLAPAERDTAG 220

Query: 310 L---PDQMVQEMLQTL-GIAMFCVNSSPAERPTMKEVVALLMEVKSAPEEL 356
               P  + +++   +  +A   V      R     ++ L+ +  +  +  
Sbjct: 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIRSAS-TLLNLMQQATAVADRT 270

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 37/234 (15%)

Query: 52  PFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPV 107
           P  ++   I++     K   ++GKG  G V+ AE     +  A+K L K      D+  V
Sbjct: 8   PSLQIKLKIED-FILHK---MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD--V 61

Query: 108 DSFAAEIQILGH-IRHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR 165
           +    E ++L     H  +  +          L  +  Y++ G+L   +Q     D  +R
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-LSR 119

Query: 166 ---YKIAVGSAQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY 221
              Y   +     L +LH       I++RD+K +NILLD      +ADFG+ K   +   
Sbjct: 120 ATFYAAEIILG--LQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLG 171

Query: 222 HHAMSRVAGSYGYIAPGKCKLQII--YGYTMNITEKSDVYSYGVVLLEILSGRS 273
               +   G+  YIAP     +I+    Y  ++    D +S+GV+L E+L G+S
Sbjct: 172 DAKTNTFCGTPDYIAP-----EILLGQKYNHSV----DWWSFGVLLYEMLIGQS 216

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 54/256 (21%), Positives = 110/256 (42%), Gaps = 75/256 (29%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           +++ + I +  +      ++G+G  GVV  A   P GE++A+KK+   +  ++P+ +   
Sbjct: 3   KRIVYNISSDFQLKS---LLGEGAYGVVCSATHKPTGEIVAIKKI---EPFDKPLFALRT 56

Query: 113 --EIQILGHIRHRNIVKLL------GYCSNKSVKLL-------LYNYISNGNLQ------ 151
             EI+IL H +H NI+ +        + +   V ++       L+  IS   L       
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116

Query: 152 ---QLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA-ILHRDVKCNNILLDSKYEAYL 207
              Q L+                    +  LH     + ++HRD+K +N+L++S  +  +
Sbjct: 117 FIYQTLRA-------------------VKVLH----GSNVIHRDLKPSNLLINSNCDLKV 153

Query: 208 ADFGLAKLMNSTNYHHAMSRVAGSY--GYI------APGKCKLQIIYG---YTMNITEKS 256
            DFGLA++++ +   ++      S    ++      AP     +++     Y+  +    
Sbjct: 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP-----EVMLTSAKYSRAM---- 204

Query: 257 DVYSYGVVLLEILSGR 272
           DV+S G +L E+   R
Sbjct: 205 DVWSCGCILAELFLRR 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 34/220 (15%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHI 120
           + L+   VIG+G    V    +     + A+K + K      ++  +D    E  +    
Sbjct: 12  DLLR---VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED--IDWVQTEKHVFEQA 66

Query: 121 -RHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQG 175
             H  +V L   C     +L  +  Y++ G+L   +Q  R L  E     Y   +  A  
Sbjct: 67  SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYSAEISLA-- 122

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           L YLH      I++RD+K +N+LLDS+    L D+G+ K           S   G+  YI
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYI 177

Query: 236 APGKCKLQIIY--GYTMNITEKSDVYSYGVVLLEILSGRS 273
           AP     +I+    Y  ++    D ++ GV++ E+++GRS
Sbjct: 178 AP-----EILRGEDYGFSV----DWWALGVLMFEMMAGRS 208

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHI 120
             L    V+GKG  G V  +E     EL AVK L K    + D+  V+    E ++L   
Sbjct: 23  NFLM---VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALP 77

Query: 121 -RHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQG 175
            +   + +L   C     +L  +  Y++ G+L   +Q       E     Y   +     
Sbjct: 78  GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHAVFYAAEIAIG-- 133

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           L +L       I++RD+K +N++LDS+    +ADFG+ K   +           G+  YI
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYI 188

Query: 236 APGKCKLQIIY--GYTMNITEKSDVYSYGVVLLEILSGRS 273
           AP     +II    Y  ++    D +++GV+L E+L+G++
Sbjct: 189 AP-----EIIAYQPYGKSV----DWWAFGVLLYEMLAGQA 219

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 34/220 (15%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHI 120
           + L+   VIG+G    V    +     + A++ + K      ++  +D    E  +    
Sbjct: 55  DLLR---VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED--IDWVQTEKHVFEQA 109

Query: 121 -RHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQG 175
             H  +V L   C     +L  +  Y++ G+L   +Q  R L  E     Y   +  A  
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYSAEISLA-- 165

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           L YLH      I++RD+K +N+LLDS+    L D+G+ K           S   G+  YI
Sbjct: 166 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYI 220

Query: 236 APGKCKLQIIY--GYTMNITEKSDVYSYGVVLLEILSGRS 273
           AP     +I+    Y  ++    D ++ GV++ E+++GRS
Sbjct: 221 AP-----EILRGEDYGFSV----DWWALGVLMFEMMAGRS 251

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.0 bits (175), Expect = 6e-14
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 39/224 (17%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTK--RDEEPVDSFAAEIQILG 118
           E L+   V+GKG  G V++         G++ A+K L K    R+ +      AE  IL 
Sbjct: 20  ELLR---VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 119 HIRHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYK-----IAVGS 172
            ++H  IV L+ Y      KL L+  Y+S G L   L+       E         I++  
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFYLAEISMA- 133

Query: 173 AQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
              L +LH       I++RD+K  NI+L+ +    L DFGL K   S +         G+
Sbjct: 134 ---LGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGT 184

Query: 232 YGYIAPGKCKLQII--YGYTMNITEKSDVYSYGVVLLEILSGRS 273
             Y+AP     +I+   G+   +    D +S G ++ ++L+G  
Sbjct: 185 IEYMAP-----EILMRSGHNRAV----DWWSLGALMYDMLTGAP 219

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 40/239 (16%)

Query: 56  LNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA-- 112
           +N    ++     D   +G G +G+V+ A +    + +A+KK+       +P     A  
Sbjct: 2   MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALR 57

Query: 113 EIQILGHIRHRNIVKLLG-YCSNKSVKLLLYNYISNGN------------LQQLLQGNRN 159
           EI+I+  + H NIVK+      + S        ++  N            L  +L+    
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL 117

Query: 160 LDWETRYKIAVGSAQ---GLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKL 215
           L+   R  +     Q   GL Y+H      +LHRD+K  N+ ++++     + DFGLA++
Sbjct: 118 LEEHARLFMY----QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170

Query: 216 MNSTNYH-HAMSR-VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           M+    H   +S  +   + Y +P     +++     N T+  D+++ G +  E+L+G+
Sbjct: 171 MDPHYSHKGHLSEGLVTKW-YRSP-----RLLLSP-NNYTKAIDMWAAGCIFAEMLTGK 222

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.7 bits (174), Expect = 7e-14
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 34/220 (15%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWK---TKRDEEPVDSFAAEIQILGHI 120
           E ++   V+GKG  G V  A +   G+L AVK L K    + D+  V+    E +IL   
Sbjct: 26  EFIR---VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD--VECTMTEKRILSLA 80

Query: 121 -RHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQG 175
             H  + +L   C     +L  +  +++ G+L   +Q +R  D E R   Y   + SA  
Sbjct: 81  RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EARARFYAAEIISA-- 136

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           L +LH      I++RD+K +N+LLD +    LADFG+ K           +   G+  YI
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYI 191

Query: 236 APGKCKLQII--YGYTMNITEKSDVYSYGVVLLEILSGRS 273
           AP     +I+    Y   +    D ++ GV+L E+L G +
Sbjct: 192 AP-----EILQEMLYGPAV----DWWAMGVLLYEMLCGHA 222

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 73/257 (28%), Positives = 108/257 (42%), Gaps = 37/257 (14%)

Query: 29  EKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEM-P 87
           ++   M+  P      S      P    +    +    LK   VIGKG  G V  A    
Sbjct: 6   QEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-FHFLK---VIGKGSFGKVLLARHKA 61

Query: 88  NGELIAVKKLWK---TKRDEEPVDSFAAEIQILG-HIRHRNIVKLLGYCSNKSVKL-LLY 142
                AVK L K    K+ E       +E  +L  +++H  +V L  +    + KL  + 
Sbjct: 62  EEVFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVL 118

Query: 143 NYISNGNLQQLLQGNRNLDWETR---YKIAVGSAQGLAYLH-HDCVPAILHRDVKCNNIL 198
           +YI+ G L   LQ  R    E R   Y   + SA  L YLH  +    I++RD+K  NIL
Sbjct: 119 DYINGGELFYHLQRERCFL-EPRARFYAAEIASA--LGYLHSLN----IVYRDLKPENIL 171

Query: 199 LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY--GYTMNITEKS 256
           LDS+    L DFGL K   +  ++   S   G+  Y+AP     ++++   Y   +    
Sbjct: 172 LDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLAP-----EVLHKQPYDRTV---- 220

Query: 257 DVYSYGVVLLEILSGRS 273
           D +  G VL E+L G  
Sbjct: 221 DWWCLGAVLYEMLYGLP 237

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 32/217 (14%)

Query: 72  VIGKGCSGVVYKAEMP----NGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRN- 124
           V+G G  G V+          G+L A+K L K    +  +  +    E Q+L HIR    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 125 IVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWE-TRYKIA-VGSAQGLAYLH- 180
           +V L  Y      KL L+ +YI+ G L   L           +  +  +  A  L +LH 
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA--LEHLHK 177

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                 I++RD+K  NILLDS     L DFGL+K     +         G+  Y+AP   
Sbjct: 178 LG----IIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAP--- 229

Query: 241 KLQII----YGYTMNITEKSDVYSYGVVLLEILSGRS 273
              I+     G+   +    D +S GV++ E+L+G S
Sbjct: 230 --DIVRGGDSGHDKAV----DWWSLGVLMYELLTGAS 260

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 43/225 (19%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWK---TKRDEEPVDSFAAEIQIL 117
           E LK   V+G+G  G V+  +  +     +L A+K L K     RD   V +   E  IL
Sbjct: 27  ELLK---VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKM-ERDIL 80

Query: 118 GHIRHRNIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQGNRNLDWETRYK-----IAVG 171
             + H  IVKL  Y      KL L+ +++  G+L   L        E   K     +A+ 
Sbjct: 81  VEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLAELALA 138

Query: 172 SAQGLAYLH-HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAG 230
               L +LH       I++RD+K  NILLD +    L DFGL+K   S ++        G
Sbjct: 139 ----LDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCG 188

Query: 231 SYGYIAPGKCKLQIIY--GYTMNITEKSDVYSYGVVLLEILSGRS 273
           +  Y+AP     +++   G+T +     D +S+GV++ E+L+G  
Sbjct: 189 TVEYMAP-----EVVNRRGHTQSA----DWWSFGVLMFEMLTGTL 224

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 60/246 (24%), Positives = 107/246 (43%), Gaps = 47/246 (19%)

Query: 55  KLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA- 112
           +++  +    E +K    +GKG  G+V+K+ +   GE++AVKK++   ++     + A  
Sbjct: 2   RVDRHVLRKYELVK---KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS----TDAQR 54

Query: 113 ---EIQILGHIR-HRNIVKLLGYCSNKSVK-LLLYNYISNGNLQQLLQGNRNLDWETRYK 167
              EI IL  +  H NIV LL      + + + L       +L  +++ N       +Y 
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV 114

Query: 168 IAVGSAQ---GLAYLHHDCVPA-ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH 223
           +     Q    + YLH       +LHRD+K +NILL+++    +ADFGL++   +     
Sbjct: 115 VY----QLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166

Query: 224 AMSRVAGSYGYIAPGKCKLQ--------------IIYG---YTMNITEKSDVYSYGVVLL 266
               ++ +         +                I+ G   YT  I    D++S G +L 
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG 222

Query: 267 EILSGR 272
           EIL G+
Sbjct: 223 EILCGK 228

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 37/167 (22%), Positives = 59/167 (35%), Gaps = 33/167 (19%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLL 129
           V+G G +G V +       E  A+K L    +          E+++     +  +IV+++
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------EVELHWRASQCPHIVRIV 77

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLD-----WETRY------KIAVGSAQGLAY 178
               N          I    + + L G           +  +      +I     + + Y
Sbjct: 78  DVYENLYAGRKCL-LI----VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 179 LH-HDCVPAILHRDVKCNNILLDSKYEA---YLADFGLAKLMNSTNY 221
           LH  +    I HRDVK  N+L  SK       L DFG AK      Y
Sbjct: 133 LHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKY 175

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 9e-10
 Identities = 41/323 (12%), Positives = 80/323 (24%), Gaps = 118/323 (36%)

Query: 10  TIALLASWILVTRNHRYKVEKASGMSTLPPGAEDFSYP-------------------WTF 50
             +LL  ++    + R           LP      + P                   W  
Sbjct: 303 VKSLLLKYL----DCR--------PQDLPREVLTTN-PRRLSIIAESIRDGLATWDNWKH 349

Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYK--AEMPNGELIAVK---KLWKTKRDEE 105
           +   KL   I++ L  L+      +      +   +  P    I       +W      +
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEY--RKM----FDRLSVFPPSAHIPTILLSLIWFDVIKSD 403

Query: 106 P---VDSFAAE------------------IQILGHIR-----HRNIV----KLLGYCSNK 135
               V+                       +++   +      HR+IV        + S+ 
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD 463

Query: 136 SVKLLLYNYISN--G-NLQQLLQGNR---------NLDWETRYKIAVGSAQGLAYLHHDC 183
            +   L  Y  +  G +L+ +    R         +  +    KI            HD 
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF-LEQKI-----------RHDS 511

Query: 184 VPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRV------AGSYGYIA 236
                   +   N L     Y+ Y+ D       N   Y   ++ +             +
Sbjct: 512 TAWNASGSI--LNTLQQLKFYKPYICD-------NDPKYERLVNAILDFLPKIEENLICS 562

Query: 237 PGKCKLQIIYGYTMNITEKSDVY 259
                L+I     M   E   ++
Sbjct: 563 KYTDLLRIAL---MA--EDEAIF 580

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.7 bits (133), Expect = 7e-09
 Identities = 53/353 (15%), Positives = 99/353 (28%), Gaps = 81/353 (22%)

Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKL------WKTKRDE 104
           +PF       + +  C K    IG+G  G V++    +   +A+K +            +
Sbjct: 11  VPFSHC-LPTEKLQRCEK----IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 105 EPVDSFAAEIQILGHI---------RHRNIVKLLGY--CSNKSVKLLLYNYIS------- 146
           +  +    EI I   +         R    + L            LLL  +         
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 147 --------------------NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
                                G +       +     T   I       LA         
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--R 182

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
             HRD+   N+LL       L      K                S G          I Y
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVS-----IIDY 226

Query: 247 GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK 306
             +    +   V+    +  ++ +G    Q  I     + +    + G + P  ++L   
Sbjct: 227 TLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYR--LMKKENNNRWGEYHPYSNVL--W 282

Query: 307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL---LMEVKSAPEEL 356
           L  L D+M+++M            ++PA +   +++      ++   SA + L
Sbjct: 283 LHYLTDKMLKQM------TFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLL 329

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 35/161 (21%), Positives = 57/161 (35%), Gaps = 23/161 (14%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEI-------QILGHIRHRN 124
           IG G  G++Y A      E  A   + K +  E        +          +     R 
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 125 IVKLLG-----YCSNKSVKLLLYNYIS----NGNLQQLLQGNRNLDWETRYKIAVGSAQG 175
            +  LG            K   Y ++       +LQ++   N      T  ++ +     
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYE--AYLADFGLAK 214
           L Y+H +     +H D+K  N+LL  K     YLAD+GL+ 
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 46/235 (19%), Positives = 92/235 (39%), Gaps = 40/235 (17%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G G    V+ A+ M N   +A+K +   + D+   ++   EI++L  +   +  K   
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 131 YCSNKSVKLLLYNYISNG--------------NLQQLLQGNRN--LDWETRYKIAVGSAQ 174
             +N  +KLL +                    NL  L++   +  +      +I+     
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAY------LADFGLAKLMNSTNYHHAMSRV 228
           GL Y+H  C   I+H D+K  N+L++            +AD G A   +    +   +R 
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200

Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
                Y +P     +++ G        +D++S   ++ E+++G    +P  G   
Sbjct: 201 -----YRSP-----EVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 35/163 (21%), Positives = 65/163 (39%), Gaps = 24/163 (14%)

Query: 73  IGKGCSGVVYKAEMPNGELIAVK-----KLWKTK----RDEEPVDSFAAEIQILGHIRHR 123
           IG+G  G +Y A+M + E +        K+  +       E      AA+ + +      
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 124 NIVKLLG-----YCSNKSVKLLLYNYIS----NGNLQQLLQ-GNRNLDWETRYKIAVGSA 173
             +K LG                Y ++       +LQ++ +   +    +T  ++++   
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYE--AYLADFGLAK 214
             L Y+H       +H D+K +N+LL+ K     YL D+GLA 
Sbjct: 163 DILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 40/229 (17%)

Query: 61  DNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           +  ++  + +++IGKG  G V KA      E +A+K +   K  +  ++    E+++L  
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLEL 106

Query: 120 IRHR------NIVKLLGYCSNKS----VKLLLYNYISNGNLQQLLQGNRNLDWETRY--K 167
           +          IV L  +   ++    V  +L     + NL  LL+             K
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-----SYNLYDLLRNTNFRGVSLNLTRK 161

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILL--DSKYEAYLADFGLAKLMNSTNYHHAM 225
            A      L +L    + +I+H D+K  NILL    +    + DFG +  +    Y +  
Sbjct: 162 FAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220

Query: 226 SRVAGSYGYIAPGKCKLQIIYG--YTMNITEKSDVYSYGVVLLEILSGR 272
           SR      Y +P     +++ G  Y + I    D++S G +L+E+ +G 
Sbjct: 221 SRF-----YRSP-----EVLLGMPYDLAI----DMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 42/218 (19%)

Query: 72  VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR------N 124
           VIGKG  G V KA      + +A+K +   + ++      A EI+IL H+R +      N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV---RNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160

Query: 125 IVKLLGYCSNKS----VKLLLYNYISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAY 178
           ++ +L   + ++       LL       NL +L++ N+          K A    Q L  
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-----NLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 179 LHHDCVPAILHRDVKCNNILL--DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           LH      I+H D+K  NILL    +    + DFG +   +   Y +  SR      Y A
Sbjct: 216 LHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRA 267

Query: 237 PGKCKLQIIYG--YTMNITEKSDVYSYGVVLLEILSGR 272
           P     ++I G  Y M I    D++S G +L E+L+G 
Sbjct: 268 P-----EVILGARYGMPI----DMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 49.3 bits (118), Expect = 6e-07
 Identities = 37/156 (23%), Positives = 60/156 (38%), Gaps = 30/156 (19%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDS----FAAEIQILGHIRH-RNIV 126
           IG G  G +Y    +  GE +A+K         E V +       E +I   ++    I 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGGVGIP 68

Query: 127 KLLGYCSNKSVKLLLYNYIS----NGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHH 181
            +    +        YN +       +L+ L    +R    +T   +A      + Y+H 
Sbjct: 69  TIRWCGAEGD-----YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 182 DCVPAILHRDVKCNNILLDSKYEA---YLADFGLAK 214
                 +HRDVK +N L+    +    Y+ DFGLAK
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 23/162 (14%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLG 130
           IG G  G +Y    +   E +A+K      +  + +     E +I   ++    I  +  
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKIYRILQGGTGIPNVRW 70

Query: 131 YCSNKSVKLLLYNYIS----NGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
           +          YN +       +L+ L    +R L  +T   +A      + ++H     
Sbjct: 71  FGVEGD-----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123

Query: 186 AILHRDVKCNNILLDSKYEA---YLADFGLAKL-MNSTNYHH 223
             LHRD+K +N L+     A   Y+ DFGLAK   +++ + H
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 30/175 (17%), Positives = 61/175 (34%), Gaps = 32/175 (18%)

Query: 73  IGKGCSGVVYKAE---------MPNGELIAVK--KLWKTKRDEEPVDSFAAEI------Q 115
             +   G++Y+A           P  +  ++K         +E+     AA+       +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS----NGNLQQLLQ--GNRNLDWETRYKIA 169
            L       I   +G+  ++      Y ++       +LQ  L       L   +  ++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQD----KYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVA 165

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEA--YLADFGLAKLMNSTNYH 222
                 L +LH +     +H +V   NI +D + ++   LA +G A     +  H
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 32/164 (19%), Positives = 60/164 (36%), Gaps = 25/164 (15%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH-RNIVKLLG 130
           IG G  G +   + +   E +A+K      R          E +    +     I ++  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 131 YCSNKSVKLLLYNYIS----NGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVP 185
           +          YN +       +L+ L    +R    +T   IA+     + Y+H     
Sbjct: 73  FGPCGK-----YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN-- 125

Query: 186 AILHRDVKCNNILL-----DSKYEAYLADFGLAKL-MNSTNYHH 223
            +++RDVK  N L+      ++   ++ DF LAK  ++     H
Sbjct: 126 -LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 32/168 (19%), Positives = 60/168 (35%), Gaps = 33/168 (19%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDS----FAAEIQILGHIRH-RNIV 126
           IG+G  GV+++   + N + +A+K         EP  S       E +    +     I 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTGIP 69

Query: 127 KLLGYCSNKSVKLLLYNYIS----NGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHH 181
            +  +          +N +       +L+ LL    R    +T    A      +  +H 
Sbjct: 70  NVYYFGQEGL-----HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 182 DCVPAILHRDVKCNNILLDSKYEA-----YLADFGLAKL-MNSTNYHH 223
                +++RD+K +N L+           Y+ DFG+ K   +     H
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 62/378 (16%), Positives = 112/378 (29%), Gaps = 139/378 (36%)

Query: 73  IGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR--------HR 123
           +G G    V+ +  +   + +A+K +   K  E   ++   EI++L  +R          
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 124 NIVKLLGYCSNKSVKLLLYNYIS-NG------------NLQQLLQGNRN--LDWETRYKI 168
            +V+LL            +     NG            +L + +  +    L      KI
Sbjct: 102 MVVQLLDD----------FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151

Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILL----------------------------- 199
                QGL YLH  C   I+H D+K  NILL                             
Sbjct: 152 IQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 200 --------------------DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
                                 K +  +AD G A  ++        +R      Y +   
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSL-- 262

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL-----HI--------- 285
              +++ G        +D++S   +  E+ +G    +P  G+       HI         
Sbjct: 263 ---EVLIG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317

Query: 286 --VEWVKK---------KMGSFEPAVSILDTKLQGLPDQMVQ---------EMLQTLGIA 325
              + +           K G  +    +   K  GL + +V+                + 
Sbjct: 318 VPRKLIVAGKYSKEFFTKKGDLKHITKL---KPWGLFEVLVEKYEWSQEEAAGFTDFLLP 374

Query: 326 MFCVNSSPAERPTMKEVV 343
           M  +   P +R T  E +
Sbjct: 375 MLELI--PEKRATAAECL 390

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 35/199 (17%), Positives = 79/199 (39%), Gaps = 24/199 (12%)

Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSF------AAEIQILGHIRHR 123
           E++IGKG    + +    + ++I  +++ K  RDE  +D        A E + L  ++  
Sbjct: 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDER-LDENIRKSRTAREARYLALVKDF 399

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
            I     +  +   K ++ +YI+    + +++ N ++ ++          + +  LH + 
Sbjct: 400 GIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKI--------GEIVGKLHKN- 450

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH----HAMSRVAGSYGYIAPGK 239
              ++H D+  +N + D     Y+ DFGL K+ N             +   S  +    +
Sbjct: 451 --DVIHNDLTTSNFIFDKD--LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDE 506

Query: 240 CKLQIIYGYTMNITEKSDV 258
              + + GY         +
Sbjct: 507 IWERFLEGYKSVYDRWEII 525

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	371
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.65
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.3
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.15
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.02
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.99
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.73
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.7
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.65
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.64
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.58
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.49
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.33
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.32
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.28
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.8
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.48
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.29
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.92
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.88
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	87.61
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	87.0
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.36
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	85.13
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	83.24

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-60  Score=425.27  Aligned_cols=267  Identities=26%  Similarity=0.389  Sum_probs=205.8

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .++..+.||+|+||+||+|.+.  ..||||++.....+....+.|.+|+.++++++|||||+++|+|.+ +..|+|||||
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            4667788999999999999864  469999986555556667899999999999999999999999865 5689999999


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++|+|.+++.. ...+++..+..++.|+|.||+|||++   +|+||||||+|||+++++.+||+|||+|+..........
T Consensus       114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence            99999999965 45699999999999999999999999   999999999999999999999999999987655443334


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ....+||+.|||||++.++    .+..++.++|||||||+||||+||+.||..... ...+...+.....         .
T Consensus       191 ~~~~~GT~~ymAPE~l~~~----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-~~~~~~~~~~~~~---------~  256 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQ----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-RDQIIFMVGRGYA---------S  256 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHTTCC---------C
T ss_pred             ecccccCCCccCHHHhhcc----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCC---------C
Confidence            4567899999999987632    234689999999999999999999999964332 1222222221111         1


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      +.+...+.....   .+.+|+.+||+.||++|||++||++.|+.++...+.
T Consensus       257 p~~~~~~~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          257 PDLSKLYKNCPK---AMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             CCSTTSCTTSCH---HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             CCcccccccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            111122222212   344577789999999999999999999988765443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-61  Score=432.62  Aligned_cols=259  Identities=25%  Similarity=0.430  Sum_probs=209.2

Q ss_pred             ccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .|...+.||+|+||.||+|.+.      ++..||||++..  .+....++|.+|+++|++++|||||+++|+|.+.+..|
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            4677789999999999999763      467899999953  34456678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceE
Q 037946          140 LLYNYISNGNLQQLLQGN-------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY  206 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~k  206 (371)
                      +|||||++|+|.++|...             ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            999999999999999653             3599999999999999999999999   999999999999999999999


Q ss_pred             EccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhH
Q 037946          207 LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHI  285 (371)
Q Consensus       207 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  285 (371)
                      |+|||+++.....+.........||+.|||||++..       ..++.++|||||||++|||+| |+.||....  ..++
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~~~~  239 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEV  239 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHH
Confidence            999999987665543334445679999999998763       478999999999999999998 899986542  2333


Q ss_pred             HHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      ...+......         +....+++       .+.+|+.+||+.||++|||++||++.|+++..+.+
T Consensus       240 ~~~i~~~~~~---------~~p~~~~~-------~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p  292 (299)
T 4asz_A          240 IECITQGRVL---------QRPRTCPQ-------EVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP  292 (299)
T ss_dssp             HHHHHHTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHHcCCCC---------CCCccchH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence            3333322110         11122333       34457788999999999999999999998865443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-60  Score=433.68  Aligned_cols=259  Identities=26%  Similarity=0.439  Sum_probs=202.4

Q ss_pred             ccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .+...+.||+|+||.||+|++.      +++.||||++..  .+....++|.+|+++|++++|||||+++|+|.+.+..|
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4566788999999999999764      478899999953  34556678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          140 LLYNYISNGNLQQLLQGN---------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      +|||||++|+|.+++...               .++++..+..++.|++.||+|||++   +|+||||||+|||+++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            999999999999999653               3589999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGL  283 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  283 (371)
                      +||+|||+++.....+.........||+.|||||++.       +..++.++|||||||+||||+| |+.||....  ..
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-------~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--~~  267 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--NT  267 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--HH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhc-------CCCCCccccccchHHHHHHHHcCCCCCCCCCC--HH
Confidence            9999999998776554444445667999999999775       4478999999999999999999 899986432  23


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .+...+......         +....+++       .+.+|+.+||+.||++|||++||+++|+.+.+.++
T Consensus       268 ~~~~~i~~g~~~---------~~p~~~~~-------~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          268 EAIDCITQGREL---------ERPRACPP-------EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             HHHHHHHHTCCC---------CCCTTCCH-------HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHcCCCC---------CCcccccH-------HHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence            333333322111         11122333       34457788999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.7e-60  Score=428.51  Aligned_cols=255  Identities=23%  Similarity=0.378  Sum_probs=206.8

Q ss_pred             cccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++..+.||+|+||.||+|.+.      +++.||||++... .+....++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            555678999999999999752      4678999999543 334456789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          141 LYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      |||||++|+|.++|...                ..+++..+..++.|||.||+|||++   +++||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            99999999999999542                3489999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGL  283 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  283 (371)
                      +||+|||+++.....+.........||+.|||||++.       +..++.++|||||||+||||+| |..||....  ..
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-------~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--~~  254 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-------YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQ  254 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--HH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHh-------CCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--HH
Confidence            9999999998776555444455678999999999875       3478999999999999999998 888986542  23


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .+...+.....         .+....+++       .+.+|+.+||+.||++||||+||+++|+.+.
T Consensus       255 ~~~~~i~~~~~---------~~~p~~~~~-------~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          255 DVVEMIRNRQV---------LPCPDDCPA-------WVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHHHHTTCC---------CCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHHcCCC---------CCCcccchH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            33333332111         011123333       2445777899999999999999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.3e-60  Score=429.66  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=200.6

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++|++++|||||++++++.+.+.+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4788999999999999999975 469999999997766666667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+||+|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+++...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999644  4578999999999999999999999   99999999999999999999999999998765432 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|||||++.+       ..++.++|||||||++|||+||+.||....  ...+...+...  ...+   
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~-------~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~--~~~~---  244 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICEN-------KPYNNKSDIWALGCVLYELCTLKHAFEAGS--MKNLVLKIISG--SFPP---  244 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHT--CCCC---
T ss_pred             -ccccccCCCccccCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcC--CCCC---
Confidence             12345679999999998763       367899999999999999999999996432  22222222211  1110   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          .....++       .+.+|+.+||+.||++|||++|++++
T Consensus       245 ----~~~~~s~-------~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          245 ----VSLHYSY-------DLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ----CCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----CCccCCH-------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                1112222       34457888999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.9e-58  Score=408.80  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             ccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec----CCeEEEEE
Q 037946           68 KDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN----KSVKLLLY  142 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  142 (371)
                      +..+.||+|+||.||+|.+ .+++.||+|++..........+.|.+|++++++++|||||+++++|.+    .+.+|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4556799999999999976 468999999997666666667889999999999999999999999865    35689999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeEcC-CCceEEccccCccccCCC
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA--ILHRDVKCNNILLDS-KYEAYLADFGLAKLMNST  219 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~  219 (371)
                      |||++|+|.+++.+.+.+++..+..++.||+.||+|||++   +  |+||||||+|||+++ ++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            9999999999999888899999999999999999999998   6  999999999999985 799999999999764332


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                          ...+.+||+.|||||++.        +.++.++|||||||++|||+||+.||..... ...+.   ........+.
T Consensus       186 ----~~~~~~GTp~YmAPE~~~--------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~---~~i~~~~~~~  249 (290)
T 3fpq_A          186 ----FAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIY---RRVTSGVKPA  249 (290)
T ss_dssp             ----SBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHH---HHHTTTCCCG
T ss_pred             ----ccCCcccCccccCHHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-HHHHH---HHHHcCCCCC
Confidence                235678999999999764        2578999999999999999999999964322 12222   2111111110


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        ..+   ...++       .+.+|+.+||+.||++|||++|+++|-+
T Consensus       250 --~~~---~~~~~-------~~~~li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          250 --SFD---KVAIP-------EVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             --GGG---GCCCH-------HHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             --CCC---ccCCH-------HHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence              000   11111       2445788899999999999999998744

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-58  Score=421.39  Aligned_cols=255  Identities=22%  Similarity=0.376  Sum_probs=207.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.. .+|+.||||++.....  ...+.+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4688889999999999999976 4699999999964332  334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ||+||+|.+++... .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+......  .
T Consensus       152 y~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~  225 (346)
T 4fih_A          152 FLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  225 (346)
T ss_dssp             CCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred             CCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC--C
Confidence            99999999999764 599999999999999999999999   99999999999999999999999999998775543  2


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...+.+||+.|||||++.+       ..|+.++|||||||++|||++|..||....  .......+....   .+..   
T Consensus       226 ~~~~~~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~---~~~~---  290 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNL---PPRL---  290 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSS---CCCC---
T ss_pred             cccccccCcCcCCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCC---CCCC---
Confidence            3456789999999998763       367899999999999999999999996432  223333332211   1100   


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                       +.....+       ..+.+|+.+||+.||++|||++|++++-+--.
T Consensus       291 -~~~~~~s-------~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          291 -KNLHKVS-------PSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             -SCGGGSC-------HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -CccccCC-------HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence             0001122       23445788899999999999999999865433

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.6e-59  Score=417.04  Aligned_cols=251  Identities=21%  Similarity=0.302  Sum_probs=207.5

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||+||+|.. .+|+.||+|++.+... .....+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3588999999999999999965 5689999999965332 2345678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |||+||+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+......
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999999888999999999999999999999999   9999999999999999999999999999987655433


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....+.+||+.|||||++.++       .++.++||||+||++|||+||..||...  +...+...+....   .     
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~-------~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~---~-----  251 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEK-------SACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIFAKIIKLE---Y-----  251 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHS-------CBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTC---C-----
T ss_pred             ccccCcccCcccCCHHHHcCC-------CCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCC---C-----
Confidence            445677899999999988643       6788999999999999999999999643  2223333222211   1     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA  344 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  344 (371)
                            ..++....   .+.+|+.+||+.||++|||++|++.
T Consensus       252 ------~~p~~~s~---~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          252 ------DFPEKFFP---KARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             ------CCCTTCCH---HHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ------CCCcccCH---HHHHHHHHHccCCHhHCcChHHHcC
Confidence                  11111112   3445788899999999999998643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.8e-58  Score=416.87  Aligned_cols=257  Identities=21%  Similarity=0.248  Sum_probs=203.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.+ .+|+.||||++.....       ..+|+.+++.++|||||++++++.+.+.+|+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4577788899999999999976 4689999999964322       2469999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+||+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||++.+| .+||+|||+|+........
T Consensus       131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999888899999999999999999999999   999999999999999988 5999999999877544321


Q ss_pred             c---ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          223 H---AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .   .....+||+.|||||++.+       ..++.++|||||||++|||+||..||.......  +...+..   ...+.
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~~---~~~~~  275 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMG-------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKIAS---EPPPI  275 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHHHH---SCCGG
T ss_pred             cceecCCccccCccccCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHHc---CCCCc
Confidence            1   1234579999999998763       368899999999999999999999997654332  1111111   11111


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                              ...++....   .+.+++.+||+.||++|||+.|++++|....+...
T Consensus       276 --------~~~~~~~s~---~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          276 --------REIPPSCAP---LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             --------GGSCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             --------hhcCccCCH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence                    111121112   23457778999999999999999999987764433

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-57  Score=402.78  Aligned_cols=253  Identities=22%  Similarity=0.304  Sum_probs=191.6

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .++|+..+.||+|+||+||+|.. .+|+.||+|++.+... .......+.+|++++++++||||+++++++.+.+..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            35799999999999999999975 4699999999965443 234456899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||| +|+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+...... 
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            9999 679999999888999999999999999999999999   99999999999999999999999999998765443 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                        ...+.+||+.|||||++.++      ..++.++||||+||++|||+||+.||...  +...+...+.....   ..  
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~------~y~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~~~~i~~~~~---~~--  231 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVLFKNISNGVY---TL--  231 (275)
T ss_dssp             ----------CTTSCHHHHSSS------SCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCC---CC--
T ss_pred             --ccCCeeECcccCChhhhcCC------CCCCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCC---CC--
Confidence              33567899999999987643      12357999999999999999999999643  22222222222111   10  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                           ....++       .+.+++.+||+.||++|||++|++++-+-
T Consensus       232 -----p~~~s~-------~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          232 -----PKFLSP-------GAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             -----CTTSCH-------HHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             -----CCCCCH-------HHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence                 011222       23457888999999999999999997653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-57  Score=422.65  Aligned_cols=254  Identities=21%  Similarity=0.376  Sum_probs=206.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            4688899999999999999976 469999999995433  3344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ||+||+|.+++... .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.+....  .
T Consensus       229 y~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~  302 (423)
T 4fie_A          229 FLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  302 (423)
T ss_dssp             CCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred             CCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence            99999999999764 599999999999999999999999   99999999999999999999999999998775543  2


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...+.+||+.|||||++.+       ..|+.++|||||||++|||++|..||....  .......+....   .+..   
T Consensus       303 ~~~~~~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~---~~~~---  367 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNL---PPRL---  367 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC---CCCC---
T ss_pred             cccccccCcCcCCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCC---CCCC---
Confidence            3456789999999998763       367899999999999999999999996432  223333332211   1100   


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                       ......++       .+.+|+.+||+.||++|||++|+++|-+--
T Consensus       368 -~~~~~~s~-------~~~dli~~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          368 -KNLHKVSP-------SLKGFLDRLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             -SCTTSSCH-------HHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             -cccccCCH-------HHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence             01112222       344577889999999999999999985543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.9e-58  Score=412.83  Aligned_cols=251  Identities=25%  Similarity=0.266  Sum_probs=197.7

Q ss_pred             hccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||+||+|+..    +++.||+|++.+..........+.+|+++|++++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            45888999999999999999652    47899999996554433444578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||||+||+|.+++.+.+.+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999999999988999999999999999999999999   99999999999999999999999999998654432


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                        ....+.+||+.|||||++.+       ..++.++|||||||++|||+||..||....  ...+...+..   ..... 
T Consensus       181 --~~~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~---~~~~~-  245 (304)
T 3ubd_A          181 --KKAYSFCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGTLPFQGKD--RKETMTMILK---AKLGM-  245 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHT-------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH---CCCCC-
T ss_pred             --ccccccccCcccCCHHHhcc-------CCCCCCCcccchHHHHHHHHhCCCCCCCcC--HHHHHHHHHc---CCCCC-
Confidence              23356789999999998763       367899999999999999999999996532  2223222222   11110 


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHH
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALL  346 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L  346 (371)
                            ....++       .+.+++.+||+.||++|||     ++|+++|-
T Consensus       246 ------p~~~s~-------~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp  283 (304)
T 3ubd_A          246 ------PQFLSP-------EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS  283 (304)
T ss_dssp             ------CTTSCH-------HHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred             ------CCcCCH-------HHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence                  011222       2445788899999999998     57888764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.9e-57  Score=412.21  Aligned_cols=259  Identities=27%  Similarity=0.357  Sum_probs=207.1

Q ss_pred             hccccCCccccCCceEEEEEEeCC------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCC-CCceeeeceEecC-C
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH-RNIVKLLGYCSNK-S  136 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~-~  136 (371)
                      ++|+..+.||+|+||.||+|.+..      ++.||||++... ......+.|.+|+++|++++| ||||+++|+|.+. +
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            678889999999999999997532      357999998543 334456789999999999965 8999999999764 6


Q ss_pred             eEEEEEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc
Q 037946          137 VKLLLYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD  200 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~  200 (371)
                      .+|+|||||++|+|.++|+..                ..+++..+..++.|||.||+|||++   +++||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence            789999999999999999643                3489999999999999999999999   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 037946          201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQI  279 (371)
Q Consensus       201 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~  279 (371)
                      +++.+||+|||+|+..............+||+.|||||++.+       ..++.++|||||||+||||+| |..||....
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-------CCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999987765543334456679999999998763       478999999999999999998 899986543


Q ss_pred             CCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      .+ ..+...+......         +....+++       .+.+++.+||+.||++|||++||+++|.++.+
T Consensus       293 ~~-~~~~~~i~~g~~~---------~~p~~~~~-------~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          293 ID-EEFCRRLKEGTRM---------RAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CS-HHHHHHHHHTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH-HHHHHHHHcCCCC---------CCCccCCH-------HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            32 2233333322111         01112232       34457777999999999999999999988754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-57  Score=411.65  Aligned_cols=271  Identities=27%  Similarity=0.314  Sum_probs=197.3

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC----eEEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS----VKLLL  141 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  141 (371)
                      .|...+.||+|+||.||+|.+ +|+.||||++...   ......+..|+..+.+++|||||+++|+|.+.+    .+|+|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            466678999999999999988 6899999998432   111222334666667889999999999997654    57999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD-----CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ||||++|+|.++++.. .+++..+..++.|++.||+|||++     +.++|+||||||+|||++.++++||+|||+++..
T Consensus        80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999999865 489999999999999999999975     2348999999999999999999999999999876


Q ss_pred             CCCCcc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC----------chh
Q 037946          217 NSTNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD----------GLH  284 (371)
Q Consensus       217 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----------~~~  284 (371)
                      ......  ......+||+.|||||++.+.... ....++.++|||||||+||||+||..|+......          ...
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~-~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCT-TCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccc-cCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            544321  122345799999999987643110 1123577999999999999999998776432211          111


Q ss_pred             HHHHHHHHhcCCCccccccCcccCCCChhh--HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          285 IVEWVKKKMGSFEPAVSILDTKLQGLPDQM--VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ...........      ..++   ..|+..  ......+.+|+.+||+.||++||||.||++.|+++.+
T Consensus       238 ~~~~~~~~~~~------~~rp---~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          238 VEEMRKVVCEQ------KLRP---NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHTTS------CCCC---CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcc------cCCC---CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            11111111111      0111   111111  1234456679999999999999999999999998864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9e-55  Score=391.43  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=187.4

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC------
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS------  136 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  136 (371)
                      .+.|+..+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|+++|++++|||||++++++.+.+      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            34588889999999999999975 468999999985432 3445578999999999999999999999986544      


Q ss_pred             ------eEEEEEeecCCCCHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEE
Q 037946          137 ------VKLLLYNYISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL  207 (371)
Q Consensus       137 ------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl  207 (371)
                            .+|+|||||++|+|.+++.....   .++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence                  36999999999999999987654   45567889999999999999999   9999999999999999999999


Q ss_pred             ccccCccccCCCCccc----------ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          208 ADFGLAKLMNSTNYHH----------AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                      +|||+|+.........          .....+||+.|||||++.+       ..++.++|||||||++|||++   ||..
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-------NSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-------CCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            9999998765432111          1234579999999998763       368899999999999999996   5542


Q ss_pred             CCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                          ..+....+.....             ...|+..........+++.+||+.||++|||+.|++++-
T Consensus       230 ----~~~~~~~~~~~~~-------------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~  281 (299)
T 4g31_A          230 ----QMERVRTLTDVRN-------------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA  281 (299)
T ss_dssp             ----HHHHHHHHHHHHT-------------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ----ccHHHHHHHHHhc-------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence                1111111111111             112222222333445688999999999999999999863

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-53  Score=396.67  Aligned_cols=271  Identities=21%  Similarity=0.299  Sum_probs=208.5

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec------CCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN------KSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  137 (371)
                      ++|+..+.||+|+||.||+|.+ .+|+.||||++..........+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5688899999999999999976 579999999997655555566788999999999999999999998753      467


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      +|+|||||+ |+|.+++...+.+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            899999996 58999999989999999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCc--ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          218 STNY--HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       218 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ....  .....+.+||+.|||||++.+.      ..++.++||||+||++|||++|..||.+.  +.......+....+.
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~------~~~~~~~DiWSlG~il~ell~G~~pF~g~--~~~~~l~~I~~~~g~  281 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSL------HEYTQAIDLWSVGCIFGEMLARRQLFPGK--NYVHQLQLIMMVLGT  281 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTC------SCCCTHHHHHHHHHHHHHHHHTSCSSCCS--SHHHHHHHHHHHHCC
T ss_pred             cCccccccccccceeChHhcCHHHhcCC------CCCCChhheehhHHHHHHHHHCCCCCCCC--CHHHHHHHHHHhcCC
Confidence            4321  1234567899999999987532      24688999999999999999999999754  233344444444433


Q ss_pred             CCcccc-ccC--------cccCCCChhhHH-----HHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          296 FEPAVS-ILD--------TKLQGLPDQMVQ-----EMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       296 ~~~~~~-~~~--------~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...... ...        ..+.........     ....+.+|+.+||..||++|||++|+++|-+
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  347 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF  347 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence            211100 000        000000000000     1124567889999999999999999999854

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-51  Score=380.93  Aligned_cols=203  Identities=28%  Similarity=0.363  Sum_probs=170.7

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCC
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKS  136 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  136 (371)
                      ++.+.|+..+.||+|+||+||+|+.+    +++.||+|++...    ....++.+|+++|+.+ +||||+++++++.+.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            34567999999999999999999653    4678999998542    2345688999999998 7999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-CceEEccccCccc
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKL  215 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~  215 (371)
                      ..|+|||||++|+|.+++.   .+++..+..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+.
T Consensus        94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999999995   489999999999999999999999   99999999999999877 8999999999986


Q ss_pred             cCCCCcc--------------------------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHH
Q 037946          216 MNSTNYH--------------------------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEIL  269 (371)
Q Consensus       216 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~  269 (371)
                      .......                          ......+||+.|+|||++.+.      ..++.++||||+||++|||+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC------PNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC------SCCCTHHHHHHHHHHHHHHH
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC------CCCCCccchhhhHHHHHHHH
Confidence            5432210                          112345799999999987532      24788999999999999999


Q ss_pred             hCCCCCCCCCC
Q 037946          270 SGRSAVQPQIG  280 (371)
Q Consensus       270 ~g~~p~~~~~~  280 (371)
                      +|+.||.....
T Consensus       242 ~G~~Pf~~~~~  252 (361)
T 4f9c_A          242 SGRYPFYKASD  252 (361)
T ss_dssp             HTCSSSSCCSS
T ss_pred             HCCCCCCCCCC
Confidence            99999975443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-51  Score=400.61  Aligned_cols=257  Identities=21%  Similarity=0.334  Sum_probs=208.0

Q ss_pred             HHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      +.+.++|+..+.||+|+||.||+|.. .+|+.||+|++...  .....+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            34557899999999999999999965 46999999998542  2344567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC--CceEEccccCcccc
Q 037946          140 LLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK--YEAYLADFGLAKLM  216 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~  216 (371)
                      +|||||+||+|.+++.. ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+++.+
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            99999999999999864 45799999999999999999999999   99999999999999854  89999999999987


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....   .....+||+.|||||++.+       ..++.++|||||||++|||++|..||....  .......+...... 
T Consensus       308 ~~~~---~~~~~~GT~~y~APEv~~~-------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--~~~~~~~i~~~~~~-  374 (573)
T 3uto_A          308 DPKQ---SVKVTTGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWN-  374 (573)
T ss_dssp             CTTS---EEEEECSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCC-
T ss_pred             cCCC---ceeeeEECccccCHHHhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHhCCCC-
Confidence            6553   3456689999999998764       367889999999999999999999996542  22222222221111 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                           .........++       .+.+|+.+||+.||.+|||++|+++|-+
T Consensus       375 -----~~~~~~~~~s~-------~~~dli~~~L~~dp~~R~t~~e~l~Hpw  413 (573)
T 3uto_A          375 -----MDDSAFSGISE-------DGKDFIRKLLLADPNTRMTIHQALEHPW  413 (573)
T ss_dssp             -----CCSGGGTTSCH-------HHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             -----CCcccccCCCH-------HHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence                 01111122222       3456888899999999999999999754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.1e-51  Score=397.40  Aligned_cols=253  Identities=21%  Similarity=0.231  Sum_probs=200.7

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC----CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR----DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      +.|+..+.||+|+||.||+|+. .+|+.||+|++.+...    ..........++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            4588889999999999999975 4699999999964321    1112223344567778889999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +|||||+||+|.+++...+.+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            9999999999999999888999999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .    ..+.+||+.|||||++..      +..|+.++|||||||++|||++|..||........  ............  
T Consensus       346 ~----~~t~~GTp~YmAPEvl~~------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~~~~--  411 (689)
T 3v5w_A          346 K----PHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAV--  411 (689)
T ss_dssp             C----CCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHHCCC--
T ss_pred             C----CCCccCCcCccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcCCCC--
Confidence            2    346789999999998752      23578999999999999999999999975433221  121222111111  


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALL  346 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L  346 (371)
                               ..|+....   .+.+|+.+||+.||.+|++     ++||++|-
T Consensus       412 ---------~~p~~~S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          412 ---------ELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             ---------CCCTTSCH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             ---------CCCccCCH---HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence                     11111112   2445788899999999998     79998874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.1e-49  Score=357.93  Aligned_cols=278  Identities=33%  Similarity=0.594  Sum_probs=222.5

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ....++|+..+.||+|+||.||+|...+++.||+|++...  .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            3455789999999999999999999888999999987542  34556789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          141 LYNYISNGNLQQLLQGNR----NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ||||+++|+|.+++....    .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999999997543    589999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-chhHHHHHHHHhcC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD-GLHIVEWVKKKMGS  295 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~  295 (371)
                      .............||+.|+|||.+.+       ..++.++||||||+++|||++|+.||...... ......|.......
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIK-------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHH-------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             ccccccccccccCCCccccCHHHhcC-------CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            54332223344568999999997652       35789999999999999999999999755443 22334443333222


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                       ......+++.......  ......+.+++.+||+.||++|||++|++++|+.+....
T Consensus       263 -~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          263 -GQLEQIVDPNLADKIR--PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             -TCCCSSSSSSCTTCSC--HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -ccHHHhcChhhccccC--HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence             2233333433332222  234455667889999999999999999999999876443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.7e-49  Score=359.87  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=208.3

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4688889999999999999976 579999999997666566667789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......   
T Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  168 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---  168 (328)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence            999999999998888899999999999999999999999   99999999999999999999999999998765443   


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....+||+.|+|||++.+.      ...+.++|||||||++|+|++|..||....  ...+...+....   ...    
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~---~~~----  233 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGK------KYDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERVLRGK---YRI----  233 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTC------CCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC---CCC----
T ss_pred             ccccccCCcceeCcccccCC------CcCCchhhhhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC---CCC----
Confidence            33556799999999987532      123478999999999999999999996432  122222222111   000    


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                         ....++       .+.+++.+||+.||.+|||++|++++-+-
T Consensus       234 ---p~~~s~-------~~~~li~~~L~~dP~~R~t~~eil~h~~~  268 (328)
T 3fe3_A          234 ---PFYMST-------DCENLLKRFLVLNPIKRGTLEQIMKDRWI  268 (328)
T ss_dssp             ---CTTSCH-------HHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred             ---CCCCCH-------HHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence               011122       34457788999999999999999998553

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.8e-48  Score=355.37  Aligned_cols=279  Identities=39%  Similarity=0.697  Sum_probs=219.7

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ....++|+..+.||+|+||.||+|...+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            334578999999999999999999887899999999865332 2223368999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          141 LYNYISNGNLQQLLQGNR----NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+++.++++||||||+||+++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            999999999999997643    4999999999999999999999986668999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC---CCCchhHHHHHHHHh
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ---IGDGLHIVEWVKKKM  293 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~---~~~~~~~~~~~~~~~  293 (371)
                      ..... .......||+.|+|||.+.+       ..++.++||||||+++|+|++|..||...   ........+++....
T Consensus       185 ~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          185 DYKDT-HVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CSSSS-CEECCCCSCGGGCCHHHHHH-------SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             Ccccc-cccccccCCcCccCHHHhcc-------CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            54432 22344569999999997653       35688999999999999999999999521   122333444444433


Q ss_pred             cCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      .. .......+........  ......+.+++.+||+.||.+|||++|++++|+....
T Consensus       257 ~~-~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          257 KE-KKLEALVDVDLQGNYK--DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             SS-CCSTTSSCTTCTTSCC--HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hc-hhhhhhcChhhccccC--HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            33 2333333333332222  2445567789999999999999999999999987543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.9e-48  Score=351.10  Aligned_cols=260  Identities=32%  Similarity=0.450  Sum_probs=200.6

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|.. +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY  115 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred             hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence            5688889999999999999987 688999999976555556667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          145 ISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLAYLHHDCVPA--ILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +++|+|.+++.....   +++..++.++.|++.||+|||++   +  ++||||||+||+++.++.+||+|||+++.....
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            999999999987654   99999999999999999999999   8  999999999999999999999999999765433


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .  .......||+.|+|||++.       +..++.++||||||+++|+|++|..||.....  ......+...... .  
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~~~~~~~~~-~--  258 (309)
T 3p86_A          193 F--LSSKSAAGTPEWMAPEVLR-------DEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKCKR-L--  258 (309)
T ss_dssp             -----------CCTTSCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--HHHHHHHHHSCCC-C--
T ss_pred             c--cccccCCCCccccChhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCC-C--
Confidence            2  1234567999999999775       33578899999999999999999999964322  2222211111110 0  


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                           ......++       .+.+++.+||+.||.+|||++++++.|+.+.....
T Consensus       259 -----~~~~~~~~-------~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          259 -----EIPRNLNP-------QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             -----CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             -----CCCccCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                 00112222       34457788999999999999999999999876543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.3e-48  Score=360.87  Aligned_cols=257  Identities=27%  Similarity=0.442  Sum_probs=206.4

Q ss_pred             hccccCCccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  135 (371)
                      ++|+..+.||+|+||.||+|...        ++..||+|++... ......+.+.+|+.+++.+ +||||++++++|.+.
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            56888899999999999999752        3457999998543 2344567899999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      +..|+||||+++|+|.+++....                .+++..++.++.|++.||.|||++   +++||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            99999999999999999997643                478999999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||+++...............+|+.|+|||++.       +..++.++|||||||++|||++ |..||...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-------TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc-------CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999998766544333344556889999999765       3467899999999999999999 88888654


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ..  ..+...+......         .....++.       .+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus       310 ~~--~~~~~~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          310 PV--EELFKLLKEGHRM---------DKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             CG--GGHHHHHHTTCCC---------CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CH--HHHHHHHhcCCCC---------CCCCCCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            32  2222222211100         00112222       3445777899999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.9e-48  Score=359.36  Aligned_cols=258  Identities=22%  Similarity=0.275  Sum_probs=207.4

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc----chHHHHHHHHHHHhccCCCCceeeeceEecCC
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE----EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS  136 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  136 (371)
                      .+.+.|+..+.||+|+||.||+|... +|+.||+|.+.......    ...+.+.+|+.++++++||||+++++++.+.+
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            45567899999999999999999764 68999999996544322    23578999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC----ceEEccccC
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFGL  212 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~  212 (371)
                      ..|+||||+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++    .+||+|||+
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999999888899999999999999999999999   999999999999998877    799999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......   ......||+.|+|||++.       ...++.++|||||||++|+|++|..||....  .......+...
T Consensus       166 a~~~~~~~---~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~  233 (361)
T 2yab_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITAV  233 (361)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTT
T ss_pred             ceEcCCCC---ccccCCCCccEECchHHc-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhc
Confidence            98765543   234567999999999765       3367899999999999999999999996532  22222222111


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...+.      .......+       ..+.+++.+||..||.+|||+.|++++-+
T Consensus       234 ~~~~~------~~~~~~~s-------~~~~~li~~~L~~dP~~R~t~~e~l~hp~  275 (361)
T 2yab_A          234 SYDFD------EEFFSQTS-------ELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (361)
T ss_dssp             CCCCC------HHHHTTSC-------HHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             CCCCC------chhccCCC-------HHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence            10000      00001111       23445788899999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=354.56  Aligned_cols=267  Identities=24%  Similarity=0.411  Sum_probs=206.6

Q ss_pred             HhccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .++|+..+.||+|+||.||+|.+.    .+..||||++... ......+.+.+|+.++++++||||+++++++.+.+..|
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            357888899999999999999764    3446999998542 24455678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999999654 5799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          219 TNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       219 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      .... .......+|+.|+|||.+.+       ..++.++||||||+++|||++ |..||.....  ..+...+...... 
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~-  273 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAF-------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEGYRL-  273 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHTTCCC-
T ss_pred             CccceeeccCCCCcccccCHhHhcC-------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCCC-
Confidence            4211 12223446889999997753       356889999999999999999 9999864322  2222222211100 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCCCC
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKT  359 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~  359 (371)
                              +.....++       .+.+++.+||+.||.+|||+.++++.|+.+...++.+.+.
T Consensus       274 --------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~  321 (325)
T 3kul_A          274 --------PAPMGCPH-------ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT  321 (325)
T ss_dssp             --------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-----
T ss_pred             --------CCCCCcCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccccc
Confidence                    01112222       3445777899999999999999999999998877776544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.8e-48  Score=350.79  Aligned_cols=257  Identities=20%  Similarity=0.319  Sum_probs=205.3

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      +..++|+..+.||+|+||.||+|.+ .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            3456799999999999999999975 568999999985433  2335678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||||+++|+|.+++... .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999999999765 599999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .  ......||+.|+|||++.       +..++.++||||||+++|+|++|..||.....  ......+.....  ... 
T Consensus       171 ~--~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~--~~~-  236 (297)
T 3fxz_A          171 S--KRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGT--PEL-  236 (297)
T ss_dssp             C--CBCCCCSCGGGCCHHHHH-------CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHCS--CCC-
T ss_pred             c--ccCCccCCcCccChhhhc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC--CCC-
Confidence            2  234567999999999765       33678999999999999999999999964322  111111111110  000 


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                              ..+....   ..+.+++.+||+.||++|||++|++++-+--
T Consensus       237 --------~~~~~~~---~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          237 --------QNPEKLS---AIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             --------SCGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             --------CCccccC---HHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence                    0111111   1244577889999999999999999976543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=367.22  Aligned_cols=261  Identities=20%  Similarity=0.253  Sum_probs=209.7

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ...+.++|+..+.||+|+||.||+|.. .+|+.+|+|++..........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            446778899999999999999999965 5789999999976554455567889999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc---CCCceEEccccCccc
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD---SKYEAYLADFGLAKL  215 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~  215 (371)
                      |+||||+++|+|.+.+.....+++..+..++.|++.||.|||++   +++||||||+|||++   .++.+||+|||++..
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999999999888899999999999999999999999   999999999999998   468899999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .....  .......||+.|+|||++.       +..++.++|||||||++|+|++|..||....  ...+...+......
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~-------~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~  231 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLR-------KDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYD  231 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCC
T ss_pred             ecCCC--ceeecccCCcccCCHHHhc-------CCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhCCCC
Confidence            65443  2234567999999999875       3367889999999999999999999996432  22333333222111


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .      ..+.....++       .+.+++.+||+.||++|||+.|++++-+
T Consensus       232 ~------~~~~~~~~s~-------~~~~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          232 F------PSPEWDTVTP-------EAKDLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             C------CTTTTTTSCH-------HHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             C------CccccccCCH-------HHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence            1      1111122222       3445778899999999999999999754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.3e-48  Score=357.79  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=209.6

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .+.++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45678999999999999999999764 68999999997655555566789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC---CceEEccccCccccC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK---YEAYLADFGLAKLMN  217 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~  217 (371)
                      ||||+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.+   +.+||+|||++....
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999998888899999999999999999999999   99999999999999865   459999999998765


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...   ......||+.|+|||++.       +..++.++|||||||++|+|++|..||....  ...+...+......+.
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~~  250 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYP  250 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCC
T ss_pred             CCc---ccccCCCCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCC
Confidence            443   234567999999999765       3367899999999999999999999996432  2223222222111100


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                            .+.....++       .+.+++.+||+.||++|||+.+++++-+
T Consensus       251 ------~~~~~~~~~-------~~~~li~~~L~~dP~~R~t~~e~l~hp~  287 (362)
T 2bdw_A          251 ------SPEWDTVTP-------EAKSLIDSMLTVNPKKRITADQALKVPW  287 (362)
T ss_dssp             ------TTGGGGSCH-------HHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred             ------cccccCCCH-------HHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence                  011111222       3445788899999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=346.05  Aligned_cols=261  Identities=28%  Similarity=0.473  Sum_probs=206.9

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|.+ .+++.||+|++..  .+....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            3577889999999999999976 4689999998843  345566789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++++|.+++.. ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999986 56799999999999999999999999   9999999999999999999999999999876443211


Q ss_pred             c------------ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          223 H------------AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       223 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      .            ......||+.|+|||++.       +..++.++||||||+++|||++|..|+...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  237 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-------GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR  237 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhc-------CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence            1            111457999999999765       346789999999999999999999998654432111000000


Q ss_pred             HHhcCCCccccccCc-ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          291 KKMGSFEPAVSILDT-KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .          ..+. ....+++.       +.+++.+||+.||++|||+.++++.|+++.....
T Consensus       238 ~----------~~~~~~~~~~~~~-------l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          238 G----------FLDRYCPPNCPPS-------FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             H----------HHHHTCCTTCCTT-------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             c----------cccccCCCCCCHH-------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            0          0000 01223332       3446777999999999999999999999875443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-46  Score=340.95  Aligned_cols=266  Identities=35%  Similarity=0.569  Sum_probs=212.2

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccC--CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      ++.||+|+||.||+|.. +++.||+|++....  ......+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  114 (307)
T 2nru_A           36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN  114 (307)
T ss_dssp             CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence            38899999999999987 68899999986533  2334567899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          148 GNLQQLLQG---NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       148 ~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++|.+++..   ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...........
T Consensus       115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            999999863   45699999999999999999999999   999999999999999999999999999987654432223


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....||+.|+|||.+.+        .++.++||||||+++|+|++|..||....... ....+..............++
T Consensus       192 ~~~~~g~~~y~aPE~~~~--------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  262 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALRG--------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYID  262 (307)
T ss_dssp             CSSCCSCGGGCCHHHHTT--------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTHHHHHHHTTSCCHHHHSC
T ss_pred             ccccCCCcCcCChHHhcC--------CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHHHHHHhhhhhhhhhhhcc
Confidence            344579999999997642        35789999999999999999999997543321 122222222222233334444


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      +.+...+.   .....+.+++.+||+.||.+|||+++++++|+++..
T Consensus       263 ~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          263 KKMNDADS---TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SSCSCCCH---HHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             ccccccch---HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            44444443   334456678899999999999999999999998763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.5e-48  Score=352.96  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=205.0

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            356888999999999999999765 789999999854322 233466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999999999999888899999999999999999999999   9999999999999999999999999999876544333


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||............+....    ...   
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----~~~---  228 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----TYL---  228 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCS------SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC----TTS---
T ss_pred             cccCCCccCcCccCcHHhccC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc----ccC---
Confidence            334566799999999987532      1236789999999999999999999976544333222221110    000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                        ......+       ..+.+++.+||+.||++|||++|++++-+-
T Consensus       229 --~~~~~~~-------~~~~~li~~~L~~dP~~R~t~~eil~h~~~  265 (323)
T 3tki_A          229 --NPWKKID-------SAPLALLHKILVENPSARITIPDIKKDRWY  265 (323)
T ss_dssp             --TTGGGSC-------HHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             --CccccCC-------HHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence              0011122       233457888999999999999999998654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-48  Score=352.18  Aligned_cols=260  Identities=22%  Similarity=0.285  Sum_probs=208.6

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc----chHHHHHHHHHHHhccCCCCceeeeceEecC
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE----EPVDSFAAEIQILGHIRHRNIVKLLGYCSNK  135 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  135 (371)
                      +++.+.|+..+.||+|+||.||+|... +++.||+|.+.......    ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            456678999999999999999999764 68999999986543321    2457899999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC----ceEEcccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFG  211 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg  211 (371)
                      +..++||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++    .+||+|||
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999999999888899999999999999999999999   999999999999999887    79999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++.......   ......||+.|+|||++.       ...++.++|||||||++|+|++|..||.....  ......+..
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~  231 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSA  231 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHH
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeec-------CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHHh
Confidence            998765433   234567999999999765       33678999999999999999999999964322  122222211


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ....   .   ........+       ..+.+++.+||+.||++|||+.|++++-+-
T Consensus       232 ~~~~---~---~~~~~~~~~-------~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  275 (326)
T 2y0a_A          232 VNYE---F---EDEYFSNTS-------ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  275 (326)
T ss_dssp             TCCC---C---CHHHHTTSC-------HHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             cCCC---c---CccccccCC-------HHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence            1100   0   000011122       234457888999999999999999997543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.7e-48  Score=353.47  Aligned_cols=276  Identities=22%  Similarity=0.343  Sum_probs=191.4

Q ss_pred             hccccCCccccCCceEEEEEEeCCC----CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE--
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNG----ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK--  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--  138 (371)
                      ++|+..+.||+|+||.||+|.....    ..||+|++..........+.+.+|++++++++||||+++++++.+....  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            4688889999999999999976443    2799999976555566678899999999999999999999999877655  


Q ss_pred             ----EEEEeecCCCCHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEc
Q 037946          139 ----LLLYNYISNGNLQQLLQGNR------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLA  208 (371)
Q Consensus       139 ----~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  208 (371)
                          ++||||+++|+|.+++....      .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence                99999999999999985432      589999999999999999999999   99999999999999999999999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  287 (371)
                      |||+++...............+|+.|+|||.+.+       ..++.++||||||+++|+|++ |..||.....  .....
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~  250 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-------NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYN  250 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHH
T ss_pred             eccccccccccccccccccccCcccccCchhhcC-------CCCCCccchhhHHHHHHHHHhCCCCCccccCh--HHHHH
Confidence            9999987655443333334557889999997653       367899999999999999999 8888865432  22222


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCCCCCchhhhhh
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTSQPLIKQS  367 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~  367 (371)
                      .+......         ......++       .+.+++.+||+.||++|||+.++++.|+++...+.-......|+-..+
T Consensus       251 ~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~~  314 (323)
T 3qup_A          251 YLIGGNRL---------KQPPECME-------EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINI  314 (323)
T ss_dssp             HHHTTCCC---------CCCTTCCH-------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------------
T ss_pred             HHhcCCCC---------CCCCccCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCCC
Confidence            21111000         00112222       345578889999999999999999999999877766555555544443


Q ss_pred             c
Q 037946          368 A  368 (371)
Q Consensus       368 ~  368 (371)
                      +
T Consensus       315 ~  315 (323)
T 3qup_A          315 E  315 (323)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-47  Score=340.66  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=205.2

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...++..||+|++....   ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4688889999999999999998888899999985432   2346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +++++|.+++.... .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ .
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~  160 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V  160 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence            99999999997654 499999999999999999999999   999999999999999999999999999987655432 1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+|+.|+|||.+.+       ..++.++||||||+++|+|++ |..||.....  ......+..   ....    
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~---~~~~----  224 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHY-------FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEVVLKVSQ---GHRL----  224 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHH-------SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHT---TCCC----
T ss_pred             cccCCCcCcccCCHHHHhc-------cCCchhhhhHHHHHHHHHHHcCCCCCccccCh--HHHHHHHHc---CCCC----
Confidence            2234457788999997753       256789999999999999999 9988864322  111111111   1000    


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                      .  .....++       .+.+++.+||+.||++|||+.+++++|+.+....
T Consensus       225 ~--~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          225 Y--RPHLASD-------TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             C--CCTTSCH-------HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             C--CCCcChH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            0  0011122       3445778899999999999999999999997543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.1e-48  Score=353.74  Aligned_cols=272  Identities=25%  Similarity=0.337  Sum_probs=204.9

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC----eEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS----VKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l  140 (371)
                      ++|+..+.||+|+||.||+|... ++.||||++...   .........|+.++++++||||+++++++.+..    ..++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            46888899999999999999874 799999998432   233445667999999999999999999997744    4699


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD-------CVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~-------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      ||||+++|+|.+++.... +++..++.++.|++.||+|||+.       ...+++||||||+|||++.++.+||+|||++
T Consensus       100 v~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             EEECCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            999999999999997754 99999999999999999999985       1238999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCch----------
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL----------  283 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----------  283 (371)
                      +...............||+.|+|||++.+...  ....++.++|||||||++|||++|+.||........          
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN--FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC--CCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccCccccccCccCccccCHhhcccccc--cCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            87665543333445679999999998764210  012345688999999999999999999975433211          


Q ss_pred             -hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          284 -HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       284 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                       ....+....... .     ..+.+..... .......+.+++.+||+.||++|||++|+++.|+++.
T Consensus       257 ~~~~~~~~~~~~~-~-----~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          257 PSLEDMQEVVVHK-K-----KRPVLRDYWQ-KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CCHHHHHHHHTTS-C-----CCCCCCGGGG-SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Cchhhhhhhhhcc-c-----CCCCcccccc-ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             111111111100 0     0011111000 0123344677899999999999999999999999876

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-48  Score=353.26  Aligned_cols=255  Identities=18%  Similarity=0.254  Sum_probs=204.6

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.++|+..+.||+|+||.||+|... +++.||+|.+..   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            3457888999999999999999764 588999999843   234456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC--CCceEEccccCccccCC
Q 037946          142 YNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS--KYEAYLADFGLAKLMNS  218 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~  218 (371)
                      |||+++|+|.+++.... .+++..++.++.|++.||.|||++   +++||||||+||+++.  ++.+||+|||++.....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999999997654 699999999999999999999999   9999999999999987  78999999999987655


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..   ......||+.|+|||++.+       ..++.++|||||||++|+|++|..||.....  ......+......+. 
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~-  223 (321)
T 1tki_A          157 GD---NFRLLFTAPEYYAPEVHQH-------DVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYTFD-  223 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTT-------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCCCCC-
T ss_pred             CC---ccccccCChhhcCcHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHcCCCCCC-
Confidence            43   2345679999999997753       2467899999999999999999999965322  222222222111100 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                           .......+       ..+.+++.+||+.||.+|||+.|++++-+-
T Consensus       224 -----~~~~~~~s-------~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  261 (321)
T 1tki_A          224 -----EEAFKEIS-------IEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             -----HHHHTTSC-------HHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             -----hhhhccCC-------HHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence                 00011122       234568888999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.4e-47  Score=350.11  Aligned_cols=251  Identities=23%  Similarity=0.272  Sum_probs=203.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|... +|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            46888899999999999999764 689999999865321 2334567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++...+.+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++......  
T Consensus        85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999998643322  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  ...+...+..   .....   
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~---~~~~~---  224 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILM---EEIRF---  224 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH---CCCCC---
T ss_pred             CcccccccChhhCChhhhcC-------CCCCchhhcccchhHHHHHhcCCCCCCCCC--HHHHHHHHHc---CCCCC---
Confidence            23355679999999998753       367889999999999999999999996432  2222222211   10000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                          ....++       .+.+++.+||+.||++||     +++|++++-
T Consensus       225 ----p~~~s~-------~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          225 ----PRTLSP-------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             ----CTTSCH-------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             ----CCCCCH-------HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence                011222       334577789999999999     999999874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3e-47  Score=349.15  Aligned_cols=253  Identities=22%  Similarity=0.313  Sum_probs=203.7

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|...+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4688889999999999999975 5789999999854321 1223457899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+ +|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred             ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence            999 679999998888899999999999999999999999   99999999999999999999999999998765543  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       .....+||+.|+|||++.+..      ..+.++|||||||++|+|++|..||.......                ....
T Consensus       163 -~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~  219 (336)
T 3h4j_B          163 -FLKTSCGSPNYAAPEVINGKL------YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------LFKK  219 (336)
T ss_dssp             -TTCCCTTSTTTSCGGGSCCSG------GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------CBCC
T ss_pred             -ccccccCCcCcCCHHHHcCCC------CCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------HHHH
Confidence             334567999999999876432      12678999999999999999999996543221                1111


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      +.......++....   .+.+++.+||+.||.+|||++|++++-+--
T Consensus       220 i~~~~~~~p~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          220 VNSCVYVMPDFLSP---GAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             CCSSCCCCCTTSCH---HHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             HHcCCCCCcccCCH---HHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence            11111122222212   345688889999999999999999986643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.7e-47  Score=341.96  Aligned_cols=268  Identities=22%  Similarity=0.278  Sum_probs=204.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46788899999999999999764 68999999997666556666788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |++++.+..+......+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  156 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--R  156 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--S
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--c
Confidence            998754455555567899999999999999999999999   99999999999999999999999999998765432  2


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc---
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV---  300 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  300 (371)
                      ......||+.|+|||++.+      ...++.++|||||||++|+|++|..|+...... ......+...........   
T Consensus       157 ~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTT
T ss_pred             cccCCccccCCcChHHHcC------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhhhh
Confidence            2345578999999997652      224789999999999999999999887544332 222233333222211100   


Q ss_pred             --cccC----------cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 --SILD----------TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 --~~~~----------~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        ...+          .........   ....+.+++.+||+.||++|||++|++++-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  285 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPK---LNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hcccccccccccccCCcchhhcccc---cChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence              0000          000001111   1123456888899999999999999998643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.8e-48  Score=361.53  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=204.4

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.+. +++.||+|.+... ......+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            46778899999999999999875 6899999998542 233445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            999999999997643 599999999999999999999999   9999999999999999999999999999865443322


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .......+++.|+|||.+..       ..++.++|||||||++|||++ |..||....  .......+......      
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~~~------  334 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNY-------GRYSSESDVWSFGILLWETFSLGASPYPNLS--NQQTREFVEKGGRL------  334 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--HHHHHHHHHTTCCC------
T ss_pred             ecCCCCCCCcCcCCHhHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC------
Confidence            22223346788999997752       356789999999999999998 888886432  22222222221100      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                         +....+++       .+.+++.+||+.||++|||++++++.|+++.
T Consensus       335 ---~~~~~~~~-------~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          335 ---PCPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ---CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCH-------HHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence               01112232       3445777899999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-47  Score=340.62  Aligned_cols=255  Identities=22%  Similarity=0.394  Sum_probs=204.6

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...+++.||+|++....   ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            4578889999999999999998888999999985433   3346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +++++|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ .
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            999999999965 44589999999999999999999999   999999999999999999999999999986644321 1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+|+.|+|||.+.       +..++.++||||||+++|+|++ |..||.....  ......+....   ...   
T Consensus       163 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~~~~~~~~~---~~~---  227 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFS-------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGF---RLY---  227 (269)
T ss_dssp             STTSTTCCGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTC---CCC---
T ss_pred             cccCcccccccCCHHHhc-------CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhcCc---cCC---
Confidence            223445788999999765       2367889999999999999999 8888864322  22222221111   000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                         .....++       .+.+++.+||+.||++|||+.+++++|.++..
T Consensus       228 ---~~~~~~~-------~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          228 ---KPRLAST-------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ---CCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCcCCH-------HHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence               0011122       34557788999999999999999999998763

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=354.30  Aligned_cols=255  Identities=23%  Similarity=0.325  Sum_probs=205.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46888999999999999999754 58899999985432 22344578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+.+|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.......  
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence            9999999999999988899999999999999999999999   99999999999999999999999999998765443  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       .....+||+.|+|||++...    .+..++.++|||||||++|||++|..||........  ...........      
T Consensus       170 -~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~~~------  236 (384)
T 4fr4_A          170 -QITTMAGTKPYMAPEMFSSR----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFETTV------  236 (384)
T ss_dssp             -CBCCCCSCGGGCCGGGTCCC----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHHHCC------
T ss_pred             -ceeccCCCccccCCeeeccC----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhhcc------
Confidence             33566799999999987532    133578899999999999999999999975443322  11111111110      


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-HHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-MKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~  345 (371)
                           ...+....   ..+.+++.+||+.||.+||+ +++++++
T Consensus       237 -----~~~p~~~s---~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          237 -----VTYPSAWS---QEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             -----CCCCTTSC---HHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             -----cCCCCcCC---HHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                 11111111   23455778899999999998 8888774

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=352.74  Aligned_cols=263  Identities=27%  Similarity=0.422  Sum_probs=206.9

Q ss_pred             HhccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      .++|+..+.||+|+||.||+|...      +++.||+|.+... ......+.+.+|+.++++++||||+++++++.+.+.
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            367888999999999999999764      3478999998543 234456789999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 037946          138 KLLLYNYISNGNLQQLLQGN------------------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVK  193 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  193 (371)
                      .++||||+++|+|.+++...                        ..+++..++.++.|++.||.|||++   +++|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            99999999999999999763                        5689999999999999999999999   99999999


Q ss_pred             CCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CC
Q 037946          194 CNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GR  272 (371)
Q Consensus       194 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~  272 (371)
                      |+||+++.++.+||+|||++................+|+.|+|||.+..       ..++.++||||||+++|||++ |.
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-------CCcCcccccHHHHHHHHHHHhcCC
Confidence            9999999999999999999987654433233345568999999997652       357899999999999999999 98


Q ss_pred             CCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          273 SAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      .||....  .......+...    ..     .......+.       .+.+++.+||+.||++|||+.++++.|+++...
T Consensus       275 ~p~~~~~--~~~~~~~~~~~----~~-----~~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          275 QPYYGMA--HEEVIYYVRDG----NI-----LACPENCPL-------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             CTTTTSC--HHHHHHHHHTT----CC-----CCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CcCCCCC--hHHHHHHHhCC----Cc-----CCCCCCCCH-------HHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            8986432  12222222111    00     001112222       344577889999999999999999999999866


Q ss_pred             Ccc
Q 037946          353 PEE  355 (371)
Q Consensus       353 ~~~  355 (371)
                      .+.
T Consensus       337 ~~~  339 (343)
T 1luf_A          337 AEG  339 (343)
T ss_dssp             ---
T ss_pred             hhh
Confidence            543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-48  Score=359.95  Aligned_cols=262  Identities=23%  Similarity=0.366  Sum_probs=207.1

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|+..+.||+|+||.||+|.+.      +++.||||++.. .........+.+|+.++++++||||+++++++.+.+..
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS-SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc-ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            56888899999999999999742      466899999853 23344556789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC---ceEEc
Q 037946          139 LLLYNYISNGNLQQLLQGN-------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY---EAYLA  208 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~  208 (371)
                      ++||||+++|+|.+++...       ..+++..++.++.|++.||+|||++   +++||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999653       3489999999999999999999999   999999999999999555   59999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  287 (371)
                      |||+++...............||+.|+|||++.       +..++.++|||||||++|||++ |..||....  ...+..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--~~~~~~  297 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM-------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLE  297 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHH
Confidence            999998654433233334566899999999775       3367899999999999999998 888886432  222222


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      .+......         ......+.       .+.+++.+||+.||++|||+.+++++|+.+...++.
T Consensus       298 ~i~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          298 FVTSGGRM---------DPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             HHHTTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HHHcCCCC---------CCCccCCH-------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence            22211100         00112222       244577889999999999999999999998766553

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3e-46  Score=339.71  Aligned_cols=271  Identities=22%  Similarity=0.337  Sum_probs=204.0

Q ss_pred             HHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .+.++|+..+.||+|+||.||+|.+.+++.||+|++............+.+|++++++++||||+++++++.+.+..++|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            44568999999999999999999988899999999966555555567889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++ +|.+++.. ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999986 77777755 44599999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                        .......||+.|+|||++.+      ...++.++|||||||++|+|++|..||......  .....+........+..
T Consensus       174 --~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~  243 (311)
T 3niz_A          174 --RSYTHEVVTLWYRAPDVLMG------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSILGTPNPRE  243 (311)
T ss_dssp             --C---CCCCCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHHCCCCTTT
T ss_pred             --ccccCCcccCCcCCHHHhcC------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHCCCChHH
Confidence              22344578999999997642      235788999999999999999999999755433  22222333222211100


Q ss_pred             --cc------cCccc---CCCChhh--HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          301 --SI------LDTKL---QGLPDQM--VQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       301 --~~------~~~~~---~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                        ..      .+...   ...+...  ......+.+++.+||+.||++|||++|++++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  302 (311)
T 3niz_A          244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP  302 (311)
T ss_dssp             SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence              00      00000   0000000  00112455688889999999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=340.85  Aligned_cols=280  Identities=18%  Similarity=0.267  Sum_probs=208.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC--eEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS--VKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  141 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            46888899999999999999765 489999999854332 334577889999999999999999999987665  78999


Q ss_pred             EeecCCCCHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE----cCCCceEEccccCcc
Q 037946          142 YNYISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL----DSKYEAYLADFGLAK  214 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~~  214 (371)
                      |||+++++|.+++.....   +++..++.++.|++.||+|||++   +++||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976443   99999999999999999999999   99999999999999    788889999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhh-cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc--hhHHHHHHH
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY-GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG--LHIVEWVKK  291 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~  291 (371)
                      ......   ......||+.|+|||++...... ..+..++.++|||||||++|||++|..||.......  ......+..
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            765543   23445799999999976532111 013467899999999999999999999997544322  122221211


Q ss_pred             HhcCCCccccc---------cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          292 KMGSFEPAVSI---------LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       292 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      .... .....+         ....+.............+.+++.+||+.||++|||++|++++..+-...
T Consensus       242 ~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          242 GKPS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HCCT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             CCCc-ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            1110 000000         00011110011112233445688999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.1e-46  Score=337.99  Aligned_cols=266  Identities=25%  Similarity=0.380  Sum_probs=206.2

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.+ .+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5688899999999999999975 46899999998654433 344578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ 
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  166 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-  166 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-
Confidence            9999999999999888899999999999999999999999   999999999999999999999999999987654331 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||.+.       +..++.++||||||+++|+|++|..||......     ...........+  ..
T Consensus       167 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~--~~  232 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAK-------GEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQDSVP--NV  232 (294)
T ss_dssp             --------CCSSCCHHHHH-------TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHSSCCC--CH
T ss_pred             cccCccccCccccCHhHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhhccCC--Cc
Confidence            1233456999999999765       336788999999999999999999999643221     111111111111  00


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhcccCCCcc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-TMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~  355 (371)
                      ........++       .+.+++.+||+.||.+|| +++++.+.|..+......
T Consensus       233 ~~~~~~~~~~-------~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          233 TTDVRKDIPQ-------SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             HHHSCTTSCH-------HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             chhcccCCCH-------HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence            0111122222       234577779999999998 999999999988655443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.1e-47  Score=344.98  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=206.8

Q ss_pred             hccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|...+.||+|+||.||+|..      .+++.||+|++... ......+.+.+|++++++++||||+++++++.+.+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            4688889999999999999975      24578999998542 3345567899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 037946          139 LLLYNYISNGNLQQLLQGNRN------------------------LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKC  194 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  194 (371)
                      ++||||+++++|.+++.....                        +++..++.++.|++.||.|||++   +++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999976443                        88999999999999999999999   999999999


Q ss_pred             CCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCC
Q 037946          195 NNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRS  273 (371)
Q Consensus       195 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~  273 (371)
                      +||+++.++.+||+|||++................+|+.|+|||.+.+       ..++.++||||||+++|||++ |..
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-------HIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-------CCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999987655443223344567899999997753       356889999999999999999 999


Q ss_pred             CCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          274 AVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ||......  .+...+......         ......++       .+.+++.+||+.||++|||+.+++++|+++..
T Consensus       252 p~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          252 PYPGIPPE--RLFNLLKTGHRM---------ERPDNCSE-------EMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             SSTTCCGG--GHHHHHHTTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHH--HHHHHhhcCCcC---------CCCccCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            98654322  222222211100         01112222       34457788999999999999999999988753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=353.78  Aligned_cols=259  Identities=27%  Similarity=0.410  Sum_probs=208.3

Q ss_pred             hccccCCccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  135 (371)
                      ++|...+.||+|+||.||+|...        .+..||+|++... ........+.+|+++++++ +||||+++++++.+.
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            57888999999999999999752        2357999998543 3445567899999999999 999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      +..++||||+++|+|.+++....                .+++..++.++.|++.||.|||++   +++||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            99999999999999999997643                489999999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||+++...............+|+.|+|||++.       +..++.++|||||||++|+|++ |..||...
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999998776554333444556889999999765       3467899999999999999999 98888643


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      .  ...+...+......         ......++       .+.+++.+||+.||++|||++|++++|+++...
T Consensus       298 ~--~~~~~~~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          298 P--VEELFKLLKEGHRM---------DKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             C--HHHHHHHHHTTCCC---------CCCSSCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C--HHHHHHHHHcCCCC---------CCCccCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            2  22222222221110         00112222       344577789999999999999999999988643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-46  Score=343.07  Aligned_cols=257  Identities=21%  Similarity=0.328  Sum_probs=204.6

Q ss_pred             cccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      |...+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            566678999999999999765 7999999998543  3344577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccc
Q 037946          146 SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM  225 (371)
Q Consensus       146 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  225 (371)
                      ++++|.+++... .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  ...
T Consensus       125 ~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~  198 (321)
T 2c30_A          125 QGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR  198 (321)
T ss_dssp             CSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCB
T ss_pred             CCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--ccc
Confidence            999999998754 599999999999999999999999   99999999999999999999999999998765432  123


Q ss_pred             ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ....||+.|+|||.+.       +..++.++||||||+++|||++|..||....  .......+..   ...+.  .  .
T Consensus       199 ~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--~~~~~~~~~~---~~~~~--~--~  262 (321)
T 2c30_A          199 KSLVGTPYWMAPEVIS-------RSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRD---SPPPK--L--K  262 (321)
T ss_dssp             CCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHH---SSCCC--C--T
T ss_pred             ccccCCccccCHhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhc---CCCCC--c--C
Confidence            4567999999999765       3467889999999999999999999996432  2222222211   10100  0  0


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .....+       ..+.+++.+||+.||++|||++|++++-+-.....+
T Consensus       263 ~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          263 NSHKVS-------PVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             TGGGSC-------HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred             ccccCC-------HHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence            001111       134457778999999999999999998776654433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.6e-47  Score=339.34  Aligned_cols=254  Identities=21%  Similarity=0.369  Sum_probs=202.2

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...++..||+|++....   ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4688889999999999999998888899999985432   2346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +++++|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ .
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence            999999999976 55699999999999999999999999   999999999999999999999999999986644321 1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+|+.|+|||.+.+       ..++.++||||||+++|+|++ |..||.....  ......+......       
T Consensus       177 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~-------  240 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGLRL-------  240 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCCC-------
T ss_pred             cccCCccCcccCCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccCh--hHHHHHHhcccCC-------
Confidence            2233457889999997652       357889999999999999998 9999864322  2222222211110       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                        ......++       .+.+++.+||+.||.+|||+++++++|.++.
T Consensus       241 --~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          241 --YRPHLASE-------KVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             --CCCTTCCH-------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCcCCH-------HHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence              00011121       3445778899999999999999999998875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.1e-46  Score=338.79  Aligned_cols=266  Identities=25%  Similarity=0.348  Sum_probs=200.8

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...+++.||+|++............+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            35788899999999999999887899999999965544444457789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +++ +|.+++... ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            986 999988754 6799999999999999999999999   99999999999999999999999999998764332  1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc----
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA----  299 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  299 (371)
                      ......||+.|+|||++.+      ...++.++|||||||++|||++|..||....  .......+..........    
T Consensus       156 ~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             ------CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccccCchheeC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhchh
Confidence            2234568999999997642      2357889999999999999999999986532  222222222222211000    


Q ss_pred             -cc--ccCcccC--------CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 -VS--ILDTKLQ--------GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 -~~--~~~~~~~--------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                       ..  ..++...        ......   ...+.+++.+||+.||++|||++|++++-+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGL---DESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSC---CHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             hhcccccccccccccCccHHHHhhhc---CHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence             00  0000000        000111   123456888899999999999999998643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.6e-47  Score=354.12  Aligned_cols=261  Identities=23%  Similarity=0.387  Sum_probs=195.8

Q ss_pred             hccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|...    ++..||+|++... ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            57888999999999999999764    5778999998543 234556789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++|+|.+++.... .+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            999999999999997654 699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             Ccc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          220 NYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ... .......+|+.|+|||.+.       ...++.++||||||+++|||++ |..||....  ...+...+......  
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--~~~~~~~i~~~~~~--  269 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIA-------YRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDVIKAVDEGYRL--  269 (373)
T ss_dssp             -------------CTTSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--HHHHHHHHHTTEEC--
T ss_pred             CccceeccCCCcCCCccChhhhc-------cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC--
Confidence            211 1112234678899999765       3367889999999999999998 999986432  22222222211100  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                             +.....+.       .+.+++.+||+.||.+||++.++++.|+++...+.
T Consensus       270 -------~~~~~~~~-------~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          270 -------PPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             -------CCCTTCBH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             -------CCCccccH-------HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence                   11112222       34557778999999999999999999998865543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.6e-47  Score=350.81  Aligned_cols=260  Identities=28%  Similarity=0.382  Sum_probs=204.9

Q ss_pred             HhccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCC
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKS  136 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  136 (371)
                      .++|+..+.||+|+||.||+|.+      .+++.||||++... ......+.+.+|+++++++ +||||+++++++.+.+
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            36788899999999999999963      34678999999542 3344557899999999999 8999999999988765


Q ss_pred             e-EEEEEeecCCCCHHHHhccCCC--------------------------------------------------------
Q 037946          137 V-KLLLYNYISNGNLQQLLQGNRN--------------------------------------------------------  159 (371)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  159 (371)
                      . .++||||+++|+|.+++.....                                                        
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence            4 8999999999999999976543                                                        


Q ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccccc
Q 037946          160 ----------LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA  229 (371)
Q Consensus       160 ----------~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  229 (371)
                                +++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++................
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence                      88999999999999999999999   99999999999999999999999999998765443333344567


Q ss_pred             ccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccC
Q 037946          230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ  308 (371)
Q Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ||+.|+|||++.       +..++.++||||||+++|||++ |..||.....+. .....+......         ....
T Consensus       257 ~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~---------~~~~  319 (359)
T 3vhe_A          257 LPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRM---------RAPD  319 (359)
T ss_dssp             ECGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCC---------CCCT
T ss_pred             CCceeEChhhhc-------CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCC---------CCCC
Confidence            899999999765       3367899999999999999998 999986544332 222222211100         0011


Q ss_pred             CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ..++       .+.+++.+||+.||.+|||+.|++++|..+.+
T Consensus       320 ~~~~-------~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          320 YTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             TCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCH-------HHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            1222       34457778999999999999999999998763

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-46  Score=344.19  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=197.1

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC----
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS----  136 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  136 (371)
                      .+.++|+..+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.++++++||||++++++|.+.+    
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            34577899999999999999999775 78999999986433 3445678999999999999999999999885543    


Q ss_pred             -----------------------------------------------------eEEEEEeecCCCCHHHHhccCCC---C
Q 037946          137 -----------------------------------------------------VKLLLYNYISNGNLQQLLQGNRN---L  160 (371)
Q Consensus       137 -----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---~  160 (371)
                                                                           ..++||||+++++|.+++.....   .
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 37999999999999999987544   5


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc----------cccccccc
Q 037946          161 DWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH----------HAMSRVAG  230 (371)
Q Consensus       161 ~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g  230 (371)
                      ++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++........          .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            6667899999999999999999   9999999999999999999999999999876554211          12234569


Q ss_pred             cccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCC
Q 037946          231 SYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGL  310 (371)
Q Consensus       231 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      |+.|+|||.+.       +..++.++||||||+++|||++|..|+.       ...........             ...
T Consensus       239 t~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~~~~~~~~~-------------~~~  291 (332)
T 3qd2_B          239 TKLYMSPEQIH-------GNNYSHKVDIFSLGLILFELLYSFSTQM-------ERVRIITDVRN-------------LKF  291 (332)
T ss_dssp             CGGGSCHHHHH-------CCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHHHHHHHHHT-------------TCC
T ss_pred             CcCccChHHhc-------CCCCcchhhHHHHHHHHHHHHHcCCChh-------HHHHHHHHhhc-------------cCC
Confidence            99999999765       3367899999999999999999876642       11111111111             011


Q ss_pred             ChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          311 PDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       311 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      +.........+.+++.+||+.||++|||++|++++-
T Consensus       292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~  327 (332)
T 3qd2_B          292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA  327 (332)
T ss_dssp             CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred             CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence            222222333456788899999999999999999863

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.5e-47  Score=339.49  Aligned_cols=262  Identities=22%  Similarity=0.309  Sum_probs=210.3

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            457888899999999999999764 5899999999766656666778899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc---eEEccccCccccCCC
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNST  219 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~  219 (371)
                      ||+++++|.+.+.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.   +||+|||++......
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            9999999999998888899999999999999999999999   9999999999999986655   999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .   ......||+.|+|||.+.       +..++.++||||||+++|+|++|..||....  .......+.......   
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~---  226 (284)
T 3kk8_A          162 E---AWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDY---  226 (284)
T ss_dssp             C---BCCCSCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCC---
T ss_pred             c---cccCCCCCcCCcCchhhc-------CCCCCcccchHHHHHHHHHHHHCCCCCCCCc--hhHHHHHHHhccccC---
Confidence            3   234467999999999765       3367889999999999999999999996432  222222222211110   


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                         ..+.....++       .+.+++.+||+.||++|||+.|++++-+-.....
T Consensus       227 ---~~~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          227 ---PSPEWDTVTP-------EAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             ---CTTTTTTSCH-------HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             ---CchhhcccCH-------HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence               0111122222       2445778899999999999999999865444333

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-47  Score=349.19  Aligned_cols=264  Identities=26%  Similarity=0.364  Sum_probs=204.8

Q ss_pred             HhccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCC
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKS  136 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  136 (371)
                      .++|+..+.||+|+||.||+|..      .++..||+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            36788899999999999999975      245689999986432 334457899999999999 8999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhccCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 037946          137 VKLLLYNYISNGNLQQLLQGNR-----------------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVK  193 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  193 (371)
                      ..++||||+++|+|.+++....                       .+++..++.++.|++.||.|||++   +++|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            9999999999999999997653                       278999999999999999999999   99999999


Q ss_pred             CCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CC
Q 037946          194 CNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GR  272 (371)
Q Consensus       194 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~  272 (371)
                      |+||+++.++.+||+|||++................||+.|+|||.+.       +..++.++||||||+++|+|+| |.
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-------EGIYTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-------cCCCChhHhHHHHHHHHHHHHcCCC
Confidence            999999999999999999998765543222334556889999999765       2367899999999999999998 99


Q ss_pred             CCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          273 SAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      .||.....+ ......+......         ......++       .+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       273 ~p~~~~~~~-~~~~~~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          273 NPYPGIPVD-ANFYKLIQNGFKM---------DQPFYATE-------EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CSSTTCCCS-HHHHHHHHTTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCcccCCcH-HHHHHHHhcCCCC---------CCCCCCCH-------HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            998654332 2222222211100         00111222       344577789999999999999999999998765


Q ss_pred             Ccc
Q 037946          353 PEE  355 (371)
Q Consensus       353 ~~~  355 (371)
                      .++
T Consensus       336 ~~~  338 (344)
T 1rjb_A          336 AEE  338 (344)
T ss_dssp             ---
T ss_pred             HHH
Confidence            543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.9e-46  Score=357.73  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=200.3

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-eEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-VKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.. .++.||||++....    ..+.+.+|+.++++++||||+++++++.+.+ ..|+|||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4677889999999999999987 47899999985432    4567999999999999999999999987665 7899999


Q ss_pred             ecCCCCHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |+++|+|.+++...+.  +++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++...... 
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            9999999999976543  79999999999999999999999   99999999999999999999999999998543321 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                          ....+++.|+|||.+.       +..++.++||||||+++|||++ |..||......  .....+......     
T Consensus       344 ----~~~~~~~~y~aPE~~~-------~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~-----  405 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKM-----  405 (450)
T ss_dssp             -------CCCTTTSCHHHHH-------SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTCCC-----
T ss_pred             ----cCCCCCcceeCHHHhc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC-----
Confidence                2336788999999765       3468899999999999999998 99998654332  222222221110     


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                          .....+++       .+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       406 ----~~p~~~~~-------~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          406 ----DAPDGCPP-------AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ----CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CCCCcCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                01122333       344577779999999999999999999988644

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.2e-47  Score=351.81  Aligned_cols=257  Identities=23%  Similarity=0.256  Sum_probs=201.9

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC---CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK---RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      +.+.|+..+.||+|+||.||+|.. .+++.||+|++....   ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            446799999999999999999975 468999999985422   1223457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc---eEEcccc
Q 037946          139 LLLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFG  211 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg  211 (371)
                      |+||||+++++|.+.+..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999888753    33589999999999999999999999   9999999999999987655   9999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++.......  .......||+.|+|||++.+       ..++.++|||||||++|+|++|..||...   ...+...+..
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~i~~  246 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKR-------EPYGKPVDVWGCGVILFILLSGCLPFYGT---KERLFEGIIK  246 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCSS---HHHHHHHHHH
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcC-------CCCCchHhhHHHHHHHHHHHHCCCCCCCc---HHHHHHHHHc
Confidence            998776543  12345679999999998753       35789999999999999999999999642   2222222221


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ....  ..    .......+       ..+.+++.+||+.||++|||+.|++++-+
T Consensus       247 ~~~~--~~----~~~~~~~s-------~~~~~li~~~L~~dP~~R~s~~e~l~hp~  289 (351)
T 3c0i_A          247 GKYK--MN----PRQWSHIS-------ESAKDLVRRMLMLDPAERITVYEALNHPW  289 (351)
T ss_dssp             TCCC--CC----HHHHTTSC-------HHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             CCCC--CC----ccccccCC-------HHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence            1100  00    00001122       23456788899999999999999998643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.7e-46  Score=334.36  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=195.3

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...  ..||+|++..........+.+.+|+.++++++||||+++++++ ..+..++||||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            46888899999999999999863  4699999976665666678899999999999999999999965 45668999999


Q ss_pred             cCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +++++|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred             cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence            999999999954 45699999999999999999999999   99999999999999999999999999998655433223


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......||+.|+|||.+...    ....++.++||||||+++|+|++|..||..... ...+...+......     ...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~-----~~~  247 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQ----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIEMVGRGSLS-----PDL  247 (289)
T ss_dssp             ------CCCTTCCHHHHC--------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-HHHHHHHHHHTSCC-----CCT
T ss_pred             cccccCCCccccCchhhccc----CCCCCCcccchHHHHHHHHHHHHCCCCccccch-HHHHHHHhcccccC-----cch
Confidence            33456799999999987522    234678899999999999999999999965432 22222332221111     001


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ......+++       .+.+++.+||+.||.+|||++++++.|+++..
T Consensus       248 ~~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 SKVRSNCPK-------RMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSSCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hhccccCCH-------HHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111122222       34457777999999999999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-46  Score=343.41  Aligned_cols=254  Identities=21%  Similarity=0.262  Sum_probs=182.0

Q ss_pred             CCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEeecCC
Q 037946           70 ENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      .+.||+|+||.||+|... +++.||+|++..     .....+.+|+.+++.+. ||||+++++++.+.+..|+||||+++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            478999999999999764 689999999843     23466789999999996 99999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC---ceEEccccCccccCCCCcccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY---EAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      |+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++   .+||+|||+++......  ..
T Consensus        91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~  165 (325)
T 3kn6_A           91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP  165 (325)
T ss_dssp             CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence            99999999988999999999999999999999999   999999999999997765   89999999998655432  22


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC--chhHHHHHHHHhcCCCccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD--GLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....||+.|+|||.+.       +..++.++||||||+++|+|++|..||......  .....+........       
T Consensus       166 ~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-------  231 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLN-------QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-------  231 (325)
T ss_dssp             -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-------
T ss_pred             ccccCCCcCccCHHHhc-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-------
Confidence            34567899999999875       336788999999999999999999999754321  01111222211111       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                         ...............+.+++.+||+.||.+|||++|++++-+--.
T Consensus       232 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          232 ---DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             ---CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             ---CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence               000011111111224556888899999999999999998876544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.6e-46  Score=335.62  Aligned_cols=266  Identities=23%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             HhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhc--cCCCCceeeeceEec----CCe
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH--IRHRNIVKLLGYCSN----KSV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~  137 (371)
                      .++|+..+.||+|+||.||+|.. +++.||||++..     .....+..|.+++..  ++||||+++++++.+    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            35788899999999999999987 789999999843     233556667777766  799999999998644    356


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeeEcCCCceEEcc
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH--------HDCVPAILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                      .++||||+++|+|.++++.. .+++..++.++.|++.||+|||        +.   +++||||||+|||++.++.+||+|
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred             eEEehhhccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence            89999999999999999654 6999999999999999999999        77   999999999999999999999999


Q ss_pred             ccCccccCCCCccc--ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhC----------CCCCCC
Q 037946          210 FGLAKLMNSTNYHH--AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG----------RSAVQP  277 (371)
Q Consensus       210 fg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g----------~~p~~~  277 (371)
                      ||+++.........  ......||+.|+|||++.+..... ...++.++||||||+++|||++|          ..||..
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD-CFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTT-CHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCC-cccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99997655443211  123347999999999876331100 00234689999999999999999          788765


Q ss_pred             CCCCchhHHHHHHHHhcCCCccccccCcccCCCChhh--HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQM--VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .................. ..        ....+...  ......+.+++.+||+.||++|||++++++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVD-QQ--------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTS-CC--------CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcchhhhhHHHhcc-CC--------CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            444332222222211111 10        01111110  12334566788999999999999999999999876

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=351.26  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=199.0

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|..+++.+ +||||+++++++.+.+..|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            56888999999999999999764 589999999865321 233456788999999988 799999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++...... 
T Consensus       103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-  178 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-  178 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence            99999999999999888899999999999999999999999   99999999999999999999999999998643332 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|+|||++.+.       .++.++|||||||++|||++|..||....  ...+...+..   ...    
T Consensus       179 -~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~---~~~----  241 (353)
T 3txo_A          179 -VTTATFCGTPDYIAPEILQEM-------LYGPAVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILN---DEV----  241 (353)
T ss_dssp             --------CCGGGCCHHHHHHH-------HCTTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH---CCC----
T ss_pred             -ccccccCCCcCeEChhhcCCC-------CcCCccCCCcchHHHHHHHhCCCCCCCCC--HHHHHHHHHc---CCC----
Confidence             233456799999999987643       46889999999999999999999996542  2222222221   100    


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH------HHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM------KEVVALL  346 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~~L  346 (371)
                             ..+.....   .+.+++.+||+.||++||++      +|++++-
T Consensus       242 -------~~p~~~~~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp  282 (353)
T 3txo_A          242 -------VYPTWLHE---DATGILKSFMTKNPTMRLGSLTQGGEHAILRHP  282 (353)
T ss_dssp             -------CCCTTSCH---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred             -------CCCCCCCH---HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence                   11111111   24457788999999999998      8888764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.2e-46  Score=342.19  Aligned_cols=259  Identities=21%  Similarity=0.261  Sum_probs=207.7

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc----chHHHHHHHHHHHhccCCCCceeeeceEecC
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE----EPVDSFAAEIQILGHIRHRNIVKLLGYCSNK  135 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  135 (371)
                      ..+.+.|+..+.||+|+||.||+|... +|+.||+|.+.......    ...+.+.+|+.++++++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            345678999999999999999999764 68999999986543322    2367899999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC----ceEEcccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFG  211 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg  211 (371)
                      +..++||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++    .+||+|||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999999999888899999999999999999999999   999999999999999888    79999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++.......   ......||+.|+|||.+.       +..++.++||||||+++|+|++|..||.....  ......+. 
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~-  231 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANIT-  231 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHH-
T ss_pred             cceecCccc---cccccCCCCCccCccccc-------CCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH-
Confidence            998765543   224556999999999765       34678999999999999999999999964322  11111111 


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        .......   .......+       ..+.+++.+||+.||++|||+.|++++-+
T Consensus       232 --~~~~~~~---~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          232 --SVSYDFD---EEFFSHTS-------ELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             --TTCCCCC---HHHHTTCC-------HHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             --hcccccC---hhhhcccC-------HHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence              1100000   00001111       23456888899999999999999999754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.1e-46  Score=349.34  Aligned_cols=207  Identities=22%  Similarity=0.304  Sum_probs=178.7

Q ss_pred             hccccCCccccC--CceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKG--CSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      ++|+..+.||+|  +||.||+|... +++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            468888999999  99999999765 689999999976655566677889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          142 YNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||.+......
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            9999999999999765  6799999999999999999999999   9999999999999999999999999998654322


Q ss_pred             Cc-----ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 037946          220 NY-----HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI  279 (371)
Q Consensus       220 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  279 (371)
                      ..     ........||+.|+|||++.+.     ...++.++|||||||++|||++|..||....
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTT-----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccccccccccccccccccCHHHHhcc-----CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            11     1112334789999999987531     2367889999999999999999999997543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.5e-47  Score=345.77  Aligned_cols=259  Identities=22%  Similarity=0.364  Sum_probs=197.4

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCE----EEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGEL----IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ++|+..+.||+|+||.||+|.+. +++.    ||+|.+.. .......+.+.+|+.++++++||||++++++|.+.+ .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            45888899999999999999753 4443    57887743 223445678999999999999999999999998765 78


Q ss_pred             EEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +|+||+.+|+|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            89999999999999976 45699999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...........+|+.|+|||.+.       +..++.++|||||||++|||++ |..||......  .+...+......  
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~--  238 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESIL-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL--  238 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC--
T ss_pred             CcccccccCCCccccccChHHhc-------cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCCCC--
Confidence            54333334456788999999765       3467899999999999999999 99998654322  222222221110  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                             +.....+       ..+..++.+||+.||.+|||+.+++++|..+...+
T Consensus       239 -------~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          239 -------PQPPICT-------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -------CCCTTBC-------HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -------CCCccCC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence                   0011111       23455778899999999999999999999886543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=343.81  Aligned_cols=264  Identities=21%  Similarity=0.303  Sum_probs=201.1

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC--CCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH--RNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||++...+++.||+|++..........+.+.+|+.+++.++|  |||+++++++.+.+..|+||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            4588889999999999999988889999999997655555666889999999999976  99999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      | +.+++|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++ ++.+||+|||+++........
T Consensus        89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            9 56779999999988999999999999999999999999   999999999999997 678999999999876554332


Q ss_pred             cccccccccccccCCCCccchhhhc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYG----YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .......||+.|+|||.+.+.....    ....++.++|||||||++|||++|..||........    .......... 
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~-  238 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNH-  238 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHHHCTTS-
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH----HHHHHhcCCc-
Confidence            2334567999999999875311100    124678899999999999999999999964332211    1111111100 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                           ........+      ..+.+++.+||+.||.+|||+.|++++.+--
T Consensus       239 -----~~~~~~~~~------~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          239 -----EIEFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             -----CCCCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             -----ccCCcccCC------HHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence                 001111111      1344577889999999999999999986543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-46  Score=352.13  Aligned_cols=259  Identities=18%  Similarity=0.271  Sum_probs=206.1

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      ...++.+.|+..+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           45 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            44556678999999999999999999764 6889999998532  23345678999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC--CCceEEccccCcc
Q 037946          138 KLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS--KYEAYLADFGLAK  214 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~  214 (371)
                      .++||||+++|+|.+++.... .+++..++.++.|++.||.|||++   +++||||||+|||++.  ++.+||+|||++.
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccce
Confidence            999999999999999997654 699999999999999999999999   9999999999999974  5779999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ......   ......||+.|+|||++.+       ..++.++|||||||++|||++|..||....  .......+.....
T Consensus       200 ~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~i~~~~~  267 (387)
T 1kob_A          200 KLNPDE---IVKVTTATAEFAAPEIVDR-------EPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDW  267 (387)
T ss_dssp             ECCTTS---CEEEECSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCCC
T ss_pred             ecCCCc---ceeeeccCCCccCchhccC-------CCCCCcccEeeHhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCC
Confidence            765543   2344579999999997753       357889999999999999999999996532  2222222221111


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .      .........++       .+.+++.+||+.||.+|||+.|++++-+
T Consensus       268 ~------~~~~~~~~~s~-------~~~~li~~~L~~dP~~Rpt~~ell~hp~  307 (387)
T 1kob_A          268 E------FDEDAFSSVSP-------EAKDFIKNLLQKEPRKRLTVHDALEHPW  307 (387)
T ss_dssp             C------CCSSTTTTSCH-------HHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             C------CCccccccCCH-------HHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence            0      00111112222       3456888899999999999999999854

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.8e-47  Score=342.96  Aligned_cols=259  Identities=28%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             hccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      ++|+..+.||+|+||.||+|..      .+++.||+|++... ......+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            5688889999999999999974      34678999998543 2334567899999999999 99999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          138 KLLLYNYISNGNLQQLLQGNR------------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      .++||||+++|+|.+++....                  .+++..++.++.|++.||.|||++   +++||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            999999999999999997644                  489999999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||++................+|+.|+|||.+.       +..++.++||||||+++|+|++ |..||...
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999998776554322334456888999999765       3367899999999999999999 89888654


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ..+ ......+......         ......+.       .+.+++.+||+.||.+|||+.|++++|+++..
T Consensus       252 ~~~-~~~~~~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          252 PVD-SKFYKMIKEGFRM---------LSPEHAPA-------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             CSS-HHHHHHHHHTCCC---------CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cch-hHHHHHhccCCCC---------CCcccCCH-------HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            332 2222222221111         00112222       34457788999999999999999999988764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.6e-46  Score=355.04  Aligned_cols=257  Identities=26%  Similarity=0.453  Sum_probs=206.5

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.|+..+.||+|+||.||+|...++..||||++...   ....+.+.+|+.++++++||||+++++++. .+..|+||||
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC---CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            467888999999999999999888889999998543   234678999999999999999999999986 5678999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++...  ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++....... 
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-
Confidence            9999999999754  3689999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .......+|+.|+|||.+.       ...++.++|||||||++|||++ |..||....  ...+...+......      
T Consensus       340 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~~~------  404 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAIN-------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRM------  404 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHHTCCC------
T ss_pred             eccCCCcccccccCHHHhc-------cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC------
Confidence            1123345788999999775       2367899999999999999999 999986432  22333333222111      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                         +....+++       .+.+++.+||+.||++|||+++|++.|+++..+.+
T Consensus       405 ---~~~~~~~~-------~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          405 ---PRPENCPE-------ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             ---CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             ---CCCCCCCH-------HHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence               11122333       34457778999999999999999999999875543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-46  Score=341.39  Aligned_cols=262  Identities=24%  Similarity=0.390  Sum_probs=194.8

Q ss_pred             hccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC----
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS----  136 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  136 (371)
                      ++|...+.||+|+||.||+|...    +++.||+|.+..........+.+.+|+.++++++||||+++++++.+.+    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            56888899999999999999653    3458999998665555566678999999999999999999999987655    


Q ss_pred             -eEEEEEeecCCCCHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcc
Q 037946          137 -VKLLLYNYISNGNLQQLLQ------GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       137 -~~~lv~e~~~~~~L~~~l~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                       ..++||||+++++|.+++.      ....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence             3599999999999999983      445699999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEW  288 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  288 (371)
                      ||++................+++.|+|||.+.       +..++.++||||||+++|+|++ |..||.....  ......
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~  261 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDY  261 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHH-------SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHH
T ss_pred             cCcceecccccccCcccccCCCccccCchhhc-------CCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHH
Confidence            99998765543322334456788999999765       3467889999999999999999 7788764432  222222


Q ss_pred             HHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      +......         ......++       .+.+++.+||+.||.+|||+.+++++|.++....+
T Consensus       262 ~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          262 LLHGHRL---------KQPEDCLD-------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HHTTCCC---------CCBTTCCH-------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHcCCCC---------CCCccccH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            2111100         01112222       34557788999999999999999999998865443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=342.22  Aligned_cols=249  Identities=23%  Similarity=0.317  Sum_probs=202.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|... +|+.||+|++.+... .....+.+.+|..+++.++||||+++++++.+.+..|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            45888899999999999999764 689999999865322 1234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.+|.+||+|||+++.....   
T Consensus        86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            9999999999999888899999999999999999999999   9999999999999999999999999999875443   


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        ....+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  ......   .......     
T Consensus       160 --~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~---~i~~~~~-----  220 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVVST-------KPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYE---KILNAEL-----  220 (318)
T ss_dssp             --BCCCCSCTTTCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHH---HHHHCCC-----
T ss_pred             --cccccCCccccCHhHhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHH---HHHhCCC-----
Confidence              245679999999997753       367889999999999999999999996432  122221   1111100     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~  347 (371)
                            ..+.....   .+.+++.+||+.||++||     +++|++++-+
T Consensus       221 ------~~p~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~  261 (318)
T 1fot_A          221 ------RFPPFFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  261 (318)
T ss_dssp             ------CCCTTSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ------CCCCCCCH---HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence                  11111111   344577889999999999     8999998743

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-46  Score=362.40  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=204.0

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      .+.+.+.|+..+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++.+.+..
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            3457788999999999999999999764 688999999976554455567899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC---CceEEccccCccc
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK---YEAYLADFGLAKL  215 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~  215 (371)
                      |+|||||++|+|.+.+.....+++..+..++.|++.||.|||++   +++||||||+|||++..   +.+||+|||++..
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999999998888899999999999999999999999   99999999999999764   5599999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .....   ......||+.|+|||++.        ..++.++|||||||++|+|++|..||....  ...+...+......
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~  255 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR--------KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQEILRKVEKGKYT  255 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCC
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC
Confidence            65443   334567999999999763        257889999999999999999999996542  22333333222111


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      +      ..+.....++       .+.+++.+||+.||.+|||+.|++++-
T Consensus       256 ~------~~~~~~~~s~-------~~~~li~~~L~~dp~~R~s~~e~l~hp  293 (494)
T 3lij_A          256 F------DSPEWKNVSE-------GAKDLIKQMLQFDSQRRISAQQALEHP  293 (494)
T ss_dssp             C------CSGGGTTSCH-------HHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             C------CchhcccCCH-------HHHHHHHHHCCCChhhCccHHHHhcCc
Confidence            1      1111122222       344577889999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-46  Score=350.74  Aligned_cols=256  Identities=22%  Similarity=0.298  Sum_probs=200.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|+.. +++.||+|++.+.... ....+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            56888999999999999999764 5789999999754332 33445688999999887 899999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++...+.+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++...... 
T Consensus       132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-  207 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  207 (396)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence            99999999999999888899999999999999999999999   99999999999999999999999999998633322 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCch----hHHHHHHHHhcCCC
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL----HIVEWVKKKMGSFE  297 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~  297 (371)
                       ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||........    ............. 
T Consensus       208 -~~~~~~~gt~~Y~aPE~l~~-------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-  278 (396)
T 4dc2_A          208 -DTTSTFCGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-  278 (396)
T ss_dssp             -CCBCCCCBCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-
T ss_pred             -CccccccCCcccCCchhhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-
Confidence             23456789999999998763       3678999999999999999999999964322110    0001111111110 


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH------HHHHHHH
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM------KEVVALL  346 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~~L  346 (371)
                                ...+.....   .+.+++.+||+.||.+||++      +|++++-
T Consensus       279 ----------~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp  320 (396)
T 4dc2_A          279 ----------IRIPRSLSV---KAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  320 (396)
T ss_dssp             ----------CCCCTTSCH---HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred             ----------cCCCCcCCH---HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence                      111111112   34457888999999999984      7888764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.9e-45  Score=329.27  Aligned_cols=255  Identities=27%  Similarity=0.503  Sum_probs=200.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcch-----HHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEP-----VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|+..+.||+|+||.||+|.+ .+++.||+|++.........     .+.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            4578888999999999999976 47899999998654433222     267899999999999999999999997665  


Q ss_pred             EEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeEcCCCc-----eEEccc
Q 037946          139 LLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPA--ILHRDVKCNNILLDSKYE-----AYLADF  210 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nill~~~~~-----~kl~Df  210 (371)
                      ++||||+++++|.+.+.. ...+++..++.++.|++.||+|||++   +  ++||||||+||+++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            699999999999888754 44699999999999999999999999   8  999999999999988776     999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |+++.....     .....||+.|+|||.+...     ...++.++||||||+++|+|++|..||.............+.
T Consensus       174 g~~~~~~~~-----~~~~~g~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          174 GLSQQSVHS-----VSGLLGNFQWMAPETIGAE-----EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             TTCBCCSSC-----EECCCCCCTTSCGGGSSCS-----SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             Ccccccccc-----ccccCCCccccCchhhccC-----CCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence            999754332     2446799999999987422     335678999999999999999999999765444332222222


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .....  .      ......++       .+.+++.+||+.||.+|||++|+++.|+++
T Consensus       244 ~~~~~--~------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EEGLR--P------TIPEDCPP-------RLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HSCCC--C------CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ccCCC--C------CCCcccCH-------HHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11100  0      00112222       344577779999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.9e-46  Score=334.75  Aligned_cols=264  Identities=27%  Similarity=0.420  Sum_probs=198.8

Q ss_pred             hccccCCccccCCceEEEEEEe-----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--Ce
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  137 (371)
                      ++|+..+.||+|+||.||+|..     .+++.||+|++..  ......+.+.+|++++++++||||+++++++...  ..
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            4688889999999999999973     3688999999843  3445567899999999999999999999998553  56


Q ss_pred             EEEEEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          138 KLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      .++||||+++|+|.+++.... .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            899999999999999997654 499999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC----------chhH
Q 037946          217 NSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD----------GLHI  285 (371)
Q Consensus       217 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----------~~~~  285 (371)
                      ...... .......+|..|+|||.+.+       ..++.++||||||+++|||++|..|+.....+          ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  237 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcC-------CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence            543311 12233457888999997653       36789999999999999999999987532110          0000


Q ss_pred             HHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      .............     .+....+++       .+.+++.+||+.||++|||++|+++.|+++...
T Consensus       238 ~~~~~~~~~~~~~-----~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          238 VFHLIELLKNNGR-----LPRPDGCPD-------EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHHTTCC-----CCCCTTCCH-------HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhccCc-----CCCCcCcCH-------HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            0011111111000     011112222       344577889999999999999999999988643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-46  Score=360.28  Aligned_cols=260  Identities=24%  Similarity=0.333  Sum_probs=208.5

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ..+.++|+..+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++.+.+..|
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            467788999999999999999999764 6899999998654434445678899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc---CCCceEEccccCcccc
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD---SKYEAYLADFGLAKLM  216 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~  216 (371)
                      +||||+.+|+|.+.+.....+++..+..++.|++.||.|||++   +++||||||+|||++   .++.+||+|||++...
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999999998888899999999999999999999999   999999999999995   4567999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....   ......||+.|+|||++.+        .++.++|||||||++|+|++|..||....  ...+...+.......
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~  241 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRG--------TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAF  241 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS--------CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCS
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCC--------CCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCC
Confidence            5443   2345679999999998642        47889999999999999999999996532  222222222211110


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .      .+.....++       .+.+++.+||+.||.+|||+.+++++-+--
T Consensus       242 ~------~~~~~~~s~-------~~~~li~~~L~~dp~~R~t~~~~l~hp~~~  281 (486)
T 3mwu_A          242 D------LPQWRTISD-------DAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (486)
T ss_dssp             C------SGGGGGSCH-------HHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred             C------CcccCCCCH-------HHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence            0      011112222       344678889999999999999999985543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.7e-46  Score=334.27  Aligned_cols=255  Identities=23%  Similarity=0.270  Sum_probs=205.1

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .++.++|+..+.||+|+||.||+|... ++..+|+|++.....  ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            456788999999999999999999764 477899999854332  34578899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE---cCCCceEEccccCcccc
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLM  216 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~  216 (371)
                      +||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||++   +.++.+||+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            9999999999999998888899999999999999999999999   99999999999999   78899999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....   ......||+.|+|||.+.        +.++.++||||||+++|+|++|..||.....  ......+...... 
T Consensus       160 ~~~~---~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~-  225 (277)
T 3f3z_A          160 KPGK---MMRTKVGTPYYVSPQVLE--------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTD--SEVMLKIREGTFT-  225 (277)
T ss_dssp             CTTS---CBCCCCSCTTTCCHHHHT--------TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC-
T ss_pred             cCcc---chhccCCCCCccChHHhc--------ccCCchhhehhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCC-
Confidence            5443   234557999999999764        2368899999999999999999999965322  2222222111100 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                       .    ........+       ..+.+++.+||+.||++|||+.+++++-
T Consensus       226 -~----~~~~~~~~~-------~~~~~li~~~l~~dp~~R~s~~~~l~h~  263 (277)
T 3f3z_A          226 -F----PEKDWLNVS-------PQAESLIRRLLTKSPKQRITSLQALEHE  263 (277)
T ss_dssp             -C----CHHHHTTSC-------HHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             -C----CchhhhcCC-------HHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence             0    000001122       2345578889999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.9e-46  Score=334.93  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=190.7

Q ss_pred             hccccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|....    +..||+|.+... ......+.+.+|+.++++++||||+++++++. .+..++
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            568888999999999999997643    456999988542 33445678999999999999999999999985 466899


Q ss_pred             EEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++++|.+++.... .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            999999999999997654 699999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. .......+|+.|+|||.+.       ...++.++||||||+++|||++ |..||......  .....+.....  . 
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~--~-  236 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAPESIN-------FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER--L-  236 (281)
T ss_dssp             ----------CCGGGCCHHHHH-------HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC--C-
T ss_pred             cc-cccccCCCcccccChhhcc-------cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCC--C-
Confidence            32 1223445788999999765       2367889999999999999997 88888654322  22222221100  0 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                            +.....++       .+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       237 ------~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          237 ------PMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             ------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  01112222       3445777899999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.3e-46  Score=342.88  Aligned_cols=259  Identities=26%  Similarity=0.420  Sum_probs=206.4

Q ss_pred             hccccCCccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  135 (371)
                      ++|+..+.||+|+||.||+|.+.        ++..||+|++... ........+.+|+.+++++ +||||+++++++.+.
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            56888899999999999999763        4678999998543 2344567899999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      +..++||||+++|+|.+++....                .+++..++.++.|++.||.|||++   +++||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            99999999999999999997654                389999999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||++................+|+.|+|||.+.+       ..++.++||||||+++|+|++ |..||...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-------CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            9999999999999987665443333344567899999997653       356889999999999999999 98888643


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      .  ...+...+......         ......+.       .+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus       264 ~--~~~~~~~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          264 P--VEELFKLLKEGHRM---------DKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             C--HHHHHHHHHHTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C--HHHHHHHHhcCCCC---------CCCccCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            2  22222222221100         01112222       344577789999999999999999999988643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-46  Score=345.87  Aligned_cols=249  Identities=18%  Similarity=0.214  Sum_probs=203.8

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            46888899999999999999764 689999999854322 2234577899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.....   
T Consensus       121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            9999999999999888899999999999999999999999   9999999999999999999999999999876543   


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        ....+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  .......+...  . ...   
T Consensus       195 --~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~--~-~~~---  257 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSG--K-VRF---  257 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC--C-CCC---
T ss_pred             --cccccCCccccCHHHhcC-------CCCCCcCCEecccHhHhHHhhCCCCCCCCC--HHHHHHHHHcC--C-CCC---
Confidence              235679999999998753       357889999999999999999999996432  22222222211  0 000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L~  347 (371)
                          ....+.       .+.+++.+||+.||.+||+     ++|++++-+
T Consensus       258 ----p~~~~~-------~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          258 ----PSHFSS-------DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             ----CTTCCH-------HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ----CCCCCH-------HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence                011222       3445778899999999998     999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=334.19  Aligned_cols=270  Identities=24%  Similarity=0.354  Sum_probs=202.5

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            457888899999999999999764 5899999998665555555678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  156 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--  156 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc--
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV--  300 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  300 (371)
                      .......||+.|+|||.+.+      ...++.++||||||+++|+|++|..||.....  ......+........+..  
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~  228 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVG------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD--VDQLYLIRKTLGDLIPRHQQ  228 (311)
T ss_dssp             ---------GGGCCHHHHHT------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHH
T ss_pred             cccCCCcCCccccChHHHhc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhccccccccc
Confidence            12345578999999997642      23578899999999999999999999965432  222222222222111000  


Q ss_pred             ---------cccCcccCCCChh---hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          301 ---------SILDTKLQGLPDQ---MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       301 ---------~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                               ....+........   .......+.+++.+||+.||++|||++|++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  286 (311)
T 4agu_A          229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP  286 (311)
T ss_dssp             HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred             ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence                     0000000000000   001112355688889999999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-46  Score=345.63  Aligned_cols=266  Identities=22%  Similarity=0.247  Sum_probs=202.6

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC---CCcchHHHHHHHHHHHhccCCCCceeeeceEec
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK---RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN  134 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  134 (371)
                      ++.++.++|+..+.||+|+||.||+|.. .+++.||+|++....   ......+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            5678889999999999999999999976 468899999985432   234556789999999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHhcc----------------------------------------CCCCCHHHHHHHHHHHHH
Q 037946          135 KSVKLLLYNYISNGNLQQLLQG----------------------------------------NRNLDWETRYKIAVGSAQ  174 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~~i~~  174 (371)
                      .+..++||||+++|+|.+++..                                        ...+++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999999852                                        112357788899999999


Q ss_pred             HHHHHHhCCCCCeEecCCCCCCeeEcCCC--ceEEccccCccccCCCCc--ccccccccccccccCCCCccchhhhcccC
Q 037946          175 GLAYLHHDCVPAILHRDVKCNNILLDSKY--EAYLADFGLAKLMNSTNY--HHAMSRVAGSYGYIAPGKCKLQIIYGYTM  250 (371)
Q Consensus       175 ~l~~lh~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  250 (371)
                      ||+|||++   +++||||||+||+++.++  .+||+|||++........  ........||+.|+|||.+..     .+.
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~  251 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT-----TNE  251 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC-----SSS
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc-----CCC
Confidence            99999999   999999999999998776  899999999986543221  112345679999999997642     134


Q ss_pred             CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccC
Q 037946          251 NITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVN  330 (371)
Q Consensus       251 ~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~  330 (371)
                      .++.++||||||+++|||++|..||.....  ...   ..........   ...+.....+       ..+.+++.+||+
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~---~~~~~~~~~~---~~~~~~~~~~-------~~~~~li~~~l~  316 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVND--ADT---ISQVLNKKLC---FENPNYNVLS-------PLARDLLSNLLN  316 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHCCCC---TTSGGGGGSC-------HHHHHHHHHHSC
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCh--HHH---HHHHHhcccc---cCCcccccCC-------HHHHHHHHHHcC
Confidence            678999999999999999999999964322  111   1111111010   0111111122       234457788999


Q ss_pred             CCCCCCCCHHHHHHHHh
Q 037946          331 SSPAERPTMKEVVALLM  347 (371)
Q Consensus       331 ~dP~~RPs~~evl~~L~  347 (371)
                      .||.+|||+.+++++-+
T Consensus       317 ~~p~~Rps~~~~l~hp~  333 (345)
T 3hko_A          317 RNVDERFDAMRALQHPW  333 (345)
T ss_dssp             SCTTTSCCHHHHHHSHH
T ss_pred             CChhHCCCHHHHhcChh
Confidence            99999999999999743

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1e-45  Score=330.28  Aligned_cols=259  Identities=24%  Similarity=0.342  Sum_probs=207.8

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            4577999999999999999999764 68999999985433 234557889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++++|.+++.....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||.+........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999999999999888899999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ........||+.|+|||.+.+.      ...+.++||||||+++|+|++|..||............+...     ...  
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~--  227 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-----KTY--  227 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCS------SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-----CTT--
T ss_pred             hhcccCCccccCccChHHHhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-----ccc--
Confidence            2233456799999999987532      123678999999999999999999997654433332222111     000  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        .......++       .+.+++.+||+.||++|||++|++++-+
T Consensus       228 --~~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (276)
T 2yex_A          228 --LNPWKKIDS-------APLALLHKILVENPSARITIPDIKKDRW  264 (276)
T ss_dssp             --STTGGGSCH-------HHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             --cCchhhcCH-------HHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence              000111222       3345788899999999999999998654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-46  Score=344.79  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=199.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCE----EEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGEL----IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ++|+..+.||+|+||.||+|.+. +++.    ||+|.+... ........+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT-TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc-ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            35777889999999999999753 4444    777877432 22333456788999999999999999999986 46689


Q ss_pred             EEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+++|+|.+++... ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999765 4689999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...........||+.|+|||.+.       +..++.++||||||+++|+|++ |..||......  .....+......  
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~--  236 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIH-------FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERL--  236 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBC--
T ss_pred             ccccccccCCCCcccccChHHhc-------cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCC--
Confidence            54333345566888999999775       3367899999999999999999 99999754332  222222221110  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                             ......+..       +.+++.+||+.||.+|||+++++++|..+...+
T Consensus       237 -------~~~~~~~~~-------~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          237 -------AQPQICTID-------VYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             -------CCCTTBCTT-------TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             -------CCCCcCcHH-------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                   000112222       334667799999999999999999999886544

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=345.62  Aligned_cols=257  Identities=22%  Similarity=0.320  Sum_probs=190.6

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .+.+.|+..+.||+|+||.||+|... +++.||+|++....    ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            45567899999999999999999775 57899999985432    23567899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEccccCccccC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLADFGLAKLMN  217 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~  217 (371)
                      ||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.   ++.+||+|||+++...
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999999999888899999999999999999999999   9999999999999975   8899999999998665


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...   ......||+.|+|||.+.       +..++.++|||||||++|||++|..||.....+. .....+   .....
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~i---~~~~~  268 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILR-------GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-FMFRRI---LNCEY  268 (349)
T ss_dssp             -------------CGGGSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-HHHHHH---HTTCC
T ss_pred             ccc---ccccccCCCCccCHHHhc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-HHHHHH---HhCCC
Confidence            432   234567999999999765       3367899999999999999999999996543321 111111   11100


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .   ...+.....+       ..+.+++.+||+.||++|||+.|++++-+--
T Consensus       269 ~---~~~~~~~~~~-------~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          269 Y---FISPWWDEVS-------LNAKDLVRKLIVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             C---CCTTTTTTSC-------HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred             c---cCCchhhhCC-------HHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            0   0111111222       2345688889999999999999999975543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.2e-46  Score=341.10  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=193.0

Q ss_pred             hccccCCccccCCceEEEEEEe----CCCCEEEEEEecccCC--CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKR--DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|+..+.||+|+||.||++..    .+++.||+|++.+...  .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            4688899999999999999976    4789999999965432  223345678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            99999999999999998888899999999999999999999999   999999999999999999999999999976433


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..  .......||+.|+|||++.       +..++.++||||||+++|+|++|..||.....  ......+....   . 
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~---~-  238 (327)
T 3a62_A          174 DG--TVTHTFCGTIEYMAPEILM-------RSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KKTIDKILKCK---L-  238 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHT-------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTC---C-
T ss_pred             CC--ccccccCCCcCccCHhhCc-------CCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCC---C-
Confidence            22  1234567999999999765       33578899999999999999999999964321  22222221110   0 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHh
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLM  347 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~  347 (371)
                                ..+.....   .+.+++.+||+.||.+||     ++.|++++-+
T Consensus       239 ----------~~p~~~~~---~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~  279 (327)
T 3a62_A          239 ----------NLPPYLTQ---EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF  279 (327)
T ss_dssp             ----------CCCTTSCH---HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred             ----------CCCCCCCH---HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence                      11111111   344577889999999999     8899998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.9e-46  Score=359.53  Aligned_cols=256  Identities=24%  Similarity=0.409  Sum_probs=205.9

Q ss_pred             hccccCCccccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.+.. +..||||.+...   ....+.+.+|+.++++++||||++++++|.+.+..|+|||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            457788899999999999998754 789999998543   2345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |+++|+|.+++...  ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999999753  4589999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                       .......+|+.|+|||.+..       ..++.++|||||||++|||++ |..||.....  ..+...+......     
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~-----  438 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRM-----  438 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCC-----
T ss_pred             -eecCCCcCCcceeCHhHHhc-------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC-----
Confidence             12233457789999998753       357889999999999999999 8888865432  2333332221110     


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                          .....+++       .+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       439 ----~~~~~~~~-------~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          439 ----ERPEGCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ----CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ----CCCCCCCH-------HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence                01122332       344577789999999999999999999988643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.8e-46  Score=355.89  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=199.6

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.|+..+.||+|+||.||+|.+.++..||||++....   ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4678888999999999999998777889999985432   234679999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++..  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++....... 
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence            999999999974  34589999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .......+|+.|+|||.+.       ...++.++||||||+++|||++ |..||....  ...+...+......      
T Consensus       336 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~~~------  400 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYRM------  400 (452)
T ss_dssp             -------CCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCCC------
T ss_pred             ecccCCcccccccCHhHHh-------cCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC------
Confidence            1223345788999999765       3367899999999999999999 888886432  22222222221110      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                         +....+++       .+.+++.+||+.||++|||++++++.|+++....+
T Consensus       401 ---~~~~~~~~-------~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          401 ---PCPPECPE-------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             ---CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---CCCCCCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence               01112222       34457778999999999999999999999875443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-45  Score=336.02  Aligned_cols=267  Identities=22%  Similarity=0.349  Sum_probs=190.2

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46888899999999999999764 68999999986433 33344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          144 YISNGNLQQLLQGN------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       144 ~~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      |+++ +|.+++...      ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            9984 999988542      3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...  .......||+.|+|||++.+      ...++.++|||||||++|||++|..||....  .......+........
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~  229 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGTPN  229 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCC
T ss_pred             CCc--ccCCCCcccccccCchHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCC
Confidence            432  12345578999999997652      2357889999999999999999999996542  2223333333222211


Q ss_pred             ccc--cc-----cCcccCCC-ChhhHH---------HHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          298 PAV--SI-----LDTKLQGL-PDQMVQ---------EMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       298 ~~~--~~-----~~~~~~~~-~~~~~~---------~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ...  ..     ..+..... +....+         ....+.+++.+||+.||++|||++|++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp  295 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP  295 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence            000  00     00000000 000000         112456788889999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-45  Score=346.04  Aligned_cols=263  Identities=21%  Similarity=0.303  Sum_probs=201.7

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC--CCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR--HRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ..|+..+.||+|+||.||+|...+++.||||++..........+.+.+|+.+++.++  ||||+++++++...+..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            358889999999999999998878999999999765555566788999999999996  599999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      | +.+++|.+++.....+++..+..++.||+.||.|||++   +++||||||+|||++ ++.+||+|||+++........
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9 56789999999888899999999999999999999999   999999999999995 588999999999876544322


Q ss_pred             cccccccccccccCCCCccchhhh----cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIY----GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .......||+.|+|||++.+....    .....++.++|||||||++|||++|..||.......    ............
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~~~~~~~~~  286 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAIIDPNHE  286 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHCTTSC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HHHHHHhCcccc
Confidence            233456799999999987532110    012357889999999999999999999996433211    111111111000


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                            ......++      ..+.+++.+||+.||.+|||+.|++++.+-
T Consensus       287 ------~~~~~~~~------~~~~~li~~~L~~dP~~Rps~~ell~hp~~  324 (390)
T 2zmd_A          287 ------IEFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLAHPYV  324 (390)
T ss_dssp             ------CCCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ------CCCCccch------HHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence                  01111111      134457788999999999999999988654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7e-46  Score=330.18  Aligned_cols=255  Identities=20%  Similarity=0.306  Sum_probs=203.1

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--CeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.+ +++.||+|++.....+....+.+.+|+.++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            4578889999999999999988 488999999976555556677899999999999999999999999887  7889999


Q ss_pred             eecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPA--ILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ||+++|+|.+++....  .+++..++.++.|++.||.|||++   +  ++||||||+||+++.++.++|+|||+......
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999998765  489999999999999999999998   8  99999999999999999999999988754322


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                             ....||+.|+|||.+.+..    ...++.++||||||+++|||++|..||.....  ....   .........
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~---~~~~~~~~~  229 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKP----EDTNRRSADMWSFAVLLWELVTREVPFADLSN--MEIG---MKVALEGLR  229 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCG----GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--HHHH---HHHHHSCCC
T ss_pred             -------cCccCCccccChhhhccCC----CCCCCchhhHHHHHHHHHHHHhCCCCccccCh--HHHH---HHHHhcCCC
Confidence                   2346899999999876431    12334589999999999999999999964322  1111   111111000


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      .     ......++       .+.+++.+||+.||++|||++++++.|.++..
T Consensus       230 ~-----~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 P-----TIPPGISP-------HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             C-----CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             C-----CCCCCCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0     00112222       34457777999999999999999999998864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=341.88  Aligned_cols=251  Identities=21%  Similarity=0.273  Sum_probs=204.3

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc------chHHHHHHHHHHHhccCCCCceeeeceE
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE------EPVDSFAAEIQILGHIRHRNIVKLLGYC  132 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~  132 (371)
                      ..++.++|+..+.||+|+||.||+|.. .+++.||+|++.......      .....+.+|+.++++++||||+++++++
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            346778999999999999999999975 568899999986543221      1334577899999999999999999999


Q ss_pred             ecCCeEEEEEeecCCC-CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcccc
Q 037946          133 SNKSVKLLLYNYISNG-NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG  211 (371)
Q Consensus       133 ~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  211 (371)
                      .+.+..++||||+.+| +|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999999777 9999999988999999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++.......   ......||+.|+|||.+.+.      ...+.++||||||+++|+|++|..||......          
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------  236 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGN------PYRGPELEMWSLGVTLYTLVFEENPFCELEET----------  236 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTC------CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCC------CCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------
Confidence            998765543   23456799999999976532      12377899999999999999999998532110          


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                       ..      ... ......++       .+.+++.+||+.||++|||+++++++-+
T Consensus       237 -~~------~~~-~~~~~~~~-------~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          237 -VE------AAI-HPPYLVSK-------ELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             -TT------TCC-CCSSCCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             -Hh------hcc-CCCcccCH-------HHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence             00      000 00111222       3455778899999999999999999854

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.7e-45  Score=339.18  Aligned_cols=256  Identities=23%  Similarity=0.312  Sum_probs=201.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            35888899999999999999764 588999999976543 334456788999999988 899999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++...... 
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence            99999999999998888899999999999999999999999   99999999999999999999999999998643322 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc----hhHHHHHHHHhcCCC
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG----LHIVEWVKKKMGSFE  297 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~  297 (371)
                       ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||.......    ............. .
T Consensus       165 -~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~  235 (345)
T 3a8x_A          165 -DTTSTFCGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-Q  235 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-C
T ss_pred             -CcccccCCCccccCccccCC-------CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-C
Confidence             23355689999999998753       367889999999999999999999996422110    0000111111111 0


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH------HHHHHHH
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM------KEVVALL  346 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~~L  346 (371)
                                ...+....   ..+.+++.+||+.||.+||++      +|++++-
T Consensus       236 ----------~~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp  277 (345)
T 3a8x_A          236 ----------IRIPRSLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  277 (345)
T ss_dssp             ----------CCCCTTSC---HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred             ----------CCCCCCCC---HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence                      01111111   134457788999999999985      7888774

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.9e-46  Score=341.83  Aligned_cols=258  Identities=16%  Similarity=0.212  Sum_probs=202.6

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.....    ...+.+|+.+++.+ +||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            4688889999999999999975 5789999999854322    23578999999999 9999999999999999999999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc-----eEEccccCcccc
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE-----AYLADFGLAKLM  216 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~~~~~  216 (371)
                      ||+ +++|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+|||++.++.     +||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 8999999976 46799999999999999999999999   9999999999999999887     999999999876


Q ss_pred             CCCCccc-----ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCch-hHHHHHH
Q 037946          217 NSTNYHH-----AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL-HIVEWVK  290 (371)
Q Consensus       217 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~  290 (371)
                      .......     ......||+.|+|||.+.       +..++.++|||||||++|||++|..||.....+.. .....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~  233 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHL-------GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG  233 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHc-------CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence            5433111     124567999999999765       34678899999999999999999999976543321 1111111


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ..... .+..    ......     .   .+.+++..||+.||.+||++++|++.|.++.
T Consensus       234 ~~~~~-~~~~----~~~~~~-----p---~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          234 DTKRA-TPIE----VLCENF-----P---EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHH-SCHH----HHTTTC-----H---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhcc-CCHH----HHhccC-----h---HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            11110 0000    000011     1   4556778899999999999999999998774

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.5e-46  Score=331.65  Aligned_cols=255  Identities=22%  Similarity=0.391  Sum_probs=204.3

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...+++.||+|++....   ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4577888999999999999998888899999985433   2346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      +++++|.+++... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ .
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  160 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  160 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence            9999999999765 4589999999999999999999999   999999999999999999999999999986543321 1


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+|+.|+|||.+.+       ..++.++||||||+++|+|++ |..||....  .......+....   ..    
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~i~~~~---~~----  224 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGF---RL----  224 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTC---CC----
T ss_pred             ccccccccccccChhhhcC-------CCccchhchhhhHHHHHHHhccCCCCCCCCC--HHHHHHHHhcCC---cC----
Confidence            2233457889999997652       357889999999999999999 888886432  222222221111   00    


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                        ......+.       .+.+++.+||+.||++|||+++++++|.++..
T Consensus       225 --~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 --YKPRLAST-------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCccCcH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              00011121       34457788999999999999999999998863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=332.55  Aligned_cols=255  Identities=30%  Similarity=0.491  Sum_probs=194.3

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|.. .++.||+|++..    ....+.+.+|++++++++||||+++++++.+  ..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            3577788999999999999987 478899999842    3345788999999999999999999998874  47899999


Q ss_pred             cCCCCHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc-eEEccccCccccCCCC
Q 037946          145 ISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE-AYLADFGLAKLMNSTN  220 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~  220 (371)
                      +++++|.+++.....   ++...++.++.|++.||.|||+.+..+++||||||+||+++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            999999999986653   789999999999999999999932229999999999999998886 799999999765432 


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                          .....||+.|+|||.+.       +..++.++||||||+++|||++|..||.............+..  .. .   
T Consensus       160 ----~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-~---  222 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFE-------GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT-R---  222 (307)
T ss_dssp             ---------CCTTSSCHHHHT-------CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC-C---
T ss_pred             ----cccCCCCCceEChhhhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC-C---
Confidence                23446999999999765       3467899999999999999999999997543332222111111  00 0   


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                         .......+.       .+.+++.+||+.||++|||++++++.|..+....+
T Consensus       223 ---~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          223 ---PPLIKNLPK-------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             ---CCCBTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             ---CCcccccCH-------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence               011122332       23457778999999999999999999998865443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=336.15  Aligned_cols=249  Identities=22%  Similarity=0.280  Sum_probs=193.8

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  140 (371)
                      +.++|+..+.||+|+||+||+|... +++.||||++...............|+..+..+ +||||++++++|.+.+..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4568999999999999999999775 789999999865544444555666666666665 99999999999999999999


Q ss_pred             EEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+ +++|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++......
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999 5688888765 44699999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .   ......||+.|+|||++.+        .++.++|||||||++|||++|..|+...    ... ..+    .. .. 
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~el~~g~~~~~~~----~~~-~~~----~~-~~-  268 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG--------SYGTAADVFSLGLTILEVACNMELPHGG----EGW-QQL----RQ-GY-  268 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT--------CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHH-HHH----TT-TC-
T ss_pred             C---CCcccCCCccccCHhHhcC--------CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHH-HHH----hc-cC-
Confidence            3   2344569999999997642        5788999999999999999997766421    111 111    11 00 


Q ss_pred             ccccCcc-cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 VSILDTK-LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                         ..+. ....+       ..+.+++.+||+.||++|||++|++++-+
T Consensus       269 ---~~~~~~~~~~-------~~l~~li~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          269 ---LPPEFTAGLS-------SELRSVLVMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             ---CCHHHHTTSC-------HHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             ---CCcccccCCC-------HHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence               0000 01111       23456788899999999999999998644

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-45  Score=331.14  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=201.0

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc----chHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE----EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      .++|+..+.||+|+||.||+|... +++.||+|.+.......    ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467888999999999999999765 68999999986543322    2367899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC----ceEEccccCcc
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFGLAK  214 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~~  214 (371)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++    .+||+|||++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999998888899999999999999999999999   999999999999998877    89999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ......   ......||+.|+|||.+.       ...++.++||||||+++|+|++|..||.....  ......+..   
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~---  225 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGETK--QETLTNISA---  225 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHT---
T ss_pred             eccCCC---cccccCCCcCccCcceec-------CCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--HHHHHHhHh---
Confidence            765433   223456999999999764       33678899999999999999999999865321  111111111   


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .....   ........+       ..+.+++.+||+.||++|||+.+++++-
T Consensus       226 ~~~~~---~~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~~~l~h~  267 (283)
T 3bhy_A          226 VNYDF---DEEYFSNTS-------ELAKDFIRRLLVKDPKRRMTIAQSLEHS  267 (283)
T ss_dssp             TCCCC---CHHHHTTCC-------HHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred             cccCC---cchhcccCC-------HHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence            10000   000001111       2345688889999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-46  Score=346.62  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=201.3

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|... +|+.||+|++.+... .......+..|..+++.+ +||||+++++++.+.+..|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            56888899999999999999764 689999999965321 123456788899999887 999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++...... 
T Consensus        97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  172 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  172 (345)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence            99999999999999888899999999999999999999999   99999999999999999999999999998643322 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  ...+...+....   ...  
T Consensus       173 -~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~---~~~--  237 (345)
T 1xjd_A          173 -AKTNTFCGTPDYIAPEILLG-------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMDN---PFY--  237 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC---CCC--
T ss_pred             -CcccCCCCCcccCChhhhcC-------CCCCChhhhHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHhCC---CCC--
Confidence             12356689999999998753       357899999999999999999999996432  222222222110   000  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHH-HHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK-EVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~~  345 (371)
                           ....+       ..+.+++.+||+.||++||++. +++++
T Consensus       238 -----p~~~s-------~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          238 -----PRWLE-------KEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             -----CTTSC-------HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -----CcccC-------HHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                 01112       1344577889999999999997 77765

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-45  Score=349.40  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=196.7

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC------cchHHHHHHHHHHHhccCCCCceeeeceE
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD------EEPVDSFAAEIQILGHIRHRNIVKLLGYC  132 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~  132 (371)
                      .+.+.++|...+.||+|+||.||+|.. .+++.||+|++......      ......+.+|+.++++++||||+++++++
T Consensus       130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            456778999999999999999999965 46899999998654321      12223578999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC---ceEEcc
Q 037946          133 SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY---EAYLAD  209 (371)
Q Consensus       133 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~D  209 (371)
                      .. +..|+||||+++|+|.+++.....+++..+..++.|++.||+|||++   +++||||||+|||++.++   .+||+|
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence            54 55799999999999999999888999999999999999999999999   999999999999997544   599999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  289 (371)
                      ||+++......   ......||+.|+|||++.+.    ....++.++|||||||++|+|++|..||...... ..+...+
T Consensus       286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i  357 (419)
T 3i6u_A          286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQI  357 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC--------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHH
T ss_pred             cccceecCCCc---cccccCCCCCccCceeeecC----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHH
Confidence            99998765432   33456799999999987531    1245678999999999999999999999754332 1222222


Q ss_pred             HHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .......      ........       ...+.+++.+||+.||++|||++|++++-+
T Consensus       358 ~~~~~~~------~~~~~~~~-------~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  402 (419)
T 3i6u_A          358 TSGKYNF------IPEVWAEV-------SEKALDLVKKLLVVDPKARFTTEEALRHPW  402 (419)
T ss_dssp             HTTCCCC------CHHHHTTS-------CHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             hcCCCCC------Cchhhccc-------CHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence            2111100      00001111       223556888899999999999999999755

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.4e-46  Score=355.22  Aligned_cols=252  Identities=26%  Similarity=0.355  Sum_probs=204.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|...+.||+|+||.||+|... +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45888899999999999999764 799999999854322 2234567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--  170 (476)
T 2y94_A           96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  170 (476)
T ss_dssp             ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence            9999999999999888899999999999999999999999   99999999999999999999999999998765543  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       .....+||+.|+|||++.+.      ...+.++|||||||++|+|++|..||.....  ..+...+..   ....    
T Consensus       171 -~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~---~~~~----  234 (476)
T 2y94_A          171 -FLRTSCGSPNYAAPEVISGR------LYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLFKKICD---GIFY----  234 (476)
T ss_dssp             -CBCCCCSCSTTCCHHHHTTC------CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHHHHHHT---TCCC----
T ss_pred             -cccccCCCcCeEChhhccCC------CCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhc---CCcC----
Confidence             23456799999999987532      1236789999999999999999999964322  222222211   1000    


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                         .....++       .+.+++.+||+.||.+|||++|++++-+
T Consensus       235 ---~p~~~s~-------~~~~Li~~~L~~dP~~Rpt~~eil~hp~  269 (476)
T 2y94_A          235 ---TPQYLNP-------SVISLLKHMLQVDPMKRATIKDIREHEW  269 (476)
T ss_dssp             ---CCTTCCH-------HHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             ---CCccCCH-------HHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence               0011222       3455788899999999999999999754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.7e-46  Score=334.70  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=200.8

Q ss_pred             hccccCC-ccccCCceEEEEEEe---CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDEN-VIGKGCSGVVYKAEM---PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~-~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+ .||+|+||.||+|.+   .+++.||+|++.....+....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            3566666 899999999999954   2468899999976555555678899999999999999999999999 5677899


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence            999999999999999888899999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          221 YH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       221 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. .......+|+.|+|||.+..       ..++.++||||||+++|+|++ |..||.....  ..+...+....    .
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~----~  238 (291)
T 1xbb_A          172 NYYKAQTHGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE----R  238 (291)
T ss_dssp             SEEEC----CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC----C
T ss_pred             CcccccccCCCCceeeChHHhcc-------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC----C
Confidence            21 11223456789999997753       246789999999999999999 9999864322  22222222111    0


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      .     ......++       .+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       239 ~-----~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          239 M-----GCPAGCPR-------EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             C-----CCCTTCCH-------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             C-----CCCCCCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0     00112222       34457778999999999999999999998753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-45  Score=343.00  Aligned_cols=265  Identities=22%  Similarity=0.339  Sum_probs=208.6

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc------chHHHHHHHHHHHhcc-CCCCceeeeceE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE------EPVDSFAAEIQILGHI-RHRNIVKLLGYC  132 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~  132 (371)
                      ..+.++|+..+.||+|+||.||+|... +|+.||||++.......      ...+.+.+|+.+++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            455678999999999999999999875 69999999986543211      1245678999999999 899999999999


Q ss_pred             ecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          133 SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       133 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      ...+..|+||||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCc
Confidence            99999999999999999999998888899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......   ......||+.|+|||.+.+... .....++.++|||||||++|+|++|..||....  .......+...
T Consensus       247 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i~~~  320 (365)
T 2y7j_A          247 SCHLEPGE---KLRELCGTPGYLAPEILKCSMD-ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--QILMLRMIMEG  320 (365)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHTTC-TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT
T ss_pred             ccccCCCc---ccccCCCCCCccChhhcccccc-ccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhC
Confidence            98765543   2345679999999998753311 112357889999999999999999999996432  22222222221


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...  .    ..+.....+       ..+.+++.+||+.||++|||+.|++++-+
T Consensus       321 ~~~--~----~~~~~~~~~-------~~~~~li~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          321 QYQ--F----SSPEWDDRS-------STVKDLISRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             CCC--C----CHHHHSSSC-------HHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             CCC--C----CCcccccCC-------HHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            110  0    001111122       23456788899999999999999998643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.8e-46  Score=338.92  Aligned_cols=259  Identities=22%  Similarity=0.377  Sum_probs=204.8

Q ss_pred             HhccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      .++|+..+.||+|+||.||+|...      +++.||+|.+... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            357888999999999999999653      3678999998532 233445678999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEE
Q 037946          138 KLLLYNYISNGNLQQLLQGN----------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL  207 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl  207 (371)
                      .++||||+++|+|.+++...          ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEE
Confidence            99999999999999998642          4578999999999999999999999   9999999999999999999999


Q ss_pred             ccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHH
Q 037946          208 ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIV  286 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  286 (371)
                      +|||++................+|+.|+|||.+.       +..++.++||||||+++|+|++ |..||....  .....
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~  250 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVL  250 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHHH
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhc-------cCCCCchhhHHHHHHHHHHHHhcCCCccccCC--HHHHH
Confidence            9999998765443322334456789999999765       2367889999999999999999 788875432  12222


Q ss_pred             HHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ..+..   . . .    .......++       .+.+++.+||+.||.+|||+.|++++|.+...
T Consensus       251 ~~~~~---~-~-~----~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RFVME---G-G-L----LDKPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHT---T-C-C----CCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHc---C-C-c----CCCCCCCCH-------HHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            22111   1 0 0    011112222       24457778999999999999999999988754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.5e-45  Score=339.35  Aligned_cols=256  Identities=21%  Similarity=0.224  Sum_probs=192.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||++... +++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            46888999999999999999765 789999999854332   23568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc--eEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE--AYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~  221 (371)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||++   +++||||||+||+++.++.  +||+|||+++...... 
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            999999999998888899999999999999999999999   9999999999999987765  9999999997543322 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNIT-EKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                        ......||+.|+|||++.+.       .++ .++|||||||++|+|++|..||....... .....+.......... 
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~-  241 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQ-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKYSI-  241 (361)
T ss_dssp             ----------CTTSCHHHHHCS-------SCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCCCC-
T ss_pred             --CCCCCcCCCCcCChhhhcCC-------CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCCCC-
Confidence              23455799999999987532       333 44899999999999999999997543321 1222222222111100 


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                          +.....+       ..+.+++.+||+.||++|||+.|++++-+-.
T Consensus       242 ----~~~~~~s-------~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  279 (361)
T 3uc3_A          242 ----PDDIRIS-------PECCHLISRIFVADPATRISIPEIKTHSWFL  279 (361)
T ss_dssp             ----CTTSCCC-------HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred             ----CCcCCCC-------HHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence                0001122       2344578889999999999999999986543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.7e-46  Score=358.70  Aligned_cols=259  Identities=25%  Similarity=0.347  Sum_probs=209.9

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .+.++|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|+.++++++||||+++++++.+.+..|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45678999999999999999999764 7899999998654332 345678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE---cCCCceEEccccCcccc
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLM  216 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~  216 (371)
                      +||||+.+|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||++   +.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            9999999999999999888899999999999999999999999   99999999999999   56789999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....   ......||+.|+|||++.        +.++.++|||||||++|+|++|..||....  ...+...+.......
T Consensus       180 ~~~~---~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~  246 (484)
T 3nyv_A          180 EASK---KMKDKIGTAYYIAPEVLH--------GTYDEKCDVWSTGVILYILLSGCPPFNGAN--EYDILKKVEKGKYTF  246 (484)
T ss_dssp             CCCC---SHHHHTTGGGTCCHHHHH--------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCC
T ss_pred             cccc---ccccCCCCccccCceeec--------CCCCCcceeHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCC
Confidence            5543   234567999999999764        257889999999999999999999996532  222333322211110


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      .      .+.....+       ..+.+++.+||+.||.+|||+.|++++-+--
T Consensus       247 ~------~~~~~~~s-------~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~  286 (484)
T 3nyv_A          247 E------LPQWKKVS-------ESAKDLIRKMLTYVPSMRISARDALDHEWIQ  286 (484)
T ss_dssp             C------SGGGGGSC-------HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             C------CcccccCC-------HHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence            0      01111122       2344678889999999999999999986543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.5e-45  Score=328.41  Aligned_cols=255  Identities=28%  Similarity=0.468  Sum_probs=188.9

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCC--cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD--EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.+ .++.||+|++......  ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            3577888999999999999987 4899999998654322  234578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC--------CCceEEccccCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS--------KYEAYLADFGLAK  214 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~--------~~~~kl~Dfg~~~  214 (371)
                      ||+++++|.+++.. ..+++..++.++.|++.||.|||+++..+++||||||+||+++.        ++.+||+|||++.
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~  164 (271)
T 3dtc_A           86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR  164 (271)
T ss_dssp             ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred             EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence            99999999999964 46999999999999999999999992112999999999999986        7789999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ......    .....||+.|+|||.+.       +..++.++||||||+++|+|++|..||.....  .....   ....
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~---~~~~  228 (271)
T 3dtc_A          165 EWHRTT----KMSAAGAYAWMAPEVIR-------ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--LAVAY---GVAM  228 (271)
T ss_dssp             ---------------CCGGGSCHHHHH-------HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--HHHHH---HHHT
T ss_pred             cccccc----ccCCCCccceeCHHHhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH---hhhc
Confidence            655432    23456999999999765       33678899999999999999999999964322  11111   1111


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      . ...    .+.....++       .+.+++.+||+.||++|||++|++++|+++
T Consensus       229 ~-~~~----~~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          229 N-KLA----LPIPSTCPE-------PFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             S-CCC----CCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             C-CCC----CCCCcccCH-------HHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1 000    011112222       344577789999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-46  Score=344.58  Aligned_cols=268  Identities=25%  Similarity=0.327  Sum_probs=201.7

Q ss_pred             hccccCCccccCCceEEEEEEe-----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe--cCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS--NKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~  137 (371)
                      ++|+..+.||+|+||.||+|..     .+++.||+|++..  ......+.+.+|++++++++||||+++++++.  +.+.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            4688889999999999999973     4688999999853  23445577999999999999999999999886  5567


Q ss_pred             EEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          138 KLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      .++||||+++++|.+++.. ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence            8999999999999999976 44599999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc----------hhH
Q 037946          217 NSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG----------LHI  285 (371)
Q Consensus       217 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----------~~~  285 (371)
                      ...... .......||+.|+|||.+.+       ..++.++||||||+++|+|++|..||.....+.          ...
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSD-------NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL  250 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred             ccCCccceeeccCCccccccCHHHhcc-------CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence            544321 12234458889999997753       246789999999999999999999985322110          000


Q ss_pred             HHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCC
Q 037946          286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELG  357 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  357 (371)
                      .... .....         ......+....   ..+.+++.+||+.||++|||++|++++|+.+........
T Consensus       251 ~~~~-~~~~~---------~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  309 (327)
T 3lxl_A          251 SRLL-ELLEE---------GQRLPAPPACP---AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE  309 (327)
T ss_dssp             HHHH-HHHHT---------TCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred             HHHH-HHhhc---------ccCCCCCCccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence            0000 10000         00011111111   234457788999999999999999999999976665444

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4e-46  Score=343.89  Aligned_cols=260  Identities=25%  Similarity=0.374  Sum_probs=204.3

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      +..+.|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            3456788889999999999999975 57899999998654332 334567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+. |+|.+++. ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9999997 57877774 456799999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .      ....||+.|+|||++...    ....++.++|||||||++|||++|..||.....  ...   .........+
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~---~~~~~~~~~~  271 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA---LYHIAQNESP  271 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTT----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH---HHHHHHSCCC
T ss_pred             C------CcccCCcceeCHhhhccc----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHH---HHHHHhcCCC
Confidence            2      345799999999976421    234678899999999999999999999864321  111   1111111111


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      .  .   .....++       .+.+++.+||+.||++|||+++++++.+-....
T Consensus       272 ~--~---~~~~~~~-------~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          272 A--L---QSGHWSE-------YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             C--C---CCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             C--C---CCCCCCH-------HHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            0  0   0011222       234577789999999999999999988766543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9e-46  Score=332.89  Aligned_cols=254  Identities=19%  Similarity=0.321  Sum_probs=198.6

Q ss_pred             hccccCCccccCCceEEEEEEeCC-C-------CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-G-------ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS  136 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  136 (371)
                      ++|+..+.||+|+||.||+|.... +       ..||+|.+..  ......+.+.+|+.++++++||||+++++++.+.+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG--GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc--ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            467888999999999999996542 3       4699999843  23345678999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc--------eEE
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE--------AYL  207 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~--------~kl  207 (371)
                      ..++||||+++++|.+++..... +++..++.++.|++.||.|||++   +++||||||+||+++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999987655 99999999999999999999999   9999999999999998887        999


Q ss_pred             ccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 037946          208 ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  287 (371)
                      +|||++......      ....||+.|+|||.+.+.      ..++.++||||||+++|||++|..|+...... .....
T Consensus       163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~  229 (289)
T 4fvq_A          163 SDPGISITVLPK------DILQERIPWVPPECIENP------KNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQ  229 (289)
T ss_dssp             CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG------GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHH
T ss_pred             ccCcccccccCc------cccCCcCcccCHHHhCCC------CCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHH
Confidence            999998754332      234588999999987531      35688999999999999999976665433221 11111


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      ...   .. ...       ....+..       +.+++.+||+.||++|||+++++++|+++.+...
T Consensus       230 ~~~---~~-~~~-------~~~~~~~-------l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          230 FYE---DR-HQL-------PAPKAAE-------LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HHH---TT-CCC-------CCCSSCT-------THHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             Hhh---cc-CCC-------CCCCCHH-------HHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            111   11 100       0111222       3446777999999999999999999999986433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-45  Score=343.89  Aligned_cols=272  Identities=22%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             HHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecC--C
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNK--S  136 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~  136 (371)
                      ..+.++|+..+.||+|+||.||+|.+ .+|+.||+|++............+.+|+.+++.+. ||||+++++++...  .
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            35677899999999999999999975 46899999999665555566778899999999997 99999999998754  3


Q ss_pred             eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ..|+||||++ ++|.+++... .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            7899999997 4999998764 699999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCC-------------------cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          217 NSTN-------------------YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       217 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                      ....                   ........+||+.|+|||++.+      ...++.++|||||||++|||++|..||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG------STKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcC------CCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            4311                   0112234579999999998753      23678999999999999999999999965


Q ss_pred             CCCCchhHHHHHHHHhcCCCcccccc---------------------CcccCCCChhhH----------HHHHHHHHHHh
Q 037946          278 QIGDGLHIVEWVKKKMGSFEPAVSIL---------------------DTKLQGLPDQMV----------QEMLQTLGIAM  326 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~----------~~~~~~~~l~~  326 (371)
                      ..  .......+......... ..+.                     ........+...          .....+.+|+.
T Consensus       234 ~~--~~~~~~~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          234 SS--TMNQLERIIGVIDFPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             SS--HHHHHHHHHHHHCCCCH-HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CC--HHHHHHHHHHhcCCCCH-HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            42  22222222222221110 0000                     000000000000          00124567889


Q ss_pred             cccCCCCCCCCCHHHHHHHH
Q 037946          327 FCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       327 ~cl~~dP~~RPs~~evl~~L  346 (371)
                      +||+.||++|||++|++++-
T Consensus       311 ~~L~~dP~~R~t~~e~l~Hp  330 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKHP  330 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTST
T ss_pred             HhhccCcccCCCHHHHhCCH
Confidence            99999999999999999983

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=330.95  Aligned_cols=255  Identities=21%  Similarity=0.305  Sum_probs=193.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc------------------------chHHHHHHHHHHHhc
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE------------------------EPVDSFAAEIQILGH  119 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~  119 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.......                        ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            4688889999999999999975 468899999986543211                        123568899999999


Q ss_pred             cCCCCceeeeceEec--CCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 037946          120 IRHRNIVKLLGYCSN--KSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNI  197 (371)
Q Consensus       120 l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Ni  197 (371)
                      ++||||+++++++.+  .+..|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++   +++||||||+||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            999999999999986  5688999999999999887654 4699999999999999999999999   999999999999


Q ss_pred             eEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          198 LLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       198 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                      +++.++.+||+|||++........  ......||+.|+|||.+.+..    ....+.++||||||+++|+|++|..||..
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETR----KIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTC----CCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCC----CCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999987654431  234557999999999875321    11136789999999999999999999964


Q ss_pred             CCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ..  .......+....   ..     .+.....++       .+.+++.+||+.||++|||++|++++-
T Consensus       243 ~~--~~~~~~~~~~~~---~~-----~~~~~~~~~-------~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          243 ER--IMCLHSKIKSQA---LE-----FPDQPDIAE-------DLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             SS--HHHHHHHHHHCC---CC-----CCSSSCCCH-------HHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             cc--HHHHHHHHhccc---CC-----CCCccccCH-------HHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            32  112222111110   00     011112222       344577889999999999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.9e-46  Score=343.41  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=202.1

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|++.+... .....+.+..|..++..+ +||||+++++++.+.+..|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            56888899999999999999765 478999999865322 233456788999999988 899999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++...... 
T Consensus       100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  175 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-  175 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence            99999999999999878899999999999999999999999   99999999999999999999999999998643322 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  ...+...+..   ...    
T Consensus       176 -~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~---~~~----  238 (353)
T 2i0e_A          176 -VTTKTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIME---HNV----  238 (353)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTT-------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH---CCC----
T ss_pred             -cccccccCCccccChhhhcC-------CCcCCcccccchHHHHHHHHcCCCCCCCCC--HHHHHHHHHh---CCC----
Confidence             13355689999999998753       357899999999999999999999996432  2222222222   100    


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVALL  346 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L  346 (371)
                             ..+....   ..+.+++.+||+.||.+||+     +++++++-
T Consensus       239 -------~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~  278 (353)
T 2i0e_A          239 -------AYPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  278 (353)
T ss_dssp             -------CCCTTSC---HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred             -------CCCCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence                   1111111   23445778899999999994     68888874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-46  Score=342.31  Aligned_cols=263  Identities=20%  Similarity=0.306  Sum_probs=194.5

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCe---
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV---  137 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  137 (371)
                      +.++|+..+.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            346788899999999999999975 57899999999654332 3445688999999999999999999999876543   


Q ss_pred             -EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          138 -KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                       .|+||||+++++|.+++...+.+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence             499999999999999998888899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          217 NSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       217 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ...... .......||+.|+|||++.       +..++.++||||||+++|+|++|..||......     .........
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~  234 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVRE  234 (311)
T ss_dssp             ---------------CCTTCCHHHHH-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHC
T ss_pred             cccccccccccccCcCcccCCHHHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcC
Confidence            543211 1223456899999999765       336788999999999999999999999643221     111111111


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH-HHHhccc
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV-ALLMEVK  350 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl-~~L~~~~  350 (371)
                      .....   .......+.       .+.+++.+||+.||++||+..+++ ..+.+..
T Consensus       235 ~~~~~---~~~~~~~~~-------~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          235 DPIPP---SARHEGLSA-------DLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CCCCH---HHHSTTCCH-------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCCc---ccccCCCCH-------HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            01000   000112222       344577889999999999655544 4555554

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7e-46  Score=341.32  Aligned_cols=256  Identities=21%  Similarity=0.278  Sum_probs=201.6

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  139 (371)
                      .+.+.|+..+.||+|+||.||+|... +++.||+|++......      ..+|++++.++ +||||+++++++.+.+..|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            45678999999999999999999764 6889999999654322      34688888888 7999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC----CceEEccccCccc
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK----YEAYLADFGLAKL  215 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~  215 (371)
                      +||||+++|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+||++.++    +.+||+|||++..
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999999999888899999999999999999999999   99999999999998443    3599999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-chhHHHHHHHHhc
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD-GLHIVEWVKKKMG  294 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~  294 (371)
                      .....  ......+||+.|+|||++.+.       .++.++|||||||++|||++|..||.....+ ...+...+.....
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  240 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQ-------GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF  240 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHH-------HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCC-------CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc
Confidence            65443  123456799999999987643       3567899999999999999999999754332 2222222222111


Q ss_pred             CCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      .      .........++       .+.+++.+||+.||++|||+.+++++-+-
T Consensus       241 ~------~~~~~~~~~s~-------~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          241 S------LSGGYWNSVSD-------TAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             C------CCSTTTTTSCH-------HHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             c------cCccccccCCH-------HHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence            0      00011112222       34457788999999999999999998654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.6e-45  Score=349.71  Aligned_cols=266  Identities=22%  Similarity=0.282  Sum_probs=198.1

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC------C
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK------S  136 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  136 (371)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|++............+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46788999999999999999965 4689999999976555556677899999999999999999999998654      4


Q ss_pred             eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ..|+||||+++ +|.+.+..  .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            57999999987 56666654  389999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....   ......||+.|+|||++.+       ..++.++|||||||++|||++|+.||....  .......+....+..
T Consensus       215 ~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pF~g~~--~~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          215 GTSF---MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTP  282 (464)
T ss_dssp             --CC---CC----CCCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCSC
T ss_pred             CCCc---ccCCCcccccccCHHHHcC-------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCC
Confidence            5432   3345679999999998753       367899999999999999999999996532  222222222222211


Q ss_pred             Ccc------------------------ccccCcccC-CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          297 EPA------------------------VSILDTKLQ-GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       297 ~~~------------------------~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .+.                        ...+..... ............+.+|+.+||+.||++|||++|++++-+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  358 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  358 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence            000                        000000000 001111112345678999999999999999999999853

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.6e-46  Score=332.91  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=197.6

Q ss_pred             HHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      .++.++|...+.||+|+||.||++.. .+++.+|+|++.... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            34567899999999999999999976 468899999986543 3344678899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE---cCCCceEEccccC
Q 037946          140 LLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGL  212 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~  212 (371)
                      +||||+++|+|.+++..    ...+++..++.++.|++.||.|||++   +++||||||+||++   +.++.+||+|||+
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            99999999999998853    46799999999999999999999999   99999999999999   4568899999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......   ......||+.|+|||.+.        ..++.++||||||+++|+|++|..||.....  ......... 
T Consensus       174 a~~~~~~~---~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--~~~~~~~~~-  239 (285)
T 3is5_A          174 AELFKSDE---HSTNAAGTALYMAPEVFK--------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQQKATY-  239 (285)
T ss_dssp             CCC-------------CTTGGGCCHHHHT--------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-
T ss_pred             ceecCCcc---cCcCcccccCcCChHHhc--------cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--HHHHhhhcc-
Confidence            98655432   234557999999999753        2568899999999999999999999965322  111111111 


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                        .....    .......++       .+.+++.+||+.||++|||+.|++++-
T Consensus       240 --~~~~~----~~~~~~~~~-------~~~~li~~~L~~dP~~Rps~~e~l~hp  280 (285)
T 3is5_A          240 --KEPNY----AVECRPLTP-------QAVDLLKQMLTKDPERRPSAAQVLHHE  280 (285)
T ss_dssp             --CCCCC----CC--CCCCH-------HHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred             --CCccc----ccccCcCCH-------HHHHHHHHHccCChhhCcCHHHHhcCH
Confidence              10000    001111222       344577889999999999999999763

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.4e-46  Score=355.92  Aligned_cols=252  Identities=22%  Similarity=0.267  Sum_probs=194.3

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            5688899999999999999975 468999999986532 23344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+ +   +++||||||+|||++.++.+||+|||+++...... 
T Consensus       228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  303 (446)
T 4ejn_A          228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-  303 (446)
T ss_dssp             CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence            999999999999888889999999999999999999998 8   99999999999999999999999999997643332 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|+|||++.       +..++.++|||||||++|||++|..||....  ...+...+..   .....  
T Consensus       304 -~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~---~~~~~--  368 (446)
T 4ejn_A          304 -ATMKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILM---EEIRF--  368 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHH-------TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH---CCCCC--
T ss_pred             -cccccccCCccccCHhhcC-------CCCCCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHHh---CCCCC--
Confidence             2334567999999999765       3467899999999999999999999996432  2222222221   10100  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHh
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLM  347 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~  347 (371)
                           ....++       .+.+++.+||+.||.+||     |++|++++-+
T Consensus       369 -----p~~~~~-------~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~  407 (446)
T 4ejn_A          369 -----PRTLGP-------EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF  407 (446)
T ss_dssp             -----CTTSCH-------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             -----CccCCH-------HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence                 011222       344577889999999999     9999998743

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=344.58  Aligned_cols=280  Identities=19%  Similarity=0.272  Sum_probs=207.6

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC--eEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS--VKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  141 (371)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++..... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            46888899999999999999765 589999999854322 334577889999999999999999999987665  78999


Q ss_pred             EeecCCCCHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE----cCCCceEEccccCcc
Q 037946          142 YNYISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL----DSKYEAYLADFGLAK  214 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~~  214 (371)
                      |||+++|+|.+++.....   +++..++.++.|++.||+|||++   +++||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976443   99999999999999999999999   99999999999999    788889999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhc-ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG-YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      ......   ......||+.|+|||++....... ....++.++|||||||++|||++|..||.+........ +.+....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~  240 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII  240 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHh
Confidence            765543   234567999999999875320000 01245678999999999999999999997544322111 1122222


Q ss_pred             cCCCc-ccccc----------CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          294 GSFEP-AVSIL----------DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       294 ~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      ..... .....          .........-.......+.+++.+||+.||++|||++++++.+.++...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11110 00000          0001110010012233445688999999999999999999999887643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-45  Score=357.77  Aligned_cols=261  Identities=25%  Similarity=0.328  Sum_probs=205.9

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc-----------chHHHHHHHHHHHhccCCCCcee
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE-----------EPVDSFAAEIQILGHIRHRNIVK  127 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~  127 (371)
                      .+.+.+.|...+.||+|+||.||+|... +++.||+|++.......           ...+.+.+|+.++++++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            3456778999999999999999999764 57899999986543221           34578899999999999999999


Q ss_pred             eeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC---c
Q 037946          128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY---E  204 (371)
Q Consensus       128 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~---~  204 (371)
                      +++++.+.+..|+|||||++|+|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++   .
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999999998888899999999999999999999999   999999999999998776   6


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH  284 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  284 (371)
                      +||+|||++.......   ......||+.|+|||++.        ..++.++|||||||++|+|++|..||....  ...
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~  254 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK--------KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQD  254 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc--------cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHH
Confidence            9999999998765543   334567999999999764        247889999999999999999999996532  222


Q ss_pred             HHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          285 IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      +...+......+.      .+.....+       ..+.+++.+||+.||.+|||++|++++-+--
T Consensus       255 ~~~~i~~~~~~~~------~~~~~~~s-------~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          255 IIKKVEKGKYYFD------FNDWKNIS-------DEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             HHHHHHHCCCCCC------HHHHTTSC-------HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHcCCCCCC------ccccCCCC-------HHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence            3222222111100      00111222       2345678889999999999999999986543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=345.03  Aligned_cols=248  Identities=21%  Similarity=0.270  Sum_probs=192.3

Q ss_pred             CCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           70 ENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .+.||+|+||.||+|.. .+|+.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            56799999999999975 46899999998542  2345578999999999999999999999999999999999999999


Q ss_pred             CHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE--cCCCceEEccccCccccCCCCccccc
Q 037946          149 NLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL--DSKYEAYLADFGLAKLMNSTNYHHAM  225 (371)
Q Consensus       149 ~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~  225 (371)
                      +|.+++... ..+++..+..++.|++.||.|||++   +++||||||+|||+  +.++.+||+|||+++......   ..
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~  245 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL  245 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence            999988654 4699999999999999999999999   99999999999999  667899999999998765543   23


Q ss_pred             ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ....||+.|+|||++.       ...++.++|||||||++|||++|..||.....  ......+......      ....
T Consensus       246 ~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~------~~~~  310 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVN-------YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AETLNNILACRWD------LEDE  310 (373)
T ss_dssp             CCCCSSCTTCCHHHHT-------TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCCC------SCSG
T ss_pred             ccccCCCcEeChhhcc-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCC------CChh
Confidence            3456999999999764       33578899999999999999999999965422  2222211111100      0011


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .....++       .+.+++.+||+.||.+|||++|++++-+
T Consensus       311 ~~~~~~~-------~~~~li~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          311 EFQDISE-------EAKEFISKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             GGTTSCH-------HHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             hhccCCH-------HHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence            1122222       3456888899999999999999999643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-46  Score=338.58  Aligned_cols=262  Identities=23%  Similarity=0.368  Sum_probs=200.1

Q ss_pred             hccccCCccccCCceEEEEEEe-----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC--Ce
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK--SV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  137 (371)
                      +.|+..+.||+|+||.||+|.+     .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.  +.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3478889999999999999973     468899999986433 344567899999999999999999999999876  67


Q ss_pred             EEEEEeecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          138 KLLLYNYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      .++||||+++++|.+++. ....+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence            899999999999999994 455699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC----------CchhH
Q 037946          217 NSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG----------DGLHI  285 (371)
Q Consensus       217 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~----------~~~~~  285 (371)
                      ...... .......||..|+|||.+.+       ..++.++||||||+++|+|++|..|+.....          .....
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-------SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecC-------CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            554321 22334568889999997753       2567899999999999999999988642210          01111


Q ss_pred             HHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ..........          .....+....   ..+.+++.+||+.||.+|||++++++.|+++.
T Consensus       250 ~~~~~~~~~~----------~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLVNTLKEG----------KRLPCPPNCP---DEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHTT----------CCCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcc----------CCCCCCCCCC---HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111111110          0011111111   23455788899999999999999999998764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-45  Score=350.94  Aligned_cols=198  Identities=25%  Similarity=0.338  Sum_probs=158.5

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-----CCe
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-----KSV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  137 (371)
                      .++|+..+.||+|+||.||+|.+. +++.||+|++..........+++.+|+.+++.++||||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            467999999999999999999654 68999999996655555667789999999999999999999999843     367


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .|+||||+. ++|.+++.....+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            899999985 69999999888899999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcc-------------------------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhC
Q 037946          218 STNYH-------------------------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG  271 (371)
Q Consensus       218 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g  271 (371)
                      .....                         ......+||+.|+|||++..      ...++.++|||||||++|||++|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL------QENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhC------CCCCCcHhHHHHHHHHHHHHHHh
Confidence            32210                         12334578999999997532      33678999999999999999993

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.1e-46  Score=351.42  Aligned_cols=263  Identities=21%  Similarity=0.236  Sum_probs=203.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|++.+... .......+.+|..++..++||||++++++|.+.+..|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            57888999999999999999765 478999999854221 1122334789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.......
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999987 56799999999999999999999999   999999999999999999999999999987654432


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|+|||++...  ......++.++|||||||++|||++|..||....  .......+........    
T Consensus       231 -~~~~~~~GT~~Y~APE~l~~~--~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~----  301 (437)
T 4aw2_A          231 -VQSSVAVGTPDYISPEILQAM--EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKERFQ----  301 (437)
T ss_dssp             -EECCSCCSCGGGCCHHHHHHH--HTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTHHHHCC----
T ss_pred             -cccccccCCcCeeChHHHhhc--ccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--hhHHHHhhhhcccccc----
Confidence             223346799999999987532  1113357889999999999999999999997532  2222222211111000    


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHHHh
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE--RPTMKEVVALLM  347 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L~  347 (371)
                       +.......++       .+.+++.+||..+|++  ||+++|++++-+
T Consensus       302 -~p~~~~~~s~-------~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf  341 (437)
T 4aw2_A          302 -FPTQVTDVSE-------NAKDLIRRLICSREHRLGQNGIEDFKKHPF  341 (437)
T ss_dssp             -CCSSCCCSCH-------HHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred             -CCcccccCCH-------HHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence             0001111222       3445778899888888  999999999854

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=338.53  Aligned_cols=260  Identities=22%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCE----EEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGEL----IAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ++|+..+.||+|+||.||+|.+. +++.    ||+|.+.. .........+.+|+.+++.++||||+++++++.... .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECC-CSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecc-ccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            45888899999999999999753 4554    57776643 233455678999999999999999999999998765 78


Q ss_pred             EEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +++|++.+|+|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            89999999999999976 45699999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...........+|+.|+|||.+.       +..++.++||||||+++|||++ |..||......  .+...+......  
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~~--  238 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESIL-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL--  238 (327)
T ss_dssp             ----------CCCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC--
T ss_pred             ccccccccCCCccccccCHHHHc-------CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCC--
Confidence            44333334455788999999775       3367889999999999999999 99998654332  222222221100  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                             +.....+.       .+.+++.+||+.||.+|||++|+++.|.++...+.
T Consensus       239 -------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  281 (327)
T 3lzb_A          239 -------PQPPICTI-------DVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             -------CCCTTBCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             -------CCCccCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence                   00111222       34557788999999999999999999999976654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=348.56  Aligned_cols=262  Identities=25%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             hccccCCccccCCceEEEEEEe----CCCCEEEEEEecccCC--CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKR--DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      ++|+..+.||+|+||.||+|..    .+++.||+|++.....  .....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788899999999999999976    3689999999854321  122335567899999999 69999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            999999999999999998888899999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .... .......||+.|+|||++.+.     ...++.++|||||||++|||++|..||....... ..............
T Consensus       211 ~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~  283 (355)
T 1vzo_A          211 ADET-ERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSEP  283 (355)
T ss_dssp             GGGG-GGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCCC
T ss_pred             cCCC-CcccCcccCcCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhccCC
Confidence            3321 223345799999999987531     2346789999999999999999999997543321 11222222211111


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHHhccc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALLMEVK  350 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~~~~  350 (371)
                                 ..+.....   .+.+++.+||+.||.+||     |++|++++.+--.
T Consensus       284 -----------~~~~~~~~---~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          284 -----------PYPQEMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             -----------CCCTTSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             -----------CCCcccCH---HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence                       11111111   234577889999999999     9999999876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.1e-45  Score=331.40  Aligned_cols=265  Identities=21%  Similarity=0.351  Sum_probs=197.4

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++.... ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35789999999999999999975 578999999986533 2344567889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          142 YNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864    55689999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...  .......||+.|+|||.+.       +..++.++||||||+++|+|++|..||.....+...+...+..   ...
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~  255 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---CDY  255 (310)
T ss_dssp             -------------CCSSCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT---TCS
T ss_pred             CCC--ccccccCCCeeEeChHHhC-------CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc---ccC
Confidence            432  1223456899999999765       3367889999999999999999999986543332222222111   100


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      +  ..   .....+.       .+.+++.+||+.||.+|||++++++.|+++.....+
T Consensus       256 ~--~~---~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          256 P--PL---PSDHYSE-------ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             C--CC---CTTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             C--CC---cccccCH-------HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            0  00   0012222       344577789999999999999999999999755444

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.3e-46  Score=341.60  Aligned_cols=263  Identities=26%  Similarity=0.360  Sum_probs=201.7

Q ss_pred             cccCCccccCCceEEEEEEeC-----CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--CCeEE
Q 037946           67 LKDENVIGKGCSGVVYKAEMP-----NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--KSVKL  139 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  139 (371)
                      |+..+.||+|+||.||++.+.     +++.||+|++... ......+.+.+|++++++++||||+++++++.+  ....+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            377889999999999988542     6789999998543 334556789999999999999999999999987  46789


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +||||+++++|.+++.... +++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++......
T Consensus       112 lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            9999999999999998765 99999999999999999999999   9999999999999999999999999999877554


Q ss_pred             Ccc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCch---------hHHHHH
Q 037946          220 NYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL---------HIVEWV  289 (371)
Q Consensus       220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---------~~~~~~  289 (371)
                      ... .......+|+.|+|||.+.+       ..++.++||||||+++|+|++|..||........         .....+
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKE-------YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccccccCCCCCceeeChHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            321 12334568889999998753       2467899999999999999999999864321100         000001


Q ss_pred             HHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                      .........     .+.....+       ..+.+++.+||+.||.+|||++|+++.|+.+....
T Consensus       261 ~~~~~~~~~-----~~~~~~~~-------~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          261 TELLERGER-----LPRPDKCP-------AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHTTCC-----CCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccC-----CCCCcccc-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            111111000     00111222       23455778899999999999999999999886433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-46  Score=352.99  Aligned_cols=260  Identities=22%  Similarity=0.245  Sum_probs=202.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|++.+... .......+.+|..+++.++||||+++++++.+.+..|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            56888899999999999999764 588999999854221 1122345789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++|+|.+++... .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++....... 
T Consensus       149 E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-  223 (410)
T 3v8s_A          149 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-  223 (410)
T ss_dssp             CCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-
T ss_pred             eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-
Confidence            999999999999764 589999999999999999999999   999999999999999999999999999987655431 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+||+.|+|||++....   ....++.++|||||||++|||++|..||....  .......+......      .
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~---~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~------~  292 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMNHKNS------L  292 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTT---TTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTHHHH------C
T ss_pred             ccccCCcCCccccCHHHhhccC---CCcCCCCcceEecchHHHHHHHhCCCCCCCCC--hhhHHHHHHhcccc------c
Confidence            1234668999999999876431   11226789999999999999999999997432  22222222211100      0


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAE--RPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L~  347 (371)
                      .-+.....+.       .+.+|+.+||+.+|.+  ||+++||++|-+
T Consensus       293 ~~p~~~~~s~-------~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~  332 (410)
T 3v8s_A          293 TFPDDNDISK-------EAKNLICAFLTDREVRLGRNGVEEIKRHLF  332 (410)
T ss_dssp             CCCTTCCCCH-------HHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred             cCCCcccccH-------HHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence            0011112222       2345777799999988  999999999854

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-45  Score=341.57  Aligned_cols=266  Identities=18%  Similarity=0.251  Sum_probs=199.0

Q ss_pred             hccccCCccccCCceEEEEEEeCC------CCEEEEEEecccCCCcc---------hHHHHHHHHHHHhccCCCCceeee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEE---------PVDSFAAEIQILGHIRHRNIVKLL  129 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~  129 (371)
                      ++|+..+.||+|+||.||+|.+..      ++.||+|++........         ....+..|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            478889999999999999997754      47899999854321100         012334566677788999999999


Q ss_pred             ceEecC----CeEEEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc--CC
Q 037946          130 GYCSNK----SVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD--SK  202 (371)
Q Consensus       130 ~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~--~~  202 (371)
                      +++...    ...|+||||+ +++|.+++... ..+++..++.++.|++.||+|||++   +++||||||+|||++  .+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence            998764    5589999999 99999999765 6799999999999999999999999   999999999999999  88


Q ss_pred             CceEEccccCccccCCCCccc-----ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 037946          203 YEAYLADFGLAKLMNSTNYHH-----AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP  277 (371)
Q Consensus       203 ~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  277 (371)
                      +.+||+|||+++.........     ......||+.|+|||++.       +..++.++|||||||++|||++|..||..
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-------GVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-------CCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999999999998765432111     113345999999999765       33578999999999999999999999975


Q ss_pred             CCCCchhHHHHHHHHhcCCCccccccCccc--CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          278 QIGDGLHIVEWVKKKMGSFEPAVSILDTKL--QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ...+.. ..........  .....+.+..+  ...+.       .+.+++..||+.||.+||++++|++.|.++..
T Consensus       264 ~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-------~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          264 NLKDPK-YVRDSKIRYR--ENIASLMDKCFPAANAPG-------EIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             GTTCHH-HHHHHHHHHH--HCHHHHHHHHSCTTCCCH-------HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccCHH-HHHHHHHHhh--hhHHHHHHHhcccccCHH-------HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            444322 2222221111  11112222221  22332       34456777999999999999999999988753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=328.00  Aligned_cols=253  Identities=24%  Similarity=0.402  Sum_probs=184.0

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            45788899999999999999976 5789999999854321 123357789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++++|.+++... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999865 5699999999999999999999999   99999999999999999999999999998765332


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .  ......||+.|+|||.+.+       ..++.++||||||+++|+|++|..||........     ...         
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~---------  223 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATR-------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNK---------  223 (278)
T ss_dssp             ----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------
T ss_pred             C--cceeccCCCCcCCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHH---------
Confidence            1  2234568999999998753       3567899999999999999999999965432210     000         


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                       ...... ..+....   ..+.+++.+||+.||++|||+++++++-+
T Consensus       224 -~~~~~~-~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~h~~  265 (278)
T 3cok_A          224 -VVLADY-EMPSFLS---IEAKDLIHQLLRRNPADRLSLSSVLDHPF  265 (278)
T ss_dssp             -CCSSCC-CCCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred             -Hhhccc-CCccccC---HHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence             000000 1111111   23446788899999999999999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-45  Score=337.73  Aligned_cols=271  Identities=18%  Similarity=0.274  Sum_probs=196.0

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      ..++|+..+.||+|+||.||+|.. .+++.||+|++............+.+|+.++++++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            346799999999999999999965 4689999999965554444556788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc-----CCCceEEccccCcccc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD-----SKYEAYLADFGLAKLM  216 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~-----~~~~~kl~Dfg~~~~~  216 (371)
                      |||+++ +|.+++.....+++..+..++.|++.||.|||++   +++||||||+|||++     .++.+||+|||++...
T Consensus       112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999985 9999999888899999999999999999999999   999999999999994     5556999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....  .......||+.|+|||++.+      ...++.++|||||||++|||++|..||.....  ......+.......
T Consensus       188 ~~~~--~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          188 GIPI--RQFTHEIITLWYRPPEILLG------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--IDQLFKIFEVLGLP  257 (329)
T ss_dssp             C-------------CCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCC
T ss_pred             CCcc--cccCCCcCCccccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH--HHHHHHHHHHhCCC
Confidence            5432  12344568999999997652      23478999999999999999999999965322  22222222222211


Q ss_pred             Cccc--cc-----cCcccCCCChhhHH------HHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          297 EPAV--SI-----LDTKLQGLPDQMVQ------EMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       297 ~~~~--~~-----~~~~~~~~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ....  ..     ..............      ....+.+++.+||+.||++|||++|++++-+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  321 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY  321 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence            1000  00     00000000000000      1124567888999999999999999998643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.9e-45  Score=329.17  Aligned_cols=255  Identities=25%  Similarity=0.446  Sum_probs=203.1

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|...+++.||+|.+....   ...+.+.+|+++++.++||||+++++++.+ +..++||||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            4688889999999999999998888899999985432   335678999999999999999999999874 558999999


Q ss_pred             cCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++++|.+++....  .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ 
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            99999999997643  699999999999999999999999   999999999999999999999999999987655432 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .......+++.|+|||.+..       ..++.++||||||+++|||++ |..||....  .......+....   ..   
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~---~~---  229 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERGY---RM---  229 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTC---CC---
T ss_pred             ccccCCCCccCccChhhhcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCcccC--HHHHHHHHhccc---CC---
Confidence            12234457889999997652       356789999999999999999 888886432  222222222111   00   


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                         ......+.       .+.+++.+||+.||++|||++++++.|+++...
T Consensus       230 ---~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          230 ---VRPDNCPE-------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ---CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCcccccH-------HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence               00112222       344577789999999999999999999988643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.1e-45  Score=339.01  Aligned_cols=262  Identities=20%  Similarity=0.257  Sum_probs=200.9

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-----CCCceeeeceEecCCe
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-----HRNIVKLLGYCSNKSV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~  137 (371)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++..   .......+..|+.+++.+.     ||||+++++++...+.
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            46799999999999999999976 4689999999842   3344567788999999986     9999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC--------------
Q 037946          138 KLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS--------------  201 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~--------------  201 (371)
                      .++||||+ +++|.+++....  .+++..+..++.|++.||+|||++   +++||||||+|||++.              
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccc
Confidence            99999999 889999997654  599999999999999999999999   9999999999999975              


Q ss_pred             -----------CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh
Q 037946          202 -----------KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS  270 (371)
Q Consensus       202 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  270 (371)
                                 ++.+||+|||++.......     ....||+.|+|||++.       +..++.++|||||||++|+|++
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVIL-------NLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHc-------CCCCCCccchHHHHHHHHHHHH
Confidence                       7899999999998654332     4557999999999775       3367899999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHHhcCCCccc----------cccC-----cccCCCChhhH--H------------HHHHH
Q 037946          271 GRSAVQPQIGDGLHIVEWVKKKMGSFEPAV----------SILD-----TKLQGLPDQMV--Q------------EMLQT  321 (371)
Q Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~-----~~~~~~~~~~~--~------------~~~~~  321 (371)
                      |..||....  .......+...........          ...+     ...........  .            ....+
T Consensus       255 g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          255 GSLLFRTHE--HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             SSCSCCCSS--HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             CCCCCCCCc--HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999996532  2222333333222211000          0000     00000000000  0            01345


Q ss_pred             HHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          322 LGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       322 ~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .+++.+||+.||++|||++|++++-
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~hp  357 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLKHK  357 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcCc
Confidence            5789999999999999999998763

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-44  Score=328.98  Aligned_cols=267  Identities=21%  Similarity=0.277  Sum_probs=199.4

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ....++|+..+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            344567999999999999999999764 6889999998654332 33457889999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      |+||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999976654


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ... .......||+.|+|||.+.+       ..++.++||||||+++|+|++|..||.....   .   .+.........
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~---~~~~~~~~~~~  252 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSE-------SHATYRADIYALTCVLYECLTGSPPYQGDQL---S---VMGAHINQAIP  252 (309)
T ss_dssp             -----------CCGGGCCGGGTCC-----------CCCHHHHHHHHHHHHHHSSCSSCSCHH---H---HHHHHHHSCCC
T ss_pred             ccc-ccccccCCCcCccCHHHHcC-------CCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H---HHHHHhccCCC
Confidence            321 12234569999999998753       3668899999999999999999999864321   1   11111111111


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhcccCCCc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-TMKEVVALLMEVKSAPE  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~  354 (371)
                      ..   .......+.       .+.+++.+||+.||++|| |++++++.|.+......
T Consensus       253 ~~---~~~~~~~~~-------~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          253 RP---STVRPGIPV-------AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CG---GGTSTTCCT-------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             Cc---cccCCCCCH-------HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            11   011122333       234467779999999999 99999999998865554

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.1e-45  Score=326.60  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec----CCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN----KSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  140 (371)
                      .|+..+.||+|+||.||+|.. .++..||+|.+..........+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            467778899999999999976 468899999997666666667889999999999999999999998765    466899


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeEc-CCCceEEccccCccccC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA--ILHRDVKCNNILLD-SKYEAYLADFGLAKLMN  217 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~  217 (371)
                      ||||+++++|.+++.....+++..++.++.|++.||.|||++   +  ++||||||+||+++ .++.+||+|||++....
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            999999999999999888899999999999999999999998   7  99999999999997 78999999999997554


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...    .....||+.|+|||.+.        ..++.++||||||+++|+|++|..||...... ...   .........
T Consensus       184 ~~~----~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~---~~~~~~~~~  247 (290)
T 1t4h_A          184 ASF----AKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQI---YRRVTSGVK  247 (290)
T ss_dssp             TTS----BEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHH---HHHHTTTCC
T ss_pred             ccc----cccccCCcCcCCHHHHh--------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-HHH---HHHHhccCC
Confidence            332    23456999999999764        24788999999999999999999999643321 111   111111111


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      +.  ...   ...+       ..+.+++.+||+.||.+|||++|++++-+
T Consensus       248 ~~--~~~---~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          248 PA--SFD---KVAI-------PEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             CG--GGG---GCCC-------HHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             cc--ccC---CCCC-------HHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence            00  000   1111       13456788899999999999999998643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=337.57  Aligned_cols=264  Identities=25%  Similarity=0.428  Sum_probs=200.2

Q ss_pred             hccccCCccccCCceEEEEEEeCC-----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ++|+..+.||+|+||.||+|....     +..||+|.+... ........+.+|+.++++++||||+++++++.+.+..+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            456677899999999999996542     235999998543 23445567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999764 5699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          219 TNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       219 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      .... .......+|+.|+|||.+.       ...++.++||||||+++|||++ |..||....  ...+...+.....  
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--~~~~~~~~~~~~~--  268 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAINDGFR--  268 (333)
T ss_dssp             -----------CCCGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTCC--
T ss_pred             ccccccccCCCCccccccCchhcc-------cCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHCCCc--
Confidence            3211 1122334688999999765       3367889999999999999999 999986432  2222222221100  


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCC
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELG  357 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  357 (371)
                       .      +.....+.       .+.+++.+||+.||++||++.++++.|+++...+....
T Consensus       269 -~------~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~  315 (333)
T 1mqb_A          269 -L------PTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK  315 (333)
T ss_dssp             -C------CCCTTCBH-------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred             -C------CCcccCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence             0      01112222       34457778999999999999999999999876665543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-45  Score=328.77  Aligned_cols=257  Identities=22%  Similarity=0.343  Sum_probs=201.4

Q ss_pred             ccccCC-ccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           66 CLKDEN-VIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        66 ~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +|...+ .||+|+||.||+|.+.   ++..||+|++... ......+.+.+|++++++++||||+++++++ ..+..++|
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            344444 8999999999999753   5778999998543 3345567899999999999999999999999 45668999


Q ss_pred             EeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++++|.+++... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999654 4599999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          221 YH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       221 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. .......+|+.|+|||.+..       ..++.++||||||+++|+|++ |..||.....  ......+......   
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~~~~~---  232 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRM---  232 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCCC---
T ss_pred             ceeeccccccccccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhcCCcC---
Confidence            21 12233457899999997652       356789999999999999998 9999865432  2222222221100   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                            ......++       .+.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus       233 ------~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          233 ------ECPPECPP-------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             ------CCCTTCCH-------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCcCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                  00112222       344577789999999999999999999998643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.1e-45  Score=328.00  Aligned_cols=250  Identities=16%  Similarity=0.272  Sum_probs=199.9

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  139 (371)
                      .+.++|+..+.||+|+||.||+|... +++.||+|++............+.+|+..+..+ +||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            34577999999999999999999765 789999999976655566677889999999999 9999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-------------
Q 037946          140 LLYNYISNGNLQQLLQGN----RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-------------  202 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-------------  202 (371)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||++   +++||||||+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999764    6699999999999999999999999   99999999999999844             


Q ss_pred             ------CceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 037946          203 ------YEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQ  276 (371)
Q Consensus       203 ------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  276 (371)
                            ..+||+|||.+.......      ...||+.|+|||.+.+      ...++.++||||||+++|+|++|.+++.
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTT------CCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcC------CCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                  479999999998765432      3459999999997652      2245579999999999999999987764


Q ss_pred             CCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          277 PQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..    ... ..+..             ......+.....   .+.+++.+||+.||++|||+.|++++-+
T Consensus       233 ~~----~~~-~~~~~-------------~~~~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h~~  282 (289)
T 1x8b_A          233 NG----DQW-HEIRQ-------------GRLPRIPQVLSQ---EFTELLKVMIHPDPERRPSAMALVKHSV  282 (289)
T ss_dssp             SS----HHH-HHHHT-------------TCCCCCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred             ch----hHH-HHHHc-------------CCCCCCCcccCH---HHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence            21    111 11111             011111111111   3445777899999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2e-45  Score=330.40  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=205.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|.+. ++..||+|.+..   +....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            46888899999999999999765 478899999843   34456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999999763  4489999999999999999999999   999999999999999999999999999987654432


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                       .......+|+.|+|||.+.+       ..++.++||||||+++|+|++ |..||.....  ......+......     
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~~~~~~-----  231 (288)
T 3kfa_A          167 -TAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRM-----  231 (288)
T ss_dssp             -EEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCC-----
T ss_pred             -ccccCCccccCcCChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhccCCC-----
Confidence             22334457889999997652       367889999999999999999 8888864432  2222222221110     


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                          ......++       .+.+++.+||+.||.+|||++++++.|..+..
T Consensus       232 ----~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          232 ----ERPEGCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ----CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCH-------HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                11112222       34457778999999999999999999988753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=342.17  Aligned_cols=260  Identities=25%  Similarity=0.412  Sum_probs=190.8

Q ss_pred             ccccCCccccCCceEEEEEEeC--C--CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-CCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP--N--GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-KSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l  140 (371)
                      .|+..+.||+|+||.||+|...  +  +..||+|.+.. .......+.+.+|+.++++++||||+++++++.. .+..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS-CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC-CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            3566788999999999999753  2  23689998853 3344566889999999999999999999998754 567899


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++|+|.+++... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999999764 4589999999999999999999999   9999999999999999999999999999866443


Q ss_pred             Cccc--ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          220 NYHH--AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       220 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....  ......+|+.|+|||.+.       +..++.++||||||+++|||++ |.+||......  .....+...... 
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~~~-  315 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRL-  315 (373)
T ss_dssp             ------------CCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTCCC-
T ss_pred             ccccccccCCCCCcccccChHHhc-------CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCCCC-
Confidence            2111  123345788999999765       3367899999999999999999 55555433222  222222211100 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                              .....+++       .+.+++.+||+.||++|||++|+++.|+++.....
T Consensus       316 --------~~p~~~~~-------~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          316 --------LQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             --------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --------CCCCCCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                    00112222       34457778999999999999999999999875544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.6e-46  Score=334.66  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe--cCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS--NKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  141 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|.+..........+.+.+|+.++++++||||+++++++.  ..+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            46888899999999999999764 6899999999765555566778999999999999999999999874  46789999


Q ss_pred             EeecCCCCHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCeeEcCCCceEEccccC
Q 037946          142 YNYISNGNLQQLLQGN----RNLDWETRYKIAVGSAQGLAYLHHDCVPA-----ILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||++   +     ++||||||+||+++.++.+||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999998643    3499999999999999999999998   7     99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......  .......||+.|+|||.+.       +..++.++||||||+++|+|++|..||....  ...+...+...
T Consensus       163 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~  231 (279)
T 2w5a_A          163 ARILNHDT--SFAKTFVGTPYYMSPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKIREG  231 (279)
T ss_dssp             HHHC---C--HHHHHHHSCCTTCCHHHHH-------CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT
T ss_pred             heeecccc--ccccccCCCccccChHHhc-------cCCCCchhhHHHHHHHHHHHHHCCCCCcccC--HHHHHHHHhhc
Confidence            98765432  1123456899999999765       3357889999999999999999999986442  22222222221


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ..  .       ......+.       .+.+++.+||+.||++|||++|++++++.-..
T Consensus       232 ~~--~-------~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          232 KF--R-------RIPYRYSD-------ELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CC--C-------CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             cc--c-------cCCcccCH-------HHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            10  0       00012222       34457778999999999999999998876553

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=337.60  Aligned_cols=269  Identities=17%  Similarity=0.203  Sum_probs=200.8

Q ss_pred             hccccCCccccCCceEEEEEEeC----CCCEEEEEEecccCCCc---------chHHHHHHHHHHHhccCCCCceeeece
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDE---------EPVDSFAAEIQILGHIRHRNIVKLLGY  131 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~~~~~  131 (371)
                      ++|+..+.||+|+||.||+|...    ++..+|+|+........         .....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888999999999999999775    57889999986432211         012346688899999999999999999


Q ss_pred             Eec----CCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC--ce
Q 037946          132 CSN----KSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY--EA  205 (371)
Q Consensus       132 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~--~~  205 (371)
                      +.+    ....|+||||+ +++|.+++...+.+++..++.++.|++.||+|||++   +++||||||+||+++.++  .+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence            887    78899999999 899999999887899999999999999999999999   999999999999998887  99


Q ss_pred             EEccccCccccCCCCcc-----cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 037946          206 YLADFGLAKLMNSTNYH-----HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG  280 (371)
Q Consensus       206 kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  280 (371)
                      ||+|||+++........     .......||+.|+|||++.       +..++.++|||||||++|||++|..||.....
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-------GVALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-------TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            99999999876433211     1123457999999999765       33678999999999999999999999965444


Q ss_pred             CchhHHHHHHHHhcCCCccccccCcccC--CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          281 DGLHIVEWVKKKMGSFEPAVSILDTKLQ--GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      +.................   .......  ..+.       .+.+++.+||+.||++|||+++|++.|++......
T Consensus       266 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  331 (345)
T 2v62_A          266 DPVAVQTAKTNLLDELPQ---SVLKWAPSGSSCC-------EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG  331 (345)
T ss_dssp             CHHHHHHHHHHHHHTTTH---HHHHHSCTTSCCH-------HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred             ccHHHHHHHHhhcccccH---HHHhhccccccHH-------HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence            433332222222211111   0000000  2222       34557777999999999999999999998765433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.5e-46  Score=341.52  Aligned_cols=284  Identities=23%  Similarity=0.298  Sum_probs=199.2

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHH--HhccCCCCceeeeceEe-----cCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQI--LGHIRHRNIVKLLGYCS-----NKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~~~~  137 (371)
                      ++|+..+.||+|+||.||+|.. +++.||+|++...     ....+..|.++  +..++||||+++++.+.     ....
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            4688889999999999999977 6899999998432     22344445555  44589999999997542     2346


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCeeEcCCCceEEcccc
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC------VPAILHRDVKCNNILLDSKYEAYLADFG  211 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------~~~i~H~dlkp~Nill~~~~~~kl~Dfg  211 (371)
                      .++||||+++|+|.+++.... .++..++.++.|++.||.|||+..      .++++||||||+|||++.++.+||+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            789999999999999997655 589999999999999999999862      2389999999999999999999999999


Q ss_pred             CccccCCCCc------ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhH
Q 037946          212 LAKLMNSTNY------HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI  285 (371)
Q Consensus       212 ~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  285 (371)
                      ++........      ........||+.|+|||++.+.........++.++|||||||++|||++|..|+..........
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987654321      1122345699999999987642111111245678999999999999999988775433221100


Q ss_pred             ------------HHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          286 ------------VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       286 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                                  ...........     ...+.+.............+.+++.+||+.||++|||++|+++.|+++....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSRE-----KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTS-----CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             HhhhcccCCCchHHHHHhhhccc-----ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence                        00000001000     0011111111111123345677899999999999999999999999998777


Q ss_pred             ccCCCCC
Q 037946          354 EELGKTS  360 (371)
Q Consensus       354 ~~~~~~~  360 (371)
                      +.....+
T Consensus       321 ~~~~~~~  327 (336)
T 3g2f_A          321 ERNKSVS  327 (336)
T ss_dssp             CC-----
T ss_pred             HhcccCC
Confidence            7655443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.9e-45  Score=336.80  Aligned_cols=262  Identities=19%  Similarity=0.275  Sum_probs=206.4

Q ss_pred             cHHHHHhccccC-CccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC
Q 037946           59 TIDNILECLKDE-NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK  135 (371)
Q Consensus        59 ~~~~~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  135 (371)
                      ..+++.+.|... +.||+|+||.||+|... +++.||+|++............+.+|+.+++.+ +||||+++++++.+.
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            457777888877 88999999999999764 689999999976665566678899999999999 569999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLADF  210 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  210 (371)
                      +..++||||+++|+|.+++...  ..+++..++.++.|++.||+|||++   +++||||||+||+++.   ++.+||+||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            9999999999999999998653  6699999999999999999999999   9999999999999988   789999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |++.......   ......||+.|+|||.+.       ...++.++||||||+++|+|++|..||.....  ......+.
T Consensus       179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~  246 (327)
T 3lm5_A          179 GMSRKIGHAC---ELREIMGTPEYLAPEILN-------YDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--QETYLNIS  246 (327)
T ss_dssp             GGCEEC------------CCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             ccccccCCcc---ccccccCCcCccCCeeec-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHH
Confidence            9998765442   234457999999999765       34678999999999999999999999965322  12111111


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      .....      .........+.       .+.+++.+||+.||.+|||+++++++-+-
T Consensus       247 ~~~~~------~~~~~~~~~~~-------~~~~li~~~L~~dP~~Rpt~~~ll~h~~~  291 (327)
T 3lm5_A          247 QVNVD------YSEETFSSVSQ-------LATDFIQSLLVKNPEKRPTAEICLSHSWL  291 (327)
T ss_dssp             HTCCC------CCTTTTTTSCH-------HHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred             hcccc------cCchhhcccCH-------HHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence            11111      01111122222       24457788999999999999999998653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.3e-45  Score=333.32  Aligned_cols=258  Identities=28%  Similarity=0.406  Sum_probs=204.2

Q ss_pred             hccccCCccccCCceEEEEEEeCC------CCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      ++|+..+.||+|+||.||+|....      ...||+|.+... ......+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            568888999999999999997632      247999998543 2334567899999999999 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC
Q 037946          138 KLLLYNYISNGNLQQLLQG--------------NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY  203 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~  203 (371)
                      .++||||+++|+|.+++..              ...+++..++.++.|++.||.|||++   +++||||||+||+++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence            9999999999999999864              34579999999999999999999999   999999999999999999


Q ss_pred             ceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCc
Q 037946          204 EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDG  282 (371)
Q Consensus       204 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  282 (371)
                      .+||+|||++................+|+.|+|||.+.       +..++.++||||||+++|||++ |..||...... 
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-  273 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-------DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-  273 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhc-------cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-
Confidence            99999999998765443222334456788999999765       2367899999999999999998 88888654332 


Q ss_pred             hhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          283 LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ......+......         ......++       .+.+++.+||+.||.+|||++++++.|+++.
T Consensus       274 ~~~~~~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 SKFYKLVKDGYQM---------AQPAFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHHHHTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCC---------CCCCCCCH-------HHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            2222222221111         00111222       3445778899999999999999999998875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-45  Score=329.82  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=199.2

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            46888899999999999999654 577999999854322 1223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--  163 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  163 (279)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999986544332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        .....||+.|+|||.+.       +..++.++||||||+++|+|++|..||.....  ......+.....   ..   
T Consensus       164 --~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~---~~---  226 (279)
T 3fdn_A          164 --RTDLCGTLDYLPPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISRVEF---TF---  226 (279)
T ss_dssp             ------CCCCTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCC---CC---
T ss_pred             --ccccCCCCCccCHhHhc-------cCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--HHHHHHHHhCCC---CC---
Confidence              23457899999999765       33668899999999999999999999964321  122221111100   00   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                          ....++       .+.+++.+||+.||.+|||++|++++-+--
T Consensus       227 ----~~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          227 ----PDFVTE-------GARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             ----CTTSCH-------HHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             ----CCcCCH-------HHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence                011222       234577889999999999999999986543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.1e-45  Score=331.28  Aligned_cols=264  Identities=20%  Similarity=0.267  Sum_probs=197.6

Q ss_pred             hcccc-CCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKD-ENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~-~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+. .+.||+|+||.||+|.. .+++.||+|++...  .......+.+|++++.++ +||||+++++++.+.+..|+|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            45666 47899999999999975 46899999998543  234457889999999985 799999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc---eEEccccCccccCC
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNS  218 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~  218 (371)
                      |||+++++|.+++.....+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999999998888899999999999999999999999   9999999999999988776   99999999876543


Q ss_pred             CCc-----ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc-----------
Q 037946          219 TNY-----HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG-----------  282 (371)
Q Consensus       219 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-----------  282 (371)
                      ...     ........||+.|+|||++.....  ....++.++|||||||++|+|++|..||.......           
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSE--EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSH--HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccc--cccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            211     011224469999999998753100  01245789999999999999999999997553321           


Q ss_pred             --hhHHHHHHHHhcCCCccccccCcccCCCChhhH-HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          283 --LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMV-QEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       283 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                        ..+...+....              ...+.... .....+.+++.+||+.||.+|||+.|++++-+--
T Consensus       245 ~~~~~~~~i~~~~--------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          245 CQNMLFESIQEGK--------------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             HHHHHHHHHHHCC--------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             HHHHHHHHHhccC--------------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence              01111111100              01111100 0112345688889999999999999999986543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-45  Score=337.16  Aligned_cols=263  Identities=22%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-----
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-----  136 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  136 (371)
                      +.++|+..+.||+|+||.||+|.+ .+|+.||+|++..........+++.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            346788899999999999999976 46899999999665555555678899999999999999999999987653     


Q ss_pred             -eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          137 -VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       137 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                       ..|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence             469999999 7799999987 4599999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ....     .....+|+.|+|||++.+      ...++.++|||||||++|||++|+.||....  .......+....+.
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~  244 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEIMKVTGT  244 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCC
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhC------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCC
Confidence            5432     244578999999997653      2357899999999999999999999996532  22222222222221


Q ss_pred             CCccc-----------------cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          296 FEPAV-----------------SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       296 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .....                 ......+......   ....+.+++.+||+.||.+|||++|++++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp  309 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN---ASPLAVNLLEKMLVLDAEQRVTAGEALAHP  309 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT---CCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCC---CCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence            10000                 0000001111111   112355688889999999999999999974

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-45  Score=363.88  Aligned_cols=251  Identities=24%  Similarity=0.366  Sum_probs=198.0

Q ss_pred             CccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|.+.   .++.||||++.....+....+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999542   46789999997665556667889999999999999999999999965 457899999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc-ccccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY-HHAMS  226 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  226 (371)
                      |+|.+++.....+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++....... .....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99999999888899999999999999999999999   999999999999999999999999999987654331 11223


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ...+|+.|+|||++.       ...++.++|||||||++|||++ |..||.....  ..+...+......         .
T Consensus       531 ~~~~t~~y~APE~~~-------~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~---------~  592 (635)
T 4fl3_A          531 HGKWPVKWYAPECIN-------YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERM---------G  592 (635)
T ss_dssp             ----CGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCC---------C
T ss_pred             CCCCceeeeChhhhc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC---------C
Confidence            345788999999875       3367899999999999999998 9999865432  2222222221110         0


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ....+++       .+.+++.+||+.||++|||+++|++.|+++.
T Consensus       593 ~p~~~~~-------~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          593 CPAGCPR-------EMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCTTCCH-------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCH-------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1122332       3445777799999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.9e-45  Score=328.63  Aligned_cols=261  Identities=26%  Similarity=0.435  Sum_probs=198.7

Q ss_pred             hccccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceE-ecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~  139 (371)
                      ..|+..+.||+|+||.||+|...+    ...+|+|.+.. .......+.+.+|+.++++++||||+++++++ ...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            457788999999999999997532    23589998854 23344567899999999999999999999986 4556789


Q ss_pred             EEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+++|+|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999975 45589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          219 TNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       219 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....  .......+|+.|+|||.+.       +..++.++||||||+++|+|++|..|+....... .....+...... 
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~-  251 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRL-  251 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-THHHHHHTTCCC-
T ss_pred             cchhccccccCCCCCccccChHHhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhcCCCC-
Confidence            3321  1223445788999999765       3367889999999999999999555543332221 222211111100 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                              ......++       .+.+++.+||+.||.+|||++|+++.|.++....
T Consensus       252 --------~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          252 --------LQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             --------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             --------CCCccCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                    00112222       3455778899999999999999999999886543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-45  Score=343.94  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=192.4

Q ss_pred             HHHHhccccC-CccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhc-cCCCCceeeeceEec---
Q 037946           61 DNILECLKDE-NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGH-IRHRNIVKLLGYCSN---  134 (371)
Q Consensus        61 ~~~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~---  134 (371)
                      ..+.+.|... +.||+|+||.||+|... +++.||+|++..       ...+.+|+.++.+ .+||||+++++++..   
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            3455566665 68999999999999764 689999999842       1456788888744 589999999998865   


Q ss_pred             -CCeEEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEc
Q 037946          135 -KSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLA  208 (371)
Q Consensus       135 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~  208 (371)
                       .+..|+||||+++|+|.+++....  .+++..+..++.|++.||.|||++   +++||||||+|||++.   ++.+||+
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence             667899999999999999997654  599999999999999999999999   9999999999999987   7899999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc--hhHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG--LHIV  286 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~  286 (371)
                      |||+++......   .....+||+.|+|||++.       +..++.++|||||||++|||++|..||.......  ....
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  276 (400)
T 1nxk_A          207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK  276 (400)
T ss_dssp             CCTTCEECC--------------CTTCCGGGSC-------CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred             ecccccccCCCC---ccccCCCCCCccCHhhcC-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence            999998665432   234567999999999875       3467899999999999999999999997554321  1122


Q ss_pred             HHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ..+.......      ..+.....+       ..+.+++.+||+.||++|||++|++++-+-..
T Consensus       277 ~~i~~~~~~~------~~~~~~~~s-------~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          277 TRIRMGQYEF------PNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             HHHHHTCCCC------CTTTTTTSC-------HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHHHcCcccC------CCcccccCC-------HHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            2222111110      001111222       23456888899999999999999999866543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.5e-45  Score=331.58  Aligned_cols=257  Identities=23%  Similarity=0.327  Sum_probs=203.3

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ..+.++|...+.||+|+||.||++... +|+.||+|.+....  ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            346678999999999999999999764 68999999986432  223456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE---cCCCceEEccccCcccc
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLM  216 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~  216 (371)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||++   +++||||||+||++   +.++.+||+|||++...
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999999999998878899999999999999999999999   99999999999999   78899999999999754


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ...    ......||+.|+|||.+.       +..++.++||||||+++|+|++|..||....  ...+...+...... 
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~-  225 (304)
T 2jam_A          160 QNG----IMSTACGTPGYVAPEVLA-------QKPYSKAVDCWSIGVITYILLCGYPPFYEET--ESKLFEKIKEGYYE-  225 (304)
T ss_dssp             CCB----TTHHHHSCCCBCCTTTBS-------SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHCCCC-
T ss_pred             CCC----ccccccCCCCccChHHhc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCC-
Confidence            332    223456999999999875       3367889999999999999999999986432  22222222221111 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                        .   ..+.....++       .+.+++.+||+.||++|||++|++++-+-
T Consensus       226 --~---~~~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (304)
T 2jam_A          226 --F---ESPFWDDISE-------SAKDFICHLLEKDPNERYTCEKALSHPWI  265 (304)
T ss_dssp             --C---CTTTTTTSCH-------HHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             --C---CccccccCCH-------HHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence              0   0011112222       34457788999999999999999997653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.8e-45  Score=331.68  Aligned_cols=260  Identities=28%  Similarity=0.384  Sum_probs=205.7

Q ss_pred             HhccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCC
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKS  136 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  136 (371)
                      .++|+..+.||+|+||.||+|.+      .+++.||+|++... ......+.+.+|+.+++++ +||||+++++++...+
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  104 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  104 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence            36788999999999999999964      35688999998543 2344556889999999999 7999999999987654


Q ss_pred             -eEEEEEeecCCCCHHHHhccCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          137 -VKLLLYNYISNGNLQQLLQGNRN----------------LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       137 -~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                       ..++||||+++++|.+++.....                +++..++.++.|++.||.|||++   +++||||||+||++
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~  181 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL  181 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEE
Confidence             58999999999999999977554                88999999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||++................||+.|+|||++.       +..++.++||||||+++|+|++ |..||...
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc-------cccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999998765543222334556899999999775       3367899999999999999998 99998654


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ..+. .....+......         ......++       .+.+++.+||+.||.+|||+.|++++|+.+.+
T Consensus       255 ~~~~-~~~~~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          255 KIDE-EFCRRLKEGTRM---------RAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCSH-HHHHHHHHTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhH-HHHHHhccCccC---------CCCCCCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            4332 222222211100         00011222       34457778999999999999999999998763

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1e-45  Score=338.55  Aligned_cols=262  Identities=24%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             hccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|+..+.||+|+||.||+|..      .+++.||+|.+.. .........+.+|+.++++++||||+++++++.+.+..
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS-SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc-ccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            5788899999999999999973      3577899999853 23344566889999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEc
Q 037946          139 LLLYNYISNGNLQQLLQGN-------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLA  208 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~  208 (371)
                      |+||||+++++|.+++...       ..+++..++.++.|++.||.|||++   +++||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999765       3489999999999999999999999   9999999999999984   4569999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  287 (371)
                      |||++................||+.|+|||.+.       +..++.++||||||+++|+|++ |..||....  ......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~  256 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM-------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLE  256 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--HHHHHH
Confidence            999997654443323334556899999999765       2367889999999999999998 888885432  222222


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      .+......         ......+.       .+.+++.+||+.||.+|||+.+++++|+.+...++-
T Consensus       257 ~~~~~~~~---------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          257 FVTSGGRM---------DPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             HHHTTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HHhcCCCC---------CCCCCCCH-------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence            22211100         00112222       344577889999999999999999999998765543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=325.48  Aligned_cols=268  Identities=22%  Similarity=0.278  Sum_probs=198.7

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC---CcchHHHHHHHHHHHhccC---CCCceeeeceEecCC
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR---DEEPVDSFAAEIQILGHIR---HRNIVKLLGYCSNKS  136 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  136 (371)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|++.....   .......+.+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            46799999999999999999975 5689999999864332   1222346677887777764   999999999997755


Q ss_pred             -----eEEEEEeecCCCCHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcc
Q 037946          137 -----VKLLLYNYISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       137 -----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                           ..++||||+.+ +|.+++.....  +++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence                 57999999974 99999987654  99999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  289 (371)
                      ||++.......   ......||+.|+|||++.       +..++.++|||||||++|+|++|..||....  .......+
T Consensus       164 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i  231 (308)
T 3g33_A          164 FGLARIYSYQM---ALTPVVVTLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKI  231 (308)
T ss_dssp             CSCTTTSTTCC---CSGGGGCCCSSCCHHHHH-------TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HHHHHHHH
T ss_pred             CccccccCCCc---ccCCccccccccCchHHc-------CCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH
Confidence            99998765432   234567999999999775       3367899999999999999999999996542  22222333


Q ss_pred             HHHhcCCCccc-----cccCcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          290 KKKMGSFEPAV-----SILDTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       290 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...........     ...............     .....+.+++.+||+.||++|||+.|++++-+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~  299 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY  299 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence            33322211100     000000000000000     01123456888899999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-44  Score=324.34  Aligned_cols=261  Identities=18%  Similarity=0.241  Sum_probs=204.5

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.....    ...+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            4688889999999999999975 5789999999854322    23478899999999 8999999999999999999999


Q ss_pred             eecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc-----eEEccccCcccc
Q 037946          143 NYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE-----AYLADFGLAKLM  216 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~~~~~  216 (371)
                      ||+ +++|.+++.... .+++..+..++.|++.||+|||++   +++||||||+||+++.++.     +||+|||++...
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999 889999998654 599999999999999999999999   9999999999999987776     999999999876


Q ss_pred             CCCCcc-----cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-chhHHHHHH
Q 037946          217 NSTNYH-----HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD-GLHIVEWVK  290 (371)
Q Consensus       217 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~  290 (371)
                      ......     .......||+.|+|||.+.       +..++.++||||||+++|||++|..||...... .......+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             ccccccccccccCccCCCCCcccCCchhhc-------CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            544321     1234557999999999765       336789999999999999999999999765432 122222222


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                      ..... .+..    ......++       .+.+++.+||+.||++|||+++|++.|.++...
T Consensus       235 ~~~~~-~~~~----~~~~~~~~-------~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          235 EKKQS-TPLR----ELCAGFPE-------EFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHH-SCHH----HHTTTSCH-------HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhccC-ccHH----HHHhhCcH-------HHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            11111 0000    00112222       344577779999999999999999999988643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.7e-45  Score=344.30  Aligned_cols=203  Identities=25%  Similarity=0.333  Sum_probs=170.5

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----C
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----S  136 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  136 (371)
                      +.++|+..+.||+|+||.||+|.+ .+++.||+|++...........++.+|+.+++.++||||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            346788999999999999999976 4588999999966555555667899999999999999999999998766     5


Q ss_pred             eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ..|+||||+.+ +|.+++.....+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            78999999874 9999999888899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc--------------------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 037946          217 NSTNYH--------------------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV  275 (371)
Q Consensus       217 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  275 (371)
                      ......                    ......+||+.|+|||++..      ...++.++|||||||++|||++|..|+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL------QENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhc------CCCCCcccccchHHHHHHHHHhccccc
Confidence            543211                    12355679999999997532      346789999999999999999865444

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=344.30  Aligned_cols=263  Identities=20%  Similarity=0.204  Sum_probs=202.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||++... +|+.||+|++.+... .......+.+|..++..++||||+++++++.+.+..|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            57888999999999999999764 689999999854221 1223345789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||+++|+|.+++... ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.......
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            999999999999764 4799999999999999999999999   999999999999999999999999999987654431


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|+|||++...........++.++|||||||++|||++|..||.....  ......+........    
T Consensus       218 -~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~~~~~~----  290 (412)
T 2vd5_A          218 -VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--AETYGKIVHYKEHLS----  290 (412)
T ss_dssp             -EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTHHHHCC----
T ss_pred             -cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccCcC----
Confidence             1223467999999999876421111123578999999999999999999999965322  222222211110000    


Q ss_pred             ccCccc-CCCChhhHHHHHHHHHHHhcccCCCCCCC---CCHHHHHHHHh
Q 037946          302 ILDTKL-QGLPDQMVQEMLQTLGIAMFCVNSSPAER---PTMKEVVALLM  347 (371)
Q Consensus       302 ~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~evl~~L~  347 (371)
                        -+.. ...+.       .+.+++.+||. +|.+|   |+++|+++|-+
T Consensus       291 --~p~~~~~~s~-------~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf  330 (412)
T 2vd5_A          291 --LPLVDEGVPE-------EARDFIQRLLC-PPETRLGRGGAGDFRTHPF  330 (412)
T ss_dssp             --CC----CCCH-------HHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred             --CCccccCCCH-------HHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence              0000 12222       34457888999 99998   69999999854

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.3e-44  Score=331.04  Aligned_cols=274  Identities=23%  Similarity=0.324  Sum_probs=206.4

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--------
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--------  134 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  134 (371)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++.+        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35789999999999999999976 578999999986655555556778899999999999999999999876        


Q ss_pred             CCeEEEEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      .+..|+||||+++ +|.+.+.. ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4568999999986 66666654 46799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc--ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          214 KLMNSTNY--HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       214 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ........  ........||+.|+|||++.+      ...++.++|||||||++|+|++|..||....  .......+..
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~  243 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQ  243 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred             ccccccccccccccCCcccccCccCchhhcC------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHH
Confidence            87653221  122345578999999997653      2356889999999999999999999987542  2233333333


Q ss_pred             HhcCCCccc-cccC-----c---ccCCCChhhHHH------HHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          292 KMGSFEPAV-SILD-----T---KLQGLPDQMVQE------MLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       292 ~~~~~~~~~-~~~~-----~---~~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ......+.. ...+     .   ............      ...+.+++.+||+.||++|||++|++++-+--
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            333221110 0000     0   000000111111      12356789999999999999999999986643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.3e-45  Score=327.21  Aligned_cols=256  Identities=25%  Similarity=0.365  Sum_probs=198.4

Q ss_pred             hccccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|.+.+    +..||+|.+... ......+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            468888999999999999997532    235999998543 2344567899999999999999999999998754 5689


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++++|.+++... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999754 4599999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. .......+|+.|+|||.+.       +..++.++||||||+++|+|++ |..||......  .....+......   
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~~---  233 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESIN-------FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDRL---  233 (281)
T ss_dssp             -------CCCCCGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCCC---
T ss_pred             cc-cccccCCCCcceeCchhhc-------cCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCCC---
Confidence            31 1223445788999999764       3367889999999999999998 99998644322  222222221110   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                            +.....++       .+.+++.+||+.||++|||+.|++++|+++..
T Consensus       234 ------~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          234 ------PKPDLCPP-------VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCH-------HHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                  00112222       24457778999999999999999999998753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=358.34  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=204.8

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      +.|+..+.||+|+||.||+|.+.++..||||++....   ...+.+.+|+++|++++||||+++++++.+ +..|+||||
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            4577888999999999999998777889999985433   234679999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++...  ..+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++....... 
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence            9999999999753  4589999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .......++..|+|||.+.       ...++.++|||||||++|||++ |..||....  ...+...+......      
T Consensus       419 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--~~~~~~~i~~~~~~------  483 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYRM------  483 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--HHHHHHHHHTTCCC------
T ss_pred             ecccCCcCcccccCHHHhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC------
Confidence            1123345788999999765       2367899999999999999999 888886432  22232322221110      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                         +....++.       .+.+|+.+||+.||++|||+++|++.|+.+....+
T Consensus       484 ---~~~~~~~~-------~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          484 ---PCPPECPE-------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             ---CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             ---CCCCCCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence               01112222       34457778999999999999999999999875443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.2e-45  Score=334.58  Aligned_cols=260  Identities=23%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC------CcchHHHHHHHHHHHhccCCCCceeeeceEe
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR------DEEPVDSFAAEIQILGHIRHRNIVKLLGYCS  133 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  133 (371)
                      ..+.++|+..+.||+|+||.||+|... +++.||+|.+.....      .......+.+|+++++.++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            456778999999999999999999764 578999999854321      1223346889999999999999999999987


Q ss_pred             cCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc---eEEccc
Q 037946          134 NKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLADF  210 (371)
Q Consensus       134 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Df  210 (371)
                      ..+ .|+||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.   +||+||
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            665 899999999999999999888999999999999999999999999   9999999999999987665   999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |++.......   ......||+.|+|||++...    ....++.++||||||+++|+|++|..||...... ..+...+.
T Consensus       162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~  233 (322)
T 2ycf_A          162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQIT  233 (322)
T ss_dssp             TTCEECCCCH---HHHHHHSCCTTCCHHHHHHT----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHH
T ss_pred             ccceeccccc---ccccccCCcCccCchhhccC----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHH
Confidence            9998765432   22345699999999976421    1346788999999999999999999999654332 12222222


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .....  ..    .......+       ..+.+++.+||+.||++|||+.+++++
T Consensus       234 ~~~~~--~~----~~~~~~~~-------~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          234 SGKYN--FI----PEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HTCCC--CC----HHHHTTSC-------HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hCccc--cC----chhhhhcC-------HHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            21110  00    00001112       234568888999999999999999865

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-45  Score=342.13  Aligned_cols=250  Identities=25%  Similarity=0.250  Sum_probs=191.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHHH-HhccCCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQI-LGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|+.. +++.||+|++.+.... ......+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            46888999999999999999764 5889999999654432 2334566777776 5778999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+|||++.+|.+||+|||+++...... 
T Consensus       118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence            99999999999999888899999999999999999999999   99999999999999999999999999998643322 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  ...+...+..   .....  
T Consensus       194 -~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~---~~~~~--  258 (373)
T 2r5t_A          194 -STTSTFCGTPEYLAPEVLHK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILN---KPLQL--  258 (373)
T ss_dssp             -CCCCSBSCCCCCCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--HHHHHHHHHH---SCCCC--
T ss_pred             -CccccccCCccccCHHHhCC-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHh---cccCC--
Confidence             23456689999999998753       367899999999999999999999996432  2222222211   10000  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH----HHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM----KEVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~evl~~  345 (371)
                           ....+.       .+.+++.+||+.||.+||++    .+++++
T Consensus       259 -----~~~~~~-------~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          259 -----KPNITN-------SARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             -----CSSSCH-------HHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             -----CCCCCH-------HHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence                 011222       23457788999999999987    456555

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.3e-45  Score=328.32  Aligned_cols=258  Identities=25%  Similarity=0.339  Sum_probs=207.9

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      .+.+.++|+..+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++.+.+..
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            4567789999999999999999999764 689999999976555555678899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC---CceEEccccCccc
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK---YEAYLADFGLAKL  215 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~  215 (371)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||++   +++|+||||+||+++.+   +.+||+|||++..
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999999998777899999999999999999999999   99999999999999764   4699999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .....   ......||+.|+|||.+.        +.++.++||||||+++|+|++|..||....  .......+......
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~  240 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLR--------GTYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYA  240 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHT--------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCC
T ss_pred             ecCCC---ccccccCcccccChHHhc--------CCCCCchhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCC
Confidence            65432   223445899999999764        247889999999999999999999986532  22222222221110


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .      ..+.....++       .+.+++.+||+.||++|||+.|++++-
T Consensus       241 ~------~~~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~ell~hp  278 (287)
T 2wei_A          241 F------DLPQWRTISD-------DAKDLIRKMLTFHPSLRITATQCLEHP  278 (287)
T ss_dssp             C------CSGGGTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             C------CchhhhhcCH-------HHHHHHHHHcccChhhCcCHHHHhcCH
Confidence            0      0011122222       345577889999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.2e-44  Score=331.60  Aligned_cols=273  Identities=26%  Similarity=0.338  Sum_probs=208.6

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhc--cCCCCceeeeceEecCC-
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH--IRHRNIVKLLGYCSNKS-  136 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~-  136 (371)
                      ...+.++|+..+.||+|+||.||+|.. +++.||+|++..     .....+.+|.+++..  ++||||+++++++...+ 
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            345668899999999999999999987 589999999843     234667889999887  79999999999998776 


Q ss_pred             ---eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeeEcCCCce
Q 037946          137 ---VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH--------HDCVPAILHRDVKCNNILLDSKYEA  205 (371)
Q Consensus       137 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dlkp~Nill~~~~~~  205 (371)
                         ..++||||+++|+|.+++... .+++..++.++.|++.||.|||        +.   +++||||||+||+++.++.+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred             ccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence               789999999999999999764 5899999999999999999999        77   99999999999999999999


Q ss_pred             EEccccCccccCCCCccc--ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhC----------CC
Q 037946          206 YLADFGLAKLMNSTNYHH--AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSG----------RS  273 (371)
Q Consensus       206 kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g----------~~  273 (371)
                      ||+|||++..........  ......||+.|+|||.+.+..... ...++.++||||||+++|||++|          ..
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK-HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTT-CHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhccccccc-ccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            999999998765443111  224457999999999875321000 00123689999999999999999          67


Q ss_pred             CCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChh--hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          274 AVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQ--MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ||............+....... .     ..+   ..+..  .......+.+++.+||+.||++|||+.+++++|+++.+
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~-~-----~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQ-K-----LRP---NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTS-C-----CCC---CCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHH-H-----hCC---CCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            7765443322222222222111 0     011   11111  11334456678899999999999999999999999864


Q ss_pred             C
Q 037946          352 A  352 (371)
Q Consensus       352 ~  352 (371)
                      +
T Consensus       337 ~  337 (342)
T 1b6c_B          337 Q  337 (342)
T ss_dssp             T
T ss_pred             H
Confidence            4

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-44  Score=324.69  Aligned_cols=254  Identities=21%  Similarity=0.388  Sum_probs=201.0

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-----
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-----  134 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----  134 (371)
                      ..+..+|+..+.||+|+||.||+|... +++.||+|++....      ..+.+|++++++++||||+++++++..     
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            345678999999999999999999775 78999999985422      246789999999999999999998854     


Q ss_pred             -----------CCeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC
Q 037946          135 -----------KSVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS  201 (371)
Q Consensus       135 -----------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~  201 (371)
                                 ....++||||+++++|.+++...  ..+++..++.++.|++.||.|||++   +++||||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                       45579999999999999999643  5699999999999999999999999   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 037946          202 KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD  281 (371)
Q Consensus       202 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  281 (371)
                      ++.+||+|||++.......   ......||+.|+|||.+.       +..++.++||||||+++|+|++|..|+...   
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~~~~~~~~~---  224 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQIS-------SQDYGKEVDLYALGLILAELLHVCDTAFET---  224 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHH-------CSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---
T ss_pred             CCCEEECcchhheeccccc---cccccCCcccccChhhhc-------cCCCcchhhhHHHHHHHHHHHhcCCcchhH---
Confidence            9999999999998765443   223456999999999765       336789999999999999999999876411   


Q ss_pred             chhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccC
Q 037946          282 GLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEEL  356 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  356 (371)
                       .   ........          .......+   .   .+.+++.+||+.||.+|||+.|++++|+.+...++..
T Consensus       225 -~---~~~~~~~~----------~~~~~~~~---~---~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          225 -S---KFFTDLRD----------GIISDIFD---K---KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             -H---HHHHHHHT----------TCCCTTSC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             -H---HHHHHhhc----------ccccccCC---H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence             1   11111111          11111111   1   2345778899999999999999999999998776654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.6e-45  Score=355.46  Aligned_cols=252  Identities=26%  Similarity=0.313  Sum_probs=202.6

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|... +|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            45778899999999999999764 689999999854321 2234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          143 NYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||+++|+|.+++....  .+++..+..++.||+.||.|||++   +++||||||+|||++.+|.+||+|||++.......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999997654  399999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc--hhHHHHHHHHhcCCCc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG--LHIVEWVKKKMGSFEP  298 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~  298 (371)
                         .....+||+.|+|||++.+       ..++.++|||||||++|||++|..||.......  ..+...+....   ..
T Consensus       341 ---~~~~~~GT~~Y~APEvl~~-------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---~~  407 (576)
T 2acx_A          341 ---TIKGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---EE  407 (576)
T ss_dssp             ---CEECCCSCGGGCCHHHHTT-------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC---CC
T ss_pred             ---cccccCCCccccCHHHHcC-------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc---cc
Confidence               2344579999999998753       356889999999999999999999997643321  12222221110   00


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVALL  346 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L  346 (371)
                      .       ....++       .+.+++.+||+.||.+||     +++|+++|-
T Consensus       408 ~-------p~~~s~-------~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp  446 (576)
T 2acx_A          408 Y-------SERFSP-------QARSLCSQLLCKDPAERLGCRGGSAREVKEHP  446 (576)
T ss_dssp             C-------CTTSCH-------HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred             C-------CccCCH-------HHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence            0       011222       344577889999999999     889999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=331.14  Aligned_cols=266  Identities=20%  Similarity=0.273  Sum_probs=202.7

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe----cCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS----NKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~  139 (371)
                      ++|+..+.||+|+||.||++.. .+++.||+|++..  ......+.+.+|+.+++.++||||+++++++.    .....+
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            5788899999999999999976 5789999999854  33455678899999999999999999999986    345789


Q ss_pred             EEEeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          140 LLYNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      +||||+++|+|.+++..    ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999865    56799999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCcc-------cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 037946          216 MNSTNYH-------HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW  288 (371)
Q Consensus       216 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  288 (371)
                      .......       .......||+.|+|||.+....    ...++.++||||||+++|+|++|..||.............
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS----HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS----EEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCC----CcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            4322100       0012345799999999875321    1235789999999999999999999985322111111111


Q ss_pred             HHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 037946          289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE  355 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  355 (371)
                      +..   . ..     .+.....+.       .+.+++.+||+.||.+|||+++++++|+.+....+.
T Consensus       260 ~~~---~-~~-----~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          260 VQN---Q-LS-----IPQSPRHSS-------ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             HHC---C--------CCCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             hhc---c-CC-----CCccccCCH-------HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence            111   0 00     000112222       345577889999999999999999999998755443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-45  Score=328.58  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=192.1

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-CeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-SVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|.. +|+.||+|.+...    ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            5688889999999999999987 5889999998432    2456789999999999999999999987544 57899999


Q ss_pred             ecCCCCHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |+++++|.+++.....  +++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            9999999999976543  89999999999999999999999   99999999999999999999999999997654332 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                          ....+++.|+|||.+.       +..++.++||||||+++|+|++ |..||......  .....+....    .  
T Consensus       172 ----~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~----~--  232 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY----K--  232 (278)
T ss_dssp             --------CCTTTSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC----C--
T ss_pred             ----cCCCccccccCHHHhC-------CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCC----C--
Confidence                2345788999999765       2367889999999999999998 99988654322  2222111110    0  


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                         .......++       .+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       233 ---~~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 ---MDAPDGCPP-------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ---CCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCcccCCH-------HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence               000112222       34457778999999999999999999998864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=327.02  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=201.6

Q ss_pred             ccccCCccccCCceEEEEEEeC-CC---CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE-EE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NG---ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK-LL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~l  140 (371)
                      .|...+.||+|+||.||+|... ++   ..+|+|.+.. .......+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            3555688999999999999653 22   3799999853 23344567899999999999999999999999776655 99


Q ss_pred             EEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+.+++|.+++.. ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999976 45689999999999999999999999   9999999999999999999999999999865443


Q ss_pred             Ccc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          220 NYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       220 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...  .......+|+.|+|||.+.       +..++.++||||||+++|+|++|..|+..... .......+......  
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~--  247 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQ-------TYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRL--  247 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCCC--
T ss_pred             cccccccCcCCCCCccccChhhhc-------cCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCCC--
Confidence            211  1223456899999999765       34678899999999999999997766544332 22222222221110  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                             +.....++       .+.+++.+||+.||.+|||++++++.|.++..+.
T Consensus       248 -------~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          248 -------PQPEYCPD-------SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             -------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -------CCCccchH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                   00112222       3445778899999999999999999999986544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-44  Score=331.63  Aligned_cols=271  Identities=22%  Similarity=0.379  Sum_probs=202.8

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357888999999999999999764 5899999998665555555677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  178 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence            9999999999988888899999999999999999999999   99999999999999999999999999998665432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc---
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA---  299 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  299 (371)
                      .......||+.|+|||.+.+      ...++.++||||||+++|+|++|..||.....  ......+........+.   
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVG------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD--IDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -----CCCCCTTCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHH
T ss_pred             cccCCCcCCccccCcccccC------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhhh
Confidence            12344579999999997642      23568899999999999999999999865432  12212222111111000   


Q ss_pred             --------ccccCcccCCC-Chh--hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 --------VSILDTKLQGL-PDQ--MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 --------~~~~~~~~~~~-~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                              .....+..... +..  .......+.+++.+||+.||++|||+.|++++-+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  309 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF  309 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence                    00000000000 000  0011224556888899999999999999998743

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=329.64  Aligned_cols=260  Identities=21%  Similarity=0.237  Sum_probs=198.6

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC--CcchHHHHHHHHHHHhccCCCCceeeeceE--ecCCe
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR--DEEPVDSFAAEIQILGHIRHRNIVKLLGYC--SNKSV  137 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~  137 (371)
                      +.++|+..+.||+|+||.||++.. .+++.||+|++.....  .......+.+|+.++++++||||+++++++  .+.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            446799999999999999999976 4688999999854321  234467899999999999999999999998  45568


Q ss_pred             EEEEEeecCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          138 KLLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      .++||||++++ |.+++..  ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999886 7777654  45699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ..............||+.|+|||++.+.     ....+.++||||||+++|+|++|..||....  .......+....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~~--  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGL-----DTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--IYKLFENIGKGS--  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCC-----SCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCc-----ccCCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHHhcCC--
Confidence            6543323333456799999999976532     2233678999999999999999999986432  122222221110  


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                       ..       .....++       .+.+++.+||+.||.+|||++|++++-+--.
T Consensus       230 -~~-------~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          230 -YA-------IPGDCGP-------PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             -CC-------CCSSSCH-------HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             -CC-------CCCccCH-------HHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence             00       0112222       3345778899999999999999999865443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-44  Score=336.91  Aligned_cols=266  Identities=22%  Similarity=0.271  Sum_probs=193.6

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC------
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS------  136 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  136 (371)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46788999999999999999975 46889999999765555556678899999999999999999999987665      


Q ss_pred             eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ..|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            78999999975 78888863  489999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....   ......||+.|+|||++.+       ..++.++|||||||++|+|++|..||.....  ......+.......
T Consensus       178 ~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          178 GTSF---MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQLGTP  245 (371)
T ss_dssp             ---------------CTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHC-CCCC
T ss_pred             cccc---ccCCceecCCccCHHHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC
Confidence            5432   2344679999999998753       3678999999999999999999999965321  11111111111100


Q ss_pred             Cc------------------------cccccCcccC-CCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          297 EP------------------------AVSILDTKLQ-GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       297 ~~------------------------~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .+                        .......... ............+.+++.+||+.||++|||++|++++-+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  321 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  321 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence            00                        0000000000 000111122345678999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-45  Score=358.32  Aligned_cols=250  Identities=22%  Similarity=0.344  Sum_probs=194.2

Q ss_pred             ccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .||+|+||.||+|.+.   ++..||||++... ......+.+.+|++++++++||||++++++|.+ +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            6999999999999653   4567999998643 334456889999999999999999999999976 5689999999999


Q ss_pred             CHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc-cccc
Q 037946          149 NLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMS  226 (371)
Q Consensus       149 ~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~  226 (371)
                      +|.+++... ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++........ ....
T Consensus       421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            999999754 4599999999999999999999999   9999999999999999999999999999876543211 1122


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ...+|+.|+|||++.       ...++.++|||||||++|||++ |..||.....  ..+...+......         .
T Consensus       498 ~~~~~~~y~APE~~~-------~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~---------~  559 (613)
T 2ozo_A          498 AGKWPLKWYAPECIN-------FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRM---------E  559 (613)
T ss_dssp             ----CCTTSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHTTCCC---------C
T ss_pred             CCCCccceeCHhhhc-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCC---------C
Confidence            334678999999775       3367899999999999999998 9999875432  2333333221110         0


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ....+++       .+.+|+.+||+.||++|||+.+|++.|..+..
T Consensus       560 ~p~~~~~-------~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          560 CPPECPP-------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             CCTTCCH-------HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCcCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            1122333       34457777999999999999999999988743

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.6e-45  Score=334.26  Aligned_cols=258  Identities=28%  Similarity=0.439  Sum_probs=198.1

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCE--EEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGEL--IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|... ++..  +|+|.+.. .......+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC-C------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecc-ccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            46888899999999999999654 4554  49998853 22334456789999999999 99999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          141 LYNYISNGNLQQLLQGNR----------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      ||||+++++|.+++....                .+++..++.++.|++.||.|||++   +++||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence            999999999999997654                699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGL  283 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  283 (371)
                      +||+|||+++......   ......+++.|+|||.+..       ..++.++||||||+++|+|++ |..||.....  .
T Consensus       181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~  248 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--A  248 (327)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H
T ss_pred             EEEcccCcCccccccc---cccCCCCCccccChhhhcc-------ccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--H
Confidence            9999999987433221   2233457889999997653       256789999999999999998 9999864321  1


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .+   ..........      ......++       .+.+++.+||+.||.+|||+++++++|+++.....
T Consensus       249 ~~---~~~~~~~~~~------~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          249 EL---YEKLPQGYRL------EKPLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             HH---HHHGGGTCCC------CCCTTBCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HH---HHHhhcCCCC------CCCCCCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            11   1111111000      00111222       34557788999999999999999999998865443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=335.88  Aligned_cols=263  Identities=17%  Similarity=0.196  Sum_probs=203.1

Q ss_pred             hccccCCccccCCceEEEEEEeCC---------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCcee--------
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN---------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVK--------  127 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------  127 (371)
                      ++|+..+.||+|+||.||+|....         ++.||+|.+...       ..+.+|++++++++||||++        
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            578889999999999999997653         789999998532       35789999999999999987        


Q ss_pred             -------eeceEec-CCeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 037946          128 -------LLGYCSN-KSVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNI  197 (371)
Q Consensus       128 -------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Ni  197 (371)
                             +++++.. .+..|+||||+ +++|.+++...  ..+++..++.++.|++.||.|||++   +++||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence                   5666655 78889999999 99999999876  6799999999999999999999999   999999999999


Q ss_pred             eEcCCC--ceEEccccCccccCCCCcc-----cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh
Q 037946          198 LLDSKY--EAYLADFGLAKLMNSTNYH-----HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS  270 (371)
Q Consensus       198 ll~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  270 (371)
                      +++.++  .+||+|||+++........     .......||+.|+|||.+.       +..++.++||||||+++|||++
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~  263 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-------GCGPSRRSDLQSLGYCMLKWLY  263 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHH
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHh
Confidence            999998  8999999999876543211     1113347999999999765       3367889999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          271 GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      |..||.....+...+.................. ......+.       .+.+++.+||+.||++|||++++++.|.++.
T Consensus       264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          264 GFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPC-GHWIRPSE-------TLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             SCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTT-SCEECCCH-------HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCCCcccCCcCHHHHHHHHHhccCChhhhhhhc-cccCCCcH-------HHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            999997655444444443333222211111000 00011222       3445777799999999999999999999886


Q ss_pred             CCC
Q 037946          351 SAP  353 (371)
Q Consensus       351 ~~~  353 (371)
                      ...
T Consensus       336 ~~~  338 (352)
T 2jii_A          336 QDL  338 (352)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-44  Score=329.55  Aligned_cols=271  Identities=26%  Similarity=0.356  Sum_probs=200.5

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc--CCCCceeeeceEecC--
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI--RHRNIVKLLGYCSNK--  135 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~--  135 (371)
                      ...+.++|+..+.||+|+||.||+|... ++.||+|++...     ....+..|.+++...  +||||+++++++.+.  
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            3456688999999999999999999874 899999998432     224455666666654  999999999999877  


Q ss_pred             --CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeeEcCCCceEEc
Q 037946          136 --SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC-----VPAILHRDVKCNNILLDSKYEAYLA  208 (371)
Q Consensus       136 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dlkp~Nill~~~~~~kl~  208 (371)
                        ...++||||+++|+|.+++... .+++..++.++.|++.||.|||++.     ..+++||||||+||+++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              7899999999999999999765 5999999999999999999999751     2389999999999999999999999


Q ss_pred             cccCccccCCCCccc--ccccccccccccCCCCccchhhhcccCCCCC------cchhHHHHHHHHHHHhC---------
Q 037946          209 DFGLAKLMNSTNYHH--AMSRVAGSYGYIAPGKCKLQIIYGYTMNITE------KSDVYSYGVVLLEILSG---------  271 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~------~~DiwslG~~l~el~~g---------  271 (371)
                      |||++..........  ......||+.|+|||++.+.       ..+.      ++|||||||++|||++|         
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-------LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTC-------CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccc-------cCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            999997665433111  12345799999999987532       2233      48999999999999999         


Q ss_pred             -CCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChh--hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          272 -RSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQ--MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       272 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                       ..||................ ... ..    ..+   ..+..  .......+.+++.+||+.||++|||+++++++|++
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~-~~~-~~----~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSYEDMREI-VCI-KK----LRP---SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHH-HTT-SC----CCC---CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccHhhhcCCCCchhhhHHH-Hhh-hc----cCc---cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence             66665433322222111111 111 00    011   11110  01233456678899999999999999999999999


Q ss_pred             ccCCC
Q 037946          349 VKSAP  353 (371)
Q Consensus       349 ~~~~~  353 (371)
                      +....
T Consensus       329 l~~~~  333 (337)
T 3mdy_A          329 MSESQ  333 (337)
T ss_dssp             HHHTT
T ss_pred             HHhhc
Confidence            87543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.5e-45  Score=326.18  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=201.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999764 578899999854322 1233467899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  168 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--  168 (284)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred             EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999997654332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        .....||+.|+|||.+.       +..++.++||||||+++|+|++|..||.....  ....   .........    
T Consensus       169 --~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~---~~~~~~~~~----  230 (284)
T 2vgo_A          169 --RRTMCGTLDYLPPEMIE-------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETH---RRIVNVDLK----  230 (284)
T ss_dssp             --BCCCCSCGGGCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH---HHHHTTCCC----
T ss_pred             --cccccCCCCcCCHHHhc-------cCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--hHHH---HHHhccccC----
Confidence              23457999999999765       33568899999999999999999999864321  1111   111111000    


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                         .....++       .+.+++.+||+.||.+|||+++++++-+-
T Consensus       231 ---~~~~~~~-------~~~~li~~~l~~~p~~Rps~~~ll~h~~~  266 (284)
T 2vgo_A          231 ---FPPFLSD-------GSKDLISKLLRYHPPQRLPLKGVMEHPWV  266 (284)
T ss_dssp             ---CCTTSCH-------HHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred             ---CCCcCCH-------HHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence               0011222       33457788999999999999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.9e-45  Score=333.80  Aligned_cols=254  Identities=20%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ..++|...+.||+|+||.||++... +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3467889999999999999999764 578999999865433 33456788999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999999998888899999999999999999999999   99999999999999999999999999998765332


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                        .......||+.|+|||++.       +..++.++||||||+++|+|++|..||.....  ......+...  . ... 
T Consensus       196 --~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~--~-~~~-  260 (335)
T 2owb_A          196 --ERKKVLCGTPNYIAPEVLS-------KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYLRIKKN--E-YSI-  260 (335)
T ss_dssp             --CCBCCCCSCCSSCCHHHHH-------TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHT--C-CCC-
T ss_pred             --ccccccCCCccccCHHHhc-------cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHhcC--C-CCC-
Confidence              1234457999999999765       33568899999999999999999999964321  1111111111  1 000 


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                            ....+.       .+.+++.+||+.||++|||++|++++-+
T Consensus       261 ------~~~~~~-------~~~~li~~~l~~dp~~Rps~~ell~~~~  294 (335)
T 2owb_A          261 ------PKHINP-------VAASLIQKMLQTDPTARPTINELLNDEF  294 (335)
T ss_dssp             ------CTTSCH-------HHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             ------CccCCH-------HHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                  011121       2345778899999999999999998754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.9e-45  Score=324.92  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=194.6

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            46888899999999999999765 689999999854321 2334568899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.......  
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                       ......||+.|+|||.+.+.      ...+.++||||||+++|+|++|..||....  .......+....   ..    
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~---~~----  229 (276)
T 2h6d_A          166 -FLRTSCGSPNYAAPEVISGR------LYAGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFKKIRGGV---FY----  229 (276)
T ss_dssp             ------------CCTGGGTTS------CCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC---CC----
T ss_pred             -ceecccCCccccCHHHHcCC------CCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCc---cc----
Confidence             22345689999999987532      123578999999999999999999986432  122222222110   00    


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                         .....+.       .+.+++.+||+.||.+|||+.|++++-+
T Consensus       230 ---~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          230 ---IPEYLNR-------SVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             ---CCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             ---CchhcCH-------HHHHHHHHHccCChhhCCCHHHHHhChh
Confidence               0011121       2445778899999999999999999754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-44  Score=326.48  Aligned_cols=254  Identities=19%  Similarity=0.282  Sum_probs=205.0

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .++|...+.||+|+||.||++... +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357888999999999999999765 578999999865433 234567889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....... 
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence            99999999999998888899999999999999999999999   99999999999999999999999999998765332 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       .......||+.|+|||.+.       +..++.++||||||+++|+|++|..||......  .   ............  
T Consensus       170 -~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~~~~~~~--  234 (294)
T 2rku_A          170 -ERKKVLCGTPNYIAPEVLS-------KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--E---TYLRIKKNEYSI--  234 (294)
T ss_dssp             -CCBCCCCSCCSSCCHHHHT-------TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHHHHTTCCCC--
T ss_pred             -cccccccCCCCcCCcchhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHHhhccCCC--
Confidence             1224456999999999765       335688999999999999999999999643221  1   111111110000  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                           ....+.       .+.+++.+||+.||++|||++|++++-+-
T Consensus       235 -----~~~~~~-------~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          235 -----PKHINP-------VAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             -----CTTSCH-------HHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             -----ccccCH-------HHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence                 011121       34457788999999999999999997553

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=333.84  Aligned_cols=249  Identities=15%  Similarity=0.149  Sum_probs=197.8

Q ss_pred             hccccCCccccCCceEEEEEE------eCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC---CCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR---HRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  135 (371)
                      +.|...+.||+|+||.||+|.      ..+++.||+|++..     .....+..|.++++.++   |+|++++++++...
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            568888899999999999993      45689999999843     23456778888888876   99999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---------
Q 037946          136 SVKLLLYNYISNGNLQQLLQ-----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---------  201 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---------  201 (371)
                      +..|+||||+++|+|.+++.     ....+++..++.++.|++.||+|||++   +++||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence            99999999999999999997     356699999999999999999999999   9999999999999998         


Q ss_pred             --CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 037946          202 --KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI  279 (371)
Q Consensus       202 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  279 (371)
                        ++.+||+|||+++...............||+.|+|||++.+       ..++.++|||||||++|||++|+.||....
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-------KPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-------CCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-------CCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence              89999999999976543332234456679999999997753       357899999999999999999999986433


Q ss_pred             CCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCC-CCHHHHHHHHhcccC
Q 037946          280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAER-PTMKEVVALLMEVKS  351 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R-Ps~~evl~~L~~~~~  351 (371)
                      ...                  ..........+.  ..   ..-+++..|++.+|.+| |+++++.+.|.++..
T Consensus       290 ~~~------------------~~~~~~~~~~~~--~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          290 GGE------------------CKPEGLFRRLPH--LD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             TTE------------------EEECSCCTTCSS--HH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCc------------------eeechhccccCc--HH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            211                  011111122221  11   22246667999999999 688888888887753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-44  Score=327.18  Aligned_cols=266  Identities=21%  Similarity=0.304  Sum_probs=207.1

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-------cchHHHHHHHHHHHhccC-CCCceeeece
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-------EEPVDSFAAEIQILGHIR-HRNIVKLLGY  131 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~~~~~  131 (371)
                      ..+.++|+..+.||+|+||.||+|... +++.||+|++......       ....+.+.+|+++++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            344567888999999999999999764 6889999998644321       123457889999999995 9999999999


Q ss_pred             EecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEcccc
Q 037946          132 CSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFG  211 (371)
Q Consensus       132 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  211 (371)
                      +.+.+..++||||+++++|.+++.....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999999998888899999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++.......   ......||+.|+|||.+.+... .....++.++||||||+++|+|++|..||....  .......+..
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~  243 (298)
T 1phk_A          170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMS  243 (298)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHC-TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH
T ss_pred             chhhcCCCc---ccccccCCccccCHHHhccccc-cccccCCcccccHhHHHHHHHHHHCCCCCcCcc--HHHHHHHHhc
Confidence            998765443   2345579999999998753311 123457889999999999999999999986432  2222222222


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ....      ...+.....+       ..+.+++.+||+.||.+|||+.|++++-+-
T Consensus       244 ~~~~------~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (298)
T 1phk_A          244 GNYQ------FGSPEWDDYS-------DTVKDLVSRFLVVQPQKRYTAEEALAHPFF  287 (298)
T ss_dssp             TCCC------CCTTTGGGSC-------HHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             CCcc------cCcccccccC-------HHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence            1111      0001111122       234557788999999999999999986543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-45  Score=343.78  Aligned_cols=248  Identities=16%  Similarity=0.186  Sum_probs=187.3

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC-CCcchHHHHHHHH---HHHhccCCCCceeee-------ceE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEI---QILGHIRHRNIVKLL-------GYC  132 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~  132 (371)
                      +.|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+   +++++++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            5678889999999999999975 468999999996543 2344567889999   555566899999998       555


Q ss_pred             ecCC-----------------eEEEEEeecCCCCHHHHhccCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCCeE
Q 037946          133 SNKS-----------------VKLLLYNYISNGNLQQLLQGNRNLDW-------ETRYKIAVGSAQGLAYLHHDCVPAIL  188 (371)
Q Consensus       133 ~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~~i~~~l~~lh~~~~~~i~  188 (371)
                      .+.+                 ..|+||||+ +|+|.+++.....+++       ..++.++.|++.||+|||++   +++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            5443                 378999999 5799999976544444       88889999999999999999   999


Q ss_pred             ecCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccch----hhhcccCCCCCcchhHHHHHH
Q 037946          189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ----IIYGYTMNITEKSDVYSYGVV  264 (371)
Q Consensus       189 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~DiwslG~~  264 (371)
                      ||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.    ........++.++|||||||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999986433     2244567 999999987633    000011257889999999999


Q ss_pred             HHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 037946          265 LLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA  344 (371)
Q Consensus       265 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  344 (371)
                      +|||++|..||......               .....+ .......++       .+.+++.+||+.||++|||+.|+++
T Consensus       303 l~elltg~~Pf~~~~~~---------------~~~~~~-~~~~~~~~~-------~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAAL---------------GGSEWI-FRSCKNIPQ-------PVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC---------------------CCSGGG-GSSCCCCCH-------HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccc---------------cchhhh-hhhccCCCH-------HHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999998643221               111111 111123333       3445777899999999999999997


Q ss_pred             H
Q 037946          345 L  345 (371)
Q Consensus       345 ~  345 (371)
                      +
T Consensus       360 h  360 (377)
T 3byv_A          360 T  360 (377)
T ss_dssp             S
T ss_pred             C
Confidence            5

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.5e-45  Score=352.26  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=200.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|... +|+.||+|++.+... .......+.+|.+++++++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            45777788999999999999764 689999999965332 1234567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLLQGN----RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ||++||+|.+++...    ..+++..+..++.||+.||.|||++   +++||||||+|||++.+|.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999998653    3699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..  ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||....... ...+.......... 
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~-------~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~~-  410 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLG-------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQAV-  410 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCCC-
T ss_pred             CC--cccccccCCccccChhhhcC-------CCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhccc-
Confidence            43  12344589999999998753       367899999999999999999999997543221 11122222111100 


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHHH
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM-----KEVVAL  345 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~  345 (371)
                                ..+.....   .+.+++.+||+.||++||++     ++++++
T Consensus       411 ----------~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          411 ----------TYPDKFSP---ASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ----------CCCTTSCH---HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ----------CCCcccCH---HHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                      11111112   33457778999999999964     778775

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-44  Score=325.73  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=204.5

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .+.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            34688889999999999999975 468999999985433 2345678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+++++|.+++.. ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.......  
T Consensus       100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999999976 4599999999999999999999999   99999999999999999999999999998765443  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||.+.       +..++.++||||||+++|+|++|..||....  .......+...  . ..    
T Consensus       174 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~--~-~~----  237 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIK-------QSAYDSKADIWSLGITAIELARGEPPHSELH--PMKVLFLIPKN--N-PP----  237 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHS--C-CC----
T ss_pred             cccCccCCCcCccCHHHHh-------cCCCCchhhhHHHHHHHHHHccCCCCCCCcC--HHHHHHHhhcC--C-CC----
Confidence            1224557999999999765       3367889999999999999999999986432  11222111111  0 00    


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                        ......+.       .+.+++.+||+.||.+|||+.+++++.+-..
T Consensus       238 --~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          238 --TLEGNYSK-------PLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             --CCCSSCCH-------HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             --CCccccCH-------HHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence              00112222       2445777899999999999999999876543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.2e-44  Score=332.64  Aligned_cols=266  Identities=21%  Similarity=0.316  Sum_probs=187.1

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----  135 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  135 (371)
                      ++.++|+..+.||+|+||.||+|.+ .+|+.||+|++............+.+|+.+++.++||||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            3446899999999999999999965 5689999999865544555667889999999999999999999998654     


Q ss_pred             -CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          136 -SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                       ...|+|||++ +++|.+++.. ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence             5679999999 6799998876 5699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      .....     .....||+.|+|||++.+      ...++.++|||||||++|||++|+.||....  .......+....+
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g  247 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVG  247 (367)
T ss_dssp             ---------------CCCTTCCHHHHTT------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHC
T ss_pred             ccccc-----CCCcCcCcCccChHHHcC------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhC
Confidence            65432     244579999999997653      2357889999999999999999999996532  2222333333222


Q ss_pred             CCCccccccCc-----------ccCCCChhhHH-----HHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          295 SFEPAVSILDT-----------KLQGLPDQMVQ-----EMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       295 ~~~~~~~~~~~-----------~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ....  .....           .+...+.....     ....+.+|+.+||+.||++|||+.|++++-+
T Consensus       248 ~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~  314 (367)
T 2fst_X          248 TPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  314 (367)
T ss_dssp             SCCH--HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCCH--HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence            2110  00000           00000000000     0123567888999999999999999999854

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=330.36  Aligned_cols=268  Identities=20%  Similarity=0.312  Sum_probs=193.9

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            46788899999999999999764 689999999854322 1112234579999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+++ +|.+++... ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--  154 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  154 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence            9985 888888664 4589999999999999999999999   99999999999999999999999999998654332  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc--c
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA--V  300 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~  300 (371)
                      .......||+.|+|||.+.+      ...++.++|||||||++|+|++|..||....  .......+..........  .
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~  226 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEETWP  226 (324)
T ss_dssp             --------CGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccCcccccChhhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHhch
Confidence            12344568999999997642      2357889999999999999999999996542  223333333333321110  0


Q ss_pred             cccCc------ccCC-CChhhH----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SILDT------KLQG-LPDQMV----QEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~~~------~~~~-~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .....      .... ......    .....+.+++.+||+.||++|||++|++++-+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF  284 (324)
T ss_dssp             TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence            00000      0000 000000    01123456888899999999999999999743

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-43  Score=324.22  Aligned_cols=260  Identities=21%  Similarity=0.246  Sum_probs=198.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEec--CCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSN--KSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++..     .....+.+|+.++++++ ||||+++++++.+  ....++
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            5788899999999999999965 5789999999842     23467899999999997 9999999999987  677899


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++++|.+++..   +++..+..++.|++.||+|||++   +++||||||+|||++.++ .+||+|||+++.....
T Consensus       111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999999999864   89999999999999999999999   999999999999999776 8999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC----
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS----  295 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----  295 (371)
                      .   ......||+.|+|||.+.+      ...++.++|||||||++|+|++|..||.....+...+.... .....    
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~-~~~~~~~~~  254 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA-KVLGTEDLY  254 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH-HHHCHHHHH
T ss_pred             C---ccccccccccccChhhhcC------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH-HhcCCchhh
Confidence            3   2345578999999997642      23578999999999999999999999965443322222111 11110    


Q ss_pred             ---------CCcc-ccccCc--------ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          296 ---------FEPA-VSILDT--------KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       296 ---------~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                               ..+. ......        ........  .....+.+++.+||+.||++|||++|++++-+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~  322 (330)
T 3nsz_A          255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH--LVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  322 (330)
T ss_dssp             HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGG--GCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred             hHHHHhccccccchhhhhhhccccchhhhccccccc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence                     0000 000000        00000000  01234566889999999999999999998743

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3e-44  Score=333.46  Aligned_cols=273  Identities=19%  Similarity=0.242  Sum_probs=195.7

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCc---------chHHHHHHHHHHHhccCCCCceeeec
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE---------EPVDSFAAEIQILGHIRHRNIVKLLG  130 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~~~~  130 (371)
                      ...+.++|+..+.||+|+||.||+|...+|+.||+|++.......         ...+.+.+|++++++++||||+++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            345567899999999999999999988889999999986543322         12478999999999999999999999


Q ss_pred             eEe-----cCCeEEEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          131 YCS-----NKSVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       131 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      ++.     .....|+||||+.+ +|.+++... ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~  172 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNND  172 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             eEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCC
Confidence            984     34468999999985 777777654 4699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH  284 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  284 (371)
                      +||+|||++.......   ......||+.|+|||.+.+      ...++.++|||||||++|+|++|..||.....  ..
T Consensus       173 ~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~  241 (362)
T 3pg1_A          173 ITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQ------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--YN  241 (362)
T ss_dssp             EEECCTTC------------------CGGGCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH
T ss_pred             EEEEecCccccccccc---ccceecccceecCcHHhcC------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH--HH
Confidence            9999999997544332   2344578999999997652      23578999999999999999999999965421  22


Q ss_pred             HHHHHHHHhcCCCcc----------ccccCcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          285 IVEWVKKKMGSFEPA----------VSILDTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ....+..........          ...........+....     .....+.+++.+||+.||++|||+.|++++-+
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            222222222111000          0000011111111000     01123556888899999999999999999743

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.4e-43  Score=317.93  Aligned_cols=262  Identities=20%  Similarity=0.305  Sum_probs=198.3

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceE-ecCCeEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLL  140 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~l  140 (371)
                      +.++|+..+.||+|+||.||+|.. .+++.||+|++......    ..+.+|+.+++.++|++++..++.+ .+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            346789999999999999999975 57899999987443322    3478899999999988877776665 66778899


Q ss_pred             EEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE---cCCCceEEccccCcccc
Q 037946          141 LYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLM  216 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~  216 (371)
                      ||||+ +++|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+||++   +.++.+||+|||++...
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99999 8899999974 55699999999999999999999999   99999999999999   78999999999999876


Q ss_pred             CCCCcc-----cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc-hhHHHHHH
Q 037946          217 NSTNYH-----HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG-LHIVEWVK  290 (371)
Q Consensus       217 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~  290 (371)
                      ......     .......||+.|+|||.+.       +..++.++|||||||++|+|++|..||....... ......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhc-------CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            554321     1223557999999999765       3367889999999999999999999997543321 11111111


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      ..... .+.    .......++       .+.+++.+||+.||++|||++++++.|.++..
T Consensus       232 ~~~~~-~~~----~~~~~~~~~-------~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          232 EKKMS-TPI----EVLCKGYPS-------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHH-SCH----HHHTTTSCH-------HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccccc-chh----hhhhccCCH-------HHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            11100 000    000012222       34557778999999999999999999998863

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.9e-44  Score=323.69  Aligned_cols=264  Identities=21%  Similarity=0.303  Sum_probs=199.7

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC--CCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR--HRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||++...+++.||+|++..........+.+.+|+.++++++  ||||+++++++.+.+..++||
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            568889999999999999998888999999999665555566788999999999996  599999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      | +.+++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||++++ +.+||+|||++.........
T Consensus       108 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          108 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            9 56789999999888899999999999999999999999   9999999999999964 89999999999876544322


Q ss_pred             cccccccccccccCCCCccchhhh----cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIY----GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .......||+.|+|||.+.+....    .....++.++||||||+++|+|++|..||.........    ..........
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~  258 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LHAIIDPNHE  258 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHHHHCTTSC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH----HHHHHhcccc
Confidence            223455799999999987531100    01235788999999999999999999999644322111    1111111000


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                            .......+      ..+.+++.+||+.||.+|||+.|++++-+--
T Consensus       259 ------~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~h~~~~  297 (313)
T 3cek_A          259 ------IEFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  297 (313)
T ss_dssp             ------CCCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ------cCCcccch------HHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence                  01111111      1344577789999999999999999986543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=325.62  Aligned_cols=259  Identities=24%  Similarity=0.300  Sum_probs=185.2

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceE--------ec
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYC--------SN  134 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~--------~~  134 (371)
                      .+|+..+.||+|+||.||+|.+ .+++.||+|++...  .....+.+.+|+.+++++. ||||+++++++        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4688899999999999999976 46899999998432  3445678899999999995 99999999998        34


Q ss_pred             CCeEEEEEeecCCCCHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeEcCCCceEEcc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQG---NRNLDWETRYKIAVGSAQGLAYLHHDCVPA--ILHRDVKCNNILLDSKYEAYLAD  209 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nill~~~~~~kl~D  209 (371)
                      ....+++|||+. |+|.+++..   ...+++..++.++.|++.||.|||++   +  ++||||||+|||++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            456899999996 699888754   55699999999999999999999998   8  99999999999999999999999


Q ss_pred             ccCccccCCCCccc----------ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 037946          210 FGLAKLMNSTNYHH----------AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI  279 (371)
Q Consensus       210 fg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  279 (371)
                      ||++..........          ......||+.|+|||++...    .+..++.++||||||+++|+|++|..||....
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY----SNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CC----TTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc----ccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99998765432110          11144589999999987421    24467889999999999999999999986322


Q ss_pred             CCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      ..     ........         .+.....+..       +.+++.+||+.||.+|||+.|++++|+.+.....
T Consensus       258 ~~-----~~~~~~~~---------~~~~~~~~~~-------~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          258 KL-----RIVNGKYS---------IPPHDTQYTV-------FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             -------------CC---------CCTTCCSSGG-------GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             HH-----HhhcCccc---------CCcccccchH-------HHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            11     11111000         0111122222       3347777999999999999999999999875433

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.7e-44  Score=331.33  Aligned_cols=200  Identities=26%  Similarity=0.427  Sum_probs=174.1

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|++... ......+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            46888899999999999999764 6899999998543 234556789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |+++++|.+++.....+++..+..++.|++.||.|||++.  +++||||||+||+++.++.+||+|||++......    
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  185 (360)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence            9999999999998888999999999999999999999831  7999999999999999999999999999765332    


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      ......||+.|+|||++.       +..++.++||||||+++|+|++|..||...
T Consensus       186 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             C----CCCCTTCCHHHHT-------TCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             cccCCCCCCCeECHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            223457999999999765       346789999999999999999999999754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=323.08  Aligned_cols=262  Identities=27%  Similarity=0.418  Sum_probs=201.1

Q ss_pred             hccccCCccccCCceEEEEEEe-----CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC--e
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-----PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS--V  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~  137 (371)
                      ++|+..+.||+|+||.||+|..     .+++.||+|++..  ......+.+.+|+.++++++||||+++++++...+  .
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            4688889999999999999973     4688999999853  34455678999999999999999999999986654  7


Q ss_pred             EEEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          138 KLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      .++||||+++++|.+++... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            89999999999999999765 4599999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC----------chhH
Q 037946          217 NSTNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD----------GLHI  285 (371)
Q Consensus       217 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----------~~~~  285 (371)
                      ...... .......++..|+|||.+.+       ..++.++||||||+++|+|++|..|+......          ....
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  268 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred             cccccccccccCCCCceeEECchhhcC-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence            554321 11233457888999997753       24678999999999999999999887532100          0000


Q ss_pred             HHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ...+.........     .+.....++       .+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       269 ~~~~~~~~~~~~~-----~~~~~~~~~-------~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          269 VFHLIELLKNNGR-----LPRPDGCPD-------EIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHHHHTTCC-----CCCCTTCCH-------HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCC-----CCCCCcccH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0011111111000     001112222       3455778899999999999999999999876

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.6e-44  Score=357.93  Aligned_cols=250  Identities=23%  Similarity=0.307  Sum_probs=202.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|++.+... .....+.+..|..++..+ +||+|+.+++++.+.+..|+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            56888899999999999999764 588999999865321 233456788999999988 799999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++...+.+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-  496 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-  496 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence            99999999999999888899999999999999999999999   99999999999999999999999999998643332 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       ......+||+.|+|||++.       ...++.++|||||||++|||++|..||....  ...+..   .......    
T Consensus       497 -~~~~~~~GT~~Y~APE~l~-------~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--~~~~~~---~i~~~~~----  559 (674)
T 3pfq_A          497 -VTTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQ---SIMEHNV----  559 (674)
T ss_dssp             -CCBCCCCSCSSSCCHHHHT-------CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHH---HHHSSCC----
T ss_pred             -cccccccCCCcccCHhhhc-------CCCCCccceEechHHHHHHHHcCCCCCCCCC--HHHHHH---HHHhCCC----
Confidence             2345678999999999875       3367899999999999999999999997532  222222   2222111    


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM-----KEVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~  345 (371)
                             ..+.....   .+.+|+.+||+.||++||++     +||+++
T Consensus       560 -------~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          560 -------AYPKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             -------CCCTTSCH---HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             -------CCCccCCH---HHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                   11111112   34557788999999999997     888876

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-44  Score=329.41  Aligned_cols=275  Identities=25%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             HHHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCc---chHHHHHHHHHHHhccCCCCceeeeceEecC
Q 037946           60 IDNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDE---EPVDSFAAEIQILGHIRHRNIVKLLGYCSNK  135 (371)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  135 (371)
                      ++...++|+..+.||+|+||.||+|... +|+.||+|++.......   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            3445678999999999999999999764 58999999985433221   1234688999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      +..++||||+++ +|.+++... ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999999986 888888754 4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ......  .......||+.|+|||++.+      ...++.++|||||||++|||++|.+||....  .......+.....
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~~~~~~~--~~~~~~~i~~~~~  230 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLG  230 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHC
T ss_pred             eccCCc--ccCCcccccccccCchHhhC------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHcC
Confidence            765433  22345679999999997642      2246889999999999999999999886442  2222222222222


Q ss_pred             CCCcc--ccc---cC----cccCCCChhh--HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          295 SFEPA--VSI---LD----TKLQGLPDQM--VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       295 ~~~~~--~~~---~~----~~~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      .....  ...   .+    ......+...  ......+.+++.+||+.||++|||++|++++-+-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence            11100  000   00    0000011000  0011345668888999999999999999998654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=323.85  Aligned_cols=254  Identities=23%  Similarity=0.365  Sum_probs=195.9

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ...+.|+..+.||+|+||.||+|... +|+.||+|.+...    .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34567888999999999999999764 5899999998542    234678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++++|.+++. ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999996 456799999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .  .......||+.|+|||.+.       +..++.++||||||+++|+|++|..||.....  ......+.   ......
T Consensus       179 ~--~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~---~~~~~~  244 (314)
T 3com_A          179 M--AKRNTVIGTPFWMAPEVIQ-------EIGYNCVADIWSLGITAIEMAEGKPPYADIHP--MRAIFMIP---TNPPPT  244 (314)
T ss_dssp             B--SCBCCCCSCGGGCCHHHHS-------SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHH---HSCCCC
T ss_pred             c--cccCccCCCCCccChhhcC-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHh---cCCCcc
Confidence            2  1224456999999999765       33578899999999999999999999864321  11111111   110000


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        ..  .....+       ..+.+++.+||+.||.+|||+.+++++-+
T Consensus       245 --~~--~~~~~~-------~~l~~li~~~l~~dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          245 --FR--KPELWS-------DNFTDFVKQCLVKSPEQRATATQLLQHPF  281 (314)
T ss_dssp             --CS--SGGGSC-------HHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             --cC--CcccCC-------HHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence              00  001111       23445788899999999999999998654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-44  Score=327.66  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=197.3

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      ..++|+..+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            3467888999999999999999775 5899999998532  344567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          142 YNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999998865 56699999999999999999999999   99999999999999999999999999975432211


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                        .......||+.|+|||.+...  ......++.++||||||+++|+|++|..||.....  ...   .........+. 
T Consensus       172 --~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~---~~~~~~~~~~~-  241 (302)
T 2j7t_A          172 --QKRDSFIGTPYWMAPEVVMCE--TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRV---LLKIAKSDPPT-  241 (302)
T ss_dssp             --HC-----CCGGGCCHHHHHHH--HTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH---HHHHHHSCCCC-
T ss_pred             --cccccccCChhhcCCeeeccc--cCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--HHH---HHHHhccCCcc-
Confidence              112345689999999987532  11234678899999999999999999999864321  111   11111110100 


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                       ..  .....+       ..+.+++.+||+.||.+|||+.+++++-+
T Consensus       242 -~~--~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~h~~  278 (302)
T 2j7t_A          242 -LL--TPSKWS-------VEFRDFLKIALDKNPETRPSAAQLLEHPF  278 (302)
T ss_dssp             -CS--SGGGSC-------HHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred             -cC--CccccC-------HHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence             00  001111       23445778899999999999999998643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.2e-44  Score=331.35  Aligned_cols=268  Identities=19%  Similarity=0.281  Sum_probs=202.6

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcc---------------hHHHHHHHHHHHhccCCCCceeee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE---------------PVDSFAAEIQILGHIRHRNIVKLL  129 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~niv~~~  129 (371)
                      ++|+..+.||+|+||.||+|.. +++.||+|++........               ..+.+.+|+.++++++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            5788899999999999999988 899999999865432211               127899999999999999999999


Q ss_pred             ceEecCCeEEEEEeecCCCCHHHH------hcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEc
Q 037946          130 GYCSNKSVKLLLYNYISNGNLQQL------LQG--NRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLD  200 (371)
Q Consensus       130 ~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~  200 (371)
                      +++.+.+..++||||+++++|.++      +..  ...+++..++.++.|++.||.|||+ +   +++||||||+||+++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence            999999999999999999999998      665  5679999999999999999999999 8   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCC-cchhHHHHHHHHHHHhCCCCCCCCC
Q 037946          201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITE-KSDVYSYGVVLLEILSGRSAVQPQI  279 (371)
Q Consensus       201 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~DiwslG~~l~el~~g~~p~~~~~  279 (371)
                      .++.+||+|||.+......    ......||+.|+|||.+.+.      ..++. ++||||||+++|+|++|..||....
T Consensus       187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE------SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC------CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC------CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999876443    23456799999999987532      13344 8999999999999999999997543


Q ss_pred             CCchhHHHHHHHHhcCCCcccc-ccCcccCCCChh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          280 GDGLHIVEWVKKKMGSFEPAVS-ILDTKLQGLPDQ-MVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .. ......+............ ............ .......+.+++.+||+.||.+|||+.|++++-+
T Consensus       257 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          257 SL-VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             CS-HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             cH-HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence            32 2222222111111000000 000000000000 0001123456888899999999999999999754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=316.10  Aligned_cols=253  Identities=24%  Similarity=0.403  Sum_probs=193.9

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      +.....||+|+||.||+|.. .+++.||+|.+...  .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            44556899999999999975 46889999998543  3344577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccCccccCCCCc
Q 037946          146 SNGNLQQLLQGN---RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       146 ~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ++++|.+++...   ..+++..+..++.|++.||.|||++   +++|+||||+||+++. ++.+||+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            999999999754   2467899999999999999999999   9999999999999987 8999999999998765432 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       .......||+.|+|||.+...     ...++.++||||||+++|+|++|..||..........   ........     
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~-----  243 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKG-----PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGMFKV-----  243 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHG-----GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHHHCC-----
T ss_pred             -CcccccCCCccccChhhhcCC-----CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhhccccc-----
Confidence             122345799999999987532     1236789999999999999999999986432211111   11111110     


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        .+   ..+.....   .+.+++.+||+.||++|||+.+++++-+
T Consensus       244 --~~---~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~~~~  281 (295)
T 2clq_A          244 --HP---EIPESMSA---EAKAFILKCFEPDPDKRACANDLLVDEF  281 (295)
T ss_dssp             --CC---CCCTTSCH---HHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred             --cc---cccccCCH---HHHHHHHHHccCChhhCCCHHHHhcChh
Confidence              01   11111111   3345778899999999999999998644

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.8e-43  Score=316.06  Aligned_cols=262  Identities=20%  Similarity=0.308  Sum_probs=201.2

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceE-ecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC-SNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.....    ...+.+|+.+++.++|++++..++++ .+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            5688899999999999999975 5789999999854332    23588999999999998877766655 6677889999


Q ss_pred             eecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE---cCCCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ||+ +++|.+++. ....+++..++.++.|++.||+|||++   +++||||||+||++   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 889999997 455799999999999999999999999   99999999999999   4889999999999987655


Q ss_pred             CCccc-----ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-chhHHHHHHHH
Q 037946          219 TNYHH-----AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD-GLHIVEWVKKK  292 (371)
Q Consensus       219 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~  292 (371)
                      .....     ......||+.|+|||.+.       +..++.++||||||+++|+|++|..||...... .......+...
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             cccccccccccccccccccccCChhhhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence            43211     124557999999999765       335788999999999999999999999754322 11222222111


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                      ... .+.    .......++       .+.+++.+||+.||++|||++++++.|+++....
T Consensus       234 ~~~-~~~----~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          234 KMS-TPI----EVLCKGYPS-------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHH-SCH----HHHTTTSCH-------HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccC-Cch----HHHHhhCCH-------HHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            111 000    000012222       3445777899999999999999999999886433

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.9e-43  Score=320.45  Aligned_cols=269  Identities=22%  Similarity=0.342  Sum_probs=199.7

Q ss_pred             hccccCCccccCCceEEEEEEe--CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc---CCCCceeeeceEe-----c
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM--PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI---RHRNIVKLLGYCS-----N  134 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  134 (371)
                      ++|+..+.||+|+||.||+|..  .+++.||+|++............+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            5688899999999999999987  4678999999865444333334566777777766   8999999999987     5


Q ss_pred             CCeEEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      ....++||||++ |+|.+++....  .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcc
Confidence            677899999998 59999987643  489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......   ......||+.|+|||.+.       +..++.++||||||+++|+|++|..||.....  ......+...
T Consensus       167 ~~~~~~~~---~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~  234 (326)
T 1blx_A          167 ARIYSFQM---ALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDV  234 (326)
T ss_dssp             CCCCCGGG---GGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHH
T ss_pred             cccccCCC---CccccccccceeCHHHHh-------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHH
Confidence            98654332   234567899999999765       33678999999999999999999999865422  2222222222


Q ss_pred             hcCCCccc---------cccC----cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HhcccCC
Q 037946          293 MGSFEPAV---------SILD----TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVKSA  352 (371)
Q Consensus       293 ~~~~~~~~---------~~~~----~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  352 (371)
                      ........         ....    ..........   ...+.+++.+||+.||++|||+.|++++  +.++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI---DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC---CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccC---CHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            22110000         0000    0000011111   1234457888999999999999999976  4444433

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-43  Score=329.66  Aligned_cols=267  Identities=22%  Similarity=0.323  Sum_probs=199.1

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE--
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK--  138 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--  138 (371)
                      ++.++|...+.||+|+||.||+|.+ .+|+.||+|++............+.+|+.+++.++||||+++++++...+..  
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            3456888899999999999999975 4689999999976555555667899999999999999999999999877665  


Q ss_pred             ----EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          139 ----LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       139 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                          |+||||+. ++|.+++..  .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             ceeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence                99999997 589888854  499999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      .....     .....||+.|+|||.+.+      ...++.++|||||||++|+|++|..||....  .......+.....
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~  259 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTG  259 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHC
T ss_pred             ccccC-----cCCcccCccccCHHHhcC------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhC
Confidence            65433     244578999999997652      2467889999999999999999999996532  2222222222111


Q ss_pred             CCCcc-ccccC--------cccCCCC-hhhH----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          295 SFEPA-VSILD--------TKLQGLP-DQMV----QEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       295 ~~~~~-~~~~~--------~~~~~~~-~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..... ...+.        ......+ ....    .....+.+++.+||+.||++|||+.|++++-+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence            11000 00000        0000000 0000    01234566888899999999999999999854

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.5e-44  Score=336.99  Aligned_cols=198  Identities=26%  Similarity=0.313  Sum_probs=169.3

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc------CCCCceeeeceEec
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI------RHRNIVKLLGYCSN  134 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~  134 (371)
                      .+..+|+..+.||+|+||.||+|... +++.||||++..   .......+.+|+.+++.+      +|+||+++++++..
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            34467899999999999999999654 588999999843   233446677888888877      57799999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc--eEEccc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE--AYLADF  210 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~--~kl~Df  210 (371)
                      .+..++||||+. ++|.+++....  .+++..+..++.|++.||+|||++   +++||||||+|||++.++.  +||+||
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            999999999996 59999887654  489999999999999999999999   9999999999999999887  999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      |++......     .....||+.|+|||++.       +..++.++|||||||++|||++|..||...
T Consensus       247 G~a~~~~~~-----~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          247 GSSCYEHQR-----VYTYIQSRFYRAPEVIL-------GARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHH-------TBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceecCCc-----ccccCCCCCccChHHHh-------CCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            999765433     23457999999999875       336789999999999999999999998654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-43  Score=330.12  Aligned_cols=258  Identities=21%  Similarity=0.290  Sum_probs=191.3

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--------
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--------  134 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  134 (371)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++..+...      ..+|+++++.++||||+++++++..        
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            45788899999999999999965 57899999998543322      2379999999999999999999843        


Q ss_pred             ------------------------------CCeEEEEEeecCCCCHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHH
Q 037946          135 ------------------------------KSVKLLLYNYISNGNLQQLL----QGNRNLDWETRYKIAVGSAQGLAYLH  180 (371)
Q Consensus       135 ------------------------------~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~~i~~~l~~lh  180 (371)
                                                    ....++||||+++ +|.+.+    .....+++..+..++.|++.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          3348899999985 776665    45677999999999999999999999


Q ss_pred             hCCCCCeEecCCCCCCeeEc-CCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhH
Q 037946          181 HDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVY  259 (371)
Q Consensus       181 ~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw  259 (371)
                      ++   +++||||||+||+++ .++.+||+|||+++......   ......||+.|+|||.+.+      ...++.++|||
T Consensus       159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~------~~~~~~~~Diw  226 (383)
T 3eb0_A          159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLG------ATEYTPSIDLW  226 (383)
T ss_dssp             TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTT------CSSCCTHHHHH
T ss_pred             HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcC------CCCCCcchhhh
Confidence            99   999999999999998 68999999999998765443   2344578999999997652      23478999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc---------ccccCcccCC------CChhhHHHHHHHHHH
Q 037946          260 SYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA---------VSILDTKLQG------LPDQMVQEMLQTLGI  324 (371)
Q Consensus       260 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~~~~~~~~l  324 (371)
                      ||||++|||++|..||.....  ......+....+.....         ....-+....      .+..   ....+.++
T Consensus       227 slG~il~ell~g~~pf~~~~~--~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  301 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETS--IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG---TPSLAIDL  301 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTT---CCHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCC---CCHHHHHH
Confidence            999999999999999975422  22222222211110000         0000000000      0010   11235568


Q ss_pred             HhcccCCCCCCCCCHHHHHHH
Q 037946          325 AMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       325 ~~~cl~~dP~~RPs~~evl~~  345 (371)
                      +.+||+.||++|||+.|++++
T Consensus       302 i~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          302 LEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHccCChhhCCCHHHHhcC
Confidence            888999999999999999976

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-43  Score=318.49  Aligned_cols=257  Identities=21%  Similarity=0.307  Sum_probs=186.1

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++..........+.+.++...++.++||||+++++++.+.+..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            4688889999999999999976 578999999986544333444455566666888999999999999999999999999


Q ss_pred             ecCCCCHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          144 YISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       144 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |+++ +|.+++.    ....+++..++.++.|++.||.|||++.  +++||||||+||+++.++.+||+|||++......
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            9975 8877764    4567999999999999999999999842  8999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .   ......||+.|+|||.+...   .....++.++||||||+++|+|++|..||.........+...+..   . ...
T Consensus       164 ~---~~~~~~~t~~y~aPE~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-~~~  233 (290)
T 3fme_A          164 V---AKDIDAGCKPYMAPERINPE---LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE---P-SPQ  233 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCC---TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS---C-CCC
T ss_pred             c---cccccCCCccccChhhcChh---hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc---C-CCC
Confidence            3   22344699999999986321   123457889999999999999999999996433222222211111   1 000


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                           ......++       .+.+++.+||+.||++|||+.|++++-
T Consensus       234 -----~~~~~~~~-------~~~~li~~~l~~~p~~Rpt~~e~l~hp  268 (290)
T 3fme_A          234 -----LPADKFSA-------EFVDFTSQCLKKNSKERPTYPELMQHP  268 (290)
T ss_dssp             -----CCTTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             -----cccccCCH-------HHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence                 00011222       345577889999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.5e-44  Score=336.57  Aligned_cols=253  Identities=12%  Similarity=0.016  Sum_probs=177.0

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhcc--CCCCceeee-------ceEec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHI--RHRNIVKLL-------GYCSN  134 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~~~  134 (371)
                      .|+..+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.+  +||||++++       +++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            4778899999999999999764 789999999976543 234456777885544444  699988754       33332


Q ss_pred             C-----------------CeEEEEEeecCCCCHHHHhccC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEec
Q 037946          135 K-----------------SVKLLLYNYISNGNLQQLLQGN-RNLDWETR------YKIAVGSAQGLAYLHHDCVPAILHR  190 (371)
Q Consensus       135 ~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~i~~~i~~~l~~lh~~~~~~i~H~  190 (371)
                      .                 ...|+||||++ |+|.+++... ..+++..+      ..++.|++.||+|||++   +++||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr  218 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG  218 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence            2                 34799999999 7999999753 33455555      77889999999999999   99999


Q ss_pred             CCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh
Q 037946          191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS  270 (371)
Q Consensus       191 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  270 (371)
                      ||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+.     ...++.++|||||||++|||++
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNAS-----TATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCS-----EEECCHHHHHHHHHHHHHHHHH
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCC-----CCCcCccccHHHHHHHHHHHHh
Confidence            999999999999999999999998664321     244577999999987421     1357899999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHHhcCCC-c---cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          271 GRSAVQPQIGDGLHIVEWVKKKMGSFE-P---AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      |..||..........       ..... .   ......+.....++       .+.+++.+||+.||++|||+.+++++-
T Consensus       289 g~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~li~~~L~~dP~~Rpt~~e~l~hp  354 (371)
T 3q60_A          289 LFLPFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPD-------FVKTLIGRFLNFDRRRRLLPLEAMETP  354 (371)
T ss_dssp             SSCSTTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCH-------HHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred             CCCCCCCcCcccccc-------hhhhhhhhccccccchhhccCCCH-------HHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence            999997653321100       00000 0   00000011112222       344577889999999999999998753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=323.87  Aligned_cols=267  Identities=22%  Similarity=0.375  Sum_probs=199.4

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|....  .+|+|++..........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  110 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL  110 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence            468889999999999999998743  599999866554445556678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC---
Q 037946          145 ISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN---  220 (371)
Q Consensus       145 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  220 (371)
                      +++++|.+++...+ .+++..++.++.|++.||.|||++   +++||||||+||+++ ++.+||+|||++.......   
T Consensus       111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            99999999998755 689999999999999999999999   999999999999998 6799999999987653221   


Q ss_pred             cccccccccccccccCCCCccchhhh--cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIY--GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .........||+.|+|||.+......  .....++.++||||||+++|||++|..||.....  ......+.   ....+
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~---~~~~~  261 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--EAIIWQMG---TGMKP  261 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--HHHHHHHH---TTCCC
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhc---cCCCC
Confidence            11122345689999999987532100  0123578899999999999999999999864322  11211111   11011


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .  .   .....+..       +.+++.+||+.||.+|||++++++.|+++.....
T Consensus       262 ~--~---~~~~~~~~-------l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          262 N--L---SQIGMGKE-------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             C--C---CCSSCCTT-------HHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             C--C---CcCCCCHH-------HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            0  0   00122332       3456777999999999999999999999985543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-43  Score=321.49  Aligned_cols=261  Identities=24%  Similarity=0.374  Sum_probs=182.1

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            4688889999999999999975 468999999885432 23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          144 YISNGNLQQLLQG--------NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       144 ~~~~~~L~~~l~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      |+++++|.+++..        ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            9999999999863        45689999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCc---ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          216 MNSTNY---HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       216 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      ......   ........||+.|+|||.+...      ..++.++||||||+++|+|++|..||.......  ...   ..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---~~  239 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQV------RGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLM---LT  239 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHH------HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHH---HH
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccc------cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHH---HH
Confidence            543321   1112345699999999976531      246889999999999999999999997543321  111   11


Q ss_pred             hcCCC-cccc-ccCcc-cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          293 MGSFE-PAVS-ILDTK-LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       293 ~~~~~-~~~~-~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..... .... ..+.. ....+.       .+.+++.+||+.||.+|||+.+++++-+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~~ll~h~~  290 (303)
T 2vwi_A          240 LQNDPPSLETGVQDKEMLKKYGK-------SFRKMISLCLQKDPEKRPTAAELLRHKF  290 (303)
T ss_dssp             HTSSCCCTTC-----CCCCCCCH-------HHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred             hccCCCccccccccchhhhhhhH-------HHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            11101 1000 00111 112222       3445778899999999999999998643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-43  Score=325.45  Aligned_cols=261  Identities=18%  Similarity=0.282  Sum_probs=199.2

Q ss_pred             HhccccCCccccCCceEEEEEEe--CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCC------CceeeeceEecC
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM--PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR------NIVKLLGYCSNK  135 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~  135 (371)
                      .++|+..+.||+|+||.||+|.+  .+++.||+|++..   .....+.+.+|+.+++.++|+      +++++++++.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            35788899999999999999975  3688999999843   234456788999999988765      499999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC------------
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS------------  201 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~------------  201 (371)
                      +..++||||+ +++|.+++....  .+++..+..++.|++.||+|||++   +++||||||+||+++.            
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999 789999997665  688999999999999999999999   9999999999999987            


Q ss_pred             -------CCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCC
Q 037946          202 -------KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA  274 (371)
Q Consensus       202 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p  274 (371)
                             ++.+||+|||++......     .....||+.|+|||++.       +..++.++||||||+++|||++|..|
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVIL-------ALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHT-------TSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhh-------CCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                   668999999999865433     23457999999999765       33678999999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHHhcCCCccc-------cccC-cc--cCCC-----------------ChhhHHHHHHHHHHHhc
Q 037946          275 VQPQIGDGLHIVEWVKKKMGSFEPAV-------SILD-TK--LQGL-----------------PDQMVQEMLQTLGIAMF  327 (371)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~--~~~~-----------------~~~~~~~~~~~~~l~~~  327 (371)
                      |....  .......+...........       .... ..  ....                 ..........+.+++.+
T Consensus       234 f~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  311 (339)
T 1z57_A          234 FPTHD--SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK  311 (339)
T ss_dssp             CCCSC--HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCC--hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence            96542  2222233333222211100       0000 00  0000                 00001223456678999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 037946          328 CVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       328 cl~~dP~~RPs~~evl~~  345 (371)
                      ||+.||.+|||+.|++++
T Consensus       312 ~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          312 MLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HTCSSTTTSCCHHHHTTS
T ss_pred             HhCcCcccccCHHHHhcC
Confidence            999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.3e-43  Score=326.71  Aligned_cols=269  Identities=23%  Similarity=0.300  Sum_probs=201.2

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----CeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----SVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  138 (371)
                      ++|+..+.||+|+||.||+|... +++.||+|++.. .........+.+|++++++++||||+++++++...     ...
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc-ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            47888999999999999999754 688999999853 22344457889999999999999999999998655     468


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      |+||||+.+ +|.+++... .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       106 ~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            999999975 999998764 599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          219 TNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       219 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .... .......||+.|+|||++.+      ...++.++|||||||++|+|++|..||.....  ......+........
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~  252 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPS  252 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHT------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG--GGHHHHHHHHHCSCC
T ss_pred             CCCccccccccccccCCCCCHHhcC------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh--HHHHHHHHHHhCCCC
Confidence            3211 11244579999999997542      23478899999999999999999999965432  222222222222111


Q ss_pred             ccc--ccc----------CcccCCCChhh--HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          298 PAV--SIL----------DTKLQGLPDQM--VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       298 ~~~--~~~----------~~~~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ...  ...          .+.....+...  ......+.+++.+||+.||++|||+.|++++-+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            000  000          00000000000  001123566888899999999999999999854

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=333.19  Aligned_cols=271  Identities=21%  Similarity=0.299  Sum_probs=185.6

Q ss_pred             HHhcccc-CCccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe--cCC
Q 037946           63 ILECLKD-ENVIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS--NKS  136 (371)
Q Consensus        63 ~~~~~~~-~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~  136 (371)
                      +.+.|+. +++||+|+||.||+|...   +++.||+|++....    ....+.+|+.+++.++||||+++++++.  ...
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            3455665 568999999999999864   57899999985332    2246789999999999999999999994  477


Q ss_pred             eEEEEEeecCCCCHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE----cCCC
Q 037946          137 VKLLLYNYISNGNLQQLLQG---------NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL----DSKY  203 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill----~~~~  203 (371)
                      ..|+||||+.+ +|.+++..         ...+++..++.++.|++.||.|||++   +++||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence            89999999975 88887742         12489999999999999999999999   99999999999999    7789


Q ss_pred             ceEEccccCccccCCCCc-ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-
Q 037946          204 EAYLADFGLAKLMNSTNY-HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD-  281 (371)
Q Consensus       204 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-  281 (371)
                      .+||+|||+++....... ........||+.|+|||++.+      ...++.++|||||||++|||++|..||.....+ 
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  243 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  243 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTT------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC------CCcccchhhhHHHHHHHHHHHhCCCCCCCccccc
Confidence            999999999987654321 122345679999999997653      124788999999999999999999999654332 


Q ss_pred             ------chhHHHHHHHHhcCCCccccccCcccCCCCh----------------hhHHH--------HHHHHHHHhcccCC
Q 037946          282 ------GLHIVEWVKKKMGSFEPAVSILDTKLQGLPD----------------QMVQE--------MLQTLGIAMFCVNS  331 (371)
Q Consensus       282 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~--------~~~~~~l~~~cl~~  331 (371)
                            .......+....+..... .+  ......+.                .....        ...+.+|+.+||+.
T Consensus       244 ~~~~~~~~~~l~~i~~~~g~p~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~  320 (405)
T 3rgf_A          244 KTSNPYHHDQLDRIFNVMGFPADK-DW--EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM  320 (405)
T ss_dssp             ---CCCCHHHHHHHHHHHCCCCTT-TC--GGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCS
T ss_pred             cccccchHHHHHHHHHhhCCCChh-hc--chhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccC
Confidence                  111222222222211100 00  00000000                00000        12456788999999


Q ss_pred             CCCCCCCHHHHHHHHhccc
Q 037946          332 SPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       332 dP~~RPs~~evl~~L~~~~  350 (371)
                      ||.+|||++|++++-+=..
T Consensus       321 dP~~R~ta~e~L~hp~f~~  339 (405)
T 3rgf_A          321 DPIKRITSEQAMQDPYFLE  339 (405)
T ss_dssp             SGGGSCCHHHHHTSGGGTS
T ss_pred             CcccCCCHHHHhcChhhcc
Confidence            9999999999999976543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.7e-43  Score=322.86  Aligned_cols=262  Identities=22%  Similarity=0.290  Sum_probs=197.0

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe-----
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV-----  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  137 (371)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            45688889999999999999976 468999999996655555556788999999999999999999999987654     


Q ss_pred             -EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          138 -KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                       .|+||||+. ++|.+++..  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence             499999997 488888754  489999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ...     .....||+.|+|||.+.+      ...++.++||||||+++|+|++|..||.....  ......+....+..
T Consensus       177 ~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~  243 (353)
T 3coi_A          177 DAE-----MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVP  243 (353)
T ss_dssp             ------------CCSBCCSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHCBC
T ss_pred             CCC-----ccccccCcCcCCHHHHhC------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC
Confidence            432     234578999999997652      23578899999999999999999999975422  22222222211110


Q ss_pred             Cc-----------------cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          297 EP-----------------AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       297 ~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..                 .............+.   ....+.+++.+||+.||++|||+.+++++-+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  308 (353)
T 3coi_A          244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR---ASPQAADLLEKMLELDVDKRLTAAQALTHPF  308 (353)
T ss_dssp             CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTT---SCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCC---cCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            00                 000000111111111   1224456788899999999999999999854

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3e-43  Score=316.68  Aligned_cols=261  Identities=25%  Similarity=0.401  Sum_probs=192.3

Q ss_pred             hccccCCccccCCceEEEEEEeC--CCC--EEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP--NGE--LIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      ++|+..+.||+|+||.||+|.+.  +++  .||+|++..... .....+.+.+|++++++++||||+++++++.+.+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            46888899999999999999752  333  689998865432 3455678999999999999999999999998765 88


Q ss_pred             EEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999998763 5689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccc-ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          219 TNYHH-AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       219 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ..... ......+|+.|+|||.+..       ..++.++||||||+++|+|++ |..||.....  .....   ......
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~---~~~~~~  241 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILH---KIDKEG  241 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH---HHHTSC
T ss_pred             cccchhhhccCCCCceeeCchhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--HHHHH---HHHccC
Confidence            43211 1234457889999997753       246789999999999999999 9999864322  22222   111110


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                      ...     +.....+.       .+.+++.+||+.||++|||+.++++.|.++.+..
T Consensus       242 ~~~-----~~~~~~~~-------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          242 ERL-----PRPEDCPQ-------DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             CCC-----CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCC-----CCCcCcCH-------HHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            000     11112222       3445777899999999999999999999887543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.3e-43  Score=327.13  Aligned_cols=268  Identities=19%  Similarity=0.245  Sum_probs=188.6

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  137 (371)
                      ......++|+..+.||+|+||.||+|.. .+++.||+|++.....   ......++++.++.++||||+++++++...+.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3455678899999999999999999976 4689999999854332   23456778888899999999999999865433


Q ss_pred             -------EEEEEeecCCCCHHHH----hccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeeEcC-CC
Q 037946          138 -------KLLLYNYISNGNLQQL----LQGNRNLDWETRYKIAVGSAQGLAYLH--HDCVPAILHRDVKCNNILLDS-KY  203 (371)
Q Consensus       138 -------~~lv~e~~~~~~L~~~----l~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~~i~H~dlkp~Nill~~-~~  203 (371)
                             .++||||+++ +|.+.    ......+++..+..++.|++.||.|||  ++   +++||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   7899999987 44433    346677999999999999999999999  87   9999999999999997 89


Q ss_pred             ceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCch
Q 037946          204 EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL  283 (371)
Q Consensus       204 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  283 (371)
                      .+||+|||++.......   ......||+.|+|||++.+      ...++.++|||||||++|+|++|..||.....  .
T Consensus       170 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~  238 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFG------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS--A  238 (360)
T ss_dssp             EEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H
T ss_pred             cEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh--H
Confidence            99999999998765543   2244568999999997642      23478999999999999999999999975432  2


Q ss_pred             hHHHHHHHHhcCCC-----------ccccccCcccCCCCh------hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          284 HIVEWVKKKMGSFE-----------PAVSILDTKLQGLPD------QMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       284 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .....+........           ........  ...+.      ........+.+++.+||+.||.+|||+.|++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  316 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNS--KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP  316 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCC--CCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhcccccc--ccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence            22222222211100           00000000  00000      0001233566788999999999999999999984

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.3e-43  Score=328.70  Aligned_cols=266  Identities=20%  Similarity=0.263  Sum_probs=198.1

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC--------CCCceeeeceEe-
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR--------HRNIVKLLGYCS-  133 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~-  133 (371)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++..   .....+.+.+|+.+++.++        |+||+++++++. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            36799999999999999999975 4688999999842   3345577899999999985        788999999987 


Q ss_pred             ---cCCeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-----
Q 037946          134 ---NKSVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-----  203 (371)
Q Consensus       134 ---~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-----  203 (371)
                         +....++||||+. ++|.+.+...  ..+++..++.++.|++.||.|||+++  +++||||||+|||++.++     
T Consensus       113 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          113 SGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred             cCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence               6678899999995 4666655433  56999999999999999999999963  899999999999999775     


Q ss_pred             --------------------------------------------ceEEccccCccccCCCCcccccccccccccccCCCC
Q 037946          204 --------------------------------------------EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK  239 (371)
Q Consensus       204 --------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  239 (371)
                                                                  .+||+|||++......     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876543     244579999999998


Q ss_pred             ccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc----hhHHHHHHHHhcCCCccc--------cccC--c
Q 037946          240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG----LHIVEWVKKKMGSFEPAV--------SILD--T  305 (371)
Q Consensus       240 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~--------~~~~--~  305 (371)
                      +.+       ..++.++|||||||++|||++|..||.......    ......+....+......        ....  .
T Consensus       265 ~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          265 LIG-------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             HHT-------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             hcC-------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            753       357899999999999999999999997654432    112222222222210000        0000  0


Q ss_pred             ccCC----CC-----------hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          306 KLQG----LP-----------DQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       306 ~~~~----~~-----------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ....    .+           .........+.+|+.+||+.||++|||+.|++++-+
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence            0000    00           001233445678999999999999999999998643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-43  Score=329.96  Aligned_cols=262  Identities=24%  Similarity=0.316  Sum_probs=191.9

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC------eE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS------VK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~  138 (371)
                      .+|+..+.||+|+||.||+|....+..+|+|++.......      .+|+++++.++||||+++++++...+      ..
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~------~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC------CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH------HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4688899999999999999988777779999985433222      36999999999999999999985443      37


Q ss_pred             EEEEeecCCCCHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc-CCCceEEccccCcc
Q 037946          139 LLLYNYISNGNLQQLL---QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD-SKYEAYLADFGLAK  214 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~  214 (371)
                      ++||||++++.+....   .....+++..+..++.|++.||+|||++   +++||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            8999999875433332   3456799999999999999999999999   999999999999999 79999999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ......   ......||+.|+|||++.+      ...++.++|||||||++|||++|..||...... ..+... ....+
T Consensus       191 ~~~~~~---~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i-~~~~g  259 (394)
T 4e7w_A          191 ILIAGE---PNVSYICSRYYRAPELIFG------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEI-IKVLG  259 (394)
T ss_dssp             ECCTTC---CCCSSCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH-HHHHC
T ss_pred             cccCCC---CCcccccCcCccCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-HHHhC
Confidence            765443   2245578999999997642      235788999999999999999999999754321 122222 22111


Q ss_pred             CCCcc------ccccCcccCCCChhhHH------HHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          295 SFEPA------VSILDTKLQGLPDQMVQ------EMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       295 ~~~~~------~~~~~~~~~~~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .....      .................      ....+.+++.+||+.||.+|||+.|++++-
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP  323 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence            10000      00000000000000000      112456688889999999999999999983

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-43  Score=351.27  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=197.9

Q ss_pred             hccccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|.+..    +..||+|++.. .......+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS-TTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc-cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            568888999999999999997642    45799998743 2334455789999999999999999999999854 56899


Q ss_pred             EEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++|+|.+++.... .+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            999999999999997544 689999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. .......+|+.|+|||.+.       ...++.++||||||+++|||++ |..||....  .......+......   
T Consensus       545 ~~-~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--~~~~~~~i~~~~~~---  611 (656)
T 2j0j_A          545 TY-YKASKGKLPIKWMAPESIN-------FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGERL---  611 (656)
T ss_dssp             ----------CCGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHHTCCC---
T ss_pred             cc-eeccCCCCCcceeCHHHhc-------CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCCC---
Confidence            32 1223445788999999765       2367889999999999999997 888886432  22222222221100   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                            +....+++       .+.+++.+||+.||++|||+.++++.|.++.
T Consensus       612 ------~~~~~~~~-------~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          612 ------PMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCccccH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                  01112222       3445778899999999999999999998875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=320.17  Aligned_cols=258  Identities=22%  Similarity=0.345  Sum_probs=192.9

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEec------
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSN------  134 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------  134 (371)
                      ..++|+..+.||+|+||.||+|.. .+++.||+|++....   .....+.+|+.+++++ +||||+++++++..      
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            346788899999999999999976 468999999985432   3346788999999999 89999999999876      


Q ss_pred             CCeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      .+..++||||+++++|.+++...  ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            56889999999999999999764  4689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......  .......||+.|+|||++....  ..+..++.++||||||+++|+|++|..||.....  ......+.. 
T Consensus       176 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-  248 (326)
T 2x7f_A          176 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDE--NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--MRALFLIPR-  248 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHH-
T ss_pred             ceecCcCc--cccccccCCccccChhhhcccc--ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhc-
Confidence            98664332  1223456999999999875321  1134678899999999999999999999864321  111111111 


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        ...+  ..   .....+.       .+.+++.+||+.||.+|||+++++++-+
T Consensus       249 --~~~~--~~---~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~hp~  289 (326)
T 2x7f_A          249 --NPAP--RL---KSKKWSK-------KFQSFIESCLVKNHSQRPATEQLMKHPF  289 (326)
T ss_dssp             --SCCC--CC---SCSCSCH-------HHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred             --Cccc--cC---CccccCH-------HHHHHHHHHhccChhhCCCHHHHhhChH
Confidence              1000  00   0112222       3445777899999999999999999744

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.8e-42  Score=326.16  Aligned_cols=261  Identities=28%  Similarity=0.347  Sum_probs=190.3

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC------CeE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK------SVK  138 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  138 (371)
                      .|+..+.||+|+||.||+|.+. +|+.||||++......      ..+|+++++.++||||+++++++...      ...
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            5888899999999999999774 6899999998543221      24699999999999999999987432      236


Q ss_pred             EEEEeecCCCCHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-CceEEccccCc
Q 037946          139 LLLYNYISNGNLQQLLQ----GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLA  213 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~  213 (371)
                      ++||||+++ +|.+.+.    ....+++..+..++.|++.||.|||++   +++||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999986 6666553    456799999999999999999999999   99999999999999965 67899999999


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      +......   ......||+.|+|||++.+      ...++.++|||||||++|||++|+.||..... ...+...+. ..
T Consensus       205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~-~l  273 (420)
T 1j1b_A          205 KQLVRGE---PNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIK-VL  273 (420)
T ss_dssp             EECCTTC---CCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH-HH
T ss_pred             hhcccCC---CceeeeeCCCcCCHHHHcC------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-Hh
Confidence            8765443   2234578999999997642      22578899999999999999999999975422 122222222 11


Q ss_pred             cCCC---------ccccccCcccCCCChhhH---HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          294 GSFE---------PAVSILDTKLQGLPDQMV---QEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       294 ~~~~---------~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      +...         ......-+.....+....   .....+.+|+.+||+.||.+|||+.|++++-+
T Consensus       274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~  339 (420)
T 1j1b_A          274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  339 (420)
T ss_dssp             CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence            1100         000000000011000000   01124566888899999999999999998743

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.1e-42  Score=328.98  Aligned_cols=259  Identities=20%  Similarity=0.304  Sum_probs=199.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC-CCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH-RNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.+ .+++.||||++......    ..+..|+++++.++| +++..+..++.+.+..++||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            5788999999999999999975 56899999987543322    347889999999977 55556666677888899999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE---cCCCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL---DSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  218 (371)
                      ||+ +++|.+++.. ...+++..++.++.||+.||.|||++   +++||||||+|||+   +.++.+||+|||+++....
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 8899999974 55799999999999999999999999   99999999999999   6889999999999987655


Q ss_pred             CCccc-----ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc-hhHHHHHHHH
Q 037946          219 TNYHH-----AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG-LHIVEWVKKK  292 (371)
Q Consensus       219 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~  292 (371)
                      .....     ......||+.|+|||.+.       +..++.++|||||||++|||++|..||....... ......+...
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred             CccccccccccccccCCCccccCHHHhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence            43211     123567999999999765       3367889999999999999999999997654332 1122211111


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ... .    .+......++.       .+.+++..||+.||++||++++|++.|.++.
T Consensus       232 ~~~-~----~~~~l~~~~p~-------~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          232 KVA-T----SIEALCRGYPT-------EFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HHH-S----CHHHHHTTSCH-------HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccc-c----cHHHHhcCCcH-------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            100 0    00111122332       3455777799999999999999999998873

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-42  Score=311.41  Aligned_cols=257  Identities=23%  Similarity=0.374  Sum_probs=190.4

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-------
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-------  134 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  134 (371)
                      +.++|+..+.||+|+||.||+|.. .+++.||+|++..   .....+.+.+|+.+++.++||||+++++++.+       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            456789999999999999999976 4789999999843   23455788999999999999999999998754       


Q ss_pred             ------CCeEEEEEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEE
Q 037946          135 ------KSVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL  207 (371)
Q Consensus       135 ------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl  207 (371)
                            .+..|+||||+++++|.+++... ..+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence                  46789999999999999999754 4578899999999999999999999   9999999999999999999999


Q ss_pred             ccccCccccCCCCc------------ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 037946          208 ADFGLAKLMNSTNY------------HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV  275 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  275 (371)
                      +|||++........            ........||+.|+|||.+.+      ...++.++||||||+++|+|++   |+
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~---p~  228 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG------TGHYNEKIDMYSLGIIFFEMIY---PF  228 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTS------CSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC------CCCCcchhhHHHHHHHHHHHHh---cc
Confidence            99999986543210            112234568999999997642      2357889999999999999998   44


Q ss_pred             CCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          276 QPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ...    ................    ..   ...+....   ..+.+++.+||+.||.+|||+++++++-+-
T Consensus       229 ~~~----~~~~~~~~~~~~~~~~----~~---~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          229 STG----MERVNILKKLRSVSIE----FP---PDFDDNKM---KVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             SSH----HHHHHHHHHHHSTTCC----CC---TTCCTTTS---HHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             CCc----hhHHHHHHhccccccc----cC---ccccccch---HHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence            311    1111222221111000    00   11111111   223457788999999999999999987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=316.72  Aligned_cols=269  Identities=21%  Similarity=0.294  Sum_probs=191.0

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe---------
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS---------  133 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---------  133 (371)
                      .++|+..+.||+|+||.||+|... +++.||+|++..  .+....+.+.+|+.++++++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            457888999999999999999765 489999999853  33455678899999999999999999998873         


Q ss_pred             -----cCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc-CCCceEE
Q 037946          134 -----NKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD-SKYEAYL  207 (371)
Q Consensus       134 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~-~~~~~kl  207 (371)
                           +.+..++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++   +++||||||+||+++ .++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence                 4477899999998 599999975 4589999999999999999999999   999999999999997 5679999


Q ss_pred             ccccCccccCCCCc-ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHH
Q 037946          208 ADFGLAKLMNSTNY-HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV  286 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  286 (371)
                      +|||++........ ........+|+.|+|||.+..      ...++.++||||||+++|||++|..||.....  ....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~  234 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--LEQM  234 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHC------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcC------cccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence            99999987643321 112234467999999997642      23578899999999999999999999975432  1222


Q ss_pred             HHHHHHhcCCCc---------cccccCcccCCCChhhH----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          287 EWVKKKMGSFEP---------AVSILDTKLQGLPDQMV----QEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       287 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ..+.........         .................    .....+.+++.+||+.||++|||++|++++-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            222111110000         00000000000000000    01124556888999999999999999998743

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.8e-42  Score=317.38  Aligned_cols=271  Identities=21%  Similarity=0.295  Sum_probs=198.5

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----Ce
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----SV  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  137 (371)
                      .++|+..+.||+|+||.||+|... +|+.||+|++.. .........+.+|+.++++++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc-cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            356888899999999999999764 689999999843 23344456788999999999999999999987654     67


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            899999997 599999876 4599999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccc--------ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 037946          218 STNYHH--------AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       218 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  289 (371)
                      ......        ......||+.|+|||++..      +..++.++|||||||++|+|++|..||.....  ......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~  235 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--RHQLLLI  235 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHS------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH
T ss_pred             cccccccCccccccchhhccccccccCCeeecc------CCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHH
Confidence            432111        1223568999999997542      24678899999999999999999999965422  1222222


Q ss_pred             HHHhcCCCcccc--cc-C-------cccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          290 KKKMGSFEPAVS--IL-D-------TKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       290 ~~~~~~~~~~~~--~~-~-------~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ............  .. .       ..+...+....     .....+.+++.+||+.||++|||++|++++-+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL  309 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            222221110000  00 0       00000000000     011234568888999999999999999997543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.2e-43  Score=320.07  Aligned_cols=260  Identities=23%  Similarity=0.349  Sum_probs=175.7

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHH-HHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQ-ILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.... .......+..|.. +++.++||||+++++++.+.+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            46788899999999999999764 68999999986533 2333445556665 777889999999999999999999999


Q ss_pred             eecCCCCHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          143 NYISNGNLQQLLQG-----NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       143 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      ||+++ +|.+++..     ...+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99986 88887753     56799999999999999999999985  289999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...   ......||+.|+|||.+....   .+..++.++||||||+++|+|++|..||.......    +.......  .
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~--~  245 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSA---SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVK--G  245 (327)
T ss_dssp             ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCC--S
T ss_pred             ccc---ccccCCCCccccCceeecccc---CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhc--C
Confidence            432   223346999999999874210   13357889999999999999999999986432110    00000000  0


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .............+.       .+.+++.+||+.||++|||+.+++++-+
T Consensus       246 ~~~~~~~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~hp~  288 (327)
T 3aln_A          246 DPPQLSNSEEREFSP-------SFINFVNLCLTKDESKRPKYKELLKHPF  288 (327)
T ss_dssp             CCCCCCCCSSCCCCH-------HHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             CCCCCCCcccccCCH-------HHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence            000000000011222       3455778899999999999999998643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.7e-42  Score=321.61  Aligned_cols=199  Identities=25%  Similarity=0.322  Sum_probs=167.2

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CC-----CceeeeceEecC
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HR-----NIVKLLGYCSNK  135 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~  135 (371)
                      +.++|+..+.||+|+||.||+|... +++.||+|++..   .......+..|+.+++.++ |+     +++++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            3567899999999999999999764 678999999843   2344567788898888884 54     499999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc--CCCceEEcccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD--SKYEAYLADFG  211 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg  211 (371)
                      +..|+||||+++ +|.+++...  ..+++..+..++.|++.||.|||++ ..+++||||||+|||++  .++.+||+|||
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            999999999965 999998765  4589999999999999999999952 12899999999999994  57889999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQ  278 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  278 (371)
                      +++.....     .....||+.|+|||++.       +..++.++|||||||++|||++|..||...
T Consensus       207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          207 SSCQLGQR-----IYQYIQSRFYRSPEVLL-------GMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cceecccc-----cccccCCccccChHHHc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99876443     23457999999999775       336789999999999999999999999754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=314.81  Aligned_cols=259  Identities=22%  Similarity=0.340  Sum_probs=180.7

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356888899999999999999764 6899999999654433333445556666788889999999999999999999999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      ||+ ++.+..+... ...+++..++.++.|++.||.|||+ .   +++||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5566666543 5679999999999999999999998 5   89999999999999999999999999997654432


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                         ......||+.|+|||.+...  ......++.++||||||+++|+|++|..||.....+ .....   ......... 
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~---~~~~~~~~~-  249 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPP--DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-FEVLT---KVLQEEPPL-  249 (318)
T ss_dssp             ----------CCTTCCHHHHC----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHH---HHHHSCCCC-
T ss_pred             ---cccccCCCccccChhhcccc--cccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-HHHHH---HHhccCCCC-
Confidence               22345699999999987532  112345788999999999999999999998643322 12111   111111110 


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                         .+.....+.       .+.+++.+||+.||.+|||+++++++-
T Consensus       250 ---~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          250 ---LPGHMGFSG-------DFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             ---CCSSSCCCH-------HHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             ---CCccCCCCH-------HHHHHHHHHccCChhHCcCHHHHhhCH
Confidence               001112222       244577779999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.8e-43  Score=320.25  Aligned_cols=255  Identities=20%  Similarity=0.291  Sum_probs=169.1

Q ss_pred             HHhccccC-CccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec----CC
Q 037946           63 ILECLKDE-NVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN----KS  136 (371)
Q Consensus        63 ~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~  136 (371)
                      +.++|... +.||+|+||.||+|... +++.||+|++...   .   ....+....++.++||||+++++++..    ..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            34567774 46999999999999765 6899999998431   1   112223334566799999999999876    45


Q ss_pred             eEEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEcccc
Q 037946          137 VKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLADFG  211 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg  211 (371)
                      ..++||||+++|+|.+++....  .+++..++.++.|++.||.|||++   +++||||||+||+++.   ++.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            6899999999999999997654  699999999999999999999999   9999999999999976   4559999999


Q ss_pred             CccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 037946          212 LAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKK  291 (371)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  291 (371)
                      ++......    ......||+.|+|||.+...       .++.++||||||+++|+|++|..||.........  .....
T Consensus       177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~  243 (336)
T 3fhr_A          177 FAKETTQN----ALQTPCYTPYYVAPEVLGPE-------KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKR  243 (336)
T ss_dssp             TCEEC--------------------------C-------HHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred             cceecccc----ccccCCCCcCccChhhhCCC-------CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHH
Confidence            99865533    22455789999999987532       4567999999999999999999999654332110  00000


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ....  .......+.....++       .+.+++.+||+.||.+|||++|++++-+-
T Consensus       244 ~~~~--~~~~~~~~~~~~~~~-------~~~~li~~~L~~dP~~Rpt~~ell~hp~~  291 (336)
T 3fhr_A          244 RIRL--GQYGFPNPEWSEVSE-------DAKQLIRLLLKTDPTERLTITQFMNHPWI  291 (336)
T ss_dssp             ---------CCCTTTSTTCCH-------HHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             hhhc--cccccCchhhccCCH-------HHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence            0000  000000111112222       34457788999999999999999997653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-42  Score=328.38  Aligned_cols=258  Identities=24%  Similarity=0.332  Sum_probs=186.4

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|...+.||+|+||+||.+...+|+.||||++...     ..+.+.+|+.+++.+ +||||+++++++.+.+..|+||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            34556789999999998776668999999998532     235678999999886 899999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC-------------Cc
Q 037946          145 ISNGNLQQLLQGNRNLD-------WETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK-------------YE  204 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~-------~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~-------------~~  204 (371)
                      +. |+|.+++.......       +..++.++.|++.||+|||++   +++||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 59999997655332       234578999999999999999   99999999999999754             48


Q ss_pred             eEEccccCccccCCCCcc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 037946          205 AYLADFGLAKLMNSTNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGD  281 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~  281 (371)
                      +||+|||++.........  .......||+.|+|||++.+.........++.++|||||||++|||++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999876554311  112345799999999987643222223568899999999999999999 88888643322


Q ss_pred             chhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          282 GLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ..   ... .......        ......+  ......+.+++.+||+.||.+|||+.+++++-
T Consensus       247 ~~---~i~-~~~~~~~--------~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          247 ES---NII-RGIFSLD--------EMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             HH---HHH-HTCCCCC--------CCTTCCC--HHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             HH---HHh-cCCCCcc--------ccccccc--ccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence            11   111 1111100        0111111  12234556788999999999999999999753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-42  Score=320.32  Aligned_cols=264  Identities=20%  Similarity=0.257  Sum_probs=197.8

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CC-CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC------ceeeeceEecC
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NG-ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN------IVKLLGYCSNK  135 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~  135 (371)
                      .++|+..+.||+|+||.||+|... ++ +.||+|++..   .....+.+.+|+.+++.++|++      ++.+++++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            357888999999999999999764 34 6899999843   2344567889999999997665      89999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE--------------
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL--------------  199 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill--------------  199 (371)
                      +..++||||+ +++|.+++...  ..+++..+..++.|++.||.|||++   +++||||||+|||+              
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            9999999999 55777766544  3699999999999999999999999   99999999999999              


Q ss_pred             -----cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCC
Q 037946          200 -----DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA  274 (371)
Q Consensus       200 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p  274 (371)
                           +.++.+||+|||++......     .....||+.|+|||++.       +..++.++|||||||++|||++|..|
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVIL-------ELGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeee-------cCCCCCccchHHHHHHHHHHHhCCCC
Confidence                 66889999999999864433     24457999999999775       33678999999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHHhcCCCccc--------cccCccc--CCCC-----------------hhhHHHHHHHHHHHhc
Q 037946          275 VQPQIGDGLHIVEWVKKKMGSFEPAV--------SILDTKL--QGLP-----------------DQMVQEMLQTLGIAMF  327 (371)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~-----------------~~~~~~~~~~~~l~~~  327 (371)
                      |.....  ......+...........        .......  ....                 .........+.+++.+
T Consensus       239 f~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  316 (355)
T 2eu9_A          239 FQTHEN--REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR  316 (355)
T ss_dssp             CCCSSH--HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCCH--HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence            975432  222233333322211100        0000000  0000                 0001223356678999


Q ss_pred             ccCCCCCCCCCHHHHHHHHhc
Q 037946          328 CVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       328 cl~~dP~~RPs~~evl~~L~~  348 (371)
                      ||+.||++|||+.|++++-+-
T Consensus       317 ~L~~dP~~Rpt~~e~l~hp~f  337 (355)
T 2eu9_A          317 MLEFDPAQRITLAEALLHPFF  337 (355)
T ss_dssp             HTCSSTTTSCCHHHHTTSGGG
T ss_pred             HhcCChhhCcCHHHHhcChhh
Confidence            999999999999999987543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.8e-43  Score=318.89  Aligned_cols=248  Identities=20%  Similarity=0.325  Sum_probs=198.5

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc----chHHHHHHHHHHHhccC--CCCceeeeceEec
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE----EPVDSFAAEIQILGHIR--HRNIVKLLGYCSN  134 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~  134 (371)
                      .+.++|+..+.||+|+||.||+|.. .+++.||+|++.......    .....+.+|+.++++++  ||||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3456789999999999999999965 568899999986543322    12245678999999996  5999999999999


Q ss_pred             CCeEEEEEeecCC-CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc-CCCceEEccccC
Q 037946          135 KSVKLLLYNYISN-GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD-SKYEAYLADFGL  212 (371)
Q Consensus       135 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~  212 (371)
                      .+..++|||++.+ ++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++ +++.+||+|||+
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            9999999999976 89999998888899999999999999999999999   999999999999999 789999999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......    .....||+.|+|||.+...      ...+.++||||||+++|||++|..||...    ...   ..  
T Consensus       197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~---~~--  257 (320)
T 3a99_A          197 GALLKDTV----YTDFDGTRVYSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEI---IR--  257 (320)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH---HH--
T ss_pred             cccccccc----ccCCCCCccCCChHHhccC------CCCCccchHHhHHHHHHHHHHCCCCCCCh----hhh---hc--
Confidence            98765432    2345699999999976532      12367899999999999999999998532    111   00  


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                       .. ..       .....++       .+.+++.+||+.||++|||++|++++-+
T Consensus       258 -~~-~~-------~~~~~~~-------~~~~li~~~l~~dp~~Rps~~~ll~hp~  296 (320)
T 3a99_A          258 -GQ-VF-------FRQRVSS-------ECQHLIRWCLALRPSDRPTFEEIQNHPW  296 (320)
T ss_dssp             -CC-CC-------CSSCCCH-------HHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             -cc-cc-------ccccCCH-------HHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence             00 00       0012222       3445778899999999999999998754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=326.70  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=183.0

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      .|...+.||+|+||+|+.....+++.||||++.....     ..+.+|+++++.+ +||||+++++++.+.+..|+||||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4777889999999997655556899999999854222     2246899999999 899999999999999999999999


Q ss_pred             cCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-----CCceEEccccCccccCC
Q 037946          145 ISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-----KYEAYLADFGLAKLMNS  218 (371)
Q Consensus       145 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~  218 (371)
                      +. |+|.+++.... ..++..++.++.|++.||.|||++   +++||||||+|||++.     ...+||+|||+++....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            97 49999987654 355556788999999999999999   9999999999999953     33588999999987654


Q ss_pred             CCcc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          219 TNYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       219 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      .... .......||+.|+|||++...    ....++.++|||||||++|||++ |..||.......      ....... 
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------~~~~~~~-  244 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSED----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ANILLGA-  244 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC-------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH------HHHHTTC-
T ss_pred             CCcceeeccccCCCcCccChhhhhcc----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH------HHHHhcc-
Confidence            3211 123446799999999987632    12356789999999999999999 888875332211      1111111 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ...        ...... ......+.+++.+||+.||.+|||++|++++
T Consensus       245 ~~~--------~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          245 CSL--------DCLHPE-KHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             CCC--------TTSCTT-CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCc--------cccCcc-ccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            000        000000 1222335568899999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.6e-42  Score=318.34  Aligned_cols=263  Identities=19%  Similarity=0.273  Sum_probs=195.3

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-----------CCCceeeeceE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-----------HRNIVKLLGYC  132 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~  132 (371)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++..   +......+.+|+.++++++           ||||+++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            4688889999999999999975 5689999999843   3344567889999999886           89999999998


Q ss_pred             ecCC----eEEEEEeecCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc------
Q 037946          133 SNKS----VKLLLYNYISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD------  200 (371)
Q Consensus       133 ~~~~----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~------  200 (371)
                      ...+    ..++|||++ +++|.+++..  ...+++..+..++.|++.||.|||++.  +++||||||+|||++      
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence            7654    789999999 8899999976  345999999999999999999999952  899999999999994      


Q ss_pred             CCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 037946          201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG  280 (371)
Q Consensus       201 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  280 (371)
                      ..+.+||+|||++......     .....||+.|+|||++.       +..++.++|||||||++|||++|..||.....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHH-------TCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHh-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            4458999999999876543     23457899999999875       33678999999999999999999999975542


Q ss_pred             C----chhHHHHHHHHhcCCCcc------------------ccccCc----------ccCCCChhhHHHHHHHHHHHhcc
Q 037946          281 D----GLHIVEWVKKKMGSFEPA------------------VSILDT----------KLQGLPDQMVQEMLQTLGIAMFC  328 (371)
Q Consensus       281 ~----~~~~~~~~~~~~~~~~~~------------------~~~~~~----------~~~~~~~~~~~~~~~~~~l~~~c  328 (371)
                      .    .......+....+.....                  ..+...          .....+.   .....+.+|+.+|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~  317 (373)
T 1q8y_A          241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK---DEAKEISDFLSPM  317 (373)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH---HHHHHHHHHHGGG
T ss_pred             cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCc---chHHHHHHHHHHH
Confidence            2    111112222222211100                  000000          0001111   2334566799999


Q ss_pred             cCCCCCCCCCHHHHHHHHhc
Q 037946          329 VNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       329 l~~dP~~RPs~~evl~~L~~  348 (371)
                      |+.||++|||++|++++-+-
T Consensus       318 L~~dP~~Rpt~~ell~hp~f  337 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVNHPWL  337 (373)
T ss_dssp             GCSSTTTCBCHHHHHTCGGG
T ss_pred             hccCccccCCHHHHhhChhh
Confidence            99999999999999997553

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=315.30  Aligned_cols=252  Identities=17%  Similarity=0.273  Sum_probs=190.1

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc----chHHHHHHHHHHHhcc----CCCCceeee
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE----EPVDSFAAEIQILGHI----RHRNIVKLL  129 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~~~  129 (371)
                      ..+.+.++|+..+.||+|+||.||+|.. .+++.||+|++.......    .....+.+|+.+++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3456677899999999999999999976 468899999985443221    1223456789999888    899999999


Q ss_pred             ceEecCCeEEEEEee-cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc-CCCceEE
Q 037946          130 GYCSNKSVKLLLYNY-ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD-SKYEAYL  207 (371)
Q Consensus       130 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~-~~~~~kl  207 (371)
                      +++.+.+..++|||+ +.+++|.+++.....+++..++.++.|++.||.|||++   +++||||||+||+++ .++.+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence            999999999999999 78999999998888899999999999999999999999   999999999999999 8999999


Q ss_pred             ccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 037946          208 ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVE  287 (371)
Q Consensus       208 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  287 (371)
                      +|||++.......    .....||+.|+|||.+...      ...+.++||||||+++|+|++|..||...    ...  
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~--  245 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRH------QYHALPATVWSLGILLYDMVCGDIPFERD----QEI--  245 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH--
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecC------CCCCccchHHHHHHHHHHHHHCCCCCCCh----HHH--
Confidence            9999998765442    2445699999999976532      12245899999999999999999998531    111  


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                       ..   .. ..       .....+.       .+.+++.+||+.||++|||++|++++-+-
T Consensus       246 -~~---~~-~~-------~~~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~~~~~  287 (312)
T 2iwi_A          246 -LE---AE-LH-------FPAHVSP-------DCCALIRRCLAPKPSSRPSLEEILLDPWM  287 (312)
T ss_dssp             -HH---TC-CC-------CCTTSCH-------HHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred             -hh---hc-cC-------CcccCCH-------HHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence             00   00 00       0011222       34457788999999999999999997553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.5e-41  Score=302.48  Aligned_cols=230  Identities=12%  Similarity=0.069  Sum_probs=182.4

Q ss_pred             HhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      .++|+..+.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            356888999999999999999774 4899999999654433 34557899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++++|.+++...  .....+..++.|++.||.|||++   +++||||||+||+++.++.+||+++|          
T Consensus       110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            9999999999999654  46667889999999999999999   99999999999999999999998543          


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                                  |++|              ++.++|||||||++|||++|+.||.........            .....
T Consensus       175 ------------~~~~--------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~------------~~~~~  216 (286)
T 3uqc_A          175 ------------TMPD--------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL------------APAER  216 (286)
T ss_dssp             ------------CCTT--------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS------------EECCB
T ss_pred             ------------ccCC--------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh------------HHHHH
Confidence                        3333              367899999999999999999999754332100            00000


Q ss_pred             ccCcc-------cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          302 ILDTK-------LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       302 ~~~~~-------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .....       ....++       .+.+++.+||+.||.+| |+.|+++.|.++.....
T Consensus       217 ~~~~~~~~~~~~~~~~~~-------~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          217 DTAGQPIEPADIDRDIPF-------QISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CTTSCBCCHHHHCTTSCH-------HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HhccCCCChhhcccCCCH-------HHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            00110       012222       34557888999999999 99999999999876544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.2e-42  Score=334.40  Aligned_cols=259  Identities=21%  Similarity=0.302  Sum_probs=192.1

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec------C
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN------K  135 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~  135 (371)
                      ..++|+..+.||+|+||.||+|.. .+|+.||+|++... ......+.+.+|++++++++||||+++++++..      .
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            346799999999999999999976 46899999998543 344556789999999999999999999998765      6


Q ss_pred             CeEEEEEeecCCCCHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc---eEEcc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNR---NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE---AYLAD  209 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~D  209 (371)
                      +..++||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence            77899999999999999997644   589999999999999999999999   9999999999999997665   99999


Q ss_pred             ccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 037946          210 FGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV  289 (371)
Q Consensus       210 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  289 (371)
                      ||++.......   ......||+.|+|||.+.       +..++.++||||||+++|+|++|..||.+...    ...|.
T Consensus       168 FG~a~~~~~~~---~~~~~~gt~~Y~APE~l~-------~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~  233 (676)
T 3qa8_A          168 LGYAKELDQGE---LCTEFVGTLQYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWH  233 (676)
T ss_dssp             CCCCCBTTSCC---CCCCCCSCCTTCSSCSSC-------CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSS
T ss_pred             ccccccccccc---ccccccCCcccCChHHhc-------cCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhh
Confidence            99998765543   234567999999999875       34678999999999999999999999965321    11110


Q ss_pred             HHHh-------cCCCccccc--cC---cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHH
Q 037946          290 KKKM-------GSFEPAVSI--LD---TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV  342 (371)
Q Consensus       290 ~~~~-------~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  342 (371)
                      ....       .........  ..   +..........   ..+.+++.+||+.||++|||+.++
T Consensus       234 ~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls---~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA---GKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             TTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGH---HHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhcccchhhhhhhhhccccccccccCCchhhchhhh---HHHHHHHHHHccCCHhhCcCHHHH
Confidence            0000       000000000  00   01111222222   344568888999999999999873

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-40  Score=300.82  Aligned_cols=235  Identities=21%  Similarity=0.284  Sum_probs=178.4

Q ss_pred             HHHHhccccC-CccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHH-hccCCCCceeeeceEec---
Q 037946           61 DNILECLKDE-NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQIL-GHIRHRNIVKLLGYCSN---  134 (371)
Q Consensus        61 ~~~~~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~---  134 (371)
                      +.+.+.|... +.||+|+||.||+|.. .+++.||+|++..       ...+.+|+.++ +..+||||+++++++.+   
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            3455567766 7799999999999976 5689999999842       24567888888 55699999999999876   


Q ss_pred             -CCeEEEEEeecCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEc
Q 037946          135 -KSVKLLLYNYISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLA  208 (371)
Q Consensus       135 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~  208 (371)
                       ....++||||+++|+|.+++....  .+++..++.++.|++.||.|||++   +++||||||+||+++.   ++.+||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence             778899999999999999997654  699999999999999999999999   9999999999999998   7889999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW  288 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  288 (371)
                      |||++.....                               ..++.++|||||||++|||++|..||........     
T Consensus       163 Dfg~a~~~~~-------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----  206 (299)
T 3m2w_A          163 DFGFAKETTG-------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----  206 (299)
T ss_dssp             CCTTCEECTT-------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------
T ss_pred             cccccccccc-------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----
Confidence            9999864321                               1346789999999999999999999964332110     


Q ss_pred             HHHHhcCCCccccccCcccCCCChhh-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhc
Q 037946          289 VKKKMGSFEPAVSILDTKLQGLPDQM-VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME  348 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  348 (371)
                          .   ......+.......+... ......+.+++.+||+.||.+|||+.|++++-+-
T Consensus       207 ----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~  260 (299)
T 3m2w_A          207 ----S---PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  260 (299)
T ss_dssp             --------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ----h---HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence                0   000011111111111110 0112235567888999999999999999997543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-40  Score=333.64  Aligned_cols=240  Identities=23%  Similarity=0.304  Sum_probs=190.2

Q ss_pred             HhccccCCccccCCceEEEEEEeC--CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCe----
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMP--NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSV----  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  137 (371)
                      .++|+..+.||+|+||.||+|.+.  +++.||||++.. .........+.+|+.++++++||||+++++++.+.+.    
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH-SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS-SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc-cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            367999999999999999999875  589999999854 2334455678999999999999999999999987665    


Q ss_pred             -EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          138 -KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       138 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                       .|+||||+++++|.+++..  .+++..++.++.|++.||.|||++   +++||||||+|||++.+ .+||+|||+++..
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence             7999999999999998765  699999999999999999999999   99999999999999885 8999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ...      ....||+.|+|||++..        .++.++|||||||++|+|++|..|+.....+..             
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~--------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------  284 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRT--------GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------  284 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHH--------CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------
T ss_pred             ccC------CccCCCccccCHHHHcC--------CCCCceehhhhHHHHHHHHhCCCCCcccccccc-------------
Confidence            443      34569999999997642        237899999999999999999888753221100             


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhcc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-TMKEVVALLMEV  349 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~  349 (371)
                                 ... .........+.+++.+||+.||.+|| +++++...|..+
T Consensus       285 -----------~~~-~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 -----------PED-DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -----------CTT-CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----------ccc-ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                       000 11112223456688999999999999 566666665544

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.3e-40  Score=303.15  Aligned_cols=246  Identities=15%  Similarity=0.104  Sum_probs=181.7

Q ss_pred             HhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCC------CcchHHHHHHHHHHHhccC---------CCCceee
Q 037946           64 LECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKR------DEEPVDSFAAEIQILGHIR---------HRNIVKL  128 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~~  128 (371)
                      .++|+..+.||+|+||.||+|.+ +|+.||+|++.....      .....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            36788899999999999999987 789999999965432      2334578899999998886         6666666


Q ss_pred             ece-----------------Eec-------------CCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q 037946          129 LGY-----------------CSN-------------KSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAY  178 (371)
Q Consensus       129 ~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~  178 (371)
                      .++                 +.+             .+..|+||||+++|++.+.+.+ ..+++..+..++.|++.||.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            554                 332             7889999999999976666644 568999999999999999999


Q ss_pred             HH-hCCCCCeEecCCCCCCeeEcCCC--------------------ceEEccccCccccCCCCcccccccccccccccCC
Q 037946          179 LH-HDCVPAILHRDVKCNNILLDSKY--------------------EAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAP  237 (371)
Q Consensus       179 lh-~~~~~~i~H~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  237 (371)
                      || ++   +++||||||+|||++.++                    .+||+|||+++.....       ...||+.|+||
T Consensus       177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP  246 (336)
T 2vuw_A          177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred             HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence            99 88   999999999999999887                    8999999999876432       34799999999


Q ss_pred             CCccchhhhcccCCCCCcchhHHHHHH-HHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHH
Q 037946          238 GKCKLQIIYGYTMNITEKSDVYSYGVV-LLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQ  316 (371)
Q Consensus       238 E~~~~~~~~~~~~~~~~~~DiwslG~~-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (371)
                      |++.+.        .+.++||||+|++ .+++++|..||...    ............. .      .............
T Consensus       247 E~~~g~--------~~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~-~------~~~~~~~~~~~~~  307 (336)
T 2vuw_A          247 DLFTGD--------GDYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQ-M------TFKTKCNTPAMKQ  307 (336)
T ss_dssp             GGGCCC--------SSHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHT-C------CCSSCCCSHHHHH
T ss_pred             hhhcCC--------CccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhh-h------ccCcccchhhhhh
Confidence            987633        2679999998777 77888999887311    0000011111100 0      0000111111123


Q ss_pred             HHHHHHHHHhcccCCCCCCCCCHHHHH-HH
Q 037946          317 EMLQTLGIAMFCVNSSPAERPTMKEVV-AL  345 (371)
Q Consensus       317 ~~~~~~~l~~~cl~~dP~~RPs~~evl-~~  345 (371)
                      ....+.+++.+||+.|     |++|++ ++
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            3445677999999976     999998 65

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-39  Score=305.18  Aligned_cols=247  Identities=17%  Similarity=0.211  Sum_probs=175.8

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCC-CCceeee-------------
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRH-RNIVKLL-------------  129 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~~~-------------  129 (371)
                      .|...+.||+|+||.||+|.+ .+|+.||||++.... ......+.+.+|+.+++.++| +|...+.             
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            466778999999999999975 569999999986322 223346789999999999987 3221111             


Q ss_pred             --------ceEec-----CCeEEEEEeecCCCCHHHHhc------c-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 037946          130 --------GYCSN-----KSVKLLLYNYISNGNLQQLLQ------G-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH  189 (371)
Q Consensus       130 --------~~~~~-----~~~~~lv~e~~~~~~L~~~l~------~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  189 (371)
                              .++..     ....+++|+++ +++|.+++.      . ...+++..++.++.|++.||+|||++   +++|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                    11111     22456777766 569999884      1 33477889999999999999999999   9999


Q ss_pred             cCCCCCCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchh-hhc--ccCCCCCcchhHHHHHHHH
Q 037946          190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQI-IYG--YTMNITEKSDVYSYGVVLL  266 (371)
Q Consensus       190 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~--~~~~~~~~~DiwslG~~l~  266 (371)
                      |||||+|||++.++.+||+|||+++.....     .....| +.|+|||++.... .++  ....++.++|||||||++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999998765433     344567 9999999874321 000  2335678999999999999


Q ss_pred             HHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          267 EILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       267 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ||++|+.||......               .....++. .....++       .+.+++.+||+.||++|||+.+++++
T Consensus       309 elltg~~Pf~~~~~~---------------~~~~~~~~-~~~~~~~-------~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          309 WIWCADLPNTDDAAL---------------GGSEWIFR-SCKNIPQ-------PVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHSSCCCCTTGGG---------------SCSGGGGS-SCCCCCH-------HHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHCCCCCCCcchh---------------hhHHHHHh-hcccCCH-------HHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999999643221               11111111 1123332       34557778999999999997666543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.2e-34  Score=277.68  Aligned_cols=186  Identities=18%  Similarity=0.114  Sum_probs=133.7

Q ss_pred             ccccCCceEEEEE-EeCCCCEEEEEEecccCCC--------cchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEEE
Q 037946           72 VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRD--------EEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        72 ~ig~G~~g~V~~~-~~~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  141 (371)
                      ..+.|++|.+..+ +..-|+.+|+|.+.++...        +...++|.+|+++|+++ .|+||+++++++.+.+..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3566777766655 3345899999999654321        23346799999999999 799999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||++|++|.++|...+.++..   .++.||+.||+|+|++   |||||||||+|||++.+|.+||+|||+++...... 
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence            9999999999999998888875   4789999999999999   99999999999999999999999999998765443 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCC
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS  273 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~  273 (371)
                       ....+.+||+.|||||++.++        +..++|+||+|+++++|.++..
T Consensus       394 -~~~~t~vGTp~YmAPE~l~g~--------~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          394 -SWPTNLVQSFFVFVNELFAEN--------KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-------------------------CCCCTTHH
T ss_pred             -ccccCceechhhccHHHhCCC--------CCCcccccccccchhhhccccc
Confidence             233556799999999987643        4567999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=9.4e-30  Score=246.86  Aligned_cols=189  Identities=18%  Similarity=0.225  Sum_probs=146.4

Q ss_pred             ccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcc------hHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           68 KDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEE------PVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      ...+.||+|+||.||+|.. .++.+++|+.........      ..+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999954 678899998754332211      134589999999999999999766666677788999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++++|.+++..        +..++.|++.||.|||++   +++||||||+|||++.  .+||+|||+++.......
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            999999999999987        568999999999999999   9999999999999998  999999999988755321


Q ss_pred             cc-----ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 037946          222 HH-----AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV  275 (371)
Q Consensus       222 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  275 (371)
                      ..     ......||+.|||||++....     ..|+..+|+|+..+-..+-+.++.++
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~-----~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFL-----EGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHH-----HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHH-----HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            11     123567999999999886421     13466789999999999988877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2.1e-24  Score=192.53  Aligned_cols=134  Identities=16%  Similarity=0.137  Sum_probs=109.0

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCc----------------chHHHHHHHHHHHhccCCCCceeeec
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDE----------------EPVDSFAAEIQILGHIRHRNIVKLLG  130 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~niv~~~~  130 (371)
                      |...+.||+|+||.||+|...+|+.||+|.+.......                .....+.+|++++++++  | +++.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            44558999999999999988779999999985432211                13457899999999998  5 66666


Q ss_pred             eEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccc
Q 037946          131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADF  210 (371)
Q Consensus       131 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  210 (371)
                      ++.. +..|+||||+++++|.+ +..      .....++.|++.||.|||++   +++||||||+|||++ ++.+||+||
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             EEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            5543 55699999999999988 432      22457999999999999999   999999999999999 999999999


Q ss_pred             cCccc
Q 037946          211 GLAKL  215 (371)
Q Consensus       211 g~~~~  215 (371)
                      |+++.
T Consensus       237 G~a~~  241 (282)
T 1zar_A          237 PQSVE  241 (282)
T ss_dssp             TTCEE
T ss_pred             CCCeE
Confidence            99863

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.1e-21  Score=172.87  Aligned_cols=138  Identities=20%  Similarity=0.213  Sum_probs=106.2

Q ss_pred             cccCCccccCCceEEEEEEe-CCCCE--EEEEEecccCCCc----------------------chHHHHHHHHHHHhccC
Q 037946           67 LKDENVIGKGCSGVVYKAEM-PNGEL--IAVKKLWKTKRDE----------------------EPVDSFAAEIQILGHIR  121 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~  121 (371)
                      |...+.||+|+||.||+|.. .+|+.  ||||++.......                      .....+.+|+..++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45668899999999999987 67888  9999874331110                      01236789999999998


Q ss_pred             CCCc--eeeeceEecCCeEEEEEeecCC-C----CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCC
Q 037946          122 HRNI--VKLLGYCSNKSVKLLLYNYISN-G----NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH-HDCVPAILHRDVK  193 (371)
Q Consensus       122 h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dlk  193 (371)
                      |+++  ..++..    +..++||||+.+ |    +|.++...   .++..+..++.|++.||.||| +.   +++|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence            8764  333322    356899999942 3    77776543   234567789999999999999 88   99999999


Q ss_pred             CCCeeEcCCCceEEccccCcccc
Q 037946          194 CNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       194 p~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      |+|||++.  .++|+|||++...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=2e-19  Score=164.77  Aligned_cols=139  Identities=12%  Similarity=0.113  Sum_probs=99.1

Q ss_pred             cccCCccccCCceEEEEEEeCCCCEEEEEEecccCCC------------cchHHHH--------HHHHHHHhccCCCCce
Q 037946           67 LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD------------EEPVDSF--------AAEIQILGHIRHRNIV  126 (371)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~--------~~e~~~l~~l~h~niv  126 (371)
                      |.+.+.||+|++|.||+|...+|+.||||+++....+            .......        .+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            7788999999999999999889999999987532111            0111112        3455666666444332


Q ss_pred             eeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC---
Q 037946          127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY---  203 (371)
Q Consensus       127 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~---  203 (371)
                       +...+. ....++||||++|++|..+...      .....++.|++.+|.+||+.   ++|||||||.|||+++++   
T Consensus       177 -vp~p~~-~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 -VPEPIA-QSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             -CCCEEE-EETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSS
T ss_pred             -CCeeee-ccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcc
Confidence             111111 1223799999999888665432      23456789999999999999   999999999999998776   


Q ss_pred             -------ceEEccccCcccc
Q 037946          204 -------EAYLADFGLAKLM  216 (371)
Q Consensus       204 -------~~kl~Dfg~~~~~  216 (371)
                             .+.|+||+-+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3889999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=3.6e-13  Score=118.46  Aligned_cols=146  Identities=14%  Similarity=0.071  Sum_probs=113.1

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  139 (371)
                      ......|+....++.|+.+.||++.. +++.+++|........  ....+.+|+.+++.+. +..+.++++++.+.+..|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            34556787777888889999999975 4689999998542211  1235788999999884 677888999998889999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC------------------------------------  183 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------------  183 (371)
                      +||||++|.+|.+.+..     ......++.+++.++..||+..                                    
T Consensus        87 lv~e~i~G~~l~~~~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCCT-----TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccCC-----cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            99999999999886421     1223467889999999999810                                    


Q ss_pred             --------------------CCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          184 --------------------VPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       184 --------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                                          ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                1359999999999999876666799998874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.38  E-value=1.2e-12  Score=114.83  Aligned_cols=128  Identities=15%  Similarity=0.108  Sum_probs=97.0

Q ss_pred             ccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--ceeeeceEecCCeEEEEEeecCCCCHH
Q 037946           74 GKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKLLGYCSNKSVKLLLYNYISNGNLQ  151 (371)
Q Consensus        74 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~L~  151 (371)
                      +.|..+.||++...+|+.+++|.....     ....+..|+.+++.+.+.+  +.+++++..+.+..++||||++|.+|.
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            456669999998777888999987432     1245678999999885544  456888888888899999999998884


Q ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 037946          152 QLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC------------------------------------------------  183 (371)
Q Consensus       152 ~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------------------------  183 (371)
                        ...   .+.   ..++.+++..|..||+..                                                
T Consensus       104 --~~~---~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          104 --SSH---LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             --TSC---CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             --cCc---CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence              221   222   356778888888888752                                                


Q ss_pred             -------CCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          184 -------VPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       184 -------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                             ...++|+|++|.||+++.++.+.|+|||.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                   0129999999999999887667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=2e-11  Score=112.35  Aligned_cols=142  Identities=16%  Similarity=0.247  Sum_probs=105.7

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEec--ccCCCcchHHHHHHHHHHHhccC--CCCceeeeceEecC---CeEEEEE
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLW--KTKRDEEPVDSFAAEIQILGHIR--HRNIVKLLGYCSNK---SVKLLLY  142 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~  142 (371)
                      .+.|+.|.++.||+.... +..+++|+..  ... .......+.+|+.+++.+.  +..+.+++.++.+.   +..|+||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            456899999999999874 4678888764  211 1122346788999999986  45578888888776   4589999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC---------------------------------------  183 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---------------------------------------  183 (371)
                      ||++|..+.+..  ...++......++.+++..|+.||+..                                       
T Consensus       121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999997775421  234778888899999999999999731                                       


Q ss_pred             ----------------CCCeEecCCCCCCeeEcCCCc--eEEccccCccc
Q 037946          184 ----------------VPAILHRDVKCNNILLDSKYE--AYLADFGLAKL  215 (371)
Q Consensus       184 ----------------~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~  215 (371)
                                      ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            247999999999999987753  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=5.9e-11  Score=106.58  Aligned_cols=190  Identities=18%  Similarity=0.178  Sum_probs=121.6

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCC--ceeeeceEecCC---eEEEEEe
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRN--IVKLLGYCSNKS---VKLLLYN  143 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e  143 (371)
                      .+.++.|....||+..    +.+++|....    ......+.+|.++++.+. +..  +.+++......+   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3468899999999873    5588888532    234567889999998883 333  334444433333   3589999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC----------------------------------------  183 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~----------------------------------------  183 (371)
                      +++|.+|.+...  ..++......++.+++..++.||+..                                        
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988865432  23677788888899999988888621                                        


Q ss_pred             ---------------CCCeEecCCCCCCeeEcC--CCceEEccccCccccCCCCcccccccccccccc---cCCCCccc-
Q 037946          184 ---------------VPAILHRDVKCNNILLDS--KYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY---IAPGKCKL-  242 (371)
Q Consensus       184 ---------------~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  242 (371)
                                     .+.++|+|++|.||+++.  +..+.++||+.+.......   ...   ....+   ..|+.... 
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~---~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFI---SLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHH---TTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHH---HHHhhccccCHHHHHHH
Confidence                           135899999999999998  5567899999987543211   000   00000   12221110 


Q ss_pred             hhhhcccC------CCCCcchhHHHHHHHHHHHhCCCCC
Q 037946          243 QIIYGYTM------NITEKSDVYSYGVVLLEILSGRSAV  275 (371)
Q Consensus       243 ~~~~~~~~------~~~~~~DiwslG~~l~el~~g~~p~  275 (371)
                      ...|+...      ......+.|++|.++|.+.+|..++
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            00011000      0011258999999999999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.67  E-value=2e-07  Score=83.45  Aligned_cols=135  Identities=17%  Similarity=0.175  Sum_probs=94.2

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCC---CceeeeceEe-cCCeEEEEEeecC
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR---NIVKLLGYCS-NKSVKLLLYNYIS  146 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~  146 (371)
                      +.++.|....||+.    ++.+++|...    .......+.+|.++++.+.+.   .+.+++.++. ..+..++|||+++
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            45788888899988    5678888742    223456789999999999653   2445555553 4566789999999


Q ss_pred             CCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 037946          147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD--------------------------------------------  182 (371)
Q Consensus       147 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------------------------------------------  182 (371)
                      |.++.+..-.  .++......++.+++..|+.||+.                                            
T Consensus        97 G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           97 GQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             SEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             CeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            9888763221  234555555666666666666543                                            


Q ss_pred             -------------CCCCeEecCCCCCCeeEcC---CCc-eEEccccCccc
Q 037946          183 -------------CVPAILHRDVKCNNILLDS---KYE-AYLADFGLAKL  215 (371)
Q Consensus       183 -------------~~~~i~H~dlkp~Nill~~---~~~-~kl~Dfg~~~~  215 (371)
                                   ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1235699999999999987   455 48999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.65  E-value=2.1e-07  Score=81.70  Aligned_cols=134  Identities=18%  Similarity=0.121  Sum_probs=96.0

Q ss_pred             ccccCCce-EEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKGCSG-VVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .+..|..| .||+.... ++..+++|+-..     .....+.+|...|+.+. +-.+.+++.++.+.+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34455555 68988654 456788997532     23456788999998884 333667888888999999999999998


Q ss_pred             CHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 037946          149 NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD----------------------------------------------  182 (371)
Q Consensus       149 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~----------------------------------------------  182 (371)
                      ++.+.....    ......+..+++..|..||+.                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887765432    122334566677777777742                                              


Q ss_pred             ---------CCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          183 ---------CVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       183 ---------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                               ....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     01248999999999999988777799998875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.46  E-value=1.8e-07  Score=85.59  Aligned_cols=81  Identities=6%  Similarity=0.045  Sum_probs=53.4

Q ss_pred             Ccc-ccCCceEEEEEEeC-------CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccC-C--CCceeeeceEecC---
Q 037946           71 NVI-GKGCSGVVYKAEMP-------NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIR-H--RNIVKLLGYCSNK---  135 (371)
Q Consensus        71 ~~i-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~---  135 (371)
                      +.| +.|....+|+....       +++.+++|....... .......+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999998654       266788887633210 0001134678888888874 2  3466777777655   


Q ss_pred             CeEEEEEeecCCCCHH
Q 037946          136 SVKLLLYNYISNGNLQ  151 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~  151 (371)
                      +..++|||+++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            4568999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.30  E-value=3e-06  Score=78.72  Aligned_cols=77  Identities=12%  Similarity=0.111  Sum_probs=49.1

Q ss_pred             CCccccCCceEEEEEEeC-CCCEEEEEEecccCC--C---cchHHHHHHHHHHHhccCC--CC-ceeeeceEecCCeEEE
Q 037946           70 ENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR--D---EEPVDSFAAEIQILGHIRH--RN-IVKLLGYCSNKSVKLL  140 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~l  140 (371)
                      .+.||.|..+.||++... +++.+++|.......  .   .....++..|.++++.+..  |. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            356899999999999653 468899998643211  0   1123466789999887742  33 3345543  3445689


Q ss_pred             EEeecCCC
Q 037946          141 LYNYISNG  148 (371)
Q Consensus       141 v~e~~~~~  148 (371)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=2.2e-05  Score=71.07  Aligned_cols=137  Identities=18%  Similarity=0.278  Sum_probs=77.2

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-----CCCceeee-c--eEecCCeEEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-----HRNIVKLL-G--YCSNKSVKLLLY  142 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~  142 (371)
                      +.|+.|..+.||+....+| .+++|+...   ..   ..+..|..+++.+.     .|.++... |  +....+..+++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR---PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS---CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC---CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            3466677889999977554 588998743   11   23344555555542     24433311 1  123466789999


Q ss_pred             eecCCCCHH-----H------Hh---c----cC--C--------CCCHHHH-----------------------------
Q 037946          143 NYISNGNLQ-----Q------LL---Q----GN--R--------NLDWETR-----------------------------  165 (371)
Q Consensus       143 e~~~~~~L~-----~------~l---~----~~--~--------~~~~~~~-----------------------------  165 (371)
                      +|++|.++.     .      .+   +    ..  .        ...|...                             
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986542     1      11   1    11  0        0112110                             


Q ss_pred             --HHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          166 --YKIAVGSAQGLAYLHH----------DCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       166 --~~i~~~i~~~l~~lh~----------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                        ..+...+..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              1111223345666653          012489999999999999888889999998874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.15  E-value=1.5e-05  Score=71.18  Aligned_cols=75  Identities=15%  Similarity=0.135  Sum_probs=58.8

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC---CCCceeeeceEecCCeEEEEEeecC
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR---HRNIVKLLGYCSNKSVKLLLYNYIS  146 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~  146 (371)
                      .+.|+.|....+|+... ++..+++|....     .....+..|...|+.+.   ...+.+++.++...+..++||||++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            34688999999999986 567888998632     13467888999998883   2567788888888888999999999


Q ss_pred             CCCH
Q 037946          147 NGNL  150 (371)
Q Consensus       147 ~~~L  150 (371)
                      +..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.02  E-value=3.9e-05  Score=71.75  Aligned_cols=31  Identities=13%  Similarity=0.254  Sum_probs=27.6

Q ss_pred             CCeEecCCCCCCeeEcCCCceEEccccCcccc
Q 037946          185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLM  216 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  216 (371)
                      ..++|+|++|.||+++.++ ++++||+.+..-
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            3899999999999998876 999999998753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.99  E-value=5.5e-05  Score=66.82  Aligned_cols=77  Identities=17%  Similarity=0.192  Sum_probs=53.5

Q ss_pred             ccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCC---CceeeeceEecCCeEEEEEee
Q 037946           68 KDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR---NIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ...+.+|.|..+.||+.+..+|+.|++|+.....  ......+..|+..|+.+...   .+.+++++.    ..++||||
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            3456789999999999999899999999863222  22234577899999888432   234444432    24789999


Q ss_pred             cCCCCH
Q 037946          145 ISNGNL  150 (371)
Q Consensus       145 ~~~~~L  150 (371)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.73  E-value=0.00011  Score=66.38  Aligned_cols=137  Identities=16%  Similarity=0.167  Sum_probs=70.6

Q ss_pred             ccccCCceE-EEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCC--CceeeeceEecCCeEEEEEeecCCC
Q 037946           72 VIGKGCSGV-VYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR--NIVKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        72 ~ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      .|+.|+... +|+....+++.+++|.......     ..+..|+.+++.+...  .+.+++.+..+.+  +++||++.+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            455555444 6677654467777776422110     1234566666666322  2445565544433  7899999776


Q ss_pred             CHHHHhccC--------------------------CCCCHHHHH-------HH-------------HHHHHHHHHHHH--
Q 037946          149 NLQQLLQGN--------------------------RNLDWETRY-------KI-------------AVGSAQGLAYLH--  180 (371)
Q Consensus       149 ~L~~~l~~~--------------------------~~~~~~~~~-------~i-------------~~~i~~~l~~lh--  180 (371)
                      ++.+++...                          ..++.....       .+             ...+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            665443211                          112221110       00             001111222221  


Q ss_pred             -hCCCCCeEecCCCCCCeeEcCC----CceEEccccCccc
Q 037946          181 -HDCVPAILHRDVKCNNILLDSK----YEAYLADFGLAKL  215 (371)
Q Consensus       181 -~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~  215 (371)
                       ......++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1123489999999999999874    6789999999864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.70  E-value=0.00011  Score=65.32  Aligned_cols=135  Identities=15%  Similarity=0.141  Sum_probs=72.8

Q ss_pred             CCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEEEeec-CC
Q 037946           70 ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLLYNYI-SN  147 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~  147 (371)
                      .+.|+.|....+|+.     +.+++|+......   ......+|..+++.+...++ .++++++  .+.-++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            456888999999999     5588888743211   11122457777777643223 3455443  33346899999 66


Q ss_pred             CCHHHH------------------hccCC-C----CCH-HHHHHHHHH--------------HHHHHH----HHHh-CCC
Q 037946          148 GNLQQL------------------LQGNR-N----LDW-ETRYKIAVG--------------SAQGLA----YLHH-DCV  184 (371)
Q Consensus       148 ~~L~~~------------------l~~~~-~----~~~-~~~~~i~~~--------------i~~~l~----~lh~-~~~  184 (371)
                      .++...                  ++... .    .+. ..+..+...              +...+.    .+.. ...
T Consensus        93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~  172 (301)
T 3dxq_A           93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP  172 (301)
T ss_dssp             EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence            444210                  01111 0    011 111111100              111111    1111 122


Q ss_pred             CCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          185 PAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ..++|+|+.+.||+ ..++.+.++||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            35899999999999 5667789999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.65  E-value=0.00016  Score=66.30  Aligned_cols=137  Identities=20%  Similarity=0.262  Sum_probs=80.9

Q ss_pred             CccccCCceEEEEEEeC--------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC-ceeeeceEecCCeEEEE
Q 037946           71 NVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN-IVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  141 (371)
                      +.|..|-...+|+....        +++.+++|+...   .......+.+|.++++.+...+ ..++++.+.+    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            45777888889999764        247899988522   1223455678999998884222 3556666554    289


Q ss_pred             EeecCCCCHHH--------------Hh---ccC-----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 037946          142 YNYISNGNLQQ--------------LL---QGN-----RNLD--WETRYKIAVGSAQ-------------------GLAY  178 (371)
Q Consensus       142 ~e~~~~~~L~~--------------~l---~~~-----~~~~--~~~~~~i~~~i~~-------------------~l~~  178 (371)
                      |||++|.+|..              .+   +..     +...  +.++.++..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99998765431              11   111     1122  3445555544322                   1233


Q ss_pred             H----HhC-CCCCeEecCCCCCCeeEcCC----CceEEccccCcc
Q 037946          179 L----HHD-CVPAILHRDVKCNNILLDSK----YEAYLADFGLAK  214 (371)
Q Consensus       179 l----h~~-~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~  214 (371)
                      |    ... ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    221 22479999999999999876    789999998875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.64  E-value=0.00035  Score=62.71  Aligned_cols=138  Identities=14%  Similarity=0.201  Sum_probs=78.8

Q ss_pred             ccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--ceeeece-----EecCCeEEEEEee
Q 037946           72 VIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKLLGY-----CSNKSVKLLLYNY  144 (371)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~  144 (371)
                      .++ |....||+....+|+.+++|.......   ....+..|..+++.+....  +.+++..     ....+..+++|++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            466 777899998776777899998742211   2345667888887774222  3334332     1234566889999


Q ss_pred             cCCCCHH-----HH------h-------ccC-----CCCCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 037946          145 ISNGNLQ-----QL------L-------QGN-----RNLDWETR----YKI---------------AVGSAQGLAYLHHD  182 (371)
Q Consensus       145 ~~~~~L~-----~~------l-------~~~-----~~~~~~~~----~~i---------------~~~i~~~l~~lh~~  182 (371)
                      ++|..+.     ..      +       ...     ...+....    ..+               ...+...+..+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875431     11      1       110     11222111    000               01111122233211


Q ss_pred             ----CCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          183 ----CVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       183 ----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                          ....++|+|+++.||+++ + .+.++||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                223789999999999999 4 889999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.58  E-value=0.00011  Score=65.98  Aligned_cols=139  Identities=14%  Similarity=0.198  Sum_probs=76.1

Q ss_pred             CccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC--ceeeece------EecCCeEEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN--IVKLLGY------CSNKSVKLLLY  142 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~  142 (371)
                      +.|+.|....+|+....+| .+++|..... ..   ...+..|..+++.+...+  +.+++..      ....+..+++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-CC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            3466788889999977555 6888987431 11   124456777777663212  2233311      12345678999


Q ss_pred             eecCCCCHHH-----H---------hc----cCC-C----CC---HHHHHH------------HHHHHHHHHHHHHhC--
Q 037946          143 NYISNGNLQQ-----L---------LQ----GNR-N----LD---WETRYK------------IAVGSAQGLAYLHHD--  182 (371)
Q Consensus       143 e~~~~~~L~~-----~---------l~----~~~-~----~~---~~~~~~------------i~~~i~~~l~~lh~~--  182 (371)
                      +|++|..+..     .         ++    ... .    ..   |...+.            +...+...+..+...  
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998865311     0         11    100 0    11   111000            001134445555431  


Q ss_pred             --CCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          183 --CVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       183 --~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                        ....++|+|+.+.||+++.+..+.++||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              12479999999999999987666899998874

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.58  E-value=0.00014  Score=68.15  Aligned_cols=72  Identities=22%  Similarity=0.336  Sum_probs=47.9

Q ss_pred             CccccCCceEEEEEEeCC--------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPN--------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLL  141 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  141 (371)
                      +.|+.|-...+|++...+        ++.+++|+....    .....+..|..+++.+...++ .++++.+.+    .+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            457888889999997653        478888887321    112455679999888853334 556665543    289


Q ss_pred             EeecCCCCH
Q 037946          142 YNYISNGNL  150 (371)
Q Consensus       142 ~e~~~~~~L  150 (371)
                      +||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.49  E-value=0.0012  Score=59.71  Aligned_cols=31  Identities=23%  Similarity=0.466  Sum_probs=27.7

Q ss_pred             CCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          185 PAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999988754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.33  E-value=0.00032  Score=64.21  Aligned_cols=73  Identities=11%  Similarity=0.155  Sum_probs=41.9

Q ss_pred             CccccCCceEEEEEEeCC---------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEE
Q 037946           71 NVIGKGCSGVVYKAEMPN---------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLL  140 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~l  140 (371)
                      +.|+.|....+|+....+         ++.+++|+....   .........|..+++.+...++ .++++..  .  -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            457788888999997643         267888876321   1111123578888887743333 3555443  2  268


Q ss_pred             EEeecCCCCH
Q 037946          141 LYNYISNGNL  150 (371)
Q Consensus       141 v~e~~~~~~L  150 (371)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.32  E-value=0.00066  Score=63.91  Aligned_cols=73  Identities=14%  Similarity=0.182  Sum_probs=45.3

Q ss_pred             CccccCCceEEEEEEeCC-CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEEEeecCCC
Q 037946           71 NVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLLYNYISNG  148 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~  148 (371)
                      +.|+.|-...+|+....+ ++.+++|+.....  .. .....+|..+++.+...++ .++++.+.  +  .+||||++|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            356778888999998754 4778888763221  11 1112578888888865444 45666663  2  2599999875


Q ss_pred             CH
Q 037946          149 NL  150 (371)
Q Consensus       149 ~L  150 (371)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.28  E-value=0.0036  Score=52.00  Aligned_cols=102  Identities=17%  Similarity=0.110  Sum_probs=66.0

Q ss_pred             CHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccccc
Q 037946          149 NLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR  227 (371)
Q Consensus       149 ~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  227 (371)
                      +|.++|.. ..+++++++|.++.|.+.+|.-+-.+.  .-..+=+.|..|++..+|.|...+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            79998864 567999999999999999988763210  112233457899999999998763 1110             


Q ss_pred             ccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 037946          228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAV  275 (371)
Q Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  275 (371)
                       .....+.|||...        ...+.+.=|||||+++|.-+-=..|.
T Consensus        98 -~~~~~~~~pe~~~--------~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 -AGEPPPVAGKLGY--------SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             ----------CCSS--------SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             -ccccCCCChhhcc--------ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence             1122456888642        13457788999999999998755543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.48  E-value=0.0047  Score=57.40  Aligned_cols=73  Identities=12%  Similarity=0.124  Sum_probs=45.7

Q ss_pred             CccccCCceEEEEEEeCC--------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCC-ceeeeceEecCCeEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPN--------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN-IVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  141 (371)
                      +.+..|-...+|+....+        ++.+++++....   ........+|..+++.+...+ ..++++.+.    -+.|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~---t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH---VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC---C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC---cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            456778888999997653        578898886321   111122357888888774323 344554332    2689


Q ss_pred             EeecCCCCH
Q 037946          142 YNYISNGNL  150 (371)
Q Consensus       142 ~e~~~~~~L  150 (371)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.29  E-value=0.024  Score=53.31  Aligned_cols=60  Identities=7%  Similarity=0.014  Sum_probs=16.2

Q ss_pred             CCccccCCceEEEEEEeCC-CCEEEE------EEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceE
Q 037946           70 ENVIGKGCSGVVYKAEMPN-GELIAV------KKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYC  132 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  132 (371)
                      .+.||   ||.||+|.+.. ..+||+      |.......+.+....+.+|..+++.++|||+++.+++.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            45565   99999997643 367888      77654444455566788999999999999999988765

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.92  E-value=0.7  Score=38.29  Aligned_cols=112  Identities=12%  Similarity=0.138  Sum_probs=76.5

Q ss_pred             CCCCceeeeceEecCCeEEEEEeecCCC-CHHHHhccCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCCee
Q 037946          121 RHRNIVKLLGYCSNKSVKLLLYNYISNG-NLQQLLQGNRNLDWETRYKIAVGSAQGLA-YLHHDCVPAILHRDVKCNNIL  198 (371)
Q Consensus       121 ~h~niv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~~~~i~H~dlkp~Nil  198 (371)
                      .||++  -..+-.+.+.+.+.++.-+++ +... +   ..++....++++.+|+.... ++++.     +|--+.|+|++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEE
Confidence            57777  333446667766767665333 3333 3   34788999999999988777 66654     89999999999


Q ss_pred             EcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhH-HHHHHHHHHHhCCCCC
Q 037946          199 LDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVY-SYGVVLLEILSGRSAV  275 (371)
Q Consensus       199 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw-slG~~l~el~~g~~p~  275 (371)
                      +|.++.+++.-.|+-.                   -++|..+.             ..|.| ++=+++..++.++..|
T Consensus       117 f~~~~~p~i~hRGi~~-------------------~lpP~e~~-------------ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          117 FNRALEPFFLHVGVKE-------------------SLPPDEWD-------------DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             ECTTCCEEESCCEETT-------------------TBSSCSCC-------------HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EeCCCcEEEEEcCCcc-------------------cCCCCCCC-------------HHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999998766642                   24554221             22333 4778888888887665

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.88  E-value=0.5  Score=39.07  Aligned_cols=115  Identities=5%  Similarity=0.076  Sum_probs=78.5

Q ss_pred             CCCCceeeeceEecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc
Q 037946          121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD  200 (371)
Q Consensus       121 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~  200 (371)
                      .||+.+.. .+-.+.+.+.+.++.-+.  ..++-. -+.++....++++.+|+....++++.     +|--+.|+|++++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~  113 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN-IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFT  113 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG-GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEEC
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH-HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEc
Confidence            58888866 455566666665555432  222211 23478899999999999988777655     8999999999999


Q ss_pred             CCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchh-HHHHHHHHHHHhCCCCCC
Q 037946          201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDV-YSYGVVLLEILSGRSAVQ  276 (371)
Q Consensus       201 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di-wslG~~l~el~~g~~p~~  276 (371)
                      .++.+++.-.|+-..                   ++|..+            + ..|. -.+=+++..+++++..|.
T Consensus       114 ~~~~p~i~~RGik~~-------------------l~P~~~------------~-ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          114 RDGLPIAKTRGLQNV-------------------VDPLPV------------S-EAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TTSCEEESCCEETTT-------------------BSCCCC------------C-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCCCEEEEEccCccC-------------------CCCCCC------------C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999986665422                   334311            1 2233 347889999999987764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=87.61  E-value=0.54  Score=27.88  Aligned_cols=6  Identities=17%  Similarity=0.623  Sum_probs=2.4

Q ss_pred             HHHHHh
Q 037946           18 ILVTRN   23 (371)
Q Consensus        18 ~~~~~~   23 (371)
                      ++++|+
T Consensus        33 ~~~RRr   38 (44)
T 2ks1_B           33 LFMRRR   38 (44)
T ss_dssp             HHHHTT
T ss_pred             HHhhhh
Confidence            344433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=87.00  E-value=0.62  Score=27.55  Aligned_cols=8  Identities=25%  Similarity=0.335  Sum_probs=3.2

Q ss_pred             HHHHHHhc
Q 037946           17 WILVTRNH   24 (371)
Q Consensus        17 ~~~~~~~~   24 (371)
                      +++++|++
T Consensus        31 ~~~~RRRr   38 (44)
T 2l2t_A           31 AVYVRRKS   38 (44)
T ss_dssp             HHHHHTTC
T ss_pred             HHHhhhhh
Confidence            34444433

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.36  E-value=0.39  Score=44.11  Aligned_cols=30  Identities=33%  Similarity=0.474  Sum_probs=25.4

Q ss_pred             CeEecCCCCCCeeE------cCCCceEEccccCccc
Q 037946          186 AILHRDVKCNNILL------DSKYEAYLADFGLAKL  215 (371)
Q Consensus       186 ~i~H~dlkp~Nill------~~~~~~kl~Dfg~~~~  215 (371)
                      .++|+|+.+.||++      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999998863

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=85.13  E-value=0.59  Score=27.62  Aligned_cols=8  Identities=38%  Similarity=0.559  Sum_probs=3.4

Q ss_pred             HHHHHHhc
Q 037946           17 WILVTRNH   24 (371)
Q Consensus        17 ~~~~~~~~   24 (371)
                      +++++|++
T Consensus        32 ~~~~RRR~   39 (44)
T 2jwa_A           32 GILIKRRQ   39 (44)
T ss_dssp             HHHHHHHC
T ss_pred             Hhheehhh
Confidence            34444443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=83.24  E-value=0.89  Score=26.86  Aligned_cols=21  Identities=5%  Similarity=0.094  Sum_probs=13.9

Q ss_pred             HHHHHHHHHHHHHHhcccchh
Q 037946            9 VTIALLASWILVTRNHRYKVE   29 (371)
Q Consensus         9 ~~i~~~~~~~~~~~~~~~~~~   29 (371)
                      ++++++++..+....+|++..
T Consensus        21 vll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           21 ILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHHHHHhheehhhhh
Confidence            555566666778877776653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	371
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-67
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-48
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-33
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 1e-67
 Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 25/287 (8%)

Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
              IG G  G VYK +      +AVK L  T    + + +F  E+ +L   RH NI+  +
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
           GY +   +  ++  +    +L   L       +      IA  +AQG+ YLH      I+
Sbjct: 71  GYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K NNI L       + DFGLA + +  +  H   +++GS  ++AP      I    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQD 182

Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
               + +SDVY++G+VL E+++G+          ++  + +   +G        L   L 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIFMVGR-----GYLSPDLS 232

Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV-KSAPE 354
            +     + M +   +   C+     ERP   +++A +  + +S P+
Sbjct: 233 KVRSNCPKAMKR---LMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-60
 Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 34/292 (11%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E LK    +G G  G V+         +AVK L   K+     D+F AE  ++  ++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHD 182
           +V+L    + + +  ++  Y+ NG+L   L+      L       +A   A+G+A++   
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y            + AP     
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAP----- 179

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
                     T KSDV+S+G++L EI++      P    G+   E ++     +      
Sbjct: 180 --EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP----GMTNPEVIQNLERGYRMV--- 230

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE 354
                   PD   +E+ Q   +   C    P +RPT   + ++L +  +A E
Sbjct: 231 -------RPDNCPEELYQ---LMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 8e-57
 Identities = 69/309 (22%), Positives = 125/309 (40%), Gaps = 49/309 (15%)

Query: 67  LKDEN-----VIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           LKD++      +G G  GVV+K    P+G ++A K +   +      +    E+Q+L   
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHEC 61

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
               IV   G   +     +   ++  G+L Q+L+    +  +   K+++   +GL YL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                 I+HRDVK +NIL++S+ E  L DFG++  +  +      +   G+  Y++P   
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPE-- 173

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV-------------- 286
                     + + +SD++S G+ L+E+  GR  + P     L ++              
Sbjct: 174 -----RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228

Query: 287 -------------EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSP 333
                           +  M  FE    I++     LP  +     Q         N  P
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN--P 286

Query: 334 AERPTMKEV 342
           AER  +K++
Sbjct: 287 AERADLKQL 295

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 3e-56
 Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 20/295 (6%)

Query: 70  ENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
           +  IGKG  G V++ +   GE +AVK     +          AEI     +RH NI+  +
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW---FREAEIYQTVMLRHENILGFI 63

Query: 130 GYCS----NKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCV- 184
              +      +   L+ +Y  +G+L   L     +  E   K+A+ +A GLA+LH + V 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 185 ----PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS--TNYHHAMSRVAGSYGYIAPG 238
               PAI HRD+K  NIL+       +AD GLA   +S       A +   G+  Y+AP 
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
                 I        +++D+Y+ G+V  EI    S         L   + V       E 
Sbjct: 183 -VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 299 AVSILDTKLQG-LPDQM--VQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
              + + KL+  +P++    + +     I   C  ++ A R T   +   L ++ 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 8e-56
 Identities = 67/301 (22%), Positives = 118/301 (39%), Gaps = 42/301 (13%)

Query: 50  FIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPN---GELIAVKKLWKTKRDEEP 106
           ++  + L            ++  +G G  G V K         + +AVK L     D   
Sbjct: 2   YLDRKLLTL----------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 51

Query: 107 VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY 166
            D   AE  ++  + +  IV+++G C  +S  +L+      G L + LQ NR++  +   
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNII 110

Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAM 225
           ++    + G+ YL        +HRD+   N+LL +++ A ++DFGL+K + +  NY+ A 
Sbjct: 111 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167

Query: 226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI 285
           +       + AP               + KSDV+S+GV++ E  S     +P    G+  
Sbjct: 168 THGKWPVKWYAP-------ECINYYKFSSKSDVWSFGVLMWEAFSYGQ--KPY--RGMKG 216

Query: 286 VEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL 345
            E              +   +  G P    +EM     +   C       RP    V   
Sbjct: 217 SEVTAM----------LEKGERMGCPAGCPREMYD---LMNLCWTYDVENRPGFAAVELR 263

Query: 346 L 346
           L
Sbjct: 264 L 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-55
 Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 34/293 (11%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN 124
           E L+ E  +G+GC G V+         +A+K L       E   +F  E Q++  +RH  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73

Query: 125 IVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN--LDWETRYKIAVGSAQGLAYLHHD 182
           +V+L    S + +  ++  Y+S G+L   L+G     L       +A   A G+AY+   
Sbjct: 74  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 183 CVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
                +HRD++  NIL+       +ADFGLA+L+    Y  A         + AP     
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP----- 183

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
                     T KSDV+S+G++L E+ +      P    G+   E + +    +      
Sbjct: 184 --EAALYGRFTIKSDVWSFGILLTELTTKGRVPYP----GMVNREVLDQVERGYRMP--- 234

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEE 355
                   P +  + +     +   C    P ERPT + + A L +  ++ E 
Sbjct: 235 -------CPPECPESLHD---LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (461), Expect = 3e-55
 Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 32/288 (11%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKT-KRDEEPVDSFAAEIQ 115
           F  D+  +   D   IG G  G VY A  + N E++A+KK+  + K+  E       E++
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQG 175
            L  +RH N ++  G    +    L+  Y        L    + L       +  G+ QG
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
           LAYLH      ++HRDVK  NILL       L DFG A +M   N         G+  ++
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWM 178

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS 295
           AP      I+         K DV+S G+  +E+   +  +       ++ +  +      
Sbjct: 179 AP----EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSALYH---- 225

Query: 296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
                 I   +   L      E  +    +       P +RPT + ++
Sbjct: 226 ------IAQNESPALQSGHWSEYFRNFVDSCLQKI--PQDRPTSEVLL 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 5e-55
 Identities = 61/287 (21%), Positives = 116/287 (40%), Gaps = 32/287 (11%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
           L     IG G  G+V+     N + +A+K + +    EE    F  E +++  + H  +V
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLV 63

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNL-DWETRYKIAVGSAQGLAYLHHDCVP 185
           +L G C  ++   L++ ++ +G L   L+  R L   ET   + +   +G+AYL   C  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121

Query: 186 AILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
            ++HRD+   N L+       ++DFG+ + +    Y  +         + +P        
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASP-------E 172

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT 305
                  + KSDV+S+GV++ E+ S          +   +VE +      ++P       
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLYKP------- 224

Query: 306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
             +     + Q M         C    P +RP    ++  L E+  +
Sbjct: 225 --RLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-54
 Identities = 54/280 (19%), Positives = 113/280 (40%), Gaps = 32/280 (11%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
             +G G  GVV   +      +A+K + +    E   D F  E +++ ++ H  +V+L G
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYG 66

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
            C+ +    ++  Y++NG L   L+  R+    +   ++     + + YL        LH
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 123

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+   N L++ +    ++DFGL++ +    Y            +  P            
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLM-------Y 175

Query: 250 MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
              + KSD++++GV++ EI S       +  +     E + + +  + P           
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLRLYRP---------HL 225

Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             +++   M         C +    ERPT K +++ +++V
Sbjct: 226 ASEKVYTIMYS-------CWHEKADERPTFKILLSNILDV 258

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 4e-54
 Identities = 67/293 (22%), Positives = 125/293 (42%), Gaps = 37/293 (12%)

Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDS 109
           +PF + ++ +            +G+G  G V  A      E +AVK +   KR  +  ++
Sbjct: 1   VPFVE-DWDL---------VQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPEN 49

Query: 110 FAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIA 169
              EI I   + H N+VK  G+    +++ L   Y S G L   ++ +  +      +  
Sbjct: 50  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 109

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
                G+ YLH      I HRD+K  N+LLD +    ++DFGLA +    N    ++++ 
Sbjct: 110 HQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166

Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV 289
           G+  Y+AP     +++     +  E  DV+S G+VL  +L+G               +W 
Sbjct: 167 GTLPYVAP-----ELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220

Query: 290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           +KK  ++      +D+    L    + ++L            +P+ R T+ ++
Sbjct: 221 EKK--TYLNPWKKIDSAPLAL----LHKILVE----------NPSARITIPDI 257

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (451), Expect = 6e-54
 Identities = 76/324 (23%), Positives = 126/324 (38%), Gaps = 62/324 (19%)

Query: 53  FQKLNFTIDNILECLKDENVIGKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEEP 106
              L +  +N    ++    IG+G  G V++A  P         ++AVK L K +   + 
Sbjct: 5   LLSLEYPRNN----IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 59

Query: 107 VDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN------- 159
              F  E  ++    + NIVKLLG C+      LL+ Y++ G+L + L+           
Sbjct: 60  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 160 -----------------LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK 202
                            L    +  IA   A G+AYL        +HRD+   N L+   
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176

Query: 203 YEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYG 262
               +ADFGL++ + S +Y+ A    A    ++ P          +    T +SDV++YG
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP-------ESIFYNRYTTESDVWAYG 229

Query: 263 VVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTL 322
           VVL EI S           G+   E +            + D  +   P+    E+    
Sbjct: 230 VVLWEIFSYGLQPYY----GMAHEEVIYY----------VRDGNILACPENCPLELYN-- 273

Query: 323 GIAMFCVNSSPAERPTMKEVVALL 346
            +   C +  PA+RP+   +  +L
Sbjct: 274 -LMRLCWSKLPADRPSFCSIHRIL 296

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (449), Expect = 1e-53
 Identities = 67/308 (21%), Positives = 120/308 (38%), Gaps = 36/308 (11%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMP----NGELIAVKKLWKTKRDEEPVDSFAA 112
            F  +  + C+K E VIG G  G V    +         +A+K L K+   E+    F +
Sbjct: 18  EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLS 76

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVG 171
           E  I+G   H N++ L G  +  +  +++  ++ NG+L   L+ N           +  G
Sbjct: 77  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
            A G+ YL        +HRD+   NIL++S     ++DFGL++ +         +   G 
Sbjct: 137 IAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193

Query: 232 YG---YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                + AP               T  SDV+SYG+V+ E++S        + +   ++  
Sbjct: 194 KIPIRWTAP-------EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINA 245

Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           +++      P            P  + Q       + + C       RP   ++V  L +
Sbjct: 246 IEQDYRLPPP---------MDCPSALHQ-------LMLDCWQKDRNHRPKFGQIVNTLDK 289

Query: 349 VKSAPEEL 356
           +   P  L
Sbjct: 290 MIRNPNSL 297

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 2e-53
 Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 35/283 (12%)

Query: 67  LKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI 125
           LK +  IG+G    VYK         +A  +L   K  +     F  E ++L  ++H NI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 126 VKLLGYC----SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH 181
           V+           K   +L+   +++G L+  L+  + +  +          +GL +LH 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 182 DCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
              P I+HRD+KC+NI +        + D GLA L  ++        V G+  ++AP   
Sbjct: 131 RTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP--- 182

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
             ++         E  DVY++G+ +LE+ +          +  +  +  ++     +PA 
Sbjct: 183 --EMYEE---KYDESVDVYAFGMCMLEMATSE----YPYSECQNAAQIYRRVTSGVKPAS 233

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
                         + E+ +   I   C+  +  ER ++K+++
Sbjct: 234 ---------FDKVAIPEVKE---IIEGCIRQNKDERYSIKDLL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-53
 Identities = 66/298 (22%), Positives = 118/298 (39%), Gaps = 37/298 (12%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKAEM---PNGELIAVKKLWKTKRDEEPVDSF 110
           +KL    DN+L     +  +G G  G V +           +A+K L K   ++   +  
Sbjct: 1   KKLFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEM 56

Query: 111 AAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIA 169
             E QI+  + +  IV+L+G C  +++ +L+      G L + L G R  +      ++ 
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN-YHHAMSRV 228
              + G+ YL        +HRD+   N+LL +++ A ++DFGL+K + + + Y+ A S  
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                + AP               + +SDV+SYGV + E LS       +    +   E 
Sbjct: 173 KWPLKWYAP-------ECINFRKFSSRSDVWSYGVTMWEALSYGQ----KPYKKMKGPEV 221

Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           +            I   K    P +   E+     +   C      +RP    V   +
Sbjct: 222 MAF----------IEQGKRMECPPECPPELYA---LMSDCWIYKWEDRPDFLTVEQRM 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-52
 Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 35/299 (11%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPNGE-----LIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
            C+  + VIG G  G VYK  +          +A+K L K    E+    F  E  I+G 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 65

Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQL-LQGNRNLDWETRYKIAVGSAQGLAY 178
             H NI++L G  S     +++  Y+ NG L +   + +          +  G A G+ Y
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 179 LHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMSRVAGSYGYIAP 237
           L +      +HRD+   NIL++S     ++DFGL++++       +  S       + AP
Sbjct: 126 LANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
                          T  SDV+S+G+V+ E+++       +    L   E +K       
Sbjct: 183 -------EAISYRKFTSASDVWSFGIVMWEVMTYG----ERPYWELSNHEVMKA------ 225

Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEEL 356
               I D      P      + Q   + M C     A RP   ++V++L ++  AP+ L
Sbjct: 226 ----INDGFRLPTPMDCPSAIYQ---LMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-52
 Identities = 68/321 (21%), Positives = 127/321 (39%), Gaps = 38/321 (11%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAA 112
           +  I      +    VIG+G  G VY   + +        AVK L +     E V  F  
Sbjct: 19  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLT 77

Query: 113 EIQILGHIRHRNIVKLLGYCS-NKSVKLLLYNYISNGNLQQLLQGNR-NLDWETRYKIAV 170
           E  I+    H N++ LLG C  ++   L++  Y+ +G+L+  ++    N   +      +
Sbjct: 78  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 137

Query: 171 GSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH--HAMSRV 228
             A+G+           +HRD+   N +LD K+   +ADFGLA+ M    +   H  +  
Sbjct: 138 QVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                ++A            T   T KSDV+S+GV+L E+++  +   P     ++  + 
Sbjct: 195 KLPVKWMALE-------SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVNTFDI 243

Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
                        +L  +    P+     + +   + + C +     RP+  E+V+ +  
Sbjct: 244 TVY----------LLQGRRLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 290

Query: 349 VKSAPEELGKTSQPLIKQSAN 369
           + S    +G+    +     N
Sbjct: 291 IFS--TFIGEHYVHVNATYVN 309

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-52
 Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 52/309 (16%)

Query: 65  ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILG 118
             L     +G G  G V +A             +AVK L  +    E  ++  +E+++L 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLS 81

Query: 119 HI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN------------------ 159
           ++  H NIV LLG C+     L++  Y   G+L   L+  R+                  
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 160 LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST 219
           LD E     +   A+G+A+L        +HRD+   NILL       + DFGLA+ + + 
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
           + +           ++AP          +    T +SDV+SYG+ L E+ S  S+  P +
Sbjct: 199 SNYVVKGNARLPVKWMAP-------ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM 339
                  + +K+      P         +  P +M         I   C ++ P +RPT 
Sbjct: 252 PVDSKFYKMIKEGFRMLSP---------EHAPAEMYD-------IMKTCWDADPLKRPTF 295

Query: 340 KEVVALLME 348
           K++V L+ +
Sbjct: 296 KQIVQLIEK 304

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-52
 Identities = 64/282 (22%), Positives = 112/282 (39%), Gaps = 36/282 (12%)

Query: 71  NVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             IG G  G   K     +G+++  K+L      E       +E+ +L  ++H NIV+  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 130 GYCSNKSVKLL--LYNYISNGNLQQLLQGNRN----LDWETRYKIAVGSAQGLAYLH--H 181
               +++   L  +  Y   G+L  ++         LD E   ++       L   H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCK 241
           D    +LHRD+K  N+ LD K    L DFGLA+++N            G+  Y++P +  
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMN 187

Query: 242 LQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS 301
                   M+  EKSD++S G +L E+ +                E   K          
Sbjct: 188 -------RMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGK---------- 225

Query: 302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
           I + K + +P +   E+ +   I    +N     RP+++E++
Sbjct: 226 IREGKFRRIPYRYSDELNE---IITRMLNLKDYHRPSVEEIL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 9e-52
 Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 40/291 (13%)

Query: 64  LECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHR 123
           ++ LK    IGKG  G V   +   G  +AVK +    +++    +F AE  ++  +RH 
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHS 60

Query: 124 NIVKLLGYCSNKSVKL-LLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLH 180
           N+V+LLG    +   L ++  Y++ G+L   L+  G   L  +   K ++   + + YL 
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
            +     +HRD+   N+L+     A ++DFGL K  +ST              + AP   
Sbjct: 121 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPE-- 170

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                       + KSDV+S+G++L EI S      P     + + + V +    ++   
Sbjct: 171 -----ALREKKFSTKSDVWSFGILLWEIYSFGRVPYP----RIPLKDVVPRVEKGYKMD- 220

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS 351
                     PD     + +   +   C +   A RP+  ++   L  +K+
Sbjct: 221 ---------APDGCPPAVYE---VMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 1e-51
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 39/289 (13%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTK-RDEEPVDSFAAEI 114
            + +++     +    +GKG  G VY A    +  ++A+K L+K +            E+
Sbjct: 2   QWALED----FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57

Query: 115 QILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQ 174
           +I  H+RH NI++L GY  + +   L+  Y   G + + LQ     D +         A 
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117

Query: 175 GLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGY 234
            L+Y H      ++HRD+K  N+LL S  E  +ADFG +    S+        + G+  Y
Sbjct: 118 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDY 170

Query: 235 IAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG 294
           + P     ++I G      EK D++S GV+  E L G+        +     E  K+   
Sbjct: 171 LPP-----EMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKR--- 215

Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVV 343
                  I   +    PD + +       +    +  +P++RP ++EV+
Sbjct: 216 -------ISRVEFT-FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 253

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (428), Expect = 1e-50
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 37/301 (12%)

Query: 64  LECLKDENVIGKGCSGVVYKAEMPN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH 122
              +  ++ +G G  G VY+         +AVK L   K D   V+ F  E  ++  I+H
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKH 72

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLH 180
            N+V+LLG C+ +    ++  +++ GNL   L+    + +       +A   +  + YL 
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                  +HRD+   N L+   +   +ADFGL++LM    Y  A +       + AP   
Sbjct: 133 K---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAP--- 185

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
                       + KSDV+++GV+L EI +   +  P I D   + E ++K      P  
Sbjct: 186 ----ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP-- 238

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL---MEVKSAPEELG 357
                  +G P+++ +       +   C   +P++RP+  E+        +  S  +E+ 
Sbjct: 239 -------EGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284

Query: 358 K 358
           K
Sbjct: 285 K 285

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-49
 Identities = 68/312 (21%), Positives = 117/312 (37%), Gaps = 57/312 (18%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPN------GELIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           E L+   V+G G  G V  A             +AVK L + K D    ++  +E++++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMT 95

Query: 119 HI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN------------------ 159
            +  H NIV LLG C+      L++ Y   G+L   L+  R                   
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 160 -----LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK 214
                L +E     A   A+G+ +L      + +HRD+   N+L+       + DFGLA+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA 274
            + S + +           ++AP          +    T KSDV+SYG++L EI S    
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAP-------ESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265

Query: 275 VQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPA 334
             P I    +  + ++      +P             +++   M         C      
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMDQP---------FYATEEIYIIMQS-------CWAFDSR 309

Query: 335 ERPTMKEVVALL 346
           +RP+   + + L
Sbjct: 310 KRPSFPNLTSFL 321

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 6e-49
 Identities = 62/274 (22%), Positives = 105/274 (38%), Gaps = 27/274 (9%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             +G G  G VYKA+      L A K +    + EE ++ +  EI IL    H NIVKLL
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMVEIDILASCDHPNIVKLL 75

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLL-QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                ++   +L  + + G +  ++ +  R L       +   +   L YLH      I+
Sbjct: 76  DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  NIL     +  LADFG++     T          G+  ++AP    +      
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPE--VVMCETSK 188

Query: 249 TMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQ 308
                 K+DV+S G+ L+E+              L+ +  + K   S  P ++       
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPH-----HELNPMRVLLKIAKSEPPTLAQPS---- 239

Query: 309 GLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                    + +       C+  +   R T  ++
Sbjct: 240 RWSSNFKDFLKK-------CLEKNVDARWTTSQL 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 5e-48
 Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 34/287 (11%)

Query: 71  NVIGKGCSGVVYKAEMP----NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNI 125
             +G G  GVV + E          +AVK L        E +D F  E+  +  + HRN+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCV 184
           ++L G      +K ++      G+L   L+ ++      T  + AV  A+G+ YL     
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR- 131

Query: 185 PAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS-RVAGSYGYIAPGKCKLQ 243
              +HRD+   N+LL ++    + DFGL + +   + H+ M       + + AP      
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP------ 183

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL 303
                T   +  SD + +GV L E+ +        + +G  I+  + K+           
Sbjct: 184 -ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLP------ 235

Query: 304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK 350
                  P+   Q++     + + C    P +RPT   +   L+E +
Sbjct: 236 ------RPEDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 6e-48
 Identities = 62/304 (20%), Positives = 118/304 (38%), Gaps = 38/304 (12%)

Query: 63  ILECLKDE-----NVIGKGCSGVVYKAE-MPNGEL----IAVKKLWKTKRDEEPVDSFAA 112
           +L  LK+       V+G G  G VYK   +P GE     +A+K+L +    +        
Sbjct: 2   LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILD 60

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS 172
           E  ++  + + ++ +LLG C   +V+L+         L  + +   N+  +      V  
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSY 232
           A+G+ YL       ++HRD+   N+L+ +     + DFGLAKL+ +    +         
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 233 GYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK 292
            ++A                T +SDV+SYGV + E+++       +  DG+   E     
Sbjct: 178 KWMALE-------SILHRIYTHQSDVWSYGVTVWELMTFG----SKPYDGIPASEISSI- 225

Query: 293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA 352
                    +   +    P     ++     I + C       RP  +E++    ++   
Sbjct: 226 ---------LEKGERLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSKMARD 273

Query: 353 PEEL 356
           P+  
Sbjct: 274 PQRY 277

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 2e-47
 Identities = 74/314 (23%), Positives = 122/314 (38%), Gaps = 51/314 (16%)

Query: 67  LKDENVIGKGCSGVVYKAEMPNGEL---IAVKKLWKTKRDEEPVDSFAAEIQILGHI-RH 122
           +K ++VIG+G  G V KA +    L    A+K++ K    ++    FA E+++L  +  H
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHH 70

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGN----------------RNLDWETRY 166
            NI+ LLG C ++    L   Y  +GNL   L+ +                  L  +   
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 167 KIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMS 226
             A   A+G+ YL        +HRD+   NIL+   Y A +ADFGL++       +   +
Sbjct: 131 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKT 184

Query: 227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIV 286
                  ++A                T  SDV+SYGV+L EI+S           G+   
Sbjct: 185 MGRLPVRWMAIE-------SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----GMTCA 233

Query: 287 EWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
           E  +K    +              P     E+     +   C    P ERP+  +++  L
Sbjct: 234 ELYEKLPQGYRLE----------KPLNCDDEVYD---LMRQCWREKPYERPSFAQILVSL 280

Query: 347 MEVKSAPEELGKTS 360
             +    +    T+
Sbjct: 281 NRMLEERKTYVNTT 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-46
 Identities = 51/276 (18%), Positives = 105/276 (38%), Gaps = 33/276 (11%)

Query: 70  ENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVK 127
             ++G+G    V  A E+      A+K L K     E  V     E  ++  + H   VK
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           L     +        +Y  NG L + ++   + D           A+ ++ L +     I
Sbjct: 73  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT---AEIVSALEYLHGKGI 129

Query: 188 LHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
           +HRD+K  NILL+      + DFG AK+++  +     +   G+  Y++P     +++  
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP-----ELLTE 184

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLH-IVEWVKKKMGSFEPAVSILDTK 306
              +  + SD+++ G ++ ++++G     P      + I + + K    F          
Sbjct: 185 --KSACKSSDLWALGCIIYQLVAGLP---PFRAGNEYLIFQKIIKLEYDFPEKFF----- 234

Query: 307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                        + L   +  ++    +R   +E+
Sbjct: 235 ----------PKARDLVEKLLVLD--ATKRLGCEEM 258

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 6e-45
 Identities = 52/273 (19%), Positives = 107/273 (39%), Gaps = 32/273 (11%)

Query: 71  NVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             IG+G SG VY A ++  G+ +A++++    + +   +    EI ++   ++ NIV  L
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
                     ++  Y++ G+L  ++      D      +     Q L +LH +    ++H
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIH 139

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+K +NILL       L DFG    +         S + G+  ++AP            
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVT-------R 190

Query: 250 MNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQG 309
                K D++S G++ +E++ G            + +  +     +  P +         
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPY-----LNENPLRALYLIATNGTPELQN------- 238

Query: 310 LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
            P+++             C++    +R + KE+
Sbjct: 239 -PEKLSAIFRD---FLNRCLDMDVEKRGSAKEL 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 8e-45
 Identities = 60/300 (20%), Positives = 121/300 (40%), Gaps = 44/300 (14%)

Query: 65  ECLKDENVIGKGCSGVVYKAE------MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILG 118
           E +     +G+G  G+VY+              +A+K + +     E ++ F  E  ++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMK 78

Query: 119 HIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN----------LDWETRYKI 168
                ++V+LLG  S     L++   ++ G+L+  L+  R                  ++
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
           A   A G+AYL+ +     +HRD+   N ++   +   + DFG+ + +  T+Y+    + 
Sbjct: 139 AGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
                +++P               T  SDV+S+GVVL EI +       Q   GL   + 
Sbjct: 196 LLPVRWMSPE-------SLKDGVFTTYSDVWSFGVVLWEIATLA----EQPYQGLSNEQV 244

Query: 289 VKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLME 348
           ++           +++  L   PD     + +   +   C   +P  RP+  E+++ + E
Sbjct: 245 LRF----------VMEGGLLDKPDNCPDMLFE---LMRMCWQYNPKMRPSFLEIISSIKE 291

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 35/290 (12%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHI 120
           E ++    IG+G  G V++    +       +A+K       D    + F  E   +   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQF 65

Query: 121 RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYL 179
            H +IVKL+G  +   V  ++    + G L+  LQ    +LD  +    A   +  LAYL
Sbjct: 66  DHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
                   +HRD+   N+L+ S     L DFGL++ M  + Y+   S+      ++AP  
Sbjct: 125 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAP-- 178

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
                        T  SDV+ +GV + EIL            G+   + + +        
Sbjct: 179 -----ESINFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVIGR-------- 221

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
             I + +   +P      +     +   C    P+ RP   E+ A L  +
Sbjct: 222 --IENGERLPMPPNCPPTLYS---LMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-44
 Identities = 75/319 (23%), Positives = 123/319 (38%), Gaps = 51/319 (15%)

Query: 51  IPFQKLNFTIDNILECLKDENVIGKGCSGVVYKA------EMPNGELIAVKKLWKTKRDE 104
           +P+    +      + LK    +G+G  G V +A      +      +AVK L +     
Sbjct: 1   LPYDASKWEFP--RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 58

Query: 105 EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL-YNYISNGNLQQLLQGNRN---- 159
           E     +    ++    H N+V LLG C+     L++   +   GNL   L+  RN    
Sbjct: 59  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118

Query: 160 ------------LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYL 207
                       L  E     +   A+G+ +L        +HRD+   NILL  K    +
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKI 175

Query: 208 ADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLE 267
            DFGLA+ +     +           ++AP          +    T +SDV+S+GV+L E
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAP-------ETIFDRVYTIQSDVWSFGVLLWE 228

Query: 268 ILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMF 327
           I S  ++  P    G+ I E   ++         + +      PD    EM Q     + 
Sbjct: 229 IFSLGASPYP----GVKIDEEFCRR---------LKEGTRMRAPDYTTPEMYQ---TMLD 272

Query: 328 CVNSSPAERPTMKEVVALL 346
           C +  P++RPT  E+V  L
Sbjct: 273 CWHGEPSQRPTFSELVEHL 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  154 bits (389), Expect = 3e-44
 Identities = 57/293 (19%), Positives = 119/293 (40%), Gaps = 34/293 (11%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q +    D++L+       +G G  GVV++  E   G   A K +      ++  ++   
Sbjct: 15  QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRK 72

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVG 171
           EIQ +  +RH  +V L     + +  +++Y ++S G L + +    N +  +   +    
Sbjct: 73  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 132

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKY--EAYLADFGLAKLMNSTNYHHAMSRVA 229
             +GL ++H +     +H D+K  NI+  +K   E  L DFGL   ++        +   
Sbjct: 133 VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 186

Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV 289
           G+  + AP     ++  G    +   +D++S GV+   +LSG S    +  +    +  V
Sbjct: 187 GTAEFAAP-----EVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNV 237

Query: 290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           K    + +       +   G+ +     + +        + + P  R T+ + 
Sbjct: 238 KSCDWNMDD------SAFSGISEDGKDFIRK-------LLLADPNTRMTIHQA 277

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 1e-42
 Identities = 59/314 (18%), Positives = 113/314 (35%), Gaps = 29/314 (9%)

Query: 61  DNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGH 119
           ++I +     +V+G G    V  AE     +L+A+K +   K  E    S   EI +L  
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-AKKALEGKEGSMENEIAVLHK 63

Query: 120 IRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYL 179
           I+H NIV L     +     L+   +S G L   +            ++       + YL
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H   +     +        LD   +  ++DFGL+K+ +       +S   G+ GY+AP  
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEV 180

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
                        ++  D +S GV+   +L G      +  +   + E + K    F+  
Sbjct: 181 LA-------QKPYSKAVDCWSIGVIAYILLCGYPPFYDE--NDAKLFEQILKAEYEFDS- 230

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA--LLMEVKSAPEELG 357
                     + D     +          +   P +R T ++ +    +    +  + + 
Sbjct: 231 -----PYWDDISDSAKDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278

Query: 358 KTSQPLIKQSANKS 371
           ++    IK++  KS
Sbjct: 279 QSVSEQIKKNFAKS 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  145 bits (368), Expect = 5e-42
 Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 31/282 (10%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKT-------KRDEEPVDSFAAEIQILGHIR 121
           + ++G+G S VV +    P  +  AVK +  T       +  +E  ++   E+ IL  + 
Sbjct: 8   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67

Query: 122 -HRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLH 180
            H NI++L       +   L+++ +  G L   L     L  +   KI     + +  LH
Sbjct: 68  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 127

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKC 240
                 I+HRD+K  NILLD      L DFG +  ++       +  V G+  Y+AP   
Sbjct: 128 KLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEII 181

Query: 241 KLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV 300
           +  +   +     ++ D++S GV++  +L+G              +  ++  M       
Sbjct: 182 ECSMNDNHP-GYGKEVDMWSTGVIMYTLLAGSPPF-----WHRKQMLMLRMIM---SGNY 232

Query: 301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                +     D +   + +        +   P +R T +E 
Sbjct: 233 QFGSPEWDDYSDTVKDLVSR-------FLVVQPQKRYTAEEA 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 9e-42
 Identities = 74/310 (23%), Positives = 130/310 (41%), Gaps = 53/310 (17%)

Query: 65  ECLKDENVIGKGCSGVVYKAEMP--------NGELIAVKKLWKTKRDEEPVDSFAAEIQI 116
           + L     +G+G  G V  AE              +AVK L K+   E+ +    +E+++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 71

Query: 117 LGHI-RHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNR----------------N 159
           +  I +H+NI+ LLG C+      ++  Y S GNL++ LQ  R                 
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 160 LDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST 219
           L  +     A   A+G+ YL        +HRD+   N+L+       +ADFGLA+ ++  
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI 279
           +Y+   +       ++AP          +    T +SDV+S+GV+L EI +   +  P  
Sbjct: 189 DYYKKTTNGRLPVKWMAP-------EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-- 239

Query: 280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM 339
             G+ + E  K           + +      P     E+     +   C ++ P++RPT 
Sbjct: 240 --GVPVEELFKL----------LKEGHRMDKPSNCTNELYM---MMRDCWHAVPSQRPTF 284

Query: 340 KEVVALLMEV 349
           K++V  L  +
Sbjct: 285 KQLVEDLDRI 294

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (365), Expect = 2e-41
 Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 21/282 (7%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
             IG+G  GVVYKA+   GE  A+KK+   K DE    +   EI IL  ++H NIVKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHR 190
               K   +L++ ++     + L      L+  T     +    G+AY H      +LHR
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124

Query: 191 DVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTM 250
           D+K  N+L++ + E  +ADFGLA+        +       +  Y AP       +   + 
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPD------VLMGSK 176

Query: 251 NITEKSDVYSYGVVLLEILSGR--------SAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
             +   D++S G +  E+++G         +    +I   L           +  P    
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMF--CVNSSPAERPTMKEV 342
             T  + LP +   + L   GI +    +   P +R T K+ 
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (369), Expect = 3e-41
 Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 40/300 (13%)

Query: 59  TIDNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWK----TKRDEEPVDSFAAE 113
           T+++         +IG+G  G VY       G++ A+K L K     K+ E    +    
Sbjct: 2   TMND----FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57

Query: 114 IQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSA 173
           + ++       IV +            + + ++ G+L   L  +           A    
Sbjct: 58  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 174 QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYG 233
            GL ++H+     +++RD+K  NILLD      ++D GLA   +    H ++    G++G
Sbjct: 118 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 170

Query: 234 YIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM 293
           Y+AP   +  + Y         +D +S G +L ++L G     P           + +  
Sbjct: 171 YMAPEVLQKGVAY------DSSADWFSLGCMLFKLLRGH---SPFRQHKTKDKHEIDRMT 221

Query: 294 GSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP 353
            +              LPD    E L++L   +   +     R       A   EVK +P
Sbjct: 222 LTMAVE----------LPDSFSPE-LRSLLEGLLQRD--VNRRLGCLGRGA--QEVKESP 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  143 bits (362), Expect = 5e-41
 Identities = 64/290 (22%), Positives = 112/290 (38%), Gaps = 33/290 (11%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVK 127
             ++G G    V+ A  +     +AVK L     RD      F  E Q    + H  IV 
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 128 LLGYCSNKSVKL----LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
           +      ++       ++  Y+    L+ ++     +  +   ++   + Q L + H + 
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 131

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAK-LMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
              I+HRDVK  NI++ +     + DFG+A+ + +S N     + V G+  Y++P     
Sbjct: 132 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---- 184

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
                   ++  +SDVYS G VL E+L+G          G   V    + +       S 
Sbjct: 185 ---QARGDSVDARSDVYSLGCVLYEVLTGEPPFT-----GDSPVSVAYQHVREDPIPPSA 236

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-TMKEVVALLMEVKS 351
               L    D +V + L            +P  R  T  E+ A L+ V +
Sbjct: 237 RHEGLSADLDAVVLKALAK----------NPENRYQTAAEMRADLVRVHN 276

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  145 bits (367), Expect = 5e-41
 Identities = 53/293 (18%), Positives = 112/293 (38%), Gaps = 34/293 (11%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q +     ++ +       +G G  GVV++  E   G +   K +      ++   +   
Sbjct: 18  QPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKN 75

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVG 171
           EI I+  + H  ++ L     +K   +L+  ++S G L   +      +           
Sbjct: 76  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 135

Query: 172 SAQGLAYLHHDCVPAILHRDVKCNNILLDSKY--EAYLADFGLAKLMNSTNYHHAMSRVA 229
           + +GL ++H     +I+H D+K  NI+ ++K      + DFGLA  +N        +   
Sbjct: 136 ACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--- 189

Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWV 289
            +  + AP     +I+      +   +D+++ GV+   +LSG S    +  D L  ++ V
Sbjct: 190 ATAEFAAP-----EIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNV 240

Query: 290 KKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           K+    F+            +  +    +          +   P +R T+ + 
Sbjct: 241 KRCDWEFDE------DAFSSVSPEAKDFIKN-------LLQKEPRKRLTVHDA 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-40
 Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 30/288 (10%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEP---VDSFAAEIQILGHIRHRNIV 126
           + +G+G    VYKA      +++A+KK+    R E       +   EI++L  + H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
            LL    +KS   L+++++       +   +  L         + + QGL YLH      
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           ILHRD+K NN+LLD      LADFGLAK   S   + A +    +  Y AP       + 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPE------LL 172

Query: 247 GYTMNITEKSDVYSYGVVLLEILSGR------------SAVQPQIGDGLHIVEWVKKKMG 294
                     D+++ G +L E+L               + +   +G            + 
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 295 SFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
            +    S     L  +      ++L  +   +F  N  P  R T  + 
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQ-GLFLFN--PCARITATQA 277

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-40
 Identities = 62/275 (22%), Positives = 108/275 (39%), Gaps = 34/275 (12%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGH-IRHRNIV 126
             ++GKG  G V+ AE     +  A+K L K     ++ V+    E ++L     H  + 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 127 KLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
            +      K     +  Y++ G+L   +Q     D       A     GL +LH      
Sbjct: 67  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--- 123

Query: 187 ILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIY 246
           I++RD+K +NILLD      +ADFG+ K     +     +   G+  YIAP     +I+ 
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAP-----EILL 176

Query: 247 GYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTK 306
           G         D +S+GV+L E+L G+S    Q  D   +   ++     +   +      
Sbjct: 177 G--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPFYPRWLE----- 227

Query: 307 LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKE 341
                     +  + L + +F     P +R  ++ 
Sbjct: 228 ----------KEAKDLLVKLFVRE--PEKRLGVRG 250

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 6e-39
 Identities = 46/275 (16%), Positives = 105/275 (38%), Gaps = 35/275 (12%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLG 130
            +G+G  G+V++  E  + +    K +     D+        EI IL   RHRNI+ L  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHE 68

Query: 131 YCSNKSVKLLLYNYISNGNLQQLLQGNRN-LDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
              +    ++++ +IS  ++ + +  +   L+            + L +LH      I H
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 190 RDVKCNNILLDSKYEAY--LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYG 247
            D++  NI+  ++  +   + +FG A+ +   +    +     +  Y AP   +      
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQ------ 176

Query: 248 YTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKL 307
               ++  +D++S G ++  +LSG +    +      I+E +     +F+          
Sbjct: 177 -HDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDE------EAF 227

Query: 308 QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           + +  + +  + +        +      R T  E 
Sbjct: 228 KEISIEAMDFVDR-------LLVKERKSRMTASEA 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  139 bits (350), Expect = 6e-39
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 21/218 (9%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQ 115
           +++ +  + L+    +G G  G V+      NG   A+K L K      + V+    E  
Sbjct: 1   YSLQD-FQILR---TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 56

Query: 116 ILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQG 175
           +L  + H  I+++ G   +     ++ +YI  G L  LL+ ++          A   A+ 
Sbjct: 57  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA---AEV 113

Query: 176 LAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYI 235
              L +     I++RD+K  NILLD      + DFG AK +    Y      + G+  YI
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYI 168

Query: 236 APGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS 273
           AP           T    +  D +S+G+++ E+L+G +
Sbjct: 169 APE-------VVSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-38
 Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 27/286 (9%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             IG+G  GVVYKA     GE++A+KK+      E    +   EI +L  + H NIVKLL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 130 GYCSNKSVKLLLYNYISNGNLQQL-LQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAIL 188
                ++   L++ ++     + +       +             QGLA+ H      +L
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VL 124

Query: 189 HRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGY 248
           HRD+K  N+L++++    LADFGLA+        +  +    +  Y AP       I   
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE------ILLG 176

Query: 249 TMNITEKSDVYSYGVVLLEILSGRS------------AVQPQIGDGLHIVEWVKKKMGSF 296
               +   D++S G +  E+++ R+             +   +G    +V      M  +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           +P+      +        + E  ++L   M   +  P +R + K  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD--PNKRISAKAA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-38
 Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 32/291 (10%)

Query: 71  NVIGKGCSGVVYKAE--MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI---RHRNI 125
             IG+G  G V+KA      G  +A+K++     +E    S   E+ +L H+    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 126 VKLLGYCSNKSVKLLLYNYISNGNLQQ------LLQGNRNLDWETRYKIAVGSAQGLAYL 179
           V+L   C+           +   ++ Q             +  ET   +     +GL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 180 HHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGK 239
           H      ++HRD+K  NIL+ S  +  LADFGLA++ +      A++ V  +  Y AP  
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE- 185

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQP--------QIGDGLHIVEWVKK 291
                      +     D++S G +  E+   +   +         +I D + +      
Sbjct: 186 ------VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
                 P  +      Q +   +         + + C+  +PA+R +    
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-37
 Identities = 72/298 (24%), Positives = 110/298 (36%), Gaps = 43/298 (14%)

Query: 68  KDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIV 126
            D  VIG G  GVVY+A+   +GEL+A+KK+ + KR +        E+QI+  + H NIV
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIV 76

Query: 127 KLLGYC------SNKSVKLLLYNYISNGNLQQLLQGNRN---LDWETRYKIAVGSAQGLA 177
           +L  +        ++    L+ +Y+     +     +R    L             + LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 178 YLHHDCVPAILHRDVKCNNILLDSKYEAY-LADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           Y+H      I HRD+K  N+LLD       L DFG AK +     + +         Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYRA 190

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS----------AVQPQIGDGLHIV 286
           P        Y      T   DV+S G VL E+L G+            V+     G    
Sbjct: 191 PELIFGATDY------TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

Query: 287 EWVKKKMGSFEPAV--SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           E +++   ++       I       +           L   +      P  R T  E 
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT--PTARLTPLEA 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-37
 Identities = 60/303 (19%), Positives = 120/303 (39%), Gaps = 32/303 (10%)

Query: 58  FTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQI 116
           F +      L     IG+G  G+V  A +  N   +A+KK+      +        EI+I
Sbjct: 4   FDVGPRYTNLS---YIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKI 59

Query: 117 LGHIRHRNIVKLLGYCSNKSVK----LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGS 172
           L   RH NI+ +       +++    + L  ++   +L +LL+    L  +         
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQI 118

Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST-NYHHAMSRVAGS 231
            +GL Y+H      +LHRD+K +N+LL++  +  + DFGLA++ +   ++   ++    +
Sbjct: 119 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR------------SAVQPQI 279
             Y AP       I   +   T+  D++S G +L E+LS R            + +   +
Sbjct: 176 RWYRAP------EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229

Query: 280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTM 339
           G            + +    +S+                 + L +    +  +P +R  +
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289

Query: 340 KEV 342
           ++ 
Sbjct: 290 EQA 292

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-37
 Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 27/286 (9%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             IG+G  G V+KA+     E++A+K++     DE    S   EI +L  ++H+NIV+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 130 GYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILH 189
               +     L++ +      +     N +LD E          Q L  L       +LH
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSRNVLH 124

Query: 190 RDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYT 249
           RD+K  N+L++   E  LA+FGLA+        ++   V   +            +    
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVVTLWYRPPD-------VLFGA 176

Query: 250 MNITEKSDVYSYGVVLLEILSGRS-------------AVQPQIGDGLHIVEWVKKKMGSF 296
              +   D++S G +  E+ +                 +   +G           K+  +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           +P      T         +    + L   +   N  P +R + +E 
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN--PVQRISAEEA 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 5e-37
 Identities = 67/300 (22%), Positives = 118/300 (39%), Gaps = 44/300 (14%)

Query: 53  FQKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTK----RDEEPV 107
           F++ N  +D+  +  +    +G G   VV K  E   G   A K + K +    R     
Sbjct: 3   FRQEN--VDDYYDTGE---ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57

Query: 108 DSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYK 167
           +    E+ IL  I+H N++ L     NK+  +L+   ++ G L   L    +L  E   +
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS----KYEAYLADFGLAKLMNSTNYHH 223
                 Q L  +++     I H D+K  NI+L      K    + DFGLA  ++  N   
Sbjct: 118 FL---KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174

Query: 224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL 283
               + G+  ++AP      + Y     +  ++D++S GV+   +LSG     P +GD  
Sbjct: 175 ---NIFGTPEFVAPE----IVNYEP---LGLEADMWSIGVITYILLSGA---SPFLGDTK 221

Query: 284 H-IVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
              +  V      FE       +    L    ++ +L             P +R T+++ 
Sbjct: 222 QETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVK----------DPKKRMTIQDS 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (334), Expect = 8e-37
 Identities = 47/287 (16%), Positives = 91/287 (31%), Gaps = 35/287 (12%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
              IG G  G +Y    +  GE +A+K      +  +       E +I   ++    +  
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPT 67

Query: 129 LGYCSNKSVKLLLYN-YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           + +C  +    ++    +           +R    +T   +A      + Y+H       
Sbjct: 68  IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 124

Query: 188 LHRDVKCNNILLDSK---YEAYLADFGLAKLMNSTN-----YHHAMSRVAGSYGYIAPGK 239
           +HRDVK +N L+         Y+ DFGLAK            +     + G+  Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI-- 182

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA 299
                  G  +  + + D+ S G VL+    G    Q               +     P 
Sbjct: 183 ---NTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236

Query: 300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL 346
              ++   +G P +    +         C +    ++P    +  L 
Sbjct: 237 ---IEVLCKGYPSEFATYLNF-------CRSLRFDDKPDYSYLRQLF 273

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-36
 Identities = 57/298 (19%), Positives = 113/298 (37%), Gaps = 37/298 (12%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLL 129
             IG+G  G V+KA     G+ +A+KK+      E    +   EI+IL  ++H N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 130 GYCSNKSVK--------LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH 181
             C  K+           L++++  +     L             ++       L  L++
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM---QMLLNGLYY 132

Query: 182 DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN--STNYHHAMSRVAGSYGYIAPGK 239
                ILHRD+K  N+L+       LADFGLA+  +    +  +  +    +  Y  P  
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 240 CKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP- 298
              +  YG         D++  G ++ E+ +    +Q       H +  + +  GS  P 
Sbjct: 193 LLGERDYGP------PIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLCGSITPE 244

Query: 299 ------------AVSILDTKLQGLPDQMVQEMLQTLGIAMF--CVNSSPAERPTMKEV 342
                        + ++  + + + D++   +     + +    +   PA+R    + 
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (325), Expect = 1e-35
 Identities = 43/292 (14%), Positives = 97/292 (33%), Gaps = 37/292 (12%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRN-IVK 127
              IG+G  GV+++   + N + +A+K   +     +       E +    +     I  
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPN 65

Query: 128 LLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAI 187
           +  +       +L+ + +       L    R    +T    A      +  +H      +
Sbjct: 66  VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122

Query: 188 LHRDVKCNNILLDSKY-----EAYLADFGLAKLMNSTN-----YHHAMSRVAGSYGYIAP 237
           ++RD+K +N L+           Y+ DFG+ K            +     ++G+  Y++ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 238 GKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE 297
                    G     + + D+ + G V +  L G    Q   G      +   +++G  +
Sbjct: 183 -----NTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQ---GLKAATNKQKYERIGEKK 232

Query: 298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV 349
            +  +      G P++  +          +  N +    P    +  L  +V
Sbjct: 233 QSTPL-RELCAGFPEEFYK-------YMHYARNLAFDATPDYDYLQGLFSKV 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 8e-35
 Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 18/216 (8%)

Query: 59  TIDNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTK-RDEEPVDSFAAEIQI 116
           T+++  + LK   ++GKG  G V        G   A+K L K     ++ V     E ++
Sbjct: 3   TMND-FDYLK---LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58

Query: 117 LGHIRHRNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGL 176
           L + RH  +  L            +  Y + G L   L   R    E         A+ +
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---AEIV 115

Query: 177 AYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIA 236
           + L +     +++RD+K  N++LD      + DFGL K   S      M    G+  Y+A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 173

Query: 237 PGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
           P   +         +     D +  GVV+ E++ GR
Sbjct: 174 PEVLE-------DNDYGRAVDWWGLGVVMYEMMCGR 202

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 2e-34
 Identities = 55/280 (19%), Positives = 101/280 (36%), Gaps = 47/280 (16%)

Query: 72  VIGKGCSGVVYKA-EMPNGELIAVKKLWKTK----RDEEPVDSFAAEIQILGHIR--HRN 124
           ++G G  G VY    + +   +A+K + K +     +         E+ +L  +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 125 IVKLLGYCSNKSVKLLLYNYISNG-NLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
           +++LL +       +L+        +L   +     L  E          + + + H+  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130

Query: 184 VPAILHRDVKCNNILLD-SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKL 242
              +LHRD+K  NIL+D ++ E  L DFG   L+  T Y        G+  Y  P     
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPE---- 179

Query: 243 QIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI 302
                Y       + V+S G++L +++ G                        FE    I
Sbjct: 180 --WIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------------------FEHDEEI 216

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEV 342
           +  ++     Q V    Q L      +   P++RPT +E+
Sbjct: 217 IRGQV--FFRQRVSSECQHLIRWCLALR--PSDRPTFEEI 252

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 3e-34
 Identities = 65/310 (20%), Positives = 124/310 (40%), Gaps = 39/310 (12%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q++  T   +    +D   +G G  G V  A +   G  +A+KKL++  + E        
Sbjct: 7   QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66

Query: 113 EIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN----GNLQQLLQGNRNLDWETRYKI 168
           E+++L H+RH N++ LL   +         ++       G     L  +  L  +    +
Sbjct: 67  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126

Query: 169 AVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRV 228
                +GL Y+H   +    HRD+K  N+ ++   E  + DFGLA+  +S      M+  
Sbjct: 127 VYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGY 178

Query: 229 AGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEW 288
             +  Y AP       +    M  T+  D++S G ++ E+++G++  +    D L  ++ 
Sbjct: 179 VVTRWYRAPE------VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS--DHLDQLKE 230

Query: 289 VKKKMGSFEPAV------SILDTKLQGLPDQMVQEMLQTLGIA----------MFCVNSS 332
           + K  G+                 ++GLP+   ++    L  A          M  ++  
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD-- 288

Query: 333 PAERPTMKEV 342
             +R T  E 
Sbjct: 289 AEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-34
 Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 33/282 (11%)

Query: 71  NVIGKGCSGVVYKAE----MPNGELIAVKKLWKTK--RDEEPVDSFAAEIQILGHIRHR- 123
            V+G G  G V+          G+L A+K L K    +  +  +    E Q+L HIR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 124 NIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC 183
            +V L      ++   L+ +YI+ G L   L                   + +  L H  
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV---GEIVLALEHLH 146

Query: 184 VPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQ 243
              I++RD+K  NILLDS     L DFGL+K   +     A     G+  Y+AP      
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAP-----D 200

Query: 244 IIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG-LHIVEWVKKKMGSFEPAVSI 302
           I+ G      +  D +S GV++ E+L+G S   P   DG  +    + +++   EP    
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEPP--- 254

Query: 303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA 344
                   P +M       +      +   P +R       A
Sbjct: 255 -------YPQEMSALAKDLI---QRLLMKDPKKRLGCGPRDA 286

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 58/276 (21%), Positives = 102/276 (36%), Gaps = 27/276 (9%)

Query: 29  EKASGMSTLPPGAEDFSYPWTFIPFQKLNFTIDNILECLKDENVIGKGCSGVVYKAE-MP 87
           E+ S    L    EDF   W           +D   + +K    +G G  G V   +   
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTA--QLDQ-FDRIK---TLGTGSFGRVMLVKHKE 64

Query: 88  NGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYIS 146
           +G   A+K L K K    + ++    E +IL  +    +VKL     + S   ++  Y++
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124

Query: 147 NGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAY 206
            G +   L+             A        YLH      +++RD+K  N+L+D +    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181

Query: 207 LADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLL 266
           + DFG AK +    +      + G+   +AP           +    +  D ++ GV++ 
Sbjct: 182 VTDFGFAKRVKGRTWT-----LCGTPEALAP-------EIILSKGYNKAVDWWALGVLIY 229

Query: 267 EILSGRSAVQPQIGDG-LHIVEWVKKKMGSFEPAVS 301
           E+ +G     P   D  + I E +      F    S
Sbjct: 230 EMAAGYP---PFFADQPIQIYEKIVSGKVRFPSHFS 262

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-33
 Identities = 62/313 (19%), Positives = 117/313 (37%), Gaps = 44/313 (14%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVK 127
             V+G G +G V +       E  A+K L    +          E+++     +  +IV+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------EVELHWRASQCPHIVR 69

Query: 128 LLGYCSNKSVK----LLLYNYISNGNLQQLLQ--GNRNLDWETRYKIAVGSAQGLAYLHH 181
           ++    N        L++   +  G L   +Q  G++        +I     + + YLH 
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 182 DCVPAILHRDVKCNNILLDSKYE---AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPG 238
                I HRDVK  N+L  SK       L DFG AK   S N          +  Y+AP 
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP- 182

Query: 239 KCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP 298
               +++        +  D++S GV++  +L G          GL I   +K ++   + 
Sbjct: 183 ----EVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQY 234

Query: 299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVA--LLMEVKSAPEEL 356
                + +   + +++   +          + + P +R T+ E +    +M+    P+  
Sbjct: 235 --EFPNPEWSEVSEEVKMLIRN-------LLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 357 GKTSQPLIKQSAN 369
             TS+ L +    
Sbjct: 286 LHTSRVLKEDKER 298

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-31
 Identities = 65/309 (21%), Positives = 124/309 (40%), Gaps = 37/309 (11%)

Query: 54  QKLNFTIDNILECLKDENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAA 112
           Q+LN TI  + E  ++ + +G G  G V  A     G  +AVKKL +  +          
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66

Query: 113 EIQILGHIRHRNIVKLLGYCSNKS-----VKLLLYNYISNGNLQQLLQGNRNLDWETRYK 167
           E+++L H++H N++ LL   +          + L  ++   +L  +++  +  D   ++ 
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF- 125

Query: 168 IAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           +     +GL Y+H   +    HRD+K +N+ ++   E  + DFGLA+  +     +  +R
Sbjct: 126 LIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182

Query: 228 VAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS--------AVQPQI 279
                 Y AP       I    M+  +  D++S G ++ E+L+GR+             I
Sbjct: 183 -----WYRAPE------IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

Query: 280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQM------VQEMLQTLGIAMFCVNSSP 333
              +        K  S E A + + +  Q               +   L   M  ++   
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD--S 289

Query: 334 AERPTMKEV 342
            +R T  + 
Sbjct: 290 DKRITAAQA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (293), Expect = 1e-30
 Identities = 54/298 (18%), Positives = 113/298 (37%), Gaps = 48/298 (16%)

Query: 71  NVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKL 128
             +G+G    V++A  + N E + VK L   K+ +        EI+IL ++R   NI+ L
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITL 95

Query: 129 LGYCSNKSVKL--LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA 186
                +   +   L++ +++N + +QL Q    L             + L Y H      
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--- 149

Query: 187 ILHRDVKCNNILLDSK-YEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQII 245
           I+HRDVK +N+++D +  +  L D+GLA+  +    ++       S  +  P       +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLVDYQM 206

Query: 246 YGYTMNITEKSDVYSYGVVLLEILSGRSAVQP------------QIGDGLHIVEWVKKKM 293
           Y Y        D++S G +L  ++  +                 ++     + +++ K  
Sbjct: 207 YDY------SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 294 GSFEPAVSILDTK-----LQGLPDQMVQEMLQTLGI----AMFCVNSSPAERPTMKEV 342
              +P  + +  +      +       Q ++    +     +   +     R T +E 
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD--HQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (274), Expect = 8e-28
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 26/223 (11%)

Query: 57  NFTIDNILECLKDENVIGKGCSGVVYKA-EMPNGELIAVKKLWKTKRDEEPVDSFAAEIQ 115
            FT+    + LK    IG G  G+V  A +      +A+KKL +  +++        E+ 
Sbjct: 12  TFTVLKRYQNLK---PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68

Query: 116 ILGHIRHRNIVKLLGYCSNKSVK------LLLYNYISNGNLQQLLQGNRNLDWETRYKIA 169
           ++  + H+NI+ LL   + +          L+   +     Q +      LD E    + 
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLL 125

Query: 170 VGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVA 229
                G+ +LH      I+HRD+K +NI++ S     + DFGLA+   +      M+   
Sbjct: 126 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYV 179

Query: 230 GSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR 272
            +  Y AP            M   E  D++S G ++ E++  +
Sbjct: 180 VTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (262), Expect = 3e-26
 Identities = 44/231 (19%), Positives = 85/231 (36%), Gaps = 30/231 (12%)

Query: 70  ENVIGKGCSGVVYKAE-MPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL 128
              +G G    V+ A+ M N   +A+K +   + D+   ++   EI++L  +   +  K 
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 129 LGYCSNKSVKLLLYNYISNGN----------------LQQLLQGNRNLDWETRYKIAVGS 172
               +N  +KLL +      N                       +R +      +I+   
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 173 AQGLAYLHHDCVPAILHRDVKCNNILLDSK-YEAYLADFGLAKLMNSTNYHHAMSRVAGS 231
             GL Y+H  C   I+H D+K  N+L++       L    +A L N+  Y    +    +
Sbjct: 135 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 232 YGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG 282
             Y +P                  +D++S   ++ E+++G    +P  G  
Sbjct: 193 REYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.8 bits (183), Expect = 2e-16
 Identities = 26/167 (15%), Positives = 52/167 (31%), Gaps = 19/167 (11%)

Query: 71  NVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPV--------DSFAAEIQILGHIRH 122
            ++G+G    V+           VK         + V          F+           
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 123 RNIVKLLGYCSNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRY--KIAVGSAQGLAYLH 180
           R + KL G    K      Y +  N  L +L+              ++     + +A  +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 181 HDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAMSR 227
           H     I+H D+   N+L+  +   ++ DF  +  +    +   + R
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILER 163

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	371
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.76
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.34
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.13
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.53
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.19
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.48

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-58  Score=407.13  Aligned_cols=267  Identities=26%  Similarity=0.397  Sum_probs=206.5

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|+..  ..||||++.....+....+.|.+|+.++++++||||+++++++.+ +..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            35788899999999999999863  469999997666667778899999999999999999999998865 568999999


Q ss_pred             cCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |++|+|.+++... ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.........
T Consensus        85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999999999654 5699999999999999999999999   99999999999999999999999999998765544333


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ......||+.|||||++..+    ....++.++|||||||++|||+||+.||..... ...+...+...... ..    .
T Consensus       162 ~~~~~~gt~~y~APE~l~~~----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~-p~----~  231 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQ----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGRGYLS-PD----L  231 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHHTSCC-CC----G
T ss_pred             cccccccCcccCCHHHHhcc----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCCC-Cc----c
Confidence            44567899999999987632    234578999999999999999999999965432 12222222221111 00    0


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      ......+++       .+.+++.+||+.||++|||++||+++|+.+..+.+
T Consensus       232 ~~~~~~~~~-------~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         232 SKVRSNCPK-------AMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             GGSCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             hhccccchH-------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            111122332       33457778999999999999999999998876543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-58  Score=405.67  Aligned_cols=257  Identities=24%  Similarity=0.330  Sum_probs=204.1

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||+||+|.. .+|+.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            4688889999999999999976 468999999986433 23344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ||++|+|.+++.....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++.........
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            999999999999888999999999999999999999999   99999999999999999999999999998775554333


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....+||+.|||||++.+.      ..++.++|||||||++|||++|+.||............+.    .. ...    
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~------~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~----~~-~~~----  225 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EK-KTY----  225 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCS------SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH----TT-CTT----
T ss_pred             cccceeeCcCccCHhHhcCC------CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh----cC-CCC----
Confidence            44567899999999987633      1235789999999999999999999975443322221111    11 000    


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      .......+       ..+.+++.+||+.||++|||++|++++-+
T Consensus       226 ~~~~~~~s-------~~~~~li~~~L~~dP~~R~t~~eil~hpw  262 (271)
T d1nvra_         226 LNPWKKID-------SAPLALLHKILVENPSARITIPDIKKDRW  262 (271)
T ss_dssp             STTGGGSC-------HHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             CCccccCC-------HHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            00011111       23445788899999999999999988643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=398.22  Aligned_cols=249  Identities=26%  Similarity=0.393  Sum_probs=204.3

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|... +++.||+|++.+... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            35888899999999999999764 689999999864332 2334567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |||++|+|.+++.....+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||++.......  
T Consensus        86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred             eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence            9999999999999888899999999999999999999999   99999999999999999999999999998665432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                        .....||+.|+|||++.+       ..++.++|||||||++|||++|+.||....  .......+.   ....     
T Consensus       161 --~~~~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~---~~~~-----  221 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEG-------RMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQETYKRIS---RVEF-----  221 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHH---TTCC-----
T ss_pred             --ccccCCCCcccCHHHHcC-------CCCCchhhhhhHhHHHHHHhcCCCCCCCCC--HHHHHHHHH---cCCC-----
Confidence              345679999999998763       367899999999999999999999996432  222222221   1100     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                            ..++...+   .+.+++.+||+.||++|||++|++++-
T Consensus       222 ------~~p~~~s~---~~~~li~~~L~~dp~~R~t~~eil~hp  256 (263)
T d2j4za1         222 ------TFPDFVTE---GARDLISRLLKHNPSQRPMLREVLEHP  256 (263)
T ss_dssp             ------CCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred             ------CCCccCCH---HHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence                  11111112   334577889999999999999999863

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.2e-57  Score=404.34  Aligned_cols=264  Identities=24%  Similarity=0.417  Sum_probs=199.0

Q ss_pred             hccccCCccccCCceEEEEEEeCC-C---CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-G---ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||+||+|..+. +   ..||||++.. .......+.|.+|+++|++++|||||+++|+|.+.+..++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            457778899999999999997642 3   2588998743 3344556789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      |||||++|+|.+++... +.+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999988764 5699999999999999999999999   9999999999999999999999999999876544


Q ss_pred             Ccccc---cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          220 NYHHA---MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       220 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .....   .....||+.|+|||.+.       +..++.++|||||||++|||+| |..||....  ...+...+......
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~~i~~~~~~  252 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQ-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQDVINAIEQDYRL  252 (299)
T ss_dssp             --------------CGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTCCC
T ss_pred             CCcceeeecccccCCccccCHHHHh-------cCCCCcccccccchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC
Confidence            32111   12245799999999765       3478899999999999999998 888886432  22333333221110


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCC
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELG  357 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  357 (371)
                               +....++.       .+.+|+.+||+.||++|||++||++.|+++.+.|+.+.
T Consensus       253 ---------~~~~~~~~-------~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~slk  298 (299)
T d1jpaa_         253 ---------PPPMDCPS-------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK  298 (299)
T ss_dssp             ---------CCCTTCCH-------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGT
T ss_pred             ---------CCCccchH-------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhCC
Confidence                     01112222       34457788999999999999999999999887766554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=393.50  Aligned_cols=255  Identities=22%  Similarity=0.384  Sum_probs=196.2

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .|+..+.||+|+||.||+|.+.+++.||||++...   ....+++.+|++++++++||||++++|+|.+.+..++||||+
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46677899999999999999888889999998543   233467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++|+|.+++... ..+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++....... ..
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~  158 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  158 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence            999999998654 5689999999999999999999999   999999999999999999999999999987655432 12


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccccC
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILD  304 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .....||+.|+|||.+.       +..++.++|||||||++|||+|++.|+.... ....+...+.......        
T Consensus       159 ~~~~~gt~~y~aPE~l~-------~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~~~~--------  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFS-------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFRLY--------  222 (263)
T ss_dssp             ------CTTSCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHHHTCCCC--------
T ss_pred             ecceecCcccCChHHhc-------CCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHHHhcCCCC--------
Confidence            23456899999999875       3468899999999999999999665554332 2233333333321110        


Q ss_pred             cccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          305 TKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                       ....+++       .+.+++.+||+.||++|||++||+++|+++.+
T Consensus       223 -~p~~~~~-------~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 -KPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -CCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CccccCH-------HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence             0112222       34567888999999999999999999998853

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-57  Score=400.32  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=191.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--CCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--KSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  141 (371)
                      +.|+..+.||+|+||.||+|.. .+|+.||+|.+.....++...+.+.+|++++++++||||+++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            3588889999999999999976 468999999997666566667789999999999999999999999865  4668999


Q ss_pred             EeecCCCCHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          142 YNYISNGNLQQLLQG----NRNLDWETRYKIAVGSAQGLAYLHHDCV--PAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ||||++|+|.+++..    ...+++..++.++.|++.||+|||+++.  .+++||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999853    4679999999999999999999998721  1499999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .....  .......||+.|+|||++.       +..++.++|||||||++|||+||..||....  ...+...+...  .
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~-------~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--~~~~~~~i~~~--~  230 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKIREG--K  230 (269)
T ss_dssp             C-------------CCCSCCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHT--C
T ss_pred             cccCC--CccccCCCCcccCCHHHHc-------CCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--HHHHHHHHHcC--C
Confidence            65443  2234567999999999875       3367899999999999999999999996432  22222222221  1


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                                 ....+.....   .+.+++.+||+.||.+|||++|++++
T Consensus       231 -----------~~~~~~~~s~---~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         231 -----------FRRIPYRYSD---ELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -----------CCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----------CCCCCcccCH---HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                       1111111112   34457788999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-56  Score=394.75  Aligned_cols=253  Identities=21%  Similarity=0.354  Sum_probs=203.8

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            34688899999999999999975 469999999986433  234577999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |||++|+|.+++... .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++......  
T Consensus        97 Ey~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             EecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            999999999988764 599999999999999999999999   99999999999999999999999999998775443  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+||+.|+|||++.       +..++.++|||||||++|+|++|..||.....  ......+....   .+.   
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~---~~~---  235 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNG---TPE---  235 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHS-------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHC---SCC---
T ss_pred             ccccccccCCCccChhhhc-------CCCCCchhceehHhHHHHHHhhCCCCCCCCCH--HHHHHHHHhCC---CCC---
Confidence            2335567999999999876       33678999999999999999999999964321  12211111111   000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                          + ..+....   ..+.+++.+||+.||++|||++|+++|-+
T Consensus       236 ----~-~~~~~~s---~~~~~li~~~L~~dP~~R~s~~eil~Hp~  272 (293)
T d1yhwa1         236 ----L-QNPEKLS---AIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (293)
T ss_dssp             ----C-SSGGGSC---HHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred             ----C-CCcccCC---HHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                0 0111111   13445788899999999999999998744

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-56  Score=388.20  Aligned_cols=252  Identities=21%  Similarity=0.363  Sum_probs=206.2

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .|+..+.||+|+||.||+|+.++++.||||++.....   ..+.|.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            5778899999999999999988888999999965333   3467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          146 SNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       146 ~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      ++|+|.+++.. ...+++..++.++.|+++||+|||++   +++||||||+||++++++.+||+|||+++........ .
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence            99999998654 55689999999999999999999999   9999999999999999999999999999876655432 3


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccccc
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSIL  303 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....||+.|+|||.+.       +..++.++|||||||++|||+| |+.||....  ..++...+......        
T Consensus       158 ~~~~~~t~~y~aPE~~~-------~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~~~~~~i~~~~~~--------  220 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLM-------YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQGLRL--------  220 (258)
T ss_dssp             CCCSCCCGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHHHTTCCC--------
T ss_pred             ecccCCCCCcCCcHHhc-------CCCCCcceeecccchhhHhHHhcCCCCCCCCC--HHHHHHHHHhCCCC--------
Confidence            33467999999999775       3467899999999999999998 788886543  22333322221110        


Q ss_pred             CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          304 DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                       ......+       ..+.+++.+||+.||++|||++|++++|.++
T Consensus       221 -~~p~~~~-------~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 -YRPHLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -CCCTTCC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -CCccccc-------HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             0011222       2345678889999999999999999999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=395.73  Aligned_cols=255  Identities=25%  Similarity=0.437  Sum_probs=203.6

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|.+++++.||||++...   ....+.|.+|++++++++||||++++|++.+ +..|+||||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            467788899999999999999888889999998543   2345679999999999999999999998865 557999999


Q ss_pred             cCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++....  .+++..+..++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++....... 
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            99999999876543  599999999999999999999999   999999999999999999999999999988765432 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||.+..       ..++.++|||||||++|||+||+.|+..... ...+...+......       
T Consensus       165 ~~~~~~~gt~~y~APE~~~~-------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~~~~~-------  229 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRM-------  229 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCC-------
T ss_pred             ccccccCCcccccChHHHhC-------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCC-------
Confidence            23345679999999998752       3578899999999999999997776654322 22232222221110       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                        .....+++       .+.+|+.+||+.||++|||++||++.|+++..
T Consensus       230 --~~p~~~~~-------~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         230 --VRPDNCPE-------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             --CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCcccChH-------HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence              00112222       34457788999999999999999999987653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=388.90  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=197.9

Q ss_pred             ccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec----CCeEEEEE
Q 037946           68 KDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN----KSVKLLLY  142 (371)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  142 (371)
                      +..+.||+|+||+||+|.+. +++.||+|++..........+.+.+|+++|++++||||+++++++.+    .+.+|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44567999999999999764 68899999997665566667789999999999999999999999864    45689999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeEc-CCCceEEccccCccccCCC
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPA--ILHRDVKCNNILLD-SKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||+++|+|.+++.+...+++..+..++.||+.||+|||++   +  ++||||||+|||++ +++.+||+|||+++.....
T Consensus        92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            9999999999999888899999999999999999999998   7  99999999999996 5789999999999764433


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                          ......||+.|+|||++.        +.++.++|||||||++|||++|+.||..... ...+...+   .....+.
T Consensus       169 ----~~~~~~GT~~Y~aPE~~~--------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-~~~~~~~i---~~~~~~~  232 (270)
T d1t4ha_         169 ----FAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRV---TSGVKPA  232 (270)
T ss_dssp             ----SBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHH---TTTCCCG
T ss_pred             ----ccCCcccCccccCHHHhC--------CCCCCcCchhhHHHHHHHHHHCCCCCCCccc-HHHHHHHH---HcCCCCc
Confidence                234567999999999764        2478999999999999999999999964322 22222211   1111110


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                        ..+   ...++       .+.+++.+||+.||++|||++|+++|
T Consensus       233 --~~~---~~~~~-------~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         233 --SFD---KVAIP-------EVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             --GGG---GCCCH-------HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --ccC---ccCCH-------HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence              000   11122       24457888999999999999999886

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.5e-57  Score=404.50  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=190.9

Q ss_pred             HHHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           61 DNILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      +++.+.|+..+.||+|+||+||+|... +|+.||||++...... .....+.+|+.+|++++||||+++++++.+.+..|
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            345677999999999999999999764 6899999999654332 23456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc---CCCceEEccccCcccc
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD---SKYEAYLADFGLAKLM  216 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~  216 (371)
                      +|||||+||+|.+++...+.+++..+..++.||+.||+|||++   +++||||||+||+++   .++.+||+|||+++..
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999999999888999999999999999999999999   999999999999994   5789999999999876


Q ss_pred             CCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          217 NSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....   .....+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  .......+...... 
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~~~~-  227 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQ-------KPYSKAVDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQILKAEYE-  227 (307)
T ss_dssp             ---------------CTTSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHTTCCC-
T ss_pred             cCCC---eeeeeeeCccccCcHHHcC-------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHhccCCC-
Confidence            5443   3345679999999998753       367899999999999999999999996432  22222222221111 


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                           ...+.....++       .+.+++.+||+.||++|||++|++++-
T Consensus       228 -----~~~~~~~~~s~-------~~~~li~~~L~~dP~~R~s~~eil~hp  265 (307)
T d1a06a_         228 -----FDSPYWDDISD-------SAKDFIRHLMEKDPEKRFTCEQALQHP  265 (307)
T ss_dssp             -----CCTTTTTTSCH-------HHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             -----CCCccccCCCH-------HHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence                 00111112222       344578889999999999999999973

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-56  Score=398.49  Aligned_cols=258  Identities=23%  Similarity=0.322  Sum_probs=205.1

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||.||+|.+ .+|+.||+|++...  .....+.+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            3578888999999999999976 46899999998543  34556788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||++|+|.+++.+ ...+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++......  
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            9999999998764 56699999999999999999999999   99999999999999999999999999997654321  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||++...  ...+..++.++|||||||++|||+||..||.....  ......+...  . .+.  .
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~--~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~~i~~~--~-~~~--~  235 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCE--TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIAKS--E-PPT--L  235 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTC--STTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHHHHHS--C-CCC--C
T ss_pred             ccccccccccccCCHHHHhhc--ccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcC--C-CCC--C
Confidence            123456799999999987643  12244678999999999999999999999975432  2222222111  1 100  0


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                        ......+       ..+.+++.+||+.||++|||++|++++-+
T Consensus       236 --~~~~~~s-------~~~~~li~~~L~~dp~~R~t~~ell~hp~  271 (288)
T d2jfla1         236 --AQPSRWS-------SNFKDFLKKCLEKNVDARWTTSQLLQHPF  271 (288)
T ss_dssp             --SSGGGSC-------HHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             --CccccCC-------HHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence              0001122       23445788899999999999999998643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-56  Score=393.79  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=197.1

Q ss_pred             CccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeecCC
Q 037946           71 NVIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYISN  147 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  147 (371)
                      +.||+|+||.||+|.+.   .++.||||++.....+....+++.+|+++|++++||||++++|+|.+ +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999753   34689999997655556667889999999999999999999999965 457899999999


Q ss_pred             CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc-cccc
Q 037946          148 GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH-HAMS  226 (371)
Q Consensus       148 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~  226 (371)
                      |+|.+++.....+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++........ ....
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99999999989999999999999999999999999   9999999999999999999999999999876554322 2223


Q ss_pred             cccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCccccccCc
Q 037946          227 RVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSILDT  305 (371)
Q Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ...||+.|+|||.+..       ..++.++|||||||++|||+| |..||....  ..++...+......         +
T Consensus       169 ~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~i~~~~~~---------~  230 (277)
T d1xbba_         169 HGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGERM---------G  230 (277)
T ss_dssp             --CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCCC---------C
T ss_pred             ccCCCceecCchhhcC-------CCCCchhhhccchhhhhHHhhCCCCCCCCCC--HHHHHHHHHcCCCC---------C
Confidence            4569999999998753       356889999999999999998 899986432  22333333221100         0


Q ss_pred             ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          306 KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ....+++       .+.+|+.+||+.||++|||+++|++.|+..
T Consensus       231 ~p~~~~~-------~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         231 CPAGCPR-------EMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCTTCCH-------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcccCH-------HHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            1122332       344577889999999999999999988764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=399.24  Aligned_cols=252  Identities=20%  Similarity=0.297  Sum_probs=201.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|.. .+|+.||||++.+.. ......+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            3588899999999999999976 468999999986432 22345578999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |||++|+|.+++...+.+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++........
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999999999888999999999999999999999999   9999999999999999999999999999877654433


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||...  +...+...+.   ....     
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~---~~~~-----  227 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKII---KLEY-----  227 (288)
T ss_dssp             -----CCCCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHH---TTCC-----
T ss_pred             cccccccCCccccCceeecc-------CCCCcccceehhhHHHHHHhhCCCCCCCc--CHHHHHHHHH---cCCC-----
Confidence            33455679999999998763       36789999999999999999999999743  2222222221   1100     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                            ..+.....   .+.+|+.+||+.||++|||++|++++
T Consensus       228 ------~~p~~~s~---~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 ------DFPEKFFP---KARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ------CCCTTCCH---HHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ------CCCccCCH---HHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                  11111112   34568889999999999999987554

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-56  Score=400.49  Aligned_cols=255  Identities=25%  Similarity=0.346  Sum_probs=205.4

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC-cchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD-EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ..+.|+..+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+++|++++||||+++++++.+.+..|+
T Consensus        13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            445688899999999999999975 56889999998654433 3445679999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTN  220 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  220 (371)
                      |||||++|+|..++.....+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||++...... 
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            999999999988888888899999999999999999999999   9999999999999999999999999999865432 


Q ss_pred             cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccc
Q 037946          221 YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAV  300 (371)
Q Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                           ....||+.|||||++.+.    ....++.++|||||||++|||++|..||.....  ...   +........+. 
T Consensus       169 -----~~~~GT~~Y~APE~~~~~----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~---~~~i~~~~~~~-  233 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA---LYHIAQNESPA-  233 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTT----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH---HHHHHHSCCCC-
T ss_pred             -----CccccCccccCHHHHhcc----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHH---HHHHHhCCCCC-
Confidence                 345799999999987532    134578899999999999999999999864321  111   11111111110 


Q ss_pred             cccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          301 SILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                       ..   ....++       .+.+++.+||+.||++|||++|+++|-+
T Consensus       234 -~~---~~~~s~-------~~~~li~~~L~~dP~~Rpt~~ell~Hp~  269 (309)
T d1u5ra_         234 -LQ---SGHWSE-------YFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (309)
T ss_dssp             -CS---CTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             -CC---CCCCCH-------HHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence             00   011222       3445778899999999999999998643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=393.61  Aligned_cols=267  Identities=25%  Similarity=0.414  Sum_probs=203.4

Q ss_pred             ccccCCccccCCceEEEEEEeCCC-----CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNG-----ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      +|+..++||+|+||.||+|.++..     ..||||++... ........|.+|++++++++|||||+++|++.+.+..++
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            567788999999999999976432     36999998543 334455679999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+.++++.+++... ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999987654 5799999999999999999999999   9999999999999999999999999999876543


Q ss_pred             Ccc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ... .......||+.|+|||.+.       +..++.++|||||||++|||++|+.|+..... ...+...+......   
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~~---  232 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRL---  232 (283)
T ss_dssp             ----------CCCGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTCCC---
T ss_pred             CccceEeccCCCCccccCHHHHc-------cCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHHHHhccCCC---
Confidence            321 1223456899999999765       34788999999999999999997777654332 22333332221110   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCccCCCCC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPEELGKTS  360 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~  360 (371)
                            +....++.       .+.+|+.+||+.||++|||++||++.|+++.+.++.+.+.+
T Consensus       233 ------~~~~~~~~-------~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~~l~  281 (283)
T d1mqba_         233 ------PTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA  281 (283)
T ss_dssp             ------CCCTTCBH-------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBC
T ss_pred             ------CCchhhHH-------HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccccccc
Confidence                  01112222       34557888999999999999999999999987776665433

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-55  Score=390.09  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=207.1

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||+||+|.+. +++.||||++..+   ....+++.+|+++|++++||||++++++|.+.+..++|||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            35777889999999999999764 5889999998543   3345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          144 YISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       144 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      ||++|+|.+++..  ...+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++.......
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999999864  35689999999999999999999999   999999999999999999999999999987655432


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       .......||+.|+|||.+.       +..++.++|||||||++|||++|+.|+..... ...+.+.+......      
T Consensus       171 -~~~~~~~g~~~y~aPE~~~-------~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~~------  235 (287)
T d1opja_         171 -TAHAGAKFPIKWTAPESLA-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRM------  235 (287)
T ss_dssp             -EEETTEEECGGGCCHHHHH-------HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCC------
T ss_pred             -eeeccccccccccChHHHc-------CCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCCC------
Confidence             2233456899999999775       34688999999999999999998877754322 22232322221110      


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                         +....+++       .+.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus       236 ---~~~~~~~~-------~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         236 ---ERPEGCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             ---CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             ---CCCccchH-------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence               11122332       345578889999999999999999999887643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=394.48  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=207.7

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCC----cchHHHHHHHHHHHhccCCCCceeeeceEecCC
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRD----EEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS  136 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  136 (371)
                      ++.++|+..+.||+|+||+||+|.. .+|+.||||++.+....    ....+.+.+|+.+|++++||||+++++++.+.+
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   86 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4556799999999999999999976 46899999998654322    234678999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC----ceEEccccC
Q 037946          137 VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY----EAYLADFGL  212 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~  212 (371)
                      ..|+|||||++|+|.+++...+.+++..+..++.|++.||+|||++   +++||||||+||+++.++    .+|++|||+
T Consensus        87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999999998888899999999999999999999999   999999999999998776    499999999


Q ss_pred             ccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          213 AKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       213 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      +.......   ......||+.|+|||++.+       ..++.++|||||||++|||++|..||.....  ......+...
T Consensus       164 a~~~~~~~---~~~~~~~t~~y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~  231 (293)
T d1jksa_         164 AHKIDFGN---EFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAV  231 (293)
T ss_dssp             CEECTTSC---BCSCCCCCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHTT
T ss_pred             hhhcCCCc---cccccCCCCcccCHHHHcC-------CCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HHHHHHHHhc
Confidence            98775543   3345679999999998753       3678999999999999999999999975322  2222222111


Q ss_pred             hcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          293 MGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ...   ..   .......+       ..+.+++.+||+.||++|||++|++++-
T Consensus       232 ~~~---~~---~~~~~~~s-------~~~~~li~~~L~~dP~~R~s~~eil~hp  272 (293)
T d1jksa_         232 NYE---FE---DEYFSNTS-------ALAKDFIRRLLVKDPKKRMTIQDSLQHP  272 (293)
T ss_dssp             CCC---CC---HHHHTTSC-------HHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             CCC---CC---chhcCCCC-------HHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            100   00   00001111       2345688899999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=390.06  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=200.7

Q ss_pred             cccCC-ccccCCceEEEEEEeC---CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           67 LKDEN-VIGKGCSGVVYKAEMP---NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        67 ~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +...+ .||+|+||.||+|.++   ++..||||++... ......++|.+|+++|++++|||||+++|+|.+ +..|+||
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            44445 4999999999999653   3457999998543 344556789999999999999999999999875 4579999


Q ss_pred             eecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          143 NYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       143 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||++|+|.+++.. ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.......
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            99999999999765 45799999999999999999999999   999999999999999999999999999988765432


Q ss_pred             c-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          222 H-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       222 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      . .......||+.|+|||.+..       ..++.++|||||||++|||+| |..||....  ..++...+......    
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~~~~~----  231 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRM----  231 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCCC----
T ss_pred             ccccccccccCccccChHHHhC-------CCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC----
Confidence            2 22234568999999998753       357889999999999999998 899987543  22333333321110    


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                           +....+++       .+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       232 -----~~p~~~~~-------~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         232 -----ECPPECPP-------ELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             -----CCCTTCCH-------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCcCCH-------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 01122332       3445788899999999999999999887653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=400.87  Aligned_cols=201  Identities=26%  Similarity=0.430  Sum_probs=177.2

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||+||+|.. .+|+.||+|++... ........+.+|+.+|++++||||++++++|.+.+..|+|||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4688889999999999999976 46899999998653 334556789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||++|+|.+++.+.+.+++..+..++.|++.||.|||+ +   +|+||||||+|||+++++.+||+|||+|+.....   
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  158 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence            99999999999888889999999999999999999997 5   8999999999999999999999999999876432   


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIG  280 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  280 (371)
                       ...+.+||+.|+|||++.+       ..++.++||||+||++|||++|+.||.+...
T Consensus       159 -~~~~~~GT~~Y~APEvl~~-------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHC-------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             -ccccccCCccccCchHHcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence             2245689999999998763       4689999999999999999999999976543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=398.84  Aligned_cols=255  Identities=26%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             hccccCCccccCCceEEEEEEeCC-C-----CEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN-G-----ELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      +.|+..+.||+|+||+||+|++.. +     ..||+|.+.... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            468888999999999999997642 2     269999885432 334456889999999998 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 037946          138 KLLLYNYISNGNLQQLLQGNR-----------------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKC  194 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  194 (371)
                      .|+|||||++|+|.+++....                       .+++..++.++.|++.||+|||++   +|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence            999999999999999996542                       488999999999999999999999   999999999


Q ss_pred             CCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCC
Q 037946          195 NNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRS  273 (371)
Q Consensus       195 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~  273 (371)
                      +||+++.++.+||+|||+++...............||+.|||||.+.       +..++.++|||||||++|||+| |..
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-------EGIYTIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-------CCCCCcceeccchhHHHHHHHhCCCC
Confidence            99999999999999999998766554333344567899999999775       3468899999999999999998 888


Q ss_pred             CCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          274 AVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ||.....+ ..+...+......         +....+++       .+.+|+.+||+.||++|||++||+++|.
T Consensus       266 Pf~~~~~~-~~~~~~~~~~~~~---------~~p~~~~~-------~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         266 PYPGIPVD-ANFYKLIQNGFKM---------DQPFYATE-------EIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SSTTCCCS-HHHHHHHHTTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCHH-HHHHHHHhcCCCC---------CCCCcCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            88654332 2233322221110         00112222       3455788899999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.7e-55  Score=399.11  Aligned_cols=254  Identities=21%  Similarity=0.338  Sum_probs=205.4

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .+.++|+..+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+|++++||||+++++++.+.+..|+
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4567899999999999999999976 46899999998532  33445788999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC--CCceEEccccCccccC
Q 037946          141 LYNYISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS--KYEAYLADFGLAKLMN  217 (371)
Q Consensus       141 v~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~  217 (371)
                      |||||++|+|.+++. ....+++..+..++.||+.||.|||++   +++||||||+|||++.  ++.+||+|||+++...
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            999999999999985 455799999999999999999999999   9999999999999964  6789999999998776


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...   ......||+.|||||++.+       ..++.++|||||||++|||++|..||....  .......+........
T Consensus       178 ~~~---~~~~~~gT~~Y~aPEv~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~  245 (350)
T d1koaa2         178 PKQ---SVKVTTGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMD  245 (350)
T ss_dssp             TTS---CEEEECSCTTTCCHHHHHT-------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCSC
T ss_pred             ccc---ccceecCcccccCHHHHcC-------CCCChhHhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCC
Confidence            543   3345679999999998763       367889999999999999999999996432  2222222222111100


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                            .......++       .+.+++.+||+.||++|||++|++++
T Consensus       246 ------~~~~~~~s~-------~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 ------DSAFSGISE-------DGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ------CGGGGGCCH-------HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ------cccccCCCH-------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  011112222       34557888999999999999999997

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=383.48  Aligned_cols=257  Identities=26%  Similarity=0.434  Sum_probs=200.2

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||.||+|.+++++.||||++....   ...+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            4688899999999999999998888899999985433   334679999999999999999999999865 557899999


Q ss_pred             cCCCCHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQG--NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|..++..  ...+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++....... 
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            999999998864  34699999999999999999999999   999999999999999999999999999987654432 


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .......||+.|+|||.+.       +..++.++|||||||++|||+||+.|+..... ...+...+......       
T Consensus       169 ~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~~~~~~-------  233 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRM-------  233 (285)
T ss_dssp             -------CCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCC-------
T ss_pred             eeeccccccccccChHHHh-------CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCC-------
Confidence            2334467999999999765       34788999999999999999998777654433 22333333321110       


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCC
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAP  353 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  353 (371)
                        +....++.       .+.+++.+||+.||++|||+++|++.|+......
T Consensus       234 --~~~~~~~~-------~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 --PCPPECPE-------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             --CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --CCCcccCH-------HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence              01112222       3445788899999999999999999999876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.2e-54  Score=395.55  Aligned_cols=253  Identities=19%  Similarity=0.290  Sum_probs=204.6

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEE
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.+.|+..+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+++|++++||||+++++++.+.+..|+|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            456799999999999999999976 57999999998543  233456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc--CCCceEEccccCccccCC
Q 037946          142 YNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD--SKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~  218 (371)
                      ||||++|+|.+++.... ++++..+..++.||+.||+|||++   +++||||||+|||++  .++.+||+|||++.....
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999999998876544 699999999999999999999999   999999999999997  678999999999988765


Q ss_pred             CCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          219 TNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..   ......||+.|+|||++.+       ..++.++|||||||++|||+||..||....  .......+.......  
T Consensus       182 ~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~--  247 (352)
T d1koba_         182 DE---IVKVTTATAEFAAPEIVDR-------EPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEF--  247 (352)
T ss_dssp             TS---CEEEECSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCCCCC--
T ss_pred             CC---ceeeccCcccccCHHHHcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCC--
Confidence            43   3345679999999998753       367899999999999999999999996432  222222222211110  


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                          ........++       .+.+|+.+||+.||.+|||++|++++
T Consensus       248 ----~~~~~~~~s~-------~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 ----DEDAFSSVSP-------EAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ----CSSTTTTSCH-------HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----CcccccCCCH-------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0111112222       34568888999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-54  Score=387.69  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|+..+.||+|+||+||+|+..      +++.||||++.. ........++.+|++++++++||||++++++|.+.+..
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT-TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh-hcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            46888899999999999999763      357899999854 23344567899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 037946          139 LLLYNYISNGNLQQLLQGN------------------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKC  194 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  194 (371)
                      +++|||+++|+|.+++...                        ..+++..+..++.|++.||+|||++   +++||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence            9999999999999998542                        2388999999999999999999999   999999999


Q ss_pred             CCeeEcCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCC-
Q 037946          195 NNILLDSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS-  273 (371)
Q Consensus       195 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~-  273 (371)
                      +|||+|.++.+||+|||+++...............||+.|+|||.+.       +..++.++|||||||++|||++|.. 
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-------YNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-------cCCCChhhhhccchhhHHHHHccCCC
Confidence            99999999999999999998765554334445667999999999775       3478999999999999999999975 


Q ss_pred             CCCCCCCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          274 AVQPQIGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ||...  +..++...+......         +....+++       .+.+|+.+||+.||++||||.||++.|+++.
T Consensus       242 p~~~~--~~~e~~~~v~~~~~~---------~~p~~~~~-------~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         242 PYYGM--AHEEVIYYVRDGNIL---------ACPENCPL-------ELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTTS--CHHHHHHHHHTTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCC--CHHHHHHHHHcCCCC---------CCCccchH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            45432  223333333221110         11122332       3456788899999999999999999999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.9e-54  Score=381.46  Aligned_cols=259  Identities=22%  Similarity=0.325  Sum_probs=208.6

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcc-------hHHHHHHHHHHHhccC-CCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEE-------PVDSFAAEIQILGHIR-HRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  135 (371)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++.+......       ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5688899999999999999976 5789999999976543321       2346889999999996 99999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      +..|+|||||++|+|.+++...+.+++..+..++.||+.||+|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence            99999999999999999998888999999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .....   ......||+.|+|||.+.+... .....++.++||||+||++|||++|+.||....  .......+......
T Consensus       160 ~~~~~---~~~~~~gt~~y~~PE~~~~~~~-~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--~~~~~~~i~~~~~~  233 (277)
T d1phka_         160 LDPGE---KLREVCGTPSYLAPEIIECSMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGNYQ  233 (277)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHHC-TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCC
T ss_pred             ccCCC---ceeeeeccCCCCCHHHhhcccc-ccCCCCCchheEcccchhhhhhccCCCCCCCCC--HHHHHHHHHhCCCC
Confidence            76543   2345679999999998875422 223457889999999999999999999997542  22222222221111


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                            ...+.....++       .+.+++.+||+.||++|||++|++++
T Consensus       234 ------~~~~~~~~~s~-------~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         234 ------FGSPEWDDYSD-------TVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ------CCTTTGGGSCH-------HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ------CCCcccccCCH-------HHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  11111122222       34557888999999999999999886

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-54  Score=389.02  Aligned_cols=250  Identities=23%  Similarity=0.291  Sum_probs=205.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||.||+|.. .+|+.||+|++.+... .....+.+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            3588889999999999999976 5799999999965432 2345677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |||++|+|.+++...+.+++..+..++.|++.||+|||++   +++||||||+|||++.+|.+||+|||+++......  
T Consensus        85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--  159 (337)
T d1o6la_          85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence            9999999999999988999999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  ...+...+..   ...     
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~-------~~y~~~~DiwSlGvilyeml~G~~pf~~~~--~~~~~~~i~~---~~~-----  222 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILM---EEI-----  222 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH---CCC-----
T ss_pred             cccccceeCHHHhhhhhccC-------CCCChhhcccchhhHHHHHHHCCCCCCCcC--HHHHHHHHhc---CCC-----
Confidence            23455789999999998763       367899999999999999999999997543  2222222221   111     


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~  345 (371)
                            ..|.....   .+.+++.+||+.||++||+     ++|+++|
T Consensus       223 ------~~p~~~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         223 ------RFPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ------CCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ------CCCccCCH---HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                  11111112   2445788899999999994     8999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-53  Score=384.16  Aligned_cols=247  Identities=22%  Similarity=0.299  Sum_probs=203.8

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      +.|+..+.||+|+||+||+|+. .+|+.||||++.+... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            3588889999999999999976 4689999999864332 2344678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |||+||+|..++.....+++..+..++.||+.||+|||++   +++||||||+|||++.+|.+||+|||+++......  
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--  158 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  158 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                         ...+||+.|+|||++.+       ..++.++|||||||++|||++|+.||....  ...+...+..   .....   
T Consensus       159 ---~~~~Gt~~Y~APE~l~~-------~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~---~~~~~---  220 (316)
T d1fota_         159 ---YTLCGTPDYIAPEVVST-------KPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILN---AELRF---  220 (316)
T ss_dssp             ---CCCCSCTTTCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHH---CCCCC---
T ss_pred             ---ccccCcccccCHHHHcC-------CCCCchhhccccchhHHHHHhCCCCCCCcC--HHHHHHHHHc---CCCCC---
Confidence               45689999999998753       367889999999999999999999996432  2222222221   10100   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~  345 (371)
                          ....++       .+.+++.+||+.||.+||     |++++++|
T Consensus       221 ----p~~~s~-------~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         221 ----PPFFNE-------DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ----CTTSCH-------HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCCH-------HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                011222       234577789999999996     99999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=377.14  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=191.5

Q ss_pred             hccccCCccccCCceEEEEEEeCC----CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN----GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|.+..    +..||||.+.. .......+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT-TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc-ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            468888999999999999997642    34688998743 3344556789999999999999999999999964 67899


Q ss_pred             EEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ||||+++|+|.+++.. ...+++..++.++.|++.||.|||++   +++||||||+||++++++.+||+|||+++.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998754 45689999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .. .......||+.|+|||.+.       +..++.++|||||||++|||+| |.+||.....  ..+...+......   
T Consensus       162 ~~-~~~~~~~gt~~y~apE~l~-------~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~~~~~~---  228 (273)
T d1mp8a_         162 TY-YKASKGKLPIKWMAPESIN-------FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGERL---  228 (273)
T ss_dssp             ----------CCGGGCCHHHHH-------HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCC---
T ss_pred             cc-eeccceecCcccchhhHhc-------cCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCC---
Confidence            32 2234556899999999875       3467899999999999999998 7888764432  2333333221110   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                            +....+++       .+.+|+.+||+.||++|||++||+++|+++.
T Consensus       229 ------~~~~~~~~-------~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         229 ------PMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             ------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCH-------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                  11122332       3445778899999999999999999998875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=375.39  Aligned_cols=248  Identities=28%  Similarity=0.413  Sum_probs=191.5

Q ss_pred             ccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-CCeEEEEEee
Q 037946           66 CLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-KSVKLLLYNY  144 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  144 (371)
                      +|+..+.||+|+||.||+|.. +|+.||||++..+    ...+.+.+|++++++++||||++++|+|.+ .+..|+||||
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            467788999999999999988 5789999998532    334678999999999999999999999865 4668999999


Q ss_pred             cCCCCHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          145 ISNGNLQQLLQGNR--NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       145 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      +++|+|.+++....  .+++..+..++.||+.||.|||+.   +++||||||+||+++.++.+||+|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999996543  489999999999999999999999   9999999999999999999999999999865433   


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                        .....+|+.|+|||.+.       +..++.++|||||||++|||+| |..|+...  +...+...+.....       
T Consensus       157 --~~~~~~~~~y~aPE~l~-------~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~-------  218 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYK-------  218 (262)
T ss_dssp             -------CCTTTSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCC-------
T ss_pred             --CccccccccCCChHHHh-------CCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC-------
Confidence              23456899999999765       3468999999999999999998 56666543  22333333322111       


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                            ...++....   .+.+++.+||+.||++|||+.+++++|+++++
T Consensus       219 ------~~~~~~~~~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         219 ------MDAPDGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ------CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCccCCH---HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                  111222112   33457888999999999999999999998863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=384.83  Aligned_cols=257  Identities=22%  Similarity=0.344  Sum_probs=197.2

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCC----EEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGE----LIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      .|+..+.||+|+||+||+|.+. +|+    .||+|++... .+....+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            3778899999999999999753 444    5888888532 3445567899999999999999999999999875 5678


Q ss_pred             EEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +||++.+|+|.+++.. ...+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8899999999887765 45799999999999999999999999   9999999999999999999999999999987665


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..........||+.|+|||.+.       +..++.++|||||||++|||+| |..||.....  ..+...+......   
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~-------~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~~~~---  232 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESIL-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERL---  232 (317)
T ss_dssp             CC--------CCTTTSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHTCCC---
T ss_pred             cccccccccccCccccChHHHh-------cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCC---
Confidence            4433444557899999999775       3368899999999999999998 6777754332  2333333332111   


Q ss_pred             cccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          299 AVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                            +....+++       .+.+|+.+||+.||++|||++||+++|..+...
T Consensus       233 ------~~p~~~~~-------~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         233 ------PQPPICTI-------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ------CCCTTBCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ------CCCcccCH-------HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                  00112222       344577889999999999999999999887543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=383.83  Aligned_cols=254  Identities=17%  Similarity=0.245  Sum_probs=203.3

Q ss_pred             HHHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEE
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++.++|+..+.||+|+||+||+|... +++.||+|++...   ......+.+|+++|++++||||+++++++.+.+..|+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            34577999999999999999999764 6889999998542   2334568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCC--CceEEccccCccccC
Q 037946          141 LYNYISNGNLQQLLQGNR-NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSK--YEAYLADFGLAKLMN  217 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~~  217 (371)
                      |||||+||+|.+++...+ .+++..+..++.||+.||.|||++   +++||||||+|||++.+  +.+||+|||+++...
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999999999999998665 699999999999999999999999   99999999999999854  579999999998765


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...   ......+|+.|+|||.+.       +..++.++|||||||++|+|++|..||.....  ......+......  
T Consensus       156 ~~~---~~~~~~~t~~y~ape~~~-------~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--~~~~~~i~~~~~~--  221 (321)
T d1tkia_         156 PGD---NFRLLFTAPEYYAPEVHQ-------HDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYT--  221 (321)
T ss_dssp             TTC---EEEEEESCGGGSCHHHHT-------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCCC--
T ss_pred             cCC---cccccccccccccchhcc-------CCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC--
Confidence            543   334567999999999765       33578899999999999999999999965422  2222222211100  


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                       .   ........+       ..+.+++.+||..||++|||++|++++-
T Consensus       222 -~---~~~~~~~~s-------~~~~~li~~~L~~dp~~R~s~~eil~hp  259 (321)
T d1tkia_         222 -F---DEEAFKEIS-------IEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             -C---CHHHHTTSC-------HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             -C---ChhhccCCC-------HHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence             0   000111122       2345688889999999999999999963

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.7e-52  Score=370.84  Aligned_cols=262  Identities=22%  Similarity=0.321  Sum_probs=200.3

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCC----e
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS----V  137 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  137 (371)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++..... +......+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            35688899999999999999975 5789999999966544 3345668999999999999999999999986543    4


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .|+||||++|++|.+++...+.+++..+..++.|++.||+|||++   +++||||||+|||++.++..+++|||.+....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence            789999999999999998888899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCC-cccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          218 STN-YHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       218 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ... .........||+.|+|||++.       +..++.++|||||||++|||+||..||.....  .   +.........
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~---~~~~~~~~~~  230 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--V---SVAYQHVRED  230 (277)
T ss_dssp             ----------------TTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--H---HHHHHHHHCC
T ss_pred             cccccccccccccCcccccCHHHHc-------CCCCCcceecccchHHHHHHHhCCCCCCCcCH--H---HHHHHHHhcC
Confidence            332 112334567999999999875       33678999999999999999999999964321  1   2222222221


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhccc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-TMKEVVALLMEVK  350 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~  350 (371)
                      .....   ......++       .+.+++.+||+.||++|| |+++++..|.++.
T Consensus       231 ~~~~~---~~~~~~s~-------~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         231 PIPPS---ARHEGLSA-------DLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCCGG---GTSSSCCH-------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCCc---hhccCCCH-------HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            11111   11122232       244577789999999999 8999999887764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-53  Score=385.81  Aligned_cols=247  Identities=19%  Similarity=0.222  Sum_probs=204.0

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccC-CCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTK-RDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++.+.. ......+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4688899999999999999976 469999999985432 22344578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          143 NYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       143 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      ||+.+|+|.+++...+.+++..+..++.||+.||.|||++   +++||||||+|||++.+|.+||+|||+++......  
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCccccc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVSI  302 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                         ....||+.|||||++.+       ..++.++|||||||++|||+||..||...  +...+...+..   .....   
T Consensus       196 ---~~~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~---~~~~~---  257 (350)
T d1rdqe_         196 ---WTLCGTPEALAPEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVS---GKVRF---  257 (350)
T ss_dssp             ---CCCEECGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHH---CCCCC---
T ss_pred             ---ccccCccccCCHHHHcC-------CCCCccccccchhHHHHHHHhCCCCCCCc--CHHHHHHHHhc---CCCCC---
Confidence               45679999999998763       36788999999999999999999999643  22222222221   10000   


Q ss_pred             cCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 037946          303 LDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVAL  345 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~  345 (371)
                          ....++       .+.+++.+||+.||.+|+     |++|+++|
T Consensus       258 ----p~~~s~-------~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         258 ----PSHFSS-------DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----CTTCCH-------HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CccCCH-------HHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                112222       244577889999999994     99999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=374.49  Aligned_cols=258  Identities=26%  Similarity=0.346  Sum_probs=194.6

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC-C
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK-S  136 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  136 (371)
                      ++|+..+.||+|+||.||+|.+.      +++.||||++... ......+.+.+|..++.++ +|+||+.+++++.+. +
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            56888999999999999999753      3468999998542 3344456788888888877 689999999987654 5


Q ss_pred             eEEEEEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEc
Q 037946          137 VKLLLYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLD  200 (371)
Q Consensus       137 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~  200 (371)
                      ..++|||||++|+|.+++...                ..+++..+..++.|++.||+|||++   +++||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence            689999999999999999643                2488999999999999999999999   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCC-CCCCCC
Q 037946          201 SKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRS-AVQPQI  279 (371)
Q Consensus       201 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~-p~~~~~  279 (371)
                      +++.+||+|||+++...............||+.|+|||.+.       +..++.++|||||||++|||+||.. ||... 
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-------~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~-  240 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-  240 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhh-------cCCCCcccceeehHHHHHHHHhCCCCCCCCC-
Confidence            99999999999998766554333445667999999999875       3467899999999999999999765 55433 


Q ss_pred             CCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .....+...+......         ......++       .+.+++.+||+.||++|||++|++++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~---------~~~~~~~~-------~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         241 KIDEEFCRRLKEGTRM---------RAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             CCSHHHHHHHHHTCCC---------CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCC---------CCCccCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2233333333322111         00112222       3455778899999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-52  Score=383.94  Aligned_cols=252  Identities=19%  Similarity=0.214  Sum_probs=199.2

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCC-cchHHHH---HHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRD-EEPVDSF---AAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      +.|+..+.||+|+||.||+|... +|+.||+|++.+.... ......+   ..++.+++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            35888899999999999999764 6999999998543211 1112223   34577788889999999999999999999


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      +|||||++|+|.+++.....+++..+..++.||+.||.|||++   +++||||||+|||++.+|.+||+|||+++.....
T Consensus        84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999999999888899999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA  299 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .    .....||+.|+|||++..      +..++.++|||||||++|||+||..||........  ............. 
T Consensus       161 ~----~~~~~GT~~y~APE~~~~------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~~~~~-  227 (364)
T d1omwa3         161 K----PHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVE-  227 (364)
T ss_dssp             C----CCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSSCCCC-
T ss_pred             c----ccccccccccchhHHhhc------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcccCCCC-
Confidence            2    345679999999998752      23578999999999999999999999976543322  1111111111000 


Q ss_pred             ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 037946          300 VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPT-----MKEVVAL  345 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~  345 (371)
                            .....++       .+.+++.+||+.||++|||     ++|+++|
T Consensus       228 ------~~~~~s~-------~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         228 ------LPDSFSP-------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ------CCSSSCH-------HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ------CCCCCCH-------HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                  0012222       2445778899999999999     7999886

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-52  Score=372.70  Aligned_cols=265  Identities=25%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             CCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc---chHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEeec
Q 037946           70 ENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE---EPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNYI  145 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  145 (371)
                      .++||+|+||+||+|.+ .+|+.||||++.......   ...+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            45799999999999976 468999999986543222   12357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccccc
Q 037946          146 SNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHAM  225 (371)
Q Consensus       146 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  225 (371)
                      .++++..+......+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++......  ...
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~  157 (299)
T d1ua2a_          83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAY  157 (299)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCC
T ss_pred             cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc--ccc
Confidence            9988888888788899999999999999999999999   99999999999999999999999999998765543  233


Q ss_pred             ccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc--cccc
Q 037946          226 SRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA--VSIL  303 (371)
Q Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  303 (371)
                      ....||+.|+|||++..      ...++.++|||||||++|||++|..||....  +......+..........  ....
T Consensus       158 ~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             CCSCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cceecChhhccHHHHcc------CCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccchh
Confidence            45679999999997652      2356889999999999999999999986442  223333333333221100  0000


Q ss_pred             ----CcccCCCChhhHH-----HHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          304 ----DTKLQGLPDQMVQ-----EMLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       304 ----~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                          .......+.....     ....+.+|+.+||+.||++|||++|+++|=+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence                0000111110011     1124567889999999999999999998743

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-52  Score=374.45  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=209.4

Q ss_pred             hccccCCccccCCceEEEEEEe------CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM------PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  137 (371)
                      ++|+..+.||+|+||.||+|++      .+++.||||++.... .......+.+|+.+++.+ +||||++++++|.+.+.
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            4688889999999999999975      245689999996433 344566899999999999 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          138 KLLLYNYISNGNLQQLLQGNR------------------NLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      .++|||||++|+|.+++....                  .+++..+..++.||+.||+|||++   +++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence            999999999999999986433                  589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQI  279 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  279 (371)
                      +.++.+|++|||.++...............||+.|+|||.+.       +..++.++|||||||++|||+|++.|+....
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc-------CCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            999999999999999876554444445667999999999765       3467899999999999999999666655444


Q ss_pred             CCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          280 GDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .....+...+........         ....++       .+.+|+.+||+.||.+|||+++|++.|+++.
T Consensus       252 ~~~~~~~~~i~~~~~~~~---------~~~~~~-------~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         252 PVDSKFYKMIKEGFRMLS---------PEHAPA-------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             CSSHHHHHHHHHTCCCCC---------CTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCC---------cccccH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            443444444433221100         011222       3455788899999999999999999998765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=378.57  Aligned_cols=258  Identities=27%  Similarity=0.406  Sum_probs=198.0

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCC--EEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecCCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGE--LIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNKSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  140 (371)
                      ++|+..+.||+|+||.||+|.+. +|.  .||||++.. .......+.+.+|+++|+++ +||||++++|+|.+.+..++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC-C------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECc-ccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            45777889999999999999764 343  478888743 22334556799999999999 79999999999999999999


Q ss_pred             EEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCc
Q 037946          141 LYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYE  204 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~  204 (371)
                      ||||+++|+|.+++...                ..+++..+..++.||+.||.|||++   +++||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence            99999999999999654                5689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCC-CCCCCCCch
Q 037946          205 AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSA-VQPQIGDGL  283 (371)
Q Consensus       205 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p-~~~~~~~~~  283 (371)
                      +||+|||+++......   ......||..|+|||.+.       +..++.++|||||||++|||++|..| |...  +..
T Consensus       166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-------~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~~~  233 (309)
T d1fvra_         166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCA  233 (309)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHHH-------HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHH
T ss_pred             eEEccccccccccccc---cccceecCCcccchHHhc-------cCCCCccceeehhHHHHHHHHhcCCCCCCCC--CHH
Confidence            9999999997654332   223456899999999775       33678899999999999999998764 4322  222


Q ss_pred             hHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCCCc
Q 037946          284 HIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSAPE  354 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  354 (371)
                      .+...+....   .          ...+.....   .+.+|+.+||+.||++|||++||+++|+++.+...
T Consensus       234 ~~~~~i~~~~---~----------~~~~~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         234 ELYEKLPQGY---R----------LEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             HHHHHGGGTC---C----------CCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHHHHhcC---C----------CCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            2222221110   0          111111112   34457788999999999999999999999875443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=371.55  Aligned_cols=255  Identities=26%  Similarity=0.454  Sum_probs=199.1

Q ss_pred             CCccccCCceEEEEEEeCCC----CEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec-CCeEEEEEee
Q 037946           70 ENVIGKGCSGVVYKAEMPNG----ELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN-KSVKLLLYNY  144 (371)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  144 (371)
                      .++||+|+||+||+|.+.++    ..||||++.. ..+....++|.+|+++|++++||||++++|++.+ .+..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            46799999999999976432    2589999853 3345566889999999999999999999999865 5688999999


Q ss_pred             cCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          145 ISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       145 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      |++|+|.+++... ...++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++.........
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            9999999988754 4578889999999999999999999   99999999999999999999999999998765543221


Q ss_pred             --ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          224 --AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                        ......||+.|+|||.+.       +..++.++||||||+++|||+||+.||...... ..+...+......   .  
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~~---~--  254 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRL---L--  254 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC---C--
T ss_pred             ceecccccccccccChHHHh-------cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCC---C--
Confidence              223456899999999765       347899999999999999999988887644322 2222222221111   0  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccCC
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKSA  352 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  352 (371)
                          ....+++       .+.+|+.+||+.||++|||++||+++|+++.+.
T Consensus       255 ----~p~~~~~-------~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         255 ----QPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ----CCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CcccCcH-------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                0112222       344577889999999999999999999998654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=376.10  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=195.5

Q ss_pred             HHhccccCC-ccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEec----C
Q 037946           63 ILECLKDEN-VIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSN----K  135 (371)
Q Consensus        63 ~~~~~~~~~-~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~  135 (371)
                      +.+.|.+.+ .||+|+||.||+|.+ .+++.||||++..       ...+.+|+.++.++ +||||+++++++.+    .
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            456787654 699999999999975 5789999999842       24567899987655 89999999999865    4


Q ss_pred             CeEEEEEeecCCCCHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN--RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLADF  210 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  210 (371)
                      ..+|+|||||+||+|.+++...  ..+++..+..++.|++.||+|||++   +++||||||+|||++.   ++.+||+||
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            6789999999999999999764  4699999999999999999999999   9999999999999975   567999999


Q ss_pred             cCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 037946          211 GLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVK  290 (371)
Q Consensus       211 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  290 (371)
                      |+++......   ......||+.|+|||++.+.       .++.++|||||||++|+|+||+.||.......  ....+.
T Consensus       159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-------~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~  226 (335)
T d2ozaa1         159 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPE-------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMK  226 (335)
T ss_dssp             TTCEECCCCC---CCCCCSCCCSSCCCCCCCGG-------GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred             ceeeeccCCC---ccccccCCcccCCcHHHcCC-------CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHH
Confidence            9998766543   33556799999999988643       56889999999999999999999996543321  111111


Q ss_pred             HHhcCCCccccccCcccCCCChhhH-HHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMV-QEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .          .+.......+.... .....+.+|+.+||+.||++|||++|++++-
T Consensus       227 ~----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  273 (335)
T d2ozaa1         227 T----------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  273 (335)
T ss_dssp             -----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred             H----------HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence            0          01111111121111 2223456788899999999999999999973

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=373.67  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=200.8

Q ss_pred             hccccCCccccCCceEEEEEEeCC--------CCEEEEEEecccCCCcchHHHHHHHHHHHhcc-CCCCceeeeceEecC
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPN--------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHI-RHRNIVKLLGYCSNK  135 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  135 (371)
                      ++|+..+.||+|+||.||+|+...        +..||||++.... .......+.+|...+.++ +||||++++++|.+.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            467888999999999999996532        2479999985433 344567889999999888 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeE
Q 037946          136 SVKLLLYNYISNGNLQQLLQGN----------------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILL  199 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill  199 (371)
                      +..++||||+++|+|.+++...                ..+++..++.++.|++.||+|||++   +++||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            9999999999999999999644                3489999999999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 037946          200 DSKYEAYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQ  278 (371)
Q Consensus       200 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  278 (371)
                      +.++.+||+|||+++...............||+.|+|||.+.       +..++.++|||||||++|||++ |.+||...
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-------~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~  241 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  241 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc-------CCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence            999999999999998876655444455677999999999775       3478999999999999999998 57776532


Q ss_pred             CCCchhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          279 IGDGLHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      .  ...+...+......         +.....++       .+.+|+.+||+.||++|||++||++.|+++.
T Consensus       242 ~--~~~~~~~i~~~~~~---------~~p~~~~~-------~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         242 P--VEELFKLLKEGHRM---------DKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             C--HHHHHHHHHTTCCC---------CCCSSCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C--HHHHHHHHHcCCCC---------CCCccchH-------HHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            2  22233322221110         00112222       3456888899999999999999999998874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=374.28  Aligned_cols=258  Identities=22%  Similarity=0.367  Sum_probs=205.2

Q ss_pred             hccccCCccccCCceEEEEEEeC------CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP------NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  138 (371)
                      ++|+..+.||+|+||.||+|.+.      +++.||||++... ........+.+|+.++++++||||++++++|...+..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            46788899999999999999652      3578999998543 3445556799999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEc
Q 037946          139 LLLYNYISNGNLQQLLQGN----------RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLA  208 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  208 (371)
                      ++||||+++|+|.+++...          ..+++..+..++.|++.||.|||++   +++||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            9999999999999988532          3478999999999999999999999   99999999999999999999999


Q ss_pred             cccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCchhHHH
Q 037946          209 DFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGR-SAVQPQIGDGLHIVE  287 (371)
Q Consensus       209 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~~~  287 (371)
                      |||+++...............||+.|+|||.+.       +..++.++||||||+++|||+||. .|+...  +..+...
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~-------~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--~~~~~~~  246 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLR  246 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-------HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHc-------cCCCCcccccccHHHHHHHHHhCCCCCCCCC--CHHHHHH
Confidence            999998776554444445557999999999765       346788999999999999999986 445322  2222222


Q ss_pred             HHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcccC
Q 037946          288 WVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVKS  351 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  351 (371)
                      .+.....         -+....+++       .+.+++.+||+.||++|||+++|+++|++..+
T Consensus       247 ~i~~~~~---------~~~p~~~~~-------~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVMEGGL---------LDKPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTTCC---------CCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHhCCC---------CCCcccchH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2221110         001112222       35557788999999999999999999988754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-53  Score=378.11  Aligned_cols=271  Identities=26%  Similarity=0.305  Sum_probs=196.3

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHH--HHHHHhccCCCCceeeeceEecCC----eE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAA--EIQILGHIRHRNIVKLLGYCSNKS----VK  138 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~~~~~~~~~~----~~  138 (371)
                      +.|...+.||+|+||.||+|+. +|+.||||++...     ....+..  |+..++.++||||++++++|.+.+    ..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            3466678899999999999987 6899999998432     2233444  555556789999999999997653    57


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          139 LLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHD-----CVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      |+|||||++|+|.+++++. .+++..++.++.|++.||+|+|+.     ...+|+||||||+|||++.++.+||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999999875 599999999999999999999973     1239999999999999999999999999999


Q ss_pred             cccCCCCcc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc---------
Q 037946          214 KLMNSTNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDG---------  282 (371)
Q Consensus       214 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---------  282 (371)
                      +........  .......||+.|+|||.+..... .....++.++|||||||+||||+||..|+.......         
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSC-TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ccccCCCcceeccccceecccCcCChhhcccccc-ccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            876544321  12345679999999998753210 011235678999999999999999988774322211         


Q ss_pred             -hhHHHHHHHHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          283 -LHIVEWVKKKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       283 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                       ..... .......     ...++.+..... .......+.+++.+||+.||++|||+.||++.|.++.
T Consensus       235 ~~~~~~-~~~~~~~-----~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         235 DPSVEE-MRKVVCE-----QKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCCHHH-HHHHHTT-----SCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchHHH-HHHHHhc-----cccCCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence             11111 1111111     001111111110 1123445667999999999999999999999999886

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=366.17  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=191.2

Q ss_pred             hccccCCccccCCceEEEEEEeC--CC--CEEEEEEecccCC-CcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP--NG--ELIAVKKLWKTKR-DEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  139 (371)
                      +.|+..+.||+|+||.||+|+..  ++  ..||||++..... .....++|.+|+.++++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            35788889999999999999653  23  3689999865443 34456789999999999999999999999976 4678


Q ss_pred             EEEeecCCCCHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCC
Q 037946          140 LLYNYISNGNLQQLLQG-NRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNS  218 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  218 (371)
                      +||||+++|++.+++.. ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999987754 45699999999999999999999999   999999999999999999999999999998755


Q ss_pred             CCcccc-cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHHhcCC
Q 037946          219 TNYHHA-MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILS-GRSAVQPQIGDGLHIVEWVKKKMGSF  296 (371)
Q Consensus       219 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ...... .....||+.|+|||.+.+       ..++.++|||||||++|||+| |..||....  .......+.   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--~~~~~~~i~---~~~  231 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKID---KEG  231 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHH---TSC
T ss_pred             CCCcceecCccccCcccCCHHHHhC-------CCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--HHHHHHHHH---hCC
Confidence            542222 234568889999998763       356889999999999999998 899886432  222222222   111


Q ss_pred             CccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhcc
Q 037946          297 EPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEV  349 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  349 (371)
                      ...     +.....++       .+.+|+.+||+.||++|||++||++.|.+.
T Consensus       232 ~~~-----~~~~~~~~-------~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ERL-----PRPEDCPQ-------DIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCC-----CCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC-----CCcccccH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            100     11123332       344578889999999999999999998764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=377.95  Aligned_cols=250  Identities=24%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCC-CcchHHHHHHHHHHHh-ccCCCCceeeeceEecCCeEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKR-DEEPVDSFAAEIQILG-HIRHRNIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  141 (371)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++.+... .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4588889999999999999976 4689999999965332 2334566777777765 68999999999999999999999


Q ss_pred             EeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCc
Q 037946          142 YNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNY  221 (371)
Q Consensus       142 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  221 (371)
                      |||+++|+|.+++.....+++..+..++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++...... 
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence            99999999999999888899999999999999999999999   99999999999999999999999999998765443 


Q ss_pred             ccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcccc
Q 037946          222 HHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPAVS  301 (371)
Q Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                       .......||+.|+|||++.       +..++.++|||||||++|||++|+.||....  ...+...+...  . ...  
T Consensus       158 -~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~--~-~~~--  222 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILL-------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMD--N-PFY--  222 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC--C-CCC--
T ss_pred             -ccccccCCCCCcCCHHHHc-------CCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHcC--C-CCC--
Confidence             2334567999999999876       3467899999999999999999999997542  22332222211  1 100  


Q ss_pred             ccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHH-HHHHH
Q 037946          302 ILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMK-EVVAL  345 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~~  345 (371)
                           ....++       .+.+|+.+||+.||++|||+. ++++|
T Consensus       223 -----p~~~s~-------~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         223 -----PRWLEK-------EAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             -----CTTSCH-------HHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -----CccCCH-------HHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                 011222       245678889999999999995 78754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=369.46  Aligned_cols=268  Identities=22%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      +.|+..+.||+|+||+||+|.+ .+|+.||+|++......+...+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4688889999999999999976 568999999996555444556789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcc
Q 037946          144 YISNGNLQQLLQ-GNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYH  222 (371)
Q Consensus       144 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  222 (371)
                      |+.++.+..... ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            998754544433 355699999999999999999999999   99999999999999999999999999998765443  


Q ss_pred             cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc-cc
Q 037946          223 HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA-VS  301 (371)
Q Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~  301 (371)
                      .......||+.|+|||.+..      ...++.++|||||||++|+|++|+.||....  .......+.......... ..
T Consensus       157 ~~~~~~~gt~~y~apE~~~~------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTST
T ss_pred             ccceeecccceeeehhhhcc------ccCCCccccccccchhhhHHhhCCCCCCCCC--HHHHHHHHHHhcCCCchhhcc
Confidence            23345679999999997653      2345789999999999999999999996432  122222222222111100 00


Q ss_pred             c---c---CcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          302 I---L---DTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       302 ~---~---~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .   .   ............     .....+.+++.+||..||++|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0   0   000000000000     111345668889999999999999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-51  Score=367.52  Aligned_cols=265  Identities=25%  Similarity=0.328  Sum_probs=204.9

Q ss_pred             hccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEee
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYNY  144 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  144 (371)
                      ++|+..+.||+|+||+||+|.+++|+.||||++......+.....+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            46888899999999999999988999999999966555555568899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCcccc
Q 037946          145 ISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHHA  224 (371)
Q Consensus       145 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  224 (371)
                      +.++.+..+....+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.+........  .
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  156 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K  156 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc--c
Confidence            99988888888888899999999999999999999999   999999999999999999999999999987655432  2


Q ss_pred             cccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc-----
Q 037946          225 MSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA-----  299 (371)
Q Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  299 (371)
                      .....|++.|+|||.+.+      ...++.++|||||||++|||++|+.||....  .......+..........     
T Consensus       157 ~~~~~~~~~y~~pE~~~~------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cceecccchhhhHHHHhC------CCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCChhhccch
Confidence            344568999999997653      2356899999999999999999999996432  222222222222211000     


Q ss_pred             cccc--Cccc--------CCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 VSIL--DTKL--------QGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 ~~~~--~~~~--------~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ....  ....        .......   ...+.+++.+||+.||++|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGL---DESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSC---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccccccCcchhhhcccC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000  0000        0001111   1234568888999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=363.41  Aligned_cols=244  Identities=20%  Similarity=0.330  Sum_probs=196.1

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCc----chHHHHHHHHHHHhccC--CCCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDE----EPVDSFAAEIQILGHIR--HRNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~  137 (371)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++.+.....    ....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4688899999999999999976 468999999986543322    11234678999999986  8999999999999999


Q ss_pred             EEEEEeecCC-CCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-CCceEEccccCccc
Q 037946          138 KLLLYNYISN-GNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-KYEAYLADFGLAKL  215 (371)
Q Consensus       138 ~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~  215 (371)
                      .|+||||+.+ +++.+++.....+++..+..++.|++.||+|||++   +++||||||+|||++. ++.+||+|||+++.
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence            9999999976 68888998888899999999999999999999999   9999999999999985 57999999999986


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ....    ......||+.|+|||++.+..      .++.++|||||||++|||++|..||...    ..+    ...  .
T Consensus       161 ~~~~----~~~~~~GT~~y~aPE~~~~~~------~~~~~~DiwSlGvilyell~g~~Pf~~~----~~i----~~~--~  220 (273)
T d1xwsa_         161 LKDT----VYTDFDGTRVYSPPEWIRYHR------YHGRSAAVWSLGILLYDMVCGDIPFEHD----EEI----IRG--Q  220 (273)
T ss_dssp             CCSS----CBCCCCSCGGGSCHHHHHHSC------BCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH----HHC--C
T ss_pred             cccc----cccccccCCCcCCHHHHcCCC------CCCcccccccceeeehhHhhCCCCCCCc----hHH----hhc--c
Confidence            5443    234567999999999876431      2356799999999999999999998632    111    110  0


Q ss_pred             CCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          296 FEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                       .    .+.   ...++       .+.+++.+||+.||++|||++|++++-
T Consensus       221 -~----~~~---~~~s~-------~~~~li~~~L~~dp~~R~s~~eil~hp  256 (273)
T d1xwsa_         221 -V----FFR---QRVSS-------ECQHLIRWCLALRPSDRPTFEEIQNHP  256 (273)
T ss_dssp             -C----CCS---SCCCH-------HHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             -c----CCC---CCCCH-------HHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence             0    011   12222       344578889999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=362.23  Aligned_cols=263  Identities=22%  Similarity=0.327  Sum_probs=196.7

Q ss_pred             hccccCCccccCCceEEEEEEe-CC-CCEEEEEEecccCCCcchHHHHHHHHHHHhcc---CCCCceeeeceEec-----
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PN-GELIAVKKLWKTKRDEEPVDSFAAEIQILGHI---RHRNIVKLLGYCSN-----  134 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----  134 (371)
                      ++|+..+.||+|+||+||+|.+ .+ ++.||||++............+.+|+.+++.+   +||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            5788999999999999999976 34 56799999866554444444566788777766   79999999999853     


Q ss_pred             CCeEEEEEeecCCCCHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCc
Q 037946          135 KSVKLLLYNYISNGNLQQLL-QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLA  213 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  213 (371)
                      ....+++|||++++++.... .....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence            35689999999988776554 3455699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHh
Q 037946          214 KLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKM  293 (371)
Q Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  293 (371)
                      +......   ......||+.|+|||++.       +..++.++||||+||++|||++|+.||....  .......+....
T Consensus       164 ~~~~~~~---~~~~~~gT~~Y~APE~~~-------~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~  231 (305)
T d1blxa_         164 RIYSFQM---ALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVI  231 (305)
T ss_dssp             CCCCGGG---GGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHH
T ss_pred             hhhcccc---cCCCcccChhhcCcchhc-------CCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhh
Confidence            8654432   345678999999999875       3468899999999999999999999996542  222222232222


Q ss_pred             cCCCccc---------cccCc----ccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          294 GSFEPAV---------SILDT----KLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       294 ~~~~~~~---------~~~~~----~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      .......         .....    .....+...   ...+.+|+.+||+.||++|||++|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI---DELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccC---CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            2111000         00000    000011111   1234457888999999999999999987

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=362.62  Aligned_cols=267  Identities=22%  Similarity=0.333  Sum_probs=198.6

Q ss_pred             HHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC-----
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS-----  136 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  136 (371)
                      +.++|+..+.||+|+||+||+|.+ .+|+.||||++..........+.+.+|+++|+.++||||++++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            456788999999999999999976 46999999999765555566778999999999999999999999997654     


Q ss_pred             -eEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          137 -VKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       137 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                       ..|+||||+ +++|..+++. ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+|++|||+++.
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence             579999999 5578877765 4599999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ....     .....||+.|+|||.+.+.      ..++.++||||+||++|+|++|..||....  ..............
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlGvil~ell~g~~pf~~~~--~~~~~~~~~~~~~~  237 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNW------MRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEIMKVTGT  237 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTT------TCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCC
T ss_pred             cCCc-----cccccccccccCHHHHcCC------CCCCccchhhcchHHHHHHHHCcCCCCCCC--hHHHHHHHHhccCC
Confidence            6543     2456799999999987532      346889999999999999999999996542  12222222221111


Q ss_pred             CCcc-----------------ccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--Hhccc
Q 037946          296 FEPA-----------------VSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVK  350 (371)
Q Consensus       296 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~  350 (371)
                      ....                 .......+.......   ...+.+|+.+||..||++|||++|+++|  ++.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA---SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTC---CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CcHHHHhhhcchhhhhhhccCCcccccchHHhccCC---CHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0000                 000000001111111   1234568888999999999999999998  55554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-49  Score=356.21  Aligned_cols=273  Identities=22%  Similarity=0.309  Sum_probs=205.9

Q ss_pred             HhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec--------
Q 037946           64 LECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN--------  134 (371)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  134 (371)
                      .++|+..+.||+|+||+||+|.+ .+|+.||||++......+.....+.+|+.+|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36799999999999999999976 579999999987665555666788999999999999999999998754        


Q ss_pred             CCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          135 KSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      .+..|+||||+.++++.........+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence            356899999999888887777778899999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc--cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHH
Q 037946          215 LMNSTNYH--HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKK  292 (371)
Q Consensus       215 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  292 (371)
                      ........  .......||+.|+|||++.+.      ..++.++|||||||++|||++|+.||...  +.......+...
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~------~~~~~k~DiwSlGvil~el~~g~~pf~~~--~~~~~~~~i~~~  237 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE------RDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQL  237 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTC------SSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHH
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCC------CCCCcHHHcccCCceeeeHhhCCCCCCCC--CHHHHHHHHHHh
Confidence            76543321  122345799999999986532      35789999999999999999999999653  233333444444


Q ss_pred             hcCCCccc-cccC-c-------ccCCCChhhHHH------HHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 037946          293 MGSFEPAV-SILD-T-------KLQGLPDQMVQE------MLQTLGIAMFCVNSSPAERPTMKEVVALLM  347 (371)
Q Consensus       293 ~~~~~~~~-~~~~-~-------~~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  347 (371)
                      ........ .... .       ............      ...+.+|+.+||+.||++|||++|+++|=+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf  307 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  307 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence            43322110 0000 0       000111111111      223457899999999999999999999855

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=350.60  Aligned_cols=266  Identities=21%  Similarity=0.283  Sum_probs=209.3

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCCeEEEEEe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKSVKLLLYN  143 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  143 (371)
                      ++|+..+.||+|+||+||+|++ .+++.||||++............+.+|+.+++.++||||+++++++.+....+++||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4688889999999999999976 578999999997666566677899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCCCccc
Q 037946          144 YISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNSTNYHH  223 (371)
Q Consensus       144 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  223 (371)
                      ++.+++|..++...+.+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||.++.......  
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence            999999999999999999999999999999999999999   999999999999999999999999999987655431  


Q ss_pred             ccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCcc----
Q 037946          224 AMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEPA----  299 (371)
Q Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  299 (371)
                      ......+++.|+|||.+..      ...++.++|||||||++|||++|+.||....+. ......+..........    
T Consensus       157 ~~~~~~~~~~~~~pe~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTT
T ss_pred             cceeeccccchhhhhHhcc------CCCCCchhhccccchHHHHHhhCCCCCCCCCCH-HHHHHHHHhhcCCCChhhhhh
Confidence            2234457889999997653      224688999999999999999999998643322 22223233322221100    


Q ss_pred             -cccc----------CcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          300 -VSIL----------DTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       300 -~~~~----------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                       ....          ...........   ...+.+|+.+||+.||.+|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKL---NATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTC---CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccccccchhhhccccC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0000          00011111111   1234567888999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=359.61  Aligned_cols=268  Identities=23%  Similarity=0.296  Sum_probs=195.5

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecCC----eEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNKS----VKL  139 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  139 (371)
                      ++|+..+.||+|+||+||+|.+ .+|+.||||++.... .....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            4688899999999999999965 579999999985422 3445678899999999999999999999986543    234


Q ss_pred             EEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccCCC
Q 037946          140 LLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMNST  219 (371)
Q Consensus       140 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  219 (371)
                      ++++++.+|+|.+++... .+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++......
T Consensus        87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            555667789999999765 599999999999999999999999   9999999999999999999999999999876544


Q ss_pred             Ccc-cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCCc
Q 037946          220 NYH-HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFEP  298 (371)
Q Consensus       220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ... .......||+.|+|||++..      +..++.++||||+||++|||++|..||.....  ................
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~~~~~~~~~~~  234 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQ  234 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTT------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCH
T ss_pred             CccceeeccccccceechHHHhhc------CCCCCchhhhhccCceehHHhhCCCCCCCCCH--HHHHHHHhhhccCCCh
Confidence            322 22345679999999998753      33567899999999999999999999964322  1111111111111100


Q ss_pred             cccc------------cCcccCCCChh-h-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          299 AVSI------------LDTKLQGLPDQ-M-VQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       299 ~~~~------------~~~~~~~~~~~-~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                      ....            ..+.....+.. . ......+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000            00000000000 0 0001235678899999999999999999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-50  Score=361.13  Aligned_cols=257  Identities=25%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             hccccCCccccCCceEEEEEEe----CCCCEEEEEEecccCC--CcchHHHHHHHHHHHhccCC-CCceeeeceEecCCe
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM----PNGELIAVKKLWKTKR--DEEPVDSFAAEIQILGHIRH-RNIVKLLGYCSNKSV  137 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  137 (371)
                      +.|+..+.||+|+||+||+|..    .+|+.||||.+.+...  +....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            4588899999999999999964    2478999999864332  22334668899999999966 899999999999999


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccccC
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKLMN  217 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  217 (371)
                      .+++|||+.+|+|.+++...+.+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++...
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            999999999999999999988899999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcCCC
Q 037946          218 STNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGSFE  297 (371)
Q Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .... .......|++.|+|||.+.+.     ...++.++|||||||+||||++|..||........ .............
T Consensus       181 ~~~~-~~~~~~~g~~~~~~pe~~~~~-----~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~~  253 (322)
T d1vzoa_         181 ADET-ERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSEP  253 (322)
T ss_dssp             GGGG-GGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCCC
T ss_pred             cccc-ccccccccccccchhHHhhcC-----CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccCCC
Confidence            4432 223456799999999987532     33567899999999999999999999976543321 1111222111111


Q ss_pred             ccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 037946          298 PAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERP-----TMKEVVAL  345 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~  345 (371)
                      +.       ....+       ..+.+++.+||++||++||     |++|+++|
T Consensus       254 ~~-------~~~~s-------~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         254 PY-------PQEMS-------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CC-------CTTSC-------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CC-------cccCC-------HHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            10       01122       2344577789999999999     58999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=350.75  Aligned_cols=262  Identities=27%  Similarity=0.332  Sum_probs=192.1

Q ss_pred             ccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEec------CCeE
Q 037946           66 CLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSN------KSVK  138 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~  138 (371)
                      .|+..++||+|+||+||+|++. +|+.||||++......      ..+|+++|++++||||+++++++..      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            4777889999999999999764 6899999999654322      2479999999999999999999843      3357


Q ss_pred             EEEEeecCCCCHHHH---hccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccccCcc
Q 037946          139 LLLYNYISNGNLQQL---LQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAK  214 (371)
Q Consensus       139 ~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~  214 (371)
                      |+|||||+++.+..+   ......+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence            899999987643333   34566799999999999999999999999   999999999999999775 89999999998


Q ss_pred             ccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc
Q 037946          215 LMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG  294 (371)
Q Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ......   ......||+.|+|||.+.+      ...++.++||||+||++|||++|..||.....  ......+....+
T Consensus       172 ~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~--~~~l~~i~~~~g  240 (350)
T d1q5ka_         172 QLVRGE---PNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLG  240 (350)
T ss_dssp             ECCTTS---CCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHC
T ss_pred             hccCCc---ccccccccccccChHHhhc------ccCCCcceeecccceEEEehhhCCCCCCCCCH--HHHHHHHHHHhC
Confidence            775543   2345679999999997642      23578999999999999999999999965432  111111111111


Q ss_pred             CCC---------ccccccCcccCC------CChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--Hhccc
Q 037946          295 SFE---------PAVSILDTKLQG------LPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL--LMEVK  350 (371)
Q Consensus       295 ~~~---------~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~  350 (371)
                      ...         ......-+....      ....   ....+.+|+.+||+.||++|||++|++++  ++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR---TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTT---SCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             CChHHhhhhhccchhhccccccccCchhhhcccC---CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            100         000000000000      0001   11234567888999999999999999986  45554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=350.18  Aligned_cols=266  Identities=21%  Similarity=0.266  Sum_probs=193.3

Q ss_pred             HHhccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEe------cC
Q 037946           63 ILECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCS------NK  135 (371)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------~~  135 (371)
                      +.++|+..++||+|+||+||+|.+. +|+.||||++...........++.+|+.++++++||||+++++++.      +.
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            3467999999999999999999764 6999999999766656666678999999999999999999999985      34


Q ss_pred             CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ...|+|||||.++.+. .+.  ..+++..+..++.||+.||.|||++   +++||||||+|||++.++.+|++|||+++.
T Consensus        95 ~~~~iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             CEEEEEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             ceeEEEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence            6889999999775554 443  4589999999999999999999999   999999999999999999999999999887


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .....   ......+|+.|+|||++.+       ..+++++||||+||++|||++|+.||.....  ......+......
T Consensus       169 ~~~~~---~~~~~~~t~~y~aPE~l~~-------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~  236 (355)
T d2b1pa1         169 AGTSF---MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGT  236 (355)
T ss_dssp             ---------------CCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCC
T ss_pred             ccccc---ccccccccccccChhhhcC-------CCCCCCcccccccchHHHHhhCCCCCCCCCH--HHHHHHHHHhccC
Confidence            65543   3355679999999998753       3678999999999999999999999864421  1111111111111


Q ss_pred             C-------------------Ccc-----ccccCcc-cCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          296 F-------------------EPA-----VSILDTK-LQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       296 ~-------------------~~~-----~~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      .                   ...     ....... ..............+.+|+.+||..||++|||++|+++|=
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp  312 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  312 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence            0                   000     0011111 1111122223345677899999999999999999999884

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-47  Score=340.94  Aligned_cols=258  Identities=20%  Similarity=0.286  Sum_probs=191.4

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceee-eceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKL-LGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~  142 (371)
                      ++|+..+.||+|+||.||+|.+ .+|+.||||++......    .++..|+++++.++|+|++.. ..++.+.+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            4688899999999999999976 46899999988543322    347889999999987766555 55567788889999


Q ss_pred             eecCCCCHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC---CCceEEccccCccccCC
Q 037946          143 NYISNGNLQQLL-QGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS---KYEAYLADFGLAKLMNS  218 (371)
Q Consensus       143 e~~~~~~L~~~l-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~  218 (371)
                      ||+.+ +|.+.+ .....+++..+..++.|++.||+|||++   +++||||||+|||++.   +..+||+|||+++....
T Consensus        83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99955 555554 5566799999999999999999999999   9999999999999854   55799999999987754


Q ss_pred             CCcc-----cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhH-H-HHHHH
Q 037946          219 TNYH-----HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHI-V-EWVKK  291 (371)
Q Consensus       219 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-~-~~~~~  291 (371)
                      ....     .......||+.|+|||.+.       +..++.++|||||||++|||++|..||.......... . .....
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHT-------TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHh-------CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            4321     1224567999999999765       3467899999999999999999999997654432111 1 11111


Q ss_pred             HhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          292 KMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ....  +    .......+++       .+.+++.+||+.||++||+++++.+.|+.+.
T Consensus       232 ~~~~--~----~~~~~~~~p~-------~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         232 KMST--P----IEVLCKGYPS-------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHS--C----HHHHTTTSCH-------HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             cCCC--C----hhHhccCCCH-------HHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            0000  0    0011122333       2345677799999999999999988887763

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.5e-47  Score=343.90  Aligned_cols=260  Identities=21%  Similarity=0.248  Sum_probs=194.6

Q ss_pred             hccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEec--CCeEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSN--KSVKLL  140 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~l  140 (371)
                      ++|+..+.||+|+||+||+|+. .+|+.||+|++..     ...+++.+|+++|+.++ ||||+++++++..  ....++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            5799999999999999999976 5689999999843     23467889999999995 9999999999874  456899


Q ss_pred             EEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCC-ceEEccccCccccCCC
Q 037946          141 LYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKY-EAYLADFGLAKLMNST  219 (371)
Q Consensus       141 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  219 (371)
                      |||||.+++|.++.   +.+++..+..++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999987764   4599999999999999999999999   999999999999998655 6999999999876554


Q ss_pred             CcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhc-----
Q 037946          220 NYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMG-----  294 (371)
Q Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----  294 (371)
                      .   ......+|+.|+|||.+.+      ...++.++||||+||++|||++|+.||........... .+....+     
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~-~i~~~~g~~~~~  253 (328)
T d3bqca1         184 Q---EYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-RIAKVLGTEDLY  253 (328)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH-HHHHHHCHHHHH
T ss_pred             C---cccccccCccccCcccccC------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH-HHHHHHCCchhh
Confidence            3   3355679999999997653      23468899999999999999999999975443221111 1111110     


Q ss_pred             --------CCCcc-ccccCcccCCC-----C-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 037946          295 --------SFEPA-VSILDTKLQGL-----P-DQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVAL  345 (371)
Q Consensus       295 --------~~~~~-~~~~~~~~~~~-----~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  345 (371)
                              ..... ...........     . .........+.+|+.+||..||++|||++|+++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    00000 00000000000     0 0000111235668899999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=350.47  Aligned_cols=268  Identities=21%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             HHHhccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCceeeeceEecC-----
Q 037946           62 NILECLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNIVKLLGYCSNK-----  135 (371)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  135 (371)
                      ++.++|+..+.||+|+||+||+|.+ .+|+.||||++.....+....+.+.+|+++|++++|||++++++++...     
T Consensus        15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            3456799999999999999999975 5799999999976655556667899999999999999999999998533     


Q ss_pred             CeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          136 SVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ...+++|+++.+|+|.+++... .+++..+..++.||+.||+|||++   +++||||||+|||++.++.+|++|||++..
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             CceEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence            3446677788899999999654 599999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHHhcC
Q 037946          216 MNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGLHIVEWVKKKMGS  295 (371)
Q Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ....     .....||+.|+|||.+.+      ...++.++|||||||++|+|++|..||....  .......+......
T Consensus       171 ~~~~-----~~~~~g~~~y~apE~~~~------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~~~~  237 (348)
T d2gfsa1         171 TDDE-----MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGT  237 (348)
T ss_dssp             CTGG-----GSSSCHHHHTSCHHHHTT------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCC
T ss_pred             cCcc-----cccccccccccCchhhcC------CccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCC
Confidence            5432     345679999999997542      2346789999999999999999999996542  22222333332222


Q ss_pred             CCcccc-c--------cCcccCCCChhhH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 037946          296 FEPAVS-I--------LDTKLQGLPDQMV-----QEMLQTLGIAMFCVNSSPAERPTMKEVVALL  346 (371)
Q Consensus       296 ~~~~~~-~--------~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  346 (371)
                      ...... .        ........+....     .....+.+|+.+||+.||.+|||++|+++|=
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp  302 (348)
T d2gfsa1         238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  302 (348)
T ss_dssp             CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence            111000 0        0000000000000     0112345688899999999999999999973

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-46  Score=334.69  Aligned_cols=259  Identities=18%  Similarity=0.248  Sum_probs=199.5

Q ss_pred             hccccCCccccCCceEEEEEEeC-CCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC-CCceeeeceEecCCeEEEEE
Q 037946           65 ECLKDENVIGKGCSGVVYKAEMP-NGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH-RNIVKLLGYCSNKSVKLLLY  142 (371)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  142 (371)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++......    ..+.+|++.++.++| +|++.+++++.+....++||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            46888999999999999999764 6899999988543222    346788899999865 89999999999999999999


Q ss_pred             eecCCCCHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcC-----CCceEEccccCcccc
Q 037946          143 NYISNGNLQQLLQGN-RNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDS-----KYEAYLADFGLAKLM  216 (371)
Q Consensus       143 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~~~~  216 (371)
                      ||+ +++|.+++... ..++...+..++.|++.||+|||++   +++||||||+|||++.     ++.+||+|||+++..
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999 67999988664 4699999999999999999999999   9999999999999964     578999999999876


Q ss_pred             CCCCcc-----cccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCch-hHHHHHH
Q 037946          217 NSTNYH-----HAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGDGL-HIVEWVK  290 (371)
Q Consensus       217 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~  290 (371)
                      ......     .......||+.|||||++.       +..++.++|||||||++|||++|..||........ .....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~  229 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  229 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhc-------CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence            543211     1234567999999999875       33688999999999999999999999975544322 2122221


Q ss_pred             HHhcCCCccccccCcccCCCChhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhccc
Q 037946          291 KKMGSFEPAVSILDTKLQGLPDQMVQEMLQTLGIAMFCVNSSPAERPTMKEVVALLMEVK  350 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  350 (371)
                      ..... .+.    ......+|++       +.+++..|++.+|++||+++.+.+.|.++.
T Consensus       230 ~~~~~-~~~----~~l~~~~p~~-------l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         230 EKKQS-TPL----RELCAGFPEE-------FYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHH-SCH----HHHTTTSCHH-------HHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hccCC-CCh----HHhcCCCCHH-------HHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11111 111    1111233332       344666699999999999999999888764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.4e-41  Score=308.04  Aligned_cols=262  Identities=18%  Similarity=0.198  Sum_probs=184.1

Q ss_pred             ccccCCccccCCceEEEEEEe-CCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-----------CCCceeeeceEe
Q 037946           66 CLKDENVIGKGCSGVVYKAEM-PNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-----------HRNIVKLLGYCS  133 (371)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  133 (371)
                      +|+..+.||+|+||+||+|+. .+|+.||||++.+   .....+.+.+|+.+++.++           |+||+++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~---~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec---cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            588899999999999999976 5799999999853   2233467788999888775           578999998875


Q ss_pred             c--CCeEEEEEeecCCCCHHHH---hccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeEcCCCc---
Q 037946          134 N--KSVKLLLYNYISNGNLQQL---LQGNRNLDWETRYKIAVGSAQGLAYLHH-DCVPAILHRDVKCNNILLDSKYE---  204 (371)
Q Consensus       134 ~--~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nill~~~~~---  204 (371)
                      .  ....+++|+++..+.....   ......+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.   
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence            4  3556677777655433222   2345568999999999999999999998 6   9999999999999987654   


Q ss_pred             ---eEEccccCccccCCCCcccccccccccccccCCCCccchhhhcccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 037946          205 ---AYLADFGLAKLMNSTNYHHAMSRVAGSYGYIAPGKCKLQIIYGYTMNITEKSDVYSYGVVLLEILSGRSAVQPQIGD  281 (371)
Q Consensus       205 ---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  281 (371)
                         ++++|||.+......     .....||+.|+|||++.       ...++.++||||+||++++|++|+.||.+....
T Consensus       168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~  235 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEGH  235 (362)
T ss_dssp             EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHH-------TCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             cceeeEeecccccccccc-----cccccccccccChhhcc-------ccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence               999999999765433     24567999999999765       336789999999999999999999999755332


Q ss_pred             c----hhHHHHHHHHhcCCCc------------------cccccCcccCC-------CChhhHHHHHHHHHHHhcccCCC
Q 037946          282 G----LHIVEWVKKKMGSFEP------------------AVSILDTKLQG-------LPDQMVQEMLQTLGIAMFCVNSS  332 (371)
Q Consensus       282 ~----~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~cl~~d  332 (371)
                      .    ...........+....                  ...........       ...........+.+|+.+||..|
T Consensus       236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d  315 (362)
T d1q8ya_         236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  315 (362)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence            1    1111111111111000                  00000000000       00001123445677999999999


Q ss_pred             CCCCCCHHHHHHH
Q 037946          333 PAERPTMKEVVAL  345 (371)
Q Consensus       333 P~~RPs~~evl~~  345 (371)
                      |.+|||++|+++|
T Consensus       316 P~~Rpta~e~L~H  328 (362)
T d1q8ya_         316 PRKRADAGGLVNH  328 (362)
T ss_dssp             TTTCBCHHHHHTC
T ss_pred             hhHCcCHHHHhcC
Confidence            9999999999997

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=2e-26  Score=191.86  Aligned_cols=136  Identities=16%  Similarity=0.178  Sum_probs=106.0

Q ss_pred             cCCccccCCceEEEEEEeCCCCEEEEEEecccCCC------------c----chHHHHHHHHHHHhccCCCCceeeeceE
Q 037946           69 DENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRD------------E----EPVDSFAAEIQILGHIRHRNIVKLLGYC  132 (371)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------~----~~~~~~~~e~~~l~~l~h~niv~~~~~~  132 (371)
                      +++.||+|+||.||+|.+.+|+.||||+++....+            .    ........|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            46789999999999998888999999987532111            0    0123345688899999999998887653


Q ss_pred             ecCCeEEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeEcCCCceEEccccC
Q 037946          133 SNKSVKLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAYLADFGL  212 (371)
Q Consensus       133 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  212 (371)
                      .    .+++|||++++.+.+       ++......++.|++.+++|||++   +++||||||+|||+++++ ++|+|||.
T Consensus        84 ~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~liDFG~  148 (191)
T d1zara2          84 G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWIIDFPQ  148 (191)
T ss_dssp             T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred             C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEEECCC
Confidence            2    379999998865433       44455678899999999999999   999999999999999654 89999999


Q ss_pred             ccccCCC
Q 037946          213 AKLMNST  219 (371)
Q Consensus       213 ~~~~~~~  219 (371)
                      +......
T Consensus       149 a~~~~~~  155 (191)
T d1zara2         149 SVEVGEE  155 (191)
T ss_dssp             CEETTST
T ss_pred             cccCCCC
Confidence            9765433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.76  E-value=5.4e-08  Score=82.95  Aligned_cols=148  Identities=14%  Similarity=0.083  Sum_probs=100.0

Q ss_pred             cHHHHHhccccCCccccCCceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccC-CCCceeeeceEecCCe
Q 037946           59 TIDNILECLKDENVIGKGCSGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIR-HRNIVKLLGYCSNKSV  137 (371)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  137 (371)
                      ....+.+.|+..+..+.++.+.||+... +++.+++|+......  .....+.+|...+..+. +--+.+++.++.+.+.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            3455566676665555555678999875 566788888743222  22234677888877763 3335667777888889


Q ss_pred             EEEEEeecCCCCHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 037946          138 KLLLYNYISNGNLQQLLQGNRNLDWETRYKIAVGSAQGLAYLHHDC----------------------------------  183 (371)
Q Consensus       138 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~----------------------------------  183 (371)
                      .++||++++|.++.+......  .   ...++.+++..++.||+..                                  
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             eEEEEEecccccccccccccc--c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            999999999988866543221  1   2334555666666666421                                  


Q ss_pred             ----------------------CCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          184 ----------------------VPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       184 ----------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                                            ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  1148999999999999987767799998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.34  E-value=8.6e-07  Score=74.83  Aligned_cols=129  Identities=16%  Similarity=0.165  Sum_probs=83.5

Q ss_pred             cccCC-ceEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCC--CCceeeeceEecCCeEEEEEeecCCCC
Q 037946           73 IGKGC-SGVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRH--RNIVKLLGYCSNKSVKLLLYNYISNGN  149 (371)
Q Consensus        73 ig~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~  149 (371)
                      +..|. .+.||+....++..+++|......     ...+..|...++.+..  -.+.+++.++.+.+..++||++++|.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            34444 368999988778888889763221     2235677887777643  235667888888889999999998866


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 037946          150 LQQLLQGNRNLDWETRYKIAVGSAQGLAYLHH------------------------------------------------  181 (371)
Q Consensus       150 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~------------------------------------------------  181 (371)
                      +.+..     .+..   ..+.+++..|+-||+                                                
T Consensus        93 ~~~~~-----~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          93 LLSSH-----LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTTSC-----CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccccc-----ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            53211     1111   112233333333332                                                


Q ss_pred             ---C----CCCCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          182 ---D----CVPAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       182 ---~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                         .    ....++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence               1    11248999999999999987767899998874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.13  E-value=4.9e-06  Score=74.87  Aligned_cols=77  Identities=13%  Similarity=0.099  Sum_probs=48.2

Q ss_pred             CccccCCceEEEEEEeCC-CCEEEEEEecccC----C-CcchHHHHHHHHHHHhccC-C-C-CceeeeceEecCCeEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPN-GELIAVKKLWKTK----R-DEEPVDSFAAEIQILGHIR-H-R-NIVKLLGYCSNKSVKLLL  141 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~-~~~~~~~~~~e~~~l~~l~-h-~-niv~~~~~~~~~~~~~lv  141 (371)
                      +.||.|....||+....+ ++.+++|.-....    . .+....+...|.+.++.+. + | .+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999997654 6789999653211    1 1123345667888887763 2 2 34455544  44556789


Q ss_pred             EeecCCCC
Q 037946          142 YNYISNGN  149 (371)
Q Consensus       142 ~e~~~~~~  149 (371)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.53  E-value=0.00027  Score=61.34  Aligned_cols=132  Identities=15%  Similarity=0.171  Sum_probs=76.1

Q ss_pred             eEEEEEEeCCCCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-----eeee--ceEecCCeEEEEEeecCCCCH-
Q 037946           79 GVVYKAEMPNGELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-----VKLL--GYCSNKSVKLLLYNYISNGNL-  150 (371)
Q Consensus        79 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~--~~~~~~~~~~lv~e~~~~~~L-  150 (371)
                      -.||+++..+|+.+++|......   ...+.+..|...+..|...++     +..-  ......+..+.++++++|..+ 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            47999998899999999874332   234567788888887743222     1111  123445667889999876432 


Q ss_pred             ----HHH------h-------ccC-----CCCCH-------------------H---HHHHHHHHHHHHHHHH-HhCCCC
Q 037946          151 ----QQL------L-------QGN-----RNLDW-------------------E---TRYKIAVGSAQGLAYL-HHDCVP  185 (371)
Q Consensus       151 ----~~~------l-------~~~-----~~~~~-------------------~---~~~~i~~~i~~~l~~l-h~~~~~  185 (371)
                          ..+      +       ...     ...+.                   .   .....+..+...+.-. .+....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                111      1       000     01111                   1   1122223333332222 122234


Q ss_pred             CeEecCCCCCCeeEcCCCceEEccccCccc
Q 037946          186 AILHRDVKCNNILLDSKYEAYLADFGLAKL  215 (371)
Q Consensus       186 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  215 (371)
                      ++||+|+.+.|||++++  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            79999999999999743  45899998863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.19  E-value=0.0011  Score=59.02  Aligned_cols=72  Identities=22%  Similarity=0.330  Sum_probs=47.6

Q ss_pred             CccccCCceEEEEEEeCC--------CCEEEEEEecccCCCcchHHHHHHHHHHHhccCCCCc-eeeeceEecCCeEEEE
Q 037946           71 NVIGKGCSGVVYKAEMPN--------GELIAVKKLWKTKRDEEPVDSFAAEIQILGHIRHRNI-VKLLGYCSNKSVKLLL  141 (371)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  141 (371)
                      +.|+.|-.-.+|++...+        ++.|.+++..   .. .......+|..+++.+.-.++ .++++++.+    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g---~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF---NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC---SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC---Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            467888888999997643        3456666652   12 223455689999998853344 467777653    578


Q ss_pred             EeecCCCCH
Q 037946          142 YNYISNGNL  150 (371)
Q Consensus       142 ~e~~~~~~L  150 (371)
                      |||++|.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.48  E-value=0.039  Score=46.70  Aligned_cols=30  Identities=23%  Similarity=0.301  Sum_probs=27.1

Q ss_pred             CCeEecCCCCCCeeEcCCCceEEccccCcc
Q 037946          185 PAILHRDVKCNNILLDSKYEAYLADFGLAK  214 (371)
Q Consensus       185 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  214 (371)
                      .++||+|+.++|++++.+...-+.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            489999999999999988777899999885